ID   A0A024R487_HUMAN        Unreviewed;       720 AA.
AC   A0A024R487;
DT   11-DEC-2019, integrated into UniProtKB/TrEMBL.
DT   11-DEC-2019, sequence version 1.
DT   22-APR-2020, entry version 3.
DE   SubName: Full=Acyl-CoA synthetase long-chain family member 3, isoform CRA_a {ECO:0000313|EMBL:EAW70808.1};
GN   Name=ACSL3 {ECO:0000313|EMBL:EAW70808.1};
GN   ORFNames=hCG_21017 {ECO:0000313|EMBL:EAW70808.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW70808.1};
RN   [1] {ECO:0000313|EMBL:EAW70808.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW70808.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH471063; EAW70807.1; -; Genomic_DNA.
DR   EMBL; CH471063; EAW70808.1; -; Genomic_DNA.
DR   EMBL; CH471063; EAW70809.1; -; Genomic_DNA.
DR   RefSeq; NP_004448.2; NM_004457.3.
DR   RefSeq; NP_976251.1; NM_203372.1.
DR   RefSeq; XP_016859073.1; XM_017003584.1.
DR   GeneID; 2181; -.
DR   KEGG; hsa:2181; -.
DR   CTD; 2181; -.
DR   eggNOG; KOG1256; Eukaryota.
DR   eggNOG; COG1022; LUCA.
DR   KO; K01897; -.
DR   OMA; GEGEKMP; -.
DR   ChiTaRS; ACSL3; human.
DR   GenomeRNAi; 2181; -.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   Gene3D; 3.40.50.12780; -; 2.
DR   InterPro; IPR020845; AMP-binding_CS.
DR   InterPro; IPR000873; AMP-dep_Synth/Lig.
DR   InterPro; IPR042099; AMP-dep_Synthh-like_sf.
DR   Pfam; PF00501; AMP-binding; 1.
DR   PROSITE; PS00455; AMP_BINDING; 1.
PE   4: Predicted;
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM        21..44
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          129..587
FT                   /note="AMP-binding"
FT                   /evidence="ECO:0000259|Pfam:PF00501"
SQ   SEQUENCE   720 AA;  80420 MW;  AAC4B0B4543EC8DD CRC64;
     MNNHVSSKPS TMKLKHTINP ILLYFIHFLI SLYTILTYIP FYFFSESRQE KSNRIKAKPV
     NSKPDSAYRS VNSLDGLASV LYPGCDTLDK VFTYAKNKFK NKRLLGTREV LNEEDEVQPN
     GKIFKKVILG QYNWLSYEDV FVRAFNFGNG LQMLGQKPKT NIAIFCETRA EWMIAAQACF
     MYNFQLVTLY ATLGGPAIVH ALNETEVTNI ITSKELLQTK LKDIVSLVPR LRHIITVDGK
     PPTWSEFPKG IIVHTMAAVE ALGAKASMEN QPHSKPLPSD IAVIMYTSGS TGLPKGVMIS
     HSNIIAGITG MAERIPELGE EDVYIGYLPL AHVLELSAEL VCLSHGCRIG YSSPQTLADQ
     SSKIKKGSKG DTSMLKPTLM AAVPEIMDRI YKNVMNKVSE MSSFQRNLFI LAYNYKMEQI
     SKGRNTPLCD SFVFRKVRSL LGGNIRLLLC GGAPLSATTQ RFMNICFCCP VGQGYGLTES
     AGAGTISEVW DYNTGRVGAP LVCCEIKLKN WEEGGYFNTD KPHPRGEILI GGQSVTMGYY
     KNEAKTKADF FEDENGQRWL CTGDIGEFEP DGCLKIIDRK KDLVKLQAGE YVSLGKVEAA
     LKNLPLVDNI CAYANSYHSY VIGFVVPNQK ELTELARKKG LKGTWEELCN SCEMENEVLK
     VLSEAAISAS LEKFEIPVKI RLSPEPWTPE TGLVTDAFKL KRKELKTHYQ ADIERMYGRK
//
ID   ACSL3_HUMAN             Reviewed;         720 AA.
AC   O95573; Q60I92; Q8IUM9;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   03-OCT-2006, sequence version 3.
DT   22-APR-2020, entry version 182.
DE   RecName: Full=Long-chain-fatty-acid--CoA ligase 3 {ECO:0000305};
DE            EC=6.2.1.3 {ECO:0000269|PubMed:22633490};
DE   AltName: Full=Arachidonate--CoA ligase {ECO:0000250|UniProtKB:Q63151};
DE            EC=6.2.1.15 {ECO:0000250|UniProtKB:Q63151};
DE   AltName: Full=Long-chain acyl-CoA synthetase 3;
DE            Short=LACS 3;
GN   Name=ACSL3 {ECO:0000312|HGNC:HGNC:3570}; Synonyms=ACS3, FACL3, LACS3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT SER-551.
RC   TISSUE=Placenta;
RX   PubMed=9177793; DOI=10.1006/geno.1997.4710;
RA   Minekura H., Fujino T., Kang M.-J., Fujita T., Endo Y., Yamamoto T.T.;
RT   "Human acyl-coenzyme A synthetase 3 cDNA and localization of its gene
RT   (ACS3) to chromosome band 2q34-q35.";
RL   Genomics 42:180-181(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], AND VARIANT SER-551.
RX   PubMed=11707336; DOI=10.1016/s0378-1119(01)00714-4;
RA   Minekura H., Kang M.-J., Inagaki Y., Suzuki H., Sato H., Fujino T.,
RA   Yamamoto T.T.;
RT   "Genomic organization and transcription units of the human acyl-CoA
RT   synthetase 3 gene.";
RL   Gene 278:185-192(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION.
RX   PubMed=18003621; DOI=10.1074/jbc.m706160200;
RA   Yao H., Ye J.;
RT   "Long chain acyl-CoA synthetase 3-mediated phosphatidylcholine synthesis is
RT   required for assembly of very low density lipoproteins in human hepatoma
RT   Huh7 cells.";
RL   J. Biol. Chem. 283:849-854(2008).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-683, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   CATALYTIC ACTIVITY, AND FUNCTION.
RX   PubMed=22633490; DOI=10.1016/j.molcel.2012.04.033;
RA   Nakahara K., Ohkuni A., Kitamura T., Abe K., Naganuma T., Ohno Y.,
RA   Zoeller R.A., Kihara A.;
RT   "The Sjogren-Larsson syndrome gene encodes a hexadecenal dehydrogenase of
RT   the sphingosine 1-phosphate degradation pathway.";
RL   Mol. Cell 46:461-471(2012).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-683, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Acyl-CoA synthetases (ACSL) activates long-chain fatty acids
CC       for both synthesis of cellular lipids, and degradation via beta-
CC       oxidation (PubMed:22633490). Required for the incorporation of fatty
CC       acids into phosphatidylcholine, the major phospholipid located on the
CC       surface of VLDL (very low density lipoproteins) (PubMed:18003621). Has
CC       mainly an anabolic role in energy metabolism. Mediates hepatic
CC       lipogenesis. Preferentially uses myristate, laurate, arachidonate and
CC       eicosapentaenoate as substrates. Both isoforms exhibit the same level
CC       of activity (By similarity). {ECO:0000250|UniProtKB:Q63151,
CC       ECO:0000269|PubMed:18003621, ECO:0000269|PubMed:22633490}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a long-chain fatty acid + ATP + CoA = a long-chain fatty acyl-
CC         CoA + AMP + diphosphate; Xref=Rhea:RHEA:15421, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, ChEBI:CHEBI:57560,
CC         ChEBI:CHEBI:83139, ChEBI:CHEBI:456215; EC=6.2.1.3;
CC         Evidence={ECO:0000269|PubMed:22633490};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:15423;
CC         Evidence={ECO:0000250|UniProtKB:Q63151};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoate + ATP + CoA =
CC         (5Z,8Z,11Z,14Z)-eicosatetraenoyl-CoA + AMP + diphosphate;
CC         Xref=Rhea:RHEA:19713, ChEBI:CHEBI:30616, ChEBI:CHEBI:32395,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, ChEBI:CHEBI:57368,
CC         ChEBI:CHEBI:456215; EC=6.2.1.15;
CC         Evidence={ECO:0000250|UniProtKB:Q63151};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19714;
CC         Evidence={ECO:0000250|UniProtKB:Q63151};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(E)-hexadec-2-enoate + ATP + CoA = (2E)-hexadecenoyl-CoA + AMP
CC         + diphosphate; Xref=Rhea:RHEA:36139, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, ChEBI:CHEBI:61526,
CC         ChEBI:CHEBI:72745, ChEBI:CHEBI:456215;
CC         Evidence={ECO:0000269|PubMed:22633490};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=15-hydroxy-(5Z,8Z,11Z,13E)-eicosatetraenoate + ATP + CoA = 15-
CC         hydroxy-(5Z,8Z,11Z,13E)-eicosatetraenoyl-CoA + AMP + diphosphate;
CC         Xref=Rhea:RHEA:52116, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:78832, ChEBI:CHEBI:136409,
CC         ChEBI:CHEBI:456215; Evidence={ECO:0000250|UniProtKB:Q63151};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52117;
CC         Evidence={ECO:0000250|UniProtKB:Q63151};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=12-hydroxy-(5Z,8Z,10E,14Z)-eicosatetraenoate + ATP + CoA = 12-
CC         hydroxy-(5Z,8Z,10E,14Z)-eicosatetraenoyl-CoA + AMP + diphosphate;
CC         Xref=Rhea:RHEA:52112, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:90718, ChEBI:CHEBI:136408,
CC         ChEBI:CHEBI:456215; Evidence={ECO:0000250|UniProtKB:Q63151};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52113;
CC         Evidence={ECO:0000250|UniProtKB:Q63151};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=5-hydroxy-(6E,8Z,11Z,14Z)-eicosatetraenoate + ATP + CoA = 5-
CC         hydroxy-(6E,8Z,11Z,14Z)-eicosatetraenoyl-CoA + AMP + diphosphate;
CC         Xref=Rhea:RHEA:52108, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:65341, ChEBI:CHEBI:136407,
CC         ChEBI:CHEBI:456215; Evidence={ECO:0000250|UniProtKB:Q63151};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52109;
CC         Evidence={ECO:0000250|UniProtKB:Q63151};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=14,15-epoxy-(5Z,8Z,11Z)-eicosatrienoate + ATP + CoA = 14,15-
CC         epoxy-(5Z,8Z,11Z)-eicosatrienoyl-CoA + AMP + diphosphate;
CC         Xref=Rhea:RHEA:52016, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:84024, ChEBI:CHEBI:136117,
CC         ChEBI:CHEBI:456215; Evidence={ECO:0000250|UniProtKB:Q63151};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52017;
CC         Evidence={ECO:0000250|UniProtKB:Q63151};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=11,12-epoxy-(5Z,8Z,14Z)-eicosatrienoate + ATP + CoA = 11,12-
CC         epoxy-(5Z,8Z,14Z)-eicosatrienoyl-CoA + AMP + diphosphate;
CC         Xref=Rhea:RHEA:52012, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:76625, ChEBI:CHEBI:136115,
CC         ChEBI:CHEBI:456215; Evidence={ECO:0000250|UniProtKB:Q63151};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52013;
CC         Evidence={ECO:0000250|UniProtKB:Q63151};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC   -!- SUBCELLULAR LOCATION: Mitochondrion outer membrane {ECO:0000250};
CC       Single-pass type III membrane protein {ECO:0000250}. Peroxisome
CC       membrane {ECO:0000250}; Single-pass type III membrane protein
CC       {ECO:0000250}. Microsome membrane {ECO:0000250}; Single-pass type III
CC       membrane protein {ECO:0000250}. Endoplasmic reticulum membrane
CC       {ECO:0000250}; Single-pass type III membrane protein {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the ATP-dependent AMP-binding enzyme family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D89053; BAA37142.1; -; mRNA.
DR   EMBL; AB061712; BAB72074.1; -; mRNA.
DR   EMBL; AB061436; BAB72139.1; -; Genomic_DNA.
DR   EMBL; BC041692; AAH41692.1; -; mRNA.
DR   CCDS; CCDS2455.1; -.
DR   RefSeq; NP_004448.2; NM_004457.3.
DR   RefSeq; NP_976251.1; NM_203372.1.
DR   RefSeq; XP_016859073.1; XM_017003584.1.
DR   SMR; O95573; -.
DR   BioGrid; 108477; 68.
DR   IntAct; O95573; 51.
DR   MINT; O95573; -.
DR   STRING; 9606.ENSP00000350012; -.
DR   DrugBank; DB00159; Icosapent.
DR   SwissLipids; SLP:000000200; -.
DR   iPTMnet; O95573; -.
DR   MetOSite; O95573; -.
DR   PhosphoSitePlus; O95573; -.
DR   SwissPalm; O95573; -.
DR   BioMuta; ACSL3; -.
DR   EPD; O95573; -.
DR   jPOST; O95573; -.
DR   MassIVE; O95573; -.
DR   MaxQB; O95573; -.
DR   PaxDb; O95573; -.
DR   PeptideAtlas; O95573; -.
DR   PRIDE; O95573; -.
DR   ProteomicsDB; 50946; -.
DR   Antibodypedia; 1945; 193 antibodies.
DR   Ensembl; ENST00000357430; ENSP00000350012; ENSG00000123983.
DR   Ensembl; ENST00000392066; ENSP00000375918; ENSG00000123983.
DR   GeneID; 2181; -.
DR   KEGG; hsa:2181; -.
DR   UCSC; uc002vni.4; human.
DR   CTD; 2181; -.
DR   DisGeNET; 2181; -.
DR   GeneCards; ACSL3; -.
DR   HGNC; HGNC:3570; ACSL3.
DR   HPA; ENSG00000123983; Tissue enriched (parathyroid).
DR   MIM; 602371; gene.
DR   neXtProt; NX_O95573; -.
DR   OpenTargets; ENSG00000123983; -.
DR   PharmGKB; PA27967; -.
DR   eggNOG; KOG1256; Eukaryota.
DR   eggNOG; COG1022; LUCA.
DR   GeneTree; ENSGT00940000155954; -.
DR   HOGENOM; CLU_000022_45_2_1; -.
DR   InParanoid; O95573; -.
DR   KO; K01897; -.
DR   OMA; GEGEKMP; -.
DR   PhylomeDB; O95573; -.
DR   TreeFam; TF314012; -.
DR   BioCyc; MetaCyc:HS04703-MONOMER; -.
DR   BRENDA; 6.2.1.3; 2681.
DR   Reactome; R-HSA-434313; Intracellular metabolism of fatty acids regulates insulin secretion.
DR   Reactome; R-HSA-75876; Synthesis of very long-chain fatty acyl-CoAs.
DR   ChiTaRS; ACSL3; human.
DR   GeneWiki; ACSL3; -.
DR   GenomeRNAi; 2181; -.
DR   Pharos; O95573; Tbio.
DR   PRO; PR:O95573; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; O95573; protein.
DR   Bgee; ENSG00000123983; Expressed in endothelial cell and 232 other tissues.
DR   ExpressionAtlas; O95573; baseline and differential.
DR   Genevisible; O95573; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005811; C:lipid droplet; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005741; C:mitochondrial outer membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005778; C:peroxisomal membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0003996; F:acyl-CoA ligase activity; IEA:UniProtKB-EC.
DR   GO; GO:0047676; F:arachidonate-CoA ligase activity; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0102391; F:decanoate-CoA ligase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004467; F:long-chain fatty acid-CoA ligase activity; IMP:UniProtKB.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0007420; P:brain development; IEA:Ensembl.
DR   GO; GO:0006633; P:fatty acid biosynthetic process; IEA:Ensembl.
DR   GO; GO:0044539; P:long-chain fatty acid import into cell; IDA:UniProtKB.
DR   GO; GO:0001676; P:long-chain fatty acid metabolic process; IMP:UniProtKB.
DR   GO; GO:0035338; P:long-chain fatty-acyl-CoA biosynthetic process; TAS:Reactome.
DR   GO; GO:0042998; P:positive regulation of Golgi to plasma membrane protein transport; IMP:UniProtKB.
DR   GO; GO:2001247; P:positive regulation of phosphatidylcholine biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0051047; P:positive regulation of secretion; IMP:UniProtKB.
DR   GO; GO:0007584; P:response to nutrient; IEA:Ensembl.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEA:Ensembl.
DR   GO; GO:0034379; P:very-low-density lipoprotein particle assembly; IMP:UniProtKB.
DR   Gene3D; 3.40.50.12780; -; 2.
DR   InterPro; IPR020845; AMP-binding_CS.
DR   InterPro; IPR000873; AMP-dep_Synth/Lig.
DR   InterPro; IPR042099; AMP-dep_Synthh-like_sf.
DR   Pfam; PF00501; AMP-binding; 1.
DR   PROSITE; PS00455; AMP_BINDING; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Endoplasmic reticulum; Fatty acid metabolism; Ligase;
KW   Lipid metabolism; Magnesium; Membrane; Microsome; Mitochondrion;
KW   Mitochondrion outer membrane; Nucleotide-binding; Peroxisome;
KW   Phosphoprotein; Polymorphism; Reference proteome; Signal-anchor;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..720
FT                   /note="Long-chain-fatty-acid--CoA ligase 3"
FT                   /id="PRO_0000193107"
FT   TRANSMEM        21..41
FT                   /note="Helical; Signal-anchor for type III membrane
FT                   protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        42..720
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         683
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18691976,
FT                   ECO:0000244|PubMed:23186163"
FT   VARIANT         551
FT                   /note="F -> S (in dbSNP:rs1046032)"
FT                   /evidence="ECO:0000269|PubMed:11707336,
FT                   ECO:0000269|PubMed:9177793"
FT                   /id="VAR_026716"
FT   CONFLICT        246
FT                   /note="E -> D (in Ref. 1; BAA37142 and 2; BAB72074/
FT                   BAB72139)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   720 AA;  80420 MW;  AAC4B0B4543EC8DD CRC64;
     MNNHVSSKPS TMKLKHTINP ILLYFIHFLI SLYTILTYIP FYFFSESRQE KSNRIKAKPV
     NSKPDSAYRS VNSLDGLASV LYPGCDTLDK VFTYAKNKFK NKRLLGTREV LNEEDEVQPN
     GKIFKKVILG QYNWLSYEDV FVRAFNFGNG LQMLGQKPKT NIAIFCETRA EWMIAAQACF
     MYNFQLVTLY ATLGGPAIVH ALNETEVTNI ITSKELLQTK LKDIVSLVPR LRHIITVDGK
     PPTWSEFPKG IIVHTMAAVE ALGAKASMEN QPHSKPLPSD IAVIMYTSGS TGLPKGVMIS
     HSNIIAGITG MAERIPELGE EDVYIGYLPL AHVLELSAEL VCLSHGCRIG YSSPQTLADQ
     SSKIKKGSKG DTSMLKPTLM AAVPEIMDRI YKNVMNKVSE MSSFQRNLFI LAYNYKMEQI
     SKGRNTPLCD SFVFRKVRSL LGGNIRLLLC GGAPLSATTQ RFMNICFCCP VGQGYGLTES
     AGAGTISEVW DYNTGRVGAP LVCCEIKLKN WEEGGYFNTD KPHPRGEILI GGQSVTMGYY
     KNEAKTKADF FEDENGQRWL CTGDIGEFEP DGCLKIIDRK KDLVKLQAGE YVSLGKVEAA
     LKNLPLVDNI CAYANSYHSY VIGFVVPNQK ELTELARKKG LKGTWEELCN SCEMENEVLK
     VLSEAAISAS LEKFEIPVKI RLSPEPWTPE TGLVTDAFKL KRKELKTHYQ ADIERMYGRK
//
ID   B4DJU9_HUMAN            Unreviewed;       849 AA.
AC   B4DJU9;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   22-APR-2020, entry version 40.
DE   SubName: Full=cDNA FLJ55278, highly similar to AF4/FMR2 family member 1 {ECO:0000313|EMBL:BAG58961.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG58961.1};
RN   [1] {ECO:0000313|EMBL:BAG58961.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Thalamus {ECO:0000313|EMBL:BAG58961.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK296243; BAG58961.1; -; mRNA.
DR   RefSeq; NP_001300889.1; NM_001313960.1.
DR   PeptideAtlas; B4DJU9; -.
DR   PRIDE; B4DJU9; -.
DR   GeneID; 4299; -.
DR   CTD; 4299; -.
DR   eggNOG; ENOG410IGJB; Eukaryota.
DR   eggNOG; ENOG410XRXU; LUCA.
DR   GenomeRNAi; 4299; -.
DR   InterPro; IPR007797; TF_AF4/FMR2.
DR   PANTHER; PTHR10528; PTHR10528; 1.
DR   Pfam; PF05110; AF-4; 1.
PE   2: Evidence at transcript level;
FT   REGION          1..595
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          730..759
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..64
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        97..124
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        223..243
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        348..366
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        419..471
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        472..517
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        547..566
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        567..582
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   849 AA;  91610 MW;  9812BA3843CC0608 CRC64;
     MTHSWPPPLT AIHTPSTAEP SKFPFPTKDS QHVSSVTQNQ KQYDTSSKTH SNSQQGTSSM
     LEDDLQLSDS EDSDSEQTPE KPPSSSAPPS APQSLPEPVA SAHSSSAESE STSDSDSSSD
     SESESSSSDS EENEPLETPA PEPEPPTTNK WQLDNWLTKV SQPAAPPEGP RSTEPPRRHP
     ESKGSSDSAT SQEHSESKDP PPKSSSKAPR APPEAPHPGK RSCQKSPAQQ EPPQRQTVGT
     KQPKKPVKAS ARAGSRTSLQ GEREPGLLPY GSRDQTSKDK PKVKTKGRPR AAASNEPKPA
     VPPSSEKKKH KSSLPAPSKA LSGPEPAKDN VEDRTPEHFA LVPLTESQGP PHSGSGSRTS
     GCRQAVVVQE DSRKDRLPLP LRDTKLLSPL RDTPPPQSLM VKITLDLLSR IPQPPGKGSR
     QRKAEDKQPP AGKKHSSEKR SSDSSSKLAK KRKGEAERDC DNKKIRLEKE IKSQSSSSSS
     SHKESSKTKP SRPSSQSSKK EMLPPPPVSS SSQKPAKPAL KRSRREADTC GQDPPKSASS
     TKSNHKDSSI PKQRRVEGKG SRSSSEHKGS SGDTANPFPV PSLPNGNSKP GKPQVKFDKQ
     QADLHMREAK KMKQKAELMT DRVGKAFKYL EAVLSFIECG IATESESQSS KSAYSVYSET
     VDLIKFIMSL KSFSDATAPT QEKIFAVLCM RCQSILNMAM FRCKKDIAIK YSRTLNKHFE
     SSSKVAQAPS PCIARSTGTP SPLSPMPSPA SSVGSQSSAG SVGSSGVAAT ISTPVTIQNM
     TSSYVTTTSH VLTAFDLWEQ AEALTRKNKE FFARLSTNVC TLALNSSLVD LVHYTRQGFQ
     QLQELTKTP
//
ID   AFF1_HUMAN              Reviewed;        1210 AA.
AC   P51825; B4DTU1; E9PBM3;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   22-APR-2020, entry version 168.
DE   RecName: Full=AF4/FMR2 family member 1;
DE   AltName: Full=ALL1-fused gene from chromosome 4 protein;
DE            Short=Protein AF-4;
DE   AltName: Full=Protein FEL;
DE   AltName: Full=Proto-oncogene AF4;
GN   Name=AFF1; Synonyms=AF4, FEL, MLLT2, PBM1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8506309; DOI=10.1073/pnas.90.10.4631;
RA   Nakamura T., Alder H., Gu Y., Prasad R., Canaani O., Kamada N., Gale R.P.,
RA   Lange B., Crist W.M., Nowell P.C., Croce C.M., Canaani E.;
RT   "Genes on chromosomes 4, 9, and 19 involved in 11q23 abnormalities in acute
RT   leukemia share sequence homology and/or common motifs.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:4631-4635(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), AND CHROMOSOMAL TRANSLOCATION WITH
RP   KMT2A.
RX   PubMed=8443374;
RA   Morrissey J., Tkachuk D.C., Milatovich A., Francke U., Link M.,
RA   Cleary M.L.;
RT   "A serine/proline-rich protein is fused to HRX in t(4;11) acute
RT   leukemias.";
RL   Blood 81:1124-1131(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   CHROMOSOMAL TRANSLOCATION WITH KMT2A.
RX   PubMed=1423625; DOI=10.1016/0092-8674(92)90603-a;
RA   Gu Y., Nakamura T., Alder H., Prasad R., Canaani O., Cimino G., Croce C.M.,
RA   Canaani E.;
RT   "The t(4;11) chromosome translocation of human acute leukemias fuses the
RT   ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene.";
RL   Cell 71:701-708(1992).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-206; SER-212 AND THR-697, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-206; SER-212; THR-220;
RP   SER-750 AND THR-755, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-206; SER-212; SER-588 AND
RP   SER-750, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-206 AND SER-750, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-681, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-206, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   IDENTIFICATION IN THE SEC COMPLEX.
RX   PubMed=22195968; DOI=10.1016/j.molcel.2011.12.008;
RA   Smith E.R., Lin C., Garrett A.S., Thornton J., Mohaghegh N., Hu D.,
RA   Jackson J., Saraf A., Swanson S.K., Seidel C., Florens L., Washburn M.P.,
RA   Eissenberg J.C., Shilatifard A.;
RT   "The little elongation complex regulates small nuclear RNA transcription.";
RL   Mol. Cell 44:954-965(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-697, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   REVIEW ON THE SUPER ELONGATION COMPLEX.
RX   PubMed=22895430; DOI=10.1038/nrm3417;
RA   Luo Z., Lin C., Shilatifard A.;
RT   "The super elongation complex (SEC) family in transcriptional control.";
RL   Nat. Rev. Mol. Cell Biol. 13:543-547(2012).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-588 AND SER-750, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   STRUCTURE BY NMR OF 738-779 IN COMPLEX WITH MLLT3.
RX   PubMed=23260655; DOI=10.1016/j.str.2012.11.011;
RA   Leach B.I., Kuntimaddi A., Schmidt C.R., Cierpicki T., Johnson S.A.,
RA   Bushweller J.H.;
RT   "Leukemia fusion target AF9 is an intrinsically disordered transcriptional
RT   regulator that recruits multiple partners via coupled folding and
RT   binding.";
RL   Structure 21:176-183(2013).
RN   [17]
RP   VARIANT [LARGE SCALE ANALYSIS] LYS-1204.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- SUBUNIT: Component of the super elongation complex (SEC), at least
CC       composed of EAF1, EAF2, CDK9, MLLT3/AF9, AFF (AFF1 or AFF4), the P-TEFb
CC       complex and ELL (ELL, ELL2 or ELL3). {ECO:0000269|PubMed:22195968,
CC       ECO:0000269|PubMed:23260655}.
CC   -!- INTERACTION:
CC       P51825-3; P53367: ARFIP1; NbExp=3; IntAct=EBI-24213872, EBI-2808808;
CC       P51825; P42568: MLLT3; NbExp=7; IntAct=EBI-2610180, EBI-716132;
CC       P51825; P04608: tat; Xeno; NbExp=3; IntAct=EBI-2610180, EBI-6164389;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P51825-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P51825-2; Sequence=VSP_046095, VSP_046096;
CC       Name=3;
CC         IsoId=P51825-3; Sequence=VSP_046096;
CC   -!- DISEASE: Note=A chromosomal aberration involving AFF1 is associated
CC       with acute leukemias. Translocation t(4;11)(q21;q23) with KMT2A/MLL1.
CC       The result is a rogue activator protein.
CC   -!- SIMILARITY: Belongs to the AF4 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA36642.1; Type=Frameshift; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/AF4ID3.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L13773; AAA58360.1; -; mRNA.
DR   EMBL; L25050; AAA36642.1; ALT_FRAME; mRNA.
DR   EMBL; AK300364; BAG62103.1; -; mRNA.
DR   EMBL; AC092658; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC093779; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC093827; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS3616.1; -. [P51825-1]
DR   CCDS; CCDS54775.1; -. [P51825-2]
DR   PIR; A58198; A58198.
DR   PIR; I39410; I39410.
DR   RefSeq; NP_001160165.1; NM_001166693.2. [P51825-2]
DR   RefSeq; NP_001300888.1; NM_001313959.1. [P51825-3]
DR   RefSeq; NP_001300889.1; NM_001313960.1.
DR   RefSeq; NP_005926.1; NM_005935.3. [P51825-1]
DR   RefSeq; XP_005263064.1; XM_005263007.3. [P51825-2]
DR   RefSeq; XP_011530275.1; XM_011531973.2. [P51825-2]
DR   PDB; 2LM0; NMR; -; A=738-779.
DR   PDBsum; 2LM0; -.
DR   SMR; P51825; -.
DR   BioGrid; 110445; 46.
DR   CORUM; P51825; -.
DR   DIP; DIP-56407N; -.
DR   IntAct; P51825; 29.
DR   MINT; P51825; -.
DR   STRING; 9606.ENSP00000378578; -.
DR   iPTMnet; P51825; -.
DR   PhosphoSitePlus; P51825; -.
DR   BioMuta; AFF1; -.
DR   DMDM; 1703194; -.
DR   EPD; P51825; -.
DR   jPOST; P51825; -.
DR   MassIVE; P51825; -.
DR   MaxQB; P51825; -.
DR   PaxDb; P51825; -.
DR   PeptideAtlas; P51825; -.
DR   PRIDE; P51825; -.
DR   ProteomicsDB; 19254; -.
DR   ProteomicsDB; 56427; -. [P51825-1]
DR   Antibodypedia; 25387; 248 antibodies.
DR   Ensembl; ENST00000307808; ENSP00000305689; ENSG00000172493. [P51825-1]
DR   Ensembl; ENST00000395146; ENSP00000378578; ENSG00000172493. [P51825-2]
DR   GeneID; 4299; -.
DR   KEGG; hsa:4299; -.
DR   UCSC; uc003hqj.5; human. [P51825-1]
DR   CTD; 4299; -.
DR   DisGeNET; 4299; -.
DR   GeneCards; AFF1; -.
DR   HGNC; HGNC:7135; AFF1.
DR   HPA; ENSG00000172493; Tissue enhanced (placenta).
DR   MalaCards; AFF1; -.
DR   MIM; 159557; gene.
DR   neXtProt; NX_P51825; -.
DR   OpenTargets; ENSG00000172493; -.
DR   Orphanet; 99860; Precursor B-cell acute lymphoblastic leukemia.
DR   PharmGKB; PA30851; -.
DR   eggNOG; ENOG410IGJB; Eukaryota.
DR   eggNOG; ENOG410XRXU; LUCA.
DR   GeneTree; ENSGT00950000182974; -.
DR   HOGENOM; CLU_006484_0_0_1; -.
DR   InParanoid; P51825; -.
DR   KO; K15184; -.
DR   OMA; ERDHDSK; -.
DR   PhylomeDB; P51825; -.
DR   TreeFam; TF326216; -.
DR   SIGNOR; P51825; -.
DR   ChiTaRS; AFF1; human.
DR   GeneWiki; AFF1; -.
DR   GenomeRNAi; 4299; -.
DR   Pharos; P51825; Tbio.
DR   PRO; PR:P51825; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   RNAct; P51825; protein.
DR   Bgee; ENSG00000172493; Expressed in placenta and 248 other tissues.
DR   ExpressionAtlas; P51825; baseline and differential.
DR   Genevisible; P51825; HS.
DR   GO; GO:0032783; C:ELL-EAF complex; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0008023; C:transcription elongation factor complex; IDA:UniProtKB.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; TAS:ProtInc.
DR   GO; GO:0010468; P:regulation of gene expression; IBA:GO_Central.
DR   InterPro; IPR007797; TF_AF4/FMR2.
DR   PANTHER; PTHR10528; PTHR10528; 1.
DR   Pfam; PF05110; AF-4; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Chromosomal rearrangement;
KW   Nucleus; Phosphoprotein; Polymorphism; Proto-oncogene; Reference proteome.
FT   CHAIN           1..1210
FT                   /note="AF4/FMR2 family member 1"
FT                   /id="PRO_0000215910"
FT   COMPBIAS        483..492
FT                   /note="Poly-Ser"
FT   COMPBIAS        835..843
FT                   /note="Poly-Ser"
FT   COMPBIAS        866..869
FT                   /note="Poly-Pro"
FT   COMPBIAS        871..874
FT                   /note="Poly-Ser"
FT   MOD_RES         199
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O88573"
FT   MOD_RES         206
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231"
FT   MOD_RES         212
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195"
FT   MOD_RES         220
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         588
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19369195,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         681
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         697
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18691976,
FT                   ECO:0000244|PubMed:21406692"
FT   MOD_RES         750
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         755
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   VAR_SEQ         1..5
FT                   /note="MAAQS -> MAFTERVNSSGN (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_046095"
FT   VAR_SEQ         1096
FT                   /note="A -> AR (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:8443374"
FT                   /id="VSP_046096"
FT   VARIANT         209
FT                   /note="P -> A (in dbSNP:rs3733378)"
FT                   /id="VAR_020370"
FT   VARIANT         1204
FT                   /note="Q -> K (in a breast cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_036130"
FT   CONFLICT        46
FT                   /note="K -> R (in Ref. 2; AAA36642)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        624
FT                   /note="E -> G (in Ref. 2; AAA36642)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        762
FT                   /note="M -> V (in Ref. 3; BAG62103)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        820
FT                   /note="R -> G (in Ref. 3; BAG62103)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        899..905
FT                   /note="SASSTKS -> VPAVPRV (in Ref. 2; AAA36642)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        928..929
FT                   /note="EH -> AD (in Ref. 2; AAA36642)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        999
FT                   /note="I -> N (in Ref. 2; AAA36642)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1140
FT                   /note="N -> I (in Ref. 2; AAA36642)"
FT                   /evidence="ECO:0000305"
FT   TURN            768..770
FT                   /evidence="ECO:0000244|PDB:2LM0"
SQ   SEQUENCE   1210 AA;  131422 MW;  F0E334DF8FC2FF04 CRC64;
     MAAQSSLYND DRNLLRIREK ERRNQEAHQE KEAFPEKIPL FGEPYKTAKG DELSSRIQNM
     LGNYEEVKEF LSTKSHTHRL DASENRLGKP KYPLIPDKGS SIPSSSFHTS VHHQSIHTPA
     SGPLSVGNIS HNPKMAQPRT EPMPSLHAKS CGPPDSQHLT QDRLGQEGFG SSHHKKGDRR
     ADGDHCASVT DSAPERELSP LISLPSPVPP LSPIHSNQQT LPRTQGSSKV HGSSNNSKGY
     CPAKSPKDLA VKVHDKETPQ DSLVAPAQPP SQTFPPPSLP SKSVAMQQKP TAYVRPMDGQ
     DQAPSESPEL KPLPEDYRQQ TFEKTDLKVP AKAKLTKLKM PSQSVEQTYS NEVHCVEEIL
     KEMTHSWPPP LTAIHTPSTA EPSKFPFPTK DSQHVSSVTQ NQKQYDTSSK THSNSQQGTS
     SMLEDDLQLS DSEDSDSEQT PEKPPSSSAP PSAPQSLPEP VASAHSSSAE SESTSDSDSS
     SDSESESSSS DSEENEPLET PAPEPEPPTT NKWQLDNWLT KVSQPAAPPE GPRSTEPPRR
     HPESKGSSDS ATSQEHSESK DPPPKSSSKA PRAPPEAPHP GKRSCQKSPA QQEPPQRQTV
     GTKQPKKPVK ASARAGSRTS LQGEREPGLL PYGSRDQTSK DKPKVKTKGR PRAAASNEPK
     PAVPPSSEKK KHKSSLPAPS KALSGPEPAK DNVEDRTPEH FALVPLTESQ GPPHSGSGSR
     TSGCRQAVVV QEDSRKDRLP LPLRDTKLLS PLRDTPPPQS LMVKITLDLL SRIPQPPGKG
     SRQRKAEDKQ PPAGKKHSSE KRSSDSSSKL AKKRKGEAER DCDNKKIRLE KEIKSQSSSS
     SSSHKESSKT KPSRPSSQSS KKEMLPPPPV SSSSQKPAKP ALKRSRREAD TCGQDPPKSA
     SSTKSNHKDS SIPKQRRVEG KGSRSSSEHK GSSGDTANPF PVPSLPNGNS KPGKPQVKFD
     KQQADLHMRE AKKMKQKAEL MTDRVGKAFK YLEAVLSFIE CGIATESESQ SSKSAYSVYS
     ETVDLIKFIM SLKSFSDATA PTQEKIFAVL CMRCQSILNM AMFRCKKDIA IKYSRTLNKH
     FESSSKVAQA PSPCIASTGT PSPLSPMPSP ASSVGSQSSA GSVGSSGVAA TISTPVTIQN
     MTSSYVTITS HVLTAFDLWE QAEALTRKNK EFFARLSTNV CTLALNSSLV DLVHYTRQGF
     QQLQELTKTP
//
ID   Q14C88_HUMAN            Unreviewed;      1211 AA.
AC   Q14C88;
DT   22-AUG-2006, integrated into UniProtKB/TrEMBL.
DT   22-AUG-2006, sequence version 1.
DT   22-APR-2020, entry version 97.
DE   SubName: Full=AF4/FMR2 family, member 1 {ECO:0000313|EMBL:AAI14931.1};
DE   SubName: Full=AF4/FMR2 family, member 1, isoform CRA_b {ECO:0000313|EMBL:EAX05979.1};
GN   Name=AFF1 {ECO:0000313|EMBL:AAI14931.1};
GN   ORFNames=hCG_1816301 {ECO:0000313|EMBL:EAX05979.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAI14931.1};
RN   [1] {ECO:0000313|EMBL:EAX05979.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:AAI14931.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M., Peck A.M.,
RA   Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S., Feolo M.,
RA   Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F., Schaefer C.F.,
RA   Buetow K., Bonner T.I., Haussler D., Kent J., Kiekhaus M., Furey T.,
RA   Brent M., Prange C., Schreiber K., Shapiro N., Bhat N.K., Hopkins R.F.,
RA   Hsie F., Driscoll T., Soares M.B., Casavant T.L., Scheetz T.E.,
RA   Brown-stein M.J., Usdin T.B., Toshiyuki S., Carninci P., Piao Y.,
RA   Dudekula D.B., Ko M.S., Kawakami K., Suzuki Y., Sugano S., Gruber C.E.,
RA   Smith M.R., Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y.,
RA   Wei C.L., Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W.,
RA   Fuh E., Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D., Granite S.J.,
RA   Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G., Blakesly R.W.,
RA   Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J.,
RA   Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L., Krzywinski M.I.,
RA   Liao N., Morin R., Morrin R., Palmquist D., Petrescu A.S., Skalska U.,
RA   Smailus D.E., Stott J.M., Schnerch A., Schein J.E., Jones S.J., Holt R.A.,
RA   Baross A., Marra M.A., Clifton S., Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3] {ECO:0000313|EMBL:EAX05979.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC114930; AAI14931.1; -; mRNA.
DR   EMBL; CH471057; EAX05979.1; -; Genomic_DNA.
DR   RefSeq; NP_001160165.1; NM_001166693.2.
DR   RefSeq; NP_001300888.1; NM_001313959.1.
DR   RefSeq; NP_001300889.1; NM_001313960.1.
DR   RefSeq; NP_005926.1; NM_005935.3.
DR   GeneID; 4299; -.
DR   KEGG; hsa:4299; -.
DR   CTD; 4299; -.
DR   PharmGKB; PA30851; -.
DR   eggNOG; ENOG410IGJB; Eukaryota.
DR   eggNOG; ENOG410XRXU; LUCA.
DR   KO; K15184; -.
DR   OrthoDB; 558558at2759; -.
DR   ChiTaRS; AFF1; human.
DR   GenomeRNAi; 4299; -.
DR   InterPro; IPR007797; TF_AF4/FMR2.
DR   PANTHER; PTHR10528; PTHR10528; 1.
DR   Pfam; PF05110; AF-4; 1.
PE   2: Evidence at transcript level;
FT   REGION          1..45
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          73..314
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          366..957
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1092..1120
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        12..37
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        99..135
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        168..191
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        213..241
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        371..426
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        459..486
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        585..605
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        710..728
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        781..833
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        834..879
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        909..928
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        929..944
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   1211 AA;  131578 MW;  FD08BE7A2BE38BFC CRC64;
     MAAQSSLYND DRNLLRIREK ERRNQEAHQE KEAFPEKIPL FGEPYKTAKG DELSSRIQNM
     LGNYEEVKEF LSTKSHTHRL DASENRLGKP KYPLIPDKGS SIPSSSFHTS VHHQSIHTPA
     SGPLSVGNIS HNPKMAQPRT EPMPSLHAKS CGPPDSQHLT QDRLGQEGFG SSHHKKGDRR
     ADGDHCASVT DSAPERELSP LISLPSPVPP LSPIHSNQQT LPRTQGSSKV HGSSNNSKGY
     CPAKSPKDLA VKVHDKETPQ DSLVAPAQPP SQTFPPPSLP SKSVAMQQKP TAYVRPMDGQ
     DQAPSESPEL KPLPEDYRQQ TFEKTDLKVP AKAKLTKLKM PSQSVEQTYS NEVHCVEEIL
     KEMTHSWPPP LTAIHTPSTA EPSKFPFPTK DSQHVSSVTQ NQKQYDTSSK THSNSQQGTS
     SMLEDDLQLS DSEDSDSEQT PEKPPSSSAP PSAPQSLPEP VASAHSSSAE SESTSDSDSS
     SDSESESSSS DSEENEPLET PAPEPEPPTT NKWQLDNWLT KVSQPAAPPE GPRSTEPPRR
     HPESKGSSDS ATSQEHSESK DPPPKSSSKA PRAPPEAPHP GKRSCQKSPA QQEPPQRQTV
     GTKQPKKPVK ASARAGSRTS LQGEREPGLL PYGSRDQTSK DKPKVKTKGR PRAAASNEPK
     PAVPPSSEKK KHKSSLPAPS KALSGPEPAK DNVEDRTPEH FALVPLTESQ GPPHSGSGSR
     TSGCRQAVVV QEDSRKDRLP LPLRDTKLLS PLRDTPPPQS LMVKITLDLL SRIPQPPGKG
     SRQRKAEDKQ PPAGKKHSSE KRSSDSSSKL AKKRKGEAER DCDNKKIRLE KEIKSQSSSS
     SSSHKESSKT KPSRPSSQSS KKEMLPPPPV SSSSQKPAKP ALKRSRREAD TCGQDPPKSA
     SSTKSNHKDS SIPKQRRVEG KGSRSSSEHK GSSGDTANPF PVPSLPNGNS KPGKPQVKFD
     KQQADLHMRE AKKMKQKAEL MTDRVGKAFK YLEAVLSFIE CGIATESESQ SSKSAYSVYS
     ETVDLIKFIM SLKSFSDATA PTQEKIFAVL CMRCQSILNM AMFRCKKDIA IKYSRTLNKH
     FESSSKVAQA PSPCIARSTG TPSPLSPMPS PASSVGSQSS AGSVGSSGVA ATISTPVTIQ
     NMTSSYVTIT SHVLTAFDLW EQAEALTRKN KEFFARLSTN VCTLALNSSL VDLVHYTRQG
     FQQLQELTKT P
//
ID   ASPC1_HUMAN             Reviewed;         553 AA.
AC   Q9BZE9; A8K3K9; Q7Z6N7; Q8WV59; Q96LS5; Q96M40;
DT   19-SEP-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   22-APR-2020, entry version 144.
DE   RecName: Full=Tether containing UBX domain for GLUT4;
DE   AltName: Full=Alveolar soft part sarcoma chromosomal region candidate gene 1 protein;
DE   AltName: Full=Alveolar soft part sarcoma locus;
DE   AltName: Full=Renal papillary cell carcinoma protein 17;
DE   AltName: Full=UBX domain-containing protein 9;
GN   Name=ASPSCR1; Synonyms=ASPL, RCC17, TUG, UBXD9, UBXN9;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), CHROMOSOMAL TRANSLOCATION WITH
RP   TFE3, TISSUE SPECIFICITY, AND INVOLVEMENT IN ASPS.
RX   PubMed=11244503; DOI=10.1038/sj.onc.1204074;
RA   Ladanyi M., Lui M.Y., Antonescu C.R., Krause-Boehm A., Meindl A.,
RA   Argani P., Healey J.H., Ueda T., Yoshikawa H., Meloni-Ehrig A.,
RA   Sorensen P.H.B., Mertens F., Mandahl N., van den Berghe H., Sciot R.,
RA   Dal Cin P., Bridge J.;
RT   "The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the
RT   TFE3 transcription factor gene to ASPL, a novel gene at 17q25.";
RL   Oncogene 20:48-57(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3), AND VARIANT
RP   GLN-252.
RC   TISSUE=Brain, Heart, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4), AND VARIANT
RP   GLN-252.
RC   TISSUE=Eye, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   CHROMOSOMAL TRANSLOCATION WITH TFE3, AND TISSUE SPECIFICITY.
RX   PubMed=11358836;
RA   Heimann P., El Housni H., Ogur G., Weterman M.A.J., Petty E.M., Vassart G.;
RT   "Fusion of a novel gene, RCC17, to the TFE3 gene in t(X;17)(p11.2;q25.3)-
RT   bearing papillary renal cell carcinomas.";
RL   Cancer Res. 61:4130-4135(2001).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-500, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [8]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH VCP.
RX   PubMed=22207755; DOI=10.1074/jbc.m111.284232;
RA   Orme C.M., Bogan J.S.;
RT   "The ubiquitin regulatory X (UBX) domain-containing protein TUG regulates
RT   the p97 ATPase and resides at the endoplasmic reticulum-golgi intermediate
RT   compartment.";
RL   J. Biol. Chem. 287:6679-6692(2012).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-275; SER-500 AND SER-502, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   FUNCTION IN VCP METHYLATION, INTERACTION WITH VCPKMT, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=23349634; DOI=10.1371/journal.pgen.1003210;
RA   Cloutier P., Lavallee-Adam M., Faubert D., Blanchette M., Coulombe B.;
RT   "A newly uncovered group of distantly related lysine methyltransferases
RT   preferentially interact with molecular chaperones to regulate their
RT   activity.";
RL   PLoS Genet. 9:E1003210-E1003210(2013).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-275; SER-500 AND SER-502, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Tethering protein that sequesters GLUT4-containing vesicles
CC       in the cytoplasm in the absence of insulin. Modulates the amount of
CC       GLUT4 that is available at the cell surface (By similarity). Enhances
CC       VCP methylation catalyzed by VCPKMT. {ECO:0000250,
CC       ECO:0000269|PubMed:23349634}.
CC   -!- SUBUNIT: Interacts with GLUT4 (By similarity). Interacts with VCPKMT.
CC       Interacts with VCP. {ECO:0000250, ECO:0000269|PubMed:22207755,
CC       ECO:0000269|PubMed:23349634}.
CC   -!- INTERACTION:
CC       Q9BZE9; Q6UY14-3: ADAMTSL4; NbExp=3; IntAct=EBI-1993677, EBI-10173507;
CC       Q9BZE9; P49760: CLK2; NbExp=3; IntAct=EBI-1993677, EBI-750020;
CC       Q9BZE9; V9HW80: HEL-S-70; NbExp=3; IntAct=EBI-1993677, EBI-10175326;
CC       Q9BZE9; Q0VD86: INCA1; NbExp=3; IntAct=EBI-1993677, EBI-6509505;
CC       Q9BZE9; Q15323: KRT31; NbExp=3; IntAct=EBI-1993677, EBI-948001;
CC       Q9BZE9; Q07627: KRTAP1-1; NbExp=3; IntAct=EBI-1993677, EBI-11959885;
CC       Q9BZE9; P60410: KRTAP10-8; NbExp=3; IntAct=EBI-1993677, EBI-10171774;
CC       Q9BZE9; Q7Z3S9: NOTCH2NLA; NbExp=3; IntAct=EBI-1993677, EBI-945833;
CC       Q9BZE9; Q9Y6A5: TACC3; NbExp=3; IntAct=EBI-1993677, EBI-2554984;
CC       Q9BZE9; P15884: TCF4; NbExp=3; IntAct=EBI-1993677, EBI-533224;
CC       Q9BZE9; P55072: VCP; NbExp=25; IntAct=EBI-1993677, EBI-355164;
CC   -!- SUBCELLULAR LOCATION: Endomembrane system {ECO:0000250}; Peripheral
CC       membrane protein {ECO:0000250}. Endoplasmic reticulum-Golgi
CC       intermediate compartment membrane {ECO:0000269|PubMed:22207755};
CC       Peripheral membrane protein. Cytoplasm {ECO:0000269|PubMed:23349634}.
CC       Nucleus {ECO:0000269|PubMed:23349634}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q9BZE9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BZE9-2; Sequence=VSP_020578;
CC       Name=3;
CC         IsoId=Q9BZE9-3; Sequence=VSP_020574, VSP_020577;
CC       Name=4;
CC         IsoId=Q9BZE9-4; Sequence=VSP_020574, VSP_020575, VSP_020576;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Highly expressed in testis, heart,
CC       skeletal muscle and pancreas. {ECO:0000269|PubMed:11244503,
CC       ECO:0000269|PubMed:11358836}.
CC   -!- DISEASE: Note=A chromosomal aberration involving ASPSCR1 is found in
CC       patients with alveolar soft part sarcoma. Translocation
CC       t(X;17)(p11;q25) with TFE3 forms a ASPSCR1-TFE3 fusion protein.
CC       {ECO:0000269|PubMed:11244503}.
CC   -!- DISEASE: Note=A chromosomal aberration involving ASPSCR1 has been found
CC       in two patients with of papillary renal cell carcinoma. Translocation
CC       t(X;17)(p11.2;q25). {ECO:0000269|PubMed:11358836}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/ASPSCR1ID358.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF324219; AAK08959.2; -; mRNA.
DR   EMBL; AK057403; BAB71472.1; -; mRNA.
DR   EMBL; AK057851; BAB71595.1; -; mRNA.
DR   EMBL; AK290624; BAF83313.1; -; mRNA.
DR   EMBL; BC006152; AAH06152.1; -; mRNA.
DR   EMBL; BC018722; AAH18722.1; -; mRNA.
DR   CCDS; CCDS11796.1; -. [Q9BZE9-1]
DR   CCDS; CCDS58611.1; -. [Q9BZE9-2]
DR   CCDS; CCDS82222.1; -. [Q9BZE9-3]
DR   RefSeq; NP_001238817.1; NM_001251888.1. [Q9BZE9-2]
DR   RefSeq; NP_001317457.1; NM_001330528.1. [Q9BZE9-3]
DR   RefSeq; NP_076988.1; NM_024083.3. [Q9BZE9-1]
DR   PDB; 5IFS; X-ray; 2.46 A; A/C=317-553.
DR   PDB; 5IFW; X-ray; 3.40 A; A=317-504.
DR   PDBsum; 5IFS; -.
DR   PDBsum; 5IFW; -.
DR   SMR; Q9BZE9; -.
DR   BioGrid; 122516; 54.
DR   IntAct; Q9BZE9; 35.
DR   MINT; Q9BZE9; -.
DR   STRING; 9606.ENSP00000306625; -.
DR   iPTMnet; Q9BZE9; -.
DR   PhosphoSitePlus; Q9BZE9; -.
DR   BioMuta; ASPSCR1; -.
DR   DMDM; 74717746; -.
DR   EPD; Q9BZE9; -.
DR   jPOST; Q9BZE9; -.
DR   MassIVE; Q9BZE9; -.
DR   MaxQB; Q9BZE9; -.
DR   PaxDb; Q9BZE9; -.
DR   PeptideAtlas; Q9BZE9; -.
DR   PRIDE; Q9BZE9; -.
DR   ProteomicsDB; 79824; -. [Q9BZE9-1]
DR   ProteomicsDB; 79825; -. [Q9BZE9-2]
DR   ProteomicsDB; 79826; -. [Q9BZE9-3]
DR   ProteomicsDB; 79827; -. [Q9BZE9-4]
DR   Antibodypedia; 19857; 288 antibodies.
DR   DNASU; 79058; -.
DR   Ensembl; ENST00000306729; ENSP00000306625; ENSG00000169696. [Q9BZE9-2]
DR   Ensembl; ENST00000306739; ENSP00000302176; ENSG00000169696. [Q9BZE9-1]
DR   Ensembl; ENST00000580534; ENSP00000462329; ENSG00000169696. [Q9BZE9-3]
DR   GeneID; 79058; -.
DR   KEGG; hsa:79058; -.
DR   UCSC; uc002kcx.3; human. [Q9BZE9-1]
DR   CTD; 79058; -.
DR   DisGeNET; 79058; -.
DR   GeneCards; ASPSCR1; -.
DR   HGNC; HGNC:13825; ASPSCR1.
DR   HPA; ENSG00000169696; Low tissue specificity.
DR   MalaCards; ASPSCR1; -.
DR   MIM; 606236; gene.
DR   neXtProt; NX_Q9BZE9; -.
DR   OpenTargets; ENSG00000169696; -.
DR   Orphanet; 163699; Alveolar soft tissue sarcoma.
DR   Orphanet; 319308; MiT family translocation renal cell carcinoma.
DR   PharmGKB; PA25058; -.
DR   eggNOG; KOG2699; Eukaryota.
DR   eggNOG; ENOG410XQQK; LUCA.
DR   GeneTree; ENSGT00940000156853; -.
DR   HOGENOM; CLU_025227_0_0_1; -.
DR   InParanoid; Q9BZE9; -.
DR   KO; K15627; -.
DR   OMA; NNCVLEM; -.
DR   OrthoDB; 1104599at2759; -.
DR   PhylomeDB; Q9BZE9; -.
DR   TreeFam; TF320363; -.
DR   Reactome; R-HSA-1445148; Translocation of SLC2A4 (GLUT4) to the plasma membrane.
DR   SIGNOR; Q9BZE9; -.
DR   ChiTaRS; ASPSCR1; human.
DR   GeneWiki; ASPSCR1; -.
DR   GenomeRNAi; 79058; -.
DR   Pharos; Q9BZE9; Tbio.
DR   PRO; PR:Q9BZE9; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q9BZE9; protein.
DR   Bgee; ENSG00000169696; Expressed in liver and 89 other tissues.
DR   ExpressionAtlas; Q9BZE9; baseline and differential.
DR   Genevisible; Q9BZE9; HS.
DR   GO; GO:0009898; C:cytoplasmic side of plasma membrane; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0012505; C:endomembrane system; IEA:UniProtKB-SubCell.
DR   GO; GO:0033116; C:endoplasmic reticulum-Golgi intermediate compartment membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0019898; C:extrinsic component of membrane; IEA:Ensembl.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0012506; C:vesicle membrane; IEA:Ensembl.
DR   GO; GO:0042593; P:glucose homeostasis; IEA:Ensembl.
DR   GO; GO:0006886; P:intracellular protein transport; IEA:Ensembl.
DR   GO; GO:0031401; P:positive regulation of protein modification process; IMP:UniProtKB.
DR   GO; GO:0046324; P:regulation of glucose import; IEA:Ensembl.
DR   InterPro; IPR021569; TUG-UBL1.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   InterPro; IPR001012; UBX_dom.
DR   Pfam; PF11470; TUG-UBL1; 1.
DR   Pfam; PF00789; UBX; 1.
DR   SUPFAM; SSF54236; SSF54236; 2.
DR   PROSITE; PS50033; UBX; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Chromosomal rearrangement;
KW   Cytoplasm; Membrane; Nucleus; Phosphoprotein; Polymorphism; Proto-oncogene;
KW   Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:22223895,
FT                   ECO:0000244|PubMed:22814378"
FT   CHAIN           2..553
FT                   /note="Tether containing UBX domain for GLUT4"
FT                   /id="PRO_0000249885"
FT   DOMAIN          386..462
FT                   /note="UBX"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00215"
FT   REGION          317..380
FT                   /note="Interaction with GLUT4"
FT                   /evidence="ECO:0000250"
FT   SITE            311..312
FT                   /note="Breakpoint for translocation to form ASPSCR1-TFE3"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000244|PubMed:22223895,
FT                   ECO:0000244|PubMed:22814378"
FT   MOD_RES         184
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VBT9"
FT   MOD_RES         275
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         500
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         502
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   VAR_SEQ         1..77
FT                   /note="Missing (in isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_020574"
FT   VAR_SEQ         390..425
FT                   /note="KVALRVLFPDRYVLQGFFRPSETVGDLRDFVRSHLG -> RRSLSLSPRLES
FT                   VVPSQLTASSASRVQVVLLPQPPK (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_020575"
FT   VAR_SEQ         426..553
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_020576"
FT   VAR_SEQ         434
FT                   /note="F -> CLSSFGRMDGRGPRCFLTRRCLLSSV (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_020577"
FT   VAR_SEQ         451
FT                   /note="Q -> QPQLGDRVAPFTLGPSLKRCLGPEQRTRLPVVGDGGDVDSGRLLFWG
FT                   PSRGRASPSTGQPPCHPVCRPSSPPSPRPSSGDPSRVKAGHKHVGTGR (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_020578"
FT   VARIANT         252
FT                   /note="L -> Q (in dbSNP:rs8074498)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334"
FT                   /id="VAR_027503"
FT   VARIANT         318
FT                   /note="V -> M (in dbSNP:rs34085048)"
FT                   /id="VAR_034745"
FT   VARIANT         487
FT                   /note="D -> E (in dbSNP:rs13087)"
FT                   /id="VAR_027504"
FT   CONFLICT        257
FT                   /note="G -> E (in Ref. 2; BAB71595)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        444
FT                   /note="D -> G (in Ref. 2; BAB71595)"
FT                   /evidence="ECO:0000305"
FT   STRAND          323..325
FT                   /evidence="ECO:0000244|PDB:5IFS"
FT   HELIX           327..329
FT                   /evidence="ECO:0000244|PDB:5IFS"
FT   HELIX           342..345
FT                   /evidence="ECO:0000244|PDB:5IFS"
FT   HELIX           349..368
FT                   /evidence="ECO:0000244|PDB:5IFS"
FT   HELIX           374..387
FT                   /evidence="ECO:0000244|PDB:5IFS"
FT   STRAND          391..396
FT                   /evidence="ECO:0000244|PDB:5IFS"
FT   STRAND          402..407
FT                   /evidence="ECO:0000244|PDB:5IFS"
FT   HELIX           413..422
FT                   /evidence="ECO:0000244|PDB:5IFS"
FT   STRAND          424..426
FT                   /evidence="ECO:0000244|PDB:5IFS"
FT   STRAND          432..435
FT                   /evidence="ECO:0000244|PDB:5IFS"
FT   TURN            436..439
FT                   /evidence="ECO:0000244|PDB:5IFS"
FT   STRAND          445..448
FT                   /evidence="ECO:0000244|PDB:5IFW"
FT   TURN            449..453
FT                   /evidence="ECO:0000244|PDB:5IFS"
FT   STRAND          456..463
FT                   /evidence="ECO:0000244|PDB:5IFS"
FT   HELIX           467..469
FT                   /evidence="ECO:0000244|PDB:5IFW"
FT   HELIX           474..477
FT                   /evidence="ECO:0000244|PDB:5IFS"
FT   HELIX           483..494
FT                   /evidence="ECO:0000244|PDB:5IFS"
SQ   SEQUENCE   553 AA;  60183 MW;  B013FDF9A48D2E5E CRC64;
     MAAPAGGGGS AVSVLAPNGR RHTVKVTPST VLLQVLEDTC RRQDFNPCEY DLKFQRSVLD
     LSLQWRFANL PNNAKLEMVP ASRSREGPEN MVRIALQLDD GSRLQDSFCS GQTLWELLSH
     FPQIRECLQH PGGATPVCVY TRDEVTGEAA LRGTTLQSLG LTGGSATIRF VMKCYDPVGK
     TPGSLGSSAS AGQAAASAPL PLESGELSRG DLSRPEDADT SGPCCEHTQE KQSTRAPAAA
     PFVPFSGGGQ RLGGPPGPTR PLTSSSAKLP KSLSSPGGPS KPKKSKSGQD PQQEQEQERE
     RDPQQEQERE RPVDREPVDR EPVVCHPDLE ERLQAWPAEL PDEFFELTVD DVRRRLAQLK
     SERKRLEEAP LVTKAFREAQ IKEKLERYPK VALRVLFPDR YVLQGFFRPS ETVGDLRDFV
     RSHLGNPELS FYLFITPPKT VLDDHTQTLF QANLFPAALV HLGAEEPAGV YLEPGLLEHA
     ISPSAADVLV ARYMSRAAGS PSPLPAPDPA PKSEPAAEEG ALVPPEPIPG TAQPVKRSLG
     KVPKWLKLPA SKR
//
ID   PUR9_HUMAN              Reviewed;         592 AA.
AC   P31939; A8K202; E9PBU3; Q13856; Q53S28;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   10-OCT-2002, sequence version 3.
DT   22-APR-2020, entry version 203.
DE   RecName: Full=Bifunctional purine biosynthesis protein PURH;
DE   Includes:
DE     RecName: Full=Phosphoribosylaminoimidazolecarboxamide formyltransferase;
DE              EC=2.1.2.3;
DE     AltName: Full=5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase;
DE     AltName: Full=AICAR transformylase;
DE   Includes:
DE     RecName: Full=IMP cyclohydrolase;
DE              EC=3.5.4.10;
DE     AltName: Full=ATIC;
DE     AltName: Full=IMP synthase;
DE     AltName: Full=Inosinicase;
DE   Contains:
DE     RecName: Full=Bifunctional purine biosynthesis protein PURH, N-terminally processed;
GN   Name=ATIC; Synonyms=PURH; ORFNames=OK/SW-cl.86;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Hepatoma;
RX   PubMed=8567683; DOI=10.1074/jbc.271.4.2225;
RA   Rayl E.A., Moroson B.A., Beardsley G.P.;
RT   "The human purH gene product, 5-aminoimidazole-4-carboxamide ribonucleotide
RT   formyltransferase/IMP cyclohydrolase. Cloning, sequencing, expression,
RT   purification, kinetic analysis, and domain mapping.";
RL   J. Biol. Chem. 271:2225-2233(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=8867801; DOI=10.1093/dnares/2.6.269;
RA   Yamauchi M., Seki N., Mita K., Saito T., Tsuji S., Hongo E., Morimyo M.,
RA   Shiomi T., Koyama H.;
RT   "Isolation of human purH gene expressed in the rodent transformant cells by
RT   subtractive enrichment of 3'-untranslated region of human transcript.";
RL   DNA Res. 2:269-275(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=9378707; DOI=10.1093/oxfordjournals.jbchem.a021754;
RA   Sugita T., Aya H., Ueno M., Ishizuka T., Kawashima K.;
RT   "Characterization of molecularly cloned human 5-aminoimidazole-4-
RT   carboxamide ribonucleotide transformylase.";
RL   J. Biochem. 122:309-313(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Colon adenocarcinoma;
RA   Shichijo S., Itoh K.;
RT   "Identification of immuno-peptidmics that are recognized by tumor-reactive
RT   CTL generated from TIL of colon cancer patients.";
RL   Submitted (MAY-2001) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT SER-116.
RC   TISSUE=Substantia nigra;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT SER-116.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 15-39; 91-97; 178-194; 208-225; 267-285 AND 417-426,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Vishwanath V., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [10]
RP   PROTEIN SEQUENCE OF 178-189 AND 267-281.
RC   TISSUE=Keratinocyte;
RX   PubMed=1286667; DOI=10.1002/elps.11501301199;
RA   Rasmussen H.H., van Damme J., Puype M., Gesser B., Celis J.E.,
RA   Vandekerckhove J.;
RT   "Microsequences of 145 proteins recorded in the two-dimensional gel protein
RT   database of normal human epidermal keratinocytes.";
RL   Electrophoresis 13:960-969(1992).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-199, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=25687571; DOI=10.1074/mcp.m114.047159;
RA   Boutchueng-Djidjou M., Collard-Simard G., Fortier S., Hebert S.S.,
RA   Kelly I., Landry C.R., Faure R.L.;
RT   "The last enzyme of the de novo purine synthesis pathway 5-aminoimidazole-
RT   4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase (ATIC)
RT   plays a central role in insulin signaling and the Golgi/endosomes protein
RT   network.";
RL   Mol. Cell. Proteomics 14:1079-1092(2015).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) IN COMPLEX WITH XMP, AND SUBUNIT.
RX   PubMed=14756553; DOI=10.1021/bi030162i;
RA   Wolan D.W., Cheong C.-G., Greasley S.E., Wilson I.A.;
RT   "Structural insights into the human and avian IMP cyclohydrolase mechanism
RT   via crystal structures with the bound XMP inhibitor.";
RL   Biochemistry 43:1171-1183(2004).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.55 ANGSTROMS) IN COMPLEX WITH AICAR; XMP AND THE
RP   INHIBITORS BW1540 AND BW2315, FUNCTION, AND SUBUNIT.
RX   PubMed=14966129; DOI=10.1074/jbc.m313691200;
RA   Cheong C.-G., Wolan D.W., Greasley S.E., Horton P.A., Beardsley G.P.,
RA   Wilson I.A.;
RT   "Crystal structures of human bifunctional enzyme aminoimidazole-4-
RT   carboxamide ribonucleotide transformylase/IMP cyclohydrolase in complex
RT   with potent sulfonyl-containing antifolates.";
RL   J. Biol. Chem. 279:18034-18045(2004).
RN   [20]
RP   VARIANT AICAR ARG-426, AND CHARACTERIZATION OF VARIANT AICAR ARG-426.
RX   PubMed=15114530; DOI=10.1086/421475;
RA   Marie S., Heron B., Bitoun P., Timmerman T., Van Den Berghe G.,
RA   Vincent M.-F.;
RT   "AICA-ribosiduria: a novel, neurologically devastating inborn error of
RT   purine biosynthesis caused by mutation of ATIC.";
RL   Am. J. Hum. Genet. 74:1276-1281(2004).
CC   -!- FUNCTION: Bifunctional enzyme that catalyzes 2 steps in purine
CC       biosynthesis. {ECO:0000269|PubMed:14966129}.
CC   -!- FUNCTION: Promotes insulin receptor/INSR autophosphorylation and is
CC       involved in INSR internalization (PubMed:25687571).
CC       {ECO:0000269|PubMed:25687571}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(6S)-10-formyltetrahydrofolate + 5-amino-1-(5-phospho-beta-D-
CC         ribosyl)imidazole-4-carboxamide = (6S)-5,6,7,8-tetrahydrofolate + 5-
CC         formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide;
CC         Xref=Rhea:RHEA:22192, ChEBI:CHEBI:57453, ChEBI:CHEBI:57454,
CC         ChEBI:CHEBI:58467, ChEBI:CHEBI:58475; EC=2.1.2.3;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + IMP = 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-
CC         carboxamide; Xref=Rhea:RHEA:18445, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:58053, ChEBI:CHEBI:58467; EC=3.5.4.10;
CC   -!- PATHWAY: Purine metabolism; IMP biosynthesis via de novo pathway; 5-
CC       formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide from 5-amino-
CC       1-(5-phospho-D-ribosyl)imidazole-4-carboxamide (10-formyl THF route):
CC       step 1/1.
CC   -!- PATHWAY: Purine metabolism; IMP biosynthesis via de novo pathway; IMP
CC       from 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide: step
CC       1/1.
CC   -!- SUBUNIT: Homodimer (PubMed:14756553, PubMed:14966129). Associates with
CC       internalized INSR complexes on Golgi/endosomal membranes. Interacts
CC       with INSR; ATIC together with PRKAA2/AMPK2 and HACD3/PTPLAD1 is
CC       proposed to be part of a signaling network regulating INSR
CC       autophosphorylation and endocytosis (PubMed:25687571).
CC       {ECO:0000269|PubMed:14756553, ECO:0000269|PubMed:14966129,
CC       ECO:0000269|PubMed:25687571}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P31939-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P31939-2; Sequence=VSP_053495;
CC   -!- DOMAIN: The IMP cyclohydrolase activity resides in the N-terminal
CC       region.
CC   -!- DISEASE: AICAR transformylase/IMP cyclohydrolase deficiency (AICAR)
CC       [MIM:608688]: A neurologically devastating inborn error of purine
CC       biosynthesis. Patients excrete massive amounts of AICA-riboside in the
CC       urine and accumulate AICA-ribotide and its derivatives in erythrocytes
CC       and fibroblasts. AICAR causes profound mental retardation, epilepsy,
CC       dysmorphic features and congenital blindness.
CC       {ECO:0000269|PubMed:15114530}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the PurH family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/ATICID227.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U37436; AAA97405.1; -; mRNA.
DR   EMBL; D82348; BAA11559.1; -; mRNA.
DR   EMBL; D89976; BAA21762.1; -; mRNA.
DR   EMBL; AB062403; BAB93490.1; -; mRNA.
DR   EMBL; AK290067; BAF82756.1; -; mRNA.
DR   EMBL; AC073284; AAY24062.1; -; Genomic_DNA.
DR   EMBL; CH471063; EAW70529.1; -; Genomic_DNA.
DR   EMBL; BC008879; AAH08879.1; -; mRNA.
DR   CCDS; CCDS2398.1; -. [P31939-1]
DR   PIR; JC4642; JC4642.
DR   RefSeq; NP_004035.2; NM_004044.6. [P31939-1]
DR   PDB; 1P4R; X-ray; 2.55 A; A/B=1-592.
DR   PDB; 1PKX; X-ray; 1.90 A; A/B/C/D=1-592.
DR   PDB; 1PL0; X-ray; 2.60 A; A/B/C/D=1-592.
DR   PDB; 5UY8; X-ray; 2.39 A; A/B/C/D=2-592.
DR   PDB; 5UZ0; X-ray; 1.79 A; A/B/C/D=2-592.
DR   PDBsum; 1P4R; -.
DR   PDBsum; 1PKX; -.
DR   PDBsum; 1PL0; -.
DR   PDBsum; 5UY8; -.
DR   PDBsum; 5UZ0; -.
DR   SMR; P31939; -.
DR   BioGrid; 106961; 86.
DR   IntAct; P31939; 13.
DR   STRING; 9606.ENSP00000236959; -.
DR   BindingDB; P31939; -.
DR   ChEMBL; CHEMBL2518; -.
DR   DrugBank; DB02309; 5-monophosphate-9-beta-D-ribofuranosyl xanthine.
DR   DrugBank; DB03442; Acid yellow 54 free acid.
DR   DrugBank; DB01700; AICA ribonucleotide.
DR   DrugBank; DB04057; Beta-Dadf, Msa, Multisubstrate Adduct Inhibitor.
DR   DrugBank; DB01972; Guanosine-5'-Monophosphate.
DR   DrugBank; DB00563; Methotrexate.
DR   DrugBank; DB00642; Pemetrexed.
DR   DrugBank; DB00116; Tetrahydrofolic acid.
DR   iPTMnet; P31939; -.
DR   MetOSite; P31939; -.
DR   PhosphoSitePlus; P31939; -.
DR   SwissPalm; P31939; -.
DR   BioMuta; ATIC; -.
DR   DMDM; 23831360; -.
DR   REPRODUCTION-2DPAGE; IPI00289499; -.
DR   UCD-2DPAGE; P31939; -.
DR   EPD; P31939; -.
DR   jPOST; P31939; -.
DR   MassIVE; P31939; -.
DR   PaxDb; P31939; -.
DR   PeptideAtlas; P31939; -.
DR   PRIDE; P31939; -.
DR   ProteomicsDB; 19298; -.
DR   ProteomicsDB; 54805; -. [P31939-1]
DR   Antibodypedia; 4601; 387 antibodies.
DR   DNASU; 471; -.
DR   Ensembl; ENST00000236959; ENSP00000236959; ENSG00000138363. [P31939-1]
DR   Ensembl; ENST00000435675; ENSP00000415935; ENSG00000138363. [P31939-2]
DR   GeneID; 471; -.
DR   KEGG; hsa:471; -.
DR   UCSC; uc002vey.5; human. [P31939-1]
DR   CTD; 471; -.
DR   DisGeNET; 471; -.
DR   GeneCards; ATIC; -.
DR   HGNC; HGNC:794; ATIC.
DR   HPA; ENSG00000138363; Low tissue specificity.
DR   MalaCards; ATIC; -.
DR   MIM; 601731; gene.
DR   MIM; 608688; phenotype.
DR   neXtProt; NX_P31939; -.
DR   OpenTargets; ENSG00000138363; -.
DR   Orphanet; 250977; AICA-ribosiduria.
DR   PharmGKB; PA25094; -.
DR   eggNOG; KOG2555; Eukaryota.
DR   eggNOG; COG0138; LUCA.
DR   GeneTree; ENSGT00390000004553; -.
DR   HOGENOM; CLU_016316_3_2_1; -.
DR   InParanoid; P31939; -.
DR   KO; K00602; -.
DR   OMA; WRVAKFV; -.
DR   PhylomeDB; P31939; -.
DR   TreeFam; TF105642; -.
DR   BioCyc; MetaCyc:HS06490-MONOMER; -.
DR   BRENDA; 2.1.2.3; 2681.
DR   BRENDA; 3.5.4.10; 2681.
DR   Reactome; R-HSA-73817; Purine ribonucleoside monophosphate biosynthesis.
DR   SABIO-RK; P31939; -.
DR   SIGNOR; P31939; -.
DR   UniPathway; UPA00074; UER00133.
DR   UniPathway; UPA00074; UER00135.
DR   ChiTaRS; ATIC; human.
DR   EvolutionaryTrace; P31939; -.
DR   GeneWiki; Inosine_monophosphate_synthase; -.
DR   GenomeRNAi; 471; -.
DR   Pharos; P31939; Tchem.
DR   PRO; PR:P31939; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; P31939; protein.
DR   Bgee; ENSG00000138363; Expressed in adrenal gland and 228 other tissues.
DR   ExpressionAtlas; P31939; baseline and differential.
DR   Genevisible; P31939; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0003937; F:IMP cyclohydrolase activity; IBA:GO_Central.
DR   GO; GO:0004643; F:phosphoribosylaminoimidazolecarboxamide formyltransferase activity; IBA:GO_Central.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:UniProtKB.
DR   GO; GO:0006189; P:'de novo' IMP biosynthetic process; IBA:GO_Central.
DR   GO; GO:0031100; P:animal organ regeneration; IEA:Ensembl.
DR   GO; GO:0003360; P:brainstem development; IEA:Ensembl.
DR   GO; GO:0098761; P:cellular response to interleukin-7; IEA:Ensembl.
DR   GO; GO:0021549; P:cerebellum development; IEA:Ensembl.
DR   GO; GO:0021987; P:cerebral cortex development; IEA:Ensembl.
DR   GO; GO:0046452; P:dihydrofolate metabolic process; IEA:Ensembl.
DR   GO; GO:0006139; P:nucleobase-containing compound metabolic process; TAS:ProtInc.
DR   GO; GO:0009116; P:nucleoside metabolic process; IEA:Ensembl.
DR   GO; GO:0009168; P:purine ribonucleoside monophosphate biosynthetic process; TAS:Reactome.
DR   GO; GO:0010035; P:response to inorganic substance; IEA:Ensembl.
DR   GO; GO:0046654; P:tetrahydrofolate biosynthetic process; IEA:Ensembl.
DR   Gene3D; 1.10.287.440; -; 1.
DR   Gene3D; 3.40.140.20; -; 2.
DR   Gene3D; 3.40.50.1380; -; 1.
DR   HAMAP; MF_00139; PurH; 1.
DR   InterPro; IPR024051; AICAR_Tfase_dup_dom_sf.
DR   InterPro; IPR024050; AICAR_Tfase_insert_dom_sf.
DR   InterPro; IPR016193; Cytidine_deaminase-like.
DR   InterPro; IPR011607; MGS-like_dom.
DR   InterPro; IPR036914; MGS-like_dom_sf.
DR   InterPro; IPR002695; PurH-like.
DR   PANTHER; PTHR11692; PTHR11692; 1.
DR   Pfam; PF01808; AICARFT_IMPCHas; 1.
DR   Pfam; PF02142; MGS; 1.
DR   PIRSF; PIRSF000414; AICARFT_IMPCHas; 1.
DR   SMART; SM00798; AICARFT_IMPCHas; 1.
DR   SMART; SM00851; MGS; 1.
DR   SUPFAM; SSF52335; SSF52335; 1.
DR   SUPFAM; SSF53927; SSF53927; 1.
DR   TIGRFAMs; TIGR00355; purH; 1.
DR   PROSITE; PS51855; MGS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Direct protein sequencing;
KW   Disease mutation; Epilepsy; Hydrolase; Multifunctional enzyme;
KW   Polymorphism; Purine biosynthesis; Reference proteome; Transferase.
FT   CHAIN           1..592
FT                   /note="Bifunctional purine biosynthesis protein PURH"
FT                   /id="PRO_0000192156"
FT   INIT_MET        1
FT                   /note="Removed; alternate"
FT                   /evidence="ECO:0000244|PubMed:22223895"
FT   CHAIN           2..592
FT                   /note="Bifunctional purine biosynthesis protein PURH, N-
FT                   terminally processed"
FT                   /id="PRO_0000434376"
FT   DOMAIN          1..146
FT                   /note="MGS-like"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01202"
FT   NP_BIND         12..14
FT                   /note="IMP"
FT   NP_BIND         34..37
FT                   /note="IMP"
FT   NP_BIND         64..67
FT                   /note="IMP"
FT   NP_BIND         101..104
FT                   /note="IMP"
FT   NP_BIND         125..127
FT                   /note="IMP"
FT   REGION          207..208
FT                   /note="AICAR binding"
FT   ACT_SITE        137
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        267
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000305"
FT   BINDING         316
FT                   /note="AICAR; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:14966129"
FT   BINDING         339
FT                   /note="AICAR"
FT                   /evidence="ECO:0000269|PubMed:14966129"
FT   BINDING         431
FT                   /note="AICAR; shared with dimeric partner"
FT                   /evidence="ECO:0000269|PubMed:14966129"
FT   BINDING         451
FT                   /note="AICAR; shared with dimeric partner"
FT                   /evidence="ECO:0000269|PubMed:14966129"
FT   BINDING         541
FT                   /note="AICAR; via carbonyl oxygen; shared with dimeric
FT                   partner"
FT                   /evidence="ECO:0000269|PubMed:14966129"
FT   BINDING         588
FT                   /note="AICAR; shared with dimeric partner"
FT                   /evidence="ECO:0000269|PubMed:14966129"
FT   SITE            266
FT                   /note="Transition state stabilizer"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000244|PubMed:19413330"
FT   MOD_RES         199
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   VAR_SEQ         1..6
FT                   /note="MAPGQL -> MSSLS (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:8567683"
FT                   /id="VSP_053495"
FT   VARIANT         116
FT                   /note="T -> S (in dbSNP:rs2372536)"
FT                   /evidence="ECO:0000269|PubMed:14702039, ECO:0000269|Ref.7"
FT                   /id="VAR_019306"
FT   VARIANT         426
FT                   /note="K -> R (in AICAR; loss of transformylase activity;
FT                   dbSNP:rs121434478)"
FT                   /evidence="ECO:0000269|PubMed:15114530"
FT                   /id="VAR_019307"
FT   CONFLICT        165
FT                   /note="D -> G (in Ref. 1; AAA97405)"
FT                   /evidence="ECO:0000305"
FT   STRAND          6..13
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   HELIX           17..26
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   STRAND          30..33
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   HELIX           35..42
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   TURN            43..45
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   HELIX           51..55
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   HELIX           61..63
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   STRAND          65..67
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   HELIX           70..77
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   HELIX           82..91
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   STRAND          96..102
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   HELIX           106..110
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   HELIX           117..122
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   HELIX           127..137
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   TURN            138..141
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   STRAND          143..145
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   HELIX           148..150
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   HELIX           151..160
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   STRAND          161..165
FT                   /evidence="ECO:0000244|PDB:1P4R"
FT   HELIX           168..197
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   TURN            200..202
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   STRAND          203..205
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   STRAND          209..211
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   STRAND          217..220
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   STRAND          222..225
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   STRAND          227..233
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   HELIX           237..257
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   STRAND          261..266
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   STRAND          269..275
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   HELIX           281..286
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   HELIX           290..295
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   HELIX           298..308
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   TURN            309..316
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   STRAND          317..323
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   HELIX           327..334
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   STRAND          338..344
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   HELIX           348..355
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   HELIX           358..360
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   STRAND          363..367
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   STRAND          375..381
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   STRAND          384..389
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   HELIX           397..400
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   HELIX           412..426
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   STRAND          433..437
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   STRAND          440..445
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   HELIX           451..467
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   HELIX           471..474
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   HELIX           484..496
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   HELIX           502..509
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   STRAND          512..514
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   HELIX           521..528
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   STRAND          534..540
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   STRAND          543..545
FT                   /evidence="ECO:0000244|PDB:1PL0"
FT   HELIX           546..552
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   TURN            553..555
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   STRAND          556..562
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   HELIX           568..577
FT                   /evidence="ECO:0000244|PDB:5UZ0"
FT   STRAND          581..586
FT                   /evidence="ECO:0000244|PDB:5UZ0"
SQ   SEQUENCE   592 AA;  64616 MW;  AD778892021F0888 CRC64;
     MAPGQLALFS VSDKTGLVEF ARNLTALGLN LVASGGTAKA LRDAGLAVRD VSELTGFPEM
     LGGRVKTLHP AVHAGILARN IPEDNADMAR LDFNLIRVVA CNLYPFVKTV ASPGVTVEEA
     VEQIDIGGVT LLRAAAKNHA RVTVVCEPED YVVVSTEMQS SESKDTSLET RRQLALKAFT
     HTAQYDEAIS DYFRKQYSKG VSQMPLRYGM NPHQTPAQLY TLQPKLPITV LNGAPGFINL
     CDALNAWQLV KELKEALGIP AAASFKHVSP AGAAVGIPLS EDEAKVCMVY DLYKTLTPIS
     AAYARARGAD RMSSFGDFVA LSDVCDVPTA KIISREVSDG IIAPGYEEEA LTILSKKKNG
     NYCVLQMDQS YKPDENEVRT LFGLHLSQKR NNGVVDKSLF SNVVTKNKDL PESALRDLIV
     ATIAVKYTQS NSVCYAKNGQ VIGIGAGQQS RIHCTRLAGD KANYWWLRHH PQVLSMKFKT
     GVKRAEISNA IDQYVTGTIG EDEDLIKWKA LFEEVPELLT EAEKKEWVEK LTEVSISSDA
     FFPFRDNVDR AKRSGVAYIA APSGSAADKV VIEACDELGI ILAHTNLRLF HH
//
ID   V9HWH7_HUMAN            Unreviewed;       592 AA.
AC   V9HWH7;
DT   19-MAR-2014, integrated into UniProtKB/TrEMBL.
DT   19-MAR-2014, sequence version 1.
DT   22-APR-2020, entry version 39.
DE   SubName: Full=Epididymis secretory sperm binding protein Li 70p {ECO:0000313|EMBL:ACJ13708.1};
GN   Name=HEL-S-70p {ECO:0000313|EMBL:ACJ13708.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACJ13708.1};
RN   [1] {ECO:0000313|EMBL:ACJ13708.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J.Y., Wang H.Y., Liu F.J., Liu J.;
RL   Submitted (JUN-2008) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EU794654; ACJ13708.1; -; mRNA.
DR   RefSeq; NP_004035.2; NM_004044.6.
DR   SMR; V9HWH7; -.
DR   MaxQB; V9HWH7; -.
DR   PRIDE; V9HWH7; -.
DR   Antibodypedia; 4601; 387 antibodies.
DR   GeneID; 471; -.
DR   KEGG; hsa:471; -.
DR   UCSC; uc002vex.5; human.
DR   CTD; 471; -.
DR   EuPathDB; HostDB:ENSG00000138363.14; -.
DR   eggNOG; KOG2555; Eukaryota.
DR   eggNOG; COG0138; LUCA.
DR   HOGENOM; CLU_016316_3_2_1; -.
DR   KO; K00602; -.
DR   OMA; WRVAKFV; -.
DR   OrthoDB; 324473at2759; -.
DR   PhylomeDB; V9HWH7; -.
DR   ChiTaRS; ATIC; human.
DR   GenomeRNAi; 471; -.
DR   Bgee; ENSG00000138363; Expressed in adrenal gland and 228 other tissues.
DR   ExpressionAtlas; V9HWH7; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0003937; F:IMP cyclohydrolase activity; IEA:Ensembl.
DR   GO; GO:0004643; F:phosphoribosylaminoimidazolecarboxamide formyltransferase activity; IEA:Ensembl.
DR   GO; GO:0006189; P:'de novo' IMP biosynthetic process; IEA:Ensembl.
DR   GO; GO:0031100; P:animal organ regeneration; IEA:Ensembl.
DR   GO; GO:0003360; P:brainstem development; IEA:Ensembl.
DR   GO; GO:0098761; P:cellular response to interleukin-7; IEA:Ensembl.
DR   GO; GO:0021549; P:cerebellum development; IEA:Ensembl.
DR   GO; GO:0021987; P:cerebral cortex development; IEA:Ensembl.
DR   GO; GO:0046452; P:dihydrofolate metabolic process; IEA:Ensembl.
DR   GO; GO:0009116; P:nucleoside metabolic process; IEA:Ensembl.
DR   GO; GO:0010035; P:response to inorganic substance; IEA:Ensembl.
DR   GO; GO:0046654; P:tetrahydrofolate biosynthetic process; IEA:Ensembl.
DR   Gene3D; 1.10.287.440; -; 1.
DR   Gene3D; 3.40.140.20; -; 2.
DR   Gene3D; 3.40.50.1380; -; 1.
DR   HAMAP; MF_00139; PurH; 1.
DR   InterPro; IPR024051; AICAR_Tfase_dup_dom_sf.
DR   InterPro; IPR024050; AICAR_Tfase_insert_dom_sf.
DR   InterPro; IPR016193; Cytidine_deaminase-like.
DR   InterPro; IPR011607; MGS-like_dom.
DR   InterPro; IPR036914; MGS-like_dom_sf.
DR   InterPro; IPR002695; PurH-like.
DR   PANTHER; PTHR11692; PTHR11692; 1.
DR   Pfam; PF01808; AICARFT_IMPCHas; 1.
DR   Pfam; PF02142; MGS; 1.
DR   PIRSF; PIRSF000414; AICARFT_IMPCHas; 1.
DR   SMART; SM00798; AICARFT_IMPCHas; 1.
DR   SMART; SM00851; MGS; 1.
DR   SUPFAM; SSF52335; SSF52335; 1.
DR   SUPFAM; SSF53927; SSF53927; 1.
DR   TIGRFAMs; TIGR00355; purH; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN          16..130
FT                   /note="MGS"
FT                   /evidence="ECO:0000259|SMART:SM00851"
SQ   SEQUENCE   592 AA;  64616 MW;  AD778892021F0888 CRC64;
     MAPGQLALFS VSDKTGLVEF ARNLTALGLN LVASGGTAKA LRDAGLAVRD VSELTGFPEM
     LGGRVKTLHP AVHAGILARN IPEDNADMAR LDFNLIRVVA CNLYPFVKTV ASPGVTVEEA
     VEQIDIGGVT LLRAAAKNHA RVTVVCEPED YVVVSTEMQS SESKDTSLET RRQLALKAFT
     HTAQYDEAIS DYFRKQYSKG VSQMPLRYGM NPHQTPAQLY TLQPKLPITV LNGAPGFINL
     CDALNAWQLV KELKEALGIP AAASFKHVSP AGAAVGIPLS EDEAKVCMVY DLYKTLTPIS
     AAYARARGAD RMSSFGDFVA LSDVCDVPTA KIISREVSDG IIAPGYEEEA LTILSKKKNG
     NYCVLQMDQS YKPDENEVRT LFGLHLSQKR NNGVVDKSLF SNVVTKNKDL PESALRDLIV
     ATIAVKYTQS NSVCYAKNGQ VIGIGAGQQS RIHCTRLAGD KANYWWLRHH PQVLSMKFKT
     GVKRAEISNA IDQYVTGTIG EDEDLIKWKA LFEEVPELLT EAEKKEWVEK LTEVSISSDA
     FFPFRDNVDR AKRSGVAYIA APSGSAADKV VIEACDELGI ILAHTNLRLF HH
//
ID   BCL7A_HUMAN             Reviewed;         210 AA.
AC   Q4VC05; B4DJN6; B7ZB21; Q13843; Q14CT7;
DT   13-JUN-2006, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2005, sequence version 1.
DT   22-APR-2020, entry version 117.
DE   RecName: Full=B-cell CLL/lymphoma 7 protein family member A;
GN   Name=BCL7A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND CHROMOSOMAL TRANSLOCATION.
RC   TISSUE=Brain;
RX   PubMed=8605326;
RA   Zani V.J., Asou N., Jadayel D., Heward J.M., Shipley J., Nacheva E.,
RA   Takasuki K., Catovsky D., Dyer M.J.S.;
RT   "Molecular cloning of complex chromosomal translocation
RT   t(8;14;12)(q24.1;q32.3;q24.1) in a Burkitt lymphoma cell line defines a new
RT   gene (BCL7A) with homology to caldesmon.";
RL   Blood 87:3124-3134(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Kidney, and Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-203 AND SER-207, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [10]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-199, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
CC   -!- INTERACTION:
CC       Q4VC05; P13196: ALAS1; NbExp=3; IntAct=EBI-359917, EBI-3905054;
CC       Q4VC05-2; Q92624: APPBP2; NbExp=3; IntAct=EBI-12065992, EBI-743771;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=Isoform b;
CC         IsoId=Q4VC05-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q4VC05-2; Sequence=VSP_019271;
CC   -!- DISEASE: Note=Chromosomal aberrations involving BCL7A may be a cause of
CC       B-cell non-Hodgkin lymphoma. Three-way translocation
CC       t(8;14;12)(q24.1;q32.3;q24.1) with MYC and with immunoglobulin gene
CC       regions. {ECO:0000269|PubMed:8605326}.
CC   -!- SIMILARITY: Belongs to the BCL7 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X89984; CAA62011.1; -; mRNA.
DR   EMBL; AK296159; BAG58898.1; -; mRNA.
DR   EMBL; AK316486; BAH14857.1; -; mRNA.
DR   EMBL; CH471054; EAW98302.1; -; Genomic_DNA.
DR   EMBL; BC094723; AAH94723.1; -; mRNA.
DR   EMBL; BC113627; AAI13628.1; -; mRNA.
DR   CCDS; CCDS53841.1; -. [Q4VC05-1]
DR   CCDS; CCDS9226.1; -. [Q4VC05-2]
DR   PIR; S58237; S58245.
DR   RefSeq; NP_001019979.1; NM_001024808.2. [Q4VC05-1]
DR   RefSeq; NP_066273.1; NM_020993.4. [Q4VC05-2]
DR   BioGrid; 107077; 58.
DR   ComplexPortal; CPX-1195; Embryonic stem cell-specific SWI/SNF ATP-dependent chromatin remodeling complex.
DR   ComplexPortal; CPX-4084; GBAF (SWI/SNF) ATP-dependent chromatin remodeling complex, ACTL6A-BICRA-SMARCA2 variant.
DR   ComplexPortal; CPX-4203; GBAF (SWI/SNF) ATP-dependent chromatin remodeling complex, ACTL6A-BICRAL-SMARCA2 variant.
DR   ComplexPortal; CPX-4206; GBAF (SWI/SNF) ATP-dependent chromatin remodeling complex, ACTL6A-BICRA-SMARCA4 variant.
DR   ComplexPortal; CPX-4207; GBAF (SWI/SNF) ATP-dependent chromatin remodeling complex, ACTL6A-BICRAL-SMARCA4 variant.
DR   ComplexPortal; CPX-4223; GBAF (SWI/SNF) ATP-dependent chromatin remodeling complex, ACTL6B-BICRA-SMARCA2 variant.
DR   ComplexPortal; CPX-4224; GBAF (SWI/SNF) ATP-dependent chromatin remodeling complex, ACTL6B-BICRAL-SMARCA2 variant.
DR   ComplexPortal; CPX-4225; GBAF (SWI/SNF) ATP-dependent chromatin remodeling complex, ACTL6B-BICRA-SMARCA4 variant.
DR   ComplexPortal; CPX-4226; GBAF (SWI/SNF) ATP-dependent chromatin remodeling complex, ACTL6B-BICRAL-SMARCA4 variant.
DR   DIP; DIP-27608N; -.
DR   IntAct; Q4VC05; 60.
DR   STRING; 9606.ENSP00000445868; -.
DR   iPTMnet; Q4VC05; -.
DR   MetOSite; Q4VC05; -.
DR   PhosphoSitePlus; Q4VC05; -.
DR   BioMuta; BCL7A; -.
DR   DMDM; 74754614; -.
DR   EPD; Q4VC05; -.
DR   jPOST; Q4VC05; -.
DR   MassIVE; Q4VC05; -.
DR   MaxQB; Q4VC05; -.
DR   PeptideAtlas; Q4VC05; -.
DR   PRIDE; Q4VC05; -.
DR   ProteomicsDB; 62295; -. [Q4VC05-1]
DR   ProteomicsDB; 62296; -. [Q4VC05-2]
DR   Antibodypedia; 31614; 187 antibodies.
DR   DNASU; 605; -.
DR   Ensembl; ENST00000261822; ENSP00000261822; ENSG00000110987. [Q4VC05-1]
DR   Ensembl; ENST00000538010; ENSP00000445868; ENSG00000110987. [Q4VC05-2]
DR   Ensembl; ENST00000635191; ENSP00000489010; ENSG00000282873. [Q4VC05-2]
DR   Ensembl; ENST00000635403; ENSP00000489305; ENSG00000282873. [Q4VC05-1]
DR   GeneID; 605; -.
DR   KEGG; hsa:605; -.
DR   UCSC; uc001ubo.4; human. [Q4VC05-1]
DR   CTD; 605; -.
DR   DisGeNET; 605; -.
DR   GeneCards; BCL7A; -.
DR   HGNC; HGNC:1004; BCL7A.
DR   HPA; ENSG00000110987; Low tissue specificity.
DR   MIM; 601406; gene.
DR   neXtProt; NX_Q4VC05; -.
DR   OpenTargets; ENSG00000110987; -.
DR   PharmGKB; PA25314; -.
DR   GeneTree; ENSGT00390000002172; -.
DR   HOGENOM; CLU_110835_0_0_1; -.
DR   InParanoid; Q4VC05; -.
DR   OMA; TISQVPR; -.
DR   OrthoDB; 1517597at2759; -.
DR   PhylomeDB; Q4VC05; -.
DR   TreeFam; TF317441; -.
DR   ChiTaRS; BCL7A; human.
DR   GenomeRNAi; 605; -.
DR   Pharos; Q4VC05; Tbio.
DR   PRO; PR:Q4VC05; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; Q4VC05; protein.
DR   Bgee; ENSG00000110987; Expressed in cerebral cortex and 195 other tissues.
DR   Genevisible; Q4VC05; HS.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; NAS:UniProtKB.
DR   InterPro; IPR006804; BCL7.
DR   PANTHER; PTHR12767; PTHR12767; 1.
DR   Pfam; PF04714; BCL_N; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Chromosomal rearrangement; Isopeptide bond;
KW   Phosphoprotein; Polymorphism; Reference proteome; Ubl conjugation.
FT   CHAIN           1..210
FT                   /note="B-cell CLL/lymphoma 7 protein family member A"
FT                   /id="PRO_0000239823"
FT   MOD_RES         203
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17525332"
FT   MOD_RES         207
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17525332"
FT   CROSSLNK        199
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25218447"
FT   VAR_SEQ         187
FT                   /note="Q -> QVPRSRSQRGSQIGREPIGLSG (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:8605326"
FT                   /id="VSP_019271"
FT   VARIANT         120
FT                   /note="N -> T (in dbSNP:rs34821485)"
FT                   /id="VAR_033539"
SQ   SEQUENCE   210 AA;  22810 MW;  4AB4AC3B309ADDB8 CRC64;
     MSGRSVRAET RSRAKDDIKR VMAAIEKVRK WEKKWVTVGD TSLRIYKWVP VTEPKVDDKN
     KNKKKGKDEK CGSEVTTPEN SSSPGMMDMH DDNSNQSSIA DASPIKQENS SNSSPAPEPN
     SAVPSDGTEA KVDEAQADGK EHPGAEDASD EQNSQSSMEH SMNSSEKVDR QPSGDSGLAA
     ETSAISQDLE GVPPSKKMKL EASQQNSEEM
//
ID   BCR_HUMAN               Reviewed;        1271 AA.
AC   P11274; P78501; Q12842; Q4LE80; Q6NZI3;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   03-APR-2007, sequence version 2.
DT   22-APR-2020, entry version 232.
DE   RecName: Full=Breakpoint cluster region protein {ECO:0000305};
DE            EC=2.7.11.1 {ECO:0000269|PubMed:1657398};
DE   AltName: Full=Renal carcinoma antigen NY-REN-26;
GN   Name=BCR {ECO:0000312|HGNC:HGNC:1014}; Synonyms=BCR1, D22S11;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANT SER-796.
RX   PubMed=3285291;
RA   Lifshitz B., Fainstein E., Marcelle C., Shtivelman E., Amson R., Gale R.P.,
RA   Canaani E.;
RT   "bcr genes and transcripts.";
RL   Oncogene 2:113-117(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND CHROMOSOMAL TRANSLOCATION.
RX   PubMed=7665185; DOI=10.1006/geno.1995.1008;
RA   Chissoe S.L., Bodenteich A., Wang Y.-F., Wang Y.-P., Burian D.,
RA   Clifton S.W., Crabtree J., Freeman A., Iyer K., Jian L., Ma Y.,
RA   McLaury H.-J., Pan H.-Q., Sarhan O.H., Toth S., Wang Z., Zhang G.,
RA   Heisterkamp N., Groffen J., Roe B.A.;
RT   "Sequence and analysis of the human ABL gene, the BCR gene, and regions
RT   involved in the Philadelphia chromosomal translocation.";
RL   Genomics 27:67-82(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT SER-796.
RC   TISSUE=Brain;
RA   Nakajima D., Saito K., Yamakawa H., Kikuno R.F., Nakayama M., Ohara R.,
RA   Okazaki N., Koga H., Nagase T., Ohara O.;
RT   "Preparation of a set of expression-ready clones of mammalian long cDNAs
RT   encoding large proteins by the ORF trap cloning method.";
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-872, CHROMOSOMAL TRANSLOCATION, INVOLVEMENT
RP   IN CML, AND VARIANT SER-796.
RX   PubMed=3107980; DOI=10.1002/j.1460-2075.1987.tb04727.x;
RA   Hariharan I.K., Adams J.M.;
RT   "cDNA sequence for human bcr, the gene that translocates to the abl
RT   oncogene in chronic myeloid leukaemia.";
RL   EMBO J. 6:115-119(1987).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-693, AND INVOLVEMENT IN CML.
RX   PubMed=3540951; DOI=10.1073/pnas.83.24.9768;
RA   Mes-Masson A.-M., McLaughlin J., Daley G.Q., Paskind M., Witte O.N.;
RT   "Overlapping cDNA clones define the complete coding region for the P210c-
RT   abl gene product associated with chronic myelogenous leukemia cells
RT   containing the Philadelphia chromosome.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:9768-9772(1986).
RN   [6]
RP   ERRATUM OF PUBMED:3540951, AND SEQUENCE REVISION.
RA   Mes-Masson A.M., McLaughlin J., Daley G.Q., Paskind M., Witte O.N.;
RL   Proc. Natl. Acad. Sci. U.S.A. 84:2507-2507(1987).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 683-1271 (ISOFORM 1).
RX   PubMed=2989703; DOI=10.1038/315758a0;
RA   Heisterkamp N., Stam K., Groffen J., de Klein A., Grosveld G.;
RT   "Structural organization of the bcr gene and its role in the Ph'
RT   translocation.";
RL   Nature 315:758-761(1985).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-46 AND 275-426.
RX   PubMed=2263470; DOI=10.1093/nar/18.23.7119;
RA   Zhu Q.S., Heisterkamp N., Groffen J.;
RT   "Unique organization of the human BCR gene promoter.";
RL   Nucleic Acids Res. 18:7119-7125(1990).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 56-426.
RX   PubMed=2825022; DOI=10.1038/330386a0;
RA   Fainstein E., Marcelle C., Rosner A., Canaani E., Gale R.P., Dreazen O.,
RA   Smith S.D., Croce C.M.;
RT   "A new fused transcript in Philadelphia chromosome positive acute
RT   lymphocytic leukaemia.";
RL   Nature 330:386-388(1987).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 362-438, AND ALTERNATIVE SPLICING.
RX   PubMed=2915904;
RA   Romero P., Beran M., Shtalrid M., Andersson B., Talpaz M., Blick M.;
RT   "Alternative 5' end of the bcr-abl transcript in chronic myelogenous
RT   leukemia.";
RL   Oncogene 4:93-98(1989).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 670-842, INVOLVEMENT IN CML, AND
RP   VARIANT SER-796.
RX   PubMed=2407300;
RA   Selleri L., von Lindern M., Hermans A., Meijer D., Torelli G., Grosveld G.;
RT   "Chronic myeloid leukemia may be associated with several bcr-abl
RT   transcripts including the acute lymphoid leukemia-type 7 kb transcript.";
RL   Blood 75:1146-1153(1990).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-4.
RX   PubMed=1900918; DOI=10.1128/mcb.11.4.1854;
RA   Shah N.P., Witte O.N., Denny C.T.;
RT   "Characterization of the BCR promoter in Philadelphia chromosome-positive
RT   and -negative cell lines.";
RL   Mol. Cell. Biol. 11:1854-1860(1991).
RN   [13]
RP   FUNCTION.
RX   PubMed=1903516; DOI=10.1038/351400a0;
RA   Diekmann D., Brill S., Garrett M.D., Totty N., Hsuan J., Monfries C.,
RA   Hall C., Lim L., Hall A.;
RT   "Bcr encodes a GTPase-activating protein for p21rac.";
RL   Nature 351:400-402(1991).
RN   [14]
RP   INTERACTION WITH ABL1 SH2-DOMAIN.
RX   PubMed=1712671; DOI=10.1016/0092-8674(91)90148-r;
RA   Pendergast A.M., Muller A.J., Havlik M.H., Maru Y., Witte O.N.;
RT   "BCR sequences essential for transformation by the BCR-ABL oncogene bind to
RT   the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner.";
RL   Cell 66:161-171(1991).
RN   [15]
RP   FUNCTION AS PROTEIN KINASE, AND CATALYTIC ACTIVITY.
RX   PubMed=1657398; DOI=10.1016/0092-8674(91)90521-y;
RA   Maru Y., Witte O.N.;
RT   "The BCR gene encodes a novel serine/threonine kinase activity within a
RT   single exon.";
RL   Cell 67:459-468(1991).
RN   [16]
RP   FUNCTION, AND DOMAIN.
RX   PubMed=7479768; DOI=10.1073/pnas.92.22.10282;
RA   Chuang T.H., Xu X., Kaartinen V., Heisterkamp N., Groffen J., Bokoch G.M.;
RT   "Abr and Bcr are multifunctional regulators of the Rho GTP-binding protein
RT   family.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:10282-10286(1995).
RN   [17]
RP   PHOSPHORYLATION AT TYR-177 BY HCK, MUTAGENESIS OF TYR-177, AND INTERACTION
RP   WITH HCK AND GRB2.
RX   PubMed=9407116; DOI=10.1074/jbc.272.52.33260;
RA   Warmuth M., Bergmann M., Priess A., Hauslmann K., Emmerich B., Hallek M.;
RT   "The Src family kinase Hck interacts with Bcr-Abl by a kinase-independent
RT   mechanism and phosphorylates the Grb2-binding site of Bcr.";
RL   J. Biol. Chem. 272:33260-33270(1997).
RN   [18]
RP   IDENTIFICATION AS A RENAL CANCER ANTIGEN.
RC   TISSUE=Renal cell carcinoma;
RX   PubMed=10508479;
RX   DOI=10.1002/(sici)1097-0215(19991112)83:4<456::aid-ijc4>3.0.co;2-5;
RA   Scanlan M.J., Gordan J.D., Williamson B., Stockert E., Bander N.H.,
RA   Jongeneel C.V., Gure A.O., Jaeger D., Jaeger E., Knuth A., Chen Y.-T.,
RA   Old L.J.;
RT   "Antigens recognized by autologous antibody in patients with renal-cell
RT   carcinoma.";
RL   Int. J. Cancer 83:456-464(1999).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1264, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=15144186; DOI=10.1021/ac035352d;
RA   Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,
RA   Peters E.C.;
RT   "Robust phosphoproteomic profiling of tyrosine phosphorylation sites from
RT   human T cells using immobilized metal affinity chromatography and tandem
RT   mass spectrometry.";
RL   Anal. Chem. 76:2763-2772(2004).
RN   [20]
RP   INTERACTION WITH FES/FPS; ABL1; PIK3R1 AND GRB2, MUTAGENESIS OF TYR-177,
RP   PHOSPHORYLATION AT TYR-246, AND FUNCTION.
RX   PubMed=15302586; DOI=10.1016/j.yexcr.2004.05.010;
RA   Laurent C.E., Smithgall T.E.;
RT   "The c-Fes tyrosine kinase cooperates with the breakpoint cluster region
RT   protein (Bcr) to induce neurite extension in a Rac- and Cdc42-dependent
RT   manner.";
RL   Exp. Cell Res. 299:188-198(2004).
RN   [21]
RP   INTERACTION WITH PDZK1, AND MUTAGENESIS OF 1269-THR--GLU-1271 AND VAL-1271.
RX   PubMed=15494376; DOI=10.1242/jcs.01472;
RA   Malmberg E.K., Andersson C.X., Gentzsch M., Chen J.H., Mengos A., Cui L.,
RA   Hansson G.C., Riordan J.R.;
RT   "Bcr (breakpoint cluster region) protein binds to PDZ-domains of scaffold
RT   protein PDZK1 and vesicle coat protein Mint3.";
RL   J. Cell Sci. 117:5535-5541(2004).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [23]
RP   FUNCTION, AND MUTAGENESIS OF ARG-1090 AND ASN-1202.
RX   PubMed=17116687; DOI=10.1128/mcb.00756-06;
RA   Cho Y.J., Cunnick J.M., Yi S.J., Kaartinen V., Groffen J., Heisterkamp N.;
RT   "Abr and Bcr, two homologous Rac GTPase-activating proteins, control
RT   multiple cellular functions of murine macrophages.";
RL   Mol. Cell. Biol. 27:899-911(2007).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-459, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-177; SER-459 AND SER-1264,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [27]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-122; SER-215 AND SER-459, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [29]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [30]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-122; SER-139; SER-202;
RP   SER-215; SER-222; SER-356; SER-377; SER-459; SER-463; SER-473; SER-488;
RP   TYR-554; THR-641; TYR-644; THR-693 AND SER-894, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [31]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-459, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [32]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 3-72, AND HOMOTETRAMERIZATION.
RX   PubMed=11780146; DOI=10.1038/nsb747;
RA   Zhao X., Ghaffari S., Lodish H., Malashkevich V.N., Kim P.S.;
RT   "Structure of the Bcr-Abl oncoprotein oligomerization domain.";
RL   Nat. Struct. Biol. 9:117-120(2002).
RN   [33]
RP   FUNCTION, INTERACTION WITH DLG4, AND MUTAGENESIS OF VAL-1271.
RX   PubMed=20962234; DOI=10.1523/jneurosci.1711-10.2010;
RA   Oh D., Han S., Seo J., Lee J.R., Choi J., Groffen J., Kim K., Cho Y.S.,
RA   Choi H.S., Shin H., Woo J., Won H., Park S.K., Kim S.Y., Jo J.,
RA   Whitcomb D.J., Cho K., Kim H., Bae Y.C., Heisterkamp N., Choi S.Y., Kim E.;
RT   "Regulation of synaptic Rac1 activity, long-term potentiation maintenance,
RT   and learning and memory by BCR and ABR Rac GTPase-activating proteins.";
RL   J. Neurosci. 30:14134-14144(2010).
RN   [34]
RP   FUNCTION, AND MUTAGENESIS OF 689-ASN-GLU-690.
RX   PubMed=23940119; DOI=10.1083/jcb.201304133;
RA   Dubash A.D., Koetsier J.L., Amargo E.V., Najor N.A., Harmon R.M.,
RA   Green K.J.;
RT   "The GEF Bcr activates RhoA/MAL signaling to promote keratinocyte
RT   differentiation via desmoglein-1.";
RL   J. Cell Biol. 202:653-666(2013).
RN   [35]
RP   INTERACTION WITH SH2D5.
RX   PubMed=25331951; DOI=10.1074/jbc.m114.615112;
RA   Gray E.J., Petsalaki E., James D.A., Bagshaw R.D., Stacey M.M., Rocks O.,
RA   Gingras A.C., Pawson T.;
RT   "src homology 2 domain containing protein 5 (sh2d5) binds the breakpoint
RT   cluster region protein, BCR, and regulates levels of Rac1-GTP.";
RL   J. Biol. Chem. 289:35397-35408(2014).
RN   [36]
RP   VARIANTS [LARGE SCALE ANALYSIS] PRO-400; MET-413; GLU-752; SER-796;
RP   CYS-910; ILE-949; LYS-1037; MET-1091; ALA-1096; GLY-1104; ASN-1106;
RP   THR-1149; LYS-1161; GLU-1187; MET-1189; GLY-1204 AND ARG-1235.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Protein with a unique structure having two opposing
CC       regulatory activities toward small GTP-binding proteins. The C-terminus
CC       is a GTPase-activating protein (GAP) domain which stimulates GTP
CC       hydrolysis by RAC1, RAC2 and CDC42. Accelerates the intrinsic rate of
CC       GTP hydrolysis of RAC1 or CDC42, leading to down-regulation of the
CC       active GTP-bound form (PubMed:7479768, PubMed:1903516,
CC       PubMed:17116687). The central Dbl homology (DH) domain functions as
CC       guanine nucleotide exchange factor (GEF) that modulates the GTPases
CC       CDC42, RHOA and RAC1. Promotes the conversion of CDC42, RHOA and RAC1
CC       from the GDP-bound to the GTP-bound form (PubMed:7479768,
CC       PubMed:23940119). The amino terminus contains an intrinsic kinase
CC       activity (PubMed:1657398). Functions as an important negative regulator
CC       of neuronal RAC1 activity (By similarity). Regulates macrophage
CC       functions such as CSF1-directed motility and phagocytosis through the
CC       modulation of RAC1 activity (PubMed:17116687). Plays a major role as a
CC       RHOA GEF in keratinocytes being involved in focal adhesion formation
CC       and keratinocyte differentiation (PubMed:23940119).
CC       {ECO:0000250|UniProtKB:Q6PAJ1, ECO:0000269|PubMed:1657398,
CC       ECO:0000269|PubMed:17116687, ECO:0000269|PubMed:1903516,
CC       ECO:0000269|PubMed:23940119, ECO:0000269|PubMed:7479768}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000269|PubMed:1657398};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:17990;
CC         Evidence={ECO:0000269|PubMed:1657398};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000269|PubMed:1657398};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46609;
CC         Evidence={ECO:0000269|PubMed:1657398};
CC   -!- SUBUNIT: Homotetramer. Interacts with PDZK1 (PubMed:15494376). May
CC       interact with CCPG1 (By similarity). Interacts with FES/FPS, ABL1,
CC       PIK3R1 and GRB2 (PubMed:15302586, PubMed:1712671, PubMed:9407116).
CC       Interacts with HCK (PubMed:9407116). Interacts with SH2D5
CC       (PubMed:25331951). Interacts with DLG4 (PubMed:20962234).
CC       {ECO:0000250|UniProtKB:Q6PAJ1, ECO:0000269|PubMed:15302586,
CC       ECO:0000269|PubMed:15494376, ECO:0000269|PubMed:1712671,
CC       ECO:0000269|PubMed:20962234, ECO:0000269|PubMed:25331951,
CC       ECO:0000269|PubMed:9407116}.
CC   -!- INTERACTION:
CC       P11274; P62993: GRB2; NbExp=9; IntAct=EBI-712838, EBI-401755;
CC       P11274-1; P18031: PTPN1; NbExp=3; IntAct=EBI-8658094, EBI-968788;
CC       P11274; Q6ZV89-1: SH2D5; NbExp=2; IntAct=EBI-712838, EBI-15101685;
CC       P11274; A2AM67: Sh2d5; Xeno; NbExp=7; IntAct=EBI-712838, EBI-15101945;
CC       P11274; Q8JZW5: Sh2d5; Xeno; NbExp=2; IntAct=EBI-712838, EBI-15101675;
CC       P11274; Q9H2K2: TNKS2; NbExp=3; IntAct=EBI-712838, EBI-4398527;
CC       P11274; P04637: TP53; NbExp=2; IntAct=EBI-712838, EBI-366083;
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic density
CC       {ECO:0000250|UniProtKB:Q6PAJ1}. Cell projection, dendritic spine
CC       {ECO:0000250|UniProtKB:Q6PAJ1}. Cell projection, axon
CC       {ECO:0000250|UniProtKB:Q6PAJ1}. Cell junction, synapse
CC       {ECO:0000250|UniProtKB:F1LXF1}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P11274-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P11274-2; Sequence=VSP_024352;
CC   -!- DOMAIN: The region involved in binding to ABL1 SH2-domain is rich in
CC       serine residues and needs to be Ser/Thr phosphorylated prior to SH2
CC       binding. This region is essential for the activation of the ABL1
CC       tyrosine kinase and transforming potential of the chimeric BCR-ABL
CC       oncogene.
CC   -!- DOMAIN: The DH domain is involved in interaction with CCPG1.
CC       {ECO:0000250|UniProtKB:Q6PAJ1}.
CC   -!- DOMAIN: The amino terminus contains an intrinsic kinase activity. The
CC       central Dbl homology (DH) domain functions as guanine nucleotide
CC       exchange factor (GEF) that modulates the GTPases CDC42, RHOA and RAC1.
CC       Promotes the conversion of CDC42, RHOA and RAC1 from the GDP-bound to
CC       the GTP-bound form. The C-terminus is a Rho-GAP domain which stimulates
CC       GTP hydrolysis by RAC1, RAC2 and CDC42. The protein has a unique
CC       structure having two opposing regulatory activities toward small GTP-
CC       binding proteins. {ECO:0000305|PubMed:7479768}.
CC   -!- PTM: Autophosphorylated. Phosphorylated by FES/FPS on tyrosine
CC       residues, leading to down-regulation of the BCR kinase activity.
CC       Phosphorylation at Tyr-177 by HCK is important for interaction with
CC       GRB2. {ECO:0000269|PubMed:15302586, ECO:0000269|PubMed:9407116}.
CC   -!- DISEASE: Leukemia, chronic myeloid (CML) [MIM:608232]: A clonal
CC       myeloproliferative disorder of a pluripotent stem cell with a specific
CC       cytogenetic abnormality, the Philadelphia chromosome (Ph), involving
CC       myeloid, erythroid, megakaryocytic, B-lymphoid, and sometimes T-
CC       lymphoid cells, but not marrow fibroblasts.
CC       {ECO:0000269|PubMed:2407300, ECO:0000269|PubMed:3107980,
CC       ECO:0000269|PubMed:3540951}. Note=The gene represented in this entry is
CC       involved in disease pathogenesis.
CC   -!- DISEASE: Note=A chromosomal aberration involving BCR has been found in
CC       patients with chronic myeloid leukemia. Translocation t(9;22)(q34;q11)
CC       with ABL1. The translocation produces a BCR-ABL found also in acute
CC       myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).
CC       {ECO:0000269|PubMed:3107980, ECO:0000269|PubMed:7665185}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAE06073.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/BCRID55.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Y00661; CAA68676.1; -; mRNA.
DR   EMBL; U07000; AAB60388.1; -; Genomic_DNA.
DR   EMBL; AB209991; BAE06073.1; ALT_INIT; mRNA.
DR   EMBL; X02596; CAA26441.1; -; mRNA.
DR   EMBL; M15025; AAA35594.1; -; Genomic_DNA.
DR   EMBL; X52828; CAA37010.1; -; Genomic_DNA.
DR   EMBL; X52829; CAA37011.1; -; Genomic_DNA.
DR   EMBL; X14676; CAA32806.1; -; mRNA.
DR   EMBL; M64437; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS13806.1; -. [P11274-1]
DR   CCDS; CCDS13807.1; -. [P11274-2]
DR   PIR; A26664; TVHUA2.
DR   PIR; A91064; TVHUBR.
DR   RefSeq; NP_004318.3; NM_004327.3. [P11274-1]
DR   RefSeq; NP_067585.2; NM_021574.2. [P11274-2]
DR   PDB; 1K1F; X-ray; 2.20 A; A/B/C/D/E/F/G/H=1-72.
DR   PDB; 2AIN; NMR; -; B=1266-1271.
DR   PDB; 5N6R; NMR; -; A=487-702.
DR   PDB; 5N7E; X-ray; 1.65 A; B=487-702.
DR   PDB; 5OC7; X-ray; 1.65 A; A/D=704-893.
DR   PDBsum; 1K1F; -.
DR   PDBsum; 2AIN; -.
DR   PDBsum; 5N6R; -.
DR   PDBsum; 5N7E; -.
DR   PDBsum; 5OC7; -.
DR   SMR; P11274; -.
DR   BioGrid; 107083; 87.
DR   ELM; P11274; -.
DR   IntAct; P11274; 92.
DR   MINT; P11274; -.
DR   STRING; 9606.ENSP00000303507; -.
DR   BindingDB; P11274; -.
DR   ChEMBL; CHEMBL5146; -.
DR   DrugBank; DB06616; Bosutinib.
DR   DrugBank; DB01254; Dasatinib.
DR   DrugBank; DB00619; Imatinib.
DR   DrugBank; DB08901; Ponatinib.
DR   DrugCentral; P11274; -.
DR   iPTMnet; P11274; -.
DR   MetOSite; P11274; -.
DR   PhosphoSitePlus; P11274; -.
DR   BioMuta; BCR; -.
DR   DMDM; 143811366; -.
DR   EPD; P11274; -.
DR   jPOST; P11274; -.
DR   MassIVE; P11274; -.
DR   MaxQB; P11274; -.
DR   PaxDb; P11274; -.
DR   PeptideAtlas; P11274; -.
DR   PRIDE; P11274; -.
DR   ProteomicsDB; 52729; -. [P11274-1]
DR   ProteomicsDB; 52730; -. [P11274-2]
DR   Antibodypedia; 9277; 622 antibodies.
DR   Ensembl; ENST00000305877; ENSP00000303507; ENSG00000186716. [P11274-1]
DR   Ensembl; ENST00000359540; ENSP00000352535; ENSG00000186716. [P11274-2]
DR   GeneID; 613; -.
DR   KEGG; hsa:613; -.
DR   UCSC; uc002zww.4; human. [P11274-1]
DR   CTD; 613; -.
DR   DisGeNET; 613; -.
DR   GeneCards; BCR; -.
DR   HGNC; HGNC:1014; BCR.
DR   HPA; ENSG00000186716; Low tissue specificity.
DR   MalaCards; BCR; -.
DR   MIM; 151410; gene.
DR   MIM; 608232; phenotype.
DR   neXtProt; NX_P11274; -.
DR   OpenTargets; ENSG00000186716; -.
DR   Orphanet; 521; Chronic myeloid leukemia.
DR   Orphanet; 261330; Distal 22q11.2 microdeletion syndrome.
DR   Orphanet; 99860; Precursor B-cell acute lymphoblastic leukemia.
DR   Orphanet; 99861; Precursor T-cell acute lymphoblastic leukemia.
DR   PharmGKB; PA25321; -.
DR   eggNOG; KOG4269; Eukaryota.
DR   eggNOG; ENOG410XPGZ; LUCA.
DR   GeneTree; ENSGT00940000153491; -.
DR   HOGENOM; CLU_004164_0_0_1; -.
DR   InParanoid; P11274; -.
DR   KO; K08878; -.
DR   OMA; YEIHKDF; -.
DR   OrthoDB; 762492at2759; -.
DR   PhylomeDB; P11274; -.
DR   TreeFam; TF105082; -.
DR   Reactome; R-HSA-1839117; Signaling by cytosolic FGFR1 fusion mutants.
DR   Reactome; R-HSA-194840; Rho GTPase cycle.
DR   Reactome; R-HSA-5655302; Signaling by FGFR1 in disease.
DR   SignaLink; P11274; -.
DR   SIGNOR; P11274; -.
DR   ChiTaRS; BCR; human.
DR   EvolutionaryTrace; P11274; -.
DR   GeneWiki; BCR_(gene); -.
DR   GenomeRNAi; 613; -.
DR   Pharos; P11274; Tclin.
DR   PRO; PR:P11274; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   RNAct; P11274; protein.
DR   Bgee; ENSG00000186716; Expressed in adenohypophysis and 214 other tissues.
DR   ExpressionAtlas; P11274; baseline and differential.
DR   Genevisible; P11274; HS.
DR   GO; GO:0030424; C:axon; IEA:UniProtKB-SubCell.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0043197; C:dendritic spine; IEA:UniProtKB-SubCell.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0098978; C:glutamatergic synapse; ISS:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IEA:Ensembl.
DR   GO; GO:0014069; C:postsynaptic density; ISS:UniProtKB.
DR   GO; GO:0099092; C:postsynaptic density, intracellular component; ISS:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IDA:MGI.
DR   GO; GO:0098685; C:Schaffer collateral - CA1 synapse; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005096; F:GTPase activator activity; IDA:UniProtKB.
DR   GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; IDA:UniProtKB.
DR   GO; GO:0016301; F:kinase activity; TAS:Reactome.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; TAS:ProtInc.
DR   GO; GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IMP:UniProtKB.
DR   GO; GO:0030036; P:actin cytoskeleton organization; IEA:Ensembl.
DR   GO; GO:0090630; P:activation of GTPase activity; IDA:UniProtKB.
DR   GO; GO:0007420; P:brain development; IEA:Ensembl.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl.
DR   GO; GO:0060216; P:definitive hemopoiesis; IEA:Ensembl.
DR   GO; GO:0048041; P:focal adhesion assembly; IMP:UniProtKB.
DR   GO; GO:0048872; P:homeostasis of number of cells; IEA:Ensembl.
DR   GO; GO:0042472; P:inner ear morphogenesis; IEA:Ensembl.
DR   GO; GO:0065002; P:intracellular protein transmembrane transport; IEA:Ensembl.
DR   GO; GO:0030216; P:keratinocyte differentiation; IMP:UniProtKB.
DR   GO; GO:0050804; P:modulation of chemical synaptic transmission; ISS:UniProtKB.
DR   GO; GO:0060313; P:negative regulation of blood vessel remodeling; IEA:Ensembl.
DR   GO; GO:0002692; P:negative regulation of cellular extravasation; IEA:Ensembl.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl.
DR   GO; GO:0043314; P:negative regulation of neutrophil degranulation; IEA:Ensembl.
DR   GO; GO:2000378; P:negative regulation of reactive oxygen species metabolic process; IEA:Ensembl.
DR   GO; GO:0060268; P:negative regulation of respiratory burst; IEA:Ensembl.
DR   GO; GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl.
DR   GO; GO:0048008; P:platelet-derived growth factor receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0050766; P:positive regulation of phagocytosis; IEA:Ensembl.
DR   GO; GO:0046777; P:protein autophosphorylation; IEA:Ensembl.
DR   GO; GO:0006468; P:protein phosphorylation; TAS:ProtInc.
DR   GO; GO:0051726; P:regulation of cell cycle; IEA:Ensembl.
DR   GO; GO:0051171; P:regulation of nitrogen compound metabolic process; IEA:Ensembl.
DR   GO; GO:0035023; P:regulation of Rho protein signal transduction; IMP:UniProtKB.
DR   GO; GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome.
DR   GO; GO:0043114; P:regulation of vascular permeability; IEA:Ensembl.
DR   GO; GO:0003014; P:renal system process; IEA:Ensembl.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0007264; P:small GTPase mediated signal transduction; IMP:UniProtKB.
DR   CDD; cd00160; RhoGEF; 1.
DR   Gene3D; 1.10.555.10; -; 1.
DR   Gene3D; 1.20.900.10; -; 1.
DR   Gene3D; 2.60.40.150; -; 1.
DR   Gene3D; 4.10.280.30; -; 1.
DR   InterPro; IPR037769; Abr/Bcr.
DR   InterPro; IPR015123; Bcr-Abl_oncoprot_oligo.
DR   InterPro; IPR036481; Bcr-Abl_oncoprot_oligo_sf.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR035892; C2_domain_sf.
DR   InterPro; IPR035899; DBL_dom_sf.
DR   InterPro; IPR000219; DH-domain.
DR   InterPro; IPR001331; GDS_CDC24_CS.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR008936; Rho_GTPase_activation_prot.
DR   InterPro; IPR000198; RhoGAP_dom.
DR   PANTHER; PTHR23182; PTHR23182; 1.
DR   Pfam; PF09036; Bcr-Abl_Oligo; 1.
DR   Pfam; PF00168; C2; 1.
DR   Pfam; PF00620; RhoGAP; 1.
DR   Pfam; PF00621; RhoGEF; 1.
DR   SMART; SM00239; C2; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00324; RhoGAP; 1.
DR   SMART; SM00325; RhoGEF; 1.
DR   SUPFAM; SSF48065; SSF48065; 1.
DR   SUPFAM; SSF48350; SSF48350; 1.
DR   SUPFAM; SSF69036; SSF69036; 1.
DR   PROSITE; PS50004; C2; 1.
DR   PROSITE; PS00741; DH_1; 1.
DR   PROSITE; PS50010; DH_2; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS50238; RHOGAP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Cell junction; Cell projection; Chromosomal rearrangement;
KW   GTPase activation; Guanine-nucleotide releasing factor; Kinase;
KW   Methylation; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Proto-oncogene; Reference proteome; Serine/threonine-protein kinase;
KW   Synapse; Transferase.
FT   CHAIN           1..1271
FT                   /note="Breakpoint cluster region protein"
FT                   /id="PRO_0000080933"
FT   DOMAIN          498..691
FT                   /note="DH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00062"
FT   DOMAIN          708..866
FT                   /note="PH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   DOMAIN          893..1020
FT                   /note="C2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   DOMAIN          1054..1248
FT                   /note="Rho-GAP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00172"
FT   REGION          1..426
FT                   /note="Kinase"
FT   REGION          197..385
FT                   /note="Binding to ABL SH2-domain"
FT   COMPBIAS        824..827
FT                   /note="Poly-Leu"
FT   SITE            426..427
FT                   /note="Breakpoint for translocation to form BCR-ABL
FT                   oncogene"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000244|PubMed:22223895"
FT   MOD_RES         122
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         139
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         177
FT                   /note="Phosphotyrosine; by HCK"
FT                   /evidence="ECO:0000244|PubMed:19690332,
FT                   ECO:0000269|PubMed:9407116"
FT   MOD_RES         202
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         215
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         222
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         236
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6PAJ1"
FT   MOD_RES         246
FT                   /note="Phosphotyrosine; by FES"
FT                   /evidence="ECO:0000269|PubMed:15302586"
FT   MOD_RES         356
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         377
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         382
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6PAJ1"
FT   MOD_RES         385
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6PAJ1"
FT   MOD_RES         459
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         463
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         471
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6PAJ1"
FT   MOD_RES         473
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         488
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         554
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         641
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         644
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         693
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         894
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         1264
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:15144186,
FT                   ECO:0000244|PubMed:19690332"
FT   VAR_SEQ         961..1004
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:3285291"
FT                   /id="VSP_024352"
FT   VARIANT         400
FT                   /note="S -> P (in a bladder transitional cell carcinoma
FT                   sample; somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041883"
FT   VARIANT         413
FT                   /note="I -> M (in dbSNP:rs56321828)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041884"
FT   VARIANT         558
FT                   /note="K -> T (in dbSNP:rs4437065)"
FT                   /id="VAR_051983"
FT   VARIANT         752
FT                   /note="D -> E (in dbSNP:rs12484731)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041885"
FT   VARIANT         796
FT                   /note="N -> S (in dbSNP:rs140504)"
FT                   /evidence="ECO:0000269|PubMed:17344846,
FT                   ECO:0000269|PubMed:2407300, ECO:0000269|PubMed:3107980,
FT                   ECO:0000269|PubMed:3285291, ECO:0000269|Ref.3"
FT                   /id="VAR_031552"
FT   VARIANT         910
FT                   /note="Y -> C (in dbSNP:rs35537221)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041886"
FT   VARIANT         949
FT                   /note="V -> I (in dbSNP:rs2229038)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041887"
FT   VARIANT         1037
FT                   /note="E -> K (in dbSNP:rs776552570)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_031553"
FT   VARIANT         1091
FT                   /note="V -> M (in dbSNP:rs778229520)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041888"
FT   VARIANT         1096
FT                   /note="T -> A (in dbSNP:rs745459086)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041889"
FT   VARIANT         1104
FT                   /note="A -> G (in dbSNP:rs11558696)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041890"
FT   VARIANT         1106
FT                   /note="D -> N (in dbSNP:rs879255379)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041891"
FT   VARIANT         1127
FT                   /note="T -> M (in dbSNP:rs35812689)"
FT                   /id="VAR_031554"
FT   VARIANT         1149
FT                   /note="A -> T (in dbSNP:rs200099830)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041892"
FT   VARIANT         1161
FT                   /note="E -> K"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041893"
FT   VARIANT         1187
FT                   /note="K -> E (in dbSNP:rs1195127922)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041894"
FT   VARIANT         1189
FT                   /note="V -> M (in dbSNP:rs55816482)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041895"
FT   VARIANT         1204
FT                   /note="A -> G (in dbSNP:rs56265970)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041896"
FT   VARIANT         1235
FT                   /note="W -> R (in dbSNP:rs55719322)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041897"
FT   MUTAGEN         177
FT                   /note="Y->F: Abolishes interaction with FES and GRB2."
FT                   /evidence="ECO:0000269|PubMed:15302586,
FT                   ECO:0000269|PubMed:9407116"
FT   MUTAGEN         689..690
FT                   /note="NE->AA: Loss of RHOA GEF activity."
FT                   /evidence="ECO:0000269|PubMed:23940119"
FT   MUTAGEN         1090
FT                   /note="R->A: Loss of GAP activity. Loss of GAP activity;
FT                   when associated with A-1202."
FT                   /evidence="ECO:0000269|PubMed:17116687"
FT   MUTAGEN         1202
FT                   /note="N->A: Loss of GAP activity; when associated with A-
FT                   1090."
FT                   /evidence="ECO:0000269|PubMed:17116687"
FT   MUTAGEN         1269..1271
FT                   /note="Missing: Abolishes interaction with PDZK1."
FT                   /evidence="ECO:0000269|PubMed:15494376"
FT   MUTAGEN         1271
FT                   /note="V->A: Reduces interaction with PDZK1. Abolishes
FT                   interaction with DLG4. No effect on synaptic localization."
FT                   /evidence="ECO:0000269|PubMed:15494376,
FT                   ECO:0000269|PubMed:20962234"
FT   CONFLICT        287
FT                   /note="M -> I (in Ref. 1; CAA68676)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        418
FT                   /note="G -> D (in Ref. 1; CAA68676)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        483
FT                   /note="E -> K (in Ref. 1; CAA68676)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        560
FT                   /note="F -> S (in Ref. 1; CAA68676)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        690
FT                   /note="E -> D (in Ref. 11)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        733
FT                   /note="D -> E (in Ref. 4; CAA26441)"
FT                   /evidence="ECO:0000305"
FT   HELIX           4..14
FT                   /evidence="ECO:0000244|PDB:1K1F"
FT   HELIX           28..64
FT                   /evidence="ECO:0000244|PDB:1K1F"
FT   HELIX           492..521
FT                   /evidence="ECO:0000244|PDB:5N7E"
FT   HELIX           524..531
FT                   /evidence="ECO:0000244|PDB:5N7E"
FT   STRAND          533..535
FT                   /evidence="ECO:0000244|PDB:5N7E"
FT   HELIX           540..546
FT                   /evidence="ECO:0000244|PDB:5N7E"
FT   TURN            547..549
FT                   /evidence="ECO:0000244|PDB:5N7E"
FT   HELIX           550..569
FT                   /evidence="ECO:0000244|PDB:5N7E"
FT   HELIX           578..586
FT                   /evidence="ECO:0000244|PDB:5N7E"
FT   HELIX           588..611
FT                   /evidence="ECO:0000244|PDB:5N7E"
FT   HELIX           613..618
FT                   /evidence="ECO:0000244|PDB:5N7E"
FT   STRAND          630..634
FT                   /evidence="ECO:0000244|PDB:5N6R"
FT   HELIX           639..651
FT                   /evidence="ECO:0000244|PDB:5N7E"
FT   HELIX           653..661
FT                   /evidence="ECO:0000244|PDB:5N7E"
FT   HELIX           670..687
FT                   /evidence="ECO:0000244|PDB:5N7E"
FT   STRAND          694..697
FT                   /evidence="ECO:0000244|PDB:5N6R"
FT   STRAND          709..719
FT                   /evidence="ECO:0000244|PDB:5OC7"
FT   STRAND          722..740
FT                   /evidence="ECO:0000244|PDB:5OC7"
FT   STRAND          751..758
FT                   /evidence="ECO:0000244|PDB:5OC7"
FT   HELIX           759..761
FT                   /evidence="ECO:0000244|PDB:5OC7"
FT   STRAND          762..767
FT                   /evidence="ECO:0000244|PDB:5OC7"
FT   STRAND          830..838
FT                   /evidence="ECO:0000244|PDB:5OC7"
FT   STRAND          843..847
FT                   /evidence="ECO:0000244|PDB:5OC7"
FT   HELIX           851..865
FT                   /evidence="ECO:0000244|PDB:5OC7"
FT   HELIX           876..885
FT                   /evidence="ECO:0000244|PDB:5OC7"
FT   STRAND          1268..1271
FT                   /evidence="ECO:0000244|PDB:2AIN"
SQ   SEQUENCE   1271 AA;  142819 MW;  4BF66FA1E9D205FE CRC64;
     MVDPVGFAEA WKAQFPDSEP PRMELRSVGD IEQELERCKA SIRRLEQEVN QERFRMIYLQ
     TLLAKEKKSY DRQRWGFRRA AQAPDGASEP RASASRPQPA PADGADPPPA EEPEARPDGE
     GSPGKARPGT ARRPGAAASG ERDDRGPPAS VAALRSNFER IRKGHGQPGA DAEKPFYVNV
     EFHHERGLVK VNDKEVSDRI SSLGSQAMQM ERKKSQHGAG SSVGDASRPP YRGRSSESSC
     GVDGDYEDAE LNPRFLKDNL IDANGGSRPP WPPLEYQPYQ SIYVGGMMEG EGKGPLLRSQ
     STSEQEKRLT WPRRSYSPRS FEDCGGGYTP DCSSNENLTS SEEDFSSGQS SRVSPSPTTY
     RMFRDKSRSP SQNSQQSFDS SSPPTPQCHK RHRHCPVVVS EATIVGVRKT GQIWPNDGEG
     AFHGDADGSF GTPPGYGCAA DRAEEQRRHQ DGLPYIDDSP SSSPHLSSKG RGSRDALVSG
     ALESTKASEL DLEKGLEMRK WVLSGILASE ETYLSHLEAL LLPMKPLKAA ATTSQPVLTS
     QQIETIFFKV PELYEIHKEF YDGLFPRVQQ WSHQQRVGDL FQKLASQLGV YRAFVDNYGV
     AMEMAEKCCQ ANAQFAEISE NLRARSNKDA KDPTTKNSLE TLLYKPVDRV TRSTLVLHDL
     LKHTPASHPD HPLLQDALRI SQNFLSSINE EITPRRQSMT VKKGEHRQLL KDSFMVELVE
     GARKLRHVFL FTDLLLCTKL KKQSGGKTQQ YDCKWYIPLT DLSFQMVDEL EAVPNIPLVP
     DEELDALKIK ISQIKNDIQR EKRANKGSKA TERLKKKLSE QESLLLLMSP SMAFRVHSRN
     GKSYTFLISS DYERAEWREN IREQQKKCFR SFSLTSVELQ MLTNSCVKLQ TVHSIPLTIN
     KEDDESPGLY GFLNVIVHSA TGFKQSSNLY CTLEVDSFGY FVNKAKTRVY RDTAEPNWNE
     EFEIELEGSQ TLRILCYEKC YNKTKIPKED GESTDRLMGK GQVQLDPQAL QDRDWQRTVI
     AMNGIEVKLS VKFNSREFSL KRMPSRKQTG VFGVKIAVVT KRERSKVPYI VRQCVEEIER
     RGMEEVGIYR VSGVATDIQA LKAAFDVNNK DVSVMMSEMD VNAIAGTLKL YFRELPEPLF
     TDEFYPNFAE GIALSDPVAK ESCMLNLLLS LPEANLLTFL FLLDHLKRVA EKEAVNKMSL
     HNLATVFGPT LLRPSEKESK LPANPSQPIT MTDSWSLEVM SQVQVLLYFL QLEAIPAPDS
     KRQSILFSTE V
//
ID   A0A024R8U8_HUMAN        Unreviewed;       401 AA.
AC   A0A024R8U8;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 46.
DE   SubName: Full=Calcium activated nucleotidase 1, isoform CRA_b {ECO:0000313|EMBL:EAW89554.1};
GN   Name=CANT1 {ECO:0000313|EMBL:EAW89554.1};
GN   ORFNames=hCG_2039938 {ECO:0000313|EMBL:EAW89554.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW89554.1};
RN   [1] {ECO:0000313|EMBL:EAW89554.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW89554.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH471099; EAW89549.1; -; Genomic_DNA.
DR   EMBL; CH471099; EAW89550.1; -; Genomic_DNA.
DR   EMBL; CH471099; EAW89551.1; -; Genomic_DNA.
DR   EMBL; CH471099; EAW89553.1; -; Genomic_DNA.
DR   EMBL; CH471099; EAW89554.1; -; Genomic_DNA.
DR   EMBL; CH471099; EAW89555.1; -; Genomic_DNA.
DR   RefSeq; NP_001153244.1; NM_001159772.1.
DR   RefSeq; NP_001153245.1; NM_001159773.1.
DR   RefSeq; NP_620148.1; NM_138793.3.
DR   RefSeq; XP_005257078.1; XM_005257021.1.
DR   RefSeq; XP_005257079.1; XM_005257022.1.
DR   RefSeq; XP_006721746.1; XM_006721683.1.
DR   RefSeq; XP_011522593.1; XM_011524291.1.
DR   RefSeq; XP_011522595.1; XM_011524293.1.
DR   RefSeq; XP_011522596.1; XM_011524294.1.
DR   RefSeq; XP_011522597.1; XM_011524295.2.
DR   Antibodypedia; 19748; 317 antibodies.
DR   GeneID; 124583; -.
DR   KEGG; hsa:124583; -.
DR   CTD; 124583; -.
DR   EuPathDB; HostDB:ENSG00000171302.16; -.
DR   eggNOG; KOG4494; Eukaryota.
DR   eggNOG; ENOG410XS4T; LUCA.
DR   HOGENOM; CLU_047493_0_0_1; -.
DR   KO; K12304; -.
DR   OMA; RTGLIYE; -.
DR   OrthoDB; 1126948at2759; -.
DR   ChiTaRS; CANT1; human.
DR   GenomeRNAi; 124583; -.
DR   Bgee; ENSG00000171302; Expressed in colonic mucosa and 213 other tissues.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:Ensembl.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0017110; F:nucleoside-diphosphatase activity; IEA:InterPro.
DR   Gene3D; 2.120.10.100; -; 1.
DR   InterPro; IPR009283; Apyrase.
DR   InterPro; IPR036258; Apyrase_sf.
DR   PANTHER; PTHR13023; PTHR13023; 1.
DR   SUPFAM; SSF101887; SSF101887; 1.
PE   4: Predicted;
SQ   SEQUENCE   401 AA;  44840 MW;  5B78EB24C0B2C4CA CRC64;
     MPVQLSEHPE WNESMHSLRI SVGGLPVLAS MTKAADPRFR PRWKVILTFF VGAAILWLLC
     SHRPAPGRPP THNAHNWRLG QAPANWYNDT YPLSPPQRTP AGIRYRIAVI ADLDTESRAQ
     EENTWFSYLK KGYLTLSDSG DKVAVEWDKD HGVLESHLAE KGRGMELSDL IVFNGKLYSV
     DDRTGVVYQI EGSKAVPWVI LSDGDGTVEK GFKAEWLAVK DERLYVGGLG KEWTTTTGDV
     VNENPEWVKV VGYKGSVDHE NWVSNYNALR AAAGIQPPGY LIHESACWSD TLQRWFFLPR
     RASQERYSEK DDERKGANLL LSASPDFGDI AVSHVGAVVP THGFSSFKFI PNTDDQIIVA
     LKSEEDSGRV ASYIMAFTLD GRFLLPETKI GSVKYEGIEF I
//
ID   CANT1_HUMAN             Reviewed;         401 AA.
AC   Q8WVQ1; B4DJ54; Q7Z2J7; Q8NG05; Q8NHP0; Q9BSD5;
DT   10-MAY-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2002, sequence version 1.
DT   22-APR-2020, entry version 156.
DE   RecName: Full=Soluble calcium-activated nucleotidase 1;
DE            Short=SCAN-1;
DE            EC=3.6.1.6 {ECO:0000269|PubMed:12234496, ECO:0000269|PubMed:15006348, ECO:0000269|PubMed:15248776, ECO:0000269|PubMed:16835225};
DE   AltName: Full=Apyrase homolog;
DE   AltName: Full=Putative MAPK-activating protein PM09;
DE   AltName: Full=Putative NF-kappa-B-activating protein 107;
GN   Name=CANT1; Synonyms=SHAPY;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, CATALYTIC ACTIVITY,
RP   COFACTOR, SUBUNIT, SUBCELLULAR LOCATION, GLYCOSYLATION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Mammary tumor;
RX   PubMed=12234496; DOI=10.1016/s0003-9861(02)00420-4;
RA   Smith T., Hicks-Berger C., Kim S., Kirley T.;
RT   "Cloning, expression, and characterization of a soluble calcium-activated
RT   nucleotidase, a human enzyme belonging to a new family of extracellular
RT   nucleotidases.";
RL   Arch. Biochem. Biophys. 406:105-115(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Lung fibroblast;
RX   PubMed=12761501; DOI=10.1038/sj.onc.1206406;
RA   Matsuda A., Suzuki Y., Honda G., Muramatsu S., Matsuzaki O., Nagano Y.,
RA   Doi T., Shimotohno K., Harada T., Nishida E., Hayashi H., Sugano S.;
RT   "Large-scale identification and characterization of human genes that
RT   activate NF-kappaB and MAPK signaling pathways.";
RL   Oncogene 22:3307-3318(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Mammary gland, and Substantia nigra;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Ovary, Pancreas, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 141-401 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=12167635; DOI=10.1074/jbc.m201656200;
RA   Failer B.U., Braun N., Zimmermann H.;
RT   "Cloning, expression, and functional characterization of a Ca2+-dependent
RT   endoplasmic reticulum nucleoside diphosphatase.";
RL   J. Biol. Chem. 277:36978-36986(2002).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, AND MUTAGENESIS OF ASP-114;
RP   GLY-152; GLU-160; ARG-163; ASP-181; ASP-205 AND ARG-301.
RX   PubMed=15248776; DOI=10.1021/bi049565o;
RA   Yang M., Kirley T.L.;
RT   "Site-directed mutagenesis of human soluble calcium-activated nucleotidase
RT   1 (hSCAN-1): identification of residues essential for enzyme activity and
RT   the Ca(2+)-induced conformational change.";
RL   Biochemistry 43:9185-9194(2004).
RN   [7]
RP   INVOLVEMENT IN DBQD1.
RX   PubMed=20425819; DOI=10.1002/ajmg.a.33404;
RA   Faden M., Al-Zahrani F., Arafah D., Alkuraya F.S.;
RT   "Mutation of CANT1 causes Desbuquois dysplasia.";
RL   Am. J. Med. Genet. A 152:1157-1160(2010).
RN   [8]
RP   FUNCTION IN PROTEOGLYCAN SYNTHESIS, AND VARIANTS DBQD1 HIS-300; ARG-303 AND
RP   ASN-374.
RX   PubMed=22539336; DOI=10.1002/humu.22104;
RA   Nizon M., Huber C., De Leonardis F., Merrina R., Forlino A., Fradin M.,
RA   Tuysuz B., Abu-Libdeh B.Y., Alanay Y., Albrecht B., Al-Gazali L.,
RA   Basaran S.Y., Clayton-Smith J., Desir J., Gill H., Greally M.T.,
RA   Koparir E., van Maarle M.C., Mackay S., Mortier G., Morton J., Sillence D.,
RA   Vilain C., Young I., Zerres K., Le Merrer M., Munnich A., Le Goff C.,
RA   Rossi A., Cormier-Daire V.;
RT   "Further delineation of CANT1 phenotypic spectrum and demonstration of its
RT   role in proteoglycan synthesis.";
RL   Hum. Mutat. 33:1261-1266(2012).
RN   [9]
RP   INVOLVEMENT IN EDM7, AND VARIANTS EDM7 PHE-171 AND MET-226.
RX   PubMed=28742282; DOI=10.1002/ajmg.a.38349;
RA   Balasubramanian K., Li B., Krakow D., Nevarez L., Ho P.J., Ainsworth J.A.,
RA   Nickerson D.A., Bamshad M.J., Immken L., Lachman R.S., Cohn D.H.;
RT   "MED resulting from recessively inherited mutations in the gene encoding
RT   calcium-activated nucleotidase CANT1.";
RL   Am. J. Med. Genet. A 173:2415-2421(2017).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 71-401 IN COMPLEX WITH SUBSTRATE
RP   ANALOG AND CALCIUM IONS, CATALYTIC ACTIVITY, COFACTOR, SUBUNIT, AND
RP   MUTAGENESIS OF ASP-112; ASP-114; GLU-166; SER-168; ASP-169; ASP-182;
RP   GLU-215; GLU-246 AND ARG-301.
RX   PubMed=15006348; DOI=10.1016/s0092-8674(04)00172-2;
RA   Dai J., Liu J., Deng Y., Smith T.M., Lu M.;
RT   "Structure and protein design of a human platelet function inhibitor.";
RL   Cell 116:649-659(2004).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 69-401 IN COMPLEX WITH CALCIUM,
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, DIMERIZATION, SUBCELLULAR LOCATION,
RP   DISULFIDE BOND, AND MUTAGENESIS OF CYS-60; SER-139; GLU-160; ILE-200;
RP   SER-202; SER-256; CYS-287; SER-308 AND ALA-317.
RX   PubMed=16835225; DOI=10.1074/jbc.m604413200;
RA   Yang M., Horii K., Herr A.B., Kirley T.L.;
RT   "Calcium-dependent dimerization of human soluble calcium activated
RT   nucleotidase: characterization of the dimer interface.";
RL   J. Biol. Chem. 281:28307-28317(2006).
RN   [12]
RP   VARIANTS DBQD1 LEU-299; CYS-300 AND HIS-300.
RX   PubMed=19853239; DOI=10.1016/j.ajhg.2009.10.001;
RA   Huber C., Oules B., Bertoli M., Chami M., Fradin M., Alanay Y.,
RA   Al-Gazali L.I., Ausems M.G., Bitoun P., Cavalcanti D.P., Krebs A.,
RA   Le Merrer M., Mortier G., Shafeghati Y., Superti-Furga A., Robertson S.P.,
RA   Le Goff C., Muda A.O., Paterlini-Brechot P., Munnich A., Cormier-Daire V.;
RT   "Identification of CANT1 mutations in Desbuquois dysplasia.";
RL   Am. J. Hum. Genet. 85:706-710(2009).
RN   [13]
RP   VARIANT DBQD1 GLU-112.
RX   PubMed=21654728; DOI=10.1038/ejhg.2011.101;
RA   Laccone F., Schoner K., Krabichler B., Kluge B., Schwerdtfeger R.,
RA   Schulze B., Zschocke J., Rehder H.;
RT   "Desbuquois dysplasia type I and fetal hydrops due to novel mutations in
RT   the CANT1 gene.";
RL   Eur. J. Hum. Genet. 19:1133-1137(2011).
RN   [14]
RP   VARIANT DBQD1 MET-226.
RX   PubMed=21412251; DOI=10.1038/jhg.2011.28;
RA   Dai J., Kim O.H., Cho T.J., Miyake N., Song H.R., Karasugi T., Sakazume S.,
RA   Ikema M., Matsui Y., Nagai T., Matsumoto N., Ohashi H., Kamatani N.,
RA   Nishimura G., Furuichi T., Takahashi A., Ikegawa S.;
RT   "A founder mutation of CANT1 common in Korean and Japanese Desbuquois
RT   dysplasia.";
RL   J. Hum. Genet. 56:398-400(2011).
RN   [15]
RP   VARIANTS DBQD1 CYS-125; THR-165; PRO-224; MET-226 AND ASP-360,
RP   CHARACTERIZATION OF VARIANTS DBQD1 CYS-125; THR-165; PRO-224; MET-226;
RP   CYS-300 AND ASP-360, AND CHARACTERIZATION OF VARIANTS THR-323 AND GLU-391.
RX   PubMed=21037275; DOI=10.1136/jmg.2010.080226;
RA   Furuichi T., Dai J., Cho T.J., Sakazume S., Ikema M., Matsui Y., Baynam G.,
RA   Nagai T., Miyake N., Matsumoto N., Ohashi H., Unger S., Superti-Furga A.,
RA   Kim O.H., Nishimura G., Ikegawa S.;
RT   "CANT1 mutation is also responsible for Desbuquois dysplasia, type 2 and
RT   Kim variant.";
RL   J. Med. Genet. 48:32-37(2011).
CC   -!- FUNCTION: Calcium-dependent nucleotidase with a preference for UDP. The
CC       order of activity with different substrates is UDP > GDP > UTP > GTP.
CC       Has very low activity towards ADP and even lower activity towards ATP.
CC       Does not hydrolyze AMP and GMP (PubMed:12234496, PubMed:15248776,
CC       PubMed:15006348, PubMed:16835225). Involved in proteoglycan synthesis
CC       (PubMed:22539336). {ECO:0000269|PubMed:12234496,
CC       ECO:0000269|PubMed:15006348, ECO:0000269|PubMed:15248776,
CC       ECO:0000269|PubMed:16835225, ECO:0000269|PubMed:22539336}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a ribonucleoside 5'-diphosphate + H2O = a ribonucleoside 5'-
CC         phosphate + H(+) + phosphate; Xref=Rhea:RHEA:36799,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:57930, ChEBI:CHEBI:58043; EC=3.6.1.6;
CC         Evidence={ECO:0000269|PubMed:12234496, ECO:0000269|PubMed:15248776,
CC         ECO:0000269|PubMed:16835225};
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000269|PubMed:12234496, ECO:0000269|PubMed:15006348,
CC         ECO:0000269|PubMed:15248776, ECO:0000269|PubMed:16835225};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Optimum pH is 6.8.;
CC   -!- SUBUNIT: Monomer (PubMed:12234496, PubMed:15006348). Homodimer;
CC       dimerization is Ca(2+)-dependent (PubMed:16835225). Homodimer;
CC       disulfide-linked (membrane form) (PubMed:16835225).
CC       {ECO:0000269|PubMed:12234496, ECO:0000269|PubMed:15006348,
CC       ECO:0000269|PubMed:16835225}.
CC   -!- INTERACTION:
CC       Q8WVQ1; P58418: CLRN1; NbExp=3; IntAct=EBI-16770554, EBI-17274839;
CC       Q8WVQ1; Q5JX71: FAM209A; NbExp=3; IntAct=EBI-16770554, EBI-18304435;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:12234496}; Single-pass type II membrane protein
CC       {ECO:0000269|PubMed:12234496}. Golgi apparatus, Golgi stack membrane
CC       {ECO:0000269|PubMed:12234496}; Single-pass type II membrane protein
CC       {ECO:0000269|PubMed:12234496}. Cell membrane
CC       {ECO:0000269|PubMed:16835225}. Note=Processed form: Secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8WVQ1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8WVQ1-2; Sequence=VSP_013760, VSP_013761;
CC       Name=3;
CC         IsoId=Q8WVQ1-3; Sequence=VSP_054260;
CC   -!- TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:12234496}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:12234496}.
CC   -!- DISEASE: Desbuquois dysplasia 1 (DBQD1) [MIM:251450]: A
CC       chondrodysplasia characterized by severe prenatal and postnatal growth
CC       retardation (less than -5 SD), joint laxity, short extremities,
CC       progressive scoliosis, round face, midface hypoplasia, prominent
CC       bulging eyes. The main radiologic features are short long bones with
CC       metaphyseal splay, a 'Swedish key' appearance of the proximal femur
CC       (exaggerated trochanter), and advance carpal and tarsal bone age. Two
CC       forms of Desbuquois dysplasia are distinguished on the basis of the
CC       presence or absence of characteristic hand anomalies: an extra
CC       ossification center distal to the second metacarpal, delta phalanx,
CC       bifid distal thumb phalanx, and phalangeal dislocations.
CC       {ECO:0000269|PubMed:19853239, ECO:0000269|PubMed:20425819,
CC       ECO:0000269|PubMed:21037275, ECO:0000269|PubMed:21412251,
CC       ECO:0000269|PubMed:21654728, ECO:0000269|PubMed:22539336}. Note=The
CC       disease is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Epiphyseal dysplasia, multiple, 7 (EDM7) [MIM:617719]: A form
CC       of multiple epiphyseal dysplasia, a generalized skeletal dysplasia
CC       associated with significant morbidity. Joint pain, joint deformity,
CC       waddling gait, and short stature are the main clinical signs and
CC       symptoms. Radiological examination of the skeleton shows delayed,
CC       irregular mineralization of the epiphyseal ossification centers and of
CC       the centers of the carpal and tarsal bones. Multiple epiphyseal
CC       dysplasia is broadly categorized into the more severe Fairbank and the
CC       milder Ribbing types. The Fairbank type is characterized by shortness
CC       of stature, short and stubby fingers, small epiphyses in several
CC       joints, including the knee, ankle, hand, and hip. The Ribbing type is
CC       confined predominantly to the hip joints and is characterized by hands
CC       that are normal and stature that is normal or near-normal. EDM7
CC       inheritance is autosomal recessive. {ECO:0000269|PubMed:28742282}.
CC       Note=The disease is caused by mutations affecting the gene represented
CC       in this entry.
CC   -!- MISCELLANEOUS: Not inhibited by azide.
CC   -!- SIMILARITY: Belongs to the apyrase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAM94564.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF328554; AAM94564.1; ALT_INIT; mRNA.
DR   EMBL; AB097006; BAC77359.1; -; mRNA.
DR   EMBL; AB097033; BAC77386.1; -; mRNA.
DR   EMBL; AK074687; BAC11139.1; -; mRNA.
DR   EMBL; AK295930; BAG58716.1; -; mRNA.
DR   EMBL; BC005104; AAH05104.1; -; mRNA.
DR   EMBL; BC017655; AAH17655.1; -; mRNA.
DR   EMBL; BC065038; AAH65038.1; -; mRNA.
DR   EMBL; AJ312208; CAC85468.1; -; mRNA.
DR   CCDS; CCDS11760.1; -. [Q8WVQ1-1]
DR   RefSeq; NP_001153244.1; NM_001159772.1. [Q8WVQ1-1]
DR   RefSeq; NP_001153245.1; NM_001159773.1. [Q8WVQ1-1]
DR   RefSeq; NP_620148.1; NM_138793.3. [Q8WVQ1-1]
DR   RefSeq; XP_005257078.1; XM_005257021.1. [Q8WVQ1-1]
DR   RefSeq; XP_005257079.1; XM_005257022.1. [Q8WVQ1-1]
DR   RefSeq; XP_006721746.1; XM_006721683.1. [Q8WVQ1-1]
DR   RefSeq; XP_011522593.1; XM_011524291.1. [Q8WVQ1-1]
DR   RefSeq; XP_011522595.1; XM_011524293.1. [Q8WVQ1-1]
DR   RefSeq; XP_011522596.1; XM_011524294.1. [Q8WVQ1-1]
DR   RefSeq; XP_011522597.1; XM_011524295.2. [Q8WVQ1-1]
DR   PDB; 1S18; X-ray; 1.70 A; A/B=71-401.
DR   PDB; 1S1D; X-ray; 1.60 A; A/B=71-401.
DR   PDB; 2H2N; X-ray; 2.30 A; A/B=69-401.
DR   PDB; 2H2U; X-ray; 2.40 A; A/B=69-401.
DR   PDBsum; 1S18; -.
DR   PDBsum; 1S1D; -.
DR   PDBsum; 2H2N; -.
DR   PDBsum; 2H2U; -.
DR   SMR; Q8WVQ1; -.
DR   BioGrid; 125875; 25.
DR   IntAct; Q8WVQ1; 13.
DR   STRING; 9606.ENSP00000307674; -.
DR   DrugBank; DB03486; Phosphomethylphosphonic acid guanosyl ester.
DR   DrugBank; DB03754; Tromethamine.
DR   GlyConnect; 1760; -.
DR   iPTMnet; Q8WVQ1; -.
DR   PhosphoSitePlus; Q8WVQ1; -.
DR   BioMuta; CANT1; -.
DR   DMDM; 66774052; -.
DR   EPD; Q8WVQ1; -.
DR   jPOST; Q8WVQ1; -.
DR   MassIVE; Q8WVQ1; -.
DR   MaxQB; Q8WVQ1; -.
DR   PaxDb; Q8WVQ1; -.
DR   PeptideAtlas; Q8WVQ1; -.
DR   PRIDE; Q8WVQ1; -.
DR   ProteomicsDB; 74813; -. [Q8WVQ1-1]
DR   ProteomicsDB; 74814; -. [Q8WVQ1-2]
DR   Antibodypedia; 19748; 317 antibodies.
DR   Ensembl; ENST00000302345; ENSP00000307674; ENSG00000171302. [Q8WVQ1-1]
DR   Ensembl; ENST00000392446; ENSP00000376241; ENSG00000171302. [Q8WVQ1-1]
DR   Ensembl; ENST00000591773; ENSP00000467437; ENSG00000171302. [Q8WVQ1-1]
DR   Ensembl; ENST00000620915; ENSP00000477798; ENSG00000171302. [Q8WVQ1-1]
DR   GeneID; 124583; -.
DR   KEGG; hsa:124583; -.
DR   UCSC; uc002jwj.4; human. [Q8WVQ1-1]
DR   CTD; 124583; -.
DR   DisGeNET; 124583; -.
DR   GeneCards; CANT1; -.
DR   HGNC; HGNC:19721; CANT1.
DR   HPA; ENSG00000171302; Low tissue specificity.
DR   MalaCards; CANT1; -.
DR   MIM; 251450; phenotype.
DR   MIM; 613165; gene.
DR   MIM; 617719; phenotype.
DR   neXtProt; NX_Q8WVQ1; -.
DR   OpenTargets; ENSG00000171302; -.
DR   Orphanet; 1425; Desbuquois syndrome.
DR   PharmGKB; PA134984439; -.
DR   eggNOG; KOG4494; Eukaryota.
DR   eggNOG; ENOG410XS4T; LUCA.
DR   GeneTree; ENSGT00390000012872; -.
DR   HOGENOM; CLU_047493_0_0_1; -.
DR   InParanoid; Q8WVQ1; -.
DR   KO; K12304; -.
DR   OMA; RTGLIYE; -.
DR   OrthoDB; 1579117at2759; -.
DR   PhylomeDB; Q8WVQ1; -.
DR   TreeFam; TF315248; -.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   ChiTaRS; CANT1; human.
DR   EvolutionaryTrace; Q8WVQ1; -.
DR   GeneWiki; CANT1; -.
DR   GenomeRNAi; 124583; -.
DR   Pharos; Q8WVQ1; Tbio.
DR   PRO; PR:Q8WVQ1; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q8WVQ1; protein.
DR   Bgee; ENSG00000171302; Expressed in colonic mucosa and 213 other tissues.
DR   ExpressionAtlas; Q8WVQ1; baseline and differential.
DR   Genevisible; Q8WVQ1; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0032580; C:Golgi cisterna membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0035580; C:specific granule lumen; TAS:Reactome.
DR   GO; GO:1904724; C:tertiary granule lumen; TAS:Reactome.
DR   GO; GO:0043262; F:adenosine-diphosphatase activity; IDA:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; IDA:UniProtKB.
DR   GO; GO:0004382; F:guanosine-diphosphatase activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0045134; F:uridine-diphosphatase activity; IBA:GO_Central.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; HMP:UniProtKB.
DR   GO; GO:0030166; P:proteoglycan biosynthetic process; IMP:UniProtKB.
DR   Gene3D; 2.120.10.100; -; 1.
DR   InterPro; IPR009283; Apyrase.
DR   InterPro; IPR036258; Apyrase_sf.
DR   PANTHER; PTHR13023; PTHR13023; 1.
DR   SUPFAM; SSF101887; SSF101887; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Cell membrane;
KW   Disease mutation; Disulfide bond; Dwarfism; Endoplasmic reticulum;
KW   Glycoprotein; Golgi apparatus; Hydrolase; Membrane; Metal-binding;
KW   Polymorphism; Reference proteome; Signal-anchor; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..401
FT                   /note="Soluble calcium-activated nucleotidase 1"
FT                   /id="PRO_0000209925"
FT   TOPO_DOM        1..44
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        45..62
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        63..401
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   METAL           168
FT                   /note="Calcium; via carbonyl oxygen"
FT                   /evidence="ECO:0000244|PDB:1S18, ECO:0000244|PDB:1S1D,
FT                   ECO:0000244|PDB:2H2N, ECO:0000244|PDB:2H2U,
FT                   ECO:0000269|PubMed:15006348, ECO:0000269|PubMed:16835225"
FT   METAL           169
FT                   /note="Calcium"
FT                   /evidence="ECO:0000244|PDB:1S18, ECO:0000244|PDB:2H2N,
FT                   ECO:0000244|PDB:2H2U, ECO:0000269|PubMed:15006348,
FT                   ECO:0000269|PubMed:16835225"
FT   METAL           215
FT                   /note="Calcium; via carbonyl oxygen"
FT                   /evidence="ECO:0000244|PDB:1S18, ECO:0000244|PDB:1S1D,
FT                   ECO:0000244|PDB:2H2N, ECO:0000244|PDB:2H2U,
FT                   ECO:0000269|PubMed:15006348, ECO:0000269|PubMed:16835225"
FT   METAL           284
FT                   /note="Calcium; via carbonyl oxygen"
FT                   /evidence="ECO:0000244|PDB:1S18, ECO:0000244|PDB:1S1D,
FT                   ECO:0000244|PDB:2H2N, ECO:0000244|PDB:2H2U,
FT                   ECO:0000269|PubMed:15006348, ECO:0000269|PubMed:16835225"
FT   METAL           345
FT                   /note="Calcium; via carbonyl oxygen"
FT                   /evidence="ECO:0000244|PDB:1S18, ECO:0000244|PDB:1S1D,
FT                   ECO:0000244|PDB:2H2N, ECO:0000244|PDB:2H2U,
FT                   ECO:0000269|PubMed:15006348, ECO:0000269|PubMed:16835225"
FT   METAL           396
FT                   /note="Calcium; via carbonyl oxygen"
FT                   /evidence="ECO:0000244|PDB:1S18, ECO:0000244|PDB:1S1D,
FT                   ECO:0000244|PDB:2H2N, ECO:0000244|PDB:2H2U,
FT                   ECO:0000269|PubMed:15006348, ECO:0000269|PubMed:16835225"
FT   SITE            160
FT                   /note="Important for dimer formation"
FT                   /evidence="ECO:0000269|PubMed:16835225"
FT   SITE            200
FT                   /note="Important for dimer formation"
FT                   /evidence="ECO:0000269|PubMed:16835225"
FT   SITE            202
FT                   /note="Important for dimer formation"
FT                   /evidence="ECO:0000269|PubMed:16835225"
FT   SITE            256
FT                   /note="Important for dimer formation"
FT                   /evidence="ECO:0000269|PubMed:16835225"
FT   CARBOHYD        88
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        60
FT                   /note="Interchain"
FT                   /evidence="ECO:0000269|PubMed:16835225"
FT   VAR_SEQ         41..91
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_054260"
FT   VAR_SEQ         220..245
FT                   /note="KDERLYVGGLGKEWTTTTGDVVNENP -> REIVRKRWRLVKQVSHVGVLGQ
FT                   WIQR (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12761501"
FT                   /id="VSP_013760"
FT   VAR_SEQ         246..401
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12761501"
FT                   /id="VSP_013761"
FT   VARIANT         112
FT                   /note="D -> E (in DBQD1; dbSNP:rs749246739)"
FT                   /evidence="ECO:0000269|PubMed:21654728"
FT                   /id="VAR_068655"
FT   VARIANT         125
FT                   /note="W -> C (in DBQD1; severely affects activity;
FT                   dbSNP:rs587776898)"
FT                   /evidence="ECO:0000269|PubMed:21037275"
FT                   /id="VAR_068656"
FT   VARIANT         165
FT                   /note="M -> T (in DBQD1; severely affects activity)"
FT                   /evidence="ECO:0000269|PubMed:21037275"
FT                   /id="VAR_068657"
FT   VARIANT         171
FT                   /note="I -> F (in EDM7; unknown pathological significance;
FT                   dbSNP:rs1014317450)"
FT                   /evidence="ECO:0000269|PubMed:28742282"
FT                   /id="VAR_080400"
FT   VARIANT         224
FT                   /note="L -> P (in DBQD1; affects protein stability and
FT                   secretion; dbSNP:rs150181226)"
FT                   /evidence="ECO:0000269|PubMed:21037275"
FT                   /id="VAR_068658"
FT   VARIANT         226
FT                   /note="V -> M (in DBQD1 and EDM7; severely affects
FT                   activity; dbSNP:rs377546036)"
FT                   /evidence="ECO:0000269|PubMed:21037275,
FT                   ECO:0000269|PubMed:21412251, ECO:0000269|PubMed:28742282"
FT                   /id="VAR_068659"
FT   VARIANT         299
FT                   /note="P -> L (in DBQD1; dbSNP:rs267606700)"
FT                   /evidence="ECO:0000269|PubMed:19853239"
FT                   /id="VAR_062980"
FT   VARIANT         300
FT                   /note="R -> C (in DBQD1; severely affects activity;
FT                   dbSNP:rs267606701)"
FT                   /evidence="ECO:0000269|PubMed:19853239,
FT                   ECO:0000269|PubMed:21037275"
FT                   /id="VAR_062981"
FT   VARIANT         300
FT                   /note="R -> H (in DBQD1; dbSNP:rs267606699)"
FT                   /evidence="ECO:0000269|PubMed:19853239,
FT                   ECO:0000269|PubMed:22539336"
FT                   /id="VAR_062982"
FT   VARIANT         303
FT                   /note="S -> R (in DBQD1)"
FT                   /evidence="ECO:0000269|PubMed:22539336"
FT                   /id="VAR_068660"
FT   VARIANT         323
FT                   /note="A -> T (polymorphism; does not affect activity;
FT                   dbSNP:rs9903215)"
FT                   /evidence="ECO:0000269|PubMed:21037275"
FT                   /id="VAR_068661"
FT   VARIANT         360
FT                   /note="A -> D (in DBQD1; affects protein secretion;
FT                   dbSNP:rs387907081)"
FT                   /evidence="ECO:0000269|PubMed:21037275"
FT                   /id="VAR_068662"
FT   VARIANT         374
FT                   /note="I -> N (in DBQD1)"
FT                   /evidence="ECO:0000269|PubMed:22539336"
FT                   /id="VAR_068663"
FT   VARIANT         391
FT                   /note="G -> E (polymorphism; does not affect activity;
FT                   dbSNP:rs34082669)"
FT                   /evidence="ECO:0000269|PubMed:21037275"
FT                   /id="VAR_068664"
FT   MUTAGEN         60
FT                   /note="C->S: Loss of dimer formation."
FT                   /evidence="ECO:0000269|PubMed:16835225"
FT   MUTAGEN         112
FT                   /note="D->A: Reduces activity by 99%."
FT                   /evidence="ECO:0000269|PubMed:15006348"
FT   MUTAGEN         114
FT                   /note="D->A: Reduces activity by 99%."
FT                   /evidence="ECO:0000269|PubMed:15006348,
FT                   ECO:0000269|PubMed:15248776"
FT   MUTAGEN         139
FT                   /note="S->C: Reduces GDPase and ADPase activities 1.7-fold.
FT                   Severe loss of dimer formation; when associated with S-
FT                   287."
FT                   /evidence="ECO:0000269|PubMed:16835225"
FT   MUTAGEN         152
FT                   /note="G->E: Slightly reduced activity."
FT                   /evidence="ECO:0000269|PubMed:15248776"
FT   MUTAGEN         160
FT                   /note="E->Y: Increases GDPase activity 2-fold and ADPase
FT                   activity 5-fold. Forms dimer even at suboptimal Ca(2+)
FT                   concentrations."
FT                   /evidence="ECO:0000269|PubMed:15248776,
FT                   ECO:0000269|PubMed:16835225"
FT   MUTAGEN         163
FT                   /note="R->A: Reduces activity by 98%."
FT                   /evidence="ECO:0000269|PubMed:15248776"
FT   MUTAGEN         166
FT                   /note="E->Q: Reduces activity by 95%."
FT                   /evidence="ECO:0000269|PubMed:15006348"
FT   MUTAGEN         168
FT                   /note="S->A: Reduces activity by over 99.9%."
FT                   /evidence="ECO:0000269|PubMed:15006348"
FT   MUTAGEN         169
FT                   /note="D->N: Reduces activity by 96%."
FT                   /evidence="ECO:0000269|PubMed:15006348"
FT   MUTAGEN         181
FT                   /note="D->A: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:15248776"
FT   MUTAGEN         182
FT                   /note="D->N: Reduces activity by over 99.9%."
FT                   /evidence="ECO:0000269|PubMed:15006348"
FT   MUTAGEN         200
FT                   /note="I->C: Reduces GDPase activity 2-fold and ADPase
FT                   activity 2.5-fold. No effect on dimer formation; when
FT                   associated with S-287."
FT                   /evidence="ECO:0000269|PubMed:16835225"
FT   MUTAGEN         202
FT                   /note="S->C: Reduces GDPase activity 1.7-fold and ADPase
FT                   activity 1.5-fold. No effect on dimer formation; when
FT                   associated with S-287."
FT                   /evidence="ECO:0000269|PubMed:16835225"
FT   MUTAGEN         205
FT                   /note="D->A: Slightly reduced activity."
FT                   /evidence="ECO:0000269|PubMed:15248776"
FT   MUTAGEN         215
FT                   /note="E->Q: Reduces activity by 99%."
FT                   /evidence="ECO:0000269|PubMed:15006348"
FT   MUTAGEN         246
FT                   /note="E->M: Increases activity 5-fold."
FT                   /evidence="ECO:0000269|PubMed:15006348"
FT   MUTAGEN         256
FT                   /note="S->C: No effect on GDPase and ADPase activities. No
FT                   effect on dimer formation; when associated with S-287."
FT                   /evidence="ECO:0000269|PubMed:16835225"
FT   MUTAGEN         287
FT                   /note="C->S: Reduces GDPase and ADPase activities 1.3-
FT                   fold."
FT                   /evidence="ECO:0000269|PubMed:16835225"
FT   MUTAGEN         301
FT                   /note="R->A: Reduces activity by 99%."
FT                   /evidence="ECO:0000269|PubMed:15006348,
FT                   ECO:0000269|PubMed:15248776"
FT   MUTAGEN         308
FT                   /note="S->C: Reduces GDPase activity 1.3-fold and ADPase
FT                   activity 2-fold. Severe loss of dimer formation; when
FT                   associated with S-287."
FT                   /evidence="ECO:0000269|PubMed:16835225"
FT   MUTAGEN         317
FT                   /note="A->C: Reduces GDPase activity 1.7-fold and ADPase
FT                   activity 1.5-fold. Severe loss of dimer formation; when
FT                   associated with S-287."
FT                   /evidence="ECO:0000269|PubMed:16835225"
FT   STRAND          92..94
FT                   /evidence="ECO:0000244|PDB:1S1D"
FT   STRAND          97..99
FT                   /evidence="ECO:0000244|PDB:1S1D"
FT   STRAND          102..112
FT                   /evidence="ECO:0000244|PDB:1S1D"
FT   HELIX           114..117
FT                   /evidence="ECO:0000244|PDB:1S1D"
FT   STRAND          125..137
FT                   /evidence="ECO:0000244|PDB:1S1D"
FT   STRAND          143..147
FT                   /evidence="ECO:0000244|PDB:1S1D"
FT   STRAND          152..157
FT                   /evidence="ECO:0000244|PDB:1S1D"
FT   STRAND          158..160
FT                   /evidence="ECO:0000244|PDB:2H2U"
FT   STRAND          167..173
FT                   /evidence="ECO:0000244|PDB:1S1D"
FT   STRAND          176..181
FT                   /evidence="ECO:0000244|PDB:1S1D"
FT   TURN            182..184
FT                   /evidence="ECO:0000244|PDB:1S1D"
FT   STRAND          186..191
FT                   /evidence="ECO:0000244|PDB:1S1D"
FT   STRAND          194..200
FT                   /evidence="ECO:0000244|PDB:1S1D"
FT   TURN            204..207
FT                   /evidence="ECO:0000244|PDB:1S1D"
FT   STRAND          208..211
FT                   /evidence="ECO:0000244|PDB:1S1D"
FT   STRAND          216..220
FT                   /evidence="ECO:0000244|PDB:1S1D"
FT   STRAND          223..227
FT                   /evidence="ECO:0000244|PDB:1S1D"
FT   STRAND          240..242
FT                   /evidence="ECO:0000244|PDB:1S1D"
FT   HELIX           244..246
FT                   /evidence="ECO:0000244|PDB:1S1D"
FT   STRAND          247..251
FT                   /evidence="ECO:0000244|PDB:1S1D"
FT   STRAND          257..261
FT                   /evidence="ECO:0000244|PDB:1S1D"
FT   HELIX           263..272
FT                   /evidence="ECO:0000244|PDB:1S1D"
FT   STRAND          280..282
FT                   /evidence="ECO:0000244|PDB:1S1D"
FT   STRAND          286..289
FT                   /evidence="ECO:0000244|PDB:1S1D"
FT   TURN            290..293
FT                   /evidence="ECO:0000244|PDB:1S1D"
FT   STRAND          294..297
FT                   /evidence="ECO:0000244|PDB:1S1D"
FT   STRAND          300..305
FT                   /evidence="ECO:0000244|PDB:1S1D"
FT   HELIX           309..312
FT                   /evidence="ECO:0000244|PDB:1S1D"
FT   STRAND          319..323
FT                   /evidence="ECO:0000244|PDB:1S1D"
FT   STRAND          330..334
FT                   /evidence="ECO:0000244|PDB:1S1D"
FT   STRAND          342..349
FT                   /evidence="ECO:0000244|PDB:1S1D"
FT   STRAND          357..366
FT                   /evidence="ECO:0000244|PDB:1S1D"
FT   STRAND          369..378
FT                   /evidence="ECO:0000244|PDB:1S1D"
FT   STRAND          383..400
FT                   /evidence="ECO:0000244|PDB:1S1D"
SQ   SEQUENCE   401 AA;  44840 MW;  5B78EB24C0B2C4CA CRC64;
     MPVQLSEHPE WNESMHSLRI SVGGLPVLAS MTKAADPRFR PRWKVILTFF VGAAILWLLC
     SHRPAPGRPP THNAHNWRLG QAPANWYNDT YPLSPPQRTP AGIRYRIAVI ADLDTESRAQ
     EENTWFSYLK KGYLTLSDSG DKVAVEWDKD HGVLESHLAE KGRGMELSDL IVFNGKLYSV
     DDRTGVVYQI EGSKAVPWVI LSDGDGTVEK GFKAEWLAVK DERLYVGGLG KEWTTTTGDV
     VNENPEWVKV VGYKGSVDHE NWVSNYNALR AAAGIQPPGY LIHESACWSD TLQRWFFLPR
     RASQERYSEK DDERKGANLL LSASPDFGDI AVSHVGAVVP THGFSSFKFI PNTDDQIIVA
     LKSEEDSGRV ASYIMAFTLD GRFLLPETKI GSVKYEGIEF I
//
ID   E5RHM5_HUMAN            Unreviewed;        46 AA.
AC   E5RHM5;
DT   08-FEB-2011, integrated into UniProtKB/TrEMBL.
DT   08-FEB-2011, sequence version 1.
DT   22-APR-2020, entry version 55.
DE   SubName: Full=Coiled-coil-helix-coiled-coil-helix domain-containing protein 7 {ECO:0000313|Ensembl:ENSP00000430882};
GN   Name=CHCHD7 {ECO:0000313|Ensembl:ENSP00000430882};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000430882, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000430882, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M.,
RA   Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L.,
RA   Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S.,
RA   Asakawa T., Blechschmidt K., Bloom T., Borowsky M.L., Butler J., Cook A.,
RA   Corum B., DeArellano K., DeCaprio D., Dooley K.T., Dorris L. III,
RA   Engels R., Glockner G., Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K.,
RA   Jaffe D.B., Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C., O'Leary S.B.,
RA   O'Neill K., Parker S.C., Polley A., Raymond C.K., Reichwald K.,
RA   Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R., Smith C.L.,
RA   Sneddon T.P., Talamas J.A., Tenzin P., Topham K., Venkataraman V., Wen G.,
RA   Yamazaki S., Young S.K., Zeng Q., Zimmer A.R., Rosenthal A., Birren B.W.,
RA   Platzer M., Shimizu N., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000430882}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC107952; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001304788.1; NM_001317859.1.
DR   SMR; E5RHM5; -.
DR   MaxQB; E5RHM5; -.
DR   PeptideAtlas; E5RHM5; -.
DR   PRIDE; E5RHM5; -.
DR   ProteomicsDB; 16029; -.
DR   Antibodypedia; 42406; 49 antibodies.
DR   Ensembl; ENST00000523061; ENSP00000430882; ENSG00000170791.
DR   GeneID; 79145; -.
DR   UCSC; uc064mza.1; human.
DR   CTD; 79145; -.
DR   EuPathDB; HostDB:ENSG00000170791.17; -.
DR   HGNC; HGNC:28314; CHCHD7.
DR   OpenTargets; ENSG00000170791; -.
DR   eggNOG; KOG4618; Eukaryota.
DR   eggNOG; ENOG4112B0H; LUCA.
DR   GeneTree; ENSGT00390000001029; -.
DR   ChiTaRS; CHCHD7; human.
DR   GenomeRNAi; 79145; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000170791; Expressed in amniotic fluid and 221 other tissues.
DR   ExpressionAtlas; E5RHM5; baseline and differential.
DR   InterPro; IPR009069; Cys_alpha_HP_mot_SF.
DR   SUPFAM; SSF47072; SSF47072; 1.
PE   1: Evidence at protein level;
KW   Disulfide bond {ECO:0000256|SAAS:SAAS00756830};
KW   Proteomics identification {ECO:0000213|MaxQB:E5RHM5,
KW   ECO:0000213|PeptideAtlas:E5RHM5, ECO:0000213|ProteomicsDB:E5RHM5};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
SQ   SEQUENCE   46 AA;  5382 MW;  639642393A62729D CRC64;
     MPSVTQRLRD PDINPCLSES DASTRCLDEN NYDRERCSTY FLRILS
//
ID   CHCH7_HUMAN             Reviewed;          85 AA.
AC   Q9BUK0; A8K223; E9PBH3; J3KNE9; Q7Z588;
DT   12-APR-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   22-APR-2020, entry version 134.
DE   RecName: Full=Coiled-coil-helix-coiled-coil-helix domain-containing protein 7;
GN   Name=CHCHD7;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RA   Guo J.H., Zan Q., Yu L.;
RL   Submitted (DEC-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Heart, and Subthalamic nucleus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M.,
RA   Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L.,
RA   Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S.,
RA   Asakawa T., Blechschmidt K., Bloom T., Borowsky M.L., Butler J., Cook A.,
RA   Corum B., DeArellano K., DeCaprio D., Dooley K.T., Dorris L. III,
RA   Engels R., Gloeckner G., Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K.,
RA   Jaffe D.B., Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C., O'Leary S.B.,
RA   O'Neill K., Parker S.C.J., Polley A., Raymond C.K., Reichwald K.,
RA   Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R., Smith C.L.,
RA   Sneddon T.P., Talamas J.A., Tenzin P., Topham K., Venkataraman V., Wen G.,
RA   Yamazaki S., Young S.K., Zeng Q., Zimmer A.R., Rosenthal A., Birren B.W.,
RA   Platzer M., Shimizu N., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   CHROMOSOMAL REARRANGEMENT WITH PLAG1.
RX   PubMed=16736500; DOI=10.1002/gcc.20346;
RA   Asp J., Persson F., Kost-Alimova M., Stenman G.;
RT   "CHCHD7-PLAG1 and TCEA1-PLAG1 gene fusions resulting from cryptic,
RT   intrachromosomal 8q rearrangements in pleomorphic salivary gland
RT   adenomas.";
RL   Genes Chromosomes Cancer 45:820-828(2006).
RN   [7]
RP   STRUCTURE BY NMR, SUBUNIT, PUTATIVE SUBCELLULAR LOCATION, IDENTIFICATION BY
RP   MASS SPECTROMETRY, AND DISULFIDE BONDS.
RX   PubMed=22842048; DOI=10.1016/j.jsb.2012.07.007;
RA   Banci L., Bertini I., Ciofi-Baffoni S., Jaiswal D., Neri S., Peruzzini R.,
RA   Winkelmann J.;
RT   "Structural characterization of CHCHD5 and CHCHD7: two atypical human twin
RT   CX9C proteins.";
RL   J. Struct. Biol. 180:190-200(2012).
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:22842048}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion intermembrane space {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q9BUK0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BUK0-2; Sequence=VSP_038076;
CC       Name=3;
CC         IsoId=Q9BUK0-3; Sequence=VSP_038076, VSP_038077;
CC       Name=4;
CC         IsoId=Q9BUK0-4; Sequence=VSP_046698;
CC       Name=5;
CC         IsoId=Q9BUK0-5; Sequence=VSP_038077;
CC   -!- DISEASE: Note=A chromosomal aberration involving CHCHD7 is found in
CC       salivary gland pleiomorphic adenomas, the most common benign epithelial
CC       tumors of the salivary gland. Translocation t(6;8)(p21.3-22;q13) with
CC       PLAG1. {ECO:0000269|PubMed:16736500}.
CC   -!- SIMILARITY: Belongs to the CHCHD7 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=EAW86776.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY070434; AAL65261.1; -; mRNA.
DR   EMBL; AK095922; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK290088; BAF82777.1; -; mRNA.
DR   EMBL; AC107952; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471068; EAW86776.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CH471068; EAW86778.1; -; Genomic_DNA.
DR   EMBL; BC002546; AAH02546.2; -; mRNA.
DR   CCDS; CCDS34895.1; -. [Q9BUK0-4]
DR   CCDS; CCDS34896.1; -. [Q9BUK0-1]
DR   CCDS; CCDS55232.1; -. [Q9BUK0-3]
DR   CCDS; CCDS55233.1; -. [Q9BUK0-5]
DR   CCDS; CCDS6166.2; -. [Q9BUK0-2]
DR   RefSeq; NP_001011667.1; NM_001011667.2.
DR   RefSeq; NP_001011668.1; NM_001011668.2. [Q9BUK0-4]
DR   RefSeq; NP_001011669.1; NM_001011669.2. [Q9BUK0-3]
DR   RefSeq; NP_001011670.1; NM_001011670.2. [Q9BUK0-5]
DR   RefSeq; NP_001011671.1; NM_001011671.2. [Q9BUK0-1]
DR   RefSeq; NP_001304787.1; NM_001317858.1. [Q9BUK0-3]
DR   RefSeq; NP_001304788.1; NM_001317859.1.
DR   RefSeq; NP_077276.2; NM_024300.4. [Q9BUK0-2]
DR   PDB; 2LQT; NMR; -; A=1-85.
DR   PDBsum; 2LQT; -.
DR   SMR; Q9BUK0; -.
DR   BioGrid; 122564; 3.
DR   IntAct; Q9BUK0; 3.
DR   STRING; 9606.ENSP00000306425; -.
DR   iPTMnet; Q9BUK0; -.
DR   PhosphoSitePlus; Q9BUK0; -.
DR   BioMuta; CHCHD7; -.
DR   DMDM; 62510507; -.
DR   EPD; Q9BUK0; -.
DR   jPOST; Q9BUK0; -.
DR   MassIVE; Q9BUK0; -.
DR   MaxQB; Q9BUK0; -.
DR   PaxDb; Q9BUK0; -.
DR   PeptideAtlas; Q9BUK0; -.
DR   PRIDE; Q9BUK0; -.
DR   ProteomicsDB; 19223; -.
DR   ProteomicsDB; 79095; -. [Q9BUK0-1]
DR   ProteomicsDB; 79096; -. [Q9BUK0-2]
DR   ProteomicsDB; 79097; -. [Q9BUK0-3]
DR   Antibodypedia; 42406; 49 antibodies.
DR   DNASU; 79145; -.
DR   Ensembl; ENST00000303759; ENSP00000306425; ENSG00000170791. [Q9BUK0-4]
DR   Ensembl; ENST00000355315; ENSP00000347469; ENSG00000170791. [Q9BUK0-1]
DR   Ensembl; ENST00000518801; ENSP00000428274; ENSG00000170791. [Q9BUK0-3]
DR   Ensembl; ENST00000519367; ENSP00000428095; ENSG00000170791. [Q9BUK0-5]
DR   Ensembl; ENST00000521524; ENSP00000430458; ENSG00000170791. [Q9BUK0-3]
DR   Ensembl; ENST00000521831; ENSP00000429635; ENSG00000170791. [Q9BUK0-5]
DR   Ensembl; ENST00000523975; ENSP00000428917; ENSG00000170791. [Q9BUK0-2]
DR   GeneID; 79145; -.
DR   KEGG; hsa:79145; -.
DR   UCSC; uc003xss.4; human. [Q9BUK0-1]
DR   CTD; 79145; -.
DR   DisGeNET; 79145; -.
DR   GeneCards; CHCHD7; -.
DR   HGNC; HGNC:28314; CHCHD7.
DR   HPA; ENSG00000170791; Low tissue specificity.
DR   MIM; 611238; gene.
DR   neXtProt; NX_Q9BUK0; -.
DR   OpenTargets; ENSG00000170791; -.
DR   PharmGKB; PA134883538; -.
DR   eggNOG; KOG4618; Eukaryota.
DR   eggNOG; ENOG4112B0H; LUCA.
DR   GeneTree; ENSGT00390000001029; -.
DR   HOGENOM; CLU_175044_1_0_1; -.
DR   InParanoid; Q9BUK0; -.
DR   OMA; NYDKERC; -.
DR   OrthoDB; 1617584at2759; -.
DR   PhylomeDB; Q9BUK0; -.
DR   TreeFam; TF300284; -.
DR   Reactome; R-HSA-1268020; Mitochondrial protein import.
DR   ChiTaRS; CHCHD7; human.
DR   GenomeRNAi; 79145; -.
DR   Pharos; Q9BUK0; Tdark.
DR   PRO; PR:Q9BUK0; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   RNAct; Q9BUK0; protein.
DR   Bgee; ENSG00000170791; Expressed in amniotic fluid and 221 other tissues.
DR   ExpressionAtlas; Q9BUK0; baseline and differential.
DR   Genevisible; Q9BUK0; HS.
DR   GO; GO:0005758; C:mitochondrial intermembrane space; IEA:UniProtKB-SubCell.
DR   InterPro; IPR009069; Cys_alpha_HP_mot_SF.
DR   SUPFAM; SSF47072; SSF47072; 1.
DR   PROSITE; PS51808; CHCH; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Chromosomal rearrangement;
KW   Disulfide bond; Mitochondrion; Reference proteome.
FT   CHAIN           1..85
FT                   /note="Coiled-coil-helix-coiled-coil-helix domain-
FT                   containing protein 7"
FT                   /id="PRO_0000129171"
FT   DOMAIN          13..55
FT                   /note="CHCH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01150"
FT   MOTIF           16..26
FT                   /note="Cx9C motif 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01150"
FT   MOTIF           37..47
FT                   /note="Cx9C motif 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01150"
FT   DISULFID        16..47
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01150,
FT                   ECO:0000269|PubMed:22842048"
FT   DISULFID        26..37
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01150,
FT                   ECO:0000269|PubMed:22842048"
FT   VAR_SEQ         1
FT                   /note="M -> MHQTRTGKKTVRM (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|Ref.1"
FT                   /id="VSP_038076"
FT   VAR_SEQ         1
FT                   /note="M -> MKCEETHAPNSNWVYVMLPSKKTVRM (in isoform 4)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_046698"
FT   VAR_SEQ         19..85
FT                   /note="ESDASTRCLDENNYDRERCSTYFLRYKNCRRFWNSIVMQRRKNGVKPFMPTA
FT                   AERDEILRAVGNMPY -> ILFYLLNDASLISVRNLMLPPDVWMKITMTGKGVPLTS
FT                   (in isoform 3 and isoform 5)"
FT                   /evidence="ECO:0000303|Ref.1"
FT                   /id="VSP_038077"
FT   HELIX           17..29
FT                   /evidence="ECO:0000244|PDB:2LQT"
FT   TURN            30..32
FT                   /evidence="ECO:0000244|PDB:2LQT"
FT   TURN            34..37
FT                   /evidence="ECO:0000244|PDB:2LQT"
FT   HELIX           38..59
FT                   /evidence="ECO:0000244|PDB:2LQT"
FT   HELIX           70..80
FT                   /evidence="ECO:0000244|PDB:2LQT"
SQ   SEQUENCE   85 AA;  10095 MW;  957C3727AB9B3C8C CRC64;
     MPSVTQRLRD PDINPCLSES DASTRCLDEN NYDRERCSTY FLRYKNCRRF WNSIVMQRRK
     NGVKPFMPTA AERDEILRAV GNMPY
//
ID   A0A024RBR1_HUMAN        Unreviewed;      1427 AA.
AC   A0A024RBR1;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 48.
DE   SubName: Full=Restin (Reed-Steinberg cell-expressed intermediate filament-associated protein), isoform CRA_b {ECO:0000313|EMBL:EAW98322.1};
GN   Name=RSN {ECO:0000313|EMBL:EAW98322.1};
GN   ORFNames=hCG_2016686 {ECO:0000313|EMBL:EAW98322.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW98322.1};
RN   [1] {ECO:0000313|EMBL:EAW98322.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW98322.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH471054; EAW98321.1; -; Genomic_DNA.
DR   EMBL; CH471054; EAW98322.1; -; Genomic_DNA.
DR   RefSeq; NP_002947.1; NM_002956.2.
DR   RefSeq; XP_016875275.1; XM_017019786.1.
DR   Antibodypedia; 3829; 292 antibodies.
DR   GeneID; 6249; -.
DR   CTD; 6249; -.
DR   EuPathDB; HostDB:ENSG00000130779.19; -.
DR   eggNOG; KOG4568; Eukaryota.
DR   eggNOG; COG5244; LUCA.
DR   OrthoDB; 1110101at2759; -.
DR   ChiTaRS; CLIP1; human.
DR   GenomeRNAi; 6249; -.
DR   Bgee; ENSG00000130779; Expressed in biceps brachii and 233 other tissues.
DR   Gene3D; 2.30.30.190; -; 2.
DR   InterPro; IPR036859; CAP-Gly_dom_sf.
DR   InterPro; IPR000938; CAP-Gly_domain.
DR   InterPro; IPR032108; CLIP1_ZNF.
DR   Pfam; PF01302; CAP_GLY; 2.
DR   Pfam; PF16641; CLIP1_ZNF; 2.
DR   SMART; SM01052; CAP_GLY; 2.
DR   SUPFAM; SSF74924; SSF74924; 2.
DR   PROSITE; PS00845; CAP_GLY_1; 2.
DR   PROSITE; PS50245; CAP_GLY_2; 2.
PE   4: Predicted;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN          78..120
FT                   /note="CAP-Gly"
FT                   /evidence="ECO:0000259|PROSITE:PS50245"
FT   DOMAIN          232..274
FT                   /note="CAP-Gly"
FT                   /evidence="ECO:0000259|PROSITE:PS50245"
FT   REGION          129..188
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          302..340
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          976..995
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1287..1308
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1384..1403
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          350..377
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          403..451
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          466..486
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          501..521
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          577..604
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          613..633
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          649..806
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          821..862
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          870..925
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1185..1205
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1231..1258
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1312..1339
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        132..188
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        979..995
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   1427 AA;  160990 MW;  0A4F166DD94254E8 CRC64;
     MSMLKPSGLK APTKILKPGS TALKTPTAVV APVEKTISSE KASSTPSSET QEEFVDDFRV
     GERVWVNGNK PGFIQFLGET QFAPGQWAGI VLDEPIGKND GSVAGVRYFQ CEPLKGIFTR
     PSKLTRKVQA EDEANGLQTT PASRATSPLC TSTASMVSSS PSTPSNIPQK PSQPAAKEPS
     ATPPISNLTK TASESISNLS EAGSIKKGER ELKIGDRVLV GGTKAGVVRF LGETDFAKGE
     WCGVELDEPL GKNDGAVAGT RYFQCQPKYG LFAPVHKVTK IGFPSTTPAK AKANAVRRVM
     ATTSASLKRS PSASSLSSMS SVASSVSSRP SRTGLLTETS SRYARKISGT TALQEALKEK
     QQHIEQLLAE RDLERAEVAK ATSHVGEIEQ ELALARDGHD QHVLELEAKM DQLRTMVEAA
     DREKVELLNQ LEEEKRKVED LQFRVEEESI TKGDLETQTK LEHARIKELE QSLLFEKTKA
     DKLQRELEDT RVATVSEKSR IMELEKDLAL RVQEVAELRR RLESNKPAGD VDMSLSLLQE
     ISSLQEKLEV TRTDHQREIT SLKEHFGARE ETHQKEIKAL YTATEKLSKE NESLKSKLEH
     ANKENSDVIA LWKSKLETAI ASHQQAMEEL KVSFSKGLGT ETAEFAELKT QIEKMRLDYQ
     HEIENLQNQQ DSERAAHAKE MEALRAKLMK VIKEKENSLE AIRSKLDKAE DQHLVEMEDT
     LNKLQEAEIK VKELEVLQAK CNEQTKVIDN FTSQLKATEE KLLDLDALRK ASSEGKSEMK
     KLRQQLEAAE KQIKHLEIEK NAESSKASSI TRELQGRELK LTNLQENLSE VSQVKETLEK
     ELQILKEKFA EASEEAVSVQ RSMQETVNKL HQKEEQFNML SSDLEKLREN LADMEAKFRE
     KDEREEQLIK AKEKLENDIA EIMKMSGDNS SQLTKMNDEL RLKERDVEEL QLKLTKANEN
     ASFLQKSIED MTVKAEQSQQ EAAKKHEEEK KELERKLSDL EKKMETSHNQ CQELKARYER
     ATSETKTKHE EILQNLQKTL LDTEDKLKGA REENSGLLQE LEELRKQADK AKAAQTAEDA
     MQIMEQMTKE KTETLASLED TKQTNAKLQN ELDTLKENNL KNVEELNKSK ELLTVENQKM
     EEFRKEIETL KQAAAQKSQQ LSALQEENVK LAEELGRSRD EVTSHQKLEE ERSVLNNQLL
     EMKKRESKFI KDADEEKASL QKSISITSAL LTEKDAELEK LRNEVTVLRG ENASAKSLHS
     VVQTLESDKV KLELKVKNLE LQLKENKRQL SSSSGNTDTQ ADEDERAQES QIDFLNSVIV
     DLQRKNQDLK MKVEMMSEAA LNGNGDDLNN YDSDDQEKQS KKKPRLFCDI CDCFDLHDTE
     DCPTQAQMSE DPPHSTHHGS RGEERPYCEI CEMFGHWATN CNDDETF
//
ID   B3KXA5_HUMAN            Unreviewed;       472 AA.
AC   B3KXA5;
DT   02-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   02-SEP-2008, sequence version 1.
DT   26-FEB-2020, entry version 53.
DE   SubName: Full=cDNA FLJ45045 fis, clone BRAWH3021580, highly similar to Restin (Cytoplasmic linker protein 170 alpha-2) {ECO:0000313|EMBL:BAG54417.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG54417.1};
RN   [1] {ECO:0000313|EMBL:BAG54417.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAG54417.1};
RA   Kawakami B., Sugiyama A., Takemoto M., Sugiyama T., Irie R., Otsuki T.,
RA   Sato H., Ota T., Wakamatsu A., Ishii S., Yamamoto J., Isono Y.,
RA   Kawai-Hio Y., Saito K., Nishikawa T., Kimura K., Yamashita H., Matsuo K.,
RA   Nakamura Y., Sekine M., Kikuchi H., Kanda K., Wagatsuma M., Murakawa K.,
RA   Kanehori K., Takahashi-Fujii A., Oshima A., Suzuki Y., Sugano S.,
RA   Nagahari K., Masuho Y., Nagai K., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK126990; BAG54417.1; -; mRNA.
DR   RefSeq; NP_002947.1; NM_002956.2.
DR   RefSeq; NP_937883.1; NM_198240.1.
DR   PeptideAtlas; B3KXA5; -.
DR   PRIDE; B3KXA5; -.
DR   GeneID; 6249; -.
DR   CTD; 6249; -.
DR   PharmGKB; PA162382349; -.
DR   eggNOG; KOG4568; Eukaryota.
DR   eggNOG; COG5244; LUCA.
DR   OrthoDB; 1110101at2759; -.
DR   GenomeRNAi; 6249; -.
DR   Genevisible; B3KXA5; HS.
DR   InterPro; IPR032108; CLIP1_ZNF.
DR   Pfam; PF16641; CLIP1_ZNF; 2.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN          410..427
FT                   /note="CLIP1_ZNF"
FT                   /evidence="ECO:0000259|Pfam:PF16641"
FT   DOMAIN          450..466
FT                   /note="CLIP1_ZNF"
FT                   /evidence="ECO:0000259|Pfam:PF16641"
FT   REGION          16..38
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          330..352
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          429..448
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          228..248
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          274..301
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        22..38
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   472 AA;  54323 MW;  4311F3A5ED51D25A CRC64;
     MKMQVFCKKS IEDMTVKAEQ SQQEAAKKHE EEKKELERKL SDLEKKMETS HNQCQELKAR
     YERATSETKT KHEEILQNLQ KTLLDTEDKL KGAREENSGL LQELEELRKQ ADKAKAAQTA
     EDAMQIMEQM TKEKTETLAS LEDTKQTNAK LQNELDTLKE NNLKNVEELN KSKELLTVEN
     QKMEEFRKEI ETLKQAAAQK SQQLSALQEE NVKLAEELGR SRDEVTSHQK LEEERSVLNN
     QLLEMKKRES KFIKDADEEK ASLQKSISIT SALLTEKDAE LEKLRNEVTV LRGENASAKS
     LHSVVQTLES DKVKLELKVK NLELQLKENK RQLSSSSGNT DTQADEDERA QESQQMIDFL
     NSVIVDLQRK NQDLKMKVEM MSEAALNGNG DDLNNYDSDD QEKQSKKKPR LFCDICDCFD
     LHDTEDCPTQ AQMSEDPPHS THHGSRGEER PYCEICEMFG HWATNCNDDE TF
//
ID   CLIP1_HUMAN             Reviewed;        1438 AA.
AC   P30622; A0AVD3; Q17RS4; Q29RG0;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   13-OCT-2009, sequence version 2.
DT   22-APR-2020, entry version 201.
DE   RecName: Full=CAP-Gly domain-containing linker protein 1;
DE   AltName: Full=Cytoplasmic linker protein 1;
DE   AltName: Full=Cytoplasmic linker protein 170 alpha-2;
DE            Short=CLIP-170;
DE   AltName: Full=Reed-Sternberg intermediate filament-associated protein;
DE   AltName: Full=Restin;
GN   Name=CLIP1; Synonyms=CYLN1, RSN;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND TISSUE SPECIFICITY.
RC   TISSUE=Peripheral blood monocyte;
RX   PubMed=1600942; DOI=10.1002/j.1460-2075.1992.tb05269.x;
RA   Bilbe G., Delabie J., Brueggen J., Richener H., Asselbergs F.A.M.,
RA   Cerletti N., Sorg C., Odink K., Tarcsay L., Wiesendanger W.,
RA   de Wolf-Peeters C., Shipman R.;
RT   "Restin: a novel intermediate filament-associated protein highly expressed
RT   in the Reed-Sternberg cells of Hodgkin's disease.";
RL   EMBO J. 11:2103-2113(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), AND VARIANT GLU-1080.
RX   PubMed=1356075; DOI=10.1016/0092-8674(92)90240-d;
RA   Pierre P., Scheel J., Rickard J.E., Kreis T.E.;
RT   "CLIP-170 links endocytic vesicles to microtubules.";
RL   Cell 70:887-900(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3), AND VARIANTS
RP   PRO-941 AND GLU-1080.
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=12433698; DOI=10.1182/blood.v100.12.4139;
RA   Sahin U., Neumann F., Tureci O., Schmits R., Perez F., Pfreundschuh M.;
RT   "Hodgkin and Reed-Sternberg cell-associated autoantigen CLIP-170/restin is
RT   a marker for dendritic cells and is involved in the trafficking of
RT   macropinosomes to the cytoskeleton, supporting a function-based concept of
RT   Hodgkin and Reed-Sternberg cells.";
RL   Blood 100:4139-4145(2002).
RN   [5]
RP   INTERACTION WITH MTOR, AND PHOSPHORYLATION BY MTOR.
RX   PubMed=12231510; DOI=10.1093/embo-reports/kvf197;
RA   Choi J.H., Bertram P.G., Drenan R., Carvalho J., Zhou H.H., Zheng X.F.;
RT   "The FKBP12-rapamycin-associated protein (FRAP) is a CLIP-170 kinase.";
RL   EMBO Rep. 3:988-994(2002).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-200 AND SER-204, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-195, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48; THR-140; SER-143;
RP   SER-147; THR-182; SER-197; SER-200 AND SER-204, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-195; SER-200 AND SER-204, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [11]
RP   INTERACTION WITH DCTN1.
RX   PubMed=20679239; DOI=10.1073/pnas.1006615107;
RA   Li H., Liu X.S., Yang X., Song B., Wang Y., Liu X.;
RT   "Polo-like kinase 1 phosphorylation of p150Glued facilitates nuclear
RT   envelope breakdown during prophase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:14633-14638(2010).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48; THR-140; SER-143;
RP   SER-200; SER-204 AND SER-1364, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-50; THR-140; SER-143;
RP   THR-182; SER-195; SER-200 AND SER-204, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-200 AND THR-1310, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   STRUCTURE BY NMR OF 1-340.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the 1st and 2nd CAP-Gly domain in human CLIP-
RT   170/Restin.";
RL   Submitted (NOV-2005) to the PDB data bank.
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 57-128, FUNCTION, SUBUNIT,
RP   SUBCELLULAR LOCATION, MUTAGENESIS OF 98-LYS-ASN-99, AND INTERACTION WITH
RP   TUBULIN.
RX   PubMed=17889670; DOI=10.1016/j.molcel.2007.07.023;
RA   Slep K.C., Vale R.D.;
RT   "Structural basis of microtubule plus end tracking by XMAP215, CLIP-170,
RT   and EB1.";
RL   Mol. Cell 27:976-991(2007).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 1388-1427 IN COMPLEX WITH DCTN1.
RX   PubMed=17828277; DOI=10.1038/nsmb1291;
RA   Weisbrich A., Honnappa S., Jaussi R., Okhrimenko O., Frey D., Jelesarov I.,
RA   Akhmanova A., Steinmetz M.O.;
RT   "Structure-function relationship of CAP-Gly domains.";
RL   Nat. Struct. Mol. Biol. 14:959-967(2007).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 1416-1438 IN COMPLEX WITH DCTN1
RP   AND ZINC, INTERACTION WITH DCTN1, AND ZINC-FINGER.
RX   PubMed=17828275; DOI=10.1038/nsmb1299;
RA   Hayashi I., Plevin M.J., Ikura M.;
RT   "CLIP170 autoinhibition mimics intermolecular interactions with p150Glued
RT   or EB1.";
RL   Nat. Struct. Mol. Biol. 14:980-981(2007).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (1.45 ANGSTROMS) OF 211-300, STRUCTURE BY NMR OF
RP   203-300 IN COMPLEX WITH TUBA1B, INTERACTION WITH TUBULIN; TUBA1B; MAPRE1
RP   AND MAPRE3, FUNCTION, AND ZINC-FINGER DOMAIN.
RX   PubMed=17563362; DOI=10.1073/pnas.0703876104;
RA   Mishima M., Maesaki R., Kasa M., Watanabe T., Fukata M., Kaibuchi K.,
RA   Hakoshima T.;
RT   "Structural basis for tubulin recognition by cytoplasmic linker protein 170
RT   and its autoinhibition.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:10346-10351(2007).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 56-127 IN COMPLEX WITH SLAIN2,
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH SLAIN2.
RX   PubMed=21646404; DOI=10.1083/jcb.201012179;
RA   van der Vaart B., Manatschal C., Grigoriev I., Olieric V., Gouveia S.M.,
RA   Bjelic S., Demmers J., Vorobjev I., Hoogenraad C.C., Steinmetz M.O.,
RA   Akhmanova A.;
RT   "SLAIN2 links microtubule plus end-tracking proteins and controls
RT   microtubule growth in interphase.";
RL   J. Cell Biol. 193:1083-1099(2011).
RN   [22]
RP   VARIANT [LARGE SCALE ANALYSIS] ILE-1213.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Binds to the plus end of microtubules and regulates the
CC       dynamics of the microtubule cytoskeleton. Promotes microtubule growth
CC       and microtubule bundling. Links cytoplasmic vesicles to microtubules
CC       and thereby plays an important role in intracellular vesicle
CC       trafficking. Plays a role macropinocytosis and endosome trafficking.
CC       {ECO:0000269|PubMed:12433698, ECO:0000269|PubMed:17563362,
CC       ECO:0000269|PubMed:17889670}.
CC   -!- SUBUNIT: Interacts with MTOR; phosphorylates and regulates CLIP1
CC       (PubMed:12231510). Interacts (via CAP-Gly domains) with tubulin
CC       (PubMed:17563362, PubMed:17889670). Interacts with SLAIN2
CC       (PubMed:21646404). Interacts (via zinc finger) with DCTN1
CC       (PubMed:17828275, PubMed:20679239). Interacts with TUBA1B, MAPRE1 and
CC       MAPRE3 (PubMed:17563362). Binds preferentially to tyrosinated
CC       microtubules, and only marginally to detyrosinated microtubules (By
CC       similarity). {ECO:0000250|UniProtKB:Q922J3,
CC       ECO:0000269|PubMed:12231510, ECO:0000269|PubMed:17563362,
CC       ECO:0000269|PubMed:17828275, ECO:0000269|PubMed:17828277,
CC       ECO:0000269|PubMed:17889670, ECO:0000269|PubMed:20679239,
CC       ECO:0000269|PubMed:21646404}.
CC   -!- INTERACTION:
CC       P30622-1; P30622-1; NbExp=12; IntAct=EBI-9640673, EBI-9640673;
CC       P30622-1; Q14203: DCTN1; NbExp=7; IntAct=EBI-9640673, EBI-724352;
CC       P30622; Q15691: MAPRE1; NbExp=2; IntAct=EBI-2683569, EBI-1004115;
CC       P30622-1; Q15691: MAPRE1; NbExp=2; IntAct=EBI-9640673, EBI-1004115;
CC       P30622-2; Q15691: MAPRE1; NbExp=4; IntAct=EBI-6479976, EBI-1004115;
CC       P30622; Q04864-2: REL; NbExp=3; IntAct=EBI-2683569, EBI-10829018;
CC       P30622-2; Q71U36: TUBA1A; NbExp=3; IntAct=EBI-6479976, EBI-302552;
CC       P30622; P68366: TUBA4A; NbExp=3; IntAct=EBI-2683569, EBI-351772;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}. Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:17889670, ECO:0000269|PubMed:21646404}. Cytoplasmic
CC       vesicle membrane {ECO:0000269|PubMed:12433698}; Peripheral membrane
CC       protein; Cytoplasmic side. Cell projection, ruffle
CC       {ECO:0000269|PubMed:12433698}. Note=Localizes to microtubule plus ends
CC       (PubMed:21646404, PubMed:17889670). Localizes preferentially to the
CC       ends of tyrosinated microtubules (By similarity). Accumulates in plasma
CC       membrane regions with ruffling and protrusions. Associates with the
CC       membranes of intermediate macropinocytic vesicles (PubMed:12433698).
CC       {ECO:0000250|UniProtKB:Q922J3, ECO:0000269|PubMed:12433698,
CC       ECO:0000269|PubMed:17889670, ECO:0000269|PubMed:21646404}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P30622-3; Sequence=Displayed;
CC       Name=2; Synonyms=Long;
CC         IsoId=P30622-1; Sequence=VSP_038201;
CC       Name=3; Synonyms=Short;
CC         IsoId=P30622-2; Sequence=VSP_000765;
CC   -!- TISSUE SPECIFICITY: Detected in dendritic cells (at protein level).
CC       Highly expressed in the Reed-Sternberg cells of Hodgkin disease.
CC       {ECO:0000269|PubMed:12433698, ECO:0000269|PubMed:1600942}.
CC   -!- DOMAIN: Intramolecular interaction between the zinc finger domain and
CC       the CAP-Gly domains may inhibit interaction with tubulin.
CC       {ECO:0000269|PubMed:17563362}.
CC   -!- PTM: Phosphorylated. Phosphorylation induces conformational changes by
CC       increasing the affinity of the N-terminus for C-terminus, resulting in
CC       inhibition of its function thus decreasing its binding to microtubules
CC       and DCTN1. Exhibits a folded, autoinhibited conformation when
CC       phosphorylated and an open conformation when dephosphorylated with
CC       increased binding affinity to microtubules and DCTN1. Phosphorylation
CC       regulates its recruitment to tyrosinated microtubules and the
CC       recruitment of vesicular cargo to microtubules in neurons (By
CC       similarity). Phosphorylation by MTOR may positively regulate CLIP1
CC       association with microtubules (PubMed:12231510).
CC       {ECO:0000250|UniProtKB:Q9JK25, ECO:0000269|PubMed:12231510}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X64838; CAA46050.1; -; mRNA.
DR   EMBL; M97501; AAA35693.1; -; mRNA.
DR   EMBL; BC114213; AAI14214.1; -; mRNA.
DR   EMBL; BC117209; AAI17210.1; -; mRNA.
DR   EMBL; BC126305; AAI26306.1; -; mRNA.
DR   CCDS; CCDS58285.1; -. [P30622-3]
DR   CCDS; CCDS9232.1; -. [P30622-1]
DR   CCDS; CCDS9233.1; -. [P30622-2]
DR   PIR; A43336; A43336.
DR   PIR; S22695; S22695.
DR   RefSeq; NP_001234926.1; NM_001247997.1. [P30622-3]
DR   RefSeq; NP_002947.1; NM_002956.2. [P30622-1]
DR   RefSeq; NP_937883.1; NM_198240.1. [P30622-2]
DR   RefSeq; XP_016875275.1; XM_017019786.1. [P30622-1]
DR   RefSeq; XP_016875279.1; XM_017019790.1. [P30622-2]
DR   PDB; 2CP5; NMR; -; A=1-128.
DR   PDB; 2CP6; NMR; -; A=181-339.
DR   PDB; 2E3H; X-ray; 1.45 A; A=211-300.
DR   PDB; 2E3I; X-ray; 2.00 A; A=56-141.
DR   PDB; 2E4H; NMR; -; A=203-300.
DR   PDB; 2HQH; X-ray; 1.80 A; E/F/G/H=1416-1438.
DR   PDB; 2QK0; X-ray; 2.00 A; A=57-128.
DR   PDB; 3E2U; X-ray; 2.60 A; E/F/G/H=1399-1438.
DR   PDB; 3RDV; X-ray; 1.75 A; A/B/C/D=56-127.
DR   PDBsum; 2CP5; -.
DR   PDBsum; 2CP6; -.
DR   PDBsum; 2E3H; -.
DR   PDBsum; 2E3I; -.
DR   PDBsum; 2E4H; -.
DR   PDBsum; 2HQH; -.
DR   PDBsum; 2QK0; -.
DR   PDBsum; 3E2U; -.
DR   PDBsum; 3RDV; -.
DR   SMR; P30622; -.
DR   BioGrid; 112163; 40.
DR   CORUM; P30622; -.
DR   DIP; DIP-42826N; -.
DR   ELM; P30622; -.
DR   IntAct; P30622; 32.
DR   MINT; P30622; -.
DR   STRING; 9606.ENSP00000479322; -.
DR   GlyConnect; 643; -.
DR   iPTMnet; P30622; -.
DR   MetOSite; P30622; -.
DR   PhosphoSitePlus; P30622; -.
DR   UniCarbKB; P30622; -.
DR   BioMuta; CLIP1; -.
DR   DMDM; 261260059; -.
DR   EPD; P30622; -.
DR   jPOST; P30622; -.
DR   MassIVE; P30622; -.
DR   PaxDb; P30622; -.
DR   PeptideAtlas; P30622; -.
DR   PRIDE; P30622; -.
DR   ProteomicsDB; 54727; -. [P30622-3]
DR   ProteomicsDB; 54728; -. [P30622-1]
DR   ProteomicsDB; 54729; -. [P30622-2]
DR   Antibodypedia; 3829; 292 antibodies.
DR   Ensembl; ENST00000302528; ENSP00000303585; ENSG00000130779. [P30622-1]
DR   Ensembl; ENST00000358808; ENSP00000351665; ENSG00000130779. [P30622-1]
DR   Ensembl; ENST00000537178; ENSP00000445531; ENSG00000130779. [P30622-2]
DR   Ensembl; ENST00000540338; ENSP00000439093; ENSG00000130779. [P30622-3]
DR   Ensembl; ENST00000620786; ENSP00000479322; ENSG00000130779. [P30622-3]
DR   GeneID; 6249; -.
DR   KEGG; hsa:6249; -.
DR   UCSC; uc001ucg.2; human. [P30622-3]
DR   CTD; 6249; -.
DR   DisGeNET; 6249; -.
DR   GeneCards; CLIP1; -.
DR   HGNC; HGNC:10461; CLIP1.
DR   HPA; ENSG00000130779; Tissue enhanced (skeletal).
DR   MalaCards; CLIP1; -.
DR   MIM; 179838; gene.
DR   neXtProt; NX_P30622; -.
DR   OpenTargets; ENSG00000130779; -.
DR   Orphanet; 88616; Autosomal recessive non-syndromic intellectual disability.
DR   PharmGKB; PA162382349; -.
DR   eggNOG; KOG4568; Eukaryota.
DR   eggNOG; COG5244; LUCA.
DR   GeneTree; ENSGT00940000155122; -.
DR   InParanoid; P30622; -.
DR   KO; K10421; -.
DR   OMA; SSKHIDD; -.
DR   OrthoDB; 1110101at2759; -.
DR   PhylomeDB; P30622; -.
DR   TreeFam; TF326096; -.
DR   Reactome; R-HSA-141444; Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal.
DR   Reactome; R-HSA-2467813; Separation of Sister Chromatids.
DR   Reactome; R-HSA-2500257; Resolution of Sister Chromatid Cohesion.
DR   Reactome; R-HSA-5626467; RHO GTPases activate IQGAPs.
DR   Reactome; R-HSA-5663220; RHO GTPases Activate Formins.
DR   Reactome; R-HSA-68877; Mitotic Prometaphase.
DR   Reactome; R-HSA-9648025; EML4 and NUDC in mitotic spindle formation.
DR   SIGNOR; P30622; -.
DR   ChiTaRS; CLIP1; human.
DR   EvolutionaryTrace; P30622; -.
DR   GeneWiki; CLIP1; -.
DR   GenomeRNAi; 6249; -.
DR   Pharos; P30622; Tbio.
DR   PRO; PR:P30622; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; P30622; protein.
DR   Bgee; ENSG00000130779; Expressed in biceps brachii and 233 other tissues.
DR   ExpressionAtlas; P30622; baseline and differential.
DR   Genevisible; P30622; HS.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005881; C:cytoplasmic microtubule; IEA:Ensembl.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005882; C:intermediate filament; TAS:ProtInc.
DR   GO; GO:0000776; C:kinetochore; TAS:UniProtKB.
DR   GO; GO:0005874; C:microtubule; IMP:Alzheimers_University_of_Toronto.
DR   GO; GO:0015630; C:microtubule cytoskeleton; IMP:UniProtKB.
DR   GO; GO:0035371; C:microtubule plus-end; IEA:Ensembl.
DR   GO; GO:0005635; C:nuclear envelope; IEA:Ensembl.
DR   GO; GO:0001726; C:ruffle; IEA:UniProtKB-SubCell.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0008017; F:microtubule binding; IDA:UniProtKB.
DR   GO; GO:0051010; F:microtubule plus-end binding; IDA:UniProtKB.
DR   GO; GO:0015631; F:tubulin binding; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IDA:UniProtKB.
DR   GO; GO:0001578; P:microtubule bundle formation; IMP:UniProtKB.
DR   GO; GO:0000278; P:mitotic cell cycle; TAS:UniProtKB.
DR   GO; GO:0031116; P:positive regulation of microtubule polymerization; IMP:UniProtKB.
DR   GO; GO:0044861; P:protein transport into plasma membrane raft; IEA:Ensembl.
DR   Gene3D; 2.30.30.190; -; 2.
DR   InterPro; IPR036859; CAP-Gly_dom_sf.
DR   InterPro; IPR000938; CAP-Gly_domain.
DR   InterPro; IPR032108; CLIP1_ZNF.
DR   Pfam; PF01302; CAP_GLY; 2.
DR   Pfam; PF16641; CLIP1_ZNF; 2.
DR   SMART; SM01052; CAP_GLY; 2.
DR   SUPFAM; SSF74924; SSF74924; 2.
DR   PROSITE; PS00845; CAP_GLY_1; 2.
DR   PROSITE; PS50245; CAP_GLY_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell projection; Coiled coil;
KW   Cytoplasm; Cytoplasmic vesicle; Cytoskeleton; Membrane; Metal-binding;
KW   Microtubule; Phosphoprotein; Polymorphism; Reference proteome; Repeat;
KW   Transport; Zinc; Zinc-finger.
FT   CHAIN           1..1438
FT                   /note="CAP-Gly domain-containing linker protein 1"
FT                   /id="PRO_0000083527"
FT   DOMAIN          78..120
FT                   /note="CAP-Gly 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00045"
FT   DOMAIN          232..274
FT                   /note="CAP-Gly 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00045"
FT   ZN_FING         1417..1434
FT                   /note="CCHC-type"
FT                   /evidence="ECO:0000269|PubMed:17563362,
FT                   ECO:0000269|PubMed:17828275"
FT   REGION          97..101
FT                   /note="Important for tubulin binding"
FT                   /evidence="ECO:0000269|PubMed:17889670"
FT   COILED          350..1353
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        143..204
FT                   /note="Ser-rich"
FT   COMPBIAS        304..331
FT                   /note="Ser-rich"
FT   MOD_RES         48
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231"
FT   MOD_RES         50
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         140
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163"
FT   MOD_RES         143
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163"
FT   MOD_RES         147
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         182
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         195
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:16964243,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163"
FT   MOD_RES         197
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         200
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         204
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163"
FT   MOD_RES         310
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JK25"
FT   MOD_RES         312
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JK25"
FT   MOD_RES         315
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q922J3"
FT   MOD_RES         348
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JK25"
FT   MOD_RES         1236
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JK25"
FT   MOD_RES         1310
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         1364
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   VAR_SEQ         457..502
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:1356075,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_000765"
FT   VAR_SEQ         457..467
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:1600942"
FT                   /id="VSP_038201"
FT   VARIANT         162
FT                   /note="S -> P (in dbSNP:rs7963597)"
FT                   /id="VAR_059206"
FT   VARIANT         780
FT                   /note="R -> W (in dbSNP:rs3741447)"
FT                   /id="VAR_048672"
FT   VARIANT         941
FT                   /note="S -> P (in dbSNP:rs17883517)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_048673"
FT   VARIANT         1080
FT                   /note="D -> E (in dbSNP:rs1129167)"
FT                   /evidence="ECO:0000269|PubMed:1356075,
FT                   ECO:0000269|PubMed:15489334"
FT                   /id="VAR_020398"
FT   VARIANT         1213
FT                   /note="M -> I (in a breast cancer sample; somatic mutation;
FT                   dbSNP:rs1183319975)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_036446"
FT   VARIANT         1224
FT                   /note="A -> S (in dbSNP:rs17881033)"
FT                   /id="VAR_048674"
FT   MUTAGEN         98..99
FT                   /note="KN->EE: Abolishes interaction with tubulin.
FT                   Abolishes localization at the microtubule plus end."
FT                   /evidence="ECO:0000269|PubMed:17889670"
FT   CONFLICT        193
FT                   /note="S -> G (in Ref. 3; AAI14214)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        324
FT                   /note="S -> P (in Ref. 3; AAI14214)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        651
FT                   /note="T -> A (in Ref. 3; AAI14214)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        682
FT                   /note="D -> N (in Ref. 3; AAI14214)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        766
FT                   /note="L -> P (in Ref. 3; AAI14214)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1432
FT                   /note="C -> R (in Ref. 3; AAI14214)"
FT                   /evidence="ECO:0000305"
FT   STRAND          37..39
FT                   /evidence="ECO:0000244|PDB:2CP5"
FT   STRAND          63..66
FT                   /evidence="ECO:0000244|PDB:3RDV"
FT   TURN            67..69
FT                   /evidence="ECO:0000244|PDB:3RDV"
FT   STRAND          70..78
FT                   /evidence="ECO:0000244|PDB:3RDV"
FT   STRAND          81..85
FT                   /evidence="ECO:0000244|PDB:3RDV"
FT   STRAND          87..95
FT                   /evidence="ECO:0000244|PDB:3RDV"
FT   STRAND          97..103
FT                   /evidence="ECO:0000244|PDB:3RDV"
FT   STRAND          106..108
FT                   /evidence="ECO:0000244|PDB:3RDV"
FT   TURN            113..115
FT                   /evidence="ECO:0000244|PDB:2QK0"
FT   STRAND          116..119
FT                   /evidence="ECO:0000244|PDB:3RDV"
FT   HELIX           121..123
FT                   /evidence="ECO:0000244|PDB:3RDV"
FT   STRAND          124..127
FT                   /evidence="ECO:0000244|PDB:2E3I"
FT   STRAND          193..196
FT                   /evidence="ECO:0000244|PDB:2CP6"
FT   STRAND          217..220
FT                   /evidence="ECO:0000244|PDB:2E3H"
FT   TURN            221..223
FT                   /evidence="ECO:0000244|PDB:2E3H"
FT   STRAND          224..233
FT                   /evidence="ECO:0000244|PDB:2E3H"
FT   STRAND          235..249
FT                   /evidence="ECO:0000244|PDB:2E3H"
FT   STRAND          252..257
FT                   /evidence="ECO:0000244|PDB:2E3H"
FT   STRAND          260..262
FT                   /evidence="ECO:0000244|PDB:2E3H"
FT   TURN            267..269
FT                   /evidence="ECO:0000244|PDB:2CP6"
FT   STRAND          270..274
FT                   /evidence="ECO:0000244|PDB:2E3H"
FT   HELIX           275..277
FT                   /evidence="ECO:0000244|PDB:2E3H"
FT   STRAND          278..280
FT                   /evidence="ECO:0000244|PDB:2E3H"
FT   STRAND          295..298
FT                   /evidence="ECO:0000244|PDB:2CP6"
FT   TURN            1420..1423
FT                   /evidence="ECO:0000244|PDB:2HQH"
FT   STRAND          1424..1427
FT                   /evidence="ECO:0000244|PDB:2HQH"
FT   HELIX           1429..1431
FT                   /evidence="ECO:0000244|PDB:2HQH"
SQ   SEQUENCE   1438 AA;  162246 MW;  A7F125F7A96DBDDB CRC64;
     MSMLKPSGLK APTKILKPGS TALKTPTAVV APVEKTISSE KASSTPSSET QEEFVDDFRV
     GERVWVNGNK PGFIQFLGET QFAPGQWAGI VLDEPIGKND GSVAGVRYFQ CEPLKGIFTR
     PSKLTRKVQA EDEANGLQTT PASRATSPLC TSTASMVSSS PSTPSNIPQK PSQPAAKEPS
     ATPPISNLTK TASESISNLS EAGSIKKGER ELKIGDRVLV GGTKAGVVRF LGETDFAKGE
     WCGVELDEPL GKNDGAVAGT RYFQCQPKYG LFAPVHKVTK IGFPSTTPAK AKANAVRRVM
     ATTSASLKRS PSASSLSSMS SVASSVSSRP SRTGLLTETS SRYARKISGT TALQEALKEK
     QQHIEQLLAE RDLERAEVAK ATSHVGEIEQ ELALARDGHD QHVLELEAKM DQLRTMVEAA
     DREKVELLNQ LEEEKRKVED LQFRVEEESI TKGDLEQKSQ ISEDPENTQT KLEHARIKEL
     EQSLLFEKTK ADKLQRELED TRVATVSEKS RIMELEKDLA LRVQEVAELR RRLESNKPAG
     DVDMSLSLLQ EISSLQEKLE VTRTDHQREI TSLKEHFGAR EETHQKEIKA LYTATEKLSK
     ENESLKSKLE HANKENSDVI ALWKSKLETA IASHQQAMEE LKVSFSKGLG TETAEFAELK
     TQIEKMRLDY QHEIENLQNQ QDSERAAHAK EMEALRAKLM KVIKEKENSL EAIRSKLDKA
     EDQHLVEMED TLNKLQEAEI KVKELEVLQA KCNEQTKVID NFTSQLKATE EKLLDLDALR
     KASSEGKSEM KKLRQQLEAA EKQIKHLEIE KNAESSKASS ITRELQGREL KLTNLQENLS
     EVSQVKETLE KELQILKEKF AEASEEAVSV QRSMQETVNK LHQKEEQFNM LSSDLEKLRE
     NLADMEAKFR EKDEREEQLI KAKEKLENDI AEIMKMSGDN SSQLTKMNDE LRLKERDVEE
     LQLKLTKANE NASFLQKSIE DMTVKAEQSQ QEAAKKHEEE KKELERKLSD LEKKMETSHN
     QCQELKARYE RATSETKTKH EEILQNLQKT LLDTEDKLKG AREENSGLLQ ELEELRKQAD
     KAKAAQTAED AMQIMEQMTK EKTETLASLE DTKQTNAKLQ NELDTLKENN LKNVEELNKS
     KELLTVENQK MEEFRKEIET LKQAAAQKSQ QLSALQEENV KLAEELGRSR DEVTSHQKLE
     EERSVLNNQL LEMKKRESKF IKDADEEKAS LQKSISITSA LLTEKDAELE KLRNEVTVLR
     GENASAKSLH SVVQTLESDK VKLELKVKNL ELQLKENKRQ LSSSSGNTDT QADEDERAQE
     SQIDFLNSVI VDLQRKNQDL KMKVEMMSEA ALNGNGDDLN NYDSDDQEKQ SKKKPRLFCD
     ICDCFDLHDT EDCPTQAQMS EDPPHSTHHG SRGEERPYCE ICEMFGHWAT NCNDDETF
//
ID   B2RP65_HUMAN            Unreviewed;      2325 AA.
AC   B2RP65;
DT   01-JUL-2008, integrated into UniProtKB/TrEMBL.
DT   01-JUL-2008, sequence version 1.
DT   26-FEB-2020, entry version 58.
DE   SubName: Full=Centrosomal protein 110kDa {ECO:0000313|EMBL:AAI37285.1};
GN   Name=CEP110 {ECO:0000313|EMBL:AAI37285.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAI37285.1};
RN   [1] {ECO:0000313|EMBL:AAI37285.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M., Peck A.M.,
RA   Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S., Feolo M.,
RA   Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F., Schaefer C.F.,
RA   Buetow K., Bonner T.I., Haussler D., Kent J., Kiekhaus M., Furey T.,
RA   Brent M., Prange C., Schreiber K., Shapiro N., Bhat N.K., Hopkins R.F.,
RA   Hsie F., Driscoll T., Soares M.B., Casavant T.L., Scheetz T.E.,
RA   Brown-stein M.J., Usdin T.B., Toshiyuki S., Carninci P., Piao Y.,
RA   Dudekula D.B., Ko M.S., Kawakami K., Suzuki Y., Sugano S., Gruber C.E.,
RA   Smith M.R., Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y.,
RA   Wei C.L., Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W.,
RA   Fuh E., Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D., Granite S.J.,
RA   Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G., Blakesly R.W.,
RA   Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J.,
RA   Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L., Krzywinski M.I.,
RA   Liao N., Morin R., Morrin R., Palmquist D., Petrescu A.S., Skalska U.,
RA   Smailus D.E., Stott J.M., Schnerch A., Schein J.E., Jones S.J., Holt R.A.,
RA   Baross A., Marra M.A., Clifton S., Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC137284; AAI37285.1; -; mRNA.
DR   RefSeq; NP_001317691.1; NM_001330762.1.
DR   PeptideAtlas; B2RP65; -.
DR   PRIDE; B2RP65; -.
DR   GeneID; 11064; -.
DR   CTD; 11064; -.
DR   eggNOG; ENOG410IJGD; Eukaryota.
DR   eggNOG; ENOG410ZX4Y; LUCA.
DR   OrthoDB; 79816at2759; -.
DR   GenomeRNAi; 11064; -.
DR   GO; GO:0005815; C:microtubule organizing center; IEA:InterPro.
DR   GO; GO:0008092; F:cytoskeletal protein binding; IEA:InterPro.
DR   GO; GO:0051493; P:regulation of cytoskeleton organization; IEA:InterPro.
DR   Gene3D; 3.80.10.10; -; 2.
DR   InterPro; IPR028640; CEP110.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR003591; Leu-rich_rpt_typical-subtyp.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   PANTHER; PTHR34491:SF2; PTHR34491:SF2; 2.
DR   SMART; SM00369; LRR_TYP; 3.
DR   PROSITE; PS51450; LRR; 5.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   REGION          1..33
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1150..1241
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2288..2325
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          269..292
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          307..341
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          439..480
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          505..546
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          557..612
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          625..697
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          705..795
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          851..885
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          895..929
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          937..964
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1008..1056
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1070..1097
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1318..1341
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1349..1390
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1428..1518
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1533..1602
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1663..1715
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1726..1746
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1754..1886
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1915..2104
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          2119..2146
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          2186..2213
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        8..33
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1151..1169
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   2325 AA;  268916 MW;  0CB58A9ACE5C037E CRC64;
     MKKGSQQKIF SKAKIPSSSH SPIPSSMSNM RSRSLSPLIG SETLPFHSGG QWCEQIEIAD
     ENNMLLDYQD HKGADSHAGV RYITEALIKK LTKQDNLALI KSLNLSLSKD GGKKFKYIEN
     LEKCVKLEVL NLSYNLIGKI EKLDKLLKLR ELNLSYNKIS KIEGIENMCN LQKLNLAGNE
     IEHIPVWLGK KLKSLRVLNL KGNKISSLQD ISKLKLLQDL ISLILVENPV VTLPHYLQFT
     IFHLRSLESL EGQPVTTQDR QEAFERFSLE EVERLERDLE KKMIETEELK SKQTRFLEEI
     KNQDKLNKSL KEEAMLQKQS CEELKSDLNT KNELLKQKTI ELTRACQKQY ELEQELAFYK
     IDAKFEPLNY YPSEYAEIDK APDESPYIGK SRYKRNMFAT ESYIIDSAQA VQIKKMEPDE
     QLRNDHMNLR GHTPLDTQLE DKEKKISAAQ TRLSELHDEI EKAEQQILRA TEEFKQLEEA
     IQLKKISEAG KDLLYKQLSG RLQLVNKLRQ EALDLELQME KQKQEIAGKQ KEIKDLQIAI
     DSLDSKDPKH SHMKAQKSGK EQQLDIMNKQ YQQLESRLDE ILSRIAKETE EIKDLEEQLT
     EGQIAANEAL KKDLEGVISG LQEYLGTIKG QATQAQNECR KLRDEKETLL QRLTEVEQER
     DQLEIVAMDA ENMRKELAEL ESALQEQHEV NASLQQTQGD LSAYEAELEA RLNLRDAEAN
     QLKEELEKVT RLTQLEQSAL QAELEKERQA LKNALGKAQF SEEKEQENSE LHAKLKHLQD
     DNNLLKQQLK DFQNHLNHVV DGLVRPEEVA ARVDELRRKL KLGTGEMNIH SPSDVLGKSL
     ADLQKQFSEI LARSKWERDE AQVRERKLQE EMALQQEKLA TGQEEFRQAC ERALEARMNF
     DKRQHEARIQ QMENEIHYLQ ENLKSMEEIQ GLTDLQLQEA DEEKERILAQ LRELEKKKKL
     EDAKSQEQVF GLDKELKKLK KAVATSDKLA TAELTIAKDQ LKSLHGTVMK INQERAEELQ
     EAERFSRKAA QAARDLTRAE AEIELLQNLL RQKGEQFRLE MEKTGVGTGA NSQVLEIEKL
     NETMERQRTE IARLQNVLDL TGSDNKGGFE NVLEEIAELR REVSYQNDYI SSMADPFKRR
     GYWYFMPPPP SSKVSSHSSQ ATKDSGVGLK YSASTPVRKP RPGQQDGKEG SQPPPASGYW
     VYSPIRSGLH KLFPSRDADS GGDSQEESEL DDQEEPPFVP PPGYMMYTVL PDGSPVPQGM
     ALYAPPPPLP NNSRPLTPGT VVYGPPPAGA PMVYGPPPPN FSIPFIPMGV LHCNVPEHHN
     LENEVSRLED IMQHLKSKKR EERWMRASKR QSEKEMEELH HNIDDLLQEK KSLECEVEEL
     HRTVQKRQQQ KDFIDGNVES LMTELEIEKS LKHHEDIVDE IECIEKTLLK RRSELREADR
     LLAEAESELS CTKEKTKNAV EKFTDAKRSL LQTESDAEEL ERRAQETAVN LVKADQQLRS
     LQADAKDLEQ HKIKQEEILK EINKIVAAKD SDFQCLSKKK EKLTEELQKL QKDIEMAERN
     EDHHLQVLKE SEVLLQAKRA ELEKLKSQVT SQQQEMAVLD RQLGHKKEEL HLLQGSMVQA
     KADLQEALRL GETEVTEKCN HIREVKSLLE ELSFQKGELN VQISERKTQL TLIKQEIEKE
     EENLQVVLRQ MSKHKTELKN ILDMLQLENH ELQGLKLQHD QRVSELEKTQ VAVLEEKLEL
     ENLQQISQQQ KGEIEWQKQL LERDKREIER MTAESRALQS CVECLSKEKE DLQEKCDIWE
     KKLAQTKRVL AAAEENSKME QSNLEKLELN VRKLQQELDQ LNRDKLSLHN DISAMQQQLQ
     EKREAVNSLQ EELANVQDHL NLAKQDLLHT TKHQDVLLSE QTRLQKDISE WANRFEDCQK
     EEETKQQQLQ VLQNEIEENK LKLVQQEMMF QRLQKERESE ESKLETSKVT LKEQQHQLEK
     ELTDQKSKLD QVLSKVLAAE ERVRTLQEEE RWCESLEKTL SQTKRQLSER EQQLVEKSGE
     LLALQKEADS MRADFSLLRN QFLTERKKAE KQVASLKEAL KIQRSQLEKN LLEQKQENSC
     IQKEMATIEL VAQDNHERAR RLMKELNQMQ YEYTELKKQM ANQKDLERRQ MEISDAMRTL
     KSEVKDEIRT SLKNLNQFLP ELPADLEAIL ERNENLEGEL ESLKENLPFT MNEGPFEEKL
     NFSQVHIMDE HWRGEALREK LRHREDRLKA QLRHCMSKQA EVLIKGKRQT EGTLHSLRRQ
     VDALGELVTS TSADSASSPS LSQLESSLTE DSQLGQNQEK NASAR
//
ID   CNTRL_HUMAN             Reviewed;        2325 AA.
AC   Q7Z7A1; A2A2Y1; B2RP67; Q3MN79; Q5FWF8; Q5JVD0; Q6MZR3; Q6PKC1; Q8TEP3;
AC   Q9Y489;
DT   18-MAR-2008, integrated into UniProtKB/Swiss-Prot.
DT   18-MAR-2008, sequence version 2.
DT   22-APR-2020, entry version 148.
DE   RecName: Full=Centriolin;
DE   AltName: Full=Centrosomal protein 1;
DE   AltName: Full=Centrosomal protein of 110 kDa;
DE            Short=Cep110;
GN   Name=CNTRL; Synonyms=CEP1, CEP110;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), TISSUE SPECIFICITY, CHROMOSOMAL
RP   TRANSLOCATION WITH FGFR1, AND SUBCELLULAR LOCATION.
RX   PubMed=10688839;
RA   Guasch G., Mack G.J., Popovici C., Dastugue N., Birnbaum D., Rattner J.B.,
RA   Pebusque M.-J.;
RT   "FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12
RT   stem cell myeloproliferative disorder with t(8;9)(p12;q33).";
RL   Blood 95:1788-1796(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT ILE-56, SUBCELLULAR
RP   LOCATION, AND FUNCTION.
RX   PubMed=12732615; DOI=10.1083/jcb.200301105;
RA   Gromley A., Jurczyk A., Sillibourne J., Halilovic E., Mogensen M.,
RA   Groisman I., Blomberg M., Doxsey S.J.;
RT   "A novel human protein of the maternal centriole is required for the final
RT   stages of cytokinesis and entry into S phase.";
RL   J. Cell Biol. 161:535-545(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Liver;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L.,
RA   Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S.,
RA   Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K.,
RA   Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C.,
RA   Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E.,
RA   Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M.,
RA   Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J.,
RA   Frankish A., Frankland J.A., French L., Fricker D.G., Garner P.,
RA   Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S.,
RA   Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E.,
RA   McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V.,
RA   Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S.,
RA   Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K.,
RA   Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J.,
RA   Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M.,
RA   West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L.,
RA   Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J.,
RA   Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-1513 (ISOFORM 2).
RC   TISSUE=Lymph, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 434-1677 (ISOFORM 1).
RX   PubMed=16112646; DOI=10.1016/j.bbrc.2005.08.024;
RA   Guinn B.-A., Bland E.A., Lodi U., Liggins A.P., Tobal K., Petters S.,
RA   Wells J.W., Banham A.H., Mufti G.J.;
RT   "Humoral detection of leukaemia-associated antigens in presentation acute
RT   myeloid leukaemia.";
RL   Biochem. Biophys. Res. Commun. 335:1293-1304(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 527-2325 (ISOFORM 5).
RC   TISSUE=Spleen;
RX   PubMed=12693554; DOI=10.1093/dnares/10.1.49;
RA   Jikuya H., Takano J., Kikuno R., Hirosawa M., Nagase T., Nomura N.,
RA   Ohara O.;
RT   "Characterization of long cDNA clones from human adult spleen. II. The
RT   complete sequences of 81 cDNA clones.";
RL   DNA Res. 10:49-57(2003).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=11956314;
RA   Ou Y.Y., Mack G.J., Zhang M., Rattner J.B.;
RT   "CEP110 and ninein are located in a specific domain of the centrosome
RT   associated with centrosome maturation.";
RL   J. Cell Sci. 115:1825-1835(2002).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND SUBCELLULAR LOCATION [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.;
RT   "Proteomic characterization of the human centrosome by protein correlation
RT   profiling.";
RL   Nature 426:570-574(2003).
RN   [10]
RP   FUNCTION, INTERACTION WITH EXOC6 AND SNAPIN, AND SUBCELLULAR LOCATION.
RX   PubMed=16213214; DOI=10.1016/j.cell.2005.07.027;
RA   Gromley A., Yeaman C., Rosa J., Redick S., Chen C.-T., Mirabelle S.,
RA   Guha M., Sillibourne J., Doxsey S.J.;
RT   "Centriolin anchoring of exocyst and SNARE complexes at the midbody is
RT   required for secretory-vesicle-mediated abscission.";
RL   Cell 123:75-87(2005).
RN   [11]
RP   INTERACTION WITH HOOK2.
RX   PubMed=17140400; DOI=10.1111/j.1600-0854.2006.00511.x;
RA   Szebenyi G., Hall B., Yu R., Hashim A.I., Kraemer H.;
RT   "Hook2 localizes to the centrosome, binds directly to centriolin/CEP110 and
RT   contributes to centrosomal function.";
RL   Traffic 8:32-46(2007).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-831 AND SER-1475, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Involved in cell cycle progression and cytokinesis. During
CC       the late steps of cytokinesis, anchors exocyst and SNARE complexes at
CC       the midbody, thereby allowing secretory vesicle-mediated abscission.
CC       {ECO:0000269|PubMed:12732615, ECO:0000269|PubMed:16213214}.
CC   -!- SUBUNIT: Interacts with HOOK2. Interacts with EXOC6 and SNAPIN.
CC       Associates with the exocyst complex. {ECO:0000269|PubMed:16213214,
CC       ECO:0000269|PubMed:17140400}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule organizing
CC       center, centrosome {ECO:0000269|PubMed:10688839,
CC       ECO:0000269|PubMed:11956314, ECO:0000269|PubMed:12732615,
CC       ECO:0000269|PubMed:14654843}. Midbody, Midbody ring
CC       {ECO:0000269|PubMed:12732615, ECO:0000269|PubMed:16213214}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q7Z7A1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q7Z7A1-2; Sequence=VSP_032048;
CC       Name=3;
CC         IsoId=Q7Z7A1-3; Sequence=VSP_032047;
CC       Name=4;
CC         IsoId=Q7Z7A1-4; Sequence=VSP_032046, VSP_032050;
CC       Name=5;
CC         IsoId=Q7Z7A1-5; Sequence=VSP_032049;
CC   -!- TISSUE SPECIFICITY: Widely expressed with highest levels in testis and
CC       trachea. {ECO:0000269|PubMed:10688839}.
CC   -!- DISEASE: Note=A chromosomal aberration involving CEP110 may be a cause
CC       of stem cell myeloproliferative disorder (MPD). Translocation
CC       t(8;9)(p12;q33) with FGFR1. MPD is characterized by myeloid
CC       hyperplasia, eosinophilia and T-cell or B-cell lymphoblastic lymphoma.
CC       In general it progresses to acute myeloid leukemia. The fusion protein
CC       CEP110-FGFR1 is found in the cytoplasm, exhibits constitutive kinase
CC       activity and may be responsible for the transforming activity.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH02932.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAH02932.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=AAH89415.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF083322; AAC32373.1; -; mRNA.
DR   EMBL; AF513978; AAP43846.1; -; mRNA.
DR   EMBL; BX640927; CAE45965.1; -; mRNA.
DR   EMBL; AL137068; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC002932; AAH02932.1; ALT_SEQ; mRNA.
DR   EMBL; BC089415; AAH89415.1; ALT_SEQ; mRNA.
DR   EMBL; BC137286; AAI37287.1; -; mRNA.
DR   EMBL; AY651261; AAX35689.1; -; mRNA.
DR   EMBL; AK074079; BAB84905.1; -; mRNA.
DR   CCDS; CCDS35118.1; -. [Q7Z7A1-1]
DR   CCDS; CCDS83409.1; -. [Q7Z7A1-2]
DR   RefSeq; NP_001317691.1; NM_001330762.1. [Q7Z7A1-2]
DR   RefSeq; NP_008949.4; NM_007018.4. [Q7Z7A1-1]
DR   RefSeq; XP_005251736.1; XM_005251679.3. [Q7Z7A1-1]
DR   SMR; Q7Z7A1; -.
DR   BioGrid; 116248; 164.
DR   DIP; DIP-47280N; -.
DR   IntAct; Q7Z7A1; 184.
DR   MINT; Q7Z7A1; -.
DR   STRING; 9606.ENSP00000362962; -.
DR   CarbonylDB; Q7Z7A1; -.
DR   iPTMnet; Q7Z7A1; -.
DR   PhosphoSitePlus; Q7Z7A1; -.
DR   BioMuta; CNTRL; -.
DR   DMDM; 172045911; -.
DR   EPD; Q7Z7A1; -.
DR   jPOST; Q7Z7A1; -.
DR   MassIVE; Q7Z7A1; -.
DR   MaxQB; Q7Z7A1; -.
DR   PaxDb; Q7Z7A1; -.
DR   PeptideAtlas; Q7Z7A1; -.
DR   PRIDE; Q7Z7A1; -.
DR   ProteomicsDB; 69493; -. [Q7Z7A1-1]
DR   ProteomicsDB; 69494; -. [Q7Z7A1-2]
DR   ProteomicsDB; 69495; -. [Q7Z7A1-3]
DR   ProteomicsDB; 69496; -. [Q7Z7A1-4]
DR   ProteomicsDB; 69497; -. [Q7Z7A1-5]
DR   Antibodypedia; 30137; 29 antibodies.
DR   Ensembl; ENST00000238341; ENSP00000238341; ENSG00000119397. [Q7Z7A1-1]
DR   Ensembl; ENST00000373850; ENSP00000362956; ENSG00000119397. [Q7Z7A1-2]
DR   Ensembl; ENST00000373855; ENSP00000362962; ENSG00000119397. [Q7Z7A1-1]
DR   Ensembl; ENST00000613863; ENSP00000481072; ENSG00000119397. [Q7Z7A1-4]
DR   GeneID; 11064; -.
DR   KEGG; hsa:11064; -.
DR   UCSC; uc004bkx.1; human. [Q7Z7A1-1]
DR   CTD; 11064; -.
DR   DisGeNET; 11064; -.
DR   GeneCards; CNTRL; -.
DR   HGNC; HGNC:1858; CNTRL.
DR   HPA; ENSG00000119397; Low tissue specificity.
DR   MIM; 605496; gene.
DR   neXtProt; NX_Q7Z7A1; -.
DR   OpenTargets; ENSG00000119397; -.
DR   PharmGKB; PA26414; -.
DR   eggNOG; ENOG410IJGD; Eukaryota.
DR   eggNOG; ENOG410ZX4Y; LUCA.
DR   GeneTree; ENSGT00940000155434; -.
DR   HOGENOM; CLU_231608_0_0_1; -.
DR   InParanoid; Q7Z7A1; -.
DR   KO; K16770; -.
DR   OMA; NQMQHEY; -.
DR   OrthoDB; 79816at2759; -.
DR   PhylomeDB; Q7Z7A1; -.
DR   TreeFam; TF101135; -.
DR   Reactome; R-HSA-1839117; Signaling by cytosolic FGFR1 fusion mutants. [Q7Z7A1-3]
DR   Reactome; R-HSA-2565942; Regulation of PLK1 Activity at G2/M Transition.
DR   Reactome; R-HSA-380259; Loss of Nlp from mitotic centrosomes.
DR   Reactome; R-HSA-380270; Recruitment of mitotic centrosome proteins and complexes.
DR   Reactome; R-HSA-380284; Loss of proteins required for interphase microtubule organization from the centrosome.
DR   Reactome; R-HSA-380320; Recruitment of NuMA to mitotic centrosomes.
DR   Reactome; R-HSA-5620912; Anchoring of the basal body to the plasma membrane.
DR   Reactome; R-HSA-5655302; Signaling by FGFR1 in disease. [Q7Z7A1-3]
DR   Reactome; R-HSA-8854518; AURKA Activation by TPX2.
DR   SIGNOR; Q7Z7A1; -.
DR   ChiTaRS; CNTRL; human.
DR   GeneWiki; CNTRL; -.
DR   GenomeRNAi; 11064; -.
DR   Pharos; Q7Z7A1; Tbio.
DR   PRO; PR:Q7Z7A1; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   RNAct; Q7Z7A1; protein.
DR   Bgee; ENSG00000119397; Expressed in testis and 201 other tissues.
DR   ExpressionAtlas; Q7Z7A1; baseline and differential.
DR   Genevisible; Q7Z7A1; HS.
DR   GO; GO:0120103; C:centriolar subdistal appendage; IDA:GO_Central.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0090543; C:Flemming body; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005815; C:microtubule organizing center; IBA:GO_Central.
DR   GO; GO:0008092; F:cytoskeletal protein binding; IBA:GO_Central.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0097711; P:ciliary basal body-plasma membrane docking; TAS:Reactome.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0051493; P:regulation of cytoskeleton organization; IBA:GO_Central.
DR   GO; GO:0010389; P:regulation of G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   Gene3D; 3.80.10.10; -; 2.
DR   InterPro; IPR028640; CEP110.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR003591; Leu-rich_rpt_typical-subtyp.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   PANTHER; PTHR34491:SF2; PTHR34491:SF2; 2.
DR   SMART; SM00369; LRR_TYP; 3.
DR   PROSITE; PS51450; LRR; 5.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell cycle; Cell division; Chromosomal rearrangement;
KW   Coiled coil; Cytoplasm; Cytoskeleton; Leucine-rich repeat; Phosphoprotein;
KW   Polymorphism; Reference proteome; Repeat.
FT   CHAIN           1..2325
FT                   /note="Centriolin"
FT                   /id="PRO_0000323675"
FT   REPEAT          126..147
FT                   /note="LRR 1"
FT   REPEAT          148..169
FT                   /note="LRR 2"
FT   REPEAT          170..191
FT                   /note="LRR 3"
FT   REPEAT          194..215
FT                   /note="LRR 4"
FT   DOMAIN          228..266
FT                   /note="LRRCT"
FT   REGION          1948..2118
FT                   /note="Required for centrosome localization"
FT   REGION          1985..2325
FT                   /note="Sufficient for interaction with HOOK2"
FT                   /evidence="ECO:0000269|PubMed:17140400"
FT   COILED          267..343
FT                   /evidence="ECO:0000255"
FT   COILED          435..799
FT                   /evidence="ECO:0000255"
FT   COILED          851..1101
FT                   /evidence="ECO:0000255"
FT   COILED          1317..2255
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        956..959
FT                   /note="Poly-Lys"
FT   COMPBIAS        1147..1150
FT                   /note="Poly-Pro"
FT   COMPBIAS        1236..1307
FT                   /note="Pro-rich"
FT   SITE            2139..2140
FT                   /note="Breakpoint for translocation to form CEP110-FGFR1"
FT   MOD_RES         831
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         1475
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   VAR_SEQ         1..1818
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_032046"
FT   VAR_SEQ         1..1331
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10688839"
FT                   /id="VSP_032047"
FT   VAR_SEQ         1..552
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_032048"
FT   VAR_SEQ         1291..1296
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:12693554"
FT                   /id="VSP_032049"
FT   VAR_SEQ         1962..1986
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_032050"
FT   VARIANT         56
FT                   /note="V -> I (in dbSNP:rs10818503)"
FT                   /evidence="ECO:0000269|PubMed:12732615"
FT                   /id="VAR_039559"
FT   VARIANT         216
FT                   /note="P -> L (in dbSNP:rs10818504)"
FT                   /id="VAR_039560"
FT   VARIANT         889
FT                   /note="A -> T (in dbSNP:rs17292952)"
FT                   /id="VAR_039561"
FT   VARIANT         1146
FT                   /note="M -> V (in dbSNP:rs35342437)"
FT                   /id="VAR_061622"
FT   CONFLICT        1389
FT                   /note="Q -> R (in Ref. 1; AAC32373)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1699
FT                   /note="K -> Q (in Ref. 1; AAC32373)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1828
FT                   /note="E -> D (in Ref. 1; AAC32373)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   2325 AA;  268886 MW;  93DD4CA08B5BD4AF CRC64;
     MKKGSQQKIF SKAKIPSSSH SPIPSSMSNM RSRSLSPLIG SETLPFHSGG QWCEQVEIAD
     ENNMLLDYQD HKGADSHAGV RYITEALIKK LTKQDNLALI KSLNLSLSKD GGKKFKYIEN
     LEKCVKLEVL NLSYNLIGKI EKLDKLLKLR ELNLSYNKIS KIEGIENMCN LQKLNLAGNE
     IEHIPVWLGK KLKSLRVLNL KGNKISSLQD ISKLKPLQDL ISLILVENPV VTLPHYLQFT
     IFHLRSLESL EGQPVTTQDR QEAFERFSLE EVERLERDLE KKMIETEELK SKQTRFLEEI
     KNQDKLNKSL KEEAMLQKQS CEELKSDLNT KNELLKQKTI ELTRACQKQY ELEQELAFYK
     IDAKFEPLNY YPSEYAEIDK APDESPYIGK SRYKRNMFAT ESYIIDSAQA VQIKKMEPDE
     QLRNDHMNLR GHTPLDTQLE DKEKKISAAQ TRLSELHDEI EKAEQQILRA TEEFKQLEEA
     IQLKKISEAG KDLLYKQLSG RLQLVNKLRQ EALDLELQME KQKQEIAGKQ KEIKDLQIAI
     DSLDSKDPKH SHMKAQKSGK EQQLDIMNKQ YQQLESRLDE ILSRIAKETE EIKDLEEQLT
     EGQIAANEAL KKDLEGVISG LQEYLGTIKG QATQAQNECR KLRDEKETLL QRLTEVEQER
     DQLEIVAMDA ENMRKELAEL ESALQEQHEV NASLQQTQGD LSAYEAELEA RLNLRDAEAN
     QLKEELEKVT RLTQLEQSAL QAELEKERQA LKNALGKAQF SEEKEQENSE LHAKLKHLQD
     DNNLLKQQLK DFQNHLNHVV DGLVRPEEVA ARVDELRRKL KLGTGEMNIH SPSDVLGKSL
     ADLQKQFSEI LARSKWERDE AQVRERKLQE EMALQQEKLA TGQEEFRQAC ERALEARMNF
     DKRQHEARIQ QMENEIHYLQ ENLKSMEEIQ GLTDLQLQEA DEEKERILAQ LRELEKKKKL
     EDAKSQEQVF GLDKELKKLK KAVATSDKLA TAELTIAKDQ LKSLHGTVMK INQERAEELQ
     EAERFSRKAA QAARDLTRAE AEIELLQNLL RQKGEQFRLE MEKTGVGTGA NSQVLEIEKL
     NETMERQRTE IARLQNVLDL TGSDNKGGFE NVLEEIAELR REVSYQNDYI SSMADPFKRR
     GYWYFMPPPP SSKVSSHSSQ ATKDSGVGLK YSASTPVRKP RPGQQDGKEG SQPPPASGYW
     VYSPIRSGLH KLFPSRDADS GGDSQEESEL DDQEEPPFVP PPGYMMYTVL PDGSPVPQGM
     ALYAPPPPLP NNSRPLTPGT VVYGPPPAGA PMVYGPPPPN FSIPFIPMGV LHCNVPEHHN
     LENEVSRLED IMQHLKSKKR EERWMRASKR QSEKEMEELH HNIDDLLQEK KSLECEVEEL
     HRTVQKRQQQ KDFIDGNVES LMTELEIEKS LKHHEDIVDE IECIEKTLLK RRSELREADR
     LLAEAESELS CTKEKTKNAV EKFTDAKRSL LQTESDAEEL ERRAQETAVN LVKADQQLRS
     LQADAKDLEQ HKIKQEEILK EINKIVAAKD SDFQCLSKKK EKLTEELQKL QKDIEMAERN
     EDHHLQVLKE SEVLLQAKRA ELEKLKSQVT SQQQEMAVLD RQLGHKKEEL HLLQGSMVQA
     KADLQEALRL GETEVTEKCN HIREVKSLLE ELSFQKGELN VQISERKTQL TLIKQEIEKE
     EENLQVVLRQ MSKHKTELKN ILDMLQLENH ELQGLKLQHD QRVSELEKTQ VAVLEEKLEL
     ENLQQISQQQ KGEIEWQKQL LERDKREIER MTAESRALQS CVECLSKEKE DLQEKCDIWE
     KKLAQTKRVL AAAEENSKME QSNLEKLELN VRKLQQELDQ LNRDKLSLHN DISAMQQQLQ
     EKREAVNSLQ EELANVQDHL NLAKQDLLHT TKHQDVLLSE QTRLQKDISE WANRFEDCQK
     EEETKQQQLQ VLQNEIEENK LKLVQQEMMF QRLQKERESE ESKLETSKVT LKEQQHQLEK
     ELTDQKSKLD QVLSKVLAAE ERVRTLQEEE RWCESLEKTL SQTKRQLSER EQQLVEKSGE
     LLALQKEADS MRADFSLLRN QFLTERKKAE KQVASLKEAL KIQRSQLEKN LLEQKQENSC
     IQKEMATIEL VAQDNHERAR RLMKELNQMQ YEYTELKKQM ANQKDLERRQ MEISDAMRTL
     KSEVKDEIRT SLKNLNQFLP ELPADLEAIL ERNENLEGEL ESLKENLPFT MNEGPFEEKL
     NFSQVHIMDE HWRGEALREK LRHREDRLKA QLRHCMSKQA EVLIKGKRQT EGTLHSLRRQ
     VDALGELVTS TSADSASSPS LSQLESSLTE DSQLGQNQEK NASAR
//
ID   CO1A1_HUMAN             Reviewed;        1464 AA.
AC   P02452; O76045; P78441; Q13896; Q13902; Q13903; Q14037; Q14992; Q15176;
AC   Q15201; Q16050; Q59F64; Q7KZ30; Q7KZ34; Q8IVI5; Q8N473; Q9UML6; Q9UMM7;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 5.
DT   22-APR-2020, entry version 240.
DE   RecName: Full=Collagen alpha-1(I) chain;
DE   AltName: Full=Alpha-1 type I collagen;
DE   Flags: Precursor;
GN   Name=COL1A1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS ALA-1019; ALA-1075; LYS-1391 AND
RP   SER-1434.
RA   Dalgleish R.;
RL   Submitted (JUL-1996) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ALA-1075 AND LYS-1391.
RX   PubMed=9443882; DOI=10.1086/301689;
RA   Korkko J.M., Ala-Kokko L., De Paepe A., Nuytinck L., Earley J.J.,
RA   Prockop D.J.;
RT   "Analysis of the COL1A1 and COL1A2 genes by PCR amplification and scanning
RT   by conformation-sensitive gel electrophoresis identifies only COL1A1
RT   mutations in 15 patients with osteogenesis imperfecta type I:
RT   identification of common sequences of null-allele mutations.";
RL   Am. J. Hum. Genet. 62:98-110(1998).
RN   [3]
RP   SEQUENCE REVISION TO 1049.
RA   Korkko J.M., Earley J.J., Nuytinck L., DePaepe A., Prockop D.J.,
RA   Ala-Kokko L.;
RL   Submitted (MAY-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-1075.
RC   TISSUE=Spleen;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS ALA-1075; ARG-1438 AND
RP   HIS-1460.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-589.
RX   PubMed=2843432; DOI=10.1016/0378-1119(88)90013-3;
RA   D'Alessio M., Bernard M.P., Pretorius P.J., de Wet W., Ramirez F.,
RA   Pretorious P.J.;
RT   "Complete nucleotide sequence of the region encompassing the first twenty-
RT   five exons of the human pro alpha 1(I) collagen gene (COL1A1).";
RL   Gene 67:105-115(1988).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-472.
RX   PubMed=3178743; DOI=10.1042/bj2530919;
RA   Tromp G., Kuivaniemi H., Stacey A., Shikata H., Baldwin C.T., Jaenisch R.,
RA   Prockup D.J.;
RT   "Structure of a full-length cDNA clone for the prepro alpha 1(I) chain of
RT   human type I procollagen.";
RL   Biochem. J. 253:919-922(1988).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-181.
RX   PubMed=6462220; DOI=10.1038/310337a0;
RA   Chu M.-L., de Wet W.J., Bernard M.P., Ding J.-F., Morabito M., Myers J.,
RA   Williams C., Ramirez F.;
RT   "Human pro alpha 1(I) collagen gene structure reveals evolutionary
RT   conservation of a pattern of introns and exons.";
RL   Nature 310:337-340(1984).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-44.
RX   PubMed=2822714;
RA   Rossouw C.M.S., Vergeer W.P., du Plooy S.J., Bernard M.P., Ramirez F.,
RA   de Wet W.;
RT   "DNA sequences in the first intron of the human pro-alpha 1(I) collagen
RT   gene enhance transcription.";
RL   J. Biol. Chem. 262:15151-15157(1987).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-34.
RX   PubMed=2857713;
RA   Chu M.-L., de Wet W., Bernard M.P., Ramirez F.;
RT   "Fine structural analysis of the human pro-alpha 1 (I) collagen gene.
RT   Promoter structure, AluI repeats, and polymorphic transcripts.";
RL   J. Biol. Chem. 260:2315-2320(1985).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-34.
RX   PubMed=3480516; DOI=10.1073/pnas.84.24.8869;
RA   Bornstein P., McKay J., Morishima J.K., Devarayalu S., Gelinas R.E.;
RT   "Regulatory elements in the first intron contribute to transcriptional
RT   control of the human alpha 1(I) collagen gene.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:8869-8873(1987).
RN   [12]
RP   PROTEIN SEQUENCE OF 33-52.
RX   PubMed=2318855;
RA   Wirtz M.K., Keene D.R., Hori H., Glanville R.W., Steinmann B., Rao V.H.,
RA   Hollister D.W.;
RT   "In vivo and in vitro noncovalent association of excised alpha 1 (I) amino-
RT   terminal propeptides with mutant pN alpha 2(I) collagen chains in native
RT   mutant collagen in a case of Ehlers-Danlos syndrome, type VII.";
RL   J. Biol. Chem. 265:6312-6317(1990).
RN   [13]
RP   NUCLEOTIDE SEQUENCE OF 156-183.
RX   PubMed=2767050; DOI=10.1002/j.1460-2075.1989.tb03562.x;
RA   Weil D., D'Alessio M., Ramirez F., de Wet W., Cole W.G., Chan D.,
RA   Bateman J.F.;
RT   "A base substitution in the exon of a collagen gene causes alternative
RT   splicing and generates a structurally abnormal polypeptide in a patient
RT   with Ehlers-Danlos syndrome type VII.";
RL   EMBO J. 8:1705-1710(1989).
RN   [14]
RP   PROTEIN SEQUENCE OF 162-301, ALLYSINE AT LYS-170, AND PYROGLUTAMATE
RP   FORMATION AT GLN-162.
RC   TISSUE=Skin;
RX   PubMed=5529814; DOI=10.1021/bi00826a012;
RA   Click E.M., Bornstein P.;
RT   "Isolation and characterization of the cyanogen bromide peptides from the
RT   alpha 1 and alpha 2 chains of human skin collagen.";
RL   Biochemistry 9:4699-4706(1970).
RN   [15]
RP   PROTEIN SEQUENCE OF 175-187 AND 274-289.
RX   PubMed=2169412; DOI=10.1111/j.1432-1033.1990.tb19208.x;
RA   Baetge B., Notbohm H., Diebold J., Lehmann H., Bodo M., Deutzmann R.,
RA   Muller P.K.;
RT   "A critical crosslink region in human-bone-derived collagen type I.
RT   Specific cleavage site at residue Leu95.";
RL   Eur. J. Biochem. 192:153-159(1990).
RN   [16]
RP   PROTEIN SEQUENCE OF 263-268, HYDROXYLATION AT LYS-265, AND GLYCOSYLATION AT
RP   LYS-265.
RC   TISSUE=Skin;
RX   PubMed=4319110;
RA   Morgan P.H., Jacobs H.G., Segrest J.P., Cunningham L.W.;
RT   "A comparative study of glycopeptides derived from selected vertebrate
RT   collagens. A possible role of the carbohydrate in fibril formation.";
RL   J. Biol. Chem. 245:5042-5048(1970).
RN   [17]
RP   NUCLEOTIDE SEQUENCE OF 281-302; 402-420; 823-842; 924-944; 1026-1045 AND
RP   1143-1162.
RX   PubMed=2374517; DOI=10.1016/s0934-8832(11)80178-2;
RA   Labhard M.E., Hollister D.W.;
RT   "Segmental amplification of the entire helical and telopeptide regions of
RT   the cDNA for human alpha 1 (I) collagen.";
RL   Matrix 10:124-130(1990).
RN   [18]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 425-1464, AND VARIANTS ALA-1019 AND ALA-1075.
RX   PubMed=6689127; DOI=10.1021/bi00291a023;
RA   Bernard M.P., Chu M.-L., Myers J.C., Ramirez F., Eikenberry E.F.,
RA   Prockop D.J.;
RT   "Nucleotide sequences of complementary deoxyribonucleic acids for the pro
RT   alpha 1 chain of human type I procollagen. Statistical evaluation of
RT   structures that are conserved during evolution.";
RL   Biochemistry 22:5213-5223(1983).
RN   [19]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 425-490; 965-1024; 999-1039 AND 1453-1464.
RX   PubMed=6183642; DOI=10.1093/nar/10.19.5925;
RA   Chu M.-L., Myers J.C., Bernard M.P., Ding J.-F., Ramirez F.;
RT   "Cloning and characterization of five overlapping cDNAs specific for the
RT   human pro alpha 1(I) collagen chain.";
RL   Nucleic Acids Res. 10:5925-5934(1982).
RN   [20]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 472-607.
RX   PubMed=2981843;
RA   Chu M.-L., Gargiulo V., Williams C.J., Ramirez F.;
RT   "Multiexon deletion in an osteogenesis imperfecta variant with increased
RT   type III collagen mRNA.";
RL   J. Biol. Chem. 260:691-694(1985).
RN   [21]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 488-625.
RX   PubMed=3857621; DOI=10.1073/pnas.82.9.2870;
RA   Barsh G.S., Roush C.L., Bonadio J., Byers P.H., Gelinas R.E.;
RT   "Intron-mediated recombination may cause a deletion in an alpha 1 type I
RT   collagen chain in a lethal form of osteogenesis imperfecta.";
RL   Proc. Natl. Acad. Sci. U.S.A. 82:2870-2874(1985).
RN   [22]
RP   NUCLEOTIDE SEQUENCE OF 710-745, AND VARIANT OI2 ARG-728.
RX   PubMed=2339700;
RA   Wallis G.A., Starman B.J., Zinn A.B., Byers P.H.;
RT   "Variable expression of osteogenesis imperfecta in a nuclear family is
RT   explained by somatic mosaicism for a lethal point mutation in the alpha
RT   1(I) gene (COL1A1) of type I collagen in a parent.";
RL   Am. J. Hum. Genet. 46:1034-1040(1990).
RN   [23]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 746-781, AND VARIANT OI3 SER-767.
RX   PubMed=7881420; DOI=10.1093/hmg/3.12.2201;
RA   Forlino A., Zolezzi F., Valli M., Pignatti P.F., Cetta G., Brunelli P.C.,
RA   Mottes M.;
RT   "Severe (type III) osteogenesis imperfecta due to glycine substitutions in
RT   the central domain of the collagen triple helix.";
RL   Hum. Mol. Genet. 3:2201-2206(1994).
RN   [24]
RP   PROTEIN SEQUENCE OF 1063-1084, IDENTIFICATION BY MASS SPECTROMETRY, AND
RP   VARIANT ALA-1075.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [25]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1179-1464, VARIANTS OI2 HIS-1277; ARG-1388
RP   AND 1337-GLU-TYR-1338 DEL, AND VARIANTS THR-1251 AND SER-1434.
RX   PubMed=8349697;
RA   Chessler S.D., Wallis G.A., Byers P.H.;
RT   "Mutations in the carboxyl-terminal propeptide of the pro alpha 1(I) chain
RT   of type I collagen result in defective chain association and produce lethal
RT   osteogenesis imperfecta.";
RL   J. Biol. Chem. 268:18218-18225(1993).
RN   [26]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1187-1220, AND VARIANT CYS-1195.
RX   PubMed=3170557;
RA   Cohn D.H., Apone S., Eyre D.R., Starman B.J., Andreassen P.,
RA   Charbonneau H., Nicholls A.C., Pope F.M., Byers P.H.;
RT   "Substitution of cysteine for glycine within the carboxyl-terminal
RT   telopeptide of the alpha 1 chain of type I collagen produces mild
RT   osteogenesis imperfecta.";
RL   J. Biol. Chem. 263:14605-14607(1988).
RN   [27]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1229-1454, AND VARIANT LYS-1391.
RC   TISSUE=Bone;
RX   PubMed=3340531; DOI=10.1093/nar/16.1.349;
RA   Maekelae J.K., Raassina M., Virta A., Vuorio E.;
RT   "Human pro alpha 1(I) collagen: cDNA sequence for the C-propeptide
RT   domain.";
RL   Nucleic Acids Res. 16:349-349(1988).
RN   [28]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1440-1464.
RX   PubMed=2295701; DOI=10.1172/jci114424;
RA   Willing M.C., Cohn D.H., Byers P.H.;
RT   "Frameshift mutation near the 3' end of the COL1A1 gene of type I collagen
RT   predicts an elongated Pro alpha 1(I) chain and results in osteogenesis
RT   imperfecta type I.";
RL   J. Clin. Invest. 85:282-290(1990).
RN   [29]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1454-1464, AND VARIANT ALA-1075.
RX   PubMed=1995349; DOI=10.1016/0014-5793(91)80237-w;
RA   Maatta A., Bornstein P., Penttinen R.P.;
RT   "Highly conserved sequences in the 3'-untranslated region of the COL1A1
RT   gene bind cell-specific nuclear proteins.";
RL   FEBS Lett. 279:9-13(1991).
RN   [30]
RP   REVIEW ON VARIANTS.
RX   PubMed=2010058; DOI=10.1096/fasebj.5.7.2010058;
RA   Kuivaniemi H., Tromp G., Prockop D.J.;
RT   "Mutations in collagen genes: causes of rare and some common diseases in
RT   humans.";
RL   FASEB J. 5:2052-2060(1991).
RN   [31]
RP   INVOLVEMENT IN EDSARTH1.
RX   PubMed=9295084;
RX   DOI=10.1002/(sici)1096-8628(19971003)72:1<94::aid-ajmg20>3.0.co;2-o;
RA   Byers P.H., Duvic M., Atkinson M., Robinow M., Smith L.T., Krane S.M.,
RA   Greally M.T., Ludman M., Matalon R., Pauker S., Quanbeck D., Schwarze U.;
RT   "Ehlers-Danlos syndrome type VIIA and VIIB result from splice-junction
RT   mutations or genomic deletions that involve exon 6 in the COL1A1 and COL1A2
RT   genes of type I collagen.";
RL   Am. J. Med. Genet. 72:94-105(1997).
RN   [32]
RP   REVIEW ON VARIANTS.
RX   PubMed=9101290;
RX   DOI=10.1002/(sici)1098-1004(1997)9:4<300::aid-humu2>3.0.co;2-9;
RA   Kuivaniemi H., Tromp G., Prockop D.J.;
RT   "Mutations in fibrillar collagens (types I, II, III, and XI), fibril-
RT   associated collagen (type IX), and network-forming collagen (type X) cause
RT   a spectrum of diseases of bone, cartilage, and blood vessels.";
RL   Hum. Mutat. 9:300-315(1997).
RN   [33]
RP   REVIEW ON VARIANTS.
RX   PubMed=1895312; DOI=10.1136/jmg.28.7.433;
RA   Byers P.H., Wallis G.A., Willing M.C.;
RT   "Osteogenesis imperfecta: translation of mutation to phenotype.";
RL   J. Med. Genet. 28:433-442(1991).
RN   [34]
RP   INTERACTION WITH TRAM2.
RX   PubMed=14749390; DOI=10.1128/mcb.24.4.1758-1768.2004;
RA   Stefanovic B., Stefanovic L., Schnabl B., Bataller R., Brenner D.A.;
RT   "TRAM2 protein interacts with endoplasmic reticulum Ca2+ pump Serca2b and
RT   is necessary for collagen type I synthesis.";
RL   Mol. Cell. Biol. 24:1758-1768(2004).
RN   [35]
RP   INVOLVEMENT IN EDSARTH1.
RX   PubMed=18409203; DOI=10.1002/ajmg.a.32213;
RA   Giunta C., Chambaz C., Pedemonte M., Scapolan S., Steinmann B.;
RT   "The arthrochalasia type of Ehlers-Danlos syndrome (EDS VIIA and VIIB): the
RT   diagnostic value of collagen fibril ultrastructure.";
RL   Am. J. Med. Genet. A 146A:1341-1346(2008).
RN   [36]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22905912; DOI=10.1021/pr300539b;
RA   Rosenow A., Noben J.P., Jocken J., Kallendrusch S., Fischer-Posovszky P.,
RA   Mariman E.C., Renes J.;
RT   "Resveratrol-induced changes of the human adipocyte secretion profile.";
RL   J. Proteome Res. 11:4733-4743(2012).
RN   [37]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [38]
RP   VARIANT OI2 CYS-1166.
RX   PubMed=3016737; DOI=10.1073/pnas.83.16.6045;
RA   Cohn D.H., Byers P.H., Steinmann B., Gelinas R.E.;
RT   "Lethal osteogenesis imperfecta resulting from a single nucleotide change
RT   in one human pro alpha 1(I) collagen allele.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:6045-6047(1986).
RN   [39]
RP   VARIANT OI2 ARG-569.
RX   PubMed=3108247;
RA   Bateman J.F., Chan D., Walkers I.D., Rogers J.G., Cole W.G.;
RT   "Lethal perinatal osteogenesis imperfecta due to the substitution of
RT   arginine for glycine at residue 391 of the alpha 1(I) chain of type I
RT   collagen.";
RL   J. Biol. Chem. 262:7021-7027(1987).
RN   [40]
RP   VARIANT OI2 CYS-926.
RX   PubMed=3667599;
RA   Vogel B.E., Minor R.R., Freund M., Prockop D.J.;
RT   "A point mutation in a type I procollagen gene converts glycine 748 of the
RT   alpha 1 chain to cysteine and destabilizes the triple helix in a lethal
RT   variant of osteogenesis imperfecta.";
RL   J. Biol. Chem. 262:14737-14744(1987).
RN   [41]
RP   VARIANT OI2 ARG-842.
RX   PubMed=3403550;
RA   Bateman J.F., Lamande S.R., Dahl H.-H.M., Chan D., Cole W.G.;
RT   "Substitution of arginine for glycine 664 in the collagen alpha 1(I) chain
RT   in lethal perinatal osteogenesis imperfecta. Demonstration of the peptide
RT   defect by in vitro expression of the mutant cDNA.";
RL   J. Biol. Chem. 263:11627-11630(1988).
RN   [42]
RP   VARIANT OI1 CYS-1195.
RX   PubMed=3244312;
RA   Labhard M.E., Wirtz M.K., Pope F.M., Nicholls A.C., Hollister D.W.;
RT   "A cysteine for glycine substitution at position 1017 in an alpha 1(I)
RT   chain of type I collagen in a patient with mild dominantly inherited
RT   osteogenesis imperfecta.";
RL   Mol. Biol. Med. 5:197-207(1988).
RN   [43]
RP   VARIANT OI2 VAL-434.
RX   PubMed=2470760;
RA   Patterson E., Smiley E., Bonadio J.;
RT   "RNA sequence analysis of a perinatal lethal osteogenesis imperfecta
RT   mutation.";
RL   J. Biol. Chem. 264:10083-10087(1989).
RN   [44]
RP   VARIANT OI4 SER-1010.
RX   PubMed=2745420;
RA   Marini J.C., Grange D.K., Gottesman G.S., Lewis M.B., Koeplin D.A.;
RT   "Osteogenesis imperfecta type IV. Detection of a point mutation in one
RT   alpha 1(I) collagen allele (COL1A1) by RNA/RNA hybrid analysis.";
RL   J. Biol. Chem. 264:11893-11900(1989).
RN   [45]
RP   VARIANTS OI2 ALA-1106; VAL-1151; ARG-1154 AND VAL-1184.
RX   PubMed=2777764;
RA   Lamande S.R., Dahl H.-H.M., Cole W.G., Bateman J.F.;
RT   "Characterization of point mutations in the collagen COL1A1 and COL1A2
RT   genes causing lethal perinatal osteogenesis imperfecta.";
RL   J. Biol. Chem. 264:15809-15812(1989).
RN   [46]
RP   VARIANT OI3 SER-1022.
RX   PubMed=2511192;
RA   Pack M., Constantinou C.D., Kalia K., Nielsen K.B., Prockop D.J.;
RT   "Substitution of serine for alpha 1(I)-glycine 844 in a severe variant of
RT   osteogenesis imperfecta minimally destabilizes the triple helix of type I
RT   procollagen. The effects of glycine substitutions on thermal stability are
RT   either position of amino acid specific.";
RL   J. Biol. Chem. 264:19694-19699(1989).
RN   [47]
RP   VARIANT OI2 CYS-1082.
RX   PubMed=2913053; DOI=10.1172/jci113920;
RA   Constantinou C.D., Nielsen K.B., Prockop D.J.;
RT   "A lethal variant of osteogenesis imperfecta has a single base mutation
RT   that substitutes cysteine for glycine 904 of the alpha 1(I) chain of type I
RT   procollagen. The asymptomatic mother has an unidentified mutation producing
RT   an overmodified and unstable type I procollagen.";
RL   J. Clin. Invest. 83:574-584(1989).
RN   [48]
RP   VARIANT OI1 CYS-272, VARIANT OI3 CYS-704, AND VARIANT OI2 CYS-896.
RX   PubMed=2794057; DOI=10.1172/jci114286;
RA   Starman B.J., Eyre D.R., Charbonneau H., Harrylock M., Weis M.A., Weiss L.,
RA   Graham J.M. Jr., Byers P.H.;
RT   "Osteogenesis imperfecta. The position of substitution for glycine by
RT   cysteine in the triple helical domain of the pro alpha 1(I) chains of type
RT   I collagen determines the clinical phenotype.";
RL   J. Clin. Invest. 84:1206-1214(1989).
RN   [49]
RP   VARIANT OI2 CYS-422.
RA   Fertala A., Westerhausen A., Morris G.M., Rooney J.E., Prockop D.J.;
RT   "Two cysteine substitutions in the type I procollagen genes (COL1A1 and
RT   COL1A2) that cause lethal osteogenesis imperfecta. The location of glycine
RT   substitutions does not in any simple way predict their effects on protein
RT   function or phenotype.";
RL   Am. J. Hum. Genet. 47:A216-A216(1990).
RN   [50]
RP   VARIANTS OI2 SER-776 AND SER-809.
RX   PubMed=2116413;
RA   Westerhausen A., Kishi J., Prockop D.J.;
RT   "Mutations that substitute serine for glycine alpha 1-598 and glycine alpha
RT   1-631 in type I procollagen. The effects on thermal unfolding of the triple
RT   helix are position-specific and demonstrate that the protein unfolds
RT   through a series of cooperative blocks.";
RL   J. Biol. Chem. 265:13995-14000(1990).
RN   [51]
RP   VARIANT OI2 ARG-1025.
RX   PubMed=2211725;
RA   Wallis G.A., Starman B.J., Schwartz M.F., Byers P.H.;
RT   "Substitution of arginine for glycine at position 847 in the triple-helical
RT   domain of the alpha 1 (I) chain of type I collagen produces lethal
RT   osteogenesis imperfecta. Molecules that contain one or two abnormal chains
RT   differ in stability and secretion.";
RL   J. Biol. Chem. 265:18628-18633(1990).
RN   [52]
RP   VARIANTS OI2 SER-1091; SER-1181; SER-1187 AND VAL-1187.
RA   Cohn D.H., Wallis G.A., Zhang X., Byers P.H.;
RT   "Serine for glycine substitutions in the alpha1(I) chain of type I
RT   collagen: biological plasticity in the Gly-Pro-Hyp clamp at the carboxyl-
RT   terminal end of triple helicalH domain.";
RL   Matrix 10:236-236(1990).
RN   [53]
RP   VARIANT OI2 ASP-719.
RX   PubMed=2035536;
RA   Zhuang J., Constantinou C.D., Ganguly A., Prockop D.J.;
RT   "A single base mutation in type I procollagen (COL1A1) that converts
RT   glycine alpha 1-541 to aspartate in a lethal variant of osteogenesis
RT   imperfecta: detection of the mutation with a carbodiimide reaction of DNA
RT   heteroduplexes and direct sequencing of products of the PCR.";
RL   Am. J. Hum. Genet. 48:1186-1191(1991).
RN   [54]
RP   VARIANT OI2 CYS-869.
RX   PubMed=1953667; DOI=10.1042/bj2790747;
RA   Steinmann B., Westerhausen A., Constantinou C.D., Superti-Furga A.,
RA   Prockop D.J.;
RT   "Substitution of cysteine for glycine-alpha 1-691 in the pro alpha 1(I)
RT   chain of type I procollagen in a proband with lethal osteogenesis
RT   imperfecta destabilizes the triple helix at a site C-terminal to the
RT   substitution.";
RL   Biochem. J. 279:747-752(1991).
RN   [55]
RP   VARIANT OI2 CYS-926.
RX   PubMed=2036375; DOI=10.1021/bi00234a035;
RA   Kadler K.E., Torre-Blanco A., Adachi E., Vogel B.E., Hojima Y.,
RA   Prockop D.J.;
RT   "A type I collagen with substitution of a cysteine for glycine-748 in the
RT   alpha 1(I) chain copolymerizes with normal type I collagen and can generate
RT   fractallike structures.";
RL   Biochemistry 30:5081-5088(1991).
RN   [56]
RP   VARIANT OI3 ARG-332, AND VARIANT OI2 SER-1181.
RX   PubMed=2037280; DOI=10.1007/bf01213088;
RA   Pruchno C.J., Cohn D.H., Wallis G.A., Willing M.C., Starman B.J., Zhang X.,
RA   Byers P.H.;
RT   "Osteogenesis imperfecta due to recurrent point mutations at CpG
RT   dinucleotides in the COL1A1 gene of type I collagen.";
RL   Hum. Genet. 87:33-40(1991).
RN   [57]
RP   VARIANT OI4 CYS-356.
RX   PubMed=1988452;
RA   Valli M., Mottes M., Tenni R., Sangalli A., Gomez Lira M., Rossi A.,
RA   Antoniazzi F., Cetta G., Pignatti P.F.;
RT   "A de novo G to T transversion in a pro-alpha 1 (I) collagen gene for a
RT   moderate case of osteogenesis imperfecta. Substitution of cysteine for
RT   glycine 178 in the triple helical domain.";
RL   J. Biol. Chem. 266:1872-1878(1991).
RN   [58]
RP   VARIANT OI2 VAL-815.
RX   PubMed=1874719;
RA   Tsuneyoshi T., Westerhausen A., Constantinou C.D., Prockop D.J.;
RT   "Substitutions for glycine alpha 1-637 and glycine alpha 2-694 of type I
RT   procollagen in lethal osteogenesis imperfecta. The conformational strain on
RT   the triple helix introduced by a glycine substitution can be transmitted
RT   along the helix.";
RL   J. Biol. Chem. 266:15608-15613(1991).
RN   [59]
RP   VARIANT OI1 ARG-263.
RX   PubMed=1718984;
RA   Deak S.B., Scholz P.M., Amenta P.S., Constantinou C.D., Levi-Minzi S.A.,
RA   Gonzalez-Lavin L., MacKenzie J.W.;
RT   "The substitution of arginine for glycine 85 of the alpha 1(I) procollagen
RT   chain results in mild osteogenesis imperfecta. The mutation provides direct
RT   evidence for three discrete domains of cooperative melting of intact type I
RT   collagen.";
RL   J. Biol. Chem. 266:21827-21832(1991).
RN   [60]
RP   VARIANT OI2 1046-GLY--PRO-1048 DEL.
RX   PubMed=1939261;
RA   Hawkins J.R., Superti-Furga A., Steinmann B., Dalgleish R.;
RT   "A 9-base pair deletion in COL1A1 in a lethal variant of osteogenesis
RT   imperfecta.";
RL   J. Biol. Chem. 266:22370-22374(1991).
RN   [61]
RP   VARIANT OI3 CYS-593, AND VARIANT OI4 CYS-593.
RX   PubMed=1770532; DOI=10.1136/jmg.28.11.757;
RA   Nicholls A.C., Oliver J.E., Renouf D.V., Keston M., Pope F.M.;
RT   "Substitution of cysteine for glycine at residue 415 of one allele of the
RT   alpha 1(I) chain of type I procollagen in type III/IV osteogenesis
RT   imperfecta.";
RL   J. Med. Genet. 28:757-764(1991).
RN   [62]
RP   VARIANT ALA-1075.
RX   PubMed=1870989; DOI=10.1093/nar/19.15.4302;
RA   Sokolov B.P., Constantinou C.D., Tsuneyoshi T., Zhuang J., Prockop D.J.;
RT   "G to A polymorphism in exon 45 of the COL1A1 gene.";
RL   Nucleic Acids Res. 19:4302-4302(1991).
RN   [63]
RP   VARIANT OI1 SER-1079.
RX   PubMed=1634225; DOI=10.1007/bf00219169;
RA   Mottes M., Sangalli A., Valli M., Gomez Lira M., Tenni R., Buttitta P.,
RA   Pignatti P.F., Cetta G.;
RT   "Mild dominant osteogenesis imperfecta with intrafamilial variability: the
RT   cause is a serine for glycine alpha 1(I) 901 substitution in a type-I
RT   collagen gene.";
RL   Hum. Genet. 89:480-484(1992).
RN   [64]
RP   VARIANT OI2 VAL-980.
RX   PubMed=1511982; DOI=10.1007/bf00221955;
RA   Bonaventure J., Cohen-Solal L., Lasselin C., Maroteaux P.;
RT   "A dominant mutation in the COL1A1 gene that substitutes glycine for valine
RT   causes recurrent lethal osteogenesis imperfecta.";
RL   Hum. Genet. 89:640-646(1992).
RN   [65]
RP   VARIANT OI2 1046-GLY--PRO-1048 DEL.
RX   PubMed=1460047;
RA   Wallis G.A., Kadler K.E., Starman B.J., Byers P.H.;
RT   "A tripeptide deletion in the triple-helical domain of the pro alpha 1(I)
RT   chain of type I procollagen in a patient with lethal osteogenesis
RT   imperfecta does not alter cleavage of the molecule by N-proteinase.";
RL   J. Biol. Chem. 267:25529-25534(1992).
RN   [66]
RP   VARIANT OI1 CYS-221.
RX   PubMed=1737847; DOI=10.1172/jci115622;
RA   Shapiro J.R., Stover M.L., Burn V.E., McKinstry M.B., Burshell A.L.,
RA   Chipman S.D., Rowe D.W.;
RT   "An osteopenic nonfracture syndrome with features of mild osteogenesis
RT   imperfecta associated with the substitution of a cysteine for glycine at
RT   triple helix position 43 in the pro alpha 1(I) chain of type I collagen.";
RL   J. Clin. Invest. 89:567-573(1992).
RN   [67]
RP   VARIANTS OI2 VAL-434; VAL-1151 AND VAL-1184.
RX   PubMed=1613761; DOI=10.1136/jmg.29.2.112;
RA   Cole W.G., Patterson E., Bonadio J., Campbell P.E., Fortune D.W.;
RT   "The clinicopathological features of three babies with osteogenesis
RT   imperfecta resulting from the substitution of glycine by valine in the pro
RT   alpha 1 (I) chain of type I procollagen.";
RL   J. Med. Genet. 29:112-118(1992).
RN   [68]
RP   VARIANT OI2 CYS-1312.
RX   PubMed=8456808; DOI=10.1002/ajmg.1320450216;
RA   Bateman J.F., Lamande S.R., Hannagan M., Moeller I., Dahl H.-H.M.,
RA   Cole W.G.;
RT   "Chemical cleavage method for the detection of RNA base changes: experience
RT   in the application to collagen mutations in osteogenesis imperfecta.";
RL   Am. J. Med. Genet. 45:233-240(1993).
RN   [69]
RP   VARIANT OI3 SER-530.
RX   PubMed=8456809; DOI=10.1002/ajmg.1320450217;
RA   Marini J.C., Lewis M.B., Chen K.J.;
RT   "Moderately severe osteogenesis imperfecta associated with substitutions of
RT   serine for glycine in the alpha 1(I) chain of type I collagen.";
RL   Am. J. Med. Genet. 45:241-245(1993).
RN   [70]
RP   VARIANT OI4 CYS-353.
RX   PubMed=8339541; DOI=10.3109/03008209309061961;
RA   Wirtz M.K., Rao V.H., Glanville R.W., Labhard M.E., Pretorius P.J.,
RA   de Vries W.N., de Wet W., Hollister D.W.;
RT   "A cysteine for glycine substitution at position 175 in an alpha 1 (I)
RT   chain of type I collagen produces a clinically heterogeneous form of
RT   osteogenesis imperfecta.";
RL   Connect. Tissue Res. 29:1-11(1993).
RN   [71]
RP   VARIANT OI2 ALA-1088.
RX   PubMed=7679635; DOI=10.1111/j.1432-1033.1993.tb17565.x;
RA   Valli M., Sangalli A., Rossi A., Mottes M., Forlino A., Tenni R.,
RA   Pignatti P.F., Cetta G.;
RT   "Osteogenesis imperfecta and type-I collagen mutations. A lethal variant
RT   caused by a Gly910-->Ala substitution in the alpha 1 (I) chain.";
RL   Eur. J. Biochem. 211:415-419(1993).
RN   [72]
RP   VARIANT OI1 VAL-263.
RX   PubMed=8223589; DOI=10.1111/j.1432-1033.1993.tb18220.x;
RA   Valli M., Zolezzi F., Mottes M., Antoniazzi F., Stanzial F., Tenni R.,
RA   Pignatti P.F., Cetta G.;
RT   "Gly85 to Val substitution in pro alpha 1(I) chain causes mild osteogenesis
RT   imperfecta and introduces a susceptibility to protease digestion.";
RL   Eur. J. Biochem. 217:77-82(1993).
RN   [73]
RP   VARIANT OI2 VAL-743.
RX   PubMed=8100209; DOI=10.1007/bf00217768;
RA   Mackay K., Lund A.M., Raghunath M., Steinmann B., Dalgleish R.;
RT   "SSCP detection of a Gly565Val substitution in the pro alpha 1(I) collagen
RT   chain resulting in osteogenesis imperfecta type II.";
RL   Hum. Genet. 91:439-444(1993).
RN   [74]
RP   VARIANTS OI2 SER-425 AND SER-530, VARIANT OI4 SER-560, VARIANT OI3 SER-719,
RP   AND VARIANT ALA-823.
RX   PubMed=7691343; DOI=10.1093/hmg/2.8.1155;
RA   Mackay K., Byers P.H., Dalgleish R.;
RT   "An RT-PCR-SSCP screening strategy for detection of mutations in the gene
RT   encoding the alpha 1 chain of type I collagen: application to four patients
RT   with osteogenesis imperfecta.";
RL   Hum. Mol. Genet. 2:1155-1160(1993).
RN   [75]
RP   VARIANT OI2 SER-593, AND VARIANT OI3 SER-593.
RX   PubMed=8364588; DOI=10.1002/humu.1380020308;
RA   Mottes M., Gomez Lira M., Valli M., Scarano G., Lonardo F., Forlino A.,
RA   Cetta G., Pignatti P.F.;
RT   "Paternal mosaicism for a COL1A1 dominant mutation (alpha 1 Ser-415) causes
RT   recurrent osteogenesis imperfecta.";
RL   Hum. Mutat. 2:196-204(1993).
RN   [76]
RP   VARIANT OI4 SER-530.
RX   PubMed=8094076;
RA   Marini J.C., Lewis M.B., Wang Q., Chen K.J., Orrison B.M.;
RT   "Serine for glycine substitutions in type I collagen in two cases of type
RT   IV osteogenesis imperfecta (OI). Additional evidence for a regional model
RT   of OI pathophysiology.";
RL   J. Biol. Chem. 268:2667-2673(1993).
RN   [77]
RP   VARIANTS OI2.
RX   PubMed=8349698;
RA   Chessler S.D., Byers P.H.;
RT   "BiP binds type I procollagen pro alpha chains with mutations in the
RT   carboxyl-terminal propeptide synthesized by cells from patients with
RT   osteogenesis imperfecta.";
RL   J. Biol. Chem. 268:18226-18233(1993).
RN   [78]
RP   VARIANT OI2 ARG-389.
RX   PubMed=7520724; DOI=10.1016/8756-3282(94)90295-x;
RA   Sztrolovics R., Glorieux F.H., Travers R., van der Rest M., Roughley P.J.;
RT   "Osteogenesis imperfecta: comparison of molecular defects with bone
RT   histological changes.";
RL   Bone 15:321-328(1994).
RN   [79]
RP   VARIANT OI3 ARG-350.
RX   PubMed=8019571; DOI=10.1002/humu.1380030327;
RA   Mackay K., de Paepe A., Nuytinck L., Dalgleish R.;
RT   "Substitution of glycine-172 by arginine in the alpha 1 chain of type I
RT   collagen in a patient with osteogenesis imperfecta, type III.";
RL   Hum. Mutat. 3:324-326(1994).
RN   [80]
RP   VARIANT OI2 CYS-1124.
RX   PubMed=7961597; DOI=10.1093/oxfordjournals.jbchem.a124429;
RA   Kurosaka D., Hattori S., Hori H., Yamaguchi N., Hasegawa T., Akimoto H.,
RA   Nagai Y.;
RT   "Substitution of cysteine for glycine-946 in the alpha 1(I) chain of type I
RT   procollagen causes lethal osteogenesis imperfecta.";
RL   J. Biochem. 115:853-857(1994).
RN   [81]
RP   VARIANT OI4 SER-1061.
RX   PubMed=7982948;
RA   Lightfoot S.J., Atkinson M.S., Murphy G., Byers P.H., Kadler K.E.;
RT   "Substitution of serine for glycine 883 in the triple helix of the pro
RT   alpha 1 (I) chain of type I procollagen produces osteogenesis imperfecta
RT   type IV and introduces a structural change in the triple helix that does
RT   not alter cleavage of the molecule by procollagen N-proteinase.";
RL   J. Biol. Chem. 269:30352-30357(1994).
RN   [82]
RP   VARIANT OI3 ARG-332.
RX   PubMed=8669434;
RX   DOI=10.1002/(sici)1096-8628(19960111)61:2<111::aid-ajmg1>3.0.co;2-#;
RA   Zhuang J., Tromp G., Kuivaniemi H., Castells S., Prockop D.J.;
RT   "Substitution of arginine for glycine at position 154 of the alpha 1 chain
RT   of type I collagen in a variant of osteogenesis imperfecta: comparison to
RT   previous cases with the same mutation.";
RL   Am. J. Med. Genet. 61:111-116(1996).
RN   [83]
RP   VARIANT OI2 SER-839.
RX   PubMed=8786074; DOI=10.1007/bf02185764;
RA   Nuytinck L., Dalgleish R., Spotila L., Renard J.-P., van Regemorter N.,
RA   de Paepe A.;
RT   "Substitution of glycine-661 by serine in the alpha1(I) and alpha2(I)
RT   chains of type I collagen results in different clinical and biochemical
RT   phenotypes.";
RL   Hum. Genet. 97:324-329(1996).
RN   [84]
RP   VARIANT OI3 PRO-1464.
RX   PubMed=8723681;
RX   DOI=10.1002/(sici)1098-1004(1996)7:4<318::aid-humu5>3.0.co;2-4;
RA   Oliver J.E., Thompson E.M., Pope F.M., Nicholls A.C.;
RT   "Mutation in the carboxy-terminal propeptide of the Pro alpha 1(I) chain of
RT   type I collagen in a child with severe osteogenesis imperfecta (OI type
RT   III): possible implications for protein folding.";
RL   Hum. Mutat. 7:318-326(1996).
RN   [85]
RP   INVOLVEMENT IN OSTEOPOROSIS.
RX   PubMed=8841196; DOI=10.1038/ng1096-203;
RA   Grant S.F.A., Reid D.M., Blake G., Herd R., Fogelman I., Ralston S.H.;
RT   "Reduced bone density and osteoporosis associated with a polymorphic Sp1
RT   binding site in the collagen type I alpha 1 gene.";
RL   Nat. Genet. 14:203-205(1996).
RN   [86]
RP   VARIANTS OI3 SER-821; SER-1040; SER-1049; SER-1058 AND SER-1076.
RX   PubMed=9101304;
RX   DOI=10.1002/(sici)1098-1004(1997)9:4<378::aid-humu16>3.0.co;2-#;
RA   Lund A.M., Skovby F., Schwartz M.;
RT   "Serine for glycine substitutions in the C-terminal third of the alpha 1(I)
RT   chain of collagen I in five patients with nonlethal osteogenesis
RT   imperfecta.";
RL   Hum. Mutat. 9:378-382(1997).
RN   [87]
RP   VARIANT OI2 VAL-764.
RX   PubMed=9143923;
RX   DOI=10.1002/(sici)1098-1004(1997)9:5<431::aid-humu9>3.0.co;2-6;
RA   Lund A.M., Skovby F., Schwartz M.;
RT   "(G586V) substitutions in the alpha 1 and alpha 2 chains of collagen I:
RT   effect of alpha-chain stoichiometry on the phenotype of osteogenesis
RT   imperfecta?";
RL   Hum. Mutat. 9:431-436(1997).
RN   [88]
RP   VARIANTS OI4 ALA-398; CYS-527 AND CYS-701.
RX   PubMed=9600458;
RX   DOI=10.1002/(sici)1098-1004(1998)11:5<395::aid-humu7>3.0.co;2-4;
RA   Sarafova A.P., Choi H., Forlino A., Gajko A., Cabral W.A., Tosi L.,
RA   Reing C.M., Marini J.C.;
RT   "Three novel type I collagen mutations in osteogenesis imperfecta type IV
RT   probands are associated with discrepancies between electrophoretic
RT   migration of osteoblast and fibroblast collagen.";
RL   Hum. Mutat. 11:395-403(1998).
RN   [89]
RP   VARIANTS OI2 SER-656 AND ASP-1172.
RX   PubMed=10627137;
RX   DOI=10.1002/(sici)1098-1004(1998)12:1<71::aid-humu16>3.0.co;2-4;
RA   Mottes M., Gomez Lira M., Zolezzi F., Valli M., Lisi V., Freising P.;
RT   "Four new cases of lethal osteogenesis imperfecta due to glycine
RT   substitutions in COL1A1 and genes.";
RL   Hum. Mutat. 12:71-72(1998).
RN   [90]
RP   INVOLVEMENT IN INVOLUTIONAL OSTEOPOROSIS.
RX   PubMed=9535665; DOI=10.1056/nejm199804093381502;
RA   Uitterlinden A.G., Burger H., Huang Q., Yue F., McGuigan F.E.A.,
RA   Grant S.F.A., Hofman A., van Leeuwen J.P.T.M., Pols H.A.P., Ralston S.H.;
RT   "Relation of alleles of the collagen type Ialpha1 gene to bone density and
RT   the risk of osteoporotic fractures in postmenopausal women.";
RL   N. Engl. J. Med. 338:1016-1021(1998).
RN   [91]
RP   VARIANT OI3 SER-866.
RX   PubMed=10408781;
RX   DOI=10.1002/(sici)1098-1004(1999)13:6<503::aid-humu11>3.0.co;2-l;
RA   Lund A.M., Astroem E., Soederhaell S., Schwartz M., Skovby F.;
RT   "Osteogenesis imperfecta: mosaicism and refinement of the genotype-
RT   phenotype map in OI type III.";
RL   Hum. Mutat. 13:503-503(1999).
RN   [92]
RP   VARIANT EDSCL1 CYS-312.
RX   PubMed=10739762; DOI=10.1086/302859;
RA   Nuytinck L., Freund M., Lagae L., Pierard G.E., Hermanns-Le T.,
RA   De Paepe A.;
RT   "Classical Ehlers-Danlos syndrome caused by a mutation in type I
RT   collagen.";
RL   Am. J. Hum. Genet. 66:1398-1402(2000).
RN   [93]
RP   DISEASE, AND CHROMOSOMAL TRANSLOCATION WITH PDGFB.
RX   PubMed=8988177; DOI=10.1038/ng0197-95;
RA   Simon M.-P., Pedeutour F., Sirvent N., Grosgeorge J., Minoletti F.,
RA   Coindre J.-M., Terrier-Lacombe M.-J., Mandahl N., Craver R.D., Blin N.,
RA   Sozzi G., Turc-Carel C., O'Brien K.P., Kedra D., Fransson I., Guilbaud C.,
RA   Dumanski J.P.;
RT   "Deregulation of the platelet-derived growth factor B-chain gene via fusion
RT   with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell
RT   fibroblastoma.";
RL   Nat. Genet. 15:95-98(1997).
RN   [94]
RP   DISEASE, AND CHROMOSOMAL TRANSLOCATION WITH PDGFB.
RX   PubMed=12660034; DOI=10.1016/s0165-4608(02)00844-0;
RA   Sandberg A.A., Anderson W.D., Fredenberg C., Hashimoto H.;
RT   "Dermatofibrosarcoma protuberans of breast.";
RL   Cancer Genet. Cytogenet. 142:56-59(2003).
RN   [95]
RP   VARIANT CAFFD CYS-1014.
RX   PubMed=15864348; DOI=10.1172/jci200522760;
RA   Gensure R.C., Maekitie O., Barclay C., Chan C., Depalma S.R., Bastepe M.,
RA   Abuzahra H., Couper R., Mundlos S., Sillence D., Ala-Kokko L.,
RA   Seidman J.G., Cole W.G., Jueppner H.;
RT   "A novel COL1A1 mutation in infantile cortical hyperostosis (Caffey
RT   disease) expands the spectrum of collagen-related disorders.";
RL   J. Clin. Invest. 115:1250-1257(2005).
RN   [96]
RP   VARIANTS OI3 VAL-203 AND SER-821, AND VARIANTS OI4 ARG-257 AND SER-683.
RX   PubMed=16879195; DOI=10.1111/j.1399-0004.2006.00646.x;
RA   Venturi G., Tedeschi E., Mottes M., Valli M., Camilot M., Viglio S.,
RA   Antoniazzi F., Tato L.;
RT   "Osteogenesis imperfecta: clinical, biochemical and molecular findings.";
RL   Clin. Genet. 70:131-139(2006).
RN   [97]
RP   VARIANTS OI1/OI3/OI4 ARG-194; ASP-242; ARG-257; SER-722; SER-767; SER-821
RP   AND SER-1058.
RX   PubMed=16705691; DOI=10.1002/humu.9423;
RA   Lee K.S., Song H.R., Cho T.J., Kim H.J., Lee T.M., Jin H.S., Park H.Y.,
RA   Kang S., Jung S.C., Koo S.K.;
RT   "Mutational spectrum of type I collagen genes in Korean patients with
RT   osteogenesis imperfecta.";
RL   Hum. Mutat. 27:599-599(2006).
RN   [98]
RP   VARIANTS OI2 ARG-22; ARG-581; VAL-734 AND ASN-1413, VARIANTS OI4 ARG-197
RP   AND CYS-338, VARIANTS OI1 VAL-320; ARG-555; SER-647 AND GLU-1219, AND
RP   VARIANTS ALA-205; LYS-288; SER-906 AND HIS-1356.
RX   PubMed=16786509; DOI=10.1002/humu.9430;
RA   Pollitt R., McMahon R., Nunn J., Bamford R., Afifi A., Bishop N.,
RA   Dalton A.;
RT   "Mutation analysis of COL1A1 and COL1A2 in patients diagnosed with
RT   osteogenesis imperfecta type I-IV.";
RL   Hum. Mutat. 27:716-716(2006).
RN   [99]
RP   VARIANT OI2 ASP-833.
RX   PubMed=16566045; DOI=10.1002/pd.1428;
RA   Aerts M., Van Holsbeke C., de Ravel T., Devlieger R.;
RT   "Prenatal diagnosis of type II osteogenesis imperfecta, describing a new
RT   mutation in the COL1A1 gene.";
RL   Prenat. Diagn. 26:394-394(2006).
RN   [100]
RP   VARIANT OI1 ASP-1157.
RX   PubMed=16638323;
RA   Wang Z., Xu D.L., Chen Z., Hu J.Y., Yang Z., Wang L.T.;
RT   "A new mutation in COL1A1 gene in a family with osteogenesis imperfecta.";
RL   Zhonghua Yi Xue Za Zhi 86:170-173(2006).
RN   [101]
RP   VARIANT EDSCL1 CYS-312, AND VARIANTS CYS-574 AND CYS-1093.
RX   PubMed=17211858; DOI=10.1002/humu.20455;
RA   Malfait F., Symoens S., De Backer J., Hermanns-Le T., Sakalihasan N.,
RA   Lapiere C.M., Coucke P., De Paepe A.;
RT   "Three arginine to cysteine substitutions in the pro-alpha (I)-collagen
RT   chain cause Ehlers-Danlos syndrome with a propensity to arterial rupture in
RT   early adulthood.";
RL   Hum. Mutat. 28:387-395(2007).
RN   [102]
RP   VARIANT CYS-1066.
RX   PubMed=17206620; DOI=10.1002/humu.20456;
RA   Cabral W.A., Makareeva E., Letocha A.D., Scribanu N., Fertala A.,
RA   Steplewski A., Keene D.R., Persikov A.V., Leikin S., Marini J.C.;
RT   "Y-position cysteine substitution in type I collagen (alpha1(I)
RT   R888C/p.R1066C) is associated with osteogenesis imperfecta/Ehlers-Danlos
RT   syndrome phenotype.";
RL   Hum. Mutat. 28:396-405(2007).
RN   [103]
RP   VARIANTS OI1 GLU-266 AND SER-287, AND VARIANT OI4 SER-353.
RX   PubMed=17875077; DOI=10.1111/j.1442-200x.2007.02422.x;
RA   Kataoka K., Ogura E., Hasegawa K., Inoue M., Seino Y., Morishima T.,
RA   Tanaka H.;
RT   "Mutations in type I collagen genes in Japanese osteogenesis imperfecta
RT   patients.";
RL   Pediatr. Int. 49:564-569(2007).
RN   [104]
RP   VARIANTS ALA-1075; GLN-1141 AND ILE-1177.
RX   PubMed=18272325; DOI=10.1016/j.ygeno.2007.12.008;
RA   Chan T.F., Poon A., Basu A., Addleman N.R., Chen J., Phong A., Byers P.H.,
RA   Klein T.E., Kwok P.Y.;
RT   "Natural variation in four human collagen genes across an ethnically
RT   diverse population.";
RL   Genomics 91:307-314(2008).
RN   [105]
RP   VARIANTS OI1 VAL-200 AND PHE-349, VARIANT OI2 SER-866, AND VARIANT OI3
RP   SER-1040.
RX   PubMed=18670065; DOI=10.1007/bf03195625;
RA   Witecka J., Augusciak-Duma A.M., Kruczek A., Szydlo A., Lesiak M.,
RA   Krzak M., Pietrzyk J.J., Mannikko M., Sieron A.L.;
RT   "Two novel COL1A1 mutations in patients with osteogenesis imperfecta (OI)
RT   affect the stability of the collagen type I triple-helix.";
RL   J. Appl. Genet. 49:283-295(2008).
RN   [106]
RP   VARIANTS OI2 THR-146; VAL-288; ASP-353; VAL-368; THR-390; SER-425; ASP-455;
RP   VAL-470; VAL-509; ALA-548; ARG-602; ASP-605; ARG-614; ARG-740; SER-809;
RP   ARG-824; ARG-845; ARG-848; HIS-855; SER-866; SER-875; SER-884; ASP-896;
RP   CYS-947; ASP-977; CYS-1001; VAL-1022; ALA-PRO-GLY-1052 INS; ASP-1055;
RP   SER-1094; ASP-1100 AND ASN-1413, AND VARIANT ALA-1075.
RX   PubMed=18996919; DOI=10.1093/hmg/ddn374;
RA   Bodian D.L., Chan T.F., Poon A., Schwarze U., Yang K., Byers P.H.,
RA   Kwok P.Y., Klein T.E.;
RT   "Mutation and polymorphism spectrum in osteogenesis imperfecta type II:
RT   implications for genotype-phenotype relationships.";
RL   Hum. Mol. Genet. 18:463-471(2009).
RN   [107]
RP   VARIANT ASN-1219, AND CHARACTERIZATION OF VARIANT ASN-1219.
RX   PubMed=21344539; DOI=10.1002/humu.21475;
RA   Lindahl K., Barnes A.M., Fratzl-Zelman N., Whyte M.P., Hefferan T.E.,
RA   Makareeva E., Brusel M., Yaszemski M.J., Rubin C.J., Kindmark A.,
RA   Roschger P., Klaushofer K., McAlister W.H., Mumm S., Leikin S., Kessler E.,
RA   Boskey A.L., Ljunggren O., Marini J.C.;
RT   "COL1 C-propeptide cleavage site mutations cause high bone mass
RT   osteogenesis imperfecta.";
RL   Hum. Mutat. 32:598-609(2011).
RN   [108]
RP   VARIANT OI1 GLU-1088.
RX   PubMed=24682174; DOI=10.3892/mmr.2014.2084;
RA   Xia X.Y., Li W.W., Li N., Wu Q.Y., Cui Y.X., Li X.J.;
RT   "A novel mild variant of osteogenesis imperfecta type I caused by a
RT   Gly1088Glu mutation in COL1A1.";
RL   Mol. Med. Report. 9:2187-2190(2014).
RN   [109]
RP   VARIANT OI2 CYS-773.
RX   PubMed=25958000; DOI=10.1186/s40246-015-0028-0;
RA   Maasalu K., Nikopensius T., Koks S., Noukas M., Kals M., Prans E.,
RA   Zhytnik L., Metspalu A., Maertson A.;
RT   "Whole-exome sequencing identifies de novo mutation in the COL1A1 gene to
RT   underlie the severe osteogenesis imperfecta.";
RL   Hum. Genomics 9:6-6(2015).
CC   -!- FUNCTION: Type I collagen is a member of group I collagen (fibrillar
CC       forming collagen).
CC   -!- SUBUNIT: Trimers of one alpha 2(I) and two alpha 1(I) chains. Interacts
CC       with MRC2 (By similarity). Interacts with TRAM2 (PubMed:14749390).
CC       Interacts with MFAP4 in a Ca (2+)-dependent manner (By similarity).
CC       {ECO:0000250|UniProtKB:P02453, ECO:0000250|UniProtKB:P02454,
CC       ECO:0000269|PubMed:14749390}.
CC   -!- INTERACTION:
CC       P02452; O01949: AAEL010235; Xeno; NbExp=5; IntAct=EBI-982999, EBI-7685554;
CC       P02452; P02751: FN1; NbExp=2; IntAct=EBI-982999, EBI-1220319;
CC       P02452; Q14145: KEAP1; NbExp=3; IntAct=EBI-982999, EBI-751001;
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix {ECO:0000255|PROSITE-ProRule:PRU00793}.
CC   -!- TISSUE SPECIFICITY: Forms the fibrils of tendon, ligaments and bones.
CC       In bones the fibrils are mineralized with calcium hydroxyapatite.
CC   -!- DOMAIN: The C-terminal propeptide, also known as COLFI domain, have
CC       crucial roles in tissue growth and repair by controlling both the
CC       intracellular assembly of procollagen molecules and the extracellular
CC       assembly of collagen fibrils. It binds a calcium ion which is essential
CC       for its function (By similarity). {ECO:0000250}.
CC   -!- PTM: Contains mostly 4-hydroxyproline. Proline residues at the third
CC       position of the tripeptide repeating unit (G-X-Y) are hydroxylated in
CC       some or all of the chains. {ECO:0000269|PubMed:4319110}.
CC   -!- PTM: Contains 3-hydroxyproline at a few sites. This modification occurs
CC       on the first proline residue in the sequence motif Gly-Pro-Hyp, where
CC       Hyp is 4-hydroxyproline. {ECO:0000250|UniProtKB:P11087}.
CC   -!- PTM: Lysine residues at the third position of the tripeptide repeating
CC       unit (G-X-Y) are 5-hydroxylated in some or all of the chains.
CC       {ECO:0000269|PubMed:4319110}.
CC   -!- PTM: O-glycosylated on hydroxylated lysine residues. The O-linked
CC       glycan consists of a Glc-Gal disaccharide.
CC       {ECO:0000269|PubMed:4319110}.
CC   -!- DISEASE: Caffey disease (CAFFD) [MIM:114000]: Characterized by an
CC       infantile episode of massive subperiosteal new bone formation that
CC       typically involves the diaphyses of the long bones, mandible, and
CC       clavicles. The involved bones may also appear inflamed, with painful
CC       swelling and systemic fever often accompanying the illness. The bone
CC       changes usually begin before 5 months of age and resolve before 2 years
CC       of age. {ECO:0000269|PubMed:15864348}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Ehlers-Danlos syndrome, classic type, 1 (EDSCL1) [MIM:130000]:
CC       A form of Ehlers-Danlos syndrome, a group of connective tissue
CC       disorders characterized by skin hyperextensibility, articular
CC       hypermobility, and tissue fragility. The main features of classic
CC       Ehlers-Danlos syndrome are joint hypermobility and dislocation, and
CC       fragile, bruisable skin. EDSCL1 inheritance is autosomal dominant.
CC       {ECO:0000269|PubMed:10739762, ECO:0000269|PubMed:17211858}. Note=The
CC       disease may be caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Ehlers-Danlos syndrome, arthrochalasia type, 1 (EDSARTH1)
CC       [MIM:130060]: A form of Ehlers-Danlos syndrome, a connective tissue
CC       disorder characterized by hyperextensible skin, atrophic cutaneous
CC       scars due to tissue fragility and joint hyperlaxity. EDSARTH1 is an
CC       autosomal dominant form characterized by frequent congenital hip
CC       dislocation and extreme joint laxity with recurrent joint subluxations
CC       and minimal skin involvement. {ECO:0000269|PubMed:18409203,
CC       ECO:0000269|PubMed:9295084}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Osteogenesis imperfecta 1 (OI1) [MIM:166200]: An autosomal
CC       dominant form of osteogenesis imperfecta, a connective tissue disorder
CC       characterized by low bone mass, bone fragility and susceptibility to
CC       fractures after minimal trauma. Disease severity ranges from very mild
CC       forms without fractures to intrauterine fractures and perinatal
CC       lethality. Extraskeletal manifestations, which affect a variable number
CC       of patients, are dentinogenesis imperfecta, hearing loss, and blue
CC       sclerae. OI1 is a non-deforming form with normal height or mild short
CC       stature, and no dentinogenesis imperfecta. {ECO:0000269|PubMed:1634225,
CC       ECO:0000269|PubMed:16638323, ECO:0000269|PubMed:16705691,
CC       ECO:0000269|PubMed:16786509, ECO:0000269|PubMed:1718984,
CC       ECO:0000269|PubMed:1737847, ECO:0000269|PubMed:17875077,
CC       ECO:0000269|PubMed:18670065, ECO:0000269|PubMed:24682174,
CC       ECO:0000269|PubMed:2794057, ECO:0000269|PubMed:3244312,
CC       ECO:0000269|PubMed:8223589}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Osteogenesis imperfecta 2 (OI2) [MIM:166210]: An autosomal
CC       dominant form of osteogenesis imperfecta, a connective tissue disorder
CC       characterized by low bone mass, bone fragility and susceptibility to
CC       fractures after minimal trauma. Disease severity ranges from very mild
CC       forms without fractures to intrauterine fractures and perinatal
CC       lethality. Extraskeletal manifestations, which affect a variable number
CC       of patients, are dentinogenesis imperfecta, hearing loss, and blue
CC       sclerae. OI2 is characterized by bone fragility, with many perinatal
CC       fractures, severe bowing of long bones, undermineralization, and death
CC       in the perinatal period due to respiratory insufficiency.
CC       {ECO:0000269|PubMed:10627137, ECO:0000269|PubMed:1460047,
CC       ECO:0000269|PubMed:1511982, ECO:0000269|PubMed:1613761,
CC       ECO:0000269|PubMed:16566045, ECO:0000269|PubMed:16786509,
CC       ECO:0000269|PubMed:18670065, ECO:0000269|PubMed:1874719,
CC       ECO:0000269|PubMed:18996919, ECO:0000269|PubMed:1939261,
CC       ECO:0000269|PubMed:1953667, ECO:0000269|PubMed:2035536,
CC       ECO:0000269|PubMed:2036375, ECO:0000269|PubMed:2037280,
CC       ECO:0000269|PubMed:2116413, ECO:0000269|PubMed:2211725,
CC       ECO:0000269|PubMed:2339700, ECO:0000269|PubMed:2470760,
CC       ECO:0000269|PubMed:25958000, ECO:0000269|PubMed:2777764,
CC       ECO:0000269|PubMed:2794057, ECO:0000269|PubMed:2913053,
CC       ECO:0000269|PubMed:3016737, ECO:0000269|PubMed:3108247,
CC       ECO:0000269|PubMed:3403550, ECO:0000269|PubMed:3667599,
CC       ECO:0000269|PubMed:7520724, ECO:0000269|PubMed:7679635,
CC       ECO:0000269|PubMed:7691343, ECO:0000269|PubMed:7961597,
CC       ECO:0000269|PubMed:8100209, ECO:0000269|PubMed:8349697,
CC       ECO:0000269|PubMed:8349698, ECO:0000269|PubMed:8364588,
CC       ECO:0000269|PubMed:8456808, ECO:0000269|PubMed:8786074,
CC       ECO:0000269|PubMed:9143923, ECO:0000269|Ref.49, ECO:0000269|Ref.52}.
CC       Note=The disease is caused by mutations affecting the gene represented
CC       in this entry.
CC   -!- DISEASE: Osteogenesis imperfecta 3 (OI3) [MIM:259420]: An autosomal
CC       dominant form of osteogenesis imperfecta, a connective tissue disorder
CC       characterized by low bone mass, bone fragility and susceptibility to
CC       fractures after minimal trauma. Disease severity ranges from very mild
CC       forms without fractures to intrauterine fractures and perinatal
CC       lethality. Extraskeletal manifestations, which affect a variable number
CC       of patients, are dentinogenesis imperfecta, hearing loss, and blue
CC       sclerae. OI3 is characterized by progressively deforming bones, very
CC       short stature, a triangular face, severe scoliosis, grayish sclera and
CC       dentinogenesis imperfecta. {ECO:0000269|PubMed:10408781,
CC       ECO:0000269|PubMed:16879195, ECO:0000269|PubMed:1770532,
CC       ECO:0000269|PubMed:18670065, ECO:0000269|PubMed:2037280,
CC       ECO:0000269|PubMed:2511192, ECO:0000269|PubMed:2794057,
CC       ECO:0000269|PubMed:7691343, ECO:0000269|PubMed:7881420,
CC       ECO:0000269|PubMed:8019571, ECO:0000269|PubMed:8364588,
CC       ECO:0000269|PubMed:8456809, ECO:0000269|PubMed:8669434,
CC       ECO:0000269|PubMed:8723681, ECO:0000269|PubMed:9101304}. Note=The
CC       disease is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Osteogenesis imperfecta 4 (OI4) [MIM:166220]: An autosomal
CC       dominant form of osteogenesis imperfecta, a connective tissue disorder
CC       characterized by low bone mass, bone fragility and susceptibility to
CC       fractures after minimal trauma. Disease severity ranges from very mild
CC       forms without fractures to intrauterine fractures and perinatal
CC       lethality. Extraskeletal manifestations, which affect a variable number
CC       of patients, are dentinogenesis imperfecta, hearing loss, and blue
CC       sclerae. OI4 is characterized by moderately short stature, mild to
CC       moderate scoliosis, grayish or white sclera and dentinogenesis
CC       imperfecta. {ECO:0000269|PubMed:16786509, ECO:0000269|PubMed:16879195,
CC       ECO:0000269|PubMed:1770532, ECO:0000269|PubMed:17875077,
CC       ECO:0000269|PubMed:1988452, ECO:0000269|PubMed:2745420,
CC       ECO:0000269|PubMed:7691343, ECO:0000269|PubMed:7982948,
CC       ECO:0000269|PubMed:8094076, ECO:0000269|PubMed:8339541,
CC       ECO:0000269|PubMed:9600458}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Osteoporosis (OSTEOP) [MIM:166710]: A systemic skeletal
CC       disorder characterized by decreased bone mass and deterioration of bone
CC       microarchitecture without alteration in the composition of bone. The
CC       result is fragile bones and an increased risk of fractures, even after
CC       minimal trauma. Osteoporosis is a chronic condition of multifactorial
CC       etiology and is usually clinically silent until a fracture occurs.
CC       {ECO:0000269|PubMed:8841196, ECO:0000269|PubMed:9535665}. Note=Disease
CC       susceptibility is associated with variations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Note=A chromosomal aberration involving COL1A1 is found in
CC       dermatofibrosarcoma protuberans. Translocation t(17;22)(q22;q13) with
CC       PDGF.
CC   -!- SIMILARITY: Belongs to the fibrillar collagen family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00793}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD92834.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Osteogenesis imperfecta variant database;
CC       Note=Collagen type I alpha 1 (COL1A1);
CC       URL="http://oi.gene.le.ac.uk/home.php?select_db=COL1A1";
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/COL1A1ID186.html";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Type-I collagen entry;
CC       URL="https://en.wikipedia.org/wiki/Type-I_collagen";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z74615; CAA98968.1; -; mRNA.
DR   EMBL; AF017178; AAB94054.3; -; Genomic_DNA.
DR   EMBL; AB209597; BAD92834.1; ALT_INIT; mRNA.
DR   EMBL; BC036531; AAH36531.1; -; mRNA.
DR   EMBL; M20789; AAB59373.1; -; Genomic_DNA.
DR   EMBL; M36546; AAA60150.1; -; mRNA.
DR   EMBL; X07884; CAA30731.1; -; mRNA.
DR   EMBL; X00820; CAA25394.1; -; Genomic_DNA.
DR   EMBL; J02829; AAA51993.1; -; Genomic_DNA.
DR   EMBL; M10627; AAA51992.1; -; Genomic_DNA.
DR   EMBL; J03559; AAA52052.1; -; Genomic_DNA.
DR   EMBL; K01228; AAA51995.1; -; mRNA.
DR   EMBL; J00110; AAA52289.1; -; mRNA.
DR   EMBL; J00111; AAA52290.1; -; mRNA.
DR   EMBL; J00112; AAA52291.1; -; mRNA.
DR   EMBL; J00113; AAN86574.1; -; mRNA.
DR   EMBL; K03179; AAA51847.1; -; Genomic_DNA.
DR   EMBL; M11162; AAA75386.1; -; Genomic_DNA.
DR   EMBL; L47667; AAB59576.1; -; Genomic_DNA.
DR   EMBL; S64596; AAB27856.1; -; mRNA.
DR   EMBL; M23213; AAB59363.1; -; Genomic_DNA.
DR   EMBL; X06269; CAA29605.1; -; mRNA.
DR   EMBL; M32798; AAA52049.1; -; mRNA.
DR   EMBL; M55998; AAA52036.1; -; Genomic_DNA.
DR   CCDS; CCDS11561.1; -.
DR   PIR; I60114; CGHU1S.
DR   RefSeq; NP_000079.2; NM_000088.3.
DR   PDB; 1Q7D; X-ray; 1.80 A; A/B/C=680-685.
DR   PDB; 2LLP; NMR; -; A/B/C=949-965.
DR   PDB; 3EJH; X-ray; 2.10 A; E/F=956-977.
DR   PDB; 3GXE; X-ray; 2.60 A; E/F=254-275.
DR   PDB; 5CTD; X-ray; 1.60 A; A=572-583, C=554-583.
DR   PDB; 5CTI; X-ray; 1.90 A; A=572-583, C=565-583, C=893-904.
DR   PDB; 5CVA; X-ray; 2.10 A; B/C/E/F=554-583, B/E=593-629.
DR   PDB; 5CVB; X-ray; 2.25 A; A/D=572-583, B/C/E/F=554-583, B/E=593-606.
DR   PDB; 5K31; X-ray; 2.20 A; A/B/C/D/E/F=1219-1464.
DR   PDB; 5OU8; X-ray; 2.50 A; C/D/E=1178-1192.
DR   PDB; 5OU9; X-ray; 2.50 A; C/D/E=1172-1192.
DR   PDBsum; 1Q7D; -.
DR   PDBsum; 2LLP; -.
DR   PDBsum; 3EJH; -.
DR   PDBsum; 3GXE; -.
DR   PDBsum; 5CTD; -.
DR   PDBsum; 5CTI; -.
DR   PDBsum; 5CVA; -.
DR   PDBsum; 5CVB; -.
DR   PDBsum; 5K31; -.
DR   PDBsum; 5OU8; -.
DR   PDBsum; 5OU9; -.
DR   SMR; P02452; -.
DR   BioGrid; 107674; 57.
DR   ComplexPortal; CPX-1650; Collagen type I trimer.
DR   ComplexPortal; CPX-4108; Collagen type I homotrimer.
DR   CORUM; P02452; -.
DR   DIP; DIP-36077N; -.
DR   IntAct; P02452; 35.
DR   MINT; P02452; -.
DR   STRING; 9606.ENSP00000225964; -.
DR   ChEMBL; CHEMBL2364188; -.
DR   DrugBank; DB11338; Clove oil.
DR   DrugBank; DB00048; Collagenase clostridium histolyticum.
DR   DrugBank; DB04866; Halofuginone.
DR   DrugBank; DB13133; Von Willebrand Factor Human.
DR   DrugBank; DB12872; Vonicog Alfa.
DR   GlyConnect; 1125; -.
DR   iPTMnet; P02452; -.
DR   MetOSite; P02452; -.
DR   PhosphoSitePlus; P02452; -.
DR   BioMuta; COL1A1; -.
DR   DMDM; 296439504; -.
DR   DOSAC-COBS-2DPAGE; P02452; -.
DR   EPD; P02452; -.
DR   jPOST; P02452; -.
DR   MassIVE; P02452; -.
DR   MaxQB; P02452; -.
DR   PaxDb; P02452; -.
DR   PeptideAtlas; P02452; -.
DR   PRIDE; P02452; -.
DR   ProteomicsDB; 51518; -.
DR   Antibodypedia; 1980; 868 antibodies.
DR   DNASU; 1277; -.
DR   Ensembl; ENST00000225964; ENSP00000225964; ENSG00000108821.
DR   GeneID; 1277; -.
DR   KEGG; hsa:1277; -.
DR   UCSC; uc002iqm.4; human.
DR   CTD; 1277; -.
DR   DisGeNET; 1277; -.
DR   GeneCards; COL1A1; -.
DR   GeneReviews; COL1A1; -.
DR   HGNC; HGNC:2197; COL1A1.
DR   HPA; ENSG00000108821; Tissue enhanced (enhanced).
DR   MalaCards; COL1A1; -.
DR   MIM; 114000; phenotype.
DR   MIM; 120150; gene.
DR   MIM; 130000; phenotype.
DR   MIM; 130060; phenotype.
DR   MIM; 166200; phenotype.
DR   MIM; 166210; phenotype.
DR   MIM; 166220; phenotype.
DR   MIM; 166710; phenotype.
DR   MIM; 259420; phenotype.
DR   MIM; 607907; phenotype.
DR   neXtProt; NX_P02452; -.
DR   Orphanet; 1899; Arthrochalasia Ehlers-Danlos syndrome.
DR   Orphanet; 1310; Caffey disease.
DR   Orphanet; 287; Classical Ehlers-Danlos syndrome.
DR   Orphanet; 31112; Dermatofibrosarcoma protuberans.
DR   Orphanet; 230857; Ehlers-Danlos/osteogenesis imperfecta syndrome.
DR   Orphanet; 314029; High bone mass osteogenesis imperfecta.
DR   Orphanet; 216796; Osteogenesis imperfecta type 1.
DR   Orphanet; 216804; Osteogenesis imperfecta type 2.
DR   Orphanet; 216812; Osteogenesis imperfecta type 3.
DR   Orphanet; 216820; Osteogenesis imperfecta type 4.
DR   PharmGKB; PA35041; -.
DR   eggNOG; KOG3544; Eukaryota.
DR   eggNOG; ENOG410XNMM; LUCA.
DR   HOGENOM; CLU_001074_2_3_1; -.
DR   InParanoid; P02452; -.
DR   KO; K06236; -.
DR   OrthoDB; 337699at2759; -.
DR   PhylomeDB; P02452; -.
DR   TreeFam; TF344135; -.
DR   Reactome; R-HSA-114604; GPVI-mediated activation cascade.
DR   Reactome; R-HSA-1442490; Collagen degradation.
DR   Reactome; R-HSA-1474244; Extracellular matrix organization.
DR   Reactome; R-HSA-1650814; Collagen biosynthesis and modifying enzymes.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-HSA-2022090; Assembly of collagen fibrils and other multimeric structures.
DR   Reactome; R-HSA-202733; Cell surface interactions at the vascular wall.
DR   Reactome; R-HSA-216083; Integrin cell surface interactions.
DR   Reactome; R-HSA-2214320; Anchoring fibril formation.
DR   Reactome; R-HSA-2243919; Crosslinking of collagen fibrils.
DR   Reactome; R-HSA-3000170; Syndecan interactions.
DR   Reactome; R-HSA-3000171; Non-integrin membrane-ECM interactions.
DR   Reactome; R-HSA-3000178; ECM proteoglycans.
DR   Reactome; R-HSA-3000480; Scavenging by Class A Receptors.
DR   Reactome; R-HSA-430116; GP1b-IX-V activation signalling.
DR   Reactome; R-HSA-75892; Platelet Adhesion to exposed collagen.
DR   Reactome; R-HSA-76009; Platelet Aggregation (Plug Formation).
DR   Reactome; R-HSA-8874081; MET activates PTK2 signaling.
DR   Reactome; R-HSA-8940973; RUNX2 regulates osteoblast differentiation.
DR   Reactome; R-HSA-8948216; Collagen chain trimerization.
DR   SIGNOR; P02452; -.
DR   ChiTaRS; COL1A1; human.
DR   EvolutionaryTrace; P02452; -.
DR   GeneWiki; Collagen,_type_I,_alpha_1; -.
DR   GenomeRNAi; 1277; -.
DR   Pharos; P02452; Tbio.
DR   PRO; PR:P02452; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; P02452; protein.
DR   Bgee; ENSG00000108821; Expressed in spinal cord and 227 other tissues.
DR   ExpressionAtlas; P02452; baseline and differential.
DR   Genevisible; P02452; HS.
DR   GO; GO:0005584; C:collagen type I trimer; IDA:CAFA.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; HDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0031012; C:extracellular matrix; IBA:GO_Central.
DR   GO; GO:0005576; C:extracellular region; HDA:BHF-UCL.
DR   GO; GO:0005615; C:extracellular space; IMP:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:Ensembl.
DR   GO; GO:0030141; C:secretory granule; IEA:Ensembl.
DR   GO; GO:0005201; F:extracellular matrix structural constituent; IBA:GO_Central.
DR   GO; GO:0030020; F:extracellular matrix structural constituent conferring tensile strength; HDA:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0048407; F:platelet-derived growth factor binding; IDA:MGI.
DR   GO; GO:0002020; F:protease binding; IPI:CAFA.
DR   GO; GO:0007596; P:blood coagulation; TAS:Reactome.
DR   GO; GO:0001568; P:blood vessel development; IMP:UniProtKB.
DR   GO; GO:0060346; P:bone trabecula formation; IEA:Ensembl.
DR   GO; GO:0060351; P:cartilage development involved in endochondral bone morphogenesis; IEA:Ensembl.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; IEA:Ensembl.
DR   GO; GO:0071364; P:cellular response to epidermal growth factor stimulus; IEA:Ensembl.
DR   GO; GO:0044344; P:cellular response to fibroblast growth factor stimulus; IEA:Ensembl.
DR   GO; GO:1902618; P:cellular response to fluoride; IEA:Ensembl.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; IEA:Ensembl.
DR   GO; GO:0071300; P:cellular response to retinoic acid; IEA:Ensembl.
DR   GO; GO:0071560; P:cellular response to transforming growth factor beta stimulus; IEA:Ensembl.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; IEA:Ensembl.
DR   GO; GO:0071306; P:cellular response to vitamin E; IEA:Ensembl.
DR   GO; GO:0032964; P:collagen biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0030199; P:collagen fibril organization; IMP:UniProtKB.
DR   GO; GO:0038063; P:collagen-activated tyrosine kinase receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0048706; P:embryonic skeletal system development; IMP:UniProtKB.
DR   GO; GO:0001958; P:endochondral ossification; IEA:Ensembl.
DR   GO; GO:0030198; P:extracellular matrix organization; IBA:GO_Central.
DR   GO; GO:0060325; P:face morphogenesis; IEA:Ensembl.
DR   GO; GO:0001957; P:intramembranous ossification; IEA:Ensembl.
DR   GO; GO:0050900; P:leukocyte migration; TAS:Reactome.
DR   GO; GO:0010812; P:negative regulation of cell-substrate adhesion; IEA:Ensembl.
DR   GO; GO:0001503; P:ossification; IBA:GO_Central.
DR   GO; GO:0001649; P:osteoblast differentiation; IEA:Ensembl.
DR   GO; GO:0030168; P:platelet activation; TAS:Reactome.
DR   GO; GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IDA:UniProtKB.
DR   GO; GO:0030335; P:positive regulation of cell migration; IDA:UniProtKB.
DR   GO; GO:0010718; P:positive regulation of epithelial to mesenchymal transition; IDA:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0034504; P:protein localization to nucleus; IDA:UniProtKB.
DR   GO; GO:0015031; P:protein transport; IEA:Ensembl.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0051591; P:response to cAMP; IEA:Ensembl.
DR   GO; GO:0031960; P:response to corticosteroid; IEA:Ensembl.
DR   GO; GO:0032355; P:response to estradiol; IEA:Ensembl.
DR   GO; GO:0042542; P:response to hydrogen peroxide; IEA:Ensembl.
DR   GO; GO:0055093; P:response to hyperoxia; IEA:Ensembl.
DR   GO; GO:0009612; P:response to mechanical stimulus; IBA:GO_Central.
DR   GO; GO:0043434; P:response to peptide hormone; IEA:Ensembl.
DR   GO; GO:0007605; P:sensory perception of sound; IMP:UniProtKB.
DR   GO; GO:0001501; P:skeletal system development; IMP:UniProtKB.
DR   GO; GO:0043588; P:skin development; IBA:GO_Central.
DR   GO; GO:0043589; P:skin morphogenesis; IMP:UniProtKB.
DR   GO; GO:0044691; P:tooth eruption; IEA:Ensembl.
DR   GO; GO:0034505; P:tooth mineralization; IMP:UniProtKB.
DR   GO; GO:0007601; P:visual perception; IMP:UniProtKB.
DR   InterPro; IPR008160; Collagen.
DR   InterPro; IPR000885; Fib_collagen_C.
DR   InterPro; IPR001007; VWF_dom.
DR   Pfam; PF01410; COLFI; 1.
DR   Pfam; PF01391; Collagen; 11.
DR   Pfam; PF00093; VWC; 1.
DR   SMART; SM00038; COLFI; 1.
DR   SMART; SM00214; VWC; 1.
DR   PROSITE; PS51461; NC1_FIB; 1.
DR   PROSITE; PS01208; VWFC_1; 1.
DR   PROSITE; PS50184; VWFC_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Chromosomal rearrangement; Collagen;
KW   Direct protein sequencing; Disease mutation; Disulfide bond; Dwarfism;
KW   Ehlers-Danlos syndrome; Extracellular matrix; Glycoprotein; Hydroxylation;
KW   Metal-binding; Osteogenesis imperfecta; Phosphoprotein; Polymorphism;
KW   Pyrrolidone carboxylic acid; Reference proteome; Repeat; Secreted; Signal.
FT   SIGNAL          1..22
FT   PROPEP          23..161
FT                   /note="N-terminal propeptide"
FT                   /evidence="ECO:0000269|PubMed:5529814"
FT                   /id="PRO_0000005719"
FT   CHAIN           162..1218
FT                   /note="Collagen alpha-1(I) chain"
FT                   /id="PRO_0000005720"
FT   PROPEP          1219..1464
FT                   /note="C-terminal propeptide"
FT                   /id="PRO_0000005721"
FT   DOMAIN          38..96
FT                   /note="VWFC"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00220"
FT   DOMAIN          1229..1464
FT                   /note="Fibrillar collagen NC1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00793"
FT   REGION          162..178
FT                   /note="Nonhelical region (N-terminal)"
FT   REGION          179..1192
FT                   /note="Triple-helical region"
FT   REGION          1193..1218
FT                   /note="Nonhelical region (C-terminal)"
FT   MOTIF           745..747
FT                   /note="Cell attachment site"
FT                   /evidence="ECO:0000255"
FT   MOTIF           1093..1095
FT                   /note="Cell attachment site"
FT                   /evidence="ECO:0000255"
FT   METAL           1277
FT                   /note="Calcium"
FT                   /evidence="ECO:0000250"
FT   METAL           1279
FT                   /note="Calcium"
FT                   /evidence="ECO:0000250"
FT   METAL           1280
FT                   /note="Calcium; via carbonyl oxygen"
FT                   /evidence="ECO:0000250"
FT   METAL           1282
FT                   /note="Calcium; via carbonyl oxygen"
FT                   /evidence="ECO:0000250"
FT   METAL           1285
FT                   /note="Calcium"
FT                   /evidence="ECO:0000250"
FT   SITE            161..162
FT                   /note="Cleavage; by procollagen N-endopeptidase"
FT   SITE            953..954
FT                   /note="Cleavage; by collagenase"
FT                   /evidence="ECO:0000250"
FT   SITE            1218..1219
FT                   /note="Cleavage; by procollagen C-endopeptidase"
FT   MOD_RES         162
FT                   /note="Pyrrolidone carboxylic acid"
FT                   /evidence="ECO:0000269|PubMed:5529814"
FT   MOD_RES         170
FT                   /note="Allysine"
FT                   /evidence="ECO:0000269|PubMed:5529814"
FT   MOD_RES         171
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P02454"
FT   MOD_RES         190
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         193
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         196
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         205
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         208
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         211
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         226
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         241
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         247
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         256
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         262
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         265
FT                   /note="5-hydroxylysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:4319110"
FT   MOD_RES         271
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P02454"
FT   MOD_RES         289
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         292
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         298
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         307
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         313
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         334
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         343
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         346
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         373
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         376
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         388
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         394
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         403
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         409
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         412
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         427
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         430
FT                   /note="5-hydroxylysine"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         436
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         439
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         451
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         460
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         475
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         481
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         490
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         496
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         505
FT                   /note="5-hydroxylysine"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         514
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         523
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         529
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         535
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         544
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         547
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         556
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         565
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         571
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         583
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         592
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         601
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         604
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         622
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         640
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         646
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         652
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         658
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         664
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         670
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         682
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         691
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         703
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         715
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         718
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         724
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         730
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         739
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         751
FT                   /note="5-hydroxylysine"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         757
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         772
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         778
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         787
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P02454"
FT   MOD_RES         799
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         805
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         808
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         817
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         823
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         841
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         850
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         859
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         862
FT                   /note="5-hydroxylysine"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         871
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         877
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         885
FT                   /note="3-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P11087"
FT   MOD_RES         886
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P11087"
FT   MOD_RES         895
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P11087"
FT   MOD_RES         898
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P11087"
FT   MOD_RES         919
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         928
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         937
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         946
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         964
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         973
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         976
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         982
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         997
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         1003
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         1009
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         1018
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         1024
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         1033
FT                   /note="5-hydroxylysine"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         1045
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         1048
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         1051
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         1096
FT                   /note="5-hydroxylysine"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         1108
FT                   /note="5-hydroxylysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         1120
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         1123
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         1126
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         1144
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         1159
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P11087"
FT   MOD_RES         1164
FT                   /note="3-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P11087"
FT   MOD_RES         1165
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P11087"
FT   MOD_RES         1179
FT                   /note="3-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P11087"
FT   MOD_RES         1180
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P11087"
FT   MOD_RES         1182
FT                   /note="3-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P11087"
FT   MOD_RES         1183
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P11087"
FT   MOD_RES         1185
FT                   /note="3-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P11087"
FT   MOD_RES         1186
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P11087"
FT   MOD_RES         1189
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P11087"
FT   MOD_RES         1192
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P11087"
FT   MOD_RES         1208
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P02453"
FT   CARBOHYD        265
FT                   /note="O-linked (Gal...) hydroxylysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:4319110"
FT   CARBOHYD        1108
FT                   /note="O-linked (Gal...) hydroxylysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   CARBOHYD        1365
FT                   /note="N-linked (GlcNAc...) asparagine"
FT   DISULFID        1259..1291
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00793"
FT   DISULFID        1265
FT                   /note="Interchain"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00793"
FT   DISULFID        1282
FT                   /note="Interchain"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00793"
FT   DISULFID        1299..1462
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00793"
FT   DISULFID        1370..1415
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00793"
FT   VARIANT         22
FT                   /note="G -> R (in OI2; dbSNP:rs72667007)"
FT                   /evidence="ECO:0000269|PubMed:16786509"
FT                   /id="VAR_063290"
FT   VARIANT         146
FT                   /note="P -> T (in OI2; rare variant; unknown pathological
FT                   significance; dbSNP:rs756846639)"
FT                   /evidence="ECO:0000269|PubMed:18996919"
FT                   /id="VAR_063291"
FT   VARIANT         194
FT                   /note="G -> R (in OI1; dbSNP:rs72667024)"
FT                   /evidence="ECO:0000269|PubMed:16705691"
FT                   /id="VAR_063292"
FT   VARIANT         197
FT                   /note="G -> C (in dbSNP:rs8179178)"
FT                   /id="VAR_001642"
FT   VARIANT         197
FT                   /note="G -> R (in OI4)"
FT                   /evidence="ECO:0000269|PubMed:16786509"
FT                   /id="VAR_063293"
FT   VARIANT         200
FT                   /note="G -> V (in OI1; patient diagnosed with OI1/OI4;
FT                   dbSNP:rs72667029)"
FT                   /evidence="ECO:0000269|PubMed:18670065"
FT                   /id="VAR_063294"
FT   VARIANT         203
FT                   /note="G -> V (in OI3; dbSNP:rs72667031)"
FT                   /evidence="ECO:0000269|PubMed:16879195"
FT                   /id="VAR_063295"
FT   VARIANT         205
FT                   /note="P -> A (in dbSNP:rs72667032)"
FT                   /evidence="ECO:0000269|PubMed:16786509"
FT                   /id="VAR_001643"
FT   VARIANT         221
FT                   /note="G -> C (in OI1; mild form; dbSNP:rs72667037)"
FT                   /evidence="ECO:0000269|PubMed:1737847"
FT                   /id="VAR_001644"
FT   VARIANT         224
FT                   /note="G -> C (in OI1; mild phenotype; dbSNP:rs72667038)"
FT                   /id="VAR_001645"
FT   VARIANT         242
FT                   /note="G -> D (in OI; dbSNP:rs72645315)"
FT                   /evidence="ECO:0000269|PubMed:16705691"
FT                   /id="VAR_063296"
FT   VARIANT         257
FT                   /note="G -> R (in OI4; dbSNP:rs72645321)"
FT                   /evidence="ECO:0000269|PubMed:16705691,
FT                   ECO:0000269|PubMed:16879195"
FT                   /id="VAR_063297"
FT   VARIANT         263
FT                   /note="G -> R (in OI1; mild form; dbSNP:rs72645323)"
FT                   /evidence="ECO:0000269|PubMed:1718984"
FT                   /id="VAR_001646"
FT   VARIANT         263
FT                   /note="G -> V (in OI1; mild form; dbSNP:rs72645324)"
FT                   /evidence="ECO:0000269|PubMed:8223589"
FT                   /id="VAR_001647"
FT   VARIANT         266
FT                   /note="G -> E (in OI1; dbSNP:rs72645325)"
FT                   /evidence="ECO:0000269|PubMed:17875077"
FT                   /id="VAR_063298"
FT   VARIANT         272
FT                   /note="G -> C (in OI1; dbSNP:rs72645331)"
FT                   /evidence="ECO:0000269|PubMed:2794057"
FT                   /id="VAR_001648"
FT   VARIANT         275
FT                   /note="G -> D (in OI2; dbSNP:rs72645333)"
FT                   /id="VAR_001649"
FT   VARIANT         287
FT                   /note="G -> S (in OI1; dbSNP:rs72645340)"
FT                   /evidence="ECO:0000269|PubMed:17875077"
FT                   /id="VAR_063299"
FT   VARIANT         288
FT                   /note="E -> K (in OI1; the patient also has mutation Glu-
FT                   1219; unknown pathological significance; dbSNP:rs72645341)"
FT                   /evidence="ECO:0000269|PubMed:16786509"
FT                   /id="VAR_063300"
FT   VARIANT         288
FT                   /note="E -> V (in OI2; rare variant; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:18996919"
FT                   /id="VAR_063301"
FT   VARIANT         312
FT                   /note="R -> C (in EDSCL1; dbSNP:rs72645347)"
FT                   /evidence="ECO:0000269|PubMed:10739762,
FT                   ECO:0000269|PubMed:17211858"
FT                   /id="VAR_013579"
FT   VARIANT         320
FT                   /note="G -> V (in OI1; dbSNP:rs72645353)"
FT                   /evidence="ECO:0000269|PubMed:16786509"
FT                   /id="VAR_063302"
FT   VARIANT         332
FT                   /note="G -> R (in OI3; mild to moderate form;
FT                   dbSNP:rs72645357)"
FT                   /evidence="ECO:0000269|PubMed:2037280,
FT                   ECO:0000269|PubMed:8669434"
FT                   /id="VAR_001650"
FT   VARIANT         338
FT                   /note="G -> C (in OI4)"
FT                   /evidence="ECO:0000269|PubMed:16786509"
FT                   /id="VAR_063303"
FT   VARIANT         349
FT                   /note="V -> F (in OI1; dbSNP:rs72645362)"
FT                   /evidence="ECO:0000269|PubMed:18670065"
FT                   /id="VAR_063304"
FT   VARIANT         350
FT                   /note="G -> R (in OI3; dbSNP:rs72645363)"
FT                   /evidence="ECO:0000269|PubMed:8019571"
FT                   /id="VAR_001651"
FT   VARIANT         353
FT                   /note="G -> C (in OI4; dbSNP:rs66721653)"
FT                   /evidence="ECO:0000269|PubMed:8339541"
FT                   /id="VAR_001652"
FT   VARIANT         353
FT                   /note="G -> D (in OI2)"
FT                   /evidence="ECO:0000269|PubMed:18996919"
FT                   /id="VAR_063305"
FT   VARIANT         353
FT                   /note="G -> S (in OI4; dbSNP:rs66721653)"
FT                   /evidence="ECO:0000269|PubMed:17875077"
FT                   /id="VAR_063306"
FT   VARIANT         356
FT                   /note="G -> C (in OI4; mild form; dbSNP:rs72645365)"
FT                   /evidence="ECO:0000269|PubMed:1988452"
FT                   /id="VAR_001653"
FT   VARIANT         368
FT                   /note="G -> V (in OI2)"
FT                   /evidence="ECO:0000269|PubMed:18996919"
FT                   /id="VAR_063307"
FT   VARIANT         383
FT                   /note="G -> C (in OI4; dbSNP:rs67182491)"
FT                   /id="VAR_001654"
FT   VARIANT         389
FT                   /note="G -> C (in OI; moderate form; dbSNP:rs66548636)"
FT                   /id="VAR_001655"
FT   VARIANT         389
FT                   /note="G -> R (in OI2; dbSNP:rs66548636)"
FT                   /evidence="ECO:0000269|PubMed:7520724"
FT                   /id="VAR_001656"
FT   VARIANT         390
FT                   /note="A -> T (in OI2; rare variant; unknown pathological
FT                   significance; dbSNP:rs116794104)"
FT                   /evidence="ECO:0000269|PubMed:18996919"
FT                   /id="VAR_063308"
FT   VARIANT         398
FT                   /note="G -> A (in OI4; dbSNP:rs66501246)"
FT                   /evidence="ECO:0000269|PubMed:9600458"
FT                   /id="VAR_001657"
FT   VARIANT         398
FT                   /note="G -> D (in OI2; dbSNP:rs66501246)"
FT                   /id="VAR_001658"
FT   VARIANT         401
FT                   /note="G -> C (in OI4; dbSNP:rs72648322)"
FT                   /id="VAR_001659"
FT   VARIANT         404
FT                   /note="G -> C (in OI; moderate form; dbSNP:rs66893386)"
FT                   /id="VAR_001660"
FT   VARIANT         422
FT                   /note="G -> C (in OI2; dbSNP:rs72648328)"
FT                   /evidence="ECO:0000269|Ref.49"
FT                   /id="VAR_001661"
FT   VARIANT         425
FT                   /note="G -> S (in OI2; lethal form; dbSNP:rs72648330)"
FT                   /evidence="ECO:0000269|PubMed:18996919,
FT                   ECO:0000269|PubMed:7691343"
FT                   /id="VAR_001662"
FT   VARIANT         434
FT                   /note="G -> V (in OI2; dbSNP:rs72648333)"
FT                   /evidence="ECO:0000269|PubMed:1613761,
FT                   ECO:0000269|PubMed:2470760"
FT                   /id="VAR_001663"
FT   VARIANT         455
FT                   /note="G -> D (in OI2)"
FT                   /evidence="ECO:0000269|PubMed:18996919"
FT                   /id="VAR_063309"
FT   VARIANT         470
FT                   /note="G -> V (in OI2)"
FT                   /evidence="ECO:0000269|PubMed:18996919"
FT                   /id="VAR_063310"
FT   VARIANT         476
FT                   /note="G -> R (in OI2; dbSNP:rs57377812)"
FT                   /id="VAR_001664"
FT   VARIANT         509
FT                   /note="G -> V (in OI2)"
FT                   /evidence="ECO:0000269|PubMed:18996919"
FT                   /id="VAR_063311"
FT   VARIANT         527
FT                   /note="G -> C (in OI4; dbSNP:rs72648353)"
FT                   /evidence="ECO:0000269|PubMed:9600458"
FT                   /id="VAR_001665"
FT   VARIANT         530
FT                   /note="G -> S (in OI2, OI3 and OI4; mild to lethal form;
FT                   dbSNP:rs67682641)"
FT                   /evidence="ECO:0000269|PubMed:7691343,
FT                   ECO:0000269|PubMed:8094076, ECO:0000269|PubMed:8456809"
FT                   /id="VAR_001666"
FT   VARIANT         533
FT                   /note="G -> D (in OI2; dbSNP:rs72648356)"
FT                   /id="VAR_001667"
FT   VARIANT         548
FT                   /note="G -> A (in OI2)"
FT                   /evidence="ECO:0000269|PubMed:18996919"
FT                   /id="VAR_063312"
FT   VARIANT         555
FT                   /note="P -> R (in OI1; dbSNP:rs72648359)"
FT                   /evidence="ECO:0000269|PubMed:16786509"
FT                   /id="VAR_063313"
FT   VARIANT         560
FT                   /note="G -> C (in OI4; dbSNP:rs67507747)"
FT                   /id="VAR_001669"
FT   VARIANT         560
FT                   /note="G -> R (in OI2; dbSNP:rs67507747)"
FT                   /id="VAR_001670"
FT   VARIANT         560
FT                   /note="G -> S (in OI4; dbSNP:rs67507747)"
FT                   /evidence="ECO:0000269|PubMed:7691343"
FT                   /id="VAR_001668"
FT   VARIANT         564
FT                   /note="R -> H (in dbSNP:rs1800211)"
FT                   /id="VAR_001671"
FT   VARIANT         569
FT                   /note="G -> R (in OI2; dbSNP:rs72648363)"
FT                   /evidence="ECO:0000269|PubMed:3108247"
FT                   /id="VAR_001672"
FT   VARIANT         574
FT                   /note="R -> C (found in a patient with isolated osteopenia
FT                   and vascular rupture; unknown pathological significance;
FT                   dbSNP:rs72648365)"
FT                   /evidence="ECO:0000269|PubMed:17211858"
FT                   /id="VAR_063314"
FT   VARIANT         581
FT                   /note="G -> R (in OI2; dbSNP:rs72648366)"
FT                   /evidence="ECO:0000269|PubMed:16786509"
FT                   /id="VAR_063315"
FT   VARIANT         593
FT                   /note="G -> C (in OI3 and OI4; dbSNP:rs66527965)"
FT                   /evidence="ECO:0000269|PubMed:1770532"
FT                   /id="VAR_001673"
FT   VARIANT         593
FT                   /note="G -> S (in OI2 and OI3; moderate to lethal form;
FT                   dbSNP:rs66527965)"
FT                   /evidence="ECO:0000269|PubMed:8364588"
FT                   /id="VAR_001674"
FT   VARIANT         602
FT                   /note="G -> R (in OI2; dbSNP:rs72651615)"
FT                   /evidence="ECO:0000269|PubMed:18996919"
FT                   /id="VAR_063316"
FT   VARIANT         605
FT                   /note="G -> D (in OI2)"
FT                   /evidence="ECO:0000269|PubMed:18996919"
FT                   /id="VAR_063317"
FT   VARIANT         614
FT                   /note="G -> R (in OI2)"
FT                   /evidence="ECO:0000269|PubMed:18996919"
FT                   /id="VAR_063318"
FT   VARIANT         647
FT                   /note="G -> S (in OI1; dbSNP:rs72651627)"
FT                   /evidence="ECO:0000269|PubMed:16786509"
FT                   /id="VAR_063319"
FT   VARIANT         656
FT                   /note="G -> S (in OI2; dbSNP:rs72651629)"
FT                   /evidence="ECO:0000269|PubMed:10627137"
FT                   /id="VAR_001676"
FT   VARIANT         683
FT                   /note="G -> S (in OI4; dbSNP:rs72651636)"
FT                   /evidence="ECO:0000269|PubMed:16879195"
FT                   /id="VAR_063320"
FT   VARIANT         701
FT                   /note="G -> C (in OI4; dbSNP:rs68114505)"
FT                   /evidence="ECO:0000269|PubMed:9600458"
FT                   /id="VAR_001677"
FT   VARIANT         704
FT                   /note="G -> C (in OI3; dbSNP:rs67368147)"
FT                   /evidence="ECO:0000269|PubMed:2794057"
FT                   /id="VAR_001678"
FT   VARIANT         719
FT                   /note="G -> D (in OI2; dbSNP:rs72651646)"
FT                   /evidence="ECO:0000269|PubMed:2035536"
FT                   /id="VAR_001679"
FT   VARIANT         719
FT                   /note="G -> S (in OI3; dbSNP:rs72651645)"
FT                   /evidence="ECO:0000269|PubMed:7691343"
FT                   /id="VAR_001680"
FT   VARIANT         722
FT                   /note="G -> S (in OI1; dbSNP:rs72651647)"
FT                   /evidence="ECO:0000269|PubMed:16705691"
FT                   /id="VAR_063321"
FT   VARIANT         728
FT                   /note="G -> R (in OI2; dbSNP:rs72651648)"
FT                   /evidence="ECO:0000269|PubMed:2339700"
FT                   /id="VAR_001681"
FT   VARIANT         734
FT                   /note="G -> V (in OI2; dbSNP:rs72651649)"
FT                   /evidence="ECO:0000269|PubMed:16786509"
FT                   /id="VAR_063322"
FT   VARIANT         737
FT                   /note="G -> D (in OI2; dbSNP:rs72651651)"
FT                   /id="VAR_001682"
FT   VARIANT         740
FT                   /note="G -> R (in OI2)"
FT                   /evidence="ECO:0000269|PubMed:18996919"
FT                   /id="VAR_063323"
FT   VARIANT         743
FT                   /note="G -> S (in OI2; dbSNP:rs72651652)"
FT                   /id="VAR_001683"
FT   VARIANT         743
FT                   /note="G -> V (in OI2; dbSNP:rs72651653)"
FT                   /evidence="ECO:0000269|PubMed:8100209"
FT                   /id="VAR_001684"
FT   VARIANT         764
FT                   /note="G -> V (in OI2; dbSNP:rs72651657)"
FT                   /evidence="ECO:0000269|PubMed:9143923"
FT                   /id="VAR_001685"
FT   VARIANT         767
FT                   /note="G -> S (in OI3; severe; dbSNP:rs72651658)"
FT                   /evidence="ECO:0000269|PubMed:16705691,
FT                   ECO:0000269|PubMed:7881420"
FT                   /id="VAR_001686"
FT   VARIANT         773
FT                   /note="G -> C (in OI2; de novo mutation)"
FT                   /evidence="ECO:0000269|PubMed:25958000"
FT                   /id="VAR_074158"
FT   VARIANT         776
FT                   /note="G -> S (in OI2; dbSNP:rs72651660)"
FT                   /evidence="ECO:0000269|PubMed:2116413"
FT                   /id="VAR_001687"
FT   VARIANT         809
FT                   /note="G -> S (in OI2; dbSNP:rs72651663)"
FT                   /evidence="ECO:0000269|PubMed:18996919,
FT                   ECO:0000269|PubMed:2116413"
FT                   /id="VAR_001688"
FT   VARIANT         815
FT                   /note="G -> V (in OI2; dbSNP:rs66929517)"
FT                   /evidence="ECO:0000269|PubMed:1874719"
FT                   /id="VAR_001689"
FT   VARIANT         821
FT                   /note="G -> S (in OI3; dbSNP:rs67693970)"
FT                   /evidence="ECO:0000269|PubMed:16705691,
FT                   ECO:0000269|PubMed:16879195, ECO:0000269|PubMed:9101304"
FT                   /id="VAR_001690"
FT   VARIANT         823
FT                   /note="P -> A (in dbSNP:rs1800214)"
FT                   /evidence="ECO:0000269|PubMed:7691343"
FT                   /id="VAR_001691"
FT   VARIANT         824
FT                   /note="G -> R (in OI2)"
FT                   /evidence="ECO:0000269|PubMed:18996919"
FT                   /id="VAR_063324"
FT   VARIANT         833
FT                   /note="G -> D (in OI2; dbSNP:rs67067133)"
FT                   /evidence="ECO:0000269|PubMed:16566045"
FT                   /id="VAR_063325"
FT   VARIANT         839
FT                   /note="G -> S (in OI2; mild to moderate form;
FT                   dbSNP:rs72653131)"
FT                   /evidence="ECO:0000269|PubMed:8786074"
FT                   /id="VAR_001692"
FT   VARIANT         842
FT                   /note="G -> R (in OI2; dbSNP:rs72653134)"
FT                   /evidence="ECO:0000269|PubMed:3403550"
FT                   /id="VAR_001693"
FT   VARIANT         845
FT                   /note="G -> R (in OI2; dbSNP:rs72653136)"
FT                   /evidence="ECO:0000269|PubMed:18996919"
FT                   /id="VAR_001694"
FT   VARIANT         848
FT                   /note="G -> R (in OI2)"
FT                   /evidence="ECO:0000269|PubMed:18996919"
FT                   /id="VAR_063342"
FT   VARIANT         851
FT                   /note="G -> D (in OI2; dbSNP:rs72653137)"
FT                   /id="VAR_001695"
FT   VARIANT         855
FT                   /note="N -> H (in OI2; rare variant; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:18996919"
FT                   /id="VAR_063326"
FT   VARIANT         866
FT                   /note="G -> S (in OI3 and OI2; dbSNP:rs67445413)"
FT                   /evidence="ECO:0000269|PubMed:10408781,
FT                   ECO:0000269|PubMed:18670065, ECO:0000269|PubMed:18996919"
FT                   /id="VAR_008118"
FT   VARIANT         869
FT                   /note="G -> C (in OI2; dbSNP:rs72653143)"
FT                   /evidence="ECO:0000269|PubMed:1953667"
FT                   /id="VAR_001696"
FT   VARIANT         875
FT                   /note="G -> S (in OI2; dbSNP:rs72653145)"
FT                   /evidence="ECO:0000269|PubMed:18996919"
FT                   /id="VAR_063327"
FT   VARIANT         884
FT                   /note="G -> S (in OI2 and OI3; extremely severe form)"
FT                   /evidence="ECO:0000269|PubMed:18996919"
FT                   /id="VAR_001697"
FT   VARIANT         896
FT                   /note="G -> C (in OI2; dbSNP:rs72653152)"
FT                   /evidence="ECO:0000269|PubMed:2794057"
FT                   /id="VAR_001698"
FT   VARIANT         896
FT                   /note="G -> D (in OI2)"
FT                   /evidence="ECO:0000269|PubMed:18996919"
FT                   /id="VAR_063328"
FT   VARIANT         906
FT                   /note="G -> S (found in a patient with mild osteogenesis
FT                   imperfecta; uncertain pathological significance;
FT                   dbSNP:rs145446512)"
FT                   /evidence="ECO:0000269|PubMed:16786509"
FT                   /id="VAR_063329"
FT   VARIANT         926
FT                   /note="G -> C (in OI2; dbSNP:rs72653154)"
FT                   /evidence="ECO:0000269|PubMed:2036375,
FT                   ECO:0000269|PubMed:3667599"
FT                   /id="VAR_001699"
FT   VARIANT         947
FT                   /note="G -> C (in OI2; dbSNP:rs72653159)"
FT                   /evidence="ECO:0000269|PubMed:18996919"
FT                   /id="VAR_063330"
FT   VARIANT         977
FT                   /note="G -> D (in OI2)"
FT                   /evidence="ECO:0000269|PubMed:18996919"
FT                   /id="VAR_063331"
FT   VARIANT         980
FT                   /note="G -> V (in OI2; dbSNP:rs72653166)"
FT                   /evidence="ECO:0000269|PubMed:1511982"
FT                   /id="VAR_001700"
FT   VARIANT         1001
FT                   /note="G -> C (in OI2; dbSNP:rs72653167)"
FT                   /evidence="ECO:0000269|PubMed:18996919"
FT                   /id="VAR_063332"
FT   VARIANT         1010
FT                   /note="G -> S (in OI4; dbSNP:rs72653169)"
FT                   /evidence="ECO:0000269|PubMed:2745420"
FT                   /id="VAR_001701"
FT   VARIANT         1014
FT                   /note="R -> C (in CAFFD; dbSNP:rs72653170)"
FT                   /evidence="ECO:0000269|PubMed:15864348"
FT                   /id="VAR_033097"
FT   VARIANT         1019
FT                   /note="G -> A (in dbSNP:rs1135348)"
FT                   /evidence="ECO:0000269|PubMed:6689127, ECO:0000269|Ref.1"
FT                   /id="VAR_030013"
FT   VARIANT         1022
FT                   /note="G -> S (in OI3; severe form; dbSNP:rs66523073)"
FT                   /evidence="ECO:0000269|PubMed:2511192"
FT                   /id="VAR_001702"
FT   VARIANT         1022
FT                   /note="G -> V (in OI2; dbSNP:rs67771061)"
FT                   /evidence="ECO:0000269|PubMed:18996919"
FT                   /id="VAR_001703"
FT   VARIANT         1025
FT                   /note="G -> R (in OI2; dbSNP:rs72653172)"
FT                   /evidence="ECO:0000269|PubMed:2211725"
FT                   /id="VAR_001704"
FT   VARIANT         1040
FT                   /note="G -> S (in OI2 and OI3; moderate to lethal form;
FT                   dbSNP:rs72653178)"
FT                   /evidence="ECO:0000269|PubMed:18670065,
FT                   ECO:0000269|PubMed:9101304"
FT                   /id="VAR_001705"
FT   VARIANT         1043
FT                   /note="G -> S (in OI2)"
FT                   /id="VAR_001706"
FT   VARIANT         1046..1048
FT                   /note="Missing (in OI2)"
FT                   /evidence="ECO:0000269|PubMed:1460047,
FT                   ECO:0000269|PubMed:1939261"
FT                   /id="VAR_001707"
FT   VARIANT         1049
FT                   /note="G -> S (in OI3; dbSNP:rs67641695)"
FT                   /evidence="ECO:0000269|PubMed:9101304"
FT                   /id="VAR_001708"
FT   VARIANT         1052
FT                   /note="G -> GAPG (in OI2)"
FT                   /id="VAR_063333"
FT   VARIANT         1055
FT                   /note="G -> D (in OI2)"
FT                   /evidence="ECO:0000269|PubMed:18996919"
FT                   /id="VAR_063334"
FT   VARIANT         1058
FT                   /note="G -> S (in OI3 and OI4; mild form;
FT                   dbSNP:rs72654795)"
FT                   /evidence="ECO:0000269|PubMed:16705691,
FT                   ECO:0000269|PubMed:9101304"
FT                   /id="VAR_001709"
FT   VARIANT         1061
FT                   /note="G -> D (in OI2; dbSNP:rs72654797)"
FT                   /id="VAR_001710"
FT   VARIANT         1061
FT                   /note="G -> S (in OI4; dbSNP:rs72654796)"
FT                   /evidence="ECO:0000269|PubMed:7982948"
FT                   /id="VAR_001711"
FT   VARIANT         1066
FT                   /note="R -> C (probable disease-associated mutation found
FT                   in a patient with overlapping features of osteogenesis
FT                   imperfecta and Ehlers-Danlos syndrome; affects dimer
FT                   formation, helix stability and organization of collagen
FT                   fibrils; dbSNP:rs72654799)"
FT                   /evidence="ECO:0000269|PubMed:17206620"
FT                   /id="VAR_063335"
FT   VARIANT         1075
FT                   /note="T -> A (in dbSNP:rs1800215)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:18272325, ECO:0000269|PubMed:1870989,
FT                   ECO:0000269|PubMed:18996919, ECO:0000269|PubMed:1995349,
FT                   ECO:0000269|PubMed:6689127, ECO:0000269|PubMed:9443882,
FT                   ECO:0000269|Ref.1, ECO:0000269|Ref.24, ECO:0000269|Ref.4"
FT                   /id="VAR_001712"
FT   VARIANT         1076
FT                   /note="G -> S (in OI3; severe form; dbSNP:rs67394386)"
FT                   /evidence="ECO:0000269|PubMed:9101304"
FT                   /id="VAR_001713"
FT   VARIANT         1079
FT                   /note="G -> S (in OI1 and OI2; mild to moderate form;
FT                   dbSNP:rs72654802)"
FT                   /evidence="ECO:0000269|PubMed:1634225"
FT                   /id="VAR_001714"
FT   VARIANT         1082
FT                   /note="G -> C (in OI2; dbSNP:rs72656303)"
FT                   /evidence="ECO:0000269|PubMed:2913053"
FT                   /id="VAR_001715"
FT   VARIANT         1088
FT                   /note="G -> A (in OI2; dbSNP:rs72656305)"
FT                   /evidence="ECO:0000269|PubMed:7679635"
FT                   /id="VAR_001716"
FT   VARIANT         1088
FT                   /note="G -> E (in OI1; de novo mutation; unknown
FT                   pathological significance)"
FT                   /evidence="ECO:0000269|PubMed:24682174"
FT                   /id="VAR_074159"
FT   VARIANT         1091
FT                   /note="G -> S (in OI2; dbSNP:rs72656306)"
FT                   /evidence="ECO:0000269|Ref.52"
FT                   /id="VAR_001717"
FT   VARIANT         1093
FT                   /note="R -> C (found in a patient with isolated osteopenia
FT                   and vascular rupture; unknown pathological significance;
FT                   dbSNP:rs72656307)"
FT                   /evidence="ECO:0000269|PubMed:17211858"
FT                   /id="VAR_063336"
FT   VARIANT         1094
FT                   /note="G -> S (in OI2)"
FT                   /evidence="ECO:0000269|PubMed:18996919"
FT                   /id="VAR_063337"
FT   VARIANT         1100
FT                   /note="G -> D (in OI2; dbSNP:rs72656308)"
FT                   /evidence="ECO:0000269|PubMed:18996919"
FT                   /id="VAR_001718"
FT   VARIANT         1106
FT                   /note="G -> A (in OI2; dbSNP:rs72656311)"
FT                   /evidence="ECO:0000269|PubMed:2777764"
FT                   /id="VAR_001719"
FT   VARIANT         1124
FT                   /note="G -> C (in OI2; dbSNP:rs72656312)"
FT                   /evidence="ECO:0000269|PubMed:7961597"
FT                   /id="VAR_001720"
FT   VARIANT         1141
FT                   /note="R -> Q (in dbSNP:rs41316713)"
FT                   /evidence="ECO:0000269|PubMed:18272325"
FT                   /id="VAR_033778"
FT   VARIANT         1142
FT                   /note="G -> S (in OI2; dbSNP:rs72656317)"
FT                   /id="VAR_001721"
FT   VARIANT         1151
FT                   /note="G -> S (in OI3; dbSNP:rs72656320)"
FT                   /id="VAR_001722"
FT   VARIANT         1151
FT                   /note="G -> V (in OI2; dbSNP:rs72656321)"
FT                   /evidence="ECO:0000269|PubMed:1613761,
FT                   ECO:0000269|PubMed:2777764"
FT                   /id="VAR_001723"
FT   VARIANT         1154
FT                   /note="G -> R (in OI2; dbSNP:rs72656322)"
FT                   /evidence="ECO:0000269|PubMed:2777764"
FT                   /id="VAR_001724"
FT   VARIANT         1157
FT                   /note="G -> D (in OI1; dbSNP:rs72656323)"
FT                   /evidence="ECO:0000269|PubMed:16638323"
FT                   /id="VAR_063338"
FT   VARIANT         1166
FT                   /note="G -> C (in OI2; dbSNP:rs72656324)"
FT                   /evidence="ECO:0000269|PubMed:3016737"
FT                   /id="VAR_001725"
FT   VARIANT         1172
FT                   /note="G -> D (in OI2; dbSNP:rs72656325)"
FT                   /evidence="ECO:0000269|PubMed:10627137"
FT                   /id="VAR_001726"
FT   VARIANT         1177
FT                   /note="V -> I (in dbSNP:rs41316719)"
FT                   /evidence="ECO:0000269|PubMed:18272325"
FT                   /id="VAR_033779"
FT   VARIANT         1181
FT                   /note="G -> S (in OI2; dbSNP:rs72656330)"
FT                   /evidence="ECO:0000269|PubMed:2037280, ECO:0000269|Ref.52"
FT                   /id="VAR_001727"
FT   VARIANT         1184
FT                   /note="G -> V (in OI2; dbSNP:rs72656331)"
FT                   /evidence="ECO:0000269|PubMed:1613761,
FT                   ECO:0000269|PubMed:2777764"
FT                   /id="VAR_001728"
FT   VARIANT         1187
FT                   /note="G -> S (in OI2 and OI3; extremely severe form;
FT                   dbSNP:rs72656332)"
FT                   /evidence="ECO:0000269|Ref.52"
FT                   /id="VAR_001729"
FT   VARIANT         1187
FT                   /note="G -> V (in OI2; dbSNP:rs66948146)"
FT                   /evidence="ECO:0000269|Ref.52"
FT                   /id="VAR_001730"
FT   VARIANT         1195
FT                   /note="G -> C (in OI1; mild form; dbSNP:rs72656334)"
FT                   /evidence="ECO:0000269|PubMed:3170557,
FT                   ECO:0000269|PubMed:3244312"
FT                   /id="VAR_001731"
FT   VARIANT         1219
FT                   /note="D -> E (in OI1; dbSNP:rs72656339)"
FT                   /evidence="ECO:0000269|PubMed:16786509"
FT                   /id="VAR_063339"
FT   VARIANT         1219
FT                   /note="D -> N (found in a patient with mild osteogenesis
FT                   imperfecta associated with increased bone mineral density;
FT                   results in defective type I procollagen processing;
FT                   incorporation of the immature procollagen into the matrix
FT                   leads to increased bone matrix mineralization and altered
FT                   collagen fibril structure; dbSNP:rs72656338)"
FT                   /evidence="ECO:0000269|PubMed:21344539"
FT                   /id="VAR_066385"
FT   VARIANT         1251
FT                   /note="S -> T (in dbSNP:rs3205325)"
FT                   /evidence="ECO:0000269|PubMed:8349697"
FT                   /id="VAR_030014"
FT   VARIANT         1277
FT                   /note="D -> H (in OI2; impaired pro-alpha chain
FT                   association; dbSNP:rs72656342)"
FT                   /evidence="ECO:0000269|PubMed:8349697"
FT                   /id="VAR_001732"
FT   VARIANT         1312
FT                   /note="W -> C (in OI2; dbSNP:rs72656343)"
FT                   /evidence="ECO:0000269|PubMed:8456808"
FT                   /id="VAR_001733"
FT   VARIANT         1337..1338
FT                   /note="Missing (in OI2; impaired pro-alpha chain
FT                   association)"
FT                   /evidence="ECO:0000269|PubMed:8349697"
FT                   /id="VAR_001734"
FT   VARIANT         1356
FT                   /note="R -> H (in dbSNP:rs149820303)"
FT                   /evidence="ECO:0000269|PubMed:16786509"
FT                   /id="VAR_063340"
FT   VARIANT         1388
FT                   /note="L -> R (in OI2; impaired pro-alpha chain
FT                   association; dbSNP:rs72656348)"
FT                   /evidence="ECO:0000269|PubMed:8349697"
FT                   /id="VAR_001735"
FT   VARIANT         1391
FT                   /note="Q -> K (in dbSNP:rs2586486)"
FT                   /evidence="ECO:0000269|PubMed:3340531,
FT                   ECO:0000269|PubMed:9443882, ECO:0000269|Ref.1"
FT                   /id="VAR_030015"
FT   VARIANT         1413
FT                   /note="D -> N (in OI2; dbSNP:rs72656349)"
FT                   /evidence="ECO:0000269|PubMed:16786509,
FT                   ECO:0000269|PubMed:18996919"
FT                   /id="VAR_063341"
FT   VARIANT         1430
FT                   /note="K -> N (in dbSNP:rs1059454)"
FT                   /id="VAR_033780"
FT   VARIANT         1431
FT                   /note="T -> P (in dbSNP:rs1059454)"
FT                   /id="VAR_033781"
FT   VARIANT         1434
FT                   /note="T -> S (in dbSNP:rs1800220)"
FT                   /evidence="ECO:0000269|PubMed:8349697, ECO:0000269|Ref.1"
FT                   /id="VAR_001736"
FT   VARIANT         1438
FT                   /note="P -> R (in dbSNP:rs17857117)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_030016"
FT   VARIANT         1460
FT                   /note="P -> H (in dbSNP:rs17853657)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_030017"
FT   VARIANT         1464
FT                   /note="L -> P (in OI3; dbSNP:rs72656353)"
FT                   /evidence="ECO:0000269|PubMed:8723681"
FT                   /id="VAR_001737"
FT   CONFLICT        59
FT                   /note="R -> Q (in Ref. 8; CAA25394)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        112..114
FT                   /note="Missing (in Ref. 2; AAB94054)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        288
FT                   /note="E -> P (in Ref. 15; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        370
FT                   /note="R -> L (in Ref. 6; AAB59373)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        484
FT                   /note="P -> L (in Ref. 19; AAA52289)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        595
FT                   /note="A -> R (in Ref. 20; AAA51847)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        721
FT                   /note="Q -> E (in Ref. 22; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        738
FT                   /note="L -> E (in Ref. 22; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        975..976
FT                   /note="LP -> PL (in Ref. 19; AAA52291)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1081
FT                   /note="V -> A (in Ref. 18; AAA51995)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1329
FT                   /note="S -> T (in Ref. 25; AAB27856)"
FT                   /evidence="ECO:0000305"
FT   STRAND          264..266
FT                   /evidence="ECO:0000244|PDB:3GXE"
FT   STRAND          966..968
FT                   /evidence="ECO:0000244|PDB:3EJH"
FT   HELIX           1227..1246
FT                   /evidence="ECO:0000244|PDB:5K31"
FT   STRAND          1251..1254
FT                   /evidence="ECO:0000244|PDB:5K31"
FT   HELIX           1259..1265
FT                   /evidence="ECO:0000244|PDB:5K31"
FT   STRAND          1271..1276
FT                   /evidence="ECO:0000244|PDB:5K31"
FT   HELIX           1283..1285
FT                   /evidence="ECO:0000244|PDB:5K31"
FT   STRAND          1287..1292
FT                   /evidence="ECO:0000244|PDB:5K31"
FT   TURN            1293..1296
FT                   /evidence="ECO:0000244|PDB:5K31"
FT   STRAND          1297..1300
FT                   /evidence="ECO:0000244|PDB:5K31"
FT   STRAND          1306..1310
FT                   /evidence="ECO:0000244|PDB:5K31"
FT   HELIX           1326..1329
FT                   /evidence="ECO:0000244|PDB:5K31"
FT   HELIX           1345..1357
FT                   /evidence="ECO:0000244|PDB:5K31"
FT   STRAND          1362..1372
FT                   /evidence="ECO:0000244|PDB:5K31"
FT   TURN            1379..1382
FT                   /evidence="ECO:0000244|PDB:5K31"
FT   STRAND          1389..1391
FT                   /evidence="ECO:0000244|PDB:5K31"
FT   STRAND          1397..1403
FT                   /evidence="ECO:0000244|PDB:5K31"
FT   STRAND          1409..1413
FT                   /evidence="ECO:0000244|PDB:5K31"
FT   STRAND          1420..1432
FT                   /evidence="ECO:0000244|PDB:5K31"
FT   HELIX           1434..1436
FT                   /evidence="ECO:0000244|PDB:5K31"
FT   STRAND          1441..1443
FT                   /evidence="ECO:0000244|PDB:5K31"
FT   STRAND          1453..1463
FT                   /evidence="ECO:0000244|PDB:5K31"
SQ   SEQUENCE   1464 AA;  138941 MW;  F0EC4DE778FFFC11 CRC64;
     MFSFVDLRLL LLLAATALLT HGQEEGQVEG QDEDIPPITC VQNGLRYHDR DVWKPEPCRI
     CVCDNGKVLC DDVICDETKN CPGAEVPEGE CCPVCPDGSE SPTDQETTGV EGPKGDTGPR
     GPRGPAGPPG RDGIPGQPGL PGPPGPPGPP GPPGLGGNFA PQLSYGYDEK STGGISVPGP
     MGPSGPRGLP GPPGAPGPQG FQGPPGEPGE PGASGPMGPR GPPGPPGKNG DDGEAGKPGR
     PGERGPPGPQ GARGLPGTAG LPGMKGHRGF SGLDGAKGDA GPAGPKGEPG SPGENGAPGQ
     MGPRGLPGER GRPGAPGPAG ARGNDGATGA AGPPGPTGPA GPPGFPGAVG AKGEAGPQGP
     RGSEGPQGVR GEPGPPGPAG AAGPAGNPGA DGQPGAKGAN GAPGIAGAPG FPGARGPSGP
     QGPGGPPGPK GNSGEPGAPG SKGDTGAKGE PGPVGVQGPP GPAGEEGKRG ARGEPGPTGL
     PGPPGERGGP GSRGFPGADG VAGPKGPAGE RGSPGPAGPK GSPGEAGRPG EAGLPGAKGL
     TGSPGSPGPD GKTGPPGPAG QDGRPGPPGP PGARGQAGVM GFPGPKGAAG EPGKAGERGV
     PGPPGAVGPA GKDGEAGAQG PPGPAGPAGE RGEQGPAGSP GFQGLPGPAG PPGEAGKPGE
     QGVPGDLGAP GPSGARGERG FPGERGVQGP PGPAGPRGAN GAPGNDGAKG DAGAPGAPGS
     QGAPGLQGMP GERGAAGLPG PKGDRGDAGP KGADGSPGKD GVRGLTGPIG PPGPAGAPGD
     KGESGPSGPA GPTGARGAPG DRGEPGPPGP AGFAGPPGAD GQPGAKGEPG DAGAKGDAGP
     PGPAGPAGPP GPIGNVGAPG AKGARGSAGP PGATGFPGAA GRVGPPGPSG NAGPPGPPGP
     AGKEGGKGPR GETGPAGRPG EVGPPGPPGP AGEKGSPGAD GPAGAPGTPG PQGIAGQRGV
     VGLPGQRGER GFPGLPGPSG EPGKQGPSGA SGERGPPGPM GPPGLAGPPG ESGREGAPGA
     EGSPGRDGSP GAKGDRGETG PAGPPGAPGA PGAPGPVGPA GKSGDRGETG PAGPTGPVGP
     VGARGPAGPQ GPRGDKGETG EQGDRGIKGH RGFSGLQGPP GPPGSPGEQG PSGASGPAGP
     RGPPGSAGAP GKDGLNGLPG PIGPPGPRGR TGDAGPVGPP GPPGPPGPPG PPSAGFDFSF
     LPQPPQEKAH DGGRYYRADD ANVVRDRDLE VDTTLKSLSQ QIENIRSPEG SRKNPARTCR
     DLKMCHSDWK SGEYWIDPNQ GCNLDAIKVF CNMETGETCV YPTQPSVAQK NWYISKNPKD
     KRHVWFGESM TDGFQFEYGG QGSDPADVAI QLTFLRLMST EASQNITYHC KNSVAYMDQQ
     TGNLKKALLL QGSNEIEIRA EGNSRFTYSV TVDGCTSHTG AWGKTVIEYK TTKTSRLPII
     DVAPLDVGAP DQEFGFDVGP VCFL
//
ID   CO2A1_HUMAN             Reviewed;        1487 AA.
AC   P02458; A6NGA0; Q12985; Q14009; Q14044; Q14045; Q14046; Q14047; Q14056;
AC   Q14058; Q16672; Q1JQ82; Q2V4X7; Q6LBY1; Q6LBY2; Q6LBY3; Q96IT5; Q99227;
AC   Q9UE38; Q9UE39; Q9UE40; Q9UE41; Q9UE42; Q9UE43;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   22-APR-2020, entry version 236.
DE   RecName: Full=Collagen alpha-1(II) chain {ECO:0000305};
DE   AltName: Full=Alpha-1 type II collagen {ECO:0000305};
DE   Contains:
DE     RecName: Full=Collagen alpha-1(II) chain {ECO:0000305};
DE   Contains:
DE     RecName: Full=Chondrocalcin {ECO:0000303|PubMed:3800925};
DE   Flags: Precursor;
GN   Name=COL2A1 {ECO:0000312|HGNC:HGNC:2200};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS SER-9 AND LEU-158.
RX   PubMed=2587267; DOI=10.1093/nar/17.22.9473;
RA   Su M.W., Lee B., Ramirez F., Machado M.A., Horton W.A.;
RT   "Nucleotide sequence of the full length cDNA encoding for human type II
RT   procollagen.";
RL   Nucleic Acids Res. 17:9473-9473(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 2), AND VARIANT SER-9.
RC   TISSUE=Blood;
RX   PubMed=8948452; DOI=10.1042/bj3080923;
RA   Ala-Kokko L., Kvist A.-P., Metsaranta M., Kivirikko K.I.,
RA   de Crombrugghe B., Prockop D.J., Vuorio E.;
RT   "Conservation of the sizes of 53 introns and over 100 intronic sequences
RT   for the binding of common transcription factors in the human and mouse
RT   genes for type II procollagen (COL2A1).";
RL   Biochem. J. 308:923-929(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C.,
RA   Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R.,
RA   Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E.,
RA   Song X.-Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y.,
RA   Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G.,
RA   Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H.,
RA   Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S.,
RA   Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M.,
RA   Nguyen B.-V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H.,
RA   Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q.,
RA   Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V.,
RA   Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E.,
RA   Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R.,
RA   David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E.,
RA   D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N.,
RA   Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N.,
RA   Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R.,
RA   Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S.,
RA   LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H.,
RA   Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P.,
RA   Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G.,
RA   Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E.,
RA   Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S.,
RA   Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O.,
RA   Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y.,
RA   Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A.,
RA   Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F.,
RA   Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L.,
RA   Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G.,
RA   Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 1109-1487 (ISOFORMS 1/2).
RC   TISSUE=Embryonic stem cell, and Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-1229 (ISOFORM 1), AND VARIANT SER-9.
RX   PubMed=2803268; DOI=10.1042/bj2620521;
RA   Baldwin C.T., Reginato A.M., Smith C., Jimenez S.A., Prockop D.J.;
RT   "Structure of cDNA clones coding for human type II procollagen. The alpha
RT   1(II) chain is more similar to the alpha 1(I) chain than two other alpha
RT   chains of fibrillar collagens.";
RL   Biochem. J. 262:521-528(1989).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-236 (ISOFORM 1), AND VARIANT SER-9.
RX   PubMed=2714801; DOI=10.1016/0888-7543(89)90353-4;
RA   Su M.W., Benson-Chanda V., Vissing H., Ramirez F.;
RT   "Organization of the exons coding for pro alpha 1(II) collagen N-propeptide
RT   confirms a distinct evolutionary history of this domain of the fibrillar
RT   collagen genes.";
RL   Genomics 4:438-441(1989).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-103 (ISOFORM 2), AND VARIANT SER-9.
RX   PubMed=2081599; DOI=10.1016/0888-7543(90)90224-i;
RA   Ryan M.C., Sieraski M., Sandell L.J.;
RT   "The human type II procollagen gene: identification of an additional
RT   protein-coding domain and location of potential regulatory sequences in the
RT   promoter and first intron.";
RL   Genomics 8:41-48(1990).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-28 (ISOFORMS 1/2).
RX   PubMed=3021582; DOI=10.1016/0378-1119(86)90037-5;
RA   Nunez A.M., Kohno K., Martin G.R., Yamada Y.;
RT   "Promoter region of the human pro-alpha 1(II)-collagen gene.";
RL   Gene 44:11-16(1986).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-28 (ISOFORMS 1/2).
RX   PubMed=1637314; DOI=10.1042/bj2850287;
RA   Vikkula M., Metsaranta M., Syvaenen A.-C., Ala-Kokko L., Vuorio E.,
RA   Peltonen L.;
RT   "Structural analysis of the regulatory elements of the type-II procollagen
RT   gene. Conservation of promoter and first intron sequences between human and
RT   mouse.";
RL   Biochem. J. 285:287-294(1992).
RN   [11]
RP   NUCLEOTIDE SEQUENCE OF 27-103 (ISOFORM 2), AND TISSUE SPECIFICITY.
RX   PubMed=2355003;
RA   Ryan M.C., Sandell L.J.;
RT   "Differential expression of a cysteine-rich domain in the amino-terminal
RT   propeptide of type II (cartilage) procollagen by alternative splicing of
RT   mRNA.";
RL   J. Biol. Chem. 265:10334-10339(1990).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 99-341 (ISOFORMS 1/2).
RC   TISSUE=Fetal sternum;
RX   PubMed=1999183; DOI=10.1111/j.1432-1033.1991.tb15742.x;
RA   Huang M.C., Seyer J.M., Thompson J.P., Spinella D.G., Cheah K.S.,
RA   Kang A.H.;
RT   "Genomic organization of the human procollagen alpha 1(II) collagen gene.";
RL   Eur. J. Biochem. 195:593-600(1991).
RN   [13]
RP   PROTEIN SEQUENCE OF 188-195 AND 1224-1236.
RX   PubMed=8660302; DOI=10.1042/bj3140327;
RA   Diab M., Wu J.J., Eyre D.R.;
RT   "Collagen type IX from human cartilage: a structural profile of
RT   intermolecular cross-linking sites.";
RL   Biochem. J. 314:327-332(1996).
RN   [14]
RP   PROTEIN SEQUENCE OF 243-261; 575-590 AND 756-779.
RX   PubMed=8529631; DOI=10.1111/j.1432-1033.1995.125_c.x;
RA   Franc S., Marzin E., Boutillon M.-M., Lafont R., Lechene de la Porte P.,
RA   Herbage D.;
RT   "Immunohistochemical and biochemical analyses of 20,000-25,000-year-old
RT   fossil cartilage.";
RL   Eur. J. Biochem. 234:125-131(1995).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 440-509 (ISOFORMS 1/2).
RX   PubMed=7847372;
RA   Tiller G.E., Weis M.A., Polumbo P.A., Gruber H.E., Rimoin D.L., Cohn D.H.,
RA   Eyre D.R.;
RT   "An RNA-splicing mutation (G+5IVS20) in the type II collagen gene (COL2A1)
RT   in a family with spondyloepiphyseal dysplasia congenita.";
RL   Am. J. Hum. Genet. 56:388-395(1995).
RN   [16]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 501-1214 (ISOFORMS 1/2).
RA   Ramirez F.;
RL   Submitted (DEC-1988) to the EMBL/GenBank/DDBJ databases.
RN   [17]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 541-578; 784-803; 1056-1109 AND
RP   1200-1487 (ISOFORMS 1/2).
RX   PubMed=2987845; DOI=10.1093/nar/13.7.2207;
RA   Sangiorgi F.O., Benson-Chanda V., de Wet W.J., Sobel M.E., Tsipouras P.,
RA   Ramirez F.;
RT   "Isolation and partial characterization of the entire human pro alpha 1(II)
RT   collagen gene.";
RL   Nucleic Acids Res. 13:2207-2225(1985).
RN   [18]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 630-785 (ISOFORMS 1/2).
RX   PubMed=2753125; DOI=10.1016/0014-5793(89)80713-6;
RA   Vikkula M., Peltonen L.;
RT   "Structural analyses of the polymorphic area in type II collagen gene.";
RL   FEBS Lett. 250:171-174(1989).
RN   [19]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1032-1487 (ISOFORMS 1/2).
RX   PubMed=3857598; DOI=10.1073/pnas.82.9.2555;
RA   Cheah K.S.E., Stoker N.G., Griffin J.R., Grosveld F.G., Solomon E.;
RT   "Identification and characterization of the human type II collagen gene
RT   (COL2A1).";
RL   Proc. Natl. Acad. Sci. U.S.A. 82:2555-2559(1985).
RN   [20]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1038-1055 (ISOFORMS 1/2), AND VARIANT
RP   HYPOCHONDROGENESIS GLU-1053.
RX   PubMed=1429602;
RA   Bogaert R., Tiller G.E., Wies M.A., Gruber H.E., Rimoin D.L., Cohn D.H.,
RA   Eyre D.R.;
RT   "An amino acid substitution (Gly853-->Glu) in the collagen alpha 1(II)
RT   chain produces hypochondrogenesis.";
RL   J. Biol. Chem. 267:22522-22526(1992).
RN   [21]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1082-1288 (ISOFORMS 1/2).
RX   PubMed=1905723;
RA   Chan D., Cole W.G.;
RT   "Low basal transcription of genes for tissue-specific collagens by
RT   fibroblasts and lymphoblastoid cells. Application to the characterization
RT   of a glycine 997 to serine substitution in alpha 1(II) collagen chains of a
RT   patient with spondyloepiphyseal dysplasia.";
RL   J. Biol. Chem. 266:12487-12494(1991).
RN   [22]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1146-1199 (ISOFORMS 1/2), AND VARIANT
RP   SEDC 1164-GLY--TYR-1399 DEL.
RX   PubMed=2543071; DOI=10.1126/science.2543071;
RA   Lee B., Vissing H., Ramirez F., Rogers D., Rimoin D.L.;
RT   "Identification of the molecular defect in a family with spondyloepiphyseal
RT   dysplasia.";
RL   Science 244:978-980(1989).
RN   [23]
RP   NUCLEOTIDE SEQUENCE OF 1164-1199 (ISOFORMS 1/2), AND VARIANT SEDC
RP   GLY-PRO-SER-GLY-LYS-ASP-GLY-ALA-ASN-GLY-ILE-PRO-GLY-PRO-ILE-1184 INS.
RX   PubMed=2339128; DOI=10.1073/pnas.87.10.3889;
RA   Tiller G.E., Rimoin D.L., Murray L.W., Cohn D.H.;
RT   "Tandem duplication within a type II collagen gene (COL2A1) exon in an
RT   individual with spondyloepiphyseal dysplasia.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:3889-3893(1990).
RN   [24]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1175-1487 (ISOFORMS 1/2).
RX   PubMed=2825137; DOI=10.1093/nar/15.22.9499;
RA   Elima K., Vuorio T., Vuorio E.;
RT   "Determination of the single polyadenylation site of the human pro alpha
RT   1(II) collagen gene.";
RL   Nucleic Acids Res. 15:9499-9504(1987).
RN   [25]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1189-1467 (ISOFORMS 1/2).
RX   PubMed=3840017; DOI=10.1042/bj2290183;
RA   Elima K., Maekelae J.K., Vuorio T., Kauppinen S., Knowles J., Vuorio E.;
RT   "Construction and identification of a cDNA clone for human type II
RT   procollagen mRNA.";
RL   Biochem. J. 229:183-188(1985).
RN   [26]
RP   PROTEIN SEQUENCE OF 1242-1265; 1295-1305 AND 1395-1408.
RX   PubMed=3800925; DOI=10.1042/bj2370923;
RA   Van der Rest M., Rosenberg L.C., Olsen B.R., Poole A.R.;
RT   "Chondrocalcin is identical with the C-propeptide of type II procollagen.";
RL   Biochem. J. 237:923-925(1986).
RN   [27]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1245-1295 (ISOFORMS 1/2/3).
RX   PubMed=6320112; DOI=10.1093/nar/12.2.1025;
RA   Strom C.M., Upholt W.B.;
RT   "Isolation and characterization of genomic clones corresponding to the
RT   human type II procollagen gene.";
RL   Nucleic Acids Res. 12:1025-1038(1984).
RN   [28]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1296-1358 (ISOFORMS 1/2/3).
RX   PubMed=3002437; DOI=10.1021/bi00344a004;
RA   Nunez A.M., Francomano C., Young M.F., Martin G.R., Yamada Y.;
RT   "Isolation and partial characterization of genomic clones coding for a
RT   human pro-alpha 1 (II) collagen chain and demonstration of restriction
RT   fragment length polymorphism at the 3' end of the gene.";
RL   Biochemistry 24:6343-6348(1985).
RN   [29]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 1238-1247.
RX   PubMed=9354468; DOI=10.1016/s1074-7613(00)80369-6;
RA   Dessen A., Lawrence C.M., Cupo S., Zaller D.M., Wiley D.C.;
RT   "X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a
RT   peptide from human collagen II.";
RL   Immunity 7:473-481(1997).
RN   [30]
RP   STRUCTURE BY NMR OF 25-162 (ISOFORM 2), AND DISULFIDE BONDS.
RX   PubMed=15466413; DOI=10.1074/jbc.m409225200;
RA   O'Leary J.M., Hamilton J.M., Deane C.M., Valeyev N.V., Sandell L.J.,
RA   Downing A.K.;
RT   "Solution structure and dynamics of a prototypical chordin-like cysteine-
RT   rich repeat (von Willebrand Factor type C module) from collagen IIA.";
RL   J. Biol. Chem. 279:53857-53866(2004).
RN   [31]
RP   INVOLVEMENT IN SEDSTN, AND VARIANT SEDSTN ARG-207.
RX   PubMed=26183434; DOI=10.1002/humu.22839;
RA   Jurgens J., Sobreira N., Modaff P., Reiser C.A., Seo S.H., Seong M.W.,
RA   Park S.S., Kim O.H., Cho T.J., Pauli R.M.;
RT   "Novel COL2A1 variant (c.619G>A, p.Gly207Arg) manifesting as a phenotype
RT   similar to progressive pseudorheumatoid dysplasia and spondyloepiphyseal
RT   dysplasia, Stanescu type.";
RL   Hum. Mutat. 36:1004-1008(2015).
RN   [32]
RP   REVIEW ON VARIANTS.
RX   PubMed=2010058; DOI=10.1096/fasebj.5.7.2010058;
RA   Kuivaniemi H., Tromp G., Prockop D.J.;
RT   "Mutations in collagen genes: causes of rare and some common diseases in
RT   humans.";
RL   FASEB J. 5:2052-2060(1991).
RN   [33]
RP   REVIEW ON VARIANTS.
RX   PubMed=9101290;
RX   DOI=10.1002/(sici)1098-1004(1997)9:4<300::aid-humu2>3.0.co;2-9;
RA   Kuivaniemi H., Tromp G., Prockop D.J.;
RT   "Mutations in fibrillar collagens (types I, II, III, and XI), fibril-
RT   associated collagen (type IX), and network-forming collagen (type X) cause
RT   a spectrum of diseases of bone, cartilage, and blood vessels.";
RL   Hum. Mutat. 9:300-315(1997).
RN   [34]
RP   VARIANT ACG2 SER-1143.
RX   PubMed=2572591;
RA   Vissing H., D'Alessio M., Lee B., Ramirez F., Godfrey M., Hollister D.W.;
RT   "Glycine to serine substitution in the triple helical domain of pro-alpha 1
RT   (II) collagen results in a lethal perinatal form of short-limbed
RT   dwarfism.";
RL   J. Biol. Chem. 264:18265-18267(1989).
RN   [35]
RP   VARIANT OSCDP CYS-719.
RX   PubMed=1975693; DOI=10.1073/pnas.87.17.6565;
RA   Ala-Kokko L., Baldwin C.T., Moskowitz R.W., Prockop D.J.;
RT   "Single base mutation in the type II procollagen gene (COL2A1) as a cause
RT   of primary osteoarthritis associated with a mild chondrodysplasia.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:6565-6568(1990).
RN   [36]
RP   VARIANT OSCDP CYS-719.
RX   PubMed=1985108; DOI=10.1172/jci114994;
RA   Eyre D.R., Weis M.A., Moskowitz R.W.;
RT   "Cartilage expression of a type II collagen mutation in an inherited form
RT   of osteoarthritis associated with a mild chondrodysplasia.";
RL   J. Clin. Invest. 87:357-361(1991).
RN   [37]
RP   VARIANT HYPOCHONDROGENESIS SER-774.
RX   PubMed=1374906; DOI=10.1073/pnas.89.10.4583;
RA   Horton W.A., Machado M.A., Ellard J., Campbell D., Bartley J., Ramirez F.,
RA   Vitale E., Lee B.;
RT   "Characterization of a type II collagen gene (COL2A1) mutation identified
RT   in cultured chondrocytes from human hypochondrogenesis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:4583-4587(1992).
RN   [38]
RP   VARIANT STL1O ASP-267.
RX   PubMed=8317498;
RA   Koerkkoe J., Ritvaniemi P., Haataja L., Kaeaeriaeinen H., Kivirikko K.I.,
RA   Prockop D.J., Ala-Kokko L.;
RT   "Mutation in type II procollagen (COL2A1) that substitutes aspartate for
RT   glycine alpha 1-67 and that causes cataracts and retinal detachment:
RT   evidence for molecular heterogeneity in the Wagner syndrome and the
RT   Stickler syndrome (arthro-ophthalmopathy).";
RL   Am. J. Hum. Genet. 53:55-61(1993).
RN   [39]
RP   VARIANTS SEMDSTWK VAL-897 AND CYS-909.
RA   Tiller G.E., Weis M.A., Lachman R.S., Cohn D.H., Rimoin D.L., Eyre D.R.;
RT   "A dominant mutation in the type II collagen gene (COL2A1) produces
RT   spondyloepimetaphyseal dysplasia (SEMD), Strudwick type.";
RL   Am. J. Hum. Genet. 53:A209-A209(1993).
RN   [40]
RP   VARIANT OSCDP CYS-719.
RX   PubMed=8507190; DOI=10.1006/bbrc.1993.1539;
RA   Holderbaum D., Malemud C.J., Moskowitz R.W., Haqqi T.M.;
RT   "Human cartilage from late stage familial osteoarthritis transcribes type
RT   II collagen mRNA encoding a cysteine in position 519.";
RL   Biochem. Biophys. Res. Commun. 192:1169-1174(1993).
RN   [41]
RP   VARIANT SPONDYLOMETAPHYSEAL DYSPLASIA ARG-354.
RX   PubMed=8486375; DOI=10.1006/geno.1993.1179;
RA   Vikkula M., Ritvaniemi P., Vuorio A.F., Kaitila I., Ala-Kokko L.,
RA   Peltonen L.;
RT   "A mutation in the amino-terminal end of the triple helix of type II
RT   collagen causing severe osteochondrodysplasia.";
RL   Genomics 16:282-285(1993).
RN   [42]
RP   VARIANT CZECHD CYS-275.
RX   PubMed=8244341; DOI=10.1007/bf00216458;
RA   Williams C.J., Considine E.L., Knowlton R.G., Reginato A., Neumann G.,
RA   Harrison D., Buxton P., Jimenez S.A., Prockop D.J.;
RT   "Spondyloepiphyseal dysplasia and precocious osteoarthritis in a family
RT   with an Arg75-->Cys mutation in the procollagen type II gene (COL2A1).";
RL   Hum. Genet. 92:499-505(1993).
RN   [43]
RP   VARIANT SEDC CYS-989.
RX   PubMed=8325895;
RA   Chan D., Taylor T.K.F., Cole W.G.;
RT   "Characterization of an arginine 789 to cysteine substitution in alpha 1
RT   (II) collagen chains of a patient with spondyloepiphyseal dysplasia.";
RL   J. Biol. Chem. 268:15238-15245(1993).
RN   [44]
RP   VARIANT SEDC SER-1197.
RX   PubMed=8423604; DOI=10.1136/jmg.30.1.27;
RA   Cole W.G., Hall R.K., Rogers J.G.;
RT   "The clinical features of spondyloepiphyseal dysplasia congenita resulting
RT   from the substitution of glycine 997 by serine in the alpha 1(II) chain of
RT   type II collagen.";
RL   J. Med. Genet. 30:27-35(1993).
RN   [45]
RP   VARIANT STL1 302-ALA--LYS-308 DEL.
RX   PubMed=7977371;
RA   Bogaert R., Wilkin D.J., Wilcox W.R., Lachman R.S., Rimoin D.L., Cohn D.H.,
RA   Eyre D.R.;
RT   "Expression, in cartilage, of a 7-amino-acid deletion in type II collagen
RT   from two unrelated individuals with Kniest dysplasia.";
RL   Am. J. Hum. Genet. 55:1128-1136(1994).
RN   [46]
RP   VARIANT KD ASP-303.
RX   PubMed=7874117; DOI=10.1093/hmg/3.11.1999;
RA   Wilkin D.J., Bogaert R., Lachman R.S., Rimoin D.L., Eyres D.R., Cohn D.H.;
RT   "A single amino acid substitution (G103D) in the type II collagen triple
RT   helix produces Kniest dysplasia.";
RL   Hum. Mol. Genet. 3:1999-2003(1994).
RN   [47]
RP   VARIANT SEDC SER-447.
RX   PubMed=8019561; DOI=10.1002/humu.1380030314;
RA   Ritvaniemi P., Sokolov B.P., Williams C.J., Considine W., Yurgenev L.,
RA   Meerson E.M., Ala-Kokko L., Prockop D.J.;
RT   "A single base mutation in the type II procollagen gene (COL2A1) that
RT   converts glycine alpha 1-247 to serine in a family with late-onset
RT   spondyloepiphyseal dysplasia.";
RL   Hum. Mutat. 3:261-267(1994).
RN   [48]
RP   VARIANT ACG2 ARG-891.
RX   PubMed=7757081; DOI=10.1093/hmg/4.2.285;
RA   Mortier G.R., Wilkin D.J., Wilcox W.R., Rimoin D.L., Lachman R.S.,
RA   Eyre D.R., Cohn D.H.;
RT   "A radiographic, morphologic, biochemical and molecular analysis of a case
RT   of achondrogenesis type II resulting from substitution for a glycine
RT   residue (Gly691-->Arg) in the type II collagen trimer.";
RL   Hum. Mol. Genet. 4:285-288(1995).
RN   [49]
RP   VARIANT CZECHD CYS-275, VARIANT SEDC SER-1176, VARIANT OSCDP CYS-719,
RP   VARIANT HYPOCHONDROGENESIS ARG-891, AND VARIANT ACG2 ARG-1188.
RX   PubMed=7757086; DOI=10.1093/hmg/4.2.309;
RA   Williams C.J., Rock M., Considine E.L., McCarron S., Gow P., Ladda R.,
RA   McLain D., Michels V.M., Murphy W., Prockop D.J., Ganguly A.;
RT   "Three new point mutations in type II procollagen (COL2A1) and
RT   identification of a fourth family with the COL2A1 Arg519-->Cys base
RT   substitution using conformation sensitive gel electrophoresis.";
RL   Hum. Mol. Genet. 4:309-312(1995).
RN   [50]
RP   VARIANT ACG2 SER-969.
RX   PubMed=7829510; DOI=10.1074/jbc.270.44.26292;
RA   Chan D., Cole W.G., Chow C.W., Mundlos S., Bateman J.F.;
RT   "A COL2A1 mutation in achondrogenesis type II results in the replacement of
RT   type II collagen by type I and III collagens in cartilage.";
RL   J. Biol. Chem. 270:1747-1753(1995).
RN   [51]
RP   VARIANTS SEMDSTWK VAL-492; CYS-504 AND CYS-909.
RX   PubMed=7550321; DOI=10.1038/ng0995-87;
RA   Tiller G.E., Polumbo P.A., Weis M.A., Bogaert R., Lachman R.S., Cohn D.H.,
RA   Rimoin D.L., Eyre D.R.;
RT   "Dominant mutations in the type II collagen gene, COL2A1, produce
RT   spondyloepimetaphyseal dysplasia, Strudwick type.";
RL   Nat. Genet. 11:87-89(1995).
RN   [52]
RP   VARIANT HYPOCHONDROGENESIS CYS-1113.
RX   PubMed=8723098;
RX   DOI=10.1002/(sici)1096-8628(19960503)63:1<129::aid-ajmg23>3.0.co;2-p;
RA   Mundlos S., Chan D., McGill J., Bateman J.F.;
RT   "An alpha 1(II) Gly913 to Cys substitution prevents the matrix
RT   incorporation of type II collagen which is replaced with type I and III
RT   collagens in cartilage from a patient with hypochondrogenesis.";
RL   Am. J. Med. Genet. 63:129-136(1996).
RN   [53]
RP   VARIANT KD 1207-PRO--GLY-1212 DEL.
RX   PubMed=8863156; DOI=10.1136/jmg.33.8.649;
RA   Winterpacht A., Superti-Furga A., Schwarze U., Stoess H., Steinmann B.,
RA   Spranger J., Zabel B.;
RT   "The deletion of six amino acids at the C-terminus of the alpha 1 (II)
RT   chain causes overmodification of type II and type XI collagen: further
RT   evidence for the association between small deletions in COL2A1 and Kniest
RT   dysplasia.";
RL   J. Med. Genet. 33:649-654(1996).
RN   [54]
RP   VARIANT EDMMD CYS-904.
RX   PubMed=9800905;
RX   DOI=10.1002/(sici)1096-8628(19981102)80:1<6::aid-ajmg2>3.0.co;2-0;
RA   Ballo R., Beighton P.H., Ramesar R.S.;
RT   "Stickler-like syndrome due to a dominant negative mutation in the COL2A1
RT   gene.";
RL   Am. J. Med. Genet. 80:6-11(1998).
RN   [55]
RP   VARIANT SPONDYLOEPIPHYSEAL DYSPLASIA CYS-719.
RX   PubMed=9711874;
RX   DOI=10.1002/(sici)1098-1004(1998)12:3<172::aid-humu4>3.0.co;2-j;
RA   Bleasel J.F., Holderbaum D., Brancolini V., Moskowitz R.W., Considine E.L.,
RA   Prockop D.J., Devoto M., Williams C.J.;
RT   "Five families with arginine 519-cysteine mutation in COL2A1: evidence for
RT   three distinct founders.";
RL   Hum. Mutat. 12:172-176(1998).
RN   [56]
RP   VARIANT STL1 CYS-565, AND VARIANT DRRD PHE-667.
RX   PubMed=11007540; DOI=10.1086/321189;
RA   Richards A.J., Baguley D.M., Yates J.R.W., Lane C., Nicol M., Harper P.S.,
RA   Scott J.D., Snead M.P.;
RT   "Variation in the vitreous phenotype of Stickler syndrome can be caused by
RT   different amino acid substitutions in the X position of the type II
RT   collagen Gly-X-Y triple helix.";
RL   Am. J. Hum. Genet. 67:1083-1094(2000).
RN   [57]
RP   VARIANT SEDC ARG-1173.
RX   PubMed=10678662;
RX   DOI=10.1002/(sici)1096-8628(20000131)90:3<239::aid-ajmg10>3.0.co;2-o;
RA   Sobetzko D., Eich G., Kalff-Suske M., Grzeschik K.-H., Superti-Furga A.;
RT   "Boy with syndactylies, macrocephaly, and severe skeletal dysplasia: not a
RT   new syndrome, but two dominant mutations (GLI3 E543X and COL2A1 G973R) in
RT   the same individual.";
RL   Am. J. Med. Genet. 90:239-242(2000).
RN   [58]
RP   VARIANTS ACG2 VAL-453; ASP-453; ASP-771; ARG-780; ARG-795; GLU-894;
RP   ASP-948; SER-981; VAL-1065 AND ARG-1119, VARIANT HYPOCHONDROGENESIS
RP   1017-GLY--VAL-1022 DEL, AND VARIANT ILE-1331.
RX   PubMed=10797431;
RX   DOI=10.1002/(sici)1096-8628(20000515)92:2<95::aid-ajmg3>3.0.co;2-9;
RA   Koerkkoe J., Cohn D.H., Ala-Kokko L., Krakow D., Prockop D.J.;
RT   "Widely distributed mutations in the COL2A1 gene produce achondrogenesis
RT   type II/hypochondrogenesis.";
RL   Am. J. Med. Genet. 92:95-100(2000).
RN   [59]
RP   VARIANTS ACG2 SER-513; VAL-717; ALA-771; CYS-1110 AND SER-1143, AND VARIANT
RP   PLSD-T ASN-1390.
RX   PubMed=10745044; DOI=10.1136/jmg.37.4.263;
RA   Mortier G.R., Weis M., Nuytinck L., King L.M., Wilkin D.J., De Paepe A.,
RA   Lachman R.S., Rimoin D.L., Eyre D.R., Cohn D.H.;
RT   "Report of five novel and one recurrent COL2A1 mutations with analysis of
RT   genotype-phenotype correlation in patients with a lethal type II collagen
RT   disorder.";
RL   J. Med. Genet. 37:263-271(2000).
RN   [60]
RP   VARIANT SEDC MET-1439.
RX   PubMed=11746045; DOI=10.1002/ajmg.10062;
RA   Unger S., Koerkkoe J., Krakow D., Lachman R.S., Rimoin D.L., Cohn D.H.;
RT   "Double heterozygosity for pseudoachondroplasia and spondyloepiphyseal
RT   dysplasia congenita.";
RL   Am. J. Med. Genet. 104:140-146(2001).
RN   [61]
RP   VARIANT VITREORETINOPATHY ASP-1305.
RX   PubMed=12205109; DOI=10.1136/jmg.39.9.661;
RA   Richards A.J., Morgan J., Bearcroft P.W.P., Pickering E., Owen M.J.,
RA   Holmans P., Williams N., Tysoe C., Pope F.M., Snead M.P., Hughes H.;
RT   "Vitreoretinopathy with phalangeal epiphyseal dysplasia, a type II
RT   collagenopathy resulting from a novel mutation in the C-propeptide region
RT   of the molecule.";
RL   J. Med. Genet. 39:661-665(2002).
RN   [62]
RP   VARIANT ACG2 ASP-516.
RX   PubMed=15054848; DOI=10.1002/ajmg.a.20597;
RA   Faivre L., Le Merrer M., Douvier S., Laurent N., Thauvin-Robinet C.,
RA   Rousseau T., Vereecke I., Sagot P., Delezoide A.-L., Coucke P., Mortier G.;
RT   "Recurrence of achondrogenesis type II within the same family: evidence for
RT   germline mosaicism.";
RL   Am. J. Med. Genet. A 126:308-312(2004).
RN   [63]
RP   INVOLVEMENT IN SPONDYLOPERIPHERAL DYSPLASIA.
RX   PubMed=15316962; DOI=10.1002/ajmg.a.30222;
RA   Zankl A., Zabel B., Hilbert K., Wildhardt G., Cuenot S., Xavier B.,
RA   Ha-Vinh R., Bonafe L., Spranger J., Superti-Furga A.;
RT   "Spondyloperipheral dysplasia is caused by truncating mutations in the C-
RT   propeptide of COL2A1.";
RL   Am. J. Med. Genet. A 129:144-148(2004).
RN   [64]
RP   VARIANT PLSD-T CYS-1391.
RX   PubMed=14729840; DOI=10.1136/jmg.2003.013722;
RA   Nishimura G., Nakashima E., Mabuchi A., Shimamoto K., Shimamoto T.,
RA   Shimao Y., Nagai T., Yamaguchi T., Kosaki R., Ohashi H., Makita Y.,
RA   Ikegawa S.;
RT   "Identification of COL2A1 mutations in platyspondylic skeletal dysplasia,
RT   Torrance type.";
RL   J. Med. Genet. 41:75-79(2004).
RN   [65]
RP   VARIANTS PLSD-T PRO-1448; HIS-1469; VAL-1484 DEL AND GLY-1485, AND
RP   DISCUSSION OF VARIANT ASN-1390.
RX   PubMed=15643621; DOI=10.1002/ajmg.a.30531;
RA   Zankl A., Neumann L., Ignatius J., Nikkels P., Schrander-Stumpel C.,
RA   Mortier G., Omran H., Wright M., Hilbert K., Bonafe L., Spranger J.,
RA   Zabel B., Superti-Furga A.;
RT   "Dominant negative mutations in the C-propeptide of COL2A1 cause
RT   platyspondylic lethal skeletal dysplasia, torrance type, and define a novel
RT   subfamily within the type 2 collagenopathies.";
RL   Am. J. Med. Genet. A 133:61-67(2005).
RN   [66]
RP   VARIANT SEMDSTWK GLY-992.
RX   PubMed=16088915; DOI=10.1002/ajmg.a.30881;
RA   Sulko J., Czarny-Ratajczak M., Wozniak A., Latos-Bielenska A.,
RA   Kozlowski K.;
RT   "Novel amino acid substitution in the Y-position of collagen type II causes
RT   spondyloepimetaphyseal dysplasia congenita.";
RL   Am. J. Med. Genet. A 137:292-297(2005).
RN   [67]
RP   VARIANTS DRRD ARG-318 AND PHE-667.
RX   PubMed=15671297; DOI=10.1167/iovs.04-1017;
RA   Richards A.J., Meredith S., Poulson A., Bearcroft P., Crossland G.,
RA   Baguley D.M., Scott J.D., Snead M.P.;
RT   "A novel mutation of COL2A1 resulting in dominantly inherited
RT   rhegmatogenous retinal detachment.";
RL   Invest. Ophthalmol. Vis. Sci. 46:663-668(2005).
RN   [68]
RP   VARIANTS ANFH1 SER-717 AND SER-1170.
RX   PubMed=15930420; DOI=10.1056/nejmoa042480;
RA   Liu Y.-F., Chen W.-M., Lin Y.-F., Yang R.-C., Lin M.-W., Li L.-H.,
RA   Chang Y.-H., Jou Y.-S., Lin P.-Y., Su J.-S., Huang S.-F., Hsiao K.-J.,
RA   Fann C.S.J., Hwang H.-W., Chen Y.-T., Tsai S.-F.;
RT   "Type II collagen gene variants and inherited osteonecrosis of the femoral
RT   head.";
RL   N. Engl. J. Med. 352:2294-2301(2005).
RN   [69]
RP   INVOLVEMENT IN STL1O.
RX   PubMed=16752401; DOI=10.1002/humu.20347;
RA   Richards A.J., Laidlaw M., Whittaker J., Treacy B., Rai H., Bearcroft P.,
RA   Baguley D.M., Poulson A., Ang A., Scott J.D., Snead M.P.;
RT   "High efficiency of mutation detection in type 1 stickler syndrome using a
RT   two-stage approach: vitreoretinal assessment coupled with exon sequencing
RT   for screening COL2A1.";
RL   Hum. Mutat. 27:696-704(2006).
RN   [70]
RP   VARIANT ACG2 VAL-547.
RX   PubMed=17994563; DOI=10.1002/ajmg.a.32047;
RA   Forzano F., Lituania M., Viassolo A., Superti-Furga V., Wildhardt G.,
RA   Zabel B., Faravelli F.;
RT   "A familial case of achondrogenesis type II caused by a dominant COL2A1
RT   mutation and 'patchy' expression in the mosaic father.";
RL   Am. J. Med. Genet. A 143:2815-2820(2007).
RN   [71]
RP   VARIANT LCPD SER-1170.
RX   PubMed=17394019; DOI=10.1007/s00439-007-0354-y;
RA   Miyamoto Y., Matsuda T., Kitoh H., Haga N., Ohashi H., Nishimura G.,
RA   Ikegawa S.;
RT   "A recurrent mutation in type II collagen gene causes Legg-Calve-Perthes
RT   disease in a Japanese family.";
RL   Hum. Genet. 121:625-629(2007).
RN   [72]
RP   VARIANT CZECHD CYS-275.
RX   PubMed=18553548; DOI=10.1002/ajmg.a.32389;
RA   Tzschach A., Tinschert S., Kaminsky E., Lusga E., Mundlos S.,
RA   Graul-Neumann L.M.;
RT   "Czech dysplasia: report of a large family and further delineation of the
RT   phenotype.";
RL   Am. J. Med. Genet. A 146:1859-1864(2008).
RN   [73]
RP   VARIANTS SER-9; ASP-142; ILE-638; THR-1051; ILE-1331 AND SER-1405.
RX   PubMed=18272325; DOI=10.1016/j.ygeno.2007.12.008;
RA   Chan T.F., Poon A., Basu A., Addleman N.R., Chen J., Phong A., Byers P.H.,
RA   Klein T.E., Kwok P.Y.;
RT   "Natural variation in four human collagen genes across an ethnically
RT   diverse population.";
RL   Genomics 91:307-314(2008).
RN   [74]
RP   VARIANT STL1O TYR-57.
RX   PubMed=17721977; DOI=10.1002/humu.20603;
RA   McAlinden A., Majava M., Bishop P.N., Perveen R., Black G.C.M.,
RA   Pierpont M.E., Ala-Kokko L., Maennikkoe M.;
RT   "Missense and nonsense mutations in the alternatively-spliced exon 2 of
RT   COL2A1 cause the ocular variant of Stickler syndrome.";
RL   Hum. Mutat. 29:83-90(2008).
RN   [75]
RP   VARIANT CZECHD CYS-275.
RX   PubMed=19764028; DOI=10.1002/ajmg.a.33010;
RA   Matsui Y., Michigami T., Tachikawa K., Yamazaki M., Kawabata H.,
RA   Nishimura G.;
RT   "Czech dysplasia occurring in a Japanese family.";
RL   Am. J. Med. Genet. A 149:2285-2289(2009).
RN   [76]
RP   VARIANTS STL1 ASP-240; ARG-270; ASP-282; ALA-453; ARG-501; CYS-904 AND
RP   ALA-1158.
RX   PubMed=20513134; DOI=10.1002/humu.21257;
RA   Richards A.J., McNinch A., Martin H., Oakhill K., Rai H., Waller S.,
RA   Treacy B., Whittaker J., Meredith S., Poulson A., Snead M.P.;
RT   "Stickler syndrome and the vitreous phenotype: mutations in COL2A1 and
RT   COL11A1.";
RL   Hum. Mutat. 31:E1461-E1471(2010).
RN   [77]
RP   VARIANT ANFH1 MET-1383.
RX   PubMed=21671384; DOI=10.1002/ajmg.a.34056;
RA   Kannu P., O'Rielly D.D., Hyland J.C., Kokko L.A.;
RT   "Avascular necrosis of the femoral head due to a novel C propeptide
RT   mutation in COL2A1.";
RL   Am. J. Med. Genet. A 155A:1759-1762(2011).
RN   [78]
RP   VARIANTS VAL-1176 AND ARG-1179.
RX   PubMed=21922596; DOI=10.1002/humu.21611;
RA   Jackson G.C., Mittaz-Crettol L., Taylor J.A., Mortier G.R., Spranger J.,
RA   Zabel B., Le Merrer M., Cormier-Daire V., Hall C.M., Offiah A.,
RA   Wright M.J., Savarirayan R., Nishimura G., Ramsden S.C., Elles R.,
RA   Bonafe L., Superti-Furga A., Unger S., Zankl A., Briggs M.D.;
RT   "Pseudoachondroplasia and multiple epiphyseal dysplasia: A 7-year
RT   comprehensive analysis of the known disease genes identify novel and
RT   recurrent mutations and provides an accurate assessment of their relative
RT   contribution.";
RL   Hum. Mutat. 33:144-157(2012).
RN   [79]
RP   VARIANT CYS-1459.
RX   PubMed=28887846; DOI=10.1002/humu.23335;
RA   Zhou X.L., He L.X., Yu L.J., Wang Y., Wang X.J., Wang E.D., Yang T.;
RT   "Mutations in KARS cause early-onset hearing loss and leukoencephalopathy:
RT   Potential pathogenic mechanism.";
RL   Hum. Mutat. 38:1740-1750(2017).
CC   -!- FUNCTION: Type II collagen is specific for cartilaginous tissues. It is
CC       essential for the normal embryonic development of the skeleton, for
CC       linear growth and for the ability of cartilage to resist compressive
CC       forces.
CC   -!- SUBUNIT: Homotrimers of alpha 1(II) chains.
CC   -!- INTERACTION:
CC       P02458-1; Q14145: KEAP1; NbExp=3; IntAct=EBI-12375799, EBI-751001;
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix {ECO:0000255|PROSITE-ProRule:PRU00793}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=2;
CC         IsoId=P02458-2; Sequence=Displayed;
CC       Name=1;
CC         IsoId=P02458-1; Sequence=VSP_022366;
CC       Name=3;
CC         IsoId=P02458-3; Sequence=VSP_022365;
CC   -!- TISSUE SPECIFICITY: Isoform 2 is highly expressed in juvenile
CC       chondrocyte and low in fetal chondrocyte. {ECO:0000269|PubMed:2355003}.
CC   -!- DOMAIN: The C-terminal propeptide, also known as COLFI domain, have
CC       crucial roles in tissue growth and repair by controlling both the
CC       intracellular assembly of procollagen molecules and the extracellular
CC       assembly of collagen fibrils. It binds a calcium ion which is essential
CC       for its function (By similarity). {ECO:0000250}.
CC   -!- PTM: The N-telopeptide is covalently linked to the helical COL2 region
CC       of alpha 1(IX), alpha 2(IX) and alpha 3(IX) chain. The C-telopeptide is
CC       covalently linked to an another site in the helical region of alpha
CC       3(IX) COL2.
CC   -!- PTM: Contains mostly 4-hydroxyproline. Prolines at the third position
CC       of the tripeptide repeating unit (G-X-P) are 4-hydroxylated in some or
CC       all of the chains. {ECO:0000250|UniProtKB:P05539}.
CC   -!- PTM: Contains 3-hydroxyproline at a few sites. This modification occurs
CC       on the first proline residue in the sequence motif Gly-Pro-Hyp, where
CC       Hyp is 4-hydroxyproline. {ECO:0000250|UniProtKB:P05539}.
CC   -!- PTM: Lysine residues at the third position of the tripeptide repeating
CC       unit (G-X-Y) are 5-hydroxylated in some or all of the chains.
CC       {ECO:0000250|UniProtKB:P05539}.
CC   -!- PTM: O-glycosylated on hydroxylated lysine residues. The O-linked
CC       glycan consists of a Glc-Gal disaccharide.
CC       {ECO:0000250|UniProtKB:P05539}.
CC   -!- DISEASE: Spondyloepiphyseal dysplasia congenital type (SEDC)
CC       [MIM:183900]: Disorder characterized by disproportionate short stature
CC       and pleiotropic involvement of the skeletal and ocular systems.
CC       {ECO:0000269|PubMed:10678662, ECO:0000269|PubMed:11746045,
CC       ECO:0000269|PubMed:2339128, ECO:0000269|PubMed:2543071,
CC       ECO:0000269|PubMed:7757086, ECO:0000269|PubMed:8019561,
CC       ECO:0000269|PubMed:8325895, ECO:0000269|PubMed:8423604}. Note=The
CC       disease is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Spondyloepiphyseal dysplasia, Stanescu type (SEDSTN)
CC       [MIM:616583]: An autosomal dominant spondyloepiphyseal dysplasia
CC       characterized by glycoproteins accumulation in chondrocytes. Clinical
CC       features include progressive joint contractures, premature degenerative
CC       joint disease particularly in the knee, hip and finger joints, and
CC       osseous distention of the metaphyseal ends of the phalanges causing
CC       swolling of interphalangeal joints of the hands. Radiological features
CC       include generalized platyspondyly, hypoplastic pelvis, epiphyseal
CC       flattening with metaphyseal splaying of the long bones, and enlarged
CC       phalangeal epimetaphyses of the hands. {ECO:0000269|PubMed:26183434}.
CC       Note=The disease is caused by mutations affecting the gene represented
CC       in this entry.
CC   -!- DISEASE: Spondyloepimetaphyseal dysplasia, Strudwick type (SEMDSTWK)
CC       [MIM:184250]: A bone disease characterized by disproportionate short
CC       stature from birth, with a very short trunk and shortened limbs, and
CC       skeletal abnormalities including lordosis, scoliosis, flattened
CC       vertebrae, pectus carinatum, coxa vara, clubfoot, and abnormal
CC       epiphyses or metaphyses. A distinctive radiographic feature is
CC       irregular sclerotic changes, described as dappled in the metaphyses of
CC       the long bones. {ECO:0000269|PubMed:16088915,
CC       ECO:0000269|PubMed:7550321, ECO:0000269|Ref.39}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Achondrogenesis 2 (ACG2) [MIM:200610]: An autosomal dominant
CC       disease characterized by the absence of ossification in the vertebral
CC       column, sacrum and pubic bones. {ECO:0000269|PubMed:10745044,
CC       ECO:0000269|PubMed:10797431, ECO:0000269|PubMed:15054848,
CC       ECO:0000269|PubMed:17994563, ECO:0000269|PubMed:2572591,
CC       ECO:0000269|PubMed:7757081, ECO:0000269|PubMed:7757086,
CC       ECO:0000269|PubMed:7829510}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Legg-Calve-Perthes disease (LCPD) [MIM:150600]: Characterized
CC       by loss of circulation to the femoral head, resulting in avascular
CC       necrosis in a growing child. Clinical pictures of the disease vary,
CC       depending on the phase of disease progression through ischemia,
CC       revascularization, fracture and collapse, and repair and remodeling of
CC       the bone. {ECO:0000269|PubMed:17394019}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Kniest dysplasia (KD) [MIM:156550]: Moderately severe
CC       chondrodysplasia phenotype that results from mutations in the COL2A1
CC       gene. Characteristics of the disorder include a short trunk and
CC       extremities, mid-face hypoplasia, cleft palate, myopia, retinal
CC       detachment, and hearing loss. {ECO:0000269|PubMed:7874117,
CC       ECO:0000269|PubMed:8863156}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Avascular necrosis of femoral head, primary, 1 (ANFH1)
CC       [MIM:608805]: A disease characterized by mechanical failure of the
CC       subchondral bone, and degeneration of the hip joint. It usually leads
CC       to destruction of the hip joint in the third to fifth decade of life.
CC       The clinical manifestations, such as pain on exertion, a limping gait,
CC       and a discrepancy in leg length, cause considerable disability. ANFH1
CC       inheritance is autosomal dominant. {ECO:0000269|PubMed:15930420,
CC       ECO:0000269|PubMed:21671384}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Osteoarthritis with mild chondrodysplasia (OSCDP)
CC       [MIM:604864]: Osteoarthritis is a common disease that produces joint
CC       pain and stiffness together with radiologic evidence of progressive
CC       degeneration of joint cartilage. {ECO:0000269|PubMed:1975693,
CC       ECO:0000269|PubMed:1985108, ECO:0000269|PubMed:7757086,
CC       ECO:0000269|PubMed:8507190}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Platyspondylic lethal skeletal dysplasia Torrance type (PLSD-
CC       T) [MIM:151210]: Platyspondylic lethal skeletal dysplasias (PLSDs) are
CC       a heterogeneous group of chondrodysplasias characterized by severe
CC       platyspondyly and limb shortening. PLSD-T is characterized by varying
CC       platyspondyly, short ribs with anterior cupping, hypoplasia of the
CC       lower ilia with broad ischial and pubic bones, and shortening of the
CC       tubular bones with splayed and cupped metaphyses. Histology of the
CC       growth plate typically shows focal hypercellularity with slightly
CC       enlarged chondrocytes in the resting cartilage and relatively well-
CC       preserved columnar formation and ossification at the chondro-osseous
CC       junction. PLSD-T is generally a perinatally lethal disease, but a few
CC       long-term survivors have been reported. {ECO:0000269|PubMed:10745044,
CC       ECO:0000269|PubMed:14729840, ECO:0000269|PubMed:15643621}. Note=The
CC       disease is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Multiple epiphyseal dysplasia with myopia and conductive
CC       deafness (EDMMD) [MIM:132450]: A generalized skeletal dysplasia
CC       associated with significant morbidity. Joint pain, joint deformity,
CC       waddling gait, and short stature are the main clinical signs and
CC       symptoms. EDMMD is an autosomal dominant disorder characterized by
CC       epiphyseal dysplasia associated with progressive myopia, retinal
CC       thinning, crenated cataracts, conductive deafness.
CC       {ECO:0000269|PubMed:9800905}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Spondyloperipheral dysplasia (SPD) [MIM:271700]: SPD patients
CC       manifest short stature, midface hypoplasia, sensorineural hearing loss,
CC       spondyloepiphyseal dysplasia, platyspondyly and brachydactyly.
CC       {ECO:0000269|PubMed:15316962}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Stickler syndrome 1 (STL1) [MIM:108300]: An autosomal dominant
CC       form of Stickler syndrome, an inherited disorder that associates ocular
CC       signs with more or less complete forms of Pierre Robin sequence, bone
CC       disorders and sensorineural deafness. Ocular disorders may include
CC       juvenile cataract, myopia, strabismus, vitreoretinal or chorioretinal
CC       degeneration, retinal detachment, and chronic uveitis. Pierre Robin
CC       sequence includes an opening in the roof of the mouth (a cleft palate),
CC       a large tongue (macroglossia), and a small lower jaw (micrognathia).
CC       Bones are affected by slight platyspondylisis and large, often
CC       defective epiphyses. Juvenile joint laxity is followed by early signs
CC       of arthrosis. The degree of hearing loss varies among affected
CC       individuals and may become more severe over time. Syndrome expressivity
CC       is variable. {ECO:0000269|PubMed:11007540, ECO:0000269|PubMed:20513134,
CC       ECO:0000269|PubMed:7977371}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Stickler syndrome 1 non-syndromic ocular (STL1O) [MIM:609508]:
CC       An autosomal dominant form of Stickler syndrome characterized by the
CC       ocular signs typically seen in Stickler syndrome type 1 such as
CC       cataract, myopia, retinal detachment. Systemic features of premature
CC       osteoarthritis, cleft palate, hearing impairment, and craniofacial
CC       abnormalities are either absent or very mild.
CC       {ECO:0000269|PubMed:16752401, ECO:0000269|PubMed:17721977,
CC       ECO:0000269|PubMed:8317498}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Rhegmatogenous retinal detachment autosomal dominant (DRRD)
CC       [MIM:609508]: A eye disease that most frequently results from a break
CC       or tear in the retina that allows fluid from the vitreous humor to
CC       enter the potential space beneath the retina. It is often associated
CC       with pathologic myopia and in most cases leads to visual impairment or
CC       blindness if untreated. {ECO:0000269|PubMed:11007540,
CC       ECO:0000269|PubMed:15671297}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Czech dysplasia (CZECHD) [MIM:609162]: A skeletal dysplasia
CC       characterized by early-onset, progressive pseudorheumatoid arthritis,
CC       platyspondyly, and short third and fourth toes.
CC       {ECO:0000269|PubMed:18553548, ECO:0000269|PubMed:19764028,
CC       ECO:0000269|PubMed:7757086, ECO:0000269|PubMed:8244341}. Note=The
CC       disease is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the fibrillar collagen family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00793}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH07252.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X16468; CAA34488.1; -; mRNA.
DR   EMBL; L10347; AAC41772.1; -; Genomic_DNA.
DR   EMBL; BT007205; AAP35869.1; -; mRNA.
DR   EMBL; AC004801; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC007252; AAH07252.1; ALT_FRAME; mRNA.
DR   EMBL; BC116449; AAI16450.1; -; mRNA.
DR   EMBL; X16711; CAA34683.1; -; mRNA.
DR   EMBL; M25730; AAA58428.2; -; Genomic_DNA.
DR   EMBL; M32168; AAA58428.2; JOINED; Genomic_DNA.
DR   EMBL; M25655; AAA58428.2; JOINED; Genomic_DNA.
DR   EMBL; M25656; AAA58428.2; JOINED; Genomic_DNA.
DR   EMBL; M64345; AAA58428.2; JOINED; Genomic_DNA.
DR   EMBL; M60299; AAA73873.1; -; Genomic_DNA.
DR   EMBL; M25698; AAA52051.1; -; Genomic_DNA.
DR   EMBL; X58709; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; X57010; CAA40330.1; -; Genomic_DNA.
DR   EMBL; U15195; AAB60370.1; -; Genomic_DNA.
DR   EMBL; X13783; CAA32030.1; -; mRNA.
DR   EMBL; M25728; AAD15287.1; -; Genomic_DNA.
DR   EMBL; X02371; CAA26223.1; -; Genomic_DNA.
DR   EMBL; X02372; CAA26223.1; JOINED; Genomic_DNA.
DR   EMBL; X02373; CAA26223.1; JOINED; Genomic_DNA.
DR   EMBL; X02374; CAA26223.1; JOINED; Genomic_DNA.
DR   EMBL; X02375; CAA26224.1; -; Genomic_DNA.
DR   EMBL; X02376; CAA26225.1; -; Genomic_DNA.
DR   EMBL; X02377; CAA26226.1; -; Genomic_DNA.
DR   EMBL; X02378; CAA26227.1; -; Genomic_DNA.
DR   EMBL; X16158; CAA34278.1; -; Genomic_DNA.
DR   EMBL; X16158; CAA34279.1; -; Genomic_DNA.
DR   EMBL; X16158; CAA34280.1; -; Genomic_DNA.
DR   EMBL; X16158; CAA34281.1; -; Genomic_DNA.
DR   EMBL; X16158; CAA34282.1; -; Genomic_DNA.
DR   EMBL; X16158; CAA34283.1; -; Genomic_DNA.
DR   EMBL; X16158; CAA34284.1; -; Genomic_DNA.
DR   EMBL; J00116; AAA51997.1; -; Genomic_DNA.
DR   EMBL; L00977; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; M63281; AAA52038.1; -; mRNA.
DR   EMBL; M27468; AAA52039.1; -; Genomic_DNA.
DR   EMBL; X06268; CAA29604.1; -; mRNA.
DR   EMBL; X00339; CAA25092.1; -; Genomic_DNA.
DR   EMBL; M12048; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS41778.1; -. [P02458-2]
DR   CCDS; CCDS8759.1; -. [P02458-1]
DR   PIR; A38513; CGHU6C.
DR   RefSeq; NP_001835.3; NM_001844.4. [P02458-2]
DR   RefSeq; NP_149162.2; NM_033150.2. [P02458-1]
DR   PDB; 1U5M; NMR; -; A=29-97.
DR   PDB; 2FSE; X-ray; 3.10 A; E/F=461-474.
DR   PDB; 2SEB; X-ray; 2.50 A; E=1238-1247.
DR   PDB; 5NIR; X-ray; 1.74 A; A/B=29-98.
DR   PDB; 5OCX; X-ray; 1.75 A; A=484-498.
DR   PDB; 5OCY; X-ray; 2.60 A; C=1120-1134.
DR   PDB; 6BIN; X-ray; 2.50 A; C=1237-1249.
DR   PDBsum; 1U5M; -.
DR   PDBsum; 2FSE; -.
DR   PDBsum; 2SEB; -.
DR   PDBsum; 5NIR; -.
DR   PDBsum; 5OCX; -.
DR   PDBsum; 5OCY; -.
DR   PDBsum; 6BIN; -.
DR   SMR; P02458; -.
DR   BioGrid; 107677; 28.
DR   ComplexPortal; CPX-1713; Collagen type II trimer.
DR   ComplexPortal; CPX-1750; Collagen type XI trimer variant 1.
DR   IntAct; P02458; 15.
DR   MINT; P02458; -.
DR   STRING; 9606.ENSP00000369889; -.
DR   ChEMBL; CHEMBL2364188; -.
DR   DrugBank; DB00048; Collagenase clostridium histolyticum.
DR   GlyConnect; 1126; -.
DR   iPTMnet; P02458; -.
DR   PhosphoSitePlus; P02458; -.
DR   BioMuta; COL2A1; -.
DR   DMDM; 124056489; -.
DR   jPOST; P02458; -.
DR   MassIVE; P02458; -.
DR   PaxDb; P02458; -.
DR   PeptideAtlas; P02458; -.
DR   PRIDE; P02458; -.
DR   ProteomicsDB; 51519; -. [P02458-2]
DR   ProteomicsDB; 51520; -. [P02458-1]
DR   ProteomicsDB; 51521; -. [P02458-3]
DR   ABCD; P02458; -.
DR   Antibodypedia; 3697; 727 antibodies.
DR   DNASU; 1280; -.
DR   Ensembl; ENST00000337299; ENSP00000338213; ENSG00000139219. [P02458-1]
DR   Ensembl; ENST00000380518; ENSP00000369889; ENSG00000139219. [P02458-2]
DR   GeneID; 1280; -.
DR   KEGG; hsa:1280; -.
DR   UCSC; uc001rqu.4; human. [P02458-2]
DR   CTD; 1280; -.
DR   DisGeNET; 1280; -.
DR   GeneCards; COL2A1; -.
DR   GeneReviews; COL2A1; -.
DR   HGNC; HGNC:2200; COL2A1.
DR   HPA; ENSG00000139219; Group enriched (epididymis, pituitary gland, retina, stomach).
DR   MalaCards; COL2A1; -.
DR   MIM; 108300; phenotype.
DR   MIM; 120140; gene+phenotype.
DR   MIM; 132450; phenotype.
DR   MIM; 150600; phenotype.
DR   MIM; 151210; phenotype.
DR   MIM; 156550; phenotype.
DR   MIM; 183900; phenotype.
DR   MIM; 184250; phenotype.
DR   MIM; 200610; phenotype.
DR   MIM; 271700; phenotype.
DR   MIM; 604864; phenotype.
DR   MIM; 608805; phenotype.
DR   MIM; 609162; phenotype.
DR   MIM; 609508; phenotype.
DR   MIM; 616583; phenotype.
DR   neXtProt; NX_P02458; -.
DR   OpenTargets; ENSG00000139219; -.
DR   Orphanet; 93296; Achondrogenesis type 2.
DR   Orphanet; 166100; Autosomal dominant otospondylomegaepiphyseal dysplasia.
DR   Orphanet; 209867; Autosomal dominant rhegmatogenous retinal detachment.
DR   Orphanet; 137678; Czech dysplasia, metatarsal type.
DR   Orphanet; 85198; Dysspondyloenchondromatosis.
DR   Orphanet; 86820; Familial avascular necrosis of femoral head.
DR   Orphanet; 93297; Hypochondrogenesis.
DR   Orphanet; 485; Kniest dysplasia.
DR   Orphanet; 2380; Legg-Calve-Perthes disease.
DR   Orphanet; 93279; Mild spondyloepiphyseal dysplasia due to COL2A1 mutation with early-onset osteoarthritis.
DR   Orphanet; 166011; Multiple epiphyseal dysplasia, Beighton type.
DR   Orphanet; 85166; Platyspondylic dysplasia, Torrance type.
DR   Orphanet; 93346; Spondyloepimetaphyseal dysplasia congenita, Strudwick type.
DR   Orphanet; 94068; Spondyloepiphyseal dysplasia congenita.
DR   Orphanet; 459051; Spondyloepiphyseal dysplasia, Stanescu type.
DR   Orphanet; 93315; Spondylometaphyseal dysplasia, 'corner fracture' type.
DR   Orphanet; 93316; Spondylometaphyseal dysplasia, Schmidt type.
DR   Orphanet; 1856; Spondyloperipheral dysplasia-short ulna syndrome.
DR   Orphanet; 90653; Stickler syndrome type 1.
DR   PharmGKB; PA26715; -.
DR   eggNOG; KOG3544; Eukaryota.
DR   eggNOG; ENOG410XNMM; LUCA.
DR   GeneTree; ENSGT00940000155224; -.
DR   HOGENOM; CLU_001074_2_3_1; -.
DR   InParanoid; P02458; -.
DR   KO; K19719; -.
DR   OMA; WGKTMIE; -.
DR   OrthoDB; 337699at2759; -.
DR   PhylomeDB; P02458; -.
DR   TreeFam; TF344135; -.
DR   Reactome; R-HSA-1442490; Collagen degradation.
DR   Reactome; R-HSA-1474244; Extracellular matrix organization.
DR   Reactome; R-HSA-1650814; Collagen biosynthesis and modifying enzymes.
DR   Reactome; R-HSA-186797; Signaling by PDGF.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-HSA-2022090; Assembly of collagen fibrils and other multimeric structures.
DR   Reactome; R-HSA-216083; Integrin cell surface interactions.
DR   Reactome; R-HSA-3000171; Non-integrin membrane-ECM interactions.
DR   Reactome; R-HSA-3000178; ECM proteoglycans.
DR   Reactome; R-HSA-419037; NCAM1 interactions.
DR   Reactome; R-HSA-8874081; MET activates PTK2 signaling.
DR   Reactome; R-HSA-8948216; Collagen chain trimerization.
DR   SIGNOR; P02458; -.
DR   ChiTaRS; COL2A1; human.
DR   EvolutionaryTrace; P02458; -.
DR   GeneWiki; Collagen,_type_II,_alpha_1; -.
DR   GenomeRNAi; 1280; -.
DR   Pharos; P02458; Tbio.
DR   PRO; PR:P02458; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; P02458; protein.
DR   Bgee; ENSG00000139219; Expressed in tibia and 84 other tissues.
DR   Genevisible; P02458; HS.
DR   GO; GO:0005604; C:basement membrane; IEA:Ensembl.
DR   GO; GO:0005581; C:collagen trimer; IBA:GO_Central.
DR   GO; GO:0005585; C:collagen type II trimer; IDA:BHF-UCL.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; HDA:UniProtKB.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0031012; C:extracellular matrix; IBA:GO_Central.
DR   GO; GO:0005576; C:extracellular region; HDA:BHF-UCL.
DR   GO; GO:0005615; C:extracellular space; IMP:UniProtKB.
DR   GO; GO:0005201; F:extracellular matrix structural constituent; IBA:GO_Central.
DR   GO; GO:0030020; F:extracellular matrix structural constituent conferring tensile strength; HDA:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; NAS:BHF-UCL.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0042289; F:MHC class II protein binding; IPI:CAFA.
DR   GO; GO:0048407; F:platelet-derived growth factor binding; IDA:MGI.
DR   GO; GO:0043394; F:proteoglycan binding; IDA:MGI.
DR   GO; GO:0097065; P:anterior head development; IEA:Ensembl.
DR   GO; GO:0001502; P:cartilage condensation; IEA:Ensembl.
DR   GO; GO:0051216; P:cartilage development; TAS:BHF-UCL.
DR   GO; GO:0060351; P:cartilage development involved in endochondral bone morphogenesis; IEA:Ensembl.
DR   GO; GO:0071773; P:cellular response to BMP stimulus; IEA:Ensembl.
DR   GO; GO:0007417; P:central nervous system development; IEA:Ensembl.
DR   GO; GO:0002062; P:chondrocyte differentiation; IEA:Ensembl.
DR   GO; GO:0030199; P:collagen fibril organization; IMP:BHF-UCL.
DR   GO; GO:0060272; P:embryonic skeletal joint morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0001958; P:endochondral ossification; IEA:Ensembl.
DR   GO; GO:0030198; P:extracellular matrix organization; IBA:GO_Central.
DR   GO; GO:0003007; P:heart morphogenesis; IEA:Ensembl.
DR   GO; GO:0042472; P:inner ear morphogenesis; IEA:Ensembl.
DR   GO; GO:0060174; P:limb bud formation; IEA:Ensembl.
DR   GO; GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl.
DR   GO; GO:0030903; P:notochord development; IBA:GO_Central.
DR   GO; GO:0071599; P:otic vesicle development; IEA:Ensembl.
DR   GO; GO:0006029; P:proteoglycan metabolic process; IEA:Ensembl.
DR   GO; GO:0010468; P:regulation of gene expression; IEA:Ensembl.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060021; P:roof of mouth development; IEA:Ensembl.
DR   GO; GO:0007605; P:sensory perception of sound; IMP:BHF-UCL.
DR   GO; GO:0001501; P:skeletal system development; IMP:BHF-UCL.
DR   GO; GO:0001894; P:tissue homeostasis; IEA:Ensembl.
DR   GO; GO:0007601; P:visual perception; IMP:UniProtKB.
DR   DisProt; DP00274; -.
DR   InterPro; IPR008160; Collagen.
DR   InterPro; IPR000885; Fib_collagen_C.
DR   InterPro; IPR001007; VWF_dom.
DR   Pfam; PF01410; COLFI; 1.
DR   Pfam; PF01391; Collagen; 6.
DR   Pfam; PF00093; VWC; 1.
DR   SMART; SM00038; COLFI; 1.
DR   SMART; SM00214; VWC; 1.
DR   PROSITE; PS51461; NC1_FIB; 1.
DR   PROSITE; PS01208; VWFC_1; 1.
DR   PROSITE; PS50184; VWFC_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Cataract; Collagen; Deafness;
KW   Direct protein sequencing; Disease mutation; Disulfide bond; Dwarfism;
KW   Extracellular matrix; Glycoprotein; Hydroxylation; Metal-binding;
KW   Polymorphism; Reference proteome; Repeat; Secreted; Signal;
KW   Stickler syndrome.
FT   SIGNAL          1..25
FT                   /evidence="ECO:0000255"
FT   PROPEP          26..181
FT                   /note="N-terminal propeptide"
FT                   /id="PRO_0000005729"
FT   CHAIN           182..1241
FT                   /note="Collagen alpha-1(II) chain"
FT                   /id="PRO_0000005730"
FT   CHAIN           1242..1487
FT                   /note="Chondrocalcin"
FT                   /id="PRO_0000005731"
FT   DOMAIN          32..90
FT                   /note="VWFC"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00220"
FT   DOMAIN          1253..1487
FT                   /note="Fibrillar collagen NC1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00793"
FT   REGION          201..1214
FT                   /note="Triple-helical region"
FT   REGION          1215..1241
FT                   /note="Nonhelical region (C-terminal)"
FT   METAL           1301
FT                   /note="Calcium"
FT                   /evidence="ECO:0000250"
FT   METAL           1303
FT                   /note="Calcium"
FT                   /evidence="ECO:0000250"
FT   METAL           1304
FT                   /note="Calcium; via carbonyl oxygen"
FT                   /evidence="ECO:0000250"
FT   METAL           1306
FT                   /note="Calcium; via carbonyl oxygen"
FT                   /evidence="ECO:0000250"
FT   METAL           1309
FT                   /note="Calcium"
FT                   /evidence="ECO:0000250"
FT   SITE            181..182
FT                   /note="Cleavage; by procollagen N-endopeptidase"
FT                   /evidence="ECO:0000250"
FT   SITE            1241..1242
FT                   /note="Cleavage; by procollagen C-endopeptidase"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         190
FT                   /note="5-hydroxylysine"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         287
FT                   /note="5-hydroxylysine"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         299
FT                   /note="5-hydroxylysine"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         308
FT                   /note="5-hydroxylysine"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         374
FT                   /note="5-hydroxylysine"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         608
FT                   /note="5-hydroxylysine"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         620
FT                   /note="5-hydroxylysine"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         659
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P05539"
FT   MOD_RES         668
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P05539"
FT   MOD_RES         670
FT                   /note="3-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P05539"
FT   MOD_RES         671
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P05539"
FT   MOD_RES         674
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P05539"
FT   MOD_RES         907
FT                   /note="3-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P05539"
FT   MOD_RES         908
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P05539"
FT   MOD_RES         914
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P05539"
FT   MOD_RES         920
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P05539"
FT   MOD_RES         1130
FT                   /note="5-hydroxylysine"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         1144
FT                   /note="3-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         1181
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P05539"
FT   MOD_RES         1186
FT                   /note="3-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P05539"
FT   MOD_RES         1187
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P05539"
FT   MOD_RES         1201
FT                   /note="3-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P05539"
FT   MOD_RES         1202
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P05539"
FT   MOD_RES         1205
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P05539"
FT   MOD_RES         1207
FT                   /note="3-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P05539"
FT   MOD_RES         1208
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P05539"
FT   MOD_RES         1211
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P05539"
FT   MOD_RES         1213
FT                   /note="3-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P05539"
FT   MOD_RES         1214
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P05539"
FT   CARBOHYD        190
FT                   /note="O-linked (Gal...) hydroxylysine"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        287
FT                   /note="O-linked (Gal...) hydroxylysine"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        299
FT                   /note="O-linked (Gal...) hydroxylysine"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        308
FT                   /note="O-linked (Gal...) hydroxylysine"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        374
FT                   /note="O-linked (Gal...) hydroxylysine"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        608
FT                   /note="O-linked (Gal...) hydroxylysine"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        620
FT                   /note="O-linked (Gal...) hydroxylysine"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        1130
FT                   /note="O-linked (Gal...) hydroxylysine"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        1388
FT                   /note="N-linked (GlcNAc...) asparagine"
FT   DISULFID        1283..1315
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00793"
FT   DISULFID        1289
FT                   /note="Interchain (with C-1306)"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00793"
FT   DISULFID        1306
FT                   /note="Interchain (with C-1289)"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00793"
FT   DISULFID        1323..1485
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00793"
FT   DISULFID        1393..1438
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00793"
FT   VAR_SEQ         1..1219
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|Ref.3"
FT                   /id="VSP_022365"
FT   VAR_SEQ         29..98
FT                   /note="QEAGSCVQDGQRYNDKDVWKPEPCRICVCDTGTVLCDDIICEDVKDCLSPEI
FT                   PFGECCPICPTDLATASG -> R (in isoform 1)"
FT                   /evidence="ECO:0000303|PubMed:2587267,
FT                   ECO:0000303|PubMed:2803268"
FT                   /id="VSP_022366"
FT   VARIANT         9
FT                   /note="T -> S (in dbSNP:rs3803183)"
FT                   /evidence="ECO:0000269|PubMed:18272325,
FT                   ECO:0000269|PubMed:2081599, ECO:0000269|PubMed:2587267,
FT                   ECO:0000269|PubMed:2714801, ECO:0000269|PubMed:2803268,
FT                   ECO:0000269|PubMed:8948452"
FT                   /id="VAR_017638"
FT   VARIANT         57
FT                   /note="C -> Y (in STL1O; dbSNP:rs121912898)"
FT                   /evidence="ECO:0000269|PubMed:17721977"
FT                   /id="VAR_063891"
FT   VARIANT         142
FT                   /note="E -> D (in dbSNP:rs34392760)"
FT                   /evidence="ECO:0000269|PubMed:18272325"
FT                   /id="VAR_033782"
FT   VARIANT         158
FT                   /note="P -> L (in dbSNP:rs1050861)"
FT                   /evidence="ECO:0000269|PubMed:2587267"
FT                   /id="VAR_019836"
FT   VARIANT         207
FT                   /note="G -> R (in SEDSTN; dbSNP:rs869312907)"
FT                   /evidence="ECO:0000269|PubMed:26183434"
FT                   /id="VAR_075729"
FT   VARIANT         240
FT                   /note="G -> D (in STL1)"
FT                   /evidence="ECO:0000269|PubMed:20513134"
FT                   /id="VAR_063892"
FT   VARIANT         267
FT                   /note="G -> D (in STL1O; dbSNP:rs121912872)"
FT                   /evidence="ECO:0000269|PubMed:8317498"
FT                   /id="VAR_001738"
FT   VARIANT         270
FT                   /note="G -> R (in STL1)"
FT                   /evidence="ECO:0000269|PubMed:20513134"
FT                   /id="VAR_063893"
FT   VARIANT         275
FT                   /note="R -> C (in CZECHD; dbSNP:rs121912876)"
FT                   /evidence="ECO:0000269|PubMed:18553548,
FT                   ECO:0000269|PubMed:19764028, ECO:0000269|PubMed:7757086,
FT                   ECO:0000269|PubMed:8244341"
FT                   /id="VAR_001739"
FT   VARIANT         282
FT                   /note="G -> D (in STL1)"
FT                   /evidence="ECO:0000269|PubMed:20513134"
FT                   /id="VAR_063894"
FT   VARIANT         302..308
FT                   /note="Missing (in STL1)"
FT                   /evidence="ECO:0000269|PubMed:7977371"
FT                   /id="VAR_001740"
FT   VARIANT         303
FT                   /note="G -> D (in KD; abnormal allele expressed in the
FT                   cartilage; dbSNP:rs121912877)"
FT                   /evidence="ECO:0000269|PubMed:7874117"
FT                   /id="VAR_001741"
FT   VARIANT         318
FT                   /note="G -> R (in DRRD; dbSNP:rs121912894)"
FT                   /evidence="ECO:0000269|PubMed:15671297"
FT                   /id="VAR_023925"
FT   VARIANT         354
FT                   /note="G -> R (in spondylometaphyseal dysplasia; congenital
FT                   type; dbSNP:rs121912871)"
FT                   /evidence="ECO:0000269|PubMed:8486375"
FT                   /id="VAR_001742"
FT   VARIANT         375
FT                   /note="G -> R (in SEDC)"
FT                   /id="VAR_001743"
FT   VARIANT         447
FT                   /note="G -> S (in SEDC)"
FT                   /evidence="ECO:0000269|PubMed:8019561"
FT                   /id="VAR_001744"
FT   VARIANT         453
FT                   /note="G -> A (in STL1; dbSNP:rs794727339)"
FT                   /evidence="ECO:0000269|PubMed:20513134"
FT                   /id="VAR_063895"
FT   VARIANT         453
FT                   /note="G -> D (in ACG2)"
FT                   /evidence="ECO:0000269|PubMed:10797431"
FT                   /id="VAR_017639"
FT   VARIANT         453
FT                   /note="G -> V (in ACG2)"
FT                   /evidence="ECO:0000269|PubMed:10797431"
FT                   /id="VAR_017640"
FT   VARIANT         492
FT                   /note="G -> V (in SEMDSTWK; dbSNP:rs121912881)"
FT                   /evidence="ECO:0000269|PubMed:7550321"
FT                   /id="VAR_001745"
FT   VARIANT         501
FT                   /note="G -> R (in STL1)"
FT                   /evidence="ECO:0000269|PubMed:20513134"
FT                   /id="VAR_063896"
FT   VARIANT         504
FT                   /note="G -> C (in SEMDSTWK; dbSNP:rs121912880)"
FT                   /evidence="ECO:0000269|PubMed:7550321"
FT                   /id="VAR_001746"
FT   VARIANT         510
FT                   /note="G -> D (in ACG2)"
FT                   /id="VAR_001747"
FT   VARIANT         513
FT                   /note="G -> S (in ACG2; dbSNP:rs1555167156)"
FT                   /evidence="ECO:0000269|PubMed:10745044"
FT                   /id="VAR_024819"
FT   VARIANT         516
FT                   /note="G -> D (in ACG2; dbSNP:rs121912888)"
FT                   /evidence="ECO:0000269|PubMed:15054848"
FT                   /id="VAR_023926"
FT   VARIANT         547
FT                   /note="D -> V (in ACG2)"
FT                   /evidence="ECO:0000269|PubMed:17994563"
FT                   /id="VAR_063897"
FT   VARIANT         565
FT                   /note="R -> C (in STL1; dbSNP:rs121912884)"
FT                   /evidence="ECO:0000269|PubMed:11007540"
FT                   /id="VAR_023927"
FT   VARIANT         638
FT                   /note="T -> I (in dbSNP:rs41263847)"
FT                   /evidence="ECO:0000269|PubMed:18272325"
FT                   /id="VAR_033783"
FT   VARIANT         667
FT                   /note="L -> F (in DRRD; dbSNP:rs121912885)"
FT                   /evidence="ECO:0000269|PubMed:11007540,
FT                   ECO:0000269|PubMed:15671297"
FT                   /id="VAR_023928"
FT   VARIANT         717
FT                   /note="G -> S (in ANFH1; dbSNP:rs387906558)"
FT                   /evidence="ECO:0000269|PubMed:15930420"
FT                   /id="VAR_023929"
FT   VARIANT         717
FT                   /note="G -> V (in ACG2)"
FT                   /evidence="ECO:0000269|PubMed:10745044"
FT                   /id="VAR_024820"
FT   VARIANT         719
FT                   /note="R -> C (in OSCDP; also in mild spondyloepiphyseal
FT                   dysplasia and precocious osteoarthritis;
FT                   dbSNP:rs121912865)"
FT                   /evidence="ECO:0000269|PubMed:1975693,
FT                   ECO:0000269|PubMed:1985108, ECO:0000269|PubMed:7757086,
FT                   ECO:0000269|PubMed:8507190, ECO:0000269|PubMed:9711874"
FT                   /id="VAR_001748"
FT   VARIANT         771
FT                   /note="G -> A (in ACG2)"
FT                   /evidence="ECO:0000269|PubMed:10745044"
FT                   /id="VAR_024821"
FT   VARIANT         771
FT                   /note="G -> D (in ACG2)"
FT                   /evidence="ECO:0000269|PubMed:10797431"
FT                   /id="VAR_017641"
FT   VARIANT         774
FT                   /note="G -> S (in SEDC and hypochondrogenesis; lethal;
FT                   dbSNP:rs121912867)"
FT                   /evidence="ECO:0000269|PubMed:1374906"
FT                   /id="VAR_001749"
FT   VARIANT         780
FT                   /note="G -> R (in ACG2)"
FT                   /evidence="ECO:0000269|PubMed:10797431"
FT                   /id="VAR_017642"
FT   VARIANT         795
FT                   /note="G -> R (in ACG2)"
FT                   /evidence="ECO:0000269|PubMed:10797431"
FT                   /id="VAR_017643"
FT   VARIANT         804
FT                   /note="G -> A (in hypochondrogenesis)"
FT                   /id="VAR_001751"
FT   VARIANT         855
FT                   /note="G -> S (in SEDC; dbSNP:rs1193507525)"
FT                   /id="VAR_023930"
FT   VARIANT         891
FT                   /note="G -> R (in ACG2 and SEDC; dbSNP:rs121912879)"
FT                   /evidence="ECO:0000269|PubMed:7757081,
FT                   ECO:0000269|PubMed:7757086"
FT                   /id="VAR_001752"
FT   VARIANT         894
FT                   /note="G -> E (in ACG2)"
FT                   /evidence="ECO:0000269|PubMed:10797431"
FT                   /id="VAR_017644"
FT   VARIANT         897
FT                   /note="G -> V (in SEMDSTWK)"
FT                   /evidence="ECO:0000269|Ref.39"
FT                   /id="VAR_023931"
FT   VARIANT         904
FT                   /note="R -> C (in EDMMD and STL1; dbSNP:rs121912882)"
FT                   /evidence="ECO:0000269|PubMed:20513134,
FT                   ECO:0000269|PubMed:9800905"
FT                   /id="VAR_017645"
FT   VARIANT         909
FT                   /note="G -> C (in SEMDSTWK; dbSNP:rs121912875)"
FT                   /evidence="ECO:0000269|PubMed:7550321, ECO:0000269|Ref.39"
FT                   /id="VAR_001753"
FT   VARIANT         948
FT                   /note="G -> D (in ACG2)"
FT                   /evidence="ECO:0000269|PubMed:10797431"
FT                   /id="VAR_017646"
FT   VARIANT         969
FT                   /note="G -> S (in ACG2; dbSNP:rs121912878)"
FT                   /evidence="ECO:0000269|PubMed:7829510"
FT                   /id="VAR_001754"
FT   VARIANT         981
FT                   /note="G -> S (in ACG2)"
FT                   /evidence="ECO:0000269|PubMed:10797431"
FT                   /id="VAR_017647"
FT   VARIANT         989
FT                   /note="R -> C (in SEDC; dbSNP:rs121912874)"
FT                   /evidence="ECO:0000269|PubMed:8325895"
FT                   /id="VAR_001755"
FT   VARIANT         992
FT                   /note="R -> G (in SEMDSTWK; dbSNP:rs121912895)"
FT                   /evidence="ECO:0000269|PubMed:16088915"
FT                   /id="VAR_023932"
FT   VARIANT         1005
FT                   /note="G -> S (in hypochondrogenesis; dbSNP:rs753342774)"
FT                   /id="VAR_001756"
FT   VARIANT         1017..1022
FT                   /note="Missing (in hypochondrogenesis)"
FT                   /evidence="ECO:0000269|PubMed:10797431"
FT                   /id="VAR_017648"
FT   VARIANT         1017
FT                   /note="G -> V (in ACG2)"
FT                   /id="VAR_001757"
FT   VARIANT         1051
FT                   /note="A -> T (in dbSNP:rs41272041)"
FT                   /evidence="ECO:0000269|PubMed:18272325"
FT                   /id="VAR_033784"
FT   VARIANT         1053
FT                   /note="G -> E (in hypochondrogenesis; lethal;
FT                   dbSNP:rs121912868)"
FT                   /evidence="ECO:0000269|PubMed:1429602"
FT                   /id="VAR_001758"
FT   VARIANT         1065
FT                   /note="G -> V (in ACG2)"
FT                   /evidence="ECO:0000269|PubMed:10797431"
FT                   /id="VAR_017649"
FT   VARIANT         1110
FT                   /note="G -> C (in ACG2)"
FT                   /evidence="ECO:0000269|PubMed:10745044"
FT                   /id="VAR_001759"
FT   VARIANT         1113
FT                   /note="G -> C (in hypochondrogenesis)"
FT                   /evidence="ECO:0000269|PubMed:8723098"
FT                   /id="VAR_001760"
FT   VARIANT         1119
FT                   /note="G -> R (in ACG2)"
FT                   /evidence="ECO:0000269|PubMed:10797431"
FT                   /id="VAR_017650"
FT   VARIANT         1143
FT                   /note="G -> S (in ACG2)"
FT                   /evidence="ECO:0000269|PubMed:10745044,
FT                   ECO:0000269|PubMed:2572591"
FT                   /id="VAR_001761"
FT   VARIANT         1158
FT                   /note="G -> A (in STL1)"
FT                   /evidence="ECO:0000269|PubMed:20513134"
FT                   /id="VAR_063898"
FT   VARIANT         1164..1199
FT                   /note="Missing (in SEDC)"
FT                   /id="VAR_001762"
FT   VARIANT         1170
FT                   /note="G -> S (in ANFH1 and LCPD; dbSNP:rs121912891)"
FT                   /evidence="ECO:0000269|PubMed:15930420,
FT                   ECO:0000269|PubMed:17394019"
FT                   /id="VAR_023933"
FT   VARIANT         1173
FT                   /note="G -> R (in SEDC; dbSNP:rs121912883)"
FT                   /evidence="ECO:0000269|PubMed:10678662"
FT                   /id="VAR_017651"
FT   VARIANT         1176
FT                   /note="G -> S (in SEDC)"
FT                   /evidence="ECO:0000269|PubMed:7757086"
FT                   /id="VAR_001763"
FT   VARIANT         1176
FT                   /note="G -> V (mutation found in a patient with features of
FT                   multiple epiphyseal dysplasia; features overlap with SEDC)"
FT                   /evidence="ECO:0000269|PubMed:21922596"
FT                   /id="VAR_066836"
FT   VARIANT         1179
FT                   /note="G -> R (mutation found in a patient with features of
FT                   multiple epiphyseal dysplasia; features overlap with SEDC)"
FT                   /evidence="ECO:0000269|PubMed:21922596"
FT                   /id="VAR_066837"
FT   VARIANT         1184
FT                   /note="I -> IGPSGKDGANGIPGPI (in SEDC)"
FT                   /evidence="ECO:0000269|PubMed:2339128"
FT                   /id="VAR_019837"
FT   VARIANT         1188
FT                   /note="G -> R (in ACG2)"
FT                   /evidence="ECO:0000269|PubMed:7757086"
FT                   /id="VAR_001764"
FT   VARIANT         1197
FT                   /note="G -> S (in SEDC; dbSNP:rs121912870)"
FT                   /evidence="ECO:0000269|PubMed:8423604"
FT                   /id="VAR_001765"
FT   VARIANT         1207..1212
FT                   /note="Missing (in KD)"
FT                   /evidence="ECO:0000269|PubMed:8863156"
FT                   /id="VAR_001766"
FT   VARIANT         1305
FT                   /note="G -> D (in vitreoretinopathy; with phalangeal
FT                   epiphyseal dysplasia; dbSNP:rs121912887)"
FT                   /evidence="ECO:0000269|PubMed:12205109"
FT                   /id="VAR_023934"
FT   VARIANT         1331
FT                   /note="V -> I (in dbSNP:rs12721427)"
FT                   /evidence="ECO:0000269|PubMed:10797431,
FT                   ECO:0000269|PubMed:18272325"
FT                   /id="VAR_017652"
FT   VARIANT         1383
FT                   /note="T -> M (in ANFH1; dbSNP:rs138498898)"
FT                   /evidence="ECO:0000269|PubMed:21671384"
FT                   /id="VAR_075730"
FT   VARIANT         1390
FT                   /note="T -> N (in PLSD-T; phenotype previously considered
FT                   as achondrogenesis-hypochondrogenesis type 2)"
FT                   /evidence="ECO:0000269|PubMed:10745044,
FT                   ECO:0000269|PubMed:15643621"
FT                   /id="VAR_024822"
FT   VARIANT         1391
FT                   /note="Y -> C (in PLSD-T; dbSNP:rs121912889)"
FT                   /evidence="ECO:0000269|PubMed:14729840"
FT                   /id="VAR_023935"
FT   VARIANT         1405
FT                   /note="G -> S (in dbSNP:rs2070739)"
FT                   /evidence="ECO:0000269|PubMed:18272325"
FT                   /id="VAR_033785"
FT   VARIANT         1439
FT                   /note="T -> M (in SEDC; dbSNP:rs121912886)"
FT                   /evidence="ECO:0000269|PubMed:11746045"
FT                   /id="VAR_017105"
FT   VARIANT         1448
FT                   /note="T -> P (in PLSD-T)"
FT                   /evidence="ECO:0000269|PubMed:15643621"
FT                   /id="VAR_024823"
FT   VARIANT         1459
FT                   /note="R -> C (in dbSNP:rs148838496)"
FT                   /evidence="ECO:0000269|PubMed:28887846"
FT                   /id="VAR_079748"
FT   VARIANT         1469
FT                   /note="D -> H (in PLSD-T)"
FT                   /evidence="ECO:0000269|PubMed:15643621"
FT                   /id="VAR_024824"
FT   VARIANT         1484
FT                   /note="Missing (in PLSD-T)"
FT                   /evidence="ECO:0000269|PubMed:15643621"
FT                   /id="VAR_024825"
FT   VARIANT         1485
FT                   /note="C -> G (in PLSD-T)"
FT                   /evidence="ECO:0000269|PubMed:15643621"
FT                   /id="VAR_024826"
FT   CONFLICT        441
FT                   /note="G -> D (in Ref. 1; CAA34488)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        457
FT                   /note="E -> K (in Ref. 1; CAA34488)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        481
FT                   /note="A -> P (in Ref. 15; AAB60370)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        641
FT                   /note="A -> E (in Ref. 1; CAA34488 and 16; CAA32030)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        677
FT                   /note="G -> A (in Ref. 16; CAA32030)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        784
FT                   /note="G -> A (in Ref. 16; CAA32030)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        832..835
FT                   /note="PAGF -> TSGI (in Ref. 1; CAA34488)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1006
FT                   /note="K -> Q (in Ref. 1; CAA34488 and 16; CAA32030)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1037
FT                   /note="E -> Q (in Ref. 6; CAA34683)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1057
FT                   /note="D -> N (in Ref. 17; AAD15287/CAA26223 and 19;
FT                   AAA51997)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1069
FT                   /note="A -> T (in Ref. 6; CAA34683, 17; AAD15287/CAA26223
FT                   and 19; AAA51997)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1243
FT                   /note="Q -> E (in Ref. 24; CAA29604)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1247
FT                   /note="G -> N (in Ref. 24; CAA29604)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1271
FT                   /note="S -> T (in Ref. 21; AAA52038)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1274
FT                   /note="G -> A (in Ref. 21; AAA52038)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1333
FT                   /note="K -> R (in Ref. 28; M12048)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1350
FT                   /note="G -> A (in Ref. 28; M12048)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1372
FT                   /note="N -> D (in Ref. 17; CAA26223)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1383
FT                   /note="T -> A (in Ref. 17; CAA26223)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1400
FT                   /note="L -> M (in Ref. 17; CAA26223)"
FT                   /evidence="ECO:0000305"
FT   STRAND          34..36
FT                   /evidence="ECO:0000244|PDB:5NIR"
FT   STRAND          39..41
FT                   /evidence="ECO:0000244|PDB:5NIR"
FT   STRAND          46..50
FT                   /evidence="ECO:0000244|PDB:5NIR"
FT   STRAND          53..58
FT                   /evidence="ECO:0000244|PDB:5NIR"
FT   STRAND          61..70
FT                   /evidence="ECO:0000244|PDB:5NIR"
FT   TURN            93..95
FT                   /evidence="ECO:0000244|PDB:5NIR"
FT   HELIX           487..489
FT                   /evidence="ECO:0000244|PDB:5OCX"
SQ   SEQUENCE   1487 AA;  141785 MW;  A8312503825BF0BB CRC64;
     MIRLGAPQTL VLLTLLVAAV LRCQGQDVQE AGSCVQDGQR YNDKDVWKPE PCRICVCDTG
     TVLCDDIICE DVKDCLSPEI PFGECCPICP TDLATASGQP GPKGQKGEPG DIKDIVGPKG
     PPGPQGPAGE QGPRGDRGDK GEKGAPGPRG RDGEPGTPGN PGPPGPPGPP GPPGLGGNFA
     AQMAGGFDEK AGGAQLGVMQ GPMGPMGPRG PPGPAGAPGP QGFQGNPGEP GEPGVSGPMG
     PRGPPGPPGK PGDDGEAGKP GKAGERGPPG PQGARGFPGT PGLPGVKGHR GYPGLDGAKG
     EAGAPGVKGE SGSPGENGSP GPMGPRGLPG ERGRTGPAGA AGARGNDGQP GPAGPPGPVG
     PAGGPGFPGA PGAKGEAGPT GARGPEGAQG PRGEPGTPGS PGPAGASGNP GTDGIPGAKG
     SAGAPGIAGA PGFPGPRGPP GPQGATGPLG PKGQTGEPGI AGFKGEQGPK GEPGPAGPQG
     APGPAGEEGK RGARGEPGGV GPIGPPGERG APGNRGFPGQ DGLAGPKGAP GERGPSGLAG
     PKGANGDPGR PGEPGLPGAR GLTGRPGDAG PQGKVGPSGA PGEDGRPGPP GPQGARGQPG
     VMGFPGPKGA NGEPGKAGEK GLPGAPGLRG LPGKDGETGA AGPPGPAGPA GERGEQGAPG
     PSGFQGLPGP PGPPGEGGKP GDQGVPGEAG APGLVGPRGE RGFPGERGSP GAQGLQGPRG
     LPGTPGTDGP KGASGPAGPP GAQGPPGLQG MPGERGAAGI AGPKGDRGDV GEKGPEGAPG
     KDGGRGLTGP IGPPGPAGAN GEKGEVGPPG PAGSAGARGA PGERGETGPP GPAGFAGPPG
     ADGQPGAKGE QGEAGQKGDA GAPGPQGPSG APGPQGPTGV TGPKGARGAQ GPPGATGFPG
     AAGRVGPPGS NGNPGPPGPP GPSGKDGPKG ARGDSGPPGR AGEPGLQGPA GPPGEKGEPG
     DDGPSGAEGP PGPQGLAGQR GIVGLPGQRG ERGFPGLPGP SGEPGKQGAP GASGDRGPPG
     PVGPPGLTGP AGEPGREGSP GADGPPGRDG AAGVKGDRGE TGAVGAPGAP GPPGSPGPAG
     PTGKQGDRGE AGAQGPMGPS GPAGARGIQG PQGPRGDKGE AGEPGERGLK GHRGFTGLQG
     LPGPPGPSGD QGASGPAGPS GPRGPPGPVG PSGKDGANGI PGPIGPPGPR GRSGETGPAG
     PPGNPGPPGP PGPPGPGIDM SAFAGLGPRE KGPDPLQYMR ADQAAGGLRQ HDAEVDATLK
     SLNNQIESIR SPEGSRKNPA RTCRDLKLCH PEWKSGDYWI DPNQGCTLDA MKVFCNMETG
     ETCVYPNPAN VPKKNWWSSK SKEKKHIWFG ETINGGFHFS YGDDNLAPNT ANVQMTFLRL
     LSTEGSQNIT YHCKNSIAYL DEAAGNLKKA LLIQGSNDVE IRAEGNSRFT YTALKDGCTK
     HTGKWGKTVI EYRSQKTSRL PIIDIAPMDI GGPEQEFGVD IGPVCFL
//
ID   CRTC3_HUMAN             Reviewed;         619 AA.
AC   Q6UUV7; Q6DK61; Q6DK62; Q8NF38; Q9H6U2;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   05-FEB-2008, sequence version 2.
DT   22-APR-2020, entry version 123.
DE   RecName: Full=CREB-regulated transcription coactivator 3;
DE   AltName: Full=Transducer of regulated cAMP response element-binding protein 3;
DE            Short=TORC-3;
DE            Short=Transducer of CREB protein 3;
GN   Name=CRTC3; Synonyms=TORC3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR LOCATION,
RP   INTERACTION WITH CREB1, AND VARIANT ASN-72.
RX   PubMed=14506290; DOI=10.1073/pnas.1932773100;
RA   Iourgenko V., Zhang W., Mickanin C., Daly I., Jiang C., Hexham J.M.,
RA   Orth A.P., Miraglia L., Meltzer J., Garza D., Chirn G.-W., McWhinnie E.,
RA   Cohen D., Skelton J., Terry R., Yu Y., Bodian D., Buxton F.P., Zhu J.,
RA   Song C., Labow M.A.;
RT   "Identification of a family of cAMP response element-binding protein
RT   coactivators by genome-scale functional analysis in mammalian cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:12147-12152(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANT ASN-72.
RC   TISSUE=Spleen;
RX   PubMed=12693554; DOI=10.1093/dnares/10.1.49;
RA   Jikuya H., Takano J., Kikuno R., Hirosawa M., Nagase T., Nomura N.,
RA   Ohara O.;
RT   "Characterization of long cDNA clones from human adult spleen. II. The
RT   complete sequences of 81 cDNA clones.";
RL   DNA Res. 10:49-57(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R., Fahey J.,
RA   Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G., Johnson E.,
RA   Jones C., Kamat A., Kaur A., Locke D.P., Madan A., Munson G., Jaffe D.B.,
RA   Lui A., Macdonald P., Mauceli E., Naylor J.W., Nesbitt R., Nicol R.,
RA   O'Leary S.B., Ratcliffe A., Rounsley S., She X., Sneddon K.M.B.,
RA   Stewart S., Sougnez C., Stone S.M., Topham K., Vincent D., Wang S.,
RA   Zimmer A.R., Birren B.W., Hood L., Lander E.S., Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human chromosome
RT   15.";
RL   Nature 440:671-675(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 217-619 (ISOFORM 1).
RC   TISSUE=Hepatoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 292-619 (ISOFORM 1), AND VARIANT
RP   SER-346.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=14536081; DOI=10.1016/j.molcel.2003.08.013;
RA   Conkright M.D., Canettieri G., Screaton R., Guzman E., Miraglia L.,
RA   Hogenesch J.B., Montminy M.;
RT   "TORCs: transducers of regulated CREB activity.";
RL   Mol. Cell 12:413-423(2003).
RN   [7]
RP   SUBCELLULAR LOCATION, FUNCTION, AND MUTAGENESIS OF TYR-282.
RX   PubMed=15454081; DOI=10.1016/j.cell.2004.09.015;
RA   Screaton R.A., Conkright M.D., Katoh Y., Best J.L., Canettieri G.,
RA   Jeffries S., Guzman E., Niessen S., Yates J.R. III, Takemori H.,
RA   Okamoto M., Montminy M.;
RT   "The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive
RT   coincidence detector.";
RL   Cell 119:61-74(2004).
RN   [8]
RP   INTERACTION WITH HTLV-1 TAX (MICROBIAL INFECTION), AND FUNCTION.
RX   PubMed=15466468; DOI=10.1074/jbc.m409021200;
RA   Koga H., Ohshima T., Shimotohno K.;
RT   "Enhanced activation of tax-dependent transcription of human T-cell
RT   leukemia virus type I (HTLV-I) long terminal repeat by TORC3.";
RL   J. Biol. Chem. 279:52978-52983(2004).
RN   [9]
RP   SUBCELLULAR LOCATION, AND PHOSPHORYLATION.
RX   PubMed=15589160; DOI=10.1016/j.cub.2004.11.002;
RA   Bittinger M.A., McWhinnie E., Meltzer J., Iourgenko V., Latario B., Liu X.,
RA   Chen C.H., Song C., Garza D., Labow M.;
RT   "Activation of cAMP response element-mediated gene expression by regulated
RT   nuclear transport of TORC proteins.";
RL   Curr. Biol. 14:2156-2161(2004).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [11]
RP   FUNCTION, SUBCELLULAR LOCATION, AND PHOSPHORYLATION.
RX   PubMed=16817901; DOI=10.1111/j.1742-4658.2006.05291.x;
RA   Katoh Y., Takemori H., Lin X.-Z., Tamura M., Muraoka M., Satoh T.,
RA   Tsuchiya Y., Min L., Doi J., Miyauchi A., Witters L.A., Nakamura H.,
RA   Okamoto M.;
RT   "Silencing the constitutive active transcription factor CREB by the LKB1-
RT   SIK signaling cascade.";
RL   FEBS J. 273:2730-2748(2006).
RN   [12]
RP   INTERACTION WITH HTLV-1 TAX (MICROBIAL INFECTION).
RX   PubMed=16809310; DOI=10.1128/jvi.00103-06;
RA   Siu Y.-T., Chin K.-T., Siu K.-L., Yee Wai Choy E., Jeang K.-T., Jin D.-Y.;
RT   "TORC1 and TORC2 coactivators are required for tax activation of the human
RT   T-cell leukemia virus type 1 long terminal repeats.";
RL   J. Virol. 80:7052-7059(2006).
RN   [13]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=16980408; DOI=10.1073/pnas.0606714103;
RA   Wu Z., Huang X., Feng Y., Handschin C., Feng Y., Gullicksen P.S., Bare O.,
RA   Labow M., Spiegelman B., Stevenson S.C.;
RT   "Transducer of regulated CREB-binding proteins (TORCs) induce PGC-1alpha
RT   transcription and mitochondrial biogenesis in muscle cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:14379-14384(2006).
RN   [14]
RP   INTERACTION WITH BCL3 IN BCL3/TORC3/CREB1 COMPLEX, AND FUNCTION.
RX   PubMed=17644518; DOI=10.1074/jbc.m702656200;
RA   Hishiki T., Ohshima T., Ego T., Shimotohno K.;
RT   "BCL3 acts as a negative regulator of transcription from the human T-cell
RT   leukemia virus type 1 long terminal repeat through interactions with
RT   TORC3.";
RL   J. Biol. Chem. 282:28335-28343(2007).
RN   [15]
RP   FUNCTION.
RX   PubMed=17210223; DOI=10.1016/j.mce.2006.12.020;
RA   Takemori H., Kanematsu M., Kajimura J., Hatano O., Katoh Y., Lin X.-Z.,
RA   Min L., Yamazaki T., Doi J., Okamoto M.;
RT   "Dephosphorylation of TORC initiates expression of the StAR gene.";
RL   Mol. Cell. Endocrinol. 265:196-204(2007).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-443, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-391 AND SER-443, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-329; SER-370 AND SER-443, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-62, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4; SER-62; SER-329; SER-332;
RP   SER-370; SER-391; SER-396 AND SER-410, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [22]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-232, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [23]
RP   INTERACTION WITH YWHAE; PPP2CA; PPP2R1A AND PPP2R2A, SUBCELLULAR LOCATION,
RP   AND PHOSPHORYLATION AT SER-273 AND SER-391.
RX   PubMed=30611118; DOI=10.1016/j.isci.2018.12.012;
RA   Sonntag T., Ostojic J., Vaughan J.M., Moresco J.J., Yoon Y.S.,
RA   Yates J.R. III, Montminy M.;
RT   "Mitogenic Signals Stimulate the CREB Coactivator CRTC3 through PP2A
RT   Recruitment.";
RL   IScience 11:134-145(2018).
CC   -!- FUNCTION: Transcriptional coactivator for CREB1 which activates
CC       transcription through both consensus and variant cAMP response element
CC       (CRE) sites. Acts as a coactivator, in the SIK/TORC signaling pathway,
CC       being active when dephosphorylated and acts independently of CREB1
CC       'Ser-133' phosphorylation. Enhances the interaction of CREB1 with TAF4.
CC       Regulates the expression of specific CREB-activated genes such as the
CC       steroidogenic gene, StAR. Potent coactivator of PPARGC1A and inducer of
CC       mitochondrial biogenesis in muscle cells. Also coactivator for TAX
CC       activation of the human T-cell leukemia virus type 1 (HTLV-1) long
CC       terminal repeats (LTR). {ECO:0000269|PubMed:14506290,
CC       ECO:0000269|PubMed:15454081, ECO:0000269|PubMed:15466468,
CC       ECO:0000269|PubMed:16817901, ECO:0000269|PubMed:16980408,
CC       ECO:0000269|PubMed:17210223, ECO:0000269|PubMed:17644518}.
CC   -!- SUBUNIT: Binding, as a tetramer, through its N-terminal region, with
CC       the bZIP domain of CREB1 enhances recruitment of TAF4 to the promoter
CC       (PubMed:14506290). 'Arg-314' in the bZIP domain of CREB1 is essential
CC       for this interaction (PubMed:14506290). Interacts (when phosphorylated
CC       at Ser-162 and Se-273) with 14-3-3 proteins (PubMed:30611118).
CC       Interacts with YWHAE (PubMed:30611118). Interacts (when phosphorylated
CC       at Ser-391) with phosphatase PP2A catalytic subunit PPP2CA and
CC       regulatory subunits PPP2R1A and PPP2R2A (PubMed:30611118). Interacts,
CC       via the N-terminal with the ankyrin repeats of BCL3, to form a complex
CC       with CREB1 on CRE and TxRE responsive elements and represses HTLV-1
CC       LTR-mediated transcription (PubMed:17644518).
CC       {ECO:0000250|UniProtKB:Q91X84, ECO:0000269|PubMed:14506290,
CC       ECO:0000269|PubMed:17644518, ECO:0000269|PubMed:30611118}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with HTLV-1 protein Tax; this
CC       interaction enhances tax transcriptional activity.
CC       {ECO:0000269|PubMed:15466468, ECO:0000269|PubMed:16809310}.
CC   -!- INTERACTION:
CC       Q6UUV7; Q8N1Q1: CA13; NbExp=3; IntAct=EBI-3453588, EBI-11982647;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15454081,
CC       ECO:0000269|PubMed:15589160, ECO:0000269|PubMed:16817901,
CC       ECO:0000269|PubMed:30611118}. Cytoplasm {ECO:0000269|PubMed:15589160,
CC       ECO:0000269|PubMed:16817901, ECO:0000269|PubMed:30611118}. Note=Appears
CC       to be mainly nuclear (PubMed:15454081). Translocates to the nucleus
CC       following adenylyl cyclase or MAP kinase activation (PubMed:30611118).
CC       {ECO:0000269|PubMed:15454081, ECO:0000269|PubMed:30611118}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q6UUV7-1; Sequence=Displayed;
CC       Name=3;
CC         IsoId=Q6UUV7-3; Sequence=VSP_031220;
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in B and T lymphocytes.
CC       Highest levels in lung. Also expressed in brain, colon, heart, kidney,
CC       ovary, and prostate. Weak expression in liver, pancreas, muscle, small
CC       intestine, spleen and stomach. {ECO:0000269|PubMed:14536081,
CC       ECO:0000269|PubMed:16980408}.
CC   -!- PTM: Phosphorylation/dephosphorylation states of Ser-273 are required
CC       for regulating transduction of CREB activity (By similarity).
CC       CRTCs/TORCs are inactive when phosphorylated, and active when
CC       dephosphorylated at this site (By similarity). May be phosphorylated at
CC       Ser-391 by MAPK3/ERK1 and/or MAPK1/ERK2 or by some cyclin-dependent
CC       kinases such as CDK1,CDK2 or CDK5 (PubMed:30611118). Following adenylyl
CC       cyclase activation, dephosphorylated at Ser-162 and Ser-273 resulting
CC       in its dissociation from 14-3-3 proteins probably promoting CRTC3
CC       translocation into the nucleus (PubMed:30611118).
CC       {ECO:0000250|UniProtKB:Q91X84, ECO:0000269|PubMed:30611118}.
CC   -!- SIMILARITY: Belongs to the TORC family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC03424.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY360173; AAQ98858.1; -; mRNA.
DR   EMBL; AK090443; BAC03424.1; ALT_FRAME; mRNA.
DR   EMBL; AC021422; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC103739; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK025521; BAB15160.1; -; mRNA.
DR   EMBL; BC074730; AAH74730.2; -; mRNA.
DR   EMBL; BC074731; AAH74731.3; -; mRNA.
DR   CCDS; CCDS32331.1; -. [Q6UUV7-1]
DR   CCDS; CCDS45348.1; -. [Q6UUV7-3]
DR   RefSeq; NP_001036039.1; NM_001042574.2. [Q6UUV7-3]
DR   RefSeq; NP_073606.3; NM_022769.4. [Q6UUV7-1]
DR   SMR; Q6UUV7; -.
DR   BioGrid; 122294; 37.
DR   DIP; DIP-59211N; -.
DR   IntAct; Q6UUV7; 25.
DR   STRING; 9606.ENSP00000268184; -.
DR   iPTMnet; Q6UUV7; -.
DR   PhosphoSitePlus; Q6UUV7; -.
DR   BioMuta; CRTC3; -.
DR   DMDM; 167009130; -.
DR   EPD; Q6UUV7; -.
DR   jPOST; Q6UUV7; -.
DR   MassIVE; Q6UUV7; -.
DR   MaxQB; Q6UUV7; -.
DR   PaxDb; Q6UUV7; -.
DR   PeptideAtlas; Q6UUV7; -.
DR   PRIDE; Q6UUV7; -.
DR   ProteomicsDB; 67424; -. [Q6UUV7-1]
DR   ProteomicsDB; 67425; -. [Q6UUV7-3]
DR   Antibodypedia; 37539; 125 antibodies.
DR   Ensembl; ENST00000268184; ENSP00000268184; ENSG00000140577. [Q6UUV7-1]
DR   Ensembl; ENST00000420329; ENSP00000416573; ENSG00000140577. [Q6UUV7-3]
DR   GeneID; 64784; -.
DR   KEGG; hsa:64784; -.
DR   UCSC; uc002bpo.5; human. [Q6UUV7-1]
DR   CTD; 64784; -.
DR   DisGeNET; 64784; -.
DR   GeneCards; CRTC3; -.
DR   HGNC; HGNC:26148; CRTC3.
DR   HPA; ENSG00000140577; Low tissue specificity.
DR   MIM; 608986; gene.
DR   neXtProt; NX_Q6UUV7; -.
DR   OpenTargets; ENSG00000140577; -.
DR   PharmGKB; PA142672074; -.
DR   eggNOG; ENOG410IGNT; Eukaryota.
DR   eggNOG; ENOG410XPDQ; LUCA.
DR   GeneTree; ENSGT00390000010652; -.
DR   HOGENOM; CLU_019357_3_0_1; -.
DR   InParanoid; Q6UUV7; -.
DR   KO; K16334; -.
DR   OMA; DGENDVH; -.
DR   PhylomeDB; Q6UUV7; -.
DR   TreeFam; TF321571; -.
DR   Reactome; R-HSA-2151201; Transcriptional activation of mitochondrial biogenesis.
DR   Reactome; R-HSA-400253; Circadian Clock.
DR   SIGNOR; Q6UUV7; -.
DR   ChiTaRS; CRTC3; human.
DR   GeneWiki; CRTC3; -.
DR   GenomeRNAi; 64784; -.
DR   Pharos; Q6UUV7; Tbio.
DR   PRO; PR:Q6UUV7; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   RNAct; Q6UUV7; protein.
DR   Bgee; ENSG00000140577; Expressed in female gonad and 239 other tissues.
DR   ExpressionAtlas; Q6UUV7; baseline and differential.
DR   Genevisible; Q6UUV7; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0008140; F:cAMP response element binding protein binding; IBA:GO_Central.
DR   GO; GO:0097009; P:energy homeostasis; IEA:Ensembl.
DR   GO; GO:0042116; P:macrophage activation; IMP:CACAO.
DR   GO; GO:0043951; P:negative regulation of cAMP-mediated signaling; IEA:Ensembl.
DR   GO; GO:0050995; P:negative regulation of lipid catabolic process; IEA:Ensembl.
DR   GO; GO:0032793; P:positive regulation of CREB transcription factor activity; IBA:GO_Central.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0051289; P:protein homotetramerization; IEA:InterPro.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   InterPro; IPR024786; TORC.
DR   InterPro; IPR024785; TORC_C.
DR   InterPro; IPR024784; TORC_M.
DR   InterPro; IPR024783; TORC_N.
DR   PANTHER; PTHR13589; PTHR13589; 1.
DR   Pfam; PF12886; TORC_C; 1.
DR   Pfam; PF12885; TORC_M; 1.
DR   Pfam; PF12884; TORC_N; 1.
PE   1: Evidence at protein level;
KW   Activator; Alternative splicing; Cytoplasm; Host-virus interaction;
KW   Isopeptide bond; Nucleus; Phosphoprotein; Polymorphism; Reference proteome;
KW   Transcription; Transcription regulation; Ubl conjugation.
FT   CHAIN           1..619
FT                   /note="CREB-regulated transcription coactivator 3"
FT                   /id="PRO_0000318531"
FT   REGION          1..103
FT                   /note="Required for interaction with HTLV-1 TAX"
FT   REGION          380..401
FT                   /note="Required for interaction with PPP2CA and PPP2R1A"
FT                   /evidence="ECO:0000250|UniProtKB:Q91X84"
FT   COMPBIAS        180..183
FT                   /note="Poly-Gly"
FT   COMPBIAS        444..451
FT                   /note="Poly-Pro"
FT   MOD_RES         4
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18691976,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         62
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         160
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q91X84"
FT   MOD_RES         162
FT                   /note="Phosphoserine; by SIK2"
FT                   /evidence="ECO:0000250|UniProtKB:Q91X84"
FT   MOD_RES         273
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:30611118"
FT   MOD_RES         329
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         332
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         370
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         391
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:30611118"
FT   MOD_RES         396
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         410
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         443
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18220336,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332"
FT   CROSSLNK        232
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   VAR_SEQ         551
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:12693554"
FT                   /id="VSP_031220"
FT   VARIANT         72
FT                   /note="S -> N (in dbSNP:rs8033595)"
FT                   /evidence="ECO:0000269|PubMed:12693554,
FT                   ECO:0000269|PubMed:14506290"
FT                   /id="VAR_038758"
FT   VARIANT         346
FT                   /note="L -> S"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_038759"
FT   MUTAGEN         282
FT                   /note="Y->F: Translocates to the cytoplasm. Represses basal
FT                   TORC3 activity towards CREB."
FT                   /evidence="ECO:0000269|PubMed:15454081"
FT   CONFLICT        545
FT                   /note="P -> S (in Ref. 4; BAB15160)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        616
FT                   /note="A -> T (in Ref. 2; BAC03424)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   619 AA;  66959 MW;  A274B96DD1C2678E CRC64;
     MAASPGSGSA NPRKFSEKIA LHTQRQAEET RAFEQLMTDL TLSRVQFQKL QQLRLTQYHG
     GSLPNVSQLR SSASEFQPSF HQADNVRGTR HHGLVERPSR NRFHPLHRRS GDKPGRQFDG
     SAFGANYSSQ PLDESWPRQQ PPWKDEKHPG FRLTSALNRT NSDSALHTSA LSTKPQDPYG
     GGGQSAWPAP YMGFCDGENN GHGEVASFPG PLKEENLLNV PKPLPKQLWE TKEIQSLSGR
     PRSCDVGGGN AFPHNGQNLG LSPFLGTLNT GGSLPDLTNL HYSTPLPASL DTTDHHFGSM
     SVGNSVNNIP AAMTHLGIRS SSGLQSSRSN PSIQATLNKT VLSSSLNNHP QTSVPNASAL
     HPSLRLFSLS NPSLSTTNLS GPSRRRQPPV SPLTLSPGPE AHQGFSRQLS STSPLAPYPT
     SQMVSSDRSQ LSFLPTEAQA QVSPPPPYPA PQELTQPLLQ QPRAPEAPAQ QPQAASSLPQ
     SDFQLLPAQG SSLTNFFPDV GFDQQSMRPG PAFPQQVPLV QQGSRELQDS FHLRPSPYSN
     CGSLPNTILP EDSSTSLFKD LNSALAGLPE VSLNVDTPFP LEEELQIEPL SLDGLNMLSD
     SSMGLLDPSV EETFRADRL
//
ID   Q8TEF4_HUMAN            Unreviewed;       503 AA.
AC   Q8TEF4;
DT   01-JUN-2002, integrated into UniProtKB/TrEMBL.
DT   01-JUN-2002, sequence version 1.
DT   26-FEB-2020, entry version 77.
DE   SubName: Full=FLJ00243 protein {ECO:0000313|EMBL:BAB84996.1};
DE   Flags: Fragment;
GN   Name=FLJ00243 {ECO:0000313|EMBL:BAB84996.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAB84996.1};
RN   [1] {ECO:0000313|EMBL:BAB84996.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Spleen {ECO:0000313|EMBL:BAB84996.1};
RA   Jikuya H., Takano J., Nomura N., Kikuno R., Nagase T., Ohara O.;
RT   "The nucleotide sequence of a long cDNA clone isolated from human spleen.";
RL   Submitted (JAN-2002) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK074170; BAB84996.1; -; mRNA.
DR   RefSeq; NP_001036039.1; NM_001042574.2.
DR   RefSeq; NP_073606.3; NM_022769.4.
DR   PeptideAtlas; Q8TEF4; -.
DR   GeneID; 64784; -.
DR   KEGG; hsa:64784; -.
DR   CTD; 64784; -.
DR   PharmGKB; PA142672074; -.
DR   eggNOG; ENOG410IGNT; Eukaryota.
DR   eggNOG; ENOG410XPDQ; LUCA.
DR   KO; K16334; -.
DR   OrthoDB; 1118500at2759; -.
DR   GenomeRNAi; 64784; -.
DR   Genevisible; Q8TEF4; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:InterPro.
DR   GO; GO:0005634; C:nucleus; IEA:InterPro.
DR   GO; GO:0032793; P:positive regulation of CREB transcription factor activity; IEA:InterPro.
DR   InterPro; IPR024786; TORC.
DR   InterPro; IPR024785; TORC_C.
DR   InterPro; IPR024784; TORC_M.
DR   PANTHER; PTHR13589; PTHR13589; 1.
DR   Pfam; PF12886; TORC_C; 1.
DR   Pfam; PF12885; TORC_M; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN          44..206
FT                   /note="TORC_M"
FT                   /evidence="ECO:0000259|Pfam:PF12885"
FT   DOMAIN          430..503
FT                   /note="TORC_C"
FT                   /evidence="ECO:0000259|Pfam:PF12886"
FT   REGION          1..70
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          260..316
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..21
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        39..64
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   NON_TER         1
FT                   /evidence="ECO:0000313|EMBL:BAB84996.1"
SQ   SEQUENCE   503 AA;  53812 MW;  F5620C45284942FE CRC64;
     RQFDGSAFGA NYSSQPLDES WPRQQPPWKD EKHPGFRLTS ALNRTNSDSA LHTSALSTKP
     QDPYGGGGQS AWPAPYMGFC DGENNGHGEV ASFPGPLKEE NLLNVPKPLP KQLWETKEIQ
     SLSGRPRSCD VGGGNAFPHN GQNLGLSPFL GTLNTGGSLP DLTNLHYSTP LPASLDTTDH
     HFGSMSVGNS VNNIPAAMTH LGIRSSSGLQ SSRSNPSIQA TLNKTVLSSS LNNHPQTSVP
     NASALHPSLR LFSLSNPSLS TTNLSGPSRR RQPPVSPLTL SPGPEANQGF SRQLSSTSPL
     APYPTSQMVS SDRSQLSFLP TEAQAQVSPP PPYPAPQELT QPLLQQPRAP EAPAQQPQAA
     SSLPQSDFQL LPAQGSSLTN FFPDVGFDQQ SMRPGPAFPQ QVPLVQQGSR ELQDSFHLRP
     SPYSNCGSLP NTILPDSSTS LFKDLNSALA GLPEVSLNVD TPFPLEEELQ IEPLSLDGLN
     MLSDSSMGLL DPSVEETFRA DRL
//
ID   DCTN1_HUMAN             Reviewed;        1278 AA.
AC   Q14203; A8MY36; B4DM45; E9PFS5; E9PGE1; G5E9H4; O95296; Q6IQ37; Q9BRM9;
AC   Q9UIU1; Q9UIU2;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   18-OCT-2001, sequence version 3.
DT   22-APR-2020, entry version 203.
DE   RecName: Full=Dynactin subunit 1;
DE   AltName: Full=150 kDa dynein-associated polypeptide;
DE   AltName: Full=DAP-150;
DE            Short=DP-150;
DE   AltName: Full=p135;
DE   AltName: Full=p150-glued;
GN   Name=DCTN1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND ALTERNATIVE SPLICING.
RX   PubMed=9799602; DOI=10.1006/geno.1998.5542;
RA   Collin G.B., Nishina P.M., Marshall J.D., Naggert J.K.;
RT   "Human DCTN1: genomic structure and evaluation as a candidate for Alstrom
RT   syndrome.";
RL   Genomics 53:359-364(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 4).
RC   TISSUE=Brain, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 9-1278.
RC   TISSUE=Brain;
RX   PubMed=8838327; DOI=10.1006/geno.1996.0068;
RA   Holzbaur E.L.F., Tokito M.K.;
RT   "Localization of the DCTN1 gene encoding p150Glued to human chromosome 2p13
RT   by fluorescence in situ hybridization.";
RL   Genomics 31:398-399(1996).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 9-1278 (ISOFORM 6), AND ALTERNATIVE SPLICING.
RC   TISSUE=Brain;
RX   PubMed=8856662; DOI=10.1091/mbc.7.8.1167;
RA   Tokito M.K., Howland D.S., Lee V.M.-Y., Holzbaur E.L.F.;
RT   "Functionally distinct isoforms of dynactin are expressed in human
RT   neurons.";
RL   Mol. Biol. Cell 7:1167-1180(1996).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 18-1278.
RX   PubMed=9805007; DOI=10.1016/s0167-4781(98)00195-x;
RA   Tokito M.K., Holzbaur E.L.F.;
RT   "The genomic structure of DCTN1, a candidate gene for limb-girdle muscular
RT   dystrophy.";
RL   Biochim. Biophys. Acta 1442:432-436(1998).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1081-1278.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   INTERACTION WITH MAPRE1; MAPRE2 AND MAPRE3.
RX   PubMed=14514668; DOI=10.1074/jbc.m306194200;
RA   Bu W., Su L.-K.;
RT   "Characterization of functional domains of human EB1 family proteins.";
RL   J. Biol. Chem. 278:49721-49731(2003).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND SUBCELLULAR LOCATION [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.;
RT   "Proteomic characterization of the human centrosome by protein correlation
RT   profiling.";
RL   Nature 426:570-574(2003).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [13]
RP   UBIQUITINATION, AND INTERACTION WITH FBXL5.
RX   PubMed=17532294; DOI=10.1016/j.bbrc.2007.05.068;
RA   Zhang N., Liu J., Ding X., Aikhionbare F., Jin C., Yao X.;
RT   "FBXL5 interacts with p150Glued and regulates its ubiquitination.";
RL   Biochem. Biophys. Res. Commun. 359:34-39(2007).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [15]
RP   INTERACTION WITH SNX6.
RX   PubMed=19935774; DOI=10.1038/cr.2009.130;
RA   Hong Z., Yang Y., Zhang C., Niu Y., Li K., Zhao X., Liu J.J.;
RT   "The retromer component SNX6 interacts with dynactin p150(Glued) and
RT   mediates endosome-to-TGN transport.";
RL   Cell Res. 19:1334-1349(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-108, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [17]
RP   INTERACTION WITH ECPAS.
RX   PubMed=20682791; DOI=10.1074/jbc.m110.154120;
RA   Gorbea C., Pratt G., Ustrell V., Bell R., Sahasrabudhe S., Hughes R.E.,
RA   Rechsteiner M.;
RT   "A protein interaction network for Ecm29 links the 26 S proteasome to
RT   molecular motors and endosomal components.";
RL   J. Biol. Chem. 285:31616-31633(2010).
RN   [18]
RP   INTERACTION WITH PARD6A, AND SUBCELLULAR LOCATION.
RX   PubMed=20719959; DOI=10.1091/mbc.e10-05-0430;
RA   Kodani A., Tonthat V., Wu B., Suetterlin C.;
RT   "Par6 alpha interacts with the dynactin subunit p150 Glued and is a
RT   critical regulator of centrosomal protein recruitment.";
RL   Mol. Biol. Cell 21:3376-3385(2010).
RN   [19]
RP   INTERACTION WITH DYNAP.
RX   PubMed=20978158; DOI=10.1158/1535-7163.mct-10-0730;
RA   Kunoh T., Noda T., Koseki K., Sekigawa M., Takagi M., Shin-ya K.,
RA   Goshima N., Iemura S., Natsume T., Wada S., Mukai Y., Ohta S., Sasaki R.,
RA   Mizukami T.;
RT   "A novel human dynactin-associated protein, dynAP, promotes activation of
RT   Akt, and ergosterol-related compounds induce dynAP-dependent apoptosis of
RT   human cancer cells.";
RL   Mol. Cancer Ther. 9:2934-2942(2010).
RN   [20]
RP   PHOSPHORYLATION AT SER-179 AND SER-212, MUTAGENESIS OF SER-179 AND SER-212,
RP   INTERACTION WITH PLK1 AND CLIP1, AND SUBCELLULAR LOCATION.
RX   PubMed=20679239; DOI=10.1073/pnas.1006615107;
RA   Li H., Liu X.S., Yang X., Song B., Wang Y., Liu X.;
RT   "Polo-like kinase 1 phosphorylation of p150Glued facilitates nuclear
RT   envelope breakdown during prophase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:14633-14638(2010).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [22]
RP   INTERACTION WITH DCDC1.
RX   PubMed=22159412; DOI=10.1242/jcs.085407;
RA   Kaplan A., Reiner O.;
RT   "Linking cytoplasmic dynein and transport of Rab8 vesicles to the midbody
RT   during cytokinesis by the doublecortin domain-containing 5 protein.";
RL   J. Cell Sci. 124:3989-4000(2011).
RN   [23]
RP   INTERACTION WITH CLN3.
RX   PubMed=22261744; DOI=10.1007/s00018-011-0913-1;
RA   Uusi-Rauva K., Kyttala A., van der Kant R., Vesa J., Tanhuanpaa K.,
RA   Neefjes J., Olkkonen V.M., Jalanko A.;
RT   "Neuronal ceroid lipofuscinosis protein CLN3 interacts with motor proteins
RT   and modifies location of late endosomal compartments.";
RL   Cell. Mol. Life Sci. 69:2075-2089(2012).
RN   [24]
RP   INTERACTION WITH CEP131.
RX   PubMed=22797915; DOI=10.1242/jcs.104059;
RA   Staples C.J., Myers K.N., Beveridge R.D., Patil A.A., Lee A.J., Swanton C.,
RA   Howell M., Boulton S.J., Collis S.J.;
RT   "The centriolar satellite protein Cep131 is important for genome
RT   stability.";
RL   J. Cell Sci. 125:4770-4779(2012).
RN   [25]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=22327364; DOI=10.1038/ncb2440;
RA   Kiyomitsu T., Cheeseman I.M.;
RT   "Chromosome- and spindle-pole-derived signals generate an intrinsic code
RT   for spindle position and orientation.";
RL   Nat. Cell Biol. 14:311-317(2012).
RN   [26]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=23386061; DOI=10.1038/emboj.2013.3;
RA   Kodani A., Salome Sirerol-Piquer M., Seol A., Garcia-Verdugo J.M.,
RA   Reiter J.F.;
RT   "Kif3a interacts with Dynactin subunit p150 Glued to organize centriole
RT   subdistal appendages.";
RL   EMBO J. 32:597-607(2013).
RN   [27]
RP   INTERACTION WITH MISP.
RX   PubMed=23509069; DOI=10.1083/jcb.201207050;
RA   Zhu M., Settele F., Kotak S., Sanchez-Pulido L., Ehret L., Ponting C.P.,
RA   Goenczy P., Hoffmann I.;
RT   "MISP is a novel Plk1 substrate required for proper spindle orientation and
RT   mitotic progression.";
RL   J. Cell Biol. 200:773-787(2013).
RN   [28]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [29]
RP   PHOSPHORYLATION AT THR-145; THR-146 AND THR-147, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF THR-145; THR-146 AND THR-147.
RX   PubMed=23985322; DOI=10.1091/mbc.e13-03-0137;
RA   Zhapparova O.N., Fokin A.I., Vorobyeva N.E., Bryantseva S.A.,
RA   Nadezhdina E.S.;
RT   "Ste20-like protein kinase SLK (LOSK) regulates microtubule organization by
RT   targeting dynactin to the centrosome.";
RL   Mol. Biol. Cell 24:3205-3214(2013).
RN   [30]
RP   INTERACTION WITH CEP126.
RX   PubMed=24867236; DOI=10.1111/boc.201300087;
RA   Bonavita R., Walas D., Brown A.K., Luini A., Stephens D.J., Colanzi A.;
RT   "Cep126 is required for pericentriolar satellite localisation to the
RT   centrosome and for primary cilium formation.";
RL   Biol. Cell 106:254-267(2014).
RN   [31]
RP   INTERACTION WITH HPS6.
RX   PubMed=25189619; DOI=10.1242/jcs.141978;
RA   Li K., Yang L., Zhang C., Niu Y., Li W., Liu J.J.;
RT   "HPS6 interacts with dynactin p150Glued to mediate retrograde trafficking
RT   and maturation of lysosomes.";
RL   J. Cell Sci. 127:4574-4588(2014).
RN   [32]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [33]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=25774020; DOI=10.1002/jcb.25160;
RA   Chen T.Y., Syu J.S., Han T.Y., Cheng H.L., Lu F.I., Wang C.Y.;
RT   "Cell cycle-dependent localization of dynactin subunit p150 glued at
RT   centrosome.";
RL   J. Cell. Biochem. 116:2049-2060(2015).
RN   [34]
RP   ASSOCIATION WITH MICROTUBULES, AND DOMAIN CAP-GLY.
RX   PubMed=26968983; DOI=10.15252/embj.201593071;
RA   McKenney R.J., Huynh W., Vale R.D., Sirajuddin M.;
RT   "Tyrosination of alpha-tubulin controls the initiation of processive
RT   dynein-dynactin motility.";
RL   EMBO J. 35:1175-1185(2016).
RN   [35]
RP   INTERACTION WITH BCCIP.
RX   PubMed=28394342; DOI=10.1038/onc.2017.92;
RA   Huhn S.C., Liu J., Ye C., Lu H., Jiang X., Feng X., Ganesan S., White E.,
RA   Shen Z.;
RT   "Regulation of spindle integrity and mitotic fidelity by BCCIP.";
RL   Oncogene 36:4750-4766(2017).
RN   [36]
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 15-107 IN COMPLEX WITH MAPRE1,
RP   AND INTERACTION WITH MAPRE1.
RX   PubMed=16109370; DOI=10.1016/j.molcel.2005.06.034;
RA   Hayashi I., Wilde A., Mal T.K., Ikura M.;
RT   "Structural basis for the activation of microtubule assembly by the EB1 and
RT   p150Glued complex.";
RL   Mol. Cell 19:449-460(2005).
RN   [37]
RP   STRUCTURE BY NMR OF 1-99.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the CAP-Gly domain in human dynactin 1.";
RL   Submitted (NOV-2005) to the PDB data bank.
RN   [38]
RP   X-RAY CRYSTALLOGRAPHY (1.86 ANGSTROMS) OF 18-111 IN COMPLEX WITH MAPRE1,
RP   AND INTERACTION WITH MAPRE1.
RX   PubMed=16949363; DOI=10.1016/j.molcel.2006.07.013;
RA   Honnappa S., Okhrimenko O., Jaussi R., Jawhari H., Jelesarov I.,
RA   Winkler F.K., Steinmetz M.O.;
RT   "Key interaction modes of dynamic +TIP networks.";
RL   Mol. Cell 23:663-671(2006).
RN   [39]
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 15-111 IN COMPLEX WITH CLIP1,
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH CLIP1.
RX   PubMed=17828277; DOI=10.1038/nsmb1291;
RA   Weisbrich A., Honnappa S., Jaussi R., Okhrimenko O., Frey D., Jelesarov I.,
RA   Akhmanova A., Steinmetz M.O.;
RT   "Structure-function relationship of CAP-Gly domains.";
RL   Nat. Struct. Mol. Biol. 14:959-967(2007).
RN   [40]
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 15-107 IN COMPLEX WITH CLIP1,
RP   INTERACTION WITH CLIP1, AND MUTAGENESIS OF LYS-68 AND ARG-90.
RX   PubMed=17828275; DOI=10.1038/nsmb1299;
RA   Hayashi I., Plevin M.J., Ikura M.;
RT   "CLIP170 autoinhibition mimics intermolecular interactions with p150Glued
RT   or EB1.";
RL   Nat. Struct. Mol. Biol. 14:980-981(2007).
RN   [41]
RP   VARIANT HMN7B SER-59.
RX   PubMed=12627231; DOI=10.1038/ng1123;
RA   Puls I., Jonnakuty C., LaMonte B.H., Holzbaur E.L., Tokito M., Mann E.,
RA   Floeter M.K., Bidus K., Drayna D., Oh S.J., Brown R.H. Jr., Ludlow C.L.,
RA   Fischbeck K.H.;
RT   "Mutant dynactin in motor neuron disease.";
RL   Nat. Genet. 33:455-456(2003).
RN   [42]
RP   INVOLVEMENT IN ALS, AND VARIANTS ALS THR-571; TRP-785 AND ILE-1249.
RX   PubMed=15326253; DOI=10.1212/01.wnl.0000134608.83927.b1;
RA   Muench C., Sedlmeier R., Meyer T., Homberg V., Sperfeld A.D., Kurt A.,
RA   Prudlo J., Peraus G., Hanemann C.O., Stumm G., Ludolph A.C.;
RT   "Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS.";
RL   Neurology 63:724-726(2004).
RN   [43]
RP   VARIANT ALS LYS-1101.
RX   PubMed=16240349; DOI=10.1002/ana.20631;
RA   Muench C., Rosenbohm A., Sperfeld A.-D., Uttner I., Reske S., Krause B.J.,
RA   Sedlmeier R., Meyer T., Hanemann C.O., Stumm G., Ludolph A.C.;
RT   "Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and
RT   FTD.";
RL   Ann. Neurol. 58:777-780(2005).
RN   [44]
RP   CHARACTERIZATION OF VARIANT HMN7B SER-59, AND INTERACTION WITH MAPRE1.
RX   PubMed=16505168; DOI=10.1083/jcb.200511068;
RA   Levy J.R., Sumner C.J., Caviston J.P., Tokito M.K., Ranganathan S.,
RA   Ligon L.A., Wallace K.E., LaMonte B.H., Harmison G.G., Puls I.,
RA   Fischbeck K.H., Holzbaur E.L.F.;
RT   "A motor neuron disease-associated mutation in p150Glued perturbs dynactin
RT   function and induces protein aggregation.";
RL   J. Cell Biol. 172:733-745(2006).
RN   [45]
RP   VARIANTS VAL-196; GLN-495 AND ILE-1249.
RX   PubMed=17824900; DOI=10.1111/j.1600-0404.2007.00884.x;
RA   Muench C., Meyer R., Linke P., Meyer T., Ludolph A.C., Haas J., Hemmer B.;
RT   "The p150 subunit of dynactin (DCTN1) gene in multiple sclerosis.";
RL   Acta Neurol. Scand. 116:231-234(2007).
RN   [46]
RP   VARIANTS PERRYS ARG-71; GLU-71; ALA-71; PRO-72 AND PRO-74, CHARACTERIZATION
RP   OF VARIANTS PERRYS ARG-71 AND PRO-74, AND CHARACTERIZATION OF VARIANT HMN7B
RP   SER-59.
RX   PubMed=19136952; DOI=10.1038/ng.293;
RA   Farrer M.J., Hulihan M.M., Kachergus J.M., Daechsel J.C., Stoessl A.J.,
RA   Grantier L.L., Calne S., Calne D.B., Lechevalier B., Chapon F., Tsuboi Y.,
RA   Yamada T., Gutmann L., Elibol B., Bhatia K.P., Wider C.,
RA   Vilarino-Gueell C., Ross O.A., Brown L.A., Castanedes-Casey M.,
RA   Dickson D.W., Wszolek Z.K.;
RT   "DCTN1 mutations in Perry syndrome.";
RL   Nat. Genet. 41:163-165(2009).
RN   [47]
RP   VARIANT ILE-1249.
RX   PubMed=19506225; DOI=10.1212/wnl.0b013e3181a92c4c;
RA   Vilarino-Gueell C., Wider C., Soto-Ortolaza A.I., Cobb S.A.,
RA   Kachergus J.M., Keeling B.H., Dachsel J.C., Hulihan M.M., Dickson D.W.,
RA   Wszolek Z.K., Uitti R.J., Graff-Radford N.R., Boeve B.F., Josephs K.A.,
RA   Miller B., Boylan K.B., Gwinn K., Adler C.H., Aasly J.O., Hentati F.,
RA   Destee A., Krygowska-Wajs A., Chartier-Harlin M.-C., Ross O.A.,
RA   Rademakers R., Farrer M.J.;
RT   "Characterization of DCTN1 genetic variability in neurodegeneration.";
RL   Neurology 72:2024-2028(2009).
RN   [48]
RP   CHARACTERIZATION OF VARIANT HMN7B SER-59.
RX   PubMed=19279216; DOI=10.1073/pnas.0810828106;
RA   Moore J.K., Sept D., Cooper J.A.;
RT   "Neurodegeneration mutations in dynactin impair dynein-dependent nuclear
RT   migration.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:5147-5152(2009).
RN   [49]
RP   CHARACTERIZATION OF VARIANT HMN7B SER-59, CHARACTERIZATION OF VARIANT
RP   196-ILE, INTERACTION WITH TBCB, AND SUBCELLULAR LOCATION.
RX   PubMed=22777741; DOI=10.1007/s00441-012-1463-z;
RA   Kuh G.F., Stockmann M., Meyer-Ohlendorf M., Linta L., Proepper C.,
RA   Ludolph A.C., Bockmann J., Boeckers T.M., Liebau S.;
RT   "Tubulin-binding cofactor B is a direct interaction partner of the dynactin
RT   subunit p150(Glued).";
RL   Cell Tissue Res. 350:13-26(2012).
RN   [50]
RP   CHARACTERIZATION OF VARIANT PERRYS PRO-74, FUNCTION, SUBUNIT, AND
RP   INTERACTION WITH MAPRE1.
RX   PubMed=23874158; DOI=10.1371/journal.pbio.1001611;
RA   Lazarus J.E., Moughamian A.J., Tokito M.K., Holzbaur E.L.;
RT   "Dynactin subunit p150(Glued) is a neuron-specific anti-catastrophe
RT   factor.";
RL   PLoS Biol. 11:E1001611-E1001611(2013).
RN   [51]
RP   VARIANT PHE-670.
RX   PubMed=24627108; DOI=10.1007/s00415-014-7289-8;
RA   Schabhuettl M., Wieland T., Senderek J., Baets J., Timmerman V.,
RA   De Jonghe P., Reilly M.M., Stieglbauer K., Laich E., Windhager R., Erwa W.,
RA   Trajanoski S., Strom T.M., Auer-Grumbach M.;
RT   "Whole-exome sequencing in patients with inherited neuropathies: outcome
RT   and challenges.";
RL   J. Neurol. 261:970-982(2014).
RN   [52]
RP   VARIANT PERRYS LEU-52.
RX   PubMed=24676999; DOI=10.1002/mds.25833;
RA   Araki E., Tsuboi Y., Daechsel J., Milnerwood A., Vilarino-Guell C.,
RA   Fujii N., Mishima T., Oka T., Hara H., Fukae J., Farrer M.J.;
RT   "A Novel DCTN1 mutation with late-onset parkinsonism and frontotemporal
RT   atrophy.";
RL   Mov. Disord. 29:1201-1204(2014).
RN   [53]
RP   CHARACTERIZATION OF VARIANTS PERRYS ARG-71 AND PRO-74, FUNCTION,
RP   INTERACTION WITH DYNEIN INTERMEDIATE CHAIN AND DYNEIN HEAVY CHAIN, AND
RP   DOMAIN CAP-GLY.
RX   PubMed=25185702; DOI=10.1038/ncomms5807;
RA   Ayloo S., Lazarus J.E., Dodda A., Tokito M., Ostap E.M., Holzbaur E.L.;
RT   "Dynactin functions as both a dynamic tether and brake during dynein-driven
RT   motility.";
RL   Nat. Commun. 5:4807-4807(2014).
RN   [54]
RP   VARIANTS PERRYS ARG-71 AND CYS-78, AND CHARACTERIZATION OF VARIANTS PERRYS
RP   ARG-71 AND CYS-78.
RX   PubMed=24881494; DOI=10.1016/j.parkreldis.2014.05.004;
RA   Tacik P., Fiesel F.C., Fujioka S., Ross O.A., Pretelt F.,
RA   Castaneda Cardona C., Kidd A., Hlavac M., Raizis A., Okun M.S., Traynor S.,
RA   Strongosky A.J., Springer W., Wszolek Z.K.;
RT   "Three families with Perry syndrome from distinct parts of the world.";
RL   Parkinsonism Relat. Disord. 20:884-888(2014).
RN   [55]
RP   CHARACTERIZATION OF VARIANT PERRYS ARG-71, SUBCELLULAR LOCATION, DOMAIN
RP   CAP-GLY, INTERACTION WITH CLIP1, AND ASSOCIATION WITH MICROTUBULES.
RX   PubMed=26972003; DOI=10.1016/j.celrep.2016.02.046;
RA   Nirschl J.J., Magiera M.M., Lazarus J.E., Janke C., Holzbaur E.L.;
RT   "Alpha-tubulin tyrosination and CLIP-170 phosphorylation regulate the
RT   initiation of dynein-driven transport in neurons.";
RL   Cell Rep. 14:2637-2652(2016).
CC   -!- FUNCTION: Plays a key role in dynein-mediated retrograde transport of
CC       vesicles and organelles along microtubules by recruiting and tethering
CC       dynein to microtubules. Binds to both dynein and microtubules providing
CC       a link between specific cargos, microtubules and dynein. Essential for
CC       targeting dynein to microtubule plus ends, recruiting dynein to
CC       membranous cargos and enhancing dynein processivity (the ability to
CC       move along a microtubule for a long distance without falling off the
CC       track). Can also act as a brake to slow the dynein motor during
CC       motility along the microtubule (PubMed:25185702). Can regulate
CC       microtubule stability by promoting microtubule formation, nucleation
CC       and polymerization and by inhibiting microtubule catastrophe in
CC       neurons. Inhibits microtubule catastrophe by binding both to
CC       microtubules and to tubulin, leading to enhanced microtubule stability
CC       along the axon (PubMed:23874158). Plays a role in metaphase spindle
CC       orientation (PubMed:22327364). Plays a role in centriole cohesion and
CC       subdistal appendage organization and function. Its recruitment to the
CC       centriole in a KIF3A-dependent manner is essential for the maintenance
CC       of centriole cohesion and the formation of subdistal appendage. Also
CC       required for microtubule anchoring at the mother centriole
CC       (PubMed:23386061). Plays a role in primary cilia formation
CC       (PubMed:25774020). {ECO:0000269|PubMed:22327364,
CC       ECO:0000269|PubMed:23386061, ECO:0000269|PubMed:23874158,
CC       ECO:0000269|PubMed:25185702, ECO:0000269|PubMed:25774020}.
CC   -!- SUBUNIT: Monomer and homodimer (PubMed:23874158). Dynactin is a large
CC       macromolecular complex of at least 10 components; p150(glued) binds
CC       directly to microtubules and to cytoplasmic dynein. Interacts with the
CC       C-terminus of MAPRE1, MAPRE2 and MAPRE3. Interacts (via C-terminus)
CC       with SNX6. Interacts with CLN3, DYNAP, ECPAS and FBXL5. Interacts with
CC       MISP; this interaction regulates its distribution at the cell cortex.
CC       Interacts with CEP131. Interacts with CEP126 (PubMed:24867236).
CC       Interacts with CLIP1 (PubMed:17828275, PubMed:17828277,
CC       PubMed:26972003, PubMed:20679239). Interacts with dynein intermediate
CC       chain and dynein heavy chain (PubMed:25185702). Interacts with PLK1
CC       (via POLO-box domain) (PubMed:20679239). Interacts with TBCB
CC       (PubMed:22777741). Binds preferentially to tyrosinated microtubules
CC       than to detyrosinated microtubules (PubMed:26972003, PubMed:26968983).
CC       Interacts with PARD6A (PubMed:20719959). Interacts with HPS6
CC       (PubMed:25189619). Interacts with KIF3A. Interacts with BICD2 (By
CC       similarity). Interacts with DST (isoform 9) (By similarity). Interacts
CC       with DST (isoform 1) (By similarity). Identified in a complex with MREG
CC       and RILP (By similarity). Interacts with BCCIP (isoform 2/alpha)
CC       (PubMed:28394342). Interacts with DCDC1 (PubMed:22159412). Interacts
CC       with AKNA (By similarity). {ECO:0000250|UniProtKB:O08788,
CC       ECO:0000269|PubMed:14514668, ECO:0000269|PubMed:16109370,
CC       ECO:0000269|PubMed:16505168, ECO:0000269|PubMed:16949363,
CC       ECO:0000269|PubMed:17532294, ECO:0000269|PubMed:17828275,
CC       ECO:0000269|PubMed:17828277, ECO:0000269|PubMed:19935774,
CC       ECO:0000269|PubMed:20679239, ECO:0000269|PubMed:20682791,
CC       ECO:0000269|PubMed:20719959, ECO:0000269|PubMed:20978158,
CC       ECO:0000269|PubMed:22159412, ECO:0000269|PubMed:22261744,
CC       ECO:0000269|PubMed:22777741, ECO:0000269|PubMed:22797915,
CC       ECO:0000269|PubMed:23509069, ECO:0000269|PubMed:23874158,
CC       ECO:0000269|PubMed:24867236, ECO:0000269|PubMed:25185702,
CC       ECO:0000269|PubMed:25189619, ECO:0000269|PubMed:26968983,
CC       ECO:0000269|PubMed:26972003, ECO:0000269|PubMed:28394342}.
CC   -!- INTERACTION:
CC       Q14203; P42025: ACTR1B; NbExp=3; IntAct=EBI-724352, EBI-367493;
CC       Q14203; Q96RK4: BBS4; NbExp=3; IntAct=EBI-724352, EBI-1805814;
CC       Q14203; P30622-1: CLIP1; NbExp=7; IntAct=EBI-724352, EBI-9640673;
CC       Q14203; P54256: Hap1; Xeno; NbExp=4; IntAct=EBI-724352, EBI-994539;
CC       Q14203; Q15691: MAPRE1; NbExp=7; IntAct=EBI-724352, EBI-1004115;
CC       Q14203; P10636-8: MAPT; NbExp=9; IntAct=EBI-724352, EBI-366233;
CC       Q14203; Q9UNH7: SNX6; NbExp=2; IntAct=EBI-724352, EBI-949294;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17828277}.
CC       Cytoplasm, cytoskeleton {ECO:0000269|PubMed:17828277,
CC       ECO:0000269|PubMed:22777741, ECO:0000269|PubMed:25774020,
CC       ECO:0000269|PubMed:26972003}. Cytoplasm, cytoskeleton, microtubule
CC       organizing center, centrosome {ECO:0000269|PubMed:14654843,
CC       ECO:0000269|PubMed:20719959, ECO:0000269|PubMed:23985322,
CC       ECO:0000269|PubMed:25774020}. Cytoplasm, cytoskeleton, microtubule
CC       organizing center, centrosome, centriole {ECO:0000269|PubMed:23386061,
CC       ECO:0000269|PubMed:25774020}. Cytoplasm, cytoskeleton, spindle
CC       {ECO:0000269|PubMed:25774020}. Nucleus envelope
CC       {ECO:0000269|PubMed:20679239}. Cytoplasm, cell cortex
CC       {ECO:0000269|PubMed:22327364}. Note=Localizes to microtubule plus ends
CC       (PubMed:17828277, PubMed:22777741, PubMed:25774020). Localizes
CC       preferentially to the ends of tyrosinated microtubules
CC       (PubMed:26972003). Localization at centrosome is regulated by SLK-
CC       dependent phosphorylation (PubMed:23985322). Localizes to centrosome in
CC       a PARKDA-dependent manner (PubMed:20719959). Localizes to the subdistal
CC       appendage region of the centriole in a KIF3A-dependent manner
CC       (PubMed:23386061). PLK1-mediated phosphorylation at Ser-179 is
CC       essential for its localization in the nuclear envelope
CC       (PubMed:20679239). {ECO:0000269|PubMed:17828277,
CC       ECO:0000269|PubMed:20679239, ECO:0000269|PubMed:20719959,
CC       ECO:0000269|PubMed:22777741, ECO:0000269|PubMed:23386061,
CC       ECO:0000269|PubMed:23985322, ECO:0000269|PubMed:25774020,
CC       ECO:0000269|PubMed:26972003}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=p150;
CC         IsoId=Q14203-1; Sequence=Displayed;
CC       Name=p135;
CC         IsoId=Q14203-2; Sequence=VSP_000760;
CC       Name=3;
CC         IsoId=Q14203-3; Sequence=VSP_045392, VSP_045393, VSP_045394;
CC       Name=4;
CC         IsoId=Q14203-4; Sequence=VSP_045393, VSP_045394;
CC       Name=5;
CC         IsoId=Q14203-5; Sequence=VSP_000760, VSP_045394;
CC       Name=6;
CC         IsoId=Q14203-6; Sequence=VSP_047174;
CC   -!- TISSUE SPECIFICITY: Brain.
CC   -!- DOMAIN: The CAP-Gly domain is essential for interactions with
CC       microtubules and its binding partners and for its motion along the
CC       microtubules. Essential for its preferential binding to tyrosinated
CC       microtubules and for promoting the sustained interaction of the dynein
CC       motor with microtubules. {ECO:0000269|PubMed:25185702,
CC       ECO:0000269|PubMed:26968983, ECO:0000269|PubMed:26972003}.
CC   -!- PTM: Ubiquitinated by a SCF complex containing FBXL5, leading to its
CC       degradation by the proteasome. {ECO:0000269|PubMed:17532294}.
CC   -!- PTM: Phosphorylation by SLK at Thr-145, Thr-146 and Thr-147 targets
CC       DCTN1 to the centrosome. It is uncertain if SLK phosphorylates all
CC       three threonines or one or two of them. PLK1-mediated phosphorylation
CC       at Ser-179 is essential for its localization in the nuclear envelope,
CC       promotes its dissociation from microtubules during early mitosis and
CC       positively regulates nuclear envelope breakdown during prophase.
CC       {ECO:0000269|PubMed:20679239, ECO:0000269|PubMed:23985322}.
CC   -!- DISEASE: Neuronopathy, distal hereditary motor, 7B (HMN7B)
CC       [MIM:607641]: A neuromuscular disorder. Distal hereditary motor
CC       neuronopathies constitute a heterogeneous group of neuromuscular
CC       disorders caused by selective degeneration of motor neurons in the
CC       anterior horn of the spinal cord, without sensory deficit in the
CC       posterior horn. The overall clinical picture consists of a classical
CC       distal muscular atrophy syndrome in the legs without clinical sensory
CC       loss. The disease starts with weakness and wasting of distal muscles of
CC       the anterior tibial and peroneal compartments of the legs. Later on,
CC       weakness and atrophy may expand to the proximal muscles of the lower
CC       limbs and/or to the distal upper limbs. {ECO:0000269|PubMed:12627231,
CC       ECO:0000269|PubMed:16505168, ECO:0000269|PubMed:19136952,
CC       ECO:0000269|PubMed:19279216, ECO:0000269|PubMed:22777741}. Note=The
CC       disease is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Amyotrophic lateral sclerosis (ALS) [MIM:105400]: A
CC       neurodegenerative disorder affecting upper motor neurons in the brain
CC       and lower motor neurons in the brain stem and spinal cord, resulting in
CC       fatal paralysis. Sensory abnormalities are absent. The pathologic
CC       hallmarks of the disease include pallor of the corticospinal tract due
CC       to loss of motor neurons, presence of ubiquitin-positive inclusions
CC       within surviving motor neurons, and deposition of pathologic
CC       aggregates. The etiology of amyotrophic lateral sclerosis is likely to
CC       be multifactorial, involving both genetic and environmental factors.
CC       The disease is inherited in 5-10% of the cases.
CC       {ECO:0000269|PubMed:15326253, ECO:0000269|PubMed:16240349}.
CC       Note=Disease susceptibility is associated with variations affecting the
CC       gene represented in this entry.
CC   -!- DISEASE: Perry syndrome (PERRYS) [MIM:168605]: A neuropsychiatric
CC       disorder characterized by mental depression not responsive to
CC       antidepressant drugs or electroconvulsive therapy, sleep disturbances,
CC       exhaustion and marked weight loss. Parkinsonism develops later and
CC       respiratory failure occurred terminally. {ECO:0000269|PubMed:19136952,
CC       ECO:0000269|PubMed:23874158, ECO:0000269|PubMed:24676999,
CC       ECO:0000269|PubMed:24881494, ECO:0000269|PubMed:25185702,
CC       ECO:0000269|PubMed:26972003}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the dynactin 150 kDa subunit family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF064205; AAD55811.1; -; Genomic_DNA.
DR   EMBL; AF064203; AAD55811.1; JOINED; Genomic_DNA.
DR   EMBL; AF064204; AAD55811.1; JOINED; Genomic_DNA.
DR   EMBL; AF064205; AAD55812.1; -; Genomic_DNA.
DR   EMBL; AF064204; AAD55812.1; JOINED; Genomic_DNA.
DR   EMBL; AK297286; BAG59757.1; -; mRNA.
DR   EMBL; AK314352; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC005041; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471053; EAW99684.1; -; Genomic_DNA.
DR   EMBL; BC071583; AAH71583.1; -; mRNA.
DR   EMBL; X98801; CAA67333.1; -; mRNA.
DR   EMBL; AF086947; AAD03694.1; -; Genomic_DNA.
DR   EMBL; AF086927; AAD03694.1; JOINED; Genomic_DNA.
DR   EMBL; AF086928; AAD03694.1; JOINED; Genomic_DNA.
DR   EMBL; AF086929; AAD03694.1; JOINED; Genomic_DNA.
DR   EMBL; AF086930; AAD03694.1; JOINED; Genomic_DNA.
DR   EMBL; AF086931; AAD03694.1; JOINED; Genomic_DNA.
DR   EMBL; AF086932; AAD03694.1; JOINED; Genomic_DNA.
DR   EMBL; AF086933; AAD03694.1; JOINED; Genomic_DNA.
DR   EMBL; AF086934; AAD03694.1; JOINED; Genomic_DNA.
DR   EMBL; AF086935; AAD03694.1; JOINED; Genomic_DNA.
DR   EMBL; AF086936; AAD03694.1; JOINED; Genomic_DNA.
DR   EMBL; AF086937; AAD03694.1; JOINED; Genomic_DNA.
DR   EMBL; AF086938; AAD03694.1; JOINED; Genomic_DNA.
DR   EMBL; AF086939; AAD03694.1; JOINED; Genomic_DNA.
DR   EMBL; AF086940; AAD03694.1; JOINED; Genomic_DNA.
DR   EMBL; AF086941; AAD03694.1; JOINED; Genomic_DNA.
DR   EMBL; AF086942; AAD03694.1; JOINED; Genomic_DNA.
DR   EMBL; AF086943; AAD03694.1; JOINED; Genomic_DNA.
DR   EMBL; AF086944; AAD03694.1; JOINED; Genomic_DNA.
DR   EMBL; AF086945; AAD03694.1; JOINED; Genomic_DNA.
DR   EMBL; AF086946; AAD03694.1; JOINED; Genomic_DNA.
DR   EMBL; BT006758; AAP35404.1; -; mRNA.
DR   CCDS; CCDS1939.1; -. [Q14203-1]
DR   CCDS; CCDS46341.1; -. [Q14203-4]
DR   CCDS; CCDS46342.1; -. [Q14203-5]
DR   CCDS; CCDS46343.1; -. [Q14203-2]
DR   CCDS; CCDS54368.1; -. [Q14203-3]
DR   CCDS; CCDS54369.1; -. [Q14203-6]
DR   RefSeq; NP_001128512.1; NM_001135040.2. [Q14203-4]
DR   RefSeq; NP_001128513.1; NM_001135041.2. [Q14203-5]
DR   RefSeq; NP_001177765.1; NM_001190836.1. [Q14203-3]
DR   RefSeq; NP_001177766.1; NM_001190837.1. [Q14203-6]
DR   RefSeq; NP_004073.2; NM_004082.4. [Q14203-1]
DR   RefSeq; NP_075408.1; NM_023019.3. [Q14203-2]
DR   PDB; 1TXQ; X-ray; 1.80 A; A=15-107.
DR   PDB; 2COY; NMR; -; A=1-99.
DR   PDB; 2HKN; X-ray; 1.87 A; A/B=18-111.
DR   PDB; 2HKQ; X-ray; 1.86 A; B=18-111.
DR   PDB; 2HL3; X-ray; 2.03 A; A/B=18-111.
DR   PDB; 2HL5; X-ray; 1.93 A; C/D=18-111.
DR   PDB; 2HQH; X-ray; 1.80 A; A/B/C/D=15-107.
DR   PDB; 3E2U; X-ray; 2.60 A; A/B/C/D=18-111.
DR   PDB; 3TQ7; X-ray; 2.30 A; P/Q=27-97.
DR   PDBsum; 1TXQ; -.
DR   PDBsum; 2COY; -.
DR   PDBsum; 2HKN; -.
DR   PDBsum; 2HKQ; -.
DR   PDBsum; 2HL3; -.
DR   PDBsum; 2HL5; -.
DR   PDBsum; 2HQH; -.
DR   PDBsum; 3E2U; -.
DR   PDBsum; 3TQ7; -.
DR   SMR; Q14203; -.
DR   BioGrid; 108007; 279.
DR   CORUM; Q14203; -.
DR   DIP; DIP-31365N; -.
DR   IntAct; Q14203; 219.
DR   MINT; Q14203; -.
DR   STRING; 9606.ENSP00000354791; -.
DR   CarbonylDB; Q14203; -.
DR   iPTMnet; Q14203; -.
DR   MetOSite; Q14203; -.
DR   PhosphoSitePlus; Q14203; -.
DR   SwissPalm; Q14203; -.
DR   BioMuta; DCTN1; -.
DR   DMDM; 17375490; -.
DR   OGP; Q14203; -.
DR   EPD; Q14203; -.
DR   jPOST; Q14203; -.
DR   MassIVE; Q14203; -.
DR   MaxQB; Q14203; -.
DR   PaxDb; Q14203; -.
DR   PeptideAtlas; Q14203; -.
DR   PRIDE; Q14203; -.
DR   ProteomicsDB; 20166; -.
DR   ProteomicsDB; 20302; -.
DR   ProteomicsDB; 2371; -.
DR   ProteomicsDB; 33940; -.
DR   ProteomicsDB; 59925; -. [Q14203-1]
DR   ProteomicsDB; 59926; -. [Q14203-2]
DR   ABCD; Q14203; -.
DR   Antibodypedia; 3966; 292 antibodies.
DR   DNASU; 1639; -.
DR   Ensembl; ENST00000361874; ENSP00000354791; ENSG00000204843. [Q14203-1]
DR   Ensembl; ENST00000394003; ENSP00000377571; ENSG00000204843. [Q14203-6]
DR   Ensembl; ENST00000409240; ENSP00000386406; ENSG00000204843. [Q14203-3]
DR   Ensembl; ENST00000409438; ENSP00000387270; ENSG00000204843. [Q14203-5]
DR   Ensembl; ENST00000409567; ENSP00000386843; ENSG00000204843. [Q14203-4]
DR   Ensembl; ENST00000633691; ENSP00000487724; ENSG00000204843. [Q14203-2]
DR   GeneID; 1639; -.
DR   KEGG; hsa:1639; -.
DR   UCSC; uc002sku.4; human. [Q14203-1]
DR   CTD; 1639; -.
DR   DisGeNET; 1639; -.
DR   GeneCards; DCTN1; -.
DR   GeneReviews; DCTN1; -.
DR   HGNC; HGNC:2711; DCTN1.
DR   HPA; ENSG00000204843; Low tissue specificity.
DR   MalaCards; DCTN1; -.
DR   MIM; 105400; phenotype.
DR   MIM; 168605; phenotype.
DR   MIM; 601143; gene.
DR   MIM; 607641; phenotype.
DR   neXtProt; NX_Q14203; -.
DR   OpenTargets; ENSG00000204843; -.
DR   Orphanet; 803; Amyotrophic lateral sclerosis.
DR   Orphanet; 139589; Distal hereditary motor neuropathy type 7.
DR   Orphanet; 178509; Perry syndrome.
DR   PharmGKB; PA27180; -.
DR   eggNOG; KOG0971; Eukaryota.
DR   eggNOG; COG5244; LUCA.
DR   GeneTree; ENSGT00940000155378; -.
DR   HOGENOM; CLU_002523_0_0_1; -.
DR   InParanoid; Q14203; -.
DR   KO; K04648; -.
DR   OMA; IEAKEQH; -.
DR   PhylomeDB; Q14203; -.
DR   TreeFam; TF105246; -.
DR   Reactome; R-HSA-2132295; MHC class II antigen presentation.
DR   Reactome; R-HSA-2565942; Regulation of PLK1 Activity at G2/M Transition. [Q14203-2]
DR   Reactome; R-HSA-3371497; HSP90 chaperone cycle for steroid hormone receptors (SHR).
DR   Reactome; R-HSA-380259; Loss of Nlp from mitotic centrosomes. [Q14203-2]
DR   Reactome; R-HSA-380270; Recruitment of mitotic centrosome proteins and complexes. [Q14203-2]
DR   Reactome; R-HSA-380284; Loss of proteins required for interphase microtubule organization from the centrosome. [Q14203-2]
DR   Reactome; R-HSA-380320; Recruitment of NuMA to mitotic centrosomes. [Q14203-2]
DR   Reactome; R-HSA-381038; XBP1(S) activates chaperone genes.
DR   Reactome; R-HSA-5620912; Anchoring of the basal body to the plasma membrane. [Q14203-2]
DR   Reactome; R-HSA-6807878; COPI-mediated anterograde transport.
DR   Reactome; R-HSA-6811436; COPI-independent Golgi-to-ER retrograde traffic.
DR   Reactome; R-HSA-8854518; AURKA Activation by TPX2. [Q14203-2]
DR   SIGNOR; Q14203; -.
DR   ChiTaRS; DCTN1; human.
DR   EvolutionaryTrace; Q14203; -.
DR   GeneWiki; DCTN1; -.
DR   GenomeRNAi; 1639; -.
DR   Pharos; Q14203; Tbio.
DR   PRO; PR:Q14203; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q14203; protein.
DR   Bgee; ENSG00000204843; Expressed in frontal cortex and 222 other tissues.
DR   ExpressionAtlas; Q14203; baseline and differential.
DR   Genevisible; Q14203; HS.
DR   GO; GO:0030424; C:axon; IEA:GOC.
DR   GO; GO:0005623; C:cell; IEA:GOC.
DR   GO; GO:0005938; C:cell cortex; IDA:UniProtKB.
DR   GO; GO:0099738; C:cell cortex region; IDA:UniProtKB.
DR   GO; GO:0120103; C:centriolar subdistal appendage; IDA:GO_Central.
DR   GO; GO:0005814; C:centriole; IDA:UniProtKB.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:ARUK-UCL.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0030286; C:dynein complex; IEA:UniProtKB-KW.
DR   GO; GO:0045171; C:intercellular bridge; IDA:HPA.
DR   GO; GO:0000776; C:kinetochore; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005874; C:microtubule; IDA:UniProtKB.
DR   GO; GO:0005875; C:microtubule associated complex; IMP:ARUK-UCL.
DR   GO; GO:0015630; C:microtubule cytoskeleton; IDA:HPA.
DR   GO; GO:0035371; C:microtubule plus-end; IDA:UniProtKB.
DR   GO; GO:0072686; C:mitotic spindle; IDA:HPA.
DR   GO; GO:0043005; C:neuron projection; IDA:ARUK-UCL.
DR   GO; GO:0043025; C:neuronal cell body; IDA:ARUK-UCL.
DR   GO; GO:0005635; C:nuclear envelope; IDA:UniProtKB.
DR   GO; GO:0005819; C:spindle; IDA:UniProtKB.
DR   GO; GO:0000922; C:spindle pole; IDA:UniProtKB.
DR   GO; GO:0008017; F:microtubule binding; IDA:UniProtKB.
DR   GO; GO:0003774; F:motor activity; IEA:UniProtKB-KW.
DR   GO; GO:0019901; F:protein kinase binding; IPI:ARUK-UCL.
DR   GO; GO:0048156; F:tau protein binding; NAS:ARUK-UCL.
DR   GO; GO:0015631; F:tubulin binding; IDA:UniProtKB.
DR   GO; GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0010457; P:centriole-centriole cohesion; IMP:UniProtKB.
DR   GO; GO:0097711; P:ciliary basal body-plasma membrane docking; TAS:Reactome.
DR   GO; GO:0006888; P:endoplasmic reticulum to Golgi vesicle-mediated transport; TAS:Reactome.
DR   GO; GO:0000132; P:establishment of mitotic spindle orientation; IMP:UniProtKB.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0036498; P:IRE1-mediated unfolded protein response; TAS:Reactome.
DR   GO; GO:0099558; P:maintenance of synapse structure; TAS:ARUK-UCL.
DR   GO; GO:0034454; P:microtubule anchoring at centrosome; IMP:UniProtKB.
DR   GO; GO:0000278; P:mitotic cell cycle; NAS:ProtInc.
DR   GO; GO:0061744; P:motor behavior; IMP:ARUK-UCL.
DR   GO; GO:0007399; P:nervous system development; NAS:UniProtKB.
DR   GO; GO:0007528; P:neuromuscular junction development; IMP:ARUK-UCL.
DR   GO; GO:0050905; P:neuromuscular process; IMP:ARUK-UCL.
DR   GO; GO:0070050; P:neuron cellular homeostasis; IMP:ARUK-UCL.
DR   GO; GO:1990535; P:neuron projection maintenance; IMP:ARUK-UCL.
DR   GO; GO:1905515; P:non-motile cilium assembly; IMP:UniProtKB.
DR   GO; GO:0051081; P:nuclear envelope disassembly; IMP:UniProtKB.
DR   GO; GO:0090063; P:positive regulation of microtubule nucleation; IDA:UniProtKB.
DR   GO; GO:0031116; P:positive regulation of microtubule polymerization; IDA:UniProtKB.
DR   GO; GO:1904398; P:positive regulation of neuromuscular junction development; IMP:ARUK-UCL.
DR   GO; GO:0010389; P:regulation of G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0060236; P:regulation of mitotic spindle organization; IMP:UniProtKB.
DR   GO; GO:0042147; P:retrograde transport, endosome to Golgi; IMP:UniProtKB.
DR   GO; GO:0010970; P:transport along microtubule; IEA:InterPro.
DR   GO; GO:0021517; P:ventral spinal cord development; IMP:ARUK-UCL.
DR   Gene3D; 2.30.30.190; -; 1.
DR   InterPro; IPR036859; CAP-Gly_dom_sf.
DR   InterPro; IPR000938; CAP-Gly_domain.
DR   InterPro; IPR027663; DCTN1.
DR   InterPro; IPR022157; Dynactin.
DR   PANTHER; PTHR18916:SF75; PTHR18916:SF75; 1.
DR   Pfam; PF01302; CAP_GLY; 1.
DR   Pfam; PF12455; Dynactin; 1.
DR   SMART; SM01052; CAP_GLY; 1.
DR   SUPFAM; SSF74924; SSF74924; 1.
DR   PROSITE; PS00845; CAP_GLY_1; 1.
DR   PROSITE; PS50245; CAP_GLY_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Amyotrophic lateral sclerosis;
KW   Cell cycle; Cell division; Coiled coil; Cytoplasm; Cytoskeleton; Dynein;
KW   Microtubule; Mitosis; Neurodegeneration; Neuropathy; Nucleus; Parkinsonism;
KW   Phosphoprotein; Polymorphism; Reference proteome; Transport;
KW   Ubl conjugation.
FT   CHAIN           1..1278
FT                   /note="Dynactin subunit 1"
FT                   /id="PRO_0000083518"
FT   DOMAIN          48..90
FT                   /note="CAP-Gly"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00045"
FT   REGION          911..1278
FT                   /note="Interaction with HPS6"
FT                   /evidence="ECO:0000269|PubMed:25189619"
FT   COILED          213..547
FT                   /evidence="ECO:0000255"
FT   COILED          943..1049
FT                   /evidence="ECO:0000255"
FT   COILED          1182..1211
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        164..191
FT                   /note="Ser-rich"
FT   MOD_RES         108
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:19690332"
FT   MOD_RES         145
FT                   /note="Phosphothreonine; by SLK"
FT                   /evidence="ECO:0000269|PubMed:23985322"
FT   MOD_RES         146
FT                   /note="Phosphothreonine; by SLK"
FT                   /evidence="ECO:0000269|PubMed:23985322"
FT   MOD_RES         147
FT                   /note="Phosphothreonine; by SLK"
FT                   /evidence="ECO:0000269|PubMed:23985322"
FT   MOD_RES         179
FT                   /note="Phosphoserine; by PLK1"
FT                   /evidence="ECO:0000269|PubMed:20679239"
FT   MOD_RES         212
FT                   /note="Phosphoserine; by CDK1"
FT                   /evidence="ECO:0000269|PubMed:20679239"
FT   VAR_SEQ         1..138
FT                   /note="MAQSKRHVYSRTPSGSRMSAEASARPLRVGSRVEVIGKGHRGTVAYVGATLF
FT                   ATGKWVGVILDEAKGKNDGTVQGRKYFTCDEGHGIFVRQSQIQVFEDGADTTSPETPDS
FT                   SASKVLKREGTDTTAKTSKLRGLKPKK -> MMRQ (in isoform p135 and
FT                   isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_000760"
FT   VAR_SEQ         1..17
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_045392"
FT   VAR_SEQ         132..151
FT                   /note="Missing (in isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_045393"
FT   VAR_SEQ         132..138
FT                   /note="Missing (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:8856662"
FT                   /id="VSP_047174"
FT   VAR_SEQ         1066..1070
FT                   /note="Missing (in isoform 3, isoform 4 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_045394"
FT   VARIANT         52
FT                   /note="F -> L (in PERRYS; mutation carriers either do not
FT                   develop depression or they do develop it late in the
FT                   disease course; dbSNP:rs886039227)"
FT                   /evidence="ECO:0000269|PubMed:24676999"
FT                   /id="VAR_071452"
FT   VARIANT         59
FT                   /note="G -> S (in HMN7B; reduced affinity for microtubules
FT                   which has been suggested to impair axonal transport; the
FT                   effect is identical to that of complete loss of the CAP-Gly
FT                   domain; decreased interaction with MAPRE1; no effect on its
FT                   interaction with TBCB; dbSNP:rs121909342)"
FT                   /evidence="ECO:0000269|PubMed:12627231,
FT                   ECO:0000269|PubMed:16505168, ECO:0000269|PubMed:19136952,
FT                   ECO:0000269|PubMed:19279216, ECO:0000269|PubMed:22777741"
FT                   /id="VAR_015850"
FT   VARIANT         71
FT                   /note="G -> A (in PERRYS; dbSNP:rs67586389)"
FT                   /evidence="ECO:0000269|PubMed:19136952"
FT                   /id="VAR_063867"
FT   VARIANT         71
FT                   /note="G -> E (in PERRYS; dbSNP:rs67586389)"
FT                   /evidence="ECO:0000269|PubMed:19136952"
FT                   /id="VAR_063868"
FT   VARIANT         71
FT                   /note="G -> R (in PERRYS; reduced microtubule binding;
FT                   results in the accumulation of intracytoplasmic inclusions;
FT                   loss of interaction with CLIP1; significant decrease in
FT                   motility of dynein-dynactin complex along microtubules;
FT                   dbSNP:rs72466485)"
FT                   /evidence="ECO:0000269|PubMed:19136952,
FT                   ECO:0000269|PubMed:24881494, ECO:0000269|PubMed:25185702,
FT                   ECO:0000269|PubMed:26972003"
FT                   /id="VAR_063869"
FT   VARIANT         72
FT                   /note="T -> P (in PERRYS; dbSNP:rs72466486)"
FT                   /evidence="ECO:0000269|PubMed:19136952"
FT                   /id="VAR_063870"
FT   VARIANT         74
FT                   /note="Q -> P (in PERRYS; diminishes microtubule binding
FT                   and lead to intracytoplasmic inclusions; significant
FT                   decrease in motility of dynein-dynactin complex along
FT                   microtubules; defective in inhibiting microtubule
FT                   catastrophe in neurons; dbSNP:rs72466487)"
FT                   /evidence="ECO:0000269|PubMed:19136952,
FT                   ECO:0000269|PubMed:23874158, ECO:0000269|PubMed:25185702"
FT                   /id="VAR_063871"
FT   VARIANT         78
FT                   /note="Y -> C (in PERRYS; significantly reduced microtubule
FT                   binding; dbSNP:rs886039229)"
FT                   /evidence="ECO:0000269|PubMed:24881494"
FT                   /id="VAR_071453"
FT   VARIANT         163
FT                   /note="A -> P"
FT                   /id="VAR_001373"
FT   VARIANT         196
FT                   /note="I -> V (no effect of its interaction with TBCB; no
FT                   loss of localization to microtubules; dbSNP:rs55862001)"
FT                   /evidence="ECO:0000269|PubMed:17824900,
FT                   ECO:0000269|PubMed:22777741"
FT                   /id="VAR_076920"
FT   VARIANT         287
FT                   /note="L -> M (in dbSNP:rs13420401)"
FT                   /id="VAR_048677"
FT   VARIANT         495
FT                   /note="R -> Q (in dbSNP:rs17721059)"
FT                   /evidence="ECO:0000269|PubMed:17824900"
FT                   /id="VAR_048678"
FT   VARIANT         571
FT                   /note="M -> T (in ALS; associated with disease
FT                   susceptibility; dbSNP:rs121909343)"
FT                   /evidence="ECO:0000269|PubMed:15326253"
FT                   /id="VAR_063872"
FT   VARIANT         670
FT                   /note="Y -> F (found in a patient with hereditary motor and
FT                   sensory neuropathy; unknown pathological significance;
FT                   dbSNP:rs765819985)"
FT                   /evidence="ECO:0000269|PubMed:24627108"
FT                   /id="VAR_073287"
FT   VARIANT         785
FT                   /note="R -> W (in ALS; associated with disease
FT                   susceptibility; dbSNP:rs121909344)"
FT                   /evidence="ECO:0000269|PubMed:15326253"
FT                   /id="VAR_063873"
FT   VARIANT         1101
FT                   /note="R -> K (in ALS; associated with disease
FT                   susceptibility; dbSNP:rs121909345)"
FT                   /evidence="ECO:0000269|PubMed:16240349"
FT                   /id="VAR_063874"
FT   VARIANT         1249
FT                   /note="T -> I (in ALS; unknown pathological significance;
FT                   dbSNP:rs72466496)"
FT                   /evidence="ECO:0000269|PubMed:15326253,
FT                   ECO:0000269|PubMed:17824900, ECO:0000269|PubMed:19506225"
FT                   /id="VAR_063875"
FT   MUTAGEN         68
FT                   /note="K->A: Abolishes interaction with CLIP1."
FT                   /evidence="ECO:0000269|PubMed:17828275"
FT   MUTAGEN         90
FT                   /note="R->E: Abolishes interaction with CLIP1."
FT                   /evidence="ECO:0000269|PubMed:17828275"
FT   MUTAGEN         145
FT                   /note="T->A: Affects centrosomal localization; when
FT                   associated with A-146 and A-147."
FT                   /evidence="ECO:0000269|PubMed:23985322"
FT   MUTAGEN         146
FT                   /note="T->A: Affects centrosomal localization; when
FT                   associated with A-145 and A-147."
FT                   /evidence="ECO:0000269|PubMed:23985322"
FT   MUTAGEN         147
FT                   /note="T->A: Affects centrosomal localization; when
FT                   associated with A-145 and A-146."
FT                   /evidence="ECO:0000269|PubMed:23985322"
FT   MUTAGEN         179
FT                   /note="S->A: Non-phosphorylatable by PLK1. Decreased
FT                   nuclear envelope localization. No loss of microtubule-
FT                   binding. No effect on its interaction with CLIP1."
FT                   /evidence="ECO:0000269|PubMed:20679239"
FT   MUTAGEN         179
FT                   /note="S->D: No loss of localization to nuclear envelope.
FT                   Decrease in microtubule-binding. No effect on its
FT                   interaction with CLIP1."
FT                   /evidence="ECO:0000269|PubMed:20679239"
FT   MUTAGEN         212
FT                   /note="S->A: No effect on its interaction with CLIP1 and
FT                   PLK1."
FT                   /evidence="ECO:0000269|PubMed:20679239"
FT   CONFLICT        10
FT                   /note="S -> N (in Ref. 7; CAA67333)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        257
FT                   /note="Q -> R (in Ref. 2; BAG59757)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        349
FT                   /note="K -> R (in Ref. 2; AK314352)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        368
FT                   /note="A -> V (in Ref. 2; AK314352)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        526
FT                   /note="H -> N (in Ref. 5; AAH71583)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        618
FT                   /note="K -> R (in Ref. 5; AAH71583)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        712
FT                   /note="D -> V (in Ref. 7; CAA67333)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1081
FT                   /note="V -> M (in Ref. 9; AAP35404)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1261
FT                   /note="R -> Q (in Ref. 2; BAG59757)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1274
FT                   /note="S -> I (in Ref. 5; AAH71583)"
FT                   /evidence="ECO:0000305"
FT   STRAND          17..19
FT                   /evidence="ECO:0000244|PDB:2COY"
FT   STRAND          32..35
FT                   /evidence="ECO:0000244|PDB:1TXQ"
FT   TURN            36..38
FT                   /evidence="ECO:0000244|PDB:1TXQ"
FT   STRAND          41..48
FT                   /evidence="ECO:0000244|PDB:1TXQ"
FT   STRAND          51..55
FT                   /evidence="ECO:0000244|PDB:1TXQ"
FT   STRAND          57..65
FT                   /evidence="ECO:0000244|PDB:1TXQ"
FT   STRAND          67..73
FT                   /evidence="ECO:0000244|PDB:1TXQ"
FT   STRAND          76..78
FT                   /evidence="ECO:0000244|PDB:1TXQ"
FT   TURN            83..85
FT                   /evidence="ECO:0000244|PDB:2HQH"
FT   STRAND          86..89
FT                   /evidence="ECO:0000244|PDB:1TXQ"
FT   HELIX           91..93
FT                   /evidence="ECO:0000244|PDB:1TXQ"
FT   STRAND          94..96
FT                   /evidence="ECO:0000244|PDB:1TXQ"
SQ   SEQUENCE   1278 AA;  141695 MW;  6DCEA5E67856E4BC CRC64;
     MAQSKRHVYS RTPSGSRMSA EASARPLRVG SRVEVIGKGH RGTVAYVGAT LFATGKWVGV
     ILDEAKGKND GTVQGRKYFT CDEGHGIFVR QSQIQVFEDG ADTTSPETPD SSASKVLKRE
     GTDTTAKTSK LRGLKPKKAP TARKTTTRRP KPTRPASTGV AGASSSLGPS GSASAGELSS
     SEPSTPAQTP LAAPIIPTPV LTSPGAVPPL PSPSKEEEGL RAQVRDLEEK LETLRLKRAE
     DKAKLKELEK HKIQLEQVQE WKSKMQEQQA DLQRRLKEAR KEAKEALEAK ERYMEEMADT
     ADAIEMATLD KEMAEERAES LQQEVEALKE RVDELTTDLE ILKAEIEEKG SDGAASSYQL
     KQLEEQNARL KDALVRMRDL SSSEKQEHVK LQKLMEKKNQ ELEVVRQQRE RLQEELSQAE
     STIDELKEQV DAALGAEEMV EMLTDRNLNL EEKVRELRET VGDLEAMNEM NDELQENARE
     TELELREQLD MAGARVREAQ KRVEAAQETV ADYQQTIKKY RQLTAHLQDV NRELTNQQEA
     SVERQQQPPP ETFDFKIKFA ETKAHAKAIE MELRQMEVAQ ANRHMSLLTA FMPDSFLRPG
     GDHDCVLVLL LMPRLICKAE LIRKQAQEKF ELSENCSERP GLRGAAGEQL SFAAGLVYSL
     SLLQATLHRY EHALSQCSVD VYKKVGSLYP EMSAHERSLD FLIELLHKDQ LDETVNVEPL
     TKAIKYYQHL YSIHLAEQPE DCTMQLADHI KFTQSALDCM SVEVGRLRAF LQGGQEATDI
     ALLLRDLETS CSDIRQFCKK IRRRMPGTDA PGIPAALAFG PQVSDTLLDC RKHLTWVVAV
     LQEVAAAAAQ LIAPLAENEG LLVAALEELA FKASEQIYGT PSSSPYECLR QSCNILISTM
     NKLATAMQEG EYDAERPPSK PPPVELRAAA LRAEITDAEG LGLKLEDRET VIKELKKSLK
     IKGEELSEAN VRLSLLEKKL DSAAKDADER IEKVQTRLEE TQALLRKKEK EFEETMDALQ
     ADIDQLEAEK AELKQRLNSQ SKRTIEGLRG PPPSGIATLV SGIAGEEQQR GAIPGQAPGS
     VPGPGLVKDS PLLLQQISAM RLHISQLQHE NSILKGAQMK ASLASLPPLH VAKLSHEGPG
     SELPAGALYR KTSQLLETLN QLSTHTHVVD ITRTSPAAKS PSAQLMEQVA QLKSLSDTVE
     KLKDEVLKET VSQRPGATVP TDFATFPSSA FLRAKEEQQD DTVYMGKVTF SCAAGFGQRH
     RLVLTQEQLH QLHSRLIS
//
ID   Q6MZZ3_HUMAN            Unreviewed;      1278 AA.
AC   Q6MZZ3;
DT   05-JUL-2004, integrated into UniProtKB/TrEMBL.
DT   05-JUL-2004, sequence version 1.
DT   11-DEC-2019, entry version 92.
DE   SubName: Full=Uncharacterized protein DKFZp686I0746 {ECO:0000313|EMBL:CAE45882.1};
GN   Name=DKFZp686I0746 {ECO:0000313|EMBL:CAE45882.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:CAE45882.1};
RN   [1] {ECO:0000313|EMBL:CAE45882.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Amygdala {ECO:0000313|EMBL:CAE45882.1};
RG   The German cDNA Consortium;
RA   Ansorge W., Krieger S., Regiert T., Rittmueller C., Schwager B.,
RA   Mewes H.W., Weil B., Amid C., Osanger A., Fobo G., Han M., Wiemann S.;
RL   Submitted (SEP-2004) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BX640799; CAE45882.1; -; mRNA.
DR   RefSeq; NP_001177766.1; NM_001190837.1.
DR   RefSeq; NP_004073.2; NM_004082.4.
DR   PeptideAtlas; Q6MZZ3; -.
DR   PRIDE; Q6MZZ3; -.
DR   DNASU; 1639; -.
DR   GeneID; 1639; -.
DR   KEGG; hsa:1639; -.
DR   CTD; 1639; -.
DR   PharmGKB; PA27180; -.
DR   eggNOG; KOG0971; Eukaryota.
DR   eggNOG; COG5244; LUCA.
DR   KO; K04648; -.
DR   OrthoDB; 1550378at2759; -.
DR   GenomeRNAi; 1639; -.
DR   Genevisible; Q6MZZ3; HS.
DR   GO; GO:0005623; C:cell; IEA:GOC.
DR   GO; GO:0005813; C:centrosome; IEA:InterPro.
DR   GO; GO:0008017; F:microtubule binding; IEA:InterPro.
DR   GO; GO:0000132; P:establishment of mitotic spindle orientation; IEA:InterPro.
DR   GO; GO:0010970; P:transport along microtubule; IEA:InterPro.
DR   Gene3D; 2.30.30.190; -; 1.
DR   InterPro; IPR036859; CAP-Gly_dom_sf.
DR   InterPro; IPR000938; CAP-Gly_domain.
DR   InterPro; IPR027663; DCTN1.
DR   InterPro; IPR022157; Dynactin.
DR   PANTHER; PTHR18916:SF75; PTHR18916:SF75; 1.
DR   Pfam; PF01302; CAP_GLY; 1.
DR   Pfam; PF12455; Dynactin; 1.
DR   SMART; SM01052; CAP_GLY; 1.
DR   SUPFAM; SSF74924; SSF74924; 1.
DR   PROSITE; PS00845; CAP_GLY_1; 1.
DR   PROSITE; PS50245; CAP_GLY_2; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN          48..90
FT                   /note="CAP-Gly"
FT                   /evidence="ECO:0000259|PROSITE:PS50245"
FT   REGION          1..25
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          100..223
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          360..383
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          388..540
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          952..1043
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1185..1205
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        1..19
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        131..150
FT                   /note="Basic"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        158..188
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   1278 AA;  141551 MW;  F2EC8478EF8899FE CRC64;
     MAQSKRHVYS RTPSGSRMSA EASARPLRVG SRVEVIGKGH RGTVAYVGAT LFATGKWVGV
     ILDEAKGKND GTVQGRKYFT CDEGHGIFVR QSQIQVFEDG ADTTSPETPD SSASKVLKRE
     GTDTTAKTSK LRGLKPKKAP TARKTTTRRP KPTRPASTGV AGASSSLGPS GSASAGELSS
     SEPSTPAQTP LAAPIIPTPV LTSPGAVPPL PSPSKEEEGL RAQVRDLEEK LETLRLKRAE
     DKAKLKELEK HKIQLEQVQE WKSKMQEQQA DLQRRLKEAR KEAKEALEAK ERYMEEMADT
     ADAIEMATLD KEMAEERAES LQQEVEALKE RVDELTTDLE ILKAEIEEKG SDGAASSYQL
     KQLEEQNARL KDALVRMRDL SSSEKQEHVK LQKLMEKKNQ ELEVVRQQRE RLQEELSQAE
     STIDELKEQV DAALGAEEMV EMLTDRNLNL EEKVRELRET VGDLEAMNEM NDELQENARE
     TELELREQLD MAGARVREAQ KRVEAAQETV ADYQQTIKKY RQLTAHLQDV NRELTNQQEA
     SVERQQQPPP ETFDFKIKFA ETKAHAKAIE MELRQMGVAQ ANRHMSLLTA FMPDSFLRPG
     GDHDCVLVLL LMPRLICKAE LIRKQAQEKF ELSENCSERP GLRGAAGEQL SFAAGLVYSL
     SLLQATLHRY EHALSQCSVD VYKKVGSLYP EMSAHERSLD FLIELLHKDQ LDETVNVEPL
     TKAIKYYQHL YSIHLAEQPE DCTMQLADHI KFTQSALDCM SVEVGRLRAF LQGGQEATDI
     ALLLRDLETS CSDIRQFCKK IRRRMPGTDA PGIPAALAFG PQVSDTLLDC RKHLTWVVAV
     LQEVAAAAAQ LIAPLAENEG LLVAALEELA FKASEQIYGT PSSSPYECLR QSCNILISTM
     NKLATAMQEG EYDAERPPSK PPPVELRAAA LRAEITDAEG LGLKLEDRET VIKELKKSLK
     IKGEELSEAN VRLSLLEKKL DSAAKDADER IEKVQTRLEE TQALLRKKEK GFEETMDALQ
     ADIDQLEAEK AELKQRLNSQ SKRTIEGLRG PPPSGIATLV SGIAGEEQQR GAIPGQAPGS
     VPGPGLVKDS PLLLQQISAM RLHISQLQHE NSILKGAQMK ASLASLPPLH VAKLSHEGPG
     SELPAGALYR KTSQLLETLN QLSTHTHVVD ITRTSPAAKS PSAQLMEQVA QLKSLSDTVE
     KLKDEVLKET VSQRPGATVP TDFATFPSSA FLRAKEEQQD DTVYMGKVTF SCAAGFGQRH
     RLVLTQEQLH QLHSRLIS
//
ID   DNJB1_HUMAN             Reviewed;         340 AA.
AC   P25685; B4DX52;
DT   01-MAY-1992, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   22-APR-2020, entry version 208.
DE   RecName: Full=DnaJ homolog subfamily B member 1;
DE   AltName: Full=DnaJ protein homolog 1;
DE   AltName: Full=Heat shock 40 kDa protein 1;
DE            Short=HSP40;
DE            Short=Heat shock protein 40;
DE   AltName: Full=Human DnaJ protein 1;
DE            Short=hDj-1;
GN   Name=DNAJB1; Synonyms=DNAJ1, HDJ1, HSPF1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=1754405; DOI=10.1093/nar/19.23.6645;
RA   Raabe T., Manley J.L.;
RT   "A human homologue of the Escherichia coli DnaJ heat-shock protein.";
RL   Nucleic Acids Res. 19:6645-6645(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND PROTEIN SEQUENCE OF 2-48.
RC   TISSUE=Placenta;
RX   PubMed=8250930; DOI=10.1006/bbrc.1993.2466;
RA   Ohtsuka K.;
RT   "Cloning of a cDNA for heat-shock protein hsp40, a human homologue of
RT   bacterial DnaJ.";
RL   Biochem. Biophys. Res. Commun. 197:235-240(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Placenta;
RX   PubMed=8975727; DOI=10.1006/geno.1996.0653;
RA   Hata M., Okumura K., Seto M., Ohtsuka K.;
RT   "Genomic cloning of a human heat shock protein 40 (Hsp40) gene (HSPF1) and
RT   its chromosomal localization to 19p13.2.";
RL   Genomics 38:446-449(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 2-49, INDUCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=1586970; DOI=10.1247/csf.17.77;
RA   Hattori H., Liu Y.-C., Tohnai I., Ueda M., Kaneda T., Kobayashi T.,
RA   Tanabe K., Ohtsuka K.;
RT   "Intracellular localization and partial amino acid sequence of a stress-
RT   inducible 40-kDa protein in HeLa cells.";
RL   Cell Struct. Funct. 17:77-86(1992).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH HSF1.
RX   PubMed=9499401; DOI=10.1101/gad.12.5.654;
RA   Shi Y., Mosser D.D., Morimoto R.I.;
RT   "Molecular chaperones as HSF1-specific transcriptional repressors.";
RL   Genes Dev. 12:654-666(1998).
RN   [9]
RP   INTERACTION WITH DNAJC3.
RX   PubMed=9920933; DOI=10.1074/jbc.274.6.3797;
RA   Melville M.W., Tan S.-L., Wambach M., Song J., Morimoto R.I., Katze M.G.;
RT   "The cellular inhibitor of the PKR protein kinase, P58(IPK), is an
RT   influenza virus-activated co-chaperone that modulates heat shock protein 70
RT   activity.";
RL   J. Biol. Chem. 274:3797-3803(1999).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-307, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   FUNCTION.
RX   PubMed=24318877; DOI=10.1074/jbc.m113.521997;
RA   Rauch J.N., Gestwicki J.E.;
RT   "Binding of human nucleotide exchange factors to heat shock protein 70
RT   (Hsp70) generates functionally distinct complexes in vitro.";
RL   J. Biol. Chem. 289:1402-1414(2014).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   STRUCTURE BY NMR OF 1-76.
RX   PubMed=8764402; DOI=10.1006/jmbi.1996.0394;
RA   Qian Y.Q., Patel D., Hartl F.-U., McColl D.J.;
RT   "Nuclear magnetic resonance solution structure of the human Hsp40 (HDJ-1)
RT   J-domain.";
RL   J. Mol. Biol. 260:224-235(1996).
CC   -!- FUNCTION: Interacts with HSP70 and can stimulate its ATPase activity.
CC       Stimulates the association between HSC70 and HIP. Negatively regulates
CC       heat shock-induced HSF1 transcriptional activity during the attenuation
CC       and recovery phase period of the heat shock response (PubMed:9499401).
CC       Stimulates ATP hydrolysis and the folding of unfolded proteins mediated
CC       by HSPA1A/B (in vitro) (PubMed:24318877). {ECO:0000269|PubMed:24318877,
CC       ECO:0000269|PubMed:9499401}.
CC   -!- SUBUNIT: Interacts with DNAJC3 (PubMed:9920933). Interacts with HSF1
CC       (via transactivation domain); this interaction results in the
CC       inhibition of heat shock- and HSF1-induced transcriptional activity
CC       during the attenuation and recovery phase period of the heat shock
CC       response (PubMed:9499401). {ECO:0000269|PubMed:9499401,
CC       ECO:0000269|PubMed:9920933}.
CC   -!- INTERACTION:
CC       P25685; Q62392: Phlda1; Xeno; NbExp=2; IntAct=EBI-357034, EBI-309727;
CC       P25685; P54274: TERF1; NbExp=2; IntAct=EBI-357034, EBI-710997;
CC       P25685; Q14166: TTLL12; NbExp=4; IntAct=EBI-357034, EBI-923010;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:1586970}. Nucleus
CC       {ECO:0000269|PubMed:1586970}. Nucleus, nucleolus
CC       {ECO:0000269|PubMed:1586970}. Note=Translocates rapidly from the
CC       cytoplasm to the nucleus, and especially to the nucleoli, upon heat
CC       shock.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P25685-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P25685-2; Sequence=VSP_056414;
CC   -!- INDUCTION: By heat shock. {ECO:0000269|PubMed:1586970}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA44287.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X62421; CAA44287.1; ALT_FRAME; mRNA.
DR   EMBL; D49547; BAA08495.1; -; mRNA.
DR   EMBL; D85429; BAA12819.1; -; Genomic_DNA.
DR   EMBL; AK301817; BAG63264.1; -; mRNA.
DR   EMBL; AC009004; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC012318; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC002352; AAH02352.1; -; mRNA.
DR   EMBL; BC019827; AAH19827.1; -; mRNA.
DR   CCDS; CCDS12312.1; -. [P25685-1]
DR   CCDS; CCDS74295.1; -. [P25685-2]
DR   PIR; JN0912; JN0912.
DR   PIR; S20062; S20062.
DR   RefSeq; NP_001287843.1; NM_001300914.1. [P25685-2]
DR   RefSeq; NP_001300893.1; NM_001313964.1. [P25685-2]
DR   RefSeq; NP_006136.1; NM_006145.2. [P25685-1]
DR   RefSeq; XP_006722796.1; XM_006722733.1. [P25685-2]
DR   RefSeq; XP_006722797.1; XM_006722734.3. [P25685-2]
DR   RefSeq; XP_011526258.1; XM_011527956.2. [P25685-2]
DR   PDB; 1HDJ; NMR; -; A=1-76.
DR   PDB; 2QLD; X-ray; 2.70 A; A=158-340.
DR   PDB; 3AGX; X-ray; 1.85 A; A/B=161-340.
DR   PDB; 3AGY; X-ray; 1.85 A; A/B=161-340.
DR   PDB; 3AGZ; X-ray; 2.51 A; A/B=151-340.
DR   PDB; 4WB7; X-ray; 1.90 A; A/B=2-70.
DR   PDB; 6BYR; X-ray; 3.66 A; A/C=2-70.
DR   PDBsum; 1HDJ; -.
DR   PDBsum; 2QLD; -.
DR   PDBsum; 3AGX; -.
DR   PDBsum; 3AGY; -.
DR   PDBsum; 3AGZ; -.
DR   PDBsum; 4WB7; -.
DR   PDBsum; 6BYR; -.
DR   SMR; P25685; -.
DR   BioGrid; 109569; 124.
DR   CORUM; P25685; -.
DR   DIP; DIP-41180N; -.
DR   IntAct; P25685; 70.
DR   MINT; P25685; -.
DR   STRING; 9606.ENSP00000254322; -.
DR   iPTMnet; P25685; -.
DR   PhosphoSitePlus; P25685; -.
DR   BioMuta; DNAJB1; -.
DR   DMDM; 1706473; -.
DR   REPRODUCTION-2DPAGE; IPI00015947; -.
DR   EPD; P25685; -.
DR   jPOST; P25685; -.
DR   MassIVE; P25685; -.
DR   PaxDb; P25685; -.
DR   PeptideAtlas; P25685; -.
DR   PRIDE; P25685; -.
DR   ProteomicsDB; 5411; -.
DR   ProteomicsDB; 54280; -. [P25685-1]
DR   Antibodypedia; 26735; 792 antibodies.
DR   DNASU; 3337; -.
DR   Ensembl; ENST00000254322; ENSP00000254322; ENSG00000132002. [P25685-1]
DR   Ensembl; ENST00000396969; ENSP00000444212; ENSG00000132002. [P25685-2]
DR   GeneID; 3337; -.
DR   KEGG; hsa:3337; -.
DR   UCSC; uc010xnr.2; human. [P25685-1]
DR   CTD; 3337; -.
DR   DisGeNET; 3337; -.
DR   GeneCards; DNAJB1; -.
DR   HGNC; HGNC:5270; DNAJB1.
DR   HPA; ENSG00000132002; Tissue enhanced (vagina).
DR   MalaCards; DNAJB1; -.
DR   MIM; 604572; gene.
DR   neXtProt; NX_P25685; -.
DR   OpenTargets; ENSG00000132002; -.
DR   Orphanet; 401920; Fibrolamellar hepatocellular carcinoma.
DR   PharmGKB; PA27412; -.
DR   eggNOG; KOG0714; Eukaryota.
DR   eggNOG; COG0484; LUCA.
DR   GeneTree; ENSGT00940000160312; -.
DR   HOGENOM; CLU_017633_0_0_1; -.
DR   InParanoid; P25685; -.
DR   KO; K09507; -.
DR   OMA; GRTMVVE; -.
DR   PhylomeDB; P25685; -.
DR   TreeFam; TF105141; -.
DR   Reactome; R-HSA-3371453; Regulation of HSF1-mediated heat shock response.
DR   Reactome; R-HSA-3371497; HSP90 chaperone cycle for steroid hormone receptors (SHR).
DR   Reactome; R-HSA-3371568; Attenuation phase.
DR   Reactome; R-HSA-3371571; HSF1-dependent transactivation.
DR   Reactome; R-HSA-5687128; MAPK6/MAPK4 signaling.
DR   SIGNOR; P25685; -.
DR   ChiTaRS; DNAJB1; human.
DR   EvolutionaryTrace; P25685; -.
DR   GeneWiki; DNAJB1; -.
DR   GenomeRNAi; 3337; -.
DR   Pharos; P25685; Tbio.
DR   PRO; PR:P25685; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; P25685; protein.
DR   Bgee; ENSG00000132002; Expressed in hypothalamus and 238 other tissues.
DR   ExpressionAtlas; P25685; baseline and differential.
DR   Genevisible; P25685; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0043197; C:dendritic spine; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0098978; C:glutamatergic synapse; IEA:Ensembl.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0014069; C:postsynaptic density; IEA:Ensembl.
DR   GO; GO:0061827; C:sperm head; IEA:Ensembl.
DR   GO; GO:0001671; F:ATPase activator activity; IDA:UniProtKB.
DR   GO; GO:0051117; F:ATPase binding; IPI:BHF-UCL.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0051087; F:chaperone binding; IPI:UniProtKB.
DR   GO; GO:0030544; F:Hsp70 protein binding; IPI:BHF-UCL.
DR   GO; GO:0044183; F:protein folding chaperone; IEA:Ensembl.
DR   GO; GO:0003714; F:transcription corepressor activity; IDA:UniProtKB.
DR   GO; GO:0051082; F:unfolded protein binding; IDA:UniProtKB.
DR   GO; GO:0051085; P:chaperone cofactor-dependent protein refolding; IDA:UniProtKB.
DR   GO; GO:0030900; P:forebrain development; IEA:Ensembl.
DR   GO; GO:0090084; P:negative regulation of inclusion body assembly; IDA:UniProtKB.
DR   GO; GO:0097201; P:negative regulation of transcription from RNA polymerase II promoter in response to stress; IDA:UniProtKB.
DR   GO; GO:0032781; P:positive regulation of ATPase activity; IDA:BHF-UCL.
DR   GO; GO:1900034; P:regulation of cellular response to heat; TAS:Reactome.
DR   GO; GO:0006986; P:response to unfolded protein; TAS:ProtInc.
DR   CDD; cd06257; DnaJ; 1.
DR   Gene3D; 1.10.287.110; -; 1.
DR   InterPro; IPR002939; DnaJ_C.
DR   InterPro; IPR001623; DnaJ_domain.
DR   InterPro; IPR018253; DnaJ_domain_CS.
DR   InterPro; IPR008971; HSP40/DnaJ_pept-bd.
DR   InterPro; IPR036869; J_dom_sf.
DR   Pfam; PF00226; DnaJ; 1.
DR   Pfam; PF01556; DnaJ_C; 1.
DR   PRINTS; PR00625; JDOMAIN.
DR   SMART; SM00271; DnaJ; 1.
DR   SUPFAM; SSF46565; SSF46565; 1.
DR   SUPFAM; SSF49493; SSF49493; 2.
DR   PROSITE; PS00636; DNAJ_1; 1.
DR   PROSITE; PS50076; DNAJ_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Chaperone; Cytoplasm;
KW   Direct protein sequencing; Nucleus; Phosphoprotein; Reference proteome;
KW   Stress response.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:1586970,
FT                   ECO:0000269|PubMed:8250930"
FT   CHAIN           2..340
FT                   /note="DnaJ homolog subfamily B member 1"
FT                   /id="PRO_0000071016"
FT   DOMAIN          2..70
FT                   /note="J"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00286"
FT   MOD_RES         307
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   VAR_SEQ         1..100
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_056414"
FT   CONFLICT        68
FT                   /note="G -> L (in Ref. 1; CAA44287)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        150
FT                   /note="R -> C (in Ref. 1; CAA44287)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        183
FT                   /note="M -> T (in Ref. 1; CAA44287)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        320
FT                   /note="V -> A (in Ref. 1; CAA44287)"
FT                   /evidence="ECO:0000305"
FT   HELIX           5..9
FT                   /evidence="ECO:0000244|PDB:4WB7"
FT   HELIX           17..31
FT                   /evidence="ECO:0000244|PDB:4WB7"
FT   TURN            33..35
FT                   /evidence="ECO:0000244|PDB:4WB7"
FT   HELIX           41..55
FT                   /evidence="ECO:0000244|PDB:4WB7"
FT   HELIX           58..70
FT                   /evidence="ECO:0000244|PDB:4WB7"
FT   STRAND          166..170
FT                   /evidence="ECO:0000244|PDB:3AGX"
FT   HELIX           172..177
FT                   /evidence="ECO:0000244|PDB:3AGX"
FT   STRAND          179..190
FT                   /evidence="ECO:0000244|PDB:3AGX"
FT   TURN            191..193
FT                   /evidence="ECO:0000244|PDB:2QLD"
FT   STRAND          197..208
FT                   /evidence="ECO:0000244|PDB:3AGX"
FT   STRAND          217..220
FT                   /evidence="ECO:0000244|PDB:3AGX"
FT   STRAND          228..230
FT                   /evidence="ECO:0000244|PDB:3AGX"
FT   STRAND          235..241
FT                   /evidence="ECO:0000244|PDB:3AGX"
FT   STRAND          248..250
FT                   /evidence="ECO:0000244|PDB:3AGX"
FT   STRAND          253..261
FT                   /evidence="ECO:0000244|PDB:3AGX"
FT   HELIX           262..267
FT                   /evidence="ECO:0000244|PDB:3AGX"
FT   STRAND          269..274
FT                   /evidence="ECO:0000244|PDB:3AGX"
FT   STRAND          280..285
FT                   /evidence="ECO:0000244|PDB:3AGX"
FT   STRAND          294..297
FT                   /evidence="ECO:0000244|PDB:3AGX"
FT   STRAND          305..307
FT                   /evidence="ECO:0000244|PDB:3AGX"
FT   STRAND          314..321
FT                   /evidence="ECO:0000244|PDB:3AGX"
FT   HELIX           328..337
FT                   /evidence="ECO:0000244|PDB:3AGX"
SQ   SEQUENCE   340 AA;  38044 MW;  17545098B0C196DF CRC64;
     MGKDYYQTLG LARGASDEEI KRAYRRQALR YHPDKNKEPG AEEKFKEIAE AYDVLSDPRK
     REIFDRYGEE GLKGSGPSGG SGGGANGTSF SYTFHGDPHA MFAEFFGGRN PFDTFFGQRN
     GEEGMDIDDP FSGFPMGMGG FTNVNFGRSR SAQEPARKKQ DPPVTHDLRV SLEEIYSGCT
     KKMKISHKRL NPDGKSIRNE DKILTIEVKK GWKEGTKITF PKEGDQTSNN IPADIVFVLK
     DKPHNIFKRD GSDVIYPARI SLREALCGCT VNVPTLDGRT IPVVFKDVIR PGMRRKVPGE
     GLPLPKTPEK RGDLIIEFEV IFPERIPQTS RTVLEQVLPI
//
ID   Q6FHS4_HUMAN            Unreviewed;       340 AA.
AC   Q6FHS4;
DT   10-MAY-2005, integrated into UniProtKB/TrEMBL.
DT   10-MAY-2005, sequence version 1.
DT   22-APR-2020, entry version 129.
DE   SubName: Full=DNAJB1 protein {ECO:0000313|EMBL:CAG46478.1};
DE   SubName: Full=DnaJ (Hsp40) homolog, subfamily B, member 1, isoform CRA_a {ECO:0000313|EMBL:EAW84432.1};
DE   SubName: Full=cDNA, FLJ93008, Homo sapiens DnaJ (Hsp40) homolog, subfamily B, member 1 (DNAJB1),mRNA {ECO:0000313|EMBL:BAG35510.1};
DE   Flags: Fragment;
GN   Name=DNAJB1 {ECO:0000313|EMBL:CAG46478.1};
GN   ORFNames=hCG_1776318 {ECO:0000313|EMBL:EAW84432.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:CAG46478.1};
RN   [1] {ECO:0000313|EMBL:EAW84432.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:CAG46478.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S., Neubert P.,
RA   Kstrang K., Schatten R., Shen B., Henze S., Mar W., Korn B., Zuo D., Hu Y.,
RA   LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:EAW84432.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:BAG35510.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Heart {ECO:0000313|EMBL:BAG35510.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Kaida T., Tsuchiya K., Iida Y.,
RA   Takayama Y., Murakawa K., Kanehori K., Andoh T., Kagawa N., Sato R.,
RA   Kawamura Y., Tanaka S., Kisu Y., Sugano S., Goshima N., Nomura N.,
RA   Isogai T.;
RT   "NEDO functional analysis of protein and research application project.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK312624; BAG35510.1; -; mRNA.
DR   EMBL; CR541677; CAG46478.1; -; mRNA.
DR   EMBL; CH471106; EAW84432.1; -; Genomic_DNA.
DR   EMBL; CH471106; EAW84433.1; -; Genomic_DNA.
DR   RefSeq; NP_006136.1; NM_006145.2.
DR   Antibodypedia; 26735; 792 antibodies.
DR   DNASU; 3337; -.
DR   GeneID; 3337; -.
DR   KEGG; hsa:3337; -.
DR   UCSC; uc002myz.2; human.
DR   CTD; 3337; -.
DR   EuPathDB; HostDB:ENSG00000132002.7; -.
DR   PharmGKB; PA27412; -.
DR   eggNOG; KOG0714; Eukaryota.
DR   eggNOG; COG0484; LUCA.
DR   HOGENOM; CLU_017633_0_0_1; -.
DR   KO; K09507; -.
DR   OMA; GRTMVVE; -.
DR   OrthoDB; 1393097at2759; -.
DR   ChiTaRS; DNAJB1; human.
DR   GenomeRNAi; 3337; -.
DR   Bgee; ENSG00000132002; Expressed in hypothalamus and 238 other tissues.
DR   GO; GO:0043197; C:dendritic spine; IEA:Ensembl.
DR   GO; GO:0098978; C:glutamatergic synapse; IEA:Ensembl.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0014069; C:postsynaptic density; IEA:Ensembl.
DR   GO; GO:0061827; C:sperm head; IEA:Ensembl.
DR   GO; GO:0044183; F:protein folding chaperone; IEA:Ensembl.
DR   GO; GO:0051082; F:unfolded protein binding; IEA:InterPro.
DR   GO; GO:0051085; P:chaperone cofactor-dependent protein refolding; IEA:Ensembl.
DR   GO; GO:0030900; P:forebrain development; IEA:Ensembl.
DR   CDD; cd06257; DnaJ; 1.
DR   Gene3D; 1.10.287.110; -; 1.
DR   InterPro; IPR002939; DnaJ_C.
DR   InterPro; IPR001623; DnaJ_domain.
DR   InterPro; IPR018253; DnaJ_domain_CS.
DR   InterPro; IPR008971; HSP40/DnaJ_pept-bd.
DR   InterPro; IPR036869; J_dom_sf.
DR   Pfam; PF00226; DnaJ; 1.
DR   Pfam; PF01556; DnaJ_C; 1.
DR   PRINTS; PR00625; JDOMAIN.
DR   SMART; SM00271; DnaJ; 1.
DR   SUPFAM; SSF46565; SSF46565; 1.
DR   SUPFAM; SSF49493; SSF49493; 2.
DR   PROSITE; PS00636; DNAJ_1; 1.
DR   PROSITE; PS50076; DNAJ_2; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN          4..68
FT                   /note="J"
FT                   /evidence="ECO:0000259|PROSITE:PS50076"
FT   NON_TER         340
FT                   /evidence="ECO:0000313|EMBL:CAG46478.1"
SQ   SEQUENCE   340 AA;  38044 MW;  17545098B0C196DF CRC64;
     MGKDYYQTLG LARGASDEEI KRAYRRQALR YHPDKNKEPG AEEKFKEIAE AYDVLSDPRK
     REIFDRYGEE GLKGSGPSGG SGGGANGTSF SYTFHGDPHA MFAEFFGGRN PFDTFFGQRN
     GEEGMDIDDP FSGFPMGMGG FTNVNFGRSR SAQEPARKKQ DPPVTHDLRV SLEEIYSGCT
     KKMKISHKRL NPDGKSIRNE DKILTIEVKK GWKEGTKITF PKEGDQTSNN IPADIVFVLK
     DKPHNIFKRD GSDVIYPARI SLREALCGCT VNVPTLDGRT IPVVFKDVIR PGMRRKVPGE
     GLPLPKTPEK RGDLIIEFEV IFPERIPQTS RTVLEQVLPI
//
ID   IF4A2_HUMAN             Reviewed;         407 AA.
AC   Q14240; D3DNU9; Q53XJ6; Q96B90; Q96EA8;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   15-MAR-2004, sequence version 2.
DT   22-APR-2020, entry version 208.
DE   RecName: Full=Eukaryotic initiation factor 4A-II;
DE            Short=eIF-4A-II;
DE            Short=eIF4A-II;
DE            EC=3.6.4.13;
DE   AltName: Full=ATP-dependent RNA helicase eIF4A-2;
GN   Name=EIF4A2; Synonyms=DDX2B, EIF4F;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=8521730; DOI=10.1159/000134145;
RA   Sudo K., Takahashi E., Nakamura Y.;
RT   "Isolation and mapping of the human EIF4A2 gene homologous to the murine
RT   protein synthesis initiation factor 4A-II gene Eif4a2.";
RL   Cytogenet. Cell Genet. 71:385-388(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Bone marrow, Brain, Lymph, and Skeletal muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INTERACTION WITH EIF4E.
RX   PubMed=11408474; DOI=10.1074/jbc.c100284200;
RA   Li W., Belsham G.J., Proud C.G.;
RT   "Eukaryotic initiation factors 4A (eIF4A) and 4G (eIF4G) mutually interact
RT   in a 1:1 ratio in vivo.";
RL   J. Biol. Chem. 276:29111-29115(2001).
RN   [7]
RP   POSSIBLE INTERACTION WITH NOM1.
RX   PubMed=15715967; DOI=10.1016/j.gene.2004.12.027;
RA   Simmons H.M., Ruis B.L., Kapoor M., Hudacek A.W., Conklin K.F.;
RT   "Identification of NOM1, a nucleolar, eIF4A binding protein encoded within
RT   the chromosome 7q36 breakpoint region targeted in cases of pediatric acute
RT   myeloid leukemia.";
RL   Gene 347:137-145(2005).
RN   [8]
RP   INTERACTION WITH HHV-1 VHS (MICROBIAL INFECTION).
RX   PubMed=16014927; DOI=10.1128/jvi.79.15.9651-9664.2005;
RA   Feng P., Everly D.N. Jr., Read G.S.;
RT   "mRNA decay during herpes simplex virus (HSV) infections: protein-protein
RT   interactions involving the HSV virion host shutoff protein and translation
RT   factors eIF4H and eIF4A.";
RL   J. Virol. 79:9651-9664(2005).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-159, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 22-240.
RX   PubMed=20941364; DOI=10.1371/journal.pone.0012791;
RA   Schutz P., Karlberg T., van den Berg S., Collins R., Lehtio L., Hogbom M.,
RA   Holmberg-Schiavone L., Tempel W., Park H.W., Hammarstrom M., Moche M.,
RA   Thorsell A.G., Schuler H.;
RT   "Comparative structural analysis of human DEAD-box RNA helicases.";
RL   PLoS ONE 5:E12791-E12791(2010).
RN   [13]
RP   VARIANT [LARGE SCALE ANALYSIS] LEU-181.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: ATP-dependent RNA helicase which is a subunit of the eIF4F
CC       complex involved in cap recognition and is required for mRNA binding to
CC       ribosome. In the current model of translation initiation, eIF4A unwinds
CC       RNA secondary structures in the 5'-UTR of mRNAs which is necessary to
CC       allow efficient binding of the small ribosomal subunit, and subsequent
CC       scanning for the initiator codon.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O = ADP + H(+) + phosphate; Xref=Rhea:RHEA:13065,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.13;
CC   -!- SUBUNIT: eIF4F is a multi-subunit complex, the composition of which
CC       varies with external and internal environmental conditions. It is
CC       composed of at least EIF4A, EIF4E and EIF4G1/EIFFG3 (By similarity).
CC       Interacts with EIF4E. May interact with NOM1. {ECO:0000250,
CC       ECO:0000269|PubMed:11408474, ECO:0000269|PubMed:16014927}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with herpes simplex virus
CC       1/HHV-1 protein Vhs. {ECO:0000269|PubMed:16014927}.
CC   -!- INTERACTION:
CC       Q14240; PRO_0000037577 [P27958]; Xeno; NbExp=4; IntAct=EBI-73473, EBI-6904388;
CC       Q14240-2; Q96D03: DDIT4L; NbExp=3; IntAct=EBI-10232522, EBI-742054;
CC       Q14240; Q7L190: DPPA4; NbExp=3; IntAct=EBI-73473, EBI-710457;
CC       Q14240-2; Q7L190: DPPA4; NbExp=3; IntAct=EBI-10232522, EBI-710457;
CC       Q14240; P04792: HSPB1; NbExp=2; IntAct=EBI-73473, EBI-352682;
CC       Q14240; Q9UI26: IPO11; NbExp=3; IntAct=EBI-73473, EBI-748752;
CC       Q14240-2; Q99750: MDFI; NbExp=3; IntAct=EBI-10232522, EBI-724076;
CC       Q14240; Q53EL6: PDCD4; NbExp=5; IntAct=EBI-73473, EBI-935824;
CC       Q14240-2; Q53EL6: PDCD4; NbExp=3; IntAct=EBI-10232522, EBI-935824;
CC       Q14240-2; Q8WWB5: PIH1D2; NbExp=3; IntAct=EBI-10232522, EBI-10232538;
CC       Q14240; Q7RTY1: SLC16A9; NbExp=3; IntAct=EBI-73473, EBI-10232636;
CC       Q14240; Q9Y2D8: SSX2IP; NbExp=3; IntAct=EBI-73473, EBI-2212028;
CC       Q14240-2; Q9Y2D8: SSX2IP; NbExp=3; IntAct=EBI-10232522, EBI-2212028;
CC       Q14240; Q9NQ86: TRIM36; NbExp=3; IntAct=EBI-73473, EBI-2341518;
CC       Q14240-2; Q9NQ86: TRIM36; NbExp=3; IntAct=EBI-10232522, EBI-2341518;
CC       Q14240; Q9HCM9: TRIM39; NbExp=4; IntAct=EBI-73473, EBI-739510;
CC       Q14240-2; Q9HCM9: TRIM39; NbExp=3; IntAct=EBI-10232522, EBI-739510;
CC       Q14240-2; Q6ZNG0: ZNF620; NbExp=3; IntAct=EBI-10232522, EBI-4395669;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q14240-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q14240-2; Sequence=VSP_009629;
CC   -!- SIMILARITY: Belongs to the DEAD box helicase family. eIF4A subfamily.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/EIF4A2ID262.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D30655; BAA06336.1; -; mRNA.
DR   EMBL; BT009860; AAP88862.1; -; mRNA.
DR   EMBL; AC112907; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471052; EAW78172.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW78177.1; -; Genomic_DNA.
DR   EMBL; BC012547; AAH12547.1; -; mRNA.
DR   EMBL; BC013708; AAH13708.1; -; mRNA.
DR   EMBL; BC015842; AAH15842.1; -; mRNA.
DR   EMBL; BC048105; AAH48105.1; -; mRNA.
DR   CCDS; CCDS3282.1; -. [Q14240-1]
DR   RefSeq; NP_001958.2; NM_001967.3. [Q14240-1]
DR   PDB; 3BOR; X-ray; 1.85 A; A=22-240.
DR   PDBsum; 3BOR; -.
DR   SMR; Q14240; -.
DR   BioGrid; 108290; 74.
DR   IntAct; Q14240; 36.
DR   MINT; Q14240; -.
DR   STRING; 9606.ENSP00000326381; -.
DR   BindingDB; Q14240; -.
DR   ChEMBL; CHEMBL4105952; -.
DR   iPTMnet; Q14240; -.
DR   MetOSite; Q14240; -.
DR   PhosphoSitePlus; Q14240; -.
DR   SwissPalm; Q14240; -.
DR   BioMuta; EIF4A2; -.
DR   DMDM; 45645183; -.
DR   EPD; Q14240; -.
DR   jPOST; Q14240; -.
DR   MassIVE; Q14240; -.
DR   MaxQB; Q14240; -.
DR   PaxDb; Q14240; -.
DR   PeptideAtlas; Q14240; -.
DR   PRIDE; Q14240; -.
DR   ProteomicsDB; 59936; -. [Q14240-1]
DR   ProteomicsDB; 59937; -. [Q14240-2]
DR   Antibodypedia; 3189; 275 antibodies.
DR   DNASU; 1974; -.
DR   Ensembl; ENST00000323963; ENSP00000326381; ENSG00000156976. [Q14240-1]
DR   Ensembl; ENST00000440191; ENSP00000398370; ENSG00000156976. [Q14240-2]
DR   GeneID; 1974; -.
DR   KEGG; hsa:1974; -.
DR   UCSC; uc003fqs.4; human. [Q14240-1]
DR   CTD; 1974; -.
DR   DisGeNET; 1974; -.
DR   GeneCards; EIF4A2; -.
DR   HGNC; HGNC:3284; EIF4A2.
DR   HPA; ENSG00000156976; Low tissue specificity.
DR   MIM; 601102; gene.
DR   neXtProt; NX_Q14240; -.
DR   OpenTargets; ENSG00000156976; -.
DR   PharmGKB; PA27712; -.
DR   eggNOG; KOG0327; Eukaryota.
DR   eggNOG; COG0513; LUCA.
DR   GeneTree; ENSGT00940000153783; -.
DR   HOGENOM; CLU_003041_1_0_1; -.
DR   InParanoid; Q14240; -.
DR   KO; K03257; -.
DR   OMA; RNPIRIL; -.
DR   OrthoDB; 726081at2759; -.
DR   PhylomeDB; Q14240; -.
DR   TreeFam; TF101524; -.
DR   Reactome; R-HSA-1169408; ISG15 antiviral mechanism.
DR   Reactome; R-HSA-156827; L13a-mediated translational silencing of Ceruloplasmin expression.
DR   Reactome; R-HSA-429947; Deadenylation of mRNA.
DR   Reactome; R-HSA-72649; Translation initiation complex formation.
DR   Reactome; R-HSA-72662; Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S.
DR   Reactome; R-HSA-72702; Ribosomal scanning and start codon recognition.
DR   Reactome; R-HSA-72706; GTP hydrolysis and joining of the 60S ribosomal subunit.
DR   SIGNOR; Q14240; -.
DR   ChiTaRS; EIF4A2; human.
DR   EvolutionaryTrace; Q14240; -.
DR   GeneWiki; EIF4A2; -.
DR   GenomeRNAi; 1974; -.
DR   Pharos; Q14240; Tbio.
DR   PRO; PR:Q14240; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; Q14240; protein.
DR   Bgee; ENSG00000156976; Expressed in Brodmann (1909) area 46 and 246 other tissues.
DR   ExpressionAtlas; Q14240; baseline and differential.
DR   Genevisible; Q14240; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0016281; C:eukaryotic translation initiation factor 4F complex; TAS:ProtInc.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:AgBase.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATPase activity; IDA:AgBase.
DR   GO; GO:0004386; F:helicase activity; TAS:ProtInc.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0003724; F:RNA helicase activity; IBA:GO_Central.
DR   GO; GO:0003743; F:translation initiation factor activity; IBA:GO_Central.
DR   GO; GO:1990830; P:cellular response to leukemia inhibitory factor; IEA:Ensembl.
DR   GO; GO:0002183; P:cytoplasmic translational initiation; IBA:GO_Central.
DR   GO; GO:1900260; P:negative regulation of RNA-directed 5'-3' RNA polymerase activity; IDA:AgBase.
DR   GO; GO:0006446; P:regulation of translational initiation; TAS:ProtInc.
DR   GO; GO:0006413; P:translational initiation; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   InterPro; IPR011545; DEAD/DEAH_box_helicase_dom.
DR   InterPro; IPR014001; Helicase_ATP-bd.
DR   InterPro; IPR001650; Helicase_C.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR000629; RNA-helicase_DEAD-box_CS.
DR   InterPro; IPR014014; RNA_helicase_DEAD_Q_motif.
DR   Pfam; PF00270; DEAD; 1.
DR   Pfam; PF00271; Helicase_C; 1.
DR   SMART; SM00487; DEXDc; 1.
DR   SMART; SM00490; HELICc; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS00039; DEAD_ATP_HELICASE; 1.
DR   PROSITE; PS51192; HELICASE_ATP_BIND_1; 1.
DR   PROSITE; PS51194; HELICASE_CTER; 1.
DR   PROSITE; PS51195; Q_MOTIF; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Helicase;
KW   Host-virus interaction; Hydrolase; Initiation factor; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Protein biosynthesis; Reference proteome;
KW   RNA-binding.
FT   CHAIN           1..407
FT                   /note="Eukaryotic initiation factor 4A-II"
FT                   /id="PRO_0000054938"
FT   DOMAIN          64..235
FT                   /note="Helicase ATP-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00541"
FT   DOMAIN          246..407
FT                   /note="Helicase C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00542"
FT   NP_BIND         77..84
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00541"
FT   MOTIF           33..61
FT                   /note="Q motif"
FT   MOTIF           183..186
FT                   /note="DEAD box"
FT   MOD_RES         159
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   VAR_SEQ         9
FT                   /note="N -> NS (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_009629"
FT   VARIANT         93
FT                   /note="Q -> H (in dbSNP:rs11538616)"
FT                   /id="VAR_052158"
FT   VARIANT         181
FT                   /note="V -> L (in a breast cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035838"
FT   CONFLICT        27
FT                   /note="N -> S (in Ref. 5; AAH15842)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        212..213
FT                   /note="LL -> FA (in Ref. 1; BAA06336)"
FT                   /evidence="ECO:0000305"
FT   HELIX           35..37
FT                   /evidence="ECO:0000244|PDB:3BOR"
FT   HELIX           42..51
FT                   /evidence="ECO:0000244|PDB:3BOR"
FT   HELIX           58..68
FT                   /evidence="ECO:0000244|PDB:3BOR"
FT   STRAND          73..75
FT                   /evidence="ECO:0000244|PDB:3BOR"
FT   HELIX           81..94
FT                   /evidence="ECO:0000244|PDB:3BOR"
FT   STRAND          104..107
FT                   /evidence="ECO:0000244|PDB:3BOR"
FT   HELIX           111..124
FT                   /evidence="ECO:0000244|PDB:3BOR"
FT   TURN            125..129
FT                   /evidence="ECO:0000244|PDB:3BOR"
FT   STRAND          132..135
FT                   /evidence="ECO:0000244|PDB:3BOR"
FT   STRAND          154..158
FT                   /evidence="ECO:0000244|PDB:3BOR"
FT   HELIX           160..168
FT                   /evidence="ECO:0000244|PDB:3BOR"
FT   STRAND          179..184
FT                   /evidence="ECO:0000244|PDB:3BOR"
FT   HELIX           185..190
FT                   /evidence="ECO:0000244|PDB:3BOR"
FT   HELIX           194..203
FT                   /evidence="ECO:0000244|PDB:3BOR"
FT   STRAND          209..213
FT                   /evidence="ECO:0000244|PDB:3BOR"
FT   HELIX           219..228
FT                   /evidence="ECO:0000244|PDB:3BOR"
FT   STRAND          233..235
FT                   /evidence="ECO:0000244|PDB:3BOR"
SQ   SEQUENCE   407 AA;  46402 MW;  FAA7D3BA9D8C6DA0 CRC64;
     MSGGSADYNR EHGGPEGMDP DGVIESNWNE IVDNFDDMNL KESLLRGIYA YGFEKPSAIQ
     QRAIIPCIKG YDVIAQAQSG TGKTATFAIS ILQQLEIEFK ETQALVLAPT RELAQQIQKV
     ILALGDYMGA TCHACIGGTN VRNEMQKLQA EAPHIVVGTP GRVFDMLNRR YLSPKWIKMF
     VLDEADEMLS RGFKDQIYEI FQKLNTSIQV VLLSATMPTD VLEVTKKFMR DPIRILVKKE
     ELTLEGIKQF YINVEREEWK LDTLCDLYET LTITQAVIFL NTRRKVDWLT EKMHARDFTV
     SALHGDMDQK ERDVIMREFR SGSSRVLITT DLLARGIDVQ QVSLVINYDL PTNRENYIHR
     IGRGGRFGRK GVAINFVTEE DKRILRDIET FYNTTVEEMP MNVADLI
//
ID   B5MBZ0_HUMAN            Unreviewed;       992 AA.
AC   B5MBZ0;
DT   14-OCT-2008, integrated into UniProtKB/TrEMBL.
DT   05-APR-2011, sequence version 3.
DT   22-APR-2020, entry version 97.
DE   SubName: Full=Echinoderm microtubule-associated protein-like 4 {ECO:0000313|Ensembl:ENSP00000384939};
GN   Name=EML4 {ECO:0000313|Ensembl:ENSP00000384939};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000384939, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000384939, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [2] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [3] {ECO:0000213|PubMed:19413330}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [4] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [5] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [6] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Burckstummer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [8] {ECO:0000313|Ensembl:ENSP00000384939}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [9] {ECO:0000213|PubMed:22814378}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [10] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC006038; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC083949; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC096668; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; XP_005264324.1; XM_005264267.1.
DR   IntAct; B5MBZ0; 1.
DR   EPD; B5MBZ0; -.
DR   jPOST; B5MBZ0; -.
DR   MaxQB; B5MBZ0; -.
DR   PeptideAtlas; B5MBZ0; -.
DR   PRIDE; B5MBZ0; -.
DR   ProteomicsDB; 5958; -.
DR   Antibodypedia; 29721; 132 antibodies.
DR   Ensembl; ENST00000401738; ENSP00000384939; ENSG00000143924.
DR   GeneID; 27436; -.
DR   UCSC; uc061iox.1; human.
DR   CTD; 27436; -.
DR   EuPathDB; HostDB:ENSG00000143924.18; -.
DR   HGNC; HGNC:1316; EML4.
DR   OpenTargets; ENSG00000143924; -.
DR   eggNOG; ENOG410ISA0; Eukaryota.
DR   eggNOG; COG2319; LUCA.
DR   GeneTree; ENSGT00940000158434; -.
DR   OMA; DSGTHLC; -.
DR   OrthoDB; 271572at2759; -.
DR   PhylomeDB; B5MBZ0; -.
DR   SignaLink; B5MBZ0; -.
DR   ChiTaRS; EML4; human.
DR   GenomeRNAi; 27436; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000143924; Expressed in metanephros and 203 other tissues.
DR   ExpressionAtlas; B5MBZ0; baseline and differential.
DR   Gene3D; 2.130.10.10; -; 2.
DR   InterPro; IPR005108; HELP.
DR   InterPro; IPR011047; Quinoprotein_ADH-like_supfam.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR019775; WD40_repeat_CS.
DR   InterPro; IPR017986; WD40_repeat_dom.
DR   InterPro; IPR036322; WD40_repeat_dom_sf.
DR   Pfam; PF03451; HELP; 1.
DR   Pfam; PF00400; WD40; 5.
DR   SMART; SM00320; WD40; 9.
DR   SUPFAM; SSF50978; SSF50978; 1.
DR   SUPFAM; SSF50998; SSF50998; 1.
DR   PROSITE; PS00678; WD_REPEATS_1; 1.
DR   PROSITE; PS50082; WD_REPEATS_2; 4.
DR   PROSITE; PS50294; WD_REPEATS_REGION; 3.
PE   1: Evidence at protein level;
KW   Proteomics identification {ECO:0000213|EPD:B5MBZ0,
KW   ECO:0000213|MaxQB:B5MBZ0, ECO:0000213|PeptideAtlas:B5MBZ0,
KW   ECO:0000213|ProteomicsDB:B5MBZ0};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Repeat {ECO:0000256|SAAS:SAAS00756755};
KW   WD repeat {ECO:0000256|PROSITE-ProRule:PRU00221,
KW   ECO:0000256|SAAS:SAAS00756638}.
FT   DOMAIN          516..557
FT                   /note="WD_REPEATS_REGION"
FT                   /evidence="ECO:0000259|PROSITE:PS50294"
FT   REPEAT          516..548
FT                   /note="WD"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00221"
FT   DOMAIN          599..769
FT                   /note="WD_REPEATS_REGION"
FT                   /evidence="ECO:0000259|PROSITE:PS50294"
FT   REPEAT          599..631
FT                   /note="WD"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00221"
FT   REPEAT          728..769
FT                   /note="WD"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00221"
FT   DOMAIN          841..883
FT                   /note="WD_REPEATS_REGION"
FT                   /evidence="ECO:0000259|PROSITE:PS50294"
FT   REPEAT          841..875
FT                   /note="WD"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00221"
FT   REGION          1..20
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          57..205
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          892..992
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        64..110
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        111..136
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        137..174
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        175..193
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        892..908
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        917..940
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        945..961
FT                   /note="Acidic"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   992 AA;  110178 MW;  0F3A05B3B4663582 CRC64;
     MDGFAGSLDD SISAASTSDV QDRLSALESR VQQQEDEITV LKAALADVLR RLAISEDHVA
     SVKKSVSSKG QPSPRAVIPM SCITNGSGAN RKPSHTSAVS IAGKETLSSA AKSGTEKKKE
     KPQGQREKKE ESHSNDQSPQ IRASPSPQPS SQPLQIHRQT PESKNATPTK SIKRPSPAEK
     SHNSWENSDD SRNKLSKIPS TPKLIPKVTK TADKHKDVII NQAKMSTREK NSQEGEYIKM
     FMRGRPITMF IPSDVDNYDD IRTELPPEKL KLEWAYGYRG KDCRANVYLL PTGKIVYFIA
     SVVVLFNYEE RTQRHYLGHT DCVKCLAIHP DKIRIATGQI AGVDKDGRPL QPHVRVWDSV
     TLSTLQIIGL GTFERGVGCL DFSKADSGVH LCIIDDSNEH MLTVWDWQKK AKGAEIKTTN
     EVVLAVEFHP TDANTIITCG KSHIFFWTWS GNSLTRKQGI FGKYEKPKFV QCLAFLGNGD
     VLTGDSGGVM LIWSKTTVEP TPGKGPKGVY QISKQIKAHD GSVFTLCQMR NGMLLTGGGK
     DRKIILWDHD LNPEREIEVP DQYGTIRAVA EGKADQFLVG TSRNFILRGT FNDGFQIEVQ
     GHTDELWGLA THPFKDLLLT CAQDRQVCLW NSMEHRLEWT RLVDEPGHCA DFHPSGTVVA
     IGTHSGRWFV LDAETRDLVS IHTDGNEQLS VMRYSIDGTF LAVGSHDNFI YLYVVSENGR
     KYSRYGRCTG HSSYITHLDW SPDNKYIMSN SGDYEILYWD IPNGCKLIRN RSDCKDIDWT
     TYTCVLGFQV FGVWPEGSDG TDINALVRSH NRKVIAVADD FCKVHLFQYP CSKAKAPSHK
     YSAHSSHVTN VSFTHNDSHL ISTGGKDMSI IQWKLVEKLS LPQNETVADT TLTKAPVSST
     ESVIQSNTPT PPPSQPLNET AEEESRISSS PTLLENSLEQ TVEPSEDHSE EESEEGSGDL
     GEPLYEEPCN EISKEQAKAT LLEDQQDPSP SS
//
ID   EMAL4_HUMAN             Reviewed;         981 AA.
AC   Q9HC35; A6H8Y6; B2RBK3; B2RTW7; B5MCW9; Q3SWW0; Q53R29; Q53TW8; Q6PJ45;
AC   Q9NV40;
DT   18-OCT-2001, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 3.
DT   22-APR-2020, entry version 183.
DE   RecName: Full=Echinoderm microtubule-associated protein-like 4;
DE            Short=EMAP-4;
DE   AltName: Full=Restrictedly overexpressed proliferation-associated protein;
DE   AltName: Full=Ropp 120;
GN   Name=EML4; Synonyms=C2orf2, EMAPL4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PARTIAL PROTEIN SEQUENCE, AND
RP   VARIANTS GLU-283 AND VAL-382.
RX   PubMed=10995578; DOI=10.1006/geno.2000.6301;
RA   Heidebrecht H.J., Buck F., Pollmann M., Siebert R., Parwaresch R.;
RT   "Cloning and localization of C2orf2(ropp120), a previously unknown WD
RT   repeat protein.";
RL   Genomics 68:348-350(2000).
RN   [2]
RP   SEQUENCE REVISION TO 121 AND 398.
RA   Heidebrecht H.J.;
RL   Submitted (APR-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS GLU-283; VAL-382 AND
RP   ARG-398.
RC   TISSUE=Hippocampus, and Ovarian carcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANTS
RP   GLU-283; VAL-382 AND ARG-398.
RC   TISSUE=Brain, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-226, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-144; SER-146; SER-895;
RP   THR-897; THR-899 AND SER-903, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-897 AND THR-899, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT SER-7; SER-13; SER-16; SER-61; SER-144; THR-899 AND SER-978,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-144; SER-146 AND SER-978, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-61; SER-144; SER-146;
RP   SER-171; SER-200; THR-201; THR-897 AND THR-899, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-96; THR-237; SER-891 AND
RP   THR-899, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: May modify the assembly dynamics of microtubules, such that
CC       microtubules are slightly longer, but more dynamic. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9HC35-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9HC35-2; Sequence=VSP_047192;
CC   -!- DEVELOPMENTAL STAGE: Strongly overexpressed during mitosis.
CC   -!- SIMILARITY: Belongs to the WD repeat EMAP family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAI04648.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=BAA91919.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/EML4ID44353ch2p21.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF177377; AAG09279.2; -; mRNA.
DR   EMBL; AK001804; BAA91919.1; ALT_INIT; mRNA.
DR   EMBL; AK314702; BAG37250.1; -; mRNA.
DR   EMBL; AC006038; AAY15086.1; -; Genomic_DNA.
DR   EMBL; AC083949; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC096668; AAY14895.1; -; Genomic_DNA.
DR   EMBL; BC023522; AAH23522.1; -; mRNA.
DR   EMBL; BC104647; AAI04648.1; ALT_SEQ; mRNA.
DR   EMBL; BC140845; AAI40846.1; -; mRNA.
DR   EMBL; BC146799; AAI46800.1; -; mRNA.
DR   CCDS; CCDS1807.1; -. [Q9HC35-1]
DR   CCDS; CCDS46266.1; -. [Q9HC35-2]
DR   RefSeq; NP_001138548.1; NM_001145076.2. [Q9HC35-2]
DR   RefSeq; NP_061936.2; NM_019063.4. [Q9HC35-1]
DR   PDB; 4CGC; X-ray; 2.90 A; A/B/C=6-64.
DR   PDBsum; 4CGC; -.
DR   SMR; Q9HC35; -.
DR   BioGrid; 118169; 32.
DR   IntAct; Q9HC35; 21.
DR   STRING; 9606.ENSP00000320663; -.
DR   iPTMnet; Q9HC35; -.
DR   PhosphoSitePlus; Q9HC35; -.
DR   BioMuta; EML4; -.
DR   DMDM; 296439364; -.
DR   EPD; Q9HC35; -.
DR   jPOST; Q9HC35; -.
DR   MassIVE; Q9HC35; -.
DR   MaxQB; Q9HC35; -.
DR   PaxDb; Q9HC35; -.
DR   PeptideAtlas; Q9HC35; -.
DR   PRIDE; Q9HC35; -.
DR   ProteomicsDB; 6116; -.
DR   ProteomicsDB; 81631; -. [Q9HC35-1]
DR   Antibodypedia; 29721; 132 antibodies.
DR   Ensembl; ENST00000318522; ENSP00000320663; ENSG00000143924. [Q9HC35-1]
DR   Ensembl; ENST00000402711; ENSP00000385059; ENSG00000143924. [Q9HC35-2]
DR   GeneID; 27436; -.
DR   KEGG; hsa:27436; -.
DR   UCSC; uc002rsi.3; human. [Q9HC35-1]
DR   CTD; 27436; -.
DR   DisGeNET; 27436; -.
DR   GeneCards; EML4; -.
DR   HGNC; HGNC:1316; EML4.
DR   HPA; ENSG00000143924; Low tissue specificity.
DR   MIM; 607442; gene.
DR   neXtProt; NX_Q9HC35; -.
DR   OpenTargets; ENSG00000143924; -.
DR   Orphanet; 357191; Selection of therapeutic option in non-small cell lung carcinoma.
DR   PharmGKB; PA27769; -.
DR   eggNOG; ENOG410ISA0; Eukaryota.
DR   eggNOG; COG2319; LUCA.
DR   GeneTree; ENSGT00940000158434; -.
DR   HOGENOM; CLU_011754_0_1_1; -.
DR   InParanoid; Q9HC35; -.
DR   KO; K15420; -.
DR   PhylomeDB; Q9HC35; -.
DR   TreeFam; TF317832; -.
DR   Reactome; R-HSA-9648025; EML4 and NUDC in mitotic spindle formation.
DR   SignaLink; Q9HC35; -.
DR   ChiTaRS; EML4; human.
DR   GeneWiki; EML4; -.
DR   GenomeRNAi; 27436; -.
DR   Pharos; Q9HC35; Tbio.
DR   PRO; PR:Q9HC35; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q9HC35; protein.
DR   Bgee; ENSG00000143924; Expressed in metanephros and 203 other tissues.
DR   ExpressionAtlas; Q9HC35; baseline and differential.
DR   Genevisible; Q9HC35; HS.
DR   GO; GO:0005737; C:cytoplasm; NAS:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005874; C:microtubule; IEA:UniProtKB-KW.
DR   GO; GO:0008017; F:microtubule binding; IBA:GO_Central.
DR   GO; GO:0000226; P:microtubule cytoskeleton organization; IBA:GO_Central.
DR   GO; GO:0007017; P:microtubule-based process; NAS:UniProtKB.
DR   GO; GO:0000278; P:mitotic cell cycle; NAS:UniProtKB.
DR   Gene3D; 2.130.10.10; -; 2.
DR   InterPro; IPR005108; HELP.
DR   InterPro; IPR011047; Quinoprotein_ADH-like_supfam.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR019775; WD40_repeat_CS.
DR   InterPro; IPR017986; WD40_repeat_dom.
DR   InterPro; IPR036322; WD40_repeat_dom_sf.
DR   Pfam; PF03451; HELP; 1.
DR   Pfam; PF00400; WD40; 5.
DR   SMART; SM00320; WD40; 9.
DR   SUPFAM; SSF50978; SSF50978; 1.
DR   SUPFAM; SSF50998; SSF50998; 1.
DR   PROSITE; PS00678; WD_REPEATS_1; 1.
DR   PROSITE; PS50082; WD_REPEATS_2; 4.
DR   PROSITE; PS50294; WD_REPEATS_REGION; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cytoplasm; Cytoskeleton;
KW   Direct protein sequencing; Microtubule; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; WD repeat.
FT   CHAIN           1..981
FT                   /note="Echinoderm microtubule-associated protein-like 4"
FT                   /id="PRO_0000050963"
FT   REPEAT          259..297
FT                   /note="WD 1"
FT   REPEAT          301..348
FT                   /note="WD 2"
FT   REPEAT          356..396
FT                   /note="WD 3"
FT   REPEAT          403..438
FT                   /note="WD 4"
FT   REPEAT          445..484
FT                   /note="WD 5"
FT   REPEAT          500..538
FT                   /note="WD 6"
FT   REPEAT          543..579
FT                   /note="WD 7"
FT   REPEAT          582..621
FT                   /note="WD 8"
FT   REPEAT          625..662
FT                   /note="WD 9"
FT   REPEAT          668..704
FT                   /note="WD 10"
FT   REPEAT          711..750
FT                   /note="WD 11"
FT   REPEAT          760..818
FT                   /note="WD 12"
FT   REPEAT          825..864
FT                   /note="WD 13"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:22814378"
FT   MOD_RES         7
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         13
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         16
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         61
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         96
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         144
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         146
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163"
FT   MOD_RES         171
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         200
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         201
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         226
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000244|PubMed:15592455"
FT   MOD_RES         237
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         891
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         895
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         897
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163"
FT   MOD_RES         899
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         903
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         978
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692"
FT   VAR_SEQ         112..169
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_047192"
FT   VARIANT         283
FT                   /note="K -> E (in dbSNP:rs6736913)"
FT                   /evidence="ECO:0000269|PubMed:10995578,
FT                   ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334"
FT                   /id="VAR_031726"
FT   VARIANT         382
FT                   /note="I -> V (in dbSNP:rs10202624)"
FT                   /evidence="ECO:0000269|PubMed:10995578,
FT                   ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334"
FT                   /id="VAR_031727"
FT   VARIANT         398
FT                   /note="K -> R (in dbSNP:rs28651764)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334"
FT                   /id="VAR_031728"
FT   VARIANT         978
FT                   /note="S -> L (in dbSNP:rs28364731)"
FT                   /id="VAR_031729"
FT   CONFLICT        768..773
FT                   /note="WTTYTC -> SSRPCW (in Ref. 4; AAY15086)"
FT                   /evidence="ECO:0000305"
FT   HELIX           18..43
FT                   /evidence="ECO:0000244|PDB:4CGC"
SQ   SEQUENCE   981 AA;  108916 MW;  7E8F2585747736B9 CRC64;
     MDGFAGSLDD SISAASTSDV QDRLSALESR VQQQEDEITV LKAALADVLR RLAISEDHVA
     SVKKSVSSKG QPSPRAVIPM SCITNGSGAN RKPSHTSAVS IAGKETLSSA AKSGTEKKKE
     KPQGQREKKE ESHSNDQSPQ IRASPSPQPS SQPLQIHRQT PESKNATPTK SIKRPSPAEK
     SHNSWENSDD SRNKLSKIPS TPKLIPKVTK TADKHKDVII NQEGEYIKMF MRGRPITMFI
     PSDVDNYDDI RTELPPEKLK LEWAYGYRGK DCRANVYLLP TGKIVYFIAS VVVLFNYEER
     TQRHYLGHTD CVKCLAIHPD KIRIATGQIA GVDKDGRPLQ PHVRVWDSVT LSTLQIIGLG
     TFERGVGCLD FSKADSGVHL CIIDDSNEHM LTVWDWQKKA KGAEIKTTNE VVLAVEFHPT
     DANTIITCGK SHIFFWTWSG NSLTRKQGIF GKYEKPKFVQ CLAFLGNGDV LTGDSGGVML
     IWSKTTVEPT PGKGPKGVYQ ISKQIKAHDG SVFTLCQMRN GMLLTGGGKD RKIILWDHDL
     NPEREIEVPD QYGTIRAVAE GKADQFLVGT SRNFILRGTF NDGFQIEVQG HTDELWGLAT
     HPFKDLLLTC AQDRQVCLWN SMEHRLEWTR LVDEPGHCAD FHPSGTVVAI GTHSGRWFVL
     DAETRDLVSI HTDGNEQLSV MRYSIDGTFL AVGSHDNFIY LYVVSENGRK YSRYGRCTGH
     SSYITHLDWS PDNKYIMSNS GDYEILYWDI PNGCKLIRNR SDCKDIDWTT YTCVLGFQVF
     GVWPEGSDGT DINALVRSHN RKVIAVADDF CKVHLFQYPC SKAKAPSHKY SAHSSHVTNV
     SFTHNDSHLI STGGKDMSII QWKLVEKLSL PQNETVADTT LTKAPVSSTE SVIQSNTPTP
     PPSQPLNETA EEESRISSSP TLLENSLEQT VEPSEDHSEE ESEEGSGDLG EPLYEEPCNE
     ISKEQAKATL LEDQQDPSPS S
//
ID   G8JLD3_HUMAN            Unreviewed;      1086 AA.
AC   G8JLD3;
DT   25-JAN-2012, integrated into UniProtKB/TrEMBL.
DT   25-JAN-2012, sequence version 1.
DT   22-APR-2020, entry version 63.
DE   SubName: Full=ELKS/Rab6-interacting/CAST family member 1 {ECO:0000313|Ensembl:ENSP00000347621};
GN   Name=ERC1 {ECO:0000313|Ensembl:ENSP00000347621};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000347621, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000347621, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RG   Baylor College of Medicine Human Genome Sequencing Center Sequence Production Team;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C.,
RA   Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R.,
RA   Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E.,
RA   Song X.Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y.,
RA   Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G.,
RA   Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H.,
RA   Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S.,
RA   Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M.,
RA   Nguyen B.V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.,
RA   Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q.,
RA   Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V.,
RA   Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E.,
RA   Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R.,
RA   David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E.,
RA   D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N.,
RA   Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N.,
RA   Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R.,
RA   Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S.,
RA   LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H.,
RA   Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P.,
RA   Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G.,
RA   Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E.,
RA   Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S.,
RA   Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O.,
RA   Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y.,
RA   Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A.,
RA   Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F.,
RA   Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L.,
RA   Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G.,
RA   Gibbs R.A., null.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [2] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [3] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [4] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [5] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Burckstummer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [6] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [7] {ECO:0000313|Ensembl:ENSP00000347621}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (NOV-2011) to UniProtKB.
RN   [8] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [9] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC004671; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC004672; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC004802; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC004803; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC004804; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC006561; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC092469; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KC877502; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF455581; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001288177.1; NM_001301248.1.
DR   RefSeq; XP_016874557.1; XM_017019068.1.
DR   ProteomicsDB; 34193; -.
DR   Antibodypedia; 10295; 165 antibodies.
DR   Ensembl; ENST00000355446; ENSP00000347621; ENSG00000082805.
DR   GeneID; 23085; -.
DR   UCSC; uc001qjf.3; human.
DR   CTD; 23085; -.
DR   EuPathDB; HostDB:ENSG00000082805.19; -.
DR   HGNC; HGNC:17072; ERC1.
DR   OpenTargets; ENSG00000082805; -.
DR   eggNOG; KOG4809; Eukaryota.
DR   eggNOG; ENOG410Y4GU; LUCA.
DR   GeneTree; ENSGT00650000093320; -.
DR   OrthoDB; 446752at2759; -.
DR   ChiTaRS; ERC1; human.
DR   GenomeRNAi; 23085; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000082805; Expressed in corpus callosum and 216 other tissues.
DR   ExpressionAtlas; G8JLD3; baseline and differential.
DR   InterPro; IPR019323; ELKS/CAST.
DR   Pfam; PF10174; Cast; 3.
PE   1: Evidence at protein level;
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
SQ   SEQUENCE   1086 AA;  124820 MW;  871074DE74C65131 CRC64;
     MYGSARSVGK VEPSSQSPGR SPRLPRSPRL GHRRTNSTGG SSGSSVGGGS GKTLSMENIQ
     SLNAAYATSG PMYLSDHENV GSETPKSTMT LGRSGGRLPY GVRMTAMGSS PNIASSGVAS
     DTIAFGEHHL PPVSMASTVP HSLRQARDNT IMDLQTQLKE VLRENDLLRK DVEVKESKLS
     SSMNSIKTFW SPELKKERAL RKDEASKITI WKEQYRVVQE ENQHMQMTIQ ALQDELRIQR
     DLNQLFQQDS SSRTGEPCVA ELTEENFQRL HAEHERQAKE LFLLRKTLEE MELRIETQKQ
     TLNARDESIK KLLEMLQSKG LSAKATEEDH ERTRRLAEAE MHVHHLESLL EQKEKENSML
     REEMHRRFEN APDSAKTKAL QTVIEMKDSK ISSMERGLRD LEEEIQMLKS NGALSTEERE
     EEMKQMEVYR SHSKFMKNKV EQLKEELSSK EAQWEELKKK AAGLQAEIGQ VKQELSRKDT
     ELLALQTKLE TLTNQFSDSK QHIEVLKESL TAKEQRAAIL QTEVDALRLR LEEKETMLNK
     KTKQIQDMAE EKGTQAGEIH DLKDMLDVKE RKVNVLQKKI ENLQEQLRDK EKQMSSLKER
     VKSLQADTTN TDTALTTLEE ALAEKERTIE RLKEQRDRDE REKQEEIDNY KKDLKDLKEK
     VSLLQGDLSE KEASLLDLKE HASSLASSGL KKDSRLKTLE IALEQKKEEC LKMESQLKKA
     HEAALEARAS PEMSDRIQHL EREITRYKDE SSKAQAEVDR LLEILKEVEN EKNDKDKKIA
     ELERQVKDQN KKVANLKHKE QVEKKKSAQM LEEARRREDN LNDSSQQLQD SLRKKDDRIE
     ELEEALRESV QITAEREMVL AQEESARTNA EKQVEELLMA MEKVKQELES MKAKLSSTQQ
     SLAEKETHLT NLRAERRKHL EEVLEMKQEA LLAAISEKDA NIALLELSSS KKKTQEEVAA
     LKREKDRLVQ QLKQQTQNRM KLMADNYEDD HFKSSHSNQT NHKPSPDQII QPLLELDQNR
     SKLKLYIGHL TTLCHDRDPL ILRGLTPPAS YNLDDDQAAW ENELQKMTRG QNPLHPKAME
     KLPFFM
//
ID   RB6I2_HUMAN             Reviewed;        1116 AA.
AC   Q8IUD2; A2RU77; A7E295; D3DUP7; D3DUP8; Q6NVK2; Q8IUD3; Q8IUD4; Q8IUD5;
AC   Q8NAS1; Q9NXN5; Q9UIK7; Q9UPS1;
DT   31-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   22-APR-2020, entry version 181.
DE   RecName: Full=ELKS/Rab6-interacting/CAST family member 1;
DE            Short=ERC-1;
DE   AltName: Full=Rab6-interacting protein 2;
GN   Name=ERC1; Synonyms=ELKS, KIAA1081, RAB6IP2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), AND CHROMOSOMAL TRANSLOCATION WITH
RP   RET.
RX   PubMed=10337992;
RX   DOI=10.1002/(sici)1098-2264(199906)25:2<97::aid-gcc4>3.0.co;2-l;
RA   Nakata T., Kitamura Y., Shimizu K., Tanaka S., Fujimori M., Yokoyama S.,
RA   Ito K., Emi M.;
RT   "Fusion of a novel gene, ELKS, to RET due to translocation
RT   t(10;12)(q11;p13) in a papillary thyroid carcinoma.";
RL   Genes Chromosomes Cancer 25:97-103(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3 AND 5), AND TISSUE
RP   SPECIFICITY.
RX   PubMed=12203787; DOI=10.1002/gcc.10095;
RA   Nakata T., Yokota T., Emi M., Minami S.;
RT   "Differential expression of multiple isoforms of the ELKS mRNAs involved in
RT   a papillary thyroid carcinoma.";
RL   Genes Chromosomes Cancer 35:30-37(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 1-652 (ISOFORM 3).
RC   TISSUE=Brain, and Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-1061 (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=10470851; DOI=10.1093/dnares/6.3.197;
RA   Kikuno R., Nagase T., Ishikawa K., Hirosawa M., Miyajima N., Tanaka A.,
RA   Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIV. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 6:197-205(1999).
RN   [6]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [7]
RP   PROTEIN SEQUENCE OF 254-269, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 733-1116 (ISOFORM 2), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 828-1116 (ISOFORMS 1/3).
RC   TISSUE=Colon;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH CHUK; IKBKB; IKBKG AND NFKBIA.
RX   PubMed=15218148; DOI=10.1126/science.1098387;
RA   Ducut Sigala J.L., Bottero V., Young D.B., Shevchenko A., Mercurio F.,
RA   Verma I.M.;
RT   "Activation of transcription factor NF-kappaB requires ELKS, an IkappaB
RT   kinase regulatory subunit.";
RL   Science 304:1963-1967(2004).
RN   [10]
RP   INTERACTION WITH PPFIA1.
RX   PubMed=12923177; DOI=10.1074/jbc.m307561200;
RA   Ko J., Na M., Kim S., Lee J.R., Kim E.;
RT   "Interaction of the ERC family of RIM-binding proteins with the liprin-
RT   alpha family of multidomain proteins.";
RL   J. Biol. Chem. 278:42377-42385(2003).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-17; SER-21 AND THR-1046, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-75, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-94, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-17 AND SER-21, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37 AND THR-38, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH SDCCAG8.
RX   PubMed=27224062; DOI=10.1371/journal.pone.0156081;
RA   Airik R., Schueler M., Airik M., Cho J., Ulanowicz K.A., Porath J.D.,
RA   Hurd T.W., Bekker-Jensen S., Schroeder J.M., Andersen J.S., Hildebrandt F.;
RT   "SDCCAG8 interacts with RAB effector proteins RABEP2 and ERC1 and is
RT   required for Hedgehog Signaling.";
RL   PLoS ONE 11:E0156081-E0156081(2016).
CC   -!- FUNCTION: Regulatory subunit of the IKK complex. Probably recruits
CC       IkappaBalpha/NFKBIA to the complex. May be involved in the organization
CC       of the cytomatrix at the nerve terminals active zone (CAZ) which
CC       regulates neurotransmitter release. May be involved in vesicle
CC       trafficking at the CAZ. May be involved in Rab-6 regulated endosomes to
CC       Golgi transport. {ECO:0000269|PubMed:15218148}.
CC   -!- SUBUNIT: Part of a complex with CHUK, IKBKB and IKBKG. Interacts with
CC       CHUK, IKBKB and IKBKG. The interaction with IKBKG is independent of
CC       CHUK and IKBKB. Interacts with NFKBIA. Isoform 4 interacts with PPFIA1,
CC       and through its C-terminus with the PDZ domains of RIMS1 and RIMS2.
CC       Interacts with ERC2/CAST1. Interacts with the GTB-bound forms of RAB6A
CC       isoform 1 and isoform 2 and with RAB6B. The interaction was strongest
CC       with RAB6B, followed by RAB6A isoform 2 and weakest with RAB6A isoform
CC       1 (By similarity). Interacts with SDCCAG8. {ECO:0000250,
CC       ECO:0000269|PubMed:27224062}.
CC   -!- INTERACTION:
CC       Q8IUD2-3; PRO_0000037573 [P27958]; Xeno; NbExp=8; IntAct=EBI-9352449, EBI-3649474;
CC       Q8IUD2-4; PRO_0000037573 [P27958]; Xeno; NbExp=3; IntAct=EBI-9352501, EBI-3649474;
CC       Q8IUD2-2; Q8R0S4: Cacnb4; Xeno; NbExp=2; IntAct=EBI-6920871, EBI-3647752;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule organizing
CC       center, centrosome {ECO:0000269|PubMed:27224062}. Cytoplasm
CC       {ECO:0000250|UniProtKB:Q811U3}. Membrane {ECO:0000250}; Peripheral
CC       membrane protein {ECO:0000250}. Golgi apparatus membrane {ECO:0000250};
CC       Peripheral membrane protein {ECO:0000250}. Cell junction, synapse,
CC       presynaptic cell membrane {ECO:0000250|UniProtKB:Q811U3}.
CC       Note=Recruited on Golgi membranes by RAB6A in a GTP-dependent manner
CC       (By similarity). {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1; Synonyms=ELKS epsilon;
CC         IsoId=Q8IUD2-1; Sequence=Displayed;
CC       Name=2; Synonyms=ELKS beta;
CC         IsoId=Q8IUD2-2; Sequence=VSP_011451, VSP_011452, VSP_011454,
CC                                  VSP_011455;
CC       Name=3; Synonyms=ELKS delta;
CC         IsoId=Q8IUD2-3; Sequence=VSP_011451;
CC       Name=4; Synonyms=ELKS alpha;
CC         IsoId=Q8IUD2-4; Sequence=VSP_011451, VSP_011452, VSP_011453,
CC                                  VSP_011454, VSP_011455;
CC       Name=5; Synonyms=ELKS gamma;
CC         IsoId=Q8IUD2-5; Sequence=VSP_011450, VSP_011452, VSP_011454,
CC                                  VSP_011455;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Isoform 2 and isoform 4 are
CC       abundantly expressed in brain. Isoform 1 and isoform 3 are
CC       predominantly expressed in testis and thyroid, and isoform 1
CC       predominates in other tissues tested. {ECO:0000269|PubMed:12203787}.
CC   -!- DISEASE: Note=A chromosomal aberration involving ERC1/RAB6IP2 is found
CC       in papillary thyroid carcinomas (PTCs). Translocation t(10;12)(q11;p13)
CC       involving RET. In vitro, isoform 1, isoform 3 and isoform 5
CC       participating in a ERC1-RET fusion protein activate tyrosine-protein
CC       kinase activity. {ECO:0000269|PubMed:10337992}.
CC   -!- MISCELLANEOUS: [Isoform 2]: May be produced at very low levels due to a
CC       premature stop codon in the mRNA, leading to nonsense-mediated mRNA
CC       decay. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 4]: May be produced at very low levels due to a
CC       premature stop codon in the mRNA, leading to nonsense-mediated mRNA
CC       decay. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 5]: May be produced at very low levels due to a
CC       premature stop codon in the mRNA, leading to nonsense-mediated mRNA
CC       decay. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH68006.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=BAA83033.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAA90975.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/ELKSID503.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB015617; BAA88763.1; -; mRNA.
DR   EMBL; AB053469; BAC54108.1; -; mRNA.
DR   EMBL; AB053468; BAC54107.1; -; mRNA.
DR   EMBL; AB053470; BAC54109.1; -; mRNA.
DR   EMBL; AB053471; BAC54110.1; -; mRNA.
DR   EMBL; CH471116; EAW88932.1; -; Genomic_DNA.
DR   EMBL; CH471116; EAW88934.1; -; Genomic_DNA.
DR   EMBL; CH471116; EAW88936.1; -; Genomic_DNA.
DR   EMBL; CH471116; EAW88938.1; -; Genomic_DNA.
DR   EMBL; BC068006; AAH68006.1; ALT_SEQ; mRNA.
DR   EMBL; BC132782; AAI32783.1; -; mRNA.
DR   EMBL; BC132784; AAI32785.1; -; mRNA.
DR   EMBL; BC150248; AAI50249.1; -; mRNA.
DR   EMBL; AB029004; BAA83033.2; ALT_INIT; mRNA.
DR   EMBL; AK000148; BAA90975.1; ALT_INIT; mRNA.
DR   EMBL; AK092201; BAC03827.1; -; mRNA.
DR   CCDS; CCDS53732.1; -. [Q8IUD2-3]
DR   CCDS; CCDS8508.1; -. [Q8IUD2-1]
DR   RefSeq; NP_829883.1; NM_178039.3. [Q8IUD2-3]
DR   RefSeq; NP_829884.1; NM_178040.3. [Q8IUD2-1]
DR   RefSeq; XP_011519243.1; XM_011520941.2. [Q8IUD2-1]
DR   RefSeq; XP_016874553.1; XM_017019064.1. [Q8IUD2-1]
DR   RefSeq; XP_016874556.1; XM_017019067.1. [Q8IUD2-3]
DR   SMR; Q8IUD2; -.
DR   BioGrid; 116714; 85.
DR   CORUM; Q8IUD2; -.
DR   IntAct; Q8IUD2; 57.
DR   MINT; Q8IUD2; -.
DR   STRING; 9606.ENSP00000468263; -.
DR   iPTMnet; Q8IUD2; -.
DR   MetOSite; Q8IUD2; -.
DR   PhosphoSitePlus; Q8IUD2; -.
DR   BioMuta; ERC1; -.
DR   DMDM; 51827892; -.
DR   EPD; Q8IUD2; -.
DR   jPOST; Q8IUD2; -.
DR   MassIVE; Q8IUD2; -.
DR   MaxQB; Q8IUD2; -.
DR   PaxDb; Q8IUD2; -.
DR   PeptideAtlas; Q8IUD2; -.
DR   PRIDE; Q8IUD2; -.
DR   ProteomicsDB; 70547; -. [Q8IUD2-1]
DR   ProteomicsDB; 70548; -. [Q8IUD2-2]
DR   ProteomicsDB; 70549; -. [Q8IUD2-3]
DR   ProteomicsDB; 70550; -. [Q8IUD2-4]
DR   ProteomicsDB; 70551; -. [Q8IUD2-5]
DR   Antibodypedia; 10295; 165 antibodies.
DR   Ensembl; ENST00000347735; ENSP00000340054; ENSG00000082805. [Q8IUD2-4]
DR   Ensembl; ENST00000360905; ENSP00000354158; ENSG00000082805. [Q8IUD2-1]
DR   Ensembl; ENST00000397203; ENSP00000380386; ENSG00000082805. [Q8IUD2-3]
DR   Ensembl; ENST00000440394; ENSP00000410064; ENSG00000082805. [Q8IUD2-2]
DR   Ensembl; ENST00000543086; ENSP00000438546; ENSG00000082805. [Q8IUD2-3]
DR   Ensembl; ENST00000545948; ENSP00000442976; ENSG00000082805. [Q8IUD2-5]
DR   Ensembl; ENST00000589028; ENSP00000468263; ENSG00000082805. [Q8IUD2-1]
DR   Ensembl; ENST00000611180; ENSP00000479523; ENSG00000082805. [Q8IUD2-5]
DR   GeneID; 23085; -.
DR   KEGG; hsa:23085; -.
DR   UCSC; uc001qjb.3; human. [Q8IUD2-1]
DR   CTD; 23085; -.
DR   DisGeNET; 23085; -.
DR   GeneCards; ERC1; -.
DR   HGNC; HGNC:17072; ERC1.
DR   HPA; ENSG00000082805; Low tissue specificity.
DR   MalaCards; ERC1; -.
DR   MIM; 607127; gene.
DR   neXtProt; NX_Q8IUD2; -.
DR   OpenTargets; ENSG00000082805; -.
DR   Orphanet; 146; Differentiated thyroid carcinoma.
DR   Orphanet; 280325; Distal monosomy 12p.
DR   PharmGKB; PA134970875; -.
DR   eggNOG; KOG4809; Eukaryota.
DR   eggNOG; ENOG410Y4GU; LUCA.
DR   GeneTree; ENSGT00650000093320; -.
DR   HOGENOM; CLU_009304_0_0_1; -.
DR   InParanoid; Q8IUD2; -.
DR   KO; K16072; -.
DR   OrthoDB; 446752at2759; -.
DR   PhylomeDB; Q8IUD2; -.
DR   TreeFam; TF324969; -.
DR   SIGNOR; Q8IUD2; -.
DR   ChiTaRS; ERC1; human.
DR   GeneWiki; ERC1; -.
DR   GenomeRNAi; 23085; -.
DR   Pharos; Q8IUD2; Tbio.
DR   PRO; PR:Q8IUD2; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; Q8IUD2; protein.
DR   Bgee; ENSG00000082805; Expressed in corpus callosum and 216 other tissues.
DR   ExpressionAtlas; Q8IUD2; baseline and differential.
DR   Genevisible; Q8IUD2; HS.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0036064; C:ciliary basal body; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0008385; C:IkappaB kinase complex; IDA:UniProtKB.
DR   GO; GO:0042734; C:presynaptic membrane; TAS:UniProtKB.
DR   GO; GO:0045202; C:synapse; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0043522; F:leucine zipper domain binding; NAS:UniProtKB.
DR   GO; GO:0030165; F:PDZ domain binding; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0017137; F:Rab GTPase binding; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0007252; P:I-kappaB phosphorylation; IDA:UniProtKB.
DR   GO; GO:0007275; P:multicellular organism development; NAS:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; TAS:UniProtKB.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; TAS:UniProtKB.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB.
DR   GO; GO:0042147; P:retrograde transport, endosome to Golgi; ISS:ParkinsonsUK-UCL.
DR   InterPro; IPR019323; ELKS/CAST.
DR   InterPro; IPR037245; FIP-RBD_C_sf.
DR   InterPro; IPR019018; Rab-bd_FIP-RBD.
DR   Pfam; PF10174; Cast; 3.
DR   Pfam; PF09457; RBD-FIP; 1.
DR   SUPFAM; SSF144270; SSF144270; 1.
DR   PROSITE; PS51511; FIP_RBD; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Cell junction; Cell membrane;
KW   Cell projection; Chromosomal rearrangement; Coiled coil; Cytoplasm;
KW   Cytoskeleton; Direct protein sequencing; Golgi apparatus; Membrane;
KW   Phosphoprotein; Polymorphism; Protein transport; Reference proteome;
KW   Synapse; Transport.
FT   CHAIN           1..1116
FT                   /note="ELKS/Rab6-interacting/CAST family member 1"
FT                   /id="PRO_0000097176"
FT   DOMAIN          1046..1108
FT                   /note="FIP-RBD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00844"
FT   COILED          144..988
FT                   /evidence="ECO:0000255"
FT   COILED          1060..1100
FT                   /evidence="ECO:0000255"
FT   SITE            719..720
FT                   /note="Breakpoint for translocation to form ERC1-RET
FT                   oncogene"
FT   MOD_RES         10
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99MI1"
FT   MOD_RES         17
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         21
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         37
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         38
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         55
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99MI1"
FT   MOD_RES         75
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332"
FT   MOD_RES         94
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         1005
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q811U3"
FT   MOD_RES         1046
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   VAR_SEQ         224..523
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:12203787"
FT                   /id="VSP_011450"
FT   VAR_SEQ         440..467
FT                   /note="Missing (in isoform 2, isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:10337992,
FT                   ECO:0000303|PubMed:10470851, ECO:0000303|PubMed:12203787,
FT                   ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334"
FT                   /id="VSP_011451"
FT   VAR_SEQ         783
FT                   /note="E -> ESLTS (in isoform 2, isoform 4 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:10337992,
FT                   ECO:0000303|PubMed:10470851, ECO:0000303|PubMed:12203787,
FT                   ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334"
FT                   /id="VSP_011452"
FT   VAR_SEQ         830..873
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:10337992"
FT                   /id="VSP_011453"
FT   VAR_SEQ         1009..1016
FT                   /note="IIQPLLEL -> DEEEGIWA (in isoform 2, isoform 4 and
FT                   isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:10337992,
FT                   ECO:0000303|PubMed:10470851, ECO:0000303|PubMed:12203787,
FT                   ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334"
FT                   /id="VSP_011454"
FT   VAR_SEQ         1017..1116
FT                   /note="Missing (in isoform 2, isoform 4 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:10337992,
FT                   ECO:0000303|PubMed:10470851, ECO:0000303|PubMed:12203787,
FT                   ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334"
FT                   /id="VSP_011455"
FT   VARIANT         50
FT                   /note="S -> G (in dbSNP:rs35037408)"
FT                   /id="VAR_051304"
FT   VARIANT         1032
FT                   /note="T -> A (in dbSNP:rs12319376)"
FT                   /id="VAR_051305"
FT   CONFLICT        828
FT                   /note="L -> G (in Ref. 8; BAA90975)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        892
FT                   /note="K -> R (in Ref. 8; BAC03827)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        910
FT                   /note="T -> I (in Ref. 8; BAC03827)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1021
FT                   /note="S -> G (in Ref. 8; BAA90975)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1116 AA;  128086 MW;  CCB70380AA7C6E69 CRC64;
     MYGSARSVGK VEPSSQSPGR SPRLPRSPRL GHRRTNSTGG SSGSSVGGGS GKTLSMENIQ
     SLNAAYATSG PMYLSDHENV GSETPKSTMT LGRSGGRLPY GVRMTAMGSS PNIASSGVAS
     DTIAFGEHHL PPVSMASTVP HSLRQARDNT IMDLQTQLKE VLRENDLLRK DVEVKESKLS
     SSMNSIKTFW SPELKKERAL RKDEASKITI WKEQYRVVQE ENQHMQMTIQ ALQDELRIQR
     DLNQLFQQDS SSRTGEPCVA ELTEENFQRL HAEHERQAKE LFLLRKTLEE MELRIETQKQ
     TLNARDESIK KLLEMLQSKG LSAKATEEDH ERTRRLAEAE MHVHHLESLL EQKEKENSML
     REEMHRRFEN APDSAKTKAL QTVIEMKDSK ISSMERGLRD LEEEIQMLKS NGALSTEERE
     EEMKQMEVYR SHSKFMKNKV EQLKEELSSK EAQWEELKKK AAGLQAEIGQ VKQELSRKDT
     ELLALQTKLE TLTNQFSDSK QHIEVLKESL TAKEQRAAIL QTEVDALRLR LEEKETMLNK
     KTKQIQDMAE EKGTQAGEIH DLKDMLDVKE RKVNVLQKKI ENLQEQLRDK EKQMSSLKER
     VKSLQADTTN TDTALTTLEE ALAEKERTIE RLKEQRDRDE REKQEEIDNY KKDLKDLKEK
     VSLLQGDLSE KEASLLDLKE HASSLASSGL KKDSRLKTLE IALEQKKEEC LKMESQLKKA
     HEAALEARAS PEMSDRIQHL EREITRYKDE SSKAQAEVDR LLEILKEVEN EKNDKDKKIA
     ELERQVKDQN KKVANLKHKE QVEKKKSAQM LEEARRREDN LNDSSQQLQD SLRKKDDRIE
     ELEEALRESV QITAEREMVL AQEESARTNA EKQVEELLMA MEKVKQELES MKAKLSSTQQ
     SLAEKETHLT NLRAERRKHL EEVLEMKQEA LLAAISEKDA NIALLELSSS KKKTQEEVAA
     LKREKDRLVQ QLKQQTQNRM KLMADNYEDD HFKSSHSNQT NHKPSPDQII QPLLELDQNR
     SKLKLYIGHL TTLCHDRDPL ILRGLTPPAS YNLDDDQAAW ENELQKMTRG QLQDELEKGE
     RDNAELQEFA NAILQQIADH CPDILEQVVN ALEESS
//
ID   X6RLX0_HUMAN            Unreviewed;      1120 AA.
AC   X6RLX0;
DT   11-JUN-2014, integrated into UniProtKB/TrEMBL.
DT   11-JUN-2014, sequence version 1.
DT   22-APR-2020, entry version 54.
DE   SubName: Full=ELKS/Rab6-interacting/CAST family member 1 {ECO:0000313|Ensembl:ENSP00000442739};
GN   Name=ERC1 {ECO:0000313|Ensembl:ENSP00000442739};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000442739, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000442739, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RG   Baylor College of Medicine Human Genome Sequencing Center Sequence Production Team;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C.,
RA   Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R.,
RA   Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E.,
RA   Song X.Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y.,
RA   Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G.,
RA   Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H.,
RA   Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S.,
RA   Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M.,
RA   Nguyen B.V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.,
RA   Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q.,
RA   Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V.,
RA   Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E.,
RA   Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R.,
RA   David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E.,
RA   D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N.,
RA   Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N.,
RA   Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R.,
RA   Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S.,
RA   LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H.,
RA   Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P.,
RA   Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G.,
RA   Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E.,
RA   Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S.,
RA   Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O.,
RA   Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y.,
RA   Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A.,
RA   Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F.,
RA   Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L.,
RA   Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G.,
RA   Gibbs R.A., null.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [2] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [3] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [4] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [5] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Burckstummer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [6] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [7] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [8] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [9] {ECO:0000313|Ensembl:ENSP00000442739}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (APR-2014) to UniProtKB.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC004671; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC004672; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC004802; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC004803; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC004804; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC006561; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC092469; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KC877502; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF455581; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; XP_016874551.1; XM_017019062.1.
DR   Antibodypedia; 10295; 165 antibodies.
DR   Ensembl; ENST00000546231; ENSP00000442739; ENSG00000082805.
DR   GeneID; 23085; -.
DR   UCSC; uc058jrc.1; human.
DR   CTD; 23085; -.
DR   EuPathDB; HostDB:ENSG00000082805.19; -.
DR   HGNC; HGNC:17072; ERC1.
DR   OpenTargets; ENSG00000082805; -.
DR   eggNOG; KOG4809; Eukaryota.
DR   eggNOG; ENOG410Y4GU; LUCA.
DR   GeneTree; ENSGT00650000093320; -.
DR   OMA; XDSKISS; -.
DR   OrthoDB; 446752at2759; -.
DR   ChiTaRS; ERC1; human.
DR   GenomeRNAi; 23085; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000082805; Expressed in corpus callosum and 216 other tissues.
DR   ExpressionAtlas; X6RLX0; baseline and differential.
DR   InterPro; IPR019323; ELKS/CAST.
DR   InterPro; IPR037245; FIP-RBD_C_sf.
DR   InterPro; IPR019018; Rab-bd_FIP-RBD.
DR   Pfam; PF10174; Cast; 3.
DR   Pfam; PF09457; RBD-FIP; 1.
DR   SUPFAM; SSF144270; SSF144270; 1.
DR   PROSITE; PS51511; FIP_RBD; 1.
PE   1: Evidence at protein level;
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
SQ   SEQUENCE   1120 AA;  128475 MW;  E66981F91E9E9586 CRC64;
     MYGSARSVGK VEPSSQSPGR SPRLPRSPRL GHRRTNSTGG SSGSSVGGGS GKTLSMENIQ
     SLNAAYATSG PMYLSDHENV GSETPKSTMT LGRSGGRLPY GVRMTAMGSS PNIASSGVAS
     DTIAFGEHHL PPVSMASTVP HSLRQARDNT IMDLQTQLKE VLRENDLLRK DVEVKESKLS
     SSMNSIKTFW SPELKKERAL RKDEASKITI WKEQYRVVQE ENQHMQMTIQ ALQDELRIQR
     DLNQLFQQDS SSRTGEPCVA ELTEENFQRL HAEHERQAKE LFLLRKTLEE MELRIETQKQ
     TLNARDESIK KLLEMLQSKG LSAKATEEDH ERTRRLAEAE MHVHHLESLL EQKEKENSML
     REEMHRRFEN APDSAKTKAL QTVIEMKDSK ISSMERGLRD LEEEIQMLKS NGALSTEERE
     EEMKQMEVYR SHSKFMKNKV EQLKEELSSK EAQWEELKKK AAGLQAEIGQ VKQELSRKDT
     ELLALQTKLE TLTNQFSDSK QHIEVLKESL TAKEQRAAIL QTEVDALRLR LEEKETMLNK
     KTKQIQDMAE EKGTQAGEIH DLKDMLDVKE RKVNVLQKKI ENLQEQLRDK EKQMSSLKER
     VKSLQADTTN TDTALTTLEE ALAEKERTIE RLKEQRDRDE REKQEEIDNY KKDLKDLKEK
     VSLLQGDLSE KEASLLDLKE HASSLASSGL KKDSRLKTLE IALEQKKEEC LKMESQLKKA
     HEAALEARAS PEMSDRIQHL EREITRYKDE SSKAQAEVDR LLEILKEVEN EKNDKDKKIA
     ELESLTSRQV KDQNKKVANL KHKEQVEKKK SAQMLEEARR REDNLNDSSQ QLQDSLRKKD
     DRIEELEEAL RESVQITAER EMVLAQEESA RTNAEKQVEE LLMAMEKVKQ ELESMKAKLS
     STQQSLAEKE THLTNLRAER RKHLEEVLEM KQEALLAAIS EKDANIALLE LSSSKKKTQE
     EVAALKREKD RLVQQLKQQT QNRMKLMADN YEDDHFKSSH SNQTNHKPSP DQIIQPLLEL
     DQNRSKLKLY IGHLTTLCHD RDPLILRGLT PPASYNLDDD QAAWENELQK MTRGQLQDEL
     EKGERDNAEL QEFANAILQQ IADHCPDILE QVVNALEESS
//
ID   EZRI_HUMAN              Reviewed;         586 AA.
AC   P15311; E1P5A8; P23714; Q4VX75; Q96CU8; Q9NSJ4;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   06-FEB-2007, sequence version 4.
DT   22-APR-2020, entry version 225.
DE   RecName: Full=Ezrin;
DE   AltName: Full=Cytovillin;
DE   AltName: Full=Villin-2;
DE   AltName: Full=p81;
GN   Name=EZR; Synonyms=VIL2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, AND VARIANT VAL-532.
RX   PubMed=2591371; DOI=10.1002/j.1460-2075.1989.tb08598.x;
RA   Gould K.L., Bretscher A., Esch F.S., Hunter T.;
RT   "cDNA cloning and sequencing of the protein-tyrosine kinase substrate,
RT   ezrin, reveals homology to band 4.1.";
RL   EMBO J. 8:4133-4142(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT VAL-532.
RC   TISSUE=Placenta;
RX   PubMed=2674140;
RA   Turunen O., Winqvist R., Pakkanen R., Grzeschik K.-H., Wahlstroem T.,
RA   Vaheri A.;
RT   "Cytovillin, a microvillar Mr 75,000 protein. cDNA sequence, prokaryotic
RT   expression, and chromosomal localization.";
RL   J. Biol. Chem. 264:16727-16732(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Melanoma;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 172-180 AND 343-350.
RX   PubMed=8713105; DOI=10.1006/bbrc.1996.1082;
RA   Egerton M., Moritz R.L., Druker B., Kelso A., Simpson R.J.;
RT   "Identification of the 70kD heat shock cognate protein (Hsc70) and alpha-
RT   actinin-1 as novel phosphotyrosine-containing proteins in T lymphocytes.";
RL   Biochem. Biophys. Res. Commun. 224:666-674(1996).
RN   [8]
RP   PROTEIN SEQUENCE OF 264-273; 428-435 AND 530-542, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [9]
RP   PHOSPHORYLATION AT TYR-146 AND TYR-354 BY PDGFR.
RX   PubMed=1382070;
RA   Krieg J., Hunter T.;
RT   "Identification of the two major epidermal growth factor-induced tyrosine
RT   phosphorylation sites in the microvillar core protein ezrin.";
RL   J. Biol. Chem. 267:19258-19265(1992).
RN   [10]
RP   PHOSPHORYLATION.
RX   PubMed=1381389;
RA   Egerton M., Burgess W.H., Chen D., Druker B.J., Bretscher A.,
RA   Samelson L.E.;
RT   "Identification of ezrin as an 81-kDa tyrosine-phosphorylated protein in T
RT   cells.";
RL   J. Immunol. 149:1847-1852(1992).
RN   [11]
RP   INTERACTION WITH SLC9A3R1.
RX   PubMed=9314537; DOI=10.1083/jcb.139.1.169;
RA   Reczek D., Berryman M., Bretscher A.;
RT   "Identification of EBP50: a PDZ-containing phosphoprotein that associates
RT   with members of the ezrin-radixin-moesin family.";
RL   J. Cell Biol. 139:169-179(1997).
RN   [12]
RP   INTERACTION WITH SCYL3.
RC   TISSUE=Kidney;
RX   PubMed=12651155; DOI=10.1016/s0014-4827(02)00054-x;
RA   Sullivan A., Uff C.R., Isacke C.M., Thorne R.F.;
RT   "PACE-1, a novel protein that interacts with the C-terminal domain of
RT   ezrin.";
RL   Exp. Cell Res. 284:224-238(2003).
RN   [13]
RP   INTERACTION WITH S100P.
RX   PubMed=12808036; DOI=10.1091/mbc.e02-09-0553;
RA   Koltzscher M., Neumann C., Konig S., Gerke V.;
RT   "Ca2+-dependent binding and activation of dormant ezrin by dimeric S100P.";
RL   Mol. Biol. Cell 14:2372-2384(2003).
RN   [14]
RP   INTERACTION WITH TMEM8B.
RX   PubMed=15498789; DOI=10.1093/carcin/bgh312;
RA   Ma J., Zhou J., Fan S., Wang L.-L., Li X.-L., Yan Q., Zhou M., Liu H.-Y.,
RA   Zhang Q., Zhou H., Gan K., Li Z., Peng C., Xiong W., Tan C., Shen S.-R.,
RA   Yang J., Li J., Li G.-Y.;
RT   "Role of a novel EGF-like domain-containing gene NGX6 in cell adhesion
RT   modulation in nasopharyngeal carcinoma cells.";
RL   Carcinogenesis 26:281-291(2005).
RN   [15]
RP   TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=15797715; DOI=10.1016/j.mcn.2004.11.014;
RA   Groenholm M., Teesalu T., Tyynelaa J., Piltti K., Boehling T.,
RA   Wartiovaara K., Vaheri A., Carpen O.;
RT   "Characterization of the NF2 protein merlin and the ERM protein ezrin in
RT   human, rat, and mouse central nervous system.";
RL   Mol. Cell. Neurosci. 28:683-693(2005).
RN   [16]
RP   INTERACTION WITH PDPN.
RX   PubMed=17046996; DOI=10.1242/jcs.03218;
RA   Martin-Villar E., Megias D., Castel S., Yurrita M.M., Vilaro S.,
RA   Quintanilla M.;
RT   "Podoplanin binds ERM proteins to activate RhoA and promote epithelial-
RT   mesenchymal transition.";
RL   J. Cell Sci. 119:4541-4553(2006).
RN   [17]
RP   INTERACTION WITH PODXL.
RX   PubMed=17616675; DOI=10.1158/0008-5472.can-06-3575;
RA   Sizemore S., Cicek M., Sizemore N., Ng K.P., Casey G.;
RT   "Podocalyxin increases the aggressive phenotype of breast and prostate
RT   cancer cells in vitro through its interaction with ezrin.";
RL   Cancer Res. 67:6183-6191(2007).
RN   [18]
RP   FUNCTION, AND INTERACTION WITH PLEKHG6.
RX   PubMed=17881735; DOI=10.1091/mbc.e06-12-1144;
RA   D'Angelo R., Aresta S., Blangy A., Del Maestro L., Louvard D., Arpin M.;
RT   "Interaction of ezrin with the novel guanine nucleotide exchange factor
RT   PLEKHG6 promotes RhoG-dependent apical cytoskeleton rearrangements in
RT   epithelial cells.";
RL   Mol. Biol. Cell 18:4780-4793(2007).
RN   [19]
RP   INTERACTION WITH FES/FPS, PHOSPHORYLATION AT TYR-146 AND TYR-478, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=18046454; DOI=10.1038/sj.emboj.7601943;
RA   Naba A., Reverdy C., Louvard D., Arpin M.;
RT   "Spatial recruitment and activation of the Fes kinase by ezrin promotes
RT   HGF-induced cell scattering.";
RL   EMBO J. 27:38-50(2008).
RN   [20]
RP   FUNCTION, AND PHOSPHORYLATION AT THR-567.
RX   PubMed=18270268; DOI=10.1242/jcs.016246;
RA   Wald F.A., Oriolo A.S., Mashukova A., Fregien N.L., Langshaw A.H.,
RA   Salas P.J.;
RT   "Atypical protein kinase C (iota) activates ezrin in the apical domain of
RT   intestinal epithelial cells.";
RL   J. Cell Sci. 121:644-654(2008).
RN   [21]
RP   FUNCTION, AND INTERACTION WITH S100P.
RX   PubMed=19111582; DOI=10.1016/j.bbamcr.2008.11.012;
RA   Austermann J., Nazmi A.R., Heil A., Fritz G., Kolinski M., Filipek S.,
RA   Gerke V.;
RT   "Generation and characterization of a novel, permanently active S100P
RT   mutant.";
RL   Biochim. Biophys. Acta 1793:1078-1085(2009).
RN   [22]
RP   INTERACTION WITH MCC.
RX   PubMed=19555689; DOI=10.1016/j.febslet.2009.06.034;
RA   Arnaud C., Sebbagh M., Nola S., Audebert S., Bidaut G., Hermant A.,
RA   Gayet O., Dusetti N.J., Ollendorff V., Santoni M.J., Borg J.P., Lecine P.;
RT   "MCC, a new interacting protein for Scrib, is required for cell migration
RT   in epithelial cells.";
RL   FEBS Lett. 583:2326-2332(2009).
RN   [23]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-60, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-366, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [26]
RP   S-NITROSYLATION, AND DOMAIN.
RX   PubMed=25417112; DOI=10.1016/j.cell.2014.09.032;
RA   Jia J., Arif A., Terenzi F., Willard B., Plow E.F., Hazen S.L., Fox P.L.;
RT   "Target-selective protein S-nitrosylation by sequence motif recognition.";
RL   Cell 159:623-634(2014).
RN   [27]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 1-297.
RX   PubMed=12429733; DOI=10.1074/jbc.m210601200;
RA   Smith W.J., Nassar N., Bretscher A., Cerione R.A., Karplus P.A.;
RT   "Structure of the active N-terminal domain of Ezrin. Conformational and
RT   mobility changes identify keystone interactions.";
RL   J. Biol. Chem. 278:4949-4956(2003).
CC   -!- FUNCTION: Probably involved in connections of major cytoskeletal
CC       structures to the plasma membrane. In epithelial cells, required for
CC       the formation of microvilli and membrane ruffles on the apical pole.
CC       Along with PLEKHG6, required for normal macropinocytosis.
CC       {ECO:0000269|PubMed:17881735, ECO:0000269|PubMed:18270268,
CC       ECO:0000269|PubMed:19111582}.
CC   -!- ACTIVITY REGULATION: A head-to-tail association, of the N-terminal and
CC       C-terminal halves results in a closed conformation (inactive form)
CC       which is incapable of actin or membrane-binding. {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with MPP5 and SLC9A3R2. Found in a complex with EZR,
CC       PODXL and SLC9A3R2 (By similarity). Interacts with MCC, PLEKHG6, PODXL,
CC       SCYL3/PACE1, SLC9A3R1 and TMEM8B (PubMed:9314537, PubMed:12651155,
CC       PubMed:15498789, PubMed:17616675, PubMed:17881735, PubMed:19555689).
CC       Interacts (when phosphorylated) with FES/FPS (PubMed:18046454).
CC       Interacts with dimeric S100P, the interaction may be activating through
CC       unmasking of F-actin binding sites (PubMed:12808036, PubMed:19111582).
CC       Identified in complexes that contain VIM, EZR, AHNAK, BFSP1, BFSP2,
CC       ANK2, PLEC, PRX and spectrin (By similarity). Detected in a complex
CC       composed of at least EZR, AHNAK, PPL and PRX (By similarity). Interacts
CC       with PDPN (via cytoplasmic domain); activates RHOA and promotes
CC       epithelial-mesenchymal transition (PubMed:17046996). Interacts with
CC       SPN, CD44 and ICAM2 (By similarity). {ECO:0000250|UniProtKB:P26040,
CC       ECO:0000250|UniProtKB:P31976, ECO:0000250|UniProtKB:P31977,
CC       ECO:0000250|UniProtKB:Q8HZQ5, ECO:0000269|PubMed:12651155,
CC       ECO:0000269|PubMed:12808036, ECO:0000269|PubMed:15498789,
CC       ECO:0000269|PubMed:17046996, ECO:0000269|PubMed:17616675,
CC       ECO:0000269|PubMed:17881735, ECO:0000269|PubMed:18046454,
CC       ECO:0000269|PubMed:19111582, ECO:0000269|PubMed:19555689,
CC       ECO:0000269|PubMed:9314537}.
CC   -!- INTERACTION:
CC       P15311; P15311; NbExp=5; IntAct=EBI-1056902, EBI-1056902;
CC       P15311; P07384: CAPN1; NbExp=2; IntAct=EBI-1056902, EBI-1542113;
CC       P15311; Q63155: Dcc; Xeno; NbExp=3; IntAct=EBI-1056902, EBI-1798965;
CC       P15311; P07332: FES; NbExp=8; IntAct=EBI-1056902, EBI-1055635;
CC       P15311; Q00987: MDM2; NbExp=3; IntAct=EBI-1056902, EBI-389668;
CC       P15311; Q8IVT2: MISP; NbExp=4; IntAct=EBI-1056902, EBI-2555085;
CC       P15311; P35241: RDX; NbExp=6; IntAct=EBI-1056902, EBI-2514878;
CC       P15311; Q8IZE3: SCYL3; NbExp=4; IntAct=EBI-1056902, EBI-1380680;
CC       P15311; P55011: SLC12A2; NbExp=3; IntAct=EBI-1056902, EBI-2801449;
CC       P15311; O14745: SLC9A3R1; NbExp=6; IntAct=EBI-1056902, EBI-349787;
CC   -!- SUBCELLULAR LOCATION: Apical cell membrane
CC       {ECO:0000269|PubMed:18046454}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:18046454}; Cytoplasmic side
CC       {ECO:0000269|PubMed:18046454}. Cell projection
CC       {ECO:0000269|PubMed:18046454}. Cell projection, microvillus membrane
CC       {ECO:0000269|PubMed:18046454}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:18046454}; Cytoplasmic side
CC       {ECO:0000269|PubMed:18046454}. Cell projection, ruffle membrane
CC       {ECO:0000269|PubMed:18046454}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:18046454}; Cytoplasmic side
CC       {ECO:0000269|PubMed:18046454}. Cytoplasm, cell cortex
CC       {ECO:0000269|PubMed:18046454}. Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:18046454}. Cell projection, microvillus
CC       {ECO:0000250|UniProtKB:P26040}. Note=Localization to the apical
CC       membrane of parietal cells depends on the interaction with MPP5.
CC       Localizes to cell extensions and peripheral processes of astrocytes (By
CC       similarity). Microvillar peripheral membrane protein (cytoplasmic
CC       side). {ECO:0000250|UniProtKB:P31977}.
CC   -!- TISSUE SPECIFICITY: Expressed in cerebral cortex, basal ganglia,
CC       hippocampus, hypophysis, and optic nerve. Weakly expressed in brain
CC       stem and diencephalon. Stronger expression was detected in gray matter
CC       of frontal lobe compared to white matter (at protein level). Component
CC       of the microvilli of intestinal epithelial cells. Preferentially
CC       expressed in astrocytes of hippocampus, frontal cortex, thalamus,
CC       parahippocampal cortex, amygdala, insula, and corpus callosum. Not
CC       detected in neurons in most tissues studied.
CC       {ECO:0000269|PubMed:15797715}.
CC   -!- DEVELOPMENTAL STAGE: Very strong staining is detected in the Purkinje
CC       cell layer and in part of the molecular layer of the infant brain
CC       compared to adult brain. {ECO:0000269|PubMed:15797715}.
CC   -!- DOMAIN: The [IL]-x-C-x-x-[DE] motif is a proposed target motif for
CC       cysteine S-nitrosylation mediated by the iNOS-S100A8/A9
CC       transnitrosylase complex. {ECO:0000305|PubMed:25417112}.
CC   -!- PTM: Phosphorylated by tyrosine-protein kinases. Phosphorylation by
CC       ROCK2 suppresses the head-to-tail association of the N-terminal and C-
CC       terminal halves resulting in an opened conformation which is capable of
CC       actin and membrane-binding (By similarity). {ECO:0000250}.
CC   -!- PTM: S-nitrosylation is induced by interferon-gamma and oxidatively-
CC       modified low-densitity lipoprotein (LDL(ox)) possibly implicating the
CC       iNOS-S100A8/9 transnitrosylase complex. {ECO:0000305|PubMed:25417112}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA61278.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=CAB82418.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X51521; CAA35893.1; -; mRNA.
DR   EMBL; J05021; AAA61278.1; ALT_INIT; mRNA.
DR   EMBL; AL162086; CAB82418.1; ALT_INIT; mRNA.
DR   EMBL; AL589931; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471051; EAW47647.1; -; Genomic_DNA.
DR   EMBL; BC013903; AAH13903.1; -; mRNA.
DR   CCDS; CCDS5258.1; -.
DR   PIR; A34400; A34400.
DR   RefSeq; NP_001104547.1; NM_001111077.1.
DR   RefSeq; NP_003370.2; NM_003379.4.
DR   PDB; 1NI2; X-ray; 2.30 A; A/B=2-297.
DR   PDB; 4RM8; X-ray; 1.90 A; A/B=1-586.
DR   PDB; 4RM9; X-ray; 2.00 A; A=1-586.
DR   PDB; 4RMA; X-ray; 1.75 A; A/B=1-296.
DR   PDBsum; 1NI2; -.
DR   PDBsum; 4RM8; -.
DR   PDBsum; 4RM9; -.
DR   PDBsum; 4RMA; -.
DR   SMR; P15311; -.
DR   BioGrid; 113271; 331.
DR   CORUM; P15311; -.
DR   DIP; DIP-38868N; -.
DR   ELM; P15311; -.
DR   IntAct; P15311; 224.
DR   MINT; P15311; -.
DR   STRING; 9606.ENSP00000356042; -.
DR   BindingDB; P15311; -.
DR   ChEMBL; CHEMBL1932896; -.
DR   iPTMnet; P15311; -.
DR   MetOSite; P15311; -.
DR   PhosphoSitePlus; P15311; -.
DR   SwissPalm; P15311; -.
DR   BioMuta; EZR; -.
DR   DMDM; 125987826; -.
DR   DOSAC-COBS-2DPAGE; P15311; -.
DR   REPRODUCTION-2DPAGE; IPI00843975; -.
DR   SWISS-2DPAGE; P15311; -.
DR   CPTAC; CPTAC-1398; -.
DR   CPTAC; CPTAC-1399; -.
DR   CPTAC; CPTAC-1400; -.
DR   CPTAC; CPTAC-1401; -.
DR   CPTAC; CPTAC-1402; -.
DR   CPTAC; CPTAC-712; -.
DR   EPD; P15311; -.
DR   jPOST; P15311; -.
DR   MassIVE; P15311; -.
DR   MaxQB; P15311; -.
DR   PaxDb; P15311; -.
DR   PeptideAtlas; P15311; -.
DR   PRIDE; P15311; -.
DR   ProteomicsDB; 53128; -.
DR   TopDownProteomics; P15311; -.
DR   ABCD; P15311; -.
DR   Antibodypedia; 3417; 1409 antibodies.
DR   DNASU; 7430; -.
DR   Ensembl; ENST00000337147; ENSP00000338934; ENSG00000092820.
DR   Ensembl; ENST00000367075; ENSP00000356042; ENSG00000092820.
DR   GeneID; 7430; -.
DR   KEGG; hsa:7430; -.
DR   UCSC; uc003qrt.5; human.
DR   CTD; 7430; -.
DR   DisGeNET; 7430; -.
DR   GeneCards; EZR; -.
DR   HGNC; HGNC:12691; EZR.
DR   HPA; ENSG00000092820; Low tissue specificity.
DR   MalaCards; EZR; -.
DR   MIM; 123900; gene.
DR   neXtProt; NX_P15311; -.
DR   OpenTargets; ENSG00000092820; -.
DR   Orphanet; 88616; Autosomal recessive non-syndromic intellectual disability.
DR   PharmGKB; PA162385512; -.
DR   eggNOG; KOG3529; Eukaryota.
DR   eggNOG; ENOG410XQFP; LUCA.
DR   GeneTree; ENSGT00960000186596; -.
DR   HOGENOM; CLU_003623_6_2_1; -.
DR   InParanoid; P15311; -.
DR   KO; K08007; -.
DR   OrthoDB; 627741at2759; -.
DR   PhylomeDB; P15311; -.
DR   TreeFam; TF313935; -.
DR   Reactome; R-HSA-373752; Netrin-1 signaling.
DR   Reactome; R-HSA-437239; Recycling pathway of L1.
DR   SIGNOR; P15311; -.
DR   ChiTaRS; EZR; human.
DR   EvolutionaryTrace; P15311; -.
DR   GeneWiki; Ezrin; -.
DR   GenomeRNAi; 7430; -.
DR   Pharos; P15311; Tbio.
DR   PRO; PR:P15311; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; P15311; protein.
DR   Bgee; ENSG00000092820; Expressed in nasal cavity epithelium and 233 other tissues.
DR   ExpressionAtlas; P15311; baseline and differential.
DR   Genevisible; P15311; HS.
DR   GO; GO:0015629; C:actin cytoskeleton; IDA:UniProtKB.
DR   GO; GO:0005884; C:actin filament; IDA:HGNC-UCL.
DR   GO; GO:0045177; C:apical part of cell; IDA:BHF-UCL.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0097449; C:astrocyte projection; IEA:Ensembl.
DR   GO; GO:0016323; C:basolateral plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005903; C:brush border; ISS:UniProtKB.
DR   GO; GO:0005623; C:cell; IEA:GOC.
DR   GO; GO:0044297; C:cell body; IEA:Ensembl.
DR   GO; GO:0071944; C:cell periphery; IDA:UniProtKB.
DR   GO; GO:0042995; C:cell projection; IDA:UniProtKB.
DR   GO; GO:0051286; C:cell tip; IEA:Ensembl.
DR   GO; GO:0036064; C:ciliary basal body; IEA:Ensembl.
DR   GO; GO:0030863; C:cortical cytoskeleton; TAS:HGNC-UCL.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0098592; C:cytoplasmic side of apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005768; C:endosome; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; HDA:UniProtKB.
DR   GO; GO:0019898; C:extrinsic component of membrane; IDA:UniProtKB.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0030175; C:filopodium; IDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0001772; C:immunological synapse; IDA:UniProtKB.
DR   GO; GO:0071437; C:invadopodium; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0044393; C:microspike; IEA:Ensembl.
DR   GO; GO:0005902; C:microvillus; IDA:BHF-UCL.
DR   GO; GO:0031528; C:microvillus membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0044853; C:plasma membrane raft; IDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:0001726; C:ruffle; IDA:UniProtKB.
DR   GO; GO:0032587; C:ruffle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0097454; C:Schwann cell microvillus; IEA:Ensembl.
DR   GO; GO:0030315; C:T-tubule; IEA:Ensembl.
DR   GO; GO:0001931; C:uropod; IEA:Ensembl.
DR   GO; GO:0031982; C:vesicle; HDA:UniProtKB.
DR   GO; GO:0003779; F:actin binding; IDA:UniProtKB.
DR   GO; GO:0051015; F:actin filament binding; IDA:UniProtKB.
DR   GO; GO:0051117; F:ATPase binding; IPI:UniProtKB.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0050839; F:cell adhesion molecule binding; IPI:BHF-UCL.
DR   GO; GO:0097718; F:disordered domain specific binding; IEA:Ensembl.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0008017; F:microtubule binding; IMP:UniProtKB.
DR   GO; GO:0008022; F:protein C-terminus binding; IEA:Ensembl.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:UniProtKB.
DR   GO; GO:0051018; F:protein kinase A binding; IPI:UniProtKB.
DR   GO; GO:0034236; F:protein kinase A catalytic subunit binding; IPI:UniProtKB.
DR   GO; GO:0034237; F:protein kinase A regulatory subunit binding; IPI:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0044548; F:S100 protein binding; IPI:UniProtKB.
DR   GO; GO:0031532; P:actin cytoskeleton reorganization; IMP:UniProtKB.
DR   GO; GO:0051017; P:actin filament bundle assembly; IDA:UniProtKB.
DR   GO; GO:0030953; P:astral microtubule organization; IMP:UniProtKB.
DR   GO; GO:0007411; P:axon guidance; TAS:Reactome.
DR   GO; GO:0034629; P:cellular protein-containing complex localization; IMP:UniProtKB.
DR   GO; GO:0071320; P:cellular response to cAMP; IMP:UniProtKB.
DR   GO; GO:0043622; P:cortical microtubule organization; IMP:UniProtKB.
DR   GO; GO:0007016; P:cytoskeletal anchoring at plasma membrane; NAS:UniProtKB.
DR   GO; GO:0051660; P:establishment of centrosome localization; IMP:UniProtKB.
DR   GO; GO:0061028; P:establishment of endothelial barrier; IGI:UniProtKB.
DR   GO; GO:0035088; P:establishment or maintenance of apical/basal cell polarity; IEA:Ensembl.
DR   GO; GO:0046847; P:filopodium assembly; IMP:UniProtKB.
DR   GO; GO:0001951; P:intestinal D-glucose absorption; IEA:Ensembl.
DR   GO; GO:0007159; P:leukocyte cell-cell adhesion; IEP:BHF-UCL.
DR   GO; GO:0022614; P:membrane to membrane docking; IEP:BHF-UCL.
DR   GO; GO:0030033; P:microvillus assembly; IMP:UniProtKB.
DR   GO; GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; IMP:UniProtKB.
DR   GO; GO:1900041; P:negative regulation of interleukin-2 secretion; IMP:UniProtKB.
DR   GO; GO:1903753; P:negative regulation of p38MAPK cascade; IMP:UniProtKB.
DR   GO; GO:0050860; P:negative regulation of T cell receptor signaling pathway; IMP:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IMP:UniProtKB.
DR   GO; GO:0048015; P:phosphatidylinositol-mediated signaling; IDA:UniProtKB.
DR   GO; GO:1903364; P:positive regulation of cellular protein catabolic process; IGI:UniProtKB.
DR   GO; GO:2000643; P:positive regulation of early endosome to late endosome transport; IMP:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; IGI:UniProtKB.
DR   GO; GO:0040018; P:positive regulation of multicellular organism growth; IEA:Ensembl.
DR   GO; GO:1902966; P:positive regulation of protein localization to early endosome; IGI:UniProtKB.
DR   GO; GO:1903078; P:positive regulation of protein localization to plasma membrane; IEA:Ensembl.
DR   GO; GO:0050714; P:positive regulation of protein secretion; IMP:UniProtKB.
DR   GO; GO:0010737; P:protein kinase A signaling; IMP:UniProtKB.
DR   GO; GO:0072697; P:protein localization to cell cortex; IMP:UniProtKB.
DR   GO; GO:0072659; P:protein localization to plasma membrane; IMP:UniProtKB.
DR   GO; GO:0031623; P:receptor internalization; IEA:Ensembl.
DR   GO; GO:0008360; P:regulation of cell shape; IMP:UniProtKB.
DR   GO; GO:0032532; P:regulation of microvillus length; IEA:Ensembl.
DR   GO; GO:1902115; P:regulation of organelle assembly; IMP:UniProtKB.
DR   GO; GO:0003376; P:sphingosine-1-phosphate receptor signaling pathway; IMP:UniProtKB.
DR   GO; GO:1902896; P:terminal web assembly; IEA:Ensembl.
DR   CDD; cd14473; FERM_B-lobe; 1.
DR   CDD; cd13194; FERM_C_ERM; 1.
DR   DisProt; DP00775; -.
DR   Gene3D; 1.20.80.10; -; 1.
DR   Gene3D; 1.25.40.1020; -; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   InterPro; IPR019749; Band_41_domain.
DR   InterPro; IPR011174; ERM.
DR   InterPro; IPR011259; ERM_C_dom.
DR   InterPro; IPR041789; ERM_FERM_C.
DR   InterPro; IPR000798; Ez/rad/moesin-like.
DR   InterPro; IPR014352; FERM/acyl-CoA-bd_prot_sf.
DR   InterPro; IPR035963; FERM_2.
DR   InterPro; IPR019748; FERM_central.
DR   InterPro; IPR019747; FERM_CS.
DR   InterPro; IPR000299; FERM_domain.
DR   InterPro; IPR018979; FERM_N.
DR   InterPro; IPR018980; FERM_PH-like_C.
DR   InterPro; IPR008954; Moesin_tail_sf.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   Pfam; PF00769; ERM; 1.
DR   Pfam; PF09380; FERM_C; 1.
DR   Pfam; PF00373; FERM_M; 1.
DR   Pfam; PF09379; FERM_N; 1.
DR   PIRSF; PIRSF002305; ERM; 1.
DR   PRINTS; PR00935; BAND41.
DR   PRINTS; PR00661; ERMFAMILY.
DR   SMART; SM00295; B41; 1.
DR   SMART; SM01196; FERM_C; 1.
DR   SUPFAM; SSF47031; SSF47031; 1.
DR   SUPFAM; SSF48678; SSF48678; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   PROSITE; PS00660; FERM_1; 1.
DR   PROSITE; PS00661; FERM_2; 1.
DR   PROSITE; PS50057; FERM_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cell membrane; Cell projection; Cell shape;
KW   Cytoplasm; Cytoskeleton; Direct protein sequencing; Membrane;
KW   Phosphoprotein; Polymorphism; Reference proteome; S-nitrosylation.
FT   CHAIN           1..586
FT                   /note="Ezrin"
FT                   /id="PRO_0000219408"
FT   DOMAIN          2..295
FT                   /note="FERM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00084"
FT   REGION          244..586
FT                   /note="Interaction with SCYL3"
FT                   /evidence="ECO:0000269|PubMed:12651155"
FT   MOTIF           115..120
FT                   /note="[IL]-x-C-x-x-[DE] motif"
FT                   /evidence="ECO:0000305|PubMed:25417112"
FT   MOD_RES         60
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         146
FT                   /note="Phosphotyrosine; by PDGFR"
FT                   /evidence="ECO:0000269|PubMed:1382070,
FT                   ECO:0000269|PubMed:18046454"
FT   MOD_RES         354
FT                   /note="Phosphotyrosine; by PDGFR"
FT                   /evidence="ECO:0000269|PubMed:1382070"
FT   MOD_RES         366
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         478
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000269|PubMed:18046454"
FT   MOD_RES         535
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P26040"
FT   MOD_RES         567
FT                   /note="Phosphothreonine; by ROCK2 and PKC/PRKCI"
FT                   /evidence="ECO:0000305|PubMed:18270268"
FT   VARIANT         180
FT                   /note="R -> C (in dbSNP:rs3103004)"
FT                   /id="VAR_030572"
FT   VARIANT         494
FT                   /note="A -> P (in dbSNP:rs2230143)"
FT                   /id="VAR_030573"
FT   VARIANT         532
FT                   /note="L -> V"
FT                   /evidence="ECO:0000269|PubMed:2591371,
FT                   ECO:0000269|PubMed:2674140"
FT                   /id="VAR_015112"
FT   STRAND          5..10
FT                   /evidence="ECO:0000244|PDB:4RMA"
FT   STRAND          15..20
FT                   /evidence="ECO:0000244|PDB:4RMA"
FT   HELIX           26..37
FT                   /evidence="ECO:0000244|PDB:4RMA"
FT   HELIX           42..44
FT                   /evidence="ECO:0000244|PDB:4RMA"
FT   STRAND          45..51
FT                   /evidence="ECO:0000244|PDB:4RMA"
FT   STRAND          56..58
FT                   /evidence="ECO:0000244|PDB:4RMA"
FT   STRAND          61..64
FT                   /evidence="ECO:0000244|PDB:4RM8"
FT   HELIX           65..67
FT                   /evidence="ECO:0000244|PDB:4RMA"
FT   STRAND          74..84
FT                   /evidence="ECO:0000244|PDB:4RMA"
FT   HELIX           89..92
FT                   /evidence="ECO:0000244|PDB:4RMA"
FT   HELIX           96..111
FT                   /evidence="ECO:0000244|PDB:4RMA"
FT   HELIX           119..134
FT                   /evidence="ECO:0000244|PDB:4RMA"
FT   TURN            139..141
FT                   /evidence="ECO:0000244|PDB:4RMA"
FT   TURN            144..149
FT                   /evidence="ECO:0000244|PDB:4RMA"
FT   HELIX           155..159
FT                   /evidence="ECO:0000244|PDB:4RMA"
FT   HELIX           165..178
FT                   /evidence="ECO:0000244|PDB:4RMA"
FT   TURN            179..181
FT                   /evidence="ECO:0000244|PDB:4RMA"
FT   HELIX           184..196
FT                   /evidence="ECO:0000244|PDB:4RMA"
FT   TURN            199..202
FT                   /evidence="ECO:0000244|PDB:4RMA"
FT   STRAND          204..210
FT                   /evidence="ECO:0000244|PDB:4RMA"
FT   STRAND          215..221
FT                   /evidence="ECO:0000244|PDB:4RMA"
FT   STRAND          224..229
FT                   /evidence="ECO:0000244|PDB:4RMA"
FT   STRAND          233..235
FT                   /evidence="ECO:0000244|PDB:4RMA"
FT   STRAND          237..241
FT                   /evidence="ECO:0000244|PDB:4RMA"
FT   HELIX           242..244
FT                   /evidence="ECO:0000244|PDB:4RMA"
FT   STRAND          245..251
FT                   /evidence="ECO:0000244|PDB:4RMA"
FT   STRAND          254..261
FT                   /evidence="ECO:0000244|PDB:4RMA"
FT   STRAND          267..270
FT                   /evidence="ECO:0000244|PDB:4RMA"
FT   HELIX           274..295
FT                   /evidence="ECO:0000244|PDB:4RMA"
FT   HELIX           520..523
FT                   /evidence="ECO:0000244|PDB:4RM8"
FT   HELIX           525..539
FT                   /evidence="ECO:0000244|PDB:4RM8"
FT   HELIX           544..546
FT                   /evidence="ECO:0000244|PDB:4RM8"
FT   HELIX           549..559
FT                   /evidence="ECO:0000244|PDB:4RM8"
FT   HELIX           564..571
FT                   /evidence="ECO:0000244|PDB:4RM8"
FT   HELIX           576..585
FT                   /evidence="ECO:0000244|PDB:4RM8"
SQ   SEQUENCE   586 AA;  69413 MW;  F1B592CF49A7CC46 CRC64;
     MPKPINVRVT TMDAELEFAI QPNTTGKQLF DQVVKTIGLR EVWYFGLHYV DNKGFPTWLK
     LDKKVSAQEV RKENPLQFKF RAKFYPEDVA EELIQDITQK LFFLQVKEGI LSDEIYCPPE
     TAVLLGSYAV QAKFGDYNKE VHKSGYLSSE RLIPQRVMDQ HKLTRDQWED RIQVWHAEHR
     GMLKDNAMLE YLKIAQDLEM YGINYFEIKN KKGTDLWLGV DALGLNIYEK DDKLTPKIGF
     PWSEIRNISF NDKKFVIKPI DKKAPDFVFY APRLRINKRI LQLCMGNHEL YMRRRKPDTI
     EVQQMKAQAR EEKHQKQLER QQLETEKKRR ETVEREKEQM MREKEELMLR LQDYEEKTKK
     AERELSEQIQ RALQLEEERK RAQEEAERLE ADRMAALRAK EELERQAVDQ IKSQEQLAAE
     LAEYTAKIAL LEEARRRKED EVEEWQHRAK EAQDDLVKTK EELHLVMTAP PPPPPPVYEP
     VSYHVQESLQ DEGAEPTGYS AELSSEGIRD DRNEEKRITE AEKNERVQRQ LLTLSSELSQ
     ARDENKRTHN DIIHNENMRQ GRDKYKTLRQ IRQGNTKQRI DEFEAL
//
ID   A0A087WV25_HUMAN        Unreviewed;       351 AA.
AC   A0A087WV25;
DT   29-OCT-2014, integrated into UniProtKB/TrEMBL.
DT   29-OCT-2014, sequence version 1.
DT   22-APR-2020, entry version 32.
DE   SubName: Full=FGFR1 oncogene partner {ECO:0000313|Ensembl:ENSP00000479115};
GN   Name=FGFR1OP {ECO:0000313|Ensembl:ENSP00000479115};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000479115, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000479115, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [2] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [3] {ECO:0000213|PubMed:19413330}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [4] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Burckstummer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [5] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [6] {ECO:0000313|Ensembl:ENSP00000479115}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2014) to UniProtKB.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z94721; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001265619.1; NM_001278690.1.
DR   EPD; A0A087WV25; -.
DR   jPOST; A0A087WV25; -.
DR   PeptideAtlas; A0A087WV25; -.
DR   PRIDE; A0A087WV25; -.
DR   Antibodypedia; 33532; 271 antibodies.
DR   Ensembl; ENST00000622353; ENSP00000479115; ENSG00000213066.
DR   GeneID; 11116; -.
DR   UCSC; uc011egp.2; human.
DR   CTD; 11116; -.
DR   EuPathDB; HostDB:ENSG00000213066.11; -.
DR   HGNC; HGNC:17012; FGFR1OP.
DR   OpenTargets; ENSG00000213066; -.
DR   GeneTree; ENSGT00390000007441; -.
DR   ChiTaRS; FGFR1OP; human.
DR   GenomeRNAi; 11116; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000213066; Expressed in amniotic fluid and 219 other tissues.
DR   ExpressionAtlas; A0A087WV25; baseline and differential.
DR   GO; GO:0005813; C:centrosome; IDA:HPA.
DR   GO; GO:0034453; P:microtubule anchoring; IEA:InterPro.
DR   InterPro; IPR018993; FOP_dimerisation-dom_N.
DR   InterPro; IPR006594; LisH.
DR   Pfam; PF09398; FOP_dimer; 1.
DR   PROSITE; PS50896; LISH; 1.
PE   1: Evidence at protein level;
KW   Proteomics identification {ECO:0000213|EPD:A0A087WV25,
KW   ECO:0000213|MaxQB:A0A087WV25, ECO:0000213|PeptideAtlas:A0A087WV25,
KW   ECO:0000213|ProteomicsDB:A0A087WV25};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN          70..102
FT                   /note="LisH"
FT                   /evidence="ECO:0000259|PROSITE:PS50896"
FT   REGION          139..170
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          190..260
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        147..170
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        208..225
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   351 AA;  38100 MW;  E9CCF927D382B728 CRC64;
     MAATAAAVVA EEDTELRDLL VQTLENSGVL NRIKAELRAA VFLALEEQEK VENKTPLVNE
     SLKKFLNTKD GRLVASLVAE FLQFFNLDFT LAVFQPETST LQGLEGRENL ARDLGIIEAE
     GTVGGPLLLE VIRRCQQKEK GPTTGEKAND EANQSDTSVS LSEPKSKSSL HLLSHETKIG
     SFLSNRTLDG KDKAGLCPDE DDMEGDSFFD DPIPKPEKTY GLRKEPRKQA GSLASLSDAP
     PLKSGLSSLA GAPSLKDSES KRGNTVLKDL KLISDKIGSL GLGTGEDDDY VDDFNSTSHR
     SEKSEISIGE EIEEDLSVEI DDINTSDKTI TQLECLLSIG ALHFKNTADI F
//
ID   B4DH64_HUMAN            Unreviewed;       365 AA.
AC   B4DH64;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   22-APR-2020, entry version 45.
DE   SubName: Full=cDNA FLJ52986, highly similar to FGFR1 oncogene partner {ECO:0000313|EMBL:BAG58025.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG58025.1};
RN   [1] {ECO:0000313|EMBL:BAG58025.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAG58025.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK294950; BAG58025.1; -; mRNA.
DR   RefSeq; NP_001265619.1; NM_001278690.1.
DR   MaxQB; B4DH64; -.
DR   PeptideAtlas; B4DH64; -.
DR   PRIDE; B4DH64; -.
DR   GeneID; 11116; -.
DR   CTD; 11116; -.
DR   GenomeRNAi; 11116; -.
DR   GO; GO:0005815; C:microtubule organizing center; IEA:InterPro.
DR   GO; GO:0034453; P:microtubule anchoring; IEA:InterPro.
DR   InterPro; IPR018993; FOP_dimerisation-dom_N.
DR   InterPro; IPR006594; LisH.
DR   Pfam; PF09398; FOP_dimer; 1.
DR   PROSITE; PS50896; LISH; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN          70..102
FT                   /note="LisH"
FT                   /evidence="ECO:0000259|PROSITE:PS50896"
FT   REGION          139..170
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          190..260
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        147..170
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        208..225
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   365 AA;  39745 MW;  F739AF6C61913B7D CRC64;
     MAATAAAVVA EEDTELRDLL VQTLENSGVL NRIKAELRAA VFLPLEEQEK VENKTPLVNE
     SLKKFLNTKD GRLVASLVAE FLQFFNLDFT LAVFQPETST LQGLEGRENL ARDLGIIEAE
     GTVGGPLLLE VIRRCQQKEK GPTTGEKAND EANQSDTSVS LSEPKSKSSL HLLSHETKIG
     SFLSNRTLDG KDKAGLCPDE DDMEGDSFFD DPIPKPEKTY GLRKEPRKQA GSLASLSDAP
     PLKSGLSSLA GAPSLKDSES KRGNTVLKDL KLISDKIGSL GLGTGEDDDY VDDFNSTSHR
     SEKSEISIGE EIEEDLSVEI DDINTSDKTI TQLECLLSIG ALHFKNTADI FLKVIFILLN
     KILPI
//
ID   FR1OP_HUMAN             Reviewed;         399 AA.
AC   O95684; A8K1D1; B2R705; Q49AI0; Q5R3F6; Q96EW1;
DT   02-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   22-APR-2020, entry version 155.
DE   RecName: Full=FGFR1 oncogene partner;
GN   Name=FGFR1OP; Synonyms=FOP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), CHROMOSOMAL TRANSLOCATION WITH
RP   FGFR1, ALTERNATIVE SPLICING, AND TISSUE SPECIFICITY.
RX   PubMed=9949182;
RA   Popovici C., Zhang B., Gregoire M.-J., Jonveaux P., Lafage-Pochitaloff M.,
RA   Birnbaum D., Pebusque M.-J.;
RT   "The t(6;8)(q27;p11) translocation in a stem cell myeloproliferative
RT   disorder fuses a novel gene, FOP, to fibroblast growth factor receptor 1.";
RL   Blood 93:1381-1389(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3), AND VARIANT
RP   ASN-271.
RC   TISSUE=Brain, and Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND SUBCELLULAR LOCATION [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.;
RT   "Proteomic characterization of the human centrosome by protein correlation
RT   profiling.";
RL   Nature 426:570-574(2003).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-156 AND SER-160, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=15144186; DOI=10.1021/ac035352d;
RA   Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,
RA   Peters E.C.;
RT   "Robust phosphoproteomic profiling of tyrosine phosphorylation sites from
RT   human T cells using immobilized metal affinity chromatography and tandem
RT   mass spectrometry.";
RL   Anal. Chem. 76:2763-2772(2004).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH MAPRE1 AND CEP350.
RX   PubMed=16314388; DOI=10.1091/mbc.e05-08-0810;
RA   Yan X., Habedanck R., Nigg E.A.;
RT   "A complex of two centrosomal proteins, CAP350 and FOP, cooperates with EB1
RT   in microtubule anchoring.";
RL   Mol. Biol. Cell 17:634-644(2006).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-156; SER-160 AND SER-202, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-156 AND SER-160, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-152, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-152; SER-156; SER-160;
RP   THR-170; SER-202; THR-234; SER-301 AND SER-326, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-143 AND SER-160, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   FUNCTION, INTERACTION WITH CEP19 AND CEP350, SUBCELLULAR LOCATION, AND
RP   PHYLOGENETIC ANALYSIS.
RX   PubMed=28625565; DOI=10.1016/j.devcel.2017.05.016;
RA   Kanie T., Abbott K.L., Mooney N.A., Plowey E.D., Demeter J., Jackson P.K.;
RT   "The CEP19-RABL2 GTPase complex binds IFT-B to initiate intraflagellar
RT   transport at the ciliary base.";
RL   Dev. Cell 42:1-15(2017).
RN   [18]
RP   INTERACTION WITH CEP19 AND CEP350, AND SUBCELLULAR LOCATION.
RX   PubMed=28428259; DOI=10.1091/mbc.e17-01-0017;
RA   Nishijima Y., Hagiya Y., Kubo T., Takei R., Katoh Y., Nakayama K.;
RT   "RABL2 interacts with the intraflagellar transport-B complex and CEP19 and
RT   participates in ciliary assembly.";
RL   Mol. Biol. Cell 28:1652-1666(2017).
RN   [19]
RP   FUNCTION, INTERACTION WITH CEP19, AND SUBCELLULAR LOCATION.
RX   PubMed=28659385; DOI=10.1098/rsob.170114;
RA   Mojarad B.A., Gupta G.D., Hasegan M., Goudiam O., Basto R., Gingras A.C.,
RA   Pelletier L.;
RT   "CEP19 cooperates with FOP and CEP350 to drive early steps in the
RT   ciliogenesis programme.";
RL   Open Biol. 7:0-0(2017).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 54-134, MUTAGENESIS OF VAL-74,
RP   SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=16690081; DOI=10.1016/j.jmb.2006.03.070;
RA   Mikolajka A., Yan X., Popowicz G.M., Smialowski P., Nigg E.A., Holak T.A.;
RT   "Structure of the N-terminal domain of the FOP (FGFR1OP) protein and
RT   implications for its dimerization and centrosomal localization.";
RL   J. Mol. Biol. 359:863-875(2006).
CC   -!- FUNCTION: Required for anchoring microtubules to the centrosomes
CC       (PubMed:16314388, PubMed:28659385). Required for ciliation
CC       (PubMed:28625565, PubMed:28659385). {ECO:0000269|PubMed:16314388,
CC       ECO:0000269|PubMed:28625565, ECO:0000269|PubMed:28659385}.
CC   -!- SUBUNIT: Homodimer (PubMed:16690081). Part of a ternary complex that
CC       contains CEP350, FGFR1OP and MAPRE1. Interacts directly with CEP350 and
CC       MAPRE1 (PubMed:16314388). Interacts with CEP19 (PubMed:28625565,
CC       PubMed:28428259, PubMed:28659385). Interacts (via N-terminus) with
CC       CEP350 (via C-terminus) (PubMed:28625565, PubMed:28428259).
CC       {ECO:0000269|PubMed:16314388, ECO:0000269|PubMed:16690081,
CC       ECO:0000269|PubMed:28428259, ECO:0000269|PubMed:28625565,
CC       ECO:0000269|PubMed:28659385}.
CC   -!- INTERACTION:
CC       O95684; Q96LK0: CEP19; NbExp=6; IntAct=EBI-1266334, EBI-741885;
CC       O95684-2; Q96LK0: CEP19; NbExp=7; IntAct=EBI-1266347, EBI-741885;
CC       O95684; P50552: VASP; NbExp=3; IntAct=EBI-1266334, EBI-748201;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule organizing
CC       center, centrosome {ECO:0000269|PubMed:14654843,
CC       ECO:0000269|PubMed:16314388, ECO:0000269|PubMed:16690081,
CC       ECO:0000269|PubMed:28659385}. Cytoplasm, cytoskeleton, microtubule
CC       organizing center, centrosome, centriole {ECO:0000269|PubMed:28428259,
CC       ECO:0000269|PubMed:28625565, ECO:0000269|PubMed:28659385}. Cytoplasm,
CC       cytoskeleton, cilium basal body {ECO:0000269|PubMed:28659385}.
CC       Note=Associated with gamma-tubulin (PubMed:16314388). Localizes on both
CC       mother and daughter centrioles (PubMed:28625565, PubMed:28428259).
CC       Localizes to an axial position on the mother centriole
CC       (PubMed:28625565). Localizes to the distal end of the centriole partly
CC       on the subdistal appendage region (PubMed:28659385).
CC       {ECO:0000269|PubMed:16314388, ECO:0000269|PubMed:28428259,
CC       ECO:0000269|PubMed:28625565, ECO:0000269|PubMed:28659385}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=O95684-1; Sequence=Displayed;
CC       Name=2; Synonyms=B;
CC         IsoId=O95684-2; Sequence=VSP_018120;
CC       Name=3;
CC         IsoId=O95684-3; Sequence=VSP_018119, VSP_018121;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Highly expressed in heart, liver,
CC       muscle, kidney, intestine, colon, adrenal gland, prostate, testis, and
CC       pancreas. {ECO:0000269|PubMed:9949182}.
CC   -!- DISEASE: Note=A chromosomal aberration involving FGFR1OP may be a cause
CC       of stem cell myeloproliferative disorder (MPD). Translocation
CC       t(6;8)(q27;p11) with FGFR1. MPD is characterized by myeloid
CC       hyperplasia, eosinophilia and T-cell or B-cell lymphoblastic lymphoma.
CC       In general it progresses to acute myeloid leukemia. The fusion proteins
CC       FGFR1OP-FGFR1 or FGFR1-FGFR1OP may exhibit constitutive kinase activity
CC       and be responsible for the transforming activity (PubMed:9949182).
CC       {ECO:0000269|PubMed:9949182}.
CC   -!- SIMILARITY: Belongs to the FGFR1OP family. {ECO:0000305}.
CC   -!- CAUTION: Interacting region of CEP19 is conflicting: According to a
CC       report, interacts via N-terminus (PubMed:28428259). According to
CC       another report, interacts via C-terminus (PubMed:28659385).
CC       {ECO:0000269|PubMed:28428259, ECO:0000269|PubMed:28659385}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/FOPID140.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Y18046; CAA77020.1; -; mRNA.
DR   EMBL; AK289846; BAF82535.1; -; mRNA.
DR   EMBL; AK312791; BAG35652.1; -; mRNA.
DR   EMBL; Z94721; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471051; EAW47509.1; -; Genomic_DNA.
DR   EMBL; CH471051; EAW47510.1; -; Genomic_DNA.
DR   EMBL; BC011902; AAH11902.1; -; mRNA.
DR   EMBL; BC037785; AAH37785.1; -; mRNA.
DR   CCDS; CCDS5296.1; -. [O95684-1]
DR   CCDS; CCDS5297.1; -. [O95684-2]
DR   RefSeq; NP_008976.1; NM_007045.3. [O95684-1]
DR   RefSeq; NP_919410.1; NM_194429.2. [O95684-2]
DR   PDB; 2D68; X-ray; 1.60 A; A/B=54-134.
DR   PDBsum; 2D68; -.
DR   SMR; O95684; -.
DR   BioGrid; 116291; 167.
DR   IntAct; O95684; 149.
DR   MINT; O95684; -.
DR   STRING; 9606.ENSP00000355812; -.
DR   iPTMnet; O95684; -.
DR   PhosphoSitePlus; O95684; -.
DR   BioMuta; FGFR1OP; -.
DR   EPD; O95684; -.
DR   jPOST; O95684; -.
DR   MassIVE; O95684; -.
DR   MaxQB; O95684; -.
DR   PaxDb; O95684; -.
DR   PeptideAtlas; O95684; -.
DR   PRIDE; O95684; -.
DR   ProteomicsDB; 50996; -. [O95684-1]
DR   ProteomicsDB; 50997; -. [O95684-2]
DR   ProteomicsDB; 50998; -. [O95684-3]
DR   Antibodypedia; 33532; 271 antibodies.
DR   DNASU; 11116; -.
DR   Ensembl; ENST00000349556; ENSP00000230248; ENSG00000213066. [O95684-2]
DR   Ensembl; ENST00000366847; ENSP00000355812; ENSG00000213066. [O95684-1]
DR   GeneID; 11116; -.
DR   KEGG; hsa:11116; -.
DR   UCSC; uc003qvj.5; human. [O95684-1]
DR   CTD; 11116; -.
DR   DisGeNET; 11116; -.
DR   GeneCards; FGFR1OP; -.
DR   HGNC; HGNC:17012; FGFR1OP.
DR   HPA; ENSG00000213066; Tissue enhanced (testis).
DR   MIM; 605392; gene.
DR   neXtProt; NX_O95684; -.
DR   OpenTargets; ENSG00000213066; -.
DR   PharmGKB; PA134941638; -.
DR   eggNOG; ENOG410IH12; Eukaryota.
DR   eggNOG; ENOG4111J6Y; LUCA.
DR   GeneTree; ENSGT00390000007441; -.
DR   HOGENOM; CLU_039837_2_0_1; -.
DR   InParanoid; O95684; -.
DR   KO; K16546; -.
DR   OMA; DITQDHT; -.
DR   OrthoDB; 1316797at2759; -.
DR   PhylomeDB; O95684; -.
DR   TreeFam; TF331893; -.
DR   Reactome; R-HSA-1839117; Signaling by cytosolic FGFR1 fusion mutants.
DR   Reactome; R-HSA-2565942; Regulation of PLK1 Activity at G2/M Transition.
DR   Reactome; R-HSA-380259; Loss of Nlp from mitotic centrosomes.
DR   Reactome; R-HSA-380270; Recruitment of mitotic centrosome proteins and complexes.
DR   Reactome; R-HSA-380284; Loss of proteins required for interphase microtubule organization from the centrosome.
DR   Reactome; R-HSA-380320; Recruitment of NuMA to mitotic centrosomes.
DR   Reactome; R-HSA-5620912; Anchoring of the basal body to the plasma membrane.
DR   Reactome; R-HSA-5655302; Signaling by FGFR1 in disease.
DR   Reactome; R-HSA-8854518; AURKA Activation by TPX2.
DR   SIGNOR; O95684; -.
DR   ChiTaRS; FGFR1OP; human.
DR   EvolutionaryTrace; O95684; -.
DR   GeneWiki; FGFR1OP; -.
DR   GenomeRNAi; 11116; -.
DR   Pharos; O95684; Tbio.
DR   PRO; PR:O95684; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; O95684; protein.
DR   Bgee; ENSG00000213066; Expressed in amniotic fluid and 219 other tissues.
DR   ExpressionAtlas; O95684; baseline and differential.
DR   Genevisible; O95684; HS.
DR   GO; GO:0042995; C:cell projection; IEA:UniProtKB-KW.
DR   GO; GO:0005814; C:centriole; IDA:CACAO.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0030292; F:protein tyrosine kinase inhibitor activity; IDA:UniProtKB.
DR   GO; GO:0097711; P:ciliary basal body-plasma membrane docking; TAS:Reactome.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0034453; P:microtubule anchoring; IEA:InterPro.
DR   GO; GO:0006469; P:negative regulation of protein kinase activity; IDA:UniProtKB.
DR   GO; GO:0030307; P:positive regulation of cell growth; IDA:UniProtKB.
DR   GO; GO:0030335; P:positive regulation of cell migration; IDA:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IDA:UniProtKB.
DR   GO; GO:0010389; P:regulation of G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   InterPro; IPR018993; FOP_dimerisation-dom_N.
DR   InterPro; IPR006594; LisH.
DR   Pfam; PF09398; FOP_dimer; 1.
DR   PROSITE; PS50896; LISH; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell projection;
KW   Chromosomal rearrangement; Cilium biogenesis/degradation; Cytoplasm;
KW   Cytoskeleton; Phosphoprotein; Polymorphism; Reference proteome.
FT   CHAIN           1..399
FT                   /note="FGFR1 oncogene partner"
FT                   /id="PRO_0000233293"
FT   DOMAIN          70..102
FT                   /note="LisH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00126"
FT   SITE            173..174
FT                   /note="Breakpoint for translocation to form FGFR1OP-FGFR1
FT                   or FGFR1-FGFR1OP fusion proteins"
FT   MOD_RES         143
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         152
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         156
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:15144186,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         160
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:15144186,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         170
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         202
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         234
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         301
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         326
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         337
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q66JX5"
FT   VAR_SEQ         1..249
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_018119"
FT   VAR_SEQ         174..193
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_018120"
FT   VAR_SEQ         376..399
FT                   /note="LDDLTQDLTVSQLSDVADYLEDVA -> TITQLECLLSIGALHFKNTADIF
FT                   (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_018121"
FT   VARIANT         190
FT                   /note="A -> G (in dbSNP:rs34617108)"
FT                   /id="VAR_061651"
FT   VARIANT         271
FT                   /note="K -> N (in dbSNP:rs17856382)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_051000"
FT   MUTAGEN         74
FT                   /note="V->F: Abolishes homodimerization and leads to
FT                   aggregation."
FT                   /evidence="ECO:0000269|PubMed:16690081"
FT   CONFLICT        63
FT                   /note="K -> R (in Ref. 5; AAH11902)"
FT                   /evidence="ECO:0000305"
FT   HELIX           60..66
FT                   /evidence="ECO:0000244|PDB:2D68"
FT   HELIX           69..84
FT                   /evidence="ECO:0000244|PDB:2D68"
FT   HELIX           88..98
FT                   /evidence="ECO:0000244|PDB:2D68"
FT   HELIX           107..113
FT                   /evidence="ECO:0000244|PDB:2D68"
FT   TURN            120..124
FT                   /evidence="ECO:0000244|PDB:2D68"
FT   HELIX           127..134
FT                   /evidence="ECO:0000244|PDB:2D68"
SQ   SEQUENCE   399 AA;  43065 MW;  7A4B65F627B9D272 CRC64;
     MAATAAAVVA EEDTELRDLL VQTLENSGVL NRIKAELRAA VFLALEEQEK VENKTPLVNE
     SLKKFLNTKD GRLVASLVAE FLQFFNLDFT LAVFQPETST LQGLEGRENL ARDLGIIEAE
     GTVGGPLLLE VIRRCQQKEK GPTTGEGALD LSDVHSPPKS PEGKTSAQTT PSKIPRYKGQ
     GKKKTSGQKA GDKKANDEAN QSDTSVSLSE PKSKSSLHLL SHETKIGSFL SNRTLDGKDK
     AGLCPDEDDM EGDSFFDDPI PKPEKTYGLR KEPRKQAGSL ASLSDAPPLK SGLSSLAGAP
     SLKDSESKRG NTVLKDLKLI SDKIGSLGLG TGEDDDYVDD FNSTSHRSEK SEISIGEEIE
     EDLSVEIDDI NTSDKLDDLT QDLTVSQLSD VADYLEDVA
//
ID   FIP1_HUMAN              Reviewed;         594 AA.
AC   Q6UN15; B4DIR3; G3XAD6; Q0VGE0; Q499Y4; Q49AU3; Q7Z608; Q8WVN3; Q96F80;
AC   Q9H077;
DT   20-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   22-APR-2020, entry version 150.
DE   RecName: Full=Pre-mRNA 3'-end-processing factor FIP1;
DE            Short=hFip1;
DE   AltName: Full=FIP1-like 1 protein;
DE   AltName: Full=Factor interacting with PAP;
DE   AltName: Full=Rearranged in hypereosinophilia;
GN   Name=FIP1L1; Synonyms=FIP1, RHE;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION IN PRE-MRNA 3'-END
RP   PROCESSING, IDENTIFICATION IN THE CPSF COMPLEX, IDENTIFICATION IN A COMPLEX
RP   WITH CPSF1 AND PAPOLA, INTERACTION WITH CPSF1; CPSF4; CSTF2; CSTF3 AND
RP   PAPOLA, RNA-BINDING, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Testis;
RX   PubMed=14749727; DOI=10.1038/sj.emboj.7600070;
RA   Kaufmann I., Martin G., Friedlein A., Langen H., Keller W.;
RT   "Human Fip1 is a subunit of CPSF that binds to U-rich RNA elements and
RT   stimulates poly(A) polymerase.";
RL   EMBO J. 23:616-626(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Uterus;
RX   PubMed=11230166; DOI=10.1101/gr.gr1547r;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H., Lauber J.,
RA   Duesterhoeft A., Beyer A., Koehrer K., Strack N., Mewes H.-W.,
RA   Ottenwaelder B., Obermaier B., Tampe J., Heubner D., Wambutt R., Korn B.,
RA   Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and analysis of
RT   500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RC   TISSUE=Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4).
RC   TISSUE=Brain, Eye, Placenta, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-339, DISEASE, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY OF THE FIP1L1-PDGFRA FUSION PROTEIN.
RC   TISSUE=Eosinophil;
RX   PubMed=12808148; DOI=10.1073/pnas.0932698100;
RA   Griffin J.H., Leung J., Bruner R.J., Caligiuri M.A., Briesewitz R.;
RT   "Discovery of a fusion kinase in EOL-1 cells and idiopathic
RT   hypereosinophilic syndrome.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:7830-7835(2003).
RN   [8]
RP   RNA-BINDING.
RX   PubMed=15767428; DOI=10.1128/jvi.79.7.4270-4288.2005;
RA   Zhao X., Oeberg D., Rush M., Fay J., Lambkin H., Schwartz S.;
RT   "A 57-nucleotide upstream early polyadenylation element in human
RT   papillomavirus type 16 interacts with hFip1, CstF-64, hnRNP C1/C2, and
RT   polypyrimidine tract binding protein.";
RL   J. Virol. 79:4270-4288(2005).
RN   [9]
RP   DISEASE.
RX   PubMed=12660384; DOI=10.1056/nejmoa025217;
RA   Cools J., DeAngelo D.J., Gotlib J., Stover E.H., Legare R.D., Cortes J.,
RA   Kutok J., Clark J., Galinsky I., Griffin J.D., Cross N.C., Tefferi A.,
RA   Malone J., Alam R., Schrier S.L., Schmid J., Rose M., Vandenberghe P.,
RA   Verhoef G., Boogaerts M., Wlodarska I., Kantarjian H., Marynen P.,
RA   Coutre S.E., Stone R., Gilliland D.G.;
RT   "A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a
RT   therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.";
RL   N. Engl. J. Med. 348:1201-1214(2003).
RN   [10]
RP   INTERACTION WITH NUDT21/CPSF5.
RX   PubMed=15937220; DOI=10.1101/gad.1298605;
RA   Venkataraman K., Brown K.M., Gilmartin G.M.;
RT   "Analysis of a noncanonical poly(A) site reveals a tripartite mechanism for
RT   vertebrate poly(A) site recognition.";
RL   Genes Dev. 19:1315-1327(2005).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-426, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-500, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-492; SER-496 AND SER-500, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-554, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by enrichment
RT   and fractionation of phosphopeptides with strong anion exchange
RT   chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [17]
RP   INTERACTION WITH AHCYL1 AND PAPOLA.
RX   PubMed=19224921; DOI=10.1074/jbc.m807136200;
RA   Kiefer H., Mizutani A., Iemura S., Natsume T., Ando H., Kuroda Y.,
RA   Mikoshiba K.;
RT   "Inositol 1,4,5-triphosphate receptor-binding protein released with
RT   inositol 1,4,5-triphosphate (IRBIT) associates with components of the mRNA
RT   3' processing machinery in a phosphorylation-dependent manner and inhibits
RT   polyadenylation.";
RL   J. Biol. Chem. 284:10694-10705(2009).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-492; THR-494; SER-496 AND
RP   SER-500, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-492 AND SER-554, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-492 AND SER-496, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-492 AND SER-500, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-500 AND SER-554, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [23]
RP   INTERACTION WITH CPSF6 AND CPSF7, AND DOMAIN.
RX   PubMed=29276085; DOI=10.1016/j.molcel.2017.11.031;
RA   Zhu Y., Wang X., Forouzmand E., Jeong J., Qiao F., Sowd G.A.,
RA   Engelman A.N., Xie X., Hertel K.J., Shi Y.;
RT   "Molecular mechanisms for CFIm-mediated regulation of mRNA alternative
RT   polyadenylation.";
RL   Mol. Cell 69:62-74(2018).
CC   -!- FUNCTION: Component of the cleavage and polyadenylation specificity
CC       factor (CPSF) complex that plays a key role in pre-mRNA 3'-end
CC       formation, recognizing the AAUAAA signal sequence and interacting with
CC       poly(A) polymerase and other factors to bring about cleavage and
CC       poly(A) addition. FIP1L1 contributes to poly(A) site recognition and
CC       stimulates poly(A) addition. Binds to U-rich RNA sequence elements
CC       surrounding the poly(A) site. May act to tether poly(A) polymerase to
CC       the CPSF complex. {ECO:0000269|PubMed:14749727}.
CC   -!- SUBUNIT: Component of the cleavage and polyadenylation specificity
CC       factor (CPSF) complex, composed of CPSF1, CPSF2, CPSF3, CPSF4 and
CC       FIP1L1. Found in a complex with CPSF1, FIP1L1 and PAPOLA. Interacts
CC       with CPSF1, CPSF4, CSTF2 and CSTF3 (PubMed:14749727). Interacts with
CC       AHCYL1 (when phosphorylated); the interaction is direct and associates
CC       AHCYL1 with the CPSF complex and RNA (PubMed:19224921). Interacts with
CC       NUDT21/CPSF5; this interaction occurs in a RNA sequence-specific manner
CC       (PubMed:15937220). Interacts (preferentially via unphosphorylated form
CC       and Arg/Glu/Asp-rich domain) with CPSF6 (via Arg/Ser-rich domain); this
CC       interaction mediates, at least in part, the interaction between the
CC       CFIm and CPSF complexes and may be inhibited by CPSF6 hyper-
CC       phosphorylation (PubMed:29276085). Interacts (preferentially via
CC       unphosphorylated form and Arg/Asp/Glu-rich domain) with CPSF7 (via
CC       Arg/Ser-rich domain); this interaction mediates, at least in part, the
CC       interaction between the CFIm and CPSF complexes and may be inhibited by
CC       CPSF7 hyper-phosphorylation (PubMed:29276085). Interacts with PAPOLA;
CC       the interaction seems to be increased by the interaction with AHCYL1
CC       (By similarity). {ECO:0000250|UniProtKB:Q9D824,
CC       ECO:0000269|PubMed:14749727, ECO:0000269|PubMed:15937220,
CC       ECO:0000269|PubMed:19224921, ECO:0000269|PubMed:29276085}.
CC   -!- INTERACTION:
CC       Q6UN15; Q08379: GOLGA2; NbExp=3; IntAct=EBI-1021914, EBI-618309;
CC       Q6UN15; P41227: NAA10; NbExp=3; IntAct=EBI-1021914, EBI-747693;
CC       Q6UN15; Q96E35: ZMYND19; NbExp=3; IntAct=EBI-1021914, EBI-746595;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q6UN15-1; Sequence=Displayed;
CC       Name=3;
CC         IsoId=Q6UN15-3; Sequence=VSP_016728, VSP_016729, VSP_016730;
CC       Name=4;
CC         IsoId=Q6UN15-4; Sequence=VSP_016728, VSP_016731, VSP_016732;
CC       Name=5;
CC         IsoId=Q6UN15-5; Sequence=VSP_016728, VSP_046213;
CC   -!- DISEASE: Note=A chromosomal aberration involving FIP1L1 is found in
CC       some cases of hypereosinophilic syndrome. Interstitial chromosomal
CC       deletion del(4)(q12q12) causes the fusion of FIP1L1 and PDGFRA (FIP1L1-
CC       PDGFRA). {ECO:0000269|PubMed:12660384, ECO:0000269|PubMed:12808148}.
CC   -!- SIMILARITY: Belongs to the FIP1 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH24016.1; Type=Miscellaneous discrepancy; Note=Intron retention.; Evidence={ECO:0000305};
CC       Sequence=AAH52959.1; Type=Miscellaneous discrepancy; Note=Intron retention.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY366510; AAQ88277.1; -; mRNA.
DR   EMBL; AL136910; CAB66844.1; -; mRNA.
DR   EMBL; AK295737; BAG58575.1; -; mRNA.
DR   EMBL; AC058822; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC095040; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC098587; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC098821; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC105384; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC110298; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC110792; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC124017; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC138607; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC138779; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471057; EAX05448.1; -; Genomic_DNA.
DR   EMBL; BC011543; AAH11543.1; -; mRNA.
DR   EMBL; BC017724; AAH17724.1; -; mRNA.
DR   EMBL; BC024016; AAH24016.1; ALT_SEQ; mRNA.
DR   EMBL; BC052959; AAH52959.1; ALT_SEQ; mRNA.
DR   EMBL; BC110383; AAI10384.1; -; mRNA.
DR   EMBL; AY229892; AAP69563.1; ALT_TERM; mRNA.
DR   CCDS; CCDS3491.1; -. [Q6UN15-1]
DR   CCDS; CCDS47055.1; -. [Q6UN15-5]
DR   CCDS; CCDS47056.1; -. [Q6UN15-3]
DR   RefSeq; NP_001128409.1; NM_001134937.1. [Q6UN15-5]
DR   RefSeq; NP_001128410.1; NM_001134938.1. [Q6UN15-3]
DR   RefSeq; NP_112179.2; NM_030917.3. [Q6UN15-1]
DR   BioGrid; 123545; 102.
DR   CORUM; Q6UN15; -.
DR   DIP; DIP-42503N; -.
DR   IntAct; Q6UN15; 64.
DR   MINT; Q6UN15; -.
DR   STRING; 9606.ENSP00000336752; -.
DR   iPTMnet; Q6UN15; -.
DR   MetOSite; Q6UN15; -.
DR   PhosphoSitePlus; Q6UN15; -.
DR   BioMuta; FIP1L1; -.
DR   DMDM; 74749365; -.
DR   EPD; Q6UN15; -.
DR   jPOST; Q6UN15; -.
DR   MassIVE; Q6UN15; -.
DR   MaxQB; Q6UN15; -.
DR   PaxDb; Q6UN15; -.
DR   PeptideAtlas; Q6UN15; -.
DR   PRIDE; Q6UN15; -.
DR   ProteomicsDB; 33719; -.
DR   ProteomicsDB; 67417; -. [Q6UN15-1]
DR   ProteomicsDB; 67418; -. [Q6UN15-3]
DR   ProteomicsDB; 67419; -. [Q6UN15-4]
DR   Antibodypedia; 12232; 146 antibodies.
DR   DNASU; 81608; -.
DR   Ensembl; ENST00000306932; ENSP00000302993; ENSG00000145216. [Q6UN15-3]
DR   Ensembl; ENST00000337488; ENSP00000336752; ENSG00000145216. [Q6UN15-1]
DR   Ensembl; ENST00000358575; ENSP00000351383; ENSG00000145216. [Q6UN15-5]
DR   Ensembl; ENST00000507922; ENSP00000425456; ENSG00000145216. [Q6UN15-4]
DR   GeneID; 81608; -.
DR   KEGG; hsa:81608; -.
DR   UCSC; uc003gzx.5; human. [Q6UN15-1]
DR   CTD; 81608; -.
DR   DisGeNET; 81608; -.
DR   GeneCards; FIP1L1; -.
DR   HGNC; HGNC:19124; FIP1L1.
DR   HPA; ENSG00000145216; Low tissue specificity.
DR   MalaCards; FIP1L1; -.
DR   MIM; 607685; phenotype.
DR   MIM; 607686; gene.
DR   neXtProt; NX_Q6UN15; -.
DR   OpenTargets; ENSG00000145216; -.
DR   Orphanet; 520; Acute promyelocytic leukemia.
DR   Orphanet; 168940; Chronic eosinophilic leukemia.
DR   Orphanet; 314950; Primary hypereosinophilic syndrome.
DR   PharmGKB; PA134875694; -.
DR   eggNOG; KOG1049; Eukaryota.
DR   eggNOG; COG5213; LUCA.
DR   GeneTree; ENSGT00980000198672; -.
DR   HOGENOM; CLU_035577_0_0_1; -.
DR   KO; K14405; -.
DR   OMA; LNKQPGK; -.
DR   OrthoDB; 929913at2759; -.
DR   PhylomeDB; Q6UN15; -.
DR   TreeFam; TF318610; -.
DR   Reactome; R-HSA-159231; Transport of Mature mRNA Derived from an Intronless Transcript.
DR   Reactome; R-HSA-72163; mRNA Splicing - Major Pathway.
DR   Reactome; R-HSA-72187; mRNA 3'-end processing.
DR   Reactome; R-HSA-73856; RNA Polymerase II Transcription Termination.
DR   Reactome; R-HSA-77595; Processing of Intronless Pre-mRNAs.
DR   SIGNOR; Q6UN15; -.
DR   ChiTaRS; FIP1L1; human.
DR   GeneWiki; FIP1L1; -.
DR   GenomeRNAi; 81608; -.
DR   Pharos; Q6UN15; Tbio.
DR   PRO; PR:Q6UN15; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   RNAct; Q6UN15; protein.
DR   Bgee; ENSG00000145216; Expressed in tendon of biceps brachii and 220 other tissues.
DR   ExpressionAtlas; Q6UN15; baseline and differential.
DR   Genevisible; Q6UN15; HS.
DR   GO; GO:0005847; C:mRNA cleavage and polyadenylation specificity factor complex; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0031124; P:mRNA 3'-end processing; TAS:Reactome.
DR   GO; GO:0006406; P:mRNA export from nucleus; TAS:Reactome.
DR   GO; GO:0006378; P:mRNA polyadenylation; IBA:GO_Central.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome.
DR   GO; GO:0098789; P:pre-mRNA cleavage required for polyadenylation; IBA:GO_Central.
DR   GO; GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome.
DR   InterPro; IPR039849; Fip1.
DR   InterPro; IPR007854; Fip1_dom.
DR   PANTHER; PTHR13484:SF5; PTHR13484:SF5; 1.
DR   Pfam; PF05182; Fip1; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; mRNA processing; Nucleus; Phosphoprotein;
KW   Reference proteome; RNA-binding.
FT   CHAIN           1..594
FT                   /note="Pre-mRNA 3'-end-processing factor FIP1"
FT                   /id="PRO_0000215037"
FT   REGION          1..356
FT                   /note="Necessary for stimulating PAPOLA activity"
FT   REGION          1..111
FT                   /note="Sufficient for interaction with PAPOLA"
FT   REGION          137..243
FT                   /note="Sufficient for interaction with CPSF4"
FT                   /evidence="ECO:0000269|PubMed:14749727"
FT   REGION          443..594
FT                   /note="Sufficient for interaction with CPSF1 and CSTF3"
FT                   /evidence="ECO:0000269|PubMed:14749727"
FT   REGION          457..490
FT                   /note="Arg/Asp/Glu-rich domain"
FT                   /evidence="ECO:0000269|PubMed:29276085"
FT   COMPBIAS        356..406
FT                   /note="Pro-rich"
FT   COMPBIAS        456..562
FT                   /note="Arg-rich"
FT   COMPBIAS        478..594
FT                   /note="Glu-rich"
FT   SITE            339..340
FT                   /note="Breakpoint for interstitial deletion to form the
FT                   FIP1L1-PDGFRA fusion protein"
FT   MOD_RES         85
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D824"
FT   MOD_RES         87
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D824"
FT   MOD_RES         89
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D824"
FT   MOD_RES         304
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D824"
FT   MOD_RES         426
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000244|PubMed:15592455"
FT   MOD_RES         492
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163"
FT   MOD_RES         494
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:19690332"
FT   MOD_RES         496
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:21406692"
FT   MOD_RES         500
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         554
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18318008,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:24275569"
FT   VAR_SEQ         29..43
FT                   /note="Missing (in isoform 3, isoform 4 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:11230166,
FT                   ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334"
FT                   /id="VSP_016728"
FT   VAR_SEQ         213..235
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:11230166"
FT                   /id="VSP_016729"
FT   VAR_SEQ         272..307
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:11230166"
FT                   /id="VSP_016730"
FT   VAR_SEQ         389
FT                   /note="P -> PPPGIPITVP (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_046213"
FT   VAR_SEQ         393
FT                   /note="F -> K (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_016731"
FT   VAR_SEQ         394..594
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_016732"
FT   CONFLICT        118
FT                   /note="V -> I (in Ref. 3; BAG58575)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        312
FT                   /note="G -> R (in Ref. 6; AAH24016/AAH52959)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        524
FT                   /note="K -> R (in Ref. 6; AAH52959)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   594 AA;  66526 MW;  B391D142419ED061 CRC64;
     MSAGEVERLV SELSGGTGGD EEEEWLYGGP WDVHVHSDLA KDLDENEVER PEEENASANP
     PSGIEDETAE NGVPKPKVTE TEDDSDSDSD DDEDDVHVTI GDIKTGAPQY GSYGTAPVNL
     NIKTGGRVYG TTGTKVKGVD LDAPGSINGV PLLEVDLDSF EDKPWRKPGA DLSDYFNYGF
     NEDTWKAYCE KQKRIRMGLE VIPVTSTTNK ITAEDCTMEV TPGAEIQDGR FNLFKVQQGR
     TGNSEKETAL PSTKAEFTSP PSLFKTGLPP SRNSTSSQSQ TSTASRKANS SVGKWQDRYG
     RAESPDLRRL PGAIDVIGQT ITISRVEGRR RANENSNIQV LSERSATEVD NNFSKPPPFF
     PPGAPPTHLP PPPFLPPPPT VSTAPPLIPP PGFPPPPGAP PPSLIPTIES GHSSGYDSRS
     ARAFPYGNVA FPHLPGSAPS WPSLVDTSKQ WDYYARREKD RDRERDRDRE RDRDRDRERE
     RTRERERERD HSPTPSVFNS DEERYRYREY AERGYERHRA SREKEERHRE RRHREKEETR
     HKSSRSNSRR RHESEEGDSH RRHKHKKSKR SKEGKEAGSE PAPEQESTEA TPAE
//
ID   GAS7_HUMAN              Reviewed;         476 AA.
AC   O60861; A8KAC2; B2RCK9; O43144; Q53Y77; Q7Z571;
DT   11-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   16-DEC-2008, sequence version 3.
DT   22-APR-2020, entry version 186.
DE   RecName: Full=Growth arrest-specific protein 7;
DE            Short=GAS-7;
GN   Name=GAS7; Synonyms=KIAA0394;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Cerebellum;
RA   Chao C.C.-K., Kuo J.T., Ju Y.-T., Lin-Chao S.;
RT   "Human gas7: conservation of a mammalian growth-arrest-specific gene.";
RL   Submitted (MAR-1998) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4).
RC   TISSUE=Brain;
RX   PubMed=9455477; DOI=10.1093/dnares/4.5.307;
RA   Ishikawa K., Nagase T., Nakajima D., Seki N., Ohira M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. VIII. 78
RT   new cDNA clones from brain which code for large proteins in vitro.";
RL   DNA Res. 4:307-313(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RA   Shan Y.X., Yu L.;
RL   Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 4).
RC   TISSUE=Thalamus, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R., Gnerre S.,
RA   Goldstein S., Grafham D.V., Grocock R., Hafez N., Hagopian D.S., Hart E.,
RA   Norman C.H., Humphray S., Jaffe D.B., Jones M., Kamal M., Khodiyar V.K.,
RA   LaButti K., Laird G., Lehoczky J., Liu X., Lokyitsang T., Loveland J.,
RA   Lui A., Macdonald P., Major J.E., Matthews L., Mauceli E., McCarroll S.A.,
RA   Mihalev A.H., Mudge J., Nguyen C., Nicol R., O'Leary S.B., Osoegawa K.,
RA   Schwartz D.C., Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in the
RT   human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Eye, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PARTIAL NUCLEOTIDE SEQUENCE [MRNA], AND CHROMOSOMAL TRANSLOCATION WITH
RP   KMT2A/MLL1.
RX   PubMed=10706619; DOI=10.1073/pnas.050397097;
RA   Megonigal M.D., Cheung N.-K.V., Rappaport E.F., Nowell P.C., Wilson R.B.,
RA   Jones D.H., Addya K., Leonard D.G.B., Kushner B.H., Williams T.M.,
RA   Lange B.J., Felix C.A.;
RT   "Detection of leukemia-associated MLL-GAS7 translocation early during
RT   chemotherapy with DNA topoisomerase II inhibitors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:2814-2819(2000).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-117, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [11]
RP   STRUCTURE BY NMR OF 79-111.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the WW domain from the human growth-arrest-specific
RT   protein 7, GAS-7.";
RL   Submitted (OCT-2007) to the PDB data bank.
CC   -!- FUNCTION: May play a role in promoting maturation and morphological
CC       differentiation of cerebellar neurons.
CC   -!- INTERACTION:
CC       O60861-1; O60861-1; NbExp=3; IntAct=EBI-11745923, EBI-11745923;
CC       O60861-1; Q16543: CDC37; NbExp=3; IntAct=EBI-11745923, EBI-295634;
CC       O60861-1; Q9Y4Z0: LSM4; NbExp=3; IntAct=EBI-11745923, EBI-372521;
CC       O60861-1; Q96EZ8: MCRS1; NbExp=3; IntAct=EBI-11745923, EBI-348259;
CC       O60861-1; Q9NZQ3-3: NCKIPSD; NbExp=5; IntAct=EBI-11745923, EBI-10963850;
CC       O60861; Q96HA8: WDYHV1; NbExp=4; IntAct=EBI-2683717, EBI-741158;
CC       O60861-1; Q96HA8: WDYHV1; NbExp=5; IntAct=EBI-11745923, EBI-741158;
CC       O60861-1; O95070: YIF1A; NbExp=3; IntAct=EBI-11745923, EBI-2799703;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=3;
CC         IsoId=O60861-3; Sequence=Displayed;
CC       Name=1;
CC         IsoId=O60861-1; Sequence=VSP_035988;
CC       Name=2; Synonyms=GAS7-CB;
CC         IsoId=O60861-2; Sequence=VSP_006802, VSP_006803;
CC       Name=4;
CC         IsoId=O60861-4; Sequence=VSP_044294, VSP_044295;
CC   -!- DISEASE: Note=A chromosomal aberration involving GAS7 is found in acute
CC       myeloid leukemia. Translocation t(11;17)(q23;p13) with KMT2A/MLL1.
CC       {ECO:0000269|PubMed:10706619}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA23690.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/GAS7ID257.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ224876; CAA12177.1; -; mRNA.
DR   EMBL; AB007854; BAA23690.2; ALT_INIT; mRNA.
DR   EMBL; AY327406; AAP92798.1; -; mRNA.
DR   EMBL; BT006891; AAP35537.1; -; mRNA.
DR   EMBL; AK292987; BAF85676.1; -; mRNA.
DR   EMBL; AK315162; BAG37606.1; -; mRNA.
DR   EMBL; AC000003; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005747; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC026591; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC083783; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC107938; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471108; EAW90013.1; -; Genomic_DNA.
DR   EMBL; CH471108; EAW90011.1; -; Genomic_DNA.
DR   EMBL; CH471108; EAW90012.1; -; Genomic_DNA.
DR   EMBL; BC001152; AAH01152.1; -; mRNA.
DR   EMBL; BC006454; AAH06454.2; -; mRNA.
DR   EMBL; AF231998; AAG26332.2; ALT_SEQ; mRNA.
DR   CCDS; CCDS11152.1; -. [O60861-3]
DR   CCDS; CCDS42263.1; -. [O60861-4]
DR   CCDS; CCDS45611.1; -. [O60861-2]
DR   CCDS; CCDS58518.1; -. [O60861-1]
DR   RefSeq; NP_001124303.1; NM_001130831.1. [O60861-1]
DR   RefSeq; NP_003635.2; NM_003644.2. [O60861-2]
DR   RefSeq; NP_958836.1; NM_201432.1. [O60861-4]
DR   RefSeq; NP_958839.1; NM_201433.1. [O60861-3]
DR   RefSeq; XP_005256888.1; XM_005256831.3. [O60861-1]
DR   RefSeq; XP_005256889.1; XM_005256832.3. [O60861-1]
DR   RefSeq; XP_011522346.1; XM_011524044.2. [O60861-1]
DR   RefSeq; XP_016880728.1; XM_017025239.1. [O60861-1]
DR   PDB; 2LX7; NMR; -; A=1-60.
DR   PDB; 2YSH; NMR; -; A=79-111.
DR   PDBsum; 2LX7; -.
DR   PDBsum; 2YSH; -.
DR   SMR; O60861; -.
DR   BioGrid; 114094; 23.
DR   IntAct; O60861; 21.
DR   MINT; O60861; -.
DR   STRING; 9606.ENSP00000407552; -.
DR   iPTMnet; O60861; -.
DR   PhosphoSitePlus; O60861; -.
DR   BioMuta; GAS7; -.
DR   jPOST; O60861; -.
DR   MassIVE; O60861; -.
DR   PaxDb; O60861; -.
DR   PeptideAtlas; O60861; -.
DR   PRIDE; O60861; -.
DR   ProteomicsDB; 1898; -.
DR   ProteomicsDB; 49633; -. [O60861-3]
DR   ProteomicsDB; 49634; -. [O60861-1]
DR   ProteomicsDB; 49635; -. [O60861-2]
DR   Antibodypedia; 24803; 417 antibodies.
DR   DNASU; 8522; -.
DR   Ensembl; ENST00000323816; ENSP00000322608; ENSG00000007237. [O60861-4]
DR   Ensembl; ENST00000432992; ENSP00000407552; ENSG00000007237. [O60861-3]
DR   Ensembl; ENST00000437099; ENSP00000410108; ENSG00000007237. [O60861-1]
DR   Ensembl; ENST00000542249; ENSP00000443265; ENSG00000007237. [O60861-1]
DR   Ensembl; ENST00000579158; ENSP00000463527; ENSG00000007237. [O60861-1]
DR   Ensembl; ENST00000580865; ENSP00000463873; ENSG00000007237. [O60861-2]
DR   Ensembl; ENST00000585266; ENSP00000464240; ENSG00000007237. [O60861-4]
DR   GeneID; 8522; -.
DR   KEGG; hsa:8522; -.
DR   UCSC; uc002gmg.2; human. [O60861-3]
DR   CTD; 8522; -.
DR   DisGeNET; 8522; -.
DR   GeneCards; GAS7; -.
DR   HGNC; HGNC:4169; GAS7.
DR   HPA; ENSG00000007237; Tissue enhanced (brain).
DR   MIM; 603127; gene.
DR   neXtProt; NX_O60861; -.
DR   OpenTargets; ENSG00000007237; -.
DR   PharmGKB; PA28583; -.
DR   eggNOG; KOG0940; Eukaryota.
DR   eggNOG; KOG2398; Eukaryota.
DR   eggNOG; ENOG410Z5NV; LUCA.
DR   GeneTree; ENSGT00940000156268; -.
DR   HOGENOM; CLU_052182_0_1_1; -.
DR   InParanoid; O60861; -.
DR   KO; K18618; -.
DR   OMA; WADKKDS; -.
DR   OrthoDB; 530520at2759; -.
DR   PhylomeDB; O60861; -.
DR   TreeFam; TF328986; -.
DR   SignaLink; O60861; -.
DR   SIGNOR; O60861; -.
DR   ChiTaRS; GAS7; human.
DR   EvolutionaryTrace; O60861; -.
DR   GeneWiki; GAS7; -.
DR   GenomeRNAi; 8522; -.
DR   Pharos; O60861; Tbio.
DR   PRO; PR:O60861; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; O60861; protein.
DR   Bgee; ENSG00000007237; Expressed in cerebellum and 243 other tissues.
DR   ExpressionAtlas; O60861; baseline and differential.
DR   Genevisible; O60861; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005856; C:cytoskeleton; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0008092; F:cytoskeletal protein binding; IBA:GO_Central.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; TAS:ProtInc.
DR   GO; GO:0007050; P:cell cycle arrest; TAS:ProtInc.
DR   GO; GO:0030182; P:neuron differentiation; IBA:GO_Central.
DR   GO; GO:0048812; P:neuron projection morphogenesis; IBA:GO_Central.
DR   CDD; cd07649; F-BAR_GAS7; 1.
DR   Gene3D; 1.20.1270.60; -; 1.
DR   InterPro; IPR027267; AH/BAR_dom_sf.
DR   InterPro; IPR031160; F_BAR.
DR   InterPro; IPR001060; FCH_dom.
DR   InterPro; IPR037957; GAS7_F-BAR.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR001202; WW_dom.
DR   InterPro; IPR036020; WW_dom_sf.
DR   Pfam; PF00611; FCH; 1.
DR   Pfam; PF14604; SH3_9; 1.
DR   Pfam; PF00397; WW; 1.
DR   SMART; SM00055; FCH; 1.
DR   SMART; SM00326; SH3; 1.
DR   SMART; SM00456; WW; 1.
DR   SUPFAM; SSF103657; SSF103657; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   SUPFAM; SSF51045; SSF51045; 1.
DR   PROSITE; PS51741; F_BAR; 1.
DR   PROSITE; PS50002; SH3; 1.
DR   PROSITE; PS01159; WW_DOMAIN_1; 1.
DR   PROSITE; PS50020; WW_DOMAIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Chromosomal rearrangement; Coiled coil;
KW   Cytoplasm; Developmental protein; Differentiation; Neurogenesis;
KW   Phosphoprotein; Proto-oncogene; Reference proteome; SH3 domain.
FT   CHAIN           1..476
FT                   /note="Growth arrest-specific protein 7"
FT                   /id="PRO_0000076057"
FT   DOMAIN          1..62
FT                   /note="SH3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   DOMAIN          77..110
FT                   /note="WW"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00224"
FT   DOMAIN          196..456
FT                   /note="F-BAR"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01077"
FT   COILED          309..419
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        67..70
FT                   /note="Poly-Pro"
FT   MOD_RES         117
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332"
FT   MOD_RES         163
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q60780"
FT   VAR_SEQ         1..140
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039, ECO:0000303|Ref.1"
FT                   /id="VSP_006802"
FT   VAR_SEQ         1..64
FT                   /note="Missing (in isoform 1)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:9455477, ECO:0000303|Ref.4"
FT                   /id="VSP_035988"
FT   VAR_SEQ         1..60
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:9455477"
FT                   /id="VSP_044294"
FT   VAR_SEQ         61
FT                   /note="E -> M (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:9455477"
FT                   /id="VSP_044295"
FT   VAR_SEQ         141..156
FT                   /note="PPETAHMSVRKSTGDS -> MSNMENSFDDVSCLSP (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039, ECO:0000303|Ref.1"
FT                   /id="VSP_006803"
FT   CONFLICT        301
FT                   /note="E -> D (in Ref. 1; CAA12177)"
FT                   /evidence="ECO:0000305"
FT   STRAND          5..9
FT                   /evidence="ECO:0000244|PDB:2LX7"
FT   STRAND          28..32
FT                   /evidence="ECO:0000244|PDB:2LX7"
FT   STRAND          40..43
FT                   /evidence="ECO:0000244|PDB:2LX7"
FT   STRAND          49..52
FT                   /evidence="ECO:0000244|PDB:2LX7"
FT   HELIX           54..56
FT                   /evidence="ECO:0000244|PDB:2LX7"
FT   STRAND          57..59
FT                   /evidence="ECO:0000244|PDB:2LX7"
FT   STRAND          84..87
FT                   /evidence="ECO:0000244|PDB:2YSH"
FT   STRAND          93..96
FT                   /evidence="ECO:0000244|PDB:2YSH"
FT   STRAND          98..100
FT                   /evidence="ECO:0000244|PDB:2YSH"
FT   STRAND          103..107
FT                   /evidence="ECO:0000244|PDB:2YSH"
SQ   SEQUENCE   476 AA;  54371 MW;  57BFB99907652745 CRC64;
     MSGARCRTLY PFSGERHGQG LRFAAGELIT LLQVPDGGWW EGEKEDGLRG WFPASYVQLL
     EKPGMVPPPP GEESQTVILP PGWQSYLSPQ GRRYYVNTTT NETTWERPSS SPGIPASPGS
     HRSSLPPTVN GYHASGTPAH PPETAHMSVR KSTGDSQNLG SSSPSKKQSK ENTITINCVT
     FPHPDTMPEQ QLLKPTEWSY CDYFWADKKD PQGNGTVAGF ELLLQKQLKG KQMQKEMSEF
     IRERIKIEED YAKNLAKLSQ NSLASQEEGS LGEAWAQVKK SLADEAEVHL KFSAKLHSEV
     EKPLMNFREN FKKDMKKCDH HIADLRKQLA SRYASVEKAR KALTERQRDL EMKTQQLEIK
     LSNKTEEDIK KARRKSTQAG DDLMRCVDLY NQAQSKWFEE MVTTTLELER LEVERVEMIR
     QHLCQYTQLR HETDMFNQST VEPVDQLLRK VDPAKDRELW VREHKTGNIR PVDMEI
//
ID   GOGA5_HUMAN             Reviewed;         731 AA.
AC   Q8TBA6; C9JRU1; O95287; Q03962; Q2TS49; Q9UQQ7;
DT   03-JUL-2003, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 3.
DT   22-APR-2020, entry version 158.
DE   RecName: Full=Golgin subfamily A member 5;
DE   AltName: Full=Cell proliferation-inducing gene 31 protein;
DE   AltName: Full=Golgin-84;
DE   AltName: Full=Protein Ret-II;
DE   AltName: Full=RET-fused gene 5 protein;
GN   Name=GOLGA5; Synonyms=RETII, RFG5; ORFNames=PIG31;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, TOPOLOGY,
RP   DIMERIZATION, INTERACTION WITH OCRL1, AND TISSUE SPECIFICITY.
RC   TISSUE=Testis;
RX   PubMed=9915833; DOI=10.1074/jbc.274.5.2953;
RA   Bascom R.A., Srinivasan S., Nussbaum R.L.;
RT   "Identification and characterization of golgin-84, a novel Golgi integral
RT   membrane protein with a cytoplasmic coiled-coil domain.";
RL   J. Biol. Chem. 274:2953-2962(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kim J.W.;
RT   "Identification of a human cell proliferation gene.";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S., Sun H.,
RA   Du H., Pepin K., Artiguenave F., Robert C., Cruaud C., Bruels T.,
RA   Jaillon O., Friedlander L., Samson G., Brottier P., Cure S., Segurens B.,
RA   Aniere F., Samain S., Crespeau H., Abbasi N., Aiach N., Boscus D.,
RA   Dickhoff R., Dors M., Dubois I., Friedman C., Gouyvenoux M., James R.,
RA   Madan A., Mairey-Estrada B., Mangenot S., Martins N., Menard M., Oztas S.,
RA   Ratcliffe A., Shaffer T., Trask B., Vacherie B., Bellemere C., Belser C.,
RA   Besnard-Gonnet M., Bartol-Mavel D., Boutard M., Briez-Silla S.,
RA   Combette S., Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C.,
RA   Muselet D., Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P.,
RA   Trybou A., Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L., Verdier J.,
RA   Verdier-Discala C., Hillier L.W., Fulton L., McPherson J., Matsuda F.,
RA   Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W., Quetier F.,
RA   Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT GLY-67.
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-497 (ISOFORM 1), AND CHROMOSOMAL
RP   TRANSLOCATION WITH RET.
RC   TISSUE=Fibroblast;
RX   PubMed=2734021;
RA   Ishizaka Y., Ochiai M., Tahira T., Suhimura T., Nahao M.;
RT   "Activation of the ret-II oncogene without a sequence encoding a
RT   transmembrane domain and transforming activity of two ret-II oncogene
RT   products differing in carboxy-termini due to alternative splicing.";
RL   Oncogene 4:789-794(1989).
RN   [7]
RP   ERRATUM OF PUBMED:2734021.
RA   Ishizaka Y., Ochiai M., Tahira T., Suhimura T., Nahao M.;
RL   Oncogene 4:1415-1415(1989).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-585, AND CHROMOSOMAL TRANSLOCATION WITH
RP   RET.
RC   TISSUE=Thyroid;
RX   PubMed=9443391;
RA   Klugbauer S., Demidchik E.P., Lengfelder E., Rabes H.M.;
RT   "Detection of a novel type of Ret rearrangement (PTC5) in thyroid
RT   carcinomas after Chernobyl and analysis of the involved Ret-fused gene
RT   RFG5.";
RL   Cancer Res. 58:198-203(1998).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 576-731 (ISOFORM 2).
RC   TISSUE=Neuroblastoma;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   FUNCTION, PHOSPHORYLATION, AND INTERACTION WITH RAB1A.
RX   PubMed=12538640; DOI=10.1083/jcb.200207045;
RA   Diao A., Rahman D., Pappin D.J.C., Lucocq J., Lowe M.;
RT   "The coiled-coil membrane protein golgin-84 is a novel rab effector
RT   required for Golgi ribbon formation.";
RL   J. Cell Biol. 160:201-212(2003).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=15144186; DOI=10.1021/ac035352d;
RA   Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,
RA   Peters E.C.;
RT   "Robust phosphoproteomic profiling of tyrosine phosphorylation sites from
RT   human T cells using immobilized metal affinity chromatography and tandem
RT   mass spectrometry.";
RL   Anal. Chem. 76:2763-2772(2004).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [13]
RP   FUNCTION, AND INTERACTION WITH CUX1.
RX   PubMed=15718469; DOI=10.1126/science.1108061;
RA   Malsam J., Satoh A., Pelletier L., Warren G.;
RT   "Golgin tethers define subpopulations of COPI vesicles.";
RL   Science 307:1095-1098(2005).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-116, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-116, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-116, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [18]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-116, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Involved in maintaining Golgi structure. Stimulates the
CC       formation of Golgi stacks and ribbons. Involved in intra-Golgi
CC       retrograde transport. {ECO:0000269|PubMed:12538640,
CC       ECO:0000269|PubMed:15718469}.
CC   -!- SUBUNIT: Homodimer. Interacts with RAB1A that has been activated by
CC       GTP-binding, and possibly also with OCRL1. Interacts with isoform CASP
CC       of CUX1. {ECO:0000269|PubMed:12538640, ECO:0000269|PubMed:15718469,
CC       ECO:0000269|PubMed:9915833}.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane
CC       {ECO:0000269|PubMed:9915833}; Single-pass type IV membrane protein
CC       {ECO:0000269|PubMed:9915833}. Note=Found throughout the Golgi, both on
CC       cisternae and, at higher abundance, on the tubulo-vesicular structures
CC       of the cis-Golgi network.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8TBA6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8TBA6-2; Sequence=VSP_007731, VSP_007732;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Highly expressed in seminiferous
CC       tubules and Leydig cells in testis, and detected at much lower levels
CC       in the other tissues tested. Expression is very low or not detectable
CC       in spermatozoa. {ECO:0000269|PubMed:9915833}.
CC   -!- PTM: Highly phosphorylated during mitosis. Phosphorylation is barely
CC       detectable during interphase. {ECO:0000269|PubMed:12538640}.
CC   -!- DISEASE: Note=A chromosomal aberration involving GOLGA5 is found in
CC       papillary thyroid carcinomas (PTCs). Translocation t(10;14)(q11;q32)
CC       with RET. The translocation generates the RET/GOLGA5 (PTC5) oncogene.
CC       {ECO:0000269|PubMed:2734021, ECO:0000269|PubMed:9443391}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA33787.1; Type=Miscellaneous discrepancy; Note=Chimeric cDNA. A chimeric cDNA originating from chromosomes 14 and 10.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF085199; AAD09753.1; -; mRNA.
DR   EMBL; AY644768; AAV85456.1; -; mRNA.
DR   EMBL; AL132987; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471061; EAW81502.1; -; Genomic_DNA.
DR   EMBL; BC023021; AAH23021.1; -; mRNA.
DR   EMBL; X15786; CAA33787.1; ALT_SEQ; mRNA.
DR   EMBL; AJ132949; CAB36967.1; -; mRNA.
DR   EMBL; BX248744; CAD66551.1; -; mRNA.
DR   CCDS; CCDS9905.1; -. [Q8TBA6-1]
DR   PIR; I38153; I38153.
DR   RefSeq; NP_005104.3; NM_005113.3. [Q8TBA6-1]
DR   RefSeq; XP_011535722.1; XM_011537420.2. [Q8TBA6-2]
DR   SMR; Q8TBA6; -.
DR   BioGrid; 115275; 102.
DR   IntAct; Q8TBA6; 44.
DR   MINT; Q8TBA6; -.
DR   STRING; 9606.ENSP00000163416; -.
DR   iPTMnet; Q8TBA6; -.
DR   PhosphoSitePlus; Q8TBA6; -.
DR   BioMuta; GOLGA5; -.
DR   DMDM; 296439337; -.
DR   EPD; Q8TBA6; -.
DR   jPOST; Q8TBA6; -.
DR   MassIVE; Q8TBA6; -.
DR   MaxQB; Q8TBA6; -.
DR   PaxDb; Q8TBA6; -.
DR   PeptideAtlas; Q8TBA6; -.
DR   PRIDE; Q8TBA6; -.
DR   ProteomicsDB; 73978; -. [Q8TBA6-1]
DR   ProteomicsDB; 73979; -. [Q8TBA6-2]
DR   ABCD; Q8TBA6; -.
DR   Antibodypedia; 15; 252 antibodies.
DR   Ensembl; ENST00000163416; ENSP00000163416; ENSG00000066455. [Q8TBA6-1]
DR   GeneID; 9950; -.
DR   KEGG; hsa:9950; -.
DR   UCSC; uc001yaz.3; human. [Q8TBA6-1]
DR   CTD; 9950; -.
DR   DisGeNET; 9950; -.
DR   GeneCards; GOLGA5; -.
DR   HGNC; HGNC:4428; GOLGA5.
DR   HPA; ENSG00000066455; Low tissue specificity.
DR   MalaCards; GOLGA5; -.
DR   MIM; 606918; gene.
DR   neXtProt; NX_Q8TBA6; -.
DR   OpenTargets; ENSG00000066455; -.
DR   Orphanet; 146; Differentiated thyroid carcinoma.
DR   PharmGKB; PA28809; -.
DR   eggNOG; KOG4677; Eukaryota.
DR   eggNOG; ENOG410XR4F; LUCA.
DR   GeneTree; ENSGT00390000018470; -.
DR   HOGENOM; CLU_022484_0_0_1; -.
DR   InParanoid; Q8TBA6; -.
DR   OMA; RYPMARV; -.
DR   OrthoDB; 1325011at2759; -.
DR   PhylomeDB; Q8TBA6; -.
DR   TreeFam; TF319468; -.
DR   Reactome; R-HSA-6811438; Intra-Golgi traffic.
DR   ChiTaRS; GOLGA5; human.
DR   GeneWiki; GOLGA5; -.
DR   GenomeRNAi; 9950; -.
DR   Pharos; Q8TBA6; Tbio.
DR   PRO; PR:Q8TBA6; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   RNAct; Q8TBA6; protein.
DR   Bgee; ENSG00000066455; Expressed in secondary oocyte and 220 other tissues.
DR   ExpressionAtlas; Q8TBA6; baseline and differential.
DR   Genevisible; Q8TBA6; HS.
DR   GO; GO:0005801; C:cis-Golgi network; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0031985; C:Golgi cisterna; IDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IBA:GO_Central.
DR   GO; GO:0016021; C:integral component of membrane; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0030133; C:transport vesicle; TAS:Reactome.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:UniProtKB.
DR   GO; GO:0017137; F:Rab GTPase binding; IDA:UniProtKB.
DR   GO; GO:0007030; P:Golgi organization; IMP:UniProtKB.
DR   GO; GO:0048193; P:Golgi vesicle transport; IMP:UniProtKB.
DR   GO; GO:0000301; P:retrograde transport, vesicle recycling within Golgi; IBA:GO_Central.
DR   InterPro; IPR019177; Golgin_subfamily_A_member_5.
DR   PANTHER; PTHR13815; PTHR13815; 1.
DR   Pfam; PF09787; Golgin_A5; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Chromosomal rearrangement; Coiled coil;
KW   Golgi apparatus; Membrane; Methylation; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transmembrane; Transmembrane helix.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:22223895"
FT   CHAIN           2..731
FT                   /note="Golgin subfamily A member 5"
FT                   /id="PRO_0000190061"
FT   TOPO_DOM        2..698
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        699..719
FT                   /note="Helical; Anchor for type IV membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        720..731
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   COILED          216..632
FT                   /evidence="ECO:0000255"
FT   SITE            497..498
FT                   /note="Breakpoint for translocation to form RET-GOLGA5
FT                   oncogene"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000244|PubMed:22223895"
FT   MOD_RES         89
FT                   /note="Dimethylated arginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q3ZU82"
FT   MOD_RES         89
FT                   /note="Omega-N-methylated arginine; alternate"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         116
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:24275569"
FT   VAR_SEQ         684..691
FT                   /note="SIRLGIFL -> RLCFTSGS (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.9"
FT                   /id="VSP_007731"
FT   VAR_SEQ         692..731
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.9"
FT                   /id="VSP_007732"
FT   VARIANT         67
FT                   /note="A -> G (in dbSNP:rs17128572)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_055859"
FT   VARIANT         486
FT                   /note="M -> V (in dbSNP:rs34139657)"
FT                   /id="VAR_055860"
FT   CONFLICT        350
FT                   /note="F -> L (in Ref. 1; AAD09753, 2; AAV85456, 4;
FT                   EAW81502, 5; AAH23021, 6; CAA33787 and 8; CAB36967)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        584..585
FT                   /note="QS -> PV (in Ref. 8; CAB36967)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   731 AA;  83024 MW;  650B5D46096A2DDE CRC64;
     MSWFVDLAGK AEDLLNRVDQ GAATALSRKD NASNIYSKNT DYTELHQQNT DLIYQTGPKS
     TYISSAADNI RNQKATILAG TANVKVGSRT PVEASHPVEN ASVPRPSSHF VRRKKSEPDD
     ELLFDFLNSS QKEPTGRVEI RKEKGKTPVF QSSQTSSVSS VNPSVTTIKT IEENSFGSQT
     HEAASNSDSS HEGQEESSKE NVSSNAACPD HTPTPNDDGK SHELSNLRLE NQLLRNEVQS
     LNQEMASLLQ RSKETQEELN KARARVEKWN ADHSKSDRMT RGLRAQVDDL TEAVAAKDSQ
     LAVLKVRLQE ADQLLSTRTE ALEALQSEKS RIMQDQSEGN SLQNQALQTF QERLHEADAT
     LKREQESYKQ MQSEFAARLN KVEMERQNLA EAITLAERKY SDEKKRVDEL QQQVKLYKLN
     LESSKQELID YKQKATRILQ SKEKLINSLK EGSGFEGLDS STASSMELEE LRHEKEMQRE
     EIQKLMGQIH QLRSELQDME AQQVNEAESA REQLQDLHDQ IAGQKASKQE LETELERLKQ
     EFHYIEEDLY RTKNTLQSRI KDRDEEIQKL RNQLTNKTLS NSSQSELENR LHQLTETLIQ
     KQTMLESLST EKNSLVFQLE RLEQQMNSAS GSSSNGSSIN MSGIDNGEGT RLRNVPVLFN
     DTETNLAGMY GKVRKAASSI DQFSIRLGIF LRRYPIARVF VIIYMALLHL WVMIVLLTYT
     PEMHHDQPYG K
//
ID   GOPC_HUMAN              Reviewed;         462 AA.
AC   Q9HD26; A6NM30; Q59FS4; Q969U8;
DT   08-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   22-APR-2020, entry version 175.
DE   RecName: Full=Golgi-associated PDZ and coiled-coil motif-containing protein;
DE   AltName: Full=CFTR-associated ligand;
DE   AltName: Full=Fused in glioblastoma;
DE   AltName: Full=PDZ protein interacting specifically with TC10;
DE            Short=PIST;
GN   Name=GOPC; Synonyms=CAL, FIG;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=11162552; DOI=10.1006/bbrc.2000.4160;
RA   Neudauer C.L., Joberty G., Macara I.G.;
RT   "PIST: a novel PDZ/coiled-coil domain binding partner for the rho-family
RT   GTPase TC10.";
RL   Biochem. Biophys. Res. Commun. 280:541-547(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), TISSUE SPECIFICITY, SUBCELLULAR
RP   LOCATION, INTERACTION WITH STX6, AND MUTAGENESIS OF LEU-175; LEU-182;
RP   LEU-189 AND LEU-196.
RC   TISSUE=Myeloid leukemia cell;
RX   PubMed=11384996; DOI=10.1074/jbc.m104137200;
RA   Charest A., Lane K., McMahon K., Housman D.E.;
RT   "Association of a novel PDZ domain-containing peripheral Golgi protein with
RT   the Q-SNARE (Q-soluble N-ethylmaleimide-sensitive fusion protein (NSF)
RT   attachment protein receptor) protein syntaxin 6.";
RL   J. Biol. Chem. 276:29456-29465(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, TISSUE SPECIFICITY,
RP   SUBCELLULAR LOCATION, OLIGOMERIZATION, INTERACTION WITH CFTR, AND DOMAIN.
RC   TISSUE=Lung;
RX   PubMed=11707463; DOI=10.1074/jbc.m110177200;
RA   Cheng J., Moyer B.D., Milewski M., Loffing J., Ikeda M., Mickle J.E.,
RA   Cutting G.R., Li M., Stanton B.A., Guggino W.B.;
RT   "A Golgi-associated PDZ domain protein modulates cystic fibrosis
RT   transmembrane regulator plasma membrane expression.";
RL   J. Biol. Chem. 277:3520-3529(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   DISEASE, AND CHROMOSOMAL TRANSLOCATION WITH ROS1.
RX   PubMed=12661006; DOI=10.1002/gcc.10207;
RA   Charest A., Lane K., McMahon K., Park J., Preisinger E., Conroy H.,
RA   Housman D.;
RT   "Fusion of FIG to the receptor tyrosine kinase ROS in a glioblastoma with
RT   an interstitial del(6)(q21q21).";
RL   Genes Chromosomes Cancer 37:58-71(2003).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=15144186; DOI=10.1021/ac035352d;
RA   Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,
RA   Peters E.C.;
RT   "Robust phosphoproteomic profiling of tyrosine phosphorylation sites from
RT   human T cells using immobilized metal affinity chromatography and tandem
RT   mass spectrometry.";
RL   Anal. Chem. 76:2763-2772(2004).
RN   [10]
RP   FUNCTION.
RX   PubMed=14570915; DOI=10.1074/jbc.m308640200;
RA   Cheng J., Wang H., Guggino W.B.;
RT   "Modulation of mature cystic fibrosis transmembrane regulator protein by
RT   the PDZ domain protein CAL.";
RL   J. Biol. Chem. 279:1892-1898(2004).
RN   [11]
RP   INTERACTION WITH ASIC3.
RX   PubMed=15317815; DOI=10.1074/jbc.m405874200;
RA   Hruska-Hageman A.M., Benson C.J., Leonard A.S., Price M.P., Welsh M.J.;
RT   "PSD-95 and Lin-7b interact with acid-sensing ion channel-3 and have
RT   opposite effects on H+- gated current.";
RL   J. Biol. Chem. 279:46962-46968(2004).
RN   [12]
RP   INTERACTION WITH ADRB1, DOMAIN, AND FUNCTION.
RX   PubMed=15358775; DOI=10.1074/jbc.m404876200;
RA   He J., Bellini M., Xu J., Castleberry A.M., Hall R.A.;
RT   "Interaction with cystic fibrosis transmembrane conductance regulator-
RT   associated ligand (CAL) inhibits beta1-adrenergic receptor surface
RT   expression.";
RL   J. Biol. Chem. 279:50190-50196(2004).
RN   [13]
RP   INTERACTION WITH RHOQ.
RX   PubMed=15546864; DOI=10.1074/jbc.m410026200;
RA   Cheng J., Wang H., Guggino W.B.;
RT   "Regulation of cystic fibrosis transmembrane regulator trafficking and
RT   protein expression by a Rho family small GTPase TC10.";
RL   J. Biol. Chem. 280:3731-3739(2005).
RN   [14]
RP   INTERACTION WITH GOLGA3, AND SUBCELLULAR LOCATION.
RX   PubMed=15951434; DOI=10.1074/jbc.m504937200;
RA   Hicks S.W., Machamer C.E.;
RT   "Isoform-specific interaction of golgin-160 with the Golgi-associated
RT   protein PIST.";
RL   J. Biol. Chem. 280:28944-28951(2005).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [18]
RP   STRUCTURE BY NMR OF 278-371, AND INTERACTION WITH NLGN1 AND FZD8.
RX   PubMed=16882988; DOI=10.1110/ps.062087506;
RA   Li X., Zhang J., Cao Z., Wu J., Shi Y.;
RT   "Solution structure of GOPC PDZ domain and its interaction with the C-
RT   terminal motif of neuroligin.";
RL   Protein Sci. 15:2149-2158(2006).
CC   -!- FUNCTION: Plays a role in intracellular protein trafficking and
CC       degradation. May regulate CFTR chloride currents and acid-induced ASIC3
CC       currents by modulating cell surface expression of both channels. May
CC       also regulate the intracellular trafficking of the ADR1B receptor. May
CC       play a role in autophagy. Overexpression results in CFTR intracellular
CC       retention and degradation in the lysosomes.
CC       {ECO:0000269|PubMed:11707463, ECO:0000269|PubMed:14570915,
CC       ECO:0000269|PubMed:15358775}.
CC   -!- SUBUNIT: Homooligomer. Interacts with FZD5, FZD8, GRID2, BECN1, CSPG5
CC       and CLCN3. May interact with CACNG2 (By similarity). Interacts with
CC       STX6, CFTR, ASIC3, GOLGA3, NLGN1 and RHOQ. {ECO:0000250,
CC       ECO:0000269|PubMed:11384996, ECO:0000269|PubMed:11707463,
CC       ECO:0000269|PubMed:15317815, ECO:0000269|PubMed:15358775,
CC       ECO:0000269|PubMed:15546864, ECO:0000269|PubMed:15951434,
CC       ECO:0000269|PubMed:16882988}.
CC   -!- INTERACTION:
CC       Q9HD26; Q9H9L7: AKIRIN1; NbExp=3; IntAct=EBI-349832, EBI-10309796;
CC       Q9HD26-2; Q7Z3C6-3: ATG9A; NbExp=5; IntAct=EBI-11102276, EBI-12006308;
CC       Q9HD26; Q16520: BATF; NbExp=3; IntAct=EBI-349832, EBI-749503;
CC       Q9HD26; Q0P5P2: C17orf67; NbExp=3; IntAct=EBI-349832, EBI-10226540;
CC       Q9HD26; Q68D86: CCDC102B; NbExp=3; IntAct=EBI-349832, EBI-10171570;
CC       Q9HD26-2; Q68D86: CCDC102B; NbExp=4; IntAct=EBI-11102276, EBI-10171570;
CC       Q9HD26-2; E9PSE9: CCDC198; NbExp=3; IntAct=EBI-11102276, EBI-11748295;
CC       Q9HD26; Q12882: DPYD; NbExp=3; IntAct=EBI-349832, EBI-2839838;
CC       Q9HD26; Q86YD7: FAM90A1; NbExp=3; IntAct=EBI-349832, EBI-6658203;
CC       Q9HD26-2; Q8IZU0: FAM9B; NbExp=3; IntAct=EBI-11102276, EBI-10175124;
CC       Q9HD26; P15408: FOSL2; NbExp=4; IntAct=EBI-349832, EBI-3893419;
CC       Q9HD26-2; P55040: GEM; NbExp=3; IntAct=EBI-11102276, EBI-744104;
CC       Q9HD26; P08631: HCK; NbExp=3; IntAct=EBI-349832, EBI-346340;
CC       Q9HD26-2; P08631-2: HCK; NbExp=3; IntAct=EBI-11102276, EBI-9834454;
CC       Q9HD26; V9HWD0: HEL-S-42; NbExp=4; IntAct=EBI-349832, EBI-10330219;
CC       Q9HD26; P05412: JUN; NbExp=3; IntAct=EBI-349832, EBI-852823;
CC       Q9HD26; Q6UWP7: LCLAT1; NbExp=3; IntAct=EBI-349832, EBI-10254507;
CC       Q9HD26; Q9R0W0: mGluR1a; Xeno; NbExp=7; IntAct=EBI-349832, EBI-8505383;
CC       Q9HD26; Q8WVZ3: MORN4; NbExp=3; IntAct=EBI-349832, EBI-10277137;
CC       Q9HD26; Q9BYD6: MRPL1; NbExp=3; IntAct=EBI-349832, EBI-5325394;
CC       Q9HD26; Q15746: MYLK; NbExp=3; IntAct=EBI-349832, EBI-968482;
CC       Q9HD26-2; Q15746-7: MYLK; NbExp=5; IntAct=EBI-11102276, EBI-12189939;
CC       Q9HD26; Q8IZQ8: MYOCD; NbExp=4; IntAct=EBI-349832, EBI-493384;
CC       Q9HD26-2; Q969R2-2: OSBP2; NbExp=3; IntAct=EBI-11102276, EBI-12211505;
CC       Q9HD26; Q99497: PARK7; NbExp=3; IntAct=EBI-349832, EBI-1164361;
CC       Q9HD26; Q7Z2X4: PID1; NbExp=3; IntAct=EBI-349832, EBI-10256685;
CC       Q9HD26-2; Q6NYC8: PPP1R18; NbExp=3; IntAct=EBI-11102276, EBI-2557469;
CC       Q9HD26; Q2TAK8-2: PWWP3A; NbExp=3; IntAct=EBI-349832, EBI-10239402;
CC       Q9HD26-2; Q86X10: RALGAPB; NbExp=3; IntAct=EBI-11102276, EBI-1755842;
CC       Q9HD26; Q96D59: RNF183; NbExp=3; IntAct=EBI-349832, EBI-743938;
CC       Q9HD26-2; Q96D59: RNF183; NbExp=3; IntAct=EBI-11102276, EBI-743938;
CC       Q9HD26; Q9BWG1: RNF220; NbExp=3; IntAct=EBI-349832, EBI-10300482;
CC       Q9HD26; Q9NTN9: SEMA4G; NbExp=3; IntAct=EBI-349832, EBI-6447340;
CC       Q9HD26; Q9H1K4: SLC25A18; NbExp=3; IntAct=EBI-349832, EBI-6269587;
CC       Q9HD26-2; Q8N9S9-2: SNX31; NbExp=3; IntAct=EBI-11102276, EBI-11745060;
CC       Q9HD26; Q6RVD6: SPATA8; NbExp=3; IntAct=EBI-349832, EBI-8635958;
CC       Q9HD26; O43805: SSNA1; NbExp=3; IntAct=EBI-349832, EBI-2515299;
CC       Q9HD26; Q14849: STARD3; NbExp=3; IntAct=EBI-349832, EBI-9819324;
CC       Q9HD26; P04004: VTN; NbExp=4; IntAct=EBI-349832, EBI-1036653;
CC       Q9HD26-2; P04004: VTN; NbExp=3; IntAct=EBI-11102276, EBI-1036653;
CC       Q9HD26; Q6ZSB9: ZBTB49; NbExp=5; IntAct=EBI-349832, EBI-2859943;
CC       Q9HD26-2; Q6ZSB9: ZBTB49; NbExp=3; IntAct=EBI-11102276, EBI-2859943;
CC       Q9HD26-2; Q8WTX9: ZDHHC1; NbExp=3; IntAct=EBI-11102276, EBI-2818796;
CC       Q9HD26; Q32MK9: ZNF509; NbExp=3; IntAct=EBI-349832, EBI-10239929;
CC       Q9HD26; Q8TBZ8: ZNF564; NbExp=3; IntAct=EBI-349832, EBI-10273713;
CC       Q9HD26; Q9P0T4: ZNF581; NbExp=3; IntAct=EBI-349832, EBI-745520;
CC       Q9HD26; Q96SQ5: ZNF587; NbExp=3; IntAct=EBI-349832, EBI-6427977;
CC       Q9HD26-2; Q9Y2P0: ZNF835; NbExp=3; IntAct=EBI-11102276, EBI-5667516;
CC       Q9HD26; Q8NBB4: ZSCAN1; NbExp=3; IntAct=EBI-349832, EBI-5292994;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Golgi apparatus membrane; Peripheral
CC       membrane protein. Golgi apparatus, trans-Golgi network membrane;
CC       Peripheral membrane protein. Cell junction, synapse {ECO:0000250}. Cell
CC       junction, synapse, postsynaptic density {ECO:0000250}. Cell projection,
CC       dendrite {ECO:0000250}. Note=Enriched in synaptosomal and postsynaptic
CC       densities (PSD) fractions. Expressed in cell bodies and dendrites of
CC       Purkinje cells. Localized at the trans-Golgi network (TGN) of
CC       spermatids and the medulla of round spermatides. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9HD26-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9HD26-2; Sequence=VSP_016062;
CC       Name=3;
CC         IsoId=Q9HD26-3; Sequence=VSP_016063, VSP_016064;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC       {ECO:0000269|PubMed:11162552, ECO:0000269|PubMed:11384996,
CC       ECO:0000269|PubMed:11707463}.
CC   -!- DOMAIN: The PDZ domain mediates interactions with FZD5, FZD8, ASIC3,
CC       GRID2, CLCN3 (By similarity). Mediates also interaction with CFTR and
CC       ADRB1. {ECO:0000250, ECO:0000269|PubMed:11707463,
CC       ECO:0000269|PubMed:15358775}.
CC   -!- DOMAIN: The coiled-coil region probably mediates association to
CC       membranes, targeting to the Golgi, and interactions with GOLGA3, and
CC       STX6. May also mediate interaction with RHOQ (By similarity).
CC       {ECO:0000250}.
CC   -!- DISEASE: Note=A chromosomal aberration involving GOPC is found in a
CC       glioblastoma multiforme sample. An intra-chromosomal deletion
CC       del(6)(q21q21) is responsible for the formation of GOPC-ROS1 chimeric
CC       protein which has a constitutive receptor tyrosine kinase activity.
CC       {ECO:0000269|PubMed:12661006}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD92622.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF287894; AAG00572.1; -; mRNA.
DR   EMBL; AY033606; AAK57733.1; -; mRNA.
DR   EMBL; AF450008; AAL47160.1; -; mRNA.
DR   EMBL; AB209385; BAD92622.1; ALT_INIT; mRNA.
DR   EMBL; AL589939; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z85999; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471051; EAW48205.1; -; Genomic_DNA.
DR   EMBL; BC009553; AAH09553.1; -; mRNA.
DR   CCDS; CCDS34523.1; -. [Q9HD26-2]
DR   CCDS; CCDS5117.1; -. [Q9HD26-1]
DR   RefSeq; NP_001017408.1; NM_001017408.2. [Q9HD26-2]
DR   RefSeq; NP_065132.1; NM_020399.3. [Q9HD26-1]
DR   PDB; 2DC2; NMR; -; A=278-371.
DR   PDB; 2LOB; NMR; -; A=286-370.
DR   PDB; 4E34; X-ray; 1.40 A; A/B=284-370.
DR   PDB; 4E35; X-ray; 1.40 A; A/B=284-370.
DR   PDB; 4JOE; X-ray; 1.14 A; A/B=284-370.
DR   PDB; 4JOF; X-ray; 1.20 A; A/B=284-370.
DR   PDB; 4JOG; X-ray; 1.46 A; A/B=284-370.
DR   PDB; 4JOH; X-ray; 1.47 A; A/B=284-370.
DR   PDB; 4JOJ; X-ray; 1.20 A; A/B=284-370.
DR   PDB; 4JOK; X-ray; 1.09 A; A/B=284-370.
DR   PDB; 4JOP; X-ray; 1.80 A; A/B=284-370.
DR   PDB; 4JOR; X-ray; 1.34 A; A/B=284-370.
DR   PDB; 4K6Y; X-ray; 1.48 A; A/B=284-370.
DR   PDB; 4K72; X-ray; 1.90 A; A/B=284-370.
DR   PDB; 4K75; X-ray; 1.50 A; A=284-370.
DR   PDB; 4K76; X-ray; 1.75 A; A/B/C/D=284-370.
DR   PDB; 4K78; X-ray; 1.80 A; A=284-370.
DR   PDB; 4NMO; X-ray; 1.40 A; A/B=284-370.
DR   PDB; 4NMP; X-ray; 1.30 A; A/B=284-370.
DR   PDB; 4NMQ; X-ray; 1.40 A; A/B=284-370.
DR   PDB; 4NMR; X-ray; 1.55 A; A/B=284-370.
DR   PDB; 4NMS; X-ray; 1.70 A; A/B=284-370.
DR   PDB; 4NMT; X-ray; 1.40 A; A/B=284-370.
DR   PDB; 4NMV; X-ray; 1.40 A; A/B=284-370.
DR   PDB; 4Q6H; X-ray; 1.90 A; A=284-370.
DR   PDB; 4Q6S; X-ray; 1.45 A; A/B=284-370.
DR   PDB; 5IC3; X-ray; 1.70 A; A/B=284-370.
DR   PDB; 5K4F; X-ray; 1.36 A; A/B=284-370.
DR   PDB; 6OV7; X-ray; 1.71 A; A/B=284-370.
DR   PDBsum; 2DC2; -.
DR   PDBsum; 2LOB; -.
DR   PDBsum; 4E34; -.
DR   PDBsum; 4E35; -.
DR   PDBsum; 4JOE; -.
DR   PDBsum; 4JOF; -.
DR   PDBsum; 4JOG; -.
DR   PDBsum; 4JOH; -.
DR   PDBsum; 4JOJ; -.
DR   PDBsum; 4JOK; -.
DR   PDBsum; 4JOP; -.
DR   PDBsum; 4JOR; -.
DR   PDBsum; 4K6Y; -.
DR   PDBsum; 4K72; -.
DR   PDBsum; 4K75; -.
DR   PDBsum; 4K76; -.
DR   PDBsum; 4K78; -.
DR   PDBsum; 4NMO; -.
DR   PDBsum; 4NMP; -.
DR   PDBsum; 4NMQ; -.
DR   PDBsum; 4NMR; -.
DR   PDBsum; 4NMS; -.
DR   PDBsum; 4NMT; -.
DR   PDBsum; 4NMV; -.
DR   PDBsum; 4Q6H; -.
DR   PDBsum; 4Q6S; -.
DR   PDBsum; 5IC3; -.
DR   PDBsum; 5K4F; -.
DR   PDBsum; 6OV7; -.
DR   SMR; Q9HD26; -.
DR   BioGrid; 121384; 147.
DR   CORUM; Q9HD26; -.
DR   IntAct; Q9HD26; 121.
DR   MINT; Q9HD26; -.
DR   STRING; 9606.ENSP00000357484; -.
DR   iPTMnet; Q9HD26; -.
DR   MetOSite; Q9HD26; -.
DR   PhosphoSitePlus; Q9HD26; -.
DR   BioMuta; GOPC; -.
DR   DMDM; 74762751; -.
DR   EPD; Q9HD26; -.
DR   jPOST; Q9HD26; -.
DR   MassIVE; Q9HD26; -.
DR   MaxQB; Q9HD26; -.
DR   PaxDb; Q9HD26; -.
DR   PeptideAtlas; Q9HD26; -.
DR   PRIDE; Q9HD26; -.
DR   ProteomicsDB; 81817; -. [Q9HD26-1]
DR   ProteomicsDB; 81818; -. [Q9HD26-2]
DR   ProteomicsDB; 81819; -. [Q9HD26-3]
DR   Antibodypedia; 19468; 446 antibodies.
DR   DNASU; 57120; -.
DR   Ensembl; ENST00000052569; ENSP00000052569; ENSG00000047932. [Q9HD26-2]
DR   Ensembl; ENST00000368498; ENSP00000357484; ENSG00000047932. [Q9HD26-1]
DR   GeneID; 57120; -.
DR   KEGG; hsa:57120; -.
DR   UCSC; uc003pxu.4; human. [Q9HD26-1]
DR   CTD; 57120; -.
DR   DisGeNET; 57120; -.
DR   GeneCards; GOPC; -.
DR   GeneReviews; GOPC; -.
DR   HGNC; HGNC:17643; GOPC.
DR   HPA; ENSG00000047932; Low tissue specificity.
DR   MalaCards; GOPC; -.
DR   MIM; 606845; gene.
DR   neXtProt; NX_Q9HD26; -.
DR   OpenTargets; ENSG00000047932; -.
DR   Orphanet; 171709; Male infertility due to globozoospermia.
DR   PharmGKB; PA134904944; -.
DR   eggNOG; ENOG410ITAF; Eukaryota.
DR   eggNOG; ENOG410XT8J; LUCA.
DR   GeneTree; ENSGT00940000156535; -.
DR   HOGENOM; CLU_045744_0_0_1; -.
DR   InParanoid; Q9HD26; -.
DR   OMA; HAKTGQN; -.
DR   OrthoDB; 1038418at2759; -.
DR   PhylomeDB; Q9HD26; -.
DR   TreeFam; TF317932; -.
DR   Reactome; R-HSA-5627083; RHO GTPases regulate CFTR trafficking.
DR   SIGNOR; Q9HD26; -.
DR   ChiTaRS; GOPC; human.
DR   EvolutionaryTrace; Q9HD26; -.
DR   GeneWiki; GOPC; -.
DR   GenomeRNAi; 57120; -.
DR   Pharos; Q9HD26; Tbio.
DR   PRO; PR:Q9HD26; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; Q9HD26; protein.
DR   Bgee; ENSG00000047932; Expressed in tibia and 203 other tissues.
DR   ExpressionAtlas; Q9HD26; baseline and differential.
DR   Genevisible; Q9HD26; HS.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0030425; C:dendrite; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0030660; C:Golgi-associated vesicle membrane; TAS:Reactome.
DR   GO; GO:0005765; C:lysosomal membrane; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0014069; C:postsynaptic density; IEA:UniProtKB-SubCell.
DR   GO; GO:0032991; C:protein-containing complex; IDA:MGI.
DR   GO; GO:0030140; C:trans-Golgi network transport vesicle; IDA:UniProtKB.
DR   GO; GO:0005109; F:frizzled binding; IEA:Ensembl.
DR   GO; GO:0030695; F:GTPase regulator activity; IEA:Ensembl.
DR   GO; GO:0042802; F:identical protein binding; IPI:UniProtKB.
DR   GO; GO:0044325; F:ion channel binding; IPI:UniProtKB.
DR   GO; GO:0008022; F:protein C-terminus binding; IEA:Ensembl.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
DR   GO; GO:0045176; P:apical protein localization; NAS:UniProtKB.
DR   GO; GO:0043004; P:cytoplasmic sequestering of CFTR protein; IMP:UniProtKB.
DR   GO; GO:0006888; P:endoplasmic reticulum to Golgi vesicle-mediated transport; NAS:UniProtKB.
DR   GO; GO:0006893; P:Golgi to plasma membrane transport; NAS:UniProtKB.
DR   GO; GO:0010360; P:negative regulation of anion channel activity; IMP:UniProtKB.
DR   GO; GO:2000009; P:negative regulation of protein localization to cell surface; IMP:UniProtKB.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   GO; GO:0007289; P:spermatid nucleus differentiation; IEA:Ensembl.
DR   DisProt; DP02150; -.
DR   InterPro; IPR038879; GOPC.
DR   InterPro; IPR001478; PDZ.
DR   InterPro; IPR036034; PDZ_sf.
DR   PANTHER; PTHR16528; PTHR16528; 1.
DR   Pfam; PF00595; PDZ; 1.
DR   SMART; SM00228; PDZ; 1.
DR   SUPFAM; SSF50156; SSF50156; 1.
DR   PROSITE; PS50106; PDZ; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cell junction;
KW   Cell projection; Chromosomal rearrangement; Coiled coil; Cytoplasm;
KW   Golgi apparatus; Membrane; Protein transport; Reference proteome; Synapse;
KW   Transport.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:22223895,
FT                   ECO:0000244|PubMed:22814378"
FT   CHAIN           2..462
FT                   /note="Golgi-associated PDZ and coiled-coil motif-
FT                   containing protein"
FT                   /id="PRO_0000087542"
FT   DOMAIN          288..371
FT                   /note="PDZ"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   COILED          83..200
FT                   /evidence="ECO:0000255"
FT   SITE            419..420
FT                   /note="Breakpoint for translocation to form GOPC-ROS1
FT                   fusion protein"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000244|PubMed:22223895,
FT                   ECO:0000244|PubMed:22814378"
FT   VAR_SEQ         150..157
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11384996,
FT                   ECO:0000303|PubMed:11707463, ECO:0000303|PubMed:15489334"
FT                   /id="VSP_016062"
FT   VAR_SEQ         305..319
FT                   /note="GGKEHGVPILISEIH -> VRSSTSSIIFYSYLV (in isoform 3)"
FT                   /evidence="ECO:0000303|Ref.4"
FT                   /id="VSP_016063"
FT   VAR_SEQ         320..462
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|Ref.4"
FT                   /id="VSP_016064"
FT   MUTAGEN         175
FT                   /note="L->V: No effect on subcellular location; when
FT                   associated with V-182; V-189 and V-196."
FT                   /evidence="ECO:0000269|PubMed:11384996"
FT   MUTAGEN         182
FT                   /note="L->V: No effect on subcellular location; when
FT                   associated with V-175; V-189 and V-196."
FT                   /evidence="ECO:0000269|PubMed:11384996"
FT   MUTAGEN         189
FT                   /note="L->V: No effect on subcellular location; when
FT                   associated with V-175; V-182 and V-196."
FT                   /evidence="ECO:0000269|PubMed:11384996"
FT   MUTAGEN         196
FT                   /note="L->V: No effect on subcellular location; when
FT                   associated with V-175; V-182 and V-189."
FT                   /evidence="ECO:0000269|PubMed:11384996"
FT   STRAND          287..292
FT                   /evidence="ECO:0000244|PDB:4JOK"
FT   STRAND          295..297
FT                   /evidence="ECO:0000244|PDB:4NMO"
FT   STRAND          301..306
FT                   /evidence="ECO:0000244|PDB:4JOK"
FT   HELIX           307..309
FT                   /evidence="ECO:0000244|PDB:4JOK"
FT   STRAND          311..318
FT                   /evidence="ECO:0000244|PDB:4JOK"
FT   HELIX           323..327
FT                   /evidence="ECO:0000244|PDB:4JOK"
FT   STRAND          334..339
FT                   /evidence="ECO:0000244|PDB:4JOK"
FT   STRAND          342..344
FT                   /evidence="ECO:0000244|PDB:2DC2"
FT   STRAND          346..348
FT                   /evidence="ECO:0000244|PDB:2LOB"
FT   HELIX           349..357
FT                   /evidence="ECO:0000244|PDB:4JOK"
FT   STRAND          361..369
FT                   /evidence="ECO:0000244|PDB:4JOK"
SQ   SEQUENCE   462 AA;  50520 MW;  8A19DDC376DCD0F4 CRC64;
     MSAGGPCPAA AGGGPGGASC SVGAPGGVSM FRWLEVLEKE FDKAFVDVDL LLGEIDPDQA
     DITYEGRQKM TSLSSCFAQL CHKAQSVSQI NHKLEAQLVD LKSELTETQA EKVVLEKEVH
     DQLLQLHSIQ LQLHAKTGQS ADSGTIKAKL SGPSVEELER ELEANKKEKM KEAQLEAEVK
     LLRKENEALR RHIAVLQAEV YGARLAAKYL DKELAGRVQQ IQLLGRDMKG PAHDKLWNQL
     EAEIHLHRHK TVIRACRGRN DLKRPMQAPP GHDQDSLKKS QGVGPIRKVL LLKEDHEGLG
     ISITGGKEHG VPILISEIHP GQPADRCGGL HVGDAILAVN GVNLRDTKHK EAVTILSQQR
     GEIEFEVVYV APEVDSDDEN VEYEDESGHR YRLYLDELEG GGNPGASCKD TSGEIKVLQG
     FNKKAVTDTH ENGDLGTASE TPLDDGASKL DDLHTLYHKK SY
//
ID   GEPH_HUMAN              Reviewed;         736 AA.
AC   Q9NQX3; Q96KU4; Q9H4E9; Q9P2G2;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   22-APR-2020, entry version 186.
DE   RecName: Full=Gephyrin {ECO:0000303|PubMed:10839351};
DE   Includes:
DE     RecName: Full=Molybdopterin adenylyltransferase;
DE              Short=MPT adenylyltransferase;
DE              EC=2.7.7.75 {ECO:0000305|PubMed:26613940};
DE     AltName: Full=Domain G;
DE   Includes:
DE     RecName: Full=Molybdopterin molybdenumtransferase;
DE              Short=MPT Mo-transferase;
DE              EC=2.10.1.1 {ECO:0000305|PubMed:22040219, ECO:0000305|PubMed:26613940};
DE     AltName: Full=Domain E;
GN   Name=GPHN {ECO:0000312|HGNC:HGNC:15465}; Synonyms=GPH, KIAA1385;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Hippocampus;
RX   PubMed=10839351; DOI=10.1016/s0896-6273(00)81165-4;
RA   Butler M.H., Hayashi A., Okoshi N., Villmann C., Becker C.M., Feng G.,
RA   De Camilli P., Solimena M.;
RT   "Autoimmunity to gephyrin in Stiff-Man syndrome.";
RL   Neuron 26:307-312(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INVOLVEMENT IN MOCODC, AND PATHWAY.
RX   PubMed=11095995; DOI=10.1086/316941;
RA   Reiss J., Gross-Hardt S., Christensen E., Schmidt P., Mendel R.R.,
RA   Schwarz G.;
RT   "A mutation in the gene for the neurotransmitter receptor-clustering
RT   protein gephyrin causes a novel form of molybdenum cofactor deficiency.";
RL   Am. J. Hum. Genet. 68:208-213(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Kidney;
RX   PubMed=11418245; DOI=10.1016/s0378-1119(01)00511-x;
RA   David-Watine B.;
RT   "The human gephyrin (GPHN) gene: structure, chromosome localization and
RT   expression in non-neuronal cells.";
RL   Gene 271:239-245(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10718198; DOI=10.1093/dnares/7.1.65;
RA   Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVI. The
RT   complete sequences of 150 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 7:65-73(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-266, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-188 AND SER-194, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-188 AND SER-194, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-188; SER-194; THR-198 AND
RP   SER-305, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 1-181, AND SUBUNIT.
RX   PubMed=11554796; DOI=10.1006/jmbi.2001.4952;
RA   Schwarz G., Schrader N., Mendel R.R., Hecht H.-J., Schindelin H.;
RT   "Crystal structures of human gephyrin and plant Cnx1 G domains: comparative
RT   analysis and functional implications.";
RL   J. Mol. Biol. 312:405-418(2001).
RN   [15]
RP   VARIANT TYR-10, CHARACTERIZATION OF VARIANT TYR-10, AND INTERACTION WITH
RP   GLRB.
RX   PubMed=12684523; DOI=10.1074/jbc.m301070200;
RA   Rees M.I., Harvey K., Ward H., White J.H., Evans L., Duguid I.C.,
RA   Hsu C.-C., Coleman S.L., Miller J., Baer K., Waldvogel H.J., Gibbon F.,
RA   Smart T.G., Owen M.J., Harvey R.J., Snell R.G.;
RT   "Isoform heterogeneity of the human gephyrin gene (GPHN), binding domains
RT   to the glycine receptor, and mutation analysis in hyperekplexia.";
RL   J. Biol. Chem. 278:24688-24696(2003).
RN   [16]
RP   VARIANT MOCODC ALA-580, AND PATHWAY.
RX   PubMed=22040219; DOI=10.1111/j.1399-0004.2011.01709.x;
RA   Reiss J., Lenz U., Aquaviva-Bourdain C., Joriot-Chekaf S.,
RA   Mention-Mulliez K., Holder-Espinasse M.;
RT   "A GPHN point mutation leading to molybdenum cofactor deficiency.";
RL   Clin. Genet. 80:598-599(2011).
RN   [17]
RP   VARIANT MOCODC ASP-375, CHARACTERIZATION OF MOCODC VARIANTS ASP-375 AND
RP   ALA-580, INTERACTION WITH GABRA3 AND GLRB, SUBCELLULAR LOCATION, SUBUNIT,
RP   FUNCTION, CATALYTIC ACTIVITY, AND PATHWAY.
RX   PubMed=26613940; DOI=10.15252/emmm.201505323;
RG   EuroEPINOMICS Dravet working group;
RA   Dejanovic B., Djemie T., Gruenewald N., Suls A., Kress V., Hetsch F.,
RA   Craiu D., Zemel M., Gormley P., Lal D., Myers C.T., Mefford H.C.,
RA   Palotie A., Helbig I., Meier J.C., De Jonghe P., Weckhuysen S., Schwarz G.;
RT   "Simultaneous impairment of neuronal and metabolic function of mutated
RT   gephyrin in a patient with epileptic encephalopathy.";
RL   EMBO Mol. Med. 7:1580-1594(2015).
CC   -!- FUNCTION: Microtubule-associated protein involved in membrane protein-
CC       cytoskeleton interactions. It is thought to anchor the inhibitory
CC       glycine receptor (GLYR) to subsynaptic microtubules. Catalyzes two
CC       steps in the biosynthesis of the molybdenum cofactor. In the first
CC       step, molybdopterin is adenylated. Subsequently, molybdate is inserted
CC       into adenylated molybdopterin and AMP is released.
CC       {ECO:0000269|PubMed:26613940}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H(+) + molybdopterin = adenylyl-molybdopterin +
CC         diphosphate; Xref=Rhea:RHEA:31331, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:58698,
CC         ChEBI:CHEBI:62727; EC=2.7.7.75;
CC         Evidence={ECO:0000305|PubMed:26613940};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=adenylyl-molybdopterin + H(+) + molybdate = AMP + H2O + Mo-
CC         molybdopterin; Xref=Rhea:RHEA:35047, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:36264, ChEBI:CHEBI:62727,
CC         ChEBI:CHEBI:71302, ChEBI:CHEBI:456215; EC=2.10.1.1;
CC         Evidence={ECO:0000305|PubMed:22040219, ECO:0000305|PubMed:26613940};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC   -!- ACTIVITY REGULATION: Inhibited by copper and tungsten. {ECO:0000250}.
CC   -!- PATHWAY: Cofactor biosynthesis; molybdopterin biosynthesis.
CC       {ECO:0000269|PubMed:11095995, ECO:0000269|PubMed:22040219,
CC       ECO:0000269|PubMed:26613940}.
CC   -!- SUBUNIT: Homotrimer, homodimer and homooligomer (PubMed:26613940).
CC       Interacts with GABARAP (By similarity). Interacts with SRGAP2 (via SH3
CC       domain) (By similarity). Interacts with GABRA3 (PubMed:26613940).
CC       Interacts with GLRB (PubMed:26613940, PubMed:12684523). GABRA3 and GLRB
CC       occupy overlapping binding sites (By similarity). Interacts with
CC       ARHGAP32; IQSEC3, INSYN1 and INSYN2A (By similarity).
CC       {ECO:0000250|UniProtKB:Q03555, ECO:0000250|UniProtKB:Q8BUV3,
CC       ECO:0000269|PubMed:12684523, ECO:0000269|PubMed:26613940}.
CC   -!- INTERACTION:
CC       Q9NQX3; P63167: DYNLL1; NbExp=2; IntAct=EBI-2371891, EBI-349105;
CC       Q9NQX3-2; Q8WV92: MITD1; NbExp=3; IntAct=EBI-11043087, EBI-2691489;
CC       Q9NQX3-2; P25786: PSMA1; NbExp=3; IntAct=EBI-11043087, EBI-359352;
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse
CC       {ECO:0000250|UniProtKB:Q03555}. Cell junction, synapse, postsynaptic
CC       cell membrane {ECO:0000269|PubMed:26613940}; Peripheral membrane
CC       protein {ECO:0000250|UniProtKB:Q03555}; Cytoplasmic side
CC       {ECO:0000250|UniProtKB:Q03555}. Cytoplasm, cytoskeleton
CC       {ECO:0000250|UniProtKB:Q03555}. Cell membrane
CC       {ECO:0000250|UniProtKB:Q03555}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:Q03555}; Cytoplasmic side
CC       {ECO:0000250|UniProtKB:Q03555}. Cell projection, dendrite
CC       {ECO:0000269|PubMed:26613940}. Cell junction, synapse, postsynaptic
CC       density {ECO:0000250|UniProtKB:Q8BUV3}. Note=Cytoplasmic face of
CC       glycinergic postsynaptic membranes. {ECO:0000250|UniProtKB:Q03555}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9NQX3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NQX3-2; Sequence=VSP_021769;
CC   -!- DISEASE: Molybdenum cofactor deficiency, complementation group C
CC       (MOCODC) [MIM:615501]: A form of molybdenum cofactor deficiency, an
CC       autosomal recessive metabolic disorder leading to the pleiotropic loss
CC       of molybdoenzyme activities. It is clinically characterized by onset in
CC       infancy of poor feeding, intractable seizures, severe psychomotor
CC       retardation, and death in early childhood in most patients.
CC       {ECO:0000269|PubMed:11095995, ECO:0000269|PubMed:22040219,
CC       ECO:0000269|PubMed:26613940}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the MoaB/Mog family.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the MoeA family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA92623.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/GPHNID317.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ272033; CAC81240.1; -; mRNA.
DR   EMBL; AF272663; AAF81785.1; -; mRNA.
DR   EMBL; AJ272343; CAC10537.1; -; mRNA.
DR   EMBL; AB037806; BAA92623.1; ALT_INIT; mRNA.
DR   EMBL; BC030016; AAH30016.1; -; mRNA.
DR   CCDS; CCDS32103.1; -. [Q9NQX3-1]
DR   CCDS; CCDS9777.1; -. [Q9NQX3-2]
DR   RefSeq; NP_001019389.1; NM_001024218.1. [Q9NQX3-1]
DR   RefSeq; NP_065857.1; NM_020806.4. [Q9NQX3-2]
DR   PDB; 1JLJ; X-ray; 1.60 A; A/B/C=1-181.
DR   PDBsum; 1JLJ; -.
DR   SMR; Q9NQX3; -.
DR   BioGrid; 115537; 40.
DR   DIP; DIP-41076N; -.
DR   IntAct; Q9NQX3; 23.
DR   MINT; Q9NQX3; -.
DR   STRING; 9606.ENSP00000417901; -.
DR   DrugBank; DB01942; Formic acid.
DR   DrugBank; DB03366; Imidazole.
DR   DrugBank; DB03766; Propanoic acid.
DR   MoonDB; Q9NQX3; Curated.
DR   MoonProt; Q9NQX3; -.
DR   iPTMnet; Q9NQX3; -.
DR   PhosphoSitePlus; Q9NQX3; -.
DR   BioMuta; GPHN; -.
DR   DMDM; 13431554; -.
DR   EPD; Q9NQX3; -.
DR   jPOST; Q9NQX3; -.
DR   MassIVE; Q9NQX3; -.
DR   MaxQB; Q9NQX3; -.
DR   PaxDb; Q9NQX3; -.
DR   PeptideAtlas; Q9NQX3; -.
DR   PRIDE; Q9NQX3; -.
DR   ProteomicsDB; 82221; -. [Q9NQX3-1]
DR   ProteomicsDB; 82222; -. [Q9NQX3-2]
DR   Antibodypedia; 144; 379 antibodies.
DR   DNASU; 10243; -.
DR   Ensembl; ENST00000315266; ENSP00000312771; ENSG00000171723. [Q9NQX3-1]
DR   Ensembl; ENST00000478722; ENSP00000417901; ENSG00000171723. [Q9NQX3-2]
DR   GeneID; 10243; -.
DR   KEGG; hsa:10243; -.
DR   UCSC; uc001xix.4; human. [Q9NQX3-1]
DR   CTD; 10243; -.
DR   DisGeNET; 10243; -.
DR   GeneCards; GPHN; -.
DR   GeneReviews; GPHN; -.
DR   HGNC; HGNC:15465; GPHN.
DR   HPA; ENSG00000171723; Low tissue specificity.
DR   MalaCards; GPHN; -.
DR   MIM; 603930; gene.
DR   MIM; 615501; phenotype.
DR   neXtProt; NX_Q9NQX3; -.
DR   OpenTargets; ENSG00000171723; -.
DR   Orphanet; 3197; Hereditary hyperekplexia.
DR   Orphanet; 308400; Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C.
DR   PharmGKB; PA28840; -.
DR   eggNOG; KOG2371; Eukaryota.
DR   eggNOG; COG0303; LUCA.
DR   eggNOG; COG0521; LUCA.
DR   GeneTree; ENSGT00390000016577; -.
DR   HOGENOM; CLU_010186_2_2_1; -.
DR   InParanoid; Q9NQX3; -.
DR   KO; K15376; -.
DR   OrthoDB; 1114121at2759; -.
DR   PhylomeDB; Q9NQX3; -.
DR   TreeFam; TF300902; -.
DR   BioCyc; MetaCyc:ENSG00000171723-MONOMER; -.
DR   Reactome; R-HSA-947581; Molybdenum cofactor biosynthesis.
DR   SIGNOR; Q9NQX3; -.
DR   UniPathway; UPA00344; -.
DR   ChiTaRS; GPHN; human.
DR   EvolutionaryTrace; Q9NQX3; -.
DR   GeneWiki; GPHN; -.
DR   GenomeRNAi; 10243; -.
DR   Pharos; Q9NQX3; Tbio.
DR   PRO; PR:Q9NQX3; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   RNAct; Q9NQX3; protein.
DR   Bgee; ENSG00000171723; Expressed in corpus callosum and 203 other tissues.
DR   ExpressionAtlas; Q9NQX3; baseline and differential.
DR   Genevisible; Q9NQX3; HS.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0030425; C:dendrite; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0014069; C:postsynaptic density; ISS:UniProtKB.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:UniProtKB.
DR   GO; GO:0099572; C:postsynaptic specialization; IBA:GO_Central.
DR   GO; GO:0099634; C:postsynaptic specialization membrane; IEA:GOC.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0061598; F:molybdopterin adenylyltransferase activity; IBA:GO_Central.
DR   GO; GO:0043546; F:molybdopterin cofactor binding; IDA:CAFA.
DR   GO; GO:0061599; F:molybdopterin molybdotransferase activity; IBA:GO_Central.
DR   GO; GO:0008940; F:nitrate reductase activity; IMP:CAFA.
DR   GO; GO:0007529; P:establishment of synaptic specificity at neuromuscular junction; IBA:GO_Central.
DR   GO; GO:0097112; P:gamma-aminobutyric acid receptor clustering; IDA:UniProtKB.
DR   GO; GO:0072579; P:glycine receptor clustering; IBA:GO_Central.
DR   GO; GO:0006777; P:Mo-molybdopterin cofactor biosynthetic process; IBA:GO_Central.
DR   GO; GO:0018315; P:molybdenum incorporation into molybdenum-molybdopterin complex; IBA:GO_Central.
DR   GO; GO:0032324; P:molybdopterin cofactor biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0098970; P:postsynaptic neurotransmitter receptor diffusion trapping; IBA:GO_Central.
DR   GO; GO:0010038; P:response to metal ion; IMP:CAFA.
DR   CDD; cd00887; MoeA; 1.
DR   CDD; cd00886; MogA_MoaB; 1.
DR   Gene3D; 2.40.340.10; -; 1.
DR   Gene3D; 3.40.980.10; -; 2.
DR   InterPro; IPR036425; MoaB/Mog-like_dom_sf.
DR   InterPro; IPR001453; MoaB/Mog_dom.
DR   InterPro; IPR008284; MoCF_biosynth_CS.
DR   InterPro; IPR038987; MoeA-like.
DR   InterPro; IPR005111; MoeA_C_domain_IV.
DR   InterPro; IPR036688; MoeA_C_domain_IV_sf.
DR   InterPro; IPR005110; MoeA_linker/N.
DR   InterPro; IPR036135; MoeA_linker/N_sf.
DR   PANTHER; PTHR10192; PTHR10192; 1.
DR   Pfam; PF00994; MoCF_biosynth; 2.
DR   Pfam; PF03454; MoeA_C; 1.
DR   Pfam; PF03453; MoeA_N; 1.
DR   SMART; SM00852; MoCF_biosynth; 2.
DR   SUPFAM; SSF53218; SSF53218; 2.
DR   SUPFAM; SSF63867; SSF63867; 1.
DR   SUPFAM; SSF63882; SSF63882; 1.
DR   TIGRFAMs; TIGR00177; molyb_syn; 2.
DR   PROSITE; PS01078; MOCF_BIOSYNTHESIS_1; 1.
DR   PROSITE; PS01079; MOCF_BIOSYNTHESIS_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cell junction;
KW   Cell membrane; Cell projection; Cytoplasm; Cytoskeleton; Disease mutation;
KW   Magnesium; Membrane; Metal-binding; Molybdenum;
KW   Molybdenum cofactor biosynthesis; Multifunctional enzyme;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Postsynaptic cell membrane; Reference proteome; Synapse; Transferase.
FT   CHAIN           1..736
FT                   /note="Gephyrin"
FT                   /id="PRO_0000170964"
FT   REGION          14..166
FT                   /note="MPT Mo-transferase"
FT   REGION          140..316
FT                   /note="Interaction with GABARAP"
FT                   /evidence="ECO:0000250"
FT   REGION          326..736
FT                   /note="MPT adenylyltransferase"
FT   MOD_RES         188
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:24275569"
FT   MOD_RES         194
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:24275569"
FT   MOD_RES         198
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         200
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BUV3"
FT   MOD_RES         262
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BUV3"
FT   MOD_RES         265
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BUV3"
FT   MOD_RES         266
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:16964243"
FT   MOD_RES         268
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BUV3"
FT   MOD_RES         270
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BUV3"
FT   MOD_RES         305
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   VAR_SEQ         243
FT                   /note="K -> KKHPFYTSPAVVMAHGEQPIPGLINYSHHSTDER (in isoform
FT                   2)"
FT                   /evidence="ECO:0000303|PubMed:11418245,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_021769"
FT   VARIANT         10
FT                   /note="N -> Y (found in a patient with hyperekplexia;
FT                   unknown pathological significance; does not disrupt GLRB-
FT                   GPHN interactions; does not affect the structural lattices
FT                   formed by GPHN; dbSNP:rs121908539)"
FT                   /evidence="ECO:0000269|PubMed:12684523"
FT                   /id="VAR_044162"
FT   VARIANT         375
FT                   /note="G -> D (in MOCODC; patient phenotype resembling
FT                   Dravet syndrome; abolishes postsynaptic clustering of GPHN;
FT                   decreases cell-surface expression of GABA receptors;
FT                   impairs postsynaptic currents; catalytically inactive;
FT                   decreases binding affinity toward GABRA3; decreases binding
FT                   affinity toward GLRB)"
FT                   /evidence="ECO:0000269|PubMed:26613940"
FT                   /id="VAR_075626"
FT   VARIANT         580
FT                   /note="D -> A (in MOCODC; lacks molybdenum cofactor
FT                   synthesis activity; dbSNP:rs397518420)"
FT                   /evidence="ECO:0000269|PubMed:22040219,
FT                   ECO:0000269|PubMed:26613940"
FT                   /id="VAR_070275"
FT   CONFLICT        261
FT                   /note="A -> V (in Ref. 1; CAC81240)"
FT                   /evidence="ECO:0000305"
FT   STRAND          16..22
FT                   /evidence="ECO:0000244|PDB:1JLJ"
FT   HELIX           24..27
FT                   /evidence="ECO:0000244|PDB:1JLJ"
FT   HELIX           34..44
FT                   /evidence="ECO:0000244|PDB:1JLJ"
FT   TURN            46..49
FT                   /evidence="ECO:0000244|PDB:1JLJ"
FT   STRAND          52..59
FT                   /evidence="ECO:0000244|PDB:1JLJ"
FT   HELIX           63..75
FT                   /evidence="ECO:0000244|PDB:1JLJ"
FT   STRAND          80..86
FT                   /evidence="ECO:0000244|PDB:1JLJ"
FT   STRAND          89..91
FT                   /evidence="ECO:0000244|PDB:1JLJ"
FT   HELIX           96..103
FT                   /evidence="ECO:0000244|PDB:1JLJ"
FT   STRAND          105..107
FT                   /evidence="ECO:0000244|PDB:1JLJ"
FT   HELIX           109..122
FT                   /evidence="ECO:0000244|PDB:1JLJ"
FT   HELIX           124..128
FT                   /evidence="ECO:0000244|PDB:1JLJ"
FT   STRAND          133..136
FT                   /evidence="ECO:0000244|PDB:1JLJ"
FT   STRAND          139..144
FT                   /evidence="ECO:0000244|PDB:1JLJ"
FT   HELIX           148..158
FT                   /evidence="ECO:0000244|PDB:1JLJ"
FT   HELIX           159..161
FT                   /evidence="ECO:0000244|PDB:1JLJ"
FT   HELIX           162..169
FT                   /evidence="ECO:0000244|PDB:1JLJ"
FT   HELIX           175..178
FT                   /evidence="ECO:0000244|PDB:1JLJ"
SQ   SEQUENCE   736 AA;  79748 MW;  E2BDA3AD3AB962C0 CRC64;
     MATEGMILTN HDHQIRVGVL TVSDSCFRNL AEDRSGINLK DLVQDPSLLG GTISAYKIVP
     DEIEEIKETL IDWCDEKELN LILTTGGTGF APRDVTPEAT KEVIEREAPG MALAMLMGSL
     NVTPLGMLSR PVCGIRGKTL IINLPGSKKG SQECFQFILP ALPHAIDLLR DAIVKVKEVH
     DELEDLPSPP PPLSPPPTTS PHKQTEDKGV QCEEEEEEKK DSGVASTEDS SSSHITAAAI
     AAKIPDSIIS RGVQVLPRDT ASLSTTPSES PRAQATSRLS TASCPTPKVQ SRCSSKENIL
     RASHSAVDIT KVARRHRMSP FPLTSMDKAF ITVLEMTPVL GTEIINYRDG MGRVLAQDVY
     AKDNLPPFPA SVKDGYAVRA ADGPGDRFII GESQAGEQPT QTVMPGQVMR VTTGAPIPCG
     ADAVVQVEDT ELIRESDDGT EELEVRILVQ ARPGQDIRPI GHDIKRGECV LAKGTHMGPS
     EIGLLATVGV TEVEVNKFPV VAVMSTGNEL LNPEDDLLPG KIRDSNRSTL LATIQEHGYP
     TINLGIVGDN PDDLLNALNE GISRADVIIT SGGVSMGEKD YLKQVLDIDL HAQIHFGRVF
     MKPGLPTTFA TLDIDGVRKI IFALPGNPVS AVVTCNLFVV PALRKMQGIL DPRPTIIKAR
     LSCDVKLDPR PEYHRCILTW HHQEPLPWAQ STGNQMSSRL MSMRSANGLL MLPPKTEQYV
     ELHKGEVVDV MVIGRL
//
ID   A4UAE9_HUMAN            Unreviewed;       275 AA.
AC   A4UAE9;
DT   15-MAY-2007, integrated into UniProtKB/TrEMBL.
DT   15-MAY-2007, sequence version 1.
DT   22-APR-2020, entry version 57.
DE   SubName: Full=Homocysteine-inducible endoplasmic reticulum stress-inducible ubiquitin-like domain member 1 protein {ECO:0000313|EMBL:ABI18163.1};
GN   Name=HERPUD1 {ECO:0000313|EMBL:ABI18163.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABI18163.1};
RN   [1] {ECO:0000313|EMBL:ABI18163.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=17420289; DOI=10.1083/jcb.200611036;
RA   Tuvia S., Taglicht D., Erez O., Alroy I., Alchanati I., Bicoviski V.,
RA   Dori-Bachash M., Ben-Avraham D., Reiss Y.;
RT   "The ubiquitin E3 ligase POSH regulates calcium homeostasis through spatial
RT   control of Herp.";
RL   J. Cell Biol. 177:51-61(2007).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ837586; ABI18163.1; -; mRNA.
DR   RefSeq; NP_001259032.1; NM_001272103.1.
DR   MaxQB; A4UAE9; -.
DR   PeptideAtlas; A4UAE9; -.
DR   PRIDE; A4UAE9; -.
DR   GeneID; 9709; -.
DR   CTD; 9709; -.
DR   eggNOG; KOG4583; Eukaryota.
DR   eggNOG; ENOG410ZJAF; LUCA.
DR   ChiTaRS; HERPUD1; human.
DR   GenomeRNAi; 9709; -.
DR   InterPro; IPR039751; HERPUD1/2.
DR   InterPro; IPR000626; Ubiquitin-like_dom.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   PANTHER; PTHR12943; PTHR12943; 1.
DR   Pfam; PF00240; ubiquitin; 1.
DR   SMART; SM00213; UBQ; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   PROSITE; PS50053; UBIQUITIN_2; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN          10..72
FT                   /note="Ubiquitin-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50053"
FT   REGION          100..126
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   275 AA;  30635 MW;  2C9917ED99406C9B CRC64;
     MESETEPEPV TLLVKSPNQR HRDLELSGDR GWSVGHLKAH LSRVYPERPR PEDQRLIYSG
     KLLLDHQCLR DLLPKQEKRH VLHLVCNVKS PSKMPEINAK VAESTEEPAG SNRGQYPEDS
     SSDGLRQREV LRNLSSPGWE NISRPEAAQQ AFQGLGPGFS GYTPYGWLQL SWFQQIYARQ
     YYMQYLAATA ASGAFVPPPS AQEIPVVSAP APAPIHNQFP AENQPANQNA APQVVVNPGA
     NQNLRMNAQG ITLGGFHLDR GRFRTSQMMV LLLTL
//
ID   HERP1_HUMAN             Reviewed;         391 AA.
AC   Q15011; E9PGD1; O60644; Q6IAN8; Q96D92;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   22-APR-2020, entry version 184.
DE   RecName: Full=Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein;
DE   AltName: Full=Methyl methanesulfonate (MMF)-inducible fragment protein 1;
GN   Name=HERPUD1; Synonyms=HERP, KIAA0025, MIF1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INDUCTION, SUBCELLULAR LOCATION,
RP   AND MEMBRANE TOPOLOGY.
RC   TISSUE=Umbilical vein endothelial cell;
RX   PubMed=10922362; DOI=10.1074/jbc.m002063200;
RA   Kokame K., Agarwala K.L., Kato H., Miyata T.;
RT   "Herp, a new ubiquitin-like membrane protein induced by endoplasmic
RT   reticulum stress.";
RL   J. Biol. Chem. 275:32846-32853(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Bone marrow;
RX   PubMed=7584026; DOI=10.1093/dnares/1.1.27;
RA   Nomura N., Miyajima N., Sazuka T., Tanaka A., Kawarabayasi Y., Sato S.,
RA   Nagase T., Seki N., Ishikawa K., Tabata S.;
RT   "Prediction of the coding sequences of unidentified human genes. I. The
RT   coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of
RT   randomly sampled cDNA clones from human immature myeloid cell line KG-1.";
RL   DNA Res. 1:27-35(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain;
RA   Yu W., Gibbs R.A.;
RL   Submitted (MAR-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=11112790; DOI=10.1074/jbc.m010486200;
RA   Kokame K., Kato H., Miyata T.;
RT   "Identification of ERSE-II, a new cis-acting element responsible for the
RT   ATF6-dependent mammalian unfolded protein response.";
RL   J. Biol. Chem. 276:9199-9205(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G.,
RA   Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E.,
RA   Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J., Buckingham J.M.,
RA   Callen D.F., Campbell C.S., Campbell M.L., Campbell E.W., Caoile C.,
RA   Challacombe J.F., Chasteen L.A., Chertkov O., Chi H.C., Christensen M.,
RA   Clark L.M., Cohn J.D., Denys M., Detter J.C., Dickson M.,
RA   Dimitrijevic-Bussod M., Escobar J., Fawcett J.J., Flowers D., Fotopulos D.,
RA   Glavina T., Gomez M., Gonzales E., Goodstein D., Goodwin L.A., Grady D.L.,
RA   Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E.,
RA   Huang W., Israni S., Jett J., Jewett P.B., Kadner K., Kimball H.,
RA   Kobayashi A., Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y.,
RA   Lowry S., Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L., Rash S.,
RA   Retterer J., Ricke D.O., Robinson D.L., Rodriguez A., Salamov A.,
RA   Saunders E.H., Scott D., Shough T., Stallings R.L., Stalvey M.,
RA   Sutherland R.D., Tapia R., Tesmer J.G., Thayer N., Thompson L.S., Tice H.,
RA   Torney D.C., Tran-Gyamfi M., Tsai M., Ulanovsky L.E., Ustaszewska A.,
RA   Vo N., White P.S., Williams A.L., Wills P.L., Wu J.-R., Wu K., Yang J.,
RA   DeJong P., Bruce D., Doggett N.A., Deaven L., Schmutz J., Grimwood J.,
RA   Richardson P., Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M.,
RA   Myers R.M., Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Brain, Eye, Placenta, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   INTERACTION WITH PSEN1 AND PSEN2.
RX   PubMed=11799129; DOI=10.1074/jbc.m112372200;
RA   Sai X., Kawamura Y., Kokame K., Yamaguchi H., Shiraishi H., Suzuki R.,
RA   Suzuki T., Kawaichi M., Miyata T., Kitamura T., De Strooper B.,
RA   Yanagisawa K., Komano H.;
RT   "Endoplasmic reticulum stress-inducible protein, Herp, enhances presenilin-
RT   mediated generation of amyloid beta-protein.";
RL   J. Biol. Chem. 277:12915-12920(2002).
RN   [9]
RP   CHARACTERIZATION.
RC   TISSUE=Skin fibroblast;
RX   PubMed=10708769; DOI=10.1016/s0014-5793(00)01253-9;
RA   van Laar T., Schouten T., Hoogervorst E., van Eck M., van der Eb A.J.,
RA   Terleth C.;
RT   "The novel MMS-inducible gene Mif1/KIAA0025 is a target of the unfolded
RT   protein response pathway.";
RL   FEBS Lett. 469:123-131(2000).
RN   [10]
RP   FUNCTION, AND INTERACTION WITH SYVN1.
RX   PubMed=16289116; DOI=10.1016/j.jmb.2005.10.020;
RA   Schulze A., Standera S., Buerger E., Kikkert M., van Voorden S., Wiertz E.,
RA   Koning F., Kloetzel P.-M., Seeger M.;
RT   "The ubiquitin-domain protein HERP forms a complex with components of the
RT   endoplasmic reticulum associated degradation pathway.";
RL   J. Mol. Biol. 354:1021-1027(2005).
RN   [11]
RP   INDUCTION.
RX   PubMed=16940180; DOI=10.1128/mcb.01046-06;
RA   Liang G., Audas T.E., Li Y., Cockram G.P., Dean J.D., Martyn A.C.,
RA   Kokame K., Lu R.;
RT   "Luman/CREB3 induces transcription of the endoplasmic reticulum (ER) stress
RT   response protein Herp through an ER stress response element.";
RL   Mol. Cell. Biol. 26:7999-8010(2006).
RN   [12]
RP   FUNCTION, AND INTERACTION WITH UBQLN1; UBQLN2 AND UBQLN4.
RX   PubMed=18307982; DOI=10.1016/j.bbrc.2008.02.086;
RA   Kim T.Y., Kim E., Yoon S.K., Yoon J.B.;
RT   "Herp enhances ER-associated protein degradation by recruiting
RT   ubiquilins.";
RL   Biochem. Biophys. Res. Commun. 369:741-746(2008).
RN   [13]
RP   INTERACTION WITH UBXN6.
RX   PubMed=18656546; DOI=10.1016/j.biocel.2008.06.008;
RA   Madsen L., Andersen K.M., Prag S., Moos T., Semple C.A., Seeger M.,
RA   Hartmann-Petersen R.;
RT   "Ubxd1 is a novel co-factor of the human p97 ATPase.";
RL   Int. J. Biochem. Cell Biol. 40:2927-2942(2008).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-135, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   STRUCTURE BY NMR OF 10-90.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the UBL-domain of HERP.";
RL   Submitted (NOV-2004) to the PDB data bank.
CC   -!- FUNCTION: Component of the endoplasmic reticulum quality control (ERQC)
CC       system also called ER-associated degradation (ERAD) involved in
CC       ubiquitin-dependent degradation of misfolded endoplasmic reticulum
CC       proteins. Could enhance presenilin-mediated amyloid-beta protein 40
CC       generation. Binds to ubiquilins and this interaction is required for
CC       efficient degradation of CD3D via the ERAD pathway (PubMed:18307982).
CC       {ECO:0000269|PubMed:16289116, ECO:0000269|PubMed:18307982}.
CC   -!- SUBUNIT: Interacts with PSEN1 and PSEN2. Interacts with SYVN1 and
CC       UBXN6. Interacts with UBQLN1, UBQLN2 and UBQLN4.
CC       {ECO:0000269|PubMed:11799129, ECO:0000269|PubMed:16289116,
CC       ECO:0000269|PubMed:18307982, ECO:0000269|PubMed:18656546}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:10922362}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:10922362}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC         Comment=Experimental confirmation may be lacking for some isoforms.;
CC       Name=1;
CC         IsoId=Q15011-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q15011-2; Sequence=VSP_006708;
CC       Name=3;
CC         IsoId=Q15011-3; Sequence=VSP_006708, VSP_006709;
CC       Name=4;
CC         IsoId=Q15011-4; Sequence=VSP_047333;
CC   -!- TISSUE SPECIFICITY: Widely expressed; in the brain, expression seems to
CC       be restricted to neurons and vascular smooth muscle cells. Present in
CC       activated microglia in senile plaques in the brain of patients with
CC       Alzheimer disease.
CC   -!- INDUCTION: Up-regulated by endoplasmic reticulum stress and CREB3.
CC       {ECO:0000269|PubMed:10922362, ECO:0000269|PubMed:16940180}.
CC   -!- MISCELLANEOUS: Although the precise topology is not known, experimental
CC       data suggest that both the N- and C-termini face the cytosol.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB034989; BAB07891.1; -; mRNA.
DR   EMBL; D14695; BAA03521.1; -; mRNA.
DR   EMBL; AF055001; AAC09355.1; -; mRNA.
DR   EMBL; AF055003; AAC09357.1; -; mRNA.
DR   EMBL; AB034990; BAB19010.1; -; Genomic_DNA.
DR   EMBL; CR457116; CAG33397.1; -; mRNA.
DR   EMBL; AC012181; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC000086; AAH00086.1; -; mRNA.
DR   EMBL; BC008320; AAH08320.1; -; mRNA.
DR   EMBL; BC009739; AAH09739.1; -; mRNA.
DR   EMBL; BC032673; AAH32673.1; -; mRNA.
DR   CCDS; CCDS10771.1; -. [Q15011-1]
DR   CCDS; CCDS45492.1; -. [Q15011-2]
DR   RefSeq; NP_001010989.1; NM_001010989.2. [Q15011-2]
DR   RefSeq; NP_001259032.1; NM_001272103.1.
DR   RefSeq; NP_055500.1; NM_014685.3. [Q15011-1]
DR   PDB; 1WGD; NMR; -; A=10-90.
DR   PDBsum; 1WGD; -.
DR   SMR; Q15011; -.
DR   BioGrid; 115060; 36.
DR   DIP; DIP-46662N; -.
DR   IntAct; Q15011; 17.
DR   MINT; Q15011; -.
DR   STRING; 9606.ENSP00000409555; -.
DR   iPTMnet; Q15011; -.
DR   PhosphoSitePlus; Q15011; -.
DR   BioMuta; HERPUD1; -.
DR   DMDM; 3123034; -.
DR   EPD; Q15011; -.
DR   jPOST; Q15011; -.
DR   MassIVE; Q15011; -.
DR   MaxQB; Q15011; -.
DR   PaxDb; Q15011; -.
DR   PeptideAtlas; Q15011; -.
DR   PRIDE; Q15011; -.
DR   ProteomicsDB; 20293; -.
DR   ProteomicsDB; 60361; -. [Q15011-1]
DR   ProteomicsDB; 60362; -. [Q15011-2]
DR   ProteomicsDB; 60363; -. [Q15011-3]
DR   Antibodypedia; 28691; 276 antibodies.
DR   DNASU; 9709; -.
DR   Ensembl; ENST00000300302; ENSP00000300302; ENSG00000051108. [Q15011-2]
DR   Ensembl; ENST00000344114; ENSP00000340931; ENSG00000051108. [Q15011-3]
DR   Ensembl; ENST00000379792; ENSP00000369118; ENSG00000051108. [Q15011-4]
DR   Ensembl; ENST00000439977; ENSP00000409555; ENSG00000051108. [Q15011-1]
DR   GeneID; 9709; -.
DR   KEGG; hsa:9709; -.
DR   UCSC; uc002eke.3; human. [Q15011-1]
DR   CTD; 9709; -.
DR   DisGeNET; 9709; -.
DR   GeneCards; HERPUD1; -.
DR   HGNC; HGNC:13744; HERPUD1.
DR   HPA; ENSG00000051108; Low tissue specificity.
DR   MIM; 608070; gene.
DR   neXtProt; NX_Q15011; -.
DR   OpenTargets; ENSG00000051108; -.
DR   PharmGKB; PA29252; -.
DR   eggNOG; KOG4583; Eukaryota.
DR   eggNOG; ENOG410ZJAF; LUCA.
DR   GeneTree; ENSGT00390000017671; -.
DR   HOGENOM; CLU_1194535_0_0_1; -.
DR   InParanoid; Q15011; -.
DR   KO; K14027; -.
DR   OMA; NQGQSPG; -.
DR   PhylomeDB; Q15011; -.
DR   TreeFam; TF324319; -.
DR   Reactome; R-HSA-380994; ATF4 activates genes in response to endoplasmic reticulum stress.
DR   SIGNOR; Q15011; -.
DR   ChiTaRS; HERPUD1; human.
DR   EvolutionaryTrace; Q15011; -.
DR   GeneWiki; HERPUD1; -.
DR   GenomeRNAi; 9709; -.
DR   Pharos; Q15011; Tbio.
DR   PRO; PR:Q15011; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   RNAct; Q15011; protein.
DR   Bgee; ENSG00000051108; Expressed in tibia and 235 other tissues.
DR   ExpressionAtlas; Q15011; baseline and differential.
DR   Genevisible; Q15011; HS.
DR   GO; GO:0005623; C:cell; IEA:GOC.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:1990037; C:Lewy body core; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0044325; F:ion channel binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:1990756; F:protein binding, bridging involved in substrate recognition for ubiquitination; IEA:Ensembl.
DR   GO; GO:0032469; P:endoplasmic reticulum calcium ion homeostasis; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0030968; P:endoplasmic reticulum unfolded protein response; IBA:GO_Central.
DR   GO; GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl.
DR   GO; GO:1902236; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; IDA:ParkinsonsUK-UCL.
DR   GO; GO:2001243; P:negative regulation of intrinsic apoptotic signaling pathway; IGI:ParkinsonsUK-UCL.
DR   GO; GO:0036499; P:PERK-mediated unfolded protein response; TAS:Reactome.
DR   GO; GO:1903071; P:positive regulation of ER-associated ubiquitin-dependent protein catabolic process; IDA:ParkinsonsUK-UCL.
DR   GO; GO:1903069; P:regulation of ER-associated ubiquitin-dependent protein catabolic process; IBA:GO_Central.
DR   GO; GO:0031396; P:regulation of protein ubiquitination; IEA:Ensembl.
DR   GO; GO:0034976; P:response to endoplasmic reticulum stress; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0006986; P:response to unfolded protein; IEP:UniProtKB.
DR   GO; GO:0030970; P:retrograde protein transport, ER to cytosol; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IBA:GO_Central.
DR   InterPro; IPR039751; HERPUD1/2.
DR   InterPro; IPR000626; Ubiquitin-like_dom.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   PANTHER; PTHR12943; PTHR12943; 1.
DR   Pfam; PF00240; ubiquitin; 1.
DR   SMART; SM00213; UBQ; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   PROSITE; PS50053; UBIQUITIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Endoplasmic reticulum;
KW   Membrane; Phosphoprotein; Polymorphism; Reference proteome; Transmembrane;
KW   Transmembrane helix; Unfolded protein response.
FT   CHAIN           1..391
FT                   /note="Homocysteine-responsive endoplasmic reticulum-
FT                   resident ubiquitin-like domain member 1 protein"
FT                   /id="PRO_0000114920"
FT   TOPO_DOM        1..263
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        264..284
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        285..289
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        290..310
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        311..391
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          10..72
FT                   /note="Ubiquitin-like"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00214"
FT   REGION          115..200
FT                   /note="Interaction with UBQLN1"
FT                   /evidence="ECO:0000269|PubMed:18307982"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000244|PubMed:22814378"
FT   MOD_RES         135
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   VAR_SEQ         75..99
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_047333"
FT   VAR_SEQ         76
FT                   /note="Missing (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334, ECO:0000303|Ref.3"
FT                   /id="VSP_006708"
FT   VAR_SEQ         145..302
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_006709"
FT   VARIANT         50
FT                   /note="R -> H (in dbSNP:rs2217332)"
FT                   /id="VAR_024277"
FT   STRAND          11..15
FT                   /evidence="ECO:0000244|PDB:1WGD"
FT   STRAND          17..20
FT                   /evidence="ECO:0000244|PDB:1WGD"
FT   STRAND          24..27
FT                   /evidence="ECO:0000244|PDB:1WGD"
FT   HELIX           34..44
FT                   /evidence="ECO:0000244|PDB:1WGD"
FT   TURN            51..53
FT                   /evidence="ECO:0000244|PDB:1WGD"
FT   STRAND          55..58
FT                   /evidence="ECO:0000244|PDB:1WGD"
FT   STRAND          65..67
FT                   /evidence="ECO:0000244|PDB:1WGD"
FT   HELIX           69..72
FT                   /evidence="ECO:0000244|PDB:1WGD"
FT   STRAND          75..77
FT                   /evidence="ECO:0000244|PDB:1WGD"
FT   STRAND          79..85
FT                   /evidence="ECO:0000244|PDB:1WGD"
SQ   SEQUENCE   391 AA;  43720 MW;  3CA827DC7EF0ED22 CRC64;
     MESETEPEPV TLLVKSPNQR HRDLELSGDR GWSVGHLKAH LSRVYPERPR PEDQRLIYSG
     KLLLDHQCLR DLLPKQEKRH VLHLVCNVKS PSKMPEINAK VAESTEEPAG SNRGQYPEDS
     SSDGLRQREV LRNLSSPGWE NISRPEAAQQ AFQGLGPGFS GYTPYGWLQL SWFQQIYARQ
     YYMQYLAATA ASGAFVPPPS AQEIPVVSAP APAPIHNQFP AENQPANQNA APQVVVNPGA
     NQNLRMNAQG GPIVEEDDEI NRDWLDWTYS AATFSVFLSI LYFYSSLSRF LMVMGATVVM
     YLHHVGWFPF RPRPVQNFPN DGPPPDVVNQ DPNNNLQEGT DPETEDPNHL PPDRDVLDGE
     QTSPSFMSTA WLVFKTFFAS LLPEGPPAIA N
//
ID   Q53FP9_HUMAN            Unreviewed;       391 AA.
AC   Q53FP9;
DT   24-MAY-2005, integrated into UniProtKB/TrEMBL.
DT   24-MAY-2005, sequence version 1.
DT   11-DEC-2019, entry version 64.
DE   SubName: Full=Homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 variant {ECO:0000313|EMBL:BAD96953.1};
DE   Flags: Fragment;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAD96953.1};
RN   [1] {ECO:0000313|EMBL:BAD96953.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Stomach mucosa {ECO:0000313|EMBL:BAD96953.1};
RX   PubMed=8125298; DOI=10.1016/0378-1119(94)90802-8;
RA   Maruyama K., Sugano S.;
RT   "Oligo-capping: a simple method to replace the cap structure of eukaryotic
RT   mRNAs with oligoribonucleotides.";
RL   Gene 138:171-174(1994).
RN   [2] {ECO:0000313|EMBL:BAD96953.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Stomach mucosa {ECO:0000313|EMBL:BAD96953.1};
RX   PubMed=9373149; DOI=10.1016/S0378-1119(97)00411-3;
RA   Suzuki Y., Yoshitomo K., Maruyama K., Suyama A., Sugano S.;
RT   "Construction and characterization of a full length-enriched and a 5'-end-
RT   enriched cDNA library.";
RL   Gene 200:149-156(1997).
RN   [3] {ECO:0000313|EMBL:BAD96953.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Stomach mucosa {ECO:0000313|EMBL:BAD96953.1};
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK223233; BAD96953.1; -; mRNA.
DR   RefSeq; NP_055500.1; NM_014685.3.
DR   PRIDE; Q53FP9; -.
DR   GeneID; 9709; -.
DR   KEGG; hsa:9709; -.
DR   CTD; 9709; -.
DR   eggNOG; KOG4583; Eukaryota.
DR   eggNOG; ENOG410ZJAF; LUCA.
DR   KO; K14027; -.
DR   OrthoDB; 1251727at2759; -.
DR   GenomeRNAi; 9709; -.
DR   InterPro; IPR039751; HERPUD1/2.
DR   InterPro; IPR000626; Ubiquitin-like_dom.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   PANTHER; PTHR12943; PTHR12943; 1.
DR   Pfam; PF00240; ubiquitin; 1.
DR   SMART; SM00213; UBQ; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   PROSITE; PS50053; UBIQUITIN_2; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN          10..72
FT                   /note="Ubiquitin-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50053"
FT   REGION          100..126
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          317..359
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        327..341
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        342..356
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   NON_TER         1
FT                   /evidence="ECO:0000313|EMBL:BAD96953.1"
SQ   SEQUENCE   391 AA;  43692 MW;  23A737C371E0ED22 CRC64;
     MESETEPEPV TLLVKSPNQR HRDLELSGDR GWSVGHLKAH LSRVYPERPR PEDQRLIYSG
     KLLLDHQCLR DLLPKQEKRH VLHLVCNVKS PSKMPEINAK VAESTEEPAG SNRGQYPEDS
     SSDGLRQREV LRNLSSPGWE NISRPEAAQQ AFQGLGPGFS GYTPYGWLQL SWFQQIYARQ
     YYMQYLAATA ASGAFVPPPS AQEIPVVSAP APAPIHNQFP AENQPANQNA APQVVVNPGA
     NQNLRMNAQG GPIVEEDDEI NRDWLDWTYS AATFSVFLSI LYFYSSLSRF LMVMGATVVM
     YLHHVGWFPF RPRPVQNFPN DGPPPDAVNQ DPNNNLQEGT DPETEDPNHL PPDRDVLDGE
     QTSPSFMSTA WLVFKTFFAS LLPEGPPAIA N
//
ID   B2R4R0_HUMAN            Unreviewed;       103 AA.
AC   B2R4R0;
DT   01-JUL-2008, integrated into UniProtKB/TrEMBL.
DT   01-JUL-2008, sequence version 1.
DT   22-APR-2020, entry version 120.
DE   RecName: Full=Histone H4 {ECO:0000256|RuleBase:RU000528};
GN   Name=HIST1H4J {ECO:0000313|EMBL:AAI48272.1};
GN   Synonyms=HIST1H4H {ECO:0000313|EMBL:EAW55556.1},
GN   HIST1H4L {ECO:0000313|EMBL:BAG70273.1};
GN   ORFNames=hCG_1640981 {ECO:0000313|EMBL:EAW55556.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG34857.1};
RN   [1] {ECO:0000313|EMBL:EAW55556.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:AAI48272.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M., Peck A.M.,
RA   Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S., Feolo M.,
RA   Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F., Schaefer C.F.,
RA   Buetow K., Bonner T.I., Haussler D., Kent J., Kiekhaus M., Furey T.,
RA   Brent M., Prange C., Schreiber K., Shapiro N., Bhat N.K., Hopkins R.F.,
RA   Hsie F., Driscoll T., Soares M.B., Casavant T.L., Scheetz T.E.,
RA   Brown-stein M.J., Usdin T.B., Toshiyuki S., Carninci P., Piao Y.,
RA   Dudekula D.B., Ko M.S., Kawakami K., Suzuki Y., Sugano S., Gruber C.E.,
RA   Smith M.R., Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y.,
RA   Wei C.L., Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W.,
RA   Fuh E., Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D., Granite S.J.,
RA   Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G., Blakesly R.W.,
RA   Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J.,
RA   Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L., Krzywinski M.I.,
RA   Liao N., Morin R., Morrin R., Palmquist D., Petrescu A.S., Skalska U.,
RA   Smailus D.E., Stott J.M., Schnerch A., Schein J.E., Jones S.J., Holt R.A.,
RA   Baross A., Marra M.A., Clifton S., Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3] {ECO:0000313|EMBL:EAW55556.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:BAG34857.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Corpus callosum {ECO:0000313|EMBL:BAG35087.1},
RC   Esophagus {ECO:0000313|EMBL:BAG38150.1},
RC   Tongue {ECO:0000313|EMBL:BAG34965.1}, and
RC   Uterus {ECO:0000313|EMBL:BAG34857.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Kaida T., Tsuchiya K., Iida Y.,
RA   Takayama Y., Murakawa K., Kanehori K., Andoh T., Kagawa N., Sato R.,
RA   Kawamura Y., Tanaka S., Kisu Y., Sugano S., Goshima N., Nomura N.,
RA   Isogai T.;
RT   "NEDO functional analysis of protein and research application project.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000313|EMBL:BAG70273.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Goshima N., Kawamura Y., Fukumoto A., Miura A., Honma R., Satoh R.,
RA   Wakamatsu A., Yamamoto J.-I., Kimura K., Nishikawa T., Andoh T., Iida Y.,
RA   Ishikawa K., Ito E., Kagawa N., Kaminaga C., Kanehori K., Kawakami B.,
RA   Kenmochi K.-I., Kimura R., Kobayashi M., Kuroita T., Kuwayama H.,
RA   Maruyama Y., Matsuo K., Minami K., Mitsubori M., Mori M., Morishita R.,
RA   Murase A., Nishikawa A., Nishikawa S., Okamoto T., Sakagami N.,
RA   Sakamoto Y., Sasaki Y., Seki T., Sono S., Sugiyama A., Sumiya T.,
RA   Takayama T., Takayama Y., Takeda H., Togashi T., Yahata K., Yamada H.,
RA   Yanagisawa Y., Endo Y., Imamoto F., Kisu Y., Tanaka S., Isogai T.,
RA   Imai J.-I., Watanabe S., Nomura N.;
RT   "Human Protein Factory: an infrastructure to convert the human
RT   transcriptome into the in vitro-expressed human proteome of versatile
RT   utility.";
RL   Submitted (JUL-2008) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact
CC       DNA into chromatin, limiting DNA accessibility to the cellular
CC       machineries which require DNA as a template. Histones thereby play a
CC       central role in transcription regulation, DNA repair, DNA replication
CC       and chromosomal stability. DNA accessibility is regulated via a complex
CC       set of post-translational modifications of histones, also called
CC       histone code, and nucleosome remodeling.
CC       {ECO:0000256|RuleBase:RU000528, ECO:0000256|SAAS:SAAS00581158}.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of
CC       DNA. {ECO:0000256|RuleBase:RU000528, ECO:0000256|SAAS:SAAS00581166}.
CC   -!- SUBCELLULAR LOCATION: Chromosome {ECO:0000256|SAAS:SAAS00846060}.
CC       Nucleus {ECO:0000256|SAAS:SAAS00846055}.
CC   -!- SIMILARITY: Belongs to the histone H4 family.
CC       {ECO:0000256|RuleBase:RU000528, ECO:0000256|SAAS:SAAS00581172}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC148271; AAI48272.1; -; mRNA.
DR   EMBL; AK311916; BAG34857.1; -; mRNA.
DR   EMBL; AK312028; BAG34965.1; -; mRNA.
DR   EMBL; AK312153; BAG35087.1; -; mRNA.
DR   EMBL; AK316561; BAG38150.1; -; mRNA.
DR   EMBL; AB451459; BAG70273.1; -; mRNA.
DR   EMBL; CH471087; EAW55556.1; -; Genomic_DNA.
DR   RefSeq; NP_001029249.1; NM_001034077.4.
DR   RefSeq; NP_003486.1; NM_003495.2.
DR   RefSeq; NP_003529.1; NM_003538.3.
DR   RefSeq; NP_003530.1; NM_003539.3.
DR   RefSeq; NP_003531.1; NM_003540.3.
DR   RefSeq; NP_003532.1; NM_003541.2.
DR   RefSeq; NP_003533.1; NM_003542.3.
DR   RefSeq; NP_003534.1; NM_003543.3.
DR   RefSeq; NP_003535.1; NM_003544.2.
DR   RefSeq; NP_003536.1; NM_003545.3.
DR   RefSeq; NP_003537.1; NM_003546.2.
DR   RefSeq; NP_003539.1; NM_003548.2.
DR   RefSeq; NP_068803.1; NM_021968.3.
DR   RefSeq; NP_778224.1; NM_175054.2.
DR   IntAct; B2R4R0; 1.
DR   Antibodypedia; 23657; 1794 antibodies.
DR   Antibodypedia; 70431; 14 antibodies.
DR   Antibodypedia; 73583; 163 antibodies.
DR   Antibodypedia; 73812; 17 antibodies.
DR   Antibodypedia; 73941; 388 antibodies.
DR   Antibodypedia; 74197; 161 antibodies.
DR   Antibodypedia; 75448; 6 antibodies.
DR   Antibodypedia; 75564; 46 antibodies.
DR   Antibodypedia; 76313; 21 antibodies.
DR   Antibodypedia; 76350; 3 antibodies.
DR   Antibodypedia; 76498; 4 antibodies.
DR   Antibodypedia; 76512; 3 antibodies.
DR   Antibodypedia; 76521; 8 antibodies.
DR   Antibodypedia; 76797; 52 antibodies.
DR   DNASU; 8294; -.
DR   DNASU; 8360; -.
DR   DNASU; 8362; -.
DR   DNASU; 8363; -.
DR   DNASU; 8364; -.
DR   DNASU; 8365; -.
DR   DNASU; 8366; -.
DR   DNASU; 8367; -.
DR   DNASU; 8368; -.
DR   DNASU; 8370; -.
DR   GeneID; 121504; -.
DR   GeneID; 554313; -.
DR   GeneID; 8294; -.
DR   GeneID; 8359; -.
DR   GeneID; 8360; -.
DR   GeneID; 8361; -.
DR   GeneID; 8362; -.
DR   GeneID; 8363; -.
DR   GeneID; 8364; -.
DR   GeneID; 8365; -.
DR   GeneID; 8366; -.
DR   GeneID; 8367; -.
DR   GeneID; 8368; -.
DR   GeneID; 8370; -.
DR   KEGG; hsa:121504; -.
DR   KEGG; hsa:554313; -.
DR   KEGG; hsa:8294; -.
DR   KEGG; hsa:8359; -.
DR   KEGG; hsa:8360; -.
DR   KEGG; hsa:8361; -.
DR   KEGG; hsa:8362; -.
DR   KEGG; hsa:8363; -.
DR   KEGG; hsa:8364; -.
DR   KEGG; hsa:8365; -.
DR   KEGG; hsa:8366; -.
DR   KEGG; hsa:8367; -.
DR   KEGG; hsa:8368; -.
DR   KEGG; hsa:8370; -.
DR   CTD; 121504; -.
DR   CTD; 554313; -.
DR   CTD; 8294; -.
DR   CTD; 8359; -.
DR   CTD; 8360; -.
DR   CTD; 8361; -.
DR   CTD; 8362; -.
DR   CTD; 8363; -.
DR   CTD; 8364; -.
DR   CTD; 8365; -.
DR   CTD; 8366; -.
DR   CTD; 8367; -.
DR   CTD; 8368; -.
DR   CTD; 8370; -.
DR   EuPathDB; HostDB:ENSG00000158406.4; -.
DR   EuPathDB; HostDB:ENSG00000197061.4; -.
DR   EuPathDB; HostDB:ENSG00000197238.4; -.
DR   EuPathDB; HostDB:ENSG00000197837.3; -.
DR   EuPathDB; HostDB:ENSG00000270276.2; -.
DR   EuPathDB; HostDB:ENSG00000270882.2; -.
DR   EuPathDB; HostDB:ENSG00000273542.1; -.
DR   EuPathDB; HostDB:ENSG00000274618.1; -.
DR   EuPathDB; HostDB:ENSG00000275126.1; -.
DR   EuPathDB; HostDB:ENSG00000276180.1; -.
DR   EuPathDB; HostDB:ENSG00000276966.2; -.
DR   EuPathDB; HostDB:ENSG00000277157.1; -.
DR   EuPathDB; HostDB:ENSG00000278637.1; -.
DR   EuPathDB; HostDB:ENSG00000278705.1; -.
DR   PharmGKB; PA29169; -.
DR   eggNOG; KOG3467; Eukaryota.
DR   eggNOG; COG2036; LUCA.
DR   HOGENOM; CLU_109117_2_3_1; -.
DR   KO; K11254; -.
DR   OMA; QKEHING; -.
DR   OrthoDB; 1594208at2759; -.
DR   ChiTaRS; HIST1H4H; human.
DR   Bgee; ENSG00000158406; Expressed in stomach and 162 other tissues.
DR   GO; GO:0000786; C:nucleosome; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0006352; P:DNA-templated transcription, initiation; IEA:InterPro.
DR   CDD; cd00076; H4; 1.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR035425; CENP-T/H4_C.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR001951; Histone_H4.
DR   InterPro; IPR019809; Histone_H4_CS.
DR   InterPro; IPR004823; TAF_TATA-bd.
DR   Pfam; PF15511; CENP-T_C; 1.
DR   PRINTS; PR00623; HISTONEH4.
DR   SMART; SM00417; H4; 1.
DR   SMART; SM00803; TAF; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
DR   PROSITE; PS00047; HISTONE_H4; 1.
PE   2: Evidence at transcript level;
KW   Chromosome {ECO:0000256|RuleBase:RU000528, ECO:0000256|SAAS:SAAS00472453};
KW   DNA-binding {ECO:0000256|RuleBase:RU000528, ECO:0000256|SAAS:SAAS00472453};
KW   Nucleosome core {ECO:0000256|RuleBase:RU000528,
KW   ECO:0000256|SAAS:SAAS00472453};
KW   Nucleus {ECO:0000256|RuleBase:RU000528, ECO:0000256|SAAS:SAAS00846057}.
FT   DOMAIN          28..93
FT                   /note="TAF"
FT                   /evidence="ECO:0000259|SMART:SM00803"
FT   REGION          1..20
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   103 AA;  11367 MW;  A9E5DFD3F8B97598 CRC64;
     MSGRGKGGKG LGKGGAKRHR KVLRDNIQGI TKPAIRRLAR RGGVKRISGL IYEETRGVLK
     VFLENVIRDA VTYTEHAKRK TVTAMDVVYA LKRQGRTLYG FGG
//
ID   H4_HUMAN                Reviewed;         103 AA.
AC   P62805; A2VCL0; P02304; P02305; Q6DRA9; Q6FGB8; Q6NWP7;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   22-APR-2020, entry version 199.
DE   RecName: Full=Histone H4;
GN   Name=H4C1; Synonyms=H4/A, H4FA, HIST1H4A;
GN   and
GN   Name=H4C2; Synonyms=H4/I, H4FI, HIST1H4B;
GN   and
GN   Name=H4C3; Synonyms=H4/G, H4FG, HIST1H4C;
GN   and
GN   Name=H4C4; Synonyms=H4/B, H4FB, HIST1H4D;
GN   and
GN   Name=H4C5; Synonyms=H4/J, H4FJ, HIST1H4E;
GN   and
GN   Name=H4C6; Synonyms=H4/C, H4FC, HIST1H4F;
GN   and
GN   Name=H4C8; Synonyms=H4/H, H4FH, HIST1H4H;
GN   and
GN   Name=H4C9; Synonyms=H4/M, H4FM, HIST1H4I;
GN   and
GN   Name=H4C11; Synonyms=H4/E, H4FE, HIST1H4J;
GN   and
GN   Name=H4C12; Synonyms=H4/D, H4FD, HIST1H4K;
GN   and
GN   Name=H4C13; Synonyms=H4/K, H4FK, HIST1H4L;
GN   and
GN   Name=H4C14; Synonyms=H4/N, H4F2, H4FN, HIST2H4, HIST2H4A;
GN   and
GN   Name=H4C15; Synonyms=H4/O, H4FO, HIST2H4B;
GN   and
GN   Name=H4-16; Synonyms=HIST4H4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=6314274; DOI=10.1093/nar/11.20.7069;
RA   Sierra F., Stein G., Stein J.;
RT   "Structure and in vitro transcription of a human H4 histone gene.";
RL   Nucleic Acids Res. 11:7069-7086(1983).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3035717; DOI=10.1126/science.3035717;
RA   Pauli U., Chrysogelos S., Stein G., Stein J., Nick H.;
RT   "Protein-DNA interactions in vivo upstream of a cell cycle-regulated human
RT   H4 histone gene.";
RL   Science 236:1308-1311(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Placenta;
RX   PubMed=1916825; DOI=10.1016/0888-7543(91)90183-f;
RA   Albig W., Kardalinou E., Drabent B., Zimmer A., Doenecke D.;
RT   "Isolation and characterization of two human H1 histone genes within
RT   clusters of core histone genes.";
RL   Genomics 10:940-948(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=7626218; DOI=10.1089/dna.1995.14.591;
RA   Drabent B., Kardalinou E., Bode C., Doenecke D.;
RT   "Association of histone H4 genes with the mammalian testis-specific H1t
RT   histone gene.";
RL   DNA Cell Biol. 14:591-597(1995).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9031620; DOI=10.1016/s0378-1119(96)00582-3;
RA   Albig W., Meergans T., Doenecke D.;
RT   "Characterization of the H1.5 gene completes the set of human H1 subtype
RT   genes.";
RL   Gene 184:141-148(1997).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9439656; DOI=10.1007/s004390050630;
RA   Albig W., Doenecke D.;
RT   "The human histone gene cluster at the D6S105 locus.";
RL   Hum. Genet. 101:284-294(1997).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9119399; DOI=10.1006/geno.1996.4592;
RA   Albig W., Kioschis P., Poustka A., Meergans K., Doenecke D.;
RT   "Human histone gene organization: nonregular arrangement within a large
RT   cluster.";
RL   Genomics 40:314-322(1997).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (H4C1; H4C2; H4C3; H4C4; H4C5; H4C6;
RP   H4C8; H4C9; H4C11; H4C12; H4C13; H4C14 AND H4-16).
RX   PubMed=12408966; DOI=10.1006/geno.2002.6850;
RA   Marzluff W.F., Gongidi P., Woods K.R., Jin J., Maltais L.J.;
RT   "The human and mouse replication-dependent histone genes.";
RL   Genomics 80:487-498(2002).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8988030;
RA   Akasaka T., Miura I., Takahashi N., Akasaka H., Yonetani N., Ohno H.,
RA   Fukuhara S., Okuma M.;
RT   "A recurring translocation, t(3;6)(q27;p21), in non-Hodgkin's lymphoma
RT   results in replacement of the 5' regulatory region of BCL6 with a novel H4
RT   histone gene.";
RL   Cancer Res. 57:7-12(1997).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=15527963; DOI=10.1016/j.gene.2004.07.036;
RA   Braastad C.D., Hovhannisyan H., van Wijnen A.J., Stein J.L., Stein G.S.;
RT   "Functional characterization of a human histone gene cluster duplication.";
RL   Gene 342:35-40(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (H4C6; H4C8 AND H4C14).
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S., Neubert P.,
RA   Kstrang K., Schatten R., Shen B., Henze S., Mar W., Korn B., Zuo D., Hu Y.,
RA   LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (H4C1; H4C2; H4C3; H4C4;
RP   H4C5; H4C6; H4C8; H4C9; H4C11; H4C12 AND H4C13).
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [14]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cerebellum, Eye, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [15]
RP   PROTEIN SEQUENCE OF 25-36; 47-56; 61-78 AND 81-93, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   TISSUE=B-cell lymphoma;
RA   Bienvenut W.V.;
RL   Submitted (MAR-2005) to UniProtKB.
RN   [16]
RP   ACETYLATION AT LYS-6; LYS-9; LYS-13 AND LYS-17.
RX   PubMed=7664735; DOI=10.1002/j.1460-2075.1995.tb00066.x;
RA   O'Neill L.P., Turner B.M.;
RT   "Histone H4 acetylation distinguishes coding regions of the human genome
RT   from heterochromatin in a differentiation-dependent but transcription-
RT   independent manner.";
RL   EMBO J. 14:3946-3957(1995).
RN   [17]
RP   DNA-BINDING REGION.
RX   PubMed=3340182; DOI=10.1038/331365a0;
RA   Ebralidse K.K., Grachev S.A., Mirzabekov A.D.;
RT   "A highly basic histone H4 domain bound to the sharply bent region of
RT   nucleosomal DNA.";
RL   Nature 331:365-367(1988).
RN   [18]
RP   ACETYLATION AT LYS-6; LYS-9; LYS-13 AND LYS-17.
RX   PubMed=2474456; DOI=10.1016/0014-5793(89)80947-0;
RA   Turner B.M., O'Neill L.P., Allan I.M.;
RT   "Histone H4 acetylation in human cells. Frequency of acetylation at
RT   different sites defined by immunolabeling with site-specific antibodies.";
RL   FEBS Lett. 253:141-145(1989).
RN   [19]
RP   METHYLATION AT ARG-4.
RX   PubMed=11448779; DOI=10.1016/s0960-9822(01)00294-9;
RA   Strahl B.D., Briggs S.D., Brame C.J., Caldwell J.A., Koh S.S., Ma H.,
RA   Cook R.G., Shabanowitz J., Hunt D.F., Stallcup M.R., Allis C.D.;
RT   "Methylation of histone H4 at arginine 3 occurs in vivo and is mediated by
RT   the nuclear receptor coactivator PRMT1.";
RL   Curr. Biol. 11:996-1000(2001).
RN   [20]
RP   METHYLATION AT ARG-4.
RX   PubMed=11387442; DOI=10.1126/science.1060781;
RA   Wang H., Huang Z.-Q., Xia L., Feng Q., Erdjument-Bromage H., Strahl B.D.,
RA   Briggs S.D., Allis C.D., Wong J., Tempst P., Zhang Y.;
RT   "Methylation of histone H4 at arginine 3 facilitating transcriptional
RT   activation by nuclear hormone receptor.";
RL   Science 293:853-857(2001).
RN   [21]
RP   INVOLVEMENT IN B-CELL NON-HODGKIN LYMPHOMA, AND CHROMOSOMAL TRANSLOCATION
RP   WITH BCL6.
RX   PubMed=12414651;
RA   Kurata M., Maesako Y., Ueda C., Nishikori M., Akasaka T., Uchiyama T.,
RA   Ohno H.;
RT   "Characterization of t(3;6)(q27;p21) breakpoints in B-cell non-Hodgkin's
RT   lymphoma and construction of the histone H4/BCL6 fusion gene, leading to
RT   altered expression of Bcl-6.";
RL   Cancer Res. 62:6224-6230(2002).
RN   [22]
RP   METHYLATION AT LYS-21.
RX   PubMed=12086618; DOI=10.1016/s1097-2765(02)00548-8;
RA   Nishioka K., Rice J.C., Sarma K., Erdjument-Bromage H., Werner J., Wang Y.,
RA   Chuikov S., Valenzuela P., Tempst P., Steward R., Lis J.T., Allis C.D.,
RA   Reinberg D.;
RT   "PR-Set7 is a nucleosome-specific methyltransferase that modifies lysine 20
RT   of histone H4 and is associated with silent chromatin.";
RL   Mol. Cell 9:1201-1213(2002).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.;
RT   "Proteomic characterization of the human centrosome by protein correlation
RT   profiling.";
RL   Nature 426:570-574(2003).
RN   [24]
RP   SUMOYLATION.
RX   PubMed=14578449; DOI=10.1073/pnas.1735528100;
RA   Shiio Y., Eisenman R.N.;
RT   "Histone sumoylation is associated with transcriptional repression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:13225-13230(2003).
RN   [25]
RP   CITRULLINATION AT ARG-4, AND METHYLATION AT ARG-4.
RX   PubMed=15345777; DOI=10.1126/science.1101400;
RA   Wang Y., Wysocka J., Sayegh J., Lee Y.-H., Perlin J.R., Leonelli L.,
RA   Sonbuchner L.S., McDonald C.H., Cook R.G., Dou Y., Roeder R.G., Clarke S.,
RA   Stallcup M.R., Allis C.D., Coonrod S.A.;
RT   "Human PAD4 regulates histone arginine methylation levels via
RT   demethylimination.";
RL   Science 306:279-283(2004).
RN   [26]
RP   METHYLATION AT LYS-21.
RX   PubMed=15964846; DOI=10.1074/jbc.m501691200;
RA   Yin Y., Liu C., Tsai S.N., Zhou B., Ngai S.M., Zhu G.;
RT   "SET8 recognizes the sequence RHRK20VLRDN within the N terminus of histone
RT   H4 and mono-methylates lysine 20.";
RL   J. Biol. Chem. 280:30025-30031(2005).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-52, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [29]
RP   UBIQUITINATION.
RX   PubMed=16678110; DOI=10.1016/j.molcel.2006.03.035;
RA   Wang H., Zhai L., Xu J., Joo H.-Y., Jackson S., Erdjument-Bromage H.,
RA   Tempst P., Xiong Y., Zhang Y.;
RT   "Histone H3 and H4 ubiquitylation by the CUL4-DDB-ROC1 ubiquitin ligase
RT   facilitates cellular response to DNA damage.";
RL   Mol. Cell 22:383-394(2006).
RN   [30]
RP   CITRULLINATION AT ARG-4.
RX   PubMed=16567635; DOI=10.1073/pnas.0509639103;
RA   Arita K., Shimizu T., Hashimoto H., Hidaka Y., Yamada M., Sato M.;
RT   "Structural basis for histone N-terminal recognition by human
RT   peptidylarginine deiminase 4.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:5291-5296(2006).
RN   [31]
RP   ACETYLATION AT SER-2; LYS-13 AND LYS-17, PHOSPHORYLATION AT SER-2, AND
RP   METHYLATION AT LYS-21.
RX   PubMed=17967882; DOI=10.1128/mcb.01517-07;
RA   Pesavento J.J., Yang H., Kelleher N.L., Mizzen C.A.;
RT   "Certain and progressive methylation of histone H4 at lysine 20 during the
RT   cell cycle.";
RL   Mol. Cell. Biol. 28:468-486(2008).
RN   [32]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [33]
RP   ACETYLATION AT LYS-92, AND UBIQUITINATION AT LYS-92.
RX   PubMed=19818714; DOI=10.1016/j.molcel.2009.08.019;
RA   Yan Q., Dutt S., Xu R., Graves K., Juszczynski P., Manis J.P., Shipp M.A.;
RT   "BBAP monoubiquitylates histone H4 at lysine 91 and selectively modulates
RT   the DNA damage response.";
RL   Mol. Cell 36:110-120(2009).
RN   [34]
RP   PROPIONYLATION AT LYS-9; LYS-17; LYS-32; LYS-45; LYS-78; LYS-80 AND LYS-92,
RP   AND BUTYRYLATION AT LYS-9; LYS-17; LYS-32; LYS-45; LYS-78; LYS-80 AND
RP   LYS-92.
RX   PubMed=17267393; DOI=10.1074/mcp.m700021-mcp200;
RA   Chen Y., Sprung R., Tang Y., Ball H., Sangras B., Kim S.C., Falck J.R.,
RA   Peng J., Gu W., Zhao Y.;
RT   "Lysine propionylation and butyrylation are novel post-translational
RT   modifications in histones.";
RL   Mol. Cell. Proteomics 6:812-819(2007).
RN   [35]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [36]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-6; LYS-9; LYS-13; LYS-17 AND
RP   LYS-32, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [37]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48 AND TYR-52, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [38]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [39]
RP   CROTONYLATION AT LYS-6; LYS-9 AND LYS-13.
RX   PubMed=21925322; DOI=10.1016/j.cell.2011.08.008;
RA   Tan M., Luo H., Lee S., Jin F., Yang J.S., Montellier E., Buchou T.,
RA   Cheng Z., Rousseaux S., Rajagopal N., Lu Z., Ye Z., Zhu Q., Wysocka J.,
RA   Ye Y., Khochbin S., Ren B., Zhao Y.;
RT   "Identification of 67 histone marks and histone lysine crotonylation as a
RT   new type of histone modification.";
RL   Cell 146:1016-1028(2011).
RN   [40]
RP   PHOSPHORYLATION AT SER-48.
RX   PubMed=21724829; DOI=10.1101/gad.2055511;
RA   Kang B., Pu M., Hu G., Wen W., Dong Z., Zhao K., Stillman B., Zhang Z.;
RT   "Phosphorylation of H4 Ser 47 promotes HIRA-mediated nucleosome assembly.";
RL   Genes Dev. 25:1359-1364(2011).
RN   [41]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [42]
RP   SUCCINYLATION AT LYS-13; LYS-32; LYS-78 AND LYS-92.
RX   PubMed=22389435; DOI=10.1074/mcp.m111.015875;
RA   Xie Z., Dai J., Dai L., Tan M., Cheng Z., Wu Y., Boeke J.D., Zhao Y.;
RT   "Lysine succinylation and lysine malonylation in histones.";
RL   Mol. Cell. Proteomics 11:100-107(2012).
RN   [43]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [44]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48 AND TYR-89, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [45]
RP   HYDROXYBUTYRYLATION AT LYS-6; LYS-9; LYS-13; LYS-17; LYS-32; LYS-45;
RP   LYS-60; LYS-78; LYS-80 AND LYS-92.
RX   PubMed=24681537; DOI=10.1038/nchembio.1497;
RA   Dai L., Peng C., Montellier E., Lu Z., Chen Y., Ishii H., Debernardi A.,
RA   Buchou T., Rousseaux S., Jin F., Sabari B.R., Deng Z., Allis C.D., Ren B.,
RA   Khochbin S., Zhao Y.;
RT   "Lysine 2-hydroxyisobutyrylation is a widely distributed active histone
RT   mark.";
RL   Nat. Chem. Biol. 10:365-370(2014).
RN   [46]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-13, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [47]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [48]
RP   BUTYRYLATION AT LYS-6; LYS-9; LYS-13 AND LYS-17.
RX   PubMed=27105113; DOI=10.1016/j.molcel.2016.03.014;
RA   Goudarzi A., Zhang D., Huang H., Barral S., Kwon O.K., Qi S., Tang Z.,
RA   Buchou T., Vitte A.L., He T., Cheng Z., Montellier E., Gaucher J.,
RA   Curtet S., Debernardi A., Charbonnier G., Puthier D., Petosa C., Panne D.,
RA   Rousseaux S., Roeder R.G., Zhao Y., Khochbin S.;
RT   "Dynamic competing histone H4 K5K8 acetylation and butyrylation are
RT   hallmarks of highly active gene promoters.";
RL   Mol. Cell 62:169-180(2016).
RN   [49]
RP   HYDROXYBUTYRYLATION AT LYS-9; LYS-13; LYS-32; LYS-78 AND LYS-92.
RX   PubMed=27105115; DOI=10.1016/j.molcel.2016.03.036;
RA   Xie Z., Zhang D., Chung D., Tang Z., Huang H., Dai L., Qi S., Li J.,
RA   Colak G., Chen Y., Xia C., Peng C., Ruan H., Kirkey M., Wang D.,
RA   Jensen L.M., Kwon O.K., Lee S., Pletcher S.D., Tan M., Lombard D.B.,
RA   White K.P., Zhao H., Li J., Roeder R.G., Yang X., Zhao Y.;
RT   "Metabolic regulation of gene expression by histone lysine beta-
RT   hydroxybutyrylation.";
RL   Mol. Cell 62:194-206(2016).
RN   [50]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-21; LYS-32; LYS-60; LYS-80 AND
RP   LYS-92, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [51]
RP   GLUTARYLATION AT LYS-6; LYS-13; LYS-32; LYS-60 LYS-78; LYS-80 AND LYS-92.
RX   PubMed=31542297; DOI=10.1016/j.molcel.2019.08.018;
RA   Bao X., Liu Z., Zhang W., Gladysz K., Fung Y.M.E., Tian G., Xiong Y.,
RA   Wong J.W.H., Yuen K.W.Y., Li X.D.;
RT   "Glutarylation of histone H4 lysine 91 regulates chromatin dynamics.";
RL   Mol. Cell 0:0-0(2019).
RN   [52]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS).
RX   PubMed=15951514; DOI=10.1093/nar/gki663;
RA   Tsunaka Y., Kajimura N., Tate S., Morikawa K.;
RT   "Alteration of the nucleosomal DNA path in the crystal structure of a human
RT   nucleosome core particle.";
RL   Nucleic Acids Res. 33:3424-3434(2005).
RN   [53] {ECO:0000244|PDB:5AY8}
RP   X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) IN COMPLEX WITH H2A; H2B AND H3.Y.
RX   PubMed=27016736; DOI=10.1093/nar/gkw202;
RA   Kujirai T., Horikoshi N., Sato K., Maehara K., Machida S., Osakabe A.,
RA   Kimura H., Ohkawa Y., Kurumizaka H.;
RT   "Structure and function of human histone H3.Y nucleosome.";
RL   Nucleic Acids Res. 44:6127-6141(2016).
RN   [54]
RP   VARIANT [LARGE SCALE ANALYSIS] GLN-64.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact
CC       DNA into chromatin, limiting DNA accessibility to the cellular
CC       machineries which require DNA as a template. Histones thereby play a
CC       central role in transcription regulation, DNA repair, DNA replication
CC       and chromosomal stability. DNA accessibility is regulated via a complex
CC       set of post-translational modifications of histones, also called
CC       histone code, and nucleosome remodeling.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of
CC       DNA.
CC   -!- INTERACTION:
CC       P62805; P35609: ACTN2; NbExp=3; IntAct=EBI-302023, EBI-77797;
CC       P62805; Q9Y294: ASF1A; NbExp=14; IntAct=EBI-302023, EBI-749553;
CC       P62805; Q12830: BPTF; NbExp=3; IntAct=EBI-302023, EBI-1560273;
CC       P62805; Q12830-4: BPTF; NbExp=16; IntAct=EBI-302023, EBI-4288838;
CC       P62805; P25440: BRD2; NbExp=5; IntAct=EBI-302023, EBI-2874802;
CC       P62805; O60885-1: BRD4; NbExp=10; IntAct=EBI-302023, EBI-9345088;
CC       P62805; P55201: BRPF1; NbExp=8; IntAct=EBI-302023, EBI-2837428;
CC       P62805; P45973: CBX5; NbExp=2; IntAct=EBI-302023, EBI-78219;
CC       P62805; P49450: CENPA; NbExp=6; IntAct=EBI-302023, EBI-1751979;
CC       P62805; P49450-1: CENPA; NbExp=2; IntAct=EBI-302023, EBI-15826012;
CC       P62805; Q9NQ92: COPRS; NbExp=3; IntAct=EBI-302023, EBI-1642558;
CC       P62805; Q92793: CREBBP; NbExp=6; IntAct=EBI-302023, EBI-81215;
CC       P62805; P45481: Crebbp; Xeno; NbExp=2; IntAct=EBI-302023, EBI-296306;
CC       P62805; P04908: H2AC8; NbExp=11; IntAct=EBI-302023, EBI-358971;
CC       P62805; P16104: H2AFX; NbExp=4; IntAct=EBI-302023, EBI-494830;
CC       P62805; P84243: H3-3B; NbExp=12; IntAct=EBI-302023, EBI-120658;
CC       P62805; P68431: H3C12; NbExp=7; IntAct=EBI-302023, EBI-79722;
CC       P62805; O14929: HAT1; NbExp=7; IntAct=EBI-302023, EBI-2339359;
CC       P62805; Q13547: HDAC1; NbExp=3; IntAct=EBI-302023, EBI-301834;
CC       P62805; Q71DI3: HIST2H3A; NbExp=4; IntAct=EBI-302023, EBI-750650;
CC       P62805; Q16695: HIST3H3; NbExp=3; IntAct=EBI-302023, EBI-358900;
CC       P62805; Q9H9V9: JMJD4; NbExp=3; IntAct=EBI-302023, EBI-2866290;
CC       P62805; O75164: KDM4A; NbExp=7; IntAct=EBI-302023, EBI-936709;
CC       P62805; Q9NQR1: KMT5A; NbExp=5; IntAct=EBI-302023, EBI-1268946;
CC       P62805; Q9Y468: L3MBTL1; NbExp=4; IntAct=EBI-302023, EBI-1265089;
CC       P62805; Q05BQ5: MBTD1; NbExp=3; IntAct=EBI-302023, EBI-5666902;
CC       P62805; P49736: MCM2; NbExp=9; IntAct=EBI-302023, EBI-374819;
CC       P62805; P25205: MCM3; NbExp=2; IntAct=EBI-302023, EBI-355153;
CC       P62805; P33992: MCM5; NbExp=2; IntAct=EBI-302023, EBI-359410;
CC       P62805; Q86UY6-1: NAA40; NbExp=3; IntAct=EBI-302023, EBI-16140302;
CC       P62805; Q9BVI0: PHF20; NbExp=3; IntAct=EBI-302023, EBI-2560802;
CC       P62805; A8MW92: PHF20L1; NbExp=2; IntAct=EBI-302023, EBI-2560834;
CC       P62805; Q99873: PRMT1; NbExp=2; IntAct=EBI-302023, EBI-78738;
CC       P62805; O14744: PRMT5; NbExp=6; IntAct=EBI-302023, EBI-351098;
CC       P62805; Q582G4: PRMT7; Xeno; NbExp=4; IntAct=EBI-302023, EBI-16101095;
CC       P62805; P62826: RAN; NbExp=2; IntAct=EBI-302023, EBI-286642;
CC       P62805; Q16576: RBBP7; NbExp=9; IntAct=EBI-302023, EBI-352227;
CC       P62805; Q14684-1: RRP1B; NbExp=3; IntAct=EBI-302023, EBI-5280110;
CC       P62805; P38890: SET5; Xeno; NbExp=2; IntAct=EBI-302023, EBI-24263;
CC       P62805; Q9VK33: Sfmbt; Xeno; NbExp=10; IntAct=EBI-302023, EBI-117801;
CC       P62805; Q8IUQ4: SIAH1; NbExp=3; IntAct=EBI-302023, EBI-747107;
CC       P62805; O60264: SMARCA5; NbExp=2; IntAct=EBI-302023, EBI-352588;
CC       P62805; Q04724: TLE1; NbExp=6; IntAct=EBI-302023, EBI-711424;
CC       P62805; Q12888: TP53BP1; NbExp=14; IntAct=EBI-302023, EBI-396540;
CC       P62805; Q12888-1: TP53BP1; NbExp=3; IntAct=EBI-302023, EBI-8022649;
CC       P62805; P63104: YWHAZ; NbExp=3; IntAct=EBI-302023, EBI-347088;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome.
CC   -!- PTM: Acetylation at Lys-6 (H4K5ac), Lys-9 (H4K8ac), Lys-13 (H4K12ac)
CC       and Lys-17 (H4K16ac) occurs in coding regions of the genome but not in
CC       heterochromatin. {ECO:0000269|PubMed:17967882,
CC       ECO:0000269|PubMed:2474456, ECO:0000269|PubMed:7664735}.
CC   -!- PTM: Citrullination at Arg-4 (H4R3ci) by PADI4 impairs methylation.
CC       {ECO:0000269|PubMed:11387442, ECO:0000269|PubMed:11448779,
CC       ECO:0000269|PubMed:15345777, ECO:0000269|PubMed:16567635}.
CC   -!- PTM: Monomethylation and asymmetric dimethylation at Arg-4 (H4R3me1 and
CC       H4R3me2a, respectively) by PRMT1 favors acetylation at Lys-9 (H4K8ac)
CC       and Lys-13 (H4K12ac). Demethylation is performed by JMJD6. Symmetric
CC       dimethylation on Arg-4 (H4R3me2s) by the PRDM1/PRMT5 complex may play a
CC       crucial role in the germ-cell lineage. {ECO:0000269|PubMed:11387442,
CC       ECO:0000269|PubMed:11448779, ECO:0000269|PubMed:15345777}.
CC   -!- PTM: Monomethylated, dimethylated or trimethylated at Lys-21 (H4K20me1,
CC       H4K20me2, H4K20me3) (PubMed:12086618, PubMed:15964846,
CC       PubMed:17967882). Monomethylation is performed by SET8
CC       (PubMed:15964846). Dimethylation and trimethylation is performed by
CC       KMT5B and KMT5C and induces gene silencing (By similarity).
CC       {ECO:0000250|UniProtKB:P62806, ECO:0000269|PubMed:12086618,
CC       ECO:0000269|PubMed:15964846, ECO:0000269|PubMed:17967882}.
CC   -!- PTM: Phosphorylated by PAK2 at Ser-48 (H4S47ph). This phosphorylation
CC       increases the association of H3.3-H4 with the histone chaperone HIRA,
CC       thus promoting nucleosome assembly of H3.3-H4 and inhibiting nucleosome
CC       assembly of H3.1-H4. {ECO:0000269|PubMed:17967882,
CC       ECO:0000269|PubMed:21724829}.
CC   -!- PTM: Ubiquitinated by the CUL4-DDB-RBX1 complex in response to
CC       ultraviolet irradiation. This may weaken the interaction between
CC       histones and DNA and facilitate DNA accessibility to repair proteins.
CC       Monoubiquitinated at Lys-92 of histone H4 (H4K91ub1) in response to DNA
CC       damage. The exact role of H4K91ub1 in DNA damage response is still
CC       unclear but it may function as a licensing signal for additional
CC       histone H4 post-translational modifications such as H4 Lys-21
CC       methylation (H4K20me). {ECO:0000269|PubMed:12086618,
CC       ECO:0000269|PubMed:15964846, ECO:0000269|PubMed:16678110,
CC       ECO:0000269|PubMed:17967882, ECO:0000269|PubMed:19818714}.
CC   -!- PTM: Sumoylated, which is associated with transcriptional repression.
CC       {ECO:0000269|PubMed:14578449}.
CC   -!- PTM: Crotonylation (Kcr) is specifically present in male germ cells and
CC       marks testis-specific genes in post-meiotic cells, including X-linked
CC       genes that escape sex chromosome inactivation in haploid cells.
CC       Crotonylation marks active promoters and enhancers and confers
CC       resistance to transcriptional repressors. It is also associated with
CC       post-meiotically activated genes on autosomes.
CC       {ECO:0000269|PubMed:21925322}.
CC   -!- PTM: Butyrylation of histones marks active promoters and competes with
CC       histone acetylation. {ECO:0000250|UniProtKB:P62806}.
CC   -!- PTM: Glutarylation at Lys-92 (H4K91glu) destabilizes nucleosomes by
CC       promoting dissociation of the H2A-H2B dimers from nucleosomes.
CC       {ECO:0000269|PubMed:31542297}.
CC   -!- DISEASE: Note=Chromosomal aberrations involving HISTONE H4 is a cause
CC       of B-cell non-Hodgkin lymphomas (B-cell NHL). Translocation
CC       t(3;6)(q27;p21), with BCL6. {ECO:0000269|PubMed:12414651}.
CC   -!- SIMILARITY: Belongs to the histone H4 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAI28106.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X00038; CAA24918.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; M16707; AAA52652.1; -; Genomic_DNA.
DR   EMBL; M60749; AAA63188.1; -; Genomic_DNA.
DR   EMBL; X60481; CAA43011.1; -; Genomic_DNA.
DR   EMBL; X60482; CAA43012.1; -; Genomic_DNA.
DR   EMBL; X60483; CAA43013.1; -; Genomic_DNA.
DR   EMBL; X60484; CAA43014.1; -; Genomic_DNA.
DR   EMBL; X60486; CAA43016.1; -; Genomic_DNA.
DR   EMBL; X60487; CAA43017.1; -; Genomic_DNA.
DR   EMBL; X67081; CAA47464.1; -; Genomic_DNA.
DR   EMBL; Z80787; CAB02549.1; -; Genomic_DNA.
DR   EMBL; X83548; CAA58538.1; -; Genomic_DNA.
DR   EMBL; AF525682; AAM83108.1; -; Genomic_DNA.
DR   EMBL; AY128653; AAN01438.1; -; Genomic_DNA.
DR   EMBL; AY128654; AAN01439.1; -; Genomic_DNA.
DR   EMBL; AY128655; AAN01440.1; -; Genomic_DNA.
DR   EMBL; AY128656; AAN01441.1; -; Genomic_DNA.
DR   EMBL; AY128657; AAN01442.1; -; Genomic_DNA.
DR   EMBL; AY128658; AAN01443.1; -; Genomic_DNA.
DR   EMBL; AY128659; AAN01444.1; -; Genomic_DNA.
DR   EMBL; AY128661; AAN01446.1; -; Genomic_DNA.
DR   EMBL; AY128662; AAN01447.1; -; Genomic_DNA.
DR   EMBL; AY128663; AAN01448.1; -; Genomic_DNA.
DR   EMBL; AY128664; AAN01449.1; -; Genomic_DNA.
DR   EMBL; AY128665; AAN01450.1; -; Genomic_DNA.
DR   EMBL; AB000905; BAA19208.1; -; Genomic_DNA.
DR   EMBL; AY648850; AAT68253.1; -; Genomic_DNA.
DR   EMBL; CR542169; CAG46966.1; -; mRNA.
DR   EMBL; CR542172; CAG46969.1; -; mRNA.
DR   EMBL; CR542180; CAG46977.1; -; mRNA.
DR   EMBL; CR542187; CAG46984.1; -; mRNA.
DR   EMBL; CR542189; CAG46986.1; -; mRNA.
DR   EMBL; AL021807; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL021917; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL031777; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL049822; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL353759; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z98744; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL591493; CAI12560.1; -; Genomic_DNA.
DR   EMBL; AL591493; CAI12567.1; -; Genomic_DNA.
DR   EMBL; CH471087; EAW55509.1; -; Genomic_DNA.
DR   EMBL; CH471087; EAW55510.1; -; Genomic_DNA.
DR   EMBL; CH471087; EAW55538.1; -; Genomic_DNA.
DR   EMBL; CH471087; EAW55549.1; -; Genomic_DNA.
DR   EMBL; CH471087; EAW55555.1; -; Genomic_DNA.
DR   EMBL; CH471094; EAW96325.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX03086.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX03111.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX03112.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX03121.1; -; Genomic_DNA.
DR   EMBL; BC017361; AAH17361.1; -; mRNA.
DR   EMBL; BC054014; AAH54014.1; -; mRNA.
DR   EMBL; BC066248; AAH66248.1; -; mRNA.
DR   EMBL; BC066249; AAH66249.1; -; mRNA.
DR   EMBL; BC066250; AAH66250.1; -; mRNA.
DR   EMBL; BC067495; AAH67495.1; -; mRNA.
DR   EMBL; BC067496; AAH67496.1; -; mRNA.
DR   EMBL; BC067497; AAH67497.1; -; mRNA.
DR   EMBL; BC069288; AAH69288.1; -; mRNA.
DR   EMBL; BC069392; AAH69392.1; -; mRNA.
DR   EMBL; BC069467; AAH69467.1; -; mRNA.
DR   EMBL; BC069654; AAH69654.1; -; mRNA.
DR   EMBL; BC093763; AAH93763.1; -; mRNA.
DR   EMBL; BC093765; AAH93765.1; -; mRNA.
DR   EMBL; BC093969; AAH93969.1; -; mRNA.
DR   EMBL; BC111093; AAI11094.1; -; mRNA.
DR   EMBL; BC111434; AAI11435.1; -; mRNA.
DR   EMBL; BC112193; AAI12194.1; -; mRNA.
DR   EMBL; BC120939; AAI20940.1; -; mRNA.
DR   EMBL; BC128104; AAI28105.1; -; mRNA.
DR   EMBL; BC128105; AAI28106.1; ALT_FRAME; mRNA.
DR   EMBL; BC130558; AAI30559.1; -; mRNA.
DR   EMBL; BC130560; AAI30561.1; -; mRNA.
DR   EMBL; BC143045; AAI43046.1; -; mRNA.
DR   CCDS; CCDS30847.1; -.
DR   CCDS; CCDS30851.1; -.
DR   CCDS; CCDS4571.1; -.
DR   CCDS; CCDS4572.1; -.
DR   CCDS; CCDS4583.1; -.
DR   CCDS; CCDS4589.1; -.
DR   CCDS; CCDS4593.1; -.
DR   CCDS; CCDS4598.1; -.
DR   CCDS; CCDS4604.1; -.
DR   CCDS; CCDS4620.1; -.
DR   CCDS; CCDS4630.1; -.
DR   CCDS; CCDS4631.1; -.
DR   CCDS; CCDS4637.1; -.
DR   CCDS; CCDS8665.1; -.
DR   PIR; D40335; HSHU4.
DR   RefSeq; NP_001029249.1; NM_001034077.4.
DR   RefSeq; NP_003486.1; NM_003495.2.
DR   RefSeq; NP_003529.1; NM_003538.3.
DR   RefSeq; NP_003530.1; NM_003539.3.
DR   RefSeq; NP_003531.1; NM_003540.3.
DR   RefSeq; NP_003532.1; NM_003541.2.
DR   RefSeq; NP_003533.1; NM_003542.3.
DR   RefSeq; NP_003534.1; NM_003543.3.
DR   RefSeq; NP_003535.1; NM_003544.2.
DR   RefSeq; NP_003536.1; NM_003545.3.
DR   RefSeq; NP_003537.1; NM_003546.2.
DR   RefSeq; NP_003539.1; NM_003548.2.
DR   RefSeq; NP_068803.1; NM_021968.3.
DR   RefSeq; NP_778224.1; NM_175054.2.
DR   PDB; 1ZKK; X-ray; 1.45 A; E/F/G/H=16-25.
DR   PDB; 2BQZ; X-ray; 1.50 A; B/F=18-26.
DR   PDB; 2CV5; X-ray; 2.50 A; B/F=1-103.
DR   PDB; 2IG0; X-ray; 1.70 A; B=17-26.
DR   PDB; 2KWN; NMR; -; B=10-24.
DR   PDB; 2KWO; NMR; -; B=2-21.
DR   PDB; 2LVM; NMR; -; B=15-28.
DR   PDB; 2QQS; X-ray; 2.82 A; C/D=17-26.
DR   PDB; 2RJE; X-ray; 1.86 A; P/Q=16-26.
DR   PDB; 2RNY; NMR; -; B=14-28.
DR   PDB; 2RS9; NMR; -; A=2-11.
DR   PDB; 3A6N; X-ray; 2.70 A; B/F=1-103.
DR   PDB; 3AFA; X-ray; 2.50 A; B/F=1-103.
DR   PDB; 3AN2; X-ray; 3.60 A; B/F=1-103.
DR   PDB; 3AV1; X-ray; 2.50 A; B/F=1-103.
DR   PDB; 3AV2; X-ray; 2.80 A; B/F=1-103.
DR   PDB; 3AYW; X-ray; 2.90 A; B/F=1-103.
DR   PDB; 3AZE; X-ray; 3.00 A; B/F=1-103.
DR   PDB; 3AZF; X-ray; 2.70 A; B/F=1-103.
DR   PDB; 3AZG; X-ray; 2.40 A; B/F=1-103.
DR   PDB; 3AZH; X-ray; 3.49 A; B/F=1-103.
DR   PDB; 3AZI; X-ray; 2.70 A; B/F=1-103.
DR   PDB; 3AZJ; X-ray; 2.89 A; B/F=1-103.
DR   PDB; 3AZK; X-ray; 3.20 A; B/F=1-103.
DR   PDB; 3AZL; X-ray; 2.70 A; B/F=1-103.
DR   PDB; 3AZM; X-ray; 2.89 A; B/F=1-103.
DR   PDB; 3AZN; X-ray; 3.00 A; B/F=1-103.
DR   PDB; 3CFS; X-ray; 2.40 A; E=28-42.
DR   PDB; 3CFV; X-ray; 2.60 A; E/F=25-42.
DR   PDB; 3F9W; X-ray; 1.60 A; E/F/G/H=16-25.
DR   PDB; 3F9X; X-ray; 1.25 A; E/F/G/H=16-25.
DR   PDB; 3F9Y; X-ray; 1.50 A; E/F=16-25.
DR   PDB; 3F9Z; X-ray; 1.60 A; E/F/G/H=16-25.
DR   PDB; 3IJ1; X-ray; 2.10 A; B=16-26.
DR   PDB; 3JPX; X-ray; 2.05 A; B=14-28.
DR   PDB; 3NQJ; X-ray; 2.10 A; B=21-103.
DR   PDB; 3NQU; X-ray; 2.50 A; B=1-103.
DR   PDB; 3O36; X-ray; 1.70 A; D/E=15-20.
DR   PDB; 3QBY; X-ray; 1.95 A; H=16-26.
DR   PDB; 3QZS; X-ray; 1.80 A; C/D=13-22.
DR   PDB; 3QZT; X-ray; 1.50 A; B=13-22.
DR   PDB; 3QZV; X-ray; 2.00 A; C=8-18.
DR   PDB; 3R45; X-ray; 2.60 A; B=1-103.
DR   PDB; 3UVW; X-ray; 1.37 A; B=2-12.
DR   PDB; 3UVX; X-ray; 1.91 A; B=12-22.
DR   PDB; 3UVY; X-ray; 2.02 A; B=16-26.
DR   PDB; 3UW9; X-ray; 2.30 A; E/F=8-18.
DR   PDB; 3W96; X-ray; 3.00 A; B/F=1-103.
DR   PDB; 3W97; X-ray; 3.20 A; B/F=1-103.
DR   PDB; 3W98; X-ray; 3.42 A; B/F=1-103.
DR   PDB; 3W99; X-ray; 3.00 A; B/F=17-103.
DR   PDB; 3WA9; X-ray; 3.07 A; B/F=1-103.
DR   PDB; 3WAA; X-ray; 3.20 A; B/F=1-103.
DR   PDB; 3WKJ; X-ray; 2.80 A; B/F=1-103.
DR   PDB; 3WTP; X-ray; 2.67 A; B/F=1-103.
DR   PDB; 3X1S; X-ray; 2.81 A; B/F=2-103.
DR   PDB; 3X1T; X-ray; 2.81 A; B/F=2-103.
DR   PDB; 3X1U; X-ray; 3.25 A; B/F=2-103.
DR   PDB; 3X1V; X-ray; 2.92 A; B/F=2-103.
DR   PDB; 4GQB; X-ray; 2.06 A; C=2-22.
DR   PDB; 4H9N; X-ray; 1.95 A; B=2-103.
DR   PDB; 4H9O; X-ray; 2.05 A; B=2-103.
DR   PDB; 4H9P; X-ray; 2.20 A; B=2-103.
DR   PDB; 4H9Q; X-ray; 1.95 A; B=2-103.
DR   PDB; 4H9R; X-ray; 2.20 A; B=2-103.
DR   PDB; 4H9S; X-ray; 2.60 A; C/D=21-103.
DR   PDB; 4HGA; X-ray; 2.80 A; C=1-103.
DR   PDB; 4M38; X-ray; 2.20 A; E/F=2-22.
DR   PDB; 4N3W; X-ray; 1.90 A; C=14-28.
DR   PDB; 4N4F; X-ray; 1.83 A; C=6-26.
DR   PDB; 4QUT; X-ray; 1.70 A; B=10-16.
DR   PDB; 4QUU; X-ray; 1.80 A; B=4-16.
DR   PDB; 4QYD; X-ray; 1.94 A; B=5-18.
DR   PDB; 4U9W; X-ray; 2.49 A; E/F/G/H=2-6.
DR   PDB; 4YM5; X-ray; 4.00 A; B/F=1-103.
DR   PDB; 4YM6; X-ray; 3.51 A; B/F=1-103.
DR   PDB; 4YY6; X-ray; 1.45 A; Z=2-12.
DR   PDB; 4YYD; X-ray; 1.52 A; Z=2-12.
DR   PDB; 4YYG; X-ray; 2.10 A; B=2-12.
DR   PDB; 4YYH; X-ray; 1.74 A; Y/Z=2-12.
DR   PDB; 4YYI; X-ray; 1.50 A; C/F=2-12.
DR   PDB; 4YYJ; X-ray; 1.85 A; C/F=2-12.
DR   PDB; 4YYK; X-ray; 1.79 A; C/F=2-12.
DR   PDB; 4YYM; X-ray; 1.50 A; Z=2-12.
DR   PDB; 4YYN; X-ray; 1.85 A; Z=2-12.
DR   PDB; 4Z2M; X-ray; 2.98 A; H/J=1-103.
DR   PDB; 4Z5T; X-ray; 2.80 A; B/F=1-103.
DR   PDB; 5AV5; X-ray; 2.40 A; B/F=1-103.
DR   PDB; 5AV6; X-ray; 2.20 A; B/F=1-103.
DR   PDB; 5AV8; X-ray; 2.20 A; B/F=1-103.
DR   PDB; 5AV9; X-ray; 2.20 A; B/F=1-103.
DR   PDB; 5AVB; X-ray; 2.40 A; B/F=1-103.
DR   PDB; 5AVC; X-ray; 2.40 A; B/F=1-103.
DR   PDB; 5AY8; X-ray; 2.80 A; B/F=1-103.
DR   PDB; 5B0Y; X-ray; 2.56 A; B/F=1-103.
DR   PDB; 5B0Z; X-ray; 1.99 A; B/F=1-103.
DR   PDB; 5B24; X-ray; 3.60 A; B/F=1-103.
DR   PDB; 5B2I; X-ray; 3.00 A; B/F=1-103.
DR   PDB; 5B2J; X-ray; 2.60 A; B/F=1-103.
DR   PDB; 5B31; X-ray; 2.20 A; B/F=1-103.
DR   PDB; 5B32; X-ray; 2.35 A; B/F=1-103.
DR   PDB; 5B33; X-ray; 2.92 A; B/F=1-103.
DR   PDB; 5B40; X-ray; 3.33 A; B/F=1-103.
DR   PDB; 5BNV; X-ray; 2.79 A; B/E=2-103.
DR   PDB; 5BNX; X-ray; 2.31 A; B=2-103.
DR   PDB; 5BO0; X-ray; 2.91 A; B=2-103.
DR   PDB; 5C3I; X-ray; 3.50 A; C/G/K/O/S/W=1-103.
DR   PDB; 5CPI; X-ray; 2.90 A; B/F=1-103.
DR   PDB; 5CPJ; X-ray; 3.15 A; B/F=1-103.
DR   PDB; 5CPK; X-ray; 2.63 A; B/F=1-103.
DR   PDB; 5FA5; X-ray; 2.34 A; C=2-21.
DR   PDB; 5FFW; X-ray; 1.50 A; C=2-11.
DR   PDB; 5FWE; X-ray; 2.05 A; C/D=2-16.
DR   PDB; 5GSE; X-ray; 3.14 A; B/F/L/P=1-103.
DR   PDB; 5GSU; X-ray; 3.10 A; B/F=2-103.
DR   PDB; 5GT0; X-ray; 2.82 A; B/F=2-103.
DR   PDB; 5GT3; X-ray; 2.91 A; B/F=2-103.
DR   PDB; 5GTC; X-ray; 2.70 A; B/F=1-103.
DR   PDB; 5GXQ; X-ray; 2.85 A; B/F=1-103.
DR   PDB; 5JA4; X-ray; 2.42 A; B=2-103.
DR   PDB; 5JRG; X-ray; 2.50 A; B/F=1-103.
DR   PDB; 5KDM; X-ray; 3.50 A; B=2-103.
DR   PDB; 5TEG; X-ray; 1.30 A; D/E=17-24.
DR   PDB; 5X7X; X-ray; 2.18 A; B/F=1-103.
DR   PDB; 5XF3; X-ray; 2.60 A; B/F=1-103.
DR   PDB; 5XF4; X-ray; 2.87 A; B/F=1-103.
DR   PDB; 5XF5; X-ray; 2.82 A; B/F=1-103.
DR   PDB; 5Y0C; X-ray; 2.09 A; B/F=1-103.
DR   PDB; 5Y0D; X-ray; 1.99 A; B/F=1-103.
DR   PDB; 5YE3; X-ray; 1.70 A; C=2-13.
DR   PDB; 5YE4; X-ray; 1.80 A; E/F=2-13.
DR   PDB; 5Z23; X-ray; 2.73 A; B/F=1-103.
DR   PDB; 5Z30; X-ray; 2.45 A; B/F=1-103.
DR   PDB; 5ZBX; X-ray; 2.58 A; B/F=1-103.
DR   PDB; 5ZGC; X-ray; 2.90 A; G/H/I/J/K/L=12-22.
DR   PDB; 6A5L; EM; 5.60 A; b/f=1-103.
DR   PDB; 6A5O; EM; 9.90 A; b/f=1-103.
DR   PDB; 6A5P; EM; 7.00 A; b/f=1-103.
DR   PDB; 6A5R; EM; 8.70 A; b/f=1-103.
DR   PDB; 6A5T; EM; 6.70 A; b/f=1-103.
DR   PDB; 6A5U; EM; 7.60 A; b/f=1-103.
DR   PDB; 6ACP; X-ray; 2.30 A; B=89-95.
DR   PDB; 6BUZ; EM; 3.92 A; B/F=1-103.
DR   PDB; 6C0W; EM; 4.00 A; B/F=1-102.
DR   PDB; 6E0C; EM; 2.63 A; B/F=1-103.
DR   PDB; 6E0P; EM; 2.60 A; B/F=1-103.
DR   PDB; 6FML; EM; 4.34 A; N/R=2-103.
DR   PDB; 6HKT; X-ray; 9.70 A; B/F/L/P/V/Z/b/f/l/p/v/z=1-103.
DR   PDB; 6HTS; EM; 4.80 A; J/N=1-103.
DR   PDB; 6INQ; EM; 6.90 A; b/f=1-103.
DR   PDB; 6IR9; EM; 3.80 A; b/f=1-103.
DR   PDB; 6J4W; EM; 7.90 A; b/f=1-103.
DR   PDB; 6J4X; EM; 4.30 A; b/f=1-103.
DR   PDB; 6J4Y; EM; 4.30 A; b/f=1-103.
DR   PDB; 6J4Z; EM; 4.10 A; b/f=1-103.
DR   PDB; 6J50; EM; 4.70 A; b/f=1-103.
DR   PDB; 6J51; EM; 4.20 A; b/f=1-103.
DR   PDB; 6JR0; X-ray; 2.50 A; B/F=1-103.
DR   PDB; 6JR1; X-ray; 2.40 A; B/F=1-103.
DR   PDB; 6K1I; X-ray; 2.75 A; B/F=1-103.
DR   PDB; 6K1J; X-ray; 2.85 A; B/F=1-103.
DR   PDB; 6K1K; X-ray; 2.20 A; B/F=1-103.
DR   PDB; 6KVD; X-ray; 2.21 A; B/F=1-103.
DR   PDB; 6L49; EM; 18.90 A; B/F/L/P/T/X=1-103.
DR   PDB; 6L4A; EM; 12.30 A; B/F/L/P/T/X=1-103.
DR   PDB; 6MLC; X-ray; 1.80 A; E/F=2-21.
DR   PDB; 6MUO; EM; 3.60 A; B/F=9-102.
DR   PDB; 6MUP; EM; 3.50 A; B/F=9-102.
DR   PDB; 6O1D; EM; 3.40 A; B/F=1-103.
DR   PDB; 6R0C; EM; 4.20 A; B/F=1-103.
DR   PDB; 6R8Y; EM; 4.30 A; B/F=1-103.
DR   PDB; 6R8Z; EM; 3.90 A; B/F=1-103.
DR   PDB; 6R90; EM; 4.50 A; B/F=1-103.
DR   PDB; 6R91; EM; 4.10 A; B/F=1-103.
DR   PDB; 6R92; EM; 4.80 A; B/F=1-103.
DR   PDB; 6R93; EM; 4.00 A; B/F=1-103.
DR   PDB; 6R94; EM; 3.50 A; B/F=1-103.
DR   PDB; 6RNY; EM; 3.90 A; B/F=1-103.
DR   PDB; 6SE0; EM; 3.80 A; B/F=1-103.
DR   PDB; 6SE6; EM; 3.50 A; B/F=1-103.
DR   PDB; 6SEE; EM; 4.20 A; B/F=1-103.
DR   PDB; 6SEF; EM; 3.70 A; B/F=1-103.
DR   PDB; 6SEG; EM; 3.10 A; B/F=1-103.
DR   PDB; 6UHD; X-ray; 1.60 A; C/D=2-21.
DR   PDB; 6UPK; EM; 4.90 A; B/F=1-103.
DR   PDB; 6UPL; EM; 7.40 A; B/F=1-103.
DR   PDB; 6V92; EM; 20.00 A; b/f=1-103.
DR   PDBsum; 1ZKK; -.
DR   PDBsum; 2BQZ; -.
DR   PDBsum; 2CV5; -.
DR   PDBsum; 2IG0; -.
DR   PDBsum; 2KWN; -.
DR   PDBsum; 2KWO; -.
DR   PDBsum; 2LVM; -.
DR   PDBsum; 2QQS; -.
DR   PDBsum; 2RJE; -.
DR   PDBsum; 2RNY; -.
DR   PDBsum; 2RS9; -.
DR   PDBsum; 3A6N; -.
DR   PDBsum; 3AFA; -.
DR   PDBsum; 3AN2; -.
DR   PDBsum; 3AV1; -.
DR   PDBsum; 3AV2; -.
DR   PDBsum; 3AYW; -.
DR   PDBsum; 3AZE; -.
DR   PDBsum; 3AZF; -.
DR   PDBsum; 3AZG; -.
DR   PDBsum; 3AZH; -.
DR   PDBsum; 3AZI; -.
DR   PDBsum; 3AZJ; -.
DR   PDBsum; 3AZK; -.
DR   PDBsum; 3AZL; -.
DR   PDBsum; 3AZM; -.
DR   PDBsum; 3AZN; -.
DR   PDBsum; 3CFS; -.
DR   PDBsum; 3CFV; -.
DR   PDBsum; 3F9W; -.
DR   PDBsum; 3F9X; -.
DR   PDBsum; 3F9Y; -.
DR   PDBsum; 3F9Z; -.
DR   PDBsum; 3IJ1; -.
DR   PDBsum; 3JPX; -.
DR   PDBsum; 3NQJ; -.
DR   PDBsum; 3NQU; -.
DR   PDBsum; 3O36; -.
DR   PDBsum; 3QBY; -.
DR   PDBsum; 3QZS; -.
DR   PDBsum; 3QZT; -.
DR   PDBsum; 3QZV; -.
DR   PDBsum; 3R45; -.
DR   PDBsum; 3UVW; -.
DR   PDBsum; 3UVX; -.
DR   PDBsum; 3UVY; -.
DR   PDBsum; 3UW9; -.
DR   PDBsum; 3W96; -.
DR   PDBsum; 3W97; -.
DR   PDBsum; 3W98; -.
DR   PDBsum; 3W99; -.
DR   PDBsum; 3WA9; -.
DR   PDBsum; 3WAA; -.
DR   PDBsum; 3WKJ; -.
DR   PDBsum; 3WTP; -.
DR   PDBsum; 3X1S; -.
DR   PDBsum; 3X1T; -.
DR   PDBsum; 3X1U; -.
DR   PDBsum; 3X1V; -.
DR   PDBsum; 4GQB; -.
DR   PDBsum; 4H9N; -.
DR   PDBsum; 4H9O; -.
DR   PDBsum; 4H9P; -.
DR   PDBsum; 4H9Q; -.
DR   PDBsum; 4H9R; -.
DR   PDBsum; 4H9S; -.
DR   PDBsum; 4HGA; -.
DR   PDBsum; 4M38; -.
DR   PDBsum; 4N3W; -.
DR   PDBsum; 4N4F; -.
DR   PDBsum; 4QUT; -.
DR   PDBsum; 4QUU; -.
DR   PDBsum; 4QYD; -.
DR   PDBsum; 4U9W; -.
DR   PDBsum; 4YM5; -.
DR   PDBsum; 4YM6; -.
DR   PDBsum; 4YY6; -.
DR   PDBsum; 4YYD; -.
DR   PDBsum; 4YYG; -.
DR   PDBsum; 4YYH; -.
DR   PDBsum; 4YYI; -.
DR   PDBsum; 4YYJ; -.
DR   PDBsum; 4YYK; -.
DR   PDBsum; 4YYM; -.
DR   PDBsum; 4YYN; -.
DR   PDBsum; 4Z2M; -.
DR   PDBsum; 4Z5T; -.
DR   PDBsum; 5AV5; -.
DR   PDBsum; 5AV6; -.
DR   PDBsum; 5AV8; -.
DR   PDBsum; 5AV9; -.
DR   PDBsum; 5AVB; -.
DR   PDBsum; 5AVC; -.
DR   PDBsum; 5AY8; -.
DR   PDBsum; 5B0Y; -.
DR   PDBsum; 5B0Z; -.
DR   PDBsum; 5B24; -.
DR   PDBsum; 5B2I; -.
DR   PDBsum; 5B2J; -.
DR   PDBsum; 5B31; -.
DR   PDBsum; 5B32; -.
DR   PDBsum; 5B33; -.
DR   PDBsum; 5B40; -.
DR   PDBsum; 5BNV; -.
DR   PDBsum; 5BNX; -.
DR   PDBsum; 5BO0; -.
DR   PDBsum; 5C3I; -.
DR   PDBsum; 5CPI; -.
DR   PDBsum; 5CPJ; -.
DR   PDBsum; 5CPK; -.
DR   PDBsum; 5FA5; -.
DR   PDBsum; 5FFW; -.
DR   PDBsum; 5FWE; -.
DR   PDBsum; 5GSE; -.
DR   PDBsum; 5GSU; -.
DR   PDBsum; 5GT0; -.
DR   PDBsum; 5GT3; -.
DR   PDBsum; 5GTC; -.
DR   PDBsum; 5GXQ; -.
DR   PDBsum; 5JA4; -.
DR   PDBsum; 5JRG; -.
DR   PDBsum; 5KDM; -.
DR   PDBsum; 5TEG; -.
DR   PDBsum; 5X7X; -.
DR   PDBsum; 5XF3; -.
DR   PDBsum; 5XF4; -.
DR   PDBsum; 5XF5; -.
DR   PDBsum; 5Y0C; -.
DR   PDBsum; 5Y0D; -.
DR   PDBsum; 5YE3; -.
DR   PDBsum; 5YE4; -.
DR   PDBsum; 5Z23; -.
DR   PDBsum; 5Z30; -.
DR   PDBsum; 5ZBX; -.
DR   PDBsum; 5ZGC; -.
DR   PDBsum; 6A5L; -.
DR   PDBsum; 6A5O; -.
DR   PDBsum; 6A5P; -.
DR   PDBsum; 6A5R; -.
DR   PDBsum; 6A5T; -.
DR   PDBsum; 6A5U; -.
DR   PDBsum; 6ACP; -.
DR   PDBsum; 6BUZ; -.
DR   PDBsum; 6C0W; -.
DR   PDBsum; 6E0C; -.
DR   PDBsum; 6E0P; -.
DR   PDBsum; 6FML; -.
DR   PDBsum; 6HKT; -.
DR   PDBsum; 6HTS; -.
DR   PDBsum; 6INQ; -.
DR   PDBsum; 6IR9; -.
DR   PDBsum; 6J4W; -.
DR   PDBsum; 6J4X; -.
DR   PDBsum; 6J4Y; -.
DR   PDBsum; 6J4Z; -.
DR   PDBsum; 6J50; -.
DR   PDBsum; 6J51; -.
DR   PDBsum; 6JR0; -.
DR   PDBsum; 6JR1; -.
DR   PDBsum; 6K1I; -.
DR   PDBsum; 6K1J; -.
DR   PDBsum; 6K1K; -.
DR   PDBsum; 6KVD; -.
DR   PDBsum; 6L49; -.
DR   PDBsum; 6L4A; -.
DR   PDBsum; 6MLC; -.
DR   PDBsum; 6MUO; -.
DR   PDBsum; 6MUP; -.
DR   PDBsum; 6O1D; -.
DR   PDBsum; 6R0C; -.
DR   PDBsum; 6R8Y; -.
DR   PDBsum; 6R8Z; -.
DR   PDBsum; 6R90; -.
DR   PDBsum; 6R91; -.
DR   PDBsum; 6R92; -.
DR   PDBsum; 6R93; -.
DR   PDBsum; 6R94; -.
DR   PDBsum; 6RNY; -.
DR   PDBsum; 6SE0; -.
DR   PDBsum; 6SE6; -.
DR   PDBsum; 6SEE; -.
DR   PDBsum; 6SEF; -.
DR   PDBsum; 6SEG; -.
DR   PDBsum; 6UHD; -.
DR   PDBsum; 6UPK; -.
DR   PDBsum; 6UPL; -.
DR   PDBsum; 6V92; -.
DR   SMR; P62805; -.
DR   BioGrid; 113899; 33.
DR   BioGrid; 113955; 476.
DR   BioGrid; 113956; 22.
DR   BioGrid; 113957; 35.
DR   BioGrid; 113958; 22.
DR   BioGrid; 113959; 25.
DR   BioGrid; 113960; 22.
DR   BioGrid; 113961; 29.
DR   BioGrid; 113962; 22.
DR   BioGrid; 113963; 27.
DR   BioGrid; 113964; 23.
DR   BioGrid; 113966; 56.
DR   BioGrid; 125732; 103.
DR   BioGrid; 299853; 32.
DR   CORUM; P62805; -.
DR   DIP; DIP-33079N; -.
DR   IntAct; P62805; 213.
DR   MINT; P62805; -.
DR   STRING; 9606.ENSP00000484789; -.
DR   BindingDB; P62805; -.
DR   ChEMBL; CHEMBL5876; -.
DR   iPTMnet; P62805; -.
DR   MetOSite; P62805; -.
DR   PhosphoSitePlus; P62805; -.
DR   SwissPalm; P62805; -.
DR   BioMuta; HIST4H4; -.
DR   DMDM; 51317339; -.
DR   SWISS-2DPAGE; P62805; -.
DR   CPTAC; CPTAC-1055; -.
DR   CPTAC; CPTAC-1056; -.
DR   EPD; P62805; -.
DR   jPOST; P62805; -.
DR   MassIVE; P62805; -.
DR   MaxQB; P62805; -.
DR   PaxDb; P62805; -.
DR   PeptideAtlas; P62805; -.
DR   PRIDE; P62805; -.
DR   ProteomicsDB; 57424; -.
DR   TopDownProteomics; P62805; -.
DR   Antibodypedia; 23657; 1794 antibodies.
DR   Antibodypedia; 70431; 14 antibodies.
DR   Antibodypedia; 73583; 163 antibodies.
DR   Antibodypedia; 73812; 17 antibodies.
DR   Antibodypedia; 73941; 388 antibodies.
DR   Antibodypedia; 74197; 161 antibodies.
DR   Antibodypedia; 75448; 6 antibodies.
DR   Antibodypedia; 75564; 46 antibodies.
DR   Antibodypedia; 76313; 21 antibodies.
DR   Antibodypedia; 76350; 3 antibodies.
DR   Antibodypedia; 76498; 4 antibodies.
DR   Antibodypedia; 76512; 3 antibodies.
DR   Antibodypedia; 76521; 8 antibodies.
DR   Antibodypedia; 76797; 52 antibodies.
DR   DNASU; 8294; -.
DR   DNASU; 8360; -.
DR   DNASU; 8362; -.
DR   DNASU; 8363; -.
DR   DNASU; 8364; -.
DR   DNASU; 8365; -.
DR   DNASU; 8366; -.
DR   DNASU; 8367; -.
DR   DNASU; 8368; -.
DR   DNASU; 8370; -.
DR   Ensembl; ENST00000244537; ENSP00000244537; ENSG00000274618.
DR   Ensembl; ENST00000355057; ENSP00000347168; ENSG00000197238.
DR   Ensembl; ENST00000358064; ENSP00000350767; ENSG00000197837.
DR   Ensembl; ENST00000377727; ENSP00000366956; ENSG00000158406.
DR   Ensembl; ENST00000377745; ENSP00000366974; ENSG00000278705.
DR   Ensembl; ENST00000377803; ENSP00000367034; ENSG00000197061.
DR   Ensembl; ENST00000539745; ENSP00000443017; ENSG00000197837.
DR   Ensembl; ENST00000578186; ENSP00000462667; ENSG00000270882.
DR   Ensembl; ENST00000579512; ENSP00000462355; ENSG00000270276.
DR   Ensembl; ENST00000611927; ENSP00000479794; ENSG00000273542.
DR   Ensembl; ENST00000612061; ENSP00000482412; ENSG00000270276.
DR   Ensembl; ENST00000613412; ENSP00000481343; ENSG00000270882.
DR   Ensembl; ENST00000614247; ENSP00000479461; ENSG00000277157.
DR   Ensembl; ENST00000614272; ENSP00000478519; ENSG00000270882.
DR   Ensembl; ENST00000615164; ENSP00000484789; ENSG00000276966.
DR   Ensembl; ENST00000615353; ENSP00000481486; ENSG00000276180.
DR   Ensembl; ENST00000617569; ENSP00000479106; ENSG00000278637.
DR   Ensembl; ENST00000618193; ENSP00000478786; ENSG00000270882.
DR   Ensembl; ENST00000618305; ENSP00000480960; ENSG00000275126.
DR   Ensembl; ENST00000621520; ENSP00000481507; ENSG00000270276.
DR   Ensembl; ENST00000634560; ENSP00000489319; ENSG00000158406.
DR   Ensembl; ENST00000634956; ENSP00000489567; ENSG00000158406.
DR   Ensembl; ENST00000635491; ENSP00000489236; ENSG00000158406.
DR   GeneID; 121504; -.
DR   GeneID; 554313; -.
DR   GeneID; 8294; -.
DR   GeneID; 8359; -.
DR   GeneID; 8360; -.
DR   GeneID; 8361; -.
DR   GeneID; 8362; -.
DR   GeneID; 8363; -.
DR   GeneID; 8364; -.
DR   GeneID; 8365; -.
DR   GeneID; 8366; -.
DR   GeneID; 8367; -.
DR   GeneID; 8368; -.
DR   GeneID; 8370; -.
DR   KEGG; hsa:121504; -.
DR   KEGG; hsa:554313; -.
DR   KEGG; hsa:8294; -.
DR   KEGG; hsa:8359; -.
DR   KEGG; hsa:8360; -.
DR   KEGG; hsa:8361; -.
DR   KEGG; hsa:8362; -.
DR   KEGG; hsa:8363; -.
DR   KEGG; hsa:8364; -.
DR   KEGG; hsa:8365; -.
DR   KEGG; hsa:8366; -.
DR   KEGG; hsa:8367; -.
DR   KEGG; hsa:8368; -.
DR   KEGG; hsa:8370; -.
DR   UCSC; uc001ess.4; human.
DR   CTD; 121504; -.
DR   CTD; 554313; -.
DR   CTD; 8294; -.
DR   CTD; 8359; -.
DR   CTD; 8360; -.
DR   CTD; 8361; -.
DR   CTD; 8362; -.
DR   CTD; 8363; -.
DR   CTD; 8364; -.
DR   CTD; 8365; -.
DR   CTD; 8366; -.
DR   CTD; 8367; -.
DR   CTD; 8368; -.
DR   CTD; 8370; -.
DR   DisGeNET; 121504; -.
DR   DisGeNET; 554313; -.
DR   DisGeNET; 8294; -.
DR   DisGeNET; 8359; -.
DR   DisGeNET; 8360; -.
DR   DisGeNET; 8361; -.
DR   DisGeNET; 8362; -.
DR   DisGeNET; 8363; -.
DR   DisGeNET; 8364; -.
DR   DisGeNET; 8365; -.
DR   DisGeNET; 8366; -.
DR   DisGeNET; 8367; -.
DR   DisGeNET; 8368; -.
DR   DisGeNET; 8370; -.
DR   GeneCards; H4-16; -.
DR   GeneCards; H4C1; -.
DR   GeneCards; H4C11; -.
DR   GeneCards; H4C12; -.
DR   GeneCards; H4C13; -.
DR   GeneCards; H4C14; -.
DR   GeneCards; H4C15; -.
DR   GeneCards; H4C2; -.
DR   GeneCards; H4C3; -.
DR   GeneCards; H4C4; -.
DR   GeneCards; H4C5; -.
DR   GeneCards; H4C6; -.
DR   GeneCards; H4C8; -.
DR   GeneCards; H4C9; -.
DR   HGNC; HGNC:20510; H4-16.
DR   HGNC; HGNC:4781; H4C1.
DR   HGNC; HGNC:4785; H4C11.
DR   HGNC; HGNC:4784; H4C12.
DR   HGNC; HGNC:4791; H4C13.
DR   HGNC; HGNC:4794; H4C14.
DR   HGNC; HGNC:29607; H4C15.
DR   HGNC; HGNC:4789; H4C2.
DR   HGNC; HGNC:4787; H4C3.
DR   HGNC; HGNC:4782; H4C4.
DR   HGNC; HGNC:4790; H4C5.
DR   HGNC; HGNC:4783; H4C6.
DR   HGNC; HGNC:4788; H4C8.
DR   HGNC; HGNC:4793; H4C9.
DR   HPA; ENSG00000158406; Tissue enhanced (lymphoid).
DR   HPA; ENSG00000197061; Group enriched (blood, lymphoid tissue).
DR   HPA; ENSG00000197238; Tissue enhanced (blood, lymphoid tissue).
DR   HPA; ENSG00000197837; Tissue enhanced (pancreas).
DR   HPA; ENSG00000270276; Tissue enhanced (blood).
DR   HPA; ENSG00000270882; Tissue enriched (lymphoid).
DR   HPA; ENSG00000273542; Tissue enhanced (brain, lung, lymphoid tissue).
DR   HPA; ENSG00000274618; Tissue enriched (lymphoid).
DR   HPA; ENSG00000275126; Tissue enriched (lymphoid).
DR   HPA; ENSG00000276180; Tissue enriched (blood).
DR   HPA; ENSG00000276966; Tissue enriched (lymphoid).
DR   HPA; ENSG00000277157; Tissue enriched (lymphoid).
DR   HPA; ENSG00000278637; Tissue enriched (lymphoid).
DR   HPA; ENSG00000278705; Tissue enhanced (lymphoid).
DR   MIM; 142750; gene.
DR   MIM; 602822; gene.
DR   MIM; 602823; gene.
DR   MIM; 602824; gene.
DR   MIM; 602825; gene.
DR   MIM; 602826; gene.
DR   MIM; 602827; gene.
DR   MIM; 602828; gene.
DR   MIM; 602829; gene.
DR   MIM; 602830; gene.
DR   MIM; 602831; gene.
DR   MIM; 602833; gene.
DR   MIM; 615069; gene.
DR   neXtProt; NX_P62805; -.
DR   OpenTargets; ENSG00000158406; -.
DR   OpenTargets; ENSG00000197061; -.
DR   OpenTargets; ENSG00000197238; -.
DR   OpenTargets; ENSG00000197837; -.
DR   OpenTargets; ENSG00000270276; -.
DR   OpenTargets; ENSG00000270882; -.
DR   OpenTargets; ENSG00000273542; -.
DR   OpenTargets; ENSG00000274618; -.
DR   OpenTargets; ENSG00000275126; -.
DR   OpenTargets; ENSG00000276180; -.
DR   OpenTargets; ENSG00000276966; -.
DR   OpenTargets; ENSG00000277157; -.
DR   OpenTargets; ENSG00000278637; -.
DR   OpenTargets; ENSG00000278705; -.
DR   PharmGKB; PA29169; -.
DR   eggNOG; KOG3467; Eukaryota.
DR   eggNOG; COG2036; LUCA.
DR   GeneTree; ENSGT00980000198478; -.
DR   GeneTree; ENSGT00980000198564; -.
DR   HOGENOM; CLU_109117_2_3_1; -.
DR   InParanoid; P62805; -.
DR   KO; K11254; -.
DR   OMA; QKEHING; -.
DR   OrthoDB; 1594208at2759; -.
DR   PhylomeDB; P62805; -.
DR   Reactome; R-HSA-110328; Recognition and association of DNA glycosylase with site containing an affected pyrimidine.
DR   Reactome; R-HSA-110329; Cleavage of the damaged pyrimidine.
DR   Reactome; R-HSA-110330; Recognition and association of DNA glycosylase with site containing an affected purine.
DR   Reactome; R-HSA-110331; Cleavage of the damaged purine.
DR   Reactome; R-HSA-1221632; Meiotic synapsis.
DR   Reactome; R-HSA-171306; Packaging Of Telomere Ends.
DR   Reactome; R-HSA-1912408; Pre-NOTCH Transcription and Translation.
DR   Reactome; R-HSA-201722; Formation of the beta-catenin:TCF transactivating complex.
DR   Reactome; R-HSA-212300; PRC2 methylates histones and DNA.
DR   Reactome; R-HSA-2299718; Condensation of Prophase Chromosomes.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-HSA-2559582; Senescence-Associated Secretory Phenotype (SASP).
DR   Reactome; R-HSA-2559586; DNA Damage/Telomere Stress Induced Senescence.
DR   Reactome; R-HSA-3214815; HDACs deacetylate histones.
DR   Reactome; R-HSA-3214841; PKMTs methylate histone lysines.
DR   Reactome; R-HSA-3214842; HDMs demethylate histones.
DR   Reactome; R-HSA-3214847; HATs acetylate histones.
DR   Reactome; R-HSA-3214858; RMTs methylate histone arginines.
DR   Reactome; R-HSA-427359; SIRT1 negatively regulates rRNA expression.
DR   Reactome; R-HSA-427389; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression.
DR   Reactome; R-HSA-427413; NoRC negatively regulates rRNA expression.
DR   Reactome; R-HSA-4551638; SUMOylation of chromatin organization proteins.
DR   Reactome; R-HSA-5250924; B-WICH complex positively regulates rRNA expression.
DR   Reactome; R-HSA-5334118; DNA methylation.
DR   Reactome; R-HSA-5578749; Transcriptional regulation by small RNAs.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   Reactome; R-HSA-5625886; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3.
DR   Reactome; R-HSA-5693565; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks.
DR   Reactome; R-HSA-5693571; Nonhomologous End-Joining (NHEJ).
DR   Reactome; R-HSA-5693607; Processing of DNA double-strand break ends.
DR   Reactome; R-HSA-606279; Deposition of new CENPA-containing nucleosomes at the centromere.
DR   Reactome; R-HSA-69473; G2/M DNA damage checkpoint.
DR   Reactome; R-HSA-73728; RNA Polymerase I Promoter Opening.
DR   Reactome; R-HSA-73772; RNA Polymerase I Promoter Escape.
DR   Reactome; R-HSA-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   Reactome; R-HSA-912446; Meiotic recombination.
DR   Reactome; R-HSA-9609690; HCMV Early Events.
DR   Reactome; R-HSA-9610379; HCMV Late Events.
DR   Reactome; R-HSA-9616222; Transcriptional regulation of granulopoiesis.
DR   Reactome; R-HSA-977225; Amyloid fiber formation.
DR   SIGNOR; P62805; -.
DR   ChiTaRS; HIST1H4A; human.
DR   ChiTaRS; HIST1H4C; human.
DR   ChiTaRS; HIST1H4E; human.
DR   ChiTaRS; HIST1H4F; human.
DR   ChiTaRS; HIST1H4H; human.
DR   ChiTaRS; HIST1H4J; human.
DR   ChiTaRS; HIST1H4K; human.
DR   ChiTaRS; HIST2H4B; human.
DR   EvolutionaryTrace; P62805; -.
DR   GeneWiki; HIST1H4A; -.
DR   GeneWiki; HIST1H4B; -.
DR   GeneWiki; HIST1H4C; -.
DR   GeneWiki; HIST1H4D; -.
DR   GeneWiki; HIST1H4E; -.
DR   GeneWiki; HIST1H4F; -.
DR   GeneWiki; HIST1H4H; -.
DR   GeneWiki; HIST1H4I; -.
DR   GeneWiki; HIST1H4J; -.
DR   GeneWiki; HIST1H4K; -.
DR   GeneWiki; HIST1H4L; -.
DR   GeneWiki; HIST2H4A; -.
DR   GeneWiki; HIST4H4; -.
DR   Pharos; P62805; Tbio.
DR   PRO; PR:P62805; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; P62805; protein.
DR   Bgee; ENSG00000158406; Expressed in stomach and 162 other tissues.
DR   ExpressionAtlas; P62805; baseline and differential.
DR   Genevisible; P62805; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0000228; C:nuclear chromosome; IDA:UniProtKB.
DR   GO; GO:0000784; C:nuclear chromosome, telomeric region; HDA:BHF-UCL.
DR   GO; GO:0000788; C:nuclear nucleosome; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0000786; C:nucleosome; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0044267; P:cellular protein metabolic process; TAS:Reactome.
DR   GO; GO:0034080; P:CENP-A containing nucleosome assembly; TAS:Reactome.
DR   GO; GO:0000183; P:chromatin silencing at rDNA; TAS:Reactome.
DR   GO; GO:0006335; P:DNA replication-dependent nucleosome assembly; IDA:UniProtKB.
DR   GO; GO:0006336; P:DNA replication-independent nucleosome assembly; IDA:UniProtKB.
DR   GO; GO:0006352; P:DNA-templated transcription, initiation; IEA:InterPro.
DR   GO; GO:0006303; P:double-strand break repair via nonhomologous end joining; TAS:Reactome.
DR   GO; GO:0045814; P:negative regulation of gene expression, epigenetic; TAS:Reactome.
DR   GO; GO:0045653; P:negative regulation of megakaryocyte differentiation; IDA:UniProtKB.
DR   GO; GO:0006334; P:nucleosome assembly; IDA:UniProtKB.
DR   GO; GO:0060964; P:regulation of gene silencing by miRNA; TAS:Reactome.
DR   GO; GO:0045652; P:regulation of megakaryocyte differentiation; TAS:Reactome.
DR   GO; GO:0016233; P:telomere capping; TAS:Reactome.
DR   GO; GO:0032200; P:telomere organization; TAS:BHF-UCL.
DR   CDD; cd00076; H4; 1.
DR   DisProt; DP02034; -.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR035425; CENP-T/H4_C.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR001951; Histone_H4.
DR   InterPro; IPR019809; Histone_H4_CS.
DR   InterPro; IPR004823; TAF_TATA-bd.
DR   Pfam; PF15511; CENP-T_C; 1.
DR   PRINTS; PR00623; HISTONEH4.
DR   SMART; SM00417; H4; 1.
DR   SMART; SM00803; TAF; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
DR   PROSITE; PS00047; HISTONE_H4; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Chromosomal rearrangement; Chromosome;
KW   Citrullination; Direct protein sequencing; DNA-binding; Hydroxylation;
KW   Isopeptide bond; Methylation; Nucleosome core; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:17967882"
FT   CHAIN           2..103
FT                   /note="Histone H4"
FT                   /id="PRO_0000158320"
FT   DNA_BIND        17..21
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000269|PubMed:17967882"
FT   MOD_RES         2
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:17967882"
FT   MOD_RES         4
FT                   /note="Asymmetric dimethylarginine; by PRMT1; alternate"
FT                   /evidence="ECO:0000269|PubMed:11387442,
FT                   ECO:0000269|PubMed:11448779, ECO:0000269|PubMed:15345777"
FT   MOD_RES         4
FT                   /note="Citrulline; alternate"
FT                   /evidence="ECO:0000269|PubMed:15345777,
FT                   ECO:0000269|PubMed:16567635"
FT   MOD_RES         4
FT                   /note="Omega-N-methylarginine; by PRMT1; alternate"
FT                   /evidence="ECO:0000269|PubMed:11387442,
FT                   ECO:0000269|PubMed:11448779, ECO:0000269|PubMed:15345777"
FT   MOD_RES         4
FT                   /note="Symmetric dimethylarginine; by PRMT5 and PRMT7;
FT                   alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62806"
FT   MOD_RES         6
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         6
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861,
FT                   ECO:0000269|PubMed:2474456, ECO:0000269|PubMed:7664735"
FT   MOD_RES         6
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105113"
FT   MOD_RES         6
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         6
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         9
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         9
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         9
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861,
FT                   ECO:0000269|PubMed:2474456, ECO:0000269|PubMed:7664735"
FT   MOD_RES         9
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:17267393,
FT                   ECO:0000269|PubMed:27105113"
FT   MOD_RES         9
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         9
FT                   /note="N6-propionyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:17267393"
FT   MOD_RES         13
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         13
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         13
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861,
FT                   ECO:0000269|PubMed:17967882, ECO:0000269|PubMed:2474456,
FT                   ECO:0000269|PubMed:7664735"
FT   MOD_RES         13
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105113"
FT   MOD_RES         13
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21925322"
FT   MOD_RES         13
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         13
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         17
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         17
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861,
FT                   ECO:0000269|PubMed:17967882, ECO:0000269|PubMed:2474456,
FT                   ECO:0000269|PubMed:7664735"
FT   MOD_RES         17
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:17267393,
FT                   ECO:0000269|PubMed:27105113"
FT   MOD_RES         17
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62806"
FT   MOD_RES         17
FT                   /note="N6-propionyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:17267393"
FT   MOD_RES         21
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:12086618,
FT                   ECO:0000269|PubMed:15964846, ECO:0000269|PubMed:17967882"
FT   MOD_RES         21
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:12086618,
FT                   ECO:0000269|PubMed:15964846, ECO:0000269|PubMed:17967882"
FT   MOD_RES         21
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:12086618,
FT                   ECO:0000269|PubMed:15964846, ECO:0000269|PubMed:17967882"
FT   MOD_RES         32
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         32
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         32
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         32
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:17267393"
FT   MOD_RES         32
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         32
FT                   /note="N6-propionyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:17267393"
FT   MOD_RES         32
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         45
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         45
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:17267393"
FT   MOD_RES         45
FT                   /note="N6-propionyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:17267393"
FT   MOD_RES         48
FT                   /note="Phosphoserine; by PAK2"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569,
FT                   ECO:0000269|PubMed:21724829"
FT   MOD_RES         52
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000244|PubMed:15592455,
FT                   ECO:0000244|PubMed:20068231"
FT   MOD_RES         60
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         60
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         78
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         78
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         78
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:17267393"
FT   MOD_RES         78
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         78
FT                   /note="N6-propionyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:17267393"
FT   MOD_RES         78
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         80
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         80
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:17267393"
FT   MOD_RES         80
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         80
FT                   /note="N6-propionyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:17267393"
FT   MOD_RES         80
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62806"
FT   MOD_RES         81
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P62806"
FT   MOD_RES         89
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         92
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24681537"
FT   MOD_RES         92
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:27105115"
FT   MOD_RES         92
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:19818714"
FT   MOD_RES         92
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:17267393"
FT   MOD_RES         92
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:31542297"
FT   MOD_RES         92
FT                   /note="N6-propionyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:17267393"
FT   MOD_RES         92
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   CROSSLNK        13
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:25218447"
FT   CROSSLNK        21
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        32
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        60
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        80
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        92
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        92
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:19818714"
FT   VARIANT         64
FT                   /note="E -> Q (in a breast cancer sample; somatic mutation;
FT                   dbSNP:rs747622981)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_036206"
FT   CONFLICT        71
FT                   /note="V -> A (in Ref. 14; AAH67496)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        77
FT                   /note="A -> P (in Ref. 11; CAG46986)"
FT                   /evidence="ECO:0000305"
FT   TURN            7..10
FT                   /evidence="ECO:0000244|PDB:4YYM"
FT   STRAND          16..18
FT                   /evidence="ECO:0000244|PDB:6MLC"
FT   STRAND          21..23
FT                   /evidence="ECO:0000244|PDB:3F9X"
FT   STRAND          28..30
FT                   /evidence="ECO:0000244|PDB:4H9N"
FT   HELIX           32..41
FT                   /evidence="ECO:0000244|PDB:4H9N"
FT   STRAND          45..47
FT                   /evidence="ECO:0000244|PDB:6E0P"
FT   HELIX           49..76
FT                   /evidence="ECO:0000244|PDB:4H9N"
FT   STRAND          80..82
FT                   /evidence="ECO:0000244|PDB:4H9N"
FT   HELIX           84..91
FT                   /evidence="ECO:0000244|PDB:4H9N"
FT   STRAND          94..96
FT                   /evidence="ECO:0000244|PDB:4H9N"
FT   TURN            97..102
FT                   /evidence="ECO:0000244|PDB:4H9N"
SQ   SEQUENCE   103 AA;  11367 MW;  A9E5DFD3F8B97598 CRC64;
     MSGRGKGGKG LGKGGAKRHR KVLRDNIQGI TKPAIRRLAR RGGVKRISGL IYEETRGVLK
     VFLENVIRDA VTYTEHAKRK TVTAMDVVYA LKRQGRTLYG FGG
//
ID   B1PKY1_HUMAN            Unreviewed;       365 AA.
AC   B1PKY1;
DT   29-APR-2008, integrated into UniProtKB/TrEMBL.
DT   29-APR-2008, sequence version 1.
DT   22-APR-2020, entry version 118.
DE   SubName: Full=HLA class I histocompatibility antigen A alpha chain {ECO:0000313|EMBL:BBD34007.1};
DE   SubName: Full=HLA-A protein {ECO:0000313|EMBL:BAB63400.1};
DE   SubName: Full=MHC class I antigen {ECO:0000313|EMBL:ACA34992.1, ECO:0000313|EMBL:CUV66664.1};
DE   SubName: Full=MHC class I protein {ECO:0000313|EMBL:QAX33596.1};
GN   Name=HLA-A {ECO:0000313|EMBL:ACA34992.1};
GN   Synonyms=HLA {ECO:0000313|EMBL:ASU50328.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACA34992.1};
RN   [1] {ECO:0000313|EMBL:BAB63400.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Hirakawa M., Yamaguchi H., Imai K., Shimada J.;
RL   Submitted (AUG-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2] {ECO:0000313|EMBL:BAB63400.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Shiina S., Tamiya G., Oka A., Inoko H.;
RT   "Homo sapiens 2,229,817bp genomic DNA of 6p21.3 HLA class I region.";
RL   Submitted (DEC-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ACA34992.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=19735485; DOI=10.1111/j.1744-313X.2009.00874.x;
RA   Zhu F., He Y., Zhang W., He J., He J., Xu X., Yan L.;
RT   "Analysis of the complete genomic sequence of HLA-A alleles in the Chinese
RT   Han population.";
RL   Int. J. Immunogenet. 36:351-360(2009).
RN   [4] {ECO:0000313|EMBL:ADE80887.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Xu Y.P., Deng Z.H., Yang B.C.;
RT   "Characterization and polymorphism analyses of HLA-A genomic full length in
RT   Chinese Han population.";
RL   Submitted (FEB-2010) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000313|EMBL:BAN59802.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=23714642; DOI=10.1186/1471-2164-14-355;
RA   Hosomichi K., Jinam T.A., Mitsunaga S., Nakaoka H., Inoue I.;
RT   "Phase-defined complete sequencing of the HLA genes by next-generation
RT   sequencing.";
RL   BMC Genomics 14:355-355(2013).
RN   [6] {ECO:0000313|EMBL:CDG23669.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Blood {ECO:0000313|EMBL:CDG23669.1};
RA   Voorter C.;
RL   Submitted (JUN-2013) to the EMBL/GenBank/DDBJ databases.
RN   [7] {ECO:0000313|EMBL:CDG23669.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Blood {ECO:0000313|EMBL:CDG23669.1};
RA   Gerritsen K.E.H., Groeneweg M., Olieslagers T.I., Palusci F.,
RA   Crijns V.B.G., Voorter C.E.M., Tilanus M.G.J.;
RT   "Identification of full length polymorphism of HLA class I by an RNA
RT   approach on peripheral blood lymphocytes.";
RL   Submitted (AUG-2013) to the EMBL/GenBank/DDBJ databases.
RN   [8] {ECO:0000313|EMBL:CDK41199.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Peripheral blood {ECO:0000313|EMBL:CDK41205.1}, and
RC   Saliva collection {ECO:0000313|EMBL:CDK41199.1};
RA   McWhinnie A.J., Robinson J.;
RT   "Confirmatory sequencing of HLA-A*03:01:01:01.";
RL   Submitted (NOV-2013) to the EMBL/GenBank/DDBJ databases.
RN   [9] {ECO:0000313|EMBL:ALO24306.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Lazaro A.M., Masaberg C., Hou L., Hurley C.K.;
RT   "Novel HLA class I allele.";
RL   Submitted (JUN-2015) to the EMBL/GenBank/DDBJ databases.
RN   [10] {ECO:0000313|EMBL:CUA55065.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Marsh S.;
RL   Submitted (JUL-2015) to the EMBL/GenBank/DDBJ databases.
RN   [11] {ECO:0000313|EMBL:ALZ40810.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Bravo-Egana V., Clark P., Monos D.;
RT   "Generation of high confidence HLA genotyping and consensus sequences for
RT   Class I HLA loci using the NGS-based Omixon Holotype HLA typing system and
RT   the Illumina MiSeq platform.";
RL   Submitted (DEC-2015) to the EMBL/GenBank/DDBJ databases.
RN   [12] {ECO:0000313|EMBL:AOE46676.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Gowda M.;
RT   "Comparative Analyses of Low, Medium and High-Resolution HLA
RT   TypingTechnologies for Human Populations.";
RL   J Clin Cell Immunol 7 (2) 2016:1-8(2016).
RN   [13] {ECO:0000313|EMBL:CZQ50133.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Peripheral blood {ECO:0000313|EMBL:CZQ50133.1};
RA   Zakharova V.;
RL   Submitted (FEB-2016) to the EMBL/GenBank/DDBJ databases.
RN   [14] {ECO:0000313|EMBL:SAI65262.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Peripheral blood {ECO:0000313|EMBL:CZQ50133.1};
RA   Zakharova V.V.;
RT   "Novel HLA-A*03:01:new allele.";
RL   Submitted (APR-2016) to the EMBL/GenBank/DDBJ databases.
RN   [15] {ECO:0000313|EMBL:ARX77874.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Lazaro A.M., Tang T., Hou L., Hurley C.K.;
RL   Submitted (JUL-2016) to the EMBL/GenBank/DDBJ databases.
RN   [16] {ECO:0000313|EMBL:ARX98023.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Lazaro A.M., Hou L., Hurley C.K.;
RT   "Novel HLA class I allele.";
RL   Submitted (AUG-2016) to the EMBL/GenBank/DDBJ databases.
RN   [17] {ECO:0000313|EMBL:CUA55065.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Marsh S.G.E.;
RT   "Full-length genomic HLA sequences.";
RL   Submitted (SEP-2016) to the EMBL/GenBank/DDBJ databases.
RN   [18] {ECO:0000313|EMBL:APO40931.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Ameen R.M.;
RT   "Establishment of Stem cell and cord blood registry in Kuwait.";
RL   Submitted (OCT-2016) to the EMBL/GenBank/DDBJ databases.
RN   [19] {ECO:0000313|EMBL:AQN67170.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Moya R., Balas A.;
RT   "Sequence of a novel A*03 allele.";
RL   Submitted (NOV-2016) to the EMBL/GenBank/DDBJ databases.
RN   [20] {ECO:0000313|EMBL:CUV66664.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=28547825; DOI=10.1111/tan.13057;
RA   Albrecht V., Zweiniger C., Surendranath V., Lang K., Schofl G., Dahl A.,
RA   Winkler S., Lange V., Bohme I., Schmidt A.H.;
RT   "Dual redundant sequencing strategy: Full-length gene characterisation of
RT   1056 novel and confirmatory HLA alleles.";
RL   HLA 90:79-87(2017).
RN   [21] {ECO:0000313|EMBL:AUP42581.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Balz V., Krause S., Enczmann J., Fischer J.;
RT   "More than 130 novel variants of HLA class 1 genes detected in German Stem
RT   Cell Donor Registry and Terasaki samples.";
RL   Submitted (FEB-2017) to the EMBL/GenBank/DDBJ databases.
RN   [22] {ECO:0000313|EMBL:AWB14528.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Yin Y., Takemura P., Bolon Y.-T., Springer B., Saito K., Reed E.F.,
RA   Zhang Q.J.;
RT   "Advances in HLA clinical relevant exon novelty detection from over 21,000
RT   donor recruitment samples.";
RL   Submitted (MAY-2017) to the EMBL/GenBank/DDBJ databases.
RN   [23] {ECO:0000313|EMBL:SLM20096.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Polvi A., Perasaari J., Linjama T., Saarinen T., Koskela S., Jaatinen T.,
RA   Voorter C.E.M., Tilanus M.G.J.;
RT   "Description of four new HLA alleles in the Finnish population.";
RL   Submitted (JUN-2017) to the EMBL/GenBank/DDBJ databases.
RN   [24] {ECO:0000313|EMBL:ASU61671.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Lazaro A.M., Hou L., Gerfen J., Enriquez E., Hurley C.K.;
RL   Submitted (JUL-2017) to the EMBL/GenBank/DDBJ databases.
RN   [25] {ECO:0000313|EMBL:SNQ25992.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Groeneweg M., Matern B., Palusci F., Meertens C., Tilanus M.G.J.,
RA   Voorter C.E.M.;
RT   "Group specific, unambiguous full-length gene HLA Class I typing by Sanger
RT   sequencing: a robust SSBT Strategy for typing and a golden reference for
RT   next generation sequencing approaches.";
RL   Submitted (AUG-2017) to the EMBL/GenBank/DDBJ databases.
RN   [26] {ECO:0000313|EMBL:AUL81601.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Lazaro A.M., Hou L., Enriquez E., Persaud M., Hurley C.K.;
RT   "Novel HLA Class I alleles.";
RL   Submitted (OCT-2017) to the EMBL/GenBank/DDBJ databases.
RN   [27] {ECO:0000313|EMBL:AUF72633.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Lazaro A.M., Hou L., Enriquez E., Persaud M., Hurley C.K.;
RL   Submitted (OCT-2017) to the EMBL/GenBank/DDBJ databases.
RN   [28] {ECO:0000313|EMBL:SOR74757.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Hayhurst D J.;
RL   Submitted (NOV-2017) to the EMBL/GenBank/DDBJ databases.
RN   [29] {ECO:0000313|EMBL:BBD34007.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=30337930; DOI=.3389/fimmu.2018.02294;
RA   Suzuki S., Ranade S., Osaki K., Ito S., Shigenari A., Ohnuki Y., Oka A.,
RA   Masuya A., Harting J., Baybayan P., Kitazume M., Sunaga J., Morishima S.,
RA   Morishima Y., Inoko H., Kulski J.K., Shiina T.;
RT   "Reference Grade Characterization of Polymorphisms in Full-Length HLA Class
RT   I and II Genes With Short-Read Sequencing on the ION PGM System and Long-
RT   Reads Generated by Single Molecule, Real-Time Sequencing on the PacBio
RT   Platform.";
RL   Front. Immunol. 9:2294-2294(2018).
RN   [30] {ECO:0000313|EMBL:ASA47542.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=29327506; DOI=.1111/tan.13210;
RA   Hurley C.K., Hou L., Lazaro A., Gerfen J., Enriquez E., Galarza P.,
RA   Rodriguez Cardozo M.B., Halagan M., Maiers M., Behm D., Ng J.;
RT   "Next generation sequencing characterizes the extent of HLA diversity in an
RT   Argentinian registry population.";
RL   HLA 91:175-186(2018).
RN   [31] {ECO:0000313|EMBL:AUF72633.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=29405566; DOI=.1111/iji.12357;
RA   Marsh S.G.;
RT   "Nomenclature for factors of the HLA system, update December 2017.";
RL   Int. J. Immunogenet. 45:88-93(2018).
RN   [32] {ECO:0000313|EMBL:BBD74353.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mimori T., Yasuda J., Kuroki Y., Shibata T.F., Katsuoka F., Saito S.,
RA   Nariai N., Ono A., Nakai-Inagaki N., Misawa K., Tateno K., Kawai Y.,
RA   Fuse N., Hozawa A., Kuriyama S., Sugawara J., Minegishi N., Suzuki K.,
RA   Kinoshita K., Nagasaki M., Yamamoto M.;
RT   "Construction of full-length Japanese reference panel of class I HLA genes
RT   with single-molecule, real-time sequencing.";
RL   Pharmacogenomics J. 0:0-0(2018).
RN   [33] {ECO:0000313|EMBL:SOX89594.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Voorter E. C., Matern B.;
RL   Submitted (JAN-2018) to the EMBL/GenBank/DDBJ databases.
RN   [34] {ECO:0000313|EMBL:SPF82192.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Albrecht V., Albrecht V., Boehme I.;
RL   Submitted (MAR-2018) to the EMBL/GenBank/DDBJ databases.
RN   [35] {ECO:0000313|EMBL:AWM62288.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Cereb N., Yang S.Y.;
RT   "HLA new alleles found by Histogenetics.";
RL   Submitted (APR-2018) to the EMBL/GenBank/DDBJ databases.
RN   [36] {ECO:0000313|EMBL:QAX33596.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Balz V., Krause S., Enczmann J.;
RT   "New HLA class 1 alleles.";
RL   Submitted (APR-2018) to the EMBL/GenBank/DDBJ databases.
RN   [37] {ECO:0000313|EMBL:AWK57490.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Hou L., Enriquez E., Persaud M., Hurley C.;
RL   Submitted (APR-2018) to the EMBL/GenBank/DDBJ databases.
RN   [38] {ECO:0000313|EMBL:SPQ44287.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Albrecht V., Albrecht V.;
RL   Submitted (MAY-2018) to the EMBL/GenBank/DDBJ databases.
RN   [39] {ECO:0000313|EMBL:AXO67719.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Lazaro A., Hou L., Enriquez E., Persaud M., Hurley C.K.;
RT   "Novel HLA Class I Allele.";
RL   Submitted (JUL-2018) to the EMBL/GenBank/DDBJ databases.
RN   [40] {ECO:0000313|EMBL:QCL09044.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Niokou D., Chowdhury T., Sathanathan T., Brown C.J.;
RL   Submitted (SEP-2018) to the EMBL/GenBank/DDBJ databases.
RN   [41] {ECO:0000313|EMBL:QDC33413.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Hurley C.K., Kidd K.;
RL   Submitted (JAN-2019) to the EMBL/GenBank/DDBJ databases.
RN   [42] {ECO:0000313|EMBL:QCP68926.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Cargou M., Elsermans V., Top I., Guidicelli G., Visentin J.;
RT   "Characterization of the novel HLA-A*03:XX allele by sequencing-based
RT   typing.";
RL   Submitted (FEB-2019) to the EMBL/GenBank/DDBJ databases.
RN   [43] {ECO:0000313|EMBL:QDC33446.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Hurley C.K.;
RL   Submitted (APR-2019) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC       {ECO:0000256|RuleBase:RU004439}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EU445472; ACA34992.1; -; Genomic_DNA.
DR   EMBL; GU812296; ADE80887.1; -; Genomic_DNA.
DR   EMBL; KT156722; ALO24306.1; -; Genomic_DNA.
DR   EMBL; KT266701; ALP46208.1; -; Genomic_DNA.
DR   EMBL; KT266702; ALP46209.1; -; Genomic_DNA.
DR   EMBL; KU528595; ALZ40810.1; -; Genomic_DNA.
DR   EMBL; KT819308; AMO26194.1; -; Genomic_DNA.
DR   EMBL; KX621302; AOE46676.1; -; Genomic_DNA.
DR   EMBL; KX962567; APO40931.1; -; Genomic_DNA.
DR   EMBL; KY072923; AQN67170.1; -; Genomic_DNA.
DR   EMBL; KX583634; ARX77874.1; -; Genomic_DNA.
DR   EMBL; KX686515; ARX98023.1; -; Genomic_DNA.
DR   EMBL; KY235394; ASA47542.1; -; Genomic_DNA.
DR   EMBL; KY368782; ASA47563.1; -; Genomic_DNA.
DR   EMBL; KY368783; ASA47564.1; -; Genomic_DNA.
DR   EMBL; KY419437; ASU50328.1; -; Genomic_DNA.
DR   EMBL; KY419438; ASU50329.1; -; Genomic_DNA.
DR   EMBL; MF474221; ASU61671.1; -; Genomic_DNA.
DR   EMBL; MF474222; ASU61672.1; -; Genomic_DNA.
DR   EMBL; MG199209; AUF72633.1; -; Genomic_DNA.
DR   EMBL; MG372846; AUL81601.1; -; Genomic_DNA.
DR   EMBL; KY613918; AUP42581.1; -; Genomic_DNA.
DR   EMBL; KY613919; AUP42582.1; -; Genomic_DNA.
DR   EMBL; MG450938; AUQ33047.1; -; Genomic_DNA.
DR   EMBL; MG584019; AUQ33079.1; -; Genomic_DNA.
DR   EMBL; MG603087; AUQ33094.1; -; Genomic_DNA.
DR   EMBL; MG756781; AUQ33246.1; -; Genomic_DNA.
DR   EMBL; MF069202; AWB14528.1; -; Genomic_DNA.
DR   EMBL; MH179252; AWK57490.1; -; Genomic_DNA.
DR   EMBL; MH179254; AWK57492.1; -; Genomic_DNA.
DR   EMBL; MH173476; AWM62234.1; -; Genomic_DNA.
DR   EMBL; MH215794; AWM62288.1; -; Genomic_DNA.
DR   EMBL; MH401226; AXN55386.1; -; Genomic_DNA.
DR   EMBL; MH704659; AXN55433.1; -; Genomic_DNA.
DR   EMBL; MH721214; AXN55438.1; -; Genomic_DNA.
DR   EMBL; MH721227; AXN55451.1; -; Genomic_DNA.
DR   EMBL; MH630135; AXO67719.1; -; Genomic_DNA.
DR   EMBL; MH758812; AZL48314.1; -; Genomic_DNA.
DR   EMBL; MH758819; AZL48320.1; -; Genomic_DNA.
DR   EMBL; MH973889; AZL48423.1; -; Genomic_DNA.
DR   EMBL; BA000025; BAB63400.1; -; Genomic_DNA.
DR   EMBL; AB774956; BAN59802.1; -; Genomic_DNA.
DR   EMBL; AB774974; BAN59820.1; -; Genomic_DNA.
DR   EMBL; LC257689; BBD34007.1; -; Genomic_DNA.
DR   EMBL; LC326117; BBD74353.1; -; Genomic_DNA.
DR   EMBL; HG327114; CDG23669.1; -; mRNA.
DR   EMBL; HG794390; CDK41199.1; -; Genomic_DNA.
DR   EMBL; HG794396; CDK41205.1; -; Genomic_DNA.
DR   EMBL; LN877322; CUA55065.1; -; Genomic_DNA.
DR   EMBL; LN994612; CUV66664.1; -; Genomic_DNA.
DR   EMBL; LN994664; CUV66716.1; -; Genomic_DNA.
DR   EMBL; LN994669; CUV66721.1; -; Genomic_DNA.
DR   EMBL; LN994733; CUV66785.1; -; Genomic_DNA.
DR   EMBL; LN999578; CUX90971.1; -; Genomic_DNA.
DR   EMBL; LN999594; CUX90987.1; -; Genomic_DNA.
DR   EMBL; LT219465; CZQ50133.1; -; Genomic_DNA.
DR   EMBL; MH269336; QAX33596.1; -; Genomic_DNA.
DR   EMBL; MH909772; QCL09044.1; -; Genomic_DNA.
DR   EMBL; MK521633; QCP68926.1; -; Genomic_DNA.
DR   EMBL; MK442077; QDC33413.1; -; Genomic_DNA.
DR   EMBL; MK684244; QDC33427.1; -; Genomic_DNA.
DR   EMBL; MK814891; QDC33446.1; -; Genomic_DNA.
DR   EMBL; LT546644; SAI65262.1; -; Genomic_DNA.
DR   EMBL; LT599184; SBW38405.1; -; Genomic_DNA.
DR   EMBL; LT827023; SLM20096.1; -; Genomic_DNA.
DR   EMBL; LT898182; SNQ25992.1; -; Genomic_DNA.
DR   EMBL; LT963213; SOR74757.1; -; Genomic_DNA.
DR   EMBL; LT963223; SOR74767.1; -; Genomic_DNA.
DR   EMBL; LT963255; SOR74799.1; -; Genomic_DNA.
DR   EMBL; LT963289; SOR74833.1; -; Genomic_DNA.
DR   EMBL; LT976502; SOX89594.1; -; Genomic_DNA.
DR   EMBL; LT986519; SPF82192.1; -; Genomic_DNA.
DR   EMBL; LS398158; SPQ44287.1; -; Genomic_DNA.
DR   RefSeq; NP_002107.3; NM_002116.7.
DR   Antibodypedia; 26136; 1298 antibodies.
DR   DNASU; 3105; -.
DR   GeneID; 3105; -.
DR   KEGG; hsa:3105; -.
DR   CTD; 3105; -.
DR   EuPathDB; HostDB:ENSG00000206503.11; -.
DR   PharmGKB; PA35055; -.
DR   eggNOG; ENOG410II5V; Eukaryota.
DR   eggNOG; ENOG4111K8F; LUCA.
DR   KO; K06751; -.
DR   OrthoDB; 1390181at2759; -.
DR   ChiTaRS; HLA-A; human.
DR   GenomeRNAi; 3105; -.
DR   Bgee; ENSG00000206503; Expressed in mononuclear cell and 238 other tissues.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0019882; P:antigen processing and presentation; IEA:InterPro.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 3.30.500.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR037055; MHC_I-like_Ag-recog_sf.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF54452; SSF54452; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAM:Phobius}; Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL          1..24
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           25..365
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5015087079"
FT   TRANSMEM        308..332
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          209..295
FT                   /note="Ig-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50835"
FT   REGION          339..365
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        341..359
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   365 AA;  40841 MW;  DEDFCEC4450E0580 CRC64;
     MAVMAPRTLL LLLSGALALT QTWAGSHSMR YFFTSVSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASQRME PRAPWIEQEG PEYWDQETRN VKAQSQTDRV DLGTLRGYYN QSEAGSHTIQ
     IMYGCDVGSD GRFLRGYRQD AYDGKDYIAL NEDLRSWTAA DMAAQITKRK WEAAHEAEQL
     RAYLDGTCVE WLRRYLENGK ETLQRTDPPK THMTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEL
     SSQPTIPIVG IIAGLVLLGA VITGAVVAAV MWRRKSSDRK GGSYTQAASS DSAQGSDVSL
     TACKV
//
ID   B2R7U3_HUMAN            Unreviewed;       365 AA.
AC   B2R7U3;
DT   01-JUL-2008, integrated into UniProtKB/TrEMBL.
DT   01-JUL-2008, sequence version 1.
DT   22-APR-2020, entry version 83.
DE   SubName: Full=cDNA, FLJ93604, highly similar to Homo sapiens major histocompatibility complex, class I, A (HLA-A),mRNA {ECO:0000313|EMBL:BAG35940.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG35940.1};
RN   [1] {ECO:0000313|EMBL:BAG35940.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Cord blood {ECO:0000313|EMBL:BAG35940.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Kaida T., Tsuchiya K., Iida Y.,
RA   Takayama Y., Murakawa K., Kanehori K., Andoh T., Kagawa N., Sato R.,
RA   Kawamura Y., Tanaka S., Kisu Y., Sugano S., Goshima N., Nomura N.,
RA   Isogai T.;
RT   "NEDO functional analysis of protein and research application project.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC       {ECO:0000256|RuleBase:RU004439}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK313119; BAG35940.1; -; mRNA.
DR   RefSeq; NP_002107.3; NM_002116.7.
DR   PeptideAtlas; B2R7U3; -.
DR   PRIDE; B2R7U3; -.
DR   DNASU; 3105; -.
DR   GeneID; 3105; -.
DR   KEGG; hsa:3105; -.
DR   CTD; 3105; -.
DR   PharmGKB; PA35055; -.
DR   eggNOG; ENOG410II5V; Eukaryota.
DR   eggNOG; ENOG4111K8F; LUCA.
DR   KO; K06751; -.
DR   OrthoDB; 1390181at2759; -.
DR   GenomeRNAi; 3105; -.
DR   Genevisible; B2R7U3; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0019882; P:antigen processing and presentation; IEA:InterPro.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 3.30.500.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR037055; MHC_I-like_Ag-recog_sf.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF54452; SSF54452; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAM:Phobius}; Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL          1..24
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           25..365
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5002780129"
FT   TRANSMEM        306..332
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          209..295
FT                   /note="Ig-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50835"
FT   REGION          339..365
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        341..359
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   365 AA;  40827 MW;  8EC0D1C4450E128B CRC64;
     MAVMAPRTLL LLLSGALALT QTWAGSHSMR YFFTSVSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASQRME PRAPWIEQEG PEYWDQETRN VKAQSQTDRV DLGTLRGYYN QSEAGSHTIQ
     IMYGCDVGSD GRFLRGYRQD AYDGKDYIAL NEDLRSWTAA DMAAQITKRK WEAAHEAEQL
     RAYLDGTCVE WLRRYLENGK ETLQRTDPPK THMTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEL
     SSQPTIPIVG VIAGLVLLGA VITGAVVAAV MWRRKSSDRK GGSYTQAASS DSAQGSDVSL
     TACKV
//
ID   HLAA_HUMAN              Reviewed;         365 AA.
AC   P04439; B1PKZ3; O02939; O02954; O02955; O02963; O19509; O19546; O19598;
AC   O19605; O19606; O19619; O19647; O19673; O19687; O19695; O19756; O19794;
AC   O19795; O43906; O43907; O46874; O62921; O62924; O77937; O77938; O77964;
AC   O78073; O78171; O98009; O98010; O98011; O98137; P01891; P01892; P05534;
AC   P06338; P10313; P10314; P10315; P10316; P13746; P16188; P16189; P16190;
AC   P18462; P30443; P30444; P30445; P30446; P30447; P30448; P30449; P30450;
AC   P30451; P30452; P30453; P30454; P30455; P30456; P30457; P30458; P30459;
AC   P30512; P30514; P79505; P79562; P79563; Q09160; Q29680; Q29747; Q29835;
AC   Q29837; Q29838; Q29899; Q29908; Q29909; Q29910; Q30208; Q31623; Q5S3G1;
AC   Q65A82; Q8MHM1; Q8MHN9; Q95352; Q95355; Q95362; Q95377; Q95380; Q95IZ5;
AC   Q9BCN0; Q9BD15; Q9BD19; Q9GJE6; Q9GJE7; Q9GJE8; Q9MW42; Q9MY89; Q9MYA3;
AC   Q9MYA5; Q9MYC4; Q9MYE6; Q9MYE9; Q9MYG4; Q9MYG5; Q9MYI5; Q9TP25; Q9TPQ3;
AC   Q9TPR8; Q9TPX8; Q9TPX9; Q9TPY0; Q9TQ24; Q9TQE8; Q9TQE9; Q9TQF1; Q9TQF5;
AC   Q9TQF8; Q9TQF9; Q9TQG0; Q9TQG5; Q9TQG7; Q9TQH5; Q9TQI3; Q9TQK5; Q9TQM6;
AC   Q9TQN5; Q9TQP5; Q9TQP6; Q9TQP7; Q9UIN1; Q9UIN2; Q9UIP7; Q9UQU3; Q9UQU6;
AC   Q9UQU7;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   22-AUG-2003, sequence version 2.
DT   22-APR-2020, entry version 196.
DE   RecName: Full=HLA class I histocompatibility antigen, A alpha chain;
DE   AltName: Full=Human leukocyte antigen A;
DE            Short=HLA-A;
DE   Flags: Precursor;
GN   Name=HLA-A {ECO:0000312|HGNC:HGNC:4931}; Synonyms=HLAA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE OF 25-298 (ALLELE A*32:01).
RX   PubMed=2431040;
RA   Wan A.M., Ennis P., Parham P., Holmes N.;
RT   "The primary structure of HLA-A32 suggests a region involved in formation
RT   of the Bw4/Bw6 epitopes.";
RL   J. Immunol. 137:3671-3674(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*02:05).
RX   PubMed=3496393;
RA   Holmes N., Ennis P., Wan A.M., Denney D.W., Parham P.;
RT   "Multiple genetic mechanisms have contributed to the generation of the HLA-
RT   A2/A28 family of class I MHC molecules.";
RL   J. Immunol. 139:936-941(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*11:01).
RX   PubMed=2460344; DOI=10.1002/j.1460-2075.1988.tb03131.x;
RA   Mayer W.E., Jonker M., Klein D., Ivanyi P., van Seventer G., Klein J.;
RT   "Nucleotide sequences of chimpanzee MHC class I alleles: evidence for
RT   trans-species mode of evolution.";
RL   EMBO J. 7:2765-2774(1988).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*29:01).
RX   PubMed=2461903; DOI=10.1007/bf02341610;
RA   Trapani J.A., Mizuno S., Kang S.H., Yang S.Y., Dupont B.;
RT   "Molecular mapping of a new public HLA class I epitope shared by all HLA-B
RT   and HLA-C antigens and defined by a monoclonal antibody.";
RL   Immunogenetics 29:25-32(1989).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ALLELES A*30:01; A*31:01 AND
RP   A*33:01).
RX   PubMed=2478623;
RA   Kato K., Trapani J.A., Allopenna J., Dupont B., Yang S.Y.;
RT   "Molecular analysis of the serologically defined HLA-Aw19 antigens. A
RT   genetically distinct family of HLA-A antigens comprising A29, A31, A32, and
RT   Aw33, but probably not A30.";
RL   J. Immunol. 143:3371-3378(1989).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ALLELE A*01:01).
RX   PubMed=2715640;
RA   Parham P., Lawlor D.A., Lomen C.E., Ennis P.D.;
RT   "Diversity and diversification of HLA-A,B,C alleles.";
RL   J. Immunol. 142:3937-3950(1989).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELES A*02:01 AND A*25:01).
RX   PubMed=2320591; DOI=10.1073/pnas.87.7.2833;
RA   Ennis P.D., Zemmour J., Salter R.D., Parham P.;
RT   "Rapid cloning of HLA-A,B cDNA by using the polymerase chain reaction:
RT   frequency and nature of errors produced in amplification.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:2833-2837(1990).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*29:02).
RX   PubMed=1782566;
RA   Tabary T., Prochnicka-Chalufour A., Cornillet P., Lehoang P., Betuel H.,
RA   Cohen H.M.;
RT   "HLA-A29 sub-types and 'Birdshot' choroido-retinopathy susceptibility: a
RT   possible 'resistance motif' in the HLA-A29.1 molecule.";
RL   C. R. Acad. Sci. III, Sci. Vie 313:599-605(1991).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELES A*23:01 AND A*24:02).
RX   PubMed=1729171; DOI=10.1007/bf00216625;
RA   Little A.-M., Madrigal J.A., Parham P.;
RT   "Molecular definition of an elusive third HLA-A9 molecule: HLA-A9.3.";
RL   Immunogenetics 35:41-45(1992).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELES A*34:01; A*36:01; A*43:01; A*66:01 AND
RP   A*74:01).
RX   PubMed=1431115;
RA   Madrigal J.A., Belich M.P., Hildebrand W.H., Benjamin R.J., Little A.-M.,
RA   Zemmour J., Ennis P.D., Ward F.E., Petzl-Erler M.L., Martell R.W.,
RA   du Toit E.D., Parham P.;
RT   "Distinctive HLA-A,B antigens of black populations formed by interallelic
RT   conversion.";
RL   J. Immunol. 149:3411-3415(1992).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*31:01).
RX   PubMed=1317015; DOI=10.1038/357326a0;
RA   Belich M.P., Madrigal J.A., Hildebrand W.H., Zemmour J., Williams R.C.,
RA   Luz R., Petzl-Erler M.L., Parham P.;
RT   "Unusual HLA-B alleles in two tribes of Brazilian Indians.";
RL   Nature 357:326-329(1992).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*26:01).
RX   PubMed=8475492; DOI=10.1111/j.1399-0039.1993.tb01982.x;
RA   Madrigal J.A., Hildebrand W.H., Belich M.P., Benjamin R.J., Little A.-M.,
RA   Zemmour J., Ennis P.D., Ward F.E., Petzl-Erler M.L., du Toit E.D.,
RA   Parham P.;
RT   "Structural diversity in the HLA-A10 family of alleles: correlations with
RT   serology.";
RL   Tissue Antigens 41:72-80(1993).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*80:01).
RX   PubMed=8284791; DOI=10.1111/j.1399-0039.1993.tb02186.x;
RA   Domena J.D., Hildebrand W.H., Bias W.B., Parham P.;
RT   "A sixth family of HLA-A alleles defined by HLA-A*8001.";
RL   Tissue Antigens 42:156-159(1993).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELES A*26:01).
RC   TISSUE=Blood;
RX   PubMed=8026990; DOI=10.1016/0198-8859(94)90263-1;
RA   Ishikawa Y., Tokunaga K., Lin L., Imanishi T., Saitou S., Kashiwase K.,
RA   Akaza T., Tadokoro K., Juji T.;
RT   "Sequences of four splits of HLA-A10 group. Implications for serologic
RT   cross-reactivities and their evolution.";
RL   Hum. Immunol. 39:220-224(1994).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*80:01).
RX   PubMed=8188325; DOI=10.1007/bf00176169;
RA   Balas A., Garcia-Sanchez F., Gomez-Reino F., Vicario J.L.;
RT   "Characterization of a new and highly distinguishable HLA-A allele in a
RT   Spanish family.";
RL   Immunogenetics 39:452-452(1994).
RN   [16]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*11:01).
RX   PubMed=8016845; DOI=10.1111/j.1399-0039.1994.tb02304.x;
RA   Lin L., Tokunaga K., Ishikawa Y., Bannai M., Kashiwase K., Kuwata S.,
RA   Akaza T., Tadokoro K., Shibata Y., Juji T.;
RT   "Sequence analysis of serological HLA-A11 split antigens, A11.1 and
RT   A11.2.";
RL   Tissue Antigens 43:78-82(1994).
RN   [17]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*30:01).
RX   PubMed=7871528; DOI=10.1111/j.1399-0039.1994.tb02393.x;
RA   Olerup O., Daniels T.J., Baxter-Lowe L.;
RT   "Correct sequence of the A*3001 allele obtained by PCR-SSP typing and
RT   automated nucleotide sequencing.";
RL   Tissue Antigens 44:265-267(1994).
RN   [18]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*11:01) (ISOFORM 2).
RX   PubMed=17092262; DOI=10.1111/j.1399-0039.2006.00687.x;
RA   Sun Y., Liu S., Luo Y., Liang F., Xi Y.;
RT   "Identification and frequency of a novel HLA-A allele, A*110104.";
RL   Tissue Antigens 68:453-454(2006).
RN   [19]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE A*03:01).
RX   PubMed=6609814; DOI=10.1002/j.1460-2075.1984.tb01901.x;
RA   Strachan T., Sodoyer R., Damotte M., Jordan B.R.;
RT   "Complete nucleotide sequence of a functional class I HLA gene, HLA-A3:
RT   implications for the evolution of HLA genes.";
RL   EMBO J. 3:887-894(1984).
RN   [20]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-297 (ALLELES A*68:01 AND A*69:01).
RX   PubMed=3877632; DOI=10.1002/j.1460-2075.1985.tb04013.x;
RA   Holmes N., Parham P.;
RT   "Exon shuffling in vivo can generate novel HLA class I molecules.";
RL   EMBO J. 4:2849-2854(1985).
RN   [21]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE A*02:01).
RX   PubMed=2982951;
RA   Koller B.H., Orr H.T.;
RT   "Cloning and complete sequence of an HLA-A2 gene: analysis of two HLA-A
RT   alleles at the nucleotide level.";
RL   J. Immunol. 134:2727-2733(1985).
RN   [22]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-365 (ALLELE A*11:01).
RX   PubMed=2437024; DOI=10.1007/bf00404694;
RA   Cowan E.P., Jelachich M.L., Biddison W.E., Coligan J.E.;
RT   "DNA sequence of HLA-A11: remarkable homology with HLA-A3 allows
RT   identification of residues involved in epitopes recognized by antibodies
RT   and T cells.";
RL   Immunogenetics 25:241-250(1987).
RN   [23]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE A*01:01).
RX   PubMed=2251137; DOI=10.1093/nar/18.22.6701;
RA   Girdlestone J.;
RT   "Nucleotide sequence of an HLA-A1 gene.";
RL   Nucleic Acids Res. 18:6701-6701(1990).
RN   [24]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE A*02:01).
RC   TISSUE=Blood;
RX   PubMed=7836067; DOI=10.1016/0198-8859(94)90087-6;
RA   Balas A., Garcia-Sanchez F., Gomez-Reino F., Vicario J.L.;
RT   "HLA class I allele (HLA-A2) expression defect associated with a mutation
RT   in its enhancer B inverted CAT box in two families.";
RL   Hum. Immunol. 41:69-73(1994).
RN   [25]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE A*31:01).
RX   PubMed=8795145; DOI=10.1111/j.1399-0039.1996.tb02580.x;
RA   Arnett K.L., Adams E.J., Parham P.;
RT   "On the sequence of A*3101.";
RL   Tissue Antigens 47:428-430(1996).
RN   [26]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE A*24:02).
RX   PubMed=9349616; DOI=10.1111/j.1399-0039.1997.tb02884.x;
RA   Laforet M., Froelich N., Parissiadis A., Bausinger H., Pfeiffer B.,
RA   Tongio M.M.;
RT   "An intronic mutation responsible for a low level of expression of an HLA-
RT   A*24 allele.";
RL   Tissue Antigens 50:340-346(1997).
RN   [27]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE A*01:01).
RX   PubMed=9349617; DOI=10.1111/j.1399-0039.1997.tb02885.x;
RA   Laforet M., Froelich N., Parissiadis A., Pfeiffer B., Schell A., Faller B.,
RA   Woehl-Jaegle M.L., Cazenave J.-P., Tongio M.M.;
RT   "A nucleotide insertion in exon 4 is responsible for the absence of
RT   expression of an HLA-A*01 allele.";
RL   Tissue Antigens 50:347-350(1997).
RN   [28]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE A*69:01).
RX   PubMed=19735485; DOI=10.1111/j.1744-313x.2009.00874.x;
RA   Zhu F., He Y., Zhang W., He J., He J., Xu X., Yan L.;
RT   "Analysis of the complete genomic sequence of HLA-A alleles in the Chinese
RT   Han population.";
RL   Int. J. Immunogenet. 36:351-360(2009).
RN   [29]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*32:01).
RA   Domena J.D.;
RL   Submitted (DEC-1993) to the EMBL/GenBank/DDBJ databases.
RN   [30]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*74:01).
RA   Hurley C.K.;
RL   Submitted (NOV-1994) to the EMBL/GenBank/DDBJ databases.
RN   [31]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*03:01).
RA   Ellexson M.E., Hildebrand W.H.;
RL   Submitted (JUL-1995) to the EMBL/GenBank/DDBJ databases.
RN   [32]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE A*03:01).
RA   Mayor N.P.;
RT   "Full length sequence of an HLA-A*0301 intron 2 variant.";
RL   Submitted (SEP-2004) to the EMBL/GenBank/DDBJ databases.
RN   [33]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [34]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [35]
RP   PROTEIN SEQUENCE OF 25-295 (ALLELE A*02:01).
RX   PubMed=92029; DOI=10.1073/pnas.76.9.4395;
RA   Orr H.T., Lopez de Castro J.A., Parham P., Ploegh H.L., Strominger J.L.;
RT   "Comparison of amino acid sequences of two human histocompatibility
RT   antigens, HLA-A2 and HLA-B7: location of putative alloantigenic sites.";
RL   Proc. Natl. Acad. Sci. U.S.A. 76:4395-4399(1979).
RN   [36]
RP   PROTEIN SEQUENCE OF 25-294 (ALLELE A*68:01).
RX   PubMed=6179086; DOI=10.1073/pnas.79.12.3813;
RA   Lopez de Castro J.A., Strominger J.L., Strong D.M., Orr H.T.;
RT   "Structure of crossreactive human histocompatibility antigens HLA-A28 and
RT   HLA-A2: possible implications for the generation of HLA polymorphism.";
RL   Proc. Natl. Acad. Sci. U.S.A. 79:3813-3817(1982).
RN   [37]
RP   FUNCTION (ALLELE A*03:01), AND CHARACTERIZATION OF VARIANT VAL-176.
RX   PubMed=2456340;
RA   Jelachich M.L., Cowan E.P., Turner R.V., Coligan J.E., Biddison W.E.;
RT   "Analysis of the molecular basis of HLA-A3 recognition by cytotoxic T cells
RT   using defined mutants of the HLA-A3 molecule.";
RL   J. Immunol. 141:1108-1113(1988).
RN   [38]
RP   FUNCTION (ALLELES A*02:01 AND A*68:01), INTERACTION WITH CD8A, DOMAIN, AND
RP   CHARACTERIZATION OF VARIANT VAL-269.
RX   PubMed=2784196; DOI=10.1038/338345a0;
RA   Salter R.D., Norment A.M., Chen B.P., Clayberger C., Krensky A.M.,
RA   Littman D.R., Parham P.;
RT   "Polymorphism in the alpha 3 domain of HLA-A molecules affects binding to
RT   CD8.";
RL   Nature 338:345-347(1989).
RN   [39]
RP   FUNCTION (ALLELE A*01:01).
RX   PubMed=1402688; DOI=10.1084/jem.176.5.1453;
RA   Traversari C., van der Bruggen P., Luescher I.F., Lurquin C., Chomez P.,
RA   Van Pel A., De Plaen E., Amar-Costesec A., Boon T.;
RT   "A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by
RT   cytolytic T lymphocytes directed against tumor antigen MZ2-E.";
RL   J. Exp. Med. 176:1453-1457(1992).
RN   [40]
RP   FUNCTION (ALLELES A*01:01 AND A*03:01), AND INTERACTION WITH B2M AND
RP   PEPTIDE.
RX   PubMed=7504010;
RA   DiBrino M., Tsuchida T., Turner R.V., Parker K.C., Coligan J.E.,
RA   Biddison W.E.;
RT   "HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins
RT   predicted from peptide binding motifs.";
RL   J. Immunol. 151:5930-5935(1993).
RN   [41]
RP   FUNCTION (ALLELE A*03:01), AND INTERACTION WITH B2M AND PEPTIDE.
RX   PubMed=7679507; DOI=10.1073/pnas.90.4.1508;
RA   DiBrino M., Parker K.C., Shiloach J., Knierman M., Lukszo J., Turner R.V.,
RA   Biddison W.E., Coligan J.E.;
RT   "Endogenous peptides bound to HLA-A3 possess a specific combination of
RT   anchor residues that permit identification of potential antigenic
RT   peptides.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:1508-1512(1993).
RN   [42]
RP   FUNCTION (ALLELE A*01:01), AND INTERACTION WITH B2M AND PEPTIDE.
RX   PubMed=7506728;
RA   DiBrino M., Parker K.C., Shiloach J., Turner R.V., Tsuchida T.,
RA   Garfield M., Biddison W.E., Coligan J.E.;
RT   "Endogenous peptides with distinct amino acid anchor residue motifs bind to
RT   HLA-A1 and HLA-B8.";
RL   J. Immunol. 152:620-631(1994).
RN   [43]
RP   FUNCTION (ALLELE A*02:01), MUTAGENESIS OF SER-156 AND THR-158, DOMAIN,
RP   INTERACTION WITH B2M, INTERACTION WITH TAP1-TAP2 COMPLEX, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=8805302; DOI=10.1016/s0960-9822(02)00611-5;
RA   Lewis J.W., Neisig A., Neefjes J., Elliott T.;
RT   "Point mutations in the alpha 2 domain of HLA-A2.1 define a functionally
RT   relevant interaction with TAP.";
RL   Curr. Biol. 6:873-883(1996).
RN   [44]
RP   FUNCTION (ALLELE A*02:01), INTERACTION WITH TAP1-TAP2 COMPLEX, AND
RP   MUTAGENESIS OF THR-158.
RX   PubMed=8630735; DOI=10.1016/s1074-7613(00)80416-1;
RA   Peace-Brewer A.L., Tussey L.G., Matsui M., Li G., Quinn D.G.,
RA   Frelinger J.A.;
RT   "A point mutation in HLA-A*0201 results in failure to bind the TAP complex
RT   and to present virus-derived peptides to CTL.";
RL   Immunity 4:505-514(1996).
RN   [45]
RP   FUNCTION (ALLELE A*29:02).
RX   PubMed=8622959; DOI=10.1073/pnas.93.8.3466;
RA   Boisgerault F., Khalil I., Tieng V., Connan F., Tabary T., Cohen J.H.,
RA   Choppin J., Charron D., Toubert A.;
RT   "Definition of the HLA-A29 peptide ligand motif allows prediction of
RT   potential T-cell epitopes from the retinal soluble antigen, a candidate
RT   autoantigen in birdshot retinopathy.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:3466-3470(1996).
RN   [46]
RP   FUNCTION (ALLELE A*24:02).
RX   PubMed=9047241; DOI=10.1016/s1074-7613(00)80426-4;
RA   Ikeda H., Lethe B.G., Lehmann F., van Baren N., Baurain J.-F., de Smet C.,
RA   Chambost H., Vitale M., Moretta A., Boon T., Coulie P.G.;
RT   "Characterization of an antigen that is recognized on a melanoma showing
RT   partial HLA loss by CTL expressing an NK inhibitory receptor.";
RL   Immunity 6:199-208(1997).
RN   [47]
RP   FUNCTION (ALLELE A*03:01).
RX   PubMed=9862734;
RA   Kawakami Y., Robbins P.F., Wang X., Tupesis J.P., Parkhurst M.R., Kang X.,
RA   Sakaguchi K., Appella E., Rosenberg S.A.;
RT   "Identification of new melanoma epitopes on melanosomal proteins recognized
RT   by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3
RT   alleles.";
RL   J. Immunol. 161:6985-6992(1998).
RN   [48]
RP   FUNCTION (ALLELE A*11:01).
RX   PubMed=10449296; DOI=10.1097/00002030-199907300-00021;
RA   Fukada K., Chujoh Y., Tomiyama H., Miwa K., Kaneko Y., Oka S.,
RA   Takiguchi M.;
RT   "HLA-A*1101-restricted cytotoxic T lymphocyte recognition of HIV-1 Pol
RT   protein.";
RL   AIDS 13:1413-1414(1999).
RN   [49]
RP   INTERACTION WITH HTLV-1 ACCESSORY PROTEIN P12I (MICROBIAL INFECTION).
RX   PubMed=11390610; DOI=10.1128/jvi.75.13.6086-6094.2001;
RA   Johnson J.M., Nicot C., Fullen J., Ciminale V., Casareto L., Mulloy J.C.,
RA   Jacobson S., Franchini G.;
RT   "Free major histocompatibility complex class I heavy chain is
RT   preferentially targeted for degradation by human T-cell
RT   leukemia/lymphotropic virus type 1 p12(I) protein.";
RL   J. Virol. 75:6086-6094(2001).
RN   [50]
RP   INTERACTION WITH HUMAN HERPESVIRUS 8 MIR1 PROTEIN (MICROBIAL INFECTION),
RP   AND UBIQUITINATION (MICROBIAL INFECTION).
RX   PubMed=12006494; DOI=10.1093/emboj/21.10.2418;
RA   Hewitt E.W., Duncan L., Mufti D., Baker J., Stevenson P.G., Lehner P.J.;
RT   "Ubiquitylation of MHC class I by the K3 viral protein signals
RT   internalization and TSG101-dependent degradation.";
RL   EMBO J. 21:2418-2429(2002).
RN   [51]
RP   FUNCTION (ALLELE A*02:01).
RX   PubMed=12138174; DOI=10.1073/pnas.112331099;
RA   Nagata Y., Ono S., Matsuo M., Gnjatic S., Valmori D., Ritter G.,
RA   Garrett W., Old L.J., Mellman I.;
RT   "Differential presentation of a soluble exogenous tumor antigen, NY-ESO-1,
RT   by distinct human dendritic cell populations.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:10629-10634(2002).
RN   [52]
RP   FUNCTION (ALLELE A*24:02).
RX   PubMed=12393434; DOI=10.1182/blood-2002-04-1240;
RA   Kuzushima K., Hayashi N., Kudoh A., Akatsuka Y., Tsujimura K.,
RA   Morishima Y., Tsurumi T.;
RT   "Tetramer-assisted identification and characterization of epitopes
RT   recognized by HLA A*2402-restricted Epstein-Barr virus-specific CD8+ T
RT   cells.";
RL   Blood 101:1460-1468(2003).
RN   [53]
RP   FUNCTION (ALLELE A*26:01).
RX   PubMed=15893615; DOI=10.1016/j.vaccine.2005.02.022;
RA   Satoh M., Takamiya Y., Oka S., Tokunaga K., Takiguchi M.;
RT   "Identification and characterization of HIV-1-specific CD8+ T cell epitopes
RT   presented by HLA-A*2601.";
RL   Vaccine 23:3783-3790(2005).
RN   [54]
RP   FUNCTION (ALLELE A*01:01).
RX   PubMed=17189421; DOI=10.1158/1078-0432.ccr-06-1337;
RA   Asemissen A.M., Keilholz U., Tenzer S., Mueller M., Walter S.,
RA   Stevanovic S., Schild H., Letsch A., Thiel E., Rammensee H.G.,
RA   Scheibenbogen C.;
RT   "Identification of a highly immunogenic HLA-A*01-binding T cell epitope of
RT   WT1.";
RL   Clin. Cancer Res. 12:7476-7482(2006).
RN   [55]
RP   FUNCTION (ALLELES A*23:01; A*24:02 AND A*32:01), AND INTERACTION WITH
RP   KIR3DL1.
RX   PubMed=17182537; DOI=10.4049/jimmunol.178.1.33;
RA   Thananchai H., Gillespie G., Martin M.P., Bashirova A., Yawata N.,
RA   Yawata M., Easterbrook P., McVicar D.W., Maenaka K., Parham P.,
RA   Carrington M., Dong T., Rowland-Jones S.;
RT   "Cutting Edge: Allele-specific and peptide-dependent interactions between
RT   KIR3DL1 and HLA-A and HLA-B.";
RL   J. Immunol. 178:33-37(2007).
RN   [56]
RP   FUNCTION (ALLELE A*02:01).
RX   PubMed=17079320; DOI=10.1128/jvi.01779-06;
RA   Robek M.D., Garcia M.L., Boyd B.S., Chisari F.V.;
RT   "Role of immunoproteasome catalytic subunits in the immune response to
RT   hepatitis B virus.";
RL   J. Virol. 81:483-491(2007).
RN   [57]
RP   FUNCTION (ALLELE A*24:02), AND INTERACTION WITH KIR3DL1.
RX   PubMed=18502829; DOI=10.1182/blood-2008-02-137521;
RA   Stern M., Ruggeri L., Capanni M., Mancusi A., Velardi A.;
RT   "Human leukocyte antigens A23, A24, and A32 but not A25 are ligands for
RT   KIR3DL1.";
RL   Blood 112:708-710(2008).
RN   [58]
RP   FUNCTION (ALLELE A*01:01).
RX   PubMed=18779413; DOI=10.1182/blood-2008-06-162883;
RA   Brennan R.M., Burrows S.R.;
RT   "A mechanism for the HLA-A*01-associated risk for EBV+ Hodgkin lymphoma and
RT   infectious mononucleosis.";
RL   Blood 112:2589-2590(2008).
RN   [59]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-110.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of multiple
RT   enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [60]
RP   FUNCTION (ALLELE A*03:01).
RX   PubMed=19543285; DOI=10.1038/nmeth.1345;
RA   Hadrup S.R., Bakker A.H., Shu C.J., Andersen R.S., van Veluw J.,
RA   Hombrink P., Castermans E., Thor Straten P., Blank C., Haanen J.B.,
RA   Heemskerk M.H., Schumacher T.N.;
RT   "Parallel detection of antigen-specific T-cell responses by
RT   multidimensional encoding of MHC multimers.";
RL   Nat. Methods 6:520-526(2009).
RN   [61]
RP   FUNCTION (ALLELE A*01:01).
RX   PubMed=20364150; DOI=10.1038/ni.1862;
RA   Parmentier N., Stroobant V., Colau D., de Diesbach P., Morel S.,
RA   Chapiro J., van Endert P., Van den Eynde B.J.;
RT   "Production of an antigenic peptide by insulin-degrading enzyme.";
RL   Nat. Immunol. 11:449-454(2010).
RN   [62]
RP   NOMENCLATURE.
RX   PubMed=20356336; DOI=10.1111/j.1399-0039.2010.01466.x;
RA   Marsh S.G., Albert E.D., Bodmer W.F., Bontrop R.E., Dupont B., Erlich H.A.,
RA   Fernandez-Vina M., Geraghty D.E., Holdsworth R., Hurley C.K., Lau M.,
RA   Lee K.W., Mach B., Maiers M., Mayr W.R., Mueller C.R., Parham P.,
RA   Petersdorf E.W., Sasazuki T., Strominger J.L., Svejgaard A., Terasaki P.I.,
RA   Tiercy J.M., Trowsdale J.;
RT   "Nomenclature for factors of the HLA system, 2010.";
RL   Tissue Antigens 75:291-455(2010).
RN   [63]
RP   INDUCTION BY IFNG, GLYCOSYLATION AT ASN-110, MUTAGENESIS OF ASN-110,
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH TAPBP.
RX   PubMed=21263072; DOI=10.4049/jimmunol.1002959;
RA   Rizvi S.M., Del Cid N., Lybarger L., Raghavan M.;
RT   "Distinct functions for the glycans of tapasin and heavy chains in the
RT   assembly of MHC class I molecules.";
RL   J. Immunol. 186:2309-2320(2011).
RN   [64]
RP   FUNCTION (ALLELE A*74:01).
RX   PubMed=21498667; DOI=10.4049/jimmunol.1003711;
RA   Matthews P.C., Adland E., Listgarten J., Leslie A., Mkhwanazi N.,
RA   Carlson J.M., Harndahl M., Stryhn A., Payne R.P., Ogwu A., Huang K.H.,
RA   Frater J., Paioni P., Kloverpris H., Jooste P., Goedhals D., van Vuuren C.,
RA   Steyn D., Riddell L., Chen F., Luzzi G., Balachandran T., Ndung'u T.,
RA   Buus S., Carrington M., Shapiro R., Heckerman D., Goulder P.J.;
RT   "HLA-A*7401-mediated control of HIV viremia is independent of its linkage
RT   disequilibrium with HLA-B*5703.";
RL   J. Immunol. 186:5675-5686(2011).
RN   [65]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-356 AND SER-359, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [66]
RP   FUNCTION (ALLELE A*24:02).
RX   PubMed=24192765; DOI=10.1038/srep03097;
RA   Shimizu A., Kawana-Tachikawa A., Yamagata A., Han C., Zhu D., Sato Y.,
RA   Nakamura H., Koibuchi T., Carlson J., Martin E., Brumme C.J., Shi Y.,
RA   Gao G.F., Brumme Z.L., Fukai S., Iwamoto A.;
RT   "Structure of TCR and antigen complexes at an immunodominant CTL epitope in
RT   HIV-1 infection.";
RL   Sci. Rep. 3:3097-3097(2013).
RN   [67]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-343; TYR-344; SER-349;
RP   SER-350; SER-352; SER-356 AND SER-359, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [68]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [69]
RP   FUNCTION (ALLELE A*01:01), AND SUBCELLULAR LOCATION.
RX   PubMed=25880248; DOI=10.1111/tan.12565;
RA   Giam K., Ayala-Perez R., Illing P.T., Schittenhelm R.B., Croft N.P.,
RA   Purcell A.W., Dudek N.L.;
RT   "A comprehensive analysis of peptides presented by HLA-A1.";
RL   Tissue Antigens 85:492-496(2015).
RN   [70]
RP   INTERACTION WITH TAPBPL.
RX   PubMed=26869717; DOI=10.1073/pnas.1519894113;
RA   Morozov G.I., Zhao H., Mage M.G., Boyd L.F., Jiang J., Dolan M.A.,
RA   Venna R., Norcross M.A., McMurtrey C.P., Hildebrand W., Schuck P.,
RA   Natarajan K., Margulies D.H.;
RT   "Interaction of TAPBPR, a tapasin homolog, with MHC-I molecules promotes
RT   peptide editing.";
RL   Proc. Natl. Acad. Sci. U.S.A. 113:E1006-E1015(2016).
RN   [71]
RP   FUNCTION (ALLELE A*02:01).
RX   PubMed=26929325; DOI=10.1073/pnas.1521812113;
RA   Tripathi S.C., Peters H.L., Taguchi A., Katayama H., Wang H., Momin A.,
RA   Jolly M.K., Celiktas M., Rodriguez-Canales J., Liu H., Behrens C.,
RA   Wistuba I.I., Ben-Jacob E., Levine H., Molldrem J.J., Hanash S.M.,
RA   Ostrin E.J.;
RT   "Immunoproteasome deficiency is a feature of non-small cell lung cancer
RT   with a mesenchymal phenotype and is associated with a poor outcome.";
RL   Proc. Natl. Acad. Sci. U.S.A. 113:E1555-E1564(2016).
RN   [72]
RP   FUNCTION (ALLELE A*03:01).
RX   PubMed=27049119; DOI=10.1038/srep24032;
RA   Ebstein F., Textoris-Taube K., Keller C., Golnik R., Vigneron N.,
RA   Van den Eynde B.J., Schuler-Thurner B., Schadendorf D., Lorenz F.K.,
RA   Uckert W., Urban S., Lehmann A., Albrecht-Koepke N., Janek K., Henklein P.,
RA   Niewienda A., Kloetzel P.M., Mishto M.;
RT   "Proteasomes generate spliced epitopes by two different mechanisms and as
RT   efficiently as non-spliced epitopes.";
RL   Sci. Rep. 6:24032-24032(2016).
RN   [73]
RP   FUNCTION (ALLELE A*01:01).
RX   PubMed=30530481; DOI=10.4049/jimmunol.1801003;
RA   Keib A., Mei Y.F., Cicin-Sain L., Busch D.H., Dennehy K.M.;
RT   "Measuring Antiviral Capacity of T Cell Responses to Adenovirus.";
RL   J. Immunol. 202:618-624(2019).
RN   [74]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 25-294 (ALLELE A*68:01), AND
RP   FUNCTION (ALLELE A*68:01).
RX   PubMed=1448153; DOI=10.1038/360364a0;
RA   Guo H.-C., Jardetzky T.S., Garrett T.P.J., Lane W.S., Strominger J.L.,
RA   Wiley D.C.;
RT   "Different length peptides bind to HLA-Aw68 similarly at their ends but
RT   bulge out in the middle.";
RL   Nature 360:364-366(1992).
RN   [75]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 25-294 (ALLELE A*68:01), AND
RP   FUNCTION (ALLELE A*68:01).
RX   PubMed=1448154; DOI=10.1038/360367a0;
RA   Silver M.L., Guo H.-C., Strominger J.L., Wiley D.C.;
RT   "Atomic structure of a human MHC molecule presenting an influenza virus
RT   peptide.";
RL   Nature 360:367-369(1992).
RN   [76]
RP   X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 25-299 (ALLELE A*02:01) IN
RP   COMPLEX WITH B2M AND PEPTIDE, FUNCTION (ALLELE A*02:01), DISULFIDE BOND,
RP   AND DOMAIN.
RX   PubMed=7694806; DOI=10.1016/0092-8674(93)90490-h;
RA   Madden D.R., Garboczi D.N., Wiley D.C.;
RT   "The antigenic identity of peptide-MHC complexes: a comparison of the
RT   conformations of five viral peptides presented by HLA-A2.";
RL   Cell 75:693-708(1993).
RN   [77]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 25-299 (ALLELE A*02:01) IN
RP   COMPLEX WITH B2M AND PEPTIDE, AND FUNCTION (ALLELE A*02:01).
RX   PubMed=7935798; DOI=10.1038/371626a0;
RA   Collins E.J., Garboczi D.N., Wiley D.C.;
RT   "Three-dimensional structure of a peptide extending from one end of a class
RT   I MHC binding site.";
RL   Nature 371:626-629(1994).
RN   [78]
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 25-299 (ALLELE A*02:01) IN
RP   COMPLEX WITH B2M AND PEPTIDE, FUNCTION (ALLELE A*02:01), AND DOMAIN.
RX   PubMed=8906788; DOI=10.1038/384134a0;
RA   Garboczi D.N., Ghosh P., Utz U., Fan Q.R., Biddison W.E., Wiley D.C.;
RT   "Structure of the complex between human T-cell receptor, viral peptide and
RT   HLA-A2.";
RL   Nature 384:134-141(1996).
RN   [79]
RP   X-RAY CRYSTALLOGRAPHY (2.65 ANGSTROMS) OF 25-300 (ALLELE A*02:01) IN
RP   COMPLEX WITH B2M AND PEPTIDE, INTERACTION WITH CD8A, AND FUNCTION (ALLELE
RP   A*02:01).
RX   PubMed=9177355; DOI=10.1038/42523;
RA   Gao G.F., Tormo J., Gerth U.C., Wyer J.R., McMichael A.J., Stuart D.I.,
RA   Bell J.I., Jones E.Y., Jakobsen B.K.;
RT   "Crystal structure of the complex between human CD8alpha(alpha) and HLA-
RT   A2.";
RL   Nature 387:630-634(1997).
RN   [80]
RP   X-RAY CRYSTALLOGRAPHY (1.40 ANGSTROMS) OF 25-299 (ALLELE A*02:01) IN
RP   COMPLEX WITH B2M AND PEPTIDE, AND FUNCTION (ALLELE A*02:01).
RX   PubMed=11502003; DOI=10.1006/jmbi.2001.4816;
RA   Hillig R.C., Coulie P.G., Stroobant V., Saenger W., Ziegler A.,
RA   Hulsmeyer M.;
RT   "High-resolution structure of HLA-A*0201 in complex with a tumour-specific
RT   antigenic peptide encoded by the MAGE-A4 gene.";
RL   J. Mol. Biol. 310:1167-1176(2001).
RN   [81]
RP   X-RAY CRYSTALLOGRAPHY (1.40 ANGSTROMS) OF 25-300 (ALLELE A*02:01) IN
RP   COMPLEX WITH B2M AND PEPTIDE, INTERACTION WITH TCR, AND FUNCTION (ALLELE
RP   A*02:01).
RX   PubMed=12796775; DOI=10.1038/ni942;
RA   Stewart-Jones G.B.E., McMichael A.J., Bell J.I., Stuart D.I., Jones E.Y.;
RT   "A structural basis for immunodominant human T cell receptor recognition.";
RL   Nat. Immunol. 4:657-663(2003).
RN   [82]
RP   X-RAY CRYSTALLOGRAPHY (1.45 ANGSTROMS) OF 25-299 (ALLELE A*11:01) IN
RP   COMPLEX WITH SARS NUCLEOCAPSID PEPTIDE, AND DISULFIDE BONDS.
RX   PubMed=16041067; DOI=10.1107/s0907444905013090;
RA   Blicher T., Kastrup J.S., Buus S., Gajhede M.;
RT   "High-resolution structure of HLA-A*1101 in complex with SARS nucleocapsid
RT   peptide.";
RL   Acta Crystallogr. D 61:1031-1040(2005).
RN   [83]
RP   X-RAY CRYSTALLOGRAPHY (1.60 ANGSTROMS) OF 25-300 (ALLELE A*02:01) IN
RP   COMPLEX WITH B2M AND PEPTIDE, INTERACTION WITH TCR, AND FUNCTION (ALLELE
RP   A*02:01).
RX   PubMed=18275829; DOI=10.1016/j.immuni.2007.12.018;
RA   Ishizuka J., Stewart-Jones G.B., van der Merwe A., Bell J.I.,
RA   McMichael A.J., Jones E.Y.;
RT   "The structural dynamics and energetics of an immunodominant T cell
RT   receptor are programmed by its Vbeta domain.";
RL   Immunity 28:171-182(2008).
RN   [84]
RP   X-RAY CRYSTALLOGRAPHY (1.60 ANGSTROMS) OF 25-298 (ALLELE A*02:01) IN
RP   COMPLEX WITH B2M AND PEPTIDE, FUNCTION (ALLELE A*02:01), AND DOMAIN.
RX   PubMed=19542454; DOI=10.4049/jimmunol.0900556;
RA   Gras S., Saulquin X., Reiser J.B., Debeaupuis E., Echasserieau K.,
RA   Kissenpfennig A., Legoux F., Chouquet A., Le Gorrec M., Machillot P.,
RA   Neveu B., Thielens N., Malissen B., Bonneville M., Housset D.;
RT   "Structural bases for the affinity-driven selection of a public TCR against
RT   a dominant human cytomegalovirus epitope.";
RL   J. Immunol. 183:430-437(2009).
RN   [85]
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 25-298 (ALLELE A*01:01) IN
RP   COMPLEX WITH B2M AND PEPTIDE, FUNCTION (ALLELE A*01:01), DOMAIN, AND
RP   DISULFIDE BOND.
RX   PubMed=19177349; DOI=10.1002/pro.4;
RA   Kumar P., Vahedi-Faridi A., Saenger W., Ziegler A., Uchanska-Ziegler B.;
RT   "Conformational changes within the HLA-A1:MAGE-A1 complex induced by
RT   binding of a recombinant antibody fragment with TCR-like specificity.";
RL   Protein Sci. 18:37-49(2009).
RN   [86]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 25-298 (ALLELE A*24:02) IN COMPLEX
RP   WITH B2M AND WITH SARS NUCLEOCAPSID PEPTIDE, DISULFIDE BONDS, FUNCTION
RP   (ALLELE A*24:02), AND DOMAIN.
RX   PubMed=20844028; DOI=10.1128/jvi.01464-10;
RA   Liu J., Wu P., Gao F., Qi J., Kawana-Tachikawa A., Xie J., Vavricka C.J.,
RA   Iwamoto A., Li T., Gao G.F.;
RT   "Novel immunodominant peptide presentation strategy: a featured HLA-A*2402-
RT   restricted cytotoxic T-lymphocyte epitope stabilized by intrachain hydrogen
RT   bonds from severe acute respiratory syndrome coronavirus nucleocapsid
RT   protein.";
RL   J. Virol. 84:11849-11857(2010).
RN   [87]
RP   X-RAY CRYSTALLOGRAPHY (1.89 ANGSTROMS) OF 25-299 (ALLELE A*02:01) IN
RP   COMPLEX WITH B2M AND PEPTIDE, FUNCTION (ALLELE A*02:01), AND DOMAIN.
RX   PubMed=20619457; DOI=10.1016/j.molimm.2010.06.005;
RA   Borbulevych O.Y., Do P., Baker B.M.;
RT   "Structures of native and affinity-enhanced WT1 epitopes bound to HLA-
RT   A*0201: implications for WT1-based cancer therapeutics.";
RL   Mol. Immunol. 47:2519-2524(2010).
RN   [88]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 25-298 (ALLELE A*03:01) IN COMPLEX
RP   WITH B2M AND PLP1 ANTIGENIC PEPTIDE, DISULFIDE BONDS, AND DOMAIN.
RX   PubMed=21543847; DOI=10.1107/s0907444911007888;
RA   McMahon R.M., Friis L., Siebold C., Friese M.A., Fugger L., Jones E.Y.;
RT   "Structure of HLA-A*0301 in complex with a peptide of proteolipid protein:
RT   insights into the role of HLA-A alleles in susceptibility to multiple
RT   sclerosis.";
RL   Acta Crystallogr. D 67:447-454(2011).
RN   [89]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 25-298 (ALLELE A*03:01) IN
RP   COMPLEX WITH B2M AND PEPTIDE, DISULFIDE BOND, DOMAIN, AND FUNCTION (ALLELE
RP   A*03:01).
RX   PubMed=21943705; DOI=10.1016/j.molimm.2011.08.015;
RA   Zhang S., Liu J., Cheng H., Tan S., Qi J., Yan J., Gao G.F.;
RT   "Structural basis of cross-allele presentation by HLA-A*0301 and HLA-A*1101
RT   revealed by two HIV-derived peptide complexes.";
RL   Mol. Immunol. 49:395-401(2011).
RN   [90]
RP   X-RAY CRYSTALLOGRAPHY (1.67 ANGSTROMS) OF 25-300 (ALLELE A*02:01) IN
RP   COMPLEX WITH B2M AND PEPTIDE, INTERACTION WITH TCR, FUNCTION (ALLELE
RP   A*02:01), DOMAIN, INDUCTION BY CYTOKINES, AND INVOLVEMENT IN IDDM (ALLELE
RP   A*02:01).
RX   PubMed=22245737; DOI=10.1038/ni.2206;
RA   Bulek A.M., Cole D.K., Skowera A., Dolton G., Gras S., Madura F.,
RA   Fuller A., Miles J.J., Gostick E., Price D.A., Drijfhout J.W., Knight R.R.,
RA   Huang G.C., Lissin N., Molloy P.E., Wooldridge L., Jakobsen B.K.,
RA   Rossjohn J., Peakman M., Rizkallah P.J., Sewell A.K.;
RT   "Structural basis for the killing of human beta cells by CD8(+) T cells in
RT   type 1 diabetes.";
RL   Nat. Immunol. 13:283-289(2012).
RN   [91]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 25-308 (ALLELE A*01:01) IN
RP   COMPLEX WITH B2M AND PEPTIDE, FUNCTION (ALLELE A*01:01), AND DOMAIN.
RX   PubMed=24395804; DOI=10.1073/pnas.1322229111;
RA   Quinones-Parra S., Grant E., Loh L., Nguyen T.H., Campbell K.A., Tong S.Y.,
RA   Miller A., Doherty P.C., Vijaykrishna D., Rossjohn J., Gras S.,
RA   Kedzierska K.;
RT   "Preexisting CD8+ T-cell immunity to the H7N9 influenza A virus varies
RT   across ethnicities.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:1049-1054(2014).
RN   [92]
RP   X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 25-298 (ALLELE A*01:01) IN
RP   COMPLEX WITH B2M AND PEPTIDE, FUNCTION (ALLELE A*01:01), DOMAIN, AND
RP   DISULFIDE BOND.
RX   PubMed=26758806; DOI=10.1038/srep18851;
RA   Raman M.C., Rizkallah P.J., Simmons R., Donnellan Z., Dukes J., Bossi G.,
RA   Le Provost G.S., Todorov P., Baston E., Hickman E., Mahon T., Hassan N.,
RA   Vuidepot A., Sami M., Cole D.K., Jakobsen B.K.;
RT   "Direct molecular mimicry enables off-target cardiovascular toxicity by an
RT   enhanced affinity TCR designed for cancer immunotherapy.";
RL   Sci. Rep. 6:18851-18851(2016).
RN   [93]
RP   X-RAY CRYSTALLOGRAPHY (2.06 ANGSTROMS) OF 25-299 (ALLELE A*02:01) IN
RP   COMPLEX WITH B2M AND PEPTIDE, FUNCTION (ALLELE A*02:01), DOMAIN, AND
RP   DISULFIDE BOND.
RX   PubMed=28250417; DOI=10.1038/nsmb.3383;
RA   Song I., Gil A., Mishra R., Ghersi D., Selin L.K., Stern L.J.;
RT   "Broad TCR repertoire and diverse structural solutions for recognition of
RT   an immunodominant CD8+ T cell epitope.";
RL   Nat. Struct. Mol. Biol. 24:395-406(2017).
RN   [94]
RP   ASSOCIATION OF ALLELE A*29:02 WITH BIRDSHOT CHORIORETINOPATHY.
RX   PubMed=1728143; DOI=10.1016/s0002-9394(14)75749-6;
RA   LeHoang P., Ozdemir N., Benhamou A., Tabary T., Edelson C., Betuel H.,
RA   Semiglia R., Cohen J.H.;
RT   "HLA-A29.2 subtype associated with birdshot retinochoroidopathy.";
RL   Am. J. Ophthalmol. 113:33-35(1992).
RN   [95]
RP   ASSOCIATION OF ALLELE A*03:01 WITH MULTIPLE SCLEROSIS.
RX   PubMed=10746785; DOI=10.1034/j.1399-0039.2000.550205.x;
RA   Fogdell-Hahn A., Ligers A., Groenning M., Hillert J., Olerup O.;
RT   "Multiple sclerosis: a modifying influence of HLA class I genes in an HLA
RT   class II associated autoimmune disease.";
RL   Tissue Antigens 55:140-148(2000).
RN   [96]
RP   ASSOCIATION OF ALLELE A*24:02 WITH IDDM.
RX   PubMed=16731854; DOI=10.2337/db05-1049;
RA   Nakanishi K., Inoko H.;
RT   "Combination of HLA-A24, -DQA1*03, and -DR9 contributes to acute-onset and
RT   early complete beta-cell destruction in type 1 diabetes: longitudinal study
RT   of residual beta-cell function.";
RL   Diabetes 55:1862-1868(2006).
RN   [97]
RP   ASSOCIATION OF ALLELE A*02:01 WITH IDDM.
RX   PubMed=18802479; DOI=10.1172/jci35449;
RA   Skowera A., Ellis R.J., Varela-Calvino R., Arif S., Huang G.C.,
RA   Van-Krinks C., Zaremba A., Rackham C., Allen J.S., Tree T.I., Zhao M.,
RA   Dayan C.M., Sewell A.K., Unger W.W., Unger W., Drijfhout J.W.,
RA   Ossendorp F., Roep B.O., Peakman M.;
RT   "CTLs are targeted to kill beta cells in patients with type 1 diabetes
RT   through recognition of a glucose-regulated preproinsulin epitope.";
RL   J. Clin. Invest. 118:3390-3402(2008).
RN   [98]
RP   ASSOCIATION OF ALLELE A*03:01 WITH MULTIPLE SCLEROSIS.
RX   PubMed=18953350; DOI=10.1038/nm.1881;
RA   Friese M.A., Jakobsen K.B., Friis L., Etzensperger R., Craner M.J.,
RA   McMahon R.M., Jensen L.T., Huygelen V., Jones E.Y., Bell J.I., Fugger L.;
RT   "Opposing effects of HLA class I molecules in tuning autoreactive CD8+ T
RT   cells in multiple sclerosis.";
RL   Nat. Med. 14:1227-1235(2008).
RN   [99]
RP   ASSOCIATION OF ALLELE A*24:02 WITH IDDM.
RX   PubMed=22522618; DOI=10.2337/db11-1520;
RA   Kronenberg D., Knight R.R., Estorninho M., Ellis R.J., Kester M.G.,
RA   de Ru A., Eichmann M., Huang G.C., Powrie J., Dayan C.M., Skowera A.,
RA   van Veelen P.A., Peakman M.;
RT   "Circulating preproinsulin signal peptide-specific CD8 T cells restricted
RT   by the susceptibility molecule HLA-A24 are expanded at onset of type 1
RT   diabetes and kill beta-cells.";
RL   Diabetes 61:1752-1759(2012).
RN   [100]
RP   ASSOCIATION OF ALLELE A*31:01 WITH CARBAMAZEPINE-INDUCED HYPERSENSITIVITY
RP   REACTIONS.
RX   PubMed=21428769; DOI=10.1056/nejmoa1013297;
RA   McCormack M., Alfirevic A., Bourgeois S., Farrell J.J., Kasperaviciute D.,
RA   Carrington M., Sills G.J., Marson T., Jia X., de Bakker P.I.,
RA   Chinthapalli K., Molokhia M., Johnson M.R., O'Connor G.D., Chaila E.,
RA   Alhusaini S., Shianna K.V., Radtke R.A., Heinzen E.L., Walley N.,
RA   Pandolfo M., Pichler W., Park B.K., Depondt C., Sisodiya S.M.,
RA   Goldstein D.B., Deloukas P., Delanty N., Cavalleri G.L., Pirmohamed M.;
RT   "HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in
RT   Europeans.";
RL   N. Engl. J. Med. 364:1134-1143(2011).
RN   [101]
RP   ASSOCIATION OF ALLELE A*26:01 WITH BEHCET DISEASE.
RX   PubMed=30872678; DOI=10.1038/s41598-019-40824-y;
RA   Nakamura J., Meguro A., Ishii G., Mihara T., Takeuchi M., Mizuki Y.,
RA   Yuda K., Yamane T., Kawagoe T., Ota M., Mizuki N.;
RT   "The association analysis between HLA-A*26 and Behcet's disease.";
RL   Sci. Rep. 9:4426-4426(2019).
RN   [102]
RP   POLYMORPHISM.
RX   PubMed=28650991; DOI=10.1371/journal.pgen.1006862;
RA   Robinson J., Guethlein L.A., Cereb N., Yang S.Y., Norman P.J.,
RA   Marsh S.G.E., Parham P.;
RT   "Distinguishing functional polymorphism from random variation in the
RT   sequences of >10,000 HLA-A, -B and -C alleles.";
RL   PLoS Genet. 13:E1006862-E1006862(2017).
CC   -!- FUNCTION: Antigen-presenting major histocompatibility complex class I
CC       (MHCI) molecule. In complex with B2M/beta 2 microglobulin displays
CC       primarily viral and tumor-derived peptides on antigen-presenting cells
CC       for recognition by alpha-beta T cell receptor (TCR) on HLA-A-restricted
CC       CD8-positive T cells, guiding antigen-specific T cell immune response
CC       to eliminate infected or transformed cells (PubMed:2456340,
CC       PubMed:2784196, PubMed:1402688, PubMed:7504010, PubMed:9862734,
CC       PubMed:10449296, PubMed:12138174, PubMed:12393434, PubMed:15893615,
CC       PubMed:17189421, PubMed:19543285, PubMed:21498667, PubMed:24192765,
CC       PubMed:7694806, PubMed:24395804, PubMed:28250417). May also present
CC       self-peptides derived from the signal sequence of secreted or membrane
CC       proteins, although T cells specific for these peptides are usually
CC       inactivated to prevent autoreactivity (PubMed:25880248, PubMed:7506728,
CC       PubMed:7679507). Both the peptide and the MHC molecule are recognized
CC       by TCR, the peptide is responsible for the fine specificity of antigen
CC       recognition and MHC residues account for the MHC restriction of T cells
CC       (PubMed:12796775, PubMed:18275829, PubMed:19542454, PubMed:28250417).
CC       Typically presents intracellular peptide antigens of 8 to 13 amino
CC       acids that arise from cytosolic proteolysis via IFNG-induced
CC       immunoproteasome or via endopeptidase IDE/insulin-degrading enzyme
CC       (PubMed:17189421, PubMed:20364150, PubMed:17079320, PubMed:26929325,
CC       PubMed:27049119). Can bind different peptides containing allele-
CC       specific binding motifs, which are mainly defined by anchor residues at
CC       position 2 and 9 (PubMed:7504010, PubMed:9862734).
CC       {ECO:0000269|PubMed:10449296, ECO:0000269|PubMed:12138174,
CC       ECO:0000269|PubMed:12393434, ECO:0000269|PubMed:12796775,
CC       ECO:0000269|PubMed:1402688, ECO:0000269|PubMed:15893615,
CC       ECO:0000269|PubMed:17079320, ECO:0000269|PubMed:17189421,
CC       ECO:0000269|PubMed:18275829, ECO:0000269|PubMed:19542454,
CC       ECO:0000269|PubMed:19543285, ECO:0000269|PubMed:20364150,
CC       ECO:0000269|PubMed:21498667, ECO:0000269|PubMed:24192765,
CC       ECO:0000269|PubMed:24395804, ECO:0000269|PubMed:2456340,
CC       ECO:0000269|PubMed:25880248, ECO:0000269|PubMed:26929325,
CC       ECO:0000269|PubMed:27049119, ECO:0000269|PubMed:2784196,
CC       ECO:0000269|PubMed:28250417, ECO:0000269|PubMed:7504010,
CC       ECO:0000269|PubMed:7506728, ECO:0000269|PubMed:7679507,
CC       ECO:0000269|PubMed:7694806, ECO:0000269|PubMed:9862734}.
CC   -!- FUNCTION: Allele A*01:01: Presents a restricted peptide repertoire
CC       including viral epitopes derived from IAV NP/nucleoprotein (CTELKLSDY),
CC       IAV PB1/polymerase basic protein 1 (VSDGGPNLY), HAdV-11 capsid L3/hexon
CC       protein (LTDLGQNLLY) as well as tumor peptide antigens including MAGE1
CC       (EADPTGHSY), MAGEA3 (EVDPIGHLY) and WT1 (TSEKRPFMCAY), all having in
CC       common a canonical motif with a negatively charged Asp or Glu residue
CC       at position 3 and a Tyr anchor residue at the C-terminus
CC       (PubMed:1402688, PubMed:7504010, PubMed:17189421, PubMed:20364150,
CC       PubMed:25880248, PubMed:30530481, PubMed:19177349, PubMed:24395804,
CC       PubMed:26758806). A number of HLA-A*01:01-restricted peptides carry a
CC       post-translational modification with oxidation and N-terminal
CC       acetylation being the most frequent (PubMed:25880248). Fails to present
CC       highly immunogenic peptides from the EBV latent antigens
CC       (PubMed:18779413). {ECO:0000269|PubMed:1402688,
CC       ECO:0000269|PubMed:17189421, ECO:0000269|PubMed:18779413,
CC       ECO:0000269|PubMed:19177349, ECO:0000269|PubMed:20364150,
CC       ECO:0000269|PubMed:24395804, ECO:0000269|PubMed:25880248,
CC       ECO:0000269|PubMed:26758806, ECO:0000269|PubMed:30530481,
CC       ECO:0000269|PubMed:7504010}.
CC   -!- FUNCTION: Allele A*02:01: A major allele in human populations, presents
CC       immunodominant viral epitopes derived from IAV M/matrix protein 1
CC       (GILGFVFTL), HIV-1 env (TLTSCNTSV), HIV-1 gag-pol (ILKEPVHGV), HTLV-1
CC       Tax (LLFGYPVYV), HBV C/core antigen (FLPSDFFPS), HCMV UL83/pp65
CC       (NLVPMVATV) as well as tumor peptide antigens including MAGEA4
CC       (GVYDGREHTV), WT1 (RMFPNAPYL) and CTAG1A/NY-ESO-1 (SLLMWITQC), all
CC       having in common hydrophobic amino acids at position 2 and at the C-
CC       terminal anchors. {ECO:0000269|PubMed:11502003,
CC       ECO:0000269|PubMed:12138174, ECO:0000269|PubMed:12796775,
CC       ECO:0000269|PubMed:17079320, ECO:0000269|PubMed:18275829,
CC       ECO:0000269|PubMed:19542454, ECO:0000269|PubMed:20619457,
CC       ECO:0000269|PubMed:22245737, ECO:0000269|PubMed:26929325,
CC       ECO:0000269|PubMed:2784196, ECO:0000269|PubMed:28250417,
CC       ECO:0000269|PubMed:7694806, ECO:0000269|PubMed:7935798,
CC       ECO:0000269|PubMed:8630735, ECO:0000269|PubMed:8805302,
CC       ECO:0000269|PubMed:8906788, ECO:0000269|PubMed:9177355}.
CC   -!- FUNCTION: Allele A*03:01: Presents viral epitopes derived from IAV NP
CC       (ILRGSVAHK), HIV-1 nef (QVPLRPMTYK), HIV-1 gag-pol (AIFQSSMTK) as well
CC       as tumor peptide antigens including PMEL (LIYRRRLMK), NODAL
CC       (HAYIQSLLK), TRP-2 (RMYNMVPFF), all having in common hydrophobic amino
CC       acids at position 2 and Lys or Arg anchor residues at the C-terminus
CC       (PubMed:7504010, PubMed:7679507, PubMed:9862734, PubMed:19543285,
CC       PubMed:21943705, PubMed:2456340). May also display spliced peptides
CC       resulting from the ligation of two separate proteasomal cleavage
CC       products that are not contiguous in the parental protein
CC       (PubMed:27049119). {ECO:0000269|PubMed:19543285,
CC       ECO:0000269|PubMed:21943705, ECO:0000269|PubMed:2456340,
CC       ECO:0000269|PubMed:27049119, ECO:0000269|PubMed:7504010,
CC       ECO:0000269|PubMed:7679507, ECO:0000269|PubMed:9862734}.
CC   -!- FUNCTION: Allele A*11:01: Presents several immunodominant epitopes
CC       derived from HIV-1 gag-pol and HHV-4 EBNA4, containing the peptide
CC       motif with Val, Ile, Thr, Leu, Tyr or Phe at position 2 and Lys anchor
CC       residue at the C-terminus. Important in the control of HIV-1, EBV and
CC       HBV infections. {ECO:0000269|PubMed:10449296}.
CC   -!- FUNCTION: Allele A*23:01: Interacts with natural killer (NK) cell
CC       receptor KIR3DL1 and may contribute to functional maturation of NK
CC       cells and self-nonself discrimination during innate immune response.
CC       {ECO:0000269|PubMed:17182537}.
CC   -!- FUNCTION: Allele A*24:02: Presents viral epitopes derived from HIV-1
CC       nef (RYPLTFGWCF), EBV lytic- and latent-cycle antigens BRLF1
CC       (TYPVLEEMF), BMLF1 (DYNFVKQLF) and LMP2 (IYVLVMLVL), SARS-CoV
CC       nucleocapsid/N (QFKDNVILL), as well as tumor peptide antigens including
CC       PRAME (LYVDSLFFL), all sharing a common signature motif, namely an
CC       aromatic residue Tyr or Phe at position 2 and a nonhydrophobic anchor
CC       residue Phe, Leu or Iso at the C-terminus (PubMed:9047241,
CC       PubMed:12393434, PubMed:24192765, PubMed:20844028). Interacts with
CC       natural killer (NK) cell receptor KIR3DL1 and may contribute to
CC       functional maturation of NK cells and self-nonself discrimination
CC       during innate immune response (PubMed:17182537, PubMed:18502829).
CC       {ECO:0000269|PubMed:12393434, ECO:0000269|PubMed:17182537,
CC       ECO:0000269|PubMed:18502829, ECO:0000269|PubMed:20844028,
CC       ECO:0000269|PubMed:24192765, ECO:0000269|PubMed:9047241}.
CC   -!- FUNCTION: Allele A*26:01: Presents several epitopes derived from HIV-1
CC       gag-pol (EVIPMFSAL, ETKLGKAGY) and env (LVSDGGPNLY), carrying as anchor
CC       residues preferentially Glu at position 1, Val or Thr at position 2 and
CC       Tyr at the C-terminus. {ECO:0000269|PubMed:15893615}.
CC   -!- FUNCTION: Allele A*29:02: Presents peptides having a common motif,
CC       namely a Glu residue at position 2 and Tyr or Leu anchor residues at
CC       the C-terminus. {ECO:0000269|PubMed:8622959}.
CC   -!- FUNCTION: Allele A*32:01: Interacts with natural killer (NK) cell
CC       receptor KIR3DL1 and may contribute to functional maturation of NK
CC       cells and self-nonself discrimination during innate immune response.
CC       {ECO:0000269|PubMed:17182537}.
CC   -!- FUNCTION: Allele A*68:01: Presents viral epitopes derived from IAV NP
CC       (KTGGPIYKR) and HIV-1 tat (ITKGLGISYGR), having a common signature
CC       motif namely, Val or Thr at position 2 and positively charged residues
CC       Arg or Lys at the C-terminal anchor. {ECO:0000269|PubMed:1448153,
CC       ECO:0000269|PubMed:1448154, ECO:0000269|PubMed:2784196}.
CC   -!- FUNCTION: Allele A*74:01: Presents immunodominant HIV-1 epitopes
CC       derived from gag-pol (GQMVHQAISPR, QIYPGIKVR) and rev (RQIHSISER),
CC       carrying an aliphatic residue at position 2 and Arg anchor residue at
CC       the C-terminus. May contribute to viral load control in chronic HIV-1
CC       infection. {ECO:0000269|PubMed:21498667}.
CC   -!- SUBUNIT: Heterotrimer that consists of an alpha chain HLA-A, a beta
CC       chain B2M and a peptide (peptide-HLA-A-B2M) (PubMed:7504010,
CC       PubMed:7679507, PubMed:21943705, PubMed:19177349, PubMed:24395804,
CC       PubMed:26758806, PubMed:7504010, PubMed:7506728, PubMed:8805302,
CC       PubMed:7694806, PubMed:7935798, PubMed:9177355, PubMed:18275829,
CC       PubMed:22245737, PubMed:28250417, PubMed:11502003, PubMed:8906788,
CC       PubMed:19542454). Early in biogenesis, HLA-A-B2M dimer interacts with
CC       the components of the peptide-loading complex composed of TAPBP, TAP1-
CC       TAP2, TAPBPL, PDIA3/ERP57 and CALR (PubMed:21263072). Interacts with
CC       TAP1-TAP2 transporter via TAPBP; this interaction is obligatory for the
CC       loading of peptide epitopes delivered to the ER by TAP1-TAP2
CC       transporter (PubMed:8805302, PubMed:8630735, PubMed:21263072).
CC       Interacts with TAPBPL; TAPBPL binds peptide-free HLA-A-B2M complexes or
CC       those loaded with low affinity peptides, likely facilitating peptide
CC       exchange for higher affinity peptides (PubMed:26869717). Only optimally
CC       assembled peptide-HLA-B2M trimer translocates to the surface of
CC       antigen-presenting cells, where it interacts with TCR and CD8
CC       coreceptor on the surface of T cells. HLA-A (via polymorphic alpha-1
CC       and alpha-2 domains) interacts with antigen-specific TCR (via CDR3
CC       domains) (PubMed:22245737, PubMed:12796775, PubMed:18275829). One HLA-A
CC       molecule (mainly via nonpolymorphic alpha-3 domain) interacts with one
CC       CD8A homodimer (via CDR-like loop); this interaction insures peptide-
CC       HLA-A-B2M recognition by CD8-positive T cells only (PubMed:9177355,
CC       PubMed:2784196). Alleles A*23:01; A*24:02 and A*32:01 interact (via Bw4
CC       motif) with KIR3DL1 on NK cells; this interaction is direct.
CC       {ECO:0000269|PubMed:11502003, ECO:0000269|PubMed:12796775,
CC       ECO:0000269|PubMed:17182537, ECO:0000269|PubMed:18275829,
CC       ECO:0000269|PubMed:18502829, ECO:0000269|PubMed:19177349,
CC       ECO:0000269|PubMed:21263072, ECO:0000269|PubMed:21943705,
CC       ECO:0000269|PubMed:22245737, ECO:0000269|PubMed:24395804,
CC       ECO:0000269|PubMed:26758806, ECO:0000269|PubMed:26869717,
CC       ECO:0000269|PubMed:2784196, ECO:0000269|PubMed:28250417,
CC       ECO:0000269|PubMed:7504010, ECO:0000269|PubMed:7506728,
CC       ECO:0000269|PubMed:7679507, ECO:0000269|PubMed:7694806,
CC       ECO:0000269|PubMed:7935798, ECO:0000269|PubMed:8630735,
CC       ECO:0000269|PubMed:8805302, ECO:0000269|PubMed:9177355}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with HHV-8 MIR1 protein.
CC       {ECO:0000269|PubMed:12006494}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with HTLV-1 accessory protein
CC       p12I. {ECO:0000269|PubMed:11390610}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:21263072,
CC       ECO:0000269|PubMed:25880248, ECO:0000269|PubMed:8805302}; Single-pass
CC       type I membrane protein {ECO:0000255}. Endoplasmic reticulum membrane
CC       {ECO:0000305|PubMed:8805302}; Single-pass type I membrane protein
CC       {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P04439-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P04439-2; Sequence=VSP_060391, VSP_060392;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. {ECO:0000305}.
CC   -!- INDUCTION: Up-regulated by IFNG, and proinflammatory cytokines IL1B and
CC       TNF. {ECO:0000269|PubMed:21263072, ECO:0000269|PubMed:22245737}.
CC   -!- DOMAIN: The alpha-1 domain is a structural part of the peptide-binding
CC       cleft. {ECO:0000269|PubMed:19177349, ECO:0000269|PubMed:19542454,
CC       ECO:0000269|PubMed:20619457, ECO:0000269|PubMed:20844028,
CC       ECO:0000269|PubMed:21943705, ECO:0000269|PubMed:22245737,
CC       ECO:0000269|PubMed:24395804, ECO:0000269|PubMed:26758806,
CC       ECO:0000269|PubMed:2784196, ECO:0000269|PubMed:7694806,
CC       ECO:0000269|PubMed:8906788}.
CC   -!- DOMAIN: The alpha-2 domain is a structural part of the peptide-binding
CC       cleft (PubMed:21543847, PubMed:21943705, PubMed:19177349,
CC       PubMed:26758806, PubMed:24395804, PubMed:7694806, PubMed:8906788,
CC       PubMed:2784196, PubMed:28250417, PubMed:22245737, PubMed:19542454,
CC       PubMed:20619457, PubMed:20844028). Mediates the interaction with TAP1-
CC       TAP2 complex (PubMed:8805302). {ECO:0000269|PubMed:19177349,
CC       ECO:0000269|PubMed:19542454, ECO:0000269|PubMed:20619457,
CC       ECO:0000269|PubMed:20844028, ECO:0000269|PubMed:21543847,
CC       ECO:0000269|PubMed:21943705, ECO:0000269|PubMed:22245737,
CC       ECO:0000269|PubMed:24395804, ECO:0000269|PubMed:26758806,
CC       ECO:0000269|PubMed:2784196, ECO:0000269|PubMed:28250417,
CC       ECO:0000269|PubMed:7694806, ECO:0000269|PubMed:8805302,
CC       ECO:0000269|PubMed:8906788}.
CC   -!- DOMAIN: The alpha-3 Ig-like domain mediates the interaction with CD8
CC       coreceptor. {ECO:0000269|PubMed:2784196}.
CC   -!- PTM: (Microbial infection) Polyubiquitinated in a post ER compartment
CC       by interaction with human herpesvirus 8 MIR1 protein. This targets the
CC       protein for rapid degradation via the ubiquitin system.
CC       {ECO:0000269|PubMed:12006494}.
CC   -!- PTM: N-linked glycosylation at Asn-110. {ECO:0000269|PubMed:19159218,
CC       ECO:0000269|PubMed:21263072}.
CC   -!- POLYMORPHISM: Highly polymorphic. Polymorphic residues encode for
CC       alpha-1 and alpha-2 domains of the peptide-binding cleft, where they
CC       contribute to variations in peptide binding and TCR recognition among
CC       different alleles. The human population is estimated to have millions
CC       of HLA-A alleles. But only 11 common HLA-A alleles are considered core
CC       alleles, representing all functionally significant variation
CC       (polymorphism) in alpha-1 and alpha-2 domains. These are: A*01:01;
CC       A*02:01; A*02:05; A*03:01; A*11:01; A*24:02; A*26:01; A*29:02; A*30:01;
CC       A*74:01 and A*80:01. Among these, A*02:01; A*11:01; A*24:02 and
CC       A*26:01, were likely passed by introgression from archaic to modern
CC       humans. Functional alleles of more recent origin (non-core) were
CC       derived by recombination (PubMed:28650991). The sequence shown is that
CC       of A*03:01. The sequences of core alleles and common representative
CC       alleles of serologically distinct allele groups are described as
CC       variants of A*03:01 (PubMed:28650991). Allele A*31:01 is associated
CC       with carbamazepine-induced hypersensitivity reactions among subjects of
CC       Northern European ancestry [MIM:608579] (PubMed:21428769).
CC       {ECO:0000269|PubMed:21428769, ECO:0000269|PubMed:28650991}.
CC   -!- DISEASE: Note=Alleles A*02:01 and A*24:02 are associated with increased
CC       susceptibility to diabetes mellitus, insulin-dependent (IDDM)
CC       (PubMed:22245737, PubMed:18802479, PubMed:16731854, PubMed:22522618).
CC       In a glucose-dependent way, allele A*02:01 may aberrantly present the
CC       signal peptide of preproinsulin (ALWGPDPAAA) on the surface of
CC       pancreatic beta cells to autoreactive CD8-positive T cells, potentially
CC       driving T-cell mediated cytotoxicity in pancreatic islets
CC       (PubMed:22245737, PubMed:18802479). Allele A*24:02 may present the
CC       signal peptide of preproinsulin (LWMRLLPLL) and contribute to acute
CC       pancreatic beta-cell destruction and early onset of IDDM
CC       (PubMed:16731854, PubMed:22522618). {ECO:0000269|PubMed:16731854,
CC       ECO:0000269|PubMed:18802479, ECO:0000269|PubMed:22245737,
CC       ECO:0000269|PubMed:22522618}.
CC   -!- DISEASE: Note=Allele A*03:01 is associated with increased
CC       susceptibility to multiple sclerosis (MS), an autoimmune disease of the
CC       central nervous system (PubMed:10746785). May contribute to the
CC       initiation phase of the disease by presenting myelin PLP1 self-peptide
CC       (KLIETYFSK) to autoreactive CD8-positive T cells capable of initiating
CC       the first autoimmune attacks (PubMed:18953350).
CC       {ECO:0000269|PubMed:10746785, ECO:0000269|PubMed:18953350}.
CC   -!- DISEASE: Note=Allele A*26:01 is associated with increased
CC       susceptibility to Behcet disease (BD) in the Northeast Asian
CC       population. Especially in the HLA-B*51-negative BD populations, HLA-
CC       A*26 is significantly associated with the onset of BD.
CC       {ECO:0000269|PubMed:30872678}.
CC   -!- DISEASE: Note=Allele A*29:02 is associated with increased
CC       susceptibility to birdshot chorioretinopathy (BSCR). May aberrantly
CC       present retinal autoantigens and induce autoimmune uveitis.
CC       {ECO:0000269|PubMed:1728143}.
CC   -!- SIMILARITY: Belongs to the MHC class I family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA25162.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305|PubMed:6609814};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U03862; AAA03603.1; -; mRNA.
DR   EMBL; X13111; CAA31503.1; -; mRNA.
DR   EMBL; M23739; AAB47873.1; -; mRNA.
DR   EMBL; U83415; AAB53373.1; -; mRNA.
DR   EMBL; U83416; AAB53374.1; -; mRNA.
DR   EMBL; M30576; AAA59612.1; -; Genomic_DNA.
DR   EMBL; M30580; AAB47870.1; -; Genomic_DNA.
DR   EMBL; M24043; AAA59652.1; -; Genomic_DNA.
DR   EMBL; M84379; AAA59606.1; -; mRNA.
DR   EMBL; M32321; AAA36234.1; -; mRNA.
DR   EMBL; X60108; CAA42702.1; -; mRNA.
DR   EMBL; M64740; AAA59600.1; -; mRNA.
DR   EMBL; M64742; AAA03662.1; -; mRNA.
DR   EMBL; X61700; CAA43869.1; -; mRNA.
DR   EMBL; X61701; CAA43870.1; -; mRNA.
DR   EMBL; X61703; CAA43872.1; -; mRNA.
DR   EMBL; X61704; CAA43873.1; -; mRNA.
DR   EMBL; X61711; CAA43880.1; -; mRNA.
DR   EMBL; M84375; AAA59599.1; -; mRNA.
DR   EMBL; U03697; AAA03720.1; -; mRNA.
DR   EMBL; L18898; AAA17012.1; -; mRNA.
DR   EMBL; D14350; BAA03279.1; -; mRNA.
DR   EMBL; U03754; AAC04322.1; -; mRNA.
DR   EMBL; D16841; BAA04117.1; -; mRNA.
DR   EMBL; U07234; AAA70162.1; -; mRNA.
DR   EMBL; AY786587; AAV53345.1; -; mRNA.
DR   EMBL; X00492; CAA25162.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; X03070; CAB56605.1; -; Genomic_DNA.
DR   EMBL; X03071; CAB56606.1; -; Genomic_DNA.
DR   EMBL; X03158; CAB56607.1; -; Genomic_DNA.
DR   EMBL; X03159; CAB56608.1; -; Genomic_DNA.
DR   EMBL; K02883; AAA98727.1; -; Genomic_DNA.
DR   EMBL; AH003070; AAA65449.1; -; Genomic_DNA.
DR   EMBL; X55710; CAA39243.1; -; Genomic_DNA.
DR   EMBL; U02935; AAA76608.2; -; Genomic_DNA.
DR   EMBL; L78918; AAB05976.1; -; Genomic_DNA.
DR   EMBL; Z72422; CAA96532.1; -; Genomic_DNA.
DR   EMBL; Z93949; CAB07989.1; -; Genomic_DNA.
DR   EMBL; EU445484; ACA35004.1; -; Genomic_DNA.
DR   EMBL; U03907; AAA03605.1; -; mRNA.
DR   EMBL; U17569; AAA56779.1; -; mRNA.
DR   EMBL; U17570; AAA56780.1; -; mRNA.
DR   EMBL; U32184; AAB63980.1; -; mRNA.
DR   EMBL; AJ748743; CAG38621.1; -; Genomic_DNA.
DR   EMBL; BC003069; AAH03069.1; -; mRNA.
DR   EMBL; BC008611; AAH08611.1; -; mRNA.
DR   EMBL; AL671277; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS34373.1; -. [P04439-1]
DR   RefSeq; NP_001229687.1; NM_001242758.1.
DR   RefSeq; NP_002107.3; NM_002116.7. [P04439-1]
DR   PDB; 1AKJ; X-ray; 2.65 A; A=25-300.
DR   PDB; 1AO7; X-ray; 2.60 A; A=25-299.
DR   PDB; 1AQD; X-ray; 2.45 A; C/F/I/L=127-141.
DR   PDB; 1B0G; X-ray; 2.50 A; A/D=25-299.
DR   PDB; 1B0R; X-ray; 2.90 A; A=25-299.
DR   PDB; 1BD2; X-ray; 2.50 A; A=25-299.
DR   PDB; 1DUY; X-ray; 2.15 A; A/D=25-299.
DR   PDB; 1DUZ; X-ray; 1.80 A; A/D=25-299.
DR   PDB; 1EEY; X-ray; 2.25 A; A/D=25-299.
DR   PDB; 1EEZ; X-ray; 2.30 A; A/D=25-299.
DR   PDB; 1HHG; X-ray; 2.60 A; A/D=25-299.
DR   PDB; 1HHH; X-ray; 3.00 A; A=25-299.
DR   PDB; 1HHI; X-ray; 2.50 A; A/D=25-299.
DR   PDB; 1HHJ; X-ray; 2.50 A; A/D=25-299.
DR   PDB; 1HHK; X-ray; 2.50 A; A/D=25-299.
DR   PDB; 1HLA; X-ray; 3.50 A; A=25-294.
DR   PDB; 1HSB; X-ray; 1.90 A; A=25-294.
DR   PDB; 1I1F; X-ray; 2.80 A; A/D=25-299.
DR   PDB; 1I1Y; X-ray; 2.20 A; A/D=25-299.
DR   PDB; 1I4F; X-ray; 1.40 A; A=25-299.
DR   PDB; 1I7R; X-ray; 2.20 A; A/D=25-299.
DR   PDB; 1I7T; X-ray; 2.80 A; A/D=25-299.
DR   PDB; 1I7U; X-ray; 1.80 A; A/D=25-299.
DR   PDB; 1IM3; X-ray; 2.20 A; A/E/I/M=25-299.
DR   PDB; 1JF1; X-ray; 1.85 A; A=25-299.
DR   PDB; 1JHT; X-ray; 2.15 A; A=25-299.
DR   PDB; 1LP9; X-ray; 2.00 A; A/H=25-299.
DR   PDB; 1OGA; X-ray; 1.40 A; A=25-300.
DR   PDB; 1P7Q; X-ray; 3.40 A; A=25-300.
DR   PDB; 1Q94; X-ray; 2.40 A; A/D=25-299.
DR   PDB; 1QEW; X-ray; 2.20 A; A=25-299.
DR   PDB; 1QR1; X-ray; 2.40 A; A/D=25-299.
DR   PDB; 1QRN; X-ray; 2.80 A; A=25-298.
DR   PDB; 1QSE; X-ray; 2.80 A; A=25-298.
DR   PDB; 1QSF; X-ray; 2.80 A; A=25-298.
DR   PDB; 1QVO; X-ray; 2.22 A; A/D=25-299.
DR   PDB; 1S8D; X-ray; 2.20 A; A=25-299.
DR   PDB; 1S9W; X-ray; 2.20 A; A=25-298.
DR   PDB; 1S9X; X-ray; 2.50 A; A=25-298.
DR   PDB; 1S9Y; X-ray; 2.30 A; A=25-298.
DR   PDB; 1T1W; X-ray; 2.20 A; A=25-299.
DR   PDB; 1T1X; X-ray; 2.20 A; A=25-299.
DR   PDB; 1T1Y; X-ray; 2.00 A; A=25-299.
DR   PDB; 1T1Z; X-ray; 1.90 A; A=25-299.
DR   PDB; 1T20; X-ray; 2.20 A; A=25-299.
DR   PDB; 1T21; X-ray; 2.19 A; A=25-299.
DR   PDB; 1T22; X-ray; 2.20 A; A=25-299.
DR   PDB; 1TMC; X-ray; 2.30 A; A=25-199.
DR   PDB; 1TVB; X-ray; 1.80 A; A/D=25-299.
DR   PDB; 1TVH; X-ray; 1.80 A; A/D=25-299.
DR   PDB; 1UR7; Model; -; A=25-299.
DR   PDB; 1W72; X-ray; 2.15 A; A/D=25-298.
DR   PDB; 1X7Q; X-ray; 1.45 A; A=25-299.
DR   PDB; 2AV1; X-ray; 1.95 A; A/D=25-299.
DR   PDB; 2AV7; X-ray; 2.05 A; A/D=25-299.
DR   PDB; 2BCK; X-ray; 2.80 A; A/D=25-300.
DR   PDB; 2BNQ; X-ray; 1.70 A; A=25-300.
DR   PDB; 2BNR; X-ray; 1.90 A; A=25-300.
DR   PDB; 2C7U; X-ray; 2.38 A; A/D=25-300.
DR   PDB; 2CLR; X-ray; 2.00 A; A/D=25-299.
DR   PDB; 2F53; X-ray; 2.10 A; A=25-299.
DR   PDB; 2F54; X-ray; 2.70 A; A/F=25-298.
DR   PDB; 2GIT; X-ray; 1.70 A; A/D=25-299.
DR   PDB; 2GJ6; X-ray; 2.56 A; A=25-299.
DR   PDB; 2GT9; X-ray; 1.75 A; A/D=25-299.
DR   PDB; 2GTW; X-ray; 1.55 A; A/D=25-299.
DR   PDB; 2GTZ; X-ray; 1.70 A; A/D=25-299.
DR   PDB; 2GUO; X-ray; 1.90 A; A/D=25-299.
DR   PDB; 2HLA; X-ray; 2.60 A; A=25-294.
DR   PDB; 2HN7; X-ray; 1.60 A; A=25-299.
DR   PDB; 2J8U; X-ray; 2.88 A; A/H=25-299.
DR   PDB; 2JCC; X-ray; 2.50 A; A/H=25-299.
DR   PDB; 2P5E; X-ray; 1.89 A; A=25-300.
DR   PDB; 2P5W; X-ray; 2.20 A; A=25-300.
DR   PDB; 2PYE; X-ray; 2.30 A; A=25-300.
DR   PDB; 2UWE; X-ray; 2.40 A; A/H=25-299.
DR   PDB; 2V2W; X-ray; 1.60 A; A/D=25-300.
DR   PDB; 2V2X; X-ray; 1.60 A; A/D=25-300.
DR   PDB; 2VLJ; X-ray; 2.40 A; A=25-300.
DR   PDB; 2VLK; X-ray; 2.50 A; A=25-300.
DR   PDB; 2VLL; X-ray; 1.60 A; A/D=25-300.
DR   PDB; 2VLR; X-ray; 2.30 A; A/F=25-300.
DR   PDB; 2X4N; X-ray; 2.34 A; A/D=25-299.
DR   PDB; 2X4O; X-ray; 2.30 A; A/D=25-299.
DR   PDB; 2X4P; X-ray; 2.30 A; A/D=25-299.
DR   PDB; 2X4Q; X-ray; 1.90 A; A/D=25-299.
DR   PDB; 2X4R; X-ray; 2.30 A; A/D=25-299.
DR   PDB; 2X4S; X-ray; 2.55 A; A/D=25-299.
DR   PDB; 2X4T; X-ray; 2.30 A; A/D=25-299.
DR   PDB; 2X4U; X-ray; 2.10 A; A/D=25-299.
DR   PDB; 2X70; X-ray; 2.00 A; A/D=25-299.
DR   PDB; 2XPG; X-ray; 2.60 A; A=25-298.
DR   PDB; 3BGM; X-ray; 1.60 A; A=25-298.
DR   PDB; 3BH8; X-ray; 1.65 A; A=25-298.
DR   PDB; 3BH9; X-ray; 1.70 A; A=25-299.
DR   PDB; 3BHB; X-ray; 2.20 A; A=25-298.
DR   PDB; 3BO8; X-ray; 1.80 A; A=25-298.
DR   PDB; 3D25; X-ray; 1.30 A; A=25-298.
DR   PDB; 3D39; X-ray; 2.81 A; A=25-299.
DR   PDB; 3D3V; X-ray; 2.80 A; A=25-299.
DR   PDB; 3FQN; X-ray; 1.65 A; A=25-299.
DR   PDB; 3FQR; X-ray; 1.70 A; A=25-299.
DR   PDB; 3FQT; X-ray; 1.80 A; A=25-299.
DR   PDB; 3FQU; X-ray; 1.80 A; A=25-299.
DR   PDB; 3FQW; X-ray; 1.93 A; A=25-299.
DR   PDB; 3FQX; X-ray; 1.70 A; A=25-299.
DR   PDB; 3FT2; X-ray; 1.80 A; A=25-299.
DR   PDB; 3FT3; X-ray; 1.95 A; A=25-299.
DR   PDB; 3FT4; X-ray; 1.90 A; A=25-299.
DR   PDB; 3GIV; X-ray; 2.00 A; A/D=25-299.
DR   PDB; 3GJF; X-ray; 1.90 A; A/D=25-300.
DR   PDB; 3GSN; X-ray; 2.80 A; H=25-298.
DR   PDB; 3GSO; X-ray; 1.60 A; A=25-298.
DR   PDB; 3GSQ; X-ray; 2.12 A; A=25-298.
DR   PDB; 3GSR; X-ray; 1.95 A; A=25-298.
DR   PDB; 3GSU; X-ray; 1.80 A; A=25-299.
DR   PDB; 3GSV; X-ray; 1.90 A; A=25-299.
DR   PDB; 3GSW; X-ray; 1.81 A; A=25-298.
DR   PDB; 3GSX; X-ray; 2.10 A; A=25-298.
DR   PDB; 3H7B; X-ray; 1.88 A; A/D=25-299.
DR   PDB; 3H9H; X-ray; 2.00 A; A/D=25-299.
DR   PDB; 3H9S; X-ray; 2.70 A; A=25-299.
DR   PDB; 3HAE; X-ray; 2.90 A; A/D/J/P=25-300.
DR   PDB; 3HLA; X-ray; 2.60 A; A=25-294.
DR   PDB; 3HPJ; X-ray; 2.00 A; A/D=25-299.
DR   PDB; 3I6G; X-ray; 2.20 A; A/D=25-299.
DR   PDB; 3I6K; X-ray; 2.80 A; A/E=25-299.
DR   PDB; 3I6L; X-ray; 2.40 A; D=25-298.
DR   PDB; 3IXA; X-ray; 2.10 A; A/D=25-299.
DR   PDB; 3KLA; X-ray; 1.65 A; A/D=25-299.
DR   PDB; 3MGO; X-ray; 2.30 A; A/D/G/J=25-299.
DR   PDB; 3MGT; X-ray; 2.20 A; A/D/G/J=25-299.
DR   PDB; 3MR9; X-ray; 1.93 A; A=25-300.
DR   PDB; 3MRB; X-ray; 1.40 A; A=25-300.
DR   PDB; 3MRC; X-ray; 1.80 A; A=25-300.
DR   PDB; 3MRD; X-ray; 1.70 A; A=25-300.
DR   PDB; 3MRE; X-ray; 1.10 A; A=25-300.
DR   PDB; 3MRF; X-ray; 2.30 A; A=25-300.
DR   PDB; 3MRG; X-ray; 1.30 A; A=25-300.
DR   PDB; 3MRH; X-ray; 2.40 A; A=25-300.
DR   PDB; 3MRI; X-ray; 2.10 A; A=25-300.
DR   PDB; 3MRJ; X-ray; 1.87 A; A=25-300.
DR   PDB; 3MRK; X-ray; 1.40 A; A=25-300.
DR   PDB; 3MRL; X-ray; 2.41 A; A=25-300.
DR   PDB; 3MRM; X-ray; 1.90 A; A=25-300.
DR   PDB; 3MRN; X-ray; 2.30 A; A=25-300.
DR   PDB; 3MRO; X-ray; 2.35 A; A=25-300.
DR   PDB; 3MRP; X-ray; 2.10 A; A=25-300.
DR   PDB; 3MRQ; X-ray; 2.20 A; A=25-300.
DR   PDB; 3MRR; X-ray; 1.60 A; A=25-300.
DR   PDB; 3MYJ; X-ray; 1.89 A; A/D=25-299.
DR   PDB; 3NFN; X-ray; 2.39 A; A=25-298.
DR   PDB; 3O3A; X-ray; 1.80 A; A/D=25-299.
DR   PDB; 3O3B; X-ray; 1.90 A; A/D=25-299.
DR   PDB; 3O3D; X-ray; 1.70 A; A/D=25-299.
DR   PDB; 3O3E; X-ray; 1.85 A; A/D=25-299.
DR   PDB; 3O4L; X-ray; 2.54 A; A=25-300.
DR   PDB; 3PWJ; X-ray; 1.70 A; A/D=25-299.
DR   PDB; 3PWL; X-ray; 1.65 A; A/D=25-299.
DR   PDB; 3PWN; X-ray; 1.60 A; A/D=25-299.
DR   PDB; 3PWP; X-ray; 2.69 A; A=25-299.
DR   PDB; 3QDG; X-ray; 2.69 A; A=25-299.
DR   PDB; 3QDJ; X-ray; 2.30 A; A=25-299.
DR   PDB; 3QDM; X-ray; 2.80 A; A=25-299.
DR   PDB; 3QEQ; X-ray; 2.59 A; A=25-299.
DR   PDB; 3QFD; X-ray; 1.68 A; A/D=25-299.
DR   PDB; 3QFJ; X-ray; 2.29 A; A=25-299.
DR   PDB; 3QZW; X-ray; 2.80 A; A/D=25-298.
DR   PDB; 3REW; X-ray; 1.90 A; A/D=25-299.
DR   PDB; 3RL1; X-ray; 2.00 A; A=25-298.
DR   PDB; 3RL2; X-ray; 2.39 A; A=25-298.
DR   PDB; 3TO2; X-ray; 2.60 A; A=25-299.
DR   PDB; 3UTQ; X-ray; 1.67 A; A=25-300.
DR   PDB; 3UTS; X-ray; 2.71 A; A/F=25-300.
DR   PDB; 3UTT; X-ray; 2.60 A; A/F=25-299.
DR   PDB; 3V5D; X-ray; 2.00 A; A/D=25-299.
DR   PDB; 3V5H; X-ray; 1.63 A; A/D=25-299.
DR   PDB; 3V5K; X-ray; 2.31 A; A/D=25-299.
DR   PDB; 3VXM; X-ray; 2.50 A; A=25-298.
DR   PDB; 3VXN; X-ray; 1.95 A; A=25-298.
DR   PDB; 3VXO; X-ray; 2.61 A; A/D=25-298.
DR   PDB; 3VXP; X-ray; 2.50 A; A/D=25-298.
DR   PDB; 3VXR; X-ray; 2.40 A; A=25-298.
DR   PDB; 3VXS; X-ray; 1.80 A; A=25-298.
DR   PDB; 3VXU; X-ray; 2.70 A; A/F=25-298.
DR   PDB; 3W0W; X-ray; 2.60 A; A=25-298.
DR   PDB; 3WL9; X-ray; 1.66 A; A=25-298.
DR   PDB; 3WLB; X-ray; 2.00 A; A=25-298.
DR   PDB; 4E5X; X-ray; 1.95 A; A/D=25-299.
DR   PDB; 4EMZ; X-ray; 2.90 A; D/E=338-365.
DR   PDB; 4EN2; X-ray; 2.58 A; D/E=338-365.
DR   PDB; 4EUP; X-ray; 2.88 A; A/D=25-299.
DR   PDB; 4F7M; X-ray; 2.40 A; A/D=25-298.
DR   PDB; 4F7P; X-ray; 1.90 A; A=25-298.
DR   PDB; 4F7T; X-ray; 1.70 A; A/D=25-298.
DR   PDB; 4FTV; X-ray; 2.74 A; A=25-299.
DR   PDB; 4GKN; X-ray; 2.75 A; A/D=25-300.
DR   PDB; 4GKS; X-ray; 2.35 A; A/D=25-300.
DR   PDB; 4HWZ; X-ray; 2.40 A; A=25-298.
DR   PDB; 4HX1; X-ray; 1.80 A; A=25-296.
DR   PDB; 4I48; X-ray; 2.80 A; A=25-296.
DR   PDB; 4I4W; X-ray; 1.77 A; A=25-300.
DR   PDB; 4JFD; X-ray; 2.46 A; A=25-300.
DR   PDB; 4JFE; X-ray; 2.70 A; A=25-300.
DR   PDB; 4JFF; X-ray; 2.43 A; A=25-300.
DR   PDB; 4JFO; X-ray; 2.11 A; A/D=25-299.
DR   PDB; 4JFP; X-ray; 1.91 A; A/D=25-300.
DR   PDB; 4JFQ; X-ray; 1.90 A; A/D=25-300.
DR   PDB; 4K7F; X-ray; 2.00 A; A/D=25-299.
DR   PDB; 4L29; X-ray; 3.09 A; A/C/E/G/I/K/M/O/Q/S/U/W/Y/a=25-300.
DR   PDB; 4L3C; X-ray; 2.64 A; A/C/E/G/I/K/M/O/Q/S/U/W/Y/a=25-300.
DR   PDB; 4L3E; X-ray; 2.56 A; A=25-299.
DR   PDB; 4MJ5; X-ray; 2.40 A; A=25-298.
DR   PDB; 4MJ6; X-ray; 2.57 A; A=25-298.
DR   PDB; 4MNQ; X-ray; 2.74 A; A=25-300.
DR   PDB; 4N8V; X-ray; 2.50 A; A/D=25-298.
DR   PDB; 4NNX; X-ray; 2.10 A; A=25-298.
DR   PDB; 4NNY; X-ray; 1.90 A; A=25-298.
DR   PDB; 4NO0; X-ray; 2.70 A; A=25-300.
DR   PDB; 4NO2; X-ray; 2.00 A; A=25-298.
DR   PDB; 4NO3; X-ray; 1.70 A; A=25-298.
DR   PDB; 4NO5; X-ray; 2.10 A; A=25-299.
DR   PDB; 4NQV; X-ray; 2.39 A; A/C/E/G/I/K=25-298.
DR   PDB; 4NQX; X-ray; 2.00 A; A/C/E/G/I/K=25-308.
DR   PDB; 4OV5; X-ray; 2.20 A; C/F/I/L/O/R=128-141.
DR   PDB; 4QOK; X-ray; 3.00 A; A=25-300.
DR   PDB; 4U6X; X-ray; 1.68 A; A=25-300.
DR   PDB; 4U6Y; X-ray; 1.47 A; A=25-300.
DR   PDB; 4UQ2; X-ray; 2.43 A; A/C=25-299.
DR   PDB; 4UQ3; X-ray; 2.10 A; A/C=25-299.
DR   PDB; 4WJ5; X-ray; 1.65 A; A/D=25-299.
DR   PDB; 4WU5; X-ray; 2.40 A; A/D=25-298.
DR   PDB; 4WU7; X-ray; 2.30 A; A/D=25-298.
DR   PDB; 4WUU; X-ray; 3.05 A; A=25-300.
DR   PDB; 5BRZ; X-ray; 2.62 A; A=25-298.
DR   PDB; 5BS0; X-ray; 2.40 A; A=25-298.
DR   PDB; 5C07; X-ray; 2.11 A; A/F=25-300.
DR   PDB; 5C08; X-ray; 2.33 A; A/F=25-300.
DR   PDB; 5C09; X-ray; 2.48 A; A/F=25-300.
DR   PDB; 5C0A; X-ray; 2.46 A; A/F=25-300.
DR   PDB; 5C0B; X-ray; 2.03 A; A/F=25-299.
DR   PDB; 5C0C; X-ray; 1.97 A; A/F=25-300.
DR   PDB; 5C0D; X-ray; 1.68 A; A=25-300.
DR   PDB; 5C0E; X-ray; 1.49 A; A=25-300.
DR   PDB; 5C0F; X-ray; 1.46 A; A=25-300.
DR   PDB; 5C0G; X-ray; 1.37 A; A=25-300.
DR   PDB; 5C0I; X-ray; 1.53 A; A=25-300.
DR   PDB; 5C0J; X-ray; 1.64 A; A=25-300.
DR   PDB; 5D2L; X-ray; 3.51 A; A/C/G/M=25-299.
DR   PDB; 5D2N; X-ray; 2.10 A; A/H=25-299.
DR   PDB; 5D9S; X-ray; 1.87 A; A=25-298.
DR   PDB; 5DDH; X-ray; 1.50 A; A=25-298.
DR   PDB; 5E00; X-ray; 1.70 A; A=25-299.
DR   PDB; 5E6I; X-ray; 4.00 A; C/I/M/R=25-299.
DR   PDB; 5E9D; X-ray; 2.51 A; A/F=25-299.
DR   PDB; 5ENW; X-ray; 1.85 A; A=25-298.
DR   PDB; 5EOT; X-ray; 2.10 A; A=26-298.
DR   PDB; 5EU3; X-ray; 1.97 A; A=25-300.
DR   PDB; 5EU4; X-ray; 2.12 A; A/D=25-300.
DR   PDB; 5EU5; X-ray; 1.54 A; A=25-300.
DR   PDB; 5EU6; X-ray; 2.02 A; A=25-300.
DR   PDB; 5EUO; X-ray; 2.10 A; A/C=25-299.
DR   PDB; 5F7D; X-ray; 2.30 A; A=26-298.
DR   PDB; 5F9J; X-ray; 2.51 A; A=25-298.
DR   PDB; 5FA3; X-ray; 1.86 A; A=26-298.
DR   PDB; 5FA4; X-ray; 2.40 A; A=25-298.
DR   PDB; 5FDW; X-ray; 2.70 A; A=25-298.
DR   PDB; 5GRD; X-ray; 1.80 A; A=25-299.
DR   PDB; 5GRG; X-ray; 1.94 A; A=25-299.
DR   PDB; 5GSD; X-ray; 2.30 A; A=25-299.
DR   PDB; 5HGA; X-ray; 2.20 A; A/D=25-298.
DR   PDB; 5HGB; X-ray; 2.40 A; A/D/G/J=25-298.
DR   PDB; 5HGD; X-ray; 2.07 A; A/D=25-298.
DR   PDB; 5HGH; X-ray; 2.39 A; A=25-298.
DR   PDB; 5HHM; X-ray; 2.50 A; A/F=25-300.
DR   PDB; 5HHN; X-ray; 2.03 A; A=25-298.
DR   PDB; 5HHO; X-ray; 2.95 A; A=25-300.
DR   PDB; 5HHP; X-ray; 1.90 A; A=25-298.
DR   PDB; 5HHQ; X-ray; 2.10 A; A=25-298.
DR   PDB; 5HYJ; X-ray; 3.06 A; A/F=25-300.
DR   PDB; 5IRO; X-ray; 2.64 A; A/E/I/M/Q/U=25-299.
DR   PDB; 5ISZ; X-ray; 2.06 A; A=25-299.
DR   PDB; 5JHD; X-ray; 2.46 A; A/F=25-299.
DR   PDB; 5JZI; X-ray; 2.50 A; A/F=25-299.
DR   PDB; 5MEN; X-ray; 2.81 A; A=25-300.
DR   PDB; 5MEO; X-ray; 1.77 A; A=25-300.
DR   PDB; 5MEP; X-ray; 2.71 A; A/D=25-300.
DR   PDB; 5MEQ; X-ray; 2.27 A; A=25-300.
DR   PDB; 5MER; X-ray; 1.88 A; A/D=25-300.
DR   PDB; 5N1Y; X-ray; 1.39 A; A=25-300.
DR   PDB; 5N6B; X-ray; 1.71 A; A/D=25-300.
DR   PDB; 5NHT; X-ray; 3.20 A; H=25-300.
DR   PDB; 5NME; X-ray; 2.94 A; A/F=25-300.
DR   PDB; 5NMF; X-ray; 2.89 A; A/F=25-300.
DR   PDB; 5NMG; X-ray; 2.75 A; A/F=25-300.
DR   PDB; 5NMH; X-ray; 1.55 A; A=25-300.
DR   PDB; 5NMK; X-ray; 1.66 A; A=25-300.
DR   PDB; 5NQK; X-ray; 3.25 A; H=25-300.
DR   PDB; 5SWQ; X-ray; 2.00 A; A=25-300.
DR   PDB; 5TEZ; X-ray; 1.70 A; A=25-299.
DR   PDB; 5W1W; X-ray; 3.10 A; C/H/M/R=3-11.
DR   PDB; 5WJL; X-ray; 3.15 A; A/D/G=25-298.
DR   PDB; 5WJN; X-ray; 2.85 A; A/D/G=25-298.
DR   PDB; 5WKF; X-ray; 2.95 A; A/F=25-298.
DR   PDB; 5WKH; X-ray; 3.20 A; A/F=25-298.
DR   PDB; 5WSH; X-ray; 2.00 A; A=25-299.
DR   PDB; 5WWI; X-ray; 3.19 A; A=25-298.
DR   PDB; 5WWJ; X-ray; 2.29 A; A/C=25-298.
DR   PDB; 5WWU; X-ray; 2.79 A; A=25-298.
DR   PDB; 5WXC; X-ray; 2.29 A; A/C=25-298.
DR   PDB; 5WXD; X-ray; 3.29 A; A=25-298.
DR   PDB; 5XOV; X-ray; 2.68 A; A/D=25-298.
DR   PDB; 5YXN; X-ray; 2.03 A; C=25-299.
DR   PDB; 5YXU; X-ray; 2.70 A; C/E=25-299.
DR   PDB; 6AM5; X-ray; 2.39 A; A=25-299.
DR   PDB; 6AMT; X-ray; 2.50 A; A/D=25-299.
DR   PDB; 6AMU; X-ray; 2.15 A; A=26-298.
DR   PDB; 6APN; X-ray; 2.22 A; A/B=26-301.
DR   PDB; 6AT9; X-ray; 2.95 A; A=25-304.
DR   PDB; 6D78; X-ray; 2.35 A; A=25-299.
DR   PDB; 6D7G; X-ray; 2.75 A; A=25-299.
DR   PDB; 6DKP; X-ray; 2.97 A; A=25-299.
DR   PDB; 6EI2; X-ray; 1.61 A; A=25-299.
DR   PDB; 6ENY; EM; 5.80 A; F=25-365.
DR   PDB; 6EQA; X-ray; 3.16 A; A=25-300.
DR   PDB; 6EQB; X-ray; 2.81 A; A=25-300.
DR   PDB; 6EWA; X-ray; 2.39 A; A/E=25-300.
DR   PDB; 6EWC; X-ray; 3.20 A; A/E=25-300.
DR   PDB; 6EWO; X-ray; 2.30 A; A/E=25-300.
DR   PDB; 6G3J; X-ray; 2.45 A; A/D=25-300.
DR   PDB; 6G3K; X-ray; 2.90 A; A/D=25-300.
DR   PDB; 6ID4; X-ray; 2.40 A; A/E=25-299.
DR   PDB; 6J1W; X-ray; 1.50 A; A=25-298.
DR   PDB; 6J29; X-ray; 1.60 A; A=25-298.
DR   PDB; 6J2A; X-ray; 1.40 A; A=25-298.
DR   PDB; 6MPP; NMR; -; A=25-303.
DR   PDB; 6NCA; X-ray; 3.30 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T=25-299.
DR   PDB; 6O9B; X-ray; 2.20 A; A=25-304.
DR   PDB; 6O9C; X-ray; 2.45 A; A=25-304.
DR   PDB; 6OPD; X-ray; 1.79 A; A=25-299.
DR   PDB; 6PBH; X-ray; 1.89 A; A=25-302.
DR   PDB; 6PTB; X-ray; 2.15 A; A/D=25-299.
DR   PDB; 6PTE; X-ray; 1.90 A; A/E/H/K=25-299.
DR   PDB; 6Q3K; X-ray; 1.50 A; A=24-299.
DR   PDB; 6Q3S; X-ray; 2.50 A; A=25-300.
DR   PDB; 6RP9; X-ray; 3.12 A; A/F=25-299.
DR   PDB; 6RPA; X-ray; 2.56 A; A=25-299.
DR   PDB; 6RPB; X-ray; 2.50 A; A/F/K/P=25-299.
DR   PDBsum; 1AKJ; -.
DR   PDBsum; 1AO7; -.
DR   PDBsum; 1AQD; -.
DR   PDBsum; 1B0G; -.
DR   PDBsum; 1B0R; -.
DR   PDBsum; 1BD2; -.
DR   PDBsum; 1DUY; -.
DR   PDBsum; 1DUZ; -.
DR   PDBsum; 1EEY; -.
DR   PDBsum; 1EEZ; -.
DR   PDBsum; 1HHG; -.
DR   PDBsum; 1HHH; -.
DR   PDBsum; 1HHI; -.
DR   PDBsum; 1HHJ; -.
DR   PDBsum; 1HHK; -.
DR   PDBsum; 1HLA; -.
DR   PDBsum; 1HSB; -.
DR   PDBsum; 1I1F; -.
DR   PDBsum; 1I1Y; -.
DR   PDBsum; 1I4F; -.
DR   PDBsum; 1I7R; -.
DR   PDBsum; 1I7T; -.
DR   PDBsum; 1I7U; -.
DR   PDBsum; 1IM3; -.
DR   PDBsum; 1JF1; -.
DR   PDBsum; 1JHT; -.
DR   PDBsum; 1LP9; -.
DR   PDBsum; 1OGA; -.
DR   PDBsum; 1P7Q; -.
DR   PDBsum; 1Q94; -.
DR   PDBsum; 1QEW; -.
DR   PDBsum; 1QR1; -.
DR   PDBsum; 1QRN; -.
DR   PDBsum; 1QSE; -.
DR   PDBsum; 1QSF; -.
DR   PDBsum; 1QVO; -.
DR   PDBsum; 1S8D; -.
DR   PDBsum; 1S9W; -.
DR   PDBsum; 1S9X; -.
DR   PDBsum; 1S9Y; -.
DR   PDBsum; 1T1W; -.
DR   PDBsum; 1T1X; -.
DR   PDBsum; 1T1Y; -.
DR   PDBsum; 1T1Z; -.
DR   PDBsum; 1T20; -.
DR   PDBsum; 1T21; -.
DR   PDBsum; 1T22; -.
DR   PDBsum; 1TMC; -.
DR   PDBsum; 1TVB; -.
DR   PDBsum; 1TVH; -.
DR   PDBsum; 1UR7; -.
DR   PDBsum; 1W72; -.
DR   PDBsum; 1X7Q; -.
DR   PDBsum; 2AV1; -.
DR   PDBsum; 2AV7; -.
DR   PDBsum; 2BCK; -.
DR   PDBsum; 2BNQ; -.
DR   PDBsum; 2BNR; -.
DR   PDBsum; 2C7U; -.
DR   PDBsum; 2CLR; -.
DR   PDBsum; 2F53; -.
DR   PDBsum; 2F54; -.
DR   PDBsum; 2GIT; -.
DR   PDBsum; 2GJ6; -.
DR   PDBsum; 2GT9; -.
DR   PDBsum; 2GTW; -.
DR   PDBsum; 2GTZ; -.
DR   PDBsum; 2GUO; -.
DR   PDBsum; 2HLA; -.
DR   PDBsum; 2HN7; -.
DR   PDBsum; 2J8U; -.
DR   PDBsum; 2JCC; -.
DR   PDBsum; 2P5E; -.
DR   PDBsum; 2P5W; -.
DR   PDBsum; 2PYE; -.
DR   PDBsum; 2UWE; -.
DR   PDBsum; 2V2W; -.
DR   PDBsum; 2V2X; -.
DR   PDBsum; 2VLJ; -.
DR   PDBsum; 2VLK; -.
DR   PDBsum; 2VLL; -.
DR   PDBsum; 2VLR; -.
DR   PDBsum; 2X4N; -.
DR   PDBsum; 2X4O; -.
DR   PDBsum; 2X4P; -.
DR   PDBsum; 2X4Q; -.
DR   PDBsum; 2X4R; -.
DR   PDBsum; 2X4S; -.
DR   PDBsum; 2X4T; -.
DR   PDBsum; 2X4U; -.
DR   PDBsum; 2X70; -.
DR   PDBsum; 2XPG; -.
DR   PDBsum; 3BGM; -.
DR   PDBsum; 3BH8; -.
DR   PDBsum; 3BH9; -.
DR   PDBsum; 3BHB; -.
DR   PDBsum; 3BO8; -.
DR   PDBsum; 3D25; -.
DR   PDBsum; 3D39; -.
DR   PDBsum; 3D3V; -.
DR   PDBsum; 3FQN; -.
DR   PDBsum; 3FQR; -.
DR   PDBsum; 3FQT; -.
DR   PDBsum; 3FQU; -.
DR   PDBsum; 3FQW; -.
DR   PDBsum; 3FQX; -.
DR   PDBsum; 3FT2; -.
DR   PDBsum; 3FT3; -.
DR   PDBsum; 3FT4; -.
DR   PDBsum; 3GIV; -.
DR   PDBsum; 3GJF; -.
DR   PDBsum; 3GSN; -.
DR   PDBsum; 3GSO; -.
DR   PDBsum; 3GSQ; -.
DR   PDBsum; 3GSR; -.
DR   PDBsum; 3GSU; -.
DR   PDBsum; 3GSV; -.
DR   PDBsum; 3GSW; -.
DR   PDBsum; 3GSX; -.
DR   PDBsum; 3H7B; -.
DR   PDBsum; 3H9H; -.
DR   PDBsum; 3H9S; -.
DR   PDBsum; 3HAE; -.
DR   PDBsum; 3HLA; -.
DR   PDBsum; 3HPJ; -.
DR   PDBsum; 3I6G; -.
DR   PDBsum; 3I6K; -.
DR   PDBsum; 3I6L; -.
DR   PDBsum; 3IXA; -.
DR   PDBsum; 3KLA; -.
DR   PDBsum; 3MGO; -.
DR   PDBsum; 3MGT; -.
DR   PDBsum; 3MR9; -.
DR   PDBsum; 3MRB; -.
DR   PDBsum; 3MRC; -.
DR   PDBsum; 3MRD; -.
DR   PDBsum; 3MRE; -.
DR   PDBsum; 3MRF; -.
DR   PDBsum; 3MRG; -.
DR   PDBsum; 3MRH; -.
DR   PDBsum; 3MRI; -.
DR   PDBsum; 3MRJ; -.
DR   PDBsum; 3MRK; -.
DR   PDBsum; 3MRL; -.
DR   PDBsum; 3MRM; -.
DR   PDBsum; 3MRN; -.
DR   PDBsum; 3MRO; -.
DR   PDBsum; 3MRP; -.
DR   PDBsum; 3MRQ; -.
DR   PDBsum; 3MRR; -.
DR   PDBsum; 3MYJ; -.
DR   PDBsum; 3NFN; -.
DR   PDBsum; 3O3A; -.
DR   PDBsum; 3O3B; -.
DR   PDBsum; 3O3D; -.
DR   PDBsum; 3O3E; -.
DR   PDBsum; 3O4L; -.
DR   PDBsum; 3PWJ; -.
DR   PDBsum; 3PWL; -.
DR   PDBsum; 3PWN; -.
DR   PDBsum; 3PWP; -.
DR   PDBsum; 3QDG; -.
DR   PDBsum; 3QDJ; -.
DR   PDBsum; 3QDM; -.
DR   PDBsum; 3QEQ; -.
DR   PDBsum; 3QFD; -.
DR   PDBsum; 3QFJ; -.
DR   PDBsum; 3QZW; -.
DR   PDBsum; 3REW; -.
DR   PDBsum; 3RL1; -.
DR   PDBsum; 3RL2; -.
DR   PDBsum; 3TO2; -.
DR   PDBsum; 3UTQ; -.
DR   PDBsum; 3UTS; -.
DR   PDBsum; 3UTT; -.
DR   PDBsum; 3V5D; -.
DR   PDBsum; 3V5H; -.
DR   PDBsum; 3V5K; -.
DR   PDBsum; 3VXM; -.
DR   PDBsum; 3VXN; -.
DR   PDBsum; 3VXO; -.
DR   PDBsum; 3VXP; -.
DR   PDBsum; 3VXR; -.
DR   PDBsum; 3VXS; -.
DR   PDBsum; 3VXU; -.
DR   PDBsum; 3W0W; -.
DR   PDBsum; 3WL9; -.
DR   PDBsum; 3WLB; -.
DR   PDBsum; 4E5X; -.
DR   PDBsum; 4EMZ; -.
DR   PDBsum; 4EN2; -.
DR   PDBsum; 4EUP; -.
DR   PDBsum; 4F7M; -.
DR   PDBsum; 4F7P; -.
DR   PDBsum; 4F7T; -.
DR   PDBsum; 4FTV; -.
DR   PDBsum; 4GKN; -.
DR   PDBsum; 4GKS; -.
DR   PDBsum; 4HWZ; -.
DR   PDBsum; 4HX1; -.
DR   PDBsum; 4I48; -.
DR   PDBsum; 4I4W; -.
DR   PDBsum; 4JFD; -.
DR   PDBsum; 4JFE; -.
DR   PDBsum; 4JFF; -.
DR   PDBsum; 4JFO; -.
DR   PDBsum; 4JFP; -.
DR   PDBsum; 4JFQ; -.
DR   PDBsum; 4K7F; -.
DR   PDBsum; 4L29; -.
DR   PDBsum; 4L3C; -.
DR   PDBsum; 4L3E; -.
DR   PDBsum; 4MJ5; -.
DR   PDBsum; 4MJ6; -.
DR   PDBsum; 4MNQ; -.
DR   PDBsum; 4N8V; -.
DR   PDBsum; 4NNX; -.
DR   PDBsum; 4NNY; -.
DR   PDBsum; 4NO0; -.
DR   PDBsum; 4NO2; -.
DR   PDBsum; 4NO3; -.
DR   PDBsum; 4NO5; -.
DR   PDBsum; 4NQV; -.
DR   PDBsum; 4NQX; -.
DR   PDBsum; 4OV5; -.
DR   PDBsum; 4QOK; -.
DR   PDBsum; 4U6X; -.
DR   PDBsum; 4U6Y; -.
DR   PDBsum; 4UQ2; -.
DR   PDBsum; 4UQ3; -.
DR   PDBsum; 4WJ5; -.
DR   PDBsum; 4WU5; -.
DR   PDBsum; 4WU7; -.
DR   PDBsum; 4WUU; -.
DR   PDBsum; 5BRZ; -.
DR   PDBsum; 5BS0; -.
DR   PDBsum; 5C07; -.
DR   PDBsum; 5C08; -.
DR   PDBsum; 5C09; -.
DR   PDBsum; 5C0A; -.
DR   PDBsum; 5C0B; -.
DR   PDBsum; 5C0C; -.
DR   PDBsum; 5C0D; -.
DR   PDBsum; 5C0E; -.
DR   PDBsum; 5C0F; -.
DR   PDBsum; 5C0G; -.
DR   PDBsum; 5C0I; -.
DR   PDBsum; 5C0J; -.
DR   PDBsum; 5D2L; -.
DR   PDBsum; 5D2N; -.
DR   PDBsum; 5D9S; -.
DR   PDBsum; 5DDH; -.
DR   PDBsum; 5E00; -.
DR   PDBsum; 5E6I; -.
DR   PDBsum; 5E9D; -.
DR   PDBsum; 5ENW; -.
DR   PDBsum; 5EOT; -.
DR   PDBsum; 5EU3; -.
DR   PDBsum; 5EU4; -.
DR   PDBsum; 5EU5; -.
DR   PDBsum; 5EU6; -.
DR   PDBsum; 5EUO; -.
DR   PDBsum; 5F7D; -.
DR   PDBsum; 5F9J; -.
DR   PDBsum; 5FA3; -.
DR   PDBsum; 5FA4; -.
DR   PDBsum; 5FDW; -.
DR   PDBsum; 5GRD; -.
DR   PDBsum; 5GRG; -.
DR   PDBsum; 5GSD; -.
DR   PDBsum; 5HGA; -.
DR   PDBsum; 5HGB; -.
DR   PDBsum; 5HGD; -.
DR   PDBsum; 5HGH; -.
DR   PDBsum; 5HHM; -.
DR   PDBsum; 5HHN; -.
DR   PDBsum; 5HHO; -.
DR   PDBsum; 5HHP; -.
DR   PDBsum; 5HHQ; -.
DR   PDBsum; 5HYJ; -.
DR   PDBsum; 5IRO; -.
DR   PDBsum; 5ISZ; -.
DR   PDBsum; 5JHD; -.
DR   PDBsum; 5JZI; -.
DR   PDBsum; 5MEN; -.
DR   PDBsum; 5MEO; -.
DR   PDBsum; 5MEP; -.
DR   PDBsum; 5MEQ; -.
DR   PDBsum; 5MER; -.
DR   PDBsum; 5N1Y; -.
DR   PDBsum; 5N6B; -.
DR   PDBsum; 5NHT; -.
DR   PDBsum; 5NME; -.
DR   PDBsum; 5NMF; -.
DR   PDBsum; 5NMG; -.
DR   PDBsum; 5NMH; -.
DR   PDBsum; 5NMK; -.
DR   PDBsum; 5NQK; -.
DR   PDBsum; 5SWQ; -.
DR   PDBsum; 5TEZ; -.
DR   PDBsum; 5W1W; -.
DR   PDBsum; 5WJL; -.
DR   PDBsum; 5WJN; -.
DR   PDBsum; 5WKF; -.
DR   PDBsum; 5WKH; -.
DR   PDBsum; 5WSH; -.
DR   PDBsum; 5WWI; -.
DR   PDBsum; 5WWJ; -.
DR   PDBsum; 5WWU; -.
DR   PDBsum; 5WXC; -.
DR   PDBsum; 5WXD; -.
DR   PDBsum; 5XOV; -.
DR   PDBsum; 5YXN; -.
DR   PDBsum; 5YXU; -.
DR   PDBsum; 6AM5; -.
DR   PDBsum; 6AMT; -.
DR   PDBsum; 6AMU; -.
DR   PDBsum; 6APN; -.
DR   PDBsum; 6AT9; -.
DR   PDBsum; 6D78; -.
DR   PDBsum; 6D7G; -.
DR   PDBsum; 6DKP; -.
DR   PDBsum; 6EI2; -.
DR   PDBsum; 6ENY; -.
DR   PDBsum; 6EQA; -.
DR   PDBsum; 6EQB; -.
DR   PDBsum; 6EWA; -.
DR   PDBsum; 6EWC; -.
DR   PDBsum; 6EWO; -.
DR   PDBsum; 6G3J; -.
DR   PDBsum; 6G3K; -.
DR   PDBsum; 6ID4; -.
DR   PDBsum; 6J1W; -.
DR   PDBsum; 6J29; -.
DR   PDBsum; 6J2A; -.
DR   PDBsum; 6MPP; -.
DR   PDBsum; 6NCA; -.
DR   PDBsum; 6O9B; -.
DR   PDBsum; 6O9C; -.
DR   PDBsum; 6OPD; -.
DR   PDBsum; 6PBH; -.
DR   PDBsum; 6PTB; -.
DR   PDBsum; 6PTE; -.
DR   PDBsum; 6Q3K; -.
DR   PDBsum; 6Q3S; -.
DR   PDBsum; 6RP9; -.
DR   PDBsum; 6RPA; -.
DR   PDBsum; 6RPB; -.
DR   SMR; P04439; -.
DR   BioGrid; 109350; 110.
DR   IntAct; P04439; 77.
DR   MINT; P04439; -.
DR   BindingDB; P04439; -.
DR   DrugBank; DB02740; 3-Indolebutyric Acid.
DR   DrugBank; DB11294; Coccidioides immitis spherule.
DR   DrugBank; DB06226; Nelipepimut-S.
DR   TCDB; 9.A.75.1.2; the mhc ii receptor (mhc2r) family.
DR   GlyConnect; 1315; -.
DR   GlyConnect; 1316; -.
DR   GlyConnect; 1317; -.
DR   GlyConnect; 1318; -.
DR   GlyConnect; 1319; -.
DR   GlyConnect; 1320; -.
DR   GlyConnect; 1321; -.
DR   GlyConnect; 1322; -.
DR   GlyConnect; 1323; -.
DR   GlyConnect; 1324; -.
DR   GlyConnect; 1325; -.
DR   GlyConnect; 1326; -.
DR   GlyConnect; 1327; -.
DR   GlyConnect; 1328; -.
DR   GlyConnect; 1329; -.
DR   iPTMnet; P04439; -.
DR   PhosphoSitePlus; P04439; -.
DR   SwissPalm; P04439; -.
DR   EPD; P04439; -.
DR   MassIVE; P04439; -.
DR   MaxQB; P04439; -.
DR   PaxDb; P04439; -.
DR   PeptideAtlas; P04439; -.
DR   PRIDE; P04439; -.
DR   ProteomicsDB; 51505; -.
DR   ProteomicsDB; 51506; -.
DR   ProteomicsDB; 51714; -.
DR   ProteomicsDB; 51843; -.
DR   ProteomicsDB; 52596; -.
DR   ProteomicsDB; 52597; -.
DR   ProteomicsDB; 52979; -.
DR   ProteomicsDB; 52980; -.
DR   ProteomicsDB; 53320; -.
DR   ProteomicsDB; 53321; -.
DR   ProteomicsDB; 53322; -.
DR   ProteomicsDB; 53564; -.
DR   ProteomicsDB; 54669; -.
DR   ProteomicsDB; 54670; -.
DR   ProteomicsDB; 54671; -.
DR   ProteomicsDB; 54672; -.
DR   ProteomicsDB; 54673; -.
DR   ProteomicsDB; 54674; -.
DR   ProteomicsDB; 54675; -.
DR   ProteomicsDB; 54676; -.
DR   ProteomicsDB; 54707; -.
DR   ProteomicsDB; 58716; -.
DR   ABCD; P04439; -.
DR   Antibodypedia; 26136; 1298 antibodies.
DR   Ensembl; ENST00000376809; ENSP00000366005; ENSG00000206503. [P04439-1]
DR   Ensembl; ENST00000396634; ENSP00000379873; ENSG00000206503. [P04439-1]
DR   GeneID; 3105; -.
DR   KEGG; hsa:3105; -.
DR   UCSC; uc021zos.2; human.
DR   CTD; 3105; -.
DR   GeneCards; HLA-A; -.
DR   HGNC; HGNC:4931; HLA-A.
DR   HPA; ENSG00000206503; Low tissue specificity.
DR   MalaCards; HLA-A; -.
DR   MIM; 126200; phenotype.
DR   MIM; 142800; gene.
DR   MIM; 222100; phenotype.
DR   neXtProt; NX_P04439; -.
DR   OpenTargets; ENSG00000206503; -.
DR   Orphanet; 179; Birdshot chorioretinopathy.
DR   Orphanet; 414750; Phenytoin or carbamazepine toxicity.
DR   PharmGKB; PA35055; -.
DR   GeneTree; ENSGT00980000198488; -.
DR   KO; K06751; -.
DR   OrthoDB; 1390181at2759; -.
DR   PhylomeDB; P04439; -.
DR   TreeFam; TF336617; -.
DR   Reactome; R-HSA-1236974; ER-Phagosome pathway.
DR   Reactome; R-HSA-1236977; Endosomal/Vacuolar pathway.
DR   Reactome; R-HSA-164940; Nef mediated downregulation of MHC class I complex cell surface expression.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-877300; Interferon gamma signaling.
DR   Reactome; R-HSA-8866654; E3 ubiquitin ligases ubiquitinate target proteins.
DR   Reactome; R-HSA-909733; Interferon alpha/beta signaling.
DR   Reactome; R-HSA-983170; Antigen Presentation: Folding, assembly and peptide loading of class I MHC.
DR   ChiTaRS; HLA-A; human.
DR   Pharos; P04439; Tbio.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000206503; Expressed in mononuclear cell and 238 other tissues.
DR   ExpressionAtlas; P04439; baseline and differential.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0070971; C:endoplasmic reticulum exit site; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0005797; C:Golgi medial cisterna; IDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral component of lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0005887; C:integral component of plasma membrane; NAS:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0042824; C:MHC class I peptide loading complex; IDA:UniProtKB.
DR   GO; GO:0042612; C:MHC class I protein complex; IDA:UniProtKB.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0055038; C:recycling endosome membrane; TAS:Reactome.
DR   GO; GO:0030881; F:beta-2-microglobulin binding; IDA:UniProtKB.
DR   GO; GO:0042610; F:CD8 receptor binding; IDA:UniProtKB.
DR   GO; GO:0042605; F:peptide antigen binding; IDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0005102; F:signaling receptor binding; IPI:BHF-UCL.
DR   GO; GO:0042608; F:T cell receptor binding; IDA:UniProtKB.
DR   GO; GO:0046977; F:TAP binding; IDA:UniProtKB.
DR   GO; GO:0062061; F:TAP complex binding; IDA:UniProtKB.
DR   GO; GO:0019731; P:antibacterial humoral response; IDA:UniProtKB.
DR   GO; GO:0019885; P:antigen processing and presentation of endogenous peptide antigen via MHC class I; IDA:UniProtKB.
DR   GO; GO:0002485; P:antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent; IMP:UniProtKB.
DR   GO; GO:0002486; P:antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent; IDA:UniProtKB.
DR   GO; GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; IDA:UniProtKB.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome.
DR   GO; GO:0036037; P:CD8-positive, alpha-beta T cell activation; IDA:UniProtKB.
DR   GO; GO:0050830; P:defense response to Gram-positive bacterium; IDA:UniProtKB.
DR   GO; GO:0016045; P:detection of bacterium; IMP:UniProtKB.
DR   GO; GO:0006955; P:immune response; IMP:UniProtKB.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:2001187; P:positive regulation of CD8-positive, alpha-beta T cell activation; IDA:BHF-UCL.
DR   GO; GO:2000566; P:positive regulation of CD8-positive, alpha-beta T cell proliferation; IDA:UniProtKB.
DR   GO; GO:0032729; P:positive regulation of interferon-gamma production; IDA:UniProtKB.
DR   GO; GO:2000568; P:positive regulation of memory T cell activation; IDA:UniProtKB.
DR   GO; GO:0002726; P:positive regulation of T cell cytokine production; IDA:BHF-UCL.
DR   GO; GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IDA:UniProtKB.
DR   GO; GO:0042270; P:protection from natural killer cell mediated cytotoxicity; IDA:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; TAS:Reactome.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0001913; P:T cell mediated cytotoxicity; IDA:UniProtKB.
DR   GO; GO:0002419; P:T cell mediated cytotoxicity directed against tumor cell target; IDA:UniProtKB.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0060337; P:type I interferon signaling pathway; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 3.30.500.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR037055; MHC_I-like_Ag-recog_sf.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF54452; SSF54452; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Adaptive immunity; Alternative splicing; Cell membrane;
KW   Direct protein sequencing; Disulfide bond; Endoplasmic reticulum;
KW   Glycoprotein; Host-virus interaction; Immunity; Immunoglobulin domain;
KW   Innate immunity; Membrane; MHC I; Phosphoprotein; Polymorphism;
KW   Reference proteome; Signal; Sulfation; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL          1..24
FT                   /evidence="ECO:0000269|PubMed:92029"
FT   CHAIN           25..365
FT                   /note="HLA class I histocompatibility antigen, A alpha
FT                   chain"
FT                   /id="PRO_0000018815"
FT   TOPO_DOM        25..308
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        309..332
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        333..365
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          209..295
FT                   /note="Ig-like C1-type"
FT                   /evidence="ECO:0000255"
FT   REGION          25..114
FT                   /note="Alpha-1"
FT                   /evidence="ECO:0000255"
FT   REGION          115..206
FT                   /note="Alpha-2"
FT                   /evidence="ECO:0000255"
FT   REGION          207..298
FT                   /note="Alpha-3"
FT                   /evidence="ECO:0000255"
FT   REGION          299..308
FT                   /note="Connecting peptide"
FT                   /evidence="ECO:0000255"
FT   BINDING         31
FT                   /note="Pathogen-derived peptide antigen"
FT                   /evidence="ECO:0000269|PubMed:21943705"
FT   BINDING         97
FT                   /note="Pathogen-derived peptide antigen"
FT                   /evidence="ECO:0000269|PubMed:21943705"
FT   BINDING         108
FT                   /note="Pathogen-derived peptide antigen"
FT                   /evidence="ECO:0000269|PubMed:21943705"
FT   BINDING         140
FT                   /note="Self-peptide antigen"
FT                   /evidence="ECO:0000269|PubMed:21543847"
FT   BINDING         167
FT                   /note="Pathogen-derived peptide antigen"
FT                   /evidence="ECO:0000269|PubMed:21943705"
FT   BINDING         170
FT                   /note="Pathogen-derived peptide antigen"
FT                   /evidence="ECO:0000269|PubMed:21943705"
FT   BINDING         183
FT                   /note="Self- and pathogen-derived peptide antigen"
FT                   /evidence="ECO:0000269|PubMed:21543847,
FT                   ECO:0000269|PubMed:21943705"
FT   BINDING         195
FT                   /note="Pathogen-derived peptide antigen"
FT                   /evidence="ECO:0000269|PubMed:21943705"
FT   MOD_RES         83
FT                   /note="Sulfotyrosine"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         343
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         344
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         349
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         350
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         352
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         356
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         359
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   CARBOHYD        110
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19159218"
FT   DISULFID        125..188
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114,
FT                   ECO:0000269|PubMed:16041067, ECO:0000269|PubMed:19177349,
FT                   ECO:0000269|PubMed:20844028, ECO:0000269|PubMed:21543847,
FT                   ECO:0000269|PubMed:21943705, ECO:0000269|PubMed:26758806,
FT                   ECO:0000269|PubMed:28250417, ECO:0000269|PubMed:7694806"
FT   DISULFID        227..283
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114,
FT                   ECO:0000269|PubMed:16041067, ECO:0000269|PubMed:19177349,
FT                   ECO:0000269|PubMed:20844028, ECO:0000269|PubMed:21543847,
FT                   ECO:0000269|PubMed:21943705, ECO:0000269|PubMed:26758806,
FT                   ECO:0000269|PubMed:28250417, ECO:0000269|PubMed:7694806"
FT   VAR_SEQ         176..187
FT                   /note="EAEQLRAYLDGT -> AAEQQRAYLEGR (in isoform 2)"
FT                   /id="VSP_060391"
FT   VAR_SEQ         337
FT                   /note="S -> SGGEGVK (in isoform 2)"
FT                   /id="VSP_060392"
FT   VARIANT         3
FT                   /note="V -> I (in allele A*34:01)"
FT                   /evidence="ECO:0000269|PubMed:1431115"
FT                   /id="VAR_082315"
FT   VARIANT         5
FT                   /note="A -> P (in allele A*80:01)"
FT                   /evidence="ECO:0000269|PubMed:8188325,
FT                   ECO:0000269|PubMed:8284791"
FT                   /id="VAR_082316"
FT   VARIANT         10
FT                   /note="L -> V (in allele A*02:01, allele A*02:05, allele
FT                   A*23:01, allele A*24:02, allele A*25:01, allele A*26:01,
FT                   allele A*34:01, allele A*43:01, allele A*66:01, allele
FT                   A*68:01 and allele A*69:01)"
FT                   /evidence="ECO:0000269|PubMed:1431115,
FT                   ECO:0000269|PubMed:1729171, ECO:0000269|PubMed:2320591,
FT                   ECO:0000269|PubMed:2982951, ECO:0000269|PubMed:3496393,
FT                   ECO:0000269|PubMed:3877632, ECO:0000269|PubMed:7836067,
FT                   ECO:0000269|PubMed:8026990, ECO:0000269|PubMed:8475492,
FT                   ECO:0000269|PubMed:9349616"
FT                   /id="VAR_082317"
FT   VARIANT         14
FT                   /note="S -> L (in allele A*29:02, allele A*31:01, allele
FT                   A*32:01, allele A*33:01 and allele A*74:01)"
FT                   /evidence="ECO:0000269|PubMed:1317015,
FT                   ECO:0000269|PubMed:1431115, ECO:0000269|PubMed:1782566,
FT                   ECO:0000269|PubMed:2431040, ECO:0000269|PubMed:2478623,
FT                   ECO:0000269|PubMed:8795145, ECO:0000269|Ref.29"
FT                   /id="VAR_082318"
FT   VARIANT         23
FT                   /note="W -> R (in allele A*74:01)"
FT                   /evidence="ECO:0000269|PubMed:1431115"
FT                   /id="VAR_082319"
FT   VARIANT         33
FT                   /note="F -> S (in allele A*23:01, allele A*24:02 and allele
FT                   A*30:01; dbSNP:rs2075684)"
FT                   /evidence="ECO:0000269|PubMed:1729171,
FT                   ECO:0000269|PubMed:2478623, ECO:0000269|PubMed:7871528,
FT                   ECO:0000269|PubMed:9349616"
FT                   /id="VAR_082320"
FT   VARIANT         33
FT                   /note="F -> T (in allele A*29:02, allele A*31:01 and allele
FT                   A*33:01; requires 2 nucleotide substitutions)"
FT                   /evidence="ECO:0000269|PubMed:1317015,
FT                   ECO:0000269|PubMed:1782566, ECO:0000269|PubMed:2478623,
FT                   ECO:0000269|PubMed:8795145"
FT                   /id="VAR_082321"
FT   VARIANT         33
FT                   /note="F -> Y (in allele A*02:05, allele A*11:01, allele
FT                   A*25:01, allele A*26:01, allele A*34:01, allele A*43:01,
FT                   allele A*66:01, allele A*68:01 and allele A*69:01;
FT                   dbSNP:rs2075684)"
FT                   /evidence="ECO:0000269|PubMed:1431115,
FT                   ECO:0000269|PubMed:2320591, ECO:0000269|PubMed:2437024,
FT                   ECO:0000269|PubMed:2460344, ECO:0000269|PubMed:3496393,
FT                   ECO:0000269|PubMed:3877632, ECO:0000269|PubMed:8016845,
FT                   ECO:0000269|PubMed:8026990, ECO:0000269|PubMed:8475492"
FT                   /id="VAR_082322"
FT   VARIANT         41
FT                   /note="R -> S (in allele A*30:01; dbSNP:rs1059423)"
FT                   /evidence="ECO:0000269|PubMed:2478623,
FT                   ECO:0000269|PubMed:7871528"
FT                   /id="VAR_082323"
FT   VARIANT         55
FT                   /note="T -> S (in allele A*80:01)"
FT                   /evidence="ECO:0000269|PubMed:8188325,
FT                   ECO:0000269|PubMed:8284791"
FT                   /id="VAR_082324"
FT   VARIANT         59
FT                   /note="R -> Q (in allele A*80:01)"
FT                   /evidence="ECO:0000269|PubMed:8188325,
FT                   ECO:0000269|PubMed:8284791"
FT                   /id="VAR_082325"
FT   VARIANT         67
FT                   /note="Q -> R (in allele A*02:05; dbSNP:rs41559117)"
FT                   /evidence="ECO:0000269|PubMed:3496393"
FT                   /id="VAR_082326"
FT   VARIANT         68
FT                   /note="R -> K (in alleles A*01:01 and allele A*36:01)"
FT                   /evidence="ECO:0000269|PubMed:1431115,
FT                   ECO:0000269|PubMed:2251137, ECO:0000269|PubMed:2715640,
FT                   ECO:0000269|PubMed:9349617"
FT                   /id="VAR_082327"
FT   VARIANT         80
FT                   /note="G -> E (in allele A*80:01)"
FT                   /evidence="ECO:0000269|PubMed:8188325,
FT                   ECO:0000269|PubMed:8284791"
FT                   /id="VAR_082328"
FT   VARIANT         80
FT                   /note="G -> R (in allele A*30:01 and allele A*31:01;
FT                   dbSNP:rs1059449)"
FT                   /evidence="ECO:0000269|PubMed:1317015,
FT                   ECO:0000269|PubMed:2478623, ECO:0000269|PubMed:7871528,
FT                   ECO:0000269|PubMed:8795145"
FT                   /id="VAR_082329"
FT   VARIANT         86
FT                   /note="Q -> E (in allele A*23:01, allele 24:02 and allele
FT                   A*80:01)"
FT                   /evidence="ECO:0000269|PubMed:1729171,
FT                   ECO:0000269|PubMed:8188325, ECO:0000269|PubMed:8284791,
FT                   ECO:0000269|PubMed:9349616"
FT                   /id="VAR_082330"
FT   VARIANT         86
FT                   /note="Q -> G (in allele A*02:01 and allele A*02:05;
FT                   requires 2 nucleotide substitutions)"
FT                   /evidence="ECO:0000269|PubMed:2320591,
FT                   ECO:0000269|PubMed:2982951, ECO:0000269|PubMed:3496393,
FT                   ECO:0000269|PubMed:7836067"
FT                   /id="VAR_082331"
FT   VARIANT         86
FT                   /note="Q -> L (in alleles A*29:02 and allele A*43:01)"
FT                   /evidence="ECO:0000269|PubMed:1431115,
FT                   ECO:0000269|PubMed:1782566"
FT                   /id="VAR_082332"
FT   VARIANT         86
FT                   /note="Q -> R (in allele A*25:01, allele A*26:01, allele
FT                   A*33:01, allele A*34:01, allele A*66:01, allele A*68:01 and
FT                   allele A*69:01)"
FT                   /evidence="ECO:0000269|PubMed:1431115,
FT                   ECO:0000269|PubMed:2320591, ECO:0000269|PubMed:2478623,
FT                   ECO:0000269|PubMed:3877632, ECO:0000269|PubMed:8026990,
FT                   ECO:0000269|PubMed:8475492"
FT                   /id="VAR_082333"
FT   VARIANT         87
FT                   /note="E -> N (in alleles A*25:01, allele A*26:01, allele
FT                   A*33:01, allele A*34:01, allele A*66:01, allele A*68:01 and
FT                   allele A*69:01; requires 2 nucleotide substitutions)"
FT                   /evidence="ECO:0000269|PubMed:1431115,
FT                   ECO:0000269|PubMed:2320591, ECO:0000269|PubMed:2478623,
FT                   ECO:0000269|PubMed:3877632, ECO:0000269|PubMed:8026990,
FT                   ECO:0000269|PubMed:8475492"
FT                   /id="VAR_082334"
FT   VARIANT         87
FT                   /note="E -> Q (in allele A*29:02 and allele A*43:01)"
FT                   /evidence="ECO:0000269|PubMed:1431115,
FT                   ECO:0000269|PubMed:1782566"
FT                   /id="VAR_082335"
FT   VARIANT         89
FT                   /note="R -> G (in allele A*23:01 and allele 24:02;
FT                   dbSNP:rs199474430)"
FT                   /evidence="ECO:0000269|PubMed:1729171,
FT                   ECO:0000269|PubMed:9349616"
FT                   /id="VAR_082336"
FT   VARIANT         90
FT                   /note="N -> K (in allele A*02:01, allele A*02:05, allele
FT                   A*23:01, allele 24:02 and allele A*34:01;
FT                   dbSNP:rs199474436)"
FT                   /evidence="ECO:0000269|PubMed:1431115,
FT                   ECO:0000269|PubMed:1729171, ECO:0000269|PubMed:2320591,
FT                   ECO:0000269|PubMed:2982951, ECO:0000269|PubMed:3496393,
FT                   ECO:0000269|PubMed:7836067, ECO:0000269|PubMed:9349616"
FT                   /id="VAR_082337"
FT   VARIANT         91
FT                   /note="V -> M (in allele A*01:01 and allele A*36:01)"
FT                   /evidence="ECO:0000269|PubMed:1431115,
FT                   ECO:0000269|PubMed:2251137, ECO:0000269|PubMed:2715640,
FT                   ECO:0000269|PubMed:9349617"
FT                   /id="VAR_082338"
FT   VARIANT         94
FT                   /note="Q -> H (in allele A*01:01, allele A*02:01, allele
FT                   A*02:05, allele A*23:01, allele 24:02, allele A*25:01,
FT                   allele A*26:01, allele A*31:01, allele A*32:01, allele
FT                   A*33:01, allele A*36:01, allele A*43:01, allele A*74:01 and
FT                   allele A*80:01; dbSNP:rs78306866)"
FT                   /evidence="ECO:0000269|PubMed:1317015,
FT                   ECO:0000269|PubMed:1431115, ECO:0000269|PubMed:1729171,
FT                   ECO:0000269|PubMed:2251137, ECO:0000269|PubMed:2320591,
FT                   ECO:0000269|PubMed:2431040, ECO:0000269|PubMed:2478623,
FT                   ECO:0000269|PubMed:2715640, ECO:0000269|PubMed:2982951,
FT                   ECO:0000269|PubMed:3496393, ECO:0000269|PubMed:7836067,
FT                   ECO:0000269|PubMed:8026990, ECO:0000269|PubMed:8188325,
FT                   ECO:0000269|PubMed:8284791, ECO:0000269|PubMed:8475492,
FT                   ECO:0000269|PubMed:8795145, ECO:0000269|PubMed:9349616,
FT                   ECO:0000269|PubMed:9349617, ECO:0000269|Ref.29"
FT                   /id="VAR_082339"
FT   VARIANT         97
FT                   /note="T -> I (in allele A*31:01 and allele A*33:01;
FT                   dbSNP:rs199474457)"
FT                   /evidence="ECO:0000269|PubMed:1317015,
FT                   ECO:0000269|PubMed:2478623, ECO:0000269|PubMed:8795145"
FT                   /id="VAR_082340"
FT   VARIANT         98
FT                   /note="D -> H (in allele A*02:01 and allele A*02:05)"
FT                   /evidence="ECO:0000269|PubMed:2320591,
FT                   ECO:0000269|PubMed:2982951, ECO:0000269|PubMed:3496393,
FT                   ECO:0000269|PubMed:7836067"
FT                   /id="VAR_082341"
FT   VARIANT         98
FT                   /note="D -> N (in allele A*80:01)"
FT                   /evidence="ECO:0000269|PubMed:8188325,
FT                   ECO:0000269|PubMed:8284791"
FT                   /id="VAR_082342"
FT   VARIANT         100
FT                   /note="V -> A (in allele A*01:01, allele A*26:01, allele
FT                   A*29:02, allele A*36:01, allele A*43:01 and allele
FT                   A*80:01)"
FT                   /evidence="ECO:0000269|PubMed:1431115,
FT                   ECO:0000269|PubMed:1782566, ECO:0000269|PubMed:2251137,
FT                   ECO:0000269|PubMed:2715640, ECO:0000269|PubMed:8026990,
FT                   ECO:0000269|PubMed:8188325, ECO:0000269|PubMed:8284791,
FT                   ECO:0000269|PubMed:8475492, ECO:0000269|PubMed:9349617"
FT                   /id="VAR_082343"
FT   VARIANT         100
FT                   /note="V -> E (in allele A*23:01, allele A*24:02, allele
FT                   A*25:01 and allele A*32:01; dbSNP:rs1071742)"
FT                   /evidence="ECO:0000269|PubMed:1729171,
FT                   ECO:0000269|PubMed:2320591, ECO:0000269|PubMed:2431040,
FT                   ECO:0000269|PubMed:9349616, ECO:0000269|Ref.29"
FT                   /id="VAR_082344"
FT   VARIANT         101
FT                   /note="D -> N (allele A*01:01, allele A*23:01, allele
FT                   A*24:02, allele A*26:01, allele A*29:02, allele A*36:01,
FT                   allele A*43:01 and allele A*80:01; dbSNP:rs1136688)"
FT                   /evidence="ECO:0000269|PubMed:1431115,
FT                   ECO:0000269|PubMed:1729171, ECO:0000269|PubMed:1782566,
FT                   ECO:0000269|PubMed:2251137, ECO:0000269|PubMed:2715640,
FT                   ECO:0000269|PubMed:8026990, ECO:0000269|PubMed:8188325,
FT                   ECO:0000269|PubMed:8284791, ECO:0000269|PubMed:8475492,
FT                   ECO:0000269|PubMed:9349616, ECO:0000269|PubMed:9349617"
FT                   /id="VAR_082345"
FT   VARIANT         101
FT                   /note="D -> S (in allele A*25:01 and allele A*32:01;
FT                   requires 2 nucleotide substitutions)"
FT                   /evidence="ECO:0000269|PubMed:2320591,
FT                   ECO:0000269|PubMed:2431040, ECO:0000269|Ref.29"
FT                   /id="VAR_082346"
FT   VARIANT         103..107
FT                   /note="GTLRG -> RIALR (in allele A*23:01, allele A*24:02,
FT                   allele A*25:01 and allele A*32:01; Bw4 motif RIALR is
FT                   involved in the recognition of NK cell inhibitory receptor
FT                   KIR3DL1)"
FT                   /evidence="ECO:0000269|PubMed:17182537,
FT                   ECO:0000269|PubMed:1729171, ECO:0000269|PubMed:18502829,
FT                   ECO:0000269|PubMed:2320591, ECO:0000269|PubMed:2431040,
FT                   ECO:0000269|PubMed:9349616, ECO:0000269|Ref.29"
FT                   /id="VAR_082347"
FT   VARIANT         114
FT                   /note="A -> D (in allele A*01:01, allele A*11:01, allele
FT                   A*25:01, allele A*26:01, allele A*34:01, allele A*36:01,
FT                   allele A*43:01, allele A*66:01 and allele A*80:01;
FT                   dbSNP:rs1136692)"
FT                   /evidence="ECO:0000269|PubMed:1431115,
FT                   ECO:0000269|PubMed:2251137, ECO:0000269|PubMed:2320591,
FT                   ECO:0000269|PubMed:2437024, ECO:0000269|PubMed:2460344,
FT                   ECO:0000269|PubMed:2715640, ECO:0000269|PubMed:8016845,
FT                   ECO:0000269|PubMed:8026990, ECO:0000269|PubMed:8188325,
FT                   ECO:0000269|PubMed:8284791, ECO:0000269|PubMed:8475492,
FT                   ECO:0000269|PubMed:9349617"
FT                   /id="VAR_082348"
FT   VARIANT         119
FT                   /note="I -> L (in allele A*02:05, allele A*23:01 and allele
FT                   24:02; dbSNP:rs1071743)"
FT                   /evidence="ECO:0000269|PubMed:1729171,
FT                   ECO:0000269|PubMed:3496393, ECO:0000269|PubMed:9349616"
FT                   /id="VAR_082349"
FT   VARIANT         119
FT                   /note="I -> V (in allele A*02:01 and allele A*69:01)"
FT                   /evidence="ECO:0000269|PubMed:2320591,
FT                   ECO:0000269|PubMed:2982951, ECO:0000269|PubMed:3877632,
FT                   ECO:0000269|PubMed:7836067"
FT                   /id="VAR_082350"
FT   VARIANT         121
FT                   /note="I -> M (in allele A*23:01, allele 24:02, allele
FT                   A*29:02, allele A*31:01, allele A*32:01, allele A*33:01,
FT                   allele A*68:01 and allele A*74:01; dbSNP:rs1136695)"
FT                   /evidence="ECO:0000269|PubMed:1317015,
FT                   ECO:0000269|PubMed:1431115, ECO:0000269|PubMed:1729171,
FT                   ECO:0000269|PubMed:1782566, ECO:0000269|PubMed:2431040,
FT                   ECO:0000269|PubMed:2478623, ECO:0000269|PubMed:3877632,
FT                   ECO:0000269|PubMed:8795145, ECO:0000269|PubMed:9349616,
FT                   ECO:0000269|Ref.29"
FT                   /id="VAR_082351"
FT   VARIANT         121
FT                   /note="I -> R (in allele A*02:01, allele A*02:05, allele
FT                   A*25:01, allele A*26:01, allele A*34:01, allele A*43:01,
FT                   allele A*66:01 and allele A*69:01)"
FT                   /evidence="ECO:0000269|PubMed:1431115,
FT                   ECO:0000269|PubMed:2320591, ECO:0000269|PubMed:2982951,
FT                   ECO:0000269|PubMed:3496393, ECO:0000269|PubMed:3877632,
FT                   ECO:0000269|PubMed:7836067, ECO:0000269|PubMed:8026990,
FT                   ECO:0000269|PubMed:8475492"
FT                   /id="VAR_082352"
FT   VARIANT         123
FT                   /note="Y -> F (in allele A*23:01, allele 24:02;
FT                   dbSNP:rs1136697)"
FT                   /evidence="ECO:0000269|PubMed:1729171,
FT                   ECO:0000269|PubMed:9349616"
FT                   /id="VAR_082353"
FT   VARIANT         129
FT                   /note="S -> P (in allele A*01:01, allele A*11:01, allele
FT                   A*25:01, allele A*26:01, allele A*32:01, allele A*34:01,
FT                   allele A*36:01, allele A*43:01, allele A*66:01 and allele
FT                   A*74:01; dbSNP:rs1136700)"
FT                   /evidence="ECO:0000269|PubMed:1431115,
FT                   ECO:0000269|PubMed:2251137, ECO:0000269|PubMed:2320591,
FT                   ECO:0000269|PubMed:2431040, ECO:0000269|PubMed:2437024,
FT                   ECO:0000269|PubMed:2460344, ECO:0000269|PubMed:2715640,
FT                   ECO:0000269|PubMed:8016845, ECO:0000269|PubMed:8026990,
FT                   ECO:0000269|PubMed:8475492, ECO:0000269|PubMed:9349617,
FT                   ECO:0000269|Ref.29"
FT                   /id="VAR_082354"
FT   VARIANT         131
FT                   /note="G -> W (in allele A*02:01, allele A*02:05 and allele
FT                   A*69:01; dbSNP:rs1136702)"
FT                   /evidence="ECO:0000269|PubMed:2320591,
FT                   ECO:0000269|PubMed:2982951, ECO:0000269|PubMed:3496393,
FT                   ECO:0000269|PubMed:3877632, ECO:0000269|PubMed:7836067"
FT                   /id="VAR_082355"
FT   VARIANT         133
FT                   /note="F -> L (in allele A*32:01 and allele A*74:01;
FT                   dbSNP:rs1059488)"
FT                   /evidence="ECO:0000269|PubMed:1431115,
FT                   ECO:0000269|PubMed:2431040, ECO:0000269|Ref.29"
FT                   /id="VAR_082356"
FT   VARIANT         138
FT                   /note="R -> E (in allele A*30:01; requires 2 nucleotide
FT                   substitutions)"
FT                   /evidence="ECO:0000269|PubMed:2478623,
FT                   ECO:0000269|PubMed:7871528"
FT                   /id="VAR_082357"
FT   VARIANT         138
FT                   /note="R -> H (in allele A*02:01, allele A*02:05, allele
FT                   A*23:01, allele A*24:02, allele A*69:01)"
FT                   /evidence="ECO:0000269|PubMed:1729171,
FT                   ECO:0000269|PubMed:2320591, ECO:0000269|PubMed:2982951,
FT                   ECO:0000269|PubMed:3496393, ECO:0000269|PubMed:3877632,
FT                   ECO:0000269|PubMed:7836067, ECO:0000269|PubMed:9349616"
FT                   /id="VAR_082358"
FT   VARIANT         138
FT                   /note="R -> Q (in allele A*25:01, allele A*26:01, allele
FT                   A*31:01, allele A*32:01, allele A*33:01, allele A*34:01,
FT                   allele A*43:01, allele A*66:01, allele A*74:01)"
FT                   /evidence="ECO:0000269|PubMed:1317015,
FT                   ECO:0000269|PubMed:1431115, ECO:0000269|PubMed:2320591,
FT                   ECO:0000269|PubMed:2431040, ECO:0000269|PubMed:2478623,
FT                   ECO:0000269|PubMed:8026990, ECO:0000269|PubMed:8475492,
FT                   ECO:0000269|PubMed:8795145, ECO:0000269|Ref.29"
FT                   /id="VAR_082359"
FT   VARIANT         140
FT                   /note="D -> H (in allele A*30:01)"
FT                   /evidence="ECO:0000269|PubMed:2478623,
FT                   ECO:0000269|PubMed:7871528"
FT                   /id="VAR_082360"
FT   VARIANT         140
FT                   /note="D -> Y (in allele A*02:01, allele A*02:05, allele
FT                   A*23:01, allele A*24:02 and allele A*69:01)"
FT                   /evidence="ECO:0000269|PubMed:1729171,
FT                   ECO:0000269|PubMed:2320591, ECO:0000269|PubMed:2982951,
FT                   ECO:0000269|PubMed:3496393, ECO:0000269|PubMed:3877632,
FT                   ECO:0000269|PubMed:7836067, ECO:0000269|PubMed:9349616"
FT                   /id="VAR_082361"
FT   VARIANT         151
FT                   /note="N -> K (in allele A*02:01, allele A*02:05, allele
FT                   A*23:01, allele A*24:02, allele A*68:01 and allele A*69:01;
FT                   dbSNP:rs1059509)"
FT                   /evidence="ECO:0000269|PubMed:1729171,
FT                   ECO:0000269|PubMed:2320591, ECO:0000269|PubMed:2982951,
FT                   ECO:0000269|PubMed:3496393, ECO:0000269|PubMed:3877632,
FT                   ECO:0000269|PubMed:7836067, ECO:0000269|PubMed:9349616"
FT                   /id="VAR_082362"
FT   VARIANT         166
FT                   /note="I -> T (in allele A*02:01, allele A*02:05, allele
FT                   A*68:01 and allele A*69:01; dbSNP:rs1059516)"
FT                   /evidence="ECO:0000269|PubMed:2320591,
FT                   ECO:0000269|PubMed:2982951, ECO:0000269|PubMed:3496393,
FT                   ECO:0000269|PubMed:3877632, ECO:0000269|PubMed:7836067"
FT                   /id="VAR_082363"
FT   VARIANT         168
FT                   /note="K -> Q (in allele A*23:01, allele A*25:01, allele
FT                   A*26:01, allele A*29:02, allele A*30:01, allele A*31:01,
FT                   allele A*32:01, allele A*33:01, allele A*34:01, allele
FT                   A*43:01, allele A*66:01 and allele A*74:01)"
FT                   /evidence="ECO:0000269|PubMed:1317015,
FT                   ECO:0000269|PubMed:1431115, ECO:0000269|PubMed:1729171,
FT                   ECO:0000269|PubMed:1782566, ECO:0000269|PubMed:2320591,
FT                   ECO:0000269|PubMed:2431040, ECO:0000269|PubMed:2478623,
FT                   ECO:0000269|PubMed:7871528, ECO:0000269|PubMed:8026990,
FT                   ECO:0000269|PubMed:8475492, ECO:0000269|PubMed:8795145,
FT                   ECO:0000269|Ref.29"
FT                   /id="VAR_082364"
FT   VARIANT         169
FT                   /note="R -> H (in allele A*02:01, allele A*02:05, allele
FT                   A*68:01 and allele A*69:01; dbSNP:rs1059520)"
FT                   /evidence="ECO:0000269|PubMed:2320591,
FT                   ECO:0000269|PubMed:2982951, ECO:0000269|PubMed:3496393,
FT                   ECO:0000269|PubMed:3877632, ECO:0000269|PubMed:7836067"
FT                   /id="VAR_082365"
FT   VARIANT         173
FT                   /note="A -> T (in allele A*25:01, allele A*26:01, allele
FT                   A*34:01, allele A*43:01 and allele A*66:01;
FT                   dbSNP:rs1059526)"
FT                   /evidence="ECO:0000269|PubMed:1431115,
FT                   ECO:0000269|PubMed:2320591, ECO:0000269|PubMed:8026990,
FT                   ECO:0000269|PubMed:8475492"
FT                   /id="VAR_082366"
FT   VARIANT         174
FT                   /note="A -> V (in allele A*01:01 and allele A*36:01)"
FT                   /evidence="ECO:0000269|PubMed:1431115,
FT                   ECO:0000269|PubMed:2251137, ECO:0000269|PubMed:2715640,
FT                   ECO:0000269|PubMed:9349617"
FT                   /id="VAR_082367"
FT   VARIANT         175
FT                   /note="H -> R (in allele A*23:01, allele A*29:02, allele
FT                   A*30:01, allele A*31:01, allele A*32:01, allele A*33:01,
FT                   allele A*74:01 and allele A*80:01)"
FT                   /evidence="ECO:0000269|PubMed:1317015,
FT                   ECO:0000269|PubMed:1431115, ECO:0000269|PubMed:1729171,
FT                   ECO:0000269|PubMed:1782566, ECO:0000269|PubMed:2431040,
FT                   ECO:0000269|PubMed:2478623, ECO:0000269|PubMed:7871528,
FT                   ECO:0000269|PubMed:8188325, ECO:0000269|PubMed:8284791,
FT                   ECO:0000269|PubMed:8795145, ECO:0000269|Ref.29"
FT                   /id="VAR_082368"
FT   VARIANT         176
FT                   /note="E -> A (in allele A*01:01, allele A*11:01 and allele
FT                   A*36:01)"
FT                   /evidence="ECO:0000269|PubMed:1431115,
FT                   ECO:0000269|PubMed:2251137, ECO:0000269|PubMed:2437024,
FT                   ECO:0000269|PubMed:2460344, ECO:0000269|PubMed:2715640,
FT                   ECO:0000269|PubMed:8016845, ECO:0000269|PubMed:9349617"
FT                   /id="VAR_082369"
FT   VARIANT         176
FT                   /note="E -> R (in allele A*80:01; requires 2 nucleotide
FT                   substitutions)"
FT                   /evidence="ECO:0000269|PubMed:8188325,
FT                   ECO:0000269|PubMed:8284791"
FT                   /id="VAR_082370"
FT   VARIANT         176
FT                   /note="E -> V (in allele A*02:01, allele A*02:05, allele
FT                   A*23:01, allele A*24:02, allele A*29:02, allele A*31:01,
FT                   allele A*32:01, allele A*33:01, allele A*68:01, allele
FT                   A*69:01 and allele A*74:01; results in inefficient T cell
FT                   recognition of epitopes derived from influenza A virus.;
FT                   dbSNP:rs9256983)"
FT                   /evidence="ECO:0000269|PubMed:1317015,
FT                   ECO:0000269|PubMed:1431115, ECO:0000269|PubMed:1729171,
FT                   ECO:0000269|PubMed:1782566, ECO:0000269|PubMed:2320591,
FT                   ECO:0000269|PubMed:2431040, ECO:0000269|PubMed:2456340,
FT                   ECO:0000269|PubMed:2478623, ECO:0000269|PubMed:2982951,
FT                   ECO:0000269|PubMed:3496393, ECO:0000269|PubMed:3877632,
FT                   ECO:0000269|PubMed:7836067, ECO:0000269|PubMed:8795145,
FT                   ECO:0000269|PubMed:9349616, ECO:0000269|Ref.29"
FT                   /id="VAR_082371"
FT   VARIANT         176
FT                   /note="E -> W (in allele A*30:01; requires 2 nucleotide
FT                   substitutions)"
FT                   /evidence="ECO:0000269|PubMed:2478623,
FT                   ECO:0000269|PubMed:7871528"
FT                   /id="VAR_082372"
FT   VARIANT         180
FT                   /note="L -> Q (in allele A*11:01 and allele A*24:02)"
FT                   /evidence="ECO:0000269|PubMed:1729171,
FT                   ECO:0000269|PubMed:2437024, ECO:0000269|PubMed:2460344,
FT                   ECO:0000269|PubMed:8016845, ECO:0000269|PubMed:9349616"
FT                   /id="VAR_082373"
FT   VARIANT         180
FT                   /note="L -> R (in allele A*01:01 and allele A*36:01)"
FT                   /evidence="ECO:0000269|PubMed:1431115,
FT                   ECO:0000269|PubMed:2251137, ECO:0000269|PubMed:2715640,
FT                   ECO:0000269|PubMed:9349617"
FT                   /id="VAR_082374"
FT   VARIANT         180
FT                   /note="L -> W (in allele A*02:05, allele A*25:01, allele
FT                   A*26:01, allele A*34:01, allele A*43:01, allele A*66:01,
FT                   allele A*68:01; dbSNP:rs9260156)"
FT                   /evidence="ECO:0000269|PubMed:1431115,
FT                   ECO:0000269|PubMed:2320591, ECO:0000269|PubMed:3496393,
FT                   ECO:0000269|PubMed:3877632, ECO:0000269|PubMed:8026990,
FT                   ECO:0000269|PubMed:8475492"
FT                   /id="VAR_082375"
FT   VARIANT         182
FT                   /note="A -> V (in allele A*01:01 and allele A*36:01)"
FT                   /evidence="ECO:0000269|PubMed:1431115,
FT                   ECO:0000269|PubMed:2251137, ECO:0000269|PubMed:2715640,
FT                   ECO:0000269|PubMed:9349617"
FT                   /id="VAR_082376"
FT   VARIANT         185
FT                   /note="D -> E (in allele A*01:01, allele A*02:01, allele
FT                   A*02:05, allele A*11:01, allele A*23:01, allele A*24:02,
FT                   allele A*25:01, allele A*26:01, allele A*29:02, allele
FT                   A*30:01, allele A*31:01, allele A*32:01, allele A*33:01,
FT                   allele A*34:01, allele A*36:01, allele A*43:01, allele
FT                   A*66:01, allele A*68:01, allele A*69:01, allele A*74:01 and
FT                   allele A*80:01; dbSNP:rs1059542)"
FT                   /evidence="ECO:0000269|PubMed:1317015,
FT                   ECO:0000269|PubMed:1431115, ECO:0000269|PubMed:1729171,
FT                   ECO:0000269|PubMed:1782566, ECO:0000269|PubMed:2251137,
FT                   ECO:0000269|PubMed:2320591, ECO:0000269|PubMed:2431040,
FT                   ECO:0000269|PubMed:2437024, ECO:0000269|PubMed:2460344,
FT                   ECO:0000269|PubMed:2478623, ECO:0000269|PubMed:2715640,
FT                   ECO:0000269|PubMed:2982951, ECO:0000269|PubMed:3496393,
FT                   ECO:0000269|PubMed:3877632, ECO:0000269|PubMed:7836067,
FT                   ECO:0000269|PubMed:7871528, ECO:0000269|PubMed:8016845,
FT                   ECO:0000269|PubMed:8026990, ECO:0000269|PubMed:8188325,
FT                   ECO:0000269|PubMed:8284791, ECO:0000269|PubMed:8475492,
FT                   ECO:0000269|PubMed:8795145, ECO:0000269|PubMed:9349616,
FT                   ECO:0000269|PubMed:9349617, ECO:0000269|Ref.29"
FT                   /id="VAR_082377"
FT   VARIANT         187
FT                   /note="T -> E (in allele A*80:01; requires 2 nucleotide
FT                   substitutions)"
FT                   /evidence="ECO:0000269|PubMed:8188325,
FT                   ECO:0000269|PubMed:8284791"
FT                   /id="VAR_082378"
FT   VARIANT         187
FT                   /note="T -> R (in allele A*01:01, allele A*11:01, allele
FT                   A*25:01, allele A*26:01, allele A*43:01 and allele
FT                   A*66:01)"
FT                   /evidence="ECO:0000269|PubMed:1431115,
FT                   ECO:0000269|PubMed:2251137, ECO:0000269|PubMed:2320591,
FT                   ECO:0000269|PubMed:2437024, ECO:0000269|PubMed:2460344,
FT                   ECO:0000269|PubMed:2715640, ECO:0000269|PubMed:8016845,
FT                   ECO:0000269|PubMed:8026990, ECO:0000269|PubMed:8475492,
FT                   ECO:0000269|PubMed:9349617"
FT                   /id="VAR_082379"
FT   VARIANT         190
FT                   /note="E -> D (in allele A*01:01, allele A*23:01, allele
FT                   A*24:02 and allele A*80:01; dbSNP:rs879577815)"
FT                   /evidence="ECO:0000269|PubMed:1729171,
FT                   ECO:0000269|PubMed:2251137, ECO:0000269|PubMed:2715640,
FT                   ECO:0000269|PubMed:8188325, ECO:0000269|PubMed:8284791,
FT                   ECO:0000269|PubMed:9349616, ECO:0000269|PubMed:9349617"
FT                   /id="VAR_082380"
FT   VARIANT         191
FT                   /note="W -> G (in allele A*01:01, allele A*23:01, allele
FT                   A*24:02 and allele A*80:01; dbSNP:rs3098019)"
FT                   /evidence="ECO:0000269|PubMed:1729171,
FT                   ECO:0000269|PubMed:2251137, ECO:0000269|PubMed:2715640,
FT                   ECO:0000269|PubMed:8188325, ECO:0000269|PubMed:8284791,
FT                   ECO:0000269|PubMed:9349616, ECO:0000269|PubMed:9349617"
FT                   /id="VAR_082381"
FT   VARIANT         195
FT                   /note="Y -> H (in allele A*33:01)"
FT                   /evidence="ECO:0000269|PubMed:2478623"
FT                   /id="VAR_082382"
FT   VARIANT         208
FT                   /note="P -> A (in allele A*02:01, allele A*02:05, allele
FT                   A*25:01, allele A*26:01, allele A*29:02, allele A*32:01,
FT                   allele A*34:01, allele A*43:01, allele A*66:01, allele
FT                   A*68:01, allele A*69:01 and allele A*74:01)"
FT                   /evidence="ECO:0000269|PubMed:1431115,
FT                   ECO:0000269|PubMed:1782566, ECO:0000269|PubMed:2320591,
FT                   ECO:0000269|PubMed:2431040, ECO:0000269|PubMed:2982951,
FT                   ECO:0000269|PubMed:3496393, ECO:0000269|PubMed:3877632,
FT                   ECO:0000269|PubMed:7836067, ECO:0000269|PubMed:8026990,
FT                   ECO:0000269|PubMed:8475492, ECO:0000269|Ref.29"
FT                   /id="VAR_082383"
FT   VARIANT         210
FT                   /note="K -> R (in allele A*33:01)"
FT                   /evidence="ECO:0000269|PubMed:2478623"
FT                   /id="VAR_082384"
FT   VARIANT         217
FT                   /note="P -> A (in allele A*02:01, allele A*02:05, allele
FT                   A*25:01, allele A*26:01, allele A*29:02, allele A*31:01,
FT                   allele A*32:01, allele A*33:01, allele A*34:01, allele
FT                   A*43:01, allele A*66:01, allele A*68:01, allele A*69:01,
FT                   allele A*74:01)"
FT                   /evidence="ECO:0000269|PubMed:1317015,
FT                   ECO:0000269|PubMed:1431115, ECO:0000269|PubMed:1782566,
FT                   ECO:0000269|PubMed:2320591, ECO:0000269|PubMed:2431040,
FT                   ECO:0000269|PubMed:2478623, ECO:0000269|PubMed:2982951,
FT                   ECO:0000269|PubMed:3496393, ECO:0000269|PubMed:3877632,
FT                   ECO:0000269|PubMed:7836067, ECO:0000269|PubMed:8026990,
FT                   ECO:0000269|PubMed:8475492, ECO:0000269|PubMed:8795145,
FT                   ECO:0000269|Ref.29"
FT                   /id="VAR_082385"
FT   VARIANT         218
FT                   /note="I -> V (in allele A*02:01, allele A*02:05, allele
FT                   A*25:01, allele A*26:01, allele A*29:02, allele A*31:01,
FT                   allele A*32:01, allele A*33:01, allele A*34:01, allele
FT                   A*43:01, allele A*66:01, allele A*68:01, allele A*69:01 and
FT                   allele A*74:01)"
FT                   /evidence="ECO:0000269|PubMed:1317015,
FT                   ECO:0000269|PubMed:1431115, ECO:0000269|PubMed:1782566,
FT                   ECO:0000269|PubMed:2320591, ECO:0000269|PubMed:2431040,
FT                   ECO:0000269|PubMed:2478623, ECO:0000269|PubMed:2982951,
FT                   ECO:0000269|PubMed:3496393, ECO:0000269|PubMed:3877632,
FT                   ECO:0000269|PubMed:7836067, ECO:0000269|PubMed:8026990,
FT                   ECO:0000269|PubMed:8475492, ECO:0000269|PubMed:8795145,
FT                   ECO:0000269|Ref.29"
FT                   /id="VAR_082386"
FT   VARIANT         231
FT                   /note="G -> S (in allele A*02:01, allele A*02:05, allele
FT                   A*25:01, allele A*26:01, allele A*29:02, allele A*31:01,
FT                   allele A*32:01, allele A*33:01, allele A*34:01, allele
FT                   A*43:01, allele A*66:01, allele A*68:01, allele A*69:01,
FT                   allele A*74:01 and allele A*80:01)"
FT                   /evidence="ECO:0000269|PubMed:1317015,
FT                   ECO:0000269|PubMed:1431115, ECO:0000269|PubMed:1782566,
FT                   ECO:0000269|PubMed:2320591, ECO:0000269|PubMed:2431040,
FT                   ECO:0000269|PubMed:2478623, ECO:0000269|PubMed:2982951,
FT                   ECO:0000269|PubMed:3496393, ECO:0000269|PubMed:3877632,
FT                   ECO:0000269|PubMed:7836067, ECO:0000269|PubMed:8026990,
FT                   ECO:0000269|PubMed:8188325, ECO:0000269|PubMed:8284791,
FT                   ECO:0000269|PubMed:8475492, ECO:0000269|PubMed:8795145,
FT                   ECO:0000269|Ref.29"
FT                   /id="VAR_082387"
FT   VARIANT         269
FT                   /note="A -> V (in allele A*68:01; impairs binding to CD8A
FT                   and reduces recognition by antigen-specific CD8-positive T
FT                   cells)"
FT                   /evidence="ECO:0000269|PubMed:2784196,
FT                   ECO:0000269|PubMed:3877632"
FT                   /id="VAR_082388"
FT   VARIANT         270
FT                   /note="A -> S (in allele A*25:01, allele A*26:01, allele
FT                   A*29:02, allele A*31:01, allele A*32:01, allele A*33:01,
FT                   allele A*34:01, allele A*43:01, allele A*66:01 and allele
FT                   A*74:01)"
FT                   /evidence="ECO:0000269|PubMed:1431115,
FT                   ECO:0000269|PubMed:1782566, ECO:0000269|PubMed:2320591,
FT                   ECO:0000269|PubMed:2431040, ECO:0000269|PubMed:2478623,
FT                   ECO:0000269|PubMed:8026990, ECO:0000269|PubMed:8475492,
FT                   ECO:0000269|Ref.29"
FT                   /id="VAR_082389"
FT   VARIANT         277
FT                   /note="E -> K (in allele A*80:01)"
FT                   /evidence="ECO:0000269|PubMed:8188325,
FT                   ECO:0000269|PubMed:8284791"
FT                   /id="VAR_082390"
FT   VARIANT         277
FT                   /note="E -> Q (in allele A*02:01, allele A*02:05, allele
FT                   A*25:01, allele A*26:01, allele A*29:02, allele A*31:01,
FT                   allele A*32:01, allele A*33:01, allele A*34:01, allele
FT                   A*43:01, allele A*66:01, allele A*68:01, allele A*69:01 and
FT                   allele A*74:01)"
FT                   /evidence="ECO:0000269|PubMed:1317015,
FT                   ECO:0000269|PubMed:1431115, ECO:0000269|PubMed:1782566,
FT                   ECO:0000269|PubMed:2320591, ECO:0000269|PubMed:2431040,
FT                   ECO:0000269|PubMed:2478623, ECO:0000269|PubMed:2982951,
FT                   ECO:0000269|PubMed:3496393, ECO:0000269|PubMed:3877632,
FT                   ECO:0000269|PubMed:7836067, ECO:0000269|PubMed:8026990,
FT                   ECO:0000269|PubMed:8475492, ECO:0000269|PubMed:8795145,
FT                   ECO:0000269|Ref.29"
FT                   /id="VAR_082391"
FT   VARIANT         279
FT                   /note="Q -> K (in allele A*80:01)"
FT                   /evidence="ECO:0000269|PubMed:8188325,
FT                   ECO:0000269|PubMed:8284791"
FT                   /id="VAR_082392"
FT   VARIANT         292
FT                   /note="K -> E (in allele A*80:01)"
FT                   /evidence="ECO:0000269|PubMed:8188325,
FT                   ECO:0000269|PubMed:8284791"
FT                   /id="VAR_082393"
FT   VARIANT         300
FT                   /note="L -> P (in allele A*02:01, allele A*02:05, allele
FT                   A*23:01, allele A*24:02, allele A*25:01, allele A*26:01,
FT                   allele A*29:02, allele A*31:01, allele A*32:01, allele
FT                   A*33:01, allele A*34:01, allele A*43:01, allele A*66:01,
FT                   allele A*68:01, allele A*69:01, allele A*74:01 and allele
FT                   A*80:01)"
FT                   /evidence="ECO:0000269|PubMed:1317015,
FT                   ECO:0000269|PubMed:1431115, ECO:0000269|PubMed:1729171,
FT                   ECO:0000269|PubMed:1782566, ECO:0000269|PubMed:2320591,
FT                   ECO:0000269|PubMed:2431040, ECO:0000269|PubMed:2478623,
FT                   ECO:0000269|PubMed:2982951, ECO:0000269|PubMed:3496393,
FT                   ECO:0000269|PubMed:3877632, ECO:0000269|PubMed:7836067,
FT                   ECO:0000269|PubMed:8026990, ECO:0000269|PubMed:8188325,
FT                   ECO:0000269|PubMed:8284791, ECO:0000269|PubMed:8475492,
FT                   ECO:0000269|PubMed:8795145, ECO:0000269|PubMed:9349616,
FT                   ECO:0000269|Ref.29"
FT                   /id="VAR_082394"
FT   VARIANT         306
FT                   /note="I -> V (in allele A*23:01 and allele A*24:02)"
FT                   /evidence="ECO:0000269|PubMed:1729171,
FT                   ECO:0000269|PubMed:9349616"
FT                   /id="VAR_082395"
FT   VARIANT         307
FT                   /note="P -> H (in allele A*23:01)"
FT                   /evidence="ECO:0000269|PubMed:1729171"
FT                   /id="VAR_082396"
FT   VARIANT         312
FT                   /note="I -> L (in allele A*34:01)"
FT                   /evidence="ECO:0000269|PubMed:1431115"
FT                   /id="VAR_082397"
FT   VARIANT         318
FT                   /note="L -> F (in allele A*02:01, allele A*02:05, allele
FT                   A*25:01, allele A*26:01, allele A*29:02, allele A*31:01,
FT                   allele A*32:01, allele A*33:01, allele A*34:01, allele
FT                   A*43:01, allele A*66:01, allele A*68:01, allele A*69:01 and
FT                   allele A*74:01)"
FT                   /evidence="ECO:0000269|PubMed:1317015,
FT                   ECO:0000269|PubMed:1431115, ECO:0000269|PubMed:1782566,
FT                   ECO:0000269|PubMed:2320591, ECO:0000269|PubMed:2431040,
FT                   ECO:0000269|PubMed:2478623, ECO:0000269|PubMed:2982951,
FT                   ECO:0000269|PubMed:3496393, ECO:0000269|PubMed:3877632,
FT                   ECO:0000269|PubMed:7836067, ECO:0000269|PubMed:8026990,
FT                   ECO:0000269|PubMed:8475492, ECO:0000269|PubMed:8795145,
FT                   ECO:0000269|Ref.29"
FT                   /id="VAR_082398"
FT   VARIANT         321
FT                   /note="V -> M (in allele A*32:01 and allele A*74:01)"
FT                   /evidence="ECO:0000269|PubMed:1431115,
FT                   ECO:0000269|PubMed:2431040, ECO:0000269|Ref.29"
FT                   /id="VAR_082399"
FT   VARIANT         322
FT                   /note="I -> F (in allele A*29:02, allele A*31:01, allele
FT                   A*32:01, allele A*33:01 and allele A*74:01)"
FT                   /evidence="ECO:0000269|PubMed:1317015,
FT                   ECO:0000269|PubMed:1431115, ECO:0000269|PubMed:1782566,
FT                   ECO:0000269|PubMed:2431040, ECO:0000269|PubMed:2478623,
FT                   ECO:0000269|PubMed:8795145, ECO:0000269|Ref.29"
FT                   /id="VAR_082400"
FT   VARIANT         323
FT                   /note="T -> A (in allele A*25:01, allele A*26:01, allele
FT                   A*29:02, allele A*31:01, allele A*32:01, allele A*33:01,
FT                   allele A*34:01, allele A*43:01, allele A*66:01, allele
FT                   A*74:01 and allele A*80:01)"
FT                   /evidence="ECO:0000269|PubMed:1317015,
FT                   ECO:0000269|PubMed:1431115, ECO:0000269|PubMed:1782566,
FT                   ECO:0000269|PubMed:2320591, ECO:0000269|PubMed:2431040,
FT                   ECO:0000269|PubMed:2478623, ECO:0000269|PubMed:8026990,
FT                   ECO:0000269|PubMed:8188325, ECO:0000269|PubMed:8284791,
FT                   ECO:0000269|PubMed:8475492, ECO:0000269|PubMed:8795145,
FT                   ECO:0000269|Ref.29"
FT                   /id="VAR_082401"
FT   VARIANT         331
FT                   /note="M -> R (in allele A*29:02, allele A*31:01, allele
FT                   A*32:01, allele A*33:01 and allele A*74:01)"
FT                   /evidence="ECO:0000269|PubMed:1317015,
FT                   ECO:0000269|PubMed:1431115, ECO:0000269|PubMed:1782566,
FT                   ECO:0000269|PubMed:2431040, ECO:0000269|PubMed:2478623,
FT                   ECO:0000269|PubMed:8795145, ECO:0000269|Ref.29"
FT                   /id="VAR_082402"
FT   VARIANT         334
FT                   /note="R -> K (allele A*80:01)"
FT                   /evidence="ECO:0000269|PubMed:8188325,
FT                   ECO:0000269|PubMed:8284791"
FT                   /id="VAR_082403"
FT   VARIANT         335
FT                   /note="K -> N (in allele A*23:01 and allele A*24:02)"
FT                   /evidence="ECO:0000269|PubMed:1729171,
FT                   ECO:0000269|PubMed:9349616"
FT                   /id="VAR_082404"
FT   VARIANT         338
FT                   /note="D -> V (allele A*80:01)"
FT                   /evidence="ECO:0000269|PubMed:8188325,
FT                   ECO:0000269|PubMed:8284791"
FT                   /id="VAR_082405"
FT   VARIANT         345
FT                   /note="T -> S (in allele A*02:01, allele A*02:05, allele
FT                   A*23:01, allele A*24:02, allele A*25:01, allele A*26:01,
FT                   allele A*29:02, allele A*31:01, allele A*32:01, allele
FT                   A*33:01, allele A*34:01, allele A*43:01, allele A*66:01,
FT                   allele A*68:01 allele A*69:01, allele A*74:01 and allele
FT                   A*80:01)"
FT                   /evidence="ECO:0000269|PubMed:1317015,
FT                   ECO:0000269|PubMed:1431115, ECO:0000269|PubMed:1729171,
FT                   ECO:0000269|PubMed:1782566, ECO:0000269|PubMed:2320591,
FT                   ECO:0000269|PubMed:2431040, ECO:0000269|PubMed:2478623,
FT                   ECO:0000269|PubMed:2982951, ECO:0000269|PubMed:3496393,
FT                   ECO:0000269|PubMed:3877632, ECO:0000269|PubMed:7836067,
FT                   ECO:0000269|PubMed:8026990, ECO:0000269|PubMed:8188325,
FT                   ECO:0000269|PubMed:8284791, ECO:0000269|PubMed:8475492,
FT                   ECO:0000269|PubMed:8795145, ECO:0000269|PubMed:9349616,
FT                   ECO:0000269|Ref.29"
FT                   /id="VAR_082406"
FT   VARIANT         358
FT                   /note="V -> M (in allele A*25:01, allele A*26:01, allele
FT                   A*29:02, allele A*31:01, allele A*32:01, allele A*33:01,
FT                   allele A*34:01, allele A*43:01, allele A*66:01 and allele
FT                   A*74:01)"
FT                   /evidence="ECO:0000269|PubMed:1317015,
FT                   ECO:0000269|PubMed:1431115, ECO:0000269|PubMed:1782566,
FT                   ECO:0000269|PubMed:2320591, ECO:0000269|PubMed:2431040,
FT                   ECO:0000269|PubMed:2478623, ECO:0000269|PubMed:8026990,
FT                   ECO:0000269|PubMed:8475492, ECO:0000269|PubMed:8795145,
FT                   ECO:0000269|Ref.29"
FT                   /id="VAR_082407"
FT   MUTAGEN         110
FT                   /note="N->Q: Impairs the recruitment of HLA-A*02 in the
FT                   peptide-loading complex."
FT                   /evidence="ECO:0000269|PubMed:21263072"
FT   MUTAGEN         156
FT                   /note="S->C: Impairs the maturation of a peptide-receptive
FT                   HLA-A*02-B2M complex."
FT                   /evidence="ECO:0000269|PubMed:8805302"
FT   MUTAGEN         158
FT                   /note="T->K: Impairs binding to TAP1-TAP2 transporter,
FT                   resulting in impaired presentation of intracellular
FT                   peptides."
FT                   /evidence="ECO:0000269|PubMed:8630735,
FT                   ECO:0000269|PubMed:8805302"
FT   STRAND          27..36
FT                   /evidence="ECO:0000244|PDB:3D25"
FT   STRAND          41..43
FT                   /evidence="ECO:0000244|PDB:5C0G"
FT   STRAND          45..52
FT                   /evidence="ECO:0000244|PDB:3D25"
FT   STRAND          55..61
FT                   /evidence="ECO:0000244|PDB:3D25"
FT   STRAND          64..66
FT                   /evidence="ECO:0000244|PDB:3D25"
FT   STRAND          70..73
FT                   /evidence="ECO:0000244|PDB:4F7T"
FT   HELIX           74..78
FT                   /evidence="ECO:0000244|PDB:3D25"
FT   HELIX           81..108
FT                   /evidence="ECO:0000244|PDB:3D25"
FT   STRAND          113..115
FT                   /evidence="ECO:0000244|PDB:3D25"
FT   STRAND          118..127
FT                   /evidence="ECO:0000244|PDB:3D25"
FT   STRAND          129..131
FT                   /evidence="ECO:0000244|PDB:1B0R"
FT   STRAND          133..142
FT                   /evidence="ECO:0000244|PDB:3D25"
FT   STRAND          145..150
FT                   /evidence="ECO:0000244|PDB:3D25"
FT   STRAND          152..155
FT                   /evidence="ECO:0000244|PDB:6EWA"
FT   STRAND          157..159
FT                   /evidence="ECO:0000244|PDB:3D25"
FT   HELIX           162..173
FT                   /evidence="ECO:0000244|PDB:3D25"
FT   HELIX           176..185
FT                   /evidence="ECO:0000244|PDB:3D25"
FT   HELIX           187..198
FT                   /evidence="ECO:0000244|PDB:3D25"
FT   HELIX           200..203
FT                   /evidence="ECO:0000244|PDB:3D25"
FT   STRAND          210..235
FT                   /evidence="ECO:0000244|PDB:3D25"
FT   STRAND          238..243
FT                   /evidence="ECO:0000244|PDB:3D25"
FT   STRAND          246..248
FT                   /evidence="ECO:0000244|PDB:3D25"
FT   HELIX           249..251
FT                   /evidence="ECO:0000244|PDB:2GTW"
FT   STRAND          252..254
FT                   /evidence="ECO:0000244|PDB:3D25"
FT   STRAND          261..263
FT                   /evidence="ECO:0000244|PDB:3D25"
FT   STRAND          265..274
FT                   /evidence="ECO:0000244|PDB:3D25"
FT   STRAND          275..277
FT                   /evidence="ECO:0000244|PDB:4JFD"
FT   HELIX           278..280
FT                   /evidence="ECO:0000244|PDB:3D25"
FT   STRAND          281..286
FT                   /evidence="ECO:0000244|PDB:3D25"
FT   STRAND          290..292
FT                   /evidence="ECO:0000244|PDB:2V2X"
FT   STRAND          294..296
FT                   /evidence="ECO:0000244|PDB:3D25"
FT   STRAND          348..350
FT                   /evidence="ECO:0000244|PDB:4EN2"
SQ   SEQUENCE   365 AA;  40841 MW;  DEDFCEC4450E0580 CRC64;
     MAVMAPRTLL LLLSGALALT QTWAGSHSMR YFFTSVSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASQRME PRAPWIEQEG PEYWDQETRN VKAQSQTDRV DLGTLRGYYN QSEAGSHTIQ
     IMYGCDVGSD GRFLRGYRQD AYDGKDYIAL NEDLRSWTAA DMAAQITKRK WEAAHEAEQL
     RAYLDGTCVE WLRRYLENGK ETLQRTDPPK THMTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEL
     SSQPTIPIVG IIAGLVLLGA VITGAVVAAV MWRRKSSDRK GGSYTQAASS DSAQGSDVSL
     TACKV
//
ID   Q5SUL5_HUMAN            Unreviewed;       365 AA.
AC   Q5SUL5;
DT   10-MAY-2005, integrated into UniProtKB/TrEMBL.
DT   10-MAY-2005, sequence version 1.
DT   22-APR-2020, entry version 155.
DE   SubName: Full=HLA class I histocompatibility antigen A alpha chain {ECO:0000313|EMBL:BBD34000.1};
DE   SubName: Full=HLA class I histocompatibility antigen, A alpha chain {ECO:0000313|Ensembl:ENSP00000404678};
DE   SubName: Full=MHC class I antigen {ECO:0000313|EMBL:AAX94768.1};
DE   SubName: Full=MHC class I protein {ECO:0000313|EMBL:AZA04796.1};
GN   Name=HLA-A {ECO:0000313|EMBL:AAX94768.1,
GN   ECO:0000313|Ensembl:ENSP00000404678};
GN   Synonyms=HLA {ECO:0000313|EMBL:ASU50316.1},
GN   HLA-A*0101 {ECO:0000313|EMBL:CAB93537.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAX94768.1};
RN   [1] {ECO:0000313|Ensembl:ENSP00000404678, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [2] {ECO:0000313|EMBL:CAD61867.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Dunn P., Downing J., Hammond L., Darke C.;
RT   "Characterization of 4 HLA null alleles identified by disparities in the
RT   serological and molecular typing of 6,000 potential bone marrow donors.";
RL   Submitted (JAN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:CAD61867.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Dunn P.P.;
RL   Submitted (JAN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:AAX94768.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Vicario J.L., Alonso-Nieto M.;
RT   "Eight new HLA class I alleles.";
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000313|EMBL:CAB93537.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Waller M.J., Robinson J., Marsh S.G.E.;
RL   Submitted (JAN-2006) to the EMBL/GenBank/DDBJ databases.
RN   [6] {ECO:0000313|EMBL:ACA34990.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=19735485; DOI=10.1111/j.1744-313X.2009.00874.x;
RA   Zhu F., He Y., Zhang W., He J., He J., Xu X., Yan L.;
RT   "Analysis of the complete genomic sequence of HLA-A alleles in the Chinese
RT   Han population.";
RL   Int. J. Immunogenet. 36:351-360(2009).
RN   [7] {ECO:0000313|EMBL:ADE80886.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Xu Y.P., Deng Z.H., Yang B.C.;
RT   "Characterization and polymorphism analyses of HLA-A genomic full length in
RT   Chinese Han population.";
RL   Submitted (FEB-2010) to the EMBL/GenBank/DDBJ databases.
RN   [8] {ECO:0000313|EMBL:BAN59796.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=23714642; DOI=10.1186/1471-2164-14-355;
RA   Hosomichi K., Jinam T.A., Mitsunaga S., Nakaoka H., Inoue I.;
RT   "Phase-defined complete sequencing of the HLA genes by next-generation
RT   sequencing.";
RL   BMC Genomics 14:355-355(2013).
RN   [9] {ECO:0000313|EMBL:CDK41182.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Lymphoblastoid cell line {ECO:0000313|EMBL:CDK41182.1};
RA   McWhinnie A.J., Robinson J.;
RT   "Confirmatory sequencing of HLA-A*01:01:01:01.";
RL   Submitted (NOV-2013) to the EMBL/GenBank/DDBJ databases.
RN   [10] {ECO:0000313|EMBL:CUV66801.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Albrecht V., Boehme I., Schmidt A.H.;
RT   "Characterisation and Confirmation of new HLA-Alleles found by DKMS Life
RT   Science Lab.";
RL   Submitted (DEC-2015) to the EMBL/GenBank/DDBJ databases.
RN   [11] {ECO:0000313|EMBL:ALZ40812.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Bravo-Egana V., Clark P., Monos D.;
RT   "Generation of high confidence HLA genotyping and consensus sequences for
RT   Class I HLA loci using the NGS-based Omixon Holotype HLA typing system and
RT   the Illumina MiSeq platform.";
RL   Submitted (DEC-2015) to the EMBL/GenBank/DDBJ databases.
RN   [12] {ECO:0000313|EMBL:AOE46675.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Gowda M.;
RT   "Comparative Analyses of Low, Medium and High-Resolution HLA
RT   TypingTechnologies for Human Populations.";
RL   J Clin Cell Immunol 7 (2) 2016:1-8(2016).
RN   [13] {ECO:0000313|EMBL:SBL08149.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Ploux O.;
RL   Submitted (MAR-2016) to the EMBL/GenBank/DDBJ databases.
RN   [14] {ECO:0000313|EMBL:SBL08864.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Lavstsen T., Jespersen J.S.;
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [15] {ECO:0000313|EMBL:SCB63957.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Kjaerup R.B., Dalgaard T.S., Juul-Madsen H.R.;
RL   Submitted (JUN-2016) to the EMBL/GenBank/DDBJ databases.
RN   [16] {ECO:0000313|EMBL:SCB63957.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Groeneweg M., Matern B., Palusci F., Meertens C., Tilanus M.G.J.,
RA   Voorter C.E.M.;
RT   "Group specific, unambiguous full-length gene HLA Class I typing by Sanger
RT   sequencing: a robust SSBT Strategy for typing and a golden reference for
RT   next generation sequencing approaches.";
RL   Submitted (SEP-2016) to the EMBL/GenBank/DDBJ databases.
RN   [17] {ECO:0000313|EMBL:SFV42133.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Capua I., De Benedictis P., Joannis T., Lombin L.H., Cattoli G.;
RL   Submitted (SEP-2016) to the EMBL/GenBank/DDBJ databases.
RN   [18] {ECO:0000313|EMBL:CUV66767.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=28547825; DOI=10.1111/tan.13057;
RA   Albrecht V., Zweiniger C., Surendranath V., Lang K., Schofl G., Dahl A.,
RA   Winkler S., Lange V., Bohme I., Schmidt A.H.;
RT   "Dual redundant sequencing strategy: Full-length gene characterisation of
RT   1056 novel and confirmatory HLA alleles.";
RL   HLA 90:79-87(2017).
RN   [19] {ECO:0000313|EMBL:ASU50316.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Balz V., Krause S., Enczmann J., Fischer J.;
RT   "More than 130 novel variants of HLA class 1 genes detected in German Stem
RT   Cell Donor Registry and Terasaki samples.";
RL   Submitted (JAN-2017) to the EMBL/GenBank/DDBJ databases.
RN   [20] {ECO:0000313|EMBL:SJX71916.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Peterson S.W.;
RL   Submitted (FEB-2017) to the EMBL/GenBank/DDBJ databases.
RN   [21] {ECO:0000313|EMBL:SBL08149.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Marsh S.G.E.;
RT   "Full-length genomic HLA sequences.";
RL   Submitted (MAR-2017) to the EMBL/GenBank/DDBJ databases.
RN   [22] {ECO:0000313|EMBL:AWB14519.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Yin Y., Takemura P., Bolon Y.-T., Springer B., Saito K., Reed E.F.,
RA   Zhang Q.J.;
RT   "Advances in HLA clinical relevant exon novelty detection from over 21,000
RT   donor recruitment samples.";
RL   Submitted (MAY-2017) to the EMBL/GenBank/DDBJ databases.
RN   [23] {ECO:0000313|EMBL:AST08336.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Kim H.J., Triplett B.A.;
RL   Submitted (JUN-2017) to the EMBL/GenBank/DDBJ databases.
RN   [24] {ECO:0000313|EMBL:ASU61665.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Lazaro A.M., Hou L., Gerfen J., Enriquez E., Hurley C.K.;
RL   Submitted (JUL-2017) to the EMBL/GenBank/DDBJ databases.
RN   [25] {ECO:0000313|EMBL:SNU78106.1}
RP   NUCLEOTIDE SEQUENCE.
RA   de Groot N.N.;
RL   Submitted (AUG-2017) to the EMBL/GenBank/DDBJ databases.
RN   [26] {ECO:0000313|EMBL:AUL81602.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Lazaro A.M., Hou L., Enriquez E., Persaud M., Hurley C.K.;
RT   "Novel HLA Class I alleles.";
RL   Submitted (OCT-2017) to the EMBL/GenBank/DDBJ databases.
RN   [27] {ECO:0000313|EMBL:AUQ33071.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Cereb N., Yang S.Y.;
RT   "HLA new alleles found by Histogenetics.";
RL   Submitted (NOV-2017) to the EMBL/GenBank/DDBJ databases.
RN   [28] {ECO:0000313|EMBL:SOR74739.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Han C.G.;
RL   Submitted (NOV-2017) to the EMBL/GenBank/DDBJ databases.
RN   [29] {ECO:0000313|EMBL:BBD34000.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=30337930; DOI=.3389/fimmu.2018.02294;
RA   Suzuki S., Ranade S., Osaki K., Ito S., Shigenari A., Ohnuki Y., Oka A.,
RA   Masuya A., Harting J., Baybayan P., Kitazume M., Sunaga J., Morishima S.,
RA   Morishima Y., Inoko H., Kulski J.K., Shiina T.;
RT   "Reference Grade Characterization of Polymorphisms in Full-Length HLA Class
RT   I and II Genes With Short-Read Sequencing on the ION PGM System and Long-
RT   Reads Generated by Single Molecule, Real-Time Sequencing on the PacBio
RT   Platform.";
RL   Front. Immunol. 9:2294-2294(2018).
RN   [30] {ECO:0000313|EMBL:ASA47538.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=29327506; DOI=.1111/tan.13210;
RA   Hurley C.K., Hou L., Lazaro A., Gerfen J., Enriquez E., Galarza P.,
RA   Rodriguez Cardozo M.B., Halagan M., Maiers M., Behm D., Ng J.;
RT   "Next generation sequencing characterizes the extent of HLA diversity in an
RT   Argentinian registry population.";
RL   HLA 91:175-186(2018).
RN   [31] {ECO:0000313|EMBL:BBD74344.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mimori T., Yasuda J., Kuroki Y., Shibata T.F., Katsuoka F., Saito S.,
RA   Nariai N., Ono A., Nakai-Inagaki N., Misawa K., Tateno K., Kawai Y.,
RA   Fuse N., Hozawa A., Kuriyama S., Sugawara J., Minegishi N., Suzuki K.,
RA   Kinoshita K., Nagasaki M., Yamamoto M.;
RT   "Construction of full-length Japanese reference panel of class I HLA genes
RT   with single-molecule, real-time sequencing.";
RL   Pharmacogenomics J. 0:0-0(2018).
RN   [32] {ECO:0000313|EMBL:AVE16194.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Hou L., Lazaro A., Enriquez E., Perdaud M., Hurley C.;
RT   "Matchis Population study -Netherlands.";
RL   Submitted (JAN-2018) to the EMBL/GenBank/DDBJ databases.
RN   [33] {ECO:0000313|EMBL:AZM68784.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Zakharova V.;
RT   "A new allele HLA-A*01:01new.";
RL   Submitted (MAR-2018) to the EMBL/GenBank/DDBJ databases.
RN   [34] {ECO:0000313|EMBL:SPF82205.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Keele B.F.;
RL   Submitted (MAR-2018) to the EMBL/GenBank/DDBJ databases.
RN   [35] {ECO:0000313|EMBL:AZA04796.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Rudilla F.;
RL   Submitted (MAR-2018) to the EMBL/GenBank/DDBJ databases.
RN   [36] {ECO:0000313|EMBL:SJX71916.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Turner T.R., Marsh S.G.E.;
RT   "HLA Typing of IHIW B-LCLs with SMRT DNA Sequencing.";
RL   Submitted (APR-2018) to the EMBL/GenBank/DDBJ databases.
RN   [37] {ECO:0000313|EMBL:QAX33591.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Balz V., Krause S., Enczmann J.;
RT   "New HLA class 1 alleles.";
RL   Submitted (APR-2018) to the EMBL/GenBank/DDBJ databases.
RN   [38] {ECO:0000313|EMBL:AWK57491.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Go L.Y., Mitchell J.A.;
RL   Submitted (APR-2018) to the EMBL/GenBank/DDBJ databases.
RN   [39] {ECO:0000313|EMBL:QAY29286.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Niokou D., Davey S., Brown C.;
RL   Submitted (MAY-2018) to the EMBL/GenBank/DDBJ databases.
RN   [40] {ECO:0000313|EMBL:SPQ44283.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Lanie J.A., Ng W.-L., Kazmierczak K.M., Andrzejewski T.M., Davidsen T.M.,
RA   Wayne K.J., Tettelin H., Glass J.I., Rusch D., Podicherti R., Tsui H.-C.T.,
RA   Winkler M.E.;
RL   Submitted (MAY-2018) to the EMBL/GenBank/DDBJ databases.
RN   [41] {ECO:0000313|EMBL:AZM68873.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Zakharova V.;
RT   "A new allele HLA-A*01:01:new.";
RL   Submitted (SEP-2018) to the EMBL/GenBank/DDBJ databases.
RN   [42] {ECO:0000313|EMBL:QDA01910.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Al Anazi H.T., Al Oufi F.A., Hajeer A.;
RL   Submitted (APR-2019) to the EMBL/GenBank/DDBJ databases.
RN   [43] {ECO:0000313|EMBL:QDC33449.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Hurley C.K.;
RL   Submitted (APR-2019) to the EMBL/GenBank/DDBJ databases.
RN   [44] {ECO:0000313|EMBL:QGN03553.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Texeraud E., Bertrand G.;
RL   Submitted (MAY-2019) to the EMBL/GenBank/DDBJ databases.
RN   [45] {ECO:0000313|Ensembl:ENSP00000404678}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JAN-2020) to UniProtKB.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC       {ECO:0000256|RuleBase:RU004439}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL645935; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL671561; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CR759913; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CR759943; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CR759960; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CT009496; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AY973959; AAX94768.1; -; Genomic_DNA.
DR   EMBL; EU445470; ACA34990.1; -; Genomic_DNA.
DR   EMBL; GU812295; ADE80886.1; -; Genomic_DNA.
DR   EMBL; KU528597; ALZ40812.1; -; Genomic_DNA.
DR   EMBL; KX621301; AOE46675.1; -; Genomic_DNA.
DR   EMBL; KX621306; AOE46680.1; -; Genomic_DNA.
DR   EMBL; KX621307; AOE46681.1; -; Genomic_DNA.
DR   EMBL; KY235390; ASA47538.1; -; Genomic_DNA.
DR   EMBL; KY235393; ASA47541.1; -; Genomic_DNA.
DR   EMBL; KY350872; ASA47555.1; -; Genomic_DNA.
DR   EMBL; MF382100; AST08336.1; -; Genomic_DNA.
DR   EMBL; KY419425; ASU50316.1; -; Genomic_DNA.
DR   EMBL; KY419426; ASU50317.1; -; Genomic_DNA.
DR   EMBL; KY419427; ASU50318.1; -; Genomic_DNA.
DR   EMBL; MF474215; ASU61665.1; -; Genomic_DNA.
DR   EMBL; MG372847; AUL81602.1; -; Genomic_DNA.
DR   EMBL; MG584011; AUQ33071.1; -; Genomic_DNA.
DR   EMBL; MG701434; AUQ33114.1; -; Genomic_DNA.
DR   EMBL; MG701457; AUQ33137.1; -; Genomic_DNA.
DR   EMBL; MG724752; AUQ33157.1; -; Genomic_DNA.
DR   EMBL; MG724778; AUQ33182.1; -; Genomic_DNA.
DR   EMBL; MG724789; AUQ33193.1; -; Genomic_DNA.
DR   EMBL; MG724791; AUQ33195.1; -; Genomic_DNA.
DR   EMBL; MG724808; AUQ33212.1; -; Genomic_DNA.
DR   EMBL; MG769698; AUQ33253.1; -; Genomic_DNA.
DR   EMBL; MG779945; AVE16194.1; -; Genomic_DNA.
DR   EMBL; MF069193; AWB14519.1; -; Genomic_DNA.
DR   EMBL; MH179253; AWK57491.1; -; Genomic_DNA.
DR   EMBL; MH173418; AWM62177.1; -; Genomic_DNA.
DR   EMBL; MH215810; AWM62304.1; -; Genomic_DNA.
DR   EMBL; MH347523; AWM62322.1; -; Genomic_DNA.
DR   EMBL; MH347539; AWM62337.1; -; Genomic_DNA.
DR   EMBL; MH347561; AWM62359.1; -; Genomic_DNA.
DR   EMBL; MH721215; AXN55439.1; -; Genomic_DNA.
DR   EMBL; MH045578; AZA04796.1; -; Genomic_DNA.
DR   EMBL; MH758800; AZL48304.1; -; Genomic_DNA.
DR   EMBL; MH758810; AZL48312.1; -; Genomic_DNA.
DR   EMBL; MH802058; AZL48329.1; -; Genomic_DNA.
DR   EMBL; MH924864; AZL48377.1; -; Genomic_DNA.
DR   EMBL; MH973872; AZL48406.1; -; Genomic_DNA.
DR   EMBL; MK032348; AZL48481.1; -; Genomic_DNA.
DR   EMBL; MK032357; AZL48490.1; -; Genomic_DNA.
DR   EMBL; MK032368; AZL48501.1; -; Genomic_DNA.
DR   EMBL; MK032373; AZL48504.1; -; Genomic_DNA.
DR   EMBL; MH043602; AZM68784.1; -; Genomic_DNA.
DR   EMBL; MH939273; AZM68873.1; -; Genomic_DNA.
DR   EMBL; AB774950; BAN59796.1; -; Genomic_DNA.
DR   EMBL; LC257682; BBD34000.1; -; Genomic_DNA.
DR   EMBL; LC326108; BBD74344.1; -; Genomic_DNA.
DR   EMBL; AJ278305; CAB93537.1; -; Genomic_DNA.
DR   EMBL; AJ538348; CAD61867.1; -; Genomic_DNA.
DR   EMBL; HG794373; CDK41182.1; -; Genomic_DNA.
DR   EMBL; LN994715; CUV66767.1; -; Genomic_DNA.
DR   EMBL; LN994725; CUV66777.1; -; Genomic_DNA.
DR   EMBL; LN994749; CUV66801.1; -; Genomic_DNA.
DR   EMBL; LN999564; CUX90957.1; -; Genomic_DNA.
DR   EMBL; LN999604; CUX90997.1; -; Genomic_DNA.
DR   EMBL; MH269331; QAX33591.1; -; Genomic_DNA.
DR   EMBL; MH269332; QAX33592.1; -; Genomic_DNA.
DR   EMBL; MH285865; QAY29286.1; -; Genomic_DNA.
DR   EMBL; MK805531; QDA01910.1; -; Genomic_DNA.
DR   EMBL; MK814894; QDC33449.1; -; Genomic_DNA.
DR   EMBL; MK279523; QDC33588.1; -; Genomic_DNA.
DR   EMBL; MK953610; QGN03553.1; -; Genomic_DNA.
DR   EMBL; LT575515; SBL08149.1; -; Genomic_DNA.
DR   EMBL; LT575612; SBL08864.1; -; Genomic_DNA.
DR   EMBL; LT599170; SBW38391.1; -; Genomic_DNA.
DR   EMBL; LT604086; SCB63957.1; -; Genomic_DNA.
DR   EMBL; LT627704; SFV42133.1; -; Genomic_DNA.
DR   EMBL; LT795516; SJX71916.1; -; Genomic_DNA.
DR   EMBL; LT906371; SNU78106.1; -; Genomic_DNA.
DR   EMBL; LT963195; SOR74739.1; -; Genomic_DNA.
DR   EMBL; LT963205; SOR74749.1; -; Genomic_DNA.
DR   EMBL; LT963235; SOR74779.1; -; Genomic_DNA.
DR   EMBL; LT963296; SOR74840.1; -; Genomic_DNA.
DR   EMBL; LT986532; SPF82205.1; -; Genomic_DNA.
DR   EMBL; LT986548; SPF82221.1; -; Genomic_DNA.
DR   EMBL; LS398154; SPQ44283.1; -; Genomic_DNA.
DR   EMBL; LS398167; SPQ44296.1; -; Genomic_DNA.
DR   EMBL; LS398199; SPQ44328.1; -; Genomic_DNA.
DR   EMBL; LS398201; SPQ44330.1; -; Genomic_DNA.
DR   RefSeq; NP_001229687.1; NM_001242758.1.
DR   IntAct; Q5SUL5; 10.
DR   DNASU; 3105; -.
DR   Ensembl; ENST00000431930; ENSP00000406366; ENSG00000229215.
DR   Ensembl; ENST00000443552; ENSP00000404678; ENSG00000224320.
DR   Ensembl; ENST00000549869; ENSP00000447635; ENSG00000224320.
DR   Ensembl; ENST00000552193; ENSP00000447614; ENSG00000229215.
DR   GeneID; 3105; -.
DR   UCSC; uc011ejq.2; human.
DR   CTD; 3105; -.
DR   HGNC; HGNC:4931; HLA-A.
DR   eggNOG; ENOG410II5V; Eukaryota.
DR   eggNOG; ENOG4111K8F; LUCA.
DR   OrthoDB; 1390181at2759; -.
DR   ChiTaRS; HLA-A; human.
DR   GenomeRNAi; 3105; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0019882; P:antigen processing and presentation; IEA:InterPro.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 3.30.500.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR037055; MHC_I-like_Ag-recog_sf.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF54452; SSF54452; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP}; Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL          1..24
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           25..365
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5015098021"
FT   TRANSMEM        308..332
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          209..295
FT                   /note="Ig-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50835"
FT   REGION          339..365
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        341..359
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   365 AA;  40846 MW;  8667AFF3F06C4932 CRC64;
     MAVMAPRTLL LLLSGALALT QTWAGSHSMR YFFTSVSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASQKME PRAPWIEQEG PEYWDQETRN MKAHSQTDRA NLGTLRGYYN QSEDGSHTIQ
     IMYGCDVGPD GRFLRGYRQD AYDGKDYIAL NEDLRSWTAA DMAAQITKRK WEAVHAAEQR
     RVYLEGRCVD GLRRYLENGK ETLQRTDPPK THMTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEL
     SSQPTIPIVG IIAGLVLLGA VITGAVVAAV MWRRKSSDRK GGSYTQAASS DSAQGSDVSL
     TACKV
//
ID   HOOK3_HUMAN             Reviewed;         718 AA.
AC   Q86VS8; D3DSY8; Q8NBH0; Q9BY13;
DT   02-FEB-2004, integrated into UniProtKB/Swiss-Prot.
DT   02-FEB-2004, sequence version 2.
DT   22-APR-2020, entry version 148.
DE   RecName: Full=Protein Hook homolog 3;
DE            Short=h-hook3;
DE            Short=hHK3;
GN   Name=HOOK3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INTERACTION WITH MICROTUBULES, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=11238449; DOI=10.1083/jcb.152.5.923;
RA   Walenta J.H., Didier A.J., Liu X., Kraemer H.;
RT   "The Golgi-associated hook3 protein is a member of a novel family of
RT   microtubule-binding proteins.";
RL   J. Cell Biol. 152:923-934(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cervix, and Duodenum;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 346-718.
RC   TISSUE=Astrocyte;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-238, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [6]
RP   FUNCTION, AND INTERACTION WITH MSR1.
RX   PubMed=17237231; DOI=10.1074/jbc.m611537200;
RA   Sano H., Ishino M., Kraemer H., Shimizu T., Mitsuzawa H., Nishitani C.,
RA   Kuroki Y.;
RT   "The microtubule-binding protein Hook3 interacts with a cytoplasmic domain
RT   of scavenger receptor A.";
RL   J. Biol. Chem. 282:7973-7981(2007).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY, IDENTIFICATION IN THE FHF COMPLEX,
RP   FUNCTION, SELF-ASSOCIATION, AND INTERACTION WITH AKTIP; HOOK1; HOOK2; VPS16
RP   AND VPS41.
RX   PubMed=18799622; DOI=10.1091/mbc.e08-05-0473;
RA   Xu L., Sowa M.E., Chen J., Li X., Gygi S.P., Harper J.W.;
RT   "An FTS/Hook/p107(FHIP) complex interacts with and promotes endosomal
RT   clustering by the homotypic vacuolar protein sorting complex.";
RL   Mol. Biol. Cell 19:5059-5071(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-238, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-238, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3; SER-6; SER-238; SER-693
RP   AND SER-707, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-238, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   FUNCTION, AND INTERACTION WITH DYNEIN INTERMEDIATE CHAIN AND DCTN1.
RX   PubMed=25035494; DOI=10.1126/science.1254198;
RA   McKenney R.J., Huynh W., Tanenbaum M.E., Bhabha G., Vale R.D.;
RT   "Activation of cytoplasmic dynein motility by dynactin-cargo adapter
RT   complexes.";
RL   Science 345:337-341(2014).
RN   [16]
RP   VARIANT [LARGE SCALE ANALYSIS] ARG-221.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Probably serves as a target for the spiC protein from
CC       Salmonella typhimurium, which inactivates it, leading to a strong
CC       alteration in cellular trafficking (By similarity). Component of the
CC       FTS/Hook/FHIP complex (FHF complex). The FHF complex may function to
CC       promote vesicle trafficking and/or fusion via the homotypic vesicular
CC       protein sorting complex (the HOPS complex). May regulate clearance of
CC       endocytosed receptors such as MSR1. Participates in defining the
CC       architecture and localization of the Golgi complex. Acts as an adapter
CC       protein linking the dynein motor complex to various cargos and converts
CC       dynein from a non-processive to a highly processive motor in the
CC       presence of dynactin. Facilitates the interaction between dynein and
CC       dynactin and activates dynein processivity (the ability to move along a
CC       microtubule for a long distance without falling off the track)
CC       (PubMed:25035494). {ECO:0000250|UniProtKB:Q8BUK6,
CC       ECO:0000269|PubMed:11238449, ECO:0000269|PubMed:17237231,
CC       ECO:0000269|PubMed:18799622, ECO:0000269|PubMed:25035494}.
CC   -!- SUBUNIT: Interacts with Salmonella typhimurium spiC (By similarity).
CC       Self-associates. Component of the FTS/Hook/FHIP complex (FHF complex),
CC       composed of AKTIP/FTS, FAM160A2, and one or more members of the Hook
CC       family of proteins HOOK1, HOOK2, and HOOK3. May interact directly with
CC       AKTIP/FTS, HOOK1 and HOOK2. Associates with several subunits of the
CC       homotypic vesicular sorting complex (the HOPS complex) including VPS16
CC       and VPS41; these interactions may be indirect (PubMed:18799622).
CC       Interacts with MSR1, and this association is stimulated by ligand
CC       binding to MSR1 (PubMed:17237231). Interacts with microtubules
CC       (PubMed:11238449). Interacts with dynein intermediate chain and
CC       dynactin (DCTN1) (PubMed:25035494). Interacts with CCDC181 (By
CC       similarity). Interacts with LRGUK (By similarity).
CC       {ECO:0000250|UniProtKB:Q8BUK6, ECO:0000269|PubMed:11238449,
CC       ECO:0000269|PubMed:17237231, ECO:0000269|PubMed:18799622,
CC       ECO:0000269|PubMed:25035494}.
CC   -!- INTERACTION:
CC       Q86VS8; O43310-2: CTIF; NbExp=3; IntAct=EBI-1777078, EBI-12180013;
CC       Q86VS8; Q9UJC3: HOOK1; NbExp=4; IntAct=EBI-1777078, EBI-746704;
CC       Q86VS8; P13646: KRT13; NbExp=3; IntAct=EBI-1777078, EBI-1223876;
CC       Q86VS8; Q7Z3Y8: KRT27; NbExp=3; IntAct=EBI-1777078, EBI-3044087;
CC       Q86VS8; Q6FHY5: MEOX2; NbExp=3; IntAct=EBI-1777078, EBI-16439278;
CC       Q86VS8; P21757: MSR1; NbExp=4; IntAct=EBI-1777078, EBI-1776976;
CC       Q86VS8; Q96PV4: PNMA5; NbExp=3; IntAct=EBI-1777078, EBI-10171633;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:11238449}. Golgi apparatus
CC       {ECO:0000269|PubMed:11238449}. Note=Enriched at the cis-face of the
CC       Golgi complex. Localizes to microtubule asters in prophase
CC       (PubMed:11238449). Localizes to the manchette in elongating spermatids
CC       (By similarity). {ECO:0000250|UniProtKB:Q8BUK6,
CC       ECO:0000269|PubMed:11238449}.
CC   -!- SIMILARITY: Belongs to the hook family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH48304.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF241830; AAK29204.1; -; mRNA.
DR   EMBL; CH471080; EAW63197.1; -; Genomic_DNA.
DR   EMBL; CH471080; EAW63198.1; -; Genomic_DNA.
DR   EMBL; BC048304; AAH48304.1; ALT_SEQ; mRNA.
DR   EMBL; BC056146; AAH56146.1; -; mRNA.
DR   EMBL; AK090540; BAC03473.1; -; mRNA.
DR   CCDS; CCDS6139.1; -.
DR   RefSeq; NP_115786.1; NM_032410.3.
DR   PDB; 5J8E; X-ray; 1.70 A; A/B=1-160.
DR   PDB; 6B9H; X-ray; 1.50 A; A=1-160.
DR   PDBsum; 5J8E; -.
DR   PDBsum; 6B9H; -.
DR   SMR; Q86VS8; -.
DR   BioGrid; 124068; 156.
DR   CORUM; Q86VS8; -.
DR   IntAct; Q86VS8; 31.
DR   STRING; 9606.ENSP00000305699; -.
DR   iPTMnet; Q86VS8; -.
DR   MetOSite; Q86VS8; -.
DR   PhosphoSitePlus; Q86VS8; -.
DR   BioMuta; HOOK3; -.
DR   DMDM; 41688581; -.
DR   EPD; Q86VS8; -.
DR   jPOST; Q86VS8; -.
DR   MassIVE; Q86VS8; -.
DR   MaxQB; Q86VS8; -.
DR   PaxDb; Q86VS8; -.
DR   PeptideAtlas; Q86VS8; -.
DR   PRIDE; Q86VS8; -.
DR   ProteomicsDB; 70068; -.
DR   Antibodypedia; 11516; 91 antibodies.
DR   Ensembl; ENST00000307602; ENSP00000305699; ENSG00000168172.
DR   GeneID; 84376; -.
DR   KEGG; hsa:84376; -.
DR   UCSC; uc003xpr.4; human.
DR   CTD; 84376; -.
DR   DisGeNET; 84376; -.
DR   GeneCards; HOOK3; -.
DR   HGNC; HGNC:23576; HOOK3.
DR   HPA; ENSG00000168172; Low tissue specificity.
DR   MIM; 607825; gene.
DR   neXtProt; NX_Q86VS8; -.
DR   OpenTargets; ENSG00000168172; -.
DR   PharmGKB; PA134961305; -.
DR   eggNOG; ENOG410IG1M; Eukaryota.
DR   eggNOG; ENOG410XQ3G; LUCA.
DR   GeneTree; ENSGT00940000158075; -.
DR   HOGENOM; CLU_011214_1_0_1; -.
DR   InParanoid; Q86VS8; -.
DR   KO; K16536; -.
DR   OMA; DELKCGQ; -.
DR   OrthoDB; 398210at2759; -.
DR   PhylomeDB; Q86VS8; -.
DR   TreeFam; TF320231; -.
DR   SIGNOR; Q86VS8; -.
DR   ChiTaRS; HOOK3; human.
DR   GeneWiki; HOOK3; -.
DR   GenomeRNAi; 84376; -.
DR   Pharos; Q86VS8; Tbio.
DR   PRO; PR:Q86VS8; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   RNAct; Q86VS8; protein.
DR   Bgee; ENSG00000168172; Expressed in corpus callosum and 211 other tissues.
DR   ExpressionAtlas; Q86VS8; baseline and differential.
DR   Genevisible; Q86VS8; HS.
DR   GO; GO:0034451; C:centriolar satellite; IEA:Ensembl.
DR   GO; GO:0005813; C:centrosome; ISS:BHF-UCL.
DR   GO; GO:0005801; C:cis-Golgi network; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IEA:GOC.
DR   GO; GO:0070695; C:FHF complex; IDA:UniProtKB.
DR   GO; GO:0005874; C:microtubule; IEA:UniProtKB-KW.
DR   GO; GO:0000242; C:pericentriolar material; ISS:BHF-UCL.
DR   GO; GO:0034452; F:dynactin binding; IDA:UniProtKB.
DR   GO; GO:0045505; F:dynein intermediate chain binding; IDA:UniProtKB.
DR   GO; GO:0045503; F:dynein light chain binding; IPI:UniProtKB.
DR   GO; GO:0051959; F:dynein light intermediate chain binding; IBA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; IPI:UniProtKB.
DR   GO; GO:0008017; F:microtubule binding; IDA:UniProtKB.
DR   GO; GO:0031122; P:cytoplasmic microtubule organization; IMP:UniProtKB.
DR   GO; GO:0030705; P:cytoskeleton-dependent intracellular transport; IBA:GO_Central.
DR   GO; GO:0045022; P:early endosome to late endosome transport; IMP:UniProtKB.
DR   GO; GO:0007032; P:endosome organization; IMP:UniProtKB.
DR   GO; GO:0008333; P:endosome to lysosome transport; IMP:UniProtKB.
DR   GO; GO:0051645; P:Golgi localization; IMP:UniProtKB.
DR   GO; GO:0022027; P:interkinetic nuclear migration; ISS:BHF-UCL.
DR   GO; GO:0007040; P:lysosome organization; IMP:UniProtKB.
DR   GO; GO:0034454; P:microtubule anchoring at centrosome; ISS:BHF-UCL.
DR   GO; GO:0050768; P:negative regulation of neurogenesis; ISS:BHF-UCL.
DR   GO; GO:0097150; P:neuronal stem cell population maintenance; IEA:Ensembl.
DR   GO; GO:0071539; P:protein localization to centrosome; ISS:BHF-UCL.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.418.10; -; 1.
DR   InterPro; IPR001715; CH-domain.
DR   InterPro; IPR036872; CH_dom_sf.
DR   InterPro; IPR008636; Hook-like_fam.
DR   Pfam; PF05622; HOOK; 1.
DR   PROSITE; PS50021; CH; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Coiled coil; Cytoplasm; Cytoskeleton;
KW   Golgi apparatus; Microtubule; Phosphoprotein; Polymorphism;
KW   Protein transport; Reference proteome; Transport.
FT   CHAIN           1..718
FT                   /note="Protein Hook homolog 3"
FT                   /id="PRO_0000219197"
FT   DOMAIN          10..126
FT                   /note="Calponin-homology (CH)"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00044"
FT   REGION          1..164
FT                   /note="Sufficient for interaction with microtubules"
FT   REGION          553..718
FT                   /note="Required for association with Golgi"
FT   REGION          556..718
FT                   /note="Required for interaction with MSR1"
FT                   /evidence="ECO:0000269|PubMed:17237231"
FT   COILED          167..433
FT                   /evidence="ECO:0000255"
FT   COILED          462..667
FT                   /evidence="ECO:0000255"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000244|PubMed:22223895,
FT                   ECO:0000244|PubMed:22814378"
FT   MOD_RES         3
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         6
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         238
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:16964243,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         693
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         707
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   VARIANT         221
FT                   /note="Q -> R (in a breast cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035710"
FT   VARIANT         670
FT                   /note="Y -> S (in dbSNP:rs34131505)"
FT                   /id="VAR_049363"
FT   CONFLICT        348
FT                   /note="M -> V (in Ref. 4; BAC03473)"
FT                   /evidence="ECO:0000305"
FT   HELIX           12..21
FT                   /evidence="ECO:0000244|PDB:6B9H"
FT   STRAND          30..32
FT                   /evidence="ECO:0000244|PDB:6B9H"
FT   HELIX           33..35
FT                   /evidence="ECO:0000244|PDB:6B9H"
FT   HELIX           39..48
FT                   /evidence="ECO:0000244|PDB:6B9H"
FT   TURN            50..52
FT                   /evidence="ECO:0000244|PDB:6B9H"
FT   HELIX           55..58
FT                   /evidence="ECO:0000244|PDB:6B9H"
FT   HELIX           69..89
FT                   /evidence="ECO:0000244|PDB:6B9H"
FT   HELIX           103..109
FT                   /evidence="ECO:0000244|PDB:6B9H"
FT   HELIX           112..126
FT                   /evidence="ECO:0000244|PDB:6B9H"
FT   HELIX           132..139
FT                   /evidence="ECO:0000244|PDB:6B9H"
FT   HELIX           144..158
FT                   /evidence="ECO:0000244|PDB:6B9H"
SQ   SEQUENCE   718 AA;  83126 MW;  9528EC9C854D39FA CRC64;
     MFSVESLERA ELCESLLTWI QTFNVDAPCQ TVEDLTNGVV MAQVLQKIDP AYFDENWLNR
     IKTEVGDNWR LKISNLKKIL KGILDYNHEI LGQQINDFTL PDVNLIGEHS DAAELGRMLQ
     LILGCAVNCE QKQEYIQAIM MMEESVQHVV MTAIQELMSK ESPVSAGNDA YVDLDRQLKK
     TTEELNEALS AKEEIAQRCH ELDMQVAALQ EEKSSLLAEN QVLMERLNQS DSIEDPNSPA
     GRRHLQLQTQ LEQLQEETFR LEAAKDDYRI RCEELEKEIS ELRQQNDELT TLADEAQSLK
     DEIDVLRHSS DKVSKLEGQV ESYKKKLEDL GDLRRQVKLL EEKNTMYMQN TVSLEEELRK
     ANAARSQLET YKRQVVELQN RLSEESKKAD KLDFEYKRLK EKVDSLQKEK DRLRTERDSL
     KETIEELRCV QAQEGQLTTQ GLMPLGSQES SDSLAAEIVT PEIREKLIRL QHENKMLKLN
     QEGSDNEKIA LLQSLLDDAN LRKNELETEN RLVNQRLLEV QSQVEELQKS LQDQGSKAED
     SVLLKKKLEE HLEKLHEANN ELQKKRAIIE DLEPRFNNSS LKIEELQEAL RKKEEEMKQM
     EERYKKYLEK AKSVIRTLDP KQNQGAAPEI QALKNQLQER DRLFHSLEKE YEKTKSQREM
     EEKYIVSAWY NMGMTLHKKA AEDRLASTGS GQSFLARQRQ ATSSRRSYPG HVQPATAR
//
ID   K9JA46_HUMAN            Unreviewed;       732 AA.
AC   K9JA46;
DT   06-MAR-2013, integrated into UniProtKB/TrEMBL.
DT   06-MAR-2013, sequence version 1.
DT   22-APR-2020, entry version 65.
DE   SubName: Full=Epididymis luminal secretory protein 52 {ECO:0000313|EMBL:ADD71695.1};
DE   SubName: Full=Epididymis secretory sperm binding protein Li 65p {ECO:0000313|EMBL:ACV87205.1};
DE   SubName: Full=Heat shock protein 90kDa alpha (Cytosolic), class A member 1, isoform CRA_a {ECO:0000313|EMBL:EAW81766.1};
GN   Name=EL52 {ECO:0000313|EMBL:ADD71695.1};
GN   Synonyms=HEL-S-65p {ECO:0000313|EMBL:ACV87205.1},
GN   HSP90AA1 {ECO:0000313|EMBL:EAW81766.1};
GN   ORFNames=hCG_1814169 {ECO:0000313|EMBL:EAW81766.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ADD71695.1};
RN   [1] {ECO:0000313|EMBL:EAW81766.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW81766.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ADD71695.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J.Y.;
RT   "Human epididymis cDNA library.";
RL   Submitted (MAY-2009) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:ACV87205.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Sahoo P.;
RL   Submitted (AUG-2009) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; GQ472230; ACV87205.1; -; mRNA.
DR   EMBL; GQ149083; ADD71695.1; -; mRNA.
DR   EMBL; CH471061; EAW81766.1; -; Genomic_DNA.
DR   RefSeq; NP_005339.3; NM_005348.3.
DR   IntAct; K9JA46; 14.
DR   Antibodypedia; 3676; 1737 antibodies.
DR   GeneID; 3320; -.
DR   KEGG; hsa:3320; -.
DR   CTD; 3320; -.
DR   EuPathDB; HostDB:ENSG00000080824.18; -.
DR   eggNOG; KOG0019; Eukaryota.
DR   eggNOG; KOG0020; Eukaryota.
DR   eggNOG; COG0326; LUCA.
DR   HOGENOM; CLU_006684_1_3_1; -.
DR   KO; K04079; -.
DR   ChiTaRS; HSP90AA1; human.
DR   GenomeRNAi; 3320; -.
DR   Bgee; ENSG00000080824; Expressed in middle temporal gyrus and 251 other tissues.
DR   GO; GO:0005737; C:cytoplasm; ISS:AgBase.
DR   GO; GO:0005634; C:nucleus; ISS:AgBase.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0051082; F:unfolded protein binding; IEA:InterPro.
DR   GO; GO:0006457; P:protein folding; IEA:InterPro.
DR   GO; GO:0046677; P:response to antibiotic; ISS:AgBase.
DR   GO; GO:0009409; P:response to cold; ISS:AgBase.
DR   GO; GO:0009408; P:response to heat; ISS:AgBase.
DR   Gene3D; 1.20.120.790; -; 1.
DR   Gene3D; 3.30.565.10; -; 1.
DR   HAMAP; MF_00505; HSP90; 1.
DR   InterPro; IPR003594; HATPase_C.
DR   InterPro; IPR036890; HATPase_C_sf.
DR   InterPro; IPR019805; Heat_shock_protein_90_CS.
DR   InterPro; IPR037196; HSP90_C.
DR   InterPro; IPR001404; Hsp90_fam.
DR   InterPro; IPR020575; Hsp90_N.
DR   InterPro; IPR020568; Ribosomal_S5_D2-typ_fold.
DR   PANTHER; PTHR11528; PTHR11528; 1.
DR   Pfam; PF02518; HATPase_c; 1.
DR   Pfam; PF00183; HSP90; 1.
DR   PIRSF; PIRSF002583; Hsp90; 1.
DR   PRINTS; PR00775; HEATSHOCK90.
DR   SMART; SM00387; HATPase_c; 1.
DR   SUPFAM; SSF110942; SSF110942; 1.
DR   SUPFAM; SSF54211; SSF54211; 1.
DR   SUPFAM; SSF55874; SSF55874; 1.
DR   PROSITE; PS00298; HSP90; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Stress response {ECO:0000313|EMBL:EAW81766.1}.
FT   DOMAIN          40..194
FT                   /note="HATPase_c"
FT                   /evidence="ECO:0000259|SMART:SM00387"
FT   REGION          225..278
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          700..732
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          551..571
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        243..257
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   732 AA;  84660 MW;  969F65FCC0BC86FD CRC64;
     MPEETQTQDQ PMEEEEVETF AFQAEIAQLM SLIINTFYSN KEIFLRELIS NSSDALDKIR
     YESLTDPSKL DSGKELHINL IPNKQDRTLT IVDTGIGMTK ADLINNLGTI AKSGTKAFME
     ALQAGADISM IGQFGVGFYS AYLVAEKVTV ITKHNDDEQY AWESSAGGSF TVRTDTGEPM
     GRGTKVILHL KEDQTEYLEE RRIKEIVKKH SQFIGYPITL FVEKERDKEV SDDEAEEKED
     KEEEKEKEEK ESEDKPEIED VGSDEEEEKK DGDKKKKKKI KEKYIDQEEL NKTKPIWTRN
     PDDITNEEYG EFYKSLTNDW EDHLAVKHFS VEGQLEFRAL LFVPRRAPFD LFENRKKKNN
     IKLYVRRVFI MDNCEELIPE YLNFIRGVVD SEDLPLNISR EMLQQSKILK VIRKNLVKKC
     LELFTELAED KENYKKFYEQ FSKNIKLGIH EDSQNRKKLS ELLRYYTSAS GDEMVSLKDY
     CTRMKENQKH IYYITGETKD QVANSAFVER LRKHGLEVIY MIEPIDEYCV QQLKEFEGKT
     LVSVTKEGLE LPEDEEEKKK QEEKKTKFEN LCKIMKDILE KKVEKVVVSN RLVTSPCCIV
     TSTYGWTANM ERIMKAQALR DNSTMGYMAA KKHLEINPDH SIIETLRQKA EADKNDKSVK
     DLVILLYETA LLSSGFSLED PQTHANRIYR MIKLGLGIDE DDPTADDTSA AVTEEMPPLE
     GDDDTSRMEE VD
//
ID   HS90A_HUMAN             Reviewed;         732 AA.
AC   P07900; A8K500; B3KPJ9; Q2PP14; Q5CAQ6; Q5CAQ7; Q9BVQ5;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 5.
DT   22-APR-2020, entry version 255.
DE   RecName: Full=Heat shock protein HSP 90-alpha;
DE   AltName: Full=Heat shock 86 kDa;
DE            Short=HSP 86;
DE            Short=HSP86;
DE   AltName: Full=Lipopolysaccharide-associated protein 2;
DE            Short=LAP-2;
DE            Short=LPS-associated protein 2;
DE   AltName: Full=Renal carcinoma antigen NY-REN-38;
GN   Name=HSP90AA1; Synonyms=HSP90A, HSPC1, HSPCA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Peripheral blood lymphocyte;
RX   PubMed=2780322; DOI=10.1093/nar/17.17.7108;
RA   Soeda E., Yokoyama K., Yamazaki M., Akaogi K., Miwa T., Imai T.;
RT   "Nucleotide sequence of a full-length cDNA for 90 kDa heat-shock protein
RT   from human peripheral blood lymphocytes.";
RL   Nucleic Acids Res. 17:7108-7108(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1368637; DOI=10.1271/bbb1961.54.3163;
RA   Yamazaki M., Tashiro H., Yokoyama K., Soeda E.;
RT   "Molecular cloning of cDNA encoding a human heat-shock protein whose
RT   expression is induced by adenovirus type 12 E1A in HeLa cells.";
RL   Agric. Biol. Chem. 54:3163-3170(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Placenta;
RX   PubMed=2527334; DOI=10.1128/mcb.9.6.2615;
RA   Hickey E., Brandon S.E., Smale G., Lloyd D., Weber L.A.;
RT   "Sequence and regulation of a gene encoding a human 89-kilodalton heat
RT   shock protein.";
RL   Mol. Cell. Biol. 9:2615-2626(1989).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND NOMENCLATURE.
RX   PubMed=16269234; DOI=10.1016/j.ygeno.2005.08.012;
RA   Chen B., Piel W.H., Gui L., Bruford E., Monteiro A.;
RT   "The HSP90 family of genes in the human genome: insights into their
RT   divergence and evolution.";
RL   Genomics 86:627-637(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (DEC-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Placenta, and Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S., Sun H.,
RA   Du H., Pepin K., Artiguenave F., Robert C., Cruaud C., Bruels T.,
RA   Jaillon O., Friedlander L., Samson G., Brottier P., Cure S., Segurens B.,
RA   Aniere F., Samain S., Crespeau H., Abbasi N., Aiach N., Boscus D.,
RA   Dickhoff R., Dors M., Dubois I., Friedman C., Gouyvenoux M., James R.,
RA   Madan A., Mairey-Estrada B., Mangenot S., Martins N., Menard M., Oztas S.,
RA   Ratcliffe A., Shaffer T., Trask B., Vacherie B., Bellemere C., Belser C.,
RA   Besnard-Gonnet M., Bartol-Mavel D., Boutard M., Briez-Silla S.,
RA   Combette S., Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C.,
RA   Muselet D., Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P.,
RA   Trybou A., Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L., Verdier J.,
RA   Verdier-Discala C., Hillier L.W., Fulton L., McPherson J., Matsuda F.,
RA   Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W., Quetier F.,
RA   Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-312.
RX   PubMed=2469626; DOI=10.1016/0378-1119(88)90182-5;
RA   Hoffmann T., Hovemann B.;
RT   "Heat-shock proteins, Hsp84 and Hsp86, of mice and men: two related genes
RT   encode formerly identified tumour-specific transplantation antigens.";
RL   Gene 74:491-501(1988).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-312.
RX   PubMed=2591742; DOI=10.1016/0378-1119(89)90408-3;
RA   Walter T., Drabent B., Krebs H., Tomalak M., Heiss S., Benecke B.J.J.;
RT   "Cloning and analysis of a human 86-kDa heat-shock-protein-encoding gene.";
RL   Gene 83:105-115(1989).
RN   [11]
RP   PROTEIN SEQUENCE OF 101-112; 210-224; 300-314; 328-338; 346-355; 387-400;
RP   465-478 AND 633-647, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Vishwanath V., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 185-732.
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 539-732.
RC   TISSUE=Heart;
RA   Tanaka M., Tanaka T., Mitsui Y., Yamamoto M., Wood J.N.;
RT   "The analysis of the genes reactive to monoclonal antibody, CE5.";
RL   Submitted (SEP-1996) to the EMBL/GenBank/DDBJ databases.
RN   [14]
RP   PROTEIN SEQUENCE OF 2-21, AND PHOSPHORYLATION AT SER-231 AND SER-263.
RX   PubMed=2492519;
RA   Lees-Miller S.P., Anderson C.W.;
RT   "Two human 90-kDa heat shock proteins are phosphorylated in vivo at
RT   conserved serines that are phosphorylated in vitro by casein kinase II.";
RL   J. Biol. Chem. 264:2431-2437(1989).
RN   [15]
RP   PROTEIN SEQUENCE OF 154-163 AND 186-191, AND INTERACTION WITH KSR1.
RX   PubMed=10409742; DOI=10.1128/mcb.19.8.5523;
RA   Stewart S., Sundaram M., Zhang Y., Lee J., Han M., Guan K.L.;
RT   "Kinase suppressor of Ras forms a multiprotein signaling complex and
RT   modulates MEK localization.";
RL   Mol. Cell. Biol. 19:5523-5534(1999).
RN   [16]
RP   PROTEIN SEQUENCE OF 592-612, FUNCTION, CATALYTIC ACTIVITY, MUTAGENESIS OF
RP   CYS-598, AND S-NITROSYLATION AT CYS-598.
RX   PubMed=15937123; DOI=10.1073/pnas.0407294102;
RA   Martinez-Ruiz A., Villanueva L., Gonzalez de Orduna C., Lopez-Ferrer D.,
RA   Higueras M.A., Tarin C., Rodriguez-Crespo I., Vazquez J., Lamas S.;
RT   "S-nitrosylation of Hsp90 promotes the inhibition of its ATPase and
RT   endothelial nitric oxide synthase regulatory activities.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:8525-8530(2005).
RN   [17]
RP   PHOSPHORYLATION AT THR-5 AND THR-7.
RX   PubMed=2507541;
RA   Lees-Miller S.P., Anderson C.W.;
RT   "The human double-stranded DNA-activated protein kinase phosphorylates the
RT   90-kDa heat-shock protein, hsp90 alpha at two NH2-terminal threonine
RT   residues.";
RL   J. Biol. Chem. 264:17275-17280(1989).
RN   [18]
RP   HOMODIMERIZATION.
RX   PubMed=8289821; DOI=10.1128/mcb.14.2.1459;
RA   Minami Y., Kimura Y., Kawasaki H., Suzuki K., Yahara I.;
RT   "The carboxy-terminal region of mammalian HSP90 is required for its
RT   dimerization and function in vivo.";
RL   Mol. Cell. Biol. 14:1459-1464(1994).
RN   [19]
RP   SUBUNIT.
RX   PubMed=7588731; DOI=10.1111/j.1432-1033.1995.001_1.x;
RA   Nemoto T., Ohara-Nemoto Y., Ota M., Takagi T., Yokoyama K.;
RT   "Mechanism of dimer formation of the 90-kDa heat-shock protein.";
RL   Eur. J. Biochem. 233:1-8(1995).
RN   [20]
RP   IDENTIFICATION IN A COMPLEX WITH NR3C1 AND FKBP4; PPID; PPP5C OR STIP1.
RX   PubMed=9195923; DOI=10.1074/jbc.272.26.16224;
RA   Silverstein A.M., Galigniana M.D., Chen M.S., Owens-Grillo J.K.,
RA   Chinkers M., Pratt W.B.;
RT   "Protein phosphatase 5 is a major component of glucocorticoid
RT   receptor.hsp90 complexes with properties of an FK506-binding
RT   immunophilin.";
RL   J. Biol. Chem. 272:16224-16230(1997).
RN   [21]
RP   INTERACTION WITH TOM34.
RX   PubMed=9660753; DOI=10.1074/jbc.273.29.18007;
RA   Young J.C., Obermann W.M., Hartl F.U.;
RT   "Specific binding of tetratricopeptide repeat proteins to the C-terminal
RT   12-kDa domain of hsp90.";
RL   J. Biol. Chem. 273:18007-18010(1998).
RN   [22]
RP   IDENTIFICATION AS A RENAL CANCER ANTIGEN.
RC   TISSUE=Renal cell carcinoma;
RX   PubMed=10508479;
RX   DOI=10.1002/(sici)1097-0215(19991112)83:4<456::aid-ijc4>3.0.co;2-5;
RA   Scanlan M.J., Gordan J.D., Williamson B., Stockert E., Bander N.H.,
RA   Jongeneel C.V., Gure A.O., Jaeger D., Jaeger E., Knuth A., Chen Y.-T.,
RA   Old L.J.;
RT   "Antigens recognized by autologous antibody in patients with renal-cell
RT   carcinoma.";
RL   Int. J. Cancer 83:456-464(1999).
RN   [23]
RP   INTERACTION WITH TERT, AND FUNCTION AS A CO-CHAPERONE IN TELOMERASE
RP   HOLOENZYME ASSEMBLY.
RX   PubMed=11274138; DOI=10.1074/jbc.c100055200;
RA   Forsythe H.L., Jarvis J.L., Turner J.W., Elmore L.W., Holt S.E.;
RT   "Stable association of hsp90 and p23, but Not hsp70, with active human
RT   telomerase.";
RL   J. Biol. Chem. 276:15571-15574(2001).
RN   [24]
RP   INTERACTION WITH HSF1.
RX   PubMed=11583998; DOI=10.1074/jbc.m105931200;
RA   Guo Y., Guettouche T., Fenna M., Boellmann F., Pratt W.B., Toft D.O.,
RA   Smith D.F., Voellmy R.;
RT   "Evidence for a mechanism of repression of heat shock factor 1
RT   transcriptional activity by a multichaperone complex.";
RL   J. Biol. Chem. 276:45791-45799(2001).
RN   [25]
RP   FUNCTION, IDENTIFICATION AS LPS RECEPTOR, INTERACTION WITH CXCR4; GDF5 AND
RP   HSPA8, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=11276205; DOI=10.1038/86342;
RA   Triantafilou K., Triantafilou M., Dedrick R.L.;
RT   "A CD14-independent LPS receptor cluster.";
RL   Nat. Immunol. 2:338-345(2001).
RN   [26]
RP   INTERACTION WITH DNAJC7.
RX   PubMed=12853476; DOI=10.1093/emboj/cdg362;
RA   Brychzy A., Rein T., Winklhofer K.F., Hartl F.U., Young J.C.,
RA   Obermann W.M.;
RT   "Cofactor Tpr2 combines two TPR domains and a J domain to regulate the
RT   Hsp70/Hsp90 chaperone system.";
RL   EMBO J. 22:3613-3623(2003).
RN   [27]
RP   INTERACTION WITH AHSA1.
RX   PubMed=12604615; DOI=10.1074/jbc.m212761200;
RA   Lotz G.P., Lin H., Harst A., Obermann W.M.J.;
RT   "Aha1 binds to the middle domain of Hsp90, contributes to client protein
RT   activation, and stimulates the ATPase activity of the molecular
RT   chaperone.";
RL   J. Biol. Chem. 278:17228-17235(2003).
RN   [28]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.;
RT   "Proteomic characterization of the human centrosome by protein correlation
RT   profiling.";
RL   Nature 426:570-574(2003).
RN   [29]
RP   INTERACTION WITH SMYD3.
RX   PubMed=15235609; DOI=10.1038/ncb1151;
RA   Hamamoto R., Furukawa Y., Morita M., Iimura Y., Silva F.P., Li M.,
RA   Yagyu R., Nakamura Y.;
RT   "SMYD3 encodes a histone methyltransferase involved in the proliferation of
RT   cancer cells.";
RL   Nat. Cell Biol. 6:731-740(2004).
RN   [30]
RP   INTERACTION WITH SGTA AND TTC1.
RX   PubMed=15708368; DOI=10.1016/j.abb.2004.12.020;
RA   Liou S.T., Wang C.;
RT   "Small glutamine-rich tetratricopeptide repeat-containing protein is
RT   composed of three structural units with distinct functions.";
RL   Arch. Biochem. Biophys. 435:253-263(2005).
RN   [31]
RP   INTERACTION WITH PPP5C, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=15383005; DOI=10.1042/bj20040690;
RA   Zeke T., Morrice N., Vazquez-Martin C., Cohen P.T.;
RT   "Human protein phosphatase 5 dissociates from heat-shock proteins and is
RT   proteolytically activated in response to arachidonic acid and the
RT   microtubule-depolymerizing drug nocodazole.";
RL   Biochem. J. 385:45-56(2005).
RN   [32]
RP   FUNCTION, AND INTERACTION WITH PPP5C.
RX   PubMed=15577939; DOI=10.1038/sj.emboj.7600496;
RA   Yang J., Roe S.M., Cliff M.J., Williams M.A., Ladbury J.E., Cohen P.T.,
RA   Barford D.;
RT   "Molecular basis for TPR domain-mediated regulation of protein phosphatase
RT   5.";
RL   EMBO J. 24:1-10(2005).
RN   [33]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-231 AND SER-263, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [34]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-263, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Pituitary;
RX   PubMed=16807684; DOI=10.1007/s11102-006-8916-x;
RA   Beranova-Giorgianni S., Zhao Y., Desiderio D.M., Giorgianni F.;
RT   "Phosphoproteomic analysis of the human pituitary.";
RL   Pituitary 9:109-120(2006).
RN   [35]
RP   INTERACTION WITH PPP5C.
RX   PubMed=16531226; DOI=10.1016/j.str.2005.12.009;
RA   Cliff M.J., Harris R., Barford D., Ladbury J.E., Williams M.A.;
RT   "Conformational diversity in the TPR domain-mediated interaction of protein
RT   phosphatase 5 with Hsp90.";
RL   Structure 14:415-426(2006).
RN   [36]
RP   INTERACTION WITH NLRP12.
RX   PubMed=17947705; DOI=10.4049/jimmunol.179.9.6291;
RA   Arthur J.C., Lich J.D., Aziz R.K., Kotb M., Ting J.P.;
RT   "Heat shock protein 90 associates with monarch-1 and regulates its ability
RT   to promote degradation of NF-kappaB-inducing kinase.";
RL   J. Immunol. 179:6291-6296(2007).
RN   [37]
RP   SUBUNIT, ACTIVITY REGULATION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=18400751; DOI=10.1074/jbc.m800540200;
RA   Richter K., Soroka J., Skalniak L., Leskovar A., Hessling M., Reinstein J.,
RA   Buchner J.;
RT   "Conserved conformational changes in the ATPase cycle of human Hsp90.";
RL   J. Biol. Chem. 283:17757-17765(2008).
RN   [38]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-263, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=T-cell;
RX   PubMed=19367720; DOI=10.1021/pr800500r;
RA   Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
RT   "Phosphorylation analysis of primary human T lymphocytes using sequential
RT   IMAC and titanium oxide enrichment.";
RL   J. Proteome Res. 7:5167-5176(2008).
RN   [39]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-252 AND SER-263, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [40]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-263, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [41]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-263, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [42]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-231 AND SER-263, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by enrichment
RT   and fractionation of phosphopeptides with strong anion exchange
RT   chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [43]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [44]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [45]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-443; LYS-458; LYS-489 AND
RP   LYS-585, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [46]
RP   INTERACTION WITH CHORDC1.
RX   PubMed=19875381; DOI=10.1074/mcp.m900261-mcp200;
RA   Gano J.J., Simon J.A.;
RT   "A proteomic investigation of ligand-dependent HSP90 complexes reveals
RT   CHORDC1 as a novel ADP-dependent HSP90-interacting protein.";
RL   Mol. Cell. Proteomics 9:255-270(2010).
RN   [47]
RP   ISGYLATION.
RX   PubMed=16139798; DOI=10.1016/j.bbrc.2005.08.132;
RA   Giannakopoulos N.V., Luo J.K., Papov V., Zou W., Lenschow D.J.,
RA   Jacobs B.S., Borden E.C., Li J., Virgin H.W., Zhang D.E.;
RT   "Proteomic identification of proteins conjugated to ISG15 in mouse and
RT   human cells.";
RL   Biochem. Biophys. Res. Commun. 336:496-506(2005).
RN   [48]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H., Mangini N.J.,
RA   Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R., Yamagishi S.,
RA   Shabanowitz J., Hearing V.J., Wu C., Appella E., Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [49]
RP   INTERACTION WITH FNIP1, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=17028174; DOI=10.1073/pnas.0603781103;
RA   Baba M., Hong S.-B., Sharma N., Warren M.B., Nickerson M.L., Iwamatsu A.,
RA   Esposito D., Gillette W.K., Hopkins R.F. III, Hartley J.L., Furihata M.,
RA   Oishi S., Zhen W., Burke T.R. Jr., Linehan W.M., Schmidt L.S., Zbar B.;
RT   "Folliculin encoded by the BHD gene interacts with a binding protein,
RT   FNIP1, and AMPK, and is involved in AMPK and mTOR signaling.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:15552-15557(2006).
RN   [50]
RP   MUTAGENESIS OF GLY-97.
RX   PubMed=18256191; DOI=10.1242/dev.018150;
RA   Hawkins T.A., Haramis A.P., Etard C., Prodromou C., Vaughan C.K.,
RA   Ashworth R., Ray S., Behra M., Holder N., Talbot W.S., Pearl L.H.,
RA   Strahle U., Wilson S.W.;
RT   "The ATPase-dependent chaperoning activity of Hsp90a regulates thick
RT   filament formation and integration during skeletal muscle
RT   myofibrillogenesis.";
RL   Development 135:1147-1156(2008).
RN   [51]
RP   MUTAGENESIS OF CYS-598.
RX   PubMed=19696785; DOI=10.1038/embor.2009.153;
RA   Retzlaff M., Stahl M., Eberl H.C., Lagleder S., Beck J., Kessler H.,
RA   Buchner J.;
RT   "Hsp90 is regulated by a switch point in the C-terminal domain.";
RL   EMBO Rep. 10:1147-1153(2009).
RN   [52]
RP   INTERACTION WITH HSP90AB1.
RX   PubMed=20353823; DOI=10.1016/j.cellsig.2010.03.012;
RA   Cheng M.B., Zhang Y., Zhong X., Sutter B., Cao C.Y., Chen X.S., Cheng X.K.,
RA   Zhang Y., Xiao L., Shen Y.F.;
RT   "Stat1 mediates an auto-regulation of hsp90beta gene in heat shock
RT   response.";
RL   Cell. Signal. 22:1206-1213(2010).
RN   [53]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [54]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [55]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-252, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [56]
RP   INTERACTION WITH CDC37.
RX   PubMed=23569206; DOI=10.1074/jbc.m112.439257;
RA   Eckl J.M., Rutz D.A., Haslbeck V., Zierer B.K., Reinstein J., Richter K.;
RT   "Cdc37 (cell division cycle 37) restricts Hsp90 (heat shock protein 90)
RT   motility by interaction with N-terminal and middle domain binding sites.";
RL   J. Biol. Chem. 288:16032-16042(2013).
RN   [57]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-231; SER-252; SER-263;
RP   SER-476 AND SER-641, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [58]
RP   FUNCTION, AND INTERACTION WITH STUB1 AND SMAD3.
RX   PubMed=24613385; DOI=10.1016/j.bbrc.2014.02.124;
RA   Shang Y., Xu X., Duan X., Guo J., Wang Y., Ren F., He D., Chang Z.;
RT   "Hsp70 and Hsp90 oppositely regulate TGF-beta signaling through
RT   CHIP/Stub1.";
RL   Biochem. Biophys. Res. Commun. 446:387-392(2014).
RN   [59]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-231, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [60]
RP   INTERACTION WITH NWD1.
RX   PubMed=24681825; DOI=10.18632/oncotarget.1850;
RA   Correa R.G., Krajewska M., Ware C.F., Gerlic M., Reed J.C.;
RT   "The NLR-related protein NWD1 is associated with prostate cancer and
RT   modulates androgen receptor signaling.";
RL   Oncotarget 5:1666-1682(2014).
RN   [61]
RP   REVIEW.
RX   PubMed=25973397; DOI=10.3389/fonc.2015.00100;
RA   Khurana N., Bhattacharyya S.;
RT   "Hsp90, the concertmaster: tuning transcription.";
RL   Front. Oncol. 5:100-100(2015).
RN   [62]
RP   INTERACTION WITH SMYD3.
RX   PubMed=25738358; DOI=10.18632/oncotarget.2970;
RA   Brown M.A., Foreman K., Harriss J., Das C., Zhu L., Edwards M., Shaaban S.,
RA   Tucker H.;
RT   "C-terminal domain of SMYD3 serves as a unique HSP90-regulated motif in
RT   oncogenesis.";
RL   Oncotarget 6:4005-4019(2015).
RN   [63]
RP   INTERACTION WITH HSF1; HIF1A; ERBB2; MET; KEAP1 AND RHOBTB2, AND
RP   MUTAGENESIS OF GLU-47 AND ASP-93.
RX   PubMed=26517842; DOI=10.1371/journal.pone.0141786;
RA   Prince T.L., Kijima T., Tatokoro M., Lee S., Tsutsumi S., Yim K., Rivas C.,
RA   Alarcon S., Schwartz H., Khamit-Kush K., Scroggins B.T., Beebe K.,
RA   Trepel J.B., Neckers L.;
RT   "Client proteins and small molecule inhibitors display distinct binding
RT   preferences for constitutive and stress-induced HSP90 isoforms and their
RT   conformationally restricted mutants.";
RL   PLoS ONE 10:E0141786-E0141786(2015).
RN   [64]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [65]
RP   REVIEW.
RX   PubMed=27295069; DOI=10.1016/j.biochi.2016.05.018;
RA   Verma S., Goyal S., Jamal S., Singh A., Grover A.;
RT   "Hsp90: Friends, clients and natural foes.";
RL   Biochimie 127:227-240(2016).
RN   [66]
RP   REVIEW.
RX   PubMed=26991466; DOI=10.1002/bip.22835;
RA   Pearl L.H.;
RT   "Review: The HSP90 molecular chaperone-an enigmatic ATPase.";
RL   Biopolymers 105:594-607(2016).
RN   [67]
RP   FUNCTION, AND INTERACTION WITH FLCN; AHSA1; HSP70; CDC37; FNIP1; FNIP2;
RP   STUB1; STIP1; PTGES3 AND PPP5C.
RX   PubMed=27353360; DOI=10.1038/ncomms12037;
RA   Woodford M.R., Dunn D.M., Blanden A.R., Capriotti D., Loiselle D.,
RA   Prodromou C., Panaretou B., Hughes P.F., Smith A., Ackerman W.,
RA   Haystead T.A., Loh S.N., Bourboulia D., Schmidt L.S., Marston Linehan W.,
RA   Bratslavsky G., Mollapour M.;
RT   "The FNIP co-chaperones decelerate the Hsp90 chaperone cycle and enhance
RT   drug binding.";
RL   Nat. Commun. 7:12037-12037(2016).
RN   [68]
RP   INTERACTION WITH HSF1.
RX   PubMed=26754925; DOI=10.1038/srep19174;
RA   Asano Y., Kawase T., Okabe A., Tsutsumi S., Ichikawa H., Tatebe S.,
RA   Kitabayashi I., Tashiro F., Namiki H., Kondo T., Semba K., Aburatani H.,
RA   Taya Y., Nakagama H., Ohki R.;
RT   "IER5 generates a novel hypo-phosphorylated active form of HSF1 and
RT   contributes to tumorigenesis.";
RL   Sci. Rep. 6:19174-19174(2016).
RN   [69]
RP   FUNCTION, ACTIVITY REGULATION, IDENTIFICATION IN A COMPLEX WITH TSC1 AND
RP   TSC2, INTERACTION WITH TSC1 AND AHSA1, SUBUNIT, AND MUTAGENESIS OF GLU-47;
RP   ASP-93; TYR-313 AND 728-MET--ASP-732.
RX   PubMed=29127155; DOI=10.15252/embj.201796700;
RA   Woodford M.R., Sager R.A., Marris E., Dunn D.M., Blanden A.R., Murphy R.L.,
RA   Rensing N., Shapiro O., Panaretou B., Prodromou C., Loh S.N., Gutmann D.H.,
RA   Bourboulia D., Bratslavsky G., Wong M., Mollapour M.;
RT   "Tumor suppressor Tsc1 is a new Hsp90 co-chaperone that facilitates folding
RT   of kinase and non-kinase clients.";
RL   EMBO J. 36:3650-3665(2017).
RN   [70]
RP   INTERACTION WITH NLRP12.
RX   PubMed=30559449; DOI=10.1038/s41467-018-07750-5;
RA   Normand S., Waldschmitt N., Neerincx A., Martinez-Torres R.J., Chauvin C.,
RA   Couturier-Maillard A., Boulard O., Cobret L., Awad F., Huot L.,
RA   Ribeiro-Ribeiro A., Lautz K., Ruez R., Delacre M., Bondu C., Guilliams M.,
RA   Scott C., Segal A., Amselem S., Hot D., Karabina S., Bohn E., Ryffel B.,
RA   Poulin L.F., Kufer T.A., Chamaillard M.;
RT   "Proteasomal degradation of NOD2 by NLRP12 in monocytes promotes bacterial
RT   tolerance and colonization by enteropathogens.";
RL   Nat. Commun. 9:5338-5338(2018).
RN   [71]
RP   INTERACTION WITH HERPES SIMPLEX VIRUS 1 PROTEIN US11 (MICROBIAL INFECTION).
RX   PubMed=29743370; DOI=10.1128/jvi.00402-18;
RA   Liu X., Main D., Ma Y., He B.;
RT   "Herpes Simplex Virus 1 Inhibits TANK-Binding Kinase 1 through Formation of
RT   the Us11-Hsp90 Complex.";
RL   J. Virol. 92:0-0(2018).
RN   [72]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 11-223 IN COMPLEX WITH
RP   GELDANAMYCIN.
RX   PubMed=9108479; DOI=10.1016/s0092-8674(00)80203-2;
RA   Stebbins C.E., Russo A.A., Schneider C., Rosen N., Hartl F.U.,
RA   Pavletich N.P.;
RT   "Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein
RT   chaperone by an antitumor agent.";
RL   Cell 89:239-250(1997).
RN   [73]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 11-223 IN COMPLEX WITH ADP,
RP   CATALYTIC ACTIVITY, AND INTERACTION WITH PTGES3.
RX   PubMed=9817749; DOI=10.1083/jcb.143.4.901;
RA   Obermann W.M., Sondermann H., Russo A.A., Pavletich N.P., Hartl F.U.;
RT   "In vivo function of Hsp90 is dependent on ATP binding and ATP
RT   hydrolysis.";
RL   J. Cell Biol. 143:901-910(1998).
RN   [74]
RP   X-RAY CRYSTALLOGRAPHY (3.30 ANGSTROMS) OF 724-732 IN COMPLEX WITH STUB1,
RP   INTERACTION WITH STUB1 AND UBE2N, AND MOTIF TPR REPEAT-BINDING.
RX   PubMed=16307917; DOI=10.1016/j.molcel.2005.09.023;
RA   Zhang M., Windheim M., Roe S.M., Peggie M., Cohen P., Prodromou C.,
RA   Pearl L.H.;
RT   "Chaperoned ubiquitylation -- crystal structures of the CHIP U box E3
RT   ubiquitin ligase and a CHIP-Ubc13-Uev1a complex.";
RL   Mol. Cell 20:525-538(2005).
CC   -!- FUNCTION: Molecular chaperone that promotes the maturation, structural
CC       maintenance and proper regulation of specific target proteins involved
CC       for instance in cell cycle control and signal transduction. Undergoes a
CC       functional cycle that is linked to its ATPase activity which is
CC       essential for its chaperone activity. This cycle probably induces
CC       conformational changes in the client proteins, thereby causing their
CC       activation. Interacts dynamically with various co-chaperones that
CC       modulate its substrate recognition, ATPase cycle and chaperone function
CC       (PubMed:11274138, PubMed:15577939, PubMed:15937123, PubMed:27353360,
CC       PubMed:29127155). Engages with a range of client protein classes via
CC       its interaction with various co-chaperone proteins or complexes, that
CC       act as adapters, simultaneously able to interact with the specific
CC       client and the central chaperone itself (PubMed:29127155). Recruitment
CC       of ATP and co-chaperone followed by client protein forms a functional
CC       chaperone. After the completion of the chaperoning process, properly
CC       folded client protein and co-chaperone leave HSP90 in an ADP-bound
CC       partially open conformation and finally, ADP is released from HSP90
CC       which acquires an open conformation for the next cycle
CC       (PubMed:27295069, PubMed:26991466). Apart from its chaperone activity,
CC       it also plays a role in the regulation of the transcription machinery.
CC       HSP90 and its co-chaperones modulate transcription at least at three
CC       different levels (PubMed:25973397). In the first place, they alter the
CC       steady-state levels of certain transcription factors in response to
CC       various physiological cues(PubMed:25973397). Second, they modulate the
CC       activity of certain epigenetic modifiers, such as histone deacetylases
CC       or DNA methyl transferases, and thereby respond to the change in the
CC       environment (PubMed:25973397). Third, they participate in the eviction
CC       of histones from the promoter region of certain genes and thereby turn
CC       on gene expression (PubMed:25973397). Binds bacterial
CC       lipopolysaccharide (LPS) and mediates LPS-induced inflammatory
CC       response, including TNF secretion by monocytes (PubMed:11276205).
CC       Antagonizes STUB1-mediated inhibition of TGF-beta signaling via
CC       inhibition of STUB1-mediated SMAD3 ubiquitination and degradation
CC       (PubMed:24613385). {ECO:0000269|PubMed:11274138,
CC       ECO:0000269|PubMed:11276205, ECO:0000269|PubMed:15577939,
CC       ECO:0000269|PubMed:15937123, ECO:0000269|PubMed:24613385,
CC       ECO:0000269|PubMed:27353360, ECO:0000269|PubMed:29127155,
CC       ECO:0000303|PubMed:25973397, ECO:0000303|PubMed:26991466,
CC       ECO:0000303|PubMed:27295069}.
CC   -!- ACTIVITY REGULATION: In the resting state, through the dimerization of
CC       its C-terminal domain, HSP90 forms a homodimer which is defined as the
CC       open conformation (PubMed:18400751). Upon ATP-binding, the N-terminal
CC       domain undergoes significant conformational changes and comes in
CC       contact to form an active closed conformation (PubMed:18400751). After
CC       HSP90 finishes its chaperoning tasks of assisting the proper folding,
CC       stabilization and activation of client proteins under the active state,
CC       ATP molecule is hydrolyzed to ADP which then dissociates from HSP90 and
CC       directs the protein back to the resting state (PubMed:18400751). Co-
CC       chaperone TSC1 promotes ATP binding and inhibits HSP90AA1 ATPase
CC       activity (PubMed:29127155). Binding to phosphorylated AHSA1 promotes
CC       HSP90AA1 ATPase activity (PubMed:29127155). Inhibited by Ganetespib
CC       (STA-9090) and SNX-2112 (PubMed:29127155).
CC       {ECO:0000269|PubMed:18400751, ECO:0000269|PubMed:29127155}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=300 uM for ATP {ECO:0000269|PubMed:18400751};
CC   -!- SUBUNIT: Homodimer (PubMed:7588731, PubMed:8289821, PubMed:18400751,
CC       PubMed:29127155). Identified in NR3C1/GCR steroid receptor-chaperone
CC       complexes formed at least by NR3C1, HSP90AA1 and a variety of proteins
CC       containing TPR repeats such as FKBP4, FKBP5, PPID, PPP5C or STIP1
CC       (PubMed:15383005, PubMed:9195923). Forms a complex containing HSP90AA1,
CC       TSC1 and TSC2; TSC1 is required to recruit TCS2 to the complex
CC       (PubMed:29127155). The closed form interacts (via the middle domain and
CC       TPR repeat-binding motif) with co-chaperone TSC1 (via C-terminus)
CC       (PubMed:29127155). Interacts with TOM34 (PubMed:9660753). Interacts
CC       with TERT; the interaction, together with PTGES3, is required for
CC       correct assembly and stabilization of the TERT holoenzyme complex
CC       (PubMed:11274138, PubMed:9817749). Interacts with CHORDC1 and DNAJC7
CC       (PubMed:12853476, PubMed:19875381). Interacts with STUB1 and UBE2N; may
CC       couple the chaperone and ubiquitination systems (PubMed:16307917,
CC       PubMed:27353360). Interacts (via TPR repeat-binding motif) with PPP5C
CC       (via TPR repeats); the interaction is direct and activates PPP5C
CC       phosphatase activity (PubMed:15383005, PubMed:15577939,
CC       PubMed:16531226, PubMed:27353360). Following LPS binding, may form a
CC       complex with CXCR4, GDF5 and HSPA8 (PubMed:11276205). Interacts with
CC       KSR1 (PubMed:10409742). Interacts with co-chaperone CDC37 (via C-
CC       terminus); the interaction inhibits HSP90AA1 ATPase activity
CC       (PubMed:23569206, PubMed:27353360). May interact with NWD1
CC       (PubMed:24681825). Interacts with FNIP1 and FNIP2; the interaction
CC       inhibits HSP90AA1 ATPase activity (PubMed:17028174, PubMed:27353360).
CC       Interacts with co-chaperone AHSA1 (phosphorylated on 'Tyr-223'); the
CC       interaction activates HSP90AA1 ATPase activity and results in the
CC       dissociation of TSC1 from HSP90AA1 (PubMed:12604615, PubMed:27353360,
CC       PubMed:29127155). Interacts with FLCN in the presence of FNIP1
CC       (PubMed:27353360). Interacts with HSP70, STIP1 and PTGES3
CC       (PubMed:27353360). Interacts with SMYD3; this interaction enhances
CC       SMYD3 histone-lysine N-methyltransferase (PubMed:15235609,
CC       PubMed:25738358). Interacts with SGTA (via TPR repeats)
CC       (PubMed:15708368). Interacts with TTC1 (via TPR repeats)
CC       (PubMed:15708368). Interacts with HSF1 in an ATP-dependent manner
CC       (PubMed:11583998. PubMed:26517842). Interacts with MET; the interaction
CC       suppresses MET kinase activity (PubMed:26517842). Interacts with ERBB2
CC       in an ATP-dependent manner; the interaction suppresses ERBB2 kinase
CC       activity (PubMed:26517842). Interacts with HIF1A, KEAP1 and RHOBTB2
CC       (PubMed:26517842). Interacts with HSF1; this interaction is decreased
CC       in a IER5-dependent manner, promoting HSF1 accumulation in the nucleus,
CC       homotrimerization and DNA-binding activities (PubMed:26754925).
CC       Interacts with STUB1 and SMAD3 (PubMed:24613385). Interacts with
CC       HSP90AB1; interaction is constitutive (PubMed:20353823). Interacts with
CC       HECTD1 (via N-terminus) (By similarity). Interacts with NR3C1 (via
CC       domain NR LBD) and NR1D1 (via domain NR LBD) (By similarity). Interacts
CC       with NLPR12 (PubMed:30559449, PubMed:17947705). Interacts with PDCL3
CC       (By similarity). {ECO:0000250|UniProtKB:P07901,
CC       ECO:0000250|UniProtKB:P82995, ECO:0000269|PubMed:10409742,
CC       ECO:0000269|PubMed:11274138, ECO:0000269|PubMed:11276205,
CC       ECO:0000269|PubMed:11583998, ECO:0000269|PubMed:12604615,
CC       ECO:0000269|PubMed:12853476, ECO:0000269|PubMed:15235609,
CC       ECO:0000269|PubMed:15383005, ECO:0000269|PubMed:15577939,
CC       ECO:0000269|PubMed:15708368, ECO:0000269|PubMed:16307917,
CC       ECO:0000269|PubMed:16531226, ECO:0000269|PubMed:17028174,
CC       ECO:0000269|PubMed:17947705, ECO:0000269|PubMed:18400751,
CC       ECO:0000269|PubMed:19875381, ECO:0000269|PubMed:20353823,
CC       ECO:0000269|PubMed:23569206, ECO:0000269|PubMed:24613385,
CC       ECO:0000269|PubMed:24681825, ECO:0000269|PubMed:25738358,
CC       ECO:0000269|PubMed:26517842, ECO:0000269|PubMed:26754925,
CC       ECO:0000269|PubMed:27353360, ECO:0000269|PubMed:29127155,
CC       ECO:0000269|PubMed:30559449, ECO:0000269|PubMed:7588731,
CC       ECO:0000269|PubMed:8289821, ECO:0000269|PubMed:9195923,
CC       ECO:0000269|PubMed:9660753, ECO:0000269|PubMed:9817749}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with herpes simplex virus 1
CC       protein US11; this interaction inhibits TBK1-induced interferon
CC       production. {ECO:0000269|PubMed:29743370}.
CC   -!- INTERACTION:
CC       P07900; P07900; NbExp=6; IntAct=EBI-296047, EBI-296047;
CC       P07900; O95433: AHSA1; NbExp=4; IntAct=EBI-296047, EBI-448610;
CC       P07900; Q8IWD4: CCDC117; NbExp=5; IntAct=EBI-296047, EBI-3387963;
CC       P07900; Q16543: CDC37; NbExp=14; IntAct=EBI-296047, EBI-295634;
CC       P07900; Q7L3B6: CDC37L1; NbExp=2; IntAct=EBI-296047, EBI-2841876;
CC       P07900; P50750: CDK9; NbExp=2; IntAct=EBI-296047, EBI-1383449;
CC       P07900; Q96G23: CERS2; NbExp=2; IntAct=EBI-296047, EBI-1057080;
CC       P07900; Q9UHD1: CHORDC1; NbExp=8; IntAct=EBI-296047, EBI-2550959;
CC       P07900; O15111: CHUK; NbExp=3; IntAct=EBI-296047, EBI-81249;
CC       P07900; P00533: EGFR; NbExp=7; IntAct=EBI-296047, EBI-297353;
CC       P07900; P04626: ERBB2; NbExp=5; IntAct=EBI-296047, EBI-641062;
CC       P07900; Q02790: FKBP4; NbExp=8; IntAct=EBI-296047, EBI-1047444;
CC       P07900; Q13451: FKBP5; NbExp=8; IntAct=EBI-296047, EBI-306914;
CC       P07900; Q14318: FKBP8; NbExp=7; IntAct=EBI-296047, EBI-724839;
CC       P07900; Q6PK50: HSP90AB1; NbExp=2; IntAct=EBI-296047, EBI-9356629;
CC       P07900; Q9Y6K9: IKBKG; NbExp=3; IntAct=EBI-296047, EBI-81279;
CC       P07900; Q9UHH9: IP6K2; NbExp=2; IntAct=EBI-296047, EBI-747509;
CC       P07900; P05412: JUN; NbExp=4; IntAct=EBI-296047, EBI-852823;
CC       P07900; Q6VAB6: KSR2; NbExp=5; IntAct=EBI-296047, EBI-6424389;
CC       P07900; P06239: LCK; NbExp=3; IntAct=EBI-296047, EBI-1348;
CC       P07900; Q99558: MAP3K14; NbExp=4; IntAct=EBI-296047, EBI-358011;
CC       P07900; O43318-2: MAP3K7; NbExp=5; IntAct=EBI-296047, EBI-358700;
CC       P07900; P04150: NR3C1; NbExp=8; IntAct=EBI-296047, EBI-493507;
CC       P07900; Q8WVJ2: NUDCD2; NbExp=4; IntAct=EBI-296047, EBI-1052153;
CC       P07900; P43034: PAFAH1B1; NbExp=5; IntAct=EBI-296047, EBI-720620;
CC       P07900; P26882: PPID; Xeno; NbExp=4; IntAct=EBI-296047, EBI-6477155;
CC       P07900; P53041: PPP5C; NbExp=11; IntAct=EBI-296047, EBI-716663;
CC       P07900; Q15185: PTGES3; NbExp=6; IntAct=EBI-296047, EBI-1049387;
CC       P07900; P04049: RAF1; NbExp=3; IntAct=EBI-296047, EBI-365996;
CC       P07900; Q9H6T3: RPAP3; NbExp=6; IntAct=EBI-296047, EBI-356928;
CC       P07900; P61247: RPS3A; NbExp=3; IntAct=EBI-296047, EBI-352378;
CC       P07900; P35467: S100a1; Xeno; NbExp=4; IntAct=EBI-296047, EBI-6477109;
CC       P07900; P12931: SRC; NbExp=2; IntAct=EBI-296047, EBI-621482;
CC       P07900; Q15831: STK11; NbExp=2; IntAct=EBI-296047, EBI-306838;
CC       P07900; Q9UNE7: STUB1; NbExp=9; IntAct=EBI-296047, EBI-357085;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P07901}. Cytoplasm
CC       {ECO:0000250|UniProtKB:P07901}. Melanosome
CC       {ECO:0000269|PubMed:17081065}. Cell membrane
CC       {ECO:0000269|PubMed:11276205}. Note=Identified by mass spectrometry in
CC       melanosome fractions from stage I to stage IV.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=HSP90AA1-1, HSP90-alpha 2;
CC         IsoId=P07900-1; Sequence=Displayed;
CC       Name=2; Synonyms=HSP90AA1-2;
CC         IsoId=P07900-2; Sequence=VSP_026604;
CC   -!- DOMAIN: The TPR repeat-binding motif mediates interaction with TPR
CC       repeat-containing proteins like the co-chaperone STUB1.
CC       {ECO:0000269|PubMed:16307917}.
CC   -!- PTM: ISGylated. {ECO:0000269|PubMed:16139798}.
CC   -!- PTM: S-nitrosylated; negatively regulates the ATPase activity and the
CC       activation of eNOS by HSP90AA1. {ECO:0000269|PubMed:15937123}.
CC   -!- PTM: Ubiquitinated via 'Lys-63'-linked polyubiquitination by HECTD1.
CC       Ubiquitination promotes translocation into the cytoplasm away from the
CC       membrane and secretory pathways. {ECO:0000250|UniProtKB:P07901}.
CC   -!- SIMILARITY: Belongs to the heat shock protein 90 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X15183; CAA33259.1; -; mRNA.
DR   EMBL; M27024; AAA63194.1; -; Genomic_DNA.
DR   EMBL; AJ890082; CAI64495.1; -; mRNA.
DR   EMBL; AJ890083; CAI64496.1; -; mRNA.
DR   EMBL; DQ314871; ABC40730.1; -; Genomic_DNA.
DR   EMBL; AK056446; BAG51711.1; -; mRNA.
DR   EMBL; AK291115; BAF83804.1; -; mRNA.
DR   EMBL; AK291607; BAF84296.1; -; mRNA.
DR   EMBL; AL133223; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471061; EAW81765.1; -; Genomic_DNA.
DR   EMBL; X07270; CAA30255.1; -; mRNA.
DR   EMBL; M30626; AAA36023.1; -; Genomic_DNA.
DR   EMBL; BC000987; AAH00987.1; -; mRNA.
DR   EMBL; BC121062; AAI21063.1; -; mRNA.
DR   EMBL; D87666; BAA13430.1; -; mRNA.
DR   EMBL; D87666; BAA13431.1; -; mRNA.
DR   CCDS; CCDS32160.1; -. [P07900-2]
DR   CCDS; CCDS9967.1; -. [P07900-1]
DR   PIR; A32319; HHHU86.
DR   RefSeq; NP_001017963.2; NM_001017963.2. [P07900-2]
DR   RefSeq; NP_005339.3; NM_005348.3. [P07900-1]
DR   PDB; 1BYQ; X-ray; 1.50 A; A=9-236.
DR   PDB; 1OSF; X-ray; 1.75 A; A=9-223.
DR   PDB; 1UY6; X-ray; 1.90 A; A=2-236.
DR   PDB; 1UY7; X-ray; 1.90 A; A=2-236.
DR   PDB; 1UY8; X-ray; 1.98 A; A=2-236.
DR   PDB; 1UY9; X-ray; 2.00 A; A=2-236.
DR   PDB; 1UYC; X-ray; 2.00 A; A=2-236.
DR   PDB; 1UYD; X-ray; 2.20 A; A=2-236.
DR   PDB; 1UYE; X-ray; 2.00 A; A=2-236.
DR   PDB; 1UYF; X-ray; 2.00 A; A=2-236.
DR   PDB; 1UYG; X-ray; 2.00 A; A=2-236.
DR   PDB; 1UYH; X-ray; 2.20 A; A=2-236.
DR   PDB; 1UYI; X-ray; 2.20 A; A=2-236.
DR   PDB; 1UYK; X-ray; 2.20 A; A=2-236.
DR   PDB; 1UYL; X-ray; 1.40 A; A=2-236.
DR   PDB; 1YC1; X-ray; 1.70 A; A=9-236.
DR   PDB; 1YC3; X-ray; 2.12 A; A=9-236.
DR   PDB; 1YC4; X-ray; 1.81 A; A=9-236.
DR   PDB; 1YER; X-ray; 1.65 A; A=9-236.
DR   PDB; 1YES; X-ray; 2.20 A; A=9-236.
DR   PDB; 1YET; X-ray; 1.90 A; A=9-236.
DR   PDB; 2BSM; X-ray; 2.05 A; A=2-236.
DR   PDB; 2BT0; X-ray; 1.90 A; A/B=2-236.
DR   PDB; 2BUG; NMR; -; B=728-732.
DR   PDB; 2BYH; X-ray; 1.90 A; A=11-236.
DR   PDB; 2BYI; X-ray; 1.60 A; A=11-236.
DR   PDB; 2BZ5; X-ray; 1.90 A; A/B=2-236.
DR   PDB; 2C2L; X-ray; 3.30 A; E/F/G/H=724-732.
DR   PDB; 2CCS; X-ray; 1.79 A; A=1-236.
DR   PDB; 2CCT; X-ray; 2.30 A; A=1-236.
DR   PDB; 2CCU; X-ray; 2.70 A; A=1-236.
DR   PDB; 2FWY; X-ray; 2.10 A; A=1-236.
DR   PDB; 2FWZ; X-ray; 2.10 A; A=1-236.
DR   PDB; 2H55; X-ray; 2.00 A; A=1-236.
DR   PDB; 2JJC; X-ray; 1.95 A; A=9-223.
DR   PDB; 2K5B; NMR; -; A=14-223.
DR   PDB; 2QF6; X-ray; 3.10 A; A/B/C/D=17-223.
DR   PDB; 2QFO; X-ray; 1.68 A; A/B=17-223.
DR   PDB; 2QG0; X-ray; 1.85 A; A/B=17-223.
DR   PDB; 2QG2; X-ray; 1.80 A; A=17-223.
DR   PDB; 2UWD; X-ray; 1.90 A; A=2-236.
DR   PDB; 2VCI; X-ray; 2.00 A; A=1-236.
DR   PDB; 2VCJ; X-ray; 2.50 A; A=1-236.
DR   PDB; 2WI1; X-ray; 2.30 A; A=1-236.
DR   PDB; 2WI2; X-ray; 2.09 A; A/B=1-236.
DR   PDB; 2WI3; X-ray; 1.90 A; A=1-236.
DR   PDB; 2WI4; X-ray; 2.40 A; A=1-236.
DR   PDB; 2WI5; X-ray; 2.10 A; A=1-236.
DR   PDB; 2WI6; X-ray; 2.18 A; A=1-236.
DR   PDB; 2WI7; X-ray; 2.50 A; A=1-236.
DR   PDB; 2XAB; X-ray; 1.90 A; A/B=9-236.
DR   PDB; 2XDK; X-ray; 1.97 A; A=9-236.
DR   PDB; 2XDL; X-ray; 1.98 A; A=9-236.
DR   PDB; 2XDS; X-ray; 1.97 A; A=9-236.
DR   PDB; 2XDU; X-ray; 1.74 A; A=14-224.
DR   PDB; 2XDX; X-ray; 2.42 A; A=9-236.
DR   PDB; 2XHR; X-ray; 2.20 A; A=9-236.
DR   PDB; 2XHT; X-ray; 2.27 A; A=9-236.
DR   PDB; 2XHX; X-ray; 2.80 A; A=9-236.
DR   PDB; 2XJG; X-ray; 2.25 A; A=9-236.
DR   PDB; 2XJJ; X-ray; 1.90 A; A/B=9-236.
DR   PDB; 2XJX; X-ray; 1.66 A; A=9-236.
DR   PDB; 2XK2; X-ray; 1.95 A; A=9-236.
DR   PDB; 2YE2; X-ray; 1.90 A; A=9-236.
DR   PDB; 2YE3; X-ray; 1.95 A; A=9-236.
DR   PDB; 2YE4; X-ray; 2.30 A; A=9-236.
DR   PDB; 2YE5; X-ray; 1.73 A; A=9-236.
DR   PDB; 2YE6; X-ray; 2.56 A; A=9-236.
DR   PDB; 2YE7; X-ray; 2.20 A; A=9-236.
DR   PDB; 2YE8; X-ray; 2.30 A; A=9-236.
DR   PDB; 2YE9; X-ray; 2.20 A; A=9-236.
DR   PDB; 2YEA; X-ray; 1.73 A; A=9-236.
DR   PDB; 2YEB; X-ray; 2.40 A; A=9-236.
DR   PDB; 2YEC; X-ray; 2.10 A; A=9-236.
DR   PDB; 2YED; X-ray; 2.10 A; A=9-236.
DR   PDB; 2YEE; X-ray; 2.30 A; A=9-236.
DR   PDB; 2YEF; X-ray; 1.55 A; A=9-236.
DR   PDB; 2YEG; X-ray; 2.50 A; A/B=9-236.
DR   PDB; 2YEH; X-ray; 2.10 A; A=9-236.
DR   PDB; 2YEI; X-ray; 2.20 A; A=9-236.
DR   PDB; 2YEJ; X-ray; 2.20 A; A=9-236.
DR   PDB; 2YI0; X-ray; 1.60 A; A=1-229.
DR   PDB; 2YI5; X-ray; 2.50 A; A=1-229.
DR   PDB; 2YI6; X-ray; 1.80 A; A=1-229.
DR   PDB; 2YI7; X-ray; 1.40 A; A=1-229.
DR   PDB; 2YJW; X-ray; 1.61 A; A=18-223.
DR   PDB; 2YJX; X-ray; 1.83 A; A=18-223.
DR   PDB; 2YK2; X-ray; 1.74 A; A=18-223.
DR   PDB; 2YK9; X-ray; 1.32 A; A=18-223.
DR   PDB; 2YKB; X-ray; 1.93 A; A=18-223.
DR   PDB; 2YKC; X-ray; 1.67 A; A=18-223.
DR   PDB; 2YKE; X-ray; 1.43 A; A=18-223.
DR   PDB; 2YKI; X-ray; 1.67 A; A=18-223.
DR   PDB; 2YKJ; X-ray; 1.46 A; A=18-223.
DR   PDB; 3B24; X-ray; 1.70 A; A/B=9-236.
DR   PDB; 3B25; X-ray; 1.75 A; A=9-236.
DR   PDB; 3B26; X-ray; 2.10 A; A/B=9-236.
DR   PDB; 3B27; X-ray; 1.50 A; A=9-236.
DR   PDB; 3B28; X-ray; 1.35 A; A/B=9-236.
DR   PDB; 3BM9; X-ray; 1.60 A; A=14-236.
DR   PDB; 3BMY; X-ray; 1.60 A; A=14-236.
DR   PDB; 3D0B; X-ray; 1.74 A; A=1-232.
DR   PDB; 3EKO; X-ray; 1.55 A; A/B=9-225.
DR   PDB; 3EKR; X-ray; 2.00 A; A/B=9-225.
DR   PDB; 3FT5; X-ray; 1.90 A; A=9-236.
DR   PDB; 3FT8; X-ray; 2.00 A; A=9-236.
DR   PDB; 3HEK; X-ray; 1.95 A; A/B=9-225.
DR   PDB; 3HHU; X-ray; 1.59 A; A/B=1-224.
DR   PDB; 3HYY; X-ray; 1.90 A; A=9-236.
DR   PDB; 3HYZ; X-ray; 2.30 A; A/B=9-236.
DR   PDB; 3HZ1; X-ray; 2.30 A; A=9-236.
DR   PDB; 3HZ5; X-ray; 1.90 A; A=9-236.
DR   PDB; 3INW; X-ray; 1.95 A; A=10-236.
DR   PDB; 3INX; X-ray; 1.75 A; A=10-236.
DR   PDB; 3K97; X-ray; 1.95 A; A=9-236.
DR   PDB; 3K98; X-ray; 2.40 A; A/B=9-225.
DR   PDB; 3K99; X-ray; 2.10 A; A/B/C/D=9-225.
DR   PDB; 3MNR; X-ray; 1.90 A; P=1-232.
DR   PDB; 3O0I; X-ray; 1.47 A; A=1-236.
DR   PDB; 3OW6; X-ray; 1.80 A; A=17-223.
DR   PDB; 3OWB; X-ray; 2.05 A; A=17-223.
DR   PDB; 3OWD; X-ray; 1.63 A; A=17-223.
DR   PDB; 3Q6M; X-ray; 3.00 A; A/B/C=293-732.
DR   PDB; 3Q6N; X-ray; 3.05 A; A/B/C/D/E/F=293-732.
DR   PDB; 3QDD; X-ray; 1.79 A; A=1-236.
DR   PDB; 3QTF; X-ray; 1.57 A; A=14-236.
DR   PDB; 3R4M; X-ray; 1.70 A; A=9-236.
DR   PDB; 3R4N; X-ray; 2.00 A; A/B=9-225.
DR   PDB; 3R4O; X-ray; 2.65 A; A/B=9-225.
DR   PDB; 3R4P; X-ray; 1.70 A; A/B=9-225.
DR   PDB; 3R91; X-ray; 1.58 A; A=14-236.
DR   PDB; 3R92; X-ray; 1.58 A; A=14-236.
DR   PDB; 3RKZ; X-ray; 1.57 A; A=14-236.
DR   PDB; 3RLP; X-ray; 1.70 A; A/B=9-225.
DR   PDB; 3RLQ; X-ray; 1.90 A; A/B=9-225.
DR   PDB; 3RLR; X-ray; 1.70 A; A/B=9-225.
DR   PDB; 3T0H; X-ray; 1.20 A; A=9-236.
DR   PDB; 3T0Z; X-ray; 2.19 A; A=9-236.
DR   PDB; 3T10; X-ray; 1.24 A; A=9-236.
DR   PDB; 3T1K; X-ray; 1.50 A; A/B=9-236.
DR   PDB; 3T2S; X-ray; 1.50 A; A/B=9-236.
DR   PDB; 3TUH; X-ray; 1.80 A; A/B=16-224.
DR   PDB; 3VHA; X-ray; 1.39 A; A=9-236.
DR   PDB; 3VHC; X-ray; 1.41 A; A=9-236.
DR   PDB; 3VHD; X-ray; 1.52 A; A/B=9-236.
DR   PDB; 3WHA; X-ray; 1.30 A; A/B=9-236.
DR   PDB; 3WQ9; X-ray; 1.80 A; A=1-236.
DR   PDB; 4AIF; X-ray; 2.01 A; D/E=726-732.
DR   PDB; 4AWO; X-ray; 1.70 A; A/B=9-236.
DR   PDB; 4AWP; X-ray; 1.82 A; A/B=9-236.
DR   PDB; 4AWQ; X-ray; 1.60 A; A/B=9-236.
DR   PDB; 4B7P; X-ray; 1.70 A; A=9-236.
DR   PDB; 4BQG; X-ray; 1.90 A; A=9-236.
DR   PDB; 4BQJ; X-ray; 2.00 A; A=9-236.
DR   PDB; 4CGQ; X-ray; 2.00 A; Q=726-732.
DR   PDB; 4CGU; X-ray; 2.11 A; C=726-732.
DR   PDB; 4CGV; X-ray; 2.54 A; E/F=726-732.
DR   PDB; 4CGW; X-ray; 3.00 A; C/D=726-732.
DR   PDB; 4CWF; X-ray; 2.00 A; A=9-236.
DR   PDB; 4CWN; X-ray; 1.80 A; A=9-236.
DR   PDB; 4CWO; X-ray; 2.31 A; A=9-236.
DR   PDB; 4CWP; X-ray; 1.95 A; A=9-236.
DR   PDB; 4CWQ; X-ray; 2.00 A; A=9-236.
DR   PDB; 4CWR; X-ray; 2.00 A; A=9-236.
DR   PDB; 4CWS; X-ray; 2.30 A; A=9-236.
DR   PDB; 4CWT; X-ray; 1.90 A; A=9-236.
DR   PDB; 4EEH; X-ray; 1.60 A; A=9-236.
DR   PDB; 4EFT; X-ray; 2.12 A; A=9-236.
DR   PDB; 4EFU; X-ray; 2.00 A; A=9-236.
DR   PDB; 4EGH; X-ray; 1.60 A; A=9-236.
DR   PDB; 4EGI; X-ray; 1.79 A; A=9-236.
DR   PDB; 4EGK; X-ray; 1.69 A; A=9-236.
DR   PDB; 4FCP; X-ray; 2.00 A; A/B=1-236.
DR   PDB; 4FCQ; X-ray; 2.15 A; A=1-236.
DR   PDB; 4FCR; X-ray; 1.70 A; A=1-236.
DR   PDB; 4HY6; X-ray; 1.65 A; A=9-236.
DR   PDB; 4JQL; X-ray; 1.72 A; A=9-236.
DR   PDB; 4L8Z; X-ray; 1.70 A; A=9-236.
DR   PDB; 4L90; X-ray; 2.00 A; A=9-236.
DR   PDB; 4L91; X-ray; 1.75 A; A=9-236.
DR   PDB; 4L93; X-ray; 1.84 A; A/B=9-236.
DR   PDB; 4L94; X-ray; 1.65 A; A=9-236.
DR   PDB; 4LWE; X-ray; 1.50 A; A=17-224.
DR   PDB; 4LWF; X-ray; 1.75 A; A=17-224.
DR   PDB; 4LWG; X-ray; 1.60 A; A=17-224.
DR   PDB; 4LWH; X-ray; 1.70 A; A=16-224.
DR   PDB; 4LWI; X-ray; 1.70 A; A=17-224.
DR   PDB; 4NH7; X-ray; 2.00 A; A/B=9-236.
DR   PDB; 4NH8; X-ray; 1.65 A; A=9-236.
DR   PDB; 4O04; X-ray; 1.82 A; A=9-236.
DR   PDB; 4O05; X-ray; 1.79 A; A=9-236.
DR   PDB; 4O07; X-ray; 1.86 A; A=9-236.
DR   PDB; 4O09; X-ray; 1.96 A; A=9-236.
DR   PDB; 4O0B; X-ray; 1.93 A; A=9-236.
DR   PDB; 4R3M; X-ray; 1.80 A; A=16-224.
DR   PDB; 4U93; X-ray; 1.55 A; A=1-236.
DR   PDB; 4W7T; X-ray; 1.80 A; A=1-236.
DR   PDB; 4XIP; X-ray; 1.70 A; A=9-236.
DR   PDB; 4XIQ; X-ray; 1.84 A; A=9-236.
DR   PDB; 4XIR; X-ray; 1.70 A; A=9-236.
DR   PDB; 4XIT; X-ray; 1.86 A; A=9-236.
DR   PDB; 4YKQ; X-ray; 1.91 A; A=2-236.
DR   PDB; 4YKR; X-ray; 1.61 A; A=2-236.
DR   PDB; 4YKT; X-ray; 1.85 A; A=2-236.
DR   PDB; 4YKU; X-ray; 1.70 A; A=2-236.
DR   PDB; 4YKW; X-ray; 1.85 A; A/B=2-236.
DR   PDB; 4YKX; X-ray; 1.80 A; A=2-236.
DR   PDB; 4YKY; X-ray; 1.78 A; A=2-236.
DR   PDB; 4YKZ; X-ray; 1.85 A; A=2-236.
DR   PDB; 5CF0; X-ray; 1.80 A; A=9-236.
DR   PDB; 5FNC; X-ray; 2.20 A; A=1-236.
DR   PDB; 5FND; X-ray; 2.00 A; A=1-236.
DR   PDB; 5FNF; X-ray; 2.10 A; A=1-236.
DR   PDB; 5GGZ; X-ray; 2.02 A; A/B/C/D=16-225.
DR   PDB; 5J20; X-ray; 1.76 A; A=17-223.
DR   PDB; 5J27; X-ray; 1.70 A; A=16-224.
DR   PDB; 5J2V; X-ray; 1.59 A; A=17-223.
DR   PDB; 5J2X; X-ray; 1.22 A; A=17-224.
DR   PDB; 5J64; X-ray; 1.38 A; A=9-236.
DR   PDB; 5J6L; X-ray; 1.75 A; A=9-236.
DR   PDB; 5J6M; X-ray; 1.64 A; A=9-234.
DR   PDB; 5J6N; X-ray; 1.90 A; A=9-234.
DR   PDB; 5J80; X-ray; 1.17 A; A=9-233.
DR   PDB; 5J82; X-ray; 2.17 A; A=9-233.
DR   PDB; 5J86; X-ray; 1.87 A; A=9-233.
DR   PDB; 5J8M; X-ray; 1.90 A; A/B=9-233.
DR   PDB; 5J8U; X-ray; 1.75 A; A/B=9-233.
DR   PDB; 5J9X; X-ray; 1.80 A; A=9-233.
DR   PDB; 5LNY; X-ray; 1.88 A; A=9-236.
DR   PDB; 5LNZ; X-ray; 1.54 A; A=9-236.
DR   PDB; 5LO0; X-ray; 2.30 A; A=9-236.
DR   PDB; 5LO1; X-ray; 2.70 A; A=9-236.
DR   PDB; 5LO5; X-ray; 1.44 A; A=9-236.
DR   PDB; 5LO6; X-ray; 2.40 A; A=9-236.
DR   PDB; 5LQ9; X-ray; 1.90 A; A=17-223.
DR   PDB; 5LR1; X-ray; 1.44 A; A=18-223.
DR   PDB; 5LR7; X-ray; 1.86 A; A=18-223.
DR   PDB; 5LRL; X-ray; 1.33 A; A=18-223.
DR   PDB; 5LRZ; X-ray; 2.00 A; A=18-223.
DR   PDB; 5LS1; X-ray; 1.85 A; A=17-223.
DR   PDB; 5M4E; X-ray; 1.90 A; A=9-236.
DR   PDB; 5M4H; X-ray; 2.00 A; A=9-236.
DR   PDB; 5NYH; X-ray; 1.65 A; A=9-236.
DR   PDB; 5NYI; X-ray; 1.44 A; A=9-235.
DR   PDB; 5OCI; X-ray; 1.62 A; A=9-236.
DR   PDB; 5OD7; X-ray; 2.00 A; A=9-236.
DR   PDB; 5ODX; X-ray; 1.82 A; A=9-236.
DR   PDB; 5T21; X-ray; 2.10 A; A=18-223.
DR   PDB; 5VYY; X-ray; 1.79 A; A=1-236.
DR   PDB; 5XQD; X-ray; 1.60 A; A=9-236.
DR   PDB; 5XQE; X-ray; 1.70 A; A=9-236.
DR   PDB; 5XR5; X-ray; 1.60 A; A=9-236.
DR   PDB; 5XR9; X-ray; 1.50 A; A=9-236.
DR   PDB; 5XRB; X-ray; 1.65 A; A=9-236.
DR   PDB; 5XRD; X-ray; 1.30 A; A=9-236.
DR   PDB; 5XRE; X-ray; 1.50 A; A=9-236.
DR   PDB; 5ZR3; X-ray; 2.50 A; A/C/E/G=1-236.
DR   PDB; 6B99; X-ray; 1.60 A; A=1-236.
DR   PDB; 6B9A; X-ray; 1.65 A; A/B=1-236.
DR   PDB; 6CEO; X-ray; 1.90 A; A=1-236.
DR   PDB; 6CYG; X-ray; 1.50 A; A/B=1-236.
DR   PDB; 6CYH; X-ray; 1.49 A; A/B=1-236.
DR   PDB; 6EI5; X-ray; 2.20 A; A=15-223.
DR   PDB; 6EL5; X-ray; 1.67 A; A=1-236.
DR   PDB; 6ELN; X-ray; 1.60 A; A=17-223.
DR   PDB; 6ELO; X-ray; 1.80 A; A=1-236.
DR   PDB; 6ELP; X-ray; 1.85 A; A=1-236.
DR   PDB; 6EY8; X-ray; 2.16 A; A=1-236.
DR   PDB; 6EY9; X-ray; 2.00 A; A=1-236.
DR   PDB; 6EYA; X-ray; 2.10 A; A=1-236.
DR   PDB; 6EYB; X-ray; 1.90 A; A=1-236.
DR   PDB; 6F1N; X-ray; 2.09 A; A=1-236.
DR   PDB; 6FCJ; X-ray; 2.49 A; A=9-236.
DR   PDB; 6FDP; NMR; -; B=724-732.
DR   PDB; 6GP4; X-ray; 1.70 A; A=1-236.
DR   PDB; 6GP8; X-ray; 1.75 A; A=1-236.
DR   PDB; 6GPF; X-ray; 1.55 A; A=1-236.
DR   PDB; 6GPH; X-ray; 1.56 A; A=1-236.
DR   PDB; 6GPO; X-ray; 1.48 A; A=1-236.
DR   PDB; 6GPP; X-ray; 1.51 A; A=1-236.
DR   PDB; 6GPR; X-ray; 2.35 A; A=1-236.
DR   PDB; 6GPT; X-ray; 2.00 A; A=1-236.
DR   PDB; 6GPW; X-ray; 1.60 A; A=1-236.
DR   PDB; 6GPY; X-ray; 2.25 A; A=1-236.
DR   PDB; 6GQ6; X-ray; 2.25 A; A=1-236.
DR   PDB; 6GQR; X-ray; 2.05 A; A=1-236.
DR   PDB; 6GQS; X-ray; 1.43 A; A=1-236.
DR   PDB; 6GQU; X-ray; 1.72 A; A=1-236.
DR   PDB; 6GR1; X-ray; 2.05 A; A=1-236.
DR   PDB; 6GR3; X-ray; 1.88 A; A=1-236.
DR   PDB; 6GR4; X-ray; 1.50 A; A=1-236.
DR   PDB; 6GR5; X-ray; 1.34 A; A=1-236.
DR   PDB; 6HHR; X-ray; 2.00 A; A=17-224.
DR   PDB; 6N8X; X-ray; 1.49 A; A=1-236.
DR   PDB; 6OLX; X-ray; 1.44 A; A=1-236.
DR   PDBsum; 1BYQ; -.
DR   PDBsum; 1OSF; -.
DR   PDBsum; 1UY6; -.
DR   PDBsum; 1UY7; -.
DR   PDBsum; 1UY8; -.
DR   PDBsum; 1UY9; -.
DR   PDBsum; 1UYC; -.
DR   PDBsum; 1UYD; -.
DR   PDBsum; 1UYE; -.
DR   PDBsum; 1UYF; -.
DR   PDBsum; 1UYG; -.
DR   PDBsum; 1UYH; -.
DR   PDBsum; 1UYI; -.
DR   PDBsum; 1UYK; -.
DR   PDBsum; 1UYL; -.
DR   PDBsum; 1YC1; -.
DR   PDBsum; 1YC3; -.
DR   PDBsum; 1YC4; -.
DR   PDBsum; 1YER; -.
DR   PDBsum; 1YES; -.
DR   PDBsum; 1YET; -.
DR   PDBsum; 2BSM; -.
DR   PDBsum; 2BT0; -.
DR   PDBsum; 2BUG; -.
DR   PDBsum; 2BYH; -.
DR   PDBsum; 2BYI; -.
DR   PDBsum; 2BZ5; -.
DR   PDBsum; 2C2L; -.
DR   PDBsum; 2CCS; -.
DR   PDBsum; 2CCT; -.
DR   PDBsum; 2CCU; -.
DR   PDBsum; 2FWY; -.
DR   PDBsum; 2FWZ; -.
DR   PDBsum; 2H55; -.
DR   PDBsum; 2JJC; -.
DR   PDBsum; 2K5B; -.
DR   PDBsum; 2QF6; -.
DR   PDBsum; 2QFO; -.
DR   PDBsum; 2QG0; -.
DR   PDBsum; 2QG2; -.
DR   PDBsum; 2UWD; -.
DR   PDBsum; 2VCI; -.
DR   PDBsum; 2VCJ; -.
DR   PDBsum; 2WI1; -.
DR   PDBsum; 2WI2; -.
DR   PDBsum; 2WI3; -.
DR   PDBsum; 2WI4; -.
DR   PDBsum; 2WI5; -.
DR   PDBsum; 2WI6; -.
DR   PDBsum; 2WI7; -.
DR   PDBsum; 2XAB; -.
DR   PDBsum; 2XDK; -.
DR   PDBsum; 2XDL; -.
DR   PDBsum; 2XDS; -.
DR   PDBsum; 2XDU; -.
DR   PDBsum; 2XDX; -.
DR   PDBsum; 2XHR; -.
DR   PDBsum; 2XHT; -.
DR   PDBsum; 2XHX; -.
DR   PDBsum; 2XJG; -.
DR   PDBsum; 2XJJ; -.
DR   PDBsum; 2XJX; -.
DR   PDBsum; 2XK2; -.
DR   PDBsum; 2YE2; -.
DR   PDBsum; 2YE3; -.
DR   PDBsum; 2YE4; -.
DR   PDBsum; 2YE5; -.
DR   PDBsum; 2YE6; -.
DR   PDBsum; 2YE7; -.
DR   PDBsum; 2YE8; -.
DR   PDBsum; 2YE9; -.
DR   PDBsum; 2YEA; -.
DR   PDBsum; 2YEB; -.
DR   PDBsum; 2YEC; -.
DR   PDBsum; 2YED; -.
DR   PDBsum; 2YEE; -.
DR   PDBsum; 2YEF; -.
DR   PDBsum; 2YEG; -.
DR   PDBsum; 2YEH; -.
DR   PDBsum; 2YEI; -.
DR   PDBsum; 2YEJ; -.
DR   PDBsum; 2YI0; -.
DR   PDBsum; 2YI5; -.
DR   PDBsum; 2YI6; -.
DR   PDBsum; 2YI7; -.
DR   PDBsum; 2YJW; -.
DR   PDBsum; 2YJX; -.
DR   PDBsum; 2YK2; -.
DR   PDBsum; 2YK9; -.
DR   PDBsum; 2YKB; -.
DR   PDBsum; 2YKC; -.
DR   PDBsum; 2YKE; -.
DR   PDBsum; 2YKI; -.
DR   PDBsum; 2YKJ; -.
DR   PDBsum; 3B24; -.
DR   PDBsum; 3B25; -.
DR   PDBsum; 3B26; -.
DR   PDBsum; 3B27; -.
DR   PDBsum; 3B28; -.
DR   PDBsum; 3BM9; -.
DR   PDBsum; 3BMY; -.
DR   PDBsum; 3D0B; -.
DR   PDBsum; 3EKO; -.
DR   PDBsum; 3EKR; -.
DR   PDBsum; 3FT5; -.
DR   PDBsum; 3FT8; -.
DR   PDBsum; 3HEK; -.
DR   PDBsum; 3HHU; -.
DR   PDBsum; 3HYY; -.
DR   PDBsum; 3HYZ; -.
DR   PDBsum; 3HZ1; -.
DR   PDBsum; 3HZ5; -.
DR   PDBsum; 3INW; -.
DR   PDBsum; 3INX; -.
DR   PDBsum; 3K97; -.
DR   PDBsum; 3K98; -.
DR   PDBsum; 3K99; -.
DR   PDBsum; 3MNR; -.
DR   PDBsum; 3O0I; -.
DR   PDBsum; 3OW6; -.
DR   PDBsum; 3OWB; -.
DR   PDBsum; 3OWD; -.
DR   PDBsum; 3Q6M; -.
DR   PDBsum; 3Q6N; -.
DR   PDBsum; 3QDD; -.
DR   PDBsum; 3QTF; -.
DR   PDBsum; 3R4M; -.
DR   PDBsum; 3R4N; -.
DR   PDBsum; 3R4O; -.
DR   PDBsum; 3R4P; -.
DR   PDBsum; 3R91; -.
DR   PDBsum; 3R92; -.
DR   PDBsum; 3RKZ; -.
DR   PDBsum; 3RLP; -.
DR   PDBsum; 3RLQ; -.
DR   PDBsum; 3RLR; -.
DR   PDBsum; 3T0H; -.
DR   PDBsum; 3T0Z; -.
DR   PDBsum; 3T10; -.
DR   PDBsum; 3T1K; -.
DR   PDBsum; 3T2S; -.
DR   PDBsum; 3TUH; -.
DR   PDBsum; 3VHA; -.
DR   PDBsum; 3VHC; -.
DR   PDBsum; 3VHD; -.
DR   PDBsum; 3WHA; -.
DR   PDBsum; 3WQ9; -.
DR   PDBsum; 4AIF; -.
DR   PDBsum; 4AWO; -.
DR   PDBsum; 4AWP; -.
DR   PDBsum; 4AWQ; -.
DR   PDBsum; 4B7P; -.
DR   PDBsum; 4BQG; -.
DR   PDBsum; 4BQJ; -.
DR   PDBsum; 4CGQ; -.
DR   PDBsum; 4CGU; -.
DR   PDBsum; 4CGV; -.
DR   PDBsum; 4CGW; -.
DR   PDBsum; 4CWF; -.
DR   PDBsum; 4CWN; -.
DR   PDBsum; 4CWO; -.
DR   PDBsum; 4CWP; -.
DR   PDBsum; 4CWQ; -.
DR   PDBsum; 4CWR; -.
DR   PDBsum; 4CWS; -.
DR   PDBsum; 4CWT; -.
DR   PDBsum; 4EEH; -.
DR   PDBsum; 4EFT; -.
DR   PDBsum; 4EFU; -.
DR   PDBsum; 4EGH; -.
DR   PDBsum; 4EGI; -.
DR   PDBsum; 4EGK; -.
DR   PDBsum; 4FCP; -.
DR   PDBsum; 4FCQ; -.
DR   PDBsum; 4FCR; -.
DR   PDBsum; 4HY6; -.
DR   PDBsum; 4JQL; -.
DR   PDBsum; 4L8Z; -.
DR   PDBsum; 4L90; -.
DR   PDBsum; 4L91; -.
DR   PDBsum; 4L93; -.
DR   PDBsum; 4L94; -.
DR   PDBsum; 4LWE; -.
DR   PDBsum; 4LWF; -.
DR   PDBsum; 4LWG; -.
DR   PDBsum; 4LWH; -.
DR   PDBsum; 4LWI; -.
DR   PDBsum; 4NH7; -.
DR   PDBsum; 4NH8; -.
DR   PDBsum; 4O04; -.
DR   PDBsum; 4O05; -.
DR   PDBsum; 4O07; -.
DR   PDBsum; 4O09; -.
DR   PDBsum; 4O0B; -.
DR   PDBsum; 4R3M; -.
DR   PDBsum; 4U93; -.
DR   PDBsum; 4W7T; -.
DR   PDBsum; 4XIP; -.
DR   PDBsum; 4XIQ; -.
DR   PDBsum; 4XIR; -.
DR   PDBsum; 4XIT; -.
DR   PDBsum; 4YKQ; -.
DR   PDBsum; 4YKR; -.
DR   PDBsum; 4YKT; -.
DR   PDBsum; 4YKU; -.
DR   PDBsum; 4YKW; -.
DR   PDBsum; 4YKX; -.
DR   PDBsum; 4YKY; -.
DR   PDBsum; 4YKZ; -.
DR   PDBsum; 5CF0; -.
DR   PDBsum; 5FNC; -.
DR   PDBsum; 5FND; -.
DR   PDBsum; 5FNF; -.
DR   PDBsum; 5GGZ; -.
DR   PDBsum; 5J20; -.
DR   PDBsum; 5J27; -.
DR   PDBsum; 5J2V; -.
DR   PDBsum; 5J2X; -.
DR   PDBsum; 5J64; -.
DR   PDBsum; 5J6L; -.
DR   PDBsum; 5J6M; -.
DR   PDBsum; 5J6N; -.
DR   PDBsum; 5J80; -.
DR   PDBsum; 5J82; -.
DR   PDBsum; 5J86; -.
DR   PDBsum; 5J8M; -.
DR   PDBsum; 5J8U; -.
DR   PDBsum; 5J9X; -.
DR   PDBsum; 5LNY; -.
DR   PDBsum; 5LNZ; -.
DR   PDBsum; 5LO0; -.
DR   PDBsum; 5LO1; -.
DR   PDBsum; 5LO5; -.
DR   PDBsum; 5LO6; -.
DR   PDBsum; 5LQ9; -.
DR   PDBsum; 5LR1; -.
DR   PDBsum; 5LR7; -.
DR   PDBsum; 5LRL; -.
DR   PDBsum; 5LRZ; -.
DR   PDBsum; 5LS1; -.
DR   PDBsum; 5M4E; -.
DR   PDBsum; 5M4H; -.
DR   PDBsum; 5NYH; -.
DR   PDBsum; 5NYI; -.
DR   PDBsum; 5OCI; -.
DR   PDBsum; 5OD7; -.
DR   PDBsum; 5ODX; -.
DR   PDBsum; 5T21; -.
DR   PDBsum; 5VYY; -.
DR   PDBsum; 5XQD; -.
DR   PDBsum; 5XQE; -.
DR   PDBsum; 5XR5; -.
DR   PDBsum; 5XR9; -.
DR   PDBsum; 5XRB; -.
DR   PDBsum; 5XRD; -.
DR   PDBsum; 5XRE; -.
DR   PDBsum; 5ZR3; -.
DR   PDBsum; 6B99; -.
DR   PDBsum; 6B9A; -.
DR   PDBsum; 6CEO; -.
DR   PDBsum; 6CYG; -.
DR   PDBsum; 6CYH; -.
DR   PDBsum; 6EI5; -.
DR   PDBsum; 6EL5; -.
DR   PDBsum; 6ELN; -.
DR   PDBsum; 6ELO; -.
DR   PDBsum; 6ELP; -.
DR   PDBsum; 6EY8; -.
DR   PDBsum; 6EY9; -.
DR   PDBsum; 6EYA; -.
DR   PDBsum; 6EYB; -.
DR   PDBsum; 6F1N; -.
DR   PDBsum; 6FCJ; -.
DR   PDBsum; 6FDP; -.
DR   PDBsum; 6GP4; -.
DR   PDBsum; 6GP8; -.
DR   PDBsum; 6GPF; -.
DR   PDBsum; 6GPH; -.
DR   PDBsum; 6GPO; -.
DR   PDBsum; 6GPP; -.
DR   PDBsum; 6GPR; -.
DR   PDBsum; 6GPT; -.
DR   PDBsum; 6GPW; -.
DR   PDBsum; 6GPY; -.
DR   PDBsum; 6GQ6; -.
DR   PDBsum; 6GQR; -.
DR   PDBsum; 6GQS; -.
DR   PDBsum; 6GQU; -.
DR   PDBsum; 6GR1; -.
DR   PDBsum; 6GR3; -.
DR   PDBsum; 6GR4; -.
DR   PDBsum; 6GR5; -.
DR   PDBsum; 6HHR; -.
DR   PDBsum; 6N8X; -.
DR   PDBsum; 6OLX; -.
DR   SMR; P07900; -.
DR   BioGrid; 109552; 917.
DR   ComplexPortal; CPX-3288; HSP90A-CDC37 chaperone complex.
DR   CORUM; P07900; -.
DR   DIP; DIP-27595N; -.
DR   IntAct; P07900; 303.
DR   MINT; P07900; -.
DR   STRING; 9606.ENSP00000335153; -.
DR   BindingDB; P07900; -.
DR   ChEMBL; CHEMBL3880; -.
DR   DrugBank; DB07317; (3E)-3-[(phenylamino)methylidene]dihydrofuran-2(3H)-one.
DR   DrugBank; DB08197; (5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime.
DR   DrugBank; DB08443; 2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol.
DR   DrugBank; DB08557; 2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide.
DR   DrugBank; DB08789; 2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE.
DR   DrugBank; DB06969; 2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide.
DR   DrugBank; DB08788; 3,6-DIAMINO-5-CYANO-4-(4-ETHOXYPHENYL)THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE.
DR   DrugBank; DB07324; 3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE.
DR   DrugBank; DB02840; 4-(1,3-Benzodioxol-5-Yl)-5-(5-Ethyl-2,4-Dihydroxyphenyl)-2h-Pyrazole-3-Carboxylic Acid.
DR   DrugBank; DB03749; 4-(1h-Imidazol-4-Yl)-3-(5-Ethyl-2,4-Dihydroxy-Phenyl)-1h-Pyrazole.
DR   DrugBank; DB08787; 4-(2,4-dichlorophenyl)-5-phenyldiazenyl-pyrimidin-2-amine.
DR   DrugBank; DB08786; 4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine.
DR   DrugBank; DB07594; 4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL.
DR   DrugBank; DB07502; 4-bromo-6-(6-hydroxy-1,2-benzisoxazol-3-yl)benzene-1,3-diol.
DR   DrugBank; DB07100; 4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL.
DR   DrugBank; DB06957; 4-CHLORO-6-(4-{4-[4-(METHYLSULFONYL)BENZYL]PIPERAZIN-1-YL}-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL.
DR   DrugBank; DB07601; 4-chloro-6-{5-[(2-morpholin-4-ylethyl)amino]-1,2-benzisoxazol-3-yl}benzene-1,3-diol.
DR   DrugBank; DB08194; 4-methyl-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-amine.
DR   DrugBank; DB08442; 4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol.
DR   DrugBank; DB07495; 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXAMIDE.
DR   DrugBank; DB06964; 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE-3-CARBOXAMIDE.
DR   DrugBank; DB06961; 5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]isoxazole-3-carboxamide.
DR   DrugBank; DB06958; 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-PIPERAZIN-1-YL-1H-PYRAZOLE-3-CARBOXAMIDE.
DR   DrugBank; DB07319; 6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE.
DR   DrugBank; DB03137; 8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9-Pent-9h-Purin-6-Ylamine.
DR   DrugBank; DB03093; 8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine.
DR   DrugBank; DB02550; 8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine.
DR   DrugBank; DB04505; 8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine.
DR   DrugBank; DB07877; 8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE.
DR   DrugBank; DB04254; 8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine.
DR   DrugBank; DB08436; 8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H.
DR   DrugBank; DB04054; 9-Butyl-8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine.
DR   DrugBank; DB02359; 9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine.
DR   DrugBank; DB03504; 9-Butyl-8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine.
DR   DrugBank; DB02754; 9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine.
DR   DrugBank; DB03809; 9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine.
DR   DrugBank; DB03899; 9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine.
DR   DrugBank; DB12442; Alvespimycin.
DR   DrugBank; DB09130; Copper.
DR   DrugBank; DB02424; Geldanamycin.
DR   DrugBank; DB06956; N-(4-ACETYLPHENYL)-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE.
DR   DrugBank; DB07325; N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE.
DR   DrugBank; DB04588; N-[4-(AMINOSULFONYL)BENZYL]-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE.
DR   DrugBank; DB00716; Nedocromil.
DR   DrugBank; DB09221; Polaprezinc.
DR   DrugBank; DB04216; Quercetin.
DR   DrugBank; DB00615; Rifabutin.
DR   DrugBank; DB06070; SNX-5422.
DR   DrugBank; DB05134; Tanespimycin.
DR   DrugCentral; P07900; -.
DR   GuidetoPHARMACOLOGY; 2905; -.
DR   MoonDB; P07900; Predicted.
DR   CarbonylDB; P07900; -.
DR   GlyConnect; 1301; -.
DR   iPTMnet; P07900; -.
DR   MetOSite; P07900; -.
DR   PhosphoSitePlus; P07900; -.
DR   SwissPalm; P07900; -.
DR   BioMuta; HSP90AA1; -.
DR   DMDM; 92090606; -.
DR   OGP; P07900; -.
DR   REPRODUCTION-2DPAGE; IPI00784295; -.
DR   EPD; P07900; -.
DR   jPOST; P07900; -.
DR   MassIVE; P07900; -.
DR   MaxQB; P07900; -.
DR   PaxDb; P07900; -.
DR   PeptideAtlas; P07900; -.
DR   PRIDE; P07900; -.
DR   ProteomicsDB; 52031; -. [P07900-1]
DR   ProteomicsDB; 52032; -. [P07900-2]
DR   TopDownProteomics; P07900-1; -. [P07900-1]
DR   Antibodypedia; 3676; 1737 antibodies.
DR   Ensembl; ENST00000216281; ENSP00000216281; ENSG00000080824. [P07900-1]
DR   Ensembl; ENST00000334701; ENSP00000335153; ENSG00000080824. [P07900-2]
DR   GeneID; 3320; -.
DR   KEGG; hsa:3320; -.
DR   UCSC; uc001yku.5; human. [P07900-1]
DR   CTD; 3320; -.
DR   DisGeNET; 3320; -.
DR   GeneCards; HSP90AA1; -.
DR   HGNC; HGNC:5253; HSP90AA1.
DR   HPA; ENSG00000080824; Tissue enhanced (vagina).
DR   MIM; 140571; gene.
DR   neXtProt; NX_P07900; -.
DR   OpenTargets; ENSG00000080824; -.
DR   PharmGKB; PA29519; -.
DR   eggNOG; KOG0019; Eukaryota.
DR   eggNOG; KOG0020; Eukaryota.
DR   eggNOG; COG0326; LUCA.
DR   GeneTree; ENSGT00950000182747; -.
DR   HOGENOM; CLU_006684_1_3_1; -.
DR   InParanoid; P07900; -.
DR   KO; K04079; -.
DR   OMA; VKRHSEF; -.
DR   OrthoDB; 188544at2759; -.
DR   PhylomeDB; P07900; -.
DR   TreeFam; TF300686; -.
DR   Reactome; R-HSA-1227986; Signaling by ERBB2.
DR   Reactome; R-HSA-1236382; Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants.
DR   Reactome; R-HSA-1474151; Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation.
DR   Reactome; R-HSA-192905; vRNP Assembly.
DR   Reactome; R-HSA-2029482; Regulation of actin dynamics for phagocytic cup formation.
DR   Reactome; R-HSA-203615; eNOS activation.
DR   Reactome; R-HSA-2565942; Regulation of PLK1 Activity at G2/M Transition.
DR   Reactome; R-HSA-3000484; Scavenging by Class F Receptors.
DR   Reactome; R-HSA-3371497; HSP90 chaperone cycle for steroid hormone receptors (SHR).
DR   Reactome; R-HSA-3371511; HSF1 activation.
DR   Reactome; R-HSA-3371568; Attenuation phase.
DR   Reactome; R-HSA-3371571; HSF1-dependent transactivation.
DR   Reactome; R-HSA-380259; Loss of Nlp from mitotic centrosomes.
DR   Reactome; R-HSA-380270; Recruitment of mitotic centrosome proteins and complexes.
DR   Reactome; R-HSA-380284; Loss of proteins required for interphase microtubule organization from the centrosome.
DR   Reactome; R-HSA-380320; Recruitment of NuMA to mitotic centrosomes.
DR   Reactome; R-HSA-399954; Sema3A PAK dependent Axon repulsion.
DR   Reactome; R-HSA-4420097; VEGFA-VEGFR2 Pathway.
DR   Reactome; R-HSA-5218920; VEGFR2 mediated vascular permeability.
DR   Reactome; R-HSA-5336415; Uptake and function of diphtheria toxin.
DR   Reactome; R-HSA-5601884; PIWI-interacting RNA (piRNA) biogenesis.
DR   Reactome; R-HSA-5620912; Anchoring of the basal body to the plasma membrane.
DR   Reactome; R-HSA-5637810; Constitutive Signaling by EGFRvIII.
DR   Reactome; R-HSA-6785807; Interleukin-4 and Interleukin-13 signaling.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-8852276; The role of GTSE1 in G2/M progression after G2 checkpoint.
DR   Reactome; R-HSA-8854518; AURKA Activation by TPX2.
DR   Reactome; R-HSA-8863795; Downregulation of ERBB2 signaling.
DR   Reactome; R-HSA-8939211; ESR-mediated signaling.
DR   Reactome; R-HSA-9009391; Extra-nuclear estrogen signaling.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   Reactome; R-HSA-9613829; Chaperone Mediated Autophagy.
DR   Reactome; R-HSA-9634285; Constitutive Signaling by Overexpressed ERBB2.
DR   Reactome; R-HSA-9646399; Aggrephagy.
DR   Reactome; R-HSA-9652282; Drug-mediated inhibition of ERBB2 signaling.
DR   Reactome; R-HSA-9664565; Signaling by ERBB2 KD Mutants.
DR   Reactome; R-HSA-9665233; Resistance of ERBB2 KD mutants to trastuzumab.
DR   Reactome; R-HSA-9665244; Resistance of ERBB2 KD mutants to sapitinib.
DR   Reactome; R-HSA-9665245; Resistance of ERBB2 KD mutants to tesevatinib.
DR   Reactome; R-HSA-9665246; Resistance of ERBB2 KD mutants to neratinib.
DR   Reactome; R-HSA-9665247; Resistance of ERBB2 KD mutants to osimertinib.
DR   Reactome; R-HSA-9665249; Resistance of ERBB2 KD mutants to afatinib.
DR   Reactome; R-HSA-9665250; Resistance of ERBB2 KD mutants to AEE788.
DR   Reactome; R-HSA-9665251; Resistance of ERBB2 KD mutants to lapatinib.
DR   SIGNOR; P07900; -.
DR   ChiTaRS; HSP90AA1; human.
DR   EvolutionaryTrace; P07900; -.
DR   GenomeRNAi; 3320; -.
DR   Pharos; P07900; Tchem.
DR   PRO; PR:P07900; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   RNAct; P07900; protein.
DR   Bgee; ENSG00000080824; Expressed in middle temporal gyrus and 251 other tissues.
DR   ExpressionAtlas; P07900; baseline and differential.
DR   Genevisible; P07900; HS.
DR   GO; GO:0044295; C:axonal growth cone; ISS:ARUK-UCL.
DR   GO; GO:0009986; C:cell surface; IBA:GO_Central.
DR   GO; GO:0005737; C:cytoplasm; IDA:CAFA.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0044294; C:dendritic growth cone; ISS:ARUK-UCL.
DR   GO; GO:0071682; C:endocytic vesicle lumen; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0043202; C:lysosomal lumen; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0043209; C:myelin sheath; IBA:GO_Central.
DR   GO; GO:0043025; C:neuronal cell body; ISS:ARUK-UCL.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISS:ARUK-UCL.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:0034774; C:secretory granule lumen; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0016887; F:ATPase activity; IDA:UniProtKB.
DR   GO; GO:0042623; F:ATPase activity, coupled; TAS:Reactome.
DR   GO; GO:0097718; F:disordered domain specific binding; IPI:CAFA.
DR   GO; GO:0070182; F:DNA polymerase binding; IPI:BHF-UCL.
DR   GO; GO:0051020; F:GTPase binding; IPI:UniProtKB.
DR   GO; GO:0042826; F:histone deacetylase binding; IPI:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; IDA:UniProtKB.
DR   GO; GO:0023026; F:MHC class II protein complex binding; HDA:UniProtKB.
DR   GO; GO:0030235; F:nitric-oxide synthase regulator activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:1990782; F:protein tyrosine kinase binding; IPI:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0097110; F:scaffold protein binding; IPI:UniProtKB.
DR   GO; GO:0048156; F:tau protein binding; IPI:ARUK-UCL.
DR   GO; GO:0030911; F:TPR domain binding; IDA:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:ARUK-UCL.
DR   GO; GO:0051082; F:unfolded protein binding; IBA:GO_Central.
DR   GO; GO:0048675; P:axon extension; ISS:ARUK-UCL.
DR   GO; GO:0034605; P:cellular response to heat; IBA:GO_Central.
DR   GO; GO:0021955; P:central nervous system neuron axonogenesis; ISS:ARUK-UCL.
DR   GO; GO:0061684; P:chaperone-mediated autophagy; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0051131; P:chaperone-mediated protein complex assembly; IDA:BHF-UCL.
DR   GO; GO:0097711; P:ciliary basal body-plasma membrane docking; TAS:Reactome.
DR   GO; GO:0051186; P:cofactor metabolic process; TAS:Reactome.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0038128; P:ERBB2 signaling pathway; TAS:Reactome.
DR   GO; GO:0030010; P:establishment of cell polarity; ISS:ARUK-UCL.
DR   GO; GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0006839; P:mitochondrial transport; TAS:UniProtKB.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:1903364; P:positive regulation of cellular protein catabolic process; IGI:ARUK-UCL.
DR   GO; GO:0045429; P:positive regulation of nitric oxide biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; ISS:ARUK-UCL.
DR   GO; GO:0051897; P:positive regulation of protein kinase B signaling; ISS:ARUK-UCL.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IDA:ARUK-UCL.
DR   GO; GO:0032273; P:positive regulation of protein polymerization; IDA:ARUK-UCL.
DR   GO; GO:1902949; P:positive regulation of tau-protein kinase activity; IDA:ARUK-UCL.
DR   GO; GO:0051973; P:positive regulation of telomerase activity; IDA:BHF-UCL.
DR   GO; GO:0006457; P:protein folding; IBA:GO_Central.
DR   GO; GO:0045040; P:protein insertion into mitochondrial outer membrane; IDA:BHF-UCL.
DR   GO; GO:0042026; P:protein refolding; TAS:UniProtKB.
DR   GO; GO:0050821; P:protein stabilization; IMP:UniProtKB.
DR   GO; GO:0043335; P:protein unfolding; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; TAS:Reactome.
DR   GO; GO:1903827; P:regulation of cellular protein localization; ISS:ARUK-UCL.
DR   GO; GO:1900034; P:regulation of cellular response to heat; TAS:Reactome.
DR   GO; GO:0010389; P:regulation of G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0050999; P:regulation of nitric-oxide synthase activity; TAS:Reactome.
DR   GO; GO:0031396; P:regulation of protein ubiquitination; IDA:BHF-UCL.
DR   GO; GO:0043254; P:regulation of protein-containing complex assembly; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0046677; P:response to antibiotic; ISS:AgBase.
DR   GO; GO:0009409; P:response to cold; ISS:AgBase.
DR   GO; GO:0009408; P:response to heat; ISS:AgBase.
DR   GO; GO:0006986; P:response to unfolded protein; NAS:UniProtKB.
DR   GO; GO:1905323; P:telomerase holoenzyme complex assembly; IDA:BHF-UCL.
DR   GO; GO:0007004; P:telomere maintenance via telomerase; IDA:BHF-UCL.
DR   GO; GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 1.20.120.790; -; 1.
DR   Gene3D; 3.30.565.10; -; 1.
DR   HAMAP; MF_00505; HSP90; 1.
DR   InterPro; IPR003594; HATPase_C.
DR   InterPro; IPR036890; HATPase_C_sf.
DR   InterPro; IPR019805; Heat_shock_protein_90_CS.
DR   InterPro; IPR037196; HSP90_C.
DR   InterPro; IPR001404; Hsp90_fam.
DR   InterPro; IPR020575; Hsp90_N.
DR   InterPro; IPR020568; Ribosomal_S5_D2-typ_fold.
DR   PANTHER; PTHR11528; PTHR11528; 1.
DR   Pfam; PF02518; HATPase_c; 1.
DR   Pfam; PF00183; HSP90; 1.
DR   PIRSF; PIRSF002583; Hsp90; 1.
DR   PRINTS; PR00775; HEATSHOCK90.
DR   SMART; SM00387; HATPase_c; 1.
DR   SUPFAM; SSF110942; SSF110942; 1.
DR   SUPFAM; SSF54211; SSF54211; 1.
DR   SUPFAM; SSF55874; SSF55874; 1.
DR   PROSITE; PS00298; HSP90; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Cell membrane; Chaperone; Cytoplasm; Direct protein sequencing;
KW   Host-virus interaction; Membrane; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; S-nitrosylation; Stress response;
KW   Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:2492519"
FT   CHAIN           2..732
FT                   /note="Heat shock protein HSP 90-alpha"
FT                   /id="PRO_0000062911"
FT   REGION          9..236
FT                   /note="Interaction with NR3C1"
FT                   /evidence="ECO:0000250|UniProtKB:P07901"
FT   REGION          271..616
FT                   /note="Interaction with NR3C1"
FT                   /evidence="ECO:0000250|UniProtKB:P07901"
FT   REGION          284..732
FT                   /note="Interaction with FLCN and FNIP1"
FT                   /evidence="ECO:0000269|PubMed:27353360"
FT   REGION          284..620
FT                   /note="Interaction with FNIP2 and TSC1"
FT                   /evidence="ECO:0000269|PubMed:27353360,
FT                   ECO:0000269|PubMed:29127155"
FT   REGION          628..731
FT                   /note="Interaction with NR1D1"
FT                   /evidence="ECO:0000250|UniProtKB:P07901"
FT   REGION          682..732
FT                   /note="Required for homodimerization"
FT                   /evidence="ECO:0000269|PubMed:8289821"
FT   REGION          728..732
FT                   /note="Essential for interaction with SMYD3, TSC1 and
FT                   STIP1/HOP"
FT                   /evidence="ECO:0000269|PubMed:25738358,
FT                   ECO:0000269|PubMed:29127155"
FT   REGION          729..732
FT                   /note="Essential for interaction with SGTA and TTC1"
FT                   /evidence="ECO:0000269|PubMed:15708368"
FT   MOTIF           723..732
FT                   /note="TPR repeat-binding"
FT                   /evidence="ECO:0000269|PubMed:16307917"
FT   BINDING         51
FT                   /note="ATP"
FT   BINDING         93
FT                   /note="ATP"
FT   BINDING         112
FT                   /note="ATP"
FT                   /evidence="ECO:0000250"
FT   BINDING         138
FT                   /note="ATP; via amide nitrogen"
FT   BINDING         400
FT                   /note="ATP"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         5
FT                   /note="Phosphothreonine; by PRKDC"
FT                   /evidence="ECO:0000269|PubMed:2507541"
FT   MOD_RES         7
FT                   /note="Phosphothreonine; by PRKDC"
FT                   /evidence="ECO:0000269|PubMed:2507541"
FT   MOD_RES         58
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P07901"
FT   MOD_RES         84
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P07901"
FT   MOD_RES         231
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:18318008, ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569, ECO:0000269|PubMed:2492519"
FT   MOD_RES         252
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18088087,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163"
FT   MOD_RES         263
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:16807684,
FT                   ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18088087,
FT                   ECO:0000244|PubMed:18318008, ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19367720,
FT                   ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:2492519"
FT   MOD_RES         313
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P07901"
FT   MOD_RES         443
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         453
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P82995"
FT   MOD_RES         458
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         476
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         489
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         492
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P07901"
FT   MOD_RES         585
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         598
FT                   /note="S-nitrosocysteine"
FT                   /evidence="ECO:0000269|PubMed:15937123"
FT   MOD_RES         641
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   VAR_SEQ         1
FT                   /note="M -> MPPCSGGDGSTPPGPSLRDRDCPAQSAEYPRDRLDPRPGSPSEASSP
FT                   PFLRSRAPVNWYQEKAQVFLWHLMVSGSTTLLCLWKQPFHVSAFPVTASLAFRQSQGAG
FT                   QHLYKDLQPFILLRLLM (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:16269234"
FT                   /id="VSP_026604"
FT   MUTAGEN         47
FT                   /note="E->A: Strong ATP-binding. Strong interaction with
FT                   HSF1, HIF1A, ERBB2, MET, KEAP1 and RHOBTB2. No effect on
FT                   interaction with TSC1."
FT                   /evidence="ECO:0000269|PubMed:26517842,
FT                   ECO:0000269|PubMed:29127155"
FT   MUTAGEN         93
FT                   /note="D->A: Impaired ATP-binding. Strong interaction with
FT                   HIF1A, MET, KEAP1 and RHOBTB2. Loss of interaction with
FT                   HSF1 and ERBB2. Los of interaction with TSC1."
FT                   /evidence="ECO:0000269|PubMed:26517842,
FT                   ECO:0000269|PubMed:29127155"
FT   MUTAGEN         97
FT                   /note="G->D: Abolishes ATPase activity."
FT                   /evidence="ECO:0000269|PubMed:18256191"
FT   MUTAGEN         313
FT                   /note="Y->E: Loss of interaction with TSC1 and increases
FT                   interacrion with AHSA1."
FT                   /evidence="ECO:0000269|PubMed:29127155"
FT   MUTAGEN         313
FT                   /note="Y->F: No deffect on the interaction with TSC1."
FT                   /evidence="ECO:0000269|PubMed:29127155"
FT   MUTAGEN         598
FT                   /note="C->A,N,D: Reduces ATPase activity and client protein
FT                   activation."
FT                   /evidence="ECO:0000269|PubMed:15937123,
FT                   ECO:0000269|PubMed:19696785"
FT   MUTAGEN         598
FT                   /note="C->S: Loss of S-nitrosylation."
FT                   /evidence="ECO:0000269|PubMed:15937123,
FT                   ECO:0000269|PubMed:19696785"
FT   MUTAGEN         728..732
FT                   /note="Missing: Loss of interaction with TSC1."
FT                   /evidence="ECO:0000269|PubMed:29127155"
FT   CONFLICT        63
FT                   /note="S -> T (in Ref. 1; CAA33259)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        74
FT                   /note="K -> R (in Ref. 4; CAI64495 and 6; BAG51711)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        86
FT                   /note="D -> G (in Ref. 4; CAI64495 and 6; BAG51711)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        162
FT                   /note="W -> D (in Ref. 15; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   HELIX           2..5
FT                   /evidence="ECO:0000244|PDB:6GQS"
FT   STRAND          18..21
FT                   /evidence="ECO:0000244|PDB:5J80"
FT   HELIX           24..35
FT                   /evidence="ECO:0000244|PDB:5J80"
FT   TURN            39..42
FT                   /evidence="ECO:0000244|PDB:6GPF"
FT   HELIX           43..65
FT                   /evidence="ECO:0000244|PDB:5J80"
FT   HELIX           67..70
FT                   /evidence="ECO:0000244|PDB:5J80"
FT   STRAND          78..83
FT                   /evidence="ECO:0000244|PDB:5J80"
FT   TURN            84..87
FT                   /evidence="ECO:0000244|PDB:5J80"
FT   STRAND          88..93
FT                   /evidence="ECO:0000244|PDB:5J80"
FT   HELIX           100..104
FT                   /evidence="ECO:0000244|PDB:5J80"
FT   TURN            105..108
FT                   /evidence="ECO:0000244|PDB:5J80"
FT   HELIX           111..123
FT                   /evidence="ECO:0000244|PDB:5J80"
FT   HELIX           128..134
FT                   /evidence="ECO:0000244|PDB:5J80"
FT   HELIX           137..143
FT                   /evidence="ECO:0000244|PDB:5J80"
FT   STRAND          145..153
FT                   /evidence="ECO:0000244|PDB:5J80"
FT   STRAND          155..157
FT                   /evidence="ECO:0000244|PDB:2WI6"
FT   STRAND          160..164
FT                   /evidence="ECO:0000244|PDB:5J80"
FT   STRAND          169..174
FT                   /evidence="ECO:0000244|PDB:5J80"
FT   STRAND          181..190
FT                   /evidence="ECO:0000244|PDB:5J80"
FT   HELIX           192..198
FT                   /evidence="ECO:0000244|PDB:5J80"
FT   HELIX           200..210
FT                   /evidence="ECO:0000244|PDB:5J80"
FT   STRAND          212..216
FT                   /evidence="ECO:0000244|PDB:3VHC"
FT   STRAND          218..220
FT                   /evidence="ECO:0000244|PDB:5J80"
FT   TURN            221..224
FT                   /evidence="ECO:0000244|PDB:3T1K"
FT   STRAND          225..227
FT                   /evidence="ECO:0000244|PDB:3T1K"
FT   HELIX           228..230
FT                   /evidence="ECO:0000244|PDB:2XJX"
FT   HELIX           296..298
FT                   /evidence="ECO:0000244|PDB:3Q6M"
FT   HELIX           306..317
FT                   /evidence="ECO:0000244|PDB:3Q6M"
FT   STRAND          324..331
FT                   /evidence="ECO:0000244|PDB:3Q6M"
FT   STRAND          333..335
FT                   /evidence="ECO:0000244|PDB:3Q6M"
FT   STRAND          337..343
FT                   /evidence="ECO:0000244|PDB:3Q6M"
FT   STRAND          361..365
FT                   /evidence="ECO:0000244|PDB:3Q6M"
FT   STRAND          368..372
FT                   /evidence="ECO:0000244|PDB:3Q6M"
FT   HELIX           380..382
FT                   /evidence="ECO:0000244|PDB:3Q6M"
FT   STRAND          386..392
FT                   /evidence="ECO:0000244|PDB:3Q6M"
FT   HELIX           408..427
FT                   /evidence="ECO:0000244|PDB:3Q6M"
FT   HELIX           431..451
FT                   /evidence="ECO:0000244|PDB:3Q6M"
FT   HELIX           453..455
FT                   /evidence="ECO:0000244|PDB:3Q6M"
FT   HELIX           456..460
FT                   /evidence="ECO:0000244|PDB:3Q6M"
FT   STRAND          464..467
FT                   /evidence="ECO:0000244|PDB:3Q6M"
FT   TURN            468..472
FT                   /evidence="ECO:0000244|PDB:3Q6M"
FT   HELIX           477..482
FT                   /evidence="ECO:0000244|PDB:3Q6M"
FT   STRAND          490..495
FT                   /evidence="ECO:0000244|PDB:3Q6M"
FT   HELIX           499..503
FT                   /evidence="ECO:0000244|PDB:3Q6M"
FT   HELIX           506..508
FT                   /evidence="ECO:0000244|PDB:3Q6M"
FT   HELIX           509..514
FT                   /evidence="ECO:0000244|PDB:3Q6M"
FT   STRAND          518..521
FT                   /evidence="ECO:0000244|PDB:3Q6M"
FT   HELIX           525..529
FT                   /evidence="ECO:0000244|PDB:3Q6M"
FT   TURN            530..532
FT                   /evidence="ECO:0000244|PDB:3Q6M"
FT   STRAND          539..543
FT                   /evidence="ECO:0000244|PDB:3Q6M"
FT   HELIX           555..567
FT                   /evidence="ECO:0000244|PDB:3Q6M"
FT   HELIX           569..578
FT                   /evidence="ECO:0000244|PDB:3Q6M"
FT   HELIX           580..582
FT                   /evidence="ECO:0000244|PDB:3Q6M"
FT   STRAND          584..588
FT                   /evidence="ECO:0000244|PDB:3Q6M"
FT   STRAND          593..601
FT                   /evidence="ECO:0000244|PDB:3Q6M"
FT   STRAND          603..605
FT                   /evidence="ECO:0000244|PDB:3Q6M"
FT   HELIX           608..613
FT                   /evidence="ECO:0000244|PDB:3Q6M"
FT   STRAND          632..636
FT                   /evidence="ECO:0000244|PDB:3Q6M"
FT   HELIX           641..652
FT                   /evidence="ECO:0000244|PDB:3Q6M"
FT   HELIX           657..673
FT                   /evidence="ECO:0000244|PDB:3Q6M"
FT   HELIX           681..694
FT                   /evidence="ECO:0000244|PDB:3Q6M"
FT   STRAND          728..730
FT                   /evidence="ECO:0000244|PDB:4CGW"
FT   VARIANT         P07900-2:71
FT                   /note="M -> L (in dbSNP:rs8005905)"
FT                   /evidence="ECO:0000305"
FT                   /id="VAR_082835"
SQ   SEQUENCE   732 AA;  84660 MW;  969F65FCC0BC86FD CRC64;
     MPEETQTQDQ PMEEEEVETF AFQAEIAQLM SLIINTFYSN KEIFLRELIS NSSDALDKIR
     YESLTDPSKL DSGKELHINL IPNKQDRTLT IVDTGIGMTK ADLINNLGTI AKSGTKAFME
     ALQAGADISM IGQFGVGFYS AYLVAEKVTV ITKHNDDEQY AWESSAGGSF TVRTDTGEPM
     GRGTKVILHL KEDQTEYLEE RRIKEIVKKH SQFIGYPITL FVEKERDKEV SDDEAEEKED
     KEEEKEKEEK ESEDKPEIED VGSDEEEEKK DGDKKKKKKI KEKYIDQEEL NKTKPIWTRN
     PDDITNEEYG EFYKSLTNDW EDHLAVKHFS VEGQLEFRAL LFVPRRAPFD LFENRKKKNN
     IKLYVRRVFI MDNCEELIPE YLNFIRGVVD SEDLPLNISR EMLQQSKILK VIRKNLVKKC
     LELFTELAED KENYKKFYEQ FSKNIKLGIH EDSQNRKKLS ELLRYYTSAS GDEMVSLKDY
     CTRMKENQKH IYYITGETKD QVANSAFVER LRKHGLEVIY MIEPIDEYCV QQLKEFEGKT
     LVSVTKEGLE LPEDEEEKKK QEEKKTKFEN LCKIMKDILE KKVEKVVVSN RLVTSPCCIV
     TSTYGWTANM ERIMKAQALR DNSTMGYMAA KKHLEINPDH SIIETLRQKA EADKNDKSVK
     DLVILLYETA LLSSGFSLED PQTHANRIYR MIKLGLGIDE DDPTADDTSA AVTEEMPPLE
     GDDDTSRMEE VD
//
ID   Q86SX1_HUMAN            Unreviewed;       262 AA.
AC   Q86SX1;
DT   01-JUN-2003, integrated into UniProtKB/TrEMBL.
DT   01-JUN-2003, sequence version 1.
DT   11-DEC-2019, entry version 99.
DE   SubName: Full=Full-length cDNA 5-PRIME end of clone CS0DN005YI08 of Adult brain of Homo sapiens (human) {ECO:0000313|EMBL:CAD66568.1};
DE   Flags: Fragment;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:CAD66568.1};
RN   [1] {ECO:0000313|EMBL:CAD66568.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Adult brain {ECO:0000313|EMBL:CAD66568.1};
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases.
RN   [2] {ECO:0000313|EMBL:CAD66568.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Adult brain {ECO:0000313|EMBL:CAD66568.1};
RA   Genoscope;
RL   Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BX248761; CAD66568.1; -; mRNA.
DR   RefSeq; NP_001017963.2; NM_001017963.2.
DR   IntAct; Q86SX1; 14.
DR   PeptideAtlas; Q86SX1; -.
DR   PRIDE; Q86SX1; -.
DR   GeneID; 3320; -.
DR   CTD; 3320; -.
DR   PharmGKB; PA29519; -.
DR   eggNOG; KOG0019; Eukaryota.
DR   eggNOG; KOG0020; Eukaryota.
DR   eggNOG; COG0326; LUCA.
DR   OrthoDB; 924636at2759; -.
DR   GenomeRNAi; 3320; -.
DR   Genevisible; Q86SX1; HS.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0051082; F:unfolded protein binding; IEA:InterPro.
DR   GO; GO:0006457; P:protein folding; IEA:InterPro.
DR   Gene3D; 3.30.565.10; -; 1.
DR   InterPro; IPR003594; HATPase_C.
DR   InterPro; IPR036890; HATPase_C_sf.
DR   InterPro; IPR019805; Heat_shock_protein_90_CS.
DR   InterPro; IPR001404; Hsp90_fam.
DR   InterPro; IPR020575; Hsp90_N.
DR   PANTHER; PTHR11528; PTHR11528; 1.
DR   Pfam; PF02518; HATPase_c; 1.
DR   PRINTS; PR00775; HEATSHOCK90.
DR   SUPFAM; SSF55874; SSF55874; 1.
DR   PROSITE; PS00298; HSP90; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN          162..260
FT                   /note="HATPase_c"
FT                   /evidence="ECO:0000259|Pfam:PF02518"
FT   REGION          1..48
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        24..38
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   NON_TER         262
FT                   /evidence="ECO:0000313|EMBL:CAD66568.1"
SQ   SEQUENCE   262 AA;  29031 MW;  886BBF5DEE3BFF29 CRC64;
     MPPCSGGDGS TPPGPSLRDR DCPAQSAEYP RDRLDPRPGS PSEASSPPFL RSRAPVNWYQ
     EKAQVFLWHL MVSGSTTLLC LWKQPFHVSA FPVTASLAFR QSQGAGQHLY KDLQPFILLR
     LLMPEETQTQ DQPMEEEEVE TFAFQAEIAQ LMSLIINTFY SNKEIFLREL ISNSSDALDK
     IRYESLTDPS KLDSGKELHI NLIPNKQDRT LTIVDTGIGM TKADLINNLG TIAKSGTKAF
     MEALQAGADI SMIGQFGVGF YS
//
ID   A0A024RD80_HUMAN        Unreviewed;       724 AA.
AC   A0A024RD80;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 52.
DE   SubName: Full=Heat shock protein 90kDa alpha (Cytosolic), class B member 1, isoform CRA_a {ECO:0000313|EMBL:EAX04260.1};
GN   Name=HSP90AB1 {ECO:0000313|EMBL:EAX04260.1};
GN   ORFNames=hCG_19001 {ECO:0000313|EMBL:EAX04260.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAX04260.1};
RN   [1] {ECO:0000313|EMBL:EAX04260.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAX04260.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH471081; EAX04258.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX04260.1; -; Genomic_DNA.
DR   RefSeq; NP_001258898.1; NM_001271969.1.
DR   RefSeq; NP_001258899.1; NM_001271970.1.
DR   RefSeq; NP_031381.2; NM_007355.3.
DR   Antibodypedia; 3929; 1600 antibodies.
DR   GeneID; 3326; -.
DR   KEGG; hsa:3326; -.
DR   CTD; 3326; -.
DR   EuPathDB; HostDB:ENSG00000096384.19; -.
DR   eggNOG; KOG0019; Eukaryota.
DR   eggNOG; KOG0020; Eukaryota.
DR   eggNOG; COG0326; LUCA.
DR   HOGENOM; CLU_006684_1_3_1; -.
DR   KO; K04079; -.
DR   OMA; RTDHGEP; -.
DR   OrthoDB; 924636at2759; -.
DR   ChiTaRS; HSP90AB1; human.
DR   GenomeRNAi; 3326; -.
DR   Bgee; ENSG00000096384; Expressed in hypothalamus and 239 other tissues.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:Ensembl.
DR   GO; GO:0044295; C:axonal growth cone; IEA:Ensembl.
DR   GO; GO:0016323; C:basolateral plasma membrane; IEA:Ensembl.
DR   GO; GO:0031526; C:brush border membrane; IEA:Ensembl.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0044294; C:dendritic growth cone; IEA:Ensembl.
DR   GO; GO:1990565; C:HSP90-CDC37 chaperone complex; IEA:Ensembl.
DR   GO; GO:0016234; C:inclusion body; IEA:Ensembl.
DR   GO; GO:0005765; C:lysosomal membrane; IEA:Ensembl.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:1990917; C:ooplasm; IEA:Ensembl.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:1990913; C:sperm head plasma membrane; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:Ensembl.
DR   GO; GO:0002135; F:CTP binding; IEA:Ensembl.
DR   GO; GO:0032564; F:dATP binding; IEA:Ensembl.
DR   GO; GO:0005525; F:GTP binding; IEA:Ensembl.
DR   GO; GO:0044325; F:ion channel binding; IEA:Ensembl.
DR   GO; GO:0044183; F:protein folding chaperone; IEA:Ensembl.
DR   GO; GO:0019901; F:protein kinase binding; IEA:Ensembl.
DR   GO; GO:0019887; F:protein kinase regulator activity; IEA:Ensembl.
DR   GO; GO:0017098; F:sulfonylurea receptor binding; IEA:Ensembl.
DR   GO; GO:0048156; F:tau protein binding; IEA:Ensembl.
DR   GO; GO:0051082; F:unfolded protein binding; IEA:InterPro.
DR   GO; GO:0002134; F:UTP binding; IEA:Ensembl.
DR   GO; GO:0048675; P:axon extension; IEA:Ensembl.
DR   GO; GO:0035690; P:cellular response to drug; IEA:Ensembl.
DR   GO; GO:0034605; P:cellular response to heat; IEA:Ensembl.
DR   GO; GO:0071353; P:cellular response to interleukin-4; IEA:Ensembl.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; IEA:Ensembl.
DR   GO; GO:0021955; P:central nervous system neuron axonogenesis; IEA:Ensembl.
DR   GO; GO:0030010; P:establishment of cell polarity; IEA:Ensembl.
DR   GO; GO:1903660; P:negative regulation of complement-dependent cytotoxicity; IEA:Ensembl.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:1901799; P:negative regulation of proteasomal protein catabolic process; IEA:Ensembl.
DR   GO; GO:0001890; P:placenta development; IEA:Ensembl.
DR   GO; GO:0045793; P:positive regulation of cell size; IEA:Ensembl.
DR   GO; GO:1904031; P:positive regulation of cyclin-dependent protein kinase activity; IEA:Ensembl.
DR   GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IEA:Ensembl.
DR   GO; GO:0032092; P:positive regulation of protein binding; IEA:Ensembl.
DR   GO; GO:0042307; P:positive regulation of protein import into nucleus; IEA:Ensembl.
DR   GO; GO:0051897; P:positive regulation of protein kinase B signaling; IEA:Ensembl.
DR   GO; GO:0071902; P:positive regulation of protein serine/threonine kinase activity; IEA:Ensembl.
DR   GO; GO:0042220; P:response to cocaine; IEA:Ensembl.
DR   GO; GO:0009651; P:response to salt stress; IEA:Ensembl.
DR   Gene3D; 1.20.120.790; -; 1.
DR   Gene3D; 3.30.565.10; -; 1.
DR   HAMAP; MF_00505; HSP90; 1.
DR   InterPro; IPR003594; HATPase_C.
DR   InterPro; IPR036890; HATPase_C_sf.
DR   InterPro; IPR019805; Heat_shock_protein_90_CS.
DR   InterPro; IPR037196; HSP90_C.
DR   InterPro; IPR001404; Hsp90_fam.
DR   InterPro; IPR020575; Hsp90_N.
DR   InterPro; IPR020568; Ribosomal_S5_D2-typ_fold.
DR   PANTHER; PTHR11528; PTHR11528; 1.
DR   Pfam; PF02518; HATPase_c; 1.
DR   Pfam; PF00183; HSP90; 1.
DR   PIRSF; PIRSF002583; Hsp90; 1.
DR   PRINTS; PR00775; HEATSHOCK90.
DR   SMART; SM00387; HATPase_c; 1.
DR   SUPFAM; SSF110942; SSF110942; 1.
DR   SUPFAM; SSF54211; SSF54211; 1.
DR   SUPFAM; SSF55874; SSF55874; 1.
DR   PROSITE; PS00298; HSP90; 1.
PE   3: Inferred from homology;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Stress response {ECO:0000313|EMBL:EAX04260.1}.
FT   DOMAIN          35..189
FT                   /note="HATPase_c"
FT                   /evidence="ECO:0000259|SMART:SM00387"
FT   REGION          222..270
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          696..724
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          543..563
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        241..270
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   724 AA;  83264 MW;  A93118C214D03810 CRC64;
     MPEEVHHGEE EVETFAFQAE IAQLMSLIIN TFYSNKEIFL RELISNASDA LDKIRYESLT
     DPSKLDSGKE LKIDIIPNPQ ERTLTLVDTG IGMTKADLIN NLGTIAKSGT KAFMEALQAG
     ADISMIGQFG VGFYSAYLVA EKVVVITKHN DDEQYAWESS AGGSFTVRAD HGEPIGRGTK
     VILHLKEDQT EYLEERRVKE VVKKHSQFIG YPITLYLEKE REKEISDDEA EEEKGEKEEE
     DKDDEEKPKI EDVGSDEEDD SGKDKKKKTK KIKEKYIDQE ELNKTKPIWT RNPDDITQEE
     YGEFYKSLTN DWEDHLAVKH FSVEGQLEFR ALLFIPRRAP FDLFENKKKK NNIKLYVRRV
     FIMDSCDELI PEYLNFIRGV VDSEDLPLNI SREMLQQSKI LKVIRKNIVK KCLELFSELA
     EDKENYKKFY EAFSKNLKLG IHEDSTNRRR LSELLRYHTS QSGDEMTSLS EYVSRMKETQ
     KSIYYITGES KEQVANSAFV ERVRKRGFEV VYMTEPIDEY CVQQLKEFDG KSLVSVTKEG
     LELPEDEEEK KKMEESKAKF ENLCKLMKEI LDKKVEKVTI SNRLVSSPCC IVTSTYGWTA
     NMERIMKAQA LRDNSTMGYM MAKKHLEINP DHPIVETLRQ KAEADKNDKA VKDLVVLLFE
     TALLSSGFSL EDPQTHSNRI YRMIKLGLGI DEDEVAAEEP NAAVPDEIPP LEGDEDASRM
     EEVD
//
ID   B4DGL0_HUMAN            Unreviewed;       714 AA.
AC   B4DGL0;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   22-APR-2020, entry version 70.
DE   SubName: Full=cDNA FLJ53619, highly similar to Heat shock protein HSP 90-beta {ECO:0000313|EMBL:BAG57821.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG57821.1};
RN   [1] {ECO:0000313|EMBL:BAG57821.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAG57821.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK294643; BAG57821.1; -; mRNA.
DR   RefSeq; NP_001258901.1; NM_001271972.1.
DR   PeptideAtlas; B4DGL0; -.
DR   PRIDE; B4DGL0; -.
DR   GeneID; 3326; -.
DR   CTD; 3326; -.
DR   eggNOG; KOG0019; Eukaryota.
DR   eggNOG; KOG0020; Eukaryota.
DR   eggNOG; COG0326; LUCA.
DR   GenomeRNAi; 3326; -.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0051082; F:unfolded protein binding; IEA:InterPro.
DR   GO; GO:0006457; P:protein folding; IEA:InterPro.
DR   Gene3D; 1.20.120.790; -; 1.
DR   Gene3D; 3.30.565.10; -; 1.
DR   HAMAP; MF_00505; HSP90; 1.
DR   InterPro; IPR003594; HATPase_C.
DR   InterPro; IPR036890; HATPase_C_sf.
DR   InterPro; IPR019805; Heat_shock_protein_90_CS.
DR   InterPro; IPR037196; HSP90_C.
DR   InterPro; IPR001404; Hsp90_fam.
DR   InterPro; IPR020575; Hsp90_N.
DR   InterPro; IPR020568; Ribosomal_S5_D2-typ_fold.
DR   PANTHER; PTHR11528; PTHR11528; 1.
DR   Pfam; PF02518; HATPase_c; 1.
DR   Pfam; PF00183; HSP90; 1.
DR   PIRSF; PIRSF002583; Hsp90; 1.
DR   PRINTS; PR00775; HEATSHOCK90.
DR   SMART; SM00387; HATPase_c; 1.
DR   SUPFAM; SSF110942; SSF110942; 1.
DR   SUPFAM; SSF54211; SSF54211; 1.
DR   SUPFAM; SSF55874; SSF55874; 1.
DR   PROSITE; PS00298; HSP90; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Stress response {ECO:0000313|EMBL:BAG57821.1}.
FT   DOMAIN          35..179
FT                   /note="HATPase_c"
FT                   /evidence="ECO:0000259|SMART:SM00387"
FT   REGION          212..260
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          686..714
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          533..553
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        231..260
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   714 AA;  82170 MW;  1C7927E5F1D9509F CRC64;
     MPEEVHHGEE EVETFAFQAE IAQLMSLIIN TFYSNKEIFL RELISNASDA LDKIRCESLT
     DPSKLDSGKE LKIDIIPNPQ ERTLTLVDTG IGMTKADLIN NLGTIAKSGT KAFMEALQAG
     VGFYSAYLVA EKVVVITKHN DDEQYAWESS AGGSFTVRAD HGDPIGRGTK VILHLKEDQT
     EYLEERRVKE VVKKHSQFIG YPITLYLEKE REKEISDDEA EEEKGEKEEE DKDDEEKPKI
     EDVGSDEEDD SGKDKKKKTK KIKEKYIDQE ELNKTKPIWT RNPDDITQEE YGEFYKSLTN
     DWEDHLAVKH FSVEGQLEFR ALLFIPRRAP FDLFENKKKK NNIKLYVRRV FIMDSCDELI
     PEYLNFIRGV VDSEDLPLNI SREMLQQSKI LKVIRKNIVK KCLELFSELA EDKENYKKFY
     EAFSKNLKLG IHEDSTNRRR LSELLRYHTS QSGDEMTSLS EYVSRMKETQ KSIYYITGES
     KEQVANSAFV ERVRKRGFEV VYMTEPIDEY CVQQLKEFDG KSLVSVTKEG LELPEDEEEK
     KKMEESKAKF ENLCKLMKEI LDKKVEKVTI SNRLVSSPCC IVTSTYGWTA NMERIMKAQA
     LRDNSTMGYM MAKKHLEINP DHPIVETLRQ KAEADKNDKA VKDLVVLLFE TALLSSGFSL
     EDPQTHSNRI YRMIKLGLGI DEDEVAAEEP NAAVPDEIPP LEGDEDASRM EEVD
//
ID   HS90B_HUMAN             Reviewed;         724 AA.
AC   P08238; B2R5P0; Q5T9W7; Q9NQW0; Q9NTK6;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   22-APR-2020, entry version 250.
DE   RecName: Full=Heat shock protein HSP 90-beta;
DE            Short=HSP 90;
DE   AltName: Full=Heat shock 84 kDa;
DE            Short=HSP 84;
DE            Short=HSP84;
GN   Name=HSP90AB1; Synonyms=HSP90B, HSPC2, HSPCB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3301534; DOI=10.1016/0378-1119(87)90012-6;
RA   Rebbe N.F., Ware J., Bertina R.M., Modrich P., Stafford D.W.;
RT   "Nucleotide sequence of a cDNA for a member of the human 90-kDa heat-shock
RT   protein family.";
RL   Gene 53:235-245(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2768249;
RA   Rebbe N.F., Hickman W.S., Ley T.J., Stafford D.W., Hickman S.;
RT   "Nucleotide sequence and regulation of a human 90-kDa heat shock protein
RT   gene.";
RL   J. Biol. Chem. 264:15006-15011(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2469626; DOI=10.1016/0378-1119(88)90182-5;
RA   Hoffmann T., Hovemann B.;
RT   "Heat-shock proteins, Hsp84 and Hsp86, of mice and men: two related genes
RT   encode formerly identified tumour-specific transplantation antigens.";
RL   Gene 74:491-501(1988).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Testis;
RA   Lu L., Huang X.Y., Yin L.L., Xu M., Li J.M., Zhou Z.M., Sha J.H.;
RT   "Cloning a new isoform of heat shock 90kDa in testis.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Amygdala;
RX   PubMed=11230166; DOI=10.1101/gr.gr1547r;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H., Lauber J.,
RA   Duesterhoeft A., Beyer A., Koehrer K., Strack N., Mewes H.-W.,
RA   Ottenwaelder B., Obermaier B., Tampe J., Heubner D., Wambutt R., Korn B.,
RA   Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and analysis of
RT   500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (DEC-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon, Lymph, Muscle, Skin, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   PROTEIN SEQUENCE OF 2-21, AND PHOSPHORYLATION.
RX   PubMed=2492519;
RA   Lees-Miller S.P., Anderson C.W.;
RT   "Two human 90-kDa heat shock proteins are phosphorylated in vivo at
RT   conserved serines that are phosphorylated in vitro by casein kinase II.";
RL   J. Biol. Chem. 264:2431-2437(1989).
RN   [12]
RP   PROTEIN SEQUENCE OF 42-107; 149-168; 181-197; 204-221; 250-265; 274-284;
RP   292-348; 360-392; 412-427; 439-448; 450-475; 482-502; 506-526; 539-551;
RP   584-604; 613-639 AND 653-679, PHOSPHORYLATION AT SER-255, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RA   Bienvenut W.V., Waridel P., Quadroni M.;
RL   Submitted (MAR-2009) to UniProtKB.
RN   [13]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 50-118.
RX   PubMed=8180474; DOI=10.1007/bf00292342;
RA   Takahashi I., Tanuma R., Hirata M., Hashimoto K.;
RT   "A cosmid clone at the D6S182 locus on human chromosome 6p12 contains the
RT   90-kDa heat shock protein beta gene (HSP90 beta).";
RL   Mamm. Genome 5:121-122(1994).
RN   [14]
RP   SEQUENCE REVISION.
RA   Takahashi I., Tanuma R., Hirata M., Hashimoto K.;
RL   Submitted (JUL-2011) to the EMBL/GenBank/DDBJ databases.
RN   [15]
RP   PROTEIN SEQUENCE OF 54-64 AND 187-199.
RC   TISSUE=Colon carcinoma;
RX   PubMed=9150948; DOI=10.1002/elps.1150180344;
RA   Ji H., Reid G.E., Moritz R.L., Eddes J.S., Burgess A.W., Simpson R.J.;
RT   "A two-dimensional gel database of human colon carcinoma proteins.";
RL   Electrophoresis 18:605-613(1997).
RN   [16]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 93-724.
RC   TISSUE=Pancreas;
RA   Mason A., O'Connor D., Greenhalf W.;
RT   "Novel sequence for human Hsp90 beta giving a substitution of R55T (R147 in
RT   original sequence) and M85R (M177 in original sequence).";
RL   Submitted (JUN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [17]
RP   HOMODIMERIZATION.
RX   PubMed=7588731; DOI=10.1111/j.1432-1033.1995.001_1.x;
RA   Nemoto T., Ohara-Nemoto Y., Ota M., Takagi T., Yokoyama K.;
RT   "Mechanism of dimer formation of the 90-kDa heat-shock protein.";
RL   Eur. J. Biochem. 233:1-8(1995).
RN   [18]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH CDK6 AND CDC37.
RX   PubMed=9482106; DOI=10.1038/sj.onc.1201570;
RA   Mahony D., Parry D.A., Lees E.;
RT   "Active cdk6 complexes are predominantly nuclear and represent only a
RT   minority of the cdk6 in T cells.";
RL   Oncogene 16:603-611(1998).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.;
RT   "Proteomic characterization of the human centrosome by protein correlation
RT   profiling.";
RL   Nature 426:570-574(2003).
RN   [20]
RP   PHOSPHORYLATION AT SER-226 AND SER-255, MUTAGENESIS OF SER-226 AND SER-255,
RP   AND INTERACTION WITH AHR.
RX   PubMed=15581363; DOI=10.1021/bi048736m;
RA   Ogiso H., Kagi N., Matsumoto E., Nishimoto M., Arai R., Shirouzu M.,
RA   Mimura J., Fujii-Kuriyama Y., Yokoyama S.;
RT   "Phosphorylation analysis of 90 kDa heat shock protein within the cytosolic
RT   arylhydrocarbon receptor complex.";
RL   Biochemistry 43:15510-15519(2004).
RN   [21]
RP   INTERACTION WITH TP53, AND REGION.
RX   PubMed=15358771; DOI=10.1074/jbc.m407687200;
RA   Mueller L., Schaupp A., Walerych D., Wegele H., Buchner J.;
RT   "Hsp90 regulates the activity of wild type p53 under physiological and
RT   elevated temperatures.";
RL   J. Biol. Chem. 279:48846-48854(2004).
RN   [22]
RP   ISGYLATION.
RX   PubMed=16139798; DOI=10.1016/j.bbrc.2005.08.132;
RA   Giannakopoulos N.V., Luo J.K., Papov V., Zou W., Lenschow D.J.,
RA   Jacobs B.S., Borden E.C., Li J., Virgin H.W., Zhang D.E.;
RT   "Proteomic identification of proteins conjugated to ISG15 in mouse and
RT   human cells.";
RL   Biochem. Biophys. Res. Commun. 336:496-506(2005).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [24]
RP   INTERACTION WITH SGTA, AND SUBCELLULAR LOCATION.
RX   PubMed=16580629; DOI=10.1016/j.bbrc.2006.03.090;
RA   Yin H., Wang H., Zong H., Chen X., Wang Y., Yun X., Wu Y., Wang J., Gu J.;
RT   "SGT, a Hsp90beta binding partner, is accumulated in the nucleus during
RT   cell apoptosis.";
RL   Biochem. Biophys. Res. Commun. 343:1153-1158(2006).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-255, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [26]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H., Mangini N.J.,
RA   Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R., Yamagishi S.,
RA   Shabanowitz J., Hearing V.J., Wu C., Appella E., Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [27]
RP   FUNCTION, AND INTERACTION WITH UNC45A.
RX   PubMed=16478993; DOI=10.1128/mcb.26.5.1722-1730.2006;
RA   Chadli A., Graham J.D., Abel M.G., Jackson T.A., Gordon D.F., Wood W.M.,
RA   Felts S.J., Horwitz K.B., Toft D.;
RT   "GCUNC-45 is a novel regulator for the progesterone receptor/hsp90
RT   chaperoning pathway.";
RL   Mol. Cell. Biol. 26:1722-1730(2006).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-297, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [29]
RP   UBIQUITINATION.
RX   PubMed=18042044; DOI=10.1042/bj20071338;
RA   Windheim M., Peggie M., Cohen P.;
RT   "Two different classes of E2 ubiquitin-conjugating enzymes are required for
RT   the mono-ubiquitination of proteins and elongation by polyubiquitin chains
RT   with a specific topology.";
RL   Biochem. J. 409:723-729(2008).
RN   [30]
RP   INTERACTION WITH DNAJC7.
RX   PubMed=18620420; DOI=10.1021/bi800770g;
RA   Moffatt N.S., Bruinsma E., Uhl C., Obermann W.M., Toft D.;
RT   "Role of the cochaperone Tpr2 in Hsp90 chaperoning.";
RL   Biochemistry 47:8203-8213(2008).
RN   [31]
RP   IDENTIFICATION BY MASS SPECTROMETRY, INTERACTION WITH BIRC2, SUBCELLULAR
RP   LOCATION, AND FUNCTION.
RX   PubMed=18239673; DOI=10.1038/cdd.2008.5;
RA   Didelot C., Lanneau D., Brunet M., Bouchot A., Cartier J., Jacquel A.,
RA   Ducoroy P., Cathelin S., Decologne N., Chiosis G., Dubrez-Daloz L.,
RA   Solary E., Garrido C.;
RT   "Interaction of heat-shock protein 90 beta isoform (HSP90 beta) with
RT   cellular inhibitor of apoptosis 1 (c-IAP1) is required for cell
RT   differentiation.";
RL   Cell Death Differ. 15:859-866(2008).
RN   [32]
RP   SUBUNIT, ACTIVITY REGULATION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=18400751; DOI=10.1074/jbc.m800540200;
RA   Richter K., Soroka J., Skalniak L., Leskovar A., Hessling M., Reinstein J.,
RA   Buchner J.;
RT   "Conserved conformational changes in the ATPase cycle of human Hsp90.";
RL   J. Biol. Chem. 283:17757-17765(2008).
RN   [33]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-226, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [34]
RP   INTERACTION WITH TTC4.
RX   PubMed=18320024; DOI=10.1371/journal.pone.0001737;
RA   Crevel G., Bennett D., Cotterill S.;
RT   "The human TPR protein TTC4 is a putative Hsp90 co-chaperone which
RT   interacts with CDC6 and shows alterations in transformed cells.";
RL   PLoS ONE 3:E0001737-E0001737(2008).
RN   [35]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-307, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [36]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-226, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by enrichment
RT   and fractionation of phosphopeptides with strong anion exchange
RT   chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [37]
RP   FUNCTION, S-NITROSYLATION AT CYS-590, AND MUTAGENESIS OF CYS-590.
RX   PubMed=19696785; DOI=10.1038/embor.2009.153;
RA   Retzlaff M., Stahl M., Eberl H.C., Lagleder S., Beck J., Kessler H.,
RA   Buchner J.;
RT   "Hsp90 is regulated by a switch point in the C-terminal domain.";
RL   EMBO Rep. 10:1147-1153(2009).
RN   [38]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-435 AND LYS-481, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [39]
RP   INTERACTION WITH TGFB1 PROCESSED FORM (LAP), AND SUBCELLULAR LOCATION.
RX   PubMed=20599762; DOI=10.1016/j.bbrc.2010.06.112;
RA   Suzuki S., Kulkarni A.B.;
RT   "Extracellular heat shock protein HSP90beta secreted by MG63 osteosarcoma
RT   cells inhibits activation of latent TGF-beta1.";
RL   Biochem. Biophys. Res. Commun. 398:525-531(2010).
RN   [40]
RP   INTERACTION WITH HSP90AA1; JAK2 AND PRKCE, INDUCTION, AND FUNCTION.
RX   PubMed=20353823; DOI=10.1016/j.cellsig.2010.03.012;
RA   Cheng M.B., Zhang Y., Zhong X., Sutter B., Cao C.Y., Chen X.S., Cheng X.K.,
RA   Zhang Y., Xiao L., Shen Y.F.;
RT   "Stat1 mediates an auto-regulation of hsp90beta gene in heat shock
RT   response.";
RL   Cell. Signal. 22:1206-1213(2010).
RN   [41]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-226, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [42]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [43]
RP   MALONYLATION AT LYS-399.
RX   PubMed=21908771; DOI=10.1074/mcp.m111.012658;
RA   Peng C., Lu Z., Xie Z., Cheng Z., Chen Y., Tan M., Luo H., Zhang Y., He W.,
RA   Yang K., Zwaans B.M., Tishkoff D., Ho L., Lombard D., He T.C., Dai J.,
RA   Verdin E., Ye Y., Zhao Y.;
RT   "The first identification of lysine malonylation substrates and its
RT   regulatory enzyme.";
RL   Mol. Cell. Proteomics 10:M111.012658.01-M111.012658.12(2011).
RN   [44]
RP   INTERACTION WITH AHSA1 AND XPO1.
RX   PubMed=22022502; DOI=10.1371/journal.pone.0026044;
RA   Echeverria P.C., Bernthaler A., Dupuis P., Mayer B., Picard D.;
RT   "An interaction network predicted from public data as a discovery tool:
RT   application to the Hsp90 molecular chaperone machine.";
RL   PLoS ONE 6:E26044-E26044(2011).
RN   [45]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-226, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [46]
RP   PHOSPHORYLATION AT SER-718 BY PLK2 AND PLK3.
RX   PubMed=22828320; DOI=10.1016/j.bbapap.2012.07.003;
RA   Salvi M., Trashi E., Cozza G., Franchin C., Arrigoni G., Pinna L.A.;
RT   "Investigation on PLK2 and PLK3 substrate recognition.";
RL   Biochim. Biophys. Acta 1824:1366-1373(2012).
RN   [47]
RP   INTERACTION WITH CDC25A.
RX   PubMed=22843495; DOI=10.1093/hmg/dds303;
RA   Giessrigl B., Krieger S., Rosner M., Huttary N., Saiko P., Alami M.,
RA   Messaoudi S., Peyrat J.F., Maciuk A., Gollinger M., Kopf S., Kazlauskas E.,
RA   Mazal P., Szekeres T., Hengstschlaeger M., Matulis D., Jaeger W.,
RA   Krupitza G.;
RT   "Hsp90 stabilizes Cdc25A and counteracts heat shock-mediated Cdc25A
RT   degradation and cell-cycle attenuation in pancreatic carcinoma cells.";
RL   Hum. Mol. Genet. 21:4615-4627(2012).
RN   [48]
RP   PROTEIN CLEAVAGE, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=22848402; DOI=10.1371/journal.pone.0040795;
RA   Beck R., Dejeans N., Glorieux C., Creton M., Delaive E., Dieu M., Raes M.,
RA   Leveque P., Gallez B., Depuydt M., Collet J.F., Calderon P.B., Verrax J.;
RT   "Hsp90 is cleaved by reactive oxygen species at a highly conserved N-
RT   terminal amino acid motif.";
RL   PLoS ONE 7:E40795-E40795(2012).
RN   [49]
RP   INTERACTION WITH NOS3, MUTAGENESIS OF TYR-301, AND PHOSPHORYLATION AT
RP   TYR-301 BY SRC.
RX   PubMed=23585225; DOI=10.1152/ajplung.00419.2012;
RA   Barabutis N., Handa V., Dimitropoulou C., Rafikov R., Snead C., Kumar S.,
RA   Joshi A., Thangjam G., Fulton D., Black S.M., Patel V., Catravas J.D.;
RT   "LPS induces pp60c-src-mediated tyrosine phosphorylation of Hsp90 in lung
RT   vascular endothelial cells and mouse lung.";
RL   Am. J. Physiol. 304:L883-L893(2013).
RN   [50]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-226; SER-255; THR-297;
RP   SER-445 AND THR-479, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [51]
RP   INTERACTION WITH MAPK7.
RX   PubMed=23428871; DOI=10.1128/mcb.01246-12;
RA   Erazo T., Moreno A., Ruiz-Babot G., Rodriguez-Asiain A., Morrice N.A.,
RA   Espadamala J., Bayascas J.R., Gomez N., Lizcano J.M.;
RT   "Canonical and kinase activity-independent mechanisms for extracellular
RT   signal-regulated kinase 5 (ERK5) nuclear translocation require dissociation
RT   of Hsp90 from the ERK5-Cdc37 complex.";
RL   Mol. Cell. Biol. 33:1671-1686(2013).
RN   [52]
RP   INTERACTION WITH KCNQ4.
RX   PubMed=23431407; DOI=10.1371/journal.pone.0057282;
RA   Gao Y., Yechikov S., Vazquez A.E., Chen D., Nie L.;
RT   "Distinct roles of molecular chaperones HSP90alpha and HSP90beta in the
RT   biogenesis of KCNQ4 channels.";
RL   PLoS ONE 8:E57282-E57282(2013).
RN   [53]
RP   FUNCTION, AND INTERACTION WITH STUB1 AND SMAD3.
RX   PubMed=24613385; DOI=10.1016/j.bbrc.2014.02.124;
RA   Shang Y., Xu X., Duan X., Guo J., Wang Y., Ren F., He D., Chang Z.;
RT   "Hsp70 and Hsp90 oppositely regulate TGF-beta signaling through
RT   CHIP/Stub1.";
RL   Biochem. Biophys. Res. Commun. 446:387-392(2014).
RN   [54]
RP   METHYLATION AT LYS-531 AND LYS-574 BY SMYD2, IDENTIFICATION BY MASS
RP   SPECTROMETRY, MUTAGENESIS OF LYS-531 AND LYS-574, INTERACTION WITH STIP1
RP   AND CDC37, AND SUBCELLULAR LOCATION.
RX   PubMed=24880080; DOI=10.1016/j.canlet.2014.05.014;
RA   Hamamoto R., Toyokawa G., Nakakido M., Ueda K., Nakamura Y.;
RT   "SMYD2-dependent HSP90 methylation promotes cancer cell proliferation by
RT   regulating the chaperone complex formation.";
RL   Cancer Lett. 351:126-133(2014).
RN   [55]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-669, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [56]
RP   INTERACTION WITH NWD1.
RX   PubMed=24681825; DOI=10.18632/oncotarget.1850;
RA   Correa R.G., Krajewska M., Ware C.F., Gerlic M., Reed J.C.;
RT   "The NLR-related protein NWD1 is associated with prostate cancer and
RT   modulates androgen receptor signaling.";
RL   Oncotarget 5:1666-1682(2014).
RN   [57]
RP   INTERACTION WITH AHSA1; BIRC2 AND CDC37, AND REGION.
RX   PubMed=25486457; DOI=10.1016/j.bbamcr.2014.11.026;
RA   Synoradzki K., Bieganowski P.;
RT   "Middle domain of human Hsp90 isoforms differentially binds Aha1 in human
RT   cells and alters Hsp90 activity in yeast.";
RL   Biochim. Biophys. Acta 1853:445-452(2015).
RN   [58]
RP   REVIEW.
RX   PubMed=25973397; DOI=10.3389/fonc.2015.00100;
RA   Khurana N., Bhattacharyya S.;
RT   "Hsp90, the concertmaster: tuning transcription.";
RL   Front. Oncol. 5:100-100(2015).
RN   [59]
RP   INTERACTION WITH HSF1; HIF1A; ERBB2; MET; KEAP1 AND RHOBTB2, AND
RP   MUTAGENESIS OF GLU-42 AND ASP-88.
RX   PubMed=26517842; DOI=10.1371/journal.pone.0141786;
RA   Prince T.L., Kijima T., Tatokoro M., Lee S., Tsutsumi S., Yim K., Rivas C.,
RA   Alarcon S., Schwartz H., Khamit-Kush K., Scroggins B.T., Beebe K.,
RA   Trepel J.B., Neckers L.;
RT   "Client proteins and small molecule inhibitors display distinct binding
RT   preferences for constitutive and stress-induced HSP90 isoforms and their
RT   conformationally restricted mutants.";
RL   PLoS ONE 10:E0141786-E0141786(2015).
RN   [60]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [61]
RP   REVIEW.
RX   PubMed=27295069; DOI=10.1016/j.biochi.2016.05.018;
RA   Verma S., Goyal S., Jamal S., Singh A., Grover A.;
RT   "Hsp90: Friends, clients and natural foes.";
RL   Biochimie 127:227-240(2016).
RN   [62]
RP   REVIEW.
RX   PubMed=26991466; DOI=10.1002/bip.22835;
RA   Pearl L.H.;
RT   "Review: The HSP90 molecular chaperone-an enigmatic ATPase.";
RL   Biopolymers 105:594-607(2016).
RN   [63]
RP   X-RAY CRYSTALLOGRAPHY (2.45 ANGSTROMS) OF 1-221 IN COMPLEX WITH PURINE
RP   ANALOG.
RX   PubMed=15217611; DOI=10.1016/j.chembiol.2004.03.033;
RA   Wright L., Barril X., Dymock B., Sheridan L., Surgenor A., Beswick M.,
RA   Drysdale M., Collier A., Massey A., Davies N., Fink A., Fromont C.,
RA   Aherne W., Boxall K., Sharp S., Workman P., Hubbard R.E.;
RT   "Structure-activity relationships in purine-based inhibitor binding to
RT   HSP90 isoforms.";
RL   Chem. Biol. 11:775-785(2004).
RN   [64]
RP   X-RAY CRYSTALLOGRAPHY (3.00 ANGSTROMS) OF 720-724 IN COMPLEX WITH FKBP4.
RX   PubMed=15159550; DOI=10.1073/pnas.0305969101;
RA   Wu B., Li P., Liu Y., Lou Z., Ding Y., Shu C., Ye S., Bartlam M., Shen B.,
RA   Rao Z.;
RT   "3D structure of human FK506-binding protein 52: implications for the
RT   assembly of the glucocorticoid receptor/Hsp90/immunophilin heterocomplex.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:8348-8353(2004).
RN   [65]
RP   X-RAY CRYSTALLOGRAPHY (2.28 ANGSTROMS) OF 284-543.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of the middle domain of human hsp90-beta.";
RL   Submitted (DEC-2010) to the PDB data bank.
CC   -!- FUNCTION: Molecular chaperone that promotes the maturation, structural
CC       maintenance and proper regulation of specific target proteins involved
CC       for instance in cell cycle control and signal transduction. Undergoes a
CC       functional cycle that is linked to its ATPase activity. This cycle
CC       probably induces conformational changes in the client proteins, thereby
CC       causing their activation. Interacts dynamically with various co-
CC       chaperones that modulate its substrate recognition, ATPase cycle and
CC       chaperone function (PubMed:16478993, PubMed:19696785). Engages with a
CC       range of client protein classes via its interaction with various co-
CC       chaperone proteins or complexes, that act as adapters, simultaneously
CC       able to interact with the specific client and the central chaperone
CC       itself. Recruitment of ATP and co-chaperone followed by client protein
CC       forms a functional chaperone. After the completion of the chaperoning
CC       process, properly folded client protein and co-chaperone leave HSP90 in
CC       an ADP-bound partially open conformation and finally, ADP is released
CC       from HSP90 which acquires an open conformation for the next cycle
CC       (PubMed:27295069, PubMed:26991466). Apart from its chaperone activity,
CC       it also plays a role in the regulation of the transcription machinery.
CC       HSP90 and its co-chaperones modulate transcription at least at three
CC       different levels. In the first place, they alter the steady-state
CC       levels of certain transcription factors in response to various
CC       physiological cues. Second, they modulate the activity of certain
CC       epigenetic modifiers, such as histone deacetylases or DNA methyl
CC       transferases, and thereby respond to the change in the environment.
CC       Third, they participate in the eviction of histones from the promoter
CC       region of certain genes and thereby turn on gene expression
CC       (PubMed:25973397). Antagonizes STUB1-mediated inhibition of TGF-beta
CC       signaling via inhibition of STUB1-mediated SMAD3 ubiquitination and
CC       degradation (PubMed:24613385). Promotes cell differentiation by
CC       chaperoning BIRC2 and thereby protecting from auto-ubiquitination and
CC       degradation by the proteasomal machinery (PubMed:18239673). Main
CC       chaperone that is involved in the phosphorylation/activation of the
CC       STAT1 by chaperoning both JAK2 and PRKCE under heat shock and in turn,
CC       activates its own transcription (PubMed:20353823).
CC       {ECO:0000269|PubMed:16478993, ECO:0000269|PubMed:18239673,
CC       ECO:0000269|PubMed:19696785, ECO:0000269|PubMed:20353823,
CC       ECO:0000269|PubMed:24613385, ECO:0000303|PubMed:25973397,
CC       ECO:0000303|PubMed:26991466, ECO:0000303|PubMed:27295069}.
CC   -!- ACTIVITY REGULATION: In the resting state, through the dimerization of
CC       its C-terminal domain, HSP90 forms a homodimer which is defined as the
CC       open conformation. Upon ATP-binding, the N-terminal domain undergoes
CC       significant conformational changes and comes in contact to form an
CC       active closed conformation. After HSP90 finishes its chaperoning tasks
CC       of assisting the proper folding, stabilization and activation of client
CC       proteins under the active state, ATP molecule is hydrolyzed to ADP
CC       which then dissociates from HSP90 and directs the protein back to the
CC       resting state. {ECO:0000269|PubMed:18400751}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=300 uM for ATP {ECO:0000269|PubMed:18400751};
CC   -!- SUBUNIT: Monomer (PubMed:24880080). Homodimer (PubMed:7588731,
CC       PubMed:18400751). Forms a complex with CDK6 and CDC37 (PubMed:9482106,
CC       PubMed:25486457). Interacts with UNC45A; binding to UNC45A involves 2
CC       UNC45A monomers per HSP90AB1 dimer (PubMed:16478993). Interacts with
CC       CHORDC1 (By similarity). Interacts with DNAJC7 (PubMed:18620420).
CC       Interacts with FKBP4 (PubMed:15159550). May interact with NWD1
CC       (PubMed:24681825). Interacts with SGTA (PubMed:16580629). Interacts
CC       with HSF1 in an ATP-dependent manner. Interacts with MET; the
CC       interaction suppresses MET kinase activity. Interacts with ERBB2 in an
CC       ATP-dependent manner; the interaction suppresses ERBB2 kinase activity.
CC       Interacts with HIF1A, KEAP1 and RHOBTB2 (PubMed:26517842). Interacts
CC       with STUB1 and SMAD3 (PubMed:24613385). Interacts with XPO1 and AHSA1
CC       (PubMed:22022502, PubMed:25486457). Interacts with BIRC2
CC       (PubMed:25486457). Interacts with KCNQ4; promotes cell surface
CC       expression of KCNQ4 (PubMed:23431407). Interacts with BIRC2; prevents
CC       auto-ubiquitination and degradation of its client protein BIRC2
CC       (PubMed:18239673). Interacts with NOS3 (PubMed:23585225). Interacts
CC       with AHR; interaction is inhibited by HSP90AB1 phosphorylation on Ser-
CC       226 and Ser-255 (PubMed:15581363). Interacts with STIP1 and CDC37; upon
CC       SMYD2-dependent methylation (PubMed:24880080). Interacts with JAK2 and
CC       PRKCE; promotes functional activation in a heat shock-dependent manner
CC       (PubMed:20353823). Interacts with HSP90AA1; interaction is constitutive
CC       (PubMed:20353823). HSP90AB1-CDC37 chaperone complex interacts with
CC       inactive MAPK7 (via N-terminal half) in resting cells; the interaction
CC       is MAP2K5-independent and prevents from ubiquitination and proteasomal
CC       degradation (PubMed:23428871). Interacts with CDC25A; prevents heat
CC       shock-mediated CDC25A degradation and contributes to cell cycle
CC       progression (PubMed:22843495). Interacts with TP53 (via DNA binding
CC       domain); suppresses TP53 aggregation and prevents from irreversible
CC       thermal inactivation (PubMed:15358771). Interacts with TGFB1 processed
CC       form (LAP); inhibits latent TGFB1 activation (PubMed:20599762).
CC       Interacts with TRIM8; prevents nucleus translocation of phosphorylated
CC       STAT3 and HSP90AB1 (By similarity). Interacts with NR3C1 (via domain NR
CC       LBD) and NR1D1 (via domain NR LBD) (By similarity). Interacts with
CC       PDCL3 (By similarity). Interacts with TTC4 (via TPR repeats)
CC       (PubMed:18320024). {ECO:0000250|UniProtKB:P11499,
CC       ECO:0000250|UniProtKB:P34058, ECO:0000269|PubMed:15159550,
CC       ECO:0000269|PubMed:15358771, ECO:0000269|PubMed:15581363,
CC       ECO:0000269|PubMed:16478993, ECO:0000269|PubMed:16580629,
CC       ECO:0000269|PubMed:18239673, ECO:0000269|PubMed:18320024,
CC       ECO:0000269|PubMed:18400751, ECO:0000269|PubMed:18620420,
CC       ECO:0000269|PubMed:20353823, ECO:0000269|PubMed:20599762,
CC       ECO:0000269|PubMed:22022502, ECO:0000269|PubMed:22843495,
CC       ECO:0000269|PubMed:23428871, ECO:0000269|PubMed:23431407,
CC       ECO:0000269|PubMed:23585225, ECO:0000269|PubMed:24613385,
CC       ECO:0000269|PubMed:24681825, ECO:0000269|PubMed:24880080,
CC       ECO:0000269|PubMed:25486457, ECO:0000269|PubMed:26517842,
CC       ECO:0000269|PubMed:7588731, ECO:0000269|PubMed:9482106}.
CC   -!- INTERACTION:
CC       P08238; P08238; NbExp=4; IntAct=EBI-352572, EBI-352572;
CC       P08238; P36896: ACVR1B; NbExp=2; IntAct=EBI-352572, EBI-1384128;
CC       P08238; Q9UL18: AGO1; NbExp=3; IntAct=EBI-352572, EBI-527363;
CC       P08238; O95433: AHSA1; NbExp=4; IntAct=EBI-352572, EBI-448610;
CC       P08238; O00170: AIP; NbExp=8; IntAct=EBI-352572, EBI-704197;
CC       P08238; P31749: AKT1; NbExp=3; IntAct=EBI-352572, EBI-296087;
CC       P08238; P31751: AKT2; NbExp=2; IntAct=EBI-352572, EBI-296058;
CC       P08238; Q9UM73: ALK; NbExp=2; IntAct=EBI-352572, EBI-357361;
CC       P08238; Q16671: AMHR2; NbExp=2; IntAct=EBI-352572, EBI-6423788;
CC       P08238; Q01432: AMPD3; NbExp=2; IntAct=EBI-352572, EBI-1223554;
CC       P08238; P10398: ARAF; NbExp=8; IntAct=EBI-352572, EBI-365961;
CC       P08238; Q96GD4: AURKB; NbExp=4; IntAct=EBI-352572, EBI-624291;
CC       P08238; P30530: AXL; NbExp=3; IntAct=EBI-352572, EBI-2850927;
CC       P08238; P51451: BLK; NbExp=2; IntAct=EBI-352572, EBI-2105445;
CC       P08238; P51813: BMX; NbExp=3; IntAct=EBI-352572, EBI-696657;
CC       P08238; P15056: BRAF; NbExp=4; IntAct=EBI-352572, EBI-365980;
CC       P08238; Q06187: BTK; NbExp=2; IntAct=EBI-352572, EBI-624835;
CC       P08238; Q9UQM7: CAMK2A; NbExp=3; IntAct=EBI-352572, EBI-1383687;
CC       P08238; Q13555: CAMK2G; NbExp=2; IntAct=EBI-352572, EBI-1383465;
CC       P08238; Q16543: CDC37; NbExp=11; IntAct=EBI-352572, EBI-295634;
CC       P08238; Q7L3B6: CDC37L1; NbExp=5; IntAct=EBI-352572, EBI-2841876;
CC       P08238; Q15131: CDK10; NbExp=2; IntAct=EBI-352572, EBI-1646959;
CC       P08238; O94921: CDK14; NbExp=2; IntAct=EBI-352572, EBI-1043945;
CC       P08238; Q96Q40: CDK15; NbExp=2; IntAct=EBI-352572, EBI-1051975;
CC       P08238; Q00526: CDK3; NbExp=2; IntAct=EBI-352572, EBI-1245761;
CC       P08238; P11802: CDK4; NbExp=4; IntAct=EBI-352572, EBI-295644;
CC       P08238; Q00534: CDK6; NbExp=2; IntAct=EBI-352572, EBI-295663;
CC       P08238; P50613: CDK7; NbExp=2; IntAct=EBI-352572, EBI-1245958;
CC       P08238; P50750: CDK9; NbExp=2; IntAct=EBI-352572, EBI-1383449;
CC       P08238; O14757: CHEK1; NbExp=3; IntAct=EBI-352572, EBI-974488;
CC       P08238; Q9UHD1: CHORDC1; NbExp=6; IntAct=EBI-352572, EBI-2550959;
CC       P08238; P49674: CSNK1E; NbExp=2; IntAct=EBI-352572, EBI-749343;
CC       P08238; Q13616: CUL1; NbExp=2; IntAct=EBI-352572, EBI-359390;
CC       P08238; Q13617: CUL2; NbExp=2; IntAct=EBI-352572, EBI-456179;
CC       P08238; Q13618: CUL3; NbExp=3; IntAct=EBI-352572, EBI-456129;
CC       P08238; Q13619: CUL4A; NbExp=2; IntAct=EBI-352572, EBI-456106;
CC       P08238; Q13620: CUL4B; NbExp=2; IntAct=EBI-352572, EBI-456067;
CC       P08238; Q16832: DDR2; NbExp=2; IntAct=EBI-352572, EBI-1381484;
CC       P08238; P00533: EGFR; NbExp=10; IntAct=EBI-352572, EBI-297353;
CC       P08238; P29317: EPHA2; NbExp=2; IntAct=EBI-352572, EBI-702104;
CC       P08238; P04626: ERBB2; NbExp=4; IntAct=EBI-352572, EBI-641062;
CC       P08238; P21860: ERBB3; NbExp=3; IntAct=EBI-352572, EBI-720706;
CC       P08238; Q15303: ERBB4; NbExp=2; IntAct=EBI-352572, EBI-80371;
CC       P08238; Q96A26: FAM162A; NbExp=3; IntAct=EBI-352572, EBI-6123466;
CC       P08238; Q9UKC9: FBXL2; NbExp=2; IntAct=EBI-352572, EBI-724253;
CC       P08238; O75426: FBXO24; NbExp=2; IntAct=EBI-352572, EBI-6425658;
CC       P08238; Q9UKT8: FBXW2; NbExp=2; IntAct=EBI-352572, EBI-914727;
CC       P08238; P11362: FGFR1; NbExp=2; IntAct=EBI-352572, EBI-1028277;
CC       P08238; P22607: FGFR3; NbExp=2; IntAct=EBI-352572, EBI-348399;
CC       P08238; P09769: FGR; NbExp=4; IntAct=EBI-352572, EBI-1383732;
CC       P08238; Q02790: FKBP4; NbExp=6; IntAct=EBI-352572, EBI-1047444;
CC       P08238; Q13451: FKBP5; NbExp=16; IntAct=EBI-352572, EBI-306914;
CC       P08238; P21333: FLNA; NbExp=2; IntAct=EBI-352572, EBI-350432;
CC       P08238; P35916: FLT4; NbExp=2; IntAct=EBI-352572, EBI-1005467;
CC       P08238; P06241: FYN; NbExp=4; IntAct=EBI-352572, EBI-515315;
CC       P08238; P49840: GSK3A; NbExp=2; IntAct=EBI-352572, EBI-1044067;
CC       P08238; Q8TF76: HASPIN; NbExp=2; IntAct=EBI-352572, EBI-1237328;
CC       P08238; P08631: HCK; NbExp=3; IntAct=EBI-352572, EBI-346340;
CC       P08238; Q9UPZ9: ICK; NbExp=2; IntAct=EBI-352572, EBI-6381479;
CC       P08238; O14920: IKBKB; NbExp=2; IntAct=EBI-352572, EBI-81266;
CC       P08238; Q14164: IKBKE; NbExp=2; IntAct=EBI-352572, EBI-307369;
CC       P08238; Q9Y6K9: IKBKG; NbExp=3; IntAct=EBI-352572, EBI-81279;
CC       P08238; Q08881: ITK; NbExp=2; IntAct=EBI-352572, EBI-968552;
CC       P08238; Q2WGJ6: KLHL38; NbExp=3; IntAct=EBI-352572, EBI-6426443;
CC       P08238; P06239: LCK; NbExp=4; IntAct=EBI-352572, EBI-1348;
CC       P08238; P53671: LIMK2; NbExp=2; IntAct=EBI-352572, EBI-1384350;
CC       P08238; P07948: LYN; NbExp=2; IntAct=EBI-352572, EBI-79452;
CC       P08238; Q13163: MAP2K5; NbExp=3; IntAct=EBI-352572, EBI-307294;
CC       P08238; Q99558: MAP3K14; NbExp=4; IntAct=EBI-352572, EBI-358011;
CC       P08238; P41279: MAP3K8; NbExp=2; IntAct=EBI-352572, EBI-354900;
CC       P08238; P80192: MAP3K9; NbExp=2; IntAct=EBI-352572, EBI-3951604;
CC       P08238; Q92918: MAP4K1; NbExp=3; IntAct=EBI-352572, EBI-881;
CC       P08238; P31152: MAPK4; NbExp=2; IntAct=EBI-352572, EBI-3906061;
CC       P08238; P10636-8: MAPT; NbExp=11; IntAct=EBI-352572, EBI-366233;
CC       P08238; P42679: MATK; NbExp=2; IntAct=EBI-352572, EBI-751664;
CC       P08238; O15146: MUSK; NbExp=2; IntAct=EBI-352572, EBI-6423196;
CC       P08238; Q9H1R3: MYLK2; NbExp=3; IntAct=EBI-352572, EBI-356910;
CC       P08238; Q86YV6: MYLK4; NbExp=2; IntAct=EBI-352572, EBI-6424604;
CC       P08238; Q8TD19: NEK9; NbExp=2; IntAct=EBI-352572, EBI-1044009;
CC       P08238; P19838: NFKB1; NbExp=3; IntAct=EBI-352572, EBI-300010;
CC       P08238; O75469: NR1I2; NbExp=2; IntAct=EBI-352572, EBI-3905991;
CC       P08238; Q8N165: PDIK1L; NbExp=2; IntAct=EBI-352572, EBI-6423298;
CC       P08238; Q9P215: POGK; NbExp=2; IntAct=EBI-352572, EBI-2555775;
CC       P08238; P53041: PPP5C; NbExp=7; IntAct=EBI-352572, EBI-716663;
CC       P08238; Q13131: PRKAA1; NbExp=2; IntAct=EBI-352572, EBI-1181405;
CC       P08238; P22694: PRKACB; NbExp=2; IntAct=EBI-352572, EBI-2679622;
CC       P08238; Q02156: PRKCE; NbExp=4; IntAct=EBI-352572, EBI-706254;
CC       P08238; P05129: PRKCG; NbExp=2; IntAct=EBI-352572, EBI-949799;
CC       P08238; Q05513: PRKCZ; NbExp=2; IntAct=EBI-352572, EBI-295351;
CC       P08238; Q15139: PRKD1; NbExp=2; IntAct=EBI-352572, EBI-1181072;
CC       P08238; O60260: PRKN; NbExp=2; IntAct=EBI-352572, EBI-716346;
CC       P08238; P51817: PRKX; NbExp=2; IntAct=EBI-352572, EBI-4302903;
CC       P08238; P11801: PSKH1; NbExp=2; IntAct=EBI-352572, EBI-3922781;
CC       P08238; Q96QS6: PSKH2; NbExp=2; IntAct=EBI-352572, EBI-6424813;
CC       P08238; Q15185: PTGES3; NbExp=4; IntAct=EBI-352572, EBI-1049387;
CC       P08238; Q13882: PTK6; NbExp=3; IntAct=EBI-352572, EBI-1383632;
CC       P08238; P04049: RAF1; NbExp=5; IntAct=EBI-352572, EBI-365996;
CC       P08238; P49758: RGS6; NbExp=2; IntAct=EBI-352572, EBI-6426927;
CC       P08238; Q01974: ROR2; NbExp=2; IntAct=EBI-352572, EBI-6422642;
CC       P08238; P62913: RPL11; NbExp=2; IntAct=EBI-352572, EBI-354380;
CC       P08238; Q15418: RPS6KA1; NbExp=4; IntAct=EBI-352572, EBI-963034;
CC       P08238; P51812: RPS6KA3; NbExp=3; IntAct=EBI-352572, EBI-1046616;
CC       P08238; P31948: STIP1; NbExp=4; IntAct=EBI-352572, EBI-1054052;
CC       P08238; Q15831: STK11; NbExp=4; IntAct=EBI-352572, EBI-306838;
CC       P08238; Q15208: STK38; NbExp=2; IntAct=EBI-352572, EBI-458376;
CC       P08238; Q9UNE7: STUB1; NbExp=5; IntAct=EBI-352572, EBI-357085;
CC       P08238; Q9Y2Z0-2: SUGT1; NbExp=2; IntAct=EBI-352572, EBI-10768076;
CC       P08238; Q9UHD2: TBK1; NbExp=2; IntAct=EBI-352572, EBI-356402;
CC       P08238; Q96S53: TESK2; NbExp=2; IntAct=EBI-352572, EBI-1384110;
CC       P08238; Q07912: TNK2; NbExp=3; IntAct=EBI-352572, EBI-603457;
CC       P08238; Q9BXA6: TSSK6; NbExp=3; IntAct=EBI-352572, EBI-851883;
CC       P08238; O95801: TTC4; NbExp=5; IntAct=EBI-352572, EBI-1050890;
CC       P08238; P29597: TYK2; NbExp=2; IntAct=EBI-352572, EBI-1383454;
CC       P08238; Q8IWX7: UNC45B; NbExp=2; IntAct=EBI-352572, EBI-9363363;
CC       P08238; P07947: YES1; NbExp=3; IntAct=EBI-352572, EBI-515331;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16580629,
CC       ECO:0000269|PubMed:18239673, ECO:0000269|PubMed:24880080,
CC       ECO:0000269|PubMed:9482106}. Melanosome {ECO:0000269|PubMed:17081065}.
CC       Nucleus {ECO:0000269|PubMed:18239673}. Secreted
CC       {ECO:0000269|PubMed:20599762}. Cell membrane
CC       {ECO:0000269|PubMed:20599762}. Note=Identified by mass spectrometry in
CC       melanosome fractions from stage I to stage IV (PubMed:17081065).
CC       Translocates with BIRC2 from the nucleus to the cytoplasm during
CC       differentiation (PubMed:18239673). Secreted when associated with TGFB1
CC       processed form (LAP) (PubMed:20599762). {ECO:0000269|PubMed:17081065,
CC       ECO:0000269|PubMed:18239673, ECO:0000269|PubMed:20599762}.
CC   -!- INDUCTION: By heat shock. {ECO:0000269|PubMed:20353823}.
CC   -!- DOMAIN: The TPR repeat-binding motif mediates interaction with TPR
CC       repeat-containing proteins. {ECO:0000250|UniProtKB:P07900}.
CC   -!- PTM: Ubiquitinated in the presence of STUB1-UBE2D1 complex (in vitro).
CC       {ECO:0000269|PubMed:18042044}.
CC   -!- PTM: ISGylated. {ECO:0000269|PubMed:16139798}.
CC   -!- PTM: S-nitrosylated; negatively regulates the ATPase activity.
CC       {ECO:0000305|PubMed:19696785}.
CC   -!- PTM: Phosphorylation at Tyr-301 by SRC is induced by lipopolysaccharide
CC       (PubMed:23585225). Phosphorylation at Ser-226 and Ser-255 inhibits AHR
CC       interaction (PubMed:15581363). {ECO:0000269|PubMed:15581363,
CC       ECO:0000269|PubMed:23585225}.
CC   -!- PTM: Methylated by SMYD2; facilitates dimerization and chaperone
CC       complex formation; promotes cancer cell proliferation.
CC       {ECO:0000269|PubMed:24880080}.
CC   -!- PTM: Cleaved following oxidative stress resulting in HSP90AB1 protein
CC       radicals formation; disrupts the chaperoning function and the
CC       degradation of its client proteins. {ECO:0000269|PubMed:22848402}.
CC   -!- SIMILARITY: Belongs to the heat shock protein 90 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD14062.3; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=CAB66478.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M16660; AAA36025.1; -; mRNA.
DR   EMBL; J04988; AAA36026.1; -; Genomic_DNA.
DR   EMBL; AY359878; AAQ63401.1; -; mRNA.
DR   EMBL; AL136543; CAB66478.1; ALT_FRAME; mRNA.
DR   EMBL; AK312255; BAG35187.1; -; mRNA.
DR   EMBL; DQ314872; ABC40731.1; -; Genomic_DNA.
DR   EMBL; AL139392; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471081; EAX04257.1; -; Genomic_DNA.
DR   EMBL; BC004928; AAH04928.1; -; mRNA.
DR   EMBL; BC009206; AAH09206.2; -; mRNA.
DR   EMBL; BC012807; AAH12807.1; -; mRNA.
DR   EMBL; BC014485; AAH14485.1; -; mRNA.
DR   EMBL; BC016753; AAH16753.1; -; mRNA.
DR   EMBL; BC068474; AAH68474.1; -; mRNA.
DR   EMBL; AH007358; AAD14062.3; ALT_INIT; Genomic_DNA.
DR   EMBL; AF275719; AAF82792.1; -; mRNA.
DR   CCDS; CCDS4909.1; -.
DR   PIR; A29461; HHHU84.
DR   PIR; T46243; T46243.
DR   RefSeq; NP_001258898.1; NM_001271969.1.
DR   RefSeq; NP_001258899.1; NM_001271970.1.
DR   RefSeq; NP_001258900.1; NM_001271971.1.
DR   RefSeq; NP_031381.2; NM_007355.3.
DR   PDB; 1QZ2; X-ray; 3.00 A; G/H=720-724.
DR   PDB; 1UYM; X-ray; 2.45 A; A=2-221.
DR   PDB; 2L6J; NMR; -; B=720-724.
DR   PDB; 3FWV; X-ray; 2.20 A; C/D=719-723.
DR   PDB; 3NMQ; X-ray; 2.20 A; A=1-223.
DR   PDB; 3PRY; X-ray; 2.28 A; A/B/C=284-543.
DR   PDB; 3UQ3; X-ray; 2.60 A; B/C=720-724.
DR   PDB; 5FWK; EM; 3.90 A; A/B=1-724.
DR   PDB; 5FWL; EM; 9.00 A; A/B=1-724.
DR   PDB; 5FWM; EM; 8.00 A; A/B=1-724.
DR   PDB; 5FWP; EM; 7.20 A; A/B=1-724.
DR   PDB; 5UC4; X-ray; 2.05 A; A/B/C/D=1-218.
DR   PDB; 5UCH; X-ray; 2.65 A; A/B/C/D=1-218.
DR   PDB; 5UCI; X-ray; 2.70 A; A/B/C/D=1-218.
DR   PDB; 5UCJ; X-ray; 1.69 A; A/B/C/D=1-218.
DR   PDB; 6N8W; X-ray; 3.09 A; A/B/C/D=1-231.
DR   PDB; 6N8Y; X-ray; 1.55 A; A=1-221.
DR   PDBsum; 1QZ2; -.
DR   PDBsum; 1UYM; -.
DR   PDBsum; 2L6J; -.
DR   PDBsum; 3FWV; -.
DR   PDBsum; 3NMQ; -.
DR   PDBsum; 3PRY; -.
DR   PDBsum; 3UQ3; -.
DR   PDBsum; 5FWK; -.
DR   PDBsum; 5FWL; -.
DR   PDBsum; 5FWM; -.
DR   PDBsum; 5FWP; -.
DR   PDBsum; 5UC4; -.
DR   PDBsum; 5UCH; -.
DR   PDBsum; 5UCI; -.
DR   PDBsum; 5UCJ; -.
DR   PDBsum; 6N8W; -.
DR   PDBsum; 6N8Y; -.
DR   SMR; P08238; -.
DR   BioGrid; 109558; 456.
DR   ComplexPortal; CPX-3285; HSP90B-CDC37 chaperone complex.
DR   CORUM; P08238; -.
DR   DIP; DIP-413N; -.
DR   IntAct; P08238; 556.
DR   MINT; P08238; -.
DR   STRING; 9606.ENSP00000360609; -.
DR   BindingDB; P08238; -.
DR   ChEMBL; CHEMBL4303; -.
DR   DrugBank; DB08293; (5E)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE.
DR   DrugBank; DB08153; (5E)-14-CHLORO-15,17-DIHYDROXY-4,7,8,9,10,11-HEXAHYDRO-2-BENZOXACYCLOPENTADECINE-1,12(3H,13H)-DIONE.
DR   DrugBank; DB08292; (5Z)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE.
DR   DrugBank; DB08346; (5Z)-13-CHLORO-14,16-DIHYDROXY-3,4,7,8,9,10-HEXAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,11(12H)-DIONE.
DR   DrugBank; DB08465; 2-(3-AMINO-2,5,6-TRIMETHOXYPHENYL)ETHYL 5-CHLORO-2,4-DIHYDROXYBENZOATE.
DR   DrugBank; DB07594; 4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL.
DR   DrugBank; DB08045; 4-{4-[4-(3-AMINOPROPOXY)PHENYL]-1H-PYRAZOL-5-YL}-6-CHLOROBENZENE-1,3-DIOL.
DR   DrugBank; DB07877; 8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE.
DR   DrugBank; DB02754; 9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine.
DR   DrugBank; DB02424; Geldanamycin.
DR   DrugBank; DB08464; METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE.
DR   DrugBank; DB09221; Polaprezinc.
DR   DrugBank; DB03758; Radicicol.
DR   DrugBank; DB06070; SNX-5422.
DR   DrugBank; DB05134; Tanespimycin.
DR   GuidetoPHARMACOLOGY; 2907; -.
DR   MoonDB; P08238; Predicted.
DR   CarbonylDB; P08238; -.
DR   GlyConnect; 1302; -.
DR   iPTMnet; P08238; -.
DR   MetOSite; P08238; -.
DR   PhosphoSitePlus; P08238; -.
DR   SwissPalm; P08238; -.
DR   BioMuta; HSP90AB1; -.
DR   DMDM; 17865718; -.
DR   OGP; P08238; -.
DR   EPD; P08238; -.
DR   jPOST; P08238; -.
DR   MassIVE; P08238; -.
DR   MaxQB; P08238; -.
DR   PaxDb; P08238; -.
DR   PeptideAtlas; P08238; -.
DR   PRIDE; P08238; -.
DR   ProteomicsDB; 52096; -.
DR   TopDownProteomics; P08238; -.
DR   Antibodypedia; 3929; 1600 antibodies.
DR   DNASU; 3326; -.
DR   Ensembl; ENST00000353801; ENSP00000325875; ENSG00000096384.
DR   Ensembl; ENST00000371554; ENSP00000360609; ENSG00000096384.
DR   Ensembl; ENST00000371646; ENSP00000360709; ENSG00000096384.
DR   Ensembl; ENST00000620073; ENSP00000481908; ENSG00000096384.
DR   GeneID; 3326; -.
DR   KEGG; hsa:3326; -.
DR   UCSC; uc003oxa.3; human.
DR   CTD; 3326; -.
DR   DisGeNET; 3326; -.
DR   GeneCards; HSP90AB1; -.
DR   HGNC; HGNC:5258; HSP90AB1.
DR   HPA; ENSG00000096384; Low tissue specificity.
DR   MIM; 140572; gene.
DR   neXtProt; NX_P08238; -.
DR   OpenTargets; ENSG00000096384; -.
DR   PharmGKB; PA29524; -.
DR   eggNOG; KOG0019; Eukaryota.
DR   eggNOG; KOG0020; Eukaryota.
DR   eggNOG; COG0326; LUCA.
DR   GeneTree; ENSGT00950000182747; -.
DR   HOGENOM; CLU_006684_1_3_1; -.
DR   InParanoid; P08238; -.
DR   KO; K04079; -.
DR   OMA; RTDHGEP; -.
DR   OrthoDB; 924636at2759; -.
DR   PhylomeDB; P08238; -.
DR   TreeFam; TF300686; -.
DR   Reactome; R-HSA-2029482; Regulation of actin dynamics for phagocytic cup formation.
DR   Reactome; R-HSA-3371497; HSP90 chaperone cycle for steroid hormone receptors (SHR).
DR   Reactome; R-HSA-3371511; HSF1 activation.
DR   Reactome; R-HSA-3371568; Attenuation phase.
DR   Reactome; R-HSA-3371571; HSF1-dependent transactivation.
DR   Reactome; R-HSA-399954; Sema3A PAK dependent Axon repulsion.
DR   Reactome; R-HSA-5336415; Uptake and function of diphtheria toxin.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-844456; The NLRP3 inflammasome.
DR   Reactome; R-HSA-8852276; The role of GTSE1 in G2/M progression after G2 checkpoint.
DR   Reactome; R-HSA-8937144; Aryl hydrocarbon receptor signalling.
DR   Reactome; R-HSA-8939211; ESR-mediated signaling.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   Reactome; R-HSA-9613829; Chaperone Mediated Autophagy.
DR   SIGNOR; P08238; -.
DR   ChiTaRS; HSP90AB1; human.
DR   EvolutionaryTrace; P08238; -.
DR   GeneWiki; HSP90AB1; -.
DR   GenomeRNAi; 3326; -.
DR   Pharos; P08238; Tchem.
DR   PRO; PR:P08238; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; P08238; protein.
DR   Bgee; ENSG00000096384; Expressed in hypothalamus and 239 other tissues.
DR   ExpressionAtlas; P08238; baseline and differential.
DR   Genevisible; P08238; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:Ensembl.
DR   GO; GO:0034751; C:aryl hydrocarbon receptor complex; IDA:UniProtKB.
DR   GO; GO:0044295; C:axonal growth cone; ISS:ARUK-UCL.
DR   GO; GO:0016323; C:basolateral plasma membrane; IEA:Ensembl.
DR   GO; GO:0031526; C:brush border membrane; IEA:Ensembl.
DR   GO; GO:0009986; C:cell surface; IBA:GO_Central.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0044294; C:dendritic growth cone; ISS:ARUK-UCL.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; IDA:UniProtKB.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:1990565; C:HSP90-CDC37 chaperone complex; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0016234; C:inclusion body; IEA:Ensembl.
DR   GO; GO:0005765; C:lysosomal membrane; IEA:Ensembl.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; HDA:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; ISS:ARUK-UCL.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:1990917; C:ooplasm; IEA:Ensembl.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISS:ARUK-UCL.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:0034774; C:secretory granule lumen; TAS:Reactome.
DR   GO; GO:1990913; C:sperm head plasma membrane; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IDA:CAFA.
DR   GO; GO:0043008; F:ATP-dependent protein binding; IPI:CAFA.
DR   GO; GO:0042623; F:ATPase activity, coupled; TAS:Reactome.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0002135; F:CTP binding; IEA:Ensembl.
DR   GO; GO:0032564; F:dATP binding; IEA:Ensembl.
DR   GO; GO:0097718; F:disordered domain specific binding; IPI:CAFA.
DR   GO; GO:0070182; F:DNA polymerase binding; IPI:BHF-UCL.
DR   GO; GO:0003725; F:double-stranded RNA binding; IDA:MGI.
DR   GO; GO:0005525; F:GTP binding; IEA:Ensembl.
DR   GO; GO:0031072; F:heat shock protein binding; IPI:UniProtKB.
DR   GO; GO:0042826; F:histone deacetylase binding; IPI:BHF-UCL.
DR   GO; GO:1990226; F:histone methyltransferase binding; IPI:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0044325; F:ion channel binding; IEA:Ensembl.
DR   GO; GO:0019900; F:kinase binding; IPI:UniProtKB.
DR   GO; GO:0023026; F:MHC class II protein complex binding; HDA:UniProtKB.
DR   GO; GO:0030235; F:nitric-oxide synthase regulator activity; ISS:UniProtKB.
DR   GO; GO:0042277; F:peptide binding; IPI:UniProtKB.
DR   GO; GO:0046983; F:protein dimerization activity; IDA:UniProtKB.
DR   GO; GO:0044183; F:protein folding chaperone; IEA:Ensembl.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:CAFA.
DR   GO; GO:0019901; F:protein kinase binding; IEA:Ensembl.
DR   GO; GO:0019887; F:protein kinase regulator activity; IEA:Ensembl.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0017098; F:sulfonylurea receptor binding; IEA:Ensembl.
DR   GO; GO:0048156; F:tau protein binding; NAS:ARUK-UCL.
DR   GO; GO:0030911; F:TPR domain binding; ISS:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:ARUK-UCL.
DR   GO; GO:0051082; F:unfolded protein binding; IBA:GO_Central.
DR   GO; GO:0002134; F:UTP binding; IEA:Ensembl.
DR   GO; GO:0048675; P:axon extension; ISS:ARUK-UCL.
DR   GO; GO:0035690; P:cellular response to drug; IEA:Ensembl.
DR   GO; GO:0034605; P:cellular response to heat; IBA:GO_Central.
DR   GO; GO:0071353; P:cellular response to interleukin-4; IEA:Ensembl.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; IEA:Ensembl.
DR   GO; GO:0021955; P:central nervous system neuron axonogenesis; ISS:ARUK-UCL.
DR   GO; GO:0051131; P:chaperone-mediated protein complex assembly; IDA:CAFA.
DR   GO; GO:0030010; P:establishment of cell polarity; ISS:ARUK-UCL.
DR   GO; GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome.
DR   GO; GO:0071157; P:negative regulation of cell cycle arrest; IMP:UniProtKB.
DR   GO; GO:1903660; P:negative regulation of complement-dependent cytotoxicity; IEA:Ensembl.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:1901799; P:negative regulation of proteasomal protein catabolic process; ISS:ARUK-UCL.
DR   GO; GO:0032435; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; IDA:UniProtKB.
DR   GO; GO:0051248; P:negative regulation of protein metabolic process; ISS:ARUK-UCL.
DR   GO; GO:1901389; P:negative regulation of transforming growth factor beta activation; IDA:UniProtKB.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0001890; P:placenta development; IEA:Ensembl.
DR   GO; GO:0045597; P:positive regulation of cell differentiation; IMP:UniProtKB.
DR   GO; GO:0045793; P:positive regulation of cell size; IEA:Ensembl.
DR   GO; GO:1904031; P:positive regulation of cyclin-dependent protein kinase activity; ISS:ARUK-UCL.
DR   GO; GO:0045429; P:positive regulation of nitric oxide biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; ISS:ARUK-UCL.
DR   GO; GO:0032516; P:positive regulation of phosphoprotein phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0032092; P:positive regulation of protein binding; IEA:Ensembl.
DR   GO; GO:0042307; P:positive regulation of protein import into nucleus; IEA:Ensembl.
DR   GO; GO:0051897; P:positive regulation of protein kinase B signaling; ISS:ARUK-UCL.
DR   GO; GO:2000010; P:positive regulation of protein localization to cell surface; IDA:UniProtKB.
DR   GO; GO:0071902; P:positive regulation of protein serine/threonine kinase activity; IEA:Ensembl.
DR   GO; GO:1902949; P:positive regulation of tau-protein kinase activity; IC:ARUK-UCL.
DR   GO; GO:0051973; P:positive regulation of telomerase activity; IDA:BHF-UCL.
DR   GO; GO:0030511; P:positive regulation of transforming growth factor beta receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0006457; P:protein folding; IBA:GO_Central.
DR   GO; GO:0050821; P:protein stabilization; IBA:GO_Central.
DR   GO; GO:1903827; P:regulation of cellular protein localization; ISS:ARUK-UCL.
DR   GO; GO:1900034; P:regulation of cellular response to heat; TAS:Reactome.
DR   GO; GO:0060334; P:regulation of interferon-gamma-mediated signaling pathway; IMP:MGI.
DR   GO; GO:0031396; P:regulation of protein ubiquitination; IDA:BHF-UCL.
DR   GO; GO:0060338; P:regulation of type I interferon-mediated signaling pathway; IMP:MGI.
DR   GO; GO:0042220; P:response to cocaine; IEA:Ensembl.
DR   GO; GO:0009651; P:response to salt stress; IEA:Ensembl.
DR   GO; GO:0006986; P:response to unfolded protein; NAS:UniProtKB.
DR   GO; GO:0097435; P:supramolecular fiber organization; IMP:CACAO.
DR   GO; GO:1905323; P:telomerase holoenzyme complex assembly; IDA:BHF-UCL.
DR   GO; GO:0007004; P:telomere maintenance via telomerase; IDA:BHF-UCL.
DR   GO; GO:0019062; P:virion attachment to host cell; IMP:CACAO.
DR   GO; GO:0006805; P:xenobiotic metabolic process; TAS:Reactome.
DR   Gene3D; 1.20.120.790; -; 1.
DR   Gene3D; 3.30.565.10; -; 1.
DR   HAMAP; MF_00505; HSP90; 1.
DR   InterPro; IPR003594; HATPase_C.
DR   InterPro; IPR036890; HATPase_C_sf.
DR   InterPro; IPR019805; Heat_shock_protein_90_CS.
DR   InterPro; IPR037196; HSP90_C.
DR   InterPro; IPR001404; Hsp90_fam.
DR   InterPro; IPR020575; Hsp90_N.
DR   InterPro; IPR020568; Ribosomal_S5_D2-typ_fold.
DR   PANTHER; PTHR11528; PTHR11528; 1.
DR   Pfam; PF02518; HATPase_c; 1.
DR   Pfam; PF00183; HSP90; 1.
DR   PIRSF; PIRSF002583; Hsp90; 1.
DR   PRINTS; PR00775; HEATSHOCK90.
DR   SMART; SM00387; HATPase_c; 1.
DR   SUPFAM; SSF110942; SSF110942; 1.
DR   SUPFAM; SSF54211; SSF54211; 1.
DR   SUPFAM; SSF55874; SSF55874; 1.
DR   PROSITE; PS00298; HSP90; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Cell membrane; Chaperone;
KW   Cytoplasm; Direct protein sequencing; Glycoprotein; Membrane; Methylation;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; S-nitrosylation; Secreted; Stress response;
KW   Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:2492519"
FT   CHAIN           2..724
FT                   /note="Heat shock protein HSP 90-beta"
FT                   /id="PRO_0000062917"
FT   REGION          2..527
FT                   /note="Interaction with TP53"
FT                   /evidence="ECO:0000269|PubMed:15358771"
FT   REGION          2..214
FT                   /note="Interaction with BIRC2"
FT                   /evidence="ECO:0000269|PubMed:25486457"
FT   REGION          9..231
FT                   /note="Interaction with NR3C1"
FT                   /evidence="ECO:0000250|UniProtKB:P11499"
FT   REGION          215..552
FT                   /note="Interaction with AHSA1"
FT                   /evidence="ECO:0000269|PubMed:25486457"
FT   REGION          264..608
FT                   /note="Interaction with NR3C1"
FT                   /evidence="ECO:0000250|UniProtKB:P11499"
FT   REGION          620..723
FT                   /note="Interaction with NR1D1"
FT                   /evidence="ECO:0000250|UniProtKB:P11499"
FT   MOTIF           720..724
FT                   /note="TPR repeat-binding"
FT   BINDING         46
FT                   /note="ATP"
FT                   /evidence="ECO:0000250"
FT   BINDING         88
FT                   /note="ATP"
FT   BINDING         107
FT                   /note="ATP"
FT                   /evidence="ECO:0000250"
FT   BINDING         133
FT                   /note="ATP; via amide nitrogen"
FT                   /evidence="ECO:0000250"
FT   BINDING         392
FT                   /note="ATP"
FT                   /evidence="ECO:0000250"
FT   SITE            126..127
FT                   /note="Cleaved under oxidative stress"
FT                   /evidence="ECO:0000269|PubMed:22848402"
FT   MOD_RES         219
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P11499"
FT   MOD_RES         226
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18088087,
FT                   ECO:0000244|PubMed:18318008, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163"
FT   MOD_RES         255
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:23186163, ECO:0000269|Ref.12"
FT   MOD_RES         261
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11499"
FT   MOD_RES         297
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:17525332,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         301
FT                   /note="Phosphotyrosine; by SRC"
FT                   /evidence="ECO:0000269|PubMed:23585225"
FT   MOD_RES         305
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P11499"
FT   MOD_RES         307
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         399
FT                   /note="N6-malonyllysine"
FT                   /evidence="ECO:0000269|PubMed:21908771"
FT   MOD_RES         435
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         445
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         479
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         481
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         484
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P11499"
FT   MOD_RES         531
FT                   /note="N6-methylated lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24880080"
FT   MOD_RES         531
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P11499"
FT   MOD_RES         574
FT                   /note="N6-methylated lysine"
FT                   /evidence="ECO:0000269|PubMed:24880080"
FT   MOD_RES         577
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P11499"
FT   MOD_RES         590
FT                   /note="S-nitrosocysteine"
FT                   /evidence="ECO:0000305|PubMed:19696785"
FT   MOD_RES         624
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P11499"
FT   MOD_RES         669
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         718
FT                   /note="Phosphoserine; by PLK2 and PLK3"
FT                   /evidence="ECO:0000269|PubMed:22828320"
FT   CARBOHYD        434
FT                   /note="O-linked (GlcNAc) serine"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        452
FT                   /note="O-linked (GlcNAc) serine"
FT                   /evidence="ECO:0000250"
FT   VARIANT         349
FT                   /note="K -> E (in dbSNP:rs11538975)"
FT                   /id="VAR_049624"
FT   MUTAGEN         42
FT                   /note="E->A: Strong ATP-binding. Strong interaction with
FT                   HSF1, HIF1A, ERBB2, MET, KEAP1 and RHOBTB2."
FT                   /evidence="ECO:0000269|PubMed:26517842"
FT   MUTAGEN         88
FT                   /note="D->A: Impaired ATP-binding. Strong interaction with
FT                   HIF1A, MET, KEAP1 and RHOBTB2. Loss of interaction with
FT                   HSF1 and ERBB2."
FT                   /evidence="ECO:0000269|PubMed:26517842"
FT   MUTAGEN         226
FT                   /note="S->A: Increases the binding affinity for AHR; when
FT                   associated with A-255. Increases AHR transcription
FT                   activity; when associated with A-255."
FT                   /evidence="ECO:0000269|PubMed:15581363"
FT   MUTAGEN         226
FT                   /note="S->E: No effect on the interaction with AHR; when
FT                   associated with E-255."
FT                   /evidence="ECO:0000269|PubMed:15581363"
FT   MUTAGEN         255
FT                   /note="S->A: Increases the binding affinity for AHR; when
FT                   associated with A-226. Increases AHR transcription
FT                   activity; when associated with A-226."
FT                   /evidence="ECO:0000269|PubMed:15581363"
FT   MUTAGEN         255
FT                   /note="S->E: No effect on the interaction with AHR; when
FT                   associated with E-226."
FT                   /evidence="ECO:0000269|PubMed:15581363"
FT   MUTAGEN         301
FT                   /note="Y->F: Decreases interaction with NOS3 and SRC.
FT                   impairs resists LPS-induced tyrosine phosphorylation. Does
FT                   not block LPS-induced pp60src phosphorylation."
FT                   /evidence="ECO:0000269|PubMed:23585225"
FT   MUTAGEN         531
FT                   /note="K->A: Highly decreases the signal of SMYD2-dependent
FT                   HSP90AB1 methylation; when associated with A-574.
FT                   Diminishes dimerized form; when associated with A-574.
FT                   Reduces interaction with STIP1 or CDC37; when associated
FT                   with A-574."
FT                   /evidence="ECO:0000269|PubMed:24880080"
FT   MUTAGEN         574
FT                   /note="K->A: Decreases the signal of SMYD2-dependent
FT                   HSP90AB1 methylation. Highly decreases the signal of SMYD2-
FT                   dependent HSP90AB1 methylation; when associated with A-531.
FT                   Diminishes dimerized form; when associated with A-531.
FT                   Reduces interaction with STIP1 or CDC37; when associated
FT                   with A-531."
FT                   /evidence="ECO:0000269|PubMed:24880080"
FT   MUTAGEN         590
FT                   /note="C->A,N,D: Reduced ATPase activity and client protein
FT                   activation."
FT                   /evidence="ECO:0000269|PubMed:19696785"
FT   CONFLICT        147
FT                   /note="T -> R (in Ref. 1; AAA36025)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        177
FT                   /note="R -> M (in Ref. 1; AAA36025)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        403
FT                   /note="V -> A (in Ref. 5; CAB66478)"
FT                   /evidence="ECO:0000305"
FT   STRAND          2..6
FT                   /evidence="ECO:0000244|PDB:6N8W"
FT   STRAND          13..16
FT                   /evidence="ECO:0000244|PDB:6N8Y"
FT   HELIX           19..30
FT                   /evidence="ECO:0000244|PDB:6N8Y"
FT   TURN            34..37
FT                   /evidence="ECO:0000244|PDB:5UCH"
FT   HELIX           38..60
FT                   /evidence="ECO:0000244|PDB:6N8Y"
FT   HELIX           62..65
FT                   /evidence="ECO:0000244|PDB:6N8Y"
FT   STRAND          73..78
FT                   /evidence="ECO:0000244|PDB:6N8Y"
FT   TURN            79..82
FT                   /evidence="ECO:0000244|PDB:6N8Y"
FT   STRAND          83..88
FT                   /evidence="ECO:0000244|PDB:6N8Y"
FT   HELIX           95..99
FT                   /evidence="ECO:0000244|PDB:6N8Y"
FT   HELIX           101..118
FT                   /evidence="ECO:0000244|PDB:6N8Y"
FT   HELIX           123..129
FT                   /evidence="ECO:0000244|PDB:6N8Y"
FT   HELIX           132..138
FT                   /evidence="ECO:0000244|PDB:6N8Y"
FT   STRAND          140..148
FT                   /evidence="ECO:0000244|PDB:6N8Y"
FT   STRAND          155..159
FT                   /evidence="ECO:0000244|PDB:6N8Y"
FT   STRAND          164..169
FT                   /evidence="ECO:0000244|PDB:6N8Y"
FT   STRAND          176..185
FT                   /evidence="ECO:0000244|PDB:6N8Y"
FT   HELIX           187..193
FT                   /evidence="ECO:0000244|PDB:6N8Y"
FT   HELIX           195..205
FT                   /evidence="ECO:0000244|PDB:6N8Y"
FT   STRAND          213..215
FT                   /evidence="ECO:0000244|PDB:6N8Y"
FT   HELIX           288..290
FT                   /evidence="ECO:0000244|PDB:3PRY"
FT   HELIX           293..295
FT                   /evidence="ECO:0000244|PDB:3PRY"
FT   HELIX           298..309
FT                   /evidence="ECO:0000244|PDB:3PRY"
FT   STRAND          316..323
FT                   /evidence="ECO:0000244|PDB:3PRY"
FT   STRAND          325..327
FT                   /evidence="ECO:0000244|PDB:3PRY"
FT   STRAND          329..335
FT                   /evidence="ECO:0000244|PDB:3PRY"
FT   STRAND          353..357
FT                   /evidence="ECO:0000244|PDB:3PRY"
FT   STRAND          360..364
FT                   /evidence="ECO:0000244|PDB:3PRY"
FT   HELIX           367..369
FT                   /evidence="ECO:0000244|PDB:3PRY"
FT   HELIX           372..374
FT                   /evidence="ECO:0000244|PDB:3PRY"
FT   STRAND          378..386
FT                   /evidence="ECO:0000244|PDB:3PRY"
FT   HELIX           395..420
FT                   /evidence="ECO:0000244|PDB:3PRY"
FT   HELIX           423..443
FT                   /evidence="ECO:0000244|PDB:3PRY"
FT   HELIX           445..447
FT                   /evidence="ECO:0000244|PDB:3PRY"
FT   HELIX           448..453
FT                   /evidence="ECO:0000244|PDB:3PRY"
FT   STRAND          456..459
FT                   /evidence="ECO:0000244|PDB:3PRY"
FT   TURN            460..464
FT                   /evidence="ECO:0000244|PDB:3PRY"
FT   HELIX           469..474
FT                   /evidence="ECO:0000244|PDB:3PRY"
FT   STRAND          482..486
FT                   /evidence="ECO:0000244|PDB:3PRY"
FT   HELIX           491..495
FT                   /evidence="ECO:0000244|PDB:3PRY"
FT   HELIX           498..504
FT                   /evidence="ECO:0000244|PDB:3PRY"
FT   TURN            505..507
FT                   /evidence="ECO:0000244|PDB:3PRY"
FT   STRAND          510..512
FT                   /evidence="ECO:0000244|PDB:3PRY"
FT   HELIX           518..525
FT                   /evidence="ECO:0000244|PDB:3PRY"
FT   STRAND          531..535
FT                   /evidence="ECO:0000244|PDB:3PRY"
SQ   SEQUENCE   724 AA;  83264 MW;  A93118C214D03810 CRC64;
     MPEEVHHGEE EVETFAFQAE IAQLMSLIIN TFYSNKEIFL RELISNASDA LDKIRYESLT
     DPSKLDSGKE LKIDIIPNPQ ERTLTLVDTG IGMTKADLIN NLGTIAKSGT KAFMEALQAG
     ADISMIGQFG VGFYSAYLVA EKVVVITKHN DDEQYAWESS AGGSFTVRAD HGEPIGRGTK
     VILHLKEDQT EYLEERRVKE VVKKHSQFIG YPITLYLEKE REKEISDDEA EEEKGEKEEE
     DKDDEEKPKI EDVGSDEEDD SGKDKKKKTK KIKEKYIDQE ELNKTKPIWT RNPDDITQEE
     YGEFYKSLTN DWEDHLAVKH FSVEGQLEFR ALLFIPRRAP FDLFENKKKK NNIKLYVRRV
     FIMDSCDELI PEYLNFIRGV VDSEDLPLNI SREMLQQSKI LKVIRKNIVK KCLELFSELA
     EDKENYKKFY EAFSKNLKLG IHEDSTNRRR LSELLRYHTS QSGDEMTSLS EYVSRMKETQ
     KSIYYITGES KEQVANSAFV ERVRKRGFEV VYMTEPIDEY CVQQLKEFDG KSLVSVTKEG
     LELPEDEEEK KKMEESKAKF ENLCKLMKEI LDKKVEKVTI SNRLVSSPCC IVTSTYGWTA
     NMERIMKAQA LRDNSTMGYM MAKKHLEINP DHPIVETLRQ KAEADKNDKA VKDLVVLLFE
     TALLSSGFSL EDPQTHSNRI YRMIKLGLGI DEDEVAAEEP NAAVPDEIPP LEGDEDASRM
     EEVD
//
ID   Q6PK50_HUMAN            Unreviewed;       351 AA.
AC   Q6PK50;
DT   05-JUL-2004, integrated into UniProtKB/TrEMBL.
DT   05-JUL-2004, sequence version 1.
DT   22-APR-2020, entry version 88.
DE   SubName: Full=HSP90AB1 protein {ECO:0000313|EMBL:AAH07327.1};
DE   Flags: Fragment;
GN   Name=HSP90AB1 {ECO:0000313|EMBL:AAH07327.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH07327.1};
RN   [1] {ECO:0000313|EMBL:AAH07327.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Pancreas {ECO:0000313|EMBL:AAH07327.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M., Peck A.M.,
RA   Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S., Feolo M.,
RA   Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F., Schaefer C.F.,
RA   Buetow K., Bonner T.I., Haussler D., Kent J., Kiekhaus M., Furey T.,
RA   Brent M., Prange C., Schreiber K., Shapiro N., Bhat N.K., Hopkins R.F.,
RA   Hsie F., Driscoll T., Soares M.B., Casavant T.L., Scheetz T.E.,
RA   Brown-stein M.J., Usdin T.B., Toshiyuki S., Carninci P., Piao Y.,
RA   Dudekula D.B., Ko M.S., Kawakami K., Suzuki Y., Sugano S., Gruber C.E.,
RA   Smith M.R., Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y.,
RA   Wei C.L., Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W.,
RA   Fuh E., Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D., Granite S.J.,
RA   Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G., Blakesly R.W.,
RA   Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J.,
RA   Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L., Krzywinski M.I.,
RA   Liao N., Morin R., Morrin R., Palmquist D., Petrescu A.S., Skalska U.,
RA   Smailus D.E., Stott J.M., Schnerch A., Schein J.E., Jones S.J., Holt R.A.,
RA   Baross A., Marra M.A., Clifton S., Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC007327; AAH07327.1; -; mRNA.
DR   RefSeq; NP_001258901.1; NM_001271972.1.
DR   IntAct; Q6PK50; 99.
DR   PeptideAtlas; Q6PK50; -.
DR   PRIDE; Q6PK50; -.
DR   GeneID; 3326; -.
DR   CTD; 3326; -.
DR   eggNOG; KOG0019; Eukaryota.
DR   eggNOG; KOG0020; Eukaryota.
DR   eggNOG; COG0326; LUCA.
DR   ChiTaRS; HSP90AB1; human.
DR   GenomeRNAi; 3326; -.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0051082; F:unfolded protein binding; IEA:InterPro.
DR   GO; GO:0006457; P:protein folding; IEA:InterPro.
DR   Gene3D; 3.30.565.10; -; 1.
DR   InterPro; IPR003594; HATPase_C.
DR   InterPro; IPR036890; HATPase_C_sf.
DR   InterPro; IPR019805; Heat_shock_protein_90_CS.
DR   InterPro; IPR001404; Hsp90_fam.
DR   InterPro; IPR020575; Hsp90_N.
DR   InterPro; IPR020568; Ribosomal_S5_D2-typ_fold.
DR   PANTHER; PTHR11528; PTHR11528; 1.
DR   Pfam; PF02518; HATPase_c; 1.
DR   Pfam; PF00183; HSP90; 1.
DR   PRINTS; PR00775; HEATSHOCK90.
DR   SMART; SM00387; HATPase_c; 1.
DR   SUPFAM; SSF54211; SSF54211; 1.
DR   SUPFAM; SSF55874; SSF55874; 1.
DR   PROSITE; PS00298; HSP90; 1.
PE   1: Evidence at protein level;
FT   DOMAIN          35..189
FT                   /note="HATPase_c"
FT                   /evidence="ECO:0000259|SMART:SM00387"
FT   REGION          222..271
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        241..271
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   NON_TER         351
FT                   /evidence="ECO:0000313|EMBL:AAH07327.1"
SQ   SEQUENCE   351 AA;  40295 MW;  5CA7AFC5181A33A5 CRC64;
     MPEEVHHGEE EVETFAFQAE IAQLMSLIIN TFYSNKEIFL RELISNASDA LDKIRYESLT
     DPSKLDSGKE LKIDIIPNPQ ERTLTLVDTG IGMTKADLIN NLGTIAKSGT KAFMEALQAG
     ADISMIGQFG VGFYSAYLVA EKVVVITKHN DDEQYAWESS AGGSFTVRAD HGEPIGRGTK
     VILHLKEDQT EYLEERRVKE VVKKHSQFIG YPITLYLEKE REKEISDDEA EEEKGEKEEE
     DKDDEEKPKI EDVGSDEEDD SGKDKKKKTK KIKEKYIDQE ELNKTKPIWT RNPDDITQEE
     YGEFYKSLTN DWEDHLAVKH FSVEGQLEFR ALLFIPRRAP FDLFEKKKKK K
//
ID   IL2_HUMAN               Reviewed;         153 AA.
AC   P60568; P01585;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   21-JUL-1986, sequence version 1.
DT   22-APR-2020, entry version 177.
DE   RecName: Full=Interleukin-2;
DE            Short=IL-2;
DE   AltName: Full=T-cell growth factor;
DE            Short=TCGF;
DE   AltName: INN=Aldesleukin;
DE   Flags: Precursor;
GN   Name=IL2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=6312994; DOI=10.1016/s0006-291x(83)80040-0;
RA   Maeda S., Nishino N., Obaru K., Mita S., Nomiyama H., Shimada K.,
RA   Fujimoto K., Teranishi T., Hirano T., Onoue K.;
RT   "Cloning of interleukin 2 mRNAs from human tonsils.";
RL   Biochem. Biophys. Res. Commun. 115:1040-1047(1983).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RX   PubMed=6403867; DOI=10.1038/302305a0;
RA   Taniguchi T., Matsui H., Fujita T., Takaoka C., Kashima N., Yoshimoto R.,
RA   Hamuro J.;
RT   "Structure and expression of a cloned cDNA for human interleukin-2.";
RL   Nature 302:305-310(1983).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=6306584; DOI=10.1093/nar/11.13.4307;
RA   Devos R., Plaetinck G., Cheroutre H., Simons G., Degrave W., Tavernier J.,
RA   Remaut E., Fiers W.;
RT   "Molecular cloning of human interleukin 2 cDNA and its expression in E.
RT   coli.";
RL   Nucleic Acids Res. 11:4307-4323(1983).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=6324170; DOI=10.1073/pnas.80.24.7437;
RA   Fujita T., Takaoka C., Matsui H., Taniguchi T.;
RT   "Structure of the human interleukin 2 gene.";
RL   Proc. Natl. Acad. Sci. U.S.A. 80:7437-7441(1983).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=6330695; DOI=10.1093/nar/12.12.5005;
RA   Holbrook N.J., Lieber M., Crabtree G.R.;
RT   "DNA sequence of the 5' flanking region of the human interleukin 2 gene:
RT   homologies with adult T-cell leukemia virus.";
RL   Nucleic Acids Res. 12:5005-5013(1984).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=6608729; DOI=10.1073/pnas.81.6.1634;
RA   Holbrook N.J., Smith K.A., Fornace A.J. Jr., Comeau C.M., Wiskocil R.L.,
RA   Crabtree G.R.;
RT   "T-cell growth factor: complete nucleotide sequence and organization of the
RT   gene in normal and malignant cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 81:1634-1638(1984).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7722480; DOI=10.1046/j.1471-4159.1995.64051928.x;
RA   Eizenberg O., Faber-Elman A., Lotan M., Schwartz M.;
RT   "Interleukin-2 transcripts in human and rodent brains: possible expression
RT   by astrocytes.";
RL   J. Neurochem. 64:1928-1936(1995).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Placenta;
RX   PubMed=8824916;
RX   DOI=10.1002/(sici)1098-2795(199602)43:2<180::aid-mrd7>3.0.co;2-n;
RA   Chernicky C.L., Tan H., Burfeind P., Ilan J., Ilan J.;
RT   "Sequence of interleukin-2 isolated from human placental poly A+ RNA:
RT   possible role in maintenance of fetal allograft.";
RL   Mol. Reprod. Dev. 43:180-186(1996).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   SeattleSNPs variation discovery resource;
RL   Submitted (MAR-2001) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Blood;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-68.
RA   Nishino N., Obaru K., Maeda S., Shimada K., Onoue K.;
RT   "Organization of the DNA regions flanking the human interleukin 2 gene.";
RL   Biomed. Res. 6:197-205(1985).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-69.
RX   PubMed=3491296; DOI=10.1128/mcb.6.9.3042;
RA   Siebenlist U., Durand D.B., Bressler P., Holbrook N.J., Norris C.A.,
RA   Kamoun M., Kant J.A., Crabtree G.R.;
RT   "Promoter region of interleukin-2 gene undergoes chromatin structure
RT   changes and confers inducibility on chloramphenicol acetyltransferase gene
RT   during activation of T cells.";
RL   Mol. Cell. Biol. 6:3042-3049(1986).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 21-153.
RX   PubMed=3264184; DOI=10.1021/bi00418a034;
RA   Weir M.P., Chaplin M.A., Wallace D.M., Dykes C.W., Hobden A.N.;
RT   "Structure-activity relationships of recombinant human interleukin 2.";
RL   Biochemistry 27:6883-6892(1988).
RN   [14]
RP   PROTEIN SEQUENCE OF 21-153, DISULFIDE BOND, AND GLYCOSYLATION AT THR-23.
RX   PubMed=6333684; DOI=10.1073/pnas.81.20.6486;
RA   Robb R.J., Kutny R.M., Panico M., Morris H.R., Chowdhry V.;
RT   "Amino acid sequence and post-translational modification of human
RT   interleukin 2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 81:6486-6490(1984).
RN   [15]
RP   GLYCOSYLATION AT THR-23.
RX   PubMed=2793860;
RA   Conradt H.S., Nimtz M., Dittmar K.E.J., Lindenmaier W., Hoppe J.,
RA   Hauser H.;
RT   "Expression of human interleukin-2 in recombinant baby hamster kidney,
RT   Ltk-, and Chinese hamster ovary cells. Structure of O-linked carbohydrate
RT   chains and their location within the polypeptide.";
RL   J. Biol. Chem. 264:17368-17373(1989).
RN   [16]
RP   CHROMOSOMAL TRANSLOCATION WITH TNFRSF17.
RX   PubMed=1396583; DOI=10.1002/j.1460-2075.1992.tb05482.x;
RA   Laabi Y., Gras M.P., Carbonnel F., Brouet J.C., Berger R., Larsen C.-J.,
RA   Tsapis A.;
RT   "A new gene, BCM, on chromosome 16 is fused to the interleukin 2 gene by a
RT   t(4;16)(q26;p13) translocation in a malignant T cell lymphoma.";
RL   EMBO J. 11:3897-3904(1992).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS).
RX   PubMed=3500515; DOI=10.1126/science.3500515;
RA   Brandhuber B.J., Boone T., Kenney W.C., McKay D.B.;
RT   "Three-dimensional structure of interleukin-2.";
RL   Science 238:1707-1709(1987).
RN   [18]
RP   COMPARISON OF X-RAY STRUCTURES.
RX   PubMed=1631562; DOI=10.1126/science.1631562;
RA   Bazan J.F.;
RT   "Unraveling the structure of IL-2.";
RL   Science 257:410-412(1992).
RN   [19]
RP   RESPONSE TO PUBMED:1631562.
RA   McKay D.B.;
RL   Science 257:412-413(1992).
RN   [20]
RP   STRUCTURE BY NMR.
RX   PubMed=1510960; DOI=10.1021/bi00148a040;
RA   Mott H.R., Driscoll P.C., Boyd J., Cooke R.M., Weir M.P., Campbell I.D.;
RT   "Secondary structure of human interleukin 2 from 3D heteronuclear NMR
RT   experiments.";
RL   Biochemistry 31:7741-7744(1992).
RN   [21]
RP   3D-STRUCTURE MODELING.
RX   PubMed=7529123; DOI=10.1016/s0969-2126(94)00085-9;
RA   Bamborough P., Hedgecock C.J., Richards W.G.;
RT   "The interleukin-2 and interleukin-4 receptors studied by molecular
RT   modelling.";
RL   Structure 2:839-851(1994).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 21-153 IN COMPLEX WITH IL2RA;
RP   IL2RB AND IL2RC.
RX   PubMed=16293754; DOI=10.1126/science.1117893;
RA   Wang X., Rickert M., Garcia K.C.;
RT   "Structure of the quaternary complex of interleukin-2 with its alpha, beta,
RT   and gammac receptors.";
RL   Science 310:1159-1163(2005).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 21-153 IN COMPLEX WITH IL2RA;
RP   IL2RB AND IL2RC, AND DISULFIDE BOND.
RX   PubMed=16477002; DOI=10.1073/pnas.0511161103;
RA   Stauber D.J., Debler E.W., Horton P.A., Smith K.A., Wilson I.A.;
RT   "Crystal structure of the IL-2 signaling complex: paradigm for a
RT   heterotrimeric cytokine receptor.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:2788-2793(2006).
CC   -!- FUNCTION: Produced by T-cells in response to antigenic or mitogenic
CC       stimulation, this protein is required for T-cell proliferation and
CC       other activities crucial to regulation of the immune response. Can
CC       stimulate B-cells, monocytes, lymphokine-activated killer cells,
CC       natural killer cells, and glioma cells.
CC   -!- INTERACTION:
CC       P60568; P01589: IL2RA; NbExp=3; IntAct=EBI-12508717, EBI-8614302;
CC       P60568; P14784: IL2RB; NbExp=5; IntAct=EBI-12508717, EBI-2866779;
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- DISEASE: Note=A chromosomal aberration involving IL2 is found in a form
CC       of T-cell acute lymphoblastic leukemia (T-ALL). Translocation
CC       t(4;16)(q26;p13) with involves TNFRSF17. {ECO:0000269|PubMed:1396583}.
CC   -!- PHARMACEUTICAL: Available under the name Proleukin (Chiron). Used in
CC       patients with renal cell carcinoma or metastatic melanoma.
CC   -!- SIMILARITY: Belongs to the IL-2 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA59140.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Interleukin-2 entry;
CC       URL="https://en.wikipedia.org/wiki/Interleukin_2";
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/il2/";
CC   -!- WEB RESOURCE: Name=SHMPD; Note=The Singapore human mutation and
CC       polymorphism database;
CC       URL="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&genename=IL2";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X00695; CAA25292.1; -; Genomic_DNA.
DR   EMBL; V00564; CAA23827.1; -; mRNA.
DR   EMBL; X01586; CAA25742.1; -; mRNA.
DR   EMBL; J00264; AAD48509.1; -; Genomic_DNA.
DR   EMBL; K02056; AAA98792.1; -; Genomic_DNA.
DR   EMBL; S77834; AAD14263.2; -; mRNA.
DR   EMBL; S82692; AAB46883.1; -; mRNA.
DR   EMBL; AF359939; AAK26665.1; -; Genomic_DNA.
DR   EMBL; BC066255; AAH66255.1; -; mRNA.
DR   EMBL; BC066257; AAH66257.1; -; mRNA.
DR   EMBL; BC070338; AAH70338.1; -; mRNA.
DR   EMBL; M33199; AAA59139.1; -; Genomic_DNA.
DR   EMBL; M13879; AAA59141.1; -; Genomic_DNA.
DR   EMBL; M22005; AAA59140.1; ALT_INIT; Genomic_DNA.
DR   CCDS; CCDS3726.1; -.
DR   PIR; A01849; ICHU2.
DR   RefSeq; NP_000577.2; NM_000586.3.
DR   PDB; 1ILM; Model; -; 2=26-153.
DR   PDB; 1ILN; Model; -; 2=26-153.
DR   PDB; 1IRL; NMR; -; A=21-153.
DR   PDB; 1M47; X-ray; 1.99 A; A=21-153.
DR   PDB; 1M48; X-ray; 1.95 A; A/B=21-153.
DR   PDB; 1M49; X-ray; 2.00 A; A/B=21-153.
DR   PDB; 1M4A; X-ray; 2.18 A; A=21-153.
DR   PDB; 1M4B; X-ray; 2.15 A; A=21-153.
DR   PDB; 1M4C; X-ray; 2.40 A; A/B=21-153.
DR   PDB; 1NBP; X-ray; 2.20 A; A=21-153.
DR   PDB; 1PW6; X-ray; 2.60 A; A/B=21-153.
DR   PDB; 1PY2; X-ray; 2.80 A; A/B/C/D=21-152.
DR   PDB; 1QVN; X-ray; 2.70 A; A/B/C/D=21-152.
DR   PDB; 1Z92; X-ray; 2.80 A; A=21-153.
DR   PDB; 2B5I; X-ray; 2.30 A; A=21-153.
DR   PDB; 2ERJ; X-ray; 3.00 A; D/H=21-153.
DR   PDB; 3INK; X-ray; 2.50 A; C/D=21-153.
DR   PDB; 3QAZ; X-ray; 3.80 A; A/D/G/J/M/P/S/V/Y/b/e/h=21-153.
DR   PDB; 3QB1; X-ray; 3.10 A; A/B/C/D/E/F/G/H=21-153.
DR   PDB; 4NEJ; X-ray; 1.92 A; A=24-153.
DR   PDB; 4NEM; X-ray; 1.93 A; A=24-153.
DR   PDB; 5LQB; X-ray; 1.95 A; A=22-153.
DR   PDB; 5M5E; X-ray; 2.30 A; D=8-153.
DR   PDB; 5UTZ; X-ray; 2.75 A; A/D/E/I=21-153.
DR   PDBsum; 1ILM; -.
DR   PDBsum; 1ILN; -.
DR   PDBsum; 1IRL; -.
DR   PDBsum; 1M47; -.
DR   PDBsum; 1M48; -.
DR   PDBsum; 1M49; -.
DR   PDBsum; 1M4A; -.
DR   PDBsum; 1M4B; -.
DR   PDBsum; 1M4C; -.
DR   PDBsum; 1NBP; -.
DR   PDBsum; 1PW6; -.
DR   PDBsum; 1PY2; -.
DR   PDBsum; 1QVN; -.
DR   PDBsum; 1Z92; -.
DR   PDBsum; 2B5I; -.
DR   PDBsum; 2ERJ; -.
DR   PDBsum; 3INK; -.
DR   PDBsum; 3QAZ; -.
DR   PDBsum; 3QB1; -.
DR   PDBsum; 4NEJ; -.
DR   PDBsum; 4NEM; -.
DR   PDBsum; 5LQB; -.
DR   PDBsum; 5M5E; -.
DR   PDBsum; 5UTZ; -.
DR   SMR; P60568; -.
DR   BioGrid; 109773; 2.
DR   CORUM; P60568; -.
DR   DIP; DIP-475N; -.
DR   IntAct; P60568; 4.
DR   STRING; 9606.ENSP00000226730; -.
DR   BindingDB; P60568; -.
DR   ChEMBL; CHEMBL5880; -.
DR   DrugBank; DB03455; (1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid.
DR   DrugBank; DB04278; 2-[2-(2-Cyclohexyl-2-Guanidino-Acetylamino)-Acetylamino]-N-(3-Mercapto-Propyl)-Propionamide.
DR   DrugBank; DB03372; 3-Mercapto-1-(1,3,4,9-Tetrahydro-B-Carbolin-2-Yl)-Propan-1-One.
DR   DrugBank; DB01327; Cefazolin.
DR   DrugBank; DB05304; Girentuximab.
DR   DrugBank; DB05299; keyhole limpet hemocyanin.
DR   DrugBank; DB03453; Methyl (2S)-2-[[2-[(3R)-1-carbamimidoylpiperidin-3-yl]acetyl]amino]-3-[4-(2-phenylethynyl)phenyl]propanoate.
DR   DrugBank; DB02581; N(2)-carbamimidoyl-N-{2-[4-(3-{4-[(5-carboxyfuran-2-yl)methoxy]-2,3-dichlorophenyl}-1-methyl-1H-pyrazol-5-yl)piperidin-1-yl]-2-oxoethyl}-D-leucinamide.
DR   DrugBank; DB00852; Pseudoephedrine.
DR   DrugBank; DB03957; SP2456.
DR   DrugBank; DB02555; SP4160.
DR   DrugBank; DB06083; Tapinarof.
DR   DrugBank; DB06584; TG4010.
DR   DrugCentral; P60568; -.
DR   GlyConnect; 225; -.
DR   GlyConnect; 297; -.
DR   GlyConnect; 298; -.
DR   GlyConnect; 299; -.
DR   GlyConnect; 300; -.
DR   iPTMnet; P60568; -.
DR   MetOSite; P60568; -.
DR   PhosphoSitePlus; P60568; -.
DR   UniCarbKB; P60568; -.
DR   BioMuta; IL2; -.
DR   DMDM; 45593462; -.
DR   MassIVE; P60568; -.
DR   PaxDb; P60568; -.
DR   PeptideAtlas; P60568; -.
DR   PRIDE; P60568; -.
DR   ProteomicsDB; 57215; -.
DR   ABCD; P60568; -.
DR   Antibodypedia; 4147; 1926 antibodies.
DR   DNASU; 3558; -.
DR   Ensembl; ENST00000226730; ENSP00000226730; ENSG00000109471.
DR   GeneID; 3558; -.
DR   KEGG; hsa:3558; -.
DR   CTD; 3558; -.
DR   DisGeNET; 3558; -.
DR   GeneCards; IL2; -.
DR   HGNC; HGNC:6001; IL2.
DR   HPA; ENSG00000109471; Tissue enhanced (blood, intestine, lymphoid tissue).
DR   MIM; 147680; gene.
DR   neXtProt; NX_P60568; -.
DR   OpenTargets; ENSG00000109471; -.
DR   PharmGKB; PA195; -.
DR   eggNOG; ENOG410J049; Eukaryota.
DR   eggNOG; ENOG41119SF; LUCA.
DR   GeneTree; ENSGT00390000003555; -.
DR   HOGENOM; CLU_124210_0_0_1; -.
DR   InParanoid; P60568; -.
DR   KO; K05429; -.
DR   OMA; FCQSIFS; -.
DR   OrthoDB; 1491449at2759; -.
DR   PhylomeDB; P60568; -.
DR   TreeFam; TF338200; -.
DR   Reactome; R-HSA-5673001; RAF/MAP kinase cascade.
DR   Reactome; R-HSA-8877330; RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs).
DR   Reactome; R-HSA-9020558; Interleukin-2 signaling.
DR   Reactome; R-HSA-912526; Interleukin receptor SHC signaling.
DR   SignaLink; P60568; -.
DR   SIGNOR; P60568; -.
DR   ChiTaRS; IL2; human.
DR   EvolutionaryTrace; P60568; -.
DR   GeneWiki; Interleukin_2; -.
DR   GenomeRNAi; 3558; -.
DR   Pharos; P60568; Tchem.
DR   PRO; PR:P60568; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   RNAct; P60568; protein.
DR   Bgee; ENSG00000109471; Expressed in small intestine Peyer's patch and 44 other tissues.
DR   ExpressionAtlas; P60568; baseline and differential.
DR   Genevisible; P60568; HS.
DR   GO; GO:0005623; C:cell; IEA:GOC.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; TAS:UniProtKB.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:Ensembl.
DR   GO; GO:0005125; F:cytokine activity; IDA:MGI.
DR   GO; GO:0043208; F:glycosphingolipid binding; IEA:Ensembl.
DR   GO; GO:0008083; F:growth factor activity; TAS:UniProtKB.
DR   GO; GO:0005134; F:interleukin-2 receptor binding; IDA:MGI.
DR   GO; GO:0031851; F:kappa-type opioid receptor binding; IEA:Ensembl.
DR   GO; GO:0019209; F:kinase activator activity; TAS:UniProtKB.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   GO; GO:0007155; P:cell adhesion; TAS:UniProtKB.
DR   GO; GO:0007267; P:cell-cell signaling; TAS:UniProtKB.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl.
DR   GO; GO:0010467; P:gene expression; IEA:Ensembl.
DR   GO; GO:0006955; P:immune response; TAS:UniProtKB.
DR   GO; GO:0038110; P:interleukin-2-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0002366; P:leukocyte activation involved in immune response; IDA:UniProtKB.
DR   GO; GO:0000165; P:MAPK cascade; TAS:Reactome.
DR   GO; GO:0030101; P:natural killer cell activation; TAS:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; TAS:UniProtKB.
DR   GO; GO:0002903; P:negative regulation of B cell apoptotic process; IDA:MGI.
DR   GO; GO:0045822; P:negative regulation of heart contraction; IEA:Ensembl.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl.
DR   GO; GO:0050672; P:negative regulation of lymphocyte proliferation; IEA:Ensembl.
DR   GO; GO:0001933; P:negative regulation of protein phosphorylation; IEA:Ensembl.
DR   GO; GO:2000320; P:negative regulation of T-helper 17 cell differentiation; IEA:Ensembl.
DR   GO; GO:0042104; P:positive regulation of activated T cell proliferation; IDA:MGI.
DR   GO; GO:0030890; P:positive regulation of B cell proliferation; IDA:MGI.
DR   GO; GO:0030307; P:positive regulation of cell growth; TAS:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; TAS:UniProtKB.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl.
DR   GO; GO:0060999; P:positive regulation of dendritic spine development; IEA:Ensembl.
DR   GO; GO:0051024; P:positive regulation of immunoglobulin secretion; IEA:Ensembl.
DR   GO; GO:0050729; P:positive regulation of inflammatory response; IC:BHF-UCL.
DR   GO; GO:0032729; P:positive regulation of interferon-gamma production; IEA:Ensembl.
DR   GO; GO:0032740; P:positive regulation of interleukin-17 production; IDA:BHF-UCL.
DR   GO; GO:0048304; P:positive regulation of isotype switching to IgG isotypes; IEA:Ensembl.
DR   GO; GO:0045591; P:positive regulation of regulatory T cell differentiation; IEA:Ensembl.
DR   GO; GO:0034105; P:positive regulation of tissue remodeling; IC:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IEA:Ensembl.
DR   GO; GO:0042531; P:positive regulation of tyrosine phosphorylation of STAT protein; IDA:BHF-UCL.
DR   GO; GO:0007205; P:protein kinase C-activating G protein-coupled receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0045589; P:regulation of regulatory T cell differentiation; TAS:Reactome.
DR   GO; GO:0046013; P:regulation of T cell homeostatic proliferation; IEA:Ensembl.
DR   GO; GO:0045471; P:response to ethanol; IEA:Ensembl.
DR   GO; GO:0030217; P:T cell differentiation; TAS:UniProtKB.
DR   InterPro; IPR009079; 4_helix_cytokine-like_core.
DR   InterPro; IPR000779; IL-2.
DR   InterPro; IPR030477; IL-2_CS.
DR   Pfam; PF00715; IL2; 1.
DR   PRINTS; PR00265; INTERLEUKIN2.
DR   SMART; SM00189; IL2; 1.
DR   SUPFAM; SSF47266; SSF47266; 1.
DR   PROSITE; PS00424; INTERLEUKIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Adaptive immunity; Chromosomal rearrangement; Cytokine;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein; Growth factor;
KW   Immunity; Pharmaceutical; Proto-oncogene; Reference proteome; Secreted;
KW   Signal.
FT   SIGNAL          1..20
FT                   /evidence="ECO:0000269|PubMed:6333684"
FT   CHAIN           21..153
FT                   /note="Interleukin-2"
FT                   /id="PRO_0000015484"
FT   CARBOHYD        23
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000269|PubMed:2793860,
FT                   ECO:0000269|PubMed:6333684"
FT                   /id="CAR_000051"
FT   DISULFID        78..125
FT                   /evidence="ECO:0000269|PubMed:16477002,
FT                   ECO:0000269|PubMed:6333684"
FT   VARIANT         21
FT                   /note="Missing (in FT-IL2-A and FT-IL2-B)"
FT                   /id="VAR_003967"
FT   VARIANT         22
FT                   /note="Missing (in FT-IL2-B)"
FT                   /id="VAR_003968"
FT   HELIX           25..49
FT                   /evidence="ECO:0000244|PDB:4NEJ"
FT   HELIX           53..59
FT                   /evidence="ECO:0000244|PDB:4NEJ"
FT   HELIX           60..62
FT                   /evidence="ECO:0000244|PDB:1IRL"
FT   STRAND          64..68
FT                   /evidence="ECO:0000244|PDB:3INK"
FT   HELIX           73..76
FT                   /evidence="ECO:0000244|PDB:4NEJ"
FT   HELIX           77..93
FT                   /evidence="ECO:0000244|PDB:4NEJ"
FT   TURN            95..97
FT                   /evidence="ECO:0000244|PDB:1M48"
FT   STRAND          98..100
FT                   /evidence="ECO:0000244|PDB:3INK"
FT   HELIX           105..117
FT                   /evidence="ECO:0000244|PDB:4NEJ"
FT   HELIX           120..122
FT                   /evidence="ECO:0000244|PDB:5LQB"
FT   STRAND          127..132
FT                   /evidence="ECO:0000244|PDB:3INK"
FT   HELIX           134..149
FT                   /evidence="ECO:0000244|PDB:4NEJ"
FT   TURN            150..152
FT                   /evidence="ECO:0000244|PDB:4NEJ"
SQ   SEQUENCE   153 AA;  17628 MW;  59E2F40F25860F84 CRC64;
     MYRMQLLSCI ALSLALVTNS APTSSSTKKT QLQLEHLLLD LQMILNGINN YKNPKLTRML
     TFKFYMPKKA TELKHLQCLE EELKPLEEVL NLAQSKNFHL RPRDLISNIN VIVLELKGSE
     TTFMCEYADE TATIVEFLNR WITFCQSIIS TLT
//
ID   Q0GK43_HUMAN            Unreviewed;       153 AA.
AC   Q0GK43;
DT   03-OCT-2006, integrated into UniProtKB/TrEMBL.
DT   03-OCT-2006, sequence version 1.
DT   22-APR-2020, entry version 118.
DE   RecName: Full=Interleukin-2 {ECO:0000256|RuleBase:RU363134};
DE            Short=IL-2 {ECO:0000256|RuleBase:RU363134};
GN   Name=IL2 {ECO:0000256|RuleBase:RU363134, ECO:0000313|EMBL:BAG70139.1};
GN   ORFNames=hCG_38828 {ECO:0000313|EMBL:EAX05227.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABI20697.1};
RN   [1] {ECO:0000313|EMBL:EAX05227.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAX05227.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ABI20697.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Saxena A., Rai A., Salunkhe S.S., Gupta P.K., Tiwari A.K., Kumar S.,
RA   Ahi Y.S., Sandey M.;
RT   "Cloning of human interleukin-2 gene in a mammalian expression vector.";
RL   Submitted (JUL-2006) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:BAG70139.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Goshima N., Kawamura Y., Fukumoto A., Miura A., Honma R., Satoh R.,
RA   Wakamatsu A., Yamamoto J.-I., Kimura K., Nishikawa T., Andoh T., Iida Y.,
RA   Ishikawa K., Ito E., Kagawa N., Kaminaga C., Kanehori K., Kawakami B.,
RA   Kenmochi K.-I., Kimura R., Kobayashi M., Kuroita T., Kuwayama H.,
RA   Maruyama Y., Matsuo K., Minami K., Mitsubori M., Mori M., Morishita R.,
RA   Murase A., Nishikawa A., Nishikawa S., Okamoto T., Sakagami N.,
RA   Sakamoto Y., Sasaki Y., Seki T., Sono S., Sugiyama A., Sumiya T.,
RA   Takayama T., Takayama Y., Takeda H., Togashi T., Yahata K., Yamada H.,
RA   Yanagisawa Y., Endo Y., Imamoto F., Kisu Y., Tanaka S., Isogai T.,
RA   Imai J.-I., Watanabe S., Nomura N.;
RT   "Human Protein Factory: an infrastructure to convert the human
RT   transcriptome into the in vitro-expressed human proteome of versatile
RT   utility.";
RL   Submitted (JUL-2008) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Produced by T-cells in response to antigenic or mitogenic
CC       stimulation, this protein is required for T-cell proliferation and
CC       other activities crucial to regulation of the immune response.
CC       {ECO:0000256|RuleBase:RU363134}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000256|RuleBase:RU363134}.
CC   -!- SIMILARITY: Belongs to the IL-2 family.
CC       {ECO:0000256|RuleBase:RU363134}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ861285; ABI20697.1; -; mRNA.
DR   EMBL; AB451325; BAG70139.1; -; mRNA.
DR   EMBL; AB451454; BAG70268.1; -; mRNA.
DR   EMBL; CH471056; EAX05227.1; -; Genomic_DNA.
DR   RefSeq; NP_000577.2; NM_000586.3.
DR   Antibodypedia; 4147; 1926 antibodies.
DR   DNASU; 3558; -.
DR   GeneID; 3558; -.
DR   KEGG; hsa:3558; -.
DR   UCSC; uc003ier.4; human.
DR   CTD; 3558; -.
DR   EuPathDB; HostDB:ENSG00000109471.4; -.
DR   PharmGKB; PA195; -.
DR   eggNOG; ENOG410J049; Eukaryota.
DR   eggNOG; ENOG41119SF; LUCA.
DR   HOGENOM; CLU_124210_0_0_1; -.
DR   KO; K05429; -.
DR   OMA; FCQSIFS; -.
DR   OrthoDB; 1491449at2759; -.
DR   ChiTaRS; IL2; human.
DR   GenomeRNAi; 3558; -.
DR   Bgee; ENSG00000109471; Expressed in small intestine Peyer's patch and 44 other tissues.
DR   GO; GO:0005623; C:cell; IEA:GOC.
DR   GO; GO:0005615; C:extracellular space; IEA:UniProtKB-KW.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:Ensembl.
DR   GO; GO:0005125; F:cytokine activity; IEA:UniProtKB-KW.
DR   GO; GO:0043208; F:glycosphingolipid binding; IEA:Ensembl.
DR   GO; GO:0008083; F:growth factor activity; IEA:UniProtKB-KW.
DR   GO; GO:0005134; F:interleukin-2 receptor binding; IEA:Ensembl.
DR   GO; GO:0031851; F:kappa-type opioid receptor binding; IEA:Ensembl.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   GO; GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl.
DR   GO; GO:0010467; P:gene expression; IEA:Ensembl.
DR   GO; GO:0045822; P:negative regulation of heart contraction; IEA:Ensembl.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl.
DR   GO; GO:0050672; P:negative regulation of lymphocyte proliferation; IEA:Ensembl.
DR   GO; GO:0001933; P:negative regulation of protein phosphorylation; IEA:Ensembl.
DR   GO; GO:2000320; P:negative regulation of T-helper 17 cell differentiation; IEA:Ensembl.
DR   GO; GO:0042104; P:positive regulation of activated T cell proliferation; IEA:Ensembl.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl.
DR   GO; GO:0060999; P:positive regulation of dendritic spine development; IEA:Ensembl.
DR   GO; GO:0051024; P:positive regulation of immunoglobulin secretion; IEA:Ensembl.
DR   GO; GO:0032729; P:positive regulation of interferon-gamma production; IEA:Ensembl.
DR   GO; GO:0048304; P:positive regulation of isotype switching to IgG isotypes; IEA:Ensembl.
DR   GO; GO:0045591; P:positive regulation of regulatory T cell differentiation; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IEA:Ensembl.
DR   GO; GO:0042531; P:positive regulation of tyrosine phosphorylation of STAT protein; IEA:Ensembl.
DR   GO; GO:0007205; P:protein kinase C-activating G protein-coupled receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0046013; P:regulation of T cell homeostatic proliferation; IEA:Ensembl.
DR   GO; GO:0045471; P:response to ethanol; IEA:Ensembl.
DR   InterPro; IPR009079; 4_helix_cytokine-like_core.
DR   InterPro; IPR000779; IL-2.
DR   InterPro; IPR030477; IL-2_CS.
DR   Pfam; PF00715; IL2; 1.
DR   PRINTS; PR00265; INTERLEUKIN2.
DR   SMART; SM00189; IL2; 1.
DR   SUPFAM; SSF47266; SSF47266; 1.
DR   PROSITE; PS00424; INTERLEUKIN_2; 1.
PE   2: Evidence at transcript level;
KW   Adaptive immunity {ECO:0000256|RuleBase:RU363134};
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Cytokine {ECO:0000256|RuleBase:RU363134};
KW   Disulfide bond {ECO:0000256|RuleBase:RU363134};
KW   Growth factor {ECO:0000256|RuleBase:RU363134};
KW   Immunity {ECO:0000256|RuleBase:RU363134};
KW   Secreted {ECO:0000256|RuleBase:RU363134};
KW   Signal {ECO:0000256|RuleBase:RU363134}.
FT   SIGNAL          1..20
FT                   /evidence="ECO:0000256|RuleBase:RU363134"
FT   CHAIN           21..153
FT                   /note="Interleukin-2"
FT                   /evidence="ECO:0000256|RuleBase:RU363134"
FT                   /id="PRO_5014205719"
FT   COILED          76..96
FT                   /evidence="ECO:0000256|SAM:Coils"
SQ   SEQUENCE   153 AA;  17628 MW;  59E2F40F25860F84 CRC64;
     MYRMQLLSCI ALSLALVTNS APTSSSTKKT QLQLEHLLLD LQMILNGINN YKNPKLTRML
     TFKFYMPKKA TELKHLQCLE EELKPLEEVL NLAQSKNFHL RPRDLISNIN VIVLELKGSE
     TTFMCEYADE TATIVEFLNR WITFCQSIIS TLT
//
ID   IL21R_HUMAN             Reviewed;         538 AA.
AC   Q9HBE5; A8K9E8; D3DWF7; Q96HZ1; Q9HB91;
DT   02-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   22-APR-2020, entry version 173.
DE   RecName: Full=Interleukin-21 receptor;
DE            Short=IL-21 receptor;
DE            Short=IL-21R;
DE   AltName: Full=Novel interleukin receptor;
DE   AltName: CD_antigen=CD360;
DE   Flags: Precursor;
GN   Name=IL21R; Synonyms=NILR; ORFNames=UNQ3121/PRO10273;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=11081504; DOI=10.1038/35040504;
RA   Parrish-Novak J., Dillon S.R., Nelson A., Hammond A., Sprecher C.,
RA   Gross J.A., Johnston J., Madden K., Xu W., West J., Schrader S.,
RA   Burkhead S., Heipel M., Brandt C., Kuijper J.L., Kramer J., Conklin D.,
RA   Presnell S.R., Berry J., Shiota F., Bort S., Hambly K., Mudri S., Clegg C.,
RA   Moore M., Grant F.J., Lofton-Day C., Gilbert T., Raymond F., Ching A.,
RA   Yao L., Smith D., Webster P., Whitmore T., Maurer M., Kaushansky K.,
RA   Holly R.D., Foster D.;
RT   "Interleukin 21 and its receptor are involved in NK cell expansion and
RT   regulation of lymphocyte function.";
RL   Nature 408:57-63(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=11016959; DOI=10.1073/pnas.200360997;
RA   Ozaki K., Kikly K., Michalovich D., Young P.R., Leonard W.J.;
RT   "Cloning of a type I cytokine receptor most related to the IL-2 receptor
RT   beta chain.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:11439-11444(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A.,
RA   Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D.,
RA   Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L.,
RA   Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C.,
RA   Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J.,
RA   Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale effort to
RT   identify novel human secreted and transmembrane proteins: a bioinformatics
RT   assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS CYS-191; ARG-318 AND
RP   SER-484.
RG   SeattleSNPs variation discovery resource;
RL   Submitted (NOV-2001) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=B-cell, and Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 20-34.
RX   PubMed=15340161; DOI=10.1110/ps.04682504;
RA   Zhang Z., Henzel W.J.;
RT   "Signal peptide prediction based on analysis of experimentally verified
RT   cleavage sites.";
RL   Protein Sci. 13:2819-2824(2004).
RN   [9]
RP   INVOLVEMENT IN B-CELL NON-HODGKIN LYMPHOMA, AND CHROMOSOMAL TRANSLOCATION
RP   WITH BCL6.
RX   PubMed=11821949; DOI=10.1038/sj.onc.1205099;
RA   Ueda C., Akasaka T., Kurata M., Maesako Y., Nishikori M., Ichinohasama R.,
RA   Imada K., Uchiyama T., Ohno H.;
RT   "The gene for interleukin-21 receptor is the partner of BCL6 in
RT   t(3;16)(q27;p11), which is recurrently observed in diffuse large B-cell
RT   lymphoma.";
RL   Oncogene 21:368-376(2002).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 20-232 IN COMPLEX WITH IL21,
RP   DOMAIN WSXWS MOTIF, GLYCOSYLATION AT ASN-73 AND TRP-214, DOMAINS
RP   FIBRONECTIN, AND DISULFIDE BONDS.
RX   PubMed=22235133; DOI=10.1074/jbc.m111.311084;
RA   Hamming O.J., Kang L., Svensson A., Karlsen J.L., Rahbek-Nielsen H.,
RA   Paludan S.R., Hjorth S.A., Bondensgaard K., Hartmann R.;
RT   "Crystal structure of interleukin-21 receptor (IL-21R) bound to IL-21
RT   reveals that sugar chain interacting with WSXWS motif is integral part of
RT   IL-21R.";
RL   J. Biol. Chem. 287:9454-9460(2012).
RN   [11]
RP   VARIANTS IMD56 81-CYS-HIS-82 DEL AND LEU-201, AND CHARACTERIZATION VARIANT
RP   IMD56 LEU-201.
RX   PubMed=23440042; DOI=10.1084/jem.20111229;
RA   Kotlarz D., Zietara N., Uzel G., Weidemann T., Braun C.J., Diestelhorst J.,
RA   Krawitz P.M., Robinson P.N., Hecht J., Puchalka J., Gertz E.M.,
RA   Schaeffer A.A., Lawrence M.G., Kardava L., Pfeifer D., Baumann U.,
RA   Pfister E.D., Hanson E.P., Schambach A., Jacobs R., Kreipe H., Moir S.,
RA   Milner J.D., Schwille P., Mundlos S., Klein C.;
RT   "Loss-of-function mutations in the IL-21 receptor gene cause a primary
RT   immunodeficiency syndrome.";
RL   J. Exp. Med. 210:433-443(2013).
CC   -!- FUNCTION: This is a receptor for interleukin-21.
CC   -!- SUBUNIT: Heterodimer with the common gamma subunit. Associates with
CC       JAK1. {ECO:0000269|PubMed:22235133}.
CC   -!- INTERACTION:
CC       Q9HBE5; P29972: AQP1; NbExp=3; IntAct=EBI-12558959, EBI-745213;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.
CC   -!- TISSUE SPECIFICITY: Selectively expressed in lymphoid tissues. Most
CC       highly expressed in thymus and spleen.
CC   -!- DOMAIN: The WSXWS motif appears to be necessary for proper protein
CC       folding and thereby efficient intracellular transport and cell-surface
CC       receptor binding. {ECO:0000269|PubMed:22235133}.
CC   -!- DOMAIN: The box 1 motif is required for JAK interaction and/or
CC       activation. {ECO:0000269|PubMed:22235133}.
CC   -!- PTM: C-mannosylated at Trp-214 in the WSXWS motif, the sugar chain
CC       makes extensive hydrogen bonds with Asn-73 sugar, and bridges the two
CC       fibronectin domains transforming the V-shaped receptor into an A-frame.
CC   -!- DISEASE: Immunodeficiency 56 (IMD56) [MIM:615207]: An autosomal
CC       recessive primary immunodeficiency characterized by B- and T-cell
CC       defects and variable dysfunction of NK cells. Patients tend to have
CC       normal numbers of lymphocytes, but show defective class-switched B-
CC       cells, low IgG, defective antibody response, and defective T-cell
CC       responses to certain antigens. {ECO:0000269|PubMed:23440042}. Note=The
CC       disease is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Note=Chromosomal aberrations involving IL21R is a cause of B-
CC       cell non-Hodgkin lymphomas (B-cell NHL). Translocation
CC       t(3;16)(q27;p11), with BCL6.
CC   -!- SIMILARITY: Belongs to the type I cytokine receptor family. Type 4
CC       subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/IL21RID40955ch16p12.html";
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/il21r/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF254067; AAG29346.1; -; mRNA.
DR   EMBL; AF269133; AAG23419.1; -; mRNA.
DR   EMBL; AY358826; AAQ89185.1; -; mRNA.
DR   EMBL; AY064474; AAL39168.1; -; Genomic_DNA.
DR   EMBL; AK292663; BAF85352.1; -; mRNA.
DR   EMBL; CH471145; EAW55746.1; -; Genomic_DNA.
DR   EMBL; CH471145; EAW55747.1; -; Genomic_DNA.
DR   EMBL; CH471145; EAW55748.1; -; Genomic_DNA.
DR   EMBL; BC004348; AAH04348.1; -; mRNA.
DR   EMBL; BC007946; AAH07946.2; -; mRNA.
DR   CCDS; CCDS10630.1; -.
DR   RefSeq; NP_068570.1; NM_021798.3.
DR   RefSeq; NP_851564.1; NM_181078.2.
DR   RefSeq; NP_851565.4; NM_181079.4.
DR   RefSeq; XP_016878746.1; XM_017023257.1.
DR   PDB; 3TGX; X-ray; 2.80 A; A/C/E/G/I/K/M/O=20-232.
DR   PDB; 4NZD; X-ray; 2.75 A; A/B/C=20-232.
DR   PDBsum; 3TGX; -.
DR   PDBsum; 4NZD; -.
DR   SMR; Q9HBE5; -.
DR   BioGrid; 119095; 2.
DR   IntAct; Q9HBE5; 1.
DR   STRING; 9606.ENSP00000338010; -.
DR   iPTMnet; Q9HBE5; -.
DR   PhosphoSitePlus; Q9HBE5; -.
DR   BioMuta; IL21R; -.
DR   DMDM; 20454997; -.
DR   jPOST; Q9HBE5; -.
DR   MassIVE; Q9HBE5; -.
DR   MaxQB; Q9HBE5; -.
DR   PaxDb; Q9HBE5; -.
DR   PeptideAtlas; Q9HBE5; -.
DR   PRIDE; Q9HBE5; -.
DR   ProteomicsDB; 81535; -.
DR   Antibodypedia; 12828; 444 antibodies.
DR   DNASU; 50615; -.
DR   Ensembl; ENST00000337929; ENSP00000338010; ENSG00000103522.
DR   Ensembl; ENST00000395754; ENSP00000379103; ENSG00000103522.
DR   Ensembl; ENST00000564089; ENSP00000456707; ENSG00000103522.
DR   GeneID; 50615; -.
DR   KEGG; hsa:50615; -.
DR   UCSC; uc002doq.2; human.
DR   CTD; 50615; -.
DR   DisGeNET; 50615; -.
DR   GeneCards; IL21R; -.
DR   HGNC; HGNC:6006; IL21R.
DR   HPA; ENSG00000103522; Group enriched (blood, lymphoid tissue).
DR   MalaCards; IL21R; -.
DR   MIM; 605383; gene.
DR   MIM; 615207; phenotype.
DR   neXtProt; NX_Q9HBE5; -.
DR   OpenTargets; ENSG00000103522; -.
DR   Orphanet; 357329; Combined immunodeficiency due to IL21R deficiency.
DR   PharmGKB; PA29821; -.
DR   eggNOG; ENOG410IEDJ; Eukaryota.
DR   eggNOG; ENOG41128NP; LUCA.
DR   GeneTree; ENSGT00510000048783; -.
DR   HOGENOM; CLU_039739_0_0_1; -.
DR   InParanoid; Q9HBE5; -.
DR   KO; K05075; -.
DR   OMA; QSEDGYP; -.
DR   OrthoDB; 774083at2759; -.
DR   PhylomeDB; Q9HBE5; -.
DR   TreeFam; TF337874; -.
DR   Reactome; R-HSA-9020958; Interleukin-21 signaling.
DR   SignaLink; Q9HBE5; -.
DR   SIGNOR; Q9HBE5; -.
DR   ChiTaRS; IL21R; human.
DR   GeneWiki; Interleukin-21_receptor; -.
DR   GenomeRNAi; 50615; -.
DR   Pharos; Q9HBE5; Tbio.
DR   PRO; PR:Q9HBE5; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   RNAct; Q9HBE5; protein.
DR   Bgee; ENSG00000103522; Expressed in prostate gland and 124 other tissues.
DR   Genevisible; Q9HBE5; HS.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0004896; F:cytokine receptor activity; IDA:MGI.
DR   GO; GO:0001532; F:interleukin-21 receptor activity; NAS:UniProtKB.
DR   GO; GO:0004888; F:transmembrane signaling receptor activity; IDA:MGI.
DR   GO; GO:0038114; P:interleukin-21-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0030101; P:natural killer cell activation; NAS:UniProtKB.
DR   CDD; cd00063; FN3; 1.
DR   Gene3D; 2.60.40.10; -; 2.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR003531; Hempt_rcpt_S_F1_CS.
DR   InterPro; IPR013783; Ig-like_fold.
DR   SUPFAM; SSF49265; SSF49265; 1.
DR   PROSITE; PS50853; FN3; 1.
DR   PROSITE; PS01355; HEMATOPO_REC_S_F1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Chromosomal rearrangement; Direct protein sequencing;
KW   Disease mutation; Disulfide bond; Glycoprotein; Membrane; Polymorphism;
KW   Receptor; Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..19
FT                   /evidence="ECO:0000269|PubMed:15340161"
FT   CHAIN           20..538
FT                   /note="Interleukin-21 receptor"
FT                   /id="PRO_0000010881"
FT   TOPO_DOM        20..232
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        233..253
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        254..538
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          21..118
FT                   /note="Fibronectin type-III 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          119..228
FT                   /note="Fibronectin type-III 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   MOTIF           214..218
FT                   /note="WSXWS motif"
FT   MOTIF           266..274
FT                   /note="Box 1 motif"
FT   CARBOHYD        73
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:22235133"
FT   CARBOHYD        97
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        104
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        125
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        135
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        214
FT                   /note="C-linked (Man) tryptophan"
FT                   /evidence="ECO:0000269|PubMed:22235133"
FT   DISULFID        20..109
FT                   /evidence="ECO:0000269|PubMed:22235133"
FT   DISULFID        25..35
FT                   /evidence="ECO:0000269|PubMed:22235133"
FT   DISULFID        65..81
FT                   /evidence="ECO:0000269|PubMed:22235133"
FT   VARIANT         81..82
FT                   /note="Missing (in IMD56; loss of function mutation)"
FT                   /evidence="ECO:0000269|PubMed:23440042"
FT                   /id="VAR_069898"
FT   VARIANT         191
FT                   /note="R -> C (in dbSNP:rs3093370)"
FT                   /evidence="ECO:0000269|Ref.4"
FT                   /id="VAR_014360"
FT   VARIANT         201
FT                   /note="R -> L (in IMD56; loss of function mutation; the
FT                   mutation results in defective trafficking of the protein,
FT                   with misfolding, impaired processing and abnormal
FT                   subcellular distribution rather than proper expression at
FT                   the plasma membrane; dbSNP:rs397514685)"
FT                   /evidence="ECO:0000269|PubMed:23440042"
FT                   /id="VAR_069899"
FT   VARIANT         318
FT                   /note="S -> R (in dbSNP:rs3093385)"
FT                   /evidence="ECO:0000269|Ref.4"
FT                   /id="VAR_014361"
FT   VARIANT         484
FT                   /note="G -> S (in dbSNP:rs3093386)"
FT                   /evidence="ECO:0000269|Ref.4"
FT                   /id="VAR_014362"
FT   CONFLICT        386
FT                   /note="G -> R (in Ref. 2; AAG23419)"
FT                   /evidence="ECO:0000305"
FT   STRAND          22..27
FT                   /evidence="ECO:0000244|PDB:4NZD"
FT   STRAND          29..31
FT                   /evidence="ECO:0000244|PDB:4NZD"
FT   STRAND          33..38
FT                   /evidence="ECO:0000244|PDB:4NZD"
FT   STRAND          40..43
FT                   /evidence="ECO:0000244|PDB:3TGX"
FT   STRAND          46..51
FT                   /evidence="ECO:0000244|PDB:3TGX"
FT   STRAND          68..72
FT                   /evidence="ECO:0000244|PDB:4NZD"
FT   STRAND          77..80
FT                   /evidence="ECO:0000244|PDB:4NZD"
FT   HELIX           85..87
FT                   /evidence="ECO:0000244|PDB:3TGX"
FT   STRAND          93..99
FT                   /evidence="ECO:0000244|PDB:4NZD"
FT   STRAND          106..113
FT                   /evidence="ECO:0000244|PDB:4NZD"
FT   HELIX           114..116
FT                   /evidence="ECO:0000244|PDB:4NZD"
FT   STRAND          124..139
FT                   /evidence="ECO:0000244|PDB:4NZD"
FT   HELIX           141..143
FT                   /evidence="ECO:0000244|PDB:3TGX"
FT   TURN            149..153
FT                   /evidence="ECO:0000244|PDB:4NZD"
FT   STRAND          154..162
FT                   /evidence="ECO:0000244|PDB:4NZD"
FT   STRAND          172..176
FT                   /evidence="ECO:0000244|PDB:4NZD"
FT   STRAND          181..185
FT                   /evidence="ECO:0000244|PDB:4NZD"
FT   HELIX           187..189
FT                   /evidence="ECO:0000244|PDB:4NZD"
FT   STRAND          195..204
FT                   /evidence="ECO:0000244|PDB:4NZD"
FT   TURN            206..209
FT                   /evidence="ECO:0000244|PDB:4NZD"
FT   STRAND          221..224
FT                   /evidence="ECO:0000244|PDB:4NZD"
SQ   SEQUENCE   538 AA;  59130 MW;  414079CCB974850A CRC64;
     MPRGWAAPLL LLLLQGGWGC PDLVCYTDYL QTVICILEMW NLHPSTLTLT WQDQYEELKD
     EATSCSLHRS AHNATHATYT CHMDVFHFMA DDIFSVNITD QSGNYSQECG SFLLAESIKP
     APPFNVTVTF SGQYNISWRS DYEDPAFYML KGKLQYELQY RNRGDPWAVS PRRKLISVDS
     RSVSLLPLEF RKDSSYELQV RAGPMPGSSY QGTWSEWSDP VIFQTQSEEL KEGWNPHLLL
     LLLLVIVFIP AFWSLKTHPL WRLWKKIWAV PSPERFFMPL YKGCSGDFKK WVGAPFTGSS
     LELGPWSPEV PSTLEVYSCH PPRSPAKRLQ LTELQEPAEL VESDGVPKPS FWPTAQNSGG
     SAYSEERDRP YGLVSIDTVT VLDAEGPCTW PCSCEDDGYP ALDLDAGLEP SPGLEDPLLD
     AGTTVLSCGC VSAGSPGLGG PLGSLLDRLK PPLADGEDWA GGLPWGGRSP GGVSESEAGS
     PLAGLDMDTF DSGFVGSDCS SPVECDFTSP GDEGPPRSYL RQWVVIPPPL SSPGPQAS
//
ID   ITK_HUMAN               Reviewed;         620 AA.
AC   Q08881; B2R752; Q32ML7;
DT   01-OCT-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1994, sequence version 1.
DT   22-APR-2020, entry version 211.
DE   RecName: Full=Tyrosine-protein kinase ITK/TSK;
DE            EC=2.7.10.2;
DE   AltName: Full=Interleukin-2-inducible T-cell kinase;
DE            Short=IL-2-inducible T-cell kinase;
DE   AltName: Full=Kinase EMT;
DE   AltName: Full=T-cell-specific kinase;
DE   AltName: Full=Tyrosine-protein kinase Lyk;
GN   Name=ITK; Synonyms=EMT, LYK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND INDUCTION.
RX   PubMed=8504851; DOI=10.1016/0014-5793(93)81520-a;
RA   Tanaka N., Asao H., Ohtani K., Nakamura M., Sugamura K.;
RT   "A novel human tyrosine kinase gene inducible in T cells by interleukin
RT   2.";
RL   FEBS Lett. 324:1-5(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Thymus;
RX   PubMed=8364206;
RA   Gibson S., Leung B., Squire J.A., Hill M., Arima N., Goss P., Hogg D.,
RA   Mills G.B.;
RT   "Identification, cloning, and characterization of a novel human T-cell-
RT   specific tyrosine kinase located at the hematopoietin complex on chromosome
RT   5q.";
RL   Blood 82:1561-1572(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 171-192, AND PHOSPHORYLATION AT TYR-180.
RX   PubMed=12573241; DOI=10.1016/s1570-9639(02)00524-1;
RA   Nore B.F., Mattsson P.T., Antonsson P., Backesjo C.-M., Westlund A.,
RA   Lennartsson J., Hansson H., Low P., Ronnstrand L., Smith C.I.E.;
RT   "Identification of phosphorylation sites within the SH3 domains of Tec
RT   family tyrosine kinases.";
RL   Biochim. Biophys. Acta 1645:123-132(2003).
RN   [7]
RP   PHOSPHORYLATION BY LCK.
RX   PubMed=9312162; DOI=10.1074/jbc.272.40.25401;
RA   Heyeck S.D., Wilcox H.M., Bunnell S.C., Berg L.J.;
RT   "Lck phosphorylates the activation loop tyrosine of the Itk kinase domain
RT   and activates Itk kinase activity.";
RL   J. Biol. Chem. 272:25401-25408(1997).
RN   [8]
RP   INDUCTION.
RX   PubMed=9701039; DOI=10.1093/intimm/10.7.1009;
RA   King P.D., Sadra A., Teng J.M., Bell G.M., Dupont B.;
RT   "CD2-mediated activation of the Tec-family tyrosine kinase ITK is
RT   controlled by proline-rich stretch-4 of the CD2 cytoplasmic tail.";
RL   Int. Immunol. 10:1009-1016(1998).
RN   [9]
RP   DOMAIN.
RX   PubMed=10795735; DOI=10.1016/s1074-7613(00)80189-2;
RA   Yang W.C., Collette Y., Nunes J.A., Olive D.;
RT   "Tec kinases: a family with multiple roles in immunity.";
RL   Immunity 12:373-382(2000).
RN   [10]
RP   FUNCTION IN PHOSPHORYLATION OF LAT.
RX   PubMed=12186560; DOI=10.1021/bi025554o;
RA   Perez-Villar J.J., Whitney G.S., Sitnick M.T., Dunn R.J., Venkatesan S.,
RA   O'Day K., Schieven G.L., Lin T.A., Kanner S.B.;
RT   "Phosphorylation of the linker for activation of T-cells by Itk promotes
RT   recruitment of Vav.";
RL   Biochemistry 41:10732-10740(2002).
RN   [11]
RP   FUNCTION.
RX   PubMed=12682224; DOI=10.4049/jimmunol.170.8.3971;
RA   Grasis J.A., Browne C.D., Tsoukas C.D.;
RT   "Inducible T cell tyrosine kinase regulates actin-dependent cytoskeletal
RT   events induced by the T cell antigen receptor.";
RL   J. Immunol. 170:3971-3976(2003).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=15144186; DOI=10.1021/ac035352d;
RA   Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,
RA   Peters E.C.;
RT   "Robust phosphoproteomic profiling of tyrosine phosphorylation sites from
RT   human T cells using immobilized metal affinity chromatography and tandem
RT   mass spectrometry.";
RL   Anal. Chem. 76:2763-2772(2004).
RN   [13]
RP   INTERACTION WITH PPIA/CYPA, AND MUTAGENESIS OF PRO-288.
RX   PubMed=15308100; DOI=10.1016/j.immuni.2004.07.005;
RA   Colgan J., Asmal M., Neagu M., Yu B., Schneidkraut J., Lee Y.,
RA   Sokolskaja E., Andreotti A., Luban J.;
RT   "Cyclophilin A regulates TCR signal strength in CD4+ T cells via a proline-
RT   directed conformational switch in Itk.";
RL   Immunity 21:189-201(2004).
RN   [14]
RP   INTERACTION WITH VAV1.
RX   PubMed=15661896; DOI=10.4049/jimmunol.174.3.1385;
RA   Dombroski D., Houghtling R.A., Labno C.M., Precht P., Takesono A.,
RA   Caplen N.J., Billadeau D.D., Wange R.L., Burkhardt J.K., Schwartzberg P.L.;
RT   "Kinase-independent functions for Itk in TCR-induced regulation of Vav and
RT   the actin cytoskeleton.";
RL   J. Immunol. 174:1385-1392(2005).
RN   [15]
RP   SUBCELLULAR LOCATION.
RX   PubMed=17060314; DOI=10.1074/jbc.m609180200;
RA   Qi Q., Sahu N., August A.;
RT   "Tec kinase Itk forms membrane clusters specifically in the vicinity of
RT   recruiting receptors.";
RL   J. Biol. Chem. 281:38529-38534(2006).
RN   [16]
RP   INTERACTION WITH FASLG.
RX   PubMed=19807924; DOI=10.1186/1471-2172-10-53;
RA   Voss M., Lettau M., Janssen O.;
RT   "Identification of SH3 domain interaction partners of human FasL (CD178) by
RT   phage display screening.";
RL   BMC Immunol. 10:53-53(2009).
RN   [17]
RP   AUTOPHOSPHORYLATION.
RX   PubMed=19523959; DOI=10.1016/j.jmb.2009.06.023;
RA   Joseph R.E., Severin A., Min L., Fulton D.B., Andreotti A.H.;
RT   "SH2-dependent autophosphorylation within the Tec family kinase Itk.";
RL   J. Mol. Biol. 391:164-177(2009).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-512 AND SER-565, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [19]
RP   UBIQUITINATION.
RX   PubMed=20596523; DOI=10.1371/journal.pone.0011332;
RA   Del Rincon S.V., Rogers J., Widschwendter M., Sun D., Sieburg H.B.,
RA   Spruck C.;
RT   "Development and validation of a method for profiling post-translational
RT   modification activities using protein microarrays.";
RL   PLoS ONE 5:E11332-E11332(2010).
RN   [20]
RP   FUNCTION IN PHOSPHORYLATION OF LCP2.
RX   PubMed=21725281; DOI=10.1038/emboj.2011.213;
RA   Sela M., Bogin Y., Beach D., Oellerich T., Lehne J., Smith-Garvin J.E.,
RA   Okumura M., Starosvetsky E., Kosoff R., Libman E., Koretzky G.,
RA   Kambayashi T., Urlaub H., Wienands J., Chernoff J., Yablonski D.;
RT   "Sequential phosphorylation of SLP-76 at tyrosine 173 is required for
RT   activation of T and mast cells.";
RL   EMBO J. 30:3160-3172(2011).
RN   [21]
RP   STRUCTURE BY NMR OF 113-239.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the BTK motif and the SH3 domain of tyrosine-protein
RT   kinase ITK from human.";
RL   Submitted (OCT-2007) to the PDB data bank.
RN   [22]
RP   VARIANTS [LARGE SCALE ANALYSIS] LYS-19; LEU-23; GLN-451; TRP-581 AND
RP   ILE-587.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [23]
RP   VARIANT LPFS1 TRP-335, AND CHARACTERIZATION OF VARIANT LPSA1 TRP-335.
RX   PubMed=19425169; DOI=10.1172/jci37901;
RA   Huck K., Feyen O., Niehues T., Rueschendorf F., Huebner N., Laws H.-J.,
RA   Telieps T., Knapp S., Wacker H.-H., Meindl A., Jumaa H., Borkhardt A.;
RT   "Girls homozygous for an IL-2-inducible T cell kinase mutation that leads
RT   to protein deficiency develop fatal EBV-associated lymphoproliferation.";
RL   J. Clin. Invest. 119:1350-1358(2009).
CC   -!- FUNCTION: Tyrosine kinase that plays an essential role in regulation of
CC       the adaptive immune response. Regulates the development, function and
CC       differentiation of conventional T-cells and nonconventional NKT-cells.
CC       When antigen presenting cells (APC) activate T-cell receptor (TCR), a
CC       series of phosphorylation lead to the recruitment of ITK to the cell
CC       membrane, in the vicinity of the stimulated TCR receptor, where it is
CC       phosphorylated by LCK. Phosphorylation leads to ITK autophosphorylation
CC       and full activation. Once activated, phosphorylates PLCG1, leading to
CC       the activation of this lipase and subsequent cleavage of its
CC       substrates. In turn, the endoplasmic reticulum releases calcium in the
CC       cytoplasm and the nuclear activator of activated T-cells (NFAT)
CC       translocates into the nucleus to perform its transcriptional duty.
CC       Phosphorylates 2 essential adapter proteins: the linker for activation
CC       of T-cells/LAT protein and LCP2. Then, a large number of signaling
CC       molecules such as VAV1 are recruited and ultimately lead to lymphokine
CC       production, T-cell proliferation and differentiation (PubMed:12186560,
CC       PubMed:12682224, PubMed:21725281). Required for TCR-mediated calcium
CC       response in gamma-delta T-cells, may also be involved in the modulation
CC       of the transcriptomic signature in the Vgamma2-positive subset of
CC       immature gamma-delta T-cells (By similarity). Phosphorylates TBX21 at
CC       'Tyr-530' and mediates its interaction with GATA3 (By similarity).
CC       {ECO:0000250|UniProtKB:Q03526, ECO:0000269|PubMed:12186560,
CC       ECO:0000269|PubMed:12682224, ECO:0000269|PubMed:21725281}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.2;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10028};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000250};
CC   -!- SUBUNIT: Homooligomerizes; this association negatively regulates kinase
CC       activity (By similarity). Interacts with PPIA/CYPA; this interaction
CC       regulates TCR signal strength via a proline-directed conformational
CC       switch in ITK. Interacts with THEMIS (By similarity). Interacts with
CC       FASLG. Interacts with VAV1; this interaction is important for VAV1
CC       localization and TCR-induced actin polarization. Interacts with TBX21
CC       (By similarity). {ECO:0000250|UniProtKB:Q03526,
CC       ECO:0000269|PubMed:15308100, ECO:0000269|PubMed:15661896,
CC       ECO:0000269|PubMed:19807924}.
CC   -!- INTERACTION:
CC       Q08881; P04626: ERBB2; NbExp=2; IntAct=EBI-968552, EBI-641062;
CC       Q08881; P48023: FASLG; NbExp=3; IntAct=EBI-968552, EBI-495538;
CC       Q08881; P08238: HSP90AB1; NbExp=2; IntAct=EBI-968552, EBI-352572;
CC       Q08881; Q13094: LCP2; NbExp=3; IntAct=EBI-968552, EBI-346946;
CC       Q08881; P10686: Plcg1; Xeno; NbExp=2; IntAct=EBI-968552, EBI-520788;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17060314}. Nucleus
CC       {ECO:0000250|UniProtKB:Q03526}. Note=Localizes in the vicinity of cell
CC       surface receptors in the plasma membrane after receptor stimulation.
CC   -!- TISSUE SPECIFICITY: T-cell lines and natural killer cell lines.
CC   -!- INDUCTION: Through a myriad of surface receptors including the TCR/CD3
CC       signaling complex, coreceptors, or chemokine receptors.
CC       {ECO:0000269|PubMed:8504851, ECO:0000269|PubMed:9701039}.
CC   -!- DOMAIN: The N-terminal PH domain allows ITK to be recruited to the
CC       plasma membrane by an activated PI3 kinase. This domain contains also a
CC       proline-rich region (PRR). The adjoining domain is a SH3 domain, which
CC       binds to PRR (from itself or from other proteins). Next, a SH2 domain
CC       is required for binding tyrosine-phosphorylated substrates. In the C-
CC       terminal region, the kinase domain is required for tyrosine
CC       phosphorylation. {ECO:0000269|PubMed:10795735}.
CC   -!- PTM: Phosphorylated at Tyr-512 in the activation loop of the kinase
CC       domain by LCK. Subsequent autophosphorylation at Tyr-180 leads to the
CC       kinase activation. The autophosphorylated Tyr-180 lies within the
CC       substrate binding sequence of the SH3 domain.
CC       {ECO:0000269|PubMed:12573241, ECO:0000269|PubMed:9312162}.
CC   -!- PTM: Ubiquitinated. {ECO:0000269|PubMed:20596523}.
CC   -!- DISEASE: Lymphoproliferative syndrome 1 (LPFS1) [MIM:613011]: A rare
CC       immunodeficiency characterized by extreme susceptibility to infection
CC       with Epstein-Barr virus (EBV). Inadequate immune response to EBV can
CC       have a fatal outcome. Clinical features include splenomegaly,
CC       lymphadenopathy, anemia, thrombocytopenia, pancytopenia, recurrent
CC       infections. There is an increased risk for lymphoma.
CC       {ECO:0000269|PubMed:19425169}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. TEC subfamily. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/ITKID43329ch5q33.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D13720; BAA02873.1; -; mRNA.
DR   EMBL; L10717; AAA36748.1; -; mRNA.
DR   EMBL; S65186; AAB28072.2; -; mRNA.
DR   EMBL; AK312846; BAG35699.1; -; mRNA.
DR   EMBL; CH471062; EAW61608.1; -; Genomic_DNA.
DR   EMBL; BC109077; AAI09078.1; -; mRNA.
DR   EMBL; BC109078; AAI09079.1; -; mRNA.
DR   CCDS; CCDS4336.1; -.
DR   PIR; S33253; S33253.
DR   RefSeq; NP_005537.3; NM_005546.3.
DR   PDB; 1SM2; X-ray; 2.30 A; A/B=357-620.
DR   PDB; 1SNU; X-ray; 2.50 A; A/B=357-620.
DR   PDB; 1SNX; X-ray; 3.20 A; A/B=357-620.
DR   PDB; 2E6I; NMR; -; A=113-169.
DR   PDB; 2LMJ; NMR; -; A=171-231.
DR   PDB; 2YUQ; NMR; -; A=162-239.
DR   PDB; 3MIY; X-ray; 1.67 A; A/B=357-620.
DR   PDB; 3MJ1; X-ray; 1.72 A; A=357-620.
DR   PDB; 3MJ2; X-ray; 1.90 A; A=357-620.
DR   PDB; 3QGW; X-ray; 2.10 A; A/B=357-620.
DR   PDB; 3QGY; X-ray; 2.10 A; A/B=357-620.
DR   PDB; 3T9T; X-ray; 1.65 A; A=354-620.
DR   PDB; 3V5J; X-ray; 2.59 A; A/B=357-620.
DR   PDB; 3V5L; X-ray; 1.86 A; A/B/C/D=357-620.
DR   PDB; 3V8T; X-ray; 2.00 A; A/B=357-620.
DR   PDB; 3V8W; X-ray; 2.27 A; A/B=357-620.
DR   PDB; 4HCT; X-ray; 1.48 A; A=354-620.
DR   PDB; 4HCU; X-ray; 1.43 A; A=354-620.
DR   PDB; 4HCV; X-ray; 1.48 A; A=354-620.
DR   PDB; 4KIO; X-ray; 2.18 A; A/B/C/D=357-620.
DR   PDB; 4L7S; X-ray; 2.03 A; A/B=357-620.
DR   PDB; 4M0Y; X-ray; 1.70 A; A=354-620.
DR   PDB; 4M0Z; X-ray; 2.00 A; A=354-620.
DR   PDB; 4M12; X-ray; 2.15 A; A=354-620.
DR   PDB; 4M13; X-ray; 1.85 A; A=354-620.
DR   PDB; 4M14; X-ray; 1.55 A; A=354-620.
DR   PDB; 4M15; X-ray; 1.52 A; A=354-620.
DR   PDB; 4MF0; X-ray; 2.67 A; A/B=357-620.
DR   PDB; 4MF1; X-ray; 2.11 A; A/B=357-620.
DR   PDB; 4PP9; X-ray; 2.58 A; A/B=357-620.
DR   PDB; 4PPA; X-ray; 2.67 A; A/B=357-620.
DR   PDB; 4PPB; X-ray; 2.82 A; A/B=357-620.
DR   PDB; 4PPC; X-ray; 2.95 A; A/B=357-620.
DR   PDB; 4PQN; X-ray; 1.71 A; A=357-620.
DR   PDB; 4QD6; X-ray; 2.45 A; A/B=357-620.
DR   PDB; 4RFM; X-ray; 2.10 A; A=357-620.
DR   PDBsum; 1SM2; -.
DR   PDBsum; 1SNU; -.
DR   PDBsum; 1SNX; -.
DR   PDBsum; 2E6I; -.
DR   PDBsum; 2LMJ; -.
DR   PDBsum; 2YUQ; -.
DR   PDBsum; 3MIY; -.
DR   PDBsum; 3MJ1; -.
DR   PDBsum; 3MJ2; -.
DR   PDBsum; 3QGW; -.
DR   PDBsum; 3QGY; -.
DR   PDBsum; 3T9T; -.
DR   PDBsum; 3V5J; -.
DR   PDBsum; 3V5L; -.
DR   PDBsum; 3V8T; -.
DR   PDBsum; 3V8W; -.
DR   PDBsum; 4HCT; -.
DR   PDBsum; 4HCU; -.
DR   PDBsum; 4HCV; -.
DR   PDBsum; 4KIO; -.
DR   PDBsum; 4L7S; -.
DR   PDBsum; 4M0Y; -.
DR   PDBsum; 4M0Z; -.
DR   PDBsum; 4M12; -.
DR   PDBsum; 4M13; -.
DR   PDBsum; 4M14; -.
DR   PDBsum; 4M15; -.
DR   PDBsum; 4MF0; -.
DR   PDBsum; 4MF1; -.
DR   PDBsum; 4PP9; -.
DR   PDBsum; 4PPA; -.
DR   PDBsum; 4PPB; -.
DR   PDBsum; 4PPC; -.
DR   PDBsum; 4PQN; -.
DR   PDBsum; 4QD6; -.
DR   PDBsum; 4RFM; -.
DR   SMR; Q08881; -.
DR   BioGrid; 109907; 36.
DR   CORUM; Q08881; -.
DR   DIP; DIP-29974N; -.
DR   IntAct; Q08881; 24.
DR   MINT; Q08881; -.
DR   STRING; 9606.ENSP00000398655; -.
DR   BindingDB; Q08881; -.
DR   ChEMBL; CHEMBL2959; -.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugBank; DB06589; Pazopanib.
DR   DrugBank; DB02010; Staurosporine.
DR   DrugBank; DB15035; Zanubrutinib.
DR   DrugCentral; Q08881; -.
DR   GuidetoPHARMACOLOGY; 2046; -.
DR   iPTMnet; Q08881; -.
DR   PhosphoSitePlus; Q08881; -.
DR   BioMuta; ITK; -.
DR   DMDM; 585361; -.
DR   jPOST; Q08881; -.
DR   MassIVE; Q08881; -.
DR   MaxQB; Q08881; -.
DR   PaxDb; Q08881; -.
DR   PeptideAtlas; Q08881; -.
DR   PRIDE; Q08881; -.
DR   ProteomicsDB; 58650; -.
DR   Antibodypedia; 16533; 470 antibodies.
DR   DNASU; 3702; -.
DR   Ensembl; ENST00000422843; ENSP00000398655; ENSG00000113263.
DR   GeneID; 3702; -.
DR   KEGG; hsa:3702; -.
DR   UCSC; uc003lwo.2; human.
DR   CTD; 3702; -.
DR   DisGeNET; 3702; -.
DR   GeneCards; ITK; -.
DR   HGNC; HGNC:6171; ITK.
DR   HPA; ENSG00000113263; Group enriched (blood, lymphoid tissue).
DR   MalaCards; ITK; -.
DR   MIM; 186973; gene.
DR   MIM; 613011; phenotype.
DR   neXtProt; NX_Q08881; -.
DR   OpenTargets; ENSG00000113263; -.
DR   Orphanet; 538963; Combined immunodeficiency due to ITK deficiency.
DR   PharmGKB; PA29968; -.
DR   eggNOG; KOG0197; Eukaryota.
DR   eggNOG; COG0515; LUCA.
DR   GeneTree; ENSGT00940000158850; -.
DR   HOGENOM; CLU_000288_7_2_1; -.
DR   InParanoid; Q08881; -.
DR   KO; K07363; -.
DR   OMA; VGCAQYD; -.
DR   OrthoDB; 1047190at2759; -.
DR   PhylomeDB; Q08881; -.
DR   TreeFam; TF351634; -.
DR   BRENDA; 2.7.10.2; 2681.
DR   Reactome; R-HSA-202433; Generation of second messenger molecules.
DR   Reactome; R-HSA-2871809; FCERI mediated Ca+2 mobilization.
DR   SignaLink; Q08881; -.
DR   SIGNOR; Q08881; -.
DR   ChiTaRS; ITK; human.
DR   EvolutionaryTrace; Q08881; -.
DR   GeneWiki; ITK_(gene); -.
DR   GenomeRNAi; 3702; -.
DR   Pharos; Q08881; Tclin.
DR   PRO; PR:Q08881; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; Q08881; protein.
DR   Bgee; ENSG00000113263; Expressed in mononuclear cell and 133 other tissues.
DR   ExpressionAtlas; Q08881; baseline and differential.
DR   Genevisible; Q08881; HS.
DR   GO; GO:0005911; C:cell-cell junction; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IDA:UniProtKB.
DR   GO; GO:0007202; P:activation of phospholipase C activity; ISS:UniProtKB.
DR   GO; GO:0002250; P:adaptive immune response; ISS:UniProtKB.
DR   GO; GO:0050853; P:B cell receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0006968; P:cellular defense response; TAS:ProtInc.
DR   GO; GO:0001816; P:cytokine production; ISS:UniProtKB.
DR   GO; GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0046629; P:gamma-delta T cell activation; ISS:UniProtKB.
DR   GO; GO:0032609; P:interferon-gamma production; IEA:Ensembl.
DR   GO; GO:0032633; P:interleukin-4 production; IEA:Ensembl.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:0001865; P:NK T cell differentiation; IBA:GO_Central.
DR   GO; GO:0038083; P:peptidyl-tyrosine autophosphorylation; IBA:GO_Central.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0042110; P:T cell activation; TAS:UniProtKB.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; ISS:UniProtKB.
DR   CDD; cd05112; PTKc_Itk; 1.
DR   CDD; cd11908; SH3_ITK; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   Gene3D; 3.30.505.10; -; 1.
DR   InterPro; IPR042785; ITK_PTKc.
DR   InterPro; IPR035583; ITK_SH3.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR036860; SH2_dom_sf.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR001562; Znf_Btk_motif.
DR   Pfam; PF00779; BTK; 1.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF00017; SH2; 1.
DR   Pfam; PF00018; SH3_1; 1.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00107; BTK; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00252; SH2; 1.
DR   SMART; SM00326; SH3; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   SUPFAM; SSF55550; SSF55550; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS50001; SH2; 1.
DR   PROSITE; PS50002; SH3; 1.
DR   PROSITE; PS51113; ZF_BTK; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Adaptive immunity; ATP-binding; Cytoplasm;
KW   Direct protein sequencing; Disease mutation; Immunity; Kinase;
KW   Metal-binding; Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; SH2 domain; SH3 domain; Transferase;
KW   Tyrosine-protein kinase; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..620
FT                   /note="Tyrosine-protein kinase ITK/TSK"
FT                   /id="PRO_0000088106"
FT   DOMAIN          4..111
FT                   /note="PH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   DOMAIN          171..231
FT                   /note="SH3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   DOMAIN          239..338
FT                   /note="SH2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00191"
FT   DOMAIN          363..615
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   ZN_FING         113..149
FT                   /note="Btk-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00432"
FT   NP_BIND         369..377
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   ACT_SITE        482
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10028"
FT   METAL           121
FT                   /note="Zinc"
FT                   /evidence="ECO:0000250"
FT   METAL           132
FT                   /note="Zinc"
FT                   /evidence="ECO:0000250"
FT   METAL           133
FT                   /note="Zinc"
FT                   /evidence="ECO:0000250"
FT   METAL           143
FT                   /note="Zinc"
FT                   /evidence="ECO:0000250"
FT   BINDING         391
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         180
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:12573241"
FT   MOD_RES         512
FT                   /note="Phosphotyrosine; by LCK"
FT                   /evidence="ECO:0000244|PubMed:19690332"
FT   MOD_RES         565
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332"
FT   VARIANT         19
FT                   /note="R -> K (in a metastatic melanoma sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041710"
FT   VARIANT         23
FT                   /note="P -> L (in a metastatic melanoma sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041711"
FT   VARIANT         193
FT                   /note="R -> Q (in dbSNP:rs17054374)"
FT                   /id="VAR_051696"
FT   VARIANT         335
FT                   /note="R -> W (in LPFS1; shows nearly undetectable mutant
FT                   ITK protein consistent with severe protein instability;
FT                   dbSNP:rs121908191)"
FT                   /evidence="ECO:0000269|PubMed:19425169"
FT                   /id="VAR_063424"
FT   VARIANT         451
FT                   /note="R -> Q (in a gastric adenocarcinoma sample; somatic
FT                   mutation; dbSNP:rs779372373)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041712"
FT   VARIANT         581
FT                   /note="R -> W (in dbSNP:rs34482255)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041713"
FT   VARIANT         587
FT                   /note="V -> I (in dbSNP:rs56005928)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041714"
FT   MUTAGEN         288
FT                   /note="P->G: Complete loss of interaction with PPIA/CYPA."
FT                   /evidence="ECO:0000269|PubMed:15308100"
FT   CONFLICT        171..172
FT                   /note="PE -> GS (in Ref. 6; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        331
FT                   /note="V -> W (in Ref. 2; AAB28072)"
FT                   /evidence="ECO:0000305"
FT   STRAND          127..133
FT                   /evidence="ECO:0000244|PDB:2E6I"
FT   STRAND          148..152
FT                   /evidence="ECO:0000244|PDB:2E6I"
FT   STRAND          171..173
FT                   /evidence="ECO:0000244|PDB:2YUQ"
FT   STRAND          175..180
FT                   /evidence="ECO:0000244|PDB:2LMJ"
FT   STRAND          187..189
FT                   /evidence="ECO:0000244|PDB:2YUQ"
FT   STRAND          197..205
FT                   /evidence="ECO:0000244|PDB:2LMJ"
FT   STRAND          208..212
FT                   /evidence="ECO:0000244|PDB:2LMJ"
FT   STRAND          214..216
FT                   /evidence="ECO:0000244|PDB:2LMJ"
FT   STRAND          218..221
FT                   /evidence="ECO:0000244|PDB:2LMJ"
FT   HELIX           223..225
FT                   /evidence="ECO:0000244|PDB:2LMJ"
FT   STRAND          226..228
FT                   /evidence="ECO:0000244|PDB:2LMJ"
FT   HELIX           360..362
FT                   /evidence="ECO:0000244|PDB:4HCU"
FT   STRAND          363..371
FT                   /evidence="ECO:0000244|PDB:4HCU"
FT   STRAND          373..375
FT                   /evidence="ECO:0000244|PDB:4KIO"
FT   STRAND          376..382
FT                   /evidence="ECO:0000244|PDB:4HCU"
FT   TURN            383..385
FT                   /evidence="ECO:0000244|PDB:4HCU"
FT   STRAND          386..393
FT                   /evidence="ECO:0000244|PDB:4HCU"
FT   TURN            395..397
FT                   /evidence="ECO:0000244|PDB:3T9T"
FT   HELIX           400..411
FT                   /evidence="ECO:0000244|PDB:4HCU"
FT   STRAND          421..425
FT                   /evidence="ECO:0000244|PDB:4HCU"
FT   STRAND          427..436
FT                   /evidence="ECO:0000244|PDB:4HCU"
FT   HELIX           443..448
FT                   /evidence="ECO:0000244|PDB:4HCU"
FT   TURN            449..452
FT                   /evidence="ECO:0000244|PDB:4HCU"
FT   HELIX           456..475
FT                   /evidence="ECO:0000244|PDB:4HCU"
FT   HELIX           485..487
FT                   /evidence="ECO:0000244|PDB:4HCU"
FT   STRAND          488..490
FT                   /evidence="ECO:0000244|PDB:4HCU"
FT   HELIX           492..494
FT                   /evidence="ECO:0000244|PDB:4HCU"
FT   STRAND          496..498
FT                   /evidence="ECO:0000244|PDB:4HCU"
FT   HELIX           503..506
FT                   /evidence="ECO:0000244|PDB:4HCU"
FT   HELIX           510..513
FT                   /evidence="ECO:0000244|PDB:4HCU"
FT   HELIX           522..524
FT                   /evidence="ECO:0000244|PDB:4HCU"
FT   HELIX           527..532
FT                   /evidence="ECO:0000244|PDB:4HCU"
FT   HELIX           537..552
FT                   /evidence="ECO:0000244|PDB:4HCU"
FT   TURN            553..555
FT                   /evidence="ECO:0000244|PDB:4PQN"
FT   TURN            558..561
FT                   /evidence="ECO:0000244|PDB:4HCU"
FT   HELIX           564..572
FT                   /evidence="ECO:0000244|PDB:4HCU"
FT   STRAND          581..583
FT                   /evidence="ECO:0000244|PDB:3V8W"
FT   HELIX           585..594
FT                   /evidence="ECO:0000244|PDB:4HCU"
FT   HELIX           599..601
FT                   /evidence="ECO:0000244|PDB:4HCU"
FT   HELIX           605..617
FT                   /evidence="ECO:0000244|PDB:4HCU"
SQ   SEQUENCE   620 AA;  71831 MW;  DAE396BD2309319D CRC64;
     MNNFILLEEQ LIKKSQQKRR TSPSNFKVRF FVLTKASLAY FEDRHGKKRT LKGSIELSRI
     KCVEIVKSDI SIPCHYKYPF QVVHDNYLLY VFAPDRESRQ RWVLALKEET RNNNSLVPKY
     HPNFWMDGKW RCCSQLEKLA TGCAQYDPTK NASKKPLPPT PEDNRRPLWE PEETVVIALY
     DYQTNDPQEL ALRRNEEYCL LDSSEIHWWR VQDRNGHEGY VPSSYLVEKS PNNLETYEWY
     NKSISRDKAE KLLLDTGKEG AFMVRDSRTA GTYTVSVFTK AVVSENNPCI KHYHIKETND
     NPKRYYVAEK YVFDSIPLLI NYHQHNGGGL VTRLRYPVCF GRQKAPVTAG LRYGKWVIDP
     SELTFVQEIG SGQFGLVHLG YWLNKDKVAI KTIREGAMSE EDFIEEAEVM MKLSHPKLVQ
     LYGVCLEQAP ICLVFEFMEH GCLSDYLRTQ RGLFAAETLL GMCLDVCEGM AYLEEACVIH
     RDLAARNCLV GENQVIKVSD FGMTRFVLDD QYTSSTGTKF PVKWASPEVF SFSRYSSKSD
     VWSFGVLMWE VFSEGKIPYE NRSNSEVVED ISTGFRLYKP RLASTHVYQI MNHCWKERPE
     DRPAFSRLLR QLAEIAESGL
//
ID   A0A024R292_HUMAN        Unreviewed;       332 AA.
AC   A0A024R292;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 33.
DE   SubName: Full=Follicular lymphoma variant translocation 1, isoform CRA_a {ECO:0000313|EMBL:EAW63141.1};
GN   Name=FVT1 {ECO:0000313|EMBL:EAW63141.1};
GN   ORFNames=hCG_34091 {ECO:0000313|EMBL:EAW63141.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW63141.1};
RN   [1] {ECO:0000313|EMBL:EAW63141.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW63141.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the short-chain dehydrogenases/reductases (SDR)
CC       family. {ECO:0000256|RuleBase:RU000363}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH471096; EAW63141.1; -; Genomic_DNA.
DR   RefSeq; NP_002026.1; NM_002035.2.
DR   SMR; A0A024R292; -.
DR   PRIDE; A0A024R292; -.
DR   Antibodypedia; 23084; 136 antibodies.
DR   GeneID; 2531; -.
DR   KEGG; hsa:2531; -.
DR   CTD; 2531; -.
DR   EuPathDB; HostDB:ENSG00000119537.15; -.
DR   eggNOG; KOG1210; Eukaryota.
DR   eggNOG; ENOG410YF8M; LUCA.
DR   KO; K04708; -.
DR   OMA; NCAGMAI; -.
DR   OrthoDB; 1210617at2759; -.
DR   PhylomeDB; A0A024R292; -.
DR   ChiTaRS; KDSR; human.
DR   GenomeRNAi; 2531; -.
DR   Bgee; ENSG00000119537; Expressed in endothelial cell and 230 other tissues.
DR   ExpressionAtlas; A0A024R292; baseline and differential.
DR   GO; GO:0016491; F:oxidoreductase activity; IEA:InterPro.
DR   GO; GO:0030148; P:sphingolipid biosynthetic process; IEA:Ensembl.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR020904; Sc_DH/Rdtase_CS.
DR   InterPro; IPR002347; SDR_fam.
DR   Pfam; PF00106; adh_short; 1.
DR   PRINTS; PR00081; GDHRDH.
DR   PRINTS; PR00080; SDRFAMILY.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   PROSITE; PS00061; ADH_SHORT; 1.
PE   3: Inferred from homology;
KW   Coiled coil {ECO:0000256|SAM:Coils}; Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL          1..25
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           26..332
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5001536577"
FT   COILED          91..111
FT                   /evidence="ECO:0000256|SAM:Coils"
SQ   SEQUENCE   332 AA;  36187 MW;  CB4BA5D020858F0C CRC64;
     MLLLAAAFLV AFVLLLYMVS PLISPKPLAL PGAHVVVTGG SSGIGKCIAI ECYKQGAFIT
     LVARNEDKLL QAKKEIEMHS INDKQVVLCI SVDVSQDYNQ VENVIKQAQE KLGPVDMLVN
     CAGMAVSGKF EDLEVSTFER LMSINYLGSV YPSRAVITTM KERRVGRIVF VSSQAGQLGL
     FGFTAYSASK FAIRGLAEAL QMEVKPYNVY ITVAYPPDTD TPGFAEENRT KPLETRLISE
     TTSVCKPEQV AKQIVKDAIQ GNFNSSLGSD GYMLSALTCG MAPVTSITEG LQQVVTMGLF
     RTIALFYLGS FDSIVRRCMM QREKSENADK TA
//
ID   K7ERC8_HUMAN            Unreviewed;       298 AA.
AC   K7ERC8;
DT   09-JAN-2013, integrated into UniProtKB/TrEMBL.
DT   20-JUN-2018, sequence version 2.
DT   22-APR-2020, entry version 54.
DE   SubName: Full=3-ketodihydrosphingosine reductase {ECO:0000313|Ensembl:ENSP00000468203};
GN   Name=KDSR {ECO:0000313|Ensembl:ENSP00000468203};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000468203, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000468203, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16177791; DOI=10.1038/nature03983;
RA   Nusbaum C., Zody M.C., Borowsky M.L., Kamal M., Kodira C.D., Taylor T.D.,
RA   Whittaker C.A., Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Abouelleil A., Allen N.R., Anderson S., Bloom T., Bugalter B., Butler J.,
RA   Cook A., DeCaprio D., Engels R., Garber M., Gnirke A., Hafez N., Hall J.L.,
RA   Norman C.H., Itoh T., Jaffe D.B., Kuroki Y., Lehoczky J., Lui A.,
RA   Macdonald P., Mauceli E., Mikkelsen T.S., Naylor J.W., Nicol R., Nguyen C.,
RA   Noguchi H., O'Leary S.B., O'Neill K., Piqani B., Smith C.L., Talamas J.A.,
RA   Topham K., Totoki Y., Toyoda A., Wain H.M., Young S.K., Zeng Q.,
RA   Zimmer A.R., Fujiyama A., Hattori M., Birren B.W., Sakaki Y., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 18.";
RL   Nature 437:551-555(2005).
RN   [2] {ECO:0000313|Ensembl:ENSP00000468203}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (NOV-2012) to UniProtKB.
CC   -!- SIMILARITY: Belongs to the short-chain dehydrogenases/reductases (SDR)
CC       family. {ECO:0000256|RuleBase:RU000363}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC021803; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC036176; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; XP_005266734.1; XM_005266677.2.
DR   SMR; K7ERC8; -.
DR   jPOST; K7ERC8; -.
DR   PeptideAtlas; K7ERC8; -.
DR   PRIDE; K7ERC8; -.
DR   Antibodypedia; 23084; 136 antibodies.
DR   Ensembl; ENST00000591902; ENSP00000468203; ENSG00000119537.
DR   GeneID; 2531; -.
DR   UCSC; uc060puw.1; human.
DR   CTD; 2531; -.
DR   EuPathDB; HostDB:ENSG00000119537.15; -.
DR   HGNC; HGNC:4021; KDSR.
DR   OpenTargets; ENSG00000119537; -.
DR   GeneTree; ENSGT00940000156961; -.
DR   HOGENOM; CLU_010194_3_2_1; -.
DR   ChiTaRS; KDSR; human.
DR   Proteomes; UP000005640; Chromosome 18.
DR   Bgee; ENSG00000119537; Expressed in endothelial cell and 230 other tissues.
DR   ExpressionAtlas; K7ERC8; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016491; F:oxidoreductase activity; IEA:InterPro.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR020904; Sc_DH/Rdtase_CS.
DR   InterPro; IPR002347; SDR_fam.
DR   Pfam; PF00106; adh_short; 1.
DR   PRINTS; PR00081; GDHRDH.
DR   PRINTS; PR00080; SDRFAMILY.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   PROSITE; PS00061; ADH_SHORT; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils}; Membrane {ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|EPD:K7ERC8,
KW   ECO:0000213|MaxQB:K7ERC8, ECO:0000213|PeptideAtlas:K7ERC8,
KW   ECO:0000213|ProteomicsDB:K7ERC8};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP}; Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL          1..25
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           26..298
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5015334661"
FT   TRANSMEM        258..281
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   COILED          91..111
FT                   /evidence="ECO:0000256|SAM:Coils"
SQ   SEQUENCE   298 AA;  32726 MW;  A1278207646C7AE6 CRC64;
     MLLLAAAFLV AFVLLLYMVS PLISPKPLAL PGAHVVVTGG SSGIGKCIAI ECYKQGAFIT
     LVARNEDKLL QAKKEIEMHS INDKQVVLCI SVDVSQDYNQ VENVIKQAQE KLGPVDMLVN
     CAGMAVSGKF EDLEVSTFER LMSINYLGSV YPSRAVITTM KERRVGRIVF VSSQAGQLGL
     FGFTAYSASK FAIRGLAEAL QMEVKPYNVY ITVAYPPDTD TPGFAEENRT KPLETRLISE
     TTSVCKPEQV AKQIVKDAIV VTMGLFRTIA LFYLGSFDSI VRRCMMQREK SENADKTA
//
ID   KDSR_HUMAN              Reviewed;         332 AA.
AC   Q06136; B2R5Y1; B4DMX0;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 1.
DT   22-APR-2020, entry version 184.
DE   RecName: Full=3-ketodihydrosphingosine reductase;
DE            Short=KDS reductase;
DE            EC=1.1.1.102;
DE   AltName: Full=3-dehydrosphinganine reductase;
DE   AltName: Full=Follicular variant translocation protein 1;
DE            Short=FVT-1;
DE   AltName: Full=Short chain dehydrogenase/reductase family 35C member 1;
DE   Flags: Precursor;
GN   Name=KDSR; Synonyms=FVT1, SDR35C1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND CHROMOSOMAL TRANSLOCATION WITH
RP   KDSR.
RX   PubMed=8417785;
RA   Rimokh R., Gadoux M., Bertheas M.-F., Berger F., Garoscio M., Deleage G.,
RA   Germain D., Magaud J.-P.;
RT   "FVT-1, a novel human transcription unit affected by variant translocation
RT   t(2;18)(p11;q21) of follicular lymphoma.";
RL   Blood 81:136-142(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Amygdala, and Heart;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16177791; DOI=10.1038/nature03983;
RA   Nusbaum C., Zody M.C., Borowsky M.L., Kamal M., Kodira C.D., Taylor T.D.,
RA   Whittaker C.A., Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Abouelleil A., Allen N.R., Anderson S., Bloom T., Bugalter B., Butler J.,
RA   Cook A., DeCaprio D., Engels R., Garber M., Gnirke A., Hafez N., Hall J.L.,
RA   Norman C.H., Itoh T., Jaffe D.B., Kuroki Y., Lehoczky J., Lui A.,
RA   Macdonald P., Mauceli E., Mikkelsen T.S., Naylor J.W., Nicol R., Nguyen C.,
RA   Noguchi H., O'Leary S.B., Piqani B., Smith C.L., Talamas J.A., Topham K.,
RA   Totoki Y., Toyoda A., Wain H.M., Young S.K., Zeng Q., Zimmer A.R.,
RA   Fujiyama A., Hattori M., Birren B.W., Sakaki Y., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 18.";
RL   Nature 437:551-555(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, AND MEMBRANE TOPOLOGY.
RX   PubMed=15328338; DOI=10.1074/jbc.m405915200;
RA   Kihara A., Igarashi Y.;
RT   "FVT-1 is a mammalian 3-ketodihydrosphingosine reductase with an active
RT   site that faces the cytosolic side of the endoplasmic reticulum membrane.";
RL   J. Biol. Chem. 279:49243-49250(2004).
RN   [8]
RP   VARIANTS EKVP4 55-GLN-GLY-56 DELINS ARG; 86-VAL--GLN-107 DEL; PHE-186 AND
RP   260-GLN--GLN-293 DEL, CHARACTERIZATION OF VARIANTS EKVP4 55-GLN-GLY-56
RP   DELINS ARG; 86-VAL--GLN-107 DEL AND 260-GLN--GLN-293 DEL, AND FUNCTION.
RX   PubMed=28575652; DOI=10.1016/j.ajhg.2017.05.003;
RA   Boyden L.M., Vincent N.G., Zhou J., Hu R., Craiglow B.G., Bayliss S.J.,
RA   Rosman I.S., Lucky A.W., Diaz L.A., Goldsmith L.A., Paller A.S.,
RA   Lifton R.P., Baserga S.J., Choate K.A.;
RT   "Mutations in KDSR cause recessive progressive symmetric
RT   erythrokeratoderma.";
RL   Am. J. Hum. Genet. 100:978-984(2017).
CC   -!- FUNCTION: Catalyzes the reduction of 3-ketodihydrosphingosine (KDS) to
CC       dihydrosphingosine (DHS). {ECO:0000269|PubMed:28575652}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=NADP(+) + sphinganine = 3-oxosphinganine + H(+) + NADPH;
CC         Xref=Rhea:RHEA:22640, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:57817, ChEBI:CHEBI:58299, ChEBI:CHEBI:58349;
CC         EC=1.1.1.102; Evidence={ECO:0000269|PubMed:15328338};
CC   -!- PATHWAY: Lipid metabolism; sphingolipid metabolism.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:15328338}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:15328338}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q06136-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q06136-2; Sequence=VSP_056641;
CC   -!- TISSUE SPECIFICITY: Expressed in all tissues examined. Highest
CC       expression in placenta. High expression in lung, kidney, stomach and
CC       small intestine, low expression in heart, spleen and skeletal muscle.
CC       Weakly expressed in normal hematopoietic tissues. Higher expression in
CC       some T-cell malignancies and PHA-stimulated lymphocytes.
CC   -!- DISEASE: Note=A chromosomal aberration involving KDSR is a cause of
CC       follicular lymphoma; also known as type II chronic lymphatic leukemia.
CC       Translocation t(2;18)(p11;q21) with a Ig J kappa chain region
CC       (PubMed:8417785). {ECO:0000269|PubMed:8417785}.
CC   -!- DISEASE: Erythrokeratodermia variabilis et progressiva 4 (EKVP4)
CC       [MIM:617526]: A form of erythrokeratodermia variabilis et progressiva,
CC       a genodermatosis characterized by the coexistence of two independent
CC       skin lesions: transient erythema and hyperkeratosis that is usually
CC       localized but occasionally occurs in its generalized form. Clinical
CC       presentation varies significantly within a family and from one family
CC       to another. Palmoplantar keratoderma is present in around 50% of cases.
CC       {ECO:0000269|PubMed:28575652}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the short-chain dehydrogenases/reductases (SDR)
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X63657; CAA45197.1; -; mRNA.
DR   EMBL; BT006782; AAP35428.1; -; mRNA.
DR   EMBL; AK297670; BAG60032.1; -; mRNA.
DR   EMBL; AK312360; BAG35278.1; -; mRNA.
DR   EMBL; AC021803; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC036176; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471096; EAW63140.1; -; Genomic_DNA.
DR   EMBL; BC008797; AAH08797.1; -; mRNA.
DR   CCDS; CCDS11982.1; -. [Q06136-1]
DR   PIR; S37652; S37652.
DR   RefSeq; NP_002026.1; NM_002035.2. [Q06136-1]
DR   SMR; Q06136; -.
DR   BioGrid; 108807; 26.
DR   IntAct; Q06136; 10.
DR   MINT; Q06136; -.
DR   STRING; 9606.ENSP00000385083; -.
DR   SwissLipids; SLP:000000155; -.
DR   iPTMnet; Q06136; -.
DR   PhosphoSitePlus; Q06136; -.
DR   SwissPalm; Q06136; -.
DR   BioMuta; KDSR; -.
DR   DMDM; 544358; -.
DR   EPD; Q06136; -.
DR   jPOST; Q06136; -.
DR   MassIVE; Q06136; -.
DR   MaxQB; Q06136; -.
DR   PaxDb; Q06136; -.
DR   PeptideAtlas; Q06136; -.
DR   PRIDE; Q06136; -.
DR   ProteomicsDB; 4650; -.
DR   ProteomicsDB; 58417; -. [Q06136-1]
DR   Antibodypedia; 23084; 136 antibodies.
DR   DNASU; 2531; -.
DR   Ensembl; ENST00000326575; ENSP00000312939; ENSG00000119537. [Q06136-2]
DR   Ensembl; ENST00000645214; ENSP00000494352; ENSG00000119537. [Q06136-1]
DR   GeneID; 2531; -.
DR   KEGG; hsa:2531; -.
DR   UCSC; uc010dpw.4; human. [Q06136-1]
DR   CTD; 2531; -.
DR   DisGeNET; 2531; -.
DR   GeneCards; KDSR; -.
DR   HGNC; HGNC:4021; KDSR.
DR   HPA; ENSG00000119537; Low tissue specificity.
DR   MalaCards; KDSR; -.
DR   MIM; 136440; gene.
DR   MIM; 617526; phenotype.
DR   neXtProt; NX_Q06136; -.
DR   OpenTargets; ENSG00000119537; -.
DR   Orphanet; 317; Erythrokeratodermia variabilis.
DR   Orphanet; 316; Progressive symmetric erythrokeratodermia.
DR   PharmGKB; PA162392777; -.
DR   eggNOG; KOG1210; Eukaryota.
DR   eggNOG; ENOG410YF8M; LUCA.
DR   GeneTree; ENSGT00940000156961; -.
DR   InParanoid; Q06136; -.
DR   KO; K04708; -.
DR   OMA; NCAGMAI; -.
DR   PhylomeDB; Q06136; -.
DR   TreeFam; TF105430; -.
DR   BioCyc; MetaCyc:HS04306-MONOMER; -.
DR   BRENDA; 1.1.1.102; 2681.
DR   Reactome; R-HSA-1660661; Sphingolipid de novo biosynthesis.
DR   UniPathway; UPA00222; -.
DR   ChiTaRS; KDSR; human.
DR   GeneWiki; 3-dehydrosphinganine_reductase; -.
DR   GenomeRNAi; 2531; -.
DR   Pharos; Q06136; Tbio.
DR   PRO; PR:Q06136; -.
DR   Proteomes; UP000005640; Chromosome 18.
DR   RNAct; Q06136; protein.
DR   Bgee; ENSG00000119537; Expressed in endothelial cell and 230 other tissues.
DR   ExpressionAtlas; Q06136; baseline and differential.
DR   Genevisible; Q06136; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:MGI.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IBA:GO_Central.
DR   GO; GO:0005615; C:extracellular space; TAS:ProtInc.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0047560; F:3-dehydrosphinganine reductase activity; IDA:MGI.
DR   GO; GO:0006666; P:3-keto-sphinganine metabolic process; IDA:MGI.
DR   GO; GO:0030148; P:sphingolipid biosynthetic process; IBA:GO_Central.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR020904; Sc_DH/Rdtase_CS.
DR   InterPro; IPR002347; SDR_fam.
DR   Pfam; PF00106; adh_short; 1.
DR   PRINTS; PR00081; GDHRDH.
DR   PRINTS; PR00080; SDRFAMILY.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   PROSITE; PS00061; ADH_SHORT; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Chromosomal rearrangement; Disease mutation;
KW   Endoplasmic reticulum; Lipid metabolism; Membrane; NADP; Oxidoreductase;
KW   Palmoplantar keratoderma; Proto-oncogene; Reference proteome; Signal;
KW   Sphingolipid metabolism; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..25
FT                   /evidence="ECO:0000255"
FT   CHAIN           26..332
FT                   /note="3-ketodihydrosphingosine reductase"
FT                   /id="PRO_0000031982"
FT   TOPO_DOM        26..270
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        271..291
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        292..293
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        294..314
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        315..332
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   NP_BIND         36..60
FT                   /note="NADP"
FT                   /evidence="ECO:0000305"
FT   ACT_SITE        186
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10001"
FT   ACT_SITE        190
FT                   /evidence="ECO:0000305"
FT   BINDING         173
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         139..202
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_056641"
FT   VARIANT         55..56
FT                   /note="QG -> R (in EKVP4; loss of 3-dehydrosphinganine
FT                   reductase activity)"
FT                   /evidence="ECO:0000269|PubMed:28575652"
FT                   /id="VAR_079185"
FT   VARIANT         86..107
FT                   /note="Missing (in EKVP4; loss of 3-dehydrosphinganine
FT                   reductase activity)"
FT                   /evidence="ECO:0000269|PubMed:28575652"
FT                   /id="VAR_079186"
FT   VARIANT         186
FT                   /note="Y -> F (in EKVP4; dbSNP:rs1114167452)"
FT                   /evidence="ECO:0000269|PubMed:28575652"
FT                   /id="VAR_079187"
FT   VARIANT         260..293
FT                   /note="Missing (in EKVP4; loss of 3-dehydrosphinganine
FT                   reductase activity)"
FT                   /evidence="ECO:0000269|PubMed:28575652"
FT                   /id="VAR_079188"
SQ   SEQUENCE   332 AA;  36187 MW;  CB4BA5D020858F0C CRC64;
     MLLLAAAFLV AFVLLLYMVS PLISPKPLAL PGAHVVVTGG SSGIGKCIAI ECYKQGAFIT
     LVARNEDKLL QAKKEIEMHS INDKQVVLCI SVDVSQDYNQ VENVIKQAQE KLGPVDMLVN
     CAGMAVSGKF EDLEVSTFER LMSINYLGSV YPSRAVITTM KERRVGRIVF VSSQAGQLGL
     FGFTAYSASK FAIRGLAEAL QMEVKPYNVY ITVAYPPDTD TPGFAEENRT KPLETRLISE
     TTSVCKPEQV AKQIVKDAIQ GNFNSSLGSD GYMLSALTCG MAPVTSITEG LQQVVTMGLF
     RTIALFYLGS FDSIVRRCMM QREKSENADK TA
//
ID   KINH_HUMAN              Reviewed;         963 AA.
AC   P33176; A0AVB2; Q5VZ85;
DT   01-OCT-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1993, sequence version 1.
DT   22-APR-2020, entry version 202.
DE   RecName: Full=Kinesin-1 heavy chain;
DE   AltName: Full=Conventional kinesin heavy chain;
DE   AltName: Full=Ubiquitous kinesin heavy chain;
DE            Short=UKHC;
GN   Name=KIF5B; Synonyms=KNS, KNS1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Placenta;
RX   PubMed=1607388; DOI=10.1083/jcb.117.6.1263;
RA   Navone F., Niclas J., Hom-Booher N., Sparks L., Bernstein H.D.,
RA   McCaffrey G., Vale R.D.;
RT   "Cloning and expression of a human kinesin heavy chain gene: interaction of
RT   the COOH-terminal domain with cytoplasmic microtubules in transfected CV-1
RT   cells.";
RL   J. Cell Biol. 117:1263-1275(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   INTERACTION WITH SYBU.
RX   PubMed=15459722; DOI=10.1038/ncb1169;
RA   Su Q., Cai Q., Gerwin C., Smith C.L., Sheng Z.-H.;
RT   "Syntabulin is a microtubule-associated protein implicated in syntaxin
RT   transport in neurons.";
RL   Nat. Cell Biol. 6:941-953(2004).
RN   [5]
RP   INTERACTION WITH PLEKHM2.
RX   PubMed=15905402; DOI=10.1126/science.1110225;
RA   Boucrot E., Henry T., Borg J.-P., Gorvel J.-P., Meresse S.;
RT   "The intracellular fate of Salmonella depends on the recruitment of
RT   kinesin.";
RL   Science 308:1174-1178(2005).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [7]
RP   INTERACTION WITH JAKMIP1.
RX   PubMed=17532644; DOI=10.1016/j.mcn.2007.04.008;
RA   Vidal R.L., Ramirez O.A., Sandoval L., Koenig-Robert R., Haertel S.,
RA   Couve A.;
RT   "Marlin-1 and conventional kinesin link GABAB receptors to the cytoskeleton
RT   and regulate receptor transport.";
RL   Mol. Cell. Neurosci. 35:501-512(2007).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [9]
RP   INTERACTION WITH ECPAS.
RX   PubMed=20682791; DOI=10.1074/jbc.m110.154120;
RA   Gorbea C., Pratt G., Ustrell V., Bell R., Sahasrabudhe S., Hughes R.E.,
RA   Rechsteiner M.;
RT   "A protein interaction network for Ecm29 links the 26 S proteasome to
RT   molecular motors and endosomal components.";
RL   J. Biol. Chem. 285:31616-31633(2010).
RN   [10]
RP   FUNCTION.
RX   PubMed=20386726; DOI=10.1371/journal.pbio.1000350;
RA   Splinter D., Tanenbaum M.E., Lindqvist A., Jaarsma D., Flotho A., Yu K.L.,
RA   Grigoriev I., Engelsma D., Haasdijk E.D., Keijzer N., Demmers J.,
RA   Fornerod M., Melchior F., Hoogenraad C.C., Medema R.H., Akhmanova A.;
RT   "Bicaudal D2, dynein, and kinesin-1 associate with nuclear pore complexes
RT   and regulate centrosome and nuclear positioning during mitotic entry.";
RL   PLoS Biol. 8:E1000350-E1000350(2010).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-933, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [14]
RP   INTERACTION WITH APP.
RX   PubMed=23011729; DOI=10.1088/1478-3975/9/5/055005;
RA   Seamster P.E., Loewenberg M., Pascal J., Chauviere A., Gonzales A.,
RA   Cristini V., Bearer E.L.;
RT   "Quantitative measurements and modeling of cargo-motor interactions during
RT   fast transport in the living axon.";
RL   Phys. Biol. 9:055005-055005(2012).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [16]
RP   INTERACTION WITH OGT; RHOT1; RHOT2 AND TRAK1.
RX   PubMed=24995978; DOI=10.1016/j.cell.2014.06.007;
RA   Pekkurnaz G., Trinidad J.C., Wang X., Kong D., Schwarz T.L.;
RT   "Glucose regulates mitochondrial motility via Milton modification by O-
RT   GlcNAc transferase.";
RL   Cell 158:54-68(2014).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-956, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [19]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-213, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 1-349 IN COMPLEX WITH ADP.
RX   PubMed=8606779; DOI=10.1038/380550a0;
RA   Kull F.J., Sablin E.P., Lau R., Fletterick R.J., Vale R.D.;
RT   "Crystal structure of the kinesin motor domain reveals a structural
RT   similarity to myosin.";
RL   Nature 380:550-555(1996).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 1-349 IN COMPLEX WITH ADP.
RX   PubMed=12368902; DOI=10.1038/nsb852;
RA   Sindelar C.V., Budny M.J., Rice S., Naber N., Fletterick R., Cooke R.;
RT   "Two conformations in the human kinesin power stroke defined by X-ray
RT   crystallography and EPR spectroscopy.";
RL   Nat. Struct. Biol. 9:844-848(2002).
RN   [22]
RP   STRUCTURE BY ELECTRON MICROSCOPY (9.0 ANGSTROMS) OF 1-325.
RX   PubMed=17470637; DOI=10.1083/jcb.200612090;
RA   Sindelar C.V., Downing K.H.;
RT   "The beginning of kinesin's force-generating cycle visualized at 9-A
RT   resolution.";
RL   J. Cell Biol. 177:377-385(2007).
CC   -!- FUNCTION: Microtubule-dependent motor required for normal distribution
CC       of mitochondria and lysosomes. Can induce formation of neurite-like
CC       membrane protrusions in non-neuronal cells in a ZFYVE27-dependent
CC       manner (By similarity). Regulates centrosome and nuclear positioning
CC       during mitotic entry. During the G2 phase of the cell cycle in a BICD2-
CC       dependent manner, antagonizes dynein function and drives the separation
CC       of nuclei and centrosomes (PubMed:20386726). Required for anterograde
CC       axonal transportation of MAPK8IP3/JIP3 which is essential for
CC       MAPK8IP3/JIP3 function in axon elongation (By similarity).
CC       {ECO:0000250|UniProtKB:Q2PQA9, ECO:0000250|UniProtKB:Q61768,
CC       ECO:0000269|PubMed:20386726}.
CC   -!- SUBUNIT: Oligomer composed of two heavy chains and two light chains.
CC       Interacts with GRIP1 and PPP1R42 (By similarity). Interacts with SYBU
CC       (PubMed:15459722). Interacts with JAKMIP1 (PubMed:17532644). Interacts
CC       with PLEKHM2 (PubMed:15905402). Interacts with ECPAS (PubMed:20682791).
CC       Interacts with ZFYVE27 (By similarity). Found in a complex with OGT,
CC       RHOT1, RHOT2 and TRAK1 (PubMed:24995978). Interacts with APP (via
CC       cytoplasmic domain) (PubMed:23011729). {ECO:0000250|UniProtKB:Q61768,
CC       ECO:0000269|PubMed:12368902, ECO:0000269|PubMed:15459722,
CC       ECO:0000269|PubMed:15905402, ECO:0000269|PubMed:17532644,
CC       ECO:0000269|PubMed:20682791, ECO:0000269|PubMed:23011729,
CC       ECO:0000269|PubMed:24995978, ECO:0000269|PubMed:8606779}.
CC   -!- INTERACTION:
CC       P33176; P33176; NbExp=5; IntAct=EBI-355878, EBI-355878;
CC       P33176; O95429: BAG4; NbExp=3; IntAct=EBI-355878, EBI-2949658;
CC       P33176; Q01850: CDR2; NbExp=3; IntAct=EBI-355878, EBI-1181367;
CC       P33176; Q14192: FHL2; NbExp=3; IntAct=EBI-355878, EBI-701903;
CC       P33176; Q9BQS8: FYCO1; NbExp=3; IntAct=EBI-355878, EBI-2869338;
CC       P33176; Q96CN9: GCC1; NbExp=3; IntAct=EBI-355878, EBI-746252;
CC       P33176; O75031: HSF2BP; NbExp=3; IntAct=EBI-355878, EBI-7116203;
CC       P33176; P52954: LBX1; NbExp=3; IntAct=EBI-355878, EBI-20141748;
CC       P33176; Q6FHY5: MEOX2; NbExp=3; IntAct=EBI-355878, EBI-16439278;
CC       P33176; P62487: POLR2G; NbExp=3; IntAct=EBI-355878, EBI-347928;
CC       P33176; P78424: POU6F2; NbExp=3; IntAct=EBI-355878, EBI-12029004;
CC       P33176; P31321: PRKAR1B; NbExp=3; IntAct=EBI-355878, EBI-2805516;
CC       P33176; P31323: PRKAR2B; NbExp=3; IntAct=EBI-355878, EBI-2930670;
CC       P33176; Q8CII8: Syne4; Xeno; NbExp=2; IntAct=EBI-355878, EBI-15752280;
CC       P33176; P68619: VACWR159; Xeno; NbExp=3; IntAct=EBI-355878, EBI-7133540;
CC       P33176; P63104: YWHAZ; NbExp=2; IntAct=EBI-355878, EBI-347088;
CC       P33176; Q96BR9: ZBTB8A; NbExp=3; IntAct=EBI-355878, EBI-742740;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000250|UniProtKB:Q2PQA9}. Note=Uniformly distributed between soma
CC       and neurites in hippocampal neurons. {ECO:0000250|UniProtKB:Q2PQA9}.
CC   -!- DOMAIN: Composed of three structural domains: a large globular N-
CC       terminal domain which is responsible for the motor activity of kinesin
CC       (it hydrolyzes ATP and binds microtubule), a central alpha-helical
CC       coiled coil domain that mediates the heavy chain dimerization; and a
CC       small globular C-terminal domain which interacts with other proteins
CC       (such as the kinesin light chains), vesicles and membranous organelles.
CC   -!- SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase
CC       superfamily. Kinesin family. Kinesin subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00283}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X65873; CAA46703.1; -; mRNA.
DR   EMBL; AL161932; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC126279; AAI26280.1; -; mRNA.
DR   EMBL; BC126281; AAI26282.1; -; mRNA.
DR   CCDS; CCDS7171.1; -.
DR   PIR; A41919; A41919.
DR   RefSeq; NP_004512.1; NM_004521.2.
DR   PDB; 1BG2; X-ray; 1.80 A; A=1-325.
DR   PDB; 1MKJ; X-ray; 2.70 A; A=1-349.
DR   PDB; 2P4N; EM; 9.00 A; K=1-325.
DR   PDB; 3J8X; EM; 5.00 A; K=1-349.
DR   PDB; 3J8Y; EM; 5.00 A; K=1-349.
DR   PDB; 4HNA; X-ray; 3.19 A; K=1-349.
DR   PDB; 4LNU; X-ray; 2.19 A; K=1-325.
DR   PDB; 5LT0; X-ray; 2.00 A; A=1-325.
DR   PDB; 5LT1; X-ray; 1.95 A; A/B=1-325.
DR   PDB; 5LT2; X-ray; 2.60 A; A/B/C/D/E/K=1-325.
DR   PDB; 5LT3; X-ray; 2.59 A; A/B/C/D/E/K=1-325.
DR   PDB; 5LT4; X-ray; 2.88 A; A/B/C/D/E/K=1-325.
DR   PDBsum; 1BG2; -.
DR   PDBsum; 1MKJ; -.
DR   PDBsum; 2P4N; -.
DR   PDBsum; 3J8X; -.
DR   PDBsum; 3J8Y; -.
DR   PDBsum; 4HNA; -.
DR   PDBsum; 4LNU; -.
DR   PDBsum; 5LT0; -.
DR   PDBsum; 5LT1; -.
DR   PDBsum; 5LT2; -.
DR   PDBsum; 5LT3; -.
DR   PDBsum; 5LT4; -.
DR   SMR; P33176; -.
DR   BioGrid; 110000; 133.
DR   CORUM; P33176; -.
DR   DIP; DIP-29244N; -.
DR   IntAct; P33176; 82.
DR   MINT; P33176; -.
DR   STRING; 9606.ENSP00000307078; -.
DR   BindingDB; P33176; -.
DR   ChEMBL; CHEMBL5864; -.
DR   TCDB; 1.P.1.1.1; the polyoma virus sv40 er penitration channel (vpec) family.
DR   CarbonylDB; P33176; -.
DR   iPTMnet; P33176; -.
DR   MetOSite; P33176; -.
DR   PhosphoSitePlus; P33176; -.
DR   SwissPalm; P33176; -.
DR   BioMuta; KIF5B; -.
DR   DMDM; 417216; -.
DR   CPTAC; CPTAC-397; -.
DR   CPTAC; CPTAC-398; -.
DR   EPD; P33176; -.
DR   jPOST; P33176; -.
DR   MassIVE; P33176; -.
DR   PaxDb; P33176; -.
DR   PeptideAtlas; P33176; -.
DR   PRIDE; P33176; -.
DR   ProteomicsDB; 54901; -.
DR   Antibodypedia; 4077; 450 antibodies.
DR   Ensembl; ENST00000302418; ENSP00000307078; ENSG00000170759.
DR   GeneID; 3799; -.
DR   KEGG; hsa:3799; -.
DR   CTD; 3799; -.
DR   DisGeNET; 3799; -.
DR   GeneCards; KIF5B; -.
DR   HGNC; HGNC:6324; KIF5B.
DR   HPA; ENSG00000170759; Low tissue specificity.
DR   MIM; 602809; gene.
DR   neXtProt; NX_P33176; -.
DR   OpenTargets; ENSG00000170759; -.
DR   PharmGKB; PA30108; -.
DR   eggNOG; KOG0240; Eukaryota.
DR   eggNOG; COG5059; LUCA.
DR   GeneTree; ENSGT00940000154801; -.
DR   HOGENOM; CLU_001485_11_1_1; -.
DR   InParanoid; P33176; -.
DR   KO; K10396; -.
DR   OMA; QYNNVIR; -.
DR   OrthoDB; 1334528at2759; -.
DR   PhylomeDB; P33176; -.
DR   TreeFam; TF105225; -.
DR   Reactome; R-HSA-2132295; MHC class II antigen presentation.
DR   Reactome; R-HSA-264876; Insulin processing.
DR   Reactome; R-HSA-5625970; RHO GTPases activate KTN1.
DR   Reactome; R-HSA-6811434; COPI-dependent Golgi-to-ER retrograde traffic.
DR   Reactome; R-HSA-983189; Kinesins.
DR   SIGNOR; P33176; -.
DR   ChiTaRS; KIF5B; human.
DR   EvolutionaryTrace; P33176; -.
DR   GeneWiki; KIF5B; -.
DR   GenomeRNAi; 3799; -.
DR   Pharos; P33176; Tbio.
DR   PRO; PR:P33176; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; P33176; protein.
DR   Bgee; ENSG00000170759; Expressed in cauda epididymis and 248 other tissues.
DR   ExpressionAtlas; P33176; baseline and differential.
DR   Genevisible; P33176; HS.
DR   GO; GO:1904115; C:axon cytoplasm; IEA:GOC.
DR   GO; GO:0044295; C:axonal growth cone; IEA:Ensembl.
DR   GO; GO:0005623; C:cell; IEA:GOC.
DR   GO; GO:0034451; C:centriolar satellite; IDA:HPA.
DR   GO; GO:0035253; C:ciliary rootlet; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0032839; C:dendrite cytoplasm; IEA:GOC.
DR   GO; GO:0005871; C:kinesin complex; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005874; C:microtubule; IBA:GO_Central.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISS:HGNC-UCL.
DR   GO; GO:0045335; C:phagocytic vesicle; IEA:Ensembl.
DR   GO; GO:0031982; C:vesicle; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0008574; F:ATP-dependent microtubule motor activity, plus-end-directed; IBA:GO_Central.
DR   GO; GO:0016887; F:ATPase activity; IBA:GO_Central.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0008432; F:JUN kinase binding; IEA:Ensembl.
DR   GO; GO:0008017; F:microtubule binding; IDA:ARUK-UCL.
DR   GO; GO:0099609; F:microtubule lateral binding; IEA:Ensembl.
DR   GO; GO:0003777; F:microtubule motor activity; IDA:ARUK-UCL.
DR   GO; GO:0099641; P:anterograde axonal protein transport; ISS:UniProtKB.
DR   GO; GO:0098971; P:anterograde dendritic transport of neurotransmitter receptor complex; IBA:GO_Central.
DR   GO; GO:1990048; P:anterograde neuronal dense core vesicle transport; ISS:ARUK-UCL.
DR   GO; GO:0007411; P:axon guidance; IBA:GO_Central.
DR   GO; GO:0071346; P:cellular response to interferon-gamma; IEA:Ensembl.
DR   GO; GO:0051642; P:centrosome localization; IMP:UniProtKB.
DR   GO; GO:0007028; P:cytoplasm organization; IEA:Ensembl.
DR   GO; GO:0030705; P:cytoskeleton-dependent intracellular transport; IBA:GO_Central.
DR   GO; GO:0021766; P:hippocampus development; IEA:Ensembl.
DR   GO; GO:0007018; P:microtubule-based movement; IBA:GO_Central.
DR   GO; GO:0072383; P:plus-end-directed vesicle transport along microtubule; IEA:Ensembl.
DR   GO; GO:0035774; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; IEA:Ensembl.
DR   GO; GO:0090316; P:positive regulation of intracellular protein transport; IEA:Ensembl.
DR   GO; GO:0043268; P:positive regulation of potassium ion transport; IDA:BHF-UCL.
DR   GO; GO:1903078; P:positive regulation of protein localization to plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0032230; P:positive regulation of synaptic transmission, GABAergic; IEA:Ensembl.
DR   GO; GO:0031340; P:positive regulation of vesicle fusion; IEA:Ensembl.
DR   GO; GO:1905152; P:positive regulation of voltage-gated sodium channel activity; IEA:Ensembl.
DR   GO; GO:0042391; P:regulation of membrane potential; IDA:BHF-UCL.
DR   GO; GO:1990049; P:retrograde neuronal dense core vesicle transport; ISS:ARUK-UCL.
DR   GO; GO:0035617; P:stress granule disassembly; ISS:BHF-UCL.
DR   GO; GO:0048489; P:synaptic vesicle transport; IBA:GO_Central.
DR   GO; GO:0047496; P:vesicle transport along microtubule; IDA:ARUK-UCL.
DR   Gene3D; 3.40.850.10; -; 1.
DR   InterPro; IPR027640; Kinesin-like_fam.
DR   InterPro; IPR019821; Kinesin_motor_CS.
DR   InterPro; IPR001752; Kinesin_motor_dom.
DR   InterPro; IPR036961; Kinesin_motor_dom_sf.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR24115; PTHR24115; 1.
DR   Pfam; PF00225; Kinesin; 1.
DR   PRINTS; PR00380; KINESINHEAVY.
DR   SMART; SM00129; KISc; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS00411; KINESIN_MOTOR_1; 1.
DR   PROSITE; PS50067; KINESIN_MOTOR_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Coiled coil; Cytoplasm;
KW   Cytoskeleton; Isopeptide bond; Methylation; Microtubule; Motor protein;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378"
FT   CHAIN           2..963
FT                   /note="Kinesin-1 heavy chain"
FT                   /id="PRO_0000125351"
FT   DOMAIN          8..325
FT                   /note="Kinesin motor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00283"
FT   NP_BIND         85..92
FT                   /note="ATP"
FT   REGION          915..963
FT                   /note="Globular"
FT   COILED          329..914
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378"
FT   MOD_RES         933
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         956
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   CROSSLNK        213
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   STRAND          8..15
FT                   /evidence="ECO:0000244|PDB:1BG2"
FT   HELIX           20..25
FT                   /evidence="ECO:0000244|PDB:1BG2"
FT   STRAND          32..34
FT                   /evidence="ECO:0000244|PDB:1BG2"
FT   TURN            35..37
FT                   /evidence="ECO:0000244|PDB:1BG2"
FT   STRAND          38..41
FT                   /evidence="ECO:0000244|PDB:1BG2"
FT   STRAND          44..47
FT                   /evidence="ECO:0000244|PDB:1BG2"
FT   STRAND          49..52
FT                   /evidence="ECO:0000244|PDB:1BG2"
FT   HELIX           58..65
FT                   /evidence="ECO:0000244|PDB:1BG2"
FT   HELIX           67..74
FT                   /evidence="ECO:0000244|PDB:1BG2"
FT   STRAND          79..84
FT                   /evidence="ECO:0000244|PDB:1BG2"
FT   HELIX           91..95
FT                   /evidence="ECO:0000244|PDB:1BG2"
FT   TURN            102..104
FT                   /evidence="ECO:0000244|PDB:1BG2"
FT   HELIX           107..122
FT                   /evidence="ECO:0000244|PDB:1BG2"
FT   STRAND          124..138
FT                   /evidence="ECO:0000244|PDB:1BG2"
FT   STRAND          141..146
FT                   /evidence="ECO:0000244|PDB:1BG2"
FT   STRAND          155..157
FT                   /evidence="ECO:0000244|PDB:1BG2"
FT   STRAND          163..165
FT                   /evidence="ECO:0000244|PDB:1BG2"
FT   STRAND          171..173
FT                   /evidence="ECO:0000244|PDB:1BG2"
FT   HELIX           176..189
FT                   /evidence="ECO:0000244|PDB:1BG2"
FT   TURN            190..193
FT                   /evidence="ECO:0000244|PDB:1BG2"
FT   HELIX           197..203
FT                   /evidence="ECO:0000244|PDB:1BG2"
FT   STRAND          204..216
FT                   /evidence="ECO:0000244|PDB:1BG2"
FT   TURN            217..219
FT                   /evidence="ECO:0000244|PDB:1BG2"
FT   STRAND          222..231
FT                   /evidence="ECO:0000244|PDB:1BG2"
FT   HELIX           238..241
FT                   /evidence="ECO:0000244|PDB:4HNA"
FT   STRAND          242..244
FT                   /evidence="ECO:0000244|PDB:1BG2"
FT   HELIX           256..269
FT                   /evidence="ECO:0000244|PDB:1BG2"
FT   HELIX           277..279
FT                   /evidence="ECO:0000244|PDB:1BG2"
FT   HELIX           281..285
FT                   /evidence="ECO:0000244|PDB:1BG2"
FT   HELIX           286..288
FT                   /evidence="ECO:0000244|PDB:1BG2"
FT   STRAND          290..293
FT                   /evidence="ECO:0000244|PDB:1BG2"
FT   STRAND          295..302
FT                   /evidence="ECO:0000244|PDB:1BG2"
FT   HELIX           306..308
FT                   /evidence="ECO:0000244|PDB:1BG2"
FT   HELIX           309..320
FT                   /evidence="ECO:0000244|PDB:1BG2"
FT   STRAND          326..329
FT                   /evidence="ECO:0000244|PDB:1MKJ"
FT   HELIX           337..348
FT                   /evidence="ECO:0000244|PDB:1MKJ"
SQ   SEQUENCE   963 AA;  109685 MW;  A1FE5760C3250C8B CRC64;
     MADLAECNIK VMCRFRPLNE SEVNRGDKYI AKFQGEDTVV IASKPYAFDR VFQSSTSQEQ
     VYNDCAKKIV KDVLEGYNGT IFAYGQTSSG KTHTMEGKLH DPEGMGIIPR IVQDIFNYIY
     SMDENLEFHI KVSYFEIYLD KIRDLLDVSK TNLSVHEDKN RVPYVKGCTE RFVCSPDEVM
     DTIDEGKSNR HVAVTNMNEH SSRSHSIFLI NVKQENTQTE QKLSGKLYLV DLAGSEKVSK
     TGAEGAVLDE AKNINKSLSA LGNVISALAE GSTYVPYRDS KMTRILQDSL GGNCRTTIVI
     CCSPSSYNES ETKSTLLFGQ RAKTIKNTVC VNVELTAEQW KKKYEKEKEK NKILRNTIQW
     LENELNRWRN GETVPIDEQF DKEKANLEAF TVDKDITLTN DKPATAIGVI GNFTDAERRK
     CEEEIAKLYK QLDDKDEEIN QQSQLVEKLK TQMLDQEELL ASTRRDQDNM QAELNRLQAE
     NDASKEEVKE VLQALEELAV NYDQKSQEVE DKTKEYELLS DELNQKSATL ASIDAELQKL
     KEMTNHQKKR AAEMMASLLK DLAEIGIAVG NNDVKQPEGT GMIDEEFTVA RLYISKMKSE
     VKTMVKRCKQ LESTQTESNK KMEENEKELA ACQLRISQHE AKIKSLTEYL QNVEQKKRQL
     EESVDALSEE LVQLRAQEKV HEMEKEHLNK VQTANEVKQA VEQQIQSHRE THQKQISSLR
     DEVEAKAKLI TDLQDQNQKM MLEQERLRVE HEKLKATDQE KSRKLHELTV MQDRREQARQ
     DLKGLEETVA KELQTLHNLR KLFVQDLATR VKKSAEIDSD DTGGSAAQKQ KISFLENNLE
     QLTKVHKQLV RDNADLRCEL PKLEKRLRAT AERVKALESA LKEAKENASR DRKRYQQEVD
     RIKEAVRSKN MARRGHSAQI AKPIRPGQHP AASPTHPSAI RGGGAFVQNS QPVAVRGGGG
     KQV
//
ID   Q6P164_HUMAN            Unreviewed;       345 AA.
AC   Q6P164;
DT   05-JUL-2004, integrated into UniProtKB/TrEMBL.
DT   05-JUL-2004, sequence version 1.
DT   11-DEC-2019, entry version 95.
DE   RecName: Full=Kinesin-like protein {ECO:0000256|RuleBase:RU000394};
DE   Flags: Fragment;
GN   Name=KIF5B {ECO:0000313|EMBL:AAH65267.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH65267.1};
RN   [1] {ECO:0000313|EMBL:AAH65267.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus {ECO:0000313|EMBL:AAH65267.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M., Peck A.M.,
RA   Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S., Feolo M.,
RA   Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F., Schaefer C.F.,
RA   Buetow K., Bonner T.I., Haussler D., Kent J., Kiekhaus M., Furey T.,
RA   Brent M., Prange C., Schreiber K., Shapiro N., Bhat N.K., Hopkins R.F.,
RA   Hsie F., Driscoll T., Soares M.B., Casavant T.L., Scheetz T.E.,
RA   Brown-stein M.J., Usdin T.B., Toshiyuki S., Carninci P., Piao Y.,
RA   Dudekula D.B., Ko M.S., Kawakami K., Suzuki Y., Sugano S., Gruber C.E.,
RA   Smith M.R., Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y.,
RA   Wei C.L., Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W.,
RA   Fuh E., Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D., Granite S.J.,
RA   Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G., Blakesly R.W.,
RA   Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J.,
RA   Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L., Krzywinski M.I.,
RA   Liao N., Morin R., Morrin R., Palmquist D., Petrescu A.S., Skalska U.,
RA   Smailus D.E., Stott J.M., Schnerch A., Schein J.E., Jones S.J., Holt R.A.,
RA   Baross A., Marra M.A., Clifton S., Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase
CC       superfamily. Kinesin family. {ECO:0000256|PROSITE-ProRule:PRU00283,
CC       ECO:0000256|RuleBase:RU000394, ECO:0000256|SAAS:SAAS00583243}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC065267; AAH65267.1; -; mRNA.
DR   RefSeq; NP_004512.1; NM_004521.2.
DR   PeptideAtlas; Q6P164; -.
DR   GeneID; 3799; -.
DR   KEGG; hsa:3799; -.
DR   CTD; 3799; -.
DR   PharmGKB; PA30108; -.
DR   eggNOG; KOG0240; Eukaryota.
DR   eggNOG; COG5059; LUCA.
DR   KO; K10396; -.
DR   OrthoDB; 1334528at2759; -.
DR   ChiTaRS; KIF5B; human.
DR   GenomeRNAi; 3799; -.
DR   Genevisible; Q6P164; HS.
DR   GO; GO:0005874; C:microtubule; IEA:UniProtKB-KW.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0008017; F:microtubule binding; IEA:InterPro.
DR   GO; GO:0003777; F:microtubule motor activity; IEA:InterPro.
DR   GO; GO:0007018; P:microtubule-based movement; IEA:InterPro.
DR   Gene3D; 3.40.850.10; -; 1.
DR   InterPro; IPR027640; Kinesin-like_fam.
DR   InterPro; IPR019821; Kinesin_motor_CS.
DR   InterPro; IPR001752; Kinesin_motor_dom.
DR   InterPro; IPR036961; Kinesin_motor_dom_sf.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR24115; PTHR24115; 1.
DR   Pfam; PF00225; Kinesin; 1.
DR   PRINTS; PR00380; KINESINHEAVY.
DR   SMART; SM00129; KISc; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS00411; KINESIN_MOTOR_1; 1.
DR   PROSITE; PS50067; KINESIN_MOTOR_2; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding {ECO:0000256|PROSITE-ProRule:PRU00283,
KW   ECO:0000256|RuleBase:RU000394, ECO:0000256|SAAS:SAAS00024021};
KW   Microtubule {ECO:0000256|RuleBase:RU000394};
KW   Motor protein {ECO:0000256|PROSITE-ProRule:PRU00283,
KW   ECO:0000256|RuleBase:RU000394};
KW   Nucleotide-binding {ECO:0000256|PROSITE-ProRule:PRU00283,
KW   ECO:0000256|RuleBase:RU000394, ECO:0000256|SAAS:SAAS00024021}.
FT   DOMAIN          8..325
FT                   /note="Kinesin motor"
FT                   /evidence="ECO:0000259|PROSITE:PS50067"
FT   NP_BIND         85..92
FT                   /note="ATP"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00283"
FT   NON_TER         345
FT                   /evidence="ECO:0000313|EMBL:AAH65267.1"
SQ   SEQUENCE   345 AA;  38716 MW;  133721DA5C8697BE CRC64;
     MADLAECNIK VMCRFRPLNE SEVNRGDKYI AKFQGEDTVV IASKPYAFDR VFQSSTSQEQ
     VYNDCAKKIV KDVLEGYNGT IFAYGQTSSG KTHTMEGKLH DPEGMGIIPR IVQDIFNYIY
     SMDENLEFHI KVSYFEIYLD KIRDLLDVSK TNLSVHEDKN RVPYVKGCTE RFVCSPDEVM
     DTIDEGKSNR HVAVTNMNEH SSRSHSIFLI NVKQENTQTE QKLSGKLYLV DLAGSEKVSK
     TGAEGAVLDE AKNINKSLSA LGNVISALAE GSTYVPYRDS KMTRILQDSL GGNCRTTIVI
     CCSPSSYNES ETKSTLLFGQ RAKTIKNTVC VNVELTAEQW KKKKK
//
ID   V9HW29_HUMAN            Unreviewed;       963 AA.
AC   V9HW29;
DT   19-MAR-2014, integrated into UniProtKB/TrEMBL.
DT   19-MAR-2014, sequence version 1.
DT   22-APR-2020, entry version 53.
DE   RecName: Full=Kinesin-like protein {ECO:0000256|RuleBase:RU000394};
GN   Name=HEL-S-61 {ECO:0000313|EMBL:ACI46016.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACI46016.1};
RN   [1] {ECO:0000313|EMBL:ACI46016.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J., Wang H., Liu J., Liu F.;
RL   Submitted (SEP-2008) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase
CC       superfamily. Kinesin family. {ECO:0000256|PROSITE-ProRule:PRU00283,
CC       ECO:0000256|RuleBase:RU000394, ECO:0000256|SAAS:SAAS00583243}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; FJ224324; ACI46016.1; -; mRNA.
DR   RefSeq; NP_004512.1; NM_004521.2.
DR   SMR; V9HW29; -.
DR   IntAct; V9HW29; 4.
DR   MaxQB; V9HW29; -.
DR   PRIDE; V9HW29; -.
DR   Antibodypedia; 4077; 450 antibodies.
DR   GeneID; 3799; -.
DR   KEGG; hsa:3799; -.
DR   UCSC; uc001iwe.5; human.
DR   CTD; 3799; -.
DR   EuPathDB; HostDB:ENSG00000170759.10; -.
DR   eggNOG; KOG0240; Eukaryota.
DR   eggNOG; COG5059; LUCA.
DR   HOGENOM; CLU_001485_11_1_1; -.
DR   KO; K10396; -.
DR   OMA; QYNNVIR; -.
DR   OrthoDB; 1334528at2759; -.
DR   PhylomeDB; V9HW29; -.
DR   ChiTaRS; KIF5B; human.
DR   GenomeRNAi; 3799; -.
DR   Bgee; ENSG00000170759; Expressed in cauda epididymis and 248 other tissues.
DR   ExpressionAtlas; V9HW29; baseline and differential.
DR   GO; GO:1904115; C:axon cytoplasm; IEA:GOC.
DR   GO; GO:0044295; C:axonal growth cone; IEA:Ensembl.
DR   GO; GO:0005623; C:cell; IEA:GOC.
DR   GO; GO:0034451; C:centriolar satellite; IDA:HPA.
DR   GO; GO:0035253; C:ciliary rootlet; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005874; C:microtubule; IEA:UniProtKB-KW.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0045335; C:phagocytic vesicle; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0008432; F:JUN kinase binding; IEA:Ensembl.
DR   GO; GO:0099609; F:microtubule lateral binding; IEA:Ensembl.
DR   GO; GO:0003777; F:microtubule motor activity; IEA:Ensembl.
DR   GO; GO:0099641; P:anterograde axonal protein transport; IEA:Ensembl.
DR   GO; GO:0071346; P:cellular response to interferon-gamma; IEA:Ensembl.
DR   GO; GO:0007028; P:cytoplasm organization; IEA:Ensembl.
DR   GO; GO:0021766; P:hippocampus development; IEA:Ensembl.
DR   GO; GO:0072383; P:plus-end-directed vesicle transport along microtubule; IEA:Ensembl.
DR   GO; GO:0035774; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; IEA:Ensembl.
DR   GO; GO:0090316; P:positive regulation of intracellular protein transport; IEA:Ensembl.
DR   GO; GO:0032230; P:positive regulation of synaptic transmission, GABAergic; IEA:Ensembl.
DR   GO; GO:0031340; P:positive regulation of vesicle fusion; IEA:Ensembl.
DR   GO; GO:1905152; P:positive regulation of voltage-gated sodium channel activity; IEA:Ensembl.
DR   GO; GO:1990049; P:retrograde neuronal dense core vesicle transport; IEA:Ensembl.
DR   GO; GO:0035617; P:stress granule disassembly; IEA:Ensembl.
DR   Gene3D; 3.40.850.10; -; 1.
DR   InterPro; IPR027640; Kinesin-like_fam.
DR   InterPro; IPR019821; Kinesin_motor_CS.
DR   InterPro; IPR001752; Kinesin_motor_dom.
DR   InterPro; IPR036961; Kinesin_motor_dom_sf.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR24115; PTHR24115; 1.
DR   Pfam; PF00225; Kinesin; 1.
DR   PRINTS; PR00380; KINESINHEAVY.
DR   SMART; SM00129; KISc; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS00411; KINESIN_MOTOR_1; 1.
DR   PROSITE; PS50067; KINESIN_MOTOR_2; 1.
PE   1: Evidence at protein level;
KW   ATP-binding {ECO:0000256|PROSITE-ProRule:PRU00283,
KW   ECO:0000256|RuleBase:RU000394, ECO:0000256|SAAS:SAAS00875240};
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Microtubule {ECO:0000256|RuleBase:RU000394};
KW   Motor protein {ECO:0000256|PROSITE-ProRule:PRU00283,
KW   ECO:0000256|RuleBase:RU000394};
KW   Nucleotide-binding {ECO:0000256|PROSITE-ProRule:PRU00283,
KW   ECO:0000256|RuleBase:RU000394, ECO:0000256|SAAS:SAAS00875240}.
FT   DOMAIN          8..325
FT                   /note="Kinesin motor"
FT                   /evidence="ECO:0000259|PROSITE:PS50067"
FT   NP_BIND         85..92
FT                   /note="ATP"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00283"
FT   REGION          908..963
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          330..364
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          418..543
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          594..684
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          691..711
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          716..757
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          768..802
FT                   /evidence="ECO:0000256|SAM:Coils"
SQ   SEQUENCE   963 AA;  109685 MW;  A1FE5760C3250C8B CRC64;
     MADLAECNIK VMCRFRPLNE SEVNRGDKYI AKFQGEDTVV IASKPYAFDR VFQSSTSQEQ
     VYNDCAKKIV KDVLEGYNGT IFAYGQTSSG KTHTMEGKLH DPEGMGIIPR IVQDIFNYIY
     SMDENLEFHI KVSYFEIYLD KIRDLLDVSK TNLSVHEDKN RVPYVKGCTE RFVCSPDEVM
     DTIDEGKSNR HVAVTNMNEH SSRSHSIFLI NVKQENTQTE QKLSGKLYLV DLAGSEKVSK
     TGAEGAVLDE AKNINKSLSA LGNVISALAE GSTYVPYRDS KMTRILQDSL GGNCRTTIVI
     CCSPSSYNES ETKSTLLFGQ RAKTIKNTVC VNVELTAEQW KKKYEKEKEK NKILRNTIQW
     LENELNRWRN GETVPIDEQF DKEKANLEAF TVDKDITLTN DKPATAIGVI GNFTDAERRK
     CEEEIAKLYK QLDDKDEEIN QQSQLVEKLK TQMLDQEELL ASTRRDQDNM QAELNRLQAE
     NDASKEEVKE VLQALEELAV NYDQKSQEVE DKTKEYELLS DELNQKSATL ASIDAELQKL
     KEMTNHQKKR AAEMMASLLK DLAEIGIAVG NNDVKQPEGT GMIDEEFTVA RLYISKMKSE
     VKTMVKRCKQ LESTQTESNK KMEENEKELA ACQLRISQHE AKIKSLTEYL QNVEQKKRQL
     EESVDALSEE LVQLRAQEKV HEMEKEHLNK VQTANEVKQA VEQQIQSHRE THQKQISSLR
     DEVEAKAKLI TDLQDQNQKM MLEQERLRVE HEKLKATDQE KSRKLHELTV MQDRREQARQ
     DLKGLEETVA KELQTLHNLR KLFVQDLATR VKKSAEIDSD DTGGSAAQKQ KISFLENNLE
     QLTKVHKQLV RDNADLRCEL PKLEKRLRAT AERVKALESA LKEAKENASR DRKRYQQEVD
     RIKEAVRSKN MARRGHSAQI AKPIRPGQHP AASPTHPSAI RGGGAFVQNS QPVAVRGGGG
     KQV
//
ID   A0A024R4J4_HUMAN        Unreviewed;       261 AA.
AC   A0A024R4J4;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 52.
DE   SubName: Full=Kallikrein 2, prostatic, isoform CRA_a {ECO:0000313|EMBL:EAW71940.1};
DE   SubName: Full=Kallikrein A3 {ECO:0000313|EMBL:SFW93199.1};
GN   Name=KLK2 {ECO:0000313|EMBL:EAW71940.1};
GN   Synonyms=KLNA3 {ECO:0000313|EMBL:SFW93199.1};
GN   ORFNames=hCG_22932 {ECO:0000313|EMBL:EAW71940.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW71940.1};
RN   [1] {ECO:0000313|EMBL:EAW71940.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW71940.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:SFW93199.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=28224083; DOI=10.1016/j.ymgmr.2017.01.009;
RA   Premzl M.;
RT   "Comparative genomic analysis of eutherian kallikrein genes.";
RL   Mol. Genet. Metab. Rep. 10:96-99(2017).
RN   [4] {ECO:0000313|EMBL:SFW93199.1}
RP   NUCLEOTIDE SEQUENCE.
RX   DOI=10.1016/j.genrep.2019.100414;
RA   Premzl M.;
RT   "Eutherian third-party data gene collections.";
RL   Gene Rep 16:100414-100414(2019).
CC   -!- SIMILARITY: Belongs to the peptidase S1 family.
CC       {ECO:0000256|SAAS:SAAS00559343}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH471135; EAW71937.1; -; Genomic_DNA.
DR   EMBL; CH471135; EAW71940.1; -; Genomic_DNA.
DR   EMBL; LT631552; SFW93199.1; -; Genomic_DNA.
DR   RefSeq; NP_005542.1; NM_005551.4.
DR   Allergome; 2836; Hom s PSA.
DR   Antibodypedia; 32384; 376 antibodies.
DR   GeneID; 3817; -.
DR   KEGG; hsa:3817; -.
DR   CTD; 3817; -.
DR   EuPathDB; HostDB:ENSG00000167751.12; -.
DR   eggNOG; KOG3627; Eukaryota.
DR   eggNOG; COG5640; LUCA.
DR   HOGENOM; CLU_006842_1_1_1; -.
DR   KO; K01325; -.
DR   OMA; GWECERH; -.
DR   OrthoDB; 1314811at2759; -.
DR   ChiTaRS; KLK2; human.
DR   GenomeRNAi; 3817; -.
DR   Bgee; ENSG00000167751; Expressed in prostate gland and 116 other tissues.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro.
DR   CDD; cd00190; Tryp_SPc; 1.
DR   InterPro; IPR009003; Peptidase_S1_PA.
DR   InterPro; IPR001314; Peptidase_S1A.
DR   InterPro; IPR001254; Trypsin_dom.
DR   InterPro; IPR018114; TRYPSIN_HIS.
DR   InterPro; IPR033116; TRYPSIN_SER.
DR   Pfam; PF00089; Trypsin; 1.
DR   PRINTS; PR00722; CHYMOTRYPSIN.
DR   SMART; SM00020; Tryp_SPc; 1.
DR   SUPFAM; SSF50494; SSF50494; 1.
DR   PROSITE; PS50240; TRYPSIN_DOM; 1.
DR   PROSITE; PS00134; TRYPSIN_HIS; 1.
DR   PROSITE; PS00135; TRYPSIN_SER; 1.
PE   3: Inferred from homology;
KW   Disulfide bond {ECO:0000256|SAAS:SAAS00037407};
KW   Hydrolase {ECO:0000256|RuleBase:RU363034};
KW   Protease {ECO:0000256|RuleBase:RU363034};
KW   Serine protease {ECO:0000256|RuleBase:RU363034};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL          1..17
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           18..261
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5014214237"
FT   DOMAIN          25..258
FT                   /note="Peptidase S1"
FT                   /evidence="ECO:0000259|PROSITE:PS50240"
SQ   SEQUENCE   261 AA;  28671 MW;  9CF7F4A1162EF42D CRC64;
     MWDLVLSIAL SVGCTGAVPL IQSRIVGGWE CEKHSQPWQV AVYSHGWAHC GGVLVHPQWV
     LTAAHCLKKN SQVWLGRHNL FEPEDTGQRV PVSHSFPHPL YNMSLLKHQS LRPDEDSSHD
     LMLLRLSEPA KITDVVKVLG LPTQEPALGT TCYASGWGSI EPEEFLRPRS LQCVSLHLLS
     NDMCARAYSE KVTEFMLCAG LWTGGKDTCG GDSGGPLVCN GVLQGITSWG PEPCALPEKP
     AVYTKVVHYR KWIKDTIAAN P
//
ID   A0A024R4N3_HUMAN        Unreviewed;       223 AA.
AC   A0A024R4N3;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 50.
DE   SubName: Full=Kallikrein 2, prostatic, isoform CRA_b {ECO:0000313|EMBL:EAW71939.1};
GN   Name=KLK2 {ECO:0000313|EMBL:EAW71939.1};
GN   ORFNames=hCG_22932 {ECO:0000313|EMBL:EAW71939.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW71939.1};
RN   [1] {ECO:0000313|EMBL:EAW71939.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW71939.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the peptidase S1 family.
CC       {ECO:0000256|SAAS:SAAS00559343}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH471135; EAW71938.1; -; Genomic_DNA.
DR   EMBL; CH471135; EAW71939.1; -; Genomic_DNA.
DR   RefSeq; NP_001002231.1; NM_001002231.2.
DR   Allergome; 2836; Hom s PSA.
DR   Antibodypedia; 32384; 376 antibodies.
DR   GeneID; 3817; -.
DR   CTD; 3817; -.
DR   EuPathDB; HostDB:ENSG00000167751.12; -.
DR   eggNOG; KOG3627; Eukaryota.
DR   eggNOG; COG5640; LUCA.
DR   ChiTaRS; KLK2; human.
DR   GenomeRNAi; 3817; -.
DR   Bgee; ENSG00000167751; Expressed in prostate gland and 116 other tissues.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro.
DR   CDD; cd00190; Tryp_SPc; 1.
DR   InterPro; IPR009003; Peptidase_S1_PA.
DR   InterPro; IPR001314; Peptidase_S1A.
DR   InterPro; IPR001254; Trypsin_dom.
DR   InterPro; IPR018114; TRYPSIN_HIS.
DR   Pfam; PF00089; Trypsin; 1.
DR   PRINTS; PR00722; CHYMOTRYPSIN.
DR   SMART; SM00020; Tryp_SPc; 1.
DR   SUPFAM; SSF50494; SSF50494; 1.
DR   PROSITE; PS50240; TRYPSIN_DOM; 1.
DR   PROSITE; PS00134; TRYPSIN_HIS; 1.
PE   3: Inferred from homology;
KW   Disulfide bond {ECO:0000256|SAAS:SAAS00037407};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL          1..17
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           18..223
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5014214239"
FT   DOMAIN          25..209
FT                   /note="Peptidase S1"
FT                   /evidence="ECO:0000259|PROSITE:PS50240"
SQ   SEQUENCE   223 AA;  24674 MW;  051F76900C2AFEA9 CRC64;
     MWDLVLSIAL SVGCTGAVPL IQSRIVGGWE CEKHSQPWQV AVYSHGWAHC GGVLVHPQWV
     LTAAHCLKKN SQVWLGRHNL FEPEDTGQRV PVSHSFPHPL YNMSLLKHQS LRPDEDSSHD
     LMLLRLSEPA KITDVVKVLG LPTQEPALGT TCYASGWGSI EPEEFLRPRS LQCVSLHLLS
     NDMCARAYSE KVTEFMLCAG LWTGGKDTCG VSHPYSQHLE GKG
//
ID   B4DU77_HUMAN            Unreviewed;       244 AA.
AC   B4DU77;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   11-DEC-2019, entry version 50.
DE   SubName: Full=cDNA FLJ52279, highly similar to Kallikrein-2 {ECO:0000313|EMBL:BAG62239.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG62239.1};
RN   [1] {ECO:0000313|EMBL:BAG62239.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Prostate {ECO:0000313|EMBL:BAG62239.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the peptidase S1 family.
CC       {ECO:0000256|SAAS:SAAS00733161}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK300527; BAG62239.1; -; mRNA.
DR   RefSeq; NP_001002231.1; NM_001002231.2.
DR   RefSeq; NP_001243009.1; NM_001256080.1.
DR   RefSeq; NP_005542.1; NM_005551.4.
DR   SMR; B4DU77; -.
DR   PeptideAtlas; B4DU77; -.
DR   PRIDE; B4DU77; -.
DR   GeneID; 3817; -.
DR   KEGG; hsa:3817; -.
DR   CTD; 3817; -.
DR   eggNOG; KOG3627; Eukaryota.
DR   eggNOG; COG5640; LUCA.
DR   KO; K01325; -.
DR   OrthoDB; 1314811at2759; -.
DR   GenomeRNAi; 3817; -.
DR   Genevisible; B4DU77; HS.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro.
DR   CDD; cd00190; Tryp_SPc; 1.
DR   InterPro; IPR009003; Peptidase_S1_PA.
DR   InterPro; IPR001314; Peptidase_S1A.
DR   InterPro; IPR001254; Trypsin_dom.
DR   InterPro; IPR033116; TRYPSIN_SER.
DR   Pfam; PF00089; Trypsin; 1.
DR   PRINTS; PR00722; CHYMOTRYPSIN.
DR   SMART; SM00020; Tryp_SPc; 1.
DR   SUPFAM; SSF50494; SSF50494; 1.
DR   PROSITE; PS50240; TRYPSIN_DOM; 1.
DR   PROSITE; PS00135; TRYPSIN_SER; 1.
PE   2: Evidence at transcript level;
KW   Disulfide bond {ECO:0000256|SAAS:SAAS00731840}.
FT   DOMAIN          1..241
FT                   /note="Peptidase S1"
FT                   /evidence="ECO:0000259|PROSITE:PS50240"
SQ   SEQUENCE   244 AA;  26421 MW;  078D1FB643B276AD CRC64;
     MGTLWGCPGA PPVGAHSCPL PKEVSRTLGS GEGMAVSHRN NSGMLPPGSL LRNSQVWLGR
     HNLFEPEDTG RRVPVSHSFP HPLYNMSLLK HQSLRPDEDS SHDLMLLRLS EPAKITDVVK
     VLGLPTQEPA LGTTCYASGW GSIEPEEFLR PRSLQCVSLH LLSNDMCARA YSEKVTEFML
     CAGLWTGGKD TCGGDSGGPL VCNGVLQGIT SWGPEPCALP EKPAVYTKVV HYRKWIKDTI
     AANP
//
ID   KLK2_HUMAN              Reviewed;         261 AA.
AC   P20151; B4DU93; B4DUB0; F5H8L3; Q15946; Q9UJZ9;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1991, sequence version 1.
DT   22-APR-2020, entry version 189.
DE   RecName: Full=Kallikrein-2;
DE            EC=3.4.21.35;
DE   AltName: Full=Glandular kallikrein-1;
DE            Short=hGK-1;
DE   AltName: Full=Tissue kallikrein-2;
DE   Flags: Precursor;
GN   Name=KLK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=2824146; DOI=10.1089/dna.1987.6.429;
RA   Schedlich L.J., Bennetts B.H., Morris B.J.;
RT   "Primary structure of a human glandular kallikrein gene.";
RL   DNA 6:429-437(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Prostate;
RX   PubMed=1726490; DOI=10.1016/0303-7207(91)90272-t;
RA   Riegman P.H., Vlietstra R.J., der Korput H.A., Romijn J.C., Trapman J.;
RT   "Identification and androgen-regulated expression of two major human
RT   glandular kallikrein-1 (hGK-1) mRNA species.";
RL   Mol. Cell. Endocrinol. 76:181-190(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND ALTERNATIVE SPLICING.
RX   PubMed=10544017; DOI=10.1006/bbrc.1999.1595;
RA   Liu X.F., Essand M., Vasmatzis G., Lee B., Pastan I.;
RT   "Identification of three new alternate human kallikrein 2 transcripts:
RT   evidence of long transcript and alternative splicing.";
RL   Biochem. Biophys. Res. Commun. 264:833-839(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=11054574; DOI=10.1016/s0378-1119(00)00382-6;
RA   Gan L., Lee I., Smith R., Argonza-Barrett R., Lei H., McCuaig J., Moss P.,
RA   Paeper B., Wang K.;
RT   "Sequencing and expression analysis of the serine protease gene cluster
RT   located in chromosome 19q13 region.";
RL   Gene 257:119-130(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 4).
RC   TISSUE=Prostate;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S).
RX   PubMed=14759258; DOI=10.1186/gb-2004-5-2-r8;
RA   Hillman R.T., Green R.E., Brenner S.E.;
RT   "An unappreciated role for RNA surveillance.";
RL   Genome Biol. 5:R8.1-R8.16(2004).
RN   [10]
RP   VARIANT LEU-18.
RX   PubMed=10391209; DOI=10.1038/10290;
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RT   "Characterization of single-nucleotide polymorphisms in coding regions of
RT   human genes.";
RL   Nat. Genet. 22:231-238(1999).
RN   [11]
RP   ERRATUM OF PUBMED:10391209.
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RL   Nat. Genet. 23:373-373(1999).
CC   -!- FUNCTION: Glandular kallikreins cleave Met-Lys and Arg-Ser bonds in
CC       kininogen to release Lys-bradykinin.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Preferential cleavage of Arg-|-Xaa bonds in small molecule
CC         substrates. Highly selective action to release kallidin (lysyl-
CC         bradykinin) from kininogen involves hydrolysis of Met-|-Xaa or Leu-|-
CC         Xaa.; EC=3.4.21.35;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=P20151-1; Sequence=Displayed;
CC       Name=2; Synonyms=PGK-10A;
CC         IsoId=P20151-2; Sequence=VSP_005399;
CC       Name=3;
CC         IsoId=P20151-3; Sequence=VSP_005400;
CC       Name=4;
CC         IsoId=P20151-4; Sequence=VSP_044709;
CC   -!- MISCELLANEOUS: [Isoform 3]: May be produced at very low levels due to a
CC       premature stop codon in the mRNA, leading to nonsense-mediated mRNA
CC       decay. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the peptidase S1 family. Kallikrein subfamily.
CC       {ECO:0000255|PROSITE-ProRule:PRU00274}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD13817.1; Type=Miscellaneous discrepancy; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M18156; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; M18157; AAA74454.1; -; Genomic_DNA.
DR   EMBL; S39329; AAD13816.1; -; mRNA.
DR   EMBL; S39329; AAD13817.1; ALT_SEQ; mRNA.
DR   EMBL; AF188745; AAF08275.1; -; mRNA.
DR   EMBL; AF188746; AAF08276.1; -; mRNA.
DR   EMBL; AF188747; AAF08277.1; -; mRNA.
DR   EMBL; AF243527; AAG33356.1; -; Genomic_DNA.
DR   EMBL; BT006650; AAP35296.1; -; mRNA.
DR   EMBL; AK300549; BAG62255.1; -; mRNA.
DR   EMBL; AK300566; BAG62272.1; -; mRNA.
DR   EMBL; AC037199; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC005196; AAH05196.1; -; mRNA.
DR   CCDS; CCDS12808.1; -. [P20151-1]
DR   CCDS; CCDS42597.1; -. [P20151-2]
DR   CCDS; CCDS58675.1; -. [P20151-4]
DR   PIR; A29586; A29586.
DR   RefSeq; NP_001002231.1; NM_001002231.2. [P20151-2]
DR   RefSeq; NP_001243009.1; NM_001256080.1. [P20151-4]
DR   RefSeq; NP_005542.1; NM_005551.4. [P20151-1]
DR   PDB; 4NFE; X-ray; 1.90 A; A=25-261.
DR   PDB; 4NFF; X-ray; 1.90 A; A=25-261.
DR   PDBsum; 4NFE; -.
DR   PDBsum; 4NFF; -.
DR   SMR; P20151; -.
DR   BioGrid; 110017; 11.
DR   IntAct; P20151; 3.
DR   STRING; 9606.ENSP00000313581; -.
DR   BindingDB; P20151; -.
DR   ChEMBL; CHEMBL2442; -.
DR   GuidetoPHARMACOLOGY; 2372; -.
DR   Allergome; 2836; Hom s PSA.
DR   MEROPS; S01.161; -.
DR   iPTMnet; P20151; -.
DR   PhosphoSitePlus; P20151; -.
DR   BioMuta; KLK2; -.
DR   DMDM; 125174; -.
DR   MassIVE; P20151; -.
DR   MaxQB; P20151; -.
DR   PaxDb; P20151; -.
DR   PeptideAtlas; P20151; -.
DR   PRIDE; P20151; -.
DR   ProteomicsDB; 27819; -.
DR   ProteomicsDB; 53728; -. [P20151-1]
DR   ProteomicsDB; 53729; -. [P20151-2]
DR   ProteomicsDB; 53730; -. [P20151-3]
DR   Antibodypedia; 32384; 376 antibodies.
DR   DNASU; 3817; -.
DR   Ensembl; ENST00000325321; ENSP00000313581; ENSG00000167751. [P20151-1]
DR   Ensembl; ENST00000358049; ENSP00000350748; ENSG00000167751. [P20151-2]
DR   Ensembl; ENST00000391810; ENSP00000375686; ENSG00000167751. [P20151-4]
DR   Ensembl; ENST00000597439; ENSP00000471214; ENSG00000167751. [P20151-3]
DR   GeneID; 3817; -.
DR   KEGG; hsa:3817; -.
DR   UCSC; uc002ptu.4; human. [P20151-1]
DR   CTD; 3817; -.
DR   DisGeNET; 3817; -.
DR   GeneCards; KLK2; -.
DR   HGNC; HGNC:6363; KLK2.
DR   HPA; ENSG00000167751; Tissue enriched (prostate).
DR   MIM; 147960; gene.
DR   neXtProt; NX_P20151; -.
DR   OpenTargets; ENSG00000167751; -.
DR   PharmGKB; PA30152; -.
DR   eggNOG; KOG3627; Eukaryota.
DR   eggNOG; COG5640; LUCA.
DR   GeneTree; ENSGT00950000182707; -.
DR   HOGENOM; CLU_006842_1_1_1; -.
DR   InParanoid; P20151; -.
DR   KO; K01325; -.
DR   OMA; GWECERH; -.
DR   PhylomeDB; P20151; -.
DR   TreeFam; TF331065; -.
DR   Reactome; R-HSA-1592389; Activation of Matrix Metalloproteinases.
DR   Reactome; R-HSA-381426; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs).
DR   Reactome; R-HSA-5625886; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3.
DR   SIGNOR; P20151; -.
DR   ChiTaRS; KLK2; human.
DR   GenomeRNAi; 3817; -.
DR   Pharos; P20151; Tchem.
DR   PRO; PR:P20151; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; P20151; protein.
DR   Bgee; ENSG00000167751; Expressed in prostate gland and 116 other tissues.
DR   ExpressionAtlas; P20151; baseline and differential.
DR   Genevisible; P20151; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0030141; C:secretory granule; IBA:GO_Central.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; IDA:BHF-UCL.
DR   GO; GO:0022617; P:extracellular matrix disassembly; TAS:Reactome.
DR   GO; GO:0003073; P:regulation of systemic arterial blood pressure; IBA:GO_Central.
DR   GO; GO:0031638; P:zymogen activation; IBA:GO_Central.
DR   CDD; cd00190; Tryp_SPc; 1.
DR   InterPro; IPR009003; Peptidase_S1_PA.
DR   InterPro; IPR001314; Peptidase_S1A.
DR   InterPro; IPR001254; Trypsin_dom.
DR   InterPro; IPR018114; TRYPSIN_HIS.
DR   InterPro; IPR033116; TRYPSIN_SER.
DR   Pfam; PF00089; Trypsin; 1.
DR   PRINTS; PR00722; CHYMOTRYPSIN.
DR   SMART; SM00020; Tryp_SPc; 1.
DR   SUPFAM; SSF50494; SSF50494; 1.
DR   PROSITE; PS50240; TRYPSIN_DOM; 1.
DR   PROSITE; PS00134; TRYPSIN_HIS; 1.
DR   PROSITE; PS00135; TRYPSIN_SER; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Disulfide bond; Glycoprotein;
KW   Hydrolase; Polymorphism; Protease; Reference proteome; Serine protease;
KW   Signal; Zymogen.
FT   SIGNAL          1..18
FT                   /evidence="ECO:0000305"
FT   PROPEP          19..24
FT                   /note="Activation peptide"
FT                   /evidence="ECO:0000305"
FT                   /id="PRO_0000027929"
FT   CHAIN           25..261
FT                   /note="Kallikrein-2"
FT                   /id="PRO_0000027930"
FT   DOMAIN          25..258
FT                   /note="Peptidase S1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00274"
FT   ACT_SITE        65
FT                   /note="Charge relay system"
FT   ACT_SITE        120
FT                   /note="Charge relay system"
FT   ACT_SITE        213
FT                   /note="Charge relay system"
FT   CARBOHYD        102
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        31..173
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00274"
FT   DISULFID        50..66
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00274"
FT   DISULFID        152..219
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00274"
FT   DISULFID        184..198
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00274"
FT   DISULFID        209..234
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00274"
FT   VAR_SEQ         1..102
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_044709"
FT   VAR_SEQ         165..261
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_005400"
FT   VAR_SEQ         211..261
FT                   /note="GDSGGPLVCNGVLQGITSWGPEPCALPEKPAVYTKVVHYRKWIKDTIAANP
FT                   -> VSHPYSQHLEGKG (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:1726490"
FT                   /id="VSP_005399"
FT   VARIANT         18
FT                   /note="V -> L (in dbSNP:rs6072)"
FT                   /evidence="ECO:0000269|PubMed:10391209"
FT                   /id="VAR_014164"
FT   VARIANT         250
FT                   /note="R -> W (in dbSNP:rs198977)"
FT                   /id="VAR_020178"
FT   VARIANT         255
FT                   /note="D -> A (in dbSNP:rs60268688)"
FT                   /id="VAR_061775"
FT   CONFLICT        143
FT                   /note="T -> A (in Ref. 6; BAG62255)"
FT                   /evidence="ECO:0000305"
FT   STRAND          39..44
FT                   /evidence="ECO:0000244|PDB:4NFE"
FT   STRAND          47..56
FT                   /evidence="ECO:0000244|PDB:4NFE"
FT   STRAND          59..62
FT                   /evidence="ECO:0000244|PDB:4NFE"
FT   HELIX           64..66
FT                   /evidence="ECO:0000244|PDB:4NFE"
FT   STRAND          72..76
FT                   /evidence="ECO:0000244|PDB:4NFE"
FT   STRAND          88..97
FT                   /evidence="ECO:0000244|PDB:4NFE"
FT   HELIX           103..105
FT                   /evidence="ECO:0000244|PDB:4NFF"
FT   STRAND          122..128
FT                   /evidence="ECO:0000244|PDB:4NFE"
FT   STRAND          134..136
FT                   /evidence="ECO:0000244|PDB:4NFF"
FT   STRAND          151..158
FT                   /evidence="ECO:0000244|PDB:4NFE"
FT   STRAND          160..164
FT                   /evidence="ECO:0000244|PDB:4NFE"
FT   STRAND          172..179
FT                   /evidence="ECO:0000244|PDB:4NFE"
FT   HELIX           181..187
FT                   /evidence="ECO:0000244|PDB:4NFE"
FT   STRAND          196..200
FT                   /evidence="ECO:0000244|PDB:4NFE"
FT   STRAND          216..219
FT                   /evidence="ECO:0000244|PDB:4NFE"
FT   STRAND          222..229
FT                   /evidence="ECO:0000244|PDB:4NFE"
FT   STRAND          241..245
FT                   /evidence="ECO:0000244|PDB:4NFE"
FT   HELIX           246..249
FT                   /evidence="ECO:0000244|PDB:4NFE"
FT   HELIX           250..259
FT                   /evidence="ECO:0000244|PDB:4NFE"
FT   CONFLICT        P20151-2:223
FT                   /note="G -> GE (in Ref. 6; BAG62272)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   261 AA;  28671 MW;  9CF7F4A1162EF42D CRC64;
     MWDLVLSIAL SVGCTGAVPL IQSRIVGGWE CEKHSQPWQV AVYSHGWAHC GGVLVHPQWV
     LTAAHCLKKN SQVWLGRHNL FEPEDTGQRV PVSHSFPHPL YNMSLLKHQS LRPDEDSSHD
     LMLLRLSEPA KITDVVKVLG LPTQEPALGT TCYASGWGSI EPEEFLRPRS LQCVSLHLLS
     NDMCARAYSE KVTEFMLCAG LWTGGKDTCG GDSGGPLVCN GVLQGITSWG PEPCALPEKP
     AVYTKVVHYR KWIKDTIAAN P
//
ID   A0A024R663_HUMAN        Unreviewed;      1357 AA.
AC   A0A024R663;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 47.
DE   SubName: Full=Kinectin 1 (Kinesin receptor), isoform CRA_a {ECO:0000313|EMBL:EAW80681.1};
DE   SubName: Full=Kinectin 1 (Kinesin receptor), isoform CRA_b {ECO:0000313|EMBL:EAW80684.1};
GN   Name=KTN1 {ECO:0000313|EMBL:EAW80684.1};
GN   ORFNames=hCG_22120 {ECO:0000313|EMBL:EAW80684.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW80684.1};
RN   [1] {ECO:0000313|EMBL:EAW80684.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW80684.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH471061; EAW80681.1; -; Genomic_DNA.
DR   EMBL; CH471061; EAW80682.1; -; Genomic_DNA.
DR   EMBL; CH471061; EAW80684.1; -; Genomic_DNA.
DR   RefSeq; NP_001072989.1; NM_001079521.1.
DR   RefSeq; XP_006720201.1; XM_006720138.2.
DR   RefSeq; XP_011535053.1; XM_011536751.2.
DR   RefSeq; XP_016876767.1; XM_017021278.1.
DR   Antibodypedia; 127; 173 antibodies.
DR   GeneID; 3895; -.
DR   KEGG; hsa:3895; -.
DR   CTD; 3895; -.
DR   EuPathDB; HostDB:ENSG00000126777.17; -.
DR   eggNOG; ENOG410IIAW; Eukaryota.
DR   eggNOG; ENOG410YAE3; LUCA.
DR   HOGENOM; CLU_005719_0_0_1; -.
DR   KO; K17975; -.
DR   OMA; LKQENCK; -.
DR   OrthoDB; 327650at2759; -.
DR   ChiTaRS; KTN1; human.
DR   GenomeRNAi; 3895; -.
DR   Bgee; ENSG00000126777; Expressed in testis and 243 other tissues.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0019894; F:kinesin binding; IEA:InterPro.
DR   GO; GO:0007018; P:microtubule-based movement; IEA:InterPro.
DR   InterPro; IPR024854; Kinectin.
DR   PANTHER; PTHR18864; PTHR18864; 1.
PE   4: Predicted;
KW   Coiled coil {ECO:0000256|SAM:Coils}; Membrane {ECO:0000256|SAM:Phobius};
KW   Receptor {ECO:0000313|EMBL:EAW80684.1};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM        7..29
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   REGION          48..81
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          103..218
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          341..368
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          405..432
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          441..496
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          564..591
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          602..643
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          651..674
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          686..720
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          730..753
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          758..785
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          796..851
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          862..920
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          928..955
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          963..983
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1015..1035
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1115..1163
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1175..1275
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1332..1352
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        63..81
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        109..139
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        162..186
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        194..218
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   1357 AA;  156275 MW;  971FCDF8AA8FC88E CRC64;
     MEFYESAYFI VLIPSIVITV IFLFFWLFMK ETLYDEVLAK QKREQKLIPT KTDKKKAEKK
     KNKKKEIQNG NLHESDSESV PRDFKLSDAL AVEDDQVAPV PLNVVETSSS VRERKKKEKK
     QKPVLEEQVI KESDASKIPG KKVEPVPVTK QPTPPSEAAA SKKKPGQKKS KNGSDDQDKK
     VETLMVPSKR QEALPLHQET KQESGSGKKK ASSKKQKTEN VFVDEPLIHA TTYIPLMDNA
     DSSPVVDKRE VIDLLKPDQV EGIQKSGTKK LKTETDKENA EVKFKDFLLS LKTMMFSEDE
     ALCVVDLLKE KSGVIQDALK KSSKGELTTL IHQLQEKDKL LAAVKEDAAA TKDRCKQLTQ
     EMMTEKERSN VVITRMKDRI GTLEKEHNVF QNKIHVSYQE TQQMQMKFQQ VREQMEAEIA
     HLKQENGILR DAVSNTTNQL ESKQSAELNK LRQDYARLVN ELTEKTGKLQ QEEVQKKNAE
     QAATQLKVQL QEAERRWEEV QSYIRKRTAE HEAAQQDLQS KFVAKENEVQ SLHSKLTDTL
     VSKQQLEQRL MQLMESEQKR VNKEESLQMQ VQDILEQNEA LKAQIQQFHS QIAAQTSASV
     LAEELHKVIA EKDKQIKQTE DSLASERDRL TSKEEELKDI QNMNFLLKAE VQKLQALANE
     QAAAAHELEK MQQSVYVKDD KIRLLEEQLQ HEISNKMEEF KILNDQNKAL KSEVQKLQTL
     VSEQPNKDVV EQMEKCIQEK DEKLKTVEEL LETGLIQVAT KEEELNAIRT ENSSLTKEVQ
     DLKAKQNDQV SFASLVEELK KVIHEKDGKI KSVEELLEAE LLKVANKEKT VQDLKQEIKA
     LKEEIGNVQL EKAQQLSITS KVQELQNLLK GKEEQMNTMK AVLEEKEKDL ANTGKWLQDL
     QEENESLKAH VQEVAQHNLK EASSASQFEE LEIVLKEKEN ELKRLEAMLK ERESDLSSKT
     QLLQDVQDEN KLFKSQIEQL KQQNYQQASS FPPHEELLKV ISEREKEISG LWNELDSLKD
     AVEHQRKKNN DLREKNWEAM EALASTEKML QDKVNKTSKE RQQQVEAVEL EAKEVLKKLF
     PKVSVPSNLS YGEWLHGFEK KAKECMAGTS GSEEVKVLEH KLKEADEMHT LLQLECEKYK
     SVLAETEGIL QKLQRSVEQE ENKWKVKVDE SHKTIKQMQS SFTSSEQELE RLRSENKDIE
     NLRREREHLE MELEKAEMER STYVTEVREL KDLLTELQKK LDDSYSEAVR QNEELNLLKA
     QLNETLTKLR TEQNERQKVA GDLHKAQQSL ELIQSKIVKA AGDTTVIENS DVSPETESSE
     KETMSVSLNQ TVTQLQQLLQ AVNQQLTKEK EHYQVLE
//
ID   KTN1_HUMAN              Reviewed;        1357 AA.
AC   Q86UP2; B4DZ88; Q13999; Q14707; Q15387; Q17RZ5; Q5GGW3; Q86W57;
DT   15-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   22-APR-2020, entry version 169.
DE   RecName: Full=Kinectin;
DE   AltName: Full=CG-1 antigen;
DE   AltName: Full=Kinesin receptor;
GN   Name=KTN1; Synonyms=CG1, KIAA0004;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Lymphoid tissue;
RX   PubMed=7787243; DOI=10.1091/mbc.6.2.161;
RA   Fuetterer A., Kruppa G., Kraemer B., Lemke H., Kroenke M.;
RT   "Molecular cloning and characterization of human kinectin.";
RL   Mol. Biol. Cell 6:161-170(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Peripheral blood lymphocyte;
RX   PubMed=8039706; DOI=10.1016/0378-1119(94)90381-6;
RA   Print C.G., Leung E., Harrison J.E.B., Watson J.D., Krissansen G.W.;
RT   "Cloning of a gene encoding a human leukocyte protein characterised by
RT   extensive heptad repeats.";
RL   Gene 144:221-228(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Wang H.-C., Chen W.-F., Su Y.-R.;
RT   "Identification of a variant of Homo sapiens kinectin mRNA.";
RL   Submitted (MAR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Bone marrow;
RX   PubMed=7584026; DOI=10.1093/dnares/1.1.27;
RA   Nomura N., Miyajima N., Sazuka T., Tanaka A., Kawarabayasi Y., Sato S.,
RA   Nagase T., Seki N., Ishikawa K., Tabata S.;
RT   "Prediction of the coding sequences of unidentified human genes. I. The
RT   coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of
RT   randomly sampled cDNA clones from human immature myeloid cell line KG-1.";
RL   DNA Res. 1:27-35(1994).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S., Sun H.,
RA   Du H., Pepin K., Artiguenave F., Robert C., Cruaud C., Bruels T.,
RA   Jaillon O., Friedlander L., Samson G., Brottier P., Cure S., Segurens B.,
RA   Aniere F., Samain S., Crespeau H., Abbasi N., Aiach N., Boscus D.,
RA   Dickhoff R., Dors M., Dubois I., Friedman C., Gouyvenoux M., James R.,
RA   Madan A., Mairey-Estrada B., Mangenot S., Martins N., Menard M., Oztas S.,
RA   Ratcliffe A., Shaffer T., Trask B., Vacherie B., Bellemere C., Belser C.,
RA   Besnard-Gonnet M., Bartol-Mavel D., Boutard M., Briez-Silla S.,
RA   Combette S., Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C.,
RA   Muselet D., Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P.,
RA   Trybou A., Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L., Verdier J.,
RA   Verdier-Discala C., Hillier L.W., Fulton L., McPherson J., Matsuda F.,
RA   Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W., Quetier F.,
RA   Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 4), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 1-870 (ISOFORMS 1/2).
RC   TISSUE=Cerebellum, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 191-195; 395-405; 545-554; 747-761 AND 811-823.
RX   PubMed=11973345;
RA   Tran H., Pankov R., Tran S.D., Hampton B., Burgess W.H., Yamada K.M.;
RT   "Integrin clustering induces kinectin accumulation.";
RL   J. Cell Sci. 115:2031-2040(2002).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 538-1357.
RC   TISSUE=Embryonic rhabdomyosarcoma;
RA   Behrends U., Gotz C., Mautner J.;
RT   "SEREX-defined rhabdomyosarcoma antigens.";
RL   Submitted (JAN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   CHROMOSOMAL LOCATION.
RX   PubMed=8575822; DOI=10.1007/bf00587304;
RA   Print C.G., Morris C.M., Spurr N.K., Rooke L., Krissansen G.W.;
RT   "The CG-1 gene, a member of the kinectin and ES/130 family, maps to human
RT   chromosome band 14q22.";
RL   Immunogenetics 43:227-229(1996).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-153, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-75; THR-153 AND SER-156, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-75 AND THR-153, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-75, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-75; SER-77; THR-153 AND
RP   SER-1313, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1084, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   PHOSPHORYLATION AT SER-75.
RX   PubMed=26091039; DOI=10.1016/j.cell.2015.05.028;
RA   Tagliabracci V.S., Wiley S.E., Guo X., Kinch L.N., Durrant E., Wen J.,
RA   Xiao J., Cui J., Nguyen K.B., Engel J.L., Coon J.J., Grishin N.,
RA   Pinna L.A., Pagliarini D.J., Dixon J.E.;
RT   "A single kinase generates the majority of the secreted phosphoproteome.";
RL   Cell 161:1619-1632(2015).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [21]
RP   VARIANTS [LARGE SCALE ANALYSIS] ARG-226 AND PRO-1316.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
RN   [22]
RP   VARIANT MET-1233.
RX   PubMed=27932480; DOI=10.1681/asn.2016040387;
RG   NephroS;
RG   UK study of Nephrotic Syndrome;
RA   Bierzynska A., Soderquest K., Dean P., Colby E., Rollason R., Jones C.,
RA   Inward C.D., McCarthy H.J., Simpson M.A., Lord G.M., Williams M.,
RA   Welsh G.I., Koziell A.B., Saleem M.A.;
RT   "MAGI2 mutations cause congenital nephrotic syndrome.";
RL   J. Am. Soc. Nephrol. 28:1614-1621(2017).
CC   -!- FUNCTION: Receptor for kinesin thus involved in kinesin-driven vesicle
CC       motility. Accumulates in integrin-based adhesion complexes (IAC) upon
CC       integrin aggregation by fibronectin.
CC   -!- SUBUNIT: Parallel homodimers formed between the membrane-bound and the
CC       cytosolic form, and also between 2 cytosolic forms. {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q86UP2; Q12983: BNIP3; NbExp=3; IntAct=EBI-359761, EBI-749464;
CC       Q86UP2-3; Q12983: BNIP3; NbExp=3; IntAct=EBI-12007212, EBI-749464;
CC       Q86UP2-3; P09693: CD3G; NbExp=3; IntAct=EBI-12007212, EBI-3862428;
CC       Q86UP2-3; P34810: CD68; NbExp=3; IntAct=EBI-12007212, EBI-2826276;
CC       Q86UP2-3; Q8WTT0: CLEC4C; NbExp=3; IntAct=EBI-12007212, EBI-12913226;
CC       Q86UP2; Q9BXN2: CLEC7A; NbExp=3; IntAct=EBI-359761, EBI-3939278;
CC       Q86UP2-3; O15552: FFAR2; NbExp=3; IntAct=EBI-12007212, EBI-2833872;
CC       Q86UP2-3; P43628: KIR2DL3; NbExp=3; IntAct=EBI-12007212, EBI-8632435;
CC       Q86UP2-3; Q8TAF8: LHFPL5; NbExp=3; IntAct=EBI-12007212, EBI-2820517;
CC       Q86UP2-3; P20645: M6PR; NbExp=3; IntAct=EBI-12007212, EBI-2907262;
CC       Q86UP2; P50222: MEOX2; NbExp=3; IntAct=EBI-359761, EBI-748397;
CC       Q86UP2-3; Q5SR56: MFSD14B; NbExp=3; IntAct=EBI-12007212, EBI-373355;
CC       Q86UP2-3; Q9BQ51: PDCD1LG2; NbExp=3; IntAct=EBI-12007212, EBI-16427978;
CC       Q86UP2; O43765: SGTA; NbExp=3; IntAct=EBI-359761, EBI-347996;
CC       Q86UP2-3; O43765: SGTA; NbExp=3; IntAct=EBI-12007212, EBI-347996;
CC       Q86UP2-3; P27105: STOM; NbExp=3; IntAct=EBI-12007212, EBI-1211440;
CC       Q86UP2-3; Q96L08: SUSD3; NbExp=3; IntAct=EBI-12007212, EBI-18194029;
CC       Q86UP2; Q8N205: SYNE4; NbExp=3; IntAct=EBI-359761, EBI-7131783;
CC       Q86UP2-3; Q8TBG9: SYNPR; NbExp=3; IntAct=EBI-12007212, EBI-10273251;
CC       Q86UP2-3; Q7Z7N9: TMEM179B; NbExp=3; IntAct=EBI-12007212, EBI-11724423;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Single-pass type
CC       II membrane protein. Note=Vesicle membrane protein anchored to the
CC       endoplasmic reticulum.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=Q86UP2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q86UP2-2; Sequence=VSP_007981, VSP_007982;
CC       Name=3;
CC         IsoId=Q86UP2-3; Sequence=VSP_043207, VSP_007982;
CC       Name=4;
CC         IsoId=Q86UP2-4; Sequence=VSP_007982;
CC   -!- TISSUE SPECIFICITY: High levels in peripheral blood lymphocytes, testis
CC       and ovary, lower levels in spleen, thymus, prostate, small intestine
CC       and colon.
CC   -!- SIMILARITY: Belongs to the kinectin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH50555.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=BAA02794.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z22551; CAA80271.1; -; mRNA.
DR   EMBL; L25616; AAB65853.1; -; mRNA.
DR   EMBL; AY264265; AAP20418.1; -; mRNA.
DR   EMBL; D13629; BAA02794.2; ALT_INIT; mRNA.
DR   EMBL; AK302797; BAG64000.1; -; mRNA.
DR   EMBL; AL138499; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL355773; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC050555; AAH50555.1; ALT_SEQ; mRNA.
DR   EMBL; BC112337; AAI12338.1; -; mRNA.
DR   EMBL; BC117132; AAI17133.1; -; mRNA.
DR   EMBL; BC143720; AAI43721.1; -; mRNA.
DR   EMBL; AY536375; AAT66048.1; -; mRNA.
DR   CCDS; CCDS41957.1; -. [Q86UP2-1]
DR   CCDS; CCDS41958.1; -. [Q86UP2-2]
DR   CCDS; CCDS41959.1; -. [Q86UP2-3]
DR   PIR; I53799; I53799.
DR   PIR; S32763; S32763.
DR   RefSeq; NP_001072989.1; NM_001079521.1. [Q86UP2-1]
DR   RefSeq; NP_001072990.1; NM_001079522.1. [Q86UP2-3]
DR   RefSeq; NP_001257943.1; NM_001271014.1. [Q86UP2-4]
DR   RefSeq; NP_004977.2; NM_004986.3. [Q86UP2-2]
DR   RefSeq; XP_006720201.1; XM_006720138.2. [Q86UP2-1]
DR   RefSeq; XP_006720202.1; XM_006720139.2. [Q86UP2-4]
DR   RefSeq; XP_011535053.1; XM_011536751.2. [Q86UP2-1]
DR   RefSeq; XP_011535055.1; XM_011536753.1. [Q86UP2-3]
DR   RefSeq; XP_016876767.1; XM_017021278.1. [Q86UP2-1]
DR   RefSeq; XP_016876771.1; XM_017021282.1. [Q86UP2-2]
DR   RefSeq; XP_016876772.1; XM_017021283.1. [Q86UP2-2]
DR   SMR; Q86UP2; -.
DR   BioGrid; 110092; 84.
DR   CORUM; Q86UP2; -.
DR   DIP; DIP-27585N; -.
DR   IntAct; Q86UP2; 93.
DR   MINT; Q86UP2; -.
DR   STRING; 9606.ENSP00000378725; -.
DR   iPTMnet; Q86UP2; -.
DR   MetOSite; Q86UP2; -.
DR   PhosphoSitePlus; Q86UP2; -.
DR   SwissPalm; Q86UP2; -.
DR   BioMuta; KTN1; -.
DR   DMDM; 34098465; -.
DR   EPD; Q86UP2; -.
DR   jPOST; Q86UP2; -.
DR   MassIVE; Q86UP2; -.
DR   MaxQB; Q86UP2; -.
DR   PaxDb; Q86UP2; -.
DR   PeptideAtlas; Q86UP2; -.
DR   PRIDE; Q86UP2; -.
DR   ProteomicsDB; 69841; -. [Q86UP2-1]
DR   ProteomicsDB; 69842; -. [Q86UP2-2]
DR   ProteomicsDB; 69843; -. [Q86UP2-3]
DR   Antibodypedia; 127; 173 antibodies.
DR   DNASU; 3895; -.
DR   Ensembl; ENST00000395308; ENSP00000378719; ENSG00000126777. [Q86UP2-3]
DR   Ensembl; ENST00000395309; ENSP00000378720; ENSG00000126777. [Q86UP2-3]
DR   Ensembl; ENST00000395311; ENSP00000378722; ENSG00000126777. [Q86UP2-3]
DR   Ensembl; ENST00000395314; ENSP00000378725; ENSG00000126777. [Q86UP2-1]
DR   Ensembl; ENST00000413890; ENSP00000394992; ENSG00000126777. [Q86UP2-3]
DR   Ensembl; ENST00000438792; ENSP00000391964; ENSG00000126777. [Q86UP2-2]
DR   Ensembl; ENST00000459737; ENSP00000432149; ENSG00000126777. [Q86UP2-1]
DR   GeneID; 3895; -.
DR   KEGG; hsa:3895; -.
DR   UCSC; uc001xcb.4; human. [Q86UP2-1]
DR   CTD; 3895; -.
DR   DisGeNET; 3895; -.
DR   GeneCards; KTN1; -.
DR   HGNC; HGNC:6467; KTN1.
DR   HPA; ENSG00000126777; Low tissue specificity.
DR   MIM; 600381; gene.
DR   neXtProt; NX_Q86UP2; -.
DR   OpenTargets; ENSG00000126777; -.
DR   PharmGKB; PA30256; -.
DR   eggNOG; ENOG410IIAW; Eukaryota.
DR   eggNOG; ENOG410YAE3; LUCA.
DR   GeneTree; ENSGT00940000158237; -.
DR   HOGENOM; CLU_005719_0_0_1; -.
DR   InParanoid; Q86UP2; -.
DR   KO; K17975; -.
DR   OMA; LKQENCK; -.
DR   PhylomeDB; Q86UP2; -.
DR   TreeFam; TF333579; -.
DR   Reactome; R-HSA-381426; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs).
DR   Reactome; R-HSA-5625970; RHO GTPases activate KTN1.
DR   Reactome; R-HSA-8957275; Post-translational protein phosphorylation.
DR   SIGNOR; Q86UP2; -.
DR   ChiTaRS; KTN1; human.
DR   GeneWiki; KTN1; -.
DR   GenomeRNAi; 3895; -.
DR   Pharos; Q86UP2; Tbio.
DR   PRO; PR:Q86UP2; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   RNAct; Q86UP2; protein.
DR   Bgee; ENSG00000126777; Expressed in testis and 243 other tissues.
DR   ExpressionAtlas; Q86UP2; baseline and differential.
DR   Genevisible; Q86UP2; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; TAS:ProtInc.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0019894; F:kinesin binding; IEA:InterPro.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0044267; P:cellular protein metabolic process; TAS:Reactome.
DR   GO; GO:0007018; P:microtubule-based movement; NAS:ProtInc.
DR   GO; GO:0043687; P:post-translational protein modification; TAS:Reactome.
DR   InterPro; IPR024854; Kinectin.
DR   PANTHER; PTHR18864; PTHR18864; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Coiled coil; Direct protein sequencing;
KW   Endoplasmic reticulum; Glycoprotein; Membrane; Phosphoprotein;
KW   Polymorphism; Reference proteome; Signal-anchor; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..1357
FT                   /note="Kinectin"
FT                   /id="PRO_0000084337"
FT   TOPO_DOM        1..6
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        7..29
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        30..1357
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   COILED          330..1356
FT                   /evidence="ECO:0000255"
FT   MOD_RES         75
FT                   /note="Phosphoserine; by FAM20C"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:26091039"
FT   MOD_RES         77
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         153
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         156
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         1084
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         1313
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   CARBOHYD        172
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        435
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        772
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        904
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1055
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1088
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1263
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1329
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         832..854
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_043207"
FT   VAR_SEQ         1031..1059
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:7584026,
FT                   ECO:0000303|PubMed:8039706"
FT                   /id="VSP_007981"
FT   VAR_SEQ         1232..1259
FT                   /note="Missing (in isoform 2, isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:7584026,
FT                   ECO:0000303|PubMed:8039706"
FT                   /id="VSP_007982"
FT   VARIANT         226
FT                   /note="P -> R (in a breast cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035931"
FT   VARIANT         282
FT                   /note="V -> M (in dbSNP:rs2274073)"
FT                   /id="VAR_016206"
FT   VARIANT         1233
FT                   /note="L -> M (in dbSNP:rs372815686)"
FT                   /evidence="ECO:0000269|PubMed:27932480"
FT                   /id="VAR_079266"
FT   VARIANT         1316
FT                   /note="T -> P (in a breast cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035932"
FT   CONFLICT        15
FT                   /note="S -> P (in Ref. 4; BAA02794)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        210
FT                   /note="Missing (in Ref. 1; CAA80271)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        373
FT                   /note="I -> M (in Ref. 1; CAA80271)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        939
FT                   /note="E -> G (in Ref. 1; CAA80271)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1357 AA;  156275 MW;  971FCDF8AA8FC88E CRC64;
     MEFYESAYFI VLIPSIVITV IFLFFWLFMK ETLYDEVLAK QKREQKLIPT KTDKKKAEKK
     KNKKKEIQNG NLHESDSESV PRDFKLSDAL AVEDDQVAPV PLNVVETSSS VRERKKKEKK
     QKPVLEEQVI KESDASKIPG KKVEPVPVTK QPTPPSEAAA SKKKPGQKKS KNGSDDQDKK
     VETLMVPSKR QEALPLHQET KQESGSGKKK ASSKKQKTEN VFVDEPLIHA TTYIPLMDNA
     DSSPVVDKRE VIDLLKPDQV EGIQKSGTKK LKTETDKENA EVKFKDFLLS LKTMMFSEDE
     ALCVVDLLKE KSGVIQDALK KSSKGELTTL IHQLQEKDKL LAAVKEDAAA TKDRCKQLTQ
     EMMTEKERSN VVITRMKDRI GTLEKEHNVF QNKIHVSYQE TQQMQMKFQQ VREQMEAEIA
     HLKQENGILR DAVSNTTNQL ESKQSAELNK LRQDYARLVN ELTEKTGKLQ QEEVQKKNAE
     QAATQLKVQL QEAERRWEEV QSYIRKRTAE HEAAQQDLQS KFVAKENEVQ SLHSKLTDTL
     VSKQQLEQRL MQLMESEQKR VNKEESLQMQ VQDILEQNEA LKAQIQQFHS QIAAQTSASV
     LAEELHKVIA EKDKQIKQTE DSLASERDRL TSKEEELKDI QNMNFLLKAE VQKLQALANE
     QAAAAHELEK MQQSVYVKDD KIRLLEEQLQ HEISNKMEEF KILNDQNKAL KSEVQKLQTL
     VSEQPNKDVV EQMEKCIQEK DEKLKTVEEL LETGLIQVAT KEEELNAIRT ENSSLTKEVQ
     DLKAKQNDQV SFASLVEELK KVIHEKDGKI KSVEELLEAE LLKVANKEKT VQDLKQEIKA
     LKEEIGNVQL EKAQQLSITS KVQELQNLLK GKEEQMNTMK AVLEEKEKDL ANTGKWLQDL
     QEENESLKAH VQEVAQHNLK EASSASQFEE LEIVLKEKEN ELKRLEAMLK ERESDLSSKT
     QLLQDVQDEN KLFKSQIEQL KQQNYQQASS FPPHEELLKV ISEREKEISG LWNELDSLKD
     AVEHQRKKNN DLREKNWEAM EALASTEKML QDKVNKTSKE RQQQVEAVEL EAKEVLKKLF
     PKVSVPSNLS YGEWLHGFEK KAKECMAGTS GSEEVKVLEH KLKEADEMHT LLQLECEKYK
     SVLAETEGIL QKLQRSVEQE ENKWKVKVDE SHKTIKQMQS SFTSSEQELE RLRSENKDIE
     NLRREREHLE MELEKAEMER STYVTEVREL KDLLTELQKK LDDSYSEAVR QNEELNLLKA
     QLNETLTKLR TEQNERQKVA GDLHKAQQSL ELIQSKIVKA AGDTTVIENS DVSPETESSE
     KETMSVSLNQ TVTQLQQLLQ AVNQQLTKEK EHYQVLE
//
ID   A0A024R1S8_HUMAN        Unreviewed;       261 AA.
AC   A0A024R1S8;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 51.
DE   SubName: Full=LIM and SH3 protein 1, isoform CRA_b {ECO:0000313|EMBL:EAW60545.1};
GN   Name=LASP1 {ECO:0000313|EMBL:EAW60545.1};
GN   ORFNames=hCG_31400 {ECO:0000313|EMBL:EAW60545.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW60545.1};
RN   [1] {ECO:0000313|EMBL:EAW60545.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW60545.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH471152; EAW60544.1; -; Genomic_DNA.
DR   EMBL; CH471152; EAW60545.1; -; Genomic_DNA.
DR   RefSeq; NP_006139.1; NM_006148.3.
DR   Antibodypedia; 1894; 381 antibodies.
DR   GeneID; 3927; -.
DR   KEGG; hsa:3927; -.
DR   CTD; 3927; -.
DR   EuPathDB; HostDB:ENSG00000002834.17; -.
DR   eggNOG; KOG1702; Eukaryota.
DR   eggNOG; ENOG4111GQ8; LUCA.
DR   HOGENOM; CLU_026811_0_1_1; -.
DR   OMA; GYEKTPY; -.
DR   OrthoDB; 1549538at2759; -.
DR   ChiTaRS; LASP1; human.
DR   GenomeRNAi; 3927; -.
DR   Bgee; ENSG00000002834; Expressed in upper lobe of lung and 237 other tissues.
DR   GO; GO:0030864; C:cortical actin cytoskeleton; IEA:Ensembl.
DR   GO; GO:0005925; C:focal adhesion; IEA:Ensembl.
DR   GO; GO:0051015; F:actin filament binding; IEA:Ensembl.
DR   GO; GO:0015075; F:ion transmembrane transporter activity; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   CDD; cd11934; SH3_Lasp1_C; 1.
DR   InterPro; IPR035630; Lasp1_SH3.
DR   InterPro; IPR000900; Nebulin_repeat.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR001781; Znf_LIM.
DR   Pfam; PF00412; LIM; 1.
DR   Pfam; PF00880; Nebulin; 2.
DR   Pfam; PF14604; SH3_9; 1.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   SMART; SM00132; LIM; 1.
DR   SMART; SM00227; NEBU; 2.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   PROSITE; PS00478; LIM_DOMAIN_1; 1.
DR   PROSITE; PS50023; LIM_DOMAIN_2; 1.
DR   PROSITE; PS51216; NEBULIN; 2.
DR   PROSITE; PS50002; SH3; 1.
PE   4: Predicted;
KW   LIM domain {ECO:0000256|PROSITE-ProRule:PRU00125,
KW   ECO:0000256|SAAS:SAAS00113461};
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00125,
KW   ECO:0000256|SAAS:SAAS00113461};
KW   SH3 domain {ECO:0000256|PROSITE-ProRule:PRU00192};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00125, ECO:0000256|SAAS:SAAS00113461}.
FT   DOMAIN          3..63
FT                   /note="LIM zinc-binding"
FT                   /evidence="ECO:0000259|PROSITE:PS50023"
FT   DOMAIN          202..261
FT                   /note="SH3"
FT                   /evidence="ECO:0000259|PROSITE:PS50002"
FT   REGION          111..186
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        116..151
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        152..182
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   261 AA;  29717 MW;  3B89B988605B3639 CRC64;
     MNPNCARCGK IVYPTEKVNC LDKFWHKACF HCETCKMTLN MKNYKGYEKK PYCNAHYPKQ
     SFTMVADTPE NLRLKQQSEL QSQVRYKEEF EKNKGKGFSV VADTPELQRI KKTQDQISNI
     KYHEEFEKSR MGPSGGEGME PERRDSQDGS SYRRPLEQQQ PHHIPTSAPV YQQPQQQPVA
     QSYGGYKEPA APVSIQRSAP GGGGKRYRAV YDYSAADEDE VSFQDGDTIV NVQQIDDGWM
     YGTVERTGDT GMLPANYVEA I
//
ID   B4DIC4_HUMAN            Unreviewed;       125 AA.
AC   B4DIC4;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   22-APR-2020, entry version 65.
DE   SubName: Full=cDNA FLJ52195, highly similar to LIM and SH3 domain protein 1 {ECO:0000313|EMBL:BAG58436.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG58436.1};
RN   [1] {ECO:0000313|EMBL:BAG58436.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Hippocampus {ECO:0000313|EMBL:BAG58436.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK295522; BAG58436.1; -; mRNA.
DR   RefSeq; NP_001258537.1; NM_001271608.1.
DR   MaxQB; B4DIC4; -.
DR   PeptideAtlas; B4DIC4; -.
DR   PRIDE; B4DIC4; -.
DR   ProteomicsDB; 4294; -.
DR   GeneID; 3927; -.
DR   CTD; 3927; -.
DR   eggNOG; KOG1702; Eukaryota.
DR   eggNOG; ENOG4111GQ8; LUCA.
DR   GenomeRNAi; 3927; -.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   InterPro; IPR000900; Nebulin_repeat.
DR   InterPro; IPR001781; Znf_LIM.
DR   Pfam; PF00412; LIM; 1.
DR   Pfam; PF00880; Nebulin; 1.
DR   SMART; SM00132; LIM; 1.
DR   SMART; SM00227; NEBU; 1.
DR   PROSITE; PS00478; LIM_DOMAIN_1; 1.
DR   PROSITE; PS50023; LIM_DOMAIN_2; 1.
DR   PROSITE; PS51216; NEBULIN; 2.
PE   2: Evidence at transcript level;
KW   LIM domain {ECO:0000256|PROSITE-ProRule:PRU00125,
KW   ECO:0000256|SAAS:SAAS00113461};
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00125,
KW   ECO:0000256|SAAS:SAAS00113461};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00125, ECO:0000256|SAAS:SAAS00113461}.
FT   DOMAIN          3..63
FT                   /note="LIM zinc-binding"
FT                   /evidence="ECO:0000259|PROSITE:PS50023"
SQ   SEQUENCE   125 AA;  14598 MW;  900F5D3C3D145534 CRC64;
     MNPNCARCGK IVYPTEKVNC LDKFWHKACF HCETCKMTLN MKNYKGYEKK PYCNAHYPKQ
     SFTMVADTPE NLRLKQQSEL QSQVRYKEEF EKNKGKGFSV VADTPELQRS SLGFLWNEIP
     PSPHL
//
ID   LASP1_HUMAN             Reviewed;         261 AA.
AC   Q14847; B4DGQ0; Q96ED2; Q96IG0;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 2.
DT   22-APR-2020, entry version 194.
DE   RecName: Full=LIM and SH3 domain protein 1;
DE            Short=LASP-1;
DE   AltName: Full=Metastatic lymph node gene 50 protein;
DE            Short=MLN 50;
GN   Name=LASP1; Synonyms=MLN50;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Mammary carcinoma;
RX   PubMed=7490069; DOI=10.1006/geno.1995.1163;
RA   Tomasetto C.L., Regnier C.H., Moog-Lutz C., Mattei M.-G., Chenard M.-P.,
RA   Lidereau R., Basset P., Rio M.-C.;
RT   "Identification of four novel human genes amplified and overexpressed in
RT   breast carcinoma and localized to the q11-q21.3 region of chromosome 17.";
RL   Genomics 28:367-376(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R., Gnerre S.,
RA   Goldstein S., Grafham D.V., Grocock R., Hafez N., Hagopian D.S., Hart E.,
RA   Norman C.H., Humphray S., Jaffe D.B., Jones M., Kamal M., Khodiyar V.K.,
RA   LaButti K., Laird G., Lehoczky J., Liu X., Lokyitsang T., Loveland J.,
RA   Lui A., Macdonald P., Major J.E., Matthews L., Mauceli E., McCarroll S.A.,
RA   Mihalev A.H., Mudge J., Nguyen C., Nicol R., O'Leary S.B., Osoegawa K.,
RA   Schwartz D.C., Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in the
RT   human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Liver, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 1-7, AND ACETYLATION AT MET-1.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A., Thomas G.R.,
RA   Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass spectrometric
RT   identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [6]
RP   DOMAINS.
RX   PubMed=7589475; DOI=10.1016/0014-5793(95)01040-l;
RA   Tomasetto C., Moog-Lutz C., Regnier C.H., Schreiber V., Basset P.,
RA   Rio M.-C.;
RT   "Lasp-1 (MLN 50) defines a new LIM protein subfamily characterized by the
RT   association of LIM and SH3 domains.";
RL   FEBS Lett. 373:245-249(1995).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-104, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa cells
RT   and high confident phosphopeptide identification by cross-validation of
RT   MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-146, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-68; THR-104 AND SER-146, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   INTERACTION WITH KBTBD10.
RX   PubMed=19726686; DOI=10.1074/jbc.m109.023259;
RA   Gray C.H., McGarry L.C., Spence H.J., Riboldi-Tunnicliffe A., Ozanne B.W.;
RT   "Novel beta-propeller of the BTB-Kelch protein Krp1 provides a binding site
RT   for Lasp-1 that is necessary for pseudopodial extension.";
RL   J. Biol. Chem. 284:30498-30507(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-68 AND THR-104, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-42, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-68; THR-104; SER-118 AND
RP   SER-146, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-68; SER-99; THR-104; SER-134
RP   AND SER-146, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-146, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT LYS-75, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Plays an important role in the regulation of dynamic actin-
CC       based, cytoskeletal activities. Agonist-dependent changes in LASP1
CC       phosphorylation may also serve to regulate actin-associated ion
CC       transport activities, not only in the parietal cell but also in certain
CC       other F-actin-rich secretory epithelial cell types (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with F-actin (By similarity). Interacts with ANKRD54
CC       (By similarity). Interacts with KBTBD10. {ECO:0000250,
CC       ECO:0000269|PubMed:19726686}.
CC   -!- INTERACTION:
CC       Q14847-2; Q49AR9: ANKS1A; NbExp=3; IntAct=EBI-9088686, EBI-11954519;
CC       Q14847; D3DTR7: ARHGEF15; NbExp=3; IntAct=EBI-742828, EBI-10176602;
CC       Q14847-2; Q5VV41: ARHGEF16; NbExp=3; IntAct=EBI-9088686, EBI-1057448;
CC       Q14847-2; Q03989: ARID5A; NbExp=3; IntAct=EBI-9088686, EBI-948603;
CC       Q14847-2; P54253: ATXN1; NbExp=3; IntAct=EBI-9088686, EBI-930964;
CC       Q14847-2; O95429: BAG4; NbExp=3; IntAct=EBI-9088686, EBI-2949658;
CC       Q14847-2; Q8TBE0: BAHD1; NbExp=3; IntAct=EBI-9088686, EBI-742750;
CC       Q14847-2; O14503: BHLHE40; NbExp=3; IntAct=EBI-9088686, EBI-711810;
CC       Q14847-2; Q8N9W6-4: BOLL; NbExp=3; IntAct=EBI-9088686, EBI-11983447;
CC       Q14847-2; Q9NWQ9: C14orf119; NbExp=3; IntAct=EBI-9088686, EBI-725606;
CC       Q14847-2; Q5BKX5-3: C19orf54; NbExp=3; IntAct=EBI-9088686, EBI-11976299;
CC       Q14847-2; Q9UQM7: CAMK2A; NbExp=3; IntAct=EBI-9088686, EBI-1383687;
CC       Q14847-2; Q8NEC5: CATSPER1; NbExp=3; IntAct=EBI-9088686, EBI-744545;
CC       Q14847-2; Q5T4B2: CERCAM; NbExp=3; IntAct=EBI-9088686, EBI-12261896;
CC       Q14847-2; Q8IWX8: CHERP; NbExp=3; IntAct=EBI-9088686, EBI-2555370;
CC       Q14847-2; P05813: CRYBA1; NbExp=3; IntAct=EBI-9088686, EBI-7043337;
CC       Q14847-2; P53672: CRYBA2; NbExp=4; IntAct=EBI-9088686, EBI-750444;
CC       Q14847-2; Q9H0L4: CSTF2T; NbExp=3; IntAct=EBI-9088686, EBI-747012;
CC       Q14847-2; Q9UI47-2: CTNNA3; NbExp=3; IntAct=EBI-9088686, EBI-11962928;
CC       Q14847-2; A8MQ03: CYSRT1; NbExp=8; IntAct=EBI-9088686, EBI-3867333;
CC       Q14847-2; Q15038: DAZAP2; NbExp=5; IntAct=EBI-9088686, EBI-724310;
CC       Q14847-2; Q9NQL9: DMRT3; NbExp=3; IntAct=EBI-9088686, EBI-9679045;
CC       Q14847-2; Q6PKX4: DOK6; NbExp=3; IntAct=EBI-9088686, EBI-2880244;
CC       Q14847-2; Q86UW9: DTX2; NbExp=3; IntAct=EBI-9088686, EBI-740376;
CC       Q14847-2; Q03828: EVX2; NbExp=3; IntAct=EBI-9088686, EBI-17280301;
CC       Q14847-2; Q92567-2: FAM168A; NbExp=3; IntAct=EBI-9088686, EBI-11978259;
CC       Q14847-2; A1KXE4-2: FAM168B; NbExp=3; IntAct=EBI-9088686, EBI-12193763;
CC       Q14847-2; Q96EF6: FBXO17; NbExp=5; IntAct=EBI-9088686, EBI-2510157;
CC       Q14847-2; O75593: FOXH1; NbExp=3; IntAct=EBI-9088686, EBI-1759806;
CC       Q14847; P51116: FXR2; NbExp=3; IntAct=EBI-742828, EBI-740459;
CC       Q14847-2; O95995: GAS8; NbExp=3; IntAct=EBI-9088686, EBI-1052570;
CC       Q14847-2; O75603: GCM2; NbExp=3; IntAct=EBI-9088686, EBI-10188645;
CC       Q14847; Q08379: GOLGA2; NbExp=3; IntAct=EBI-742828, EBI-618309;
CC       Q14847-2; Q96NT3-2: GUCD1; NbExp=3; IntAct=EBI-9088686, EBI-11978177;
CC       Q14847-2; O14964: HGS; NbExp=3; IntAct=EBI-9088686, EBI-740220;
CC       Q14847-2; P52597: HNRNPF; NbExp=3; IntAct=EBI-9088686, EBI-352986;
CC       Q14847-2; P49639: HOXA1; NbExp=3; IntAct=EBI-9088686, EBI-740785;
CC       Q14847-2; Q5TA45: INTS11; NbExp=3; IntAct=EBI-9088686, EBI-748258;
CC       Q14847-2; P60410: KRTAP10-8; NbExp=3; IntAct=EBI-9088686, EBI-10171774;
CC       Q14847-2; P60329: KRTAP12-4; NbExp=3; IntAct=EBI-9088686, EBI-10176396;
CC       Q14847-2; Q7Z4W3: KRTAP19-3; NbExp=3; IntAct=EBI-9088686, EBI-12020132;
CC       Q14847-2; Q3LI73: KRTAP19-4; NbExp=3; IntAct=EBI-9088686, EBI-12958461;
CC       Q14847-2; Q3LI70: KRTAP19-6; NbExp=3; IntAct=EBI-9088686, EBI-12805508;
CC       Q14847-2; Q6PEX3: KRTAP26-1; NbExp=3; IntAct=EBI-9088686, EBI-3957672;
CC       Q14847-2; Q9BYR7: KRTAP3-2; NbExp=3; IntAct=EBI-9088686, EBI-751260;
CC       Q14847-2; Q9BYR6: KRTAP3-3; NbExp=3; IntAct=EBI-9088686, EBI-3957694;
CC       Q14847; Q9BYR5: KRTAP4-2; NbExp=3; IntAct=EBI-742828, EBI-10172511;
CC       Q14847-2; Q3LI66: KRTAP6-2; NbExp=3; IntAct=EBI-9088686, EBI-11962084;
CC       Q14847-2; Q96PV6: LENG8; NbExp=3; IntAct=EBI-9088686, EBI-739546;
CC       Q14847-2; P61968: LMO4; NbExp=3; IntAct=EBI-9088686, EBI-2798728;
CC       Q14847; Q93052: LPP; NbExp=3; IntAct=EBI-742828, EBI-718388;
CC       Q14847; Q9BRK4: LZTS2; NbExp=3; IntAct=EBI-742828, EBI-741037;
CC       Q14847; Q99750: MDFI; NbExp=3; IntAct=EBI-742828, EBI-724076;
CC       Q14847-2; Q99750: MDFI; NbExp=3; IntAct=EBI-9088686, EBI-724076;
CC       Q14847-2; Q71SY5: MED25; NbExp=3; IntAct=EBI-9088686, EBI-394558;
CC       Q14847-2; Q13064: MKRN3; NbExp=3; IntAct=EBI-9088686, EBI-2340269;
CC       Q14847-2; Q86UR1-2: NOXA1; NbExp=3; IntAct=EBI-9088686, EBI-12025760;
CC       Q14847-2; P61970: NUTF2; NbExp=3; IntAct=EBI-9088686, EBI-591778;
CC       Q14847-2; P32242: OTX1; NbExp=3; IntAct=EBI-9088686, EBI-740446;
CC       Q14847-2; Q8TDS5: OXER1; NbExp=3; IntAct=EBI-9088686, EBI-12813389;
CC       Q14847-2; P78337: PITX1; NbExp=5; IntAct=EBI-9088686, EBI-748265;
CC       Q14847-2; P28340: POLD1; NbExp=3; IntAct=EBI-9088686, EBI-716569;
CC       Q14847-2; P28069: POU1F1; NbExp=5; IntAct=EBI-9088686, EBI-8673859;
CC       Q14847-2; Q7Z5V6-2: PPP1R32; NbExp=3; IntAct=EBI-9088686, EBI-12000762;
CC       Q14847-2; P86480: PRR20D; NbExp=3; IntAct=EBI-9088686, EBI-12754095;
CC       Q14847-2; P0CG20: PRR35; NbExp=3; IntAct=EBI-9088686, EBI-11986293;
CC       Q14847; P25788: PSMA3; NbExp=3; IntAct=EBI-742828, EBI-348380;
CC       Q14847-2; Q2TAL8: QRICH1; NbExp=3; IntAct=EBI-9088686, EBI-2798044;
CC       Q14847-2; Q9NWB1-5: RBFOX1; NbExp=3; IntAct=EBI-9088686, EBI-12123390;
CC       Q14847-2; Q93062-3: RBPMS; NbExp=8; IntAct=EBI-9088686, EBI-740343;
CC       Q14847-2; Q6ZRY4: RBPMS2; NbExp=3; IntAct=EBI-9088686, EBI-11987469;
CC       Q14847; Q04864: REL; NbExp=3; IntAct=EBI-742828, EBI-307352;
CC       Q14847; Q9BQY4: RHOXF2; NbExp=3; IntAct=EBI-742828, EBI-372094;
CC       Q14847-2; Q9BQY4: RHOXF2; NbExp=3; IntAct=EBI-9088686, EBI-372094;
CC       Q14847-2; Q9H0F5: RNF38; NbExp=3; IntAct=EBI-9088686, EBI-2341200;
CC       Q14847; Q9UH03: SEPTIN3; NbExp=3; IntAct=EBI-742828, EBI-727037;
CC       Q14847; Q9NP31: SH2D2A; NbExp=2; IntAct=EBI-742828, EBI-490630;
CC       Q14847-2; Q99932-2: SPAG8; NbExp=3; IntAct=EBI-9088686, EBI-11959123;
CC       Q14847; O43597: SPRY2; NbExp=3; IntAct=EBI-742828, EBI-742487;
CC       Q14847; P15884: TCF4; NbExp=3; IntAct=EBI-742828, EBI-533224;
CC       Q14847-2; Q9BXF9: TEKT3; NbExp=3; IntAct=EBI-9088686, EBI-8644516;
CC       Q14847-2; Q8WW24: TEKT4; NbExp=3; IntAct=EBI-9088686, EBI-750487;
CC       Q14847-2; Q96M29: TEKT5; NbExp=3; IntAct=EBI-9088686, EBI-10239812;
CC       Q14847-2; Q92734: TFG; NbExp=3; IntAct=EBI-9088686, EBI-357061;
CC       Q14847; Q9NVV9: THAP1; NbExp=3; IntAct=EBI-742828, EBI-741515;
CC       Q14847; Q9UDY2: TJP2; NbExp=9; IntAct=EBI-742828, EBI-1042602;
CC       Q14847-2; O43711: TLX3; NbExp=5; IntAct=EBI-9088686, EBI-3939165;
CC       Q14847-2; Q63HR2: TNS2; NbExp=3; IntAct=EBI-9088686, EBI-949753;
CC       Q14847; P14373: TRIM27; NbExp=3; IntAct=EBI-742828, EBI-719493;
CC       Q14847; Q15645: TRIP13; NbExp=7; IntAct=EBI-742828, EBI-358993;
CC       Q14847-2; Q15645: TRIP13; NbExp=3; IntAct=EBI-9088686, EBI-358993;
CC       Q14847-2; Q9UHD9: UBQLN2; NbExp=3; IntAct=EBI-9088686, EBI-947187;
CC       Q14847-2; Q6NVU6: UFSP1; NbExp=3; IntAct=EBI-9088686, EBI-12068150;
CC       Q14847-2; Q08AM6: VAC14; NbExp=3; IntAct=EBI-9088686, EBI-2107455;
CC       Q14847-2; Q14119: VEZF1; NbExp=3; IntAct=EBI-9088686, EBI-11980193;
CC       Q14847-2; A8MV65-2: VGLL3; NbExp=3; IntAct=EBI-9088686, EBI-11957216;
CC       Q14847-2; A5D8V6: VPS37C; NbExp=3; IntAct=EBI-9088686, EBI-2559305;
CC       Q14847-2; Q9NZC7-5: WWOX; NbExp=3; IntAct=EBI-9088686, EBI-12040603;
CC       Q14847-2; P07947: YES1; NbExp=3; IntAct=EBI-9088686, EBI-515331;
CC       Q14847-2; Q9BYJ9: YTHDF1; NbExp=3; IntAct=EBI-9088686, EBI-1051237;
CC       Q14847; Q96C00: ZBTB9; NbExp=4; IntAct=EBI-742828, EBI-395708;
CC       Q14847; Q96GY0: ZC2HC1A; NbExp=3; IntAct=EBI-742828, EBI-5458880;
CC       Q14847-2; Q96K80: ZC3H10; NbExp=3; IntAct=EBI-9088686, EBI-742550;
CC       Q14847-2; Q8IUH5: ZDHHC17; NbExp=3; IntAct=EBI-9088686, EBI-524753;
CC       Q14847; Q15942: ZYX; NbExp=5; IntAct=EBI-742828, EBI-444225;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cell cortex {ECO:0000250}. Cytoplasm,
CC       cytoskeleton {ECO:0000250}. Note=Associated with the F-actin rich
CC       cortical cytoskeleton. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q14847-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q14847-2; Sequence=VSP_016554;
CC       Name=3;
CC         IsoId=Q14847-3; Sequence=VSP_054611;
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/Lasp1ID203.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X82456; CAA57833.1; -; mRNA.
DR   EMBL; AK294704; BAG57861.1; -; mRNA.
DR   EMBL; AC006441; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC110749; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC007560; AAH07560.1; -; mRNA.
DR   EMBL; BC012460; AAH12460.1; -; mRNA.
DR   CCDS; CCDS11331.1; -. [Q14847-1]
DR   CCDS; CCDS62164.1; -. [Q14847-3]
DR   PIR; S68234; S68234.
DR   RefSeq; NP_001258537.1; NM_001271608.1. [Q14847-3]
DR   RefSeq; NP_006139.1; NM_006148.3. [Q14847-1]
DR   PDB; 3I35; X-ray; 1.40 A; A=202-261.
DR   PDBsum; 3I35; -.
DR   SMR; Q14847; -.
DR   BioGrid; 110120; 106.
DR   IntAct; Q14847; 139.
DR   MINT; Q14847; -.
DR   STRING; 9606.ENSP00000325240; -.
DR   iPTMnet; Q14847; -.
DR   MetOSite; Q14847; -.
DR   PhosphoSitePlus; Q14847; -.
DR   SwissPalm; Q14847; -.
DR   BioMuta; LASP1; -.
DR   DMDM; 3122342; -.
DR   OGP; Q14847; -.
DR   SWISS-2DPAGE; Q14847; -.
DR   CPTAC; CPTAC-86; -.
DR   CPTAC; CPTAC-87; -.
DR   CPTAC; CPTAC-928; -.
DR   EPD; Q14847; -.
DR   jPOST; Q14847; -.
DR   MassIVE; Q14847; -.
DR   MaxQB; Q14847; -.
DR   PaxDb; Q14847; -.
DR   PeptideAtlas; Q14847; -.
DR   PRIDE; Q14847; -.
DR   ProteomicsDB; 4149; -.
DR   ProteomicsDB; 60206; -. [Q14847-1]
DR   ProteomicsDB; 60207; -. [Q14847-2]
DR   Antibodypedia; 1894; 381 antibodies.
DR   DNASU; 3927; -.
DR   Ensembl; ENST00000318008; ENSP00000325240; ENSG00000002834. [Q14847-1]
DR   Ensembl; ENST00000433206; ENSP00000401048; ENSG00000002834. [Q14847-3]
DR   Ensembl; ENST00000435347; ENSP00000392853; ENSG00000002834. [Q14847-1]
DR   GeneID; 3927; -.
DR   KEGG; hsa:3927; -.
DR   UCSC; uc002hra.3; human. [Q14847-1]
DR   CTD; 3927; -.
DR   DisGeNET; 3927; -.
DR   GeneCards; LASP1; -.
DR   HGNC; HGNC:6513; LASP1.
DR   HPA; ENSG00000002834; Tissue enhanced (intestine).
DR   MIM; 602920; gene.
DR   neXtProt; NX_Q14847; -.
DR   OpenTargets; ENSG00000002834; -.
DR   PharmGKB; PA30298; -.
DR   eggNOG; KOG1702; Eukaryota.
DR   eggNOG; ENOG4111GQ8; LUCA.
DR   GeneTree; ENSGT00940000154775; -.
DR   HOGENOM; CLU_026811_0_1_1; -.
DR   InParanoid; Q14847; -.
DR   OMA; GYEKTPY; -.
DR   PhylomeDB; Q14847; -.
DR   TreeFam; TF319104; -.
DR   SIGNOR; Q14847; -.
DR   ChiTaRS; LASP1; human.
DR   EvolutionaryTrace; Q14847; -.
DR   GeneWiki; LASP1; -.
DR   GenomeRNAi; 3927; -.
DR   Pharos; Q14847; Tbio.
DR   PRO; PR:Q14847; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q14847; protein.
DR   Bgee; ENSG00000002834; Expressed in upper lobe of lung and 237 other tissues.
DR   ExpressionAtlas; Q14847; baseline and differential.
DR   Genevisible; Q14847; HS.
DR   GO; GO:0030864; C:cortical actin cytoskeleton; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0051015; F:actin filament binding; IBA:GO_Central.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0015075; F:ion transmembrane transporter activity; ISS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005070; F:SH3/SH2 adaptor activity; TAS:ProtInc.
DR   GO; GO:0006811; P:ion transport; ISS:UniProtKB.
DR   CDD; cd11934; SH3_Lasp1_C; 1.
DR   InterPro; IPR035630; Lasp1_SH3.
DR   InterPro; IPR000900; Nebulin_repeat.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR001781; Znf_LIM.
DR   Pfam; PF00412; LIM; 1.
DR   Pfam; PF00880; Nebulin; 2.
DR   Pfam; PF14604; SH3_9; 1.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   SMART; SM00132; LIM; 1.
DR   SMART; SM00227; NEBU; 2.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   PROSITE; PS00478; LIM_DOMAIN_1; 1.
DR   PROSITE; PS50023; LIM_DOMAIN_2; 1.
DR   PROSITE; PS51216; NEBULIN; 2.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Actin-binding; Alternative splicing; Cytoplasm;
KW   Cytoskeleton; Direct protein sequencing; Ion transport; LIM domain;
KW   Metal-binding; Methylation; Phosphoprotein; Reference proteome; Repeat;
KW   SH3 domain; Transport; Zinc.
FT   CHAIN           1..261
FT                   /note="LIM and SH3 domain protein 1"
FT                   /id="PRO_0000075761"
FT   DOMAIN          5..56
FT                   /note="LIM zinc-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00125"
FT   REPEAT          61..95
FT                   /note="Nebulin 1"
FT   REPEAT          97..131
FT                   /note="Nebulin 2"
FT   DOMAIN          202..261
FT                   /note="SH3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   COMPBIAS        201..204
FT                   /note="Poly-Gly"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000269|PubMed:12665801"
FT   MOD_RES         42
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         68
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         75
FT                   /note="N6-methyllysine"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         99
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         104
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:17924679,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163"
FT   MOD_RES         112
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61792"
FT   MOD_RES         118
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         134
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         146
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18088087,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   VAR_SEQ         1..83
FT                   /note="MNPNCARCGKIVYPTEKVNCLDKFWHKACFHCETCKMTLNMKNYKGYEKKPY
FT                   CNAHYPKQSFTMVADTPENLRLKQQSELQSQ -> MLPLRDLQDDTEHEELQGLREEAL
FT                   LQR (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_054611"
FT   VAR_SEQ         201..261
FT                   /note="GGGGKRYRAVYDYSAADEDEVSFQDGDTIVNVQQIDDGWMYGTVERTGDTGM
FT                   LPANYVEAI -> ICLQHIPRHRIRPGRDPSILQCLCFLKPATACDSYPSSSFFCQLKP
FT                   SSATSAGSLLWQASPLIDFLVFSLDGTGMGLSGGGRGPWGRAGMGDLLACGPHLPLCSL
FT                   PSHPPAQLLTYPHIPGLG (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_016554"
FT   CONFLICT        79
FT                   /note="E -> R (in Ref. 4; AAH12460)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        210
FT                   /note="V -> A (in Ref. 4; AAH12460)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        220
FT                   /note="E -> A (in Ref. 4; AAH12460)"
FT                   /evidence="ECO:0000305"
FT   STRAND          207..211
FT                   /evidence="ECO:0000244|PDB:3I35"
FT   STRAND          228..236
FT                   /evidence="ECO:0000244|PDB:3I35"
FT   STRAND          239..244
FT                   /evidence="ECO:0000244|PDB:3I35"
FT   TURN            245..248
FT                   /evidence="ECO:0000244|PDB:3I35"
FT   STRAND          249..254
FT                   /evidence="ECO:0000244|PDB:3I35"
FT   HELIX           255..257
FT                   /evidence="ECO:0000244|PDB:3I35"
FT   STRAND          258..260
FT                   /evidence="ECO:0000244|PDB:3I35"
SQ   SEQUENCE   261 AA;  29717 MW;  3B89B988605B3639 CRC64;
     MNPNCARCGK IVYPTEKVNC LDKFWHKACF HCETCKMTLN MKNYKGYEKK PYCNAHYPKQ
     SFTMVADTPE NLRLKQQSEL QSQVRYKEEF EKNKGKGFSV VADTPELQRI KKTQDQISNI
     KYHEEFEKSR MGPSGGEGME PERRDSQDGS SYRRPLEQQQ PHHIPTSAPV YQQPQQQPVA
     QSYGGYKEPA APVSIQRSAP GGGGKRYRAV YDYSAADEDE VSFQDGDTIV NVQQIDDGWM
     YGTVERTGDT GMLPANYVEA I
//
ID   A8K1Z4_HUMAN            Unreviewed;      1097 AA.
AC   A8K1Z4;
DT   04-DEC-2007, integrated into UniProtKB/TrEMBL.
DT   04-DEC-2007, sequence version 1.
DT   11-DEC-2019, entry version 64.
DE   SubName: Full=cDNA FLJ76704, highly similar to Homo sapiens leukemia inhibitory factor receptor (LIFR), mRNA {ECO:0000313|EMBL:BAF82748.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAF82748.1};
RN   [1] {ECO:0000313|EMBL:BAF82748.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Hippocampus {ECO:0000313|EMBL:BAF82748.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK290059; BAF82748.1; -; mRNA.
DR   RefSeq; NP_001121143.1; NM_001127671.1.
DR   PeptideAtlas; A8K1Z4; -.
DR   PRIDE; A8K1Z4; -.
DR   DNASU; 3977; -.
DR   GeneID; 3977; -.
DR   KEGG; hsa:3977; -.
DR   CTD; 3977; -.
DR   PharmGKB; PA30371; -.
DR   eggNOG; ENOG410IF1V; Eukaryota.
DR   eggNOG; ENOG410ZMDF; LUCA.
DR   KO; K05058; -.
DR   OrthoDB; 331447at2759; -.
DR   GenomeRNAi; 3977; -.
DR   Genevisible; A8K1Z4; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0004896; F:cytokine receptor activity; IEA:InterPro.
DR   CDD; cd00063; FN3; 3.
DR   Gene3D; 2.60.40.10; -; 8.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR003529; Hematopoietin_rcpt_Gp130_CS.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR040817; LIFR_D2.
DR   InterPro; IPR040901; LIFR_N.
DR   Pfam; PF00041; fn3; 1.
DR   Pfam; PF17971; LIFR_D2; 1.
DR   Pfam; PF18207; LIFR_N; 1.
DR   SMART; SM00060; FN3; 5.
DR   SUPFAM; SSF49265; SSF49265; 4.
DR   PROSITE; PS50853; FN3; 5.
DR   PROSITE; PS01353; HEMATOPO_REC_L_F2; 1.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAM:Phobius}; Receptor {ECO:0000313|EMBL:BAF82748.1};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM        834..859
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          49..138
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          335..434
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          435..534
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          538..629
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          724..833
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   REGION          983..1004
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1069..1097
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1082..1097
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   1097 AA;  123831 MW;  5E600CB2EE929FF6 CRC64;
     MMDIYVCLKR PSWMVDNKRM RTASNFQWLL STFILLYLMN QVNSQKKGAP HDLKCVTNNL
     QVWNCSWKAP SGTGRGTDYE VCIENRSRSC YQLEKTSIKI PALSHGDYEI TINSLHDFGS
     STSKFTLNEQ NVSLIPDTPE ILNLSADFST STLYLKWNDR GSVFPHRSNV IWEIKVLRKE
     SMELVKLVTH NTTLNGKDTL HHWSWASDMP LECAIHFVEI RCYIDNLHFS GLEEWSDWSP
     VRNISWIPDS QTKVFPQDKV ILVGSDITFC CVSQEKVLSA LIGHTNCPLI HLDGENVAIK
     IRNISVSASS GTNVVFTTED NIFGTVIFAG YPPDTPQQLN CETHDLKEII CSWNPGRVTA
     LVGPRATSYT LVESFSGKYV RLKRAEAPTN ESYQLLFQML PNQEIYNFTL NAHNPLGRSQ
     STILVNITEK VYPHTPTSFK VKDINSTAVK LSWHLPGNFA KINFLCEIEI KKSNSVQEQR
     NVTIKGVENS SYLVALDKLN PYTLYTFRIR CSTETFWKWS KWSNKKQHLT TEASPSKGPD
     TWREWSSDGK NLIIYWKPLP INEANGKILS YNVSCSSDEE TQSLSEIPDP QHKAEIRLDK
     NDYIISVVAK NSVGSSPPSK IASMEIPNDD LKIEQVVGMG KGILLTWHYD PNMTCDYVIK
     WCNSSRSEPC LMDWRKVPSN STETVIESDE FRPGIRYNFF LYGCRNQGYQ LLRSMIGYIE
     ELAPIVAPNF TVEDTSADSI LVKWEDIPVE ELRGFLRGYL FYFGKGERDT SKMRVLESGR
     SDIKVKNITD ISQKTLRIAD LQGKTSYHLV LRAYTDGGVG PEKSMYVVTK ENSVGLIIAI
     LIPVAVAVIV GVVTSILCYR KREWIKETFY PDIPNPENCK ALQFQKSVCE GSSALKTLEM
     NPCTPNNVEV LETRSAFPKI EDTEIISPVA ERPEDRSDAE PENHVVVSYC PPIIEEEIPN
     PAADEAGGTA QVIYIDVQSM YQPQAKPEEE QENDPVGGAG YKPQMHLPIN STVEDIAAEE
     DLDKTAGYRP QANVNTWNLV SPDSPRSIDS NSEIVSFGSP CSINSRQFLI PPKDEDFPKS
     NGGGWSFTNF FQNKPND
//
ID   LIFR_HUMAN              Reviewed;        1097 AA.
AC   P42702; Q6LCD9;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 1.
DT   22-APR-2020, entry version 188.
DE   RecName: Full=Leukemia inhibitory factor receptor;
DE            Short=LIF receptor;
DE            Short=LIF-R;
DE   AltName: CD_antigen=CD118;
DE   Flags: Precursor;
GN   Name=LIFR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=1915266; DOI=10.1002/j.1460-2075.1991.tb07833.x;
RA   Gearing D.P., Thut C.J., Vanden Bos T., Gimpel S.D., Delaney P.B., King J.,
RA   Price V., Cosman D., Beckmann M.P.;
RT   "Leukemia inhibitory factor receptor is structurally related to the IL-6
RT   signal transducer, gp130.";
RL   EMBO J. 10:2839-2848(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 942-1097.
RA   Wang Z., Melmed S.;
RT   "Human LIF receptor 3' non-coding region.";
RL   Submitted (AUG-1996) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   CHROMOSOMAL TRANSLOCATION WITH PLAG1.
RX   PubMed=9525740; DOI=10.1038/sj.onc.1201660;
RA   Voz M.L., Astrom A.-K., Kas K., Mark J., Stenman G., Van de Ven W.J.M.;
RT   "The recurrent translocation t(5;8)(p13;q12) in pleomorphic adenomas
RT   results in upregulation of PLAG1 gene expression under control of the LIFR
RT   promoter.";
RL   Oncogene 16:1409-1416(1998).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-927, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (3.1 ANGSTROMS) OF 52-534, IDENTIFICATION IN A
RP   COMPLEX WITH IL6ST; CNTF AND CNTFR, GLYCOSYLATION AT ASN-131; ASN-303;
RP   ASN-407 AND ASN-426, DISULFIDE BONDS, ELECTRON MICROSCOPY, AND SUBUNIT.
RX   PubMed=18775332; DOI=10.1016/j.molcel.2008.08.011;
RA   Skiniotis G., Lupardus P.J., Martick M., Walz T., Garcia K.C.;
RT   "Structural organization of a full-length gp130/LIF-R cytokine receptor
RT   transmembrane complex.";
RL   Mol. Cell 31:737-748(2008).
RN   [6]
RP   VARIANT STWS PRO-279.
RX   PubMed=14740318; DOI=10.1086/381715;
RA   Dagoneau N., Scheffer D., Huber C., Al-Gazali L.I., Di Rocco M., Godard A.,
RA   Martinovic J., Raas-Rothschild A., Sigaudy S., Unger S., Nicole S.,
RA   Fontaine B., Taupin J.-L., Moreau J.-F., Superti-Furga A., Le Merrer M.,
RA   Bonaventure J., Munnich A., Legeai-Mallet L., Cormier-Daire V.;
RT   "Null leukemia inhibitory factor receptor (LIFR) mutations in Stueve-
RT   Wiedemann/Schwartz-Jampel type 2 syndrome.";
RL   Am. J. Hum. Genet. 74:298-305(2004).
RN   [7]
RP   VARIANT [LARGE SCALE ANALYSIS] LEU-1068.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Signal-transducing molecule. May have a common pathway with
CC       IL6ST. The soluble form inhibits the biological activity of LIF by
CC       blocking its binding to receptors on target cells.
CC   -!- SUBUNIT: Heterodimer composed of LIFR and IL6ST. The heterodimer formed
CC       by LIFR and IL6ST interacts with the complex formed by CNTF and CNTFR.
CC       {ECO:0000269|PubMed:18775332}.
CC   -!- INTERACTION:
CC       P42702; P26441: CNTF; NbExp=9; IntAct=EBI-7702162, EBI-1050897;
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Cell membrane; Single-pass type I
CC       membrane protein.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=Membrane;
CC         IsoId=P42702-1; Sequence=Displayed;
CC       Name=2; Synonyms=Secreted;
CC         IsoId=P42702-2; Sequence=Not described;
CC   -!- DOMAIN: The WSXWS motif appears to be necessary for proper protein
CC       folding and thereby efficient intracellular transport and cell-surface
CC       receptor binding.
CC   -!- DOMAIN: The box 1 motif is required for JAK interaction and/or
CC       activation.
CC   -!- DISEASE: Stueve-Wiedemann syndrome (STWS) [MIM:601559]: Severe
CC       autosomal recessive condition and belongs to the group of the bent-bone
CC       dysplasias. SWS is characterized by bowing of the lower limbs, with
CC       internal cortical thickening, wide metaphyses with abnormal trabecular
CC       pattern, and camptodactyly. Additional features include feeding and
CC       swallowing difficulties, as well as respiratory distress and
CC       hyperthermic episodes, which cause death in the first months of life.
CC       The rare survivors develop progressive scoliosis, spontaneous
CC       fractures, bowing of the lower limbs, with prominent joints and
CC       dysautonomia symptoms, including temperature instability, absent
CC       corneal and patellar reflexes, and smooth tongue.
CC       {ECO:0000269|PubMed:14740318}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Note=A chromosomal aberration involving LIFR is found in
CC       salivary gland pleiomorphic adenomas, the most common benign epithelial
CC       tumors of the salivary gland. Translocation t(5;8)(p13;q12) with PLAG1.
CC   -!- SIMILARITY: Belongs to the type I cytokine receptor family. Type 2
CC       subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/LIFRID410ch5p13.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X61615; CAA43805.1; -; mRNA.
DR   EMBL; U66563; AAB61897.1; -; mRNA.
DR   CCDS; CCDS3927.1; -. [P42702-1]
DR   PIR; S17308; S17308.
DR   RefSeq; NP_001121143.1; NM_001127671.1. [P42702-1]
DR   RefSeq; NP_002301.1; NM_002310.5. [P42702-1]
DR   RefSeq; XP_011512342.1; XM_011514040.2.
DR   RefSeq; XP_011512344.1; XM_011514042.2. [P42702-1]
DR   RefSeq; XP_016864952.1; XM_017009463.1. [P42702-1]
DR   PDB; 3E0G; X-ray; 3.10 A; A=52-534.
DR   PDBsum; 3E0G; -.
DR   SMR; P42702; -.
DR   BioGrid; 110165; 17.
DR   CORUM; P42702; -.
DR   DIP; DIP-5770N; -.
DR   IntAct; P42702; 14.
DR   MINT; P42702; -.
DR   STRING; 9606.ENSP00000263409; -.
DR   iPTMnet; P42702; -.
DR   PhosphoSitePlus; P42702; -.
DR   BioMuta; LIFR; -.
DR   DMDM; 1170784; -.
DR   EPD; P42702; -.
DR   jPOST; P42702; -.
DR   MassIVE; P42702; -.
DR   PaxDb; P42702; -.
DR   PeptideAtlas; P42702; -.
DR   PRIDE; P42702; -.
DR   ProteomicsDB; 55546; -. [P42702-1]
DR   Antibodypedia; 4137; 422 antibodies.
DR   DNASU; 3977; -.
DR   Ensembl; ENST00000263409; ENSP00000263409; ENSG00000113594. [P42702-1]
DR   Ensembl; ENST00000453190; ENSP00000398368; ENSG00000113594. [P42702-1]
DR   GeneID; 3977; -.
DR   KEGG; hsa:3977; -.
DR   UCSC; uc003jli.3; human. [P42702-1]
DR   CTD; 3977; -.
DR   DisGeNET; 3977; -.
DR   GeneCards; LIFR; -.
DR   HGNC; HGNC:6597; LIFR.
DR   HPA; ENSG00000113594; Low tissue specificity.
DR   MalaCards; LIFR; -.
DR   MIM; 151443; gene.
DR   MIM; 601559; phenotype.
DR   neXtProt; NX_P42702; -.
DR   OpenTargets; ENSG00000113594; -.
DR   Orphanet; 3206; Stueve-Wiedemann syndrome.
DR   PharmGKB; PA30371; -.
DR   eggNOG; ENOG410IF1V; Eukaryota.
DR   eggNOG; ENOG410ZMDF; LUCA.
DR   GeneTree; ENSGT00940000155776; -.
DR   HOGENOM; CLU_283805_0_0_1; -.
DR   InParanoid; P42702; -.
DR   KO; K05058; -.
DR   OMA; GYKPQMR; -.
DR   OrthoDB; 331447at2759; -.
DR   PhylomeDB; P42702; -.
DR   TreeFam; TF338122; -.
DR   Reactome; R-HSA-6788467; IL-6-type cytokine receptor ligand interactions.
DR   Reactome; R-HSA-8939247; RUNX1 regulates transcription of genes involved in interleukin signaling.
DR   SignaLink; P42702; -.
DR   SIGNOR; P42702; -.
DR   ChiTaRS; LIFR; human.
DR   EvolutionaryTrace; P42702; -.
DR   GeneWiki; Leukemia_inhibitory_factor_receptor; -.
DR   GenomeRNAi; 3977; -.
DR   Pharos; P42702; Tbio.
DR   PRO; PR:P42702; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; P42702; protein.
DR   Bgee; ENSG00000113594; Expressed in placenta and 217 other tissues.
DR   ExpressionAtlas; P42702; baseline and differential.
DR   Genevisible; P42702; HS.
DR   GO; GO:0009897; C:external side of plasma membrane; IBA:GO_Central.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0043235; C:receptor complex; IDA:BHF-UCL.
DR   GO; GO:0005127; F:ciliary neurotrophic factor receptor binding; IPI:BHF-UCL.
DR   GO; GO:0019955; F:cytokine binding; IBA:GO_Central.
DR   GO; GO:0004896; F:cytokine receptor activity; IBA:GO_Central.
DR   GO; GO:0019838; F:growth factor binding; IPI:BHF-UCL.
DR   GO; GO:0004923; F:leukemia inhibitory factor receptor activity; IDA:MGI.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc.
DR   GO; GO:0070120; P:ciliary neurotrophic factor-mediated signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; IDA:MGI.
DR   GO; GO:0048861; P:leukemia inhibitory factor signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0038165; P:oncostatin-M-mediated signaling pathway; IMP:BHF-UCL.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IDA:BHF-UCL.
DR   GO; GO:0001959; P:regulation of cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0034097; P:response to cytokine; IDA:BHF-UCL.
DR   CDD; cd00063; FN3; 3.
DR   Gene3D; 2.60.40.10; -; 8.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR003529; Hematopoietin_rcpt_Gp130_CS.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR040817; LIFR_D2.
DR   InterPro; IPR040901; LIFR_N.
DR   Pfam; PF00041; fn3; 1.
DR   Pfam; PF17971; LIFR_D2; 1.
DR   Pfam; PF18207; LIFR_N; 1.
DR   SMART; SM00060; FN3; 5.
DR   SUPFAM; SSF49265; SSF49265; 4.
DR   PROSITE; PS50853; FN3; 5.
DR   PROSITE; PS01353; HEMATOPO_REC_L_F2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane;
KW   Chromosomal rearrangement; Disease mutation; Disulfide bond; Glycoprotein;
KW   Membrane; Phosphoprotein; Polymorphism; Receptor; Reference proteome;
KW   Repeat; Secreted; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..44
FT                   /evidence="ECO:0000255"
FT   CHAIN           45..1097
FT                   /note="Leukemia inhibitory factor receptor"
FT                   /id="PRO_0000010902"
FT   TOPO_DOM        45..833
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        834..858
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        859..1097
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          49..138
FT                   /note="Fibronectin type-III 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          335..434
FT                   /note="Fibronectin type-III 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          435..534
FT                   /note="Fibronectin type-III 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          538..629
FT                   /note="Fibronectin type-III 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          627..719
FT                   /note="Fibronectin type-III 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          724..833
FT                   /note="Fibronectin type-III 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   MOTIF           519..523
FT                   /note="WSXWS motif"
FT   MOTIF           869..877
FT                   /note="Box 1 motif"
FT   MOD_RES         927
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         1044
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P42703"
FT   CARBOHYD        64
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        85
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        131
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:18775332"
FT   CARBOHYD        143
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        191
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        243
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        303
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:18775332"
FT   CARBOHYD        390
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        407
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:18775332"
FT   CARBOHYD        426
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:18775332"
FT   CARBOHYD        445
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        481
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        489
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        572
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        652
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        663
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        680
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        729
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        787
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        55..65
FT                   /evidence="ECO:0000269|PubMed:18775332"
FT   DISULFID        82..90
FT                   /evidence="ECO:0000269|PubMed:18775332"
FT   DISULFID        213..270
FT                   /evidence="ECO:0000269|PubMed:18775332"
FT   DISULFID        341..351
FT                   /evidence="ECO:0000269|PubMed:18775332"
FT   DISULFID        466..511
FT                   /evidence="ECO:0000269|PubMed:18775332"
FT   VARIANT         116
FT                   /note="H -> Y (in dbSNP:rs3729734)"
FT                   /id="VAR_029109"
FT   VARIANT         279
FT                   /note="S -> P (in STWS)"
FT                   /evidence="ECO:0000269|PubMed:14740318"
FT                   /id="VAR_025666"
FT   VARIANT         578
FT                   /note="D -> N (in dbSNP:rs3729740)"
FT                   /id="VAR_029110"
FT   VARIANT         633
FT                   /note="I -> M (in dbSNP:rs2303743)"
FT                   /id="VAR_021996"
FT   VARIANT         664
FT                   /note="S -> L (in dbSNP:rs3729744)"
FT                   /id="VAR_038626"
FT   VARIANT         785
FT                   /note="V -> I (in dbSNP:rs3110234)"
FT                   /id="VAR_029111"
FT   VARIANT         1068
FT                   /note="F -> L (in a colorectal cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_036166"
FT   STRAND          55..59
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   STRAND          62..66
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   STRAND          71..73
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   STRAND          79..83
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   STRAND          85..87
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   STRAND          89..97
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   STRAND          104..106
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   STRAND          110..113
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   STRAND          145..147
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   TURN            148..151
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   STRAND          152..159
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   HELIX           161..163
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   STRAND          169..181
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   STRAND          183..192
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   HELIX           194..196
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   STRAND          199..206
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   STRAND          216..225
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   STRAND          231..233
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   STRAND          242..244
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   STRAND          254..256
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   STRAND          258..262
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   STRAND          267..271
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   STRAND          277..284
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   STRAND          293..295
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   STRAND          297..301
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   STRAND          312..320
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   STRAND          322..330
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   STRAND          337..345
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   STRAND          348..354
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   HELIX           363..365
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   STRAND          368..373
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   TURN            374..376
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   STRAND          379..382
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   STRAND          393..398
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   STRAND          406..413
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   STRAND          418..425
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   HELIX           427..430
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   STRAND          437..441
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   STRAND          444..448
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   STRAND          451..454
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   STRAND          467..471
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   STRAND          473..475
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   STRAND          479..481
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   STRAND          488..491
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   STRAND          501..504
FT                   /evidence="ECO:0000244|PDB:3E0G"
FT   STRAND          506..510
FT                   /evidence="ECO:0000244|PDB:3E0G"
SQ   SEQUENCE   1097 AA;  123743 MW;  C8602897E359FCE5 CRC64;
     MMDIYVCLKR PSWMVDNKRM RTASNFQWLL STFILLYLMN QVNSQKKGAP HDLKCVTNNL
     QVWNCSWKAP SGTGRGTDYE VCIENRSRSC YQLEKTSIKI PALSHGDYEI TINSLHDFGS
     STSKFTLNEQ NVSLIPDTPE ILNLSADFST STLYLKWNDR GSVFPHRSNV IWEIKVLRKE
     SMELVKLVTH NTTLNGKDTL HHWSWASDMP LECAIHFVEI RCYIDNLHFS GLEEWSDWSP
     VKNISWIPDS QTKVFPQDKV ILVGSDITFC CVSQEKVLSA LIGHTNCPLI HLDGENVAIK
     IRNISVSASS GTNVVFTTED NIFGTVIFAG YPPDTPQQLN CETHDLKEII CSWNPGRVTA
     LVGPRATSYT LVESFSGKYV RLKRAEAPTN ESYQLLFQML PNQEIYNFTL NAHNPLGRSQ
     STILVNITEK VYPHTPTSFK VKDINSTAVK LSWHLPGNFA KINFLCEIEI KKSNSVQEQR
     NVTIKGVENS SYLVALDKLN PYTLYTFRIR CSTETFWKWS KWSNKKQHLT TEASPSKGPD
     TWREWSSDGK NLIIYWKPLP INEANGKILS YNVSCSSDEE TQSLSEIPDP QHKAEIRLDK
     NDYIISVVAK NSVGSSPPSK IASMEIPNDD LKIEQVVGMG KGILLTWHYD PNMTCDYVIK
     WCNSSRSEPC LMDWRKVPSN STETVIESDE FRPGIRYNFF LYGCRNQGYQ LLRSMIGYIE
     ELAPIVAPNF TVEDTSADSI LVKWEDIPVE ELRGFLRGYL FYFGKGERDT SKMRVLESGR
     SDIKVKNITD ISQKTLRIAD LQGKTSYHLV LRAYTDGGVG PEKSMYVVTK ENSVGLIIAI
     LIPVAVAVIV GVVTSILCYR KREWIKETFY PDIPNPENCK ALQFQKSVCE GSSALKTLEM
     NPCTPNNVEV LETRSAFPKI EDTEIISPVA ERPEDRSDAE PENHVVVSYC PPIIEEEIPN
     PAADEAGGTA QVIYIDVQSM YQPQAKPEEE QENDPVGGAG YKPQMHLPIN STVEDIAAEE
     DLDKTAGYRP QANVNTWNLV SPDSPRSIDS NSEIVSFGSP CSINSRQFLI PPKDEDSPKS
     NGGGWSFTNF FQNKPND
//
ID   A0A384MQX1_HUMAN        Unreviewed;       664 AA.
AC   A0A384MQX1;
DT   05-DEC-2018, integrated into UniProtKB/TrEMBL.
DT   05-DEC-2018, sequence version 1.
DT   22-APR-2020, entry version 10.
DE   SubName: Full=Epididymis secretory sperm binding protein {ECO:0000313|EMBL:ADO22171.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ADO22171.1};
RN   [1] {ECO:0000313|EMBL:ADO22171.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Hoernsten L., Su C., Osbourn A.E., Hellman U., Wernstedt C., Oliw E.H.;
RL   Submitted (SEP-2009) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the intermediate filament family.
CC       {ECO:0000256|RuleBase:RU000685, ECO:0000256|SAAS:SAAS01036505}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; GQ891309; ADO22171.1; -; mRNA.
DR   RefSeq; NP_733821.1; NM_170707.3.
DR   SMR; A0A384MQX1; -.
DR   Antibodypedia; 1676; 1551 antibodies.
DR   GeneID; 4000; -.
DR   KEGG; hsa:4000; -.
DR   CTD; 4000; -.
DR   KO; K12641; -.
DR   OMA; ERMMSEF; -.
DR   ExpressionAtlas; A0A384MQX1; baseline and differential.
DR   GO; GO:0005638; C:lamin filament; IEA:Ensembl.
DR   GO; GO:0031965; C:nuclear membrane; IEA:Ensembl.
DR   GO; GO:0030951; P:establishment or maintenance of microtubule cytoskeleton polarity; IEA:Ensembl.
DR   GO; GO:1903243; P:negative regulation of cardiac muscle hypertrophy in response to stress; IEA:Ensembl.
DR   GO; GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IEA:Ensembl.
DR   GO; GO:0072201; P:negative regulation of mesenchymal cell proliferation; IEA:Ensembl.
DR   GO; GO:0090201; P:negative regulation of release of cytochrome c from mitochondria; IEA:Ensembl.
DR   GO; GO:0006998; P:nuclear envelope organization; IEA:Ensembl.
DR   GO; GO:0010628; P:positive regulation of gene expression; IEA:Ensembl.
DR   GO; GO:1900114; P:positive regulation of histone H3-K9 trimethylation; IEA:Ensembl.
DR   GO; GO:0006606; P:protein import into nucleus; IEA:Ensembl.
DR   GO; GO:0030334; P:regulation of cell migration; IEA:Ensembl.
DR   GO; GO:1900180; P:regulation of protein localization to nucleus; IEA:Ensembl.
DR   GO; GO:0031647; P:regulation of protein stability; IEA:Ensembl.
DR   GO; GO:0055015; P:ventricular cardiac muscle cell development; IEA:Ensembl.
DR   Gene3D; 1.20.5.1160; -; 1.
DR   Gene3D; 2.60.40.1260; -; 1.
DR   InterPro; IPR018039; IF_conserved.
DR   InterPro; IPR039008; IF_rod_dom.
DR   InterPro; IPR042180; IF_rod_dom_coil1B.
DR   InterPro; IPR001322; Lamin_tail_dom.
DR   InterPro; IPR036415; Lamin_tail_dom_sf.
DR   Pfam; PF00038; Filament; 1.
DR   Pfam; PF00932; LTD; 1.
DR   SMART; SM01391; Filament; 1.
DR   SUPFAM; SSF74853; SSF74853; 1.
DR   PROSITE; PS00226; IF_ROD_1; 1.
DR   PROSITE; PS51842; IF_ROD_2; 1.
DR   PROSITE; PS51841; LTD; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAAS:SAAS01036532, ECO:0000256|SAM:Coils};
KW   Intermediate filament {ECO:0000256|RuleBase:RU000685,
KW   ECO:0000256|SAAS:SAAS01036494}.
FT   DOMAIN          31..387
FT                   /note="IF rod"
FT                   /evidence="ECO:0000259|PROSITE:PS51842"
FT   DOMAIN          428..545
FT                   /note="LTD"
FT                   /evidence="ECO:0000259|PROSITE:PS51841"
FT   REGION          1..25
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          384..442
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          552..576
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          598..619
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          28..69
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          78..221
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          242..269
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          292..369
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        391..417
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   664 AA;  74139 MW;  E0855F7699F0318B CRC64;
     METPSQRRAT RSGAQASSTP LSPTRITRLQ EKEDLQELND RLAVYIDRVR SLETENAGLR
     LRITESEEVV SREVSGIKAA YEAELGDARK TLDSVAKERA RLQLELSKVR EEFKELKARN
     TKKEGDLIAA QARLKDLEAL LNSKEAALST ALSEKRTLEG ELHDLRGQVA KLEAALGEAK
     KQLQDEMLRR VDAENRLQTM KEELDFQKNI YSEELRETKR RHETRLVEID NGKQREFESR
     LADALQELRA QHEDQVEQYK KELEKTYSAK LDNARQSAER NSNLVGAAHE ELQQSRIRID
     SLSAQLSQLQ KQLAAKEAKL RDLEDSLARE RDTSRRLLAE KEREMAEMRA RMQQQLDEYQ
     ELLDIKLALD MEIHAYRKLL EGEEERLRLS PSPTSQRSRG RASSHSSQTQ GGGSVTKKRK
     LESTESRSSF SQHARTSGRV AVEEVDEEGK FVRLRNKSNE DQSMGNWQIK RQNGDDPLLT
     YRFPPKFTLK AGQVVTIWAA GAGATHSPPT DLVWKAQNTW GCGNSLRTAL INSTGEEVAM
     RKLVRSVTVV EDDEDEDGDD LLHHHHGSHC SSSGDPAEYN LRSRTVLCGT CGQPADKASA
     SGSGAQVGGP ISSGSSASSV TVTRSYRSVG GSGGGSFGDN LVTRSYLLGN SSPRTQSPQN
     CSIM
//
ID   LMNA_HUMAN              Reviewed;         664 AA.
AC   P02545; B4DI32; D3DVB0; D6RAQ3; E7EUI9; P02546; Q5I6Y4; Q5I6Y6; Q5TCJ2;
AC   Q5TCJ3; Q6UYC3; Q969I8; Q96JA2;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   20-MAR-1987, sequence version 1.
DT   22-APR-2020, entry version 256.
DE   RecName: Full=Prelamin-A/C;
DE   Contains:
DE     RecName: Full=Lamin-A/C;
DE     AltName: Full=70 kDa lamin;
DE     AltName: Full=Renal carcinoma antigen NY-REN-32;
DE   Flags: Precursor;
GN   Name=LMNA; Synonyms=LMN1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A AND C).
RX   PubMed=3453101; DOI=10.1038/319463a0;
RA   McKeon F.D., Kirschner M.W., Caput D.;
RT   "Homologies in both primary and secondary structure between nuclear
RT   envelope and intermediate filament proteins.";
RL   Nature 319:463-468(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A AND C), AND PROTEIN SEQUENCE OF
RP   583-644.
RX   PubMed=3462705; DOI=10.1073/pnas.83.17.6450;
RA   Fisher D.Z., Chaudhary N., Blobel G.;
RT   "cDNA sequencing of nuclear lamins A and C reveals primary and secondary
RT   structural homology to intermediate filament proteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:6450-6454(1986).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A), SUBCELLULAR LOCATION (ISOFORM C),
RP   VARIANTS CMD1A TRP-190; GLY-192 AND SER-541, AND CHARACTERIZATION OF
RP   VARIANTS CMD1A GLY-192 AND SER-541.
RX   PubMed=16061563; DOI=10.1136/jmg.2004.023283;
RA   Sylvius N., Bilinska Z.T., Veinot J.P., Fidzianska A., Bolongo P.M.,
RA   Poon S., McKeown P., Davies R.A., Chan K.-L., Tang A.S.L., Dyack S.,
RA   Grzybowski J., Ruzyllo W., McBride H., Tesson F.;
RT   "In vivo and in vitro examination of the functional significances of novel
RT   lamin gene mutations in heart failure patients.";
RL   J. Med. Genet. 42:639-647(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 6).
RA   Csoka A.B.;
RT   "The progerin allele of lamin A disrupts chromatin organization.";
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Corpus callosum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS A AND C).
RC   TISSUE=Kidney, Lung, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 12-25; 29-90; 102-117; 120-166; 172-189; 197-216;
RP   226-233; 241-260; 281-316; 320-329; 352-386; 440-453; 456-482; 472-482;
RP   516-542; 585-624 AND 628-644, PHOSPHORYLATION AT SER-22, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY.
RC   TISSUE=Ovarian carcinoma;
RA   Bienvenut W.V., Lilla S., von Kriegsheim A., Lempens A., Kolch W.,
RA   Norman J.C.;
RL   Submitted (OCT-2009) to UniProtKB.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 375-664 (ISOFORM ADELTA10).
RC   TISSUE=Colon;
RX   PubMed=8621584; DOI=10.1074/jbc.271.16.9249;
RA   Machiels B.M., Zorenc A.H., Endert J.M., Kuijpers H.J., van Eys G.J.,
RA   Ramaekers F.C., Broers J.L.;
RT   "An alternative splicing product of the lamin A/C gene lacks exon 10.";
RL   J. Biol. Chem. 271:9249-9253(1996).
RN   [11]
RP   PROTEOLYTIC CLEAVAGE, ISOPRENYLATION AT CYS-661, AND METHYLATION AT
RP   CYS-661.
RX   PubMed=8175923;
RA   Sinensky M., Fantle K., Trujillo M., McLain T., Kupfer A., Dalton M.;
RT   "The processing pathway of prelamin A.";
RL   J. Cell Sci. 107:61-67(1994).
RN   [12]
RP   PROTEOLYTIC CLEAVAGE, ISOPRENYLATION AT CYS-661, AND METHYLATION AT
RP   CYS-661.
RX   PubMed=9030603; DOI=10.1074/jbc.272.8.5298;
RA   Kilic F., Dalton M.B., Burrell S.K., Mayer J.P., Patterson S.D.,
RA   Sinensky M.;
RT   "In vitro assay and characterization of the farnesylation-dependent
RT   prelamin A endoprotease.";
RL   J. Biol. Chem. 272:5298-5304(1997).
RN   [13]
RP   IDENTIFICATION AS A RENAL CANCER ANTIGEN.
RC   TISSUE=Renal cell carcinoma;
RX   PubMed=10508479;
RX   DOI=10.1002/(sici)1097-0215(19991112)83:4<456::aid-ijc4>3.0.co;2-5;
RA   Scanlan M.J., Gordan J.D., Williamson B., Stockert E., Bander N.H.,
RA   Jongeneel C.V., Gure A.O., Jaeger D., Jaeger E., Knuth A., Chen Y.-T.,
RA   Old L.J.;
RT   "Antigens recognized by autologous antibody in patients with renal-cell
RT   carcinoma.";
RL   Int. J. Cancer 83:456-464(1999).
RN   [14]
RP   INTERACTION WITH NARF, AND MUTAGENESIS OF CYS-661.
RX   PubMed=10514485; DOI=10.1074/jbc.274.42.30008;
RA   Barton R.M., Worman H.J.;
RT   "Prenylated prelamin A interacts with Narf, a novel nuclear protein.";
RL   J. Biol. Chem. 274:30008-30018(1999).
RN   [15]
RP   INTERACTION WITH TMPO-ALPHA AND RB1.
RX   PubMed=12475961; DOI=10.1091/mbc.e02-07-0450;
RA   Markiewicz E., Dechat T., Foisner R., Quinlan R.A., Hutchison C.J.;
RT   "Lamin A/C binding protein LAP2alpha is required for nuclear anchorage of
RT   retinoblastoma protein.";
RL   Mol. Biol. Cell 13:4401-4413(2002).
RN   [16]
RP   ALTERNATIVE SPLICING, INVOLVEMENT IN HGPS (ISOFORM 6), AND VARIANTS HGPS
RP   LYS-145 AND SER-608.
RX   PubMed=12714972; DOI=10.1038/nature01629;
RA   Eriksson M., Brown W.T., Gordon L.B., Glynn M.W., Singer J., Scott L.,
RA   Erdos M.R., Robbins C.M., Moses T.Y., Berglund P., Dutra A., Pak E.,
RA   Durkin S., Csoka A.B., Boehnke M., Glover T.W., Collins F.S.;
RT   "Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford
RT   progeria syndrome.";
RL   Nature 423:293-298(2003).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-277, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-19; SER-22; SER-390; SER-392;
RP   SER-395; SER-628; SER-632 AND SER-636, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-628, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa cells
RT   and high confident phosphopeptide identification by cross-validation of
RT   MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [20]
RP   SUBCELLULAR LOCATION, SUMOYLATION AT LYS-201, MUTAGENESIS OF LYS-201, AND
RP   CHARACTERIZATION OF VARIANTS CMD1A GLY-203 AND LYS-203.
RX   PubMed=18606848; DOI=10.1083/jcb.200712124;
RA   Zhang Y.Q., Sarge K.D.;
RT   "Sumoylation regulates lamin A function and is lost in lamin A mutants
RT   associated with familial cardiomyopathies.";
RL   J. Cell Biol. 182:35-39(2008).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-628, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-632, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12; SER-18; THR-19; SER-22;
RP   SER-301; SER-390; SER-392; SER-395; SER-458; SER-628; SER-632; SER-636 AND
RP   SER-652, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [25]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH EMD.
RX   PubMed=19323649; DOI=10.1042/bc20080175;
RA   Capanni C., Del Coco R., Mattioli E., Camozzi D., Columbaro M., Schena E.,
RA   Merlini L., Squarzoni S., Maraldi N.M., Lattanzi G.;
RT   "Emerin-prelamin A interplay in human fibroblasts.";
RL   Biol. Cell 101:541-554(2009).
RN   [26]
RP   SUBCELLULAR LOCATION, AND CHARACTERIZATION OF VARIANTS FPLD2 CYS-439 AND
RP   TRP-482.
RX   PubMed=19220582; DOI=10.1111/j.1582-4934.2009.00690.x;
RA   Verstraeten V.L., Caputo S., van Steensel M.A., Duband-Goulet I.,
RA   Zinn-Justin S., Kamps M., Kuijpers H.J., Ostlund C., Worman H.J.,
RA   Briede J.J., Le Dour C., Marcelis C.L., van Geel M., Steijlen P.M.,
RA   van den Wijngaard A., Ramaekers F.C., Broers J.L.;
RT   "The R439C mutation in LMNA causes lamin oligomerization and susceptibility
RT   to oxidative stress.";
RL   J. Cell. Mol. Med. 13:959-971(2009).
RN   [27]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-108; LYS-270; LYS-311 AND
RP   LYS-450, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [28]
RP   FUNCTION.
RX   PubMed=20079404; DOI=10.1016/j.bbagen.2010.01.002;
RA   De Vos W.H., Houben F., Hoebe R.A., Hennekam R., van Engelen B.,
RA   Manders E.M., Ramaekers F.C., Broers J.L., Van Oostveldt P.;
RT   "Increased plasticity of the nuclear envelope and hypermobility of
RT   telomeres due to the loss of A-type lamins.";
RL   Biochim. Biophys. Acta 1800:448-458(2010).
RN   [29]
RP   SUBCELLULAR LOCATION, AND VARIANTS CMD1A LEU-89; PRO-101; PRO-166; GLN-190;
RP   LYS-203; SER-210; PRO-215; THR-318; HIS-388; CYS-399 AND HIS-471.
RX   PubMed=20160190; DOI=10.1161/circgenetics.109.905422;
RA   Cowan J., Li D., Gonzalez-Quintana J., Morales A., Hershberger R.E.;
RT   "Morphological analysis of 13 LMNA variants identified in a cohort of 324
RT   unrelated patients with idiopathic or familial dilated cardiomyopathy.";
RL   Circ. Cardiovasc. Genet. 3:6-14(2010).
RN   [30]
RP   FUNCTION, PROTEOLYTIC PROCESSING, AND TISSUE SPECIFICITY.
RX   PubMed=20458013; DOI=10.1161/circulationaha.109.902056;
RA   Ragnauth C.D., Warren D.T., Liu Y., McNair R., Tajsic T., Figg N.,
RA   Shroff R., Skepper J., Shanahan C.M.;
RT   "Prelamin A acts to accelerate smooth muscle cell senescence and is a novel
RT   biomarker of human vascular aging.";
RL   Circulation 121:2200-2210(2010).
RN   [31]
RP   INTERACTION WITH SUN1, CHARACTERIZATION OF VARIANTS EDMD2 PRO-527 AND
RP   PRO-530, AND CHARACTERIZATION OF VARIANT HGPS SER-608.
RX   PubMed=19933576; DOI=10.1074/jbc.m109.071910;
RA   Haque F., Mazzeo D., Patel J.T., Smallwood D.T., Ellis J.A., Shanahan C.M.,
RA   Shackleton S.;
RT   "Mammalian SUN protein interaction networks at the inner nuclear membrane
RT   and their role in laminopathy disease processes.";
RL   J. Biol. Chem. 285:3487-3498(2010).
RN   [32]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT THR-3; SER-12; THR-19; SER-22; SER-212; SER-277; SER-301;
RP   SER-390; SER-392; SER-395; SER-404; SER-414; SER-431; SER-458; SER-463;
RP   THR-505; SER-628; SER-632; SER-636 AND SER-652, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [33]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [34]
RP   INTERACTION WITH MLIP.
RX   PubMed=21498514; DOI=10.1074/jbc.m110.165548;
RA   Ahmady E., Deeke S.A., Rabaa S., Kouri L., Kenney L., Stewart A.F.,
RA   Burgon P.G.;
RT   "Identification of a novel muscle enriched A-type Lamin interacting protein
RT   (MLIP).";
RL   J. Biol. Chem. 286:19702-19713(2011).
RN   [35]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-390; SER-392; SER-404;
RP   SER-414; SER-458 AND SER-636, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [36]
RP   MUTAGENESIS OF ARG-644; LEU-647; LEU-648; ASN-650 AND CYS-661, AND
RP   CHARACTERIZATION OF VARIANT HGPS CYS-644.
RX   PubMed=22355414; DOI=10.1371/journal.pone.0032120;
RA   Barrowman J., Hamblet C., Kane M.S., Michaelis S.;
RT   "Requirements for efficient proteolytic cleavage of prelamin A by
RT   ZMPSTE24.";
RL   PLoS ONE 7:E32120-E32120(2012).
RN   [37]
RP   FUNCTION, SUBCELLULAR LOCATION, INVOLVEMENT IN HGPS, VARIANT HGPS GLY-300,
RP   AND CHARACTERIZATION OF VARIANT HGPS GLY-300.
RX   PubMed=23666920; DOI=10.1002/ajmg.a.35971;
RA   Kane M.S., Lindsay M.E., Judge D.P., Barrowman J., Ap Rhys C., Simonson L.,
RA   Dietz H.C., Michaelis S.;
RT   "LMNA-associated cardiocutaneous progeria: An inherited autosomal dominant
RT   premature aging syndrome with late onset.";
RL   Am. J. Med. Genet. A 161:1599-1611(2013).
RN   [38]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12; THR-19; SER-22; SER-51;
RP   SER-66; SER-71; SER-107; SER-212; SER-301; SER-390; SER-392; SER-398;
RP   SER-429; SER-458; SER-463; SER-533; SER-613; SER-619; SER-628; SER-632 AND
RP   SER-636, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [39]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH SUV39H1.
RX   PubMed=23695662; DOI=10.1038/ncomms2885;
RA   Liu B., Wang Z., Zhang L., Ghosh S., Zheng H., Zhou Z.;
RT   "Depleting the methyltransferase Suv39h1 improves DNA repair and extends
RT   lifespan in a progeria mouse model.";
RL   Nat. Commun. 4:1868-1868(2013).
RN   [40]
RP   INTERACTION WITH DMPK.
RX   PubMed=21949239; DOI=10.1074/jbc.m111.241455;
RA   Harmon E.B., Harmon M.L., Larsen T.D., Yang J., Glasford J.W.,
RA   Perryman M.B.;
RT   "Myotonic dystrophy protein kinase is critical for nuclear envelope
RT   integrity.";
RL   J. Biol. Chem. 286:40296-40306(2011).
RN   [41]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12; THR-19; SER-22; SER-212;
RP   SER-301; SER-307; SER-390; SER-395; SER-403; SER-404; SER-414; SER-458;
RP   SER-463; SER-612 AND SER-636, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [42]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-97; LYS-208; LYS-233; LYS-311;
RP   LYS-378; LYS-417 AND LYS-420, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [43]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-233 AND LYS-597, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [44]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-97; LYS-311; LYS-378 AND LYS-420,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [45]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-233; LYS-260; LYS-270; LYS-378;
RP   LYS-417 AND LYS-420, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.o114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to replication
RT   stress reveals novel small ubiquitin-like modified target proteins and
RT   acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [46]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [47]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-32; LYS-97; LYS-171; LYS-201;
RP   LYS-208; LYS-219; LYS-233; LYS-260; LYS-270; LYS-311; LYS-366; LYS-378;
RP   LYS-417; LYS-420; LYS-450; LYS-470; LYS-486 AND LYS-597, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [48]
RP   INTERACTION WITH ITSN1 ISOFORM 2, AND SUBCELLULAR LOCATION.
RX   PubMed=29599122; DOI=10.1042/bcj20170897;
RA   Alvisi G., Paolini L., Contarini A., Zambarda C., Di Antonio V.,
RA   Colosini A., Mercandelli N., Timmoneri M., Palu G., Caimi L., Ricotta D.,
RA   Radeghieri A.;
RT   "Intersectin goes nuclear: secret life of an endocytic protein.";
RL   Biochem. J. 475:1455-1472(2018).
RN   [49]
RP   X-RAY CRYSTALLOGRAPHY (1.4 ANGSTROMS) OF 435-552.
RX   PubMed=11901143; DOI=10.1074/jbc.c200038200;
RA   Dhe-Paganon S., Werner E.D., Chi Y.I., Shoelson S.E.;
RT   "Structure of the globular tail of nuclear lamin.";
RL   J. Biol. Chem. 277:17381-17384(2002).
RN   [50]
RP   STRUCTURE BY NMR OF 428-549.
RX   PubMed=12057196; DOI=10.1016/s0969-2126(02)00777-3;
RA   Krimm I., Ostlund C., Gilquin B., Couprie J., Hossenlopp P., Mornon J.-P.,
RA   Bonne G., Courvalin J.-C., Worman H.J., Zinn-Justin S.;
RT   "The Ig-like structure of the C-terminal domain of lamin A/C, mutated in
RT   muscular dystrophies, cardiomyopathy, and partial lipodystrophy.";
RL   Structure 10:811-823(2002).
RN   [51]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 305-387.
RX   PubMed=15476822; DOI=10.1016/j.jmb.2004.08.093;
RA   Strelkov S.V., Schumacher J., Burkhard P., Aebi U., Herrmann H.;
RT   "Crystal structure of the human lamin A coil 2B dimer: implications for the
RT   head-to-tail association of nuclear lamins.";
RL   J. Mol. Biol. 343:1067-1080(2004).
RN   [52]
RP   VARIANTS EDMD2 TRP-453; PRO-527 AND PRO-530, AND FUNCTION.
RX   PubMed=10080180; DOI=10.1038/6799;
RA   Bonne G., Di Barletta M.R., Varnous S., Becane H.-M., Hammouda E.-H.,
RA   Merlini L., Muntoni F., Greenberg C.R., Gary F., Urtizberea J.-A.,
RA   Duboc D., Fardeau M., Toniolo D., Schwartz K.;
RT   "Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-
RT   Dreifuss muscular dystrophy.";
RL   Nat. Genet. 21:285-288(1999).
RN   [53]
RP   VARIANTS CMD1A GLY-60; ARG-85; LYS-195 AND GLY-203, AND FUNCTION.
RX   PubMed=10580070; DOI=10.1056/nejm199912023412302;
RA   Fatkin D., MacRae C., Sasaki T., Wolff M.R., Porcu M., Frenneaux M.,
RA   Atherton J., Vidaillet H.J. Jr., Spudich S., De Girolami U., Seidman J.G.,
RA   Seidman C.E.;
RT   "Missense mutations in the rod domain of the lamin A/C gene as causes of
RT   dilated cardiomyopathy and conduction-system disease.";
RL   N. Engl. J. Med. 341:1715-1724(1999).
RN   [54]
RP   VARIANTS FPLD2 ASP-465; GLN-482; TRP-482 AND HIS-582.
RX   PubMed=10739751; DOI=10.1086/302836;
RA   Speckman R.A., Garg A., Du F., Bennett L., Veile R., Arioglu E.,
RA   Taylor S.I., Lovett M., Bowcock A.M.;
RT   "Mutational and haplotype analyses of families with familial partial
RT   lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the
RT   globular C-terminal domain of lamin A/C.";
RL   Am. J. Hum. Genet. 66:1192-1198(2000).
RN   [55]
RP   ERRATUM OF PUBMED:10739751.
RA   Speckman R.A., Garg A., Du F., Bennett L., Veile R., Arioglu E.,
RA   Taylor S.I., Lovett M., Bowcock A.M.;
RL   Am. J. Hum. Genet. 67:775-775(2000).
RN   [56]
RP   VARIANTS EDMD2 TYR-222; GLN-249; GLN-336; TRP-453; THR-469; PRO-527 AND
RP   LYS-528.
RX   PubMed=10739764; DOI=10.1086/302869;
RA   Raffaele di Barletta M., Ricci E., Galluzzi G., Tonali P., Mora M.,
RA   Morandi L., Romorini A., Voit T., Orstavik K.H., Merlini L., Trevisan C.,
RA   Biancalana V., Housmanowa-Petrusewicz I., Bione S., Ricotti R.,
RA   Schwartz K., Bonne G., Toniolo D.;
RT   "Different mutations in the LMNA gene cause autosomal dominant and
RT   autosomal recessive Emery-Dreifuss muscular dystrophy.";
RL   Am. J. Hum. Genet. 66:1407-1412(2000).
RN   [57]
RP   VARIANTS EDMD2 CYS-45; PRO-50; SER-63; GLU-112 DEL; PRO-222; GLU-232;
RP   GLN-249; LYS-261 DEL; PRO-294; LYS-358; LYS-371; LYS-386; TRP-453; LYS-456;
RP   SER-520; PRO-527 AND LYS-528.
RX   PubMed=10939567;
RX   DOI=10.1002/1531-8249(200008)48:2<170::aid-ana6>3.0.co;2-j;
RA   Bonne G., Mercuri E., Muchir A., Urtizberea A., Becane H.M., Recan D.,
RA   Merlini L., Wehnert M., Boor R., Reuner U., Vorgerd M., Wicklein E.M.,
RA   Eymard B., Duboc D., Penisson-Besnier I., Cuisset J.M., Ferrer X.,
RA   Desguerre I., Lacombe D., Bushby K., Pollitt C., Toniolo D., Fardeau M.,
RA   Schwartz K., Muntoni F.;
RT   "Clinical and molecular genetic spectrum of autosomal dominant Emery-
RT   Dreifuss muscular dystrophy due to mutations of the lamin A/C gene.";
RL   Ann. Neurol. 48:170-180(2000).
RN   [58]
RP   VARIANT FPLD2 GLN-482.
RX   PubMed=10587585; DOI=10.1093/hmg/9.1.109;
RA   Cao H., Hegele R.A.;
RT   "Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type
RT   familial partial lipodystrophy.";
RL   Hum. Mol. Genet. 9:109-112(2000).
RN   [59]
RP   VARIANTS EDMD2 LYS-208 DEL AND HIS-377, AND FUNCTION.
RX   PubMed=10814726; DOI=10.1093/hmg/9.9.1453;
RA   Muchir A., Bonne G., van der Kooi A.J., van Meegen M., Baas F.,
RA   Bolhuis P.A., de Visser M., Schwartz K.;
RT   "Identification of mutations in the gene encoding lamins A/C in autosomal
RT   dominant limb girdle muscular dystrophy with atrioventricular conduction
RT   disturbances (LGMD1B).";
RL   Hum. Mol. Genet. 9:1453-1459(2000).
RN   [60]
RP   VARIANTS FPLD2 LEU-482 AND TRP-482.
RX   PubMed=10655060; DOI=10.1038/72807;
RA   Shackleton S., Lloyd D.J., Jackson S.N.J., Evans R., Niermeijer M.F.,
RA   Singh B.M., Schmidt H., Brabant G., Kumar S., Durrington P.N., Gregory S.,
RA   O'Rahilly S., Trembath R.C.;
RT   "LMNA, encoding lamin A/C, is mutated in partial lipodystrophy.";
RL   Nat. Genet. 24:153-156(2000).
RN   [61]
RP   VARIANTS EDMD2 PRO-150 AND LYS-261 DEL.
RX   PubMed=10908904; DOI=10.1212/wnl.55.2.275;
RA   Felice K.J., Schwartz R.C., Brown C.A., Leicher C.R., Grunnet M.L.;
RT   "Autosomal dominant Emery-Dreifuss dystrophy due to mutations in rod domain
RT   of the lamin A/C gene.";
RL   Neurology 55:275-280(2000).
RN   [62]
RP   VARIANTS EDMD2 PRO-25; THR-43; SER-50; PRO-133; 196-ARG--THR-199 DELINS
RP   SER; GLN-249; LYS-261 DEL; LYS-358; TRP-453; ILE-456; PRO-527 AND HIS-624.
RX   PubMed=11503164; DOI=10.1002/ajmg.1463;
RA   Brown C.A., Lanning R.W., McKinney K.Q., Salvino A.R., Cherniske E.,
RA   Crowe C.A., Darras B.T., Gominak S., Greenberg C.R., Grosmann C.,
RA   Heydemann P., Mendell J.R., Pober B.R., Sasaki T., Shapiro F.,
RA   Simpson D.A., Suchowersky O., Spence J.E.;
RT   "Novel and recurrent mutations in lamin A/C in patients with Emery-Dreifuss
RT   muscular dystrophy.";
RL   Am. J. Med. Genet. 102:359-367(2001).
RN   [63]
RP   VARIANT CMD1A LYS-203.
RX   PubMed=11561226; DOI=10.1054/jcaf.2001.26339;
RA   Jakobs P.M., Hanson E.L., Crispell K.A., Toy W., Keegan H., Schilling K.,
RA   Icenogle T.B., Litt M., Hershberger R.E.;
RT   "Novel lamin A/C mutations in two families with dilated cardiomyopathy and
RT   conduction system disease.";
RL   J. Card. Fail. 7:249-256(2001).
RN   [64]
RP   CHARACTERIZATION OF VARIANTS CMD1A GLY-60; ARG-85; LYS-195 AND GLY-203,
RP   CHARACTERIZATION OF VARIANTS EDMD2 LYS-358; LYS-371; LYS-386; TRP-453;
RP   SER-520; PRO-527; LYS-528 AND PRO-530, AND CHARACTERIZATION OF VARIANTS
RP   FPLD2 GLN-482; TRP-482 AND ASN-486.
RX   PubMed=11792809;
RA   Oestlund C., Bonne G., Schwartz K., Worman H.J.;
RT   "Properties of lamin A mutants found in Emery-Dreifuss muscular dystrophy,
RT   cardiomyopathy and Dunnigan-type partial lipodystrophy.";
RL   J. Cell Sci. 114:4435-4445(2001).
RN   [65]
RP   VARIANT EDMD2 HIS-481.
RX   PubMed=11525883; DOI=10.1016/s0960-8966(01)00207-3;
RA   Kitaguchi T., Matsubara S., Sato M., Miyamoto K., Hirai S., Schwartz K.,
RA   Bonne G.;
RT   "A missense mutation in the exon 8 of lamin A/C gene in a Japanese case of
RT   autosomal dominant limb-girdle muscular dystrophy and cardiac conduction
RT   block.";
RL   Neuromuscul. Disord. 11:542-546(2001).
RN   [66]
RP   VARIANT CMD1A PRO-215.
RX   PubMed=12486434; DOI=10.1067/mhj.2002.126737;
RA   Hershberger R.E., Hanson E.L., Jakobs P.M., Keegan H., Coates K.,
RA   Bousman S., Litt M.;
RT   "A novel lamin A/C mutation in a family with dilated cardiomyopathy,
RT   prominent conduction system disease, and need for permanent pacemaker
RT   implantation.";
RL   Am. Heart J. 144:1081-1086(2002).
RN   [67]
RP   VARIANT CMT2B1 CYS-298, AND FUNCTION.
RX   PubMed=11799477; DOI=10.1086/339274;
RA   De Sandre-Giovannoli A., Chaouch M., Kozlov S., Vallat J.-M., Tazir M.,
RA   Kassouri N., Szepetowski P., Hammadouche T., Vandenberghe A., Stewart C.L.,
RA   Grid D., Levy N.;
RT   "Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins,
RT   cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth
RT   disorder type 2) and mouse.";
RL   Am. J. Hum. Genet. 70:726-736(2002).
RN   [68]
RP   ERRATUM OF PUBMED:11799477.
RA   De Sandre-Giovannoli A., Chaouch M., Kozlov S., Vallat J.-M., Tazir M.,
RA   Kassouri N., Szepetowski P., Hammadouche T., Vandenberghe A., Stewart C.L.,
RA   Grid D., Levy N.;
RL   Am. J. Hum. Genet. 70:1075-1075(2002).
RN   [69]
RP   VARIANT MADA HIS-527, AND FUNCTION.
RX   PubMed=12075506; DOI=10.1086/341908;
RA   Novelli G., Muchir A., Sangiuolo F., Helbling-Leclerc A., D'Apice M.R.,
RA   Massart C., Capon F., Sbraccia P., Federici M., Lauro R., Tudisco C.,
RA   Pallotta R., Scarano G., Dallapiccola B., Merlini L., Bonne G.;
RT   "Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin
RT   A/C.";
RL   Am. J. Hum. Genet. 71:426-431(2002).
RN   [70]
RP   VARIANTS FPLD2 TRP-28 AND GLY-62.
RX   PubMed=12015247; DOI=10.1016/s0002-9343(02)01070-7;
RA   Garg A., Speckman R.A., Bowcock A.M.;
RT   "Multisystem dystrophy syndrome due to novel missense mutations in the
RT   amino-terminal head and alpha-helical rod domains of the lamin A/C gene.";
RL   Am. J. Med. 112:549-555(2002).
RN   [71]
RP   VARIANTS CMD1A GLU-97; TRP-190 AND LYS-317.
RX   PubMed=11897440; DOI=10.1016/s0735-1097(02)01724-2;
RA   Arbustini E., Pilotto A., Repetto A., Grasso M., Negri A., Diegoli M.,
RA   Campana C., Scelsi L., Baldini E., Gavazzi A., Tavazzi L.;
RT   "Autosomal dominant dilated cardiomyopathy with atrioventricular block: a
RT   lamin A/C defect-related disease.";
RL   J. Am. Coll. Cardiol. 39:981-990(2002).
RN   [72]
RP   VARIANT EDMD2 GLN-249, AND VARIANT EDMD2 LEU-377.
RX   PubMed=12032588; DOI=10.1007/s100380200029;
RA   Ki C.-S., Hong J.S., Jeong G.-Y., Ahn K.J., Choi K.-M., Kim D.-K.,
RA   Kim J.-W.;
RT   "Identification of lamin A/C (LMNA) gene mutations in Korean patients with
RT   autosomal dominant Emery-Dreifuss muscular dystrophy and limb-girdle
RT   muscular dystrophy 1B.";
RL   J. Hum. Genet. 47:225-228(2002).
RN   [73]
RP   VARIANTS FPLD2 GLY-60 AND PRO-527.
RX   PubMed=12196663; DOI=10.1212/wnl.59.4.620;
RA   van der Kooi A.J., Bonne G., Eymard B., Duboc D., Talim B.,
RA   Van der Valk M., Reiss P., Richard P., Demay L., Merlini L., Schwartz K.,
RA   Busch H.F.M., de Visser M.;
RT   "Lamin A/C mutations with lipodystrophy, cardiac abnormalities, and
RT   muscular dystrophy.";
RL   Neurology 59:620-623(2002).
RN   [74]
RP   VARIANTS EDMD2 LYS-32 DEL; ASN-63; GLN-336; GLN-343 AND CYS-401.
RX   PubMed=12467752; DOI=10.1016/s0960-8966(02)00178-5;
RA   Vytopil M., Ricci E., Dello Russo A., Hanisch F., Neudecker S., Zierz S.,
RA   Ricotti R., Demay L., Richard P., Wehnert M., Bonne G., Merlini L.,
RA   Toniolo D.;
RT   "Frequent low penetrance mutations in the Lamin A/C gene, causing Emery
RT   Dreifuss muscular dystrophy.";
RL   Neuromuscul. Disord. 12:958-963(2002).
RN   [75]
RP   VARIANT CMD1A CYS-541.
RX   PubMed=14675861; DOI=10.1016/s1388-9842(03)00149-1;
RA   Forissier J.-F., Bonne G., Bouchier C., Duboscq-Bidot L., Richard P.,
RA   Wisnewski C., Briault S., Moraine C., Dubourg O., Schwartz K., Komajda M.;
RT   "Apical left ventricular aneurysm without atrio-ventricular block due to a
RT   lamin A/C gene mutation.";
RL   Eur. J. Heart Fail. 5:821-825(2003).
RN   [76]
RP   VARIANT EDMD2 HIS-377.
RX   PubMed=12673789; DOI=10.1002/humu.10170;
RA   Charniot J.-C., Pascal C., Bouchier C., Sebillon P., Salama J.,
RA   Duboscq-Bidot L., Peuchmaurd M., Desnos M., Artigou J.-Y., Komajda M.;
RT   "Functional consequences of an LMNA mutation associated with a new cardiac
RT   and non-cardiac phenotype.";
RL   Hum. Mutat. 21:473-481(2003).
RN   [77]
RP   VARIANTS CMD1A LEU-89; HIS-377 AND LEU-573.
RX   PubMed=12628721; DOI=10.1016/s0735-1097(02)02954-6;
RG   Familial dilated cardiomyopathy registry research group;
RA   Taylor M.R.G., Fain P.R., Sinagra G., Robinson M.L., Robertson A.D.,
RA   Carniel E., Di Lenarda A., Bohlmeyer T.J., Ferguson D.A., Brodsky G.L.,
RA   Boucek M.M., Lascor J., Moss A.C., Li W.-L.P., Stetler G.L., Muntoni F.,
RA   Bristow M.R., Mestroni L.;
RT   "Natural history of dilated cardiomyopathy due to lamin A/C gene
RT   mutations.";
RL   J. Am. Coll. Cardiol. 41:771-780(2003).
RN   [78]
RP   ERRATUM OF PUBMED:12628721.
RG   Familial dilated cardiomyopathy registry research group;
RA   Taylor M.R.G., Fain P.R., Sinagra G., Robinson M.L., Robertson A.D.,
RA   Carniel E., Di Lenarda A., Bohlmeyer T.J., Ferguson D.A., Brodsky G.L.,
RA   Boucek M.M., Lascor J., Moss A.C., Li W.-L.P., Stetler G.L., Muntoni F.,
RA   Bristow M.R., Mestroni L.;
RL   J. Am. Coll. Cardiol. 42:590-590(2003).
RN   [79]
RP   VARIANT FPLD2 LEU-133.
RX   PubMed=12629077; DOI=10.1210/jc.2002-021506;
RA   Caux F., Dubosclard E., Lascols O., Buendia B., Chazouilleres O., Cohen A.,
RA   Courvalin J.-C., Laroche L., Capeau J., Vigouroux C., Christin-Maitre S.;
RT   "A new clinical condition linked to a novel mutation in lamins A and C with
RT   generalized lipoatrophy, insulin-resistant diabetes, disseminated
RT   leukomelanodermic papules, liver steatosis, and cardiomyopathy.";
RL   J. Clin. Endocrinol. Metab. 88:1006-1013(2003).
RN   [80]
RP   VARIANTS HGPS CYS-471; CYS-527 AND SER-608.
RX   PubMed=12768443; DOI=10.1007/s10038-003-0025-3;
RA   Cao H., Hegele R.A.;
RT   "LMNA is mutated in Hutchinson-Gilford progeria (MIM 176670) but not in
RT   Wiedemann-Rautenstrauch progeroid syndrome (MIM 264090).";
RL   J. Hum. Genet. 48:271-274(2003).
RN   [81]
RP   VARIANT CMD1A LYS-161.
RX   PubMed=12920062; DOI=10.1136/jmg.40.8.560;
RA   Sebillon P., Bouchier C., Bidot L.D., Bonne G., Ahamed K., Charron P.,
RA   Drouin-Garraud V., Millaire A., Desrumeaux G., Benaiche A., Charniot J.-C.,
RA   Schwartz K., Villard E., Komajda M.;
RT   "Expanding the phenotype of LMNA mutations in dilated cardiomyopathy and
RT   functional consequences of these mutations.";
RL   J. Med. Genet. 40:560-567(2003).
RN   [82]
RP   VARIANTS EDMD2 GLY-25; LYS-32 DEL; VAL-35; GLY-65; GLU-112 DEL; PRO-248;
RP   GLN-249; CYS-267; VAL-446; TRP-453; ARG-528 AND HIS-541, AND VARIANT CMD1A
RP   CYS-435.
RX   PubMed=14684700; DOI=10.1136/jmg.40.12.e132;
RA   Vytopil M., Benedetti S., Ricci E., Galluzzi G., Dello Russo A.,
RA   Merlini L., Boriani G., Gallina M., Morandi L., Politano L., Moggio M.,
RA   Chiveri L., Hausmanova-Petrusewicz I., Ricotti R., Vohanka S., Toman J.,
RA   Toniolo D.;
RT   "Mutation analysis of the lamin A/C gene (LMNA) among patients with
RT   different cardiomuscular phenotypes.";
RL   J. Med. Genet. 40:E132-E132(2003).
RN   [83]
RP   VARIANT CMDHH PRO-57, VARIANT HGPS ARG-140, AND FUNCTION.
RX   PubMed=12927431; DOI=10.1016/s0140-6736(03)14069-x;
RA   Chen L., Lee L., Kudlow B.A., Dos Santos H.G., Sletvold O., Shafeghati Y.,
RA   Botha E.G., Garg A., Hanson N.B., Martin G.M., Mian I.S., Kennedy B.K.,
RA   Oshima J.;
RT   "LMNA mutations in atypical Werner's syndrome.";
RL   Lancet 362:440-445(2003).
RN   [84]
RP   VARIANTS EDMD2 ASN-63; PRO-140; GLN-249; LEU-377; LYS-386 AND PRO-527.
RX   PubMed=12649505; DOI=10.1161/01.str.0000064322.47667.49;
RA   Boriani G., Gallina M., Merlini L., Bonne G., Toniolo D., Amati S.,
RA   Biffi M., Martignani C., Frabetti L., Bonvicini M., Rapezzi C., Branzi A.;
RT   "Clinical relevance of atrial fibrillation/flutter, stroke, pacemaker
RT   implant, and heart failure in Emery-Dreifuss muscular dystrophy: a long-
RT   term longitudinal study.";
RL   Stroke 34:901-908(2003).
RN   [85]
RP   VARIANTS CMD1A TRP-190 AND LEU-349.
RX   PubMed=15219508; DOI=10.1016/j.amjcard.2004.03.029;
RA   Hermida-Prieto M., Monserrat L., Castro-Beiras A., Laredo R., Soler R.,
RA   Peteiro J., Rodriguez E., Bouzas B., Alvarez N., Muniz J., Crespo-Leiro M.;
RT   "Familial dilated cardiomyopathy and isolated left ventricular
RT   noncompaction associated with lamin A/C gene mutations.";
RL   Am. J. Cardiol. 94:50-54(2004).
RN   [86]
RP   VARIANT CMD1A PRO-143.
RX   PubMed=15140538; DOI=10.1016/j.ehj.2004.01.020;
RA   Kaerkkaeinen S., Helioe T., Miettinen R., Tuomainen P., Peltola P.,
RA   Rummukainen J., Ylitalo K., Kaartinen M., Kuusisto J., Toivonen L.,
RA   Nieminen M.S., Laakso M., Peuhkurinen K.;
RT   "A novel mutation, Ser143Pro, in the lamin A/C gene is common in Finnish
RT   patients with familial dilated cardiomyopathy.";
RL   Eur. Heart J. 25:885-893(2004).
RN   [87]
RP   INVOLVEMENT IN LTSCS, AND FUNCTION.
RX   PubMed=15317753; DOI=10.1093/hmg/ddh265;
RA   Navarro C.L., De Sandre-Giovannoli A., Bernard R., Boccaccio I., Boyer A.,
RA   Genevieve D., Hadj-Rabia S., Gaudy-Marqueste C., Smitt H.S., Vabres P.,
RA   Faivre L., Verloes A., Van Essen T., Flori E., Hennekam R., Beemer F.A.,
RA   Laurent N., Le Merrer M., Cau P., Levy N.;
RT   "Lamin A and ZMPSTE24 (FACE-1) defects cause nuclear disorganization and
RT   identify restrictive dermopathy as a lethal neonatal laminopathy.";
RL   Hum. Mol. Genet. 13:2493-2503(2004).
RN   [88]
RP   VARIANT HGPS CYS-644, AND VARIANTS ILE-10 AND VAL-578.
RX   PubMed=15060110; DOI=10.1136/jmg.2003.015651;
RA   Csoka A.B., Cao H., Sammak P.J., Constantinescu D., Schatten G.P.,
RA   Hegele R.A.;
RT   "Novel lamin A/C gene (LMNA) mutations in atypical progeroid syndromes.";
RL   J. Med. Genet. 41:304-308(2004).
RN   [89]
RP   VARIANT HGPS ASN-542.
RX   PubMed=15286156; DOI=10.1136/jmg.2004.019661;
RA   Plasilova M., Chattopadhyay C., Pal P., Schaub N.A., Buechner S.A.,
RA   Mueller H., Miny P., Ghosh A., Heinimann K.;
RT   "Homozygous missense mutation in the lamin A/C gene causes autosomal
RT   recessive Hutchinson-Gilford progeria syndrome.";
RL   J. Med. Genet. 41:609-614(2004).
RN   [90]
RP   VARIANT CMT2 ASP-33, AND VARIANT EDMD2 GLY-33.
RX   PubMed=14985400; DOI=10.1136/jmg.2003.013383;
RA   Goizet C., Yaou R.B., Demay L., Richard P., Bouillot S., Rouanet M.,
RA   Hermosilla E., Le Masson G., Lagueny A., Bonne G., Ferrer X.;
RT   "A new mutation of the lamin A/C gene leading to autosomal dominant axonal
RT   neuropathy, muscular dystrophy, cardiac disease, and leuconychia.";
RL   J. Med. Genet. 41:E29-E29(2004).
RN   [91]
RP   SUBCELLULAR LOCATION, CHARACTERIZATION OF VARIANTS EDMD2 LYS-32 DEL;
RP   SER-63; GLN-249; LYS-358; CYS-401; TRP-453 AND PRO-527, CHARACTERIZATION OF
RP   VARIANTS EDMD2 LYS-208 DEL AND HIS-377, CHARACTERIZATION OF VARIANT FPLD2
RP   LEU-482, AND CHARACTERIZATION OF VARIANT CMD1A CYS-541.
RX   PubMed=15372542; DOI=10.1002/mus.20122;
RA   Muchir A., Medioni J., Laluc M., Massart C., Arimura T., van der Kooi A.J.,
RA   Desguerre I., Mayer M., Ferrer X., Briault S., Hirano M., Worman H.J.,
RA   Mallet A., Wehnert M., Schwartz K., Bonne G.;
RT   "Nuclear envelope alterations in fibroblasts from patients with muscular
RT   dystrophy, cardiomyopathy, and partial lipodystrophy carrying lamin A/C
RT   gene mutations.";
RL   Muscle Nerve 30:444-450(2004).
RN   [92]
RP   VARIANT HGPS PHE-143.
RX   PubMed=15622532; DOI=10.1002/ana.20359;
RA   Kirschner J., Brune T., Wehnert M., Denecke J., Wasner C., Feuer A.,
RA   Marquardt T., Ketelsen U.-P., Wieacker P., Boennemann C.G.,
RA   Korinthenberg R.;
RT   "p.S143F mutation in lamin A/C: a new phenotype combining myopathy and
RT   progeria.";
RL   Ann. Neurol. 57:148-151(2005).
RN   [93]
RP   VARIANT CMDA1 ASN-260.
RX   PubMed=16156025;
RA   Arbustini Eloisa A.E., Pilotto A., Pasotti M., Grasso M., Diegoli M.,
RA   Campana C., Gavazzi A., Alessandra R., Tavazzi L.;
RT   "Gene symbol: LMNA. Disease: cardiomyopathy, dilated, with conduction
RT   defect 1.";
RL   Hum. Genet. 117:298-298(2005).
RN   [94]
RP   VARIANT MADA VAL-529.
RX   PubMed=15998779; DOI=10.1210/jc.2004-2560;
RA   Garg A., Cogulu O., Ozkinay F., Onay H., Agarwal A.K.;
RT   "A novel homozygous Ala529Val LMNA mutation in Turkish patients with
RT   mandibuloacral dysplasia.";
RL   J. Clin. Endocrinol. Metab. 90:5259-5264(2005).
RN   [95]
RP   VARIANT EDMD2 HIS-377, AND VARIANTS EDMD2 ASN-63; PRO-140; GLN-190; GLN-249
RP   AND PRO-527.
RX   PubMed=15744034; DOI=10.1136/jmg.2004.026112;
RA   Cenni V., Sabatelli P., Mattioli E., Marmiroli S., Capanni C., Ognibene A.,
RA   Squarzoni S., Maraldi N.M., Bonne G., Columbaro M., Merlini L.,
RA   Lattanzi G.;
RT   "Lamin A N-terminal phosphorylation is associated with myoblast activation:
RT   impairment in Emery-Dreifuss muscular dystrophy.";
RL   J. Med. Genet. 42:214-220(2005).
RN   [96]
RP   VARIANT MADA LEU-573.
RX   PubMed=16278265; DOI=10.1210/jc.2005-1297;
RA   Van Esch H., Agarwal A.K., Debeer P., Fryns J.-P., Garg A.;
RT   "A homozygous mutation in the lamin A/C gene associated with a novel
RT   syndrome of arthropathy, tendinous calcinosis, and progeroid features.";
RL   J. Clin. Endocrinol. Metab. 91:517-521(2006).
RN   [97]
RP   VARIANT CMDHH ARG-59.
RX   PubMed=17150192; DOI=10.1016/j.bbrc.2006.11.070;
RA   Nguyen D., Leistritz D.F., Turner L., MacGregor D., Ohson K., Dancey P.,
RA   Martin G.M., Oshima J.;
RT   "Collagen expression in fibroblasts with a novel LMNA mutation.";
RL   Biochem. Biophys. Res. Commun. 352:603-608(2007).
RN   [98]
RP   VARIANTS FPLD2 ASN-230; CYS-399 AND LEU-573.
RX   PubMed=17250669; DOI=10.1111/j.1399-0004.2007.00740.x;
RA   Lanktree M., Cao H., Rabkin S.W., Hanna A., Hegele R.A.;
RT   "Novel LMNA mutations seen in patients with familial partial lipodystrophy
RT   subtype 2 (FPLD2; MIM 151660).";
RL   Clin. Genet. 71:183-186(2007).
RN   [99]
RP   VARIANT EDMD2 HIS-377.
RX   PubMed=17136397; DOI=10.1007/s10048-006-0070-0;
RA   Rudnik-Schoeneborn S., Botzenhart E., Eggermann T., Senderek J.,
RA   Schoser B.G.H., Schroeder R., Wehnert M., Wirth B., Zerres K.;
RT   "Mutations of the LMNA gene can mimic autosomal dominant proximal spinal
RT   muscular atrophy.";
RL   Neurogenetics 8:137-142(2007).
RN   [100]
RP   VARIANT PRO-421.
RX   PubMed=17711925; DOI=10.1210/jc.2007-0654;
RA   Decaudain A., Vantyghem M.C., Guerci B., Hecart A.C., Auclair M.,
RA   Reznik Y., Narbonne H., Ducluzeau P.H., Donadille B., Lebbe C.,
RA   Bereziat V., Capeau J., Lascols O., Vigouroux C.;
RT   "New metabolic phenotypes in laminopathies: LMNA mutations in patients with
RT   severe metabolic syndrome.";
RL   J. Clin. Endocrinol. Metab. 92:4835-4844(2007).
RN   [101]
RP   VARIANTS MDCL SER-39; PRO-50; TRP-249; PRO-302; LYS-358; SER-380; PRO-453;
RP   PRO-455 AND ASP-456.
RX   PubMed=18551513; DOI=10.1002/ana.21417;
RA   Quijano-Roy S., Mbieleu B., Bonnemann C.G., Jeannet P.Y., Colomer J.,
RA   Clarke N.F., Cuisset J.M., Roper H., De Meirleir L., D'Amico A.,
RA   Ben Yaou R., Nascimento A., Barois A., Demay L., Bertini E., Ferreiro A.,
RA   Sewry C.A., Romero N.B., Ryan M., Muntoni F., Guicheney P., Richard P.,
RA   Bonne G., Estournet B.;
RT   "De novo LMNA mutations cause a new form of congenital muscular
RT   dystrophy.";
RL   Ann. Neurol. 64:177-186(2008).
RN   [102]
RP   INVOLVEMENT IN HHS-SLOVENIAN, AND FUNCTION.
RX   PubMed=18611980; DOI=10.1136/jmg.2008.060020;
RA   Renou L., Stora S., Yaou R.B., Volk M., Sinkovec M., Demay L., Richard P.,
RA   Peterlin B., Bonne G.;
RT   "Heart-hand syndrome of Slovenian type: a new kind of laminopathy.";
RL   J. Med. Genet. 45:666-671(2008).
RN   [103]
RP   VARIANT CMDHH ARG-59.
RX   PubMed=19283854; DOI=10.1002/ajmg.a.32627;
RA   McPherson E., Turner L., Zador I., Reynolds K., Macgregor D.,
RA   Giampietro P.F.;
RT   "Ovarian failure and dilated cardiomyopathy due to a novel lamin
RT   mutation.";
RL   Am. J. Med. Genet. A 149:567-572(2009).
RN   [104]
RP   VARIANTS SER-125; ILE-415 AND PRO-488.
RX   PubMed=19427440; DOI=10.1016/j.amjcard.2009.01.354;
RA   Brauch K.M., Chen L.Y., Olson T.M.;
RT   "Comprehensive mutation scanning of LMNA in 268 patients with lone atrial
RT   fibrillation.";
RL   Am. J. Cardiol. 103:1426-1428(2009).
RN   [105]
RP   VARIANT CMD1A CYS-541.
RX   PubMed=19167105; DOI=10.1016/j.ijcard.2008.12.083;
RA   Saj M., Jankowska A., Lewandowski M., Szwed H., Szperl M., Ploski R.,
RA   Bilinska Z.T.;
RT   "Dilated cardiomyopathy with profound segmental wall motion abnormalities
RT   and ventricular arrhythmia caused by the R541C mutation in the LMNA gene.";
RL   Int. J. Cardiol. 144:E51-E53(2010).
RN   [106]
RP   VARIANTS CMD1A PHE-92; LYS-161; LYS-317 AND ARG-523.
RX   PubMed=21846512; DOI=10.1016/j.ejmg.2011.07.005;
RA   Millat G., Bouvagnet P., Chevalier P., Sebbag L., Dulac A., Dauphin C.,
RA   Jouk P.S., Delrue M.A., Thambo J.B., Le Metayer P., Seronde M.F.,
RA   Faivre L., Eicher J.C., Rousson R.;
RT   "Clinical and mutational spectrum in a cohort of 105 unrelated patients
RT   with dilated cardiomyopathy.";
RL   Eur. J. Med. Genet. 54:E570-E575(2011).
RN   [107]
RP   VARIANT HGPS LYS-138.
RX   PubMed=21791255; DOI=10.1016/j.ejmg.2011.06.012;
RA   Gonzalez-Quereda L., Delgadillo V., Juan-Mateu J., Verdura E.,
RA   Rodriguez M.J., Baiget M., Pineda M., Gallano P.;
RT   "LMNA mutation in progeroid syndrome in association with strokes.";
RL   Eur. J. Med. Genet. 54:E576-E579(2011).
RN   [108]
RP   VARIANTS EDMD2 SER-39; CYS-45; PRO-150; PRO-189; ARG-190 INS; LEU-206;
RP   TRP-249; GLN-249; PRO-268; PRO-271; PRO-294; PRO-295; PRO-303; GLN-355 DEL;
RP   LYS-358; LYS-361; LYS-386; ASP-449; TRP-453; PRO-454; TYR-461; ARG-467;
RP   PRO-527; LYS-528; ARG-528; SER-541; PRO-541; SER-602 AND CYS-644, AND
RP   CHARACTERIZATION OF VARIANTS EDMD2 PRO-25; TRP-249; ILE-456 AND PRO-541.
RX   PubMed=20848652; DOI=10.1002/humu.21361;
RA   Scharner J., Brown C.A., Bower M., Iannaccone S.T., Khatri I.A.,
RA   Escolar D., Gordon E., Felice K., Crowe C.A., Grosmann C., Meriggioli M.N.,
RA   Asamoah A., Gordon O., Gnocchi V.F., Ellis J.A., Mendell J.R., Zammit P.S.;
RT   "Novel LMNA mutations in patients with Emery-Dreifuss muscular dystrophy
RT   and functional characterization of four LMNA mutations.";
RL   Hum. Mutat. 32:152-167(2011).
RN   [109]
RP   VARIANTS ASP-411 AND ASP-631.
RX   PubMed=21724554; DOI=10.1093/hmg/ddr294;
RA   Dutour A., Roll P., Gaborit B., Courrier S., Alessi M.C., Tregouet D.A.,
RA   Angelis F., Robaglia-Schlupp A., Lesavre N., Cau P., Levy N., Badens C.,
RA   Morange P.E.;
RT   "High prevalence of laminopathies among patients with metabolic syndrome.";
RL   Hum. Mol. Genet. 20:3779-3786(2011).
RN   [110]
RP   VARIANT EDMD3 GLN-225, AND FUNCTION.
RX   PubMed=22431096; DOI=10.1002/mus.22324;
RA   Jimenez-Escrig A., Gobernado I., Garcia-Villanueva M., Sanchez-Herranz A.;
RT   "Autosomal recessive Emery-Dreifuss muscular dystrophy caused by a novel
RT   mutation (R225Q) in the lamin A/C gene identified by exome sequencing.";
RL   Muscle Nerve 45:605-610(2012).
RN   [111]
RP   CHARACTERIZATION OF VARIANTS CYS-401; ASP-411; CYS-413; ILE-415; CYS-419;
RP   PRO-421 AND GLY-427, AND INTERACTION WITH SYNE2.
RX   PubMed=23977161; DOI=10.1371/journal.pone.0071850;
RA   Yang L., Munck M., Swamvdinathan K., Kapinos L.E., Noegel A.A., Neumann S.;
RT   "Mutations in LMNA modulate the lamin A--Nesprin-2 interaction and cause
RT   LINC complex alterations.";
RL   PLoS ONE 8:E71850-E71850(2013).
RN   [112]
RP   VARIANT FPLD2 GLU-515.
RX   PubMed=24485160; DOI=10.1016/j.diabet.2013.12.008;
RA   Chirico V., Ferrau V., Loddo I., Briuglia S., Amorini M., Salpietro V.,
RA   Lacquaniti A., Salpietro C., Arrigo T.;
RT   "LMNA gene mutation as a model of cardiometabolic dysfunction: from genetic
RT   analysis to treatment response.";
RL   Diabetes Metab. 40:224-228(2014).
RN   [113]
RP   VARIANT EDMD3 SER-24, AND VARIANT EDMD2 CYS-259.
RX   PubMed=27234031; DOI=10.1111/cge.12810;
RA   Fattahi Z., Kalhor Z., Fadaee M., Vazehan R., Parsimehr E., Abolhassani A.,
RA   Beheshtian M., Zamani G., Nafissi S., Nilipour Y., Akbari M.R., Kahrizi K.,
RA   Kariminejad A., Najmabadi H.;
RT   "Improved diagnostic yield of neuromuscular disorders applying clinical
RT   exome sequencing in patients arising from a consanguineous population.";
RL   Clin. Genet. 91:386-402(2017).
CC   -!- FUNCTION: Lamins are components of the nuclear lamina, a fibrous layer
CC       on the nucleoplasmic side of the inner nuclear membrane, which is
CC       thought to provide a framework for the nuclear envelope and may also
CC       interact with chromatin. Lamin A and C are present in equal amounts in
CC       the lamina of mammals. Plays an important role in nuclear assembly,
CC       chromatin organization, nuclear membrane and telomere dynamics.
CC       Required for normal development of peripheral nervous system and
CC       skeletal muscle and for muscle satellite cell proliferation
CC       (PubMed:10080180, PubMed:22431096, PubMed:10814726, PubMed:11799477,
CC       PubMed:18551513). Required for osteoblastogenesis and bone formation
CC       (PubMed:12075506, PubMed:15317753, PubMed:18611980). Also prevents fat
CC       infiltration of muscle and bone marrow, helping to maintain the volume
CC       and strength of skeletal muscle and bone (PubMed:10587585). Required
CC       for cardiac homeostasis (PubMed:10580070, PubMed:12927431,
CC       PubMed:18611980, PubMed:23666920). {ECO:0000269|PubMed:10080180,
CC       ECO:0000269|PubMed:10580070, ECO:0000269|PubMed:10587585,
CC       ECO:0000269|PubMed:10814726, ECO:0000269|PubMed:11799477,
CC       ECO:0000269|PubMed:12075506, ECO:0000269|PubMed:12927431,
CC       ECO:0000269|PubMed:15317753, ECO:0000269|PubMed:18551513,
CC       ECO:0000269|PubMed:18611980, ECO:0000269|PubMed:22431096,
CC       ECO:0000269|PubMed:23666920}.
CC   -!- FUNCTION: Prelamin-A/C can accelerate smooth muscle cell senescence. It
CC       acts to disrupt mitosis and induce DNA damage in vascular smooth muscle
CC       cells (VSMCs), leading to mitotic failure, genomic instability, and
CC       premature senescence.
CC   -!- SUBUNIT: Homodimer of lamin A and lamin C. Interacts with lamin-
CC       associated polypeptides IA, IB and TMPO-alpha, RB1 and with emerin.
CC       Interacts with SREBF1, SREBF2, SUN2 and TMEM43. Interacts with TMEM201
CC       (By similarity). Proteolytically processed isoform A interacts with
CC       NARF. Interacts with SUN1. Prelamin-A/C interacts with EMD. Interacts
CC       with MLIP. Interacts with DMPK; may regulate nuclear envelope
CC       stability. Interacts with SUV39H1; the interaction increases stability
CC       of SUV39H1. Interacts with SYNE2. Interacts with ITSN1 isoform 2
CC       (PubMed:29599122). {ECO:0000250, ECO:0000269|PubMed:10514485,
CC       ECO:0000269|PubMed:12475961, ECO:0000269|PubMed:19323649,
CC       ECO:0000269|PubMed:19933576, ECO:0000269|PubMed:21498514,
CC       ECO:0000269|PubMed:21949239, ECO:0000269|PubMed:23695662,
CC       ECO:0000269|PubMed:23977161, ECO:0000269|PubMed:29599122}.
CC   -!- INTERACTION:
CC       P02545-2; P02545-2; NbExp=4; IntAct=EBI-351953, EBI-351953;
CC       P02545; P18054: ALOX12; NbExp=4; IntAct=EBI-351935, EBI-1633210;
CC       P02545; Q9UII6: DUSP13; NbExp=7; IntAct=EBI-351935, EBI-749800;
CC       P02545; P50402: EMD; NbExp=4; IntAct=EBI-351935, EBI-489887;
CC       P02545; P16104: H2AFX; NbExp=3; IntAct=EBI-351935, EBI-494830;
CC       P02545; Q71DI3: HIST2H3A; NbExp=6; IntAct=EBI-351935, EBI-750650;
CC       P02545-6; Q71DI3: HIST2H3A; NbExp=3; IntAct=EBI-9034379, EBI-750650;
CC       P02545; P60409: KRTAP10-7; NbExp=3; IntAct=EBI-351935, EBI-10172290;
CC       P02545; P20700: LMNB1; NbExp=9; IntAct=EBI-351935, EBI-968218;
CC       P02545-1; P20700: LMNB1; NbExp=5; IntAct=EBI-351949, EBI-968218;
CC       P02545-2; P20700: LMNB1; NbExp=19; IntAct=EBI-351953, EBI-968218;
CC       P02545; Q03252: LMNB2; NbExp=5; IntAct=EBI-351935, EBI-2830427;
CC       P02545; P10215: NEC1; Xeno; NbExp=2; IntAct=EBI-351935, EBI-7183650;
CC       P02545; P10218: NEC2; Xeno; NbExp=2; IntAct=EBI-351935, EBI-7183680;
CC       P02545; Q96RG2: PASK; NbExp=2; IntAct=EBI-351935, EBI-1042651;
CC       P02545; Q96FA3: PELI1; NbExp=3; IntAct=EBI-351935, EBI-448369;
CC       P02545-1; PRO_0000314029 [P36956]: SREBF1; NbExp=6; IntAct=EBI-351949, EBI-22057616;
CC       P02545; Q9UH99: SUN2; NbExp=4; IntAct=EBI-351935, EBI-1044964;
CC       P02545-2; Q8N0S2: SYCE1; NbExp=3; IntAct=EBI-351953, EBI-6872807;
CC       P02545; Q8WXH0-1: SYNE2; NbExp=3; IntAct=EBI-351935, EBI-6170976;
CC       P02545; P42166: TMPO; NbExp=4; IntAct=EBI-351935, EBI-395393;
CC       P02545; P63104: YWHAZ; NbExp=2; IntAct=EBI-351935, EBI-347088;
CC       P02545-1; O75844: ZMPSTE24; NbExp=2; IntAct=EBI-351949, EBI-1056377;
CC       P02545; Q8TBZ8: ZNF564; NbExp=3; IntAct=EBI-351935, EBI-10273713;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15372542}. Nucleus
CC       envelope {ECO:0000269|PubMed:29599122}. Nucleus lamina. Nucleus,
CC       nucleoplasm. Note=Farnesylation of prelamin-A/C facilitates nuclear
CC       envelope targeting and subsequent cleavage by ZMPSTE24/FACE1 to remove
CC       the farnesyl group produces mature lamin-A/C, which can then be
CC       inserted into the nuclear lamina. EMD is required for proper
CC       localization of non-farnesylated prelamin-A/C.
CC   -!- SUBCELLULAR LOCATION: [Isoform C]: Nucleus speckle
CC       {ECO:0000269|PubMed:16061563}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=A; Synonyms=Lamin A;
CC         IsoId=P02545-1; Sequence=Displayed;
CC       Name=C; Synonyms=Lamin C;
CC         IsoId=P02545-2; Sequence=VSP_002469, VSP_002470;
CC       Name=ADelta10; Synonyms=Lamin ADelta10;
CC         IsoId=P02545-3; Sequence=VSP_002468;
CC       Name=4;
CC         IsoId=P02545-4; Sequence=VSP_045977, VSP_045978, VSP_045979;
CC       Name=5;
CC         IsoId=P02545-5; Sequence=VSP_053503, VSP_053504;
CC       Name=6; Synonyms=Progerin;
CC         IsoId=P02545-6; Sequence=VSP_053505;
CC   -!- TISSUE SPECIFICITY: In the arteries, prelamin-A/C accumulation is not
CC       observed in young healthy vessels but is prevalent in medial vascular
CC       smooth muscle cells (VSMCs) from aged individuals and in
CC       atherosclerotic lesions, where it often colocalizes with senescent and
CC       degenerate VSMCs. Prelamin-A/C expression increases with age and
CC       disease. In normal aging, the accumulation of prelamin-A/C is caused in
CC       part by the down-regulation of ZMPSTE24/FACE1 in response to oxidative
CC       stress. {ECO:0000269|PubMed:20458013}.
CC   -!- PTM: Increased phosphorylation of the lamins occurs before envelope
CC       disintegration and probably plays a role in regulating lamin
CC       associations. {ECO:0000269|Ref.9}.
CC   -!- PTM: Proteolytic cleavage of the C-terminal of 18 residues of prelamin-
CC       A/C results in the production of lamin-A/C. The prelamin-A/C maturation
CC       pathway includes farnesylation of CAAX motif, ZMPSTE24/FACE1 mediated
CC       cleavage of the last three amino acids, methylation of the C-terminal
CC       cysteine and endoproteolytic removal of the last 15 C-terminal amino
CC       acids. Proteolytic cleavage requires prior farnesylation and
CC       methylation, and absence of these blocks cleavage.
CC       {ECO:0000269|PubMed:20458013, ECO:0000269|PubMed:8175923,
CC       ECO:0000269|PubMed:9030603}.
CC   -!- PTM: Sumoylation is necessary for the localization to the nuclear
CC       envelope. {ECO:0000269|PubMed:18606848}.
CC   -!- PTM: Farnesylation of prelamin-A/C facilitates nuclear envelope
CC       targeting.
CC   -!- DISEASE: Emery-Dreifuss muscular dystrophy 2, autosomal dominant
CC       (EDMD2) [MIM:181350]: A form of Emery-Dreifuss muscular dystrophy, a
CC       degenerative myopathy characterized by weakness and atrophy of muscle
CC       without involvement of the nervous system, early contractures of the
CC       elbows, Achilles tendons and spine, and cardiomyopathy associated with
CC       cardiac conduction defects. {ECO:0000269|PubMed:10080180,
CC       ECO:0000269|PubMed:10739764, ECO:0000269|PubMed:10814726,
CC       ECO:0000269|PubMed:10908904, ECO:0000269|PubMed:10939567,
CC       ECO:0000269|PubMed:11503164, ECO:0000269|PubMed:11525883,
CC       ECO:0000269|PubMed:11792809, ECO:0000269|PubMed:12032588,
CC       ECO:0000269|PubMed:12467752, ECO:0000269|PubMed:12649505,
CC       ECO:0000269|PubMed:12673789, ECO:0000269|PubMed:14684700,
CC       ECO:0000269|PubMed:14985400, ECO:0000269|PubMed:15372542,
CC       ECO:0000269|PubMed:15744034, ECO:0000269|PubMed:17136397,
CC       ECO:0000269|PubMed:19933576, ECO:0000269|PubMed:20848652,
CC       ECO:0000269|PubMed:27234031}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Emery-Dreifuss muscular dystrophy 3, autosomal recessive
CC       (EDMD3) [MIM:616516]: A form of Emery-Dreifuss muscular dystrophy, a
CC       degenerative myopathy characterized by weakness and atrophy of muscle
CC       without involvement of the nervous system, early contractures of the
CC       elbows, Achilles tendons and spine, and cardiomyopathy associated with
CC       cardiac conduction defects. {ECO:0000269|PubMed:22431096,
CC       ECO:0000269|PubMed:27234031}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Cardiomyopathy, dilated 1A (CMD1A) [MIM:115200]: A disorder
CC       characterized by ventricular dilation and impaired systolic function,
CC       resulting in congestive heart failure and arrhythmia. Patients are at
CC       risk of premature death. {ECO:0000269|PubMed:10580070,
CC       ECO:0000269|PubMed:11561226, ECO:0000269|PubMed:11792809,
CC       ECO:0000269|PubMed:11897440, ECO:0000269|PubMed:12486434,
CC       ECO:0000269|PubMed:12628721, ECO:0000269|PubMed:12920062,
CC       ECO:0000269|PubMed:14675861, ECO:0000269|PubMed:14684700,
CC       ECO:0000269|PubMed:15140538, ECO:0000269|PubMed:15219508,
CC       ECO:0000269|PubMed:15372542, ECO:0000269|PubMed:16061563,
CC       ECO:0000269|PubMed:18606848, ECO:0000269|PubMed:19167105,
CC       ECO:0000269|PubMed:20160190, ECO:0000269|PubMed:21846512}. Note=The
CC       disease is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Lipodystrophy, familial partial, 2 (FPLD2) [MIM:151660]: A
CC       disorder characterized by the loss of subcutaneous adipose tissue in
CC       the lower parts of the body (limbs, buttocks, trunk). It is accompanied
CC       by an accumulation of adipose tissue in the face and neck causing a
CC       double chin, fat neck, or cushingoid appearance. Adipose tissue may
CC       also accumulate in the axillae, back, labia majora, and intraabdominal
CC       region. Affected patients are insulin-resistant and may develop glucose
CC       intolerance and diabetes mellitus after age 20 years,
CC       hypertriglyceridemia, and low levels of high density lipoprotein
CC       cholesterol. {ECO:0000269|PubMed:10587585, ECO:0000269|PubMed:10655060,
CC       ECO:0000269|PubMed:10739751, ECO:0000269|PubMed:11792809,
CC       ECO:0000269|PubMed:12015247, ECO:0000269|PubMed:12196663,
CC       ECO:0000269|PubMed:12629077, ECO:0000269|PubMed:15372542,
CC       ECO:0000269|PubMed:17250669, ECO:0000269|PubMed:19220582,
CC       ECO:0000269|PubMed:24485160}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Charcot-Marie-Tooth disease 2B1 (CMT2B1) [MIM:605588]: A
CC       recessive axonal form of Charcot-Marie-Tooth disease, a disorder of the
CC       peripheral nervous system, characterized by progressive weakness and
CC       atrophy, initially of the peroneal muscles and later of the distal
CC       muscles of the arms. Charcot-Marie-Tooth disease is classified in two
CC       main groups on the basis of electrophysiologic properties and
CC       histopathology: primary peripheral demyelinating neuropathies
CC       (designated CMT1 when they are dominantly inherited) and primary
CC       peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group
CC       are characterized by signs of axonal degeneration in the absence of
CC       obvious myelin alterations, normal or slightly reduced nerve conduction
CC       velocities, and progressive distal muscle weakness and atrophy.
CC       {ECO:0000269|PubMed:11799477}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Hutchinson-Gilford progeria syndrome (HGPS) [MIM:176670]: Rare
CC       genetic disorder characterized by features reminiscent of marked
CC       premature aging. {ECO:0000269|PubMed:12714972,
CC       ECO:0000269|PubMed:12768443, ECO:0000269|PubMed:12927431,
CC       ECO:0000269|PubMed:15060110, ECO:0000269|PubMed:15286156,
CC       ECO:0000269|PubMed:15622532, ECO:0000269|PubMed:19933576,
CC       ECO:0000269|PubMed:21791255, ECO:0000269|PubMed:22355414,
CC       ECO:0000269|PubMed:23666920}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry. HGPS is caused by the
CC       toxic accumulation of a truncated form of lamin-A/C. This mutant
CC       protein, called progerin (isoform 6), acts to deregulate mitosis and
CC       DNA damage signaling, leading to premature cell death and senescence.
CC       The mutant form is mainly generated by a silent or missense mutation at
CC       codon 608 of prelamin A that causes activation of a cryptic splice
CC       donor site, resulting in production of isoform 6 with a deletion of 50
CC       amino acids near the C terminus. Progerin lacks the conserved
CC       ZMPSTE24/FACE1 cleavage site and therefore remains permanently
CC       farnesylated. Thus, although it can enter the nucleus and associate
CC       with the nuclear envelope, it cannot incorporate normally into the
CC       nuclear lamina (PubMed:12714972). {ECO:0000269|PubMed:12714972}.
CC   -!- DISEASE: Cardiomyopathy, dilated, with hypergonadotropic hypogonadism
CC       (CMDHH) [MIM:212112]: A disorder characterized by the association of
CC       genital anomalies, hypergonadotropic hypogonadism and dilated
CC       cardiomyopathy. Patients can present other variable clinical
CC       manifestations including mental retardation, skeletal anomalies,
CC       scleroderma-like skin, graying and thinning of hair, osteoporosis.
CC       Dilated cardiomyopathy is characterized by ventricular dilation and
CC       impaired systolic function, resulting in congestive heart failure and
CC       arrhythmia. {ECO:0000269|PubMed:12927431, ECO:0000269|PubMed:17150192,
CC       ECO:0000269|PubMed:19283854}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Mandibuloacral dysplasia with type A lipodystrophy (MADA)
CC       [MIM:248370]: A disorder characterized by mandibular and clavicular
CC       hypoplasia, acroosteolysis, delayed closure of the cranial suture,
CC       progeroid appearance, partial alopecia, soft tissue calcinosis, joint
CC       contractures, and partial lipodystrophy with loss of subcutaneous fat
CC       from the extremities. Adipose tissue in the face, neck and trunk is
CC       normal or increased. {ECO:0000269|PubMed:12075506,
CC       ECO:0000269|PubMed:15998779, ECO:0000269|PubMed:16278265}. Note=The
CC       disease is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Lethal tight skin contracture syndrome (LTSCS) [MIM:275210]:
CC       Rare disorder mainly characterized by intrauterine growth retardation,
CC       tight and rigid skin with erosions, prominent superficial vasculature
CC       and epidermal hyperkeratosis, facial features (small mouth, small
CC       pinched nose and micrognathia), sparse/absent eyelashes and eyebrows,
CC       mineralization defects of the skull, thin dysplastic clavicles,
CC       pulmonary hypoplasia, multiple joint contractures and an early neonatal
CC       lethal course. Liveborn children usually die within the first week of
CC       life. The overall prevalence of consanguineous cases suggested an
CC       autosomal recessive inheritance. {ECO:0000269|PubMed:15317753}.
CC       Note=The disease is caused by mutations affecting the gene represented
CC       in this entry.
CC   -!- DISEASE: Heart-hand syndrome Slovenian type (HHS-Slovenian)
CC       [MIM:610140]: Heart-hand syndrome (HHS) is a clinically and genetically
CC       heterogeneous disorder characterized by the co-occurrence of a
CC       congenital cardiac disease and limb malformations.
CC       {ECO:0000269|PubMed:18611980}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Muscular dystrophy congenital LMNA-related (MDCL)
CC       [MIM:613205]: A form of congenital muscular dystrophy. Patients present
CC       at birth, or within the first few months of life, with hypotonia,
CC       muscle weakness and often with joint contractures.
CC       {ECO:0000269|PubMed:18551513}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Note=Defects in LMNA may cause a late-onset cardiocutaneous
CC       progeria syndrome characterized by cutaneous manifestations of aging
CC       appearing in the third decade of life, cardiac valve calcification and
CC       dysfunction, prominent atherosclerosis, and cardiomyopathy, leading to
CC       death on average in the fourth decade. {ECO:0000269|PubMed:23666920}.
CC   -!- MISCELLANEOUS: There are three types of lamins in human cells: A, B,
CC       and C.
CC   -!- MISCELLANEOUS: The structural integrity of the lamina is strictly
CC       controlled by the cell cycle, as seen by the disintegration and
CC       formation of the nuclear envelope in prophase and telophase,
CC       respectively.
CC   -!- MISCELLANEOUS: [Isoform 6]: Disease-associated isoform. Polymorphism at
CC       codon 608 results in activation of a cryptic splice donor site within
CC       exon 11, resulting in a truncated protein product that lacks the site
CC       for endoproteolytic cleavage. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the intermediate filament family.
CC       {ECO:0000255|PROSITE-ProRule:PRU01188}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA27173.1; Type=Frameshift; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Human Intermediate Filament Mutation Database;
CC       URL="http://www.interfil.org";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X03444; CAA27173.1; ALT_FRAME; mRNA.
DR   EMBL; X03445; CAA27174.1; -; mRNA.
DR   EMBL; M13451; AAA36164.1; -; mRNA.
DR   EMBL; M13452; AAA36160.1; -; mRNA.
DR   EMBL; AY847597; AAW32540.1; -; mRNA.
DR   EMBL; AY847595; AAW32538.1; -; mRNA.
DR   EMBL; AY357727; AAR29466.1; -; mRNA.
DR   EMBL; AK295390; BAG58344.1; -; mRNA.
DR   EMBL; AL135927; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL355388; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL356734; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471121; EAW52997.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW52999.1; -; Genomic_DNA.
DR   EMBL; BC000511; AAH00511.1; -; mRNA.
DR   EMBL; BC003162; AAH03162.1; -; mRNA.
DR   EMBL; BC014507; AAH14507.1; -; mRNA.
DR   EMBL; AF381029; AAK59326.1; -; mRNA.
DR   CCDS; CCDS1129.1; -. [P02545-1]
DR   CCDS; CCDS1131.1; -. [P02545-2]
DR   CCDS; CCDS58038.1; -. [P02545-4]
DR   CCDS; CCDS72941.1; -. [P02545-6]
DR   PIR; A02961; VEHULA.
DR   PIR; A02962; VEHULC.
DR   RefSeq; NP_001244303.1; NM_001257374.2. [P02545-4]
DR   RefSeq; NP_001269553.1; NM_001282624.1.
DR   RefSeq; NP_001269554.1; NM_001282625.1. [P02545-2]
DR   RefSeq; NP_001269555.1; NM_001282626.1. [P02545-6]
DR   RefSeq; NP_005563.1; NM_005572.3. [P02545-2]
DR   RefSeq; NP_733821.1; NM_170707.3. [P02545-1]
DR   RefSeq; NP_733822.1; NM_170708.3. [P02545-3]
DR   PDB; 1IFR; X-ray; 1.40 A; A=436-552.
DR   PDB; 1IVT; NMR; -; A=428-549.
DR   PDB; 1X8Y; X-ray; 2.20 A; A=305-387.
DR   PDB; 2XV5; X-ray; 2.40 A; A/B=328-398.
DR   PDB; 2YPT; X-ray; 3.80 A; F/G/H/I=661-664.
DR   PDB; 3GEF; X-ray; 1.50 A; A/B/C/D=436-552.
DR   PDB; 3V4Q; X-ray; 3.06 A; A=313-386.
DR   PDB; 3V4W; X-ray; 3.70 A; A=313-386.
DR   PDB; 3V5B; X-ray; 3.00 A; A=313-386.
DR   PDB; 6GHD; X-ray; 2.10 A; B/F=428-546.
DR   PDB; 6JLB; X-ray; 3.21 A; A/B/C/D=1-300.
DR   PDB; 6SNZ; X-ray; 2.60 A; A/B/C/D=65-222.
DR   PDBsum; 1IFR; -.
DR   PDBsum; 1IVT; -.
DR   PDBsum; 1X8Y; -.
DR   PDBsum; 2XV5; -.
DR   PDBsum; 2YPT; -.
DR   PDBsum; 3GEF; -.
DR   PDBsum; 3V4Q; -.
DR   PDBsum; 3V4W; -.
DR   PDBsum; 3V5B; -.
DR   PDBsum; 6GHD; -.
DR   PDBsum; 6JLB; -.
DR   PDBsum; 6SNZ; -.
DR   SMR; P02545; -.
DR   BioGrid; 110186; 810.
DR   CORUM; P02545; -.
DR   DIP; DIP-32948N; -.
DR   DIP; DIP-58162N; -.
DR   IntAct; P02545; 279.
DR   MINT; P02545; -.
DR   STRING; 9606.ENSP00000357283; -.
DR   ChEMBL; CHEMBL1293235; -.
DR   iPTMnet; P02545; -.
DR   MetOSite; P02545; -.
DR   PhosphoSitePlus; P02545; -.
DR   SwissPalm; P02545; -.
DR   BioMuta; LMNA; -.
DR   DMDM; 125962; -.
DR   REPRODUCTION-2DPAGE; IPI00021405; -.
DR   REPRODUCTION-2DPAGE; IPI00216952; -.
DR   REPRODUCTION-2DPAGE; P02545; -.
DR   SWISS-2DPAGE; P02545; -.
DR   CPTAC; CPTAC-399; -.
DR   CPTAC; CPTAC-400; -.
DR   CPTAC; CPTAC-973; -.
DR   CPTAC; CPTAC-974; -.
DR   EPD; P02545; -.
DR   jPOST; P02545; -.
DR   MassIVE; P02545; -.
DR   MaxQB; P02545; -.
DR   PaxDb; P02545; -.
DR   PeptideAtlas; P02545; -.
DR   PRIDE; P02545; -.
DR   ProteomicsDB; 13394; -.
DR   ProteomicsDB; 18441; -.
DR   ProteomicsDB; 51530; -. [P02545-1]
DR   ProteomicsDB; 51531; -. [P02545-2]
DR   ProteomicsDB; 51532; -. [P02545-3]
DR   ProteomicsDB; 67698; -.
DR   TopDownProteomics; P02545-1; -. [P02545-1]
DR   TopDownProteomics; P02545-2; -. [P02545-2]
DR   TopDownProteomics; P02545-4; -. [P02545-4]
DR   Antibodypedia; 1676; 1551 antibodies.
DR   DNASU; 4000; -.
DR   Ensembl; ENST00000347559; ENSP00000292304; ENSG00000160789. [P02545-3]
DR   Ensembl; ENST00000368299; ENSP00000357282; ENSG00000160789. [P02545-6]
DR   Ensembl; ENST00000368300; ENSP00000357283; ENSG00000160789. [P02545-1]
DR   Ensembl; ENST00000368301; ENSP00000357284; ENSG00000160789. [P02545-2]
DR   Ensembl; ENST00000448611; ENSP00000395597; ENSG00000160789. [P02545-4]
DR   Ensembl; ENST00000473598; ENSP00000421821; ENSG00000160789. [P02545-5]
DR   GeneID; 4000; -.
DR   KEGG; hsa:4000; -.
DR   UCSC; uc001fnf.3; human. [P02545-1]
DR   CTD; 4000; -.
DR   DisGeNET; 4000; -.
DR   GeneCards; LMNA; -.
DR   GeneReviews; LMNA; -.
DR   HGNC; HGNC:6636; LMNA.
DR   HPA; ENSG00000160789; Low tissue specificity.
DR   MalaCards; LMNA; -.
DR   MIM; 115200; phenotype.
DR   MIM; 150330; gene.
DR   MIM; 151660; phenotype.
DR   MIM; 176670; phenotype.
DR   MIM; 181350; phenotype.
DR   MIM; 212112; phenotype.
DR   MIM; 248370; phenotype.
DR   MIM; 275210; phenotype.
DR   MIM; 605588; phenotype.
DR   MIM; 610140; phenotype.
DR   MIM; 613205; phenotype.
DR   MIM; 616516; phenotype.
DR   neXtProt; NX_P02545; -.
DR   OpenTargets; ENSG00000160789; -.
DR   Orphanet; 79474; Atypical Werner syndrome.
DR   Orphanet; 98853; Autosomal dominant Emery-Dreifuss muscular dystrophy.
DR   Orphanet; 98855; Autosomal recessive Emery-Dreifuss muscular dystrophy.
DR   Orphanet; 280365; Autosomal semi-dominant severe lipodystrophic laminopathy.
DR   Orphanet; 98856; Charcot-Marie-Tooth disease type 2B1.
DR   Orphanet; 157973; Congenital muscular dystrophy due to LMNA mutation.
DR   Orphanet; 2229; Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome.
DR   Orphanet; 300751; Familial dilated cardiomyopathy with conduction defect due to LMNA mutation.
DR   Orphanet; 293899; Familial isolated arrhythmogenic ventricular dysplasia, biventricular form.
DR   Orphanet; 293888; Familial isolated arrhythmogenic ventricular dysplasia, left dominant form.
DR   Orphanet; 293910; Familial isolated arrhythmogenic ventricular dysplasia, right dominant form.
DR   Orphanet; 2348; Familial partial lipodystrophy, Dunnigan type.
DR   Orphanet; 79084; Familial partial lipodystrophy, Koebberling type.
DR   Orphanet; 168796; Heart-hand syndrome, Slovenian type.
DR   Orphanet; 740; Hutchinson-Gilford progeria syndrome.
DR   Orphanet; 54260; Left ventricular noncompaction.
DR   Orphanet; 363618; LMNA-related cardiocutaneous progeria syndrome.
DR   Orphanet; 90153; Mandibuloacral dysplasia with type A lipodystrophy.
DR   Orphanet; 1662; Restrictive dermopathy.
DR   PharmGKB; PA231; -.
DR   eggNOG; KOG0977; Eukaryota.
DR   eggNOG; ENOG410Y2H6; LUCA.
DR   GeneTree; ENSGT00940000157244; -.
DR   HOGENOM; CLU_012560_9_1_1; -.
DR   InParanoid; P02545; -.
DR   KO; K12641; -.
DR   OMA; ERMMSEF; -.
DR   OrthoDB; 701388at2759; -.
DR   PhylomeDB; P02545; -.
DR   TreeFam; TF101181; -.
DR   Reactome; R-HSA-1221632; Meiotic synapsis. [P02545-2]
DR   Reactome; R-HSA-2980766; Nuclear Envelope Breakdown.
DR   Reactome; R-HSA-2995383; Initiation of Nuclear Envelope Reformation.
DR   Reactome; R-HSA-352238; Breakdown of the nuclear lamina. [P02545-1]
DR   Reactome; R-HSA-381038; XBP1(S) activates chaperone genes.
DR   Reactome; R-HSA-4419969; Depolymerisation of the Nuclear Lamina.
DR   Reactome; R-HSA-6802952; Signaling by BRAF and RAF fusions.
DR   Reactome; R-HSA-8862803; Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models. [P02545-1]
DR   SIGNOR; P02545; -.
DR   ChiTaRS; LMNA; human.
DR   EvolutionaryTrace; P02545; -.
DR   GeneWiki; LMNA; -.
DR   GenomeRNAi; 4000; -.
DR   Pharos; P02545; Tbio.
DR   PRO; PR:P02545; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; P02545; protein.
DR   Bgee; ENSG00000160789; Expressed in mucosa of stomach and 238 other tissues.
DR   ExpressionAtlas; P02545; baseline and differential.
DR   Genevisible; P02545; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005882; C:intermediate filament; TAS:UniProtKB.
DR   GO; GO:0005638; C:lamin filament; TAS:UniProtKB.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0005635; C:nuclear envelope; IDA:UniProtKB.
DR   GO; GO:0005652; C:nuclear lamina; TAS:UniProtKB.
DR   GO; GO:0031965; C:nuclear membrane; HDA:UniProtKB.
DR   GO; GO:0016607; C:nuclear speck; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:CAFA.
DR   GO; GO:0005634; C:nucleus; IDA:ARUK-UCL.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005198; F:structural molecule activity; TAS:UniProtKB.
DR   GO; GO:0034613; P:cellular protein localization; IMP:CAFA.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEP:UniProtKB.
DR   GO; GO:0030951; P:establishment or maintenance of microtubule cytoskeleton polarity; ISS:BHF-UCL.
DR   GO; GO:0036498; P:IRE1-mediated unfolded protein response; TAS:Reactome.
DR   GO; GO:0007084; P:mitotic nuclear envelope reassembly; TAS:Reactome.
DR   GO; GO:0007517; P:muscle organ development; IMP:UniProtKB.
DR   GO; GO:1903243; P:negative regulation of cardiac muscle hypertrophy in response to stress; ISS:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; IMP:CAFA.
DR   GO; GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IEA:Ensembl.
DR   GO; GO:0072201; P:negative regulation of mesenchymal cell proliferation; IEA:Ensembl.
DR   GO; GO:0090201; P:negative regulation of release of cytochrome c from mitochondria; IEA:Ensembl.
DR   GO; GO:0006998; P:nuclear envelope organization; IMP:CAFA.
DR   GO; GO:0090343; P:positive regulation of cell aging; IDA:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; IEA:Ensembl.
DR   GO; GO:1900114; P:positive regulation of histone H3-K9 trimethylation; IEA:Ensembl.
DR   GO; GO:0006606; P:protein import into nucleus; IEA:Ensembl.
DR   GO; GO:0034504; P:protein localization to nucleus; ISS:UniProtKB.
DR   GO; GO:0030334; P:regulation of cell migration; ISS:BHF-UCL.
DR   GO; GO:1900180; P:regulation of protein localization to nucleus; IEA:Ensembl.
DR   GO; GO:0031647; P:regulation of protein stability; IEA:Ensembl.
DR   GO; GO:0032204; P:regulation of telomere maintenance; IMP:BHF-UCL.
DR   GO; GO:0055015; P:ventricular cardiac muscle cell development; IEA:Ensembl.
DR   DisProt; DP00716; -.
DR   Gene3D; 1.20.5.1160; -; 1.
DR   Gene3D; 2.60.40.1260; -; 1.
DR   InterPro; IPR018039; IF_conserved.
DR   InterPro; IPR039008; IF_rod_dom.
DR   InterPro; IPR042180; IF_rod_dom_coil1B.
DR   InterPro; IPR001322; Lamin_tail_dom.
DR   InterPro; IPR036415; Lamin_tail_dom_sf.
DR   Pfam; PF00038; Filament; 1.
DR   Pfam; PF00932; LTD; 1.
DR   SMART; SM01391; Filament; 1.
DR   SUPFAM; SSF74853; SSF74853; 1.
DR   PROSITE; PS00226; IF_ROD_1; 1.
DR   PROSITE; PS51842; IF_ROD_2; 1.
DR   PROSITE; PS51841; LTD; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cardiomyopathy;
KW   Charcot-Marie-Tooth disease; Coiled coil; Congenital muscular dystrophy;
KW   Direct protein sequencing; Disease mutation;
KW   Emery-Dreifuss muscular dystrophy; Intermediate filament; Isopeptide bond;
KW   Limb-girdle muscular dystrophy; Lipoprotein; Methylation;
KW   Neurodegeneration; Neuropathy; Nucleus; Phosphoprotein; Polymorphism;
KW   Prenylation; Reference proteome; Ubl conjugation.
FT   CHAIN           1..661
FT                   /note="Prelamin-A/C"
FT                   /id="PRO_0000398835"
FT   CHAIN           1..646
FT                   /note="Lamin-A/C"
FT                   /id="PRO_0000063810"
FT   PROPEP          647..661
FT                   /note="Removed in Lamin-A/C form"
FT                   /id="PRO_0000398836"
FT   PROPEP          662..664
FT                   /note="Removed in Prelamin-A/C form and in Lamin-A/C form"
FT                   /id="PRO_0000403442"
FT   DOMAIN          31..387
FT                   /note="IF rod"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01188"
FT   DOMAIN          428..545
FT                   /note="LTD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01187"
FT   REGION          1..130
FT                   /note="Interaction with MLIP"
FT                   /evidence="ECO:0000269|PubMed:21498514"
FT   REGION          1..33
FT                   /note="Head"
FT   REGION          34..70
FT                   /note="Coil 1A"
FT   REGION          71..80
FT                   /note="Linker 1"
FT   REGION          81..218
FT                   /note="Coil 1B"
FT   REGION          219..242
FT                   /note="Linker 2"
FT   REGION          243..383
FT                   /note="Coil 2"
FT   REGION          384..664
FT                   /note="Tail"
FT   MOTIF           417..422
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   SITE            266
FT                   /note="Heptad change of phase"
FT   SITE            325
FT                   /note="Stutter"
FT                   /evidence="ECO:0000250"
FT   SITE            330
FT                   /note="Heptad change of phase"
FT   SITE            646..647
FT                   /note="Cleavage; by endoprotease"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         3
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         12
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         18
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         19
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:16964243,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         22
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:16964243,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569,
FT                   ECO:0000269|Ref.9"
FT   MOD_RES         32
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P48678"
FT   MOD_RES         32
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P48678"
FT   MOD_RES         51
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         66
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         71
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         107
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         108
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         123
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P48678"
FT   MOD_RES         135
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P48678"
FT   MOD_RES         155
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P48678"
FT   MOD_RES         171
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P48678"
FT   MOD_RES         171
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P48678"
FT   MOD_RES         201
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P48678"
FT   MOD_RES         212
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         260
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P48678"
FT   MOD_RES         270
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         277
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:20068231"
FT   MOD_RES         301
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         307
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         311
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         390
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:16964243,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         392
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:16964243,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163"
FT   MOD_RES         395
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:16964243,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         398
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         403
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         404
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:24275569"
FT   MOD_RES         407
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P48678"
FT   MOD_RES         414
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:24275569"
FT   MOD_RES         429
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         431
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         450
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         457
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P48678"
FT   MOD_RES         458
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         463
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         496
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P48679"
FT   MOD_RES         505
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         510
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P48679"
FT   MOD_RES         533
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         546
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P48678"
FT   MOD_RES         548
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P48678"
FT   MOD_RES         568
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P48678"
FT   MOD_RES         571
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P48678"
FT   MOD_RES         612
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         613
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         616
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P48678"
FT   MOD_RES         619
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         628
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:16964243,
FT                   ECO:0000244|PubMed:17924679, ECO:0000244|PubMed:18220336,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         632
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:16964243,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163"
FT   MOD_RES         636
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:16964243,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         652
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231"
FT   MOD_RES         661
FT                   /note="Cysteine methyl ester"
FT                   /evidence="ECO:0000269|PubMed:8175923,
FT                   ECO:0000269|PubMed:9030603"
FT   LIPID           661
FT                   /note="S-farnesyl cysteine"
FT                   /evidence="ECO:0000269|PubMed:8175923,
FT                   ECO:0000269|PubMed:9030603"
FT   CROSSLNK        32
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        97
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:25772364, ECO:0000244|PubMed:28112733"
FT   CROSSLNK        171
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        201
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO); alternate"
FT   CROSSLNK        201
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        208
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        219
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        233
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25114211,
FT                   ECO:0000244|PubMed:25218447, ECO:0000244|PubMed:25755297,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        260
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:25755297,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        270
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:25755297,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        311
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:25772364, ECO:0000244|PubMed:28112733"
FT   CROSSLNK        366
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        378
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:25772364,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        417
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:28112733"
FT   CROSSLNK        420
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:25772364,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        450
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        470
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        486
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        597
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000244|PubMed:25114211"
FT   CROSSLNK        597
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:25114211,
FT                   ECO:0000244|PubMed:28112733"
FT   VAR_SEQ         1..99
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_053503"
FT   VAR_SEQ         1..7
FT                   /note="METPSQR -> MGNSEGC (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_045977"
FT   VAR_SEQ         8..119
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_045978"
FT   VAR_SEQ         100..119
FT                   /note="ARLQLELSKVREEFKELKAR -> MDLEAWDPHLEPDAEAMVDG (in
FT                   isoform 5)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_053504"
FT   VAR_SEQ         537..566
FT                   /note="Missing (in isoform ADelta10)"
FT                   /evidence="ECO:0000303|PubMed:8621584"
FT                   /id="VSP_002468"
FT   VAR_SEQ         567..572
FT                   /note="GSHCSS -> VSGSRR (in isoform C)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:3453101, ECO:0000303|PubMed:3462705"
FT                   /id="VSP_002469"
FT   VAR_SEQ         573..664
FT                   /note="Missing (in isoform C)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:3453101, ECO:0000303|PubMed:3462705"
FT                   /id="VSP_002470"
FT   VAR_SEQ         607..656
FT                   /note="Missing (in isoform 6)"
FT                   /evidence="ECO:0000303|Ref.4"
FT                   /id="VSP_053505"
FT   VAR_SEQ         664
FT                   /note="M -> IQEMGMRWEVEEGRRKVSLSCLP (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_045979"
FT   VARIANT         10
FT                   /note="T -> I (in an atypical progeroid patient; diagnosed
FT                   as Seip syndrome; unknown pathological significance;
FT                   dbSNP:rs57077886)"
FT                   /evidence="ECO:0000269|PubMed:15060110"
FT                   /id="VAR_039745"
FT   VARIANT         24
FT                   /note="T -> S (in EDMD3)"
FT                   /evidence="ECO:0000269|PubMed:27234031"
FT                   /id="VAR_076562"
FT   VARIANT         25
FT                   /note="R -> G (in EDMD2; dbSNP:rs58327533)"
FT                   /evidence="ECO:0000269|PubMed:14684700"
FT                   /id="VAR_039746"
FT   VARIANT         25
FT                   /note="R -> P (in EDMD2; mis-localized in the nucleus;
FT                   causes nuclear deformations and LMNB1 redistribution;
FT                   dbSNP:rs61578124)"
FT                   /evidence="ECO:0000269|PubMed:11503164,
FT                   ECO:0000269|PubMed:20848652"
FT                   /id="VAR_039747"
FT   VARIANT         28
FT                   /note="R -> W (in FPLD2; dbSNP:rs59914820)"
FT                   /evidence="ECO:0000269|PubMed:12015247"
FT                   /id="VAR_039748"
FT   VARIANT         32
FT                   /note="Missing (in EDMD2; abnormal nuclear localization in
FT                   a honeycomb expression pattern in about 11% of cultured
FT                   skin fibroblasts from heterozygous patients; no effect on
FT                   protein level)"
FT                   /evidence="ECO:0000269|PubMed:12467752,
FT                   ECO:0000269|PubMed:14684700, ECO:0000269|PubMed:15372542"
FT                   /id="VAR_039749"
FT   VARIANT         33
FT                   /note="E -> D (in CMT2; autosomal dominant form;
FT                   dbSNP:rs57966821)"
FT                   /evidence="ECO:0000269|PubMed:14985400"
FT                   /id="VAR_039750"
FT   VARIANT         33
FT                   /note="E -> G (in EDMD2; dbSNP:rs267607614)"
FT                   /evidence="ECO:0000269|PubMed:14985400"
FT                   /id="VAR_039751"
FT   VARIANT         35
FT                   /note="L -> V (in EDMD2; dbSNP:rs56694480)"
FT                   /evidence="ECO:0000269|PubMed:14684700"
FT                   /id="VAR_039752"
FT   VARIANT         39
FT                   /note="N -> S (in MDCL and EDMD2; dbSNP:rs57983345)"
FT                   /evidence="ECO:0000269|PubMed:18551513,
FT                   ECO:0000269|PubMed:20848652"
FT                   /id="VAR_063588"
FT   VARIANT         43
FT                   /note="A -> T (in EDMD2; dbSNP:rs60446065)"
FT                   /evidence="ECO:0000269|PubMed:11503164"
FT                   /id="VAR_039753"
FT   VARIANT         45
FT                   /note="Y -> C (in EDMD2; dbSNP:rs58436778)"
FT                   /evidence="ECO:0000269|PubMed:10939567,
FT                   ECO:0000269|PubMed:20848652"
FT                   /id="VAR_009971"
FT   VARIANT         50
FT                   /note="R -> P (in EDMD2 and MDCL; dbSNP:rs60695352)"
FT                   /evidence="ECO:0000269|PubMed:10939567,
FT                   ECO:0000269|PubMed:18551513"
FT                   /id="VAR_009972"
FT   VARIANT         50
FT                   /note="R -> S (in EDMD2; dbSNP:rs59931416)"
FT                   /evidence="ECO:0000269|PubMed:11503164"
FT                   /id="VAR_039754"
FT   VARIANT         57
FT                   /note="A -> P (in CMDHH; phenotype originally designated as
FT                   atypical Werner syndrome; dbSNP:rs28928903)"
FT                   /evidence="ECO:0000269|PubMed:12927431"
FT                   /id="VAR_017656"
FT   VARIANT         59
FT                   /note="L -> R (in CMDHH; dbSNP:rs58922911)"
FT                   /evidence="ECO:0000269|PubMed:17150192,
FT                   ECO:0000269|PubMed:19283854"
FT                   /id="VAR_064055"
FT   VARIANT         60
FT                   /note="R -> G (in CMD1A and FPLD2; interacts with itself
FT                   and with wild-type LMNA and LMNB1; no decrease in the
FT                   stability compared with wild-type; dbSNP:rs28928900)"
FT                   /evidence="ECO:0000269|PubMed:10580070,
FT                   ECO:0000269|PubMed:11792809, ECO:0000269|PubMed:12196663"
FT                   /id="VAR_034706"
FT   VARIANT         62
FT                   /note="R -> G (in FPLD2; dbSNP:rs56793579)"
FT                   /evidence="ECO:0000269|PubMed:12015247"
FT                   /id="VAR_039755"
FT   VARIANT         63
FT                   /note="I -> N (in EDMD2; dbSNP:rs57793737)"
FT                   /evidence="ECO:0000269|PubMed:12467752,
FT                   ECO:0000269|PubMed:12649505, ECO:0000269|PubMed:15744034"
FT                   /id="VAR_039756"
FT   VARIANT         63
FT                   /note="I -> S (in EDMD2; no effect on protein level; no
FT                   obvious effect on nuclear morphology in cultured skin
FT                   fibroblasts from heterozygous patients; dbSNP:rs57793737)"
FT                   /evidence="ECO:0000269|PubMed:10939567,
FT                   ECO:0000269|PubMed:15372542"
FT                   /id="VAR_009974"
FT   VARIANT         65
FT                   /note="E -> G (in EDMD2)"
FT                   /evidence="ECO:0000269|PubMed:14684700"
FT                   /id="VAR_039757"
FT   VARIANT         85
FT                   /note="L -> R (in CMD1A; interacts with itself and with
FT                   wild-type LMNA and LMNB1; no decrease in the stability
FT                   compared with wild-type; dbSNP:rs28933090)"
FT                   /evidence="ECO:0000269|PubMed:10580070,
FT                   ECO:0000269|PubMed:11792809"
FT                   /id="VAR_009975"
FT   VARIANT         89
FT                   /note="R -> L (in CMD1A; dramatically aberrant localization
FT                   with almost no nuclear rim staining and formation of
FT                   intranuclear foci; dbSNP:rs59040894)"
FT                   /evidence="ECO:0000269|PubMed:12628721,
FT                   ECO:0000269|PubMed:20160190"
FT                   /id="VAR_039758"
FT   VARIANT         92
FT                   /note="L -> F (in CMD1A; dbSNP:rs267607560)"
FT                   /evidence="ECO:0000269|PubMed:21846512"
FT                   /id="VAR_067257"
FT   VARIANT         97
FT                   /note="K -> E (in CMD1A; dbSNP:rs59065411)"
FT                   /evidence="ECO:0000269|PubMed:11897440"
FT                   /id="VAR_039759"
FT   VARIANT         101
FT                   /note="R -> P (in CMD1A; dramatically aberrant localization
FT                   with almost no nuclear rim staining and formation of
FT                   intranuclear foci; dbSNP:rs267607568)"
FT                   /evidence="ECO:0000269|PubMed:20160190"
FT                   /id="VAR_070174"
FT   VARIANT         112
FT                   /note="Missing (in EDMD2)"
FT                   /evidence="ECO:0000269|PubMed:10939567,
FT                   ECO:0000269|PubMed:14684700"
FT                   /id="VAR_009976"
FT   VARIANT         125
FT                   /note="G -> S (polymorphism; found in patients with atrial
FT                   fibrillation; dbSNP:rs267607605)"
FT                   /evidence="ECO:0000269|PubMed:19427440"
FT                   /id="VAR_072817"
FT   VARIANT         133
FT                   /note="R -> L (in FPLD2; dbSNP:rs60864230)"
FT                   /evidence="ECO:0000269|PubMed:12629077"
FT                   /id="VAR_016913"
FT   VARIANT         133
FT                   /note="R -> P (in EDMD2; dbSNP:rs60864230)"
FT                   /evidence="ECO:0000269|PubMed:11503164"
FT                   /id="VAR_017657"
FT   VARIANT         138
FT                   /note="E -> K (in HGPS; might be associated with early and
FT                   severe strokes; dbSNP:rs267607649)"
FT                   /evidence="ECO:0000269|PubMed:21791255"
FT                   /id="VAR_070175"
FT   VARIANT         140
FT                   /note="L -> P (in EDMD2; dbSNP:rs60652225)"
FT                   /evidence="ECO:0000269|PubMed:12649505,
FT                   ECO:0000269|PubMed:15744034"
FT                   /id="VAR_039760"
FT   VARIANT         140
FT                   /note="L -> R (in HGPS; phenotype originally designated as
FT                   atypical Werner syndrome; dbSNP:rs60652225)"
FT                   /evidence="ECO:0000269|PubMed:12927431"
FT                   /id="VAR_017658"
FT   VARIANT         143
FT                   /note="S -> F (in HGPS; dbSNP:rs58912633)"
FT                   /evidence="ECO:0000269|PubMed:15622532"
FT                   /id="VAR_034707"
FT   VARIANT         143
FT                   /note="S -> P (in CMD1A; dbSNP:rs61661343)"
FT                   /evidence="ECO:0000269|PubMed:15140538"
FT                   /id="VAR_039761"
FT   VARIANT         145
FT                   /note="E -> K (in HGPS; atypical; dbSNP:rs60310264)"
FT                   /evidence="ECO:0000269|PubMed:12714972"
FT                   /id="VAR_017659"
FT   VARIANT         150
FT                   /note="T -> P (in EDMD2; dbSNP:rs58917027)"
FT                   /evidence="ECO:0000269|PubMed:10908904,
FT                   ECO:0000269|PubMed:20848652"
FT                   /id="VAR_039762"
FT   VARIANT         161
FT                   /note="E -> K (in CMD1A; dbSNP:rs28933093)"
FT                   /evidence="ECO:0000269|PubMed:12920062,
FT                   ECO:0000269|PubMed:21846512"
FT                   /id="VAR_017660"
FT   VARIANT         166
FT                   /note="R -> P (in CMD1A; dramatically aberrant localization
FT                   with almost no nuclear rim staining and formation of
FT                   intranuclear foci; dbSNP:rs267607570)"
FT                   /evidence="ECO:0000269|PubMed:20160190"
FT                   /id="VAR_070176"
FT   VARIANT         189
FT                   /note="R -> P (in EDMD2; found also in a patient with limb-
FT                   girdle muscular dystrophy; sporadic; dbSNP:rs267607643)"
FT                   /evidence="ECO:0000269|PubMed:20848652"
FT                   /id="VAR_064962"
FT   VARIANT         190
FT                   /note="R -> Q (in EDMD2 and CMD1A; aberrant localization
FT                   with decreased nuclear rim staining and increased formation
FT                   of intranuclear foci; dbSNP:rs267607571)"
FT                   /evidence="ECO:0000269|PubMed:15744034,
FT                   ECO:0000269|PubMed:20160190"
FT                   /id="VAR_039763"
FT   VARIANT         190
FT                   /note="R -> RR (in EDMD2)"
FT                   /evidence="ECO:0000269|PubMed:20848652"
FT                   /id="VAR_064963"
FT   VARIANT         190
FT                   /note="R -> W (in CMD1A; dbSNP:rs59026483)"
FT                   /evidence="ECO:0000269|PubMed:11897440,
FT                   ECO:0000269|PubMed:15219508, ECO:0000269|PubMed:16061563"
FT                   /id="VAR_039764"
FT   VARIANT         192
FT                   /note="D -> G (in CMD1A; dramatically increases the size of
FT                   intranuclear speckles and reduces their number; this
FT                   phenotype is only partially reversed by coexpression of the
FT                   G-192 mutation and wild-type lamin-C; precludes insertion
FT                   of lamin-C into the nuclear envelope when co-transfected
FT                   with the G-192 LMNA; G-192 lamin-C expression totally
FT                   disrupts the SUMO1 pattern; dbSNP:rs57045855)"
FT                   /evidence="ECO:0000269|PubMed:16061563"
FT                   /id="VAR_039765"
FT   VARIANT         195
FT                   /note="N -> K (in CMD1A; dramatically aberrant localization
FT                   with decreased nuclear rim staining and formation of
FT                   intranuclear foci; distribution of endogenous LMNA, LMNB1
FT                   and LMNB2 are altered in cells expressing this mutant;
FT                   causes an increased loss of endogenous EMD from the nuclear
FT                   envelope; interacts with itself and with wild-type LMNA and
FT                   LMNB1; no decrease in the stability compared with wild-
FT                   type; dbSNP:rs28933091)"
FT                   /evidence="ECO:0000269|PubMed:10580070,
FT                   ECO:0000269|PubMed:11792809"
FT                   /id="VAR_009977"
FT   VARIANT         196..199
FT                   /note="RLQT -> S (in EDMD2)"
FT                   /evidence="ECO:0000269|PubMed:11503164"
FT                   /id="VAR_039766"
FT   VARIANT         203
FT                   /note="E -> G (in CMD1A; interacts with itself and with
FT                   wild-type LMNA and LMNB1; no decrease in the stability
FT                   compared with wild-type; decreased sumoylation; aberrant
FT                   localization with decreased nuclear rim staining and
FT                   formation of intranuclear foci; associated with increased
FT                   cell death; dbSNP:rs28933092)"
FT                   /evidence="ECO:0000269|PubMed:10580070,
FT                   ECO:0000269|PubMed:11792809, ECO:0000269|PubMed:18606848"
FT                   /id="VAR_009978"
FT   VARIANT         203
FT                   /note="E -> K (in CMD1A; decreased sumoylation; aberrant
FT                   localization with decreased nuclear rim staining and
FT                   formation of intranuclear foci; associated with increased
FT                   cell death; dbSNP:rs61195471)"
FT                   /evidence="ECO:0000269|PubMed:11561226,
FT                   ECO:0000269|PubMed:18606848, ECO:0000269|PubMed:20160190"
FT                   /id="VAR_039767"
FT   VARIANT         206
FT                   /note="F -> L (in EDMD2; dbSNP:rs267607629)"
FT                   /evidence="ECO:0000269|PubMed:20848652"
FT                   /id="VAR_064964"
FT   VARIANT         208
FT                   /note="Missing (in EDMD2; no obvious effect on nuclear
FT                   morphology in cultured skin fibroblasts from heterozygous
FT                   patients; no effect on protein level)"
FT                   /evidence="ECO:0000269|PubMed:10814726,
FT                   ECO:0000269|PubMed:15372542"
FT                   /id="VAR_034708"
FT   VARIANT         210
FT                   /note="I -> S (in CMD1A; dramatically aberrant localization
FT                   with almost no nuclear rim staining and increased formation
FT                   of intranuclear foci; dbSNP:rs267607572)"
FT                   /evidence="ECO:0000269|PubMed:20160190"
FT                   /id="VAR_070177"
FT   VARIANT         215
FT                   /note="L -> P (in CMD1A; aberrant localization with
FT                   decreased nuclear rim staining and formation of
FT                   intranuclear foci; dbSNP:rs61295588)"
FT                   /evidence="ECO:0000269|PubMed:12486434,
FT                   ECO:0000269|PubMed:20160190"
FT                   /id="VAR_039768"
FT   VARIANT         222
FT                   /note="H -> P (in EDMD2; dbSNP:rs58034145)"
FT                   /evidence="ECO:0000269|PubMed:10939567"
FT                   /id="VAR_039769"
FT   VARIANT         222
FT                   /note="H -> Y (in EDMD2; dbSNP:rs28928901)"
FT                   /evidence="ECO:0000269|PubMed:10739764"
FT                   /id="VAR_009979"
FT   VARIANT         225
FT                   /note="R -> Q (in EDMD3; dbSNP:rs199474724)"
FT                   /evidence="ECO:0000269|PubMed:22431096"
FT                   /id="VAR_067697"
FT   VARIANT         230
FT                   /note="D -> N (in FPLD2; dbSNP:rs61214927)"
FT                   /evidence="ECO:0000269|PubMed:17250669"
FT                   /id="VAR_039770"
FT   VARIANT         232
FT                   /note="G -> E (in EDMD2; dbSNP:rs57207746)"
FT                   /evidence="ECO:0000269|PubMed:10939567"
FT                   /id="VAR_039771"
FT   VARIANT         248
FT                   /note="L -> P (in EDMD2; dbSNP:rs58850446)"
FT                   /evidence="ECO:0000269|PubMed:14684700"
FT                   /id="VAR_039772"
FT   VARIANT         249
FT                   /note="R -> Q (in EDMD2; no obvious effect on nuclear
FT                   morphology in cultured skin fibroblasts from heterozygous
FT                   patients; no effect on protein level; dbSNP:rs59332535)"
FT                   /evidence="ECO:0000269|PubMed:10739764,
FT                   ECO:0000269|PubMed:10939567, ECO:0000269|PubMed:11503164,
FT                   ECO:0000269|PubMed:12032588, ECO:0000269|PubMed:12649505,
FT                   ECO:0000269|PubMed:14684700, ECO:0000269|PubMed:15372542,
FT                   ECO:0000269|PubMed:15744034, ECO:0000269|PubMed:20848652"
FT                   /id="VAR_009980"
FT   VARIANT         249
FT                   /note="R -> W (in MDCL and EDMD2; mislocalized in the
FT                   nucleus; causes nuclear deformations and LMNB1
FT                   redistribution; dbSNP:rs121912496)"
FT                   /evidence="ECO:0000269|PubMed:18551513,
FT                   ECO:0000269|PubMed:20848652"
FT                   /id="VAR_063589"
FT   VARIANT         259
FT                   /note="Y -> C (in EDMD2)"
FT                   /evidence="ECO:0000269|PubMed:27234031"
FT                   /id="VAR_076563"
FT   VARIANT         260
FT                   /note="K -> N (in CMDA1)"
FT                   /evidence="ECO:0000269|PubMed:16156025"
FT                   /id="VAR_039773"
FT   VARIANT         261
FT                   /note="Missing (in EDMD2)"
FT                   /evidence="ECO:0000269|PubMed:10908904,
FT                   ECO:0000269|PubMed:10939567, ECO:0000269|PubMed:11503164"
FT                   /id="VAR_009981"
FT   VARIANT         267
FT                   /note="Y -> C (in EDMD2; dbSNP:rs57048196)"
FT                   /evidence="ECO:0000269|PubMed:14684700"
FT                   /id="VAR_039774"
FT   VARIANT         268
FT                   /note="S -> P (in EDMD2; dbSNP:rs267607630)"
FT                   /evidence="ECO:0000269|PubMed:20848652"
FT                   /id="VAR_064965"
FT   VARIANT         271
FT                   /note="L -> P (in EDMD2; dbSNP:rs267607641)"
FT                   /evidence="ECO:0000269|PubMed:20848652"
FT                   /id="VAR_064966"
FT   VARIANT         294
FT                   /note="Q -> P (in EDMD2; dbSNP:rs61616775)"
FT                   /evidence="ECO:0000269|PubMed:10939567,
FT                   ECO:0000269|PubMed:20848652"
FT                   /id="VAR_009982"
FT   VARIANT         295
FT                   /note="S -> P (in EDMD2; dbSNP:rs267607633)"
FT                   /evidence="ECO:0000269|PubMed:20848652"
FT                   /id="VAR_064967"
FT   VARIANT         298
FT                   /note="R -> C (in CMT2B1; dbSNP:rs59885338)"
FT                   /evidence="ECO:0000269|PubMed:11799477"
FT                   /id="VAR_017661"
FT   VARIANT         300
FT                   /note="D -> G (in HGPS; atypical form with late onset;
FT                   abnormal nuclear morphology with single or multple blebs,
FT                   lobulation and occasional ringed or donut shaped nuclei;
FT                   dbSNP:rs79907212)"
FT                   /evidence="ECO:0000269|PubMed:23666920"
FT                   /id="VAR_070178"
FT   VARIANT         302
FT                   /note="L -> P (in MDCL; dbSNP:rs267607596)"
FT                   /evidence="ECO:0000269|PubMed:18551513"
FT                   /id="VAR_063590"
FT   VARIANT         303
FT                   /note="S -> P (in EDMD2; dbSNP:rs61527854)"
FT                   /evidence="ECO:0000269|PubMed:20848652"
FT                   /id="VAR_064968"
FT   VARIANT         317
FT                   /note="E -> K (in CMD1A; dbSNP:rs56816490)"
FT                   /evidence="ECO:0000269|PubMed:11897440,
FT                   ECO:0000269|PubMed:21846512"
FT                   /id="VAR_039775"
FT   VARIANT         318
FT                   /note="A -> T (in CMD1A; no effect on nuclear morphology
FT                   and lamin A localization; dbSNP:rs267607574)"
FT                   /evidence="ECO:0000269|PubMed:20160190"
FT                   /id="VAR_070179"
FT   VARIANT         336
FT                   /note="R -> Q (in EDMD2; dbSNP:rs58105277)"
FT                   /evidence="ECO:0000269|PubMed:10739764,
FT                   ECO:0000269|PubMed:12467752"
FT                   /id="VAR_009983"
FT   VARIANT         343
FT                   /note="R -> Q (in EDMD2; dbSNP:rs61177390)"
FT                   /evidence="ECO:0000269|PubMed:12467752"
FT                   /id="VAR_009984"
FT   VARIANT         349
FT                   /note="R -> L (in CMD1A; dbSNP:rs58789393)"
FT                   /evidence="ECO:0000269|PubMed:15219508"
FT                   /id="VAR_039776"
FT   VARIANT         355
FT                   /note="Missing (in EDMD2)"
FT                   /evidence="ECO:0000269|PubMed:20848652"
FT                   /id="VAR_064969"
FT   VARIANT         358
FT                   /note="E -> K (in EDMD2 and MDCL; aberrant localization
FT                   with decreased nuclear rim staining and formation of
FT                   intranuclear foci when transfected in C2C12 myoblasts; no
FT                   obvious effect on nuclear morphology in cultured skin
FT                   fibroblasts from heterozygous patients; distribution of
FT                   endogenous LMNA, LMNB1 and LMNB2 are altered in cells
FT                   expressing this mutant; interacts with itself and with
FT                   wild-type LMNA and LMNB1; no effect on protein level;
FT                   dbSNP:rs60458016)"
FT                   /evidence="ECO:0000269|PubMed:10939567,
FT                   ECO:0000269|PubMed:11503164, ECO:0000269|PubMed:11792809,
FT                   ECO:0000269|PubMed:15372542, ECO:0000269|PubMed:18551513,
FT                   ECO:0000269|PubMed:20848652"
FT                   /id="VAR_009985"
FT   VARIANT         361
FT                   /note="E -> K (in EDMD2; dbSNP:rs267607634)"
FT                   /evidence="ECO:0000269|PubMed:20848652"
FT                   /id="VAR_064970"
FT   VARIANT         371
FT                   /note="M -> K (in EDMD2; dramatically aberrant localization
FT                   with decreased nuclear rim staining and formation of
FT                   intranuclear foci; distribution of endogenous LMNA, LMNB1
FT                   and LMNB2 are altered in cells expressing this mutant;
FT                   causes an increased loss of endogenous EMD from the nuclear
FT                   envelope; interacts with itself and with wild-type LMNA and
FT                   LMNB1; no decrease in the stability compared with wild-
FT                   type; dbSNP:rs59653062)"
FT                   /evidence="ECO:0000269|PubMed:10939567,
FT                   ECO:0000269|PubMed:11792809"
FT                   /id="VAR_009986"
FT   VARIANT         377
FT                   /note="R -> H (in EDMD2; no obvious effect on nuclear
FT                   morphology in cultured skin fibroblasts from heterozygous
FT                   patients; no effect on protein level; dbSNP:rs61672878)"
FT                   /evidence="ECO:0000269|PubMed:10814726,
FT                   ECO:0000269|PubMed:12628721, ECO:0000269|PubMed:12673789,
FT                   ECO:0000269|PubMed:15372542, ECO:0000269|PubMed:15744034,
FT                   ECO:0000269|PubMed:17136397"
FT                   /id="VAR_016205"
FT   VARIANT         377
FT                   /note="R -> L (in EDMD2; dbSNP:rs61672878)"
FT                   /evidence="ECO:0000269|PubMed:12032588,
FT                   ECO:0000269|PubMed:12649505"
FT                   /id="VAR_039777"
FT   VARIANT         380
FT                   /note="L -> S (in MDCL; dbSNP:rs121912495)"
FT                   /evidence="ECO:0000269|PubMed:18551513"
FT                   /id="VAR_063591"
FT   VARIANT         386
FT                   /note="R -> K (in EDMD2; dramatically aberrant localization
FT                   with decreased nuclear rim staining and formation of
FT                   intranuclear foci; distribution of endogenous LMNA, LMNB1
FT                   and LMNB2 are altered in cells expressing this mutant;
FT                   causes an increased loss of endogenous EMD from the nuclear
FT                   envelope; interacts with itself and with wild-type LMNA and
FT                   LMNB1; no decrease in the stability compared with wild-
FT                   type; dbSNP:rs267607545)"
FT                   /evidence="ECO:0000269|PubMed:10939567,
FT                   ECO:0000269|PubMed:11792809, ECO:0000269|PubMed:12649505,
FT                   ECO:0000269|PubMed:20848652"
FT                   /id="VAR_009987"
FT   VARIANT         388
FT                   /note="R -> H (in CMD1A; no effect on nuclear morphology
FT                   but restricts lamin A to the cytoplasm; dbSNP:rs267607576)"
FT                   /evidence="ECO:0000269|PubMed:20160190"
FT                   /id="VAR_070180"
FT   VARIANT         399
FT                   /note="R -> C (in FPLD2 and CMD1A; no effect on nuclear
FT                   morphology and lamin A localization; dbSNP:rs58672172)"
FT                   /evidence="ECO:0000269|PubMed:17250669,
FT                   ECO:0000269|PubMed:20160190"
FT                   /id="VAR_039778"
FT   VARIANT         401
FT                   /note="R -> C (in EDMD2; abnormal nuclear localization in a
FT                   honeycomb expression pattern in about 22% of cultured skin
FT                   fibroblasts from heterozygous patients; enhances the
FT                   interaction with SYNE2; no effect on nuclear localization;
FT                   no effect on protein level; dbSNP:rs61094188)"
FT                   /evidence="ECO:0000269|PubMed:12467752,
FT                   ECO:0000269|PubMed:15372542, ECO:0000269|PubMed:23977161"
FT                   /id="VAR_072818"
FT   VARIANT         411
FT                   /note="G -> D (probable disease-associated mutation found
FT                   in patients with metabolic syndromes; probable
FT                   lipodystrophy causing mutation; no effect on nuclear lamin
FT                   A localization; no effect on the interaction with SYNE2;
FT                   dbSNP:rs267607647)"
FT                   /evidence="ECO:0000269|PubMed:21724554,
FT                   ECO:0000269|PubMed:23977161"
FT                   /id="VAR_072819"
FT   VARIANT         413
FT                   /note="G -> C (polymorphism; found in patients with
FT                   skeletal and cardiac muscular dystrophies; no effect on
FT                   nuclear lamin A localization; no effect on the interaction
FT                   with SYNE2; dbSNP:rs766811975)"
FT                   /evidence="ECO:0000269|PubMed:23977161"
FT                   /id="VAR_072820"
FT   VARIANT         415
FT                   /note="V -> I (rare variant; found in patients with atrial
FT                   fibrillation; unknown pathological significance; no effect
FT                   on nuclear lamin A localization; enhances the interaction
FT                   with SYNE2; causes nuclear deformations in heat shock
FT                   experiments; dbSNP:rs267607606)"
FT                   /evidence="ECO:0000269|PubMed:19427440,
FT                   ECO:0000269|PubMed:23977161"
FT                   /id="VAR_072821"
FT   VARIANT         419
FT                   /note="R -> C (polymorphism; found in patients with
FT                   lipodystrophy; no effect on nuclear lamin A localization;
FT                   no effect on the interaction with SYNE2;
FT                   dbSNP:rs755686359)"
FT                   /evidence="ECO:0000269|PubMed:23977161"
FT                   /id="VAR_072822"
FT   VARIANT         421
FT                   /note="L -> P (disease-associated mutation found in patient
FT                   with severe metabolic syndrome; probable lipodystrophy
FT                   causing mutation; no effect on nuclear lamin A
FT                   localization; no effect on the interaction with SYNE2;
FT                   dbSNP:rs267607564)"
FT                   /evidence="ECO:0000269|PubMed:17711925,
FT                   ECO:0000269|PubMed:23977161"
FT                   /id="VAR_072823"
FT   VARIANT         427
FT                   /note="R -> G (polymorphism; found in patients with
FT                   skeletal and cardiac muscular dystrophies; no effect on
FT                   nuclear lamin A localization; no effect on the interaction
FT                   with SYNE2)"
FT                   /evidence="ECO:0000269|PubMed:23977161"
FT                   /id="VAR_072824"
FT   VARIANT         435
FT                   /note="R -> C (in CMD1A; dbSNP:rs150840924)"
FT                   /evidence="ECO:0000269|PubMed:14684700"
FT                   /id="VAR_039779"
FT   VARIANT         439
FT                   /note="R -> C (in FPLD2; increase in nuclear blebbing and
FT                   formation of honeycomb-like structures in the nuclei with
FT                   no accumulation of prelamin A in skin fibroblasts; causes
FT                   oligomerization of the C-terminal globular domain of lamins
FT                   A and C under no-reducing conditions and increases binding
FT                   affinity for DNA; increases sensitivity to oxidative
FT                   stress; no significant differences in stability and
FT                   structure compared with the wild-type; dbSNP:rs62636506)"
FT                   /evidence="ECO:0000269|PubMed:19220582"
FT                   /id="VAR_070181"
FT   VARIANT         446
FT                   /note="D -> V (in EDMD2; dbSNP:rs58541611)"
FT                   /evidence="ECO:0000269|PubMed:14684700"
FT                   /id="VAR_039780"
FT   VARIANT         449
FT                   /note="G -> D (in EDMD2; dbSNP:rs267607637)"
FT                   /evidence="ECO:0000269|PubMed:20848652"
FT                   /id="VAR_064971"
FT   VARIANT         453
FT                   /note="R -> P (in MDCL; dbSNP:rs267607598)"
FT                   /evidence="ECO:0000269|PubMed:18551513"
FT                   /id="VAR_063592"
FT   VARIANT         453
FT                   /note="R -> W (in EDMD2; abnormal nuclear localization;
FT                   forms nuclear foci in about 8% of cultured skin fibroblasts
FT                   from heterozygous patients; interacts with itself and with
FT                   wild-type LMNA and LMNB1; no effect on protein level;
FT                   dbSNP:rs58932704)"
FT                   /evidence="ECO:0000269|PubMed:10080180,
FT                   ECO:0000269|PubMed:10739764, ECO:0000269|PubMed:10939567,
FT                   ECO:0000269|PubMed:11503164, ECO:0000269|PubMed:11792809,
FT                   ECO:0000269|PubMed:14684700, ECO:0000269|PubMed:15372542,
FT                   ECO:0000269|PubMed:20848652"
FT                   /id="VAR_009988"
FT   VARIANT         454
FT                   /note="L -> P (in EDMD2; dbSNP:rs267607638)"
FT                   /evidence="ECO:0000269|PubMed:20848652"
FT                   /id="VAR_064972"
FT   VARIANT         455
FT                   /note="R -> P (in MDCL; dbSNP:rs267607597)"
FT                   /evidence="ECO:0000269|PubMed:18551513"
FT                   /id="VAR_063593"
FT   VARIANT         456
FT                   /note="N -> D (in MDCL; dbSNP:rs267607599)"
FT                   /evidence="ECO:0000269|PubMed:18551513"
FT                   /id="VAR_063594"
FT   VARIANT         456
FT                   /note="N -> I (in EDMD2; mislocalized in the nucleus; does
FT                   not alter nuclear size or shape; dbSNP:rs60992550)"
FT                   /evidence="ECO:0000269|PubMed:11503164,
FT                   ECO:0000269|PubMed:20848652"
FT                   /id="VAR_039781"
FT   VARIANT         456
FT                   /note="N -> K (in EDMD2; dbSNP:rs61235244)"
FT                   /evidence="ECO:0000269|PubMed:10939567"
FT                   /id="VAR_039782"
FT   VARIANT         461
FT                   /note="D -> Y (in EDMD2; dbSNP:rs267607642)"
FT                   /evidence="ECO:0000269|PubMed:20848652"
FT                   /id="VAR_064973"
FT   VARIANT         465
FT                   /note="G -> D (in FPLD2; dbSNP:rs61282106)"
FT                   /evidence="ECO:0000269|PubMed:10739751"
FT                   /id="VAR_009989"
FT   VARIANT         467
FT                   /note="W -> R (in EDMD2; dbSNP:rs267607639)"
FT                   /evidence="ECO:0000269|PubMed:20848652"
FT                   /id="VAR_064974"
FT   VARIANT         469
FT                   /note="I -> T (in EDMD2; dbSNP:rs57394692)"
FT                   /evidence="ECO:0000269|PubMed:10739764"
FT                   /id="VAR_009990"
FT   VARIANT         471
FT                   /note="R -> C (in HGPS; dbSNP:rs28928902)"
FT                   /evidence="ECO:0000269|PubMed:12768443"
FT                   /id="VAR_017662"
FT   VARIANT         471
FT                   /note="R -> H (in CMD1A; no effect on nuclear morphology
FT                   and lamin A localization; dbSNP:rs267607578)"
FT                   /evidence="ECO:0000269|PubMed:20160190"
FT                   /id="VAR_070182"
FT   VARIANT         481
FT                   /note="Y -> H (in EDMD2; dbSNP:rs57747780)"
FT                   /evidence="ECO:0000269|PubMed:11525883"
FT                   /id="VAR_039783"
FT   VARIANT         482
FT                   /note="R -> L (in FPLD2; abnormal nuclear localization in a
FT                   honeycomb expression pattern in about 10% of cultured skin
FT                   fibroblasts from heterozygous patients; no effect on
FT                   protein level; dbSNP:rs11575937)"
FT                   /evidence="ECO:0000269|PubMed:10655060,
FT                   ECO:0000269|PubMed:15372542"
FT                   /id="VAR_009991"
FT   VARIANT         482
FT                   /note="R -> Q (in FPLD2; interacts with itself and with
FT                   wild-type LMNA and LMNB1; no decrease in the stability
FT                   compared with wild-type; dbSNP:rs11575937)"
FT                   /evidence="ECO:0000269|PubMed:10587585,
FT                   ECO:0000269|PubMed:10739751, ECO:0000269|PubMed:11792809"
FT                   /id="VAR_009992"
FT   VARIANT         482
FT                   /note="R -> W (in FPLD2; interacts with itself and with
FT                   wild-type LMNA and LMNB1; no decrease in the stability
FT                   compared with wild-type; decreases binding affinity for
FT                   DNA; increases sensitivity to oxidative stress;
FT                   dbSNP:rs57920071)"
FT                   /evidence="ECO:0000269|PubMed:10655060,
FT                   ECO:0000269|PubMed:10739751, ECO:0000269|PubMed:11792809,
FT                   ECO:0000269|PubMed:19220582"
FT                   /id="VAR_009993"
FT   VARIANT         486
FT                   /note="K -> N (in FPLD2; interacts with itself and with
FT                   wild-type LMNA and LMNB1; no decrease in the stability
FT                   compared with wild-type; dbSNP:rs59981161)"
FT                   /evidence="ECO:0000269|PubMed:11792809"
FT                   /id="VAR_009994"
FT   VARIANT         488
FT                   /note="T -> P (polymorphism; found in patient with atrial
FT                   fibrillation; dbSNP:rs267607607)"
FT                   /evidence="ECO:0000269|PubMed:19427440"
FT                   /id="VAR_072825"
FT   VARIANT         515
FT                   /note="K -> E (in FPLD2)"
FT                   /evidence="ECO:0000269|PubMed:24485160"
FT                   /id="VAR_071968"
FT   VARIANT         520
FT                   /note="W -> S (in EDMD2; interacts with itself and with
FT                   wild-type LMNA and LMNB1; no decrease in the stability
FT                   compared with wild-type; dbSNP:rs58362413)"
FT                   /evidence="ECO:0000269|PubMed:10939567,
FT                   ECO:0000269|PubMed:11792809"
FT                   /id="VAR_039784"
FT   VARIANT         523
FT                   /note="G -> R (in CMD1A; dbSNP:rs201583907)"
FT                   /evidence="ECO:0000269|PubMed:21846512"
FT                   /id="VAR_067258"
FT   VARIANT         527
FT                   /note="R -> C (in HGPS; dbSNP:rs57318642)"
FT                   /evidence="ECO:0000269|PubMed:12768443"
FT                   /id="VAR_017663"
FT   VARIANT         527
FT                   /note="R -> H (in MADA; dbSNP:rs57520892)"
FT                   /evidence="ECO:0000269|PubMed:12075506"
FT                   /id="VAR_018727"
FT   VARIANT         527
FT                   /note="R -> P (in EDMD2 and FPLD2; interacts with itself
FT                   and with wild-type LMNA and LMNB1; reduced binding to SUN1;
FT                   abnormal nuclear localization; forms nuclear foci in about
FT                   13% of cultured skin fibroblasts from heterozygous
FT                   patients; no effect on protein level; dbSNP:rs57520892)"
FT                   /evidence="ECO:0000269|PubMed:10080180,
FT                   ECO:0000269|PubMed:10739764, ECO:0000269|PubMed:10939567,
FT                   ECO:0000269|PubMed:11503164, ECO:0000269|PubMed:11792809,
FT                   ECO:0000269|PubMed:12196663, ECO:0000269|PubMed:12649505,
FT                   ECO:0000269|PubMed:15372542, ECO:0000269|PubMed:15744034,
FT                   ECO:0000269|PubMed:19933576, ECO:0000269|PubMed:20848652"
FT                   /id="VAR_009995"
FT   VARIANT         528
FT                   /note="T -> K (in EDMD2; interacts with itself and with
FT                   wild-type LMNA and LMNB1; no decrease in the stability
FT                   compared with wild-type; dbSNP:rs57629361)"
FT                   /evidence="ECO:0000269|PubMed:10739764,
FT                   ECO:0000269|PubMed:10939567, ECO:0000269|PubMed:11792809,
FT                   ECO:0000269|PubMed:20848652"
FT                   /id="VAR_009996"
FT   VARIANT         528
FT                   /note="T -> R (in EDMD2; dbSNP:rs57629361)"
FT                   /evidence="ECO:0000269|PubMed:14684700,
FT                   ECO:0000269|PubMed:20848652"
FT                   /id="VAR_039785"
FT   VARIANT         529
FT                   /note="A -> V (in MADA; dbSNP:rs60580541)"
FT                   /evidence="ECO:0000269|PubMed:15998779"
FT                   /id="VAR_034709"
FT   VARIANT         530
FT                   /note="L -> P (in EDMD2; interacts with itself and with
FT                   wild-type LMNA and LMNB1; reduced binding to SUN1; no
FT                   decrease in the stability compared with wild-type;
FT                   dbSNP:rs60934003)"
FT                   /evidence="ECO:0000269|PubMed:10080180,
FT                   ECO:0000269|PubMed:11792809, ECO:0000269|PubMed:19933576"
FT                   /id="VAR_009997"
FT   VARIANT         541
FT                   /note="R -> C (in CMD1A; grossly abnormal nuclear shape
FT                   with the nuclear envelope producing prominent lobules in
FT                   about 10% of cultured skin fibroblasts from heterozygous
FT                   patients; dbSNP:rs56984562)"
FT                   /evidence="ECO:0000269|PubMed:14675861,
FT                   ECO:0000269|PubMed:15372542, ECO:0000269|PubMed:19167105"
FT                   /id="VAR_039786"
FT   VARIANT         541
FT                   /note="R -> H (in EDMD2; dbSNP:rs61444459)"
FT                   /evidence="ECO:0000269|PubMed:14684700"
FT                   /id="VAR_039787"
FT   VARIANT         541
FT                   /note="R -> P (in EDMD2; mis-localized in the nucleus; does
FT                   not alter nuclear size or shape; dbSNP:rs61444459)"
FT                   /evidence="ECO:0000269|PubMed:20848652"
FT                   /id="VAR_064975"
FT   VARIANT         541
FT                   /note="R -> S (in EDMD2 and CMD1A; modest and non-specific
FT                   nuclear membrane alterations; the phenotype is entirely
FT                   reversed by coexpression of the S-541 mutation and wild-
FT                   type lamin-C; dbSNP:rs56984562)"
FT                   /evidence="ECO:0000269|PubMed:16061563,
FT                   ECO:0000269|PubMed:20848652"
FT                   /id="VAR_039788"
FT   VARIANT         542
FT                   /note="K -> N (in HGPS; dbSNP:rs56673169)"
FT                   /evidence="ECO:0000269|PubMed:15286156"
FT                   /id="VAR_034710"
FT   VARIANT         573
FT                   /note="S -> L (in CMD1A, FPLD2 and MADA; dbSNP:rs60890628)"
FT                   /evidence="ECO:0000269|PubMed:12628721,
FT                   ECO:0000269|PubMed:16278265, ECO:0000269|PubMed:17250669"
FT                   /id="VAR_039789"
FT   VARIANT         578
FT                   /note="E -> V (in an atypical progeroid patient; diagnosed
FT                   as Werner syndrome; dbSNP:rs61224243)"
FT                   /evidence="ECO:0000269|PubMed:15060110"
FT                   /id="VAR_039790"
FT   VARIANT         582
FT                   /note="R -> H (in FPLD2; dbSNP:rs57830985)"
FT                   /evidence="ECO:0000269|PubMed:10739751"
FT                   /id="VAR_009998"
FT   VARIANT         602
FT                   /note="G -> S (in EDMD2; dbSNP:rs60662302)"
FT                   /evidence="ECO:0000269|PubMed:20848652"
FT                   /id="VAR_064976"
FT   VARIANT         608
FT                   /note="G -> S (in HGPS; reduced binding to SUN1; may affect
FT                   splicing by activating a cryptic splice donor site;
FT                   dbSNP:rs61064130)"
FT                   /evidence="ECO:0000269|PubMed:12714972,
FT                   ECO:0000269|PubMed:12768443, ECO:0000269|PubMed:19933576"
FT                   /id="VAR_017664"
FT   VARIANT         624
FT                   /note="R -> H (in EDMD2; dbSNP:rs13768)"
FT                   /evidence="ECO:0000269|PubMed:11503164"
FT                   /id="VAR_039791"
FT   VARIANT         631
FT                   /note="G -> D (probable disease-associated mutation found
FT                   in a patient with metabolic syndrome; dbSNP:rs267607648)"
FT                   /evidence="ECO:0000269|PubMed:21724554"
FT                   /id="VAR_072826"
FT   VARIANT         644
FT                   /note="R -> C (in HGPS and EDMD2; partially inhibits tail
FT                   cleavage; dbSNP:rs142000963)"
FT                   /evidence="ECO:0000269|PubMed:15060110,
FT                   ECO:0000269|PubMed:20848652, ECO:0000269|PubMed:22355414"
FT                   /id="VAR_039792"
FT   MUTAGEN         201
FT                   /note="K->L: Decreased sumoylation; aberrant localization
FT                   with decreased nuclear rim staining and formation of
FT                   intranuclear foci; associated with increased cell death."
FT                   /evidence="ECO:0000269|PubMed:18606848"
FT   MUTAGEN         644
FT                   /note="R->A: Does not affect tail cleavage."
FT                   /evidence="ECO:0000269|PubMed:22355414"
FT   MUTAGEN         647
FT                   /note="L->R: Completely inhibits tail cleavage."
FT                   /evidence="ECO:0000269|PubMed:22355414"
FT   MUTAGEN         648
FT                   /note="L->A: Completely inhibits tail cleavage."
FT                   /evidence="ECO:0000269|PubMed:22355414"
FT   MUTAGEN         650
FT                   /note="N->A: Partially inhibits tail cleavage."
FT                   /evidence="ECO:0000269|PubMed:22355414"
FT   MUTAGEN         661
FT                   /note="C->S: Loss of interaction with NARF. Abolishes
FT                   farnesylation."
FT                   /evidence="ECO:0000269|PubMed:10514485,
FT                   ECO:0000269|PubMed:22355414"
FT   CONFLICT        340
FT                   /note="E -> K (in Ref. 5; BAG58344)"
FT                   /evidence="ECO:0000305"
FT   HELIX           28..44
FT                   /evidence="ECO:0000244|PDB:6JLB"
FT   HELIX           65..218
FT                   /evidence="ECO:0000244|PDB:6SNZ"
FT   HELIX           252..278
FT                   /evidence="ECO:0000244|PDB:6JLB"
FT   HELIX           316..384
FT                   /evidence="ECO:0000244|PDB:1X8Y"
FT   STRAND          430..436
FT                   /evidence="ECO:0000244|PDB:6GHD"
FT   STRAND          438..445
FT                   /evidence="ECO:0000244|PDB:1IFR"
FT   STRAND          449..456
FT                   /evidence="ECO:0000244|PDB:1IFR"
FT   STRAND          458..460
FT                   /evidence="ECO:0000244|PDB:1IFR"
FT   HELIX           464..466
FT                   /evidence="ECO:0000244|PDB:1IVT"
FT   STRAND          468..473
FT                   /evidence="ECO:0000244|PDB:1IFR"
FT   STRAND          479..482
FT                   /evidence="ECO:0000244|PDB:1IFR"
FT   STRAND          494..499
FT                   /evidence="ECO:0000244|PDB:1IFR"
FT   HELIX           500..502
FT                   /evidence="ECO:0000244|PDB:3GEF"
FT   TURN            508..510
FT                   /evidence="ECO:0000244|PDB:1IFR"
FT   STRAND          511..514
FT                   /evidence="ECO:0000244|PDB:1IFR"
FT   STRAND          526..531
FT                   /evidence="ECO:0000244|PDB:1IFR"
FT   STRAND          537..543
FT                   /evidence="ECO:0000244|PDB:1IFR"
FT   CONFLICT        P02545-4:556
FT                   /note="G -> R (in Ref. 5; BAG58344)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   664 AA;  74139 MW;  E0855F7699F0318B CRC64;
     METPSQRRAT RSGAQASSTP LSPTRITRLQ EKEDLQELND RLAVYIDRVR SLETENAGLR
     LRITESEEVV SREVSGIKAA YEAELGDARK TLDSVAKERA RLQLELSKVR EEFKELKARN
     TKKEGDLIAA QARLKDLEAL LNSKEAALST ALSEKRTLEG ELHDLRGQVA KLEAALGEAK
     KQLQDEMLRR VDAENRLQTM KEELDFQKNI YSEELRETKR RHETRLVEID NGKQREFESR
     LADALQELRA QHEDQVEQYK KELEKTYSAK LDNARQSAER NSNLVGAAHE ELQQSRIRID
     SLSAQLSQLQ KQLAAKEAKL RDLEDSLARE RDTSRRLLAE KEREMAEMRA RMQQQLDEYQ
     ELLDIKLALD MEIHAYRKLL EGEEERLRLS PSPTSQRSRG RASSHSSQTQ GGGSVTKKRK
     LESTESRSSF SQHARTSGRV AVEEVDEEGK FVRLRNKSNE DQSMGNWQIK RQNGDDPLLT
     YRFPPKFTLK AGQVVTIWAA GAGATHSPPT DLVWKAQNTW GCGNSLRTAL INSTGEEVAM
     RKLVRSVTVV EDDEDEDGDD LLHHHHGSHC SSSGDPAEYN LRSRTVLCGT CGQPADKASA
     SGSGAQVGGP ISSGSSASSV TVTRSYRSVG GSGGGSFGDN LVTRSYLLGN SSPRTQSPQN
     CSIM
//
ID   Q5TCI8_HUMAN            Unreviewed;       491 AA.
AC   Q5TCI8;
DT   21-DEC-2004, integrated into UniProtKB/TrEMBL.
DT   21-DEC-2004, sequence version 1.
DT   22-APR-2020, entry version 124.
DE   SubName: Full=Prelamin-A/C {ECO:0000313|Ensembl:ENSP00000357280};
GN   Name=LMNA {ECO:0000313|Ensembl:ENSP00000357280};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000357280, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000213|PubMed:17081983}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [2] {ECO:0000213|PubMed:16964243}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [3] {ECO:0000313|Ensembl:ENSP00000357280, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I., Aubin K., Babbage A.K., Bagguley C.L., Bailey J., Beasley H.,
RA   Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G., Clee C.,
RA   Cobley V., Collier R.E., Corby N., Coville G.J., Davies J., Deadman R.,
RA   Dunn M., Earthrowl M., Ellington A.G., Errington H., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Gay L., Ghori M.R.,
RA   Gibson R., Gilby L.M., Gillett W., Glithero R.J., Grafham D.V.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Hammond S., Harrison E.S.,
RA   Hart E., Haugen E., Heath P.D., Holmes S., Holt K., Howden P.J., Hunt A.R.,
RA   Hunt S.E., Hunter G., Isherwood J., James R., Johnson C., Johnson D.,
RA   Joy A., Kay M., Kershaw J.K., Kibukawa M., Kimberley A.M., King A.,
RA   Knights A.J., Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S., McLaren S., Milne S.,
RA   Mistry S., Moore M.J., Nickerson T., O'Dell C.N., Oliver K., Palmeiri A.,
RA   Palmer S.A., Parker A., Patel D., Pearce A.V., Peck A.I., Pelan S.,
RA   Phelps K., Phillimore B.J., Plumb R., Rajan J., Raymond C., Rouse G.,
RA   Saenphimmachak C., Sehra H.K., Sheridan E., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M., Steward C., Subramanian S., Sycamore N., Tracey A.,
RA   Tromans A., Van Helmond Z., Wall M., Wallis J.M., White S., Whitehead S.L.,
RA   Wilkinson J.E., Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z.,
RA   Coulson A., Vaudin M., Sulston J.E., Durbin R., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R., Banerjee R., Bryant S.P., Burford D.C.,
RA   Burrill W.D., Clegg S.M., Dhami P., Dovey O., Faulkner L.M., Gribble S.M.,
RA   Langford C.F., Pandian R.D., Porter K.M., Prigmore E.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4] {ECO:0000213|PubMed:17924679}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa cells
RT   and high confident phosphopeptide identification by cross-validation of
RT   MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [5] {ECO:0000213|PubMed:18691976}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [6] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7] {ECO:0000213|PubMed:19608861}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [8] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [9] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Burckstummer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [11] {ECO:0000313|Ensembl:ENSP00000357280}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
RN   [12] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14] {ECO:0000213|PubMed:25218447}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [15] {ECO:0000213|PubMed:25114211}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [16] {ECO:0000213|PubMed:25772364}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [17] {ECO:0000213|PubMed:25755297}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurethsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to replication
RT   stress reveals novel small ubiquitin-like modified target proteins and
RT   acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [18] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [19] {ECO:0000213|PubMed:28112733}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- SIMILARITY: Belongs to the intermediate filament family.
CC       {ECO:0000256|RuleBase:RU000685, ECO:0000256|SAAS:SAAS01036505}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL135927; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL355388; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL356734; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001269553.1; NM_001282624.1.
DR   SMR; Q5TCI8; -.
DR   SwissPalm; Q5TCI8; -.
DR   jPOST; Q5TCI8; -.
DR   MaxQB; Q5TCI8; -.
DR   PeptideAtlas; Q5TCI8; -.
DR   PRIDE; Q5TCI8; -.
DR   ProteomicsDB; 64961; -.
DR   Antibodypedia; 1676; 1551 antibodies.
DR   Ensembl; ENST00000368297; ENSP00000357280; ENSG00000160789.
DR   GeneID; 4000; -.
DR   UCSC; uc001fnj.5; human.
DR   CTD; 4000; -.
DR   EuPathDB; HostDB:ENSG00000160789.19; -.
DR   HGNC; HGNC:6636; LMNA.
DR   OpenTargets; ENSG00000160789; -.
DR   eggNOG; KOG0977; Eukaryota.
DR   eggNOG; ENOG410Y2H6; LUCA.
DR   GeneTree; ENSGT00940000157244; -.
DR   HOGENOM; CLU_012560_9_0_1; -.
DR   ChiTaRS; LMNA; human.
DR   GenomeRNAi; 4000; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000160789; Expressed in mucosa of stomach and 238 other tissues.
DR   ExpressionAtlas; Q5TCI8; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005882; C:intermediate filament; IEA:UniProtKB-KW.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   Gene3D; 1.20.5.1160; -; 1.
DR   Gene3D; 2.60.40.1260; -; 1.
DR   InterPro; IPR018039; IF_conserved.
DR   InterPro; IPR039008; IF_rod_dom.
DR   InterPro; IPR042180; IF_rod_dom_coil1B.
DR   InterPro; IPR001322; Lamin_tail_dom.
DR   InterPro; IPR036415; Lamin_tail_dom_sf.
DR   Pfam; PF00038; Filament; 1.
DR   Pfam; PF00932; LTD; 1.
DR   SMART; SM01391; Filament; 1.
DR   SUPFAM; SSF74853; SSF74853; 1.
DR   PROSITE; PS00226; IF_ROD_1; 1.
DR   PROSITE; PS51842; IF_ROD_2; 1.
DR   PROSITE; PS51841; LTD; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAAS:SAAS01036532, ECO:0000256|SAM:Coils};
KW   Intermediate filament {ECO:0000256|RuleBase:RU000685,
KW   ECO:0000256|SAAS:SAAS01036494};
KW   Proteomics identification {ECO:0000213|EPD:Q5TCI8,
KW   ECO:0000213|MaxQB:Q5TCI8, ECO:0000213|PeptideAtlas:Q5TCI8,
KW   ECO:0000213|ProteomicsDB:Q5TCI8};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN          1..306
FT                   /note="IF rod"
FT                   /evidence="ECO:0000259|PROSITE:PS51842"
FT   DOMAIN          347..464
FT                   /note="LTD"
FT                   /evidence="ECO:0000259|PROSITE:PS51841"
FT   REGION          303..361
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          472..491
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          39..140
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          161..188
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          211..288
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        310..336
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   491 AA;  55762 MW;  620B6533D9D65D70 CRC64;
     MQPLLCLGNL EDARERTGTL LAQHPAWGRT RAKPGSPLNT KKEGDLIAAQ ARLKDLEALL
     NSKEAALSTA LSEKRTLEGE LHDLRGQVAK LEAALGEAKK QLQDEMLRRV DAENRLQTMK
     EELDFQKNIY SEELRETKRR HETRLVEIDN GKQREFESRL ADALQELRAQ HEDQVEQYKK
     ELEKTYSAKL DNARQSAERN SNLVGAAHEE LQQSRIRIDS LSAQLSQLQK QLAAKEAKLR
     DLEDSLARER DTSRRLLAEK EREMAEMRAR MQQQLDEYQE LLDIKLALDM EIHAYRKLLE
     GEEERLRLSP SPTSQRSRGR ASSHSSQTQG GGSVTKKRKL ESTESRSSFS QHARTSGRVA
     VEEVDEEGKF VRLRNKSNED QSMGNWQIKR QNGDDPLLTY RFPPKFTLKA GQVVTIWAAG
     AGATHSPPTD LVWKAQNTWG CGNSLRTALI NSTGEEVAMR KLVRSVTVVE DDEDEDGDDL
     LHHHHVSGSR R
//
ID   ENL_HUMAN               Reviewed;         559 AA.
AC   Q03111; Q14768;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   22-APR-2020, entry version 175.
DE   RecName: Full=Protein ENL;
DE   AltName: Full=YEATS domain-containing protein 1;
GN   Name=MLLT1; Synonyms=ENL, LTG19, YEATS1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1423624; DOI=10.1016/0092-8674(92)90602-9;
RA   Tkachuk D.C., Kohler S., Cleary M.L.;
RT   "Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal
RT   translocations in acute leukemias.";
RL   Cell 71:691-700(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8378076;
RA   Yamamoto K., Seto M., Komatsu H., Iida S., Akao Y., Kojima S., Kodera Y.,
RA   Nakazawa S., Ariyoshi Y., Takahashi T., Ueda R.;
RT   "Two distinct portions of LTG19/ENL at 19p13 are involved in t(11;19)
RT   leukemia.";
RL   Oncogene 8:2617-2625(1993).
RN   [3]
RP   CHARACTERIZATION.
RX   PubMed=8080983;
RA   Rubnitz J.E., Morrissey J., Savage P.A., Cleary M.L.;
RT   "ENL, the gene fused with HRX in t(11;19) leukemias, encodes a nuclear
RT   protein with transcriptional activation potential in lymphoid and myeloid
RT   cells.";
RL   Blood 84:1747-1752(1994).
RN   [4]
RP   IDENTIFICATION IN A SWI/SNF-LIKE EBAFB COMPLEX.
RX   PubMed=12665591; DOI=10.1128/mcb.23.8.2942-2952.2003;
RA   Nie Z., Yan Z., Chen E.H., Sechi S., Ling C., Zhou S., Xue Y., Yang D.,
RA   Murray D., Kanakubo E., Cleary M.L., Wang W.;
RT   "Novel SWI/SNF chromatin-remodeling complexes contain a mixed-lineage
RT   leukemia chromosomal translocation partner.";
RL   Mol. Cell. Biol. 23:2942-2952(2003).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-292 AND SER-296, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-155, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-292, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [10]
RP   FUNCTION, AND IDENTIFICATION IN THE SEC COMPLEX.
RX   PubMed=20159561; DOI=10.1016/j.molcel.2010.01.026;
RA   Lin C., Smith E.R., Takahashi H., Lai K.C., Martin-Brown S., Florens L.,
RA   Washburn M.P., Conaway J.W., Conaway R.C., Shilatifard A.;
RT   "AFF4, a component of the ELL/P-TEFb elongation complex and a shared
RT   subunit of MLL chimeras, can link transcription elongation to leukemia.";
RL   Mol. Cell 37:429-437(2010).
RN   [11]
RP   FUNCTION, AND IDENTIFICATION IN THE SEC COMPLEX.
RX   PubMed=20471948; DOI=10.1016/j.molcel.2010.04.013;
RA   He N., Liu M., Hsu J., Xue Y., Chou S., Burlingame A., Krogan N.J.,
RA   Alber T., Zhou Q.;
RT   "HIV-1 Tat and host AFF4 recruit two transcription elongation factors into
RT   a bifunctional complex for coordinated activation of HIV-1 transcription.";
RL   Mol. Cell 38:428-438(2010).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-292; SER-296; SER-359 AND
RP   SER-361, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   IDENTIFICATION IN THE SEC COMPLEX.
RX   PubMed=22195968; DOI=10.1016/j.molcel.2011.12.008;
RA   Smith E.R., Lin C., Garrett A.S., Thornton J., Mohaghegh N., Hu D.,
RA   Jackson J., Saraf A., Swanson S.K., Seidel C., Florens L., Washburn M.P.,
RA   Eissenberg J.C., Shilatifard A.;
RT   "The little elongation complex regulates small nuclear RNA transcription.";
RL   Mol. Cell 44:954-965(2011).
RN   [14]
RP   INTERACTION WITH ALKBH4.
RX   PubMed=23145062; DOI=10.1371/journal.pone.0049045;
RA   Bjornstad L.G., Meza T.J., Otterlei M., Olafsrud S.M., Meza-Zepeda L.A.,
RA   Falnes P.O.;
RT   "Human ALKBH4 interacts with proteins associated with transcription.";
RL   PLoS ONE 7:E49045-E49045(2012).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   FUNCTION, AND DOMAIN.
RX   PubMed=27105114; DOI=10.1016/j.molcel.2016.03.028;
RA   Li Y., Sabari B.R., Panchenko T., Wen H., Zhao D., Guan H., Wan L.,
RA   Huang H., Tang Z., Zhao Y., Roeder R.G., Shi X., Allis C.D., Li H.;
RT   "Molecular coupling of histone crotonylation and active transcription by
RT   AF9 YEATS domain.";
RL   Mol. Cell 62:181-193(2016).
RN   [18]
RP   FUNCTION.
RX   PubMed=28241139; DOI=10.1038/nature21688;
RA   Erb M.A., Scott T.G., Li B.E., Xie H., Paulk J., Seo H.S., Souza A.,
RA   Roberts J.M., Dastjerdi S., Buckley D.L., Sanjana N.E., Shalem O.,
RA   Nabet B., Zeid R., Offei-Addo N.K., Dhe-Paganon S., Zhang F., Orkin S.H.,
RA   Winter G.E., Bradner J.E.;
RT   "Transcription control by the ENL YEATS domain in acute leukaemia.";
RL   Nature 543:270-274(2017).
RN   [19]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-240; LYS-262 AND LYS-342, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [20]
RP   ACTIVITY REGULATION.
RX   PubMed=30374167; DOI=10.1038/s41589-018-0144-y;
RA   Li X., Li X.M., Jiang Y., Liu Z., Cui Y., Fung K.Y., van der Beelen S.H.E.,
RA   Tian G., Wan L., Shi X., Allis C.D., Li H., Li Y., Li X.D.;
RT   "Structure-guided development of YEATS domain inhibitors by targeting pi-
RT   pi-pi stacking.";
RL   Nat. Chem. Biol. 14:1140-1149(2018).
RN   [21] {ECO:0000244|PDB:5J9S}
RP   X-RAY CRYSTALLOGRAPHY (2.70 ANGSTROMS) OF 1-148 IN COMPLEX WITH ACETYLATED
RP   HISTONE, AND FUNCTION.
RX   PubMed=28241141; DOI=10.1038/nature21687;
RA   Wan L., Wen H., Li Y., Lyu J., Xi Y., Hoshii T., Joseph J.K., Wang X.,
RA   Loh Y.E., Erb M.A., Souza A.L., Bradner J.E., Shen L., Li W., Li H.,
RA   Allis C.D., Armstrong S.A., Shi X.;
RT   "ENL links histone acetylation to oncogenic gene expression in acute
RT   myeloid leukaemia.";
RL   Nature 543:265-269(2017).
CC   -!- FUNCTION: Chromatin reader component of the super elongation complex
CC       (SEC), a complex required to increase the catalytic rate of RNA
CC       polymerase II transcription by suppressing transient pausing by the
CC       polymerase at multiple sites along the DNA (PubMed:20159561,
CC       PubMed:20471948). Specifically recognizes and binds acetylated and
CC       crotonylated histones, with a preference for histones that are
CC       crotonylated (PubMed:27105114). Has a slightly higher affinity for
CC       binding histone H3 crotonylated at 'Lys-27' (H3K27cr) than 'Lys-20'
CC       (H3K9cr20) (PubMed:27105114). {ECO:0000269|PubMed:20159561,
CC       ECO:0000269|PubMed:20471948, ECO:0000269|PubMed:27105114}.
CC   -!- FUNCTION: Acts as a key chromatin reader in acute myeloid leukemia by
CC       recognizing and binding to acetylated histones via its YEATS domain,
CC       thereby regulating oncogenic gene transcription.
CC       {ECO:0000269|PubMed:28241139, ECO:0000269|PubMed:28241141}.
CC   -!- ACTIVITY REGULATION: Acylated lysine-binding is specifically inhibited
CC       by the tripeptide XL-13m, carrying a 2-furancarbonyl side chain,
CC       preventing recruitment to chromatin. {ECO:0000269|PubMed:30374167}.
CC   -!- SUBUNIT: Component of the super elongation complex (SEC), at least
CC       composed of EAF1, EAF2, CDK9, MLLT3/AF9, AFF (AFF1 or AFF4), the P-TEFb
CC       complex and ELL (ELL, ELL2 or ELL3) (PubMed:20159561, PubMed:20471948,
CC       PubMed:22195968). Interacts with ALKBH4 (PubMed:23145062). Component of
CC       a SWI/SNF-like EBAFb complex, at least composed of
CC       SMARCA4/BRG1/BAF190A, SMARCB1/BAF47/SNF5, ACTL6A/BAF53A, SMARCE1/BAF57,
CC       SMARCD1/BAF60A, SMARCD2/BAF60B, SMARCC1/BAF155, SMARCC2/BAF170,
CC       ARID1B/BAF250B, MLLT1/ENL and actin (PubMed:12665591).
CC       {ECO:0000269|PubMed:12665591, ECO:0000269|PubMed:20159561,
CC       ECO:0000269|PubMed:20471948, ECO:0000269|PubMed:22195968,
CC       ECO:0000269|PubMed:23145062}.
CC   -!- INTERACTION:
CC       Q03111; Q9UHB7: AFF4; NbExp=8; IntAct=EBI-1384215, EBI-395282;
CC       Q03111; Q8TEK3: DOT1L; NbExp=6; IntAct=EBI-1384215, EBI-2619253;
CC       Q03111; O95070: YIF1A; NbExp=3; IntAct=EBI-1384215, EBI-2799703;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- DOMAIN: The YEATS domain specifically recognizes and binds acylated
CC       histones, with a preference for histones that are crotonylated.
CC       {ECO:0000269|PubMed:27105114}.
CC   -!- DISEASE: Note=A chromosomal aberration involving MLLT1 is associated
CC       with acute leukemias. Translocation t(11;19)(q23;p13.3) with
CC       KMT2A/MLL1. The result is a rogue activator protein.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/ENLID9.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L04285; AAA58457.1; -; mRNA.
DR   EMBL; D14539; BAA03406.1; -; mRNA.
DR   CCDS; CCDS12160.1; -.
DR   PIR; B44265; B44265.
DR   RefSeq; NP_005925.2; NM_005934.3.
DR   PDB; 5J9S; X-ray; 2.70 A; A=1-148.
DR   PDB; 6HPW; X-ray; 1.90 A; A=1-148.
DR   PDB; 6HPX; X-ray; 2.30 A; A=1-148.
DR   PDB; 6HPY; X-ray; 2.00 A; A=1-148.
DR   PDB; 6HPZ; X-ray; 2.30 A; A=1-148.
DR   PDB; 6HQ0; X-ray; 1.81 A; A=1-148.
DR   PDB; 6HT0; X-ray; 1.80 A; A=1-148.
DR   PDB; 6HT1; X-ray; 2.10 A; A=1-148.
DR   PDB; 6T1I; X-ray; 1.80 A; A=1-148.
DR   PDB; 6T1J; X-ray; 1.97 A; A=1-148.
DR   PDB; 6T1L; X-ray; 2.00 A; A=1-148.
DR   PDB; 6T1M; X-ray; 1.85 A; A=1-148.
DR   PDB; 6T1N; X-ray; 1.95 A; A=1-148.
DR   PDB; 6T1O; X-ray; 1.90 A; A=1-148.
DR   PDBsum; 5J9S; -.
DR   PDBsum; 6HPW; -.
DR   PDBsum; 6HPX; -.
DR   PDBsum; 6HPY; -.
DR   PDBsum; 6HPZ; -.
DR   PDBsum; 6HQ0; -.
DR   PDBsum; 6HT0; -.
DR   PDBsum; 6HT1; -.
DR   PDBsum; 6T1I; -.
DR   PDBsum; 6T1J; -.
DR   PDBsum; 6T1L; -.
DR   PDBsum; 6T1M; -.
DR   PDBsum; 6T1N; -.
DR   PDBsum; 6T1O; -.
DR   SMR; Q03111; -.
DR   BioGrid; 110444; 59.
DR   CORUM; Q03111; -.
DR   IntAct; Q03111; 33.
DR   STRING; 9606.ENSP00000252674; -.
DR   iPTMnet; Q03111; -.
DR   PhosphoSitePlus; Q03111; -.
DR   BioMuta; MLLT1; -.
DR   DMDM; 116241350; -.
DR   EPD; Q03111; -.
DR   jPOST; Q03111; -.
DR   MassIVE; Q03111; -.
DR   MaxQB; Q03111; -.
DR   PaxDb; Q03111; -.
DR   PeptideAtlas; Q03111; -.
DR   PRIDE; Q03111; -.
DR   ProteomicsDB; 58185; -.
DR   Antibodypedia; 11832; 132 antibodies.
DR   DNASU; 4298; -.
DR   Ensembl; ENST00000252674; ENSP00000252674; ENSG00000130382.
DR   GeneID; 4298; -.
DR   KEGG; hsa:4298; -.
DR   UCSC; uc002mek.4; human.
DR   CTD; 4298; -.
DR   DisGeNET; 4298; -.
DR   GeneCards; MLLT1; -.
DR   HGNC; HGNC:7134; MLLT1.
DR   HPA; ENSG00000130382; Low tissue specificity.
DR   MIM; 159556; gene.
DR   neXtProt; NX_Q03111; -.
DR   OpenTargets; ENSG00000130382; -.
DR   PharmGKB; PA30848; -.
DR   eggNOG; KOG3149; Eukaryota.
DR   eggNOG; COG5033; LUCA.
DR   GeneTree; ENSGT00940000158800; -.
DR   HOGENOM; CLU_036086_0_0_1; -.
DR   InParanoid; Q03111; -.
DR   KO; K15187; -.
DR   OMA; FEPGQKP; -.
DR   OrthoDB; 727038at2759; -.
DR   PhylomeDB; Q03111; -.
DR   TreeFam; TF314586; -.
DR   Reactome; R-HSA-112382; Formation of RNA Pol II elongation complex.
DR   Reactome; R-HSA-674695; RNA Polymerase II Pre-transcription Events.
DR   Reactome; R-HSA-75955; RNA Polymerase II Transcription Elongation.
DR   SIGNOR; Q03111; -.
DR   ChiTaRS; MLLT1; human.
DR   GeneWiki; MLLT1; -.
DR   GenomeRNAi; 4298; -.
DR   Pharos; Q03111; Tbio.
DR   PRO; PR:Q03111; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q03111; protein.
DR   Bgee; ENSG00000130382; Expressed in placenta and 198 other tissues.
DR   Genevisible; Q03111; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0008023; C:transcription elongation factor complex; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; TAS:ProtInc.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISM:NTNU_SB.
DR   GO; GO:0006469; P:negative regulation of protein kinase activity; IEA:Ensembl.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; TAS:Reactome.
DR   GO; GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome.
DR   Gene3D; 2.60.40.1970; -; 1.
DR   InterPro; IPR040930; AF-9_AHD.
DR   InterPro; IPR038704; YEAST_sf.
DR   InterPro; IPR005033; YEATS.
DR   PANTHER; PTHR23195; PTHR23195; 1.
DR   Pfam; PF17793; AHD; 1.
DR   Pfam; PF03366; YEATS; 1.
DR   PROSITE; PS51037; YEATS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Activator; Chromosomal rearrangement;
KW   Isopeptide bond; Nucleus; Phosphoprotein; Proto-oncogene;
KW   Reference proteome; Transcription; Transcription regulation;
KW   Ubl conjugation.
FT   CHAIN           1..559
FT                   /note="Protein ENL"
FT                   /id="PRO_0000215938"
FT   DOMAIN          8..112
FT                   /note="YEATS"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00376"
FT   REGION          56..58
FT                   /note="Acylated histone binding"
FT                   /evidence="ECO:0000244|PDB:5J9S,
FT                   ECO:0000269|PubMed:28241141"
FT   REGION          78..80
FT                   /note="Acylated histone binding"
FT                   /evidence="ECO:0000244|PDB:5J9S,
FT                   ECO:0000269|PubMed:28241141"
FT   COMPBIAS        272..280
FT                   /note="Poly-Pro"
FT   COMPBIAS        319..325
FT                   /note="Poly-Ser"
FT   COMPBIAS        374..389
FT                   /note="Poly-Ser"
FT   COMPBIAS        457..460
FT                   /note="Poly-Pro"
FT   COMPBIAS        463..466
FT                   /note="Poly-Pro"
FT   BINDING         103
FT                   /note="Acylated histone"
FT                   /evidence="ECO:0000244|PDB:5J9S,
FT                   ECO:0000269|PubMed:28241141"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000244|PubMed:22814378"
FT   MOD_RES         155
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         292
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18691976,
FT                   ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:20068231"
FT   MOD_RES         296
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18691976,
FT                   ECO:0000244|PubMed:20068231"
FT   MOD_RES         359
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         361
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   CROSSLNK        240
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        262
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        342
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CONFLICT        269..270
FT                   /note="KG -> NP (in Ref. 1; AAA58457)"
FT                   /evidence="ECO:0000305"
FT   STRAND          6..19
FT                   /evidence="ECO:0000244|PDB:6HT0"
FT   STRAND          30..37
FT                   /evidence="ECO:0000244|PDB:6HT0"
FT   HELIX           44..46
FT                   /evidence="ECO:0000244|PDB:6HT0"
FT   STRAND          48..54
FT                   /evidence="ECO:0000244|PDB:6HT0"
FT   STRAND          59..61
FT                   /evidence="ECO:0000244|PDB:6HT0"
FT   STRAND          63..69
FT                   /evidence="ECO:0000244|PDB:6HT0"
FT   STRAND          71..79
FT                   /evidence="ECO:0000244|PDB:6HT0"
FT   STRAND          81..90
FT                   /evidence="ECO:0000244|PDB:6HT0"
FT   STRAND          92..94
FT                   /evidence="ECO:0000244|PDB:6HT0"
FT   STRAND          97..104
FT                   /evidence="ECO:0000244|PDB:6HT0"
FT   STRAND          114..126
FT                   /evidence="ECO:0000244|PDB:6HT0"
FT   HELIX           129..137
FT                   /evidence="ECO:0000244|PDB:6HT0"
FT   STRAND          141..143
FT                   /evidence="ECO:0000244|PDB:6HT0"
SQ   SEQUENCE   559 AA;  62056 MW;  A8480BA0F8742173 CRC64;
     MDNQCTVQVR LELGHRAQLR KKPTTEGFTH DWMVFVRGPE QCDIQHFVEK VVFWLHDSFP
     KPRRVCKEPP YKVEESGYAG FIMPIEVHFK NKEEPRKVCF TYDLFLNLEG NPPVNHLRCE
     KLTFNNPTTE FRYKLLRAGG VMVMPEGADT VSRPSPDYPM LPTIPLSAFS DPKKTKPSHG
     SKDANKESSK TSKPHKVTKE HRERPRKDSE SKSSSKELER EQAKSSKDTS RKLGEGRLPK
     EEKAPPPKAA FKEPKMALKE TKLESTSPKG GPPPPPPPPP RASSKRPATA DSPKPSAKKQ
     KKSSSKGSRS APGTSPRTSS SSSFSDKKPA KDKSSTRGEK VKAESEPREA KKALEVEESN
     SEDEASFKSE SAQSSPSNSS SSSDSSSDSD FEPSQNHSQG PLRSMVEDLQ SEESDEDDSS
     SGEEAAGKTN PGRDSRLSFS DSESDNSADS SLPSREPPPP QKPPPPNSKV SGRRSPESCS
     KPEKILKKGT YDKAYTDELV ELHRRLMALR ERNVLQQIVN LIEETGHFNV TNTTFDFDLF
     SLDETTVRKL QSCLEAVAT
//
ID   AF1Q_HUMAN              Reviewed;          90 AA.
AC   Q13015;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   22-APR-2020, entry version 142.
DE   RecName: Full=Protein AF1q;
GN   Name=MLLT11; Synonyms=AF1Q;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], CHROMOSOMAL REARRANGEMENT, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=7833468;
RA   Tse W., Zhu W., Chen H.S., Cohen A.;
RT   "A novel gene, AF1q, fused to MLL in t(1;11)(q21;q23), is specifically
RT   expressed in leukemic and immature hematopoietic cells.";
RL   Blood 85:650-656(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Bone marrow, Brain, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, MUTAGENESIS OF 24-LEU--LEU-32,
RP   UBIQUITINATION, AND NUCLEAR EXPORT SIGNAL.
RX   PubMed=21715312; DOI=10.1182/blood-2011-01-333179;
RA   Parcelier A., Maharzi N., Delord M., Robledo-Sarmiento M., Nelson E.,
RA   Belakhdar-Mekid H., Pla M., Kuranda K., Parietti V., Goodhardt M.,
RA   Legrand N., Bernstein I.D., Gluckman J.C., Sigaux F., Canque B.;
RT   "AF1q/MLLT11 regulates the emergence of human prothymocytes through
RT   cooperative interaction with the Notch signaling pathway.";
RL   Blood 118:1784-1796(2011).
RN   [8]
RP   INTERACTION WITH HSPA8 AND LAMP2.
RX   PubMed=24880125; DOI=10.1016/j.yexcr.2014.05.013;
RA   Li P., Ji M., Lu F., Zhang J., Li H., Cui T., Li Wang X., Tang D., Ji C.;
RT   "Degradation of AF1Q by chaperone-mediated autophagy.";
RL   Exp. Cell Res. 327:48-56(2014).
RN   [9]
RP   FUNCTION, INTERACTION WITH TCF7, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=26079538; DOI=10.18632/oncotarget.4136;
RA   Park J., Schlederer M., Schreiber M., Ice R., Merkel O., Bilban M.,
RA   Hofbauer S., Kim S., Addison J., Zou J., Ji C., Bunting S.T., Wang Z.,
RA   Shoham M., Huang G., Bago-Horvath Z., Gibson L.F., Rojanasakul Y.,
RA   Remick S., Ivanov A., Pugacheva E., Bunting K.D., Moriggl R., Kenner L.,
RA   Tse W.;
RT   "AF1q is a novel TCF7 co-factor which activates CD44 and promotes breast
RT   cancer metastasis.";
RL   Oncotarget 6:20697-20710(2015).
CC   -!- FUNCTION: Cofactor for the transcription factor TCF7 (PubMed:26079538).
CC       Involved in regulation of lymphoid development by driving multipotent
CC       hematopoietic progenitor cells towards a T cell fate (PubMed:21715312).
CC       {ECO:0000269|PubMed:21715312, ECO:0000269|PubMed:26079538}.
CC   -!- SUBUNIT: Interacts with HSPA8 and LAMP2 isoform A; the interaction may
CC       target MLLT11 for degradation via chaperone-mediated autophagy
CC       (PubMed:24880125). Interacts with TCF7 (PubMed:26079538).
CC       {ECO:0000269|PubMed:24880125, ECO:0000269|PubMed:26079538}.
CC   -!- INTERACTION:
CC       Q13015; P36402: TCF7; NbExp=2; IntAct=EBI-6269719, EBI-2119465;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:21715312,
CC       ECO:0000269|PubMed:26079538}. Cytoplasm {ECO:0000269|PubMed:21715312,
CC       ECO:0000269|PubMed:26079538}. Cytoplasm, cytoskeleton, microtubule
CC       organizing center, centrosome {ECO:0000269|PubMed:21715312}.
CC       Note=Continuous nuclear export is followed by degradation.
CC       {ECO:0000269|PubMed:21715312}.
CC   -!- TISSUE SPECIFICITY: Expressed in myoepithelial cells of normal breast
CC       tissue (at protein level) (PubMed:26079538). Highly expressed in thymus
CC       (PubMed:7833468). Expressed in colon, small intestine, prostate and
CC       ovary. Not detected in peripheral blood lymphocytes and spleen
CC       (PubMed:7833468). {ECO:0000269|PubMed:26079538,
CC       ECO:0000269|PubMed:7833468}.
CC   -!- PTM: Ubiquitinated, leading to degradation.
CC       {ECO:0000269|PubMed:21715312}.
CC   -!- DISEASE: Note=A chromosomal aberration involving MLLT11 is found in
CC       acute leukemias. Translocation t(1;11)(q21;q23) with KMT2A/MLL1.
CC   -!- SIMILARITY: Belongs to the MLLT11 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/AF1qID12.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U16954; AAA70088.1; -; mRNA.
DR   EMBL; BT006799; AAP35445.1; -; mRNA.
DR   EMBL; CR456879; CAG33160.1; -; mRNA.
DR   EMBL; AL590133; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC006471; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC008445; AAH08445.1; -; mRNA.
DR   EMBL; BC009624; AAH09624.1; -; mRNA.
DR   EMBL; BC019253; AAH19253.1; -; mRNA.
DR   EMBL; BC021703; AAH21703.1; -; mRNA.
DR   EMBL; BC022448; AAH22448.1; -; mRNA.
DR   CCDS; CCDS982.1; -.
DR   PIR; I38889; I38889.
DR   RefSeq; NP_006809.1; NM_006818.3.
DR   SMR; Q13015; -.
DR   BioGrid; 116161; 14.
DR   IntAct; Q13015; 17.
DR   MINT; Q13015; -.
DR   STRING; 9606.ENSP00000357917; -.
DR   iPTMnet; Q13015; -.
DR   MetOSite; Q13015; -.
DR   PhosphoSitePlus; Q13015; -.
DR   BioMuta; MLLT11; -.
DR   EPD; Q13015; -.
DR   jPOST; Q13015; -.
DR   MassIVE; Q13015; -.
DR   PaxDb; Q13015; -.
DR   PeptideAtlas; Q13015; -.
DR   PRIDE; Q13015; -.
DR   ProteomicsDB; 59101; -.
DR   TopDownProteomics; Q13015; -.
DR   Antibodypedia; 34047; 110 antibodies.
DR   DNASU; 10962; -.
DR   Ensembl; ENST00000368921; ENSP00000357917; ENSG00000213190.
DR   GeneID; 10962; -.
DR   KEGG; hsa:10962; -.
DR   CTD; 10962; -.
DR   DisGeNET; 10962; -.
DR   GeneCards; MLLT11; -.
DR   HGNC; HGNC:16997; MLLT11.
DR   HPA; ENSG00000213190; Tissue enhanced (brain).
DR   MIM; 604684; gene.
DR   neXtProt; NX_Q13015; -.
DR   OpenTargets; ENSG00000213190; -.
DR   PharmGKB; PA142671347; -.
DR   eggNOG; ENOG410IZF7; Eukaryota.
DR   eggNOG; ENOG4112CHF; LUCA.
DR   GeneTree; ENSGT00390000009895; -.
DR   HOGENOM; CLU_2440320_0_0_1; -.
DR   InParanoid; Q13015; -.
DR   OMA; YWKEPIA; -.
DR   OrthoDB; 1586302at2759; -.
DR   PhylomeDB; Q13015; -.
DR   TreeFam; TF336906; -.
DR   SIGNOR; Q13015; -.
DR   ChiTaRS; MLLT11; human.
DR   GenomeRNAi; 10962; -.
DR   Pharos; Q13015; Tbio.
DR   PRO; PR:Q13015; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q13015; protein.
DR   Bgee; ENSG00000213190; Expressed in forebrain and 223 other tissues.
DR   ExpressionAtlas; Q13015; baseline and differential.
DR   Genevisible; Q13015; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005815; C:microtubule organizing center; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0097191; P:extrinsic apoptotic signaling pathway; IDA:UniProtKB.
DR   GO; GO:0097193; P:intrinsic apoptotic signaling pathway; IDA:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB.
DR   GO; GO:0051901; P:positive regulation of mitochondrial depolarization; IDA:UniProtKB.
DR   GO; GO:0090200; P:positive regulation of release of cytochrome c from mitochondria; IDA:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   InterPro; IPR026778; MLLT11_fam.
DR   InterPro; IPR033461; WRNPLPNID.
DR   PANTHER; PTHR15404; PTHR15404; 1.
DR   Pfam; PF15017; WRNPLPNID; 1.
PE   1: Evidence at protein level;
KW   Chromosomal rearrangement; Cytoplasm; Cytoskeleton; Nucleus;
KW   Phosphoprotein; Proto-oncogene; Reference proteome; Ubl conjugation.
FT   CHAIN           1..90
FT                   /note="Protein AF1q"
FT                   /id="PRO_0000064471"
FT   MOTIF           24..32
FT                   /note="Nuclear export signal"
FT                   /evidence="ECO:0000269|PubMed:21715312"
FT   MOD_RES         84
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P97783"
FT   MUTAGEN         24..32
FT                   /note="LSELEGLGL->ASEAEGAGA: Constitutive nuclear
FT                   sequestration."
FT                   /evidence="ECO:0000269|PubMed:21715312"
SQ   SEQUENCE   90 AA;  10061 MW;  B37C6F7303C9EBF8 CRC64;
     MRDPVSSQYS SFLFWRMPIP ELDLSELEGL GLSDTATYKV KDSSVGKMIG QATAADQEKN
     PEGDGLLEYS TFNFWRAPIA SIHSFELDLL
//
ID   Q6FGF7_HUMAN            Unreviewed;        90 AA.
AC   Q6FGF7;
DT   10-MAY-2005, integrated into UniProtKB/TrEMBL.
DT   10-MAY-2005, sequence version 1.
DT   22-APR-2020, entry version 112.
DE   SubName: Full=AF1Q protein {ECO:0000313|EMBL:CAG46947.1};
DE   SubName: Full=Myeloid/lymphoid or mixed-lineage leukemia (Trithorax homolog, Drosophila) translocated to, 11 {ECO:0000313|EMBL:AAH06471.1};
DE   SubName: Full=cDNA FLJ31527 fis, clone NT2RI2000344, highly similar to Protein AF1q {ECO:0000313|EMBL:BAG51620.1};
DE   Flags: Fragment;
GN   Name=AF1Q {ECO:0000313|EMBL:CAG46947.1};
GN   Synonyms=MLLT11 {ECO:0000313|EMBL:AAH06471.1};
GN   ORFNames=hCG_1778767 {ECO:0000313|EMBL:EAW53476.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:CAG46947.1};
RN   [1] {ECO:0000313|EMBL:EAW53476.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:AAH06471.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung {ECO:0000313|EMBL:AAH06471.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M., Peck A.M.,
RA   Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S., Feolo M.,
RA   Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F., Schaefer C.F.,
RA   Buetow K., Bonner T.I., Haussler D., Kent J., Kiekhaus M., Furey T.,
RA   Brent M., Prange C., Schreiber K., Shapiro N., Bhat N.K., Hopkins R.F.,
RA   Hsie F., Driscoll T., Soares M.B., Casavant T.L., Scheetz T.E.,
RA   Brown-stein M.J., Usdin T.B., Toshiyuki S., Carninci P., Piao Y.,
RA   Dudekula D.B., Ko M.S., Kawakami K., Suzuki Y., Sugano S., Gruber C.E.,
RA   Smith M.R., Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y.,
RA   Wei C.L., Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W.,
RA   Fuh E., Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D., Granite S.J.,
RA   Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G., Blakesly R.W.,
RA   Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J.,
RA   Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L., Krzywinski M.I.,
RA   Liao N., Morin R., Morrin R., Palmquist D., Petrescu A.S., Skalska U.,
RA   Smailus D.E., Stott J.M., Schnerch A., Schein J.E., Jones S.J., Holt R.A.,
RA   Baross A., Marra M.A., Clifton S., Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3] {ECO:0000313|EMBL:BAG51620.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M.,
RA   Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S.,
RA   Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S.,
RA   Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H.,
RA   Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M.,
RA   Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M.,
RA   Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y.,
RA   Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N.,
RA   Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S.,
RA   Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T.,
RA   Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M.,
RA   Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y.,
RA   Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y.,
RA   Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T.,
RA   Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4] {ECO:0000313|EMBL:CAG46947.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S., Neubert P.,
RA   Kstrang K., Schatten R., Shen B., Henze S., Mar W., Korn B., Zuo D., Hu Y.,
RA   LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000313|EMBL:EAW53476.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC006471; AAH06471.1; -; mRNA.
DR   EMBL; AK056089; BAG51620.1; -; mRNA.
DR   EMBL; CR542150; CAG46947.1; -; mRNA.
DR   EMBL; CH471121; EAW53476.1; -; Genomic_DNA.
DR   RefSeq; NP_006809.1; NM_006818.3.
DR   Antibodypedia; 34047; 110 antibodies.
DR   DNASU; 10962; -.
DR   GeneID; 10962; -.
DR   KEGG; hsa:10962; -.
DR   UCSC; uc001ewq.4; human.
DR   CTD; 10962; -.
DR   EuPathDB; HostDB:ENSG00000213190.3; -.
DR   PharmGKB; PA142671347; -.
DR   eggNOG; ENOG410IZF7; Eukaryota.
DR   eggNOG; ENOG4112CHF; LUCA.
DR   HOGENOM; CLU_2440320_0_0_1; -.
DR   OMA; YWKEPIA; -.
DR   OrthoDB; 1586302at2759; -.
DR   ChiTaRS; MLLT11; human.
DR   GenomeRNAi; 10962; -.
DR   Bgee; ENSG00000213190; Expressed in forebrain and 223 other tissues.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0097190; P:apoptotic signaling pathway; IEA:InterPro.
DR   InterPro; IPR026778; MLLT11_fam.
DR   InterPro; IPR033461; WRNPLPNID.
DR   PANTHER; PTHR15404; PTHR15404; 1.
DR   Pfam; PF15017; WRNPLPNID; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN          7..79
FT                   /note="WRNPLPNID"
FT                   /evidence="ECO:0000259|Pfam:PF15017"
FT   NON_TER         90
FT                   /evidence="ECO:0000313|EMBL:CAG46947.1"
SQ   SEQUENCE   90 AA;  10061 MW;  B37C6F7303C9EBF8 CRC64;
     MRDPVSSQYS SFLFWRMPIP ELDLSELEGL GLSDTATYKV KDSSVGKMIG QATAADQEKN
     PEGDGLLEYS TFNFWRAPIA SIHSFELDLL
//
ID   A0A0S2Z448_HUMAN        Unreviewed;       568 AA.
AC   A0A0S2Z448;
DT   17-FEB-2016, integrated into UniProtKB/TrEMBL.
DT   17-FEB-2016, sequence version 1.
DT   22-APR-2020, entry version 25.
DE   SubName: Full=Myeloid/lymphoid or mixed-lineage leukemia translocated to 3 isoform 1 {ECO:0000313|EMBL:ALQ33647.1};
DE   Flags: Fragment;
GN   Name=MLLT3 {ECO:0000313|EMBL:ALQ33647.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ALQ33647.1};
RN   [1] {ECO:0000313|EMBL:ALQ33647.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by Alternative
RT   Splicing.";
RL   Cell 164:805-817(2016).
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|PROSITE-ProRule:PRU00376}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; KU178189; ALQ33647.1; -; mRNA.
DR   RefSeq; NP_004520.2; NM_004529.3.
DR   SMR; A0A0S2Z448; -.
DR   PRIDE; A0A0S2Z448; -.
DR   Antibodypedia; 1068; 270 antibodies.
DR   GeneID; 4300; -.
DR   KEGG; hsa:4300; -.
DR   CTD; 4300; -.
DR   KO; K15187; -.
DR   OMA; PNRSVHT; -.
DR   OrthoDB; 727038at2759; -.
DR   PhylomeDB; A0A0S2Z448; -.
DR   ChiTaRS; MLLT3; human.
DR   GenomeRNAi; 4300; -.
DR   ExpressionAtlas; A0A0S2Z448; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   GO; GO:0007379; P:segment specification; IEA:Ensembl.
DR   Gene3D; 2.60.40.1970; -; 1.
DR   InterPro; IPR040930; AF-9_AHD.
DR   InterPro; IPR038704; YEAST_sf.
DR   InterPro; IPR005033; YEATS.
DR   PANTHER; PTHR23195; PTHR23195; 1.
DR   Pfam; PF17793; AHD; 1.
DR   Pfam; PF03366; YEATS; 1.
DR   PROSITE; PS51037; YEATS; 1.
PE   2: Evidence at transcript level;
KW   Nucleus {ECO:0000256|PROSITE-ProRule:PRU00376}.
FT   DOMAIN          503..563
FT                   /note="AHD"
FT                   /evidence="ECO:0000259|Pfam:PF17793"
FT   REGION          137..475
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        143..195
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        196..262
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        282..304
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        323..354
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        373..403
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        414..428
FT                   /note="Acidic"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        441..461
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   NON_TER         568
FT                   /evidence="ECO:0000313|EMBL:ALQ33647.1"
SQ   SEQUENCE   568 AA;  63351 MW;  0A020B7FB34132F9 CRC64;
     MASSCAVQVK LELGHRAQVR KKPTVEGFTH DWMVFVRGPE HSNIQHFVEK VVFHLHESFP
     RPKRVCKDPP YKVEESGYAG FILPIEVYFK NKEEPRKVRF DYDLFLHLEG HPPVNHLRCE
     KLTFNNPTED FRRKLLKAGG DPNRSIHTSS SSSSSSSSSS SSSSSSSSSS SSSSSSSSSS
     SSSSSSSSSS TSFSKPHKLM KEHKEKPSKD SREHKSAFKE PSRDHNKSSK ESSKKPKENK
     PLKEEKIVPK MAFKEPKPMS KEPKPDSNLL TITSGQDKKA PSKRPPISDS EELSAKKRKK
     SSSEALFKSF SSAPPLILTC SADKKQIKDK SHVKMGKVKI ESETSEKKKS TLPPFDDIVD
     PNDSDVEENI SSKSDSEQPS PASSSSSSSS SFTPSQTRQQ GPLRSIMKDL HSDDNEEESD
     EVEDNDNDSE MERPVNRGGS RSRRVSLSDG SDSESSSASS PLHHEPPPPL LKTNNNQILE
     VKSPIKQSKS DKQIKNGECD KAYLDELVEL HRRLMTLRER HILQQIVNLI EETGHFHITN
     TTFDFDLCSL DKTTVRKLQS YLETSGTS
//
ID   AF9_HUMAN               Reviewed;         568 AA.
AC   P42568; B1AMQ2; B2R7B3; B7Z755; D3DRJ8; Q8IVB0;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 2.
DT   22-APR-2020, entry version 173.
DE   RecName: Full=Protein AF-9 {ECO:0000305};
DE   AltName: Full=ALL1-fused gene from chromosome 9 protein {ECO:0000303|PubMed:10861294};
DE   AltName: Full=Myeloid/lymphoid or mixed-lineage leukemia translocated to chromosome 3 protein {ECO:0000303|PubMed:16001262};
DE   AltName: Full=YEATS domain-containing protein 3;
GN   Name=MLLT3 {ECO:0000303|PubMed:16001262, ECO:0000312|HGNC:HGNC:7136};
GN   Synonyms=AF9 {ECO:0000303|PubMed:10861294}, YEATS3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND CHROMOSOMAL TRANSLOCATION WITH
RP   KMT2A.
RX   PubMed=8506309; DOI=10.1073/pnas.90.10.4631;
RA   Nakamura T., Alder H., Gu Y., Prasad R., Canaani O., Kamada N., Gale R.P.,
RA   Lange B., Crist W.M., Nowell P.C., Croce C.M., Canaani E.;
RT   "Genes on chromosomes 4, 9, and 19 involved in 11q23 abnormalities in acute
RT   leukemia share sequence homology and/or common motifs.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:4631-4635(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, and Synovium;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L.,
RA   Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S.,
RA   Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K.,
RA   Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C.,
RA   Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E.,
RA   Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M.,
RA   Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J.,
RA   Frankish A., Frankland J.A., French L., Fricker D.G., Garner P.,
RA   Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S.,
RA   Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E.,
RA   McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V.,
RA   Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S.,
RA   Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K.,
RA   Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J.,
RA   Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M.,
RA   West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L.,
RA   Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J.,
RA   Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INTERACTION WITH BCOR.
RX   PubMed=10898795;
RA   Huynh K.D., Fischle W., Verdin E., Bardwell V.J.;
RT   "BCoR, a novel corepressor involved in BCL-6 repression.";
RL   Genes Dev. 14:1810-1823(2000).
RN   [7]
RP   CHROMOSOMAL TRANSLOCATION.
RX   PubMed=10861294; DOI=10.1093/hmg/9.11.1671;
RA   Strissel P.L., Strick R., Tomek R.J., Roe B.A., Rowley J.D.,
RA   Zeleznik-Le N.J.;
RT   "DNA structural properties of AF9 are similar to MLL and could act as
RT   recombination hot spots resulting in MLL/AF9 translocations and
RT   leukemogenesis.";
RL   Hum. Mol. Genet. 9:1671-1679(2000).
RN   [8]
RP   INTERACTION WITH CBX8.
RX   PubMed=11313972; DOI=10.1038/sj.onc.1204108;
RA   Garcia-Cuellar M.P., Zilles O., Schreiner S.A., Birke M., Winkler T.H.,
RA   Slany R.K.;
RT   "The ENL moiety of the childhood leukemia-associated MLL-ENL oncoprotein
RT   recruits human Polycomb 3.";
RL   Oncogene 20:411-419(2001).
RN   [9]
RP   CHROMOSOMAL TRANSLOCATION.
RX   PubMed=16001262; DOI=10.1007/s00439-005-0004-1;
RA   Pramparo T., Grosso S., Messa J., Zatterale A., Bonaglia M.C., Chessa L.,
RA   Balestri P., Rocchi M., Zuffardi O., Giorda R.;
RT   "Loss-of-function mutation of the AF9/MLLT3 gene in a girl with neuromotor
RT   development delay, cerebellar ataxia, and epilepsy.";
RL   Hum. Genet. 118:76-81(2005).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-294 AND SER-483, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-288; SER-294 AND SER-483, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-412 AND SER-419, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [14]
RP   FUNCTION, AND IDENTIFICATION IN THE SEC COMPLEX.
RX   PubMed=20471948; DOI=10.1016/j.molcel.2010.04.013;
RA   He N., Liu M., Hsu J., Xue Y., Chou S., Burlingame A., Krogan N.J.,
RA   Alber T., Zhou Q.;
RT   "HIV-1 Tat and host AFF4 recruit two transcription elongation factors into
RT   a bifunctional complex for coordinated activation of HIV-1 transcription.";
RL   Mol. Cell 38:428-438(2010).
RN   [15]
RP   FUNCTION, AND IDENTIFICATION IN THE SEC COMPLEX.
RX   PubMed=20159561; DOI=10.1016/j.molcel.2010.01.026;
RA   Lin C., Smith E.R., Takahashi H., Lai K.C., Martin-Brown S., Florens L.,
RA   Washburn M.P., Conaway J.W., Conaway R.C., Shilatifard A.;
RT   "AFF4, a component of the ELL/P-TEFb elongation complex and a shared
RT   subunit of MLL chimeras, can link transcription elongation to leukemia.";
RL   Mol. Cell 37:429-437(2010).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-483, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [17]
RP   IDENTIFICATION IN THE SEC COMPLEX.
RX   PubMed=22195968; DOI=10.1016/j.molcel.2011.12.008;
RA   Smith E.R., Lin C., Garrett A.S., Thornton J., Mohaghegh N., Hu D.,
RA   Jackson J., Saraf A., Swanson S.K., Seidel C., Florens L., Washburn M.P.,
RA   Eissenberg J.C., Shilatifard A.;
RT   "The little elongation complex regulates small nuclear RNA transcription.";
RL   Mol. Cell 44:954-965(2011).
RN   [18]
RP   INTERACTION OF FUSION PROTEIN KMT2A-MLLT3 WITH MEN1.
RX   PubMed=22936661; DOI=10.1182/blood-2012-05-429274;
RA   Shi A., Murai M.J., He S., Lund G., Hartley T., Purohit T., Reddy G.,
RA   Chruszcz M., Grembecka J., Cierpicki T.;
RT   "Structural insights into inhibition of the bivalent menin-MLL interaction
RT   by small molecules in leukemia.";
RL   Blood 120:4461-4469(2012).
RN   [19]
RP   REVIEW ON THE SUPER ELONGATION COMPLEX.
RX   PubMed=22895430; DOI=10.1038/nrm3417;
RA   Luo Z., Lin C., Shilatifard A.;
RT   "The super elongation complex (SEC) family in transcriptional control.";
RL   Nat. Rev. Mol. Cell Biol. 13:543-547(2012).
RN   [20]
RP   INTERACTION WITH ALKBH4.
RX   PubMed=23145062; DOI=10.1371/journal.pone.0049045;
RA   Bjornstad L.G., Meza T.J., Otterlei M., Olafsrud S.M., Meza-Zepeda L.A.,
RA   Falnes P.O.;
RT   "Human ALKBH4 interacts with proteins associated with transcription.";
RL   PLoS ONE 7:E49045-E49045(2012).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-294 AND SER-483, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [22]
RP   INTERACTION OF FUSION PROTEIN KMT2A-MLLT3 WITH PSIP1 AND MEN1.
RX   PubMed=25305204; DOI=10.1182/blood-2014-01-550079;
RA   Murai M.J., Pollock J., He S., Miao H., Purohit T., Yokom A., Hess J.L.,
RA   Muntean A.G., Grembecka J., Cierpicki T.;
RT   "The same site on the integrase-binding domain of lens epithelium-derived
RT   growth factor is a therapeutic target for MLL leukemia and HIV.";
RL   Blood 124:3730-3737(2014).
RN   [23]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-339, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [24]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-339, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [25]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=31776511; DOI=10.1038/s41586-019-1790-2;
RA   Calvanese V., Nguyen A.T., Bolan T.J., Vavilina A., Su T., Lee L.K.,
RA   Wang Y., Lay F.D., Magnusson M., Crooks G.M., Kurdistani S.K.,
RA   Mikkola H.K.A.;
RT   "MLLT3 governs human haematopoietic stem-cell self-renewal and
RT   engraftment.";
RL   Nature 0:0-0(2019).
RN   [26]
RP   STRUCTURE BY NMR OF 490-568 IN COMPLEX WITH AFF1.
RX   PubMed=23260655; DOI=10.1016/j.str.2012.11.011;
RA   Leach B.I., Kuntimaddi A., Schmidt C.R., Cierpicki T., Johnson S.A.,
RA   Bushweller J.H.;
RT   "Leukemia fusion target AF9 is an intrinsically disordered transcriptional
RT   regulator that recruits multiple partners via coupled folding and
RT   binding.";
RL   Structure 21:176-183(2013).
RN   [27]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 1-138 IN COMPLEX WITH H3K9AC
RP   PEPTIDE, FUNCTION, SUBCELLULAR LOCATION, DOMAIN, AND MUTAGENESIS OF PHE-28;
RP   HIS-56; SER-58; PHE-59; GLY-77; TYR-78; PHE-81 AND ASP-103.
RX   PubMed=25417107; DOI=10.1016/j.cell.2014.09.049;
RA   Li Y., Wen H., Xi Y., Tanaka K., Wang H., Peng D., Ren Y., Jin Q.,
RA   Dent S.Y., Li W., Li H., Shi X.;
RT   "AF9 YEATS domain links histone acetylation to DOT1L-mediated H3K79
RT   methylation.";
RL   Cell 159:558-571(2014).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (2.70 ANGSTROMS) OF 1-138 IN COMPLEX WITH H3K9CR
RP   PEPTIDE, FUNCTION, SUBCELLULAR LOCATION, DOMAIN, AND MUTAGENESIS OF PHE-28;
RP   HIS-56; SER-58; PHE-59; GLY-77 AND TYR-78.
RX   PubMed=27105114; DOI=10.1016/j.molcel.2016.03.028;
RA   Li Y., Sabari B.R., Panchenko T., Wen H., Zhao D., Guan H., Wan L.,
RA   Huang H., Tang Z., Zhao Y., Roeder R.G., Shi X., Allis C.D., Li H.;
RT   "Molecular coupling of histone crotonylation and active transcription by
RT   AF9 YEATS domain.";
RL   Mol. Cell 62:181-193(2016).
RN   [29]
RP   STRUCTURE BY NMR OF 1-138, FUNCTION, DOMAIN, AND MUTAGENESIS OF PHE-59 AND
RP   TYR-78.
RX   PubMed=27545619; DOI=10.1016/j.str.2016.05.023;
RA   Zhang Q., Zeng L., Zhao C., Ju Y., Konuma T., Zhou M.M.;
RT   "Structural insights into histone crotonyl-lysine recognition by the AF9
RT   YEATS domain.";
RL   Structure 24:1606-1612(2016).
RN   [30] {ECO:0000244|PDB:5YYF}
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 1-138 IN COMPLEX WITH INHIBITOR,
RP   FUNCTION, DOMAIN, AND ACTIVITY REGULATION.
RX   PubMed=30374167; DOI=10.1038/s41589-018-0144-y;
RA   Li X., Li X.M., Jiang Y., Liu Z., Cui Y., Fung K.Y., van der Beelen S.H.E.,
RA   Tian G., Wan L., Shi X., Allis C.D., Li H., Li Y., Li X.D.;
RT   "Structure-guided development of YEATS domain inhibitors by targeting pi-
RT   pi-pi stacking.";
RL   Nat. Chem. Biol. 14:1140-1149(2018).
RN   [31] {ECO:0000244|PDB:6MIL, ECO:0000244|PDB:6MIM}
RP   X-RAY CRYSTALLOGRAPHY (1.93 ANGSTROMS) OF 1-138 IN COMPLEX WITH H3K9CR
RP   PEPTIDE, FUNCTION, DOMAIN, AND MUTAGENESIS OF 61-ARG--LYS-67; 78-TYR-ALA-79
RP   AND TYR-78.
RX   PubMed=30385749; DOI=10.1038/s41467-018-07072-6;
RA   Klein B.J., Vann K.R., Andrews F.H., Wang W.W., Zhang J., Zhang Y.,
RA   Beloglazkina A.A., Mi W., Li Y., Li H., Shi X., Kutateladze A.G.,
RA   Strahl B.D., Liu W.R., Kutateladze T.G.;
RT   "Structural insights into the pi-pi-pi stacking mechanism and DNA-binding
RT   activity of the YEATS domain.";
RL   Nat. Commun. 9:4574-4574(2018).
CC   -!- FUNCTION: Chromatin reader component of the super elongation complex
CC       (SEC), a complex required to increase the catalytic rate of RNA
CC       polymerase II transcription by suppressing transient pausing by the
CC       polymerase at multiple sites along the DNA (PubMed:20159561,
CC       PubMed:20471948, PubMed:25417107, PubMed:27105114, PubMed:27545619).
CC       Specifically recognizes and binds acylated histone H3, with a
CC       preference for histone H3 that is crotonylated (PubMed:25417107,
CC       PubMed:27105114, PubMed:27545619, PubMed:30374167, PubMed:30385749).
CC       Crotonylation marks active promoters and enhancers and confers
CC       resistance to transcriptional repressors (PubMed:25417107,
CC       PubMed:27105114, PubMed:27545619). Recognizes and binds histone H3
CC       crotonylated at 'Lys-9' (H3K9cr), and with slightly lower affinity
CC       histone H3 crotonylated at 'Lys-18' (H3K18cr) (PubMed:27105114). Also
CC       recognizes and binds histone H3 acetylated and butyrylated at 'Lys-9'
CC       (H3K9ac and H3K9bu, respectively), but with lower affinity than
CC       crotonylated histone H3 (PubMed:25417107, PubMed:27105114,
CC       PubMed:30385749). In the SEC complex, MLLT3 is required to recruit the
CC       complex to crotonylated histones (PubMed:27105114, PubMed:27545619).
CC       Recruitment of the SEC complex to crotonylated histones promotes
CC       recruitment of DOT1L on active chromatin to deposit histone H3 'Lys-79'
CC       methylation (H3K79me) (PubMed:25417107). Plays a key role in
CC       hematopoietic stem cell (HSC) maintenance by preserving, rather than
CC       confering, HSC stemness (PubMed:31776511). Acts by binding to the
CC       transcription start site of active genes in HSCs and sustaining level
CC       of H3K79me2, probably by recruiting DOT1L (PubMed:31776511).
CC       {ECO:0000269|PubMed:20159561, ECO:0000269|PubMed:20471948,
CC       ECO:0000269|PubMed:25417107, ECO:0000269|PubMed:27105114,
CC       ECO:0000269|PubMed:27545619, ECO:0000269|PubMed:30374167,
CC       ECO:0000269|PubMed:30385749, ECO:0000269|PubMed:31776511}.
CC   -!- ACTIVITY REGULATION: Crotonylated lysine binding is strongly inhibited
CC       by the peptide XL-07i, carrying a 2-furancarbonyl side chain and capped
CC       with a hydrophobic carboxybenzyl group (PubMed:30374167). XL-07i
CC       targets the unique pi-pi-pi stacking interaction at the crotonylation
CC       recognition site (PubMed:30374167). {ECO:0000269|PubMed:30374167}.
CC   -!- SUBUNIT: Component of the super elongation complex (SEC), at least
CC       composed of EAF1, EAF2, CDK9, MLLT3/AF9, AFF (AFF1 or AFF4), the P-TEFb
CC       complex and ELL (ELL, ELL2 or ELL3) (PubMed:20159561, PubMed:20471948,
CC       PubMed:22195968, PubMed:23260655, PubMed:25417107). Interacts with BCOR
CC       (PubMed:10898795). Interacts with CBX8 (PubMed:11313972). Interacts
CC       with ALKBH4 (PubMed:23145062). {ECO:0000269|PubMed:10898795,
CC       ECO:0000269|PubMed:11313972, ECO:0000269|PubMed:20159561,
CC       ECO:0000269|PubMed:20471948, ECO:0000269|PubMed:22195968,
CC       ECO:0000269|PubMed:23145062, ECO:0000269|PubMed:23260655,
CC       ECO:0000269|PubMed:25417107}.
CC   -!- INTERACTION:
CC       P42568; P51825: AFF1; NbExp=7; IntAct=EBI-716132, EBI-2610180;
CC       P42568; Q9UHB7: AFF4; NbExp=4; IntAct=EBI-716132, EBI-395282;
CC       P42568; Q9NXW9: ALKBH4; NbExp=5; IntAct=EBI-716132, EBI-8637516;
CC       P42568; Q92624: APPBP2; NbExp=4; IntAct=EBI-716132, EBI-743771;
CC       P42568; Q6W2J9-1: BCOR; NbExp=2; IntAct=EBI-716132, EBI-16028932;
CC       P42568; Q9HC52: CBX8; NbExp=2; IntAct=EBI-716132, EBI-712912;
CC       P42568; Q8TEK3: DOT1L; NbExp=6; IntAct=EBI-716132, EBI-2619253;
CC       P42568; Q8IZU1: FAM9A; NbExp=4; IntAct=EBI-716132, EBI-8468186;
CC       P42568; Q5JXC2: MIIP; NbExp=3; IntAct=EBI-716132, EBI-2801965;
CC       P42568; Q5SQQ9-2: VAX1; NbExp=3; IntAct=EBI-716132, EBI-12227803;
CC       P42568; Q7Z3I7: ZNF572; NbExp=3; IntAct=EBI-716132, EBI-10172590;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00376,
CC       ECO:0000269|PubMed:27105114}. Chromosome {ECO:0000269|PubMed:25417107,
CC       ECO:0000269|PubMed:27105114}. Note=Colocalizes with acylated histone H3
CC       (PubMed:25417107, PubMed:27105114). Colocalizes with histone H3
CC       crotonylated at 'Lys-18' (H3K18cr) (PubMed:27105114).
CC       {ECO:0000269|PubMed:25417107, ECO:0000269|PubMed:27105114}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P42568-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P42568-2; Sequence=VSP_054924;
CC   -!- TISSUE SPECIFICITY: Enriched in undifferentiated hematopoietic stem
CC       cells in fetal liver, cord blood and bone marrow.
CC       {ECO:0000269|PubMed:31776511}.
CC   -!- DOMAIN: The YEATS domain specifically recognizes and binds acylated
CC       histones, with a marked preference for histones that are crotonylated
CC       (PubMed:27105114, PubMed:27545619). Also binds histone H3 acetylated at
CC       'Lys-9' (H3K9ac), but with lower affinity (PubMed:25417107,
CC       PubMed:27105114). Binds crotonylated lysine through a non-canonical pi-
CC       pi-pi stacking mechanism (PubMed:30374167, PubMed:30385749). The YEATS
CC       domain also binds DNA (PubMed:30385749). {ECO:0000269|PubMed:25417107,
CC       ECO:0000269|PubMed:27105114, ECO:0000269|PubMed:27545619,
CC       ECO:0000269|PubMed:30374167, ECO:0000269|PubMed:30385749}.
CC   -!- DISEASE: Note=A chromosomal aberration involving MLLT3 is associated
CC       with acute leukemias. Translocation t(9;11)(p22;q23) with KMT2A/MLL1.
CC       The result is a rogue activator protein. Fusion protein KMT2A-MLLT3
CC       interacts with MEN1 and PSIP1 (PubMed:22936661, PubMed:25305204).
CC       {ECO:0000269|PubMed:10861294, ECO:0000269|PubMed:22936661,
CC       ECO:0000269|PubMed:25305204, ECO:0000269|PubMed:8506309}.
CC   -!- DISEASE: Note=A chromosomal aberration involving MLLT3 was observed in
CC       a patient with neuromotor development delay, cerebellar ataxia and
CC       epilepsy. Translocation t(4;9)(q35;p22). {ECO:0000269|PubMed:16001262}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/AF9ID5.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L13744; AAA58361.1; -; mRNA.
DR   EMBL; AK301474; BAH13491.1; -; mRNA.
DR   EMBL; AK312914; BAG35760.1; -; mRNA.
DR   EMBL; AL354879; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL512635; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL513498; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL163193; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL627410; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471071; EAW58631.1; -; Genomic_DNA.
DR   EMBL; CH471071; EAW58632.1; -; Genomic_DNA.
DR   EMBL; BC036089; AAH36089.1; -; mRNA.
DR   CCDS; CCDS6494.1; -. [P42568-1]
DR   CCDS; CCDS69579.1; -. [P42568-2]
DR   PIR; I39411; I39411.
DR   RefSeq; NP_001273620.1; NM_001286691.1. [P42568-2]
DR   RefSeq; NP_004520.2; NM_004529.3. [P42568-1]
DR   PDB; 2LM0; NMR; -; A=490-568.
DR   PDB; 2MV7; NMR; -; A=500-568.
DR   PDB; 2N4Q; NMR; -; B=500-568.
DR   PDB; 2NDF; NMR; -; A=1-138.
DR   PDB; 2NDG; NMR; -; A=1-138.
DR   PDB; 4TMP; X-ray; 2.30 A; A/C=1-138.
DR   PDB; 5HJB; X-ray; 2.70 A; A=1-138.
DR   PDB; 5HJD; X-ray; 2.81 A; A/C/E/G/K/N/Q/T=1-138.
DR   PDB; 5YYF; X-ray; 1.90 A; A/C=1-138.
DR   PDB; 6B7G; NMR; -; A=500-568.
DR   PDB; 6MIL; X-ray; 1.93 A; A/C=1-138.
DR   PDB; 6MIM; X-ray; 2.52 A; A/C=1-138.
DR   PDBsum; 2LM0; -.
DR   PDBsum; 2MV7; -.
DR   PDBsum; 2N4Q; -.
DR   PDBsum; 2NDF; -.
DR   PDBsum; 2NDG; -.
DR   PDBsum; 4TMP; -.
DR   PDBsum; 5HJB; -.
DR   PDBsum; 5HJD; -.
DR   PDBsum; 5YYF; -.
DR   PDBsum; 6B7G; -.
DR   PDBsum; 6MIL; -.
DR   PDBsum; 6MIM; -.
DR   SMR; P42568; -.
DR   BioGrid; 110446; 67.
DR   CORUM; P42568; -.
DR   DIP; DIP-56409N; -.
DR   IntAct; P42568; 51.
DR   MINT; P42568; -.
DR   STRING; 9606.ENSP00000369695; -.
DR   iPTMnet; P42568; -.
DR   PhosphoSitePlus; P42568; -.
DR   BioMuta; MLLT3; -.
DR   DMDM; 215273971; -.
DR   jPOST; P42568; -.
DR   MassIVE; P42568; -.
DR   MaxQB; P42568; -.
DR   PaxDb; P42568; -.
DR   PeptideAtlas; P42568; -.
DR   PRIDE; P42568; -.
DR   ProteomicsDB; 55517; -. [P42568-1]
DR   ProteomicsDB; 6833; -.
DR   Antibodypedia; 1068; 270 antibodies.
DR   Ensembl; ENST00000380338; ENSP00000369695; ENSG00000171843. [P42568-1]
DR   Ensembl; ENST00000630269; ENSP00000485996; ENSG00000171843. [P42568-2]
DR   GeneID; 4300; -.
DR   KEGG; hsa:4300; -.
DR   UCSC; uc003zoe.3; human. [P42568-1]
DR   CTD; 4300; -.
DR   DisGeNET; 4300; -.
DR   GeneCards; MLLT3; -.
DR   HGNC; HGNC:7136; MLLT3.
DR   HPA; ENSG00000171843; Low tissue specificity.
DR   MalaCards; MLLT3; -.
DR   MIM; 159558; gene.
DR   neXtProt; NX_P42568; -.
DR   OpenTargets; ENSG00000171843; -.
DR   Orphanet; 402017; Acute myeloid leukemia with t(9;11)(p22;q23).
DR   PharmGKB; PA30852; -.
DR   eggNOG; KOG3149; Eukaryota.
DR   eggNOG; COG5033; LUCA.
DR   GeneTree; ENSGT00940000155903; -.
DR   InParanoid; P42568; -.
DR   KO; K15187; -.
DR   OMA; PNRSVHT; -.
DR   PhylomeDB; P42568; -.
DR   TreeFam; TF314586; -.
DR   Reactome; R-HSA-112382; Formation of RNA Pol II elongation complex.
DR   Reactome; R-HSA-674695; RNA Polymerase II Pre-transcription Events.
DR   Reactome; R-HSA-75955; RNA Polymerase II Transcription Elongation.
DR   SIGNOR; P42568; -.
DR   ChiTaRS; MLLT3; human.
DR   GeneWiki; MLLT3; -.
DR   GenomeRNAi; 4300; -.
DR   Pharos; P42568; Tbio.
DR   PRO; PR:P42568; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   RNAct; P42568; protein.
DR   Bgee; ENSG00000171843; Expressed in frontal cortex and 192 other tissues.
DR   ExpressionAtlas; P42568; baseline and differential.
DR   Genevisible; P42568; HS.
DR   GO; GO:0005694; C:chromosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0008023; C:transcription elongation factor complex; IDA:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISM:NTNU_SB.
DR   GO; GO:0042393; F:histone binding; IDA:UniProtKB.
DR   GO; GO:0070577; F:lysine-acetylated histone binding; IDA:UniProtKB.
DR   GO; GO:0140030; F:modification-dependent protein binding; IDA:UniProtKB.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IDA:MGI.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:2000096; P:positive regulation of Wnt signaling pathway, planar cell polarity pathway; IGI:MGI.
DR   GO; GO:0007379; P:segment specification; IEA:Ensembl.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; TAS:Reactome.
DR   GO; GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome.
DR   DisProt; DP01070; -.
DR   Gene3D; 2.60.40.1970; -; 1.
DR   InterPro; IPR040930; AF-9_AHD.
DR   InterPro; IPR038704; YEAST_sf.
DR   InterPro; IPR005033; YEATS.
DR   PANTHER; PTHR23195; PTHR23195; 1.
DR   Pfam; PF17793; AHD; 1.
DR   Pfam; PF03366; YEATS; 1.
DR   PROSITE; PS51037; YEATS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing; Chromosomal rearrangement;
KW   Chromosome; DNA-binding; Isopeptide bond; Nucleus; Phosphoprotein;
KW   Proto-oncogene; Reference proteome; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   CHAIN           1..568
FT                   /note="Protein AF-9"
FT                   /id="PRO_0000215921"
FT   DOMAIN          8..112
FT                   /note="YEATS"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00376"
FT   REGION          56..58
FT                   /note="Inhibitor XL-07i binding"
FT                   /evidence="ECO:0000244|PDB:5YYF,
FT                   ECO:0000269|PubMed:30374167"
FT   REGION          78..80
FT                   /note="Histone H3K9cr binding"
FT                   /evidence="ECO:0000244|PDB:5HJB, ECO:0000244|PDB:5HJD,
FT                   ECO:0000244|PDB:6MIL, ECO:0000244|PDB:6MIM,
FT                   ECO:0000269|PubMed:27105114, ECO:0000269|PubMed:30385749"
FT   REGION          106..109
FT                   /note="Inhibitor XL-07i binding"
FT                   /evidence="ECO:0000244|PDB:5YYF,
FT                   ECO:0000269|PubMed:30374167"
FT   REGION          106..108
FT                   /note="Histone H3K9cr binding"
FT                   /evidence="ECO:0000244|PDB:5HJB, ECO:0000244|PDB:5HJD,
FT                   ECO:0000244|PDB:6MIL, ECO:0000244|PDB:6MIM,
FT                   ECO:0000269|PubMed:27105114, ECO:0000269|PubMed:30385749"
FT   MOTIF           295..300
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        149..194
FT                   /note="Poly-Ser"
FT   COMPBIAS        383..391
FT                   /note="Poly-Ser"
FT   COMPBIAS        466..469
FT                   /note="Poly-Pro"
FT   BINDING         58
FT                   /note="Histone H3K9cr"
FT                   /evidence="ECO:0000244|PDB:5HJB, ECO:0000244|PDB:5HJD,
FT                   ECO:0000244|PDB:6MIL, ECO:0000244|PDB:6MIM,
FT                   ECO:0000269|PubMed:27105114, ECO:0000269|PubMed:30385749"
FT   BINDING         80
FT                   /note="Inhibitor XL-07i; via carbonyl oxygen"
FT                   /evidence="ECO:0000244|PDB:5YYF,
FT                   ECO:0000269|PubMed:30374167"
FT   BINDING         103
FT                   /note="Histone H3K9cr"
FT                   /evidence="ECO:0000244|PDB:5HJB, ECO:0000244|PDB:5HJD,
FT                   ECO:0000244|PDB:6MIL, ECO:0000244|PDB:6MIM,
FT                   ECO:0000269|PubMed:27105114, ECO:0000269|PubMed:30385749"
FT   BINDING         103
FT                   /note="Inhibitor XL-07i"
FT                   /evidence="ECO:0000244|PDB:5YYF,
FT                   ECO:0000269|PubMed:30374167"
FT   SITE            375
FT                   /note="KMT2A/MLL1 fusion point (in acute myeloid leukemia
FT                   patient CO)"
FT                   /evidence="ECO:0000269|PubMed:8506309"
FT   SITE            481
FT                   /note="KMT2A/MLL1 fusion point (in acute myeloid leukemia
FT                   patient F1)"
FT                   /evidence="ECO:0000269|PubMed:8506309"
FT   MOD_RES         288
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         294
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:23186163"
FT   MOD_RES         412
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332"
FT   MOD_RES         419
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332"
FT   MOD_RES         483
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163"
FT   CROSSLNK        339
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:28112733"
FT   VAR_SEQ         1..4
FT                   /note="MASS -> M (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_054924"
FT   MUTAGEN         28
FT                   /note="F->A: Decreased binding to crotonylated histone H3.
FT                   Decreased binding to acetylated histone H3."
FT                   /evidence="ECO:0000269|PubMed:25417107,
FT                   ECO:0000269|PubMed:27105114"
FT   MUTAGEN         56
FT                   /note="H->A: Decreased binding to crotonylated histone H3.
FT                   Decreased binding to acetylated histone H3."
FT                   /evidence="ECO:0000269|PubMed:25417107,
FT                   ECO:0000269|PubMed:27105114"
FT   MUTAGEN         58
FT                   /note="S->A: Decreased binding to crotonylated histone H3.
FT                   Decreased binding to acetylated histone H3."
FT                   /evidence="ECO:0000269|PubMed:25417107,
FT                   ECO:0000269|PubMed:27105114"
FT   MUTAGEN         59
FT                   /note="F->A: Strongly decreased binding to crotonylated
FT                   histone H3. Decreased binding to acetylated histone H3."
FT                   /evidence="ECO:0000269|PubMed:25417107,
FT                   ECO:0000269|PubMed:27105114, ECO:0000269|PubMed:27545619"
FT   MUTAGEN         61..67
FT                   /note="RPKRVCK->EPERVCE: Decreased DNA-binding."
FT                   /evidence="ECO:0000269|PubMed:30385749"
FT   MUTAGEN         77
FT                   /note="G->A: Decreased binding to crotonylated histone H3.
FT                   Decreased binding to acetylated histone H3."
FT                   /evidence="ECO:0000269|PubMed:25417107,
FT                   ECO:0000269|PubMed:27105114"
FT   MUTAGEN         78..79
FT                   /note="YA->WG: Binds equally well acetylated and
FT                   crotonylated histone H3."
FT                   /evidence="ECO:0000269|PubMed:30385749"
FT   MUTAGEN         78
FT                   /note="Y->A: Strongly decreased binding to crotonylated
FT                   histone H3. Decreased binding to acetylated histone H3."
FT                   /evidence="ECO:0000269|PubMed:25417107,
FT                   ECO:0000269|PubMed:27105114, ECO:0000269|PubMed:27545619"
FT   MUTAGEN         78
FT                   /note="Y->W: Does not affect ability to discriminate
FT                   between acetylated and crotonylated histone H3."
FT                   /evidence="ECO:0000269|PubMed:30385749"
FT   MUTAGEN         81
FT                   /note="F->A: Decreased binding to acetylated histone H3."
FT                   /evidence="ECO:0000269|PubMed:25417107"
FT   MUTAGEN         103
FT                   /note="D->A: Decreased binding to acetylated histone H3."
FT                   /evidence="ECO:0000269|PubMed:25417107"
FT   CONFLICT        6
FT                   /note="A -> S (in Ref. 1; AAA58361 and 2; BAG35760)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        173
FT                   /note="S -> G (in Ref. 5; AAH36089)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        419
FT                   /note="S -> P (in Ref. 2; BAG35760)"
FT                   /evidence="ECO:0000305"
FT   STRAND          6..19
FT                   /evidence="ECO:0000244|PDB:5YYF"
FT   STRAND          30..37
FT                   /evidence="ECO:0000244|PDB:5YYF"
FT   HELIX           39..41
FT                   /evidence="ECO:0000244|PDB:5YYF"
FT   TURN            45..47
FT                   /evidence="ECO:0000244|PDB:5YYF"
FT   STRAND          48..54
FT                   /evidence="ECO:0000244|PDB:5YYF"
FT   STRAND          59..61
FT                   /evidence="ECO:0000244|PDB:5YYF"
FT   STRAND          63..90
FT                   /evidence="ECO:0000244|PDB:5YYF"
FT   STRAND          92..94
FT                   /evidence="ECO:0000244|PDB:5YYF"
FT   STRAND          97..104
FT                   /evidence="ECO:0000244|PDB:5YYF"
FT   STRAND          114..126
FT                   /evidence="ECO:0000244|PDB:5YYF"
FT   HELIX           129..135
FT                   /evidence="ECO:0000244|PDB:5YYF"
FT   HELIX           504..515
FT                   /evidence="ECO:0000244|PDB:2LM0"
FT   HELIX           523..531
FT                   /evidence="ECO:0000244|PDB:2LM0"
FT   STRAND          536..538
FT                   /evidence="ECO:0000244|PDB:2LM0"
FT   STRAND          543..545
FT                   /evidence="ECO:0000244|PDB:2LM0"
FT   TURN            547..549
FT                   /evidence="ECO:0000244|PDB:2LM0"
FT   HELIX           552..561
FT                   /evidence="ECO:0000244|PDB:2LM0"
SQ   SEQUENCE   568 AA;  63351 MW;  0A020B7FB34132F9 CRC64;
     MASSCAVQVK LELGHRAQVR KKPTVEGFTH DWMVFVRGPE HSNIQHFVEK VVFHLHESFP
     RPKRVCKDPP YKVEESGYAG FILPIEVYFK NKEEPRKVRF DYDLFLHLEG HPPVNHLRCE
     KLTFNNPTED FRRKLLKAGG DPNRSIHTSS SSSSSSSSSS SSSSSSSSSS SSSSSSSSSS
     SSSSSSSSSS TSFSKPHKLM KEHKEKPSKD SREHKSAFKE PSRDHNKSSK ESSKKPKENK
     PLKEEKIVPK MAFKEPKPMS KEPKPDSNLL TITSGQDKKA PSKRPPISDS EELSAKKRKK
     SSSEALFKSF SSAPPLILTC SADKKQIKDK SHVKMGKVKI ESETSEKKKS TLPPFDDIVD
     PNDSDVEENI SSKSDSEQPS PASSSSSSSS SFTPSQTRQQ GPLRSIMKDL HSDDNEEESD
     EVEDNDNDSE MERPVNRGGS RSRRVSLSDG SDSESSSASS PLHHEPPPPL LKTNNNQILE
     VKSPIKQSKS DKQIKNGECD KAYLDELVEL HRRLMTLRER HILQQIVNLI EETGHFHITN
     TTFDFDLCSL DKTTVRKLQS YLETSGTS
//
ID   AF17_HUMAN              Reviewed;        1093 AA.
AC   P55198; Q59F28; Q96IU3; Q9H5F6; Q9UF49;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   28-MAR-2018, sequence version 3.
DT   22-APR-2020, entry version 162.
DE   RecName: Full=Protein AF-17;
DE   AltName: Full=ALL1-fused gene from chromosome 17 protein;
GN   Name=MLLT6; Synonyms=AF17;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CHROMOSOMAL TRANSLOCATION WITH KMT2A/MLL1.
RX   PubMed=8058765; DOI=10.1073/pnas.91.17.8107;
RA   Prasad R., Leshkowitz D., Gu Y., Alder H., Nakamura T., Saito H.,
RA   Huebner K., Berger R., Croce C.M., Canaani E.;
RT   "Leucine-zipper dimerization motif encoded by the AF17 gene fused to ALL-1
RT   (MLL) in acute leukemia.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:8107-8111(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R., Gnerre S.,
RA   Goldstein S., Grafham D.V., Grocock R., Hafez N., Hagopian D.S., Hart E.,
RA   Norman C.H., Humphray S., Jaffe D.B., Jones M., Kamal M., Khodiyar V.K.,
RA   LaButti K., Laird G., Lehoczky J., Liu X., Lokyitsang T., Loveland J.,
RA   Lui A., Macdonald P., Major J.E., Matthews L., Mauceli E., McCarroll S.A.,
RA   Mihalev A.H., Mudge J., Nguyen C., Nicol R., O'Leary S.B., Osoegawa K.,
RA   Schwartz D.C., Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in the
RT   human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 5-1093.
RC   TISSUE=Spleen;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 624-1093.
RC   TISSUE=Ileal mucosa;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 624-1093.
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 648-1093.
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-451, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-258; SER-378 AND SER-423, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [9]
RP   INTERACTION WITH HISTONE H3.
RX   PubMed=26439302; DOI=10.1016/j.molcel.2015.08.019;
RA   Chen S., Yang Z., Wilkinson A.W., Deshpande A.J., Sidoli S., Krajewski K.,
RA   Strahl B.D., Garcia B.A., Armstrong S.A., Patel D.J., Gozani O.;
RT   "The PZP Domain of AF10 Senses Unmodified H3K27 to Regulate DOT1L-Mediated
RT   Methylation of H3K79.";
RL   Mol. Cell 60:319-327(2015).
CC   -!- SUBUNIT: Interacts with histone H3; interaction is necessary for MLLT6
CC       binding to nucleosomes; interaction is inhibited by histone H3 'Lys-27'
CC       methylations (H3K27me1, H3K27me2 and H3K27me3).
CC       {ECO:0000269|PubMed:26439302}.
CC   -!- INTERACTION:
CC       P55198; Q02930-3: CREB5; NbExp=3; IntAct=EBI-740216, EBI-10192698;
CC       P55198; Q4V328: GRIPAP1; NbExp=3; IntAct=EBI-740216, EBI-717919;
CC       P55198; B7ZLY0: PHC2; NbExp=3; IntAct=EBI-740216, EBI-14568740;
CC       P55198; Q13526: PIN1; NbExp=3; IntAct=EBI-740216, EBI-714158;
CC       P55198; Q08117-2: TLE5; NbExp=3; IntAct=EBI-740216, EBI-11741437;
CC       P55198; Q9UMX0-2: UBQLN1; NbExp=3; IntAct=EBI-740216, EBI-10173939;
CC       P55198; Q9NRR5: UBQLN4; NbExp=2; IntAct=EBI-740216, EBI-711226;
CC       P55198; Q96E35: ZMYND19; NbExp=3; IntAct=EBI-740216, EBI-746595;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- DISEASE: Note=A chromosomal aberration involving MLLT6 is associated
CC       with acute leukemias. Translocation t(11;17)(q23;q21) with KMT2A/MLL1.
CC       The result is a rogue activator protein.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH07237.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAB15670.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/AF17ID7.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U07932; AAA21145.1; -; mRNA.
DR   EMBL; AC006449; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AB209633; BAD92870.1; -; mRNA.
DR   EMBL; AK027133; BAB15670.1; ALT_INIT; mRNA.
DR   EMBL; BC007237; AAH07237.1; ALT_INIT; mRNA.
DR   EMBL; AL133659; CAB63772.2; -; mRNA.
DR   CCDS; CCDS11327.1; -.
DR   PIR; I38533; I38533.
DR   RefSeq; NP_005928.2; NM_005937.3.
DR   SMR; P55198; -.
DR   BioGrid; 110448; 51.
DR   IntAct; P55198; 42.
DR   STRING; 9606.ENSP00000479910; -.
DR   iPTMnet; P55198; -.
DR   PhosphoSitePlus; P55198; -.
DR   BioMuta; MLLT6; -.
DR   DMDM; 215273929; -.
DR   EPD; P55198; -.
DR   jPOST; P55198; -.
DR   MassIVE; P55198; -.
DR   PaxDb; P55198; -.
DR   PeptideAtlas; P55198; -.
DR   PRIDE; P55198; -.
DR   ProteomicsDB; 56804; -.
DR   Antibodypedia; 73458; 108 antibodies.
DR   Ensembl; ENST00000618876; ENSP00000477969; ENSG00000275851.
DR   Ensembl; ENST00000621332; ENSP00000479910; ENSG00000275023.
DR   GeneID; 4302; -.
DR   KEGG; hsa:4302; -.
DR   CTD; 4302; -.
DR   DisGeNET; 4302; -.
DR   GeneCards; MLLT6; -.
DR   HGNC; HGNC:7138; MLLT6.
DR   MIM; 600328; gene.
DR   neXtProt; NX_P55198; -.
DR   OpenTargets; ENSG00000275023; -.
DR   PharmGKB; PA30854; -.
DR   eggNOG; KOG0956; Eukaryota.
DR   eggNOG; COG5141; LUCA.
DR   GeneTree; ENSGT00940000158572; -.
DR   InParanoid; P55198; -.
DR   KO; K23588; -.
DR   OMA; EKHPAHH; -.
DR   OrthoDB; 327785at2759; -.
DR   PhylomeDB; P55198; -.
DR   TreeFam; TF316118; -.
DR   ChiTaRS; MLLT6; human.
DR   GenomeRNAi; 4302; -.
DR   Pharos; P55198; Tdark.
DR   PRO; PR:P55198; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; P55198; protein.
DR   ExpressionAtlas; P55198; baseline and differential.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0042393; F:histone binding; IPI:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0031491; F:nucleosome binding; IDA:UniProtKB.
DR   GO; GO:2001161; P:negative regulation of histone H3-K79 methylation; IEA:Ensembl.
DR   GO; GO:0035811; P:negative regulation of urine volume; IEA:Ensembl.
DR   GO; GO:0010765; P:positive regulation of sodium ion transport; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; TAS:ProtInc.
DR   GO; GO:0036359; P:renal potassium excretion; IEA:Ensembl.
DR   GO; GO:0035812; P:renal sodium excretion; IEA:Ensembl.
DR   Gene3D; 3.30.40.10; -; 2.
DR   InterPro; IPR034732; EPHD.
DR   InterPro; IPR019786; Zinc_finger_PHD-type_CS.
DR   InterPro; IPR011011; Znf_FYVE_PHD.
DR   InterPro; IPR001965; Znf_PHD.
DR   InterPro; IPR019787; Znf_PHD-finger.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   SMART; SM00249; PHD; 2.
DR   SUPFAM; SSF57903; SSF57903; 1.
DR   PROSITE; PS51805; EPHD; 1.
DR   PROSITE; PS01359; ZF_PHD_1; 1.
DR   PROSITE; PS50016; ZF_PHD_2; 1.
PE   1: Evidence at protein level;
KW   Chromosomal rearrangement; Metal-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Proto-oncogene; Reference proteome; Repeat; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..1093
FT                   /note="Protein AF-17"
FT                   /id="PRO_0000215937"
FT   ZN_FING         5..57
FT                   /note="PHD-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00146"
FT   ZN_FING         62..95
FT                   /note="C2HC pre-PHD-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01146"
FT   ZN_FING         118..181
FT                   /note="PHD-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01146"
FT   REGION          729..764
FT                   /note="Leucine-zipper"
FT   COMPBIAS        190..211
FT                   /note="Gly/Ser-rich"
FT   COMPBIAS        275..282
FT                   /note="Poly-Ser"
FT   COMPBIAS        326..338
FT                   /note="Poly-Ser"
FT   COMPBIAS        822..829
FT                   /note="Poly-Ser"
FT   COMPBIAS        834..862
FT                   /note="Pro-rich"
FT   COMPBIAS        935..984
FT                   /note="Gln-rich"
FT   COMPBIAS        1040..1051
FT                   /note="Poly-Ala"
FT   COMPBIAS        1069..1080
FT                   /note="Gly-rich"
FT   SITE            551
FT                   /note="KMT2A/MLL1 fusion point (in acute myeloid leukemia
FT                   patient)"
FT   MOD_RES         258
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         378
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         423
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         451
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:19690332"
FT   VARIANT         33
FT                   /note="A -> V (in dbSNP:rs17855918)"
FT                   /id="VAR_080170"
FT   VARIANT         198
FT                   /note="A -> T (in dbSNP:rs2241012)"
FT                   /id="VAR_022076"
FT   CONFLICT        126
FT                   /note="Q -> T (in Ref. 1; AAA21145)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        735
FT                   /note="R -> W (in Ref. 3; BAD92870)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1065
FT                   /note="L -> P (in Ref. 4; BAB15670)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1093 AA;  112048 MW;  C55F0801D9A0A5C1 CRC64;
     MKEMVGGCCV CSDERGWAEN PLVYCDGHAC SVAVHQACYG IVQVPTGPWF CRKCESQERA
     ARVRCELCPH KDGALKRTDN GGWAHVVCAL YIPEVQFANV LTMEPIVLQY VPHDRFNKTC
     YICEEQGRES KAASGACMTC NRHGCRQAFH VTCAQMAGLL CEEEVLEVDN VKYCGYCKYH
     FSKMKTSRHS SGGGGGGAGG GGGSMGGGGS GFISGRRSRS ASPSTQQEKH PTHHERGQKK
     SRKDKERLKQ KHKKRPESPP SILTPPVVPT ADKVSSSASS SSHHEASTQE TSESSRESKG
     KKSSSHSLSH KGKKLSSGKG VSSFTSASSS SSSSSSSSGG PFQPAVSSLQ SSPDFSAFPK
     LEQPEEDKYS KPTAPAPSAP PSPSAPEPPK ADLFEQKVVF SGFGPIMRFS TTTSSSGRAR
     APSPGDYKSP HVTGSGASAG THKRMPALSA TPVPADETPE TGLKEKKHKA SKRSRHGPGR
     PKGSRNKEGT GGPAAPSLPS AQLAGFTATA ASPFSGGSLV SSGLGGLSSR TFGPSGSLPS
     LSLESPLLGA GIYTSNKDPI SHSGGMLRAV CSTPLSSSLL GPPGTSALPR LSRSPFTSTL
     PSSSASISTT QVFSLAGSTF SLPSTHIFGT PMGAVNPLLS QAESSHTEPD LEDCSFRCRG
     TSPQESLSSM SPISSLPALF DQTASAPCGG GQLDPAAPGT TNMEQLLEKQ GDGEAGVNIV
     EMLKALHALQ KENQRLQEQI LSLTAKKERL QILNVQLSVP FPALPAALPA ANGPVPGPYG
     LPPQAGSSDS LSTSKSPPGK SSLGLDNSLS TSSEDPHSGC PSRSSSSLSF HSTPPPLPLL
     QQSPATLPLA LPGAPAPLPP QPQNGLGRAP GAAGLGAMPM AEGLLGGLAG SGGLPLNGLL
     GGLNGAAAPN PASLSQAGGA PTLQLPGCLN SLTEQQRHLL QQQEQQLQQL QQLLASPQLT
     PEHQTVVYQM IQQIQQKREL QRLQMAGGSQ LPMASLLAGS STPLLSAGTP GLLPTASAPP
     LLPAGALVAP SLGNNTSLMA AAAAAAAVAA AGGPPVLTAQ TNPFLSLSGA EGSGGGPKGG
     TADKGASANQ EKG
//
ID   MOES_HUMAN              Reviewed;         577 AA.
AC   P26038;
DT   01-MAY-1992, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   22-APR-2020, entry version 225.
DE   RecName: Full=Moesin {ECO:0000303|PubMed:1924289};
DE   AltName: Full=Membrane-organizing extension spike protein;
GN   Name=MSN {ECO:0000312|HGNC:HGNC:7373};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 2-16; 54-60 AND
RP   414-435.
RC   TISSUE=Placenta;
RX   PubMed=1924289; DOI=10.1073/pnas.88.19.8297;
RA   Lankes W.T., Furthmayr H.;
RT   "Moesin: a member of the protein 4.1-talin-ezrin family of proteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:8297-8301(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L.,
RA   Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C.,
RA   Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A.,
RA   Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P.,
RA   Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D.,
RA   Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D.,
RA   Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L.,
RA   Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P.,
RA   Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G.,
RA   Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J.,
RA   Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D.,
RA   Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L.,
RA   Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z.,
RA   Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O.,
RA   Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H.,
RA   Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T.,
RA   Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L.,
RA   Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R.,
RA   Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y.,
RA   Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K.,
RA   Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J.,
RA   Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L.,
RA   Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S.,
RA   Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A.,
RA   Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L.,
RA   Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S.,
RA   Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C.,
RA   Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S.,
RA   Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V.,
RA   Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K.,
RA   Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B.,
RA   Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C.,
RA   d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q.,
RA   Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N.,
RA   Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A.,
RA   Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J.,
RA   Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A.,
RA   Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L.,
RA   Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S.,
RA   Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PROTEIN SEQUENCE OF 2-8.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A., Thomas G.R.,
RA   Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass spectrometric
RT   identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [5]
RP   INTERACTION WITH CD46, AND SUBCELLULAR LOCATION.
RX   PubMed=7884872;
RA   Schneider-Schaulies J., Dunster L.M., Schwartz-Albiez R., Krohne G.,
RA   ter Meulen V.;
RT   "Physical association of moesin and CD46 as a receptor complex for measles
RT   virus.";
RL   J. Virol. 69:2248-2256(1995).
RN   [6]
RP   INTERACTION WITH SLC9A3R1.
RX   PubMed=9314537; DOI=10.1083/jcb.139.1.169;
RA   Reczek D., Berryman M., Bretscher A.;
RT   "Identification of EBP50: a PDZ-containing phosphoprotein that associates
RT   with members of the ezrin-radixin-moesin family.";
RL   J. Cell Biol. 139:169-179(1997).
RN   [7]
RP   INTERACTION WITH HIV-1 ENVELOPE PROTEIN GP120.
RX   PubMed=9213396; DOI=10.1016/s0168-1702(97)00039-7;
RA   Hecker C., Weise C., Schneider-Schaulies J., Holmes H.C., ter Meulen V.;
RT   "Specific binding of HIV-1 envelope protein gp120 to the structural
RT   membrane proteins ezrin and moesin.";
RL   Virus Res. 49:215-223(1997).
RN   [8]
RP   FUNCTION, INTERACTION WITH ICAM3 AND CD44, AND SUBCELLULAR LOCATION.
RX   PubMed=9298994; DOI=10.1083/jcb.138.6.1409;
RA   Serrador J.M., Alonso-Lebrero J.L., del Pozo M.A., Furthmayr H.,
RA   Schwartz-Albiez R., Calvo J., Lozano F., Sanchez-Madrid F.;
RT   "Moesin interacts with the cytoplasmic region of intercellular adhesion
RT   molecule-3 and is redistributed to the uropod of T lymphocytes during cell
RT   polarization.";
RL   J. Cell Biol. 138:1409-1423(1997).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH SPN/CD43.
RX   PubMed=9616160;
RA   Serrador J.M., Nieto M., Alonso-Lebrero J.L., del Pozo M.A., Calvo J.,
RA   Furthmayr H., Schwartz-Albiez R., Lozano F., Gonzalez-Amaro R.,
RA   Sanchez-Mateos P., Sanchez-Madrid F.;
RT   "CD43 interacts with moesin and ezrin and regulates its redistribution to
RT   the uropods of T lymphocytes at the cell-cell contacts.";
RL   Blood 91:4632-4644(1998).
RN   [10]
RP   FUNCTION, MUTAGENESIS OF THR-558, AND INTERACTION WITH F-ACTIN.
RX   PubMed=10212266; DOI=10.1074/jbc.274.18.12803;
RA   Huang L., Wong T.Y., Lin R.C., Furthmayr H.;
RT   "Replacement of threonine 558, a critical site of phosphorylation of moesin
RT   in vivo, with aspartate activates F-actin binding of moesin. Regulation by
RT   conformational change.";
RL   J. Biol. Chem. 274:12803-12810(1999).
RN   [11]
RP   FUNCTION, INTERACTION WITH SPN/CD43, AND SUBCELLULAR LOCATION.
RX   PubMed=11728332; DOI=10.1016/s1074-7613(01)00231-x;
RA   Delon J., Kaibuchi K., Germain R.N.;
RT   "Exclusion of CD43 from the immunological synapse is mediated by
RT   phosphorylation-regulated relocation of the cytoskeletal adaptor moesin.";
RL   Immunity 15:691-701(2001).
RN   [12]
RP   INTERACTION WITH SELPLG AND SYK, AND FUNCTION.
RX   PubMed=12387735; DOI=10.1016/s1074-7613(02)00420-x;
RA   Urzainqui A., Serrador J.M., Viedma F., Yanez-Mo M., Rodriguez A.,
RA   Corbi A.L., Alonso-Lebrero J.L., Luque A., Deckert M., Vazquez J.,
RA   Sanchez-Madrid F.;
RT   "ITAM-based interaction of ERM proteins with Syk mediates signaling by the
RT   leukocyte adhesion receptor PSGL-1.";
RL   Immunity 17:401-412(2002).
RN   [13]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=15039356; DOI=10.1128/iai.72.4.2312-2320.2004;
RA   Iontcheva I., Amar S., Zawawi K.H., Kantarci A., Van Dyke T.E.;
RT   "Role for moesin in lipopolysaccharide-stimulated signal transduction.";
RL   Infect. Immun. 72:2312-2320(2004).
RN   [14]
RP   INTERACTION WITH PDPN.
RX   PubMed=17046996; DOI=10.1242/jcs.03218;
RA   Martin-Villar E., Megias D., Castel S., Yurrita M.M., Vilaro S.,
RA   Quintanilla M.;
RT   "Podoplanin binds ERM proteins to activate RhoA and promote epithelial-
RT   mesenchymal transition.";
RL   J. Cell Sci. 119:4541-4553(2006).
RN   [15]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH PPP1R16B.
RX   PubMed=18586956; DOI=10.1152/ajplung.00325.2007;
RA   Csortos C., Czikora I., Bogatcheva N.V., Adyshev D.M., Poirier C., Olah G.,
RA   Verin A.D.;
RT   "TIMAP is a positive regulator of pulmonary endothelial barrier function.";
RL   Am. J. Physiol. 295:L440-L450(2008).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [17]
RP   PHOSPHORYLATION AT THR-558, AND MUTAGENESIS OF TYR-556 AND THR-558.
RX   PubMed=19255442; DOI=10.1073/pnas.0805963106;
RA   Belkina N.V., Liu Y., Hao J.J., Karasuyama H., Shaw S.;
RT   "LOK is a major ERM kinase in resting lymphocytes and regulates
RT   cytoskeletal rearrangement through ERM phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:4707-4712(2009).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-116, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-79 AND LYS-139, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [21]
RP   FUNCTION, AND INTERACTION WITH PDZD8.
RX   PubMed=21549406; DOI=10.1016/j.virol.2011.04.006;
RA   Henning M.S., Stiedl P., Barry D.S., McMahon R., Morham S.G., Walsh D.,
RA   Naghavi M.H.;
RT   "PDZD8 is a novel moesin-interacting cytoskeletal regulatory protein that
RT   suppresses infection by herpes simplex virus type 1.";
RL   Virology 415:114-121(2011).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-74; SER-407 AND SER-527, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [24]
RP   S-NITROSYLATION AT CYS-117, MUTAGENESIS OF ILE-115 AND GLU-120, AND DOMAIN.
RX   PubMed=25417112; DOI=10.1016/j.cell.2014.09.032;
RA   Jia J., Arif A., Terenzi F., Willard B., Plow E.F., Hazen S.L., Fox P.L.;
RT   "Target-selective protein S-nitrosylation by sequence motif recognition.";
RL   Cell 159:623-634(2014).
RN   [25]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [26]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [27]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 4-577.
RX   PubMed=10847681; DOI=10.1016/s0092-8674(00)80836-3;
RA   Pearson M.A., Reczek D., Bretscher A., Karplus P.A.;
RT   "Structure of the ERM protein moesin reveals the FERM domain fold masked by
RT   an extended actin binding tail domain.";
RL   Cell 101:259-270(2000).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 1-346.
RX   PubMed=11401550; DOI=10.1021/bi010419h;
RA   Edwards S.D., Keep N.H.;
RT   "The 2.7 A crystal structure of the activated FERM domain of moesin: an
RT   analysis of structural changes on activation.";
RL   Biochemistry 40:7061-7068(2001).
RN   [29]
RP   X-RAY CRYSTALLOGRAPHY (3.5 ANGSTROMS) OF 1-297 IN COMPLEX WITH SLC9A3R1.
RX   PubMed=15020681; DOI=10.1242/jcs.01038;
RA   Finnerty C.M., Chambers D., Ingraffea J., Faber H.R., Karplus P.A.,
RA   Bretscher A.;
RT   "The EBP50-moesin interaction involves a binding site regulated by direct
RT   masking on the FERM domain.";
RL   J. Cell Sci. 117:1547-1552(2004).
RN   [30]
RP   VARIANT IMD50 TRP-171, CHARACTERIZATION OF VARIANT IMD50 TRP-171, AND
RP   FUNCTION.
RX   PubMed=27405666; DOI=10.1016/j.jaci.2016.04.032;
RA   Lagresle-Peyrou C., Luce S., Ouchani F., Soheili T.S., Sadek H.,
RA   Chouteau M., Durand A., Pic I., Majewski J., Brouzes C., Lambert N.,
RA   Bohineust A., Verhoeyen E., Cosset F.L., Magerus-Chatinet A.,
RA   Rieux-Laucat F., Gandemer V., Monnier D., Heijmans C., van Gijn M.,
RA   Dalm V.A., Mahlaoui N., Stephan J.L., Picard C., Durandy A., Kracker S.,
RA   Hivroz C., Jabado N., de Saint Basile G., Fischer A., Cavazzana M.,
RA   Andre-Schmutz I.;
RT   "X-linked primary immunodeficiency associated with hemizygous mutations in
RT   the moesin (MSN) gene.";
RL   J. Allergy Clin. Immunol. 138:1681-1689(2016).
CC   -!- FUNCTION: Ezrin-radixin-moesin (ERM) family protein that connects the
CC       actin cytoskeleton to the plasma membrane and thereby regulates the
CC       structure and function of specific domains of the cell cortex. Tethers
CC       actin filaments by oscillating between a resting and an activated state
CC       providing transient interactions between moesin and the actin
CC       cytoskeleton (PubMed:10212266). Once phosphorylated on its C-terminal
CC       threonine, moesin is activated leading to interaction with F-actin and
CC       cytoskeletal rearrangement (PubMed:10212266). These rearrangements
CC       regulate many cellular processes, including cell shape determination,
CC       membrane transport, and signal transduction (PubMed:12387735,
CC       PubMed:15039356). The role of moesin is particularly important in
CC       immunity acting on both T and B-cells homeostasis and self-tolerance,
CC       regulating lymphocyte egress from lymphoid organs (PubMed:9298994,
CC       PubMed:9616160). Modulates phagolysosomal biogenesis in macrophages (By
CC       similarity). Participates also in immunologic synapse formation
CC       (PubMed:27405666). {ECO:0000250|UniProtKB:P26041,
CC       ECO:0000269|PubMed:10212266, ECO:0000269|PubMed:12387735,
CC       ECO:0000269|PubMed:15039356, ECO:0000269|PubMed:27405666,
CC       ECO:0000269|PubMed:9298994, ECO:0000269|PubMed:9616160}.
CC   -!- ACTIVITY REGULATION: A head-to-tail association, of the N-terminal and
CC       C-terminal halves results in a closed conformation (inactive form)
CC       which is incapable of actin or membrane-binding.
CC       {ECO:0000269|PubMed:10212266}.
CC   -!- SUBUNIT: In resting T-cells, part of a PAG1-SLC9A3R1-MSN complex which
CC       is disrupted upon TCR activation. Interacts with SLC9A3R1
CC       (PubMed:9314537, PubMed:15020681). Interacts with PPP1R16B
CC       (PubMed:18586956). Interacts with PDZD8. Interacts with SELPLG and SYK;
CC       these interaction mediate the activation of SYK by SELPLG
CC       (PubMed:12387735). Interacts with PDPN (via cytoplasmic domain); this
CC       interaction activates RHOA and promotes epithelial-mesenchymal
CC       transition (PubMed:17046996). Interacts with SPN/CD43 (PubMed:9616160,
CC       PubMed:11728332). Interacts with CD44 (PubMed:9298994). Interacts with
CC       ICAM2 (By similarity). Interacts with ICAM3 (via C-terminus)
CC       (PubMed:9298994). Interacts with PDZD8 (PubMed:21549406). Interacts
CC       with F-actin (PubMed:10212266). Interacts with CD46 (PubMed:7884872).
CC       Interacts with PTPN6 (By similarity). {ECO:0000250|UniProtKB:P26041,
CC       ECO:0000269|PubMed:10212266, ECO:0000269|PubMed:11728332,
CC       ECO:0000269|PubMed:12387735, ECO:0000269|PubMed:15020681,
CC       ECO:0000269|PubMed:17046996, ECO:0000269|PubMed:18586956,
CC       ECO:0000269|PubMed:21549406, ECO:0000269|PubMed:7884872,
CC       ECO:0000269|PubMed:9298994, ECO:0000269|PubMed:9314537,
CC       ECO:0000269|PubMed:9616160}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with HIV-1 envelope protein
CC       gp120. {ECO:0000269|PubMed:9213396}.
CC   -!- INTERACTION:
CC       P26038; P16070: CD44; NbExp=6; IntAct=EBI-528768, EBI-490245;
CC       P26038; P25791-3: LMO2; NbExp=3; IntAct=EBI-528768, EBI-11959475;
CC       P26038; Q5S007: LRRK2; NbExp=19; IntAct=EBI-528768, EBI-5323863;
CC       P26038; Q5S006: Lrrk2; Xeno; NbExp=2; IntAct=EBI-528768, EBI-2693710;
CC       P26038; P97820: Map4k4; Xeno; NbExp=2; IntAct=EBI-528768, EBI-644181;
CC       P26038; O14745: SLC9A3R1; NbExp=4; IntAct=EBI-528768, EBI-349787;
CC       P26038; P54274: TERF1; NbExp=2; IntAct=EBI-528768, EBI-710997;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:11728332,
CC       ECO:0000269|PubMed:15039356, ECO:0000269|PubMed:18586956,
CC       ECO:0000269|PubMed:7884872, ECO:0000269|PubMed:9298994}; Peripheral
CC       membrane protein {ECO:0000250|UniProtKB:P26041}; Cytoplasmic side
CC       {ECO:0000250|UniProtKB:P26041}. Cytoplasm, cytoskeleton
CC       {ECO:0000250|UniProtKB:P26041}. Apical cell membrane
CC       {ECO:0000250|UniProtKB:P26041}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:P26041}; Cytoplasmic side
CC       {ECO:0000250|UniProtKB:P26041}. Cell projection, microvillus membrane
CC       {ECO:0000250|UniProtKB:P26041}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:P26041}; Cytoplasmic side
CC       {ECO:0000250|UniProtKB:P26041}. Cell projection, microvillus
CC       {ECO:0000250|UniProtKB:P26041}. Note=Phosphorylated form is enriched in
CC       microvilli-like structures at apical membrane. Increased cell membrane
CC       localization of both phosphorylated and non-phosphorylated forms seen
CC       after thrombin treatment (By similarity). Localizes at the uropods of T
CC       lymphoblasts. {ECO:0000250|UniProtKB:P26041,
CC       ECO:0000269|PubMed:18586956, ECO:0000269|PubMed:9298994}.
CC   -!- TISSUE SPECIFICITY: In all tissues and cultured cells studied.
CC   -!- DOMAIN: The [IL]-x-C-x-x-[DE] motif is a proposed target motif for
CC       cysteine S-nitrosylation mediated by the iNOS-S100A8/A9
CC       transnitrosylase complex. {ECO:0000305|PubMed:25417112}.
CC   -!- PTM: Phosphorylation on Thr-558 is crucial for the formation of
CC       microvilli-like structures. Phosphorylation by ROCK2 suppresses the
CC       head-to-tail association of the N-terminal and C-terminal halves
CC       resulting in an opened conformation which is capable of actin and
CC       membrane-binding (By similarity). Phosphorylation on Thr-558 by STK10
CC       negatively regulates lymphocyte migration and polarization.
CC       {ECO:0000250, ECO:0000269|PubMed:19255442}.
CC   -!- PTM: S-nitrosylation of Cys-117 is induced by interferon-gamma and
CC       oxidatively-modified low-densitity lipoprotein (LDL(ox)) implicating
CC       the iNOS-S100A8/9 transnitrosylase complex.
CC       {ECO:0000269|PubMed:25417112}.
CC   -!- DISEASE: Immunodeficiency 50 (IMD50) [MIM:300988]: A primary
CC       immunodeficiency disorder characterized by onset of recurrent bacterial
CC       or varicella zoster virus infections in early childhood, profound
CC       lymphopenia, hypogammaglobulinemia, fluctuating monocytopenia and
CC       neutropenia, and a poor immune response to vaccine antigens.
CC       {ECO:0000269|PubMed:27405666}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/MSNID363.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M69066; AAA36322.1; -; mRNA.
DR   EMBL; Z98946; CAB46379.1; -; Genomic_DNA.
DR   EMBL; BC017293; AAH17293.1; -; mRNA.
DR   CCDS; CCDS14382.1; -.
DR   PIR; A41289; A41289.
DR   RefSeq; NP_002435.1; NM_002444.2.
DR   PDB; 1E5W; X-ray; 2.70 A; A=2-346.
DR   PDB; 1EF1; X-ray; 1.90 A; A/B=4-297, C/D=488-577.
DR   PDB; 1SGH; X-ray; 3.50 A; A=1-297.
DR   PDBsum; 1E5W; -.
DR   PDBsum; 1EF1; -.
DR   PDBsum; 1SGH; -.
DR   SMR; P26038; -.
DR   BioGrid; 110584; 147.
DR   DIP; DIP-33841N; -.
DR   IntAct; P26038; 40.
DR   MINT; P26038; -.
DR   STRING; 9606.ENSP00000353408; -.
DR   iPTMnet; P26038; -.
DR   MetOSite; P26038; -.
DR   PhosphoSitePlus; P26038; -.
DR   SwissPalm; P26038; -.
DR   BioMuta; MSN; -.
DR   DMDM; 127234; -.
DR   OGP; P26038; -.
DR   CPTAC; CPTAC-94; -.
DR   EPD; P26038; -.
DR   jPOST; P26038; -.
DR   MassIVE; P26038; -.
DR   PaxDb; P26038; -.
DR   PeptideAtlas; P26038; -.
DR   PRIDE; P26038; -.
DR   ProteomicsDB; 54311; -.
DR   TopDownProteomics; P26038; -.
DR   Antibodypedia; 2774; 951 antibodies.
DR   DNASU; 4478; -.
DR   Ensembl; ENST00000360270; ENSP00000353408; ENSG00000147065.
DR   GeneID; 4478; -.
DR   KEGG; hsa:4478; -.
DR   CTD; 4478; -.
DR   DisGeNET; 4478; -.
DR   GeneCards; MSN; -.
DR   HGNC; HGNC:7373; MSN.
DR   HPA; ENSG00000147065; Low tissue specificity.
DR   MalaCards; MSN; -.
DR   MIM; 300988; phenotype.
DR   MIM; 309845; gene.
DR   neXtProt; NX_P26038; -.
DR   OpenTargets; ENSG00000147065; -.
DR   Orphanet; 504530; Combined immunodeficiency due to Moesin deficiency.
DR   PharmGKB; PA31178; -.
DR   eggNOG; KOG3529; Eukaryota.
DR   eggNOG; ENOG410XQFP; LUCA.
DR   GeneTree; ENSGT00960000186596; -.
DR   HOGENOM; CLU_003623_6_2_1; -.
DR   InParanoid; P26038; -.
DR   KO; K05763; -.
DR   OMA; HRGMIRE; -.
DR   OrthoDB; 627741at2759; -.
DR   PhylomeDB; P26038; -.
DR   TreeFam; TF313935; -.
DR   Reactome; R-HSA-437239; Recycling pathway of L1.
DR   Reactome; R-HSA-8950505; Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation.
DR   SIGNOR; P26038; -.
DR   ChiTaRS; MSN; human.
DR   EvolutionaryTrace; P26038; -.
DR   GeneWiki; Moesin; -.
DR   GenomeRNAi; 4478; -.
DR   Pharos; P26038; Tbio.
DR   PRO; PR:P26038; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   RNAct; P26038; protein.
DR   Bgee; ENSG00000147065; Expressed in lung and 240 other tissues.
DR   ExpressionAtlas; P26038; baseline and differential.
DR   Genevisible; P26038; HS.
DR   GO; GO:0045177; C:apical part of cell; IDA:BHF-UCL.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0016323; C:basolateral plasma membrane; IEA:Ensembl.
DR   GO; GO:0072562; C:blood microparticle; HDA:UniProtKB.
DR   GO; GO:0071944; C:cell periphery; IDA:UniProtKB.
DR   GO; GO:0009986; C:cell surface; IDA:CAFA.
DR   GO; GO:0005737; C:cytoplasm; HDA:UniProtKB.
DR   GO; GO:0005856; C:cytoskeleton; TAS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; HDA:UniProtKB.
DR   GO; GO:0030175; C:filopodium; IDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0071437; C:invadopodium; IDA:UniProtKB.
DR   GO; GO:0005902; C:microvillus; IDA:BHF-UCL.
DR   GO; GO:0031528; C:microvillus membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0031143; C:pseudopodium; IDA:UniProtKB.
DR   GO; GO:0001931; C:uropod; IEA:Ensembl.
DR   GO; GO:0031982; C:vesicle; HDA:UniProtKB.
DR   GO; GO:0003779; F:actin binding; IEA:InterPro.
DR   GO; GO:0050839; F:cell adhesion molecule binding; IPI:BHF-UCL.
DR   GO; GO:0003725; F:double-stranded RNA binding; IDA:MGI.
DR   GO; GO:0019899; F:enzyme binding; IPI:CAFA.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0005102; F:signaling receptor binding; IPI:UniProtKB.
DR   GO; GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc.
DR   GO; GO:0071394; P:cellular response to testosterone stimulus; IDA:UniProtKB.
DR   GO; GO:0061028; P:establishment of endothelial barrier; IGI:UniProtKB.
DR   GO; GO:0045198; P:establishment of epithelial cell apical/basal polarity; IMP:UniProtKB.
DR   GO; GO:0022612; P:gland morphogenesis; IMP:UniProtKB.
DR   GO; GO:0001771; P:immunological synapse formation; IDA:UniProtKB.
DR   GO; GO:0035722; P:interleukin-12-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0007159; P:leukocyte cell-cell adhesion; IEP:BHF-UCL.
DR   GO; GO:0050900; P:leukocyte migration; IEP:BHF-UCL.
DR   GO; GO:0022614; P:membrane to membrane docking; IEP:BHF-UCL.
DR   GO; GO:1903364; P:positive regulation of cellular protein catabolic process; IGI:UniProtKB.
DR   GO; GO:2000643; P:positive regulation of early endosome to late endosome transport; IGI:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; IGI:UniProtKB.
DR   GO; GO:0071803; P:positive regulation of podosome assembly; IEA:Ensembl.
DR   GO; GO:1902966; P:positive regulation of protein localization to early endosome; IGI:UniProtKB.
DR   GO; GO:0008360; P:regulation of cell shape; IMP:UniProtKB.
DR   GO; GO:0008361; P:regulation of cell size; IMP:UniProtKB.
DR   GO; GO:2000401; P:regulation of lymphocyte migration; IMP:UniProtKB.
DR   GO; GO:1902115; P:regulation of organelle assembly; IGI:UniProtKB.
DR   GO; GO:0070489; P:T cell aggregation; IDA:UniProtKB.
DR   GO; GO:0072678; P:T cell migration; IDA:UniProtKB.
DR   GO; GO:0042098; P:T cell proliferation; IDA:UniProtKB.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   CDD; cd14473; FERM_B-lobe; 1.
DR   CDD; cd13194; FERM_C_ERM; 1.
DR   Gene3D; 1.20.80.10; -; 1.
DR   Gene3D; 1.25.40.1020; -; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   InterPro; IPR019749; Band_41_domain.
DR   InterPro; IPR011174; ERM.
DR   InterPro; IPR011259; ERM_C_dom.
DR   InterPro; IPR041789; ERM_FERM_C.
DR   InterPro; IPR000798; Ez/rad/moesin-like.
DR   InterPro; IPR014352; FERM/acyl-CoA-bd_prot_sf.
DR   InterPro; IPR035963; FERM_2.
DR   InterPro; IPR019748; FERM_central.
DR   InterPro; IPR019747; FERM_CS.
DR   InterPro; IPR000299; FERM_domain.
DR   InterPro; IPR018979; FERM_N.
DR   InterPro; IPR018980; FERM_PH-like_C.
DR   InterPro; IPR008954; Moesin_tail_sf.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   Pfam; PF00769; ERM; 1.
DR   Pfam; PF09380; FERM_C; 1.
DR   Pfam; PF00373; FERM_M; 1.
DR   Pfam; PF09379; FERM_N; 1.
DR   PIRSF; PIRSF002305; ERM; 1.
DR   PRINTS; PR00935; BAND41.
DR   PRINTS; PR00661; ERMFAMILY.
DR   SMART; SM00295; B41; 1.
DR   SMART; SM01196; FERM_C; 1.
DR   SUPFAM; SSF47031; SSF47031; 1.
DR   SUPFAM; SSF48678; SSF48678; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   PROSITE; PS00660; FERM_1; 1.
DR   PROSITE; PS00661; FERM_2; 1.
DR   PROSITE; PS50057; FERM_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cell membrane; Cell projection; Cytoplasm;
KW   Cytoskeleton; Direct protein sequencing; Disease mutation;
KW   Host-virus interaction; Membrane; Phosphoprotein; Reference proteome;
KW   S-nitrosylation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:12665801,
FT                   ECO:0000269|PubMed:1924289"
FT   CHAIN           2..577
FT                   /note="Moesin"
FT                   /id="PRO_0000219416"
FT   DOMAIN          2..295
FT                   /note="FERM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00084"
FT   MOTIF           115..120
FT                   /note="[IL]-x-C-x-x-[DE] motif"
FT                   /evidence="ECO:0000305|PubMed:25417112"
FT   MOD_RES         74
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         79
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         83
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P26043"
FT   MOD_RES         116
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000244|PubMed:19690332"
FT   MOD_RES         117
FT                   /note="S-nitrosocysteine"
FT                   /evidence="ECO:0000269|PubMed:25417112"
FT   MOD_RES         139
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         165
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P26041"
FT   MOD_RES         407
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         527
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         558
FT                   /note="Phosphothreonine; by ROCK2 and STK10"
FT                   /evidence="ECO:0000269|PubMed:19255442"
FT   VARIANT         171
FT                   /note="R -> W (in IMD50; decreased protein abundance in T
FT                   cell; loss of T cell proliferation after T cell activation;
FT                   does not affect immunologic synapses formation; decreased T
FT                   cell migration in response to activation by chemokines;
FT                   increased T cell adhesion in response to activation by
FT                   integrins; dbSNP:rs1057519074)"
FT                   /evidence="ECO:0000269|PubMed:27405666"
FT                   /id="VAR_078026"
FT   MUTAGEN         115
FT                   /note="I->M: Inhibits S-nitrosylation of Cys-117; when
FT                   associated with M-120."
FT                   /evidence="ECO:0000269|PubMed:25417112"
FT   MUTAGEN         120
FT                   /note="E->M: Inhibits S-nitrosylation of Cys-117; when
FT                   associated with M-115."
FT                   /evidence="ECO:0000269|PubMed:25417112"
FT   MUTAGEN         556
FT                   /note="Y->R: Impairs phosphorylation by STK10."
FT                   /evidence="ECO:0000269|PubMed:19255442"
FT   MUTAGEN         558
FT                   /note="T->A: Abolishes phosphorylation by STK10."
FT                   /evidence="ECO:0000269|PubMed:19255442"
FT   MUTAGEN         558
FT                   /note="T->D: Completely abolishes the interaction between
FT                   N- and C-terminal domains."
FT                   /evidence="ECO:0000269|PubMed:10212266"
FT   MUTAGEN         558
FT                   /note="T->D: Phosphomimetic mutant."
FT                   /evidence="ECO:0000269|PubMed:19255442"
FT   STRAND          5..11
FT                   /evidence="ECO:0000244|PDB:1EF1"
FT   STRAND          14..20
FT                   /evidence="ECO:0000244|PDB:1EF1"
FT   HELIX           26..37
FT                   /evidence="ECO:0000244|PDB:1EF1"
FT   HELIX           42..44
FT                   /evidence="ECO:0000244|PDB:1EF1"
FT   STRAND          45..51
FT                   /evidence="ECO:0000244|PDB:1EF1"
FT   STRAND          56..58
FT                   /evidence="ECO:0000244|PDB:1EF1"
FT   STRAND          61..64
FT                   /evidence="ECO:0000244|PDB:1EF1"
FT   HELIX           65..67
FT                   /evidence="ECO:0000244|PDB:1EF1"
FT   STRAND          74..84
FT                   /evidence="ECO:0000244|PDB:1EF1"
FT   HELIX           89..92
FT                   /evidence="ECO:0000244|PDB:1EF1"
FT   HELIX           96..111
FT                   /evidence="ECO:0000244|PDB:1EF1"
FT   HELIX           119..134
FT                   /evidence="ECO:0000244|PDB:1EF1"
FT   TURN            139..141
FT                   /evidence="ECO:0000244|PDB:1EF1"
FT   TURN            144..149
FT                   /evidence="ECO:0000244|PDB:1EF1"
FT   HELIX           155..160
FT                   /evidence="ECO:0000244|PDB:1EF1"
FT   HELIX           165..178
FT                   /evidence="ECO:0000244|PDB:1EF1"
FT   TURN            179..181
FT                   /evidence="ECO:0000244|PDB:1EF1"
FT   HELIX           184..195
FT                   /evidence="ECO:0000244|PDB:1EF1"
FT   TURN            199..202
FT                   /evidence="ECO:0000244|PDB:1EF1"
FT   STRAND          204..209
FT                   /evidence="ECO:0000244|PDB:1EF1"
FT   STRAND          215..221
FT                   /evidence="ECO:0000244|PDB:1EF1"
FT   STRAND          224..229
FT                   /evidence="ECO:0000244|PDB:1EF1"
FT   STRAND          233..235
FT                   /evidence="ECO:0000244|PDB:1EF1"
FT   STRAND          237..241
FT                   /evidence="ECO:0000244|PDB:1EF1"
FT   HELIX           242..244
FT                   /evidence="ECO:0000244|PDB:1EF1"
FT   STRAND          245..251
FT                   /evidence="ECO:0000244|PDB:1EF1"
FT   STRAND          254..264
FT                   /evidence="ECO:0000244|PDB:1EF1"
FT   STRAND          267..270
FT                   /evidence="ECO:0000244|PDB:1EF1"
FT   HELIX           274..295
FT                   /evidence="ECO:0000244|PDB:1EF1"
FT   HELIX           301..343
FT                   /evidence="ECO:0000244|PDB:1E5W"
FT   HELIX           504..507
FT                   /evidence="ECO:0000244|PDB:1EF1"
FT   HELIX           511..514
FT                   /evidence="ECO:0000244|PDB:1EF1"
FT   HELIX           516..530
FT                   /evidence="ECO:0000244|PDB:1EF1"
FT   HELIX           540..550
FT                   /evidence="ECO:0000244|PDB:1EF1"
FT   HELIX           555..562
FT                   /evidence="ECO:0000244|PDB:1EF1"
FT   HELIX           567..575
FT                   /evidence="ECO:0000244|PDB:1EF1"
SQ   SEQUENCE   577 AA;  67820 MW;  865A6C5CB14AE586 CRC64;
     MPKTISVRVT TMDAELEFAI QPNTTGKQLF DQVVKTIGLR EVWFFGLQYQ DTKGFSTWLK
     LNKKVTAQDV RKESPLLFKF RAKFYPEDVS EELIQDITQR LFFLQVKEGI LNDDIYCPPE
     TAVLLASYAV QSKYGDFNKE VHKSGYLAGD KLLPQRVLEQ HKLNKDQWEE RIQVWHEEHR
     GMLREDAVLE YLKIAQDLEM YGVNYFSIKN KKGSELWLGV DALGLNIYEQ NDRLTPKIGF
     PWSEIRNISF NDKKFVIKPI DKKAPDFVFY APRLRINKRI LALCMGNHEL YMRRRKPDTI
     EVQQMKAQAR EEKHQKQMER AMLENEKKKR EMAEKEKEKI EREKEELMER LKQIEEQTKK
     AQQELEEQTR RALELEQERK RAQSEAEKLA KERQEAEEAK EALLQASRDQ KKTQEQLALE
     MAELTARISQ LEMARQKKES EAVEWQQKAQ MVQEDLEKTR AELKTAMSTP HVAEPAENEQ
     DEQDENGAEA SADLRADAMA KDRSEEERTT EAEKNERVQK HLKALTSELA NARDESKKTA
     NDMIHAENMR LGRDKYKTLR QIRQGNTKQR IDEFESM
//
ID   V9HWC0_HUMAN            Unreviewed;       577 AA.
AC   V9HWC0;
DT   19-MAR-2014, integrated into UniProtKB/TrEMBL.
DT   19-MAR-2014, sequence version 1.
DT   22-APR-2020, entry version 57.
DE   SubName: Full=Epididymis luminal protein 70 {ECO:0000313|EMBL:ACJ13690.1};
DE   SubName: Full=Moesin, isoform CRA_a {ECO:0000313|EMBL:EAX05398.1};
GN   Name=HEL70 {ECO:0000313|EMBL:ACJ13690.1};
GN   Synonyms=MSN {ECO:0000313|EMBL:EAX05398.1};
GN   ORFNames=hCG_18939 {ECO:0000313|EMBL:EAX05398.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACJ13690.1};
RN   [1] {ECO:0000313|EMBL:EAX05398.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAX05398.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ACJ13690.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J.Y., Wang H.Y., Liu F.J., Liu J.;
RL   Submitted (JUN-2008) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EU794636; ACJ13690.1; -; mRNA.
DR   EMBL; CH471132; EAX05398.1; -; Genomic_DNA.
DR   RefSeq; NP_002435.1; NM_002444.2.
DR   Antibodypedia; 2774; 951 antibodies.
DR   GeneID; 4478; -.
DR   KEGG; hsa:4478; -.
DR   UCSC; uc004dwf.4; human.
DR   CTD; 4478; -.
DR   EuPathDB; HostDB:ENSG00000147065.16; -.
DR   eggNOG; KOG3529; Eukaryota.
DR   eggNOG; ENOG410XQFP; LUCA.
DR   HOGENOM; CLU_003623_6_2_1; -.
DR   KO; K05763; -.
DR   OMA; HRGMIRE; -.
DR   OrthoDB; 627741at2759; -.
DR   ChiTaRS; MSN; human.
DR   GenomeRNAi; 4478; -.
DR   Bgee; ENSG00000147065; Expressed in lung and 240 other tissues.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:Ensembl.
DR   GO; GO:0016323; C:basolateral plasma membrane; IEA:Ensembl.
DR   GO; GO:0005856; C:cytoskeleton; IEA:InterPro.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005902; C:microvillus; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0001931; C:uropod; IEA:Ensembl.
DR   GO; GO:0003779; F:actin binding; IEA:InterPro.
DR   GO; GO:0071803; P:positive regulation of podosome assembly; IEA:Ensembl.
DR   CDD; cd14473; FERM_B-lobe; 1.
DR   CDD; cd13194; FERM_C_ERM; 1.
DR   Gene3D; 1.20.80.10; -; 1.
DR   Gene3D; 1.25.40.1020; -; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   InterPro; IPR019749; Band_41_domain.
DR   InterPro; IPR011174; ERM.
DR   InterPro; IPR011259; ERM_C_dom.
DR   InterPro; IPR041789; ERM_FERM_C.
DR   InterPro; IPR000798; Ez/rad/moesin-like.
DR   InterPro; IPR014352; FERM/acyl-CoA-bd_prot_sf.
DR   InterPro; IPR035963; FERM_2.
DR   InterPro; IPR019748; FERM_central.
DR   InterPro; IPR019747; FERM_CS.
DR   InterPro; IPR000299; FERM_domain.
DR   InterPro; IPR018979; FERM_N.
DR   InterPro; IPR018980; FERM_PH-like_C.
DR   InterPro; IPR008954; Moesin_tail_sf.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   Pfam; PF00769; ERM; 1.
DR   Pfam; PF09380; FERM_C; 1.
DR   Pfam; PF00373; FERM_M; 1.
DR   Pfam; PF09379; FERM_N; 1.
DR   PIRSF; PIRSF002305; ERM; 1.
DR   PRINTS; PR00935; BAND41.
DR   PRINTS; PR00661; ERMFAMILY.
DR   SMART; SM00295; B41; 1.
DR   SMART; SM01196; FERM_C; 1.
DR   SUPFAM; SSF47031; SSF47031; 1.
DR   SUPFAM; SSF48678; SSF48678; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   PROSITE; PS00660; FERM_1; 1.
DR   PROSITE; PS00661; FERM_2; 1.
DR   PROSITE; PS50057; FERM_3; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN          5..295
FT                   /note="FERM"
FT                   /evidence="ECO:0000259|PROSITE:PS50057"
FT   REGION          60..63
FT                   /note="Phosphatidylinositol binding"
FT                   /evidence="ECO:0000256|PIRSR:PIRSR002305-1"
FT   REGION          323..342
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          375..409
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          466..518
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          158..178
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        488..518
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         278
FT                   /note="Phosphatidylinositol"
FT                   /evidence="ECO:0000256|PIRSR:PIRSR002305-1"
SQ   SEQUENCE   577 AA;  67820 MW;  865A6C5CB14AE586 CRC64;
     MPKTISVRVT TMDAELEFAI QPNTTGKQLF DQVVKTIGLR EVWFFGLQYQ DTKGFSTWLK
     LNKKVTAQDV RKESPLLFKF RAKFYPEDVS EELIQDITQR LFFLQVKEGI LNDDIYCPPE
     TAVLLASYAV QSKYGDFNKE VHKSGYLAGD KLLPQRVLEQ HKLNKDQWEE RIQVWHEEHR
     GMLREDAVLE YLKIAQDLEM YGVNYFSIKN KKGSELWLGV DALGLNIYEQ NDRLTPKIGF
     PWSEIRNISF NDKKFVIKPI DKKAPDFVFY APRLRINKRI LALCMGNHEL YMRRRKPDTI
     EVQQMKAQAR EEKHQKQMER AMLENEKKKR EMAEKEKEKI EREKEELMER LKQIEEQTKK
     AQQELEEQTR RALELEQERK RAQSEAEKLA KERQEAEEAK EALLQASRDQ KKTQEQLALE
     MAELTARISQ LEMARQKKES EAVEWQQKAQ MVQEDLEKTR AELKTAMSTP HVAEPAENEQ
     DEQDENGAEA SADLRADAMA KDRSEEERTT EAEKNERVQK HLKALTSELA NARDESKKTA
     NDMIHAENMR LGRDKYKTLR QIRQGNTKQR IDEFESM
//
ID   A0A087X0L2_HUMAN        Unreviewed;       239 AA.
AC   A0A087X0L2;
DT   29-OCT-2014, integrated into UniProtKB/TrEMBL.
DT   29-OCT-2014, sequence version 1.
DT   22-APR-2020, entry version 39.
DE   SubName: Full=Mucin-1 {ECO:0000313|Ensembl:ENSP00000483482};
GN   Name=MUC1 {ECO:0000313|Ensembl:ENSP00000483482};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000483482, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000483482, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I., Aubin K., Babbage A.K., Bagguley C.L., Bailey J., Beasley H.,
RA   Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G., Clee C.,
RA   Cobley V., Collier R.E., Corby N., Coville G.J., Davies J., Deadman R.,
RA   Dunn M., Earthrowl M., Ellington A.G., Errington H., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Gay L., Ghori M.R.,
RA   Gibson R., Gilby L.M., Gillett W., Glithero R.J., Grafham D.V.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Hammond S., Harrison E.S.,
RA   Hart E., Haugen E., Heath P.D., Holmes S., Holt K., Howden P.J., Hunt A.R.,
RA   Hunt S.E., Hunter G., Isherwood J., James R., Johnson C., Johnson D.,
RA   Joy A., Kay M., Kershaw J.K., Kibukawa M., Kimberley A.M., King A.,
RA   Knights A.J., Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S., McLaren S., Milne S.,
RA   Mistry S., Moore M.J., Nickerson T., O'Dell C.N., Oliver K., Palmeiri A.,
RA   Palmer S.A., Parker A., Patel D., Pearce A.V., Peck A.I., Pelan S.,
RA   Phelps K., Phillimore B.J., Plumb R., Rajan J., Raymond C., Rouse G.,
RA   Saenphimmachak C., Sehra H.K., Sheridan E., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M., Steward C., Subramanian S., Sycamore N., Tracey A.,
RA   Tromans A., Van Helmond Z., Wall M., Wallis J.M., White S., Whitehead S.L.,
RA   Wilkinson J.E., Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z.,
RA   Coulson A., Vaudin M., Sulston J.E., Durbin R., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R., Banerjee R., Bryant S.P., Burford D.C.,
RA   Burrill W.D., Clegg S.M., Dhami P., Dovey O., Faulkner L.M., Gribble S.M.,
RA   Langford C.F., Pandian R.D., Porter K.M., Prigmore E.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [2] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [3] {ECO:0000313|Ensembl:ENSP00000483482}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2014) to UniProtKB.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC234582; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001191221.1; NM_001204292.1.
DR   SMR; A0A087X0L2; -.
DR   jPOST; A0A087X0L2; -.
DR   PeptideAtlas; A0A087X0L2; -.
DR   PRIDE; A0A087X0L2; -.
DR   Antibodypedia; 1298; 4363 antibodies.
DR   Ensembl; ENST00000610359; ENSP00000483482; ENSG00000185499.
DR   GeneID; 4582; -.
DR   UCSC; uc009wpx.4; human.
DR   CTD; 4582; -.
DR   EuPathDB; HostDB:ENSG00000185499.16; -.
DR   HGNC; HGNC:7508; MUC1.
DR   OpenTargets; ENSG00000185499; -.
DR   eggNOG; ENOG410IX6R; Eukaryota.
DR   eggNOG; ENOG410ZQ7Z; LUCA.
DR   GeneTree; ENSGT00710000106874; -.
DR   ChiTaRS; MUC1; human.
DR   GenomeRNAi; 4582; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000185499; Expressed in body of stomach and 198 other tissues.
DR   ExpressionAtlas; A0A087X0L2; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
PE   1: Evidence at protein level;
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|EPD:A0A087X0L2,
KW   ECO:0000213|MaxQB:A0A087X0L2, ECO:0000213|PeptideAtlas:A0A087X0L2,
KW   ECO:0000213|ProteomicsDB:A0A087X0L2};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP}; Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           24..239
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5001832146"
FT   TRANSMEM        143..168
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   REGION          26..67
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          198..221
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        201..221
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   239 AA;  25405 MW;  2D7880F01A8FD2BD CRC64;
     MTPGTQSPFF LLLLLTVLTA TTAPKPATVV TGSGHASSTP GGEKETSATQ RSSVPSSTEK
     NAIPAPTTTK SCRETFLKWP GSVVVQLTLA FREGTINVHD VETQFNQYKT EAASRYNLTI
     SDVSVSDVPF PFSAQSGAGV PGWGIALLVL VCVLVALAIV YLIALAVCQC RRKNYGQLDI
     FPARDTYHPM SEYPTYHTHG RYVPPSSTDR SPYEKVSAGN GGSSLSYTNP AVAATSANL
//
ID   A0A087X2A4_HUMAN        Unreviewed;       484 AA.
AC   A0A087X2A4;
DT   29-OCT-2014, integrated into UniProtKB/TrEMBL.
DT   29-OCT-2014, sequence version 1.
DT   22-APR-2020, entry version 37.
DE   SubName: Full=Mucin-1 {ECO:0000313|Ensembl:ENSP00000484824};
GN   Name=MUC1 {ECO:0000313|Ensembl:ENSP00000484824};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000484824, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000484824, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I., Aubin K., Babbage A.K., Bagguley C.L., Bailey J., Beasley H.,
RA   Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G., Clee C.,
RA   Cobley V., Collier R.E., Corby N., Coville G.J., Davies J., Deadman R.,
RA   Dunn M., Earthrowl M., Ellington A.G., Errington H., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Gay L., Ghori M.R.,
RA   Gibson R., Gilby L.M., Gillett W., Glithero R.J., Grafham D.V.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Hammond S., Harrison E.S.,
RA   Hart E., Haugen E., Heath P.D., Holmes S., Holt K., Howden P.J., Hunt A.R.,
RA   Hunt S.E., Hunter G., Isherwood J., James R., Johnson C., Johnson D.,
RA   Joy A., Kay M., Kershaw J.K., Kibukawa M., Kimberley A.M., King A.,
RA   Knights A.J., Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S., McLaren S., Milne S.,
RA   Mistry S., Moore M.J., Nickerson T., O'Dell C.N., Oliver K., Palmeiri A.,
RA   Palmer S.A., Parker A., Patel D., Pearce A.V., Peck A.I., Pelan S.,
RA   Phelps K., Phillimore B.J., Plumb R., Rajan J., Raymond C., Rouse G.,
RA   Saenphimmachak C., Sehra H.K., Sheridan E., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M., Steward C., Subramanian S., Sycamore N., Tracey A.,
RA   Tromans A., Van Helmond Z., Wall M., Wallis J.M., White S., Whitehead S.L.,
RA   Wilkinson J.E., Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z.,
RA   Coulson A., Vaudin M., Sulston J.E., Durbin R., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R., Banerjee R., Bryant S.P., Burford D.C.,
RA   Burrill W.D., Clegg S.M., Dhami P., Dovey O., Faulkner L.M., Gribble S.M.,
RA   Langford C.F., Pandian R.D., Porter K.M., Prigmore E.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [2] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [3] {ECO:0000313|Ensembl:ENSP00000484824}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2014) to UniProtKB.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC234582; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001191215.1; NM_001204286.1.
DR   SMR; A0A087X2A4; -.
DR   jPOST; A0A087X2A4; -.
DR   PeptideAtlas; A0A087X2A4; -.
DR   PRIDE; A0A087X2A4; -.
DR   Antibodypedia; 1298; 4363 antibodies.
DR   Ensembl; ENST00000612778; ENSP00000484824; ENSG00000185499.
DR   GeneID; 4582; -.
DR   KEGG; hsa:4582; -.
DR   UCSC; uc057lmt.1; human.
DR   CTD; 4582; -.
DR   EuPathDB; HostDB:ENSG00000185499.16; -.
DR   HGNC; HGNC:7508; MUC1.
DR   OpenTargets; ENSG00000185499; -.
DR   eggNOG; ENOG410IX6R; Eukaryota.
DR   eggNOG; ENOG410ZQ7Z; LUCA.
DR   GeneTree; ENSGT00710000106874; -.
DR   KO; K06568; -.
DR   OrthoDB; 945460at2759; -.
DR   ChiTaRS; MUC1; human.
DR   GenomeRNAi; 4582; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000185499; Expressed in body of stomach and 198 other tissues.
DR   ExpressionAtlas; A0A087X2A4; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   Gene3D; 3.30.70.960; -; 1.
DR   InterPro; IPR000082; SEA_dom.
DR   InterPro; IPR036364; SEA_dom_sf.
DR   Pfam; PF01390; SEA; 1.
DR   SMART; SM00200; SEA; 1.
DR   SUPFAM; SSF82671; SSF82671; 1.
DR   PROSITE; PS50024; SEA; 1.
PE   1: Evidence at protein level;
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|EPD:A0A087X2A4,
KW   ECO:0000213|MaxQB:A0A087X2A4, ECO:0000213|PeptideAtlas:A0A087X2A4,
KW   ECO:0000213|ProteomicsDB:A0A087X2A4};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP}; Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           24..484
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5001832227"
FT   TRANSMEM        388..413
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          268..377
FT                   /note="SEA"
FT                   /evidence="ECO:0000259|PROSITE:PS50024"
FT   REGION          26..262
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          443..466
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        26..92
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        98..127
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        182..262
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        446..466
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   484 AA;  50063 MW;  FE0B2FC6FB205D29 CRC64;
     MTPGTQSPFF LLLLLTVLTA TTAPKPATVV TGSGHASSTP GGEKETSATQ RSSVPSSTEK
     NAVSMTSSVL SSHSPGSGSS TTQGQDVTLA PATEPASGSA ATWGQDVTSV PVTRPALGST
     TPPAHDVTSA PDNKPAPGST APPAHGVTSA PDTRPAPGST APPAHGVTSA PDNRPALGST
     APPVHNVTSA SGSASGSAST LVHNGTSARA TTTPASKSTP FSIPSHHSDT PTTLASHSTK
     TDASSTHHST VPPLTSSNHS TSPQLSTGVS FFFLSFHISN LQFNSSLEDP STDYYQELQR
     DISEMFLQIY KQGGFLGLSN IKFRPGSVVV QLTLAFREGT INVHDVETQF NQYKTEAASR
     YNLTISDVSV SDVPFPFSAQ SGAGVPGWGI ALLVLVCVLV ALAIVYLIAL AVCQCRRKNY
     GQLDIFPARD TYHPMSEYPT YHTHGRYVPP SSTDRSPYEK VSAGNGGSSL SYTNPAVAAT
     SANL
//
ID   A0A0A0MRB3_HUMAN        Unreviewed;       241 AA.
AC   A0A0A0MRB3;
DT   07-JAN-2015, integrated into UniProtKB/TrEMBL.
DT   07-JAN-2015, sequence version 1.
DT   22-APR-2020, entry version 38.
DE   SubName: Full=Mucin-1 {ECO:0000313|Ensembl:ENSP00000343482};
GN   Name=MUC1 {ECO:0000313|Ensembl:ENSP00000343482};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000343482, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000343482, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I., Aubin K., Babbage A.K., Bagguley C.L., Bailey J., Beasley H.,
RA   Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G., Clee C.,
RA   Cobley V., Collier R.E., Corby N., Coville G.J., Davies J., Deadman R.,
RA   Dunn M., Earthrowl M., Ellington A.G., Errington H., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Gay L., Ghori M.R.,
RA   Gibson R., Gilby L.M., Gillett W., Glithero R.J., Grafham D.V.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Hammond S., Harrison E.S.,
RA   Hart E., Haugen E., Heath P.D., Holmes S., Holt K., Howden P.J., Hunt A.R.,
RA   Hunt S.E., Hunter G., Isherwood J., James R., Johnson C., Johnson D.,
RA   Joy A., Kay M., Kershaw J.K., Kibukawa M., Kimberley A.M., King A.,
RA   Knights A.J., Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S., McLaren S., Milne S.,
RA   Mistry S., Moore M.J., Nickerson T., O'Dell C.N., Oliver K., Palmeiri A.,
RA   Palmer S.A., Parker A., Patel D., Pearce A.V., Peck A.I., Pelan S.,
RA   Phelps K., Phillimore B.J., Plumb R., Rajan J., Raymond C., Rouse G.,
RA   Saenphimmachak C., Sehra H.K., Sheridan E., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M., Steward C., Subramanian S., Sycamore N., Tracey A.,
RA   Tromans A., Van Helmond Z., Wall M., Wallis J.M., White S., Whitehead S.L.,
RA   Wilkinson J.E., Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z.,
RA   Coulson A., Vaudin M., Sulston J.E., Durbin R., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R., Banerjee R., Bryant S.P., Burford D.C.,
RA   Burrill W.D., Clegg S.M., Dhami P., Dovey O., Faulkner L.M., Gribble S.M.,
RA   Langford C.F., Pandian R.D., Porter K.M., Prigmore E.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [2] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [3] {ECO:0000313|Ensembl:ENSP00000343482}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (NOV-2014) to UniProtKB.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC234582; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001191220.1; NM_001204291.1.
DR   SMR; A0A0A0MRB3; -.
DR   jPOST; A0A0A0MRB3; -.
DR   PeptideAtlas; A0A0A0MRB3; -.
DR   PRIDE; A0A0A0MRB3; -.
DR   Antibodypedia; 1298; 4363 antibodies.
DR   Ensembl; ENST00000338684; ENSP00000343482; ENSG00000185499.
DR   GeneID; 4582; -.
DR   UCSC; uc009wpt.4; human.
DR   CTD; 4582; -.
DR   EuPathDB; HostDB:ENSG00000185499.16; -.
DR   HGNC; HGNC:7508; MUC1.
DR   OpenTargets; ENSG00000185499; -.
DR   eggNOG; ENOG410IX6R; Eukaryota.
DR   eggNOG; ENOG410ZQ7Z; LUCA.
DR   GeneTree; ENSGT00710000106874; -.
DR   ChiTaRS; MUC1; human.
DR   GenomeRNAi; 4582; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000185499; Expressed in body of stomach and 198 other tissues.
DR   ExpressionAtlas; A0A0A0MRB3; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   InterPro; IPR000082; SEA_dom.
DR   InterPro; IPR036364; SEA_dom_sf.
DR   SMART; SM00200; SEA; 1.
DR   SUPFAM; SSF82671; SSF82671; 1.
DR   PROSITE; PS50024; SEA; 1.
PE   1: Evidence at protein level;
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|EPD:A0A0A0MRB3,
KW   ECO:0000213|MaxQB:A0A0A0MRB3, ECO:0000213|PeptideAtlas:A0A0A0MRB3,
KW   ECO:0000213|ProteomicsDB:A0A0A0MRB3};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP}; Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           24..241
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5001967087"
FT   TRANSMEM        145..170
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          26..134
FT                   /note="SEA"
FT                   /evidence="ECO:0000259|PROSITE:PS50024"
FT   REGION          26..56
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          200..223
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        203..223
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   241 AA;  25655 MW;  F919FE9E3F664EE2 CRC64;
     MTPGTQSPFF LLLLLTVLTA TTAPKPATVV TGSGHASSTP GGEKETSATQ RSSVPSSTEK
     NAFLQIYKQG GFLGLSNIKF RPGSVVVQLT LAFREGTINV HDVETQFNQY KTEAASRYNL
     TISDVSVSDV PFPFSAQSGA GVPGWGIALL VLVCVLVALA IVYLIALAVC QCRRKNYGQL
     DIFPARDTYH PMSEYPTYHT HGRYVPPSST DRSPYEKVSA GNGGSSLSYT NPAVAATSAN
     L
//
ID   A0A0C4DGW3_HUMAN        Unreviewed;       475 AA.
AC   A0A0C4DGW3;
DT   01-APR-2015, integrated into UniProtKB/TrEMBL.
DT   01-APR-2015, sequence version 1.
DT   22-APR-2020, entry version 35.
DE   SubName: Full=Mucin-1 {ECO:0000313|Ensembl:ENSP00000481231};
GN   Name=MUC1 {ECO:0000313|Ensembl:ENSP00000481231};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000481231, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000481231, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I., Aubin K., Babbage A.K., Bagguley C.L., Bailey J., Beasley H.,
RA   Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G., Clee C.,
RA   Cobley V., Collier R.E., Corby N., Coville G.J., Davies J., Deadman R.,
RA   Dunn M., Earthrowl M., Ellington A.G., Errington H., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Gay L., Ghori M.R.,
RA   Gibson R., Gilby L.M., Gillett W., Glithero R.J., Grafham D.V.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Hammond S., Harrison E.S.,
RA   Hart E., Haugen E., Heath P.D., Holmes S., Holt K., Howden P.J., Hunt A.R.,
RA   Hunt S.E., Hunter G., Isherwood J., James R., Johnson C., Johnson D.,
RA   Joy A., Kay M., Kershaw J.K., Kibukawa M., Kimberley A.M., King A.,
RA   Knights A.J., Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S., McLaren S., Milne S.,
RA   Mistry S., Moore M.J., Nickerson T., O'Dell C.N., Oliver K., Palmeiri A.,
RA   Palmer S.A., Parker A., Patel D., Pearce A.V., Peck A.I., Pelan S.,
RA   Phelps K., Phillimore B.J., Plumb R., Rajan J., Raymond C., Rouse G.,
RA   Saenphimmachak C., Sehra H.K., Sheridan E., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M., Steward C., Subramanian S., Sycamore N., Tracey A.,
RA   Tromans A., Van Helmond Z., Wall M., Wallis J.M., White S., Whitehead S.L.,
RA   Wilkinson J.E., Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z.,
RA   Coulson A., Vaudin M., Sulston J.E., Durbin R., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R., Banerjee R., Bryant S.P., Burford D.C.,
RA   Burrill W.D., Clegg S.M., Dhami P., Dovey O., Faulkner L.M., Gribble S.M.,
RA   Langford C.F., Pandian R.D., Porter K.M., Prigmore E.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [2] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [3] {ECO:0000313|Ensembl:ENSP00000481231}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2015) to UniProtKB.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC234582; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001191214.1; NM_001204285.1.
DR   MEROPS; S71.001; -.
DR   jPOST; A0A0C4DGW3; -.
DR   PeptideAtlas; A0A0C4DGW3; -.
DR   PRIDE; A0A0C4DGW3; -.
DR   Antibodypedia; 1298; 4363 antibodies.
DR   Ensembl; ENST00000620103; ENSP00000481231; ENSG00000185499.
DR   GeneID; 4582; -.
DR   CTD; 4582; -.
DR   EuPathDB; HostDB:ENSG00000185499.16; -.
DR   HGNC; HGNC:7508; MUC1.
DR   OpenTargets; ENSG00000185499; -.
DR   eggNOG; ENOG410IX6R; Eukaryota.
DR   eggNOG; ENOG410ZQ7Z; LUCA.
DR   GeneTree; ENSGT00710000106874; -.
DR   HOGENOM; CLU_029446_1_0_1; -.
DR   PhylomeDB; A0A0C4DGW3; -.
DR   ChiTaRS; MUC1; human.
DR   GenomeRNAi; 4582; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000185499; Expressed in body of stomach and 198 other tissues.
DR   ExpressionAtlas; A0A0C4DGW3; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   Gene3D; 3.30.70.960; -; 1.
DR   InterPro; IPR000082; SEA_dom.
DR   InterPro; IPR036364; SEA_dom_sf.
DR   Pfam; PF01390; SEA; 1.
DR   SMART; SM00200; SEA; 1.
DR   SUPFAM; SSF82671; SSF82671; 1.
DR   PROSITE; PS50024; SEA; 1.
PE   1: Evidence at protein level;
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|EPD:A0A0C4DGW3,
KW   ECO:0000213|MaxQB:A0A0C4DGW3, ECO:0000213|PeptideAtlas:A0A0C4DGW3,
KW   ECO:0000213|ProteomicsDB:A0A0C4DGW3};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP}; Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           24..475
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5002181428"
FT   TRANSMEM        379..404
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          259..368
FT                   /note="SEA"
FT                   /evidence="ECO:0000259|PROSITE:PS50024"
FT   REGION          23..253
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          434..457
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        23..83
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        89..118
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        173..253
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        437..457
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   475 AA;  49224 MW;  CB64D56690818614 CRC64;
     MTPGTQSPFF LLLLLTVLTV VTGSGHASST PGGEKETSAT QRSSVPSSTE KNAVSMTSSV
     LSSHSPGSGS STTQGQDVTL APATEPASGS AATWGQDVTS VPVTRPALGS TTPPAHDVTS
     APDNKPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDNRPALGS TAPPVHNVTS
     ASGSASGSAS TLVHNGTSAR ATTTPASKST PFSIPSHHSD TPTTLASHST KTDASSTHHS
     TVPPLTSSNH STSPQLSTGV SFFFLSFHIS NLQFNSSLED PSTDYYQELQ RDISEMFLQI
     YKQGGFLGLS NIKFRPGSVV VQLTLAFREG TINVHDVETQ FNQYKTEAAS RYNLTISDVS
     VSDVPFPFSA QSGAGVPGWG IALLVLVCVL VALAIVYLIA LAVCQCRRKN YGQLDIFPAR
     DTYHPMSEYP TYHTHGRYVP PSSTDRSPYE KVSAGNGGSS LSYTNPAVAA TSANL
//
ID   A0A384NPK6_HUMAN        Unreviewed;       159 AA.
AC   A0A384NPK6;
DT   05-DEC-2018, integrated into UniProtKB/TrEMBL.
DT   05-DEC-2018, sequence version 1.
DT   22-APR-2020, entry version 8.
DE   SubName: Full=Epididymis secretory sperm binding protein {ECO:0000313|EMBL:ADO22188.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ADO22188.1};
RN   [1] {ECO:0000313|EMBL:ADO22188.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Hoernsten L., Su C., Osbourn A.E., Hellman U., Wernstedt C., Oliw E.H.;
RL   Submitted (SEP-2009) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; GQ891326; ADO22188.1; -; mRNA.
DR   RefSeq; NP_001037857.1; NM_001044392.2.
DR   SMR; A0A384NPK6; -.
DR   Antibodypedia; 1298; 4363 antibodies.
DR   GeneID; 4582; -.
DR   CTD; 4582; -.
DR   ExpressionAtlas; A0A384NPK6; baseline and differential.
DR   Gene3D; 3.30.70.960; -; 1.
DR   InterPro; IPR036364; SEA_dom_sf.
PE   2: Evidence at transcript level;
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           24..159
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5017387969"
FT   REGION          26..74
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          118..148
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        121..148
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   159 AA;  17090 MW;  2C3B69F515D73168 CRC64;
     MTPGTQSPFF LLLLLTVLTA TTAPKPATVV TGSGHASSTP GGEKETSATQ RSSVPSSTEK
     NAFNSSLEDP STDYYQELQR DISEMAVCQC RRKNYGQLDI FPARDTYHPM SEYPTYHTHG
     RYVPPSSTDR SPYEKVSAGN GGSSLSYTNP AVAATSANL
//
ID   A5YRU5_HUMAN            Unreviewed;       282 AA.
AC   A5YRU5;
DT   10-JUL-2007, integrated into UniProtKB/TrEMBL.
DT   10-JUL-2007, sequence version 1.
DT   22-APR-2020, entry version 73.
DE   SubName: Full=MUC1 isoform Z-LSP {ECO:0000313|EMBL:ABQ59622.1};
GN   Name=MUC1 {ECO:0000313|EMBL:ABQ59622.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABQ59622.1};
RN   [1] {ECO:0000313|EMBL:ABQ59622.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=22941036; DOI=10.1007/s00262-012-1325-2;
RA   Zhang L., Vlad A., Milcarek C., Finn O.J.;
RT   "Human mucin MUC1 RNA undergoes different types of alternative splicing
RT   resulting in multiple isoforms.";
RL   Cancer Immunol. Immunother. 62:423-435(2013).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EF583647; ABQ59622.1; -; mRNA.
DR   RefSeq; NP_001191216.1; NM_001204287.1.
DR   MaxQB; A5YRU5; -.
DR   PeptideAtlas; A5YRU5; -.
DR   PRIDE; A5YRU5; -.
DR   DNASU; 4582; -.
DR   GeneID; 4582; -.
DR   CTD; 4582; -.
DR   ChiTaRS; MUC1; human.
DR   GenomeRNAi; 4582; -.
DR   Genevisible; A5YRU5; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.70.960; -; 1.
DR   InterPro; IPR000082; SEA_dom.
DR   InterPro; IPR036364; SEA_dom_sf.
DR   Pfam; PF01390; SEA; 1.
DR   SMART; SM00200; SEA; 1.
DR   SUPFAM; SSF82671; SSF82671; 1.
DR   PROSITE; PS50024; SEA; 1.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAM:Phobius}; Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           24..282
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5002690093"
FT   TRANSMEM        186..211
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          66..175
FT                   /note="SEA"
FT                   /evidence="ECO:0000259|PROSITE:PS50024"
FT   REGION          28..60
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          241..264
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        244..264
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   282 AA;  30431 MW;  2E431D8053353D57 CRC64;
     MTPGTQSPFF LLLLLTVLTA TTAPKPATVV TGSGHASSTP GGEKETSATQ RSSVPSSTEK
     NALSTGVSFF FLSFHISNLQ FNSSLEDPST DYYQELQRDI SEMFLQIYKQ GGFLGLSNIK
     FRPGSVVVQL TLAFREGTIN VHDVETQFNQ YKTEAASRYN LTISDVSVSD VPFPFSAQSG
     AGVPGWGIAL LVLVCVLVAL AIVYLIALAV CQCRRKNYGQ LDIFPARDTY HPMSEYPTYH
     THGRYVPPSS TDRSPYEKVS AGNGGSSLSY TNPAVAATSA NL
//
ID   A5YRU7_HUMAN            Unreviewed;       219 AA.
AC   A5YRU7;
DT   10-JUL-2007, integrated into UniProtKB/TrEMBL.
DT   10-JUL-2007, sequence version 1.
DT   22-APR-2020, entry version 59.
DE   SubName: Full=MUC1 isoform T7 {ECO:0000313|EMBL:ABQ59624.1};
GN   Name=MUC1 {ECO:0000313|EMBL:ABQ59624.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABQ59624.1};
RN   [1] {ECO:0000313|EMBL:ABQ59624.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=22941036; DOI=10.1007/s00262-012-1325-2;
RA   Zhang L., Vlad A., Milcarek C., Finn O.J.;
RT   "Human mucin MUC1 RNA undergoes different types of alternative splicing
RT   resulting in multiple isoforms.";
RL   Cancer Immunol. Immunother. 62:423-435(2013).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EF583649; ABQ59624.1; -; mRNA.
DR   RefSeq; NP_001191217.1; NM_001204288.1.
DR   SMR; A5YRU7; -.
DR   PeptideAtlas; A5YRU7; -.
DR   PRIDE; A5YRU7; -.
DR   DNASU; 4582; -.
DR   GeneID; 4582; -.
DR   CTD; 4582; -.
DR   ChiTaRS; MUC1; human.
DR   GenomeRNAi; 4582; -.
DR   Genevisible; A5YRU7; HS.
DR   Gene3D; 3.30.70.960; -; 1.
DR   InterPro; IPR000082; SEA_dom.
DR   InterPro; IPR036364; SEA_dom_sf.
DR   Pfam; PF01390; SEA; 1.
DR   SMART; SM00200; SEA; 1.
DR   SUPFAM; SSF82671; SSF82671; 1.
DR   PROSITE; PS50024; SEA; 1.
PE   2: Evidence at transcript level;
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           24..219
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5002690152"
FT   DOMAIN          44..157
FT                   /note="SEA"
FT                   /evidence="ECO:0000259|PROSITE:PS50024"
FT   REGION          26..68
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   219 AA;  23466 MW;  C0DB674812B59BB5 CRC64;
     MTPGTQSPFF LLLLLTVLTA TTAPKPATVV TGSGHASSTP GGEKETSATQ RSSVPSSTEK
     NAFNSSLEDP STDYYQELQR DISEMFLQIY KQGGFLGLSN IKFRPGSVVV QLTLAFREGT
     INVHDVETQF NQYKTEAASR YNLTISDVSV WGWGARLGHR AAGAGLCSGC AGHCLSHCLG
     CLSVPPKELR AAGHLSSPGY LPSYERVPHL PHPWALCAP
//
ID   A5YRV0_HUMAN            Unreviewed;       238 AA.
AC   A5YRV0;
DT   10-JUL-2007, integrated into UniProtKB/TrEMBL.
DT   10-JUL-2007, sequence version 1.
DT   22-APR-2020, entry version 66.
DE   SubName: Full=MUC1 isoform G-LSP {ECO:0000313|EMBL:ABQ59627.1};
GN   Name=MUC1 {ECO:0000313|EMBL:ABQ59627.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABQ59627.1};
RN   [1] {ECO:0000313|EMBL:ABQ59627.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=22941036; DOI=10.1007/s00262-012-1325-2;
RA   Zhang L., Vlad A., Milcarek C., Finn O.J.;
RT   "Human mucin MUC1 RNA undergoes different types of alternative splicing
RT   resulting in multiple isoforms.";
RL   Cancer Immunol. Immunother. 62:423-435(2013).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EF583652; ABQ59627.1; -; mRNA.
DR   RefSeq; NP_001191218.1; NM_001204289.1.
DR   SMR; A5YRV0; -.
DR   MEROPS; S71.001; -.
DR   PeptideAtlas; A5YRV0; -.
DR   PRIDE; A5YRV0; -.
DR   DNASU; 4582; -.
DR   GeneID; 4582; -.
DR   CTD; 4582; -.
DR   eggNOG; ENOG410IX6R; Eukaryota.
DR   eggNOG; ENOG410ZQ7Z; LUCA.
DR   ChiTaRS; MUC1; human.
DR   GenomeRNAi; 4582; -.
DR   Genevisible; A5YRV0; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   InterPro; IPR000082; SEA_dom.
DR   InterPro; IPR036364; SEA_dom_sf.
DR   SMART; SM00200; SEA; 1.
DR   SUPFAM; SSF82671; SSF82671; 1.
DR   PROSITE; PS50024; SEA; 1.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAM:Phobius}; Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           24..238
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5002690095"
FT   TRANSMEM        142..167
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          19..131
FT                   /note="SEA"
FT                   /evidence="ECO:0000259|PROSITE:PS50024"
FT   REGION          26..59
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          197..220
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        200..220
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   238 AA;  25267 MW;  253AFB230AE79A8D CRC64;
     MTPGTQSPFF LLLLLTVLTA TTAPKPATVV TGSGHASSTP GGEKETSATQ RSSVPSSTEK
     NAIYKQGGFL GLSNIKFRPG SVVVQLTLAF REGTINVHDV ETQFNQYKTE AASRYNLTIS
     DVSVSDVPFP FSAQSGAGVP GWGIALLVLV CVLVALAIVY LIALAVCQCR RKNYGQLDIF
     PARDTYHPMS EYPTYHTHGR YVPPSSTDRS PYEKVSAGNG GSSLSYTNPA VAATSANL
//
ID   A5YRV2_HUMAN            Unreviewed;       217 AA.
AC   A5YRV2;
DT   10-JUL-2007, integrated into UniProtKB/TrEMBL.
DT   10-JUL-2007, sequence version 1.
DT   22-APR-2020, entry version 66.
DE   SubName: Full=MUC1 isoform T11 {ECO:0000313|EMBL:ABQ59629.1};
GN   Name=MUC1 {ECO:0000313|EMBL:ABQ59629.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABQ59629.1};
RN   [1] {ECO:0000313|EMBL:ABQ59629.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=22941036; DOI=10.1007/s00262-012-1325-2;
RA   Zhang L., Vlad A., Milcarek C., Finn O.J.;
RT   "Human mucin MUC1 RNA undergoes different types of alternative splicing
RT   resulting in multiple isoforms.";
RL   Cancer Immunol. Immunother. 62:423-435(2013).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EF583654; ABQ59629.1; -; mRNA.
DR   RefSeq; NP_001191219.1; NM_001204290.1.
DR   SMR; A5YRV2; -.
DR   MaxQB; A5YRV2; -.
DR   PeptideAtlas; A5YRV2; -.
DR   PRIDE; A5YRV2; -.
DR   DNASU; 4582; -.
DR   GeneID; 4582; -.
DR   CTD; 4582; -.
DR   eggNOG; ENOG410IX6R; Eukaryota.
DR   eggNOG; ENOG410ZQ7Z; LUCA.
DR   ChiTaRS; MUC1; human.
DR   GenomeRNAi; 4582; -.
DR   Genevisible; A5YRV2; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   InterPro; IPR000082; SEA_dom.
DR   InterPro; IPR036364; SEA_dom_sf.
DR   SMART; SM00200; SEA; 1.
DR   SUPFAM; SSF82671; SSF82671; 1.
DR   PROSITE; PS50024; SEA; 1.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAM:Phobius}; Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL          1..21
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           22..217
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5002690021"
FT   TRANSMEM        121..146
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          1..110
FT                   /note="SEA"
FT                   /evidence="ECO:0000259|PROSITE:PS50024"
FT   REGION          176..199
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        179..199
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   217 AA;  23346 MW;  A890B6A231FB3A22 CRC64;
     MTPGTQSPFF LLLLLTVLTG GEKETSATQR SSVPSSTEKN AIYKQGGFLG LSNIKFRPGS
     VVVQLTLAFR EGTINVHDVE TQFNQYKTEA ASRYNLTISD VSVSDVPFPF SAQSGAGVPG
     WGIALLVLVC VLVALAIVYL IALAVCQCRR KNYGQLDIFP ARDTYHPMSE YPTYHTHGRY
     VPPSSTDRSP YEKVSAGNGG SSLSYTNPAV AATSANL
//
ID   A6ZID6_HUMAN            Unreviewed;       241 AA.
AC   A6ZID6;
DT   21-AUG-2007, integrated into UniProtKB/TrEMBL.
DT   21-AUG-2007, sequence version 1.
DT   22-APR-2020, entry version 67.
DE   SubName: Full=MUC1 isoform M3 {ECO:0000313|EMBL:ABS01295.1};
GN   Name=MUC1 {ECO:0000313|EMBL:ABS01295.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABS01295.1};
RN   [1] {ECO:0000313|EMBL:ABS01295.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=22941036; DOI=10.1007/s00262-012-1325-2;
RA   Zhang L., Vlad A., Milcarek C., Finn O.J.;
RT   "Human mucin MUC1 RNA undergoes different types of alternative splicing
RT   resulting in multiple isoforms.";
RL   Cancer Immunol. Immunother. 62:423-435(2013).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EF670708; ABS01295.1; -; mRNA.
DR   RefSeq; NP_001191220.1; NM_001204291.1.
DR   SMR; A6ZID6; -.
DR   PeptideAtlas; A6ZID6; -.
DR   PRIDE; A6ZID6; -.
DR   DNASU; 4582; -.
DR   GeneID; 4582; -.
DR   CTD; 4582; -.
DR   eggNOG; ENOG410IX6R; Eukaryota.
DR   eggNOG; ENOG410ZQ7Z; LUCA.
DR   ChiTaRS; MUC1; human.
DR   GenomeRNAi; 4582; -.
DR   Genevisible; A6ZID6; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   InterPro; IPR000082; SEA_dom.
DR   InterPro; IPR036364; SEA_dom_sf.
DR   SMART; SM00200; SEA; 1.
DR   SUPFAM; SSF82671; SSF82671; 1.
DR   PROSITE; PS50024; SEA; 1.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAM:Phobius}; Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           24..241
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5002705887"
FT   TRANSMEM        145..170
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          26..134
FT                   /note="SEA"
FT                   /evidence="ECO:0000259|PROSITE:PS50024"
FT   REGION          26..56
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          200..223
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        203..223
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   241 AA;  25656 MW;  F4AFFB0837464EE2 CRC64;
     MTPGTQSPFF LLLLLTVLTA TTAPKPATVV TGSGHASSTP GGEKETSATQ RSSVPSSTEK
     NAFLQIYKQG GFLGLSNIKF RPGSVVVQLT LAFREGTINV HDVETQFNQY ETEAASRYNL
     TISDVSVSDV PFPFSAQSGA GVPGWGIALL VLVCVLVALA IVYLIALAVC QCRRKNYGQL
     DIFPARDTYH PMSEYPTYHT HGRYVPPSST DRSPYEKVSA GNGGSSLSYT NPAVAATSAN
     L
//
ID   A6ZID7_HUMAN            Unreviewed;       239 AA.
AC   A6ZID7;
DT   21-AUG-2007, integrated into UniProtKB/TrEMBL.
DT   21-AUG-2007, sequence version 1.
DT   22-APR-2020, entry version 68.
DE   SubName: Full=MUC1 isoform M4 {ECO:0000313|EMBL:ABS01296.1};
GN   Name=MUC1 {ECO:0000313|EMBL:ABS01296.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABS01296.1};
RN   [1] {ECO:0000313|EMBL:ABS01296.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=22941036; DOI=10.1007/s00262-012-1325-2;
RA   Zhang L., Vlad A., Milcarek C., Finn O.J.;
RT   "Human mucin MUC1 RNA undergoes different types of alternative splicing
RT   resulting in multiple isoforms.";
RL   Cancer Immunol. Immunother. 62:423-435(2013).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EF670709; ABS01296.1; -; mRNA.
DR   RefSeq; NP_001191221.1; NM_001204292.1.
DR   SMR; A6ZID7; -.
DR   MEROPS; S71.001; -.
DR   PeptideAtlas; A6ZID7; -.
DR   PRIDE; A6ZID7; -.
DR   DNASU; 4582; -.
DR   GeneID; 4582; -.
DR   CTD; 4582; -.
DR   eggNOG; ENOG410IX6R; Eukaryota.
DR   eggNOG; ENOG410ZQ7Z; LUCA.
DR   ChiTaRS; MUC1; human.
DR   GenomeRNAi; 4582; -.
DR   Genevisible; A6ZID7; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAM:Phobius}; Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           24..239
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5002703655"
FT   TRANSMEM        143..168
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   REGION          26..67
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          198..221
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        201..221
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   239 AA;  25378 MW;  B47880EA33840BAC CRC64;
     MTPGTQSPFF LLLLLTVLTA TTAPKPATVV TGSGHASSTP GGEKETSATQ RSSVPSSTEK
     NAIPAPTTTK SCRETFLKWP GSVVVQLTLA FREGTINVHD VETQFSQYKT EAASRYNLTI
     SDVSVSDVPF PFSAQSGAGV PGWGIALLVL VCVLVALAIV YLIALAVCQC RRKNYGQLDI
     FPARDTYHPM SEYPTYHTHG RYVPPSSTDR SPYEKVSAGN GGSSLSYTNP AVAATSANL
//
ID   A6ZIE4_HUMAN            Unreviewed;       189 AA.
AC   A6ZIE4;
DT   21-AUG-2007, integrated into UniProtKB/TrEMBL.
DT   21-AUG-2007, sequence version 1.
DT   22-APR-2020, entry version 85.
DE   SubName: Full=MUC1 isoform M10 {ECO:0000313|EMBL:ABS01303.1};
DE   SubName: Full=Mucin-1 {ECO:0000313|Ensembl:ENSP00000483473};
GN   Name=MUC1 {ECO:0000313|EMBL:ABS01303.1,
GN   ECO:0000313|Ensembl:ENSP00000483473};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABS01303.1};
RN   [1] {ECO:0000313|Ensembl:ENSP00000483473, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I., Aubin K., Babbage A.K., Bagguley C.L., Bailey J., Beasley H.,
RA   Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G., Clee C.,
RA   Cobley V., Collier R.E., Corby N., Coville G.J., Davies J., Deadman R.,
RA   Dunn M., Earthrowl M., Ellington A.G., Errington H., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Gay L., Ghori M.R.,
RA   Gibson R., Gilby L.M., Gillett W., Glithero R.J., Grafham D.V.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Hammond S., Harrison E.S.,
RA   Hart E., Haugen E., Heath P.D., Holmes S., Holt K., Howden P.J., Hunt A.R.,
RA   Hunt S.E., Hunter G., Isherwood J., James R., Johnson C., Johnson D.,
RA   Joy A., Kay M., Kershaw J.K., Kibukawa M., Kimberley A.M., King A.,
RA   Knights A.J., Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S., McLaren S., Milne S.,
RA   Mistry S., Moore M.J., Nickerson T., O'Dell C.N., Oliver K., Palmeiri A.,
RA   Palmer S.A., Parker A., Patel D., Pearce A.V., Peck A.I., Pelan S.,
RA   Phelps K., Phillimore B.J., Plumb R., Rajan J., Raymond C., Rouse G.,
RA   Saenphimmachak C., Sehra H.K., Sheridan E., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M., Steward C., Subramanian S., Sycamore N., Tracey A.,
RA   Tromans A., Van Helmond Z., Wall M., Wallis J.M., White S., Whitehead S.L.,
RA   Wilkinson J.E., Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z.,
RA   Coulson A., Vaudin M., Sulston J.E., Durbin R., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R., Banerjee R., Bryant S.P., Burford D.C.,
RA   Burrill W.D., Clegg S.M., Dhami P., Dovey O., Faulkner L.M., Gribble S.M.,
RA   Langford C.F., Pandian R.D., Porter K.M., Prigmore E.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [2] {ECO:0000313|EMBL:ABS01303.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=22941036; DOI=10.1007/s00262-012-1325-2;
RA   Zhang L., Vlad A., Milcarek C., Finn O.J.;
RT   "Human mucin MUC1 RNA undergoes different types of alternative splicing
RT   resulting in multiple isoforms.";
RL   Cancer Immunol. Immunother. 62:423-435(2013).
RN   [3] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [4] {ECO:0000313|Ensembl:ENSP00000483473}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2014) to UniProtKB.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC234582; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; EF670716; ABS01303.1; -; mRNA.
DR   RefSeq; NP_001191224.1; NM_001204295.1.
DR   MEROPS; S71.001; -.
DR   Antibodypedia; 1298; 4363 antibodies.
DR   DNASU; 4582; -.
DR   Ensembl; ENST00000615517; ENSP00000483473; ENSG00000185499.
DR   GeneID; 4582; -.
DR   UCSC; uc009wpl.4; human.
DR   CTD; 4582; -.
DR   EuPathDB; HostDB:ENSG00000185499.16; -.
DR   HGNC; HGNC:7508; MUC1.
DR   OpenTargets; ENSG00000185499; -.
DR   eggNOG; ENOG410IX6R; Eukaryota.
DR   eggNOG; ENOG410ZQ7Z; LUCA.
DR   GeneTree; ENSGT00710000106874; -.
DR   ChiTaRS; MUC1; human.
DR   GenomeRNAi; 4582; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000185499; Expressed in body of stomach and 198 other tissues.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   Gene3D; 3.30.70.960; -; 1.
DR   InterPro; IPR036364; SEA_dom_sf.
PE   1: Evidence at protein level;
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|EPD:A6ZIE4,
KW   ECO:0000213|MaxQB:A6ZIE4, ECO:0000213|PeptideAtlas:A6ZIE4,
KW   ECO:0000213|ProteomicsDB:A6ZIE4};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP}; Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           24..189
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5014565778"
FT   TRANSMEM        93..118
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   REGION          28..69
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          148..171
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        151..171
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   189 AA;  20037 MW;  C617B22043CAD95A CRC64;
     MTPGTQSPFF LLLLLTVLTA TTAPKPATVV TGSGHASSTP GGEKETSATQ RSSVPSSTEK
     NAFNSSLEDP STDYYQELQR DISEMSGAGV PGWGIALLVL VCVLVALAIV YLIALAVCQC
     RRKNYGQLDI FPARDTYHPM SEYPTYHTHG RYVPPSSTDR SPYEKVSAGN GGSSLSYTNP
     AVAATSANL
//
ID   A6ZIE6_HUMAN            Unreviewed;       177 AA.
AC   A6ZIE6;
DT   21-AUG-2007, integrated into UniProtKB/TrEMBL.
DT   21-AUG-2007, sequence version 1.
DT   22-APR-2020, entry version 70.
DE   SubName: Full=MUC1 isoform S-LSP {ECO:0000313|EMBL:ABS01305.1};
GN   Name=MUC1 {ECO:0000313|EMBL:ABS01305.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABS01305.1};
RN   [1] {ECO:0000313|EMBL:ABS01305.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=22941036; DOI=10.1007/s00262-012-1325-2;
RA   Zhang L., Vlad A., Milcarek C., Finn O.J.;
RT   "Human mucin MUC1 RNA undergoes different types of alternative splicing
RT   resulting in multiple isoforms.";
RL   Cancer Immunol. Immunother. 62:423-435(2013).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EF670718; ABS01305.1; -; mRNA.
DR   RefSeq; NP_001191226.1; NM_001204297.1.
DR   SMR; A6ZIE6; -.
DR   MEROPS; S71.001; -.
DR   PeptideAtlas; A6ZIE6; -.
DR   PRIDE; A6ZIE6; -.
DR   DNASU; 4582; -.
DR   GeneID; 4582; -.
DR   CTD; 4582; -.
DR   eggNOG; ENOG410IX6R; Eukaryota.
DR   eggNOG; ENOG410ZQ7Z; LUCA.
DR   ChiTaRS; MUC1; human.
DR   GenomeRNAi; 4582; -.
DR   Genevisible; A6ZIE6; HS.
DR   Gene3D; 3.30.70.960; -; 1.
DR   InterPro; IPR000082; SEA_dom.
DR   InterPro; IPR036364; SEA_dom_sf.
DR   Pfam; PF01390; SEA; 1.
DR   SUPFAM; SSF82671; SSF82671; 1.
DR   PROSITE; PS50024; SEA; 1.
PE   2: Evidence at transcript level;
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           24..177
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5002705839"
FT   DOMAIN          66..103
FT                   /note="SEA"
FT                   /evidence="ECO:0000259|PROSITE:PS50024"
FT   REGION          26..60
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          136..159
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        139..159
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   177 AA;  19116 MW;  2C60A683BB1643A0 CRC64;
     MTPGTQSPFF LLLLLTVLTA TTAPKPATVV TGSGHASSTP GGEKETSATQ RSSVPSSTEK
     NALSTGVSFF FLSFHISNLQ FNSSLEDPST DYYQELQRDI SEMAVCQCRR KNYGQLDIFP
     ARDTYHPMSE YPTYHTHGRY VPPSSTDRSP YEKVSAGNGG SSLSYTNPAV AATSANL
//
ID   B6ECB3_HUMAN            Unreviewed;       212 AA.
AC   B6ECB3;
DT   25-NOV-2008, integrated into UniProtKB/TrEMBL.
DT   25-NOV-2008, sequence version 1.
DT   22-APR-2020, entry version 60.
DE   SubName: Full=MUC1 isoform J24 {ECO:0000313|EMBL:ACI25184.1};
GN   Name=MUC1 {ECO:0000313|EMBL:ACI25184.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACI25184.1};
RN   [1] {ECO:0000313|EMBL:ACI25184.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=22941036; DOI=10.1007/s00262-012-1325-2;
RA   Zhang L., Vlad A., Milcarek C., Finn O.J.;
RT   "Human mucin MUC1 RNA undergoes different types of alternative splicing
RT   resulting in multiple isoforms.";
RL   Cancer Immunol. Immunother. 62:423-435(2013).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; FJ226053; ACI25184.1; -; mRNA.
DR   RefSeq; NP_001191225.1; NM_001204296.1.
DR   SMR; B6ECB3; -.
DR   MaxQB; B6ECB3; -.
DR   PeptideAtlas; B6ECB3; -.
DR   PRIDE; B6ECB3; -.
DR   DNASU; 4582; -.
DR   GeneID; 4582; -.
DR   CTD; 4582; -.
DR   eggNOG; ENOG410IX6R; Eukaryota.
DR   eggNOG; ENOG410ZQ7Z; LUCA.
DR   ChiTaRS; MUC1; human.
DR   GenomeRNAi; 4582; -.
DR   Genevisible; B6ECB3; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAM:Phobius}; Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           24..212
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5002844348"
FT   TRANSMEM        116..141
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   REGION          28..66
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          171..194
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        174..194
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   212 AA;  22395 MW;  FF70E57FCE3318E9 CRC64;
     MTPGTQSPFF LLLLLTVLTA TTAPKPATVV TGSGHASSTP GGEKETSATQ RSSVPSSTEK
     NAIPAPTTTK SCRETFLKCF CRFINKGVFW ASPILSSVSD VPFPFSAQSG AGVPGWGIAL
     LVLVCVLVAL AIVYLIALAV CQCRRKNYGQ LDIFPARDTY HPMSEYPTYH THGRYVPPSS
     TDRSPYEKVS AGNGGSSLSY TNPAVAATSA NL
//
ID   MUC1_HUMAN              Reviewed;        1255 AA.
AC   P15941; A5YRV1; A6ZID9; A6ZIE0; B1AVQ8; B1AVR0; B6ECA1; E7ESE5; E7EUG9;
AC   P13931; P15942; P17626; Q0VAP5; Q0VAP6; Q14128; Q14876; Q16437; Q16442;
AC   Q16615; Q6S4Y3; Q7Z547; Q7Z548; Q7Z550; Q7Z552; Q9BXA4; Q9UE75; Q9UE76;
AC   Q9UQL1; Q9Y4J2;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 3.
DT   22-APR-2020, entry version 221.
DE   RecName: Full=Mucin-1;
DE            Short=MUC-1;
DE   AltName: Full=Breast carcinoma-associated antigen DF3;
DE   AltName: Full=Cancer antigen 15-3;
DE            Short=CA 15-3;
DE   AltName: Full=Carcinoma-associated mucin;
DE   AltName: Full=Episialin;
DE   AltName: Full=H23AG;
DE   AltName: Full=Krebs von den Lungen-6;
DE            Short=KL-6;
DE   AltName: Full=PEMT;
DE   AltName: Full=Peanut-reactive urinary mucin;
DE            Short=PUM;
DE   AltName: Full=Polymorphic epithelial mucin;
DE            Short=PEM;
DE   AltName: Full=Tumor-associated epithelial membrane antigen;
DE            Short=EMA;
DE   AltName: Full=Tumor-associated mucin;
DE   AltName: CD_antigen=CD227;
DE   Contains:
DE     RecName: Full=Mucin-1 subunit alpha;
DE              Short=MUC1-NT;
DE              Short=MUC1-alpha;
DE   Contains:
DE     RecName: Full=Mucin-1 subunit beta;
DE              Short=MUC1-beta;
DE     AltName: Full=MUC1-CT;
DE   Flags: Precursor;
GN   Name=MUC1; Synonyms=PUM;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Pancreatic carcinoma;
RX   PubMed=2394722;
RA   Lan M.S., Batra S.K., Qi W.-N., Metzgar R.S., Hollingsworth M.A.;
RT   "Cloning and sequencing of a human pancreatic tumor mucin cDNA.";
RL   J. Biol. Chem. 265:15294-15299(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=2318825;
RA   Ligtenberg M.J.L., Vos H.L., Gennissen A.M.C., Hilkens J.;
RT   "Episialin, a carcinoma-associated mucin, is generated by a polymorphic
RT   gene encoding splice variants with alternative amino termini.";
RL   J. Biol. Chem. 265:5573-5578(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Mammary carcinoma;
RX   PubMed=1697589;
RA   Gendler S.J., Lancaster C.A., Taylor-Papadimitriou J., Duhig T., Peat N.,
RA   Burchell J., Pemberton L., Lalani E.-N., Wilson D.;
RT   "Molecular cloning and expression of human tumor-associated polymorphic
RT   epithelial mucin.";
RL   J. Biol. Chem. 265:15286-15293(1990).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=2268309; DOI=10.1016/s0006-291x(05)80888-5;
RA   Lancaster C.A., Peat N., Duhig T., Wilson D., Taylor-Papadimitriou J.,
RA   Gendler S.J.;
RT   "Structure and expression of the human polymorphic epithelial mucin gene:
RT   an expressed VNTR unit.";
RL   Biochem. Biophys. Res. Commun. 173:1019-1029(1990).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5).
RC   TISSUE=Mammary carcinoma;
RX   PubMed=2351132; DOI=10.1111/j.1432-1033.1990.tb15511.x;
RA   Wreschner D.H., Hareuveni M., Tsarfaty I., Smorodinsky N., Horev J.,
RA   Zaretsky J., Kotkes P., Weiss M., Lathe R., Dion A., Keydar I.;
RT   "Human epithelial tumor antigen cDNA sequences. Differential splicing may
RT   generate multiple protein forms.";
RL   Eur. J. Biochem. 189:463-473(1990).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Mammary carcinoma;
RX   PubMed=2112460; DOI=10.1111/j.1432-1033.1990.tb15512.x;
RA   Hareuveni M., Tsarfaty I., Zaretsky J., Kotkes P., Horev J., Zrihan S.,
RA   Weiss M., Green S., Lathe R., Keydar I., Wreschner D.H.;
RT   "A transcribed gene, containing a variable number of tandem repeats, codes
RT   for a human epithelial tumor antigen. cDNA cloning, expression of the
RT   transfected gene and over-expression in breast cancer tissue.";
RL   Eur. J. Biochem. 189:475-486(1990).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=1688329; DOI=10.1016/0378-1119(90)90242-j;
RA   Tsarfaty I., Hareuveni M., Horev J., Zaretsky J., Weiss M., Jeltsch J.-M.,
RA   Garnier J.-M., Lathe R., Keydar I., Wreschner D.H.;
RT   "Isolation and characterization of an expressed hypervariable gene coding
RT   for a breast-cancer-associated antigen.";
RL   Gene 93:313-318(1990).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM Y).
RX   PubMed=7925397; DOI=10.1111/j.1432-1033.1994.00787.x;
RA   Zrihan-Licht S., Vos H.L., Baruch A., Elroy-Stein O., Sagiv D., Keydar I.,
RA   Hilkens J., Wreschner D.H.;
RT   "Characterization and molecular cloning of a novel MUC1 protein, devoid of
RT   tandem repeats, expressed in human breast cancer tissue.";
RL   Eur. J. Biochem. 224:787-795(1994).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 6; Y AND 8), AND TISSUE SPECIFICITY.
RX   PubMed=9212228;
RX   DOI=10.1002/(sici)1097-0215(19970703)72:1<87::aid-ijc13>3.0.co;2-7;
RA   Oosterkamp H.M., Scheiner L., Stefanova M.C., Lloyd K.O., Finstad C.L.;
RT   "Comparison of MUC-1 mucin expression in epithelial and non-epithelial
RT   cancer cell lines and demonstration of a new short variant form (MUC-
RT   1/Z).";
RL   Int. J. Cancer 72:87-94(1997).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM ZD).
RX   PubMed=15623537; DOI=10.1074/jbc.m406943200;
RA   Levitin F., Baruch A., Weiss M., Stiegman K., Hartmann M.L.,
RA   Yoeli-Lerner M., Ziv R., Zrihan-Licht S., Shina S., Gat A., Lifschitz B.,
RA   Simha M., Stadler Y., Cholostoy A., Gil B., Greaves D., Keydar I.,
RA   Zaretsky J., Smorodinsky N., Wreschner D.H.;
RT   "A novel protein derived from the MUC1 gene by alternative splicing and
RT   frameshifting.";
RL   J. Biol. Chem. 280:10655-10663(2005).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 6; E2; J13; M6; S2; T10; Y-LSP AND
RP   ZD), ALTERNATIVE SPLICING, AND VARIANT MET-1117.
RX   PubMed=22941036; DOI=10.1007/s00262-012-1325-2;
RA   Zhang L., Vlad A., Milcarek C., Finn O.J.;
RT   "Human mucin MUC1 RNA undergoes different types of alternative splicing
RT   resulting in multiple isoforms.";
RL   Cancer Immunol. Immunother. 62:423-435(2013).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 9).
RC   TISSUE=Carcinoma;
RA   Zhang L.X., Li C.H., Sun L.Y., Yue W.;
RT   "Cloning of a new potential secreted short variant form of MUC1 mucin in
RT   epithelial cancer cell line.";
RL   Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM Y), AND VARIANT MET-1117.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=15969018;
RA   Zhang L.X., Li C.H., Sun L.Y., Wang M., Lu H.J.;
RT   "Soluble expression of peptide containing MUC1/Y-specific epitope in
RT   Escherichia coli and preparation of the antibody.";
RL   Sheng Wu Gong Cheng Xue Bao 19:337-342(2003).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM F).
RA   Zhang L.X., Lu H.J.;
RT   "Cloning of a new MUC1 short variant mRNA F from HeLa cells.";
RL   Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [15]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM S2).
RA   Zhang L.X., Lu H.J.;
RT   "Cloning of a new MUC1 short variant mRNA S2 from HeLa cells.";
RL   Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [16]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM M6).
RA   Zhang L., Finn O.J.;
RT   "Isolation of MUC1 isoforms from MCF7 cells.";
RL   Submitted (JUN-2007) to the EMBL/GenBank/DDBJ databases.
RN   [17]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS MET-1117 AND ASN-1142.
RG   NIEHS SNPs program;
RL   Submitted (NOV-2003) to the EMBL/GenBank/DDBJ databases.
RN   [18]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [19]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [20]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS Y AND Y-LSP).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [21]
RP   PARTIAL NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3417635;
RA   Gendler S.J., Taylor-Papadimitriou J., Duhig T., Rothbard J., Burchell J.;
RT   "A highly immunogenic region of a human polymorphic epithelial mucin
RT   expressed by carcinomas is made up of tandem repeats.";
RL   J. Biol. Chem. 263:12820-12823(1988).
RN   [22]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-160 (ISOFORM 2).
RX   PubMed=2597151; DOI=10.1016/s0006-291x(89)80014-2;
RA   Abe M., Siddiqui J., Kufe D.;
RT   "Sequence analysis of the 5' region of the human DF3 breast carcinoma-
RT   associated antigen gene.";
RL   Biochem. Biophys. Res. Commun. 165:644-649(1989).
RN   [23]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-109 (ISOFORM 2).
RC   TISSUE=Thyroid;
RX   PubMed=8608966;
RX   DOI=10.1002/(sici)1097-0215(19960328)66:1<55::aid-ijc10>3.0.co;2-a;
RA   Weiss M., Baruch A., Keydar I., Wreschner D.H.;
RT   "Preoperative diagnosis of thyroid papillary carcinoma by reverse
RT   transcriptase polymerase chain reaction of the MUC1 gene.";
RL   Int. J. Cancer 66:55-59(1996).
RN   [24]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-89.
RC   TISSUE=Lung;
RX   PubMed=8604237; DOI=10.1159/000227547;
RA   Yu C.J., Yang P.C., Shew J.Y., Hong T.M., Yang S.C., Lee Y.C., Lee L.N.,
RA   Luh K.T., Wu C.W.;
RT   "Mucin mRNA expression in lung adenocarcinoma cell lines and tissues.";
RL   Oncology 53:118-126(1996).
RN   [25]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-46 (ISOFORMS 3 AND 4).
RC   TISSUE=Mammary carcinoma;
RA   Buluwela L., Liu Q., Luqmani Y.A., Gomm J.J., Coombes R.C.;
RL   Submitted (OCT-1992) to the EMBL/GenBank/DDBJ databases.
RN   [26]
RP   PROTEIN SEQUENCE OF 24-33; 28-37 AND 1098-1107, AND PROTEOLYTIC PROCESSING.
RX   PubMed=11341784; DOI=10.1006/bbrc.2001.4775;
RA   Parry S., Silverman H.S., McDermott K., Willis A., Hollingsworth M.A.,
RA   Harris A.;
RT   "Identification of MUC1 proteolytic cleavage sites in vivo.";
RL   Biochem. Biophys. Res. Commun. 283:715-720(2001).
RN   [27]
RP   PROTEIN SEQUENCE OF 1098-1111, PROTEOLYTIC CLEAVAGE, AND MUTAGENESIS OF
RP   SER-1098.
RX   PubMed=15987679; DOI=10.1074/jbc.m506047200;
RA   Levitin F., Stern O., Weiss M., Gil-Henn C., Ziv R., Prokocimer Z.,
RA   Smorodinsky N.I., Rubinstein D.B., Wreschner D.H.;
RT   "The MUC1 SEA module is a self-cleaving domain.";
RL   J. Biol. Chem. 280:33374-33386(2005).
RN   [28]
RP   PROTEIN SEQUENCE OF TANDEM REPEAT, IDENTIFICATION BY MASS SPECTROMETRY, AND
RP   GLYCOSYLATION.
RX   PubMed=10373415; DOI=10.1074/jbc.274.26.18165;
RA   Mueller S., Alving K., Peter-Katalinic J., Zachara N., Gooley A.A.,
RA   Hanisch F.-G.;
RT   "High density O-glycosylation on tandem repeat peptide from secretory MUC1
RT   of T47D breast cancer cells.";
RL   J. Biol. Chem. 274:18165-18172(1999).
RN   [29]
RP   PHOSPHORYLATION.
RX   PubMed=7988707; DOI=10.1016/0014-5793(94)01251-2;
RA   Zrihan-Licht S., Baruch A., Elroy-Stein O., Keydar I., Wreschner D.H.;
RT   "Tyrosine phosphorylation of the MUC1 breast cancer membrane proteins.
RT   Cytokine receptor-like molecules.";
RL   FEBS Lett. 356:130-136(1994).
RN   [30]
RP   IDENTIFICATION IN A COMPLEX WITH SOS1 AND GRB2, INTERACTION WITH GRB2 AND
RP   SOS1, AND PHOSPHORYLATION.
RX   PubMed=7664271;
RA   Pandey P., Kharbanda S., Kufe D.;
RT   "Association of the DF3/MUC1 breast cancer antigen with Grb2 and the
RT   Sos/Ras exchange protein.";
RL   Cancer Res. 55:4000-4003(1995).
RN   [31]
RP   GLYCOSYLATION AT THR-131 AND THR-139, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=7744025; DOI=10.1111/j.1432-1033.1995.0140l.x;
RA   Stadie T.R., Chai W., Lawson A.M., Byfield P.G., Hanisch F.G.;
RT   "Studies on the order and site specificity of GalNAc transfer to MUC1
RT   tandem repeats by UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase
RT   from milk or mammary carcinoma cells.";
RL   Eur. J. Biochem. 229:140-147(1995).
RN   [32]
RP   INTERACTION WITH CTNNB1 AND JUP, AND FUNCTION.
RX   PubMed=9139698; DOI=10.1074/jbc.272.19.12492;
RA   Yamamoto M., Bharti A., Li Y., Kufe D.;
RT   "Interaction of the DF3/MUC1 breast carcinoma-associated antigen and beta-
RT   catenin in cell adhesion.";
RL   J. Biol. Chem. 272:12492-12494(1997).
RN   [33]
RP   GLYCOSYLATION.
RX   PubMed=9312074; DOI=10.1074/jbc.272.40.24780;
RA   Mueller S., Goletz S., Packer N.H., Gooley A.A., Lawson A.M.,
RA   Hanisch F.-G.;
RT   "Localization of O-glycosylation sites on glycopeptide fragments from
RT   lactation-associated MUC1. All putative sites within the tandem repeat are
RT   glycosylation targets in vivo.";
RL   J. Biol. Chem. 272:24780-24793(1997).
RN   [34]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=9536947; DOI=10.1136/gut.42.2.220;
RA   Reid C.J., Harris A.;
RT   "Developmental expression of mucin genes in the human gastrointestinal
RT   system.";
RL   Gut 42:220-226(1998).
RN   [35]
RP   GLYCOSYLATION AT THR-131 AND THR-139, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=9597769;
RX   DOI=10.1002/(sici)1096-9888(199804)33:4<358::aid-jms642>3.0.co;2-3;
RA   Hanisch F.G., Green B.N., Bateman R., Peter-Katalinic J.;
RT   "Localization of O-glycosylation sites of MUC1 tandem repeats by QTOF ESI
RT   mass spectrometry.";
RL   J. Mass Spectrom. 33:358-362(1998).
RN   [36]
RP   INTERACTION WITH GSK3B AND CTNNB1, PHOSPHORYLATION AT SER-1227, AND
RP   MUTAGENESIS OF SER-1223 AND SER-1227.
RX   PubMed=9819408; DOI=10.1128/mcb.18.12.7216;
RA   Li Y., Bharti A., Chen D., Gong J., Kufe D.;
RT   "Interaction of glycogen synthase kinase 3beta with the DF3/MUC1 carcinoma-
RT   associated antigen and beta-catenin.";
RL   Mol. Cell. Biol. 18:7216-7224(1998).
RN   [37]
RP   CHARACTERIZATION (ISOFORM Y), AND MUTAGENESIS OF ASP-1116.
RX   PubMed=10197628;
RA   Baruch A., Hartmann M.-L., Yoeli M., Adereth Y., Greenstein S., Stadler Y.,
RA   Skornik Y., Zaretsky J., Smorodinsky N.I., Keydar I., Wreschner D.H.;
RT   "The breast cancer-associated MUC1 gene generates both a receptor and its
RT   cognate binding protein.";
RL   Cancer Res. 59:1552-1561(1999).
RN   [38]
RP   INTERACTION WITH ICAM1.
RX   PubMed=11173916; DOI=10.1159/000051917;
RA   Hayashi T., Takahashi T., Motoya S., Ishida T., Itoh F., Adachi M.,
RA   Hinoda Y., Imai K.;
RT   "MUC1 mucin core protein binds to the domain 1 of ICAM-1.";
RL   Digestion 63 Suppl. 1:87-92(2001).
RN   [39]
RP   SUBCELLULAR LOCATION.
RX   PubMed=11118479; DOI=10.1177/002215540104900107;
RA   Bennett R. Jr., Jaervelae T., Engelhardt P., Kostamovaara L., Sparks P.,
RA   Carpen O., Turunen O., Vaheri A.;
RT   "Mucin MUC1 is seen in cell surface protrusions together with ezrin in
RT   immunoelectron tomography and is concentrated at tips of filopodial
RT   protrusions in MCF-7 breast carcinoma cells.";
RL   J. Histochem. Cytochem. 49:67-77(2001).
RN   [40]
RP   INTERACTION WITH SRC; GSK3B AND CTNNB1, PHOSPHORYLATION AT TYR-1229, AND
RP   MUTAGENESIS OF TYR-1229.
RX   PubMed=11152665; DOI=10.1074/jbc.c000754200;
RA   Li Y., Kuwahara H., Ren J., Wen G., Kufe D.;
RT   "The c-Src tyrosine kinase regulates signaling of the human DF3/MUC1
RT   carcinoma-associated antigen with GSK3 beta and beta-catenin.";
RL   J. Biol. Chem. 276:6061-6064(2001).
RN   [41]
RP   POLYMORPHISM WITHIN THE REPEAT.
RX   PubMed=11350974; DOI=10.1074/jbc.m103187200;
RA   Engelmann K., Baldus S.E., Hanisch F.-G.;
RT   "Identification and topology of variant sequences within individual repeat
RT   domains of the human epithelial tumor mucin MUC1.";
RL   J. Biol. Chem. 276:27764-27769(2001).
RN   [42]
RP   INTERACTION WITH EGFR, PHOSPHORYLATION AT TYR-1229 BY EGFR, AND MUTAGENESIS
RP   OF TYR-1191; TYR-1203; TYR-1209; TYR-1218 AND TYR-1229.
RX   PubMed=11483589; DOI=10.1074/jbc.c100359200;
RA   Li Y., Ren J., Yu W., Li Q., Kuwahara H., Yin L., Carraway K.L. III,
RA   Kufe D.;
RT   "The epidermal growth factor receptor regulates interaction of the human
RT   DF3/MUC1 carcinoma antigen with c-Src and beta-catenin.";
RL   J. Biol. Chem. 276:35239-35242(2001).
RN   [43]
RP   PHOSPHORYLATION AT THR-1224, INTERACTION WITH PRKCD, FUNCTION, AND
RP   MUTAGENESIS OF SER-1223; THR-1224 AND SER-1227.
RX   PubMed=11877440; DOI=10.1074/jbc.m200436200;
RA   Ren J., Li Y., Kufe D.;
RT   "Protein kinase C delta regulates function of the DF3/MUC1 carcinoma
RT   antigen in beta-catenin signaling.";
RL   J. Biol. Chem. 277:17616-17622(2002).
RN   [44]
RP   PHOSPHORYLATION AT TYR-1203; TYR-1212; TYR-1229 AND TYR-1243.
RX   PubMed=14521915; DOI=10.1016/j.bbrc.2003.09.030;
RA   Wang H., Lillehoj E.P., Kim K.C.;
RT   "Identification of four sites of stimulated tyrosine phosphorylation in the
RT   MUC1 cytoplasmic tail.";
RL   Biochem. Biophys. Res. Commun. 310:341-346(2003).
RN   [45]
RP   INTERACTION WITH LYN, AND PHOSPHORYLATION.
RX   PubMed=12750561; DOI=10.4161/cbt.2.2.282;
RA   Li Y., Chen W., Ren J., Yu W.H., Li Q., Yoshida K., Kufe D.;
RT   "DF3/MUC1 signaling in multiple myeloma cells is regulated by interleukin-
RT   7.";
RL   Cancer Biol. Ther. 2:187-193(2003).
RN   [46]
RP   INTERACTION WITH CTNNB1, FUNCTION, AND MUTAGENESIS OF TYR-1229.
RX   PubMed=14688481;
RA   Huang L., Ren J., Chen D., Li Y., Kharbanda S., Kufe D.;
RT   "MUC1 cytoplasmic domain coactivates Wnt target gene transcription and
RT   confers transformation.";
RL   Cancer Biol. Ther. 2:702-706(2003).
RN   [47]
RP   INTERACTION WITH ADAM17, AND CLEAVAGE.
RX   PubMed=12441351; DOI=10.1074/jbc.m208326200;
RA   Thathiah A., Blobel C.P., Carson D.D.;
RT   "Tumor necrosis factor-alpha converting enzyme/ADAM 17 mediates MUC1
RT   shedding.";
RL   J. Biol. Chem. 278:3386-3394(2003).
RN   [48]
RP   INTERACTION WITH CTNNB1, AND SUBCELLULAR LOCATION.
RX   PubMed=12832415; DOI=10.1074/jbc.m304333200;
RA   Wen Y., Caffrey T.C., Wheelock M.J., Johnson K.R., Hollingsworth M.A.;
RT   "Nuclear association of the cytoplasmic tail of MUC1 and beta-catenin.";
RL   J. Biol. Chem. 278:38029-38039(2003).
RN   [49]
RP   INTERACTION WITH ERBB2; ERBB3 AND ERBB4, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF 1187-ARG--LYS-1189.
RX   PubMed=12939402;
RA   Li Y., Yu W.-H., Ren J., Chen W., Huang L., Kharbanda S., Loda M., Kufe D.;
RT   "Heregulin targets gamma-catenin to the nucleolus by a mechanism dependent
RT   on the DF3/MUC1 oncoprotein.";
RL   Mol. Cancer Res. 1:765-775(2003).
RN   [50]
RP   INTERACTION WITH AP1S2 AND GRB2, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   TYR-1191; TYR-1203; TYR-1229 AND TYR-1243.
RX   PubMed=15471854; DOI=10.1074/jbc.m409360200;
RA   Kinlough C.L., Poland P.A., Bruns J.B., Harkleroad K.L., Hughey R.P.;
RT   "MUC1 membrane trafficking is modulated by multiple interactions.";
RL   J. Biol. Chem. 279:53071-53077(2004).
RN   [51]
RP   INTERACTION WITH TP53, AND FUNCTION.
RX   PubMed=15710329; DOI=10.1016/j.ccr.2005.01.008;
RA   Wei X., Xu H., Kufe D.;
RT   "Human MUC1 oncoprotein regulates p53-responsive gene transcription in the
RT   genotoxic stress response.";
RL   Cancer Cell 7:167-178(2005).
RN   [52]
RP   INTERACTION WITH GSK3B, PHOSPHORYLATION, AND FUNCTION.
RX   PubMed=16288032; DOI=10.1158/0008-5472.can-05-2474;
RA   Huang L., Chen D., Liu D., Yin L., Kharbanda S., Kufe D.;
RT   "MUC1 oncoprotein blocks glycogen synthase kinase 3beta-mediated
RT   phosphorylation and degradation of beta-catenin.";
RL   Cancer Res. 65:10413-10422(2005).
RN   [53]
RP   ERRATUM OF PUBMED:16288032.
RA   Kinlough C.L., Poland P.A., Bruns J.B., Harkleroad K.L., Hughey R.P.;
RL   J. Biol. Chem. 280:28827-28827(2005).
RN   [54]
RP   STRUCTURE OF CARBOHYDRATES, IDENTIFICATION BY MASS SPECTROMETRY, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=15972891; DOI=10.1093/glycob/cwi099;
RA   Engelmann K., Kinlough C.L., Muller S., Razawi H., Baldus S.E.,
RA   Hughey R.P., Hanisch F.-G.;
RT   "Transmembrane and secreted MUC1 probes show trafficking-dependent changes
RT   in O-glycan core profiles.";
RL   Glycobiology 15:1111-1124(2005).
RN   [55]
RP   INTERACTION WITH LCK, PHOSPHORYLATION, FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=15513966; DOI=10.1189/jlb.0604333;
RA   Mukherjee P., Tinder T.L., Basu G.D., Gendler S.J.;
RT   "MUC1 (CD227) interacts with lck tyrosine kinase in Jurkat lymphoma cells
RT   and normal T cells.";
RL   J. Leukoc. Biol. 77:90-99(2005).
RN   [56]
RP   PALMITOYLATION AT CYS-1184 AND CYS-1186, SUBCELLULAR LOCATION, INTERACTION
RP   WITH AP1S1 AND AP1S2, AND MUTAGENESIS OF CYS-1184; CYS-1186; TYR-1203 AND
RP   1187-ARG--LYS-1189.
RX   PubMed=16507569; DOI=10.1074/jbc.m512996200;
RA   Kinlough C.L., McMahan R.J., Poland P.A., Bruns J.B., Harkleroad K.L.,
RA   Stremple R.J., Kashlan O.B., Weixel K.M., Weisz O.A., Hughey R.P.;
RT   "Recycling of MUC1 is dependent on its palmitoylation.";
RL   J. Biol. Chem. 281:12112-12122(2006).
RN   [57]
RP   INTERACTION WITH ESR1.
RX   PubMed=16427018; DOI=10.1016/j.molcel.2005.11.030;
RA   Wei X., Xu H., Kufe D.;
RT   "MUC1 oncoprotein stabilizes and activates estrogen receptor alpha.";
RL   Mol. Cell 21:295-305(2006).
RN   [58]
RP   INTERACTION WITH CTNNB1, SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=17524503; DOI=10.1016/j.bbamcr.2007.04.009;
RA   Lillehoj E.P., Lu W., Kiser T., Goldblum S.E., Kim K.C.;
RT   "MUC1 inhibits cell proliferation by a beta-catenin-dependent mechanism.";
RL   Biochim. Biophys. Acta 1773:1028-1038(2007).
RN   [59]
RP   INTERACTION WITH KLF4, AND FUNCTION.
RX   PubMed=17308127; DOI=10.1158/0008-5472.can-06-3063;
RA   Wei X., Xu H., Kufe D.;
RT   "Human mucin 1 oncoprotein represses transcription of the p53 tumor
RT   suppressor gene.";
RL   Cancer Res. 67:1853-1858(2007).
RN   [60]
RP   PHOSPHORYLATION AT TYR-1203; TYR-1218 AND TYR-1229, MUTAGENESIS OF TYR-1203
RP   AND TYR-1218, SUBCELLULAR LOCATION, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=17545600; DOI=10.1158/0008-5472.can-06-4647;
RA   Singh P.K., Wen Y., Swanson B.J., Shanmugam K., Kazlauskas A., Cerny R.L.,
RA   Gendler S.J., Hollingsworth M.A.;
RT   "Platelet-derived growth factor receptor beta-mediated phosphorylation of
RT   MUC1 enhances invasiveness in pancreatic adenocarcinoma cells.";
RL   Cancer Res. 67:5201-5210(2007).
RN   [61]
RP   INTERACTION WITH EGFR, AND FUNCTION.
RX   PubMed=16983337; DOI=10.1038/sj.onc.1209976;
RA   Pochampalli M.R., el Bejjani R.M., Schroeder J.A.;
RT   "MUC1 is a novel regulator of ErbB1 receptor trafficking.";
RL   Oncogene 26:1693-1701(2007).
RN   [62]
RP   MARKER IN BREAST CANCER.
RX   PubMed=20816948; DOI=10.1016/j.cca.2010.08.039;
RA   Duffy M.J., Evoy D., McDermott E.W.;
RT   "CA 15-3: uses and limitation as a biomarker for breast cancer.";
RL   Clin. Chim. Acta 411:1869-1874(2010).
RN   [63]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1227, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [64]
RP   INVOLVEMENT IN MCKD1.
RX   PubMed=23396133; DOI=10.1038/ng.2543;
RA   Kirby A., Gnirke A., Jaffe D.B., Baresova V., Pochet N., Blumenstiel B.,
RA   Ye C., Aird D., Stevens C., Robinson J.T., Cabili M.N., Gat-Viks I.,
RA   Kelliher E., Daza R., DeFelice M., Hulkova H., Sovova J., Vylet'al P.,
RA   Antignac C., Guttman M., Handsaker R.E., Perrin D., Steelman S.,
RA   Sigurdsson S., Scheinman S.J., Sougnez C., Cibulskis K., Parkin M.,
RA   Green T., Rossin E., Zody M.C., Xavier R.J., Pollak M.R., Alper S.L.,
RA   Lindblad-Toh K., Gabriel S., Hart P.S., Regev A., Nusbaum C., Kmoch S.,
RA   Bleyer A.J., Lander E.S., Daly M.J.;
RT   "Mutations causing medullary cystic kidney disease type 1 lie in a large
RT   VNTR in MUC1 missed by massively parallel sequencing.";
RL   Nat. Genet. 45:299-303(2013).
RN   [65]
RP   STRUCTURE BY NMR OF 1041-1097 AND 1098-1152 OF WILD TYPE AND MUTANT
RP   ALA-1098, IDENTIFICATION BY MASS SPECTROMETRY, STRUCTURE OF CARBOHYDRATES,
RP   AND AUTOCATALYTIC CLEAVAGE.
RX   PubMed=16585136; DOI=10.1093/glycob/cwj110;
RA   Parry S., Hanisch F.G., Leir S.H., Sutton-Smith M., Morris H.R., Dell A.,
RA   Harris A.;
RT   "N-glycosylation of the MUC1 mucin in epithelial cells and secretions.";
RL   Glycobiology 16:623-634(2006).
CC   -!- FUNCTION: The alpha subunit has cell adhesive properties. Can act both
CC       as an adhesion and an anti-adhesion protein. May provide a protective
CC       layer on epithelial cells against bacterial and enzyme attack.
CC   -!- FUNCTION: The beta subunit contains a C-terminal domain which is
CC       involved in cell signaling, through phosphorylations and protein-
CC       protein interactions. Modulates signaling in ERK, SRC and NF-kappa-B
CC       pathways. In activated T-cells, influences directly or indirectly the
CC       Ras/MAPK pathway. Promotes tumor progression. Regulates TP53-mediated
CC       transcription and determines cell fate in the genotoxic stress
CC       response. Binds, together with KLF4, the PE21 promoter element of TP53
CC       and represses TP53 activity.
CC   -!- SUBUNIT: The alpha subunit forms a tight, non-covalent heterodimeric
CC       complex with the proteolytically-released beta-subunit. Interaction,
CC       via the tandem repeat region, with domain 1 of ICAM1 is implicated in
CC       cell migration and metastases. Isoform 1 binds directly the SH2 domain
CC       of GRB2, and forms a MUC1/GRB2/SOS1 complex involved in RAS signaling.
CC       The cytoplasmic tail (MUC1CT) interacts with several proteins such as
CC       SRC, CTNNB1 and ERBs. Interaction with the SH2 domain of CSK decreases
CC       interaction with GSK3B. Interacts with CTNNB1/beta-catenin and
CC       JUP/gamma-catenin and promotes cell adhesion. Interaction with
CC       JUP/gamma-catenin is induced by heregulin. Binds PRKCD, ERBB2, ERBB3
CC       and ERBB4. Heregulin (HRG) stimulates the interaction with ERBB2 and,
CC       to a much lesser extent, the interaction with ERBB3 and ERBB4.
CC       Interacts with P53 in response to DNA damage. Interacts with KLF4.
CC       Interacts with estrogen receptor alpha/ESR1, through its DNA-binding
CC       domain, and stimulates its transcription activity. Binds ADAM17.
CC       Isoform ZD forms disulfide-linked oligomers.
CC       {ECO:0000269|PubMed:11152665, ECO:0000269|PubMed:11173916,
CC       ECO:0000269|PubMed:11483589, ECO:0000269|PubMed:11877440,
CC       ECO:0000269|PubMed:12441351, ECO:0000269|PubMed:12750561,
CC       ECO:0000269|PubMed:12832415, ECO:0000269|PubMed:12939402,
CC       ECO:0000269|PubMed:14688481, ECO:0000269|PubMed:15471854,
CC       ECO:0000269|PubMed:15513966, ECO:0000269|PubMed:15710329,
CC       ECO:0000269|PubMed:16288032, ECO:0000269|PubMed:16427018,
CC       ECO:0000269|PubMed:16507569, ECO:0000269|PubMed:16983337,
CC       ECO:0000269|PubMed:17308127, ECO:0000269|PubMed:17524503,
CC       ECO:0000269|PubMed:7664271, ECO:0000269|PubMed:9139698,
CC       ECO:0000269|PubMed:9819408}.
CC   -!- INTERACTION:
CC       P15941; P15941-7; NbExp=2; IntAct=EBI-2804728, EBI-4396776;
CC       P15941; P00519: ABL1; NbExp=8; IntAct=EBI-2804728, EBI-375543;
CC       P15941-11; Q08AM2: ADAM33; NbExp=3; IntAct=EBI-17263240, EBI-10225815;
CC       P15941-11; O60242: ADGRB3; NbExp=3; IntAct=EBI-17263240, EBI-2682765;
CC       P15941-11; Q15848: ADIPOQ; NbExp=3; IntAct=EBI-17263240, EBI-10827839;
CC       P15941-11; Q86W74-2: ANKRD46; NbExp=3; IntAct=EBI-17263240, EBI-12109402;
CC       P15941-11; P02652: APOA2; NbExp=3; IntAct=EBI-17263240, EBI-1171525;
CC       P15941-11; P05067-2: APP; NbExp=3; IntAct=EBI-17263240, EBI-17264467;
CC       P15941-11; P29972: AQP1; NbExp=3; IntAct=EBI-17263240, EBI-745213;
CC       P15941-11; P41181: AQP2; NbExp=3; IntAct=EBI-17263240, EBI-12701138;
CC       P15941-11; Q92482: AQP3; NbExp=3; IntAct=EBI-17263240, EBI-2808854;
CC       P15941-11; Q9H2C2: ARV1; NbExp=3; IntAct=EBI-17263240, EBI-11724186;
CC       P15941-11; Q92843: BCL2L2; NbExp=3; IntAct=EBI-17263240, EBI-707714;
CC       P15941-11; Q6PL45-2: BRICD5; NbExp=3; IntAct=EBI-17263240, EBI-12244618;
CC       P15941-11; Q8WVV5: BTN2A2; NbExp=3; IntAct=EBI-17263240, EBI-8648738;
CC       P15941-11; P06681: C2; NbExp=3; IntAct=EBI-17263240, EBI-2835920;
CC       P15941-11; O14523: C2CD2L; NbExp=3; IntAct=EBI-17263240, EBI-12822627;
CC       P15941-11; Q06432: CACNG1; NbExp=3; IntAct=EBI-17263240, EBI-9686780;
CC       P15941-11; Q9P0B6: CCDC167; NbExp=3; IntAct=EBI-17263240, EBI-9083477;
CC       P15941-11; Q08722-3: CD47; NbExp=3; IntAct=EBI-17263240, EBI-17263290;
CC       P15941-11; P19397: CD53; NbExp=3; IntAct=EBI-17263240, EBI-6657396;
CC       P15941-11; P34810: CD68; NbExp=3; IntAct=EBI-17263240, EBI-2826276;
CC       PRO_0000317447; P17676: CEBPB; NbExp=8; IntAct=EBI-10053698, EBI-969696;
CC       P15941-11; Q8N6F1-2: CLDN19; NbExp=3; IntAct=EBI-17263240, EBI-12256978;
CC       P15941-11; P56747: CLDN6; NbExp=3; IntAct=EBI-17263240, EBI-12955011;
CC       P15941-11; Q8NHS1: CLDND2; NbExp=3; IntAct=EBI-17263240, EBI-11959453;
CC       P15941-11; Q96FZ5: CMTM7; NbExp=3; IntAct=EBI-17263240, EBI-2807956;
CC       P15941-11; Q4VAQ0: COL8A2; NbExp=3; IntAct=EBI-17263240, EBI-10241815;
CC       P15941-11; Q8N6G5: CSGALNACT2; NbExp=3; IntAct=EBI-17263240, EBI-10267100;
CC       P15941-11; Q07325: CXCL9; NbExp=3; IntAct=EBI-17263240, EBI-3911467;
CC       P15941-11; O43169: CYB5B; NbExp=3; IntAct=EBI-17263240, EBI-1058710;
CC       P15941-11; P78329: CYP4F2; NbExp=3; IntAct=EBI-17263240, EBI-1752413;
CC       P15941-11; P56851: EDDM3B; NbExp=3; IntAct=EBI-17263240, EBI-10215665;
CC       P15941; P00533: EGFR; NbExp=4; IntAct=EBI-2804728, EBI-297353;
CC       P15941-11; Q9BV81: EMC6; NbExp=3; IntAct=EBI-17263240, EBI-2820492;
CC       P15941-11; P54852: EMP3; NbExp=3; IntAct=EBI-17263240, EBI-3907816;
CC       P15941-11; O75355-2: ENTPD3; NbExp=3; IntAct=EBI-17263240, EBI-12279764;
CC       P15941-11; Q9UKR5: ERG28; NbExp=3; IntAct=EBI-17263240, EBI-711490;
CC       P15941-11; P01350: GAST; NbExp=3; IntAct=EBI-17263240, EBI-3436637;
CC       P15941-11; P39905-3: GDNF; NbExp=3; IntAct=EBI-17263240, EBI-12702062;
CC       P15941-11; Q9Y3E0: GOLT1B; NbExp=3; IntAct=EBI-17263240, EBI-4402607;
CC       P15941-11; Q9NPR9: GPR108; NbExp=3; IntAct=EBI-17263240, EBI-11343451;
CC       P15941-11; Q9HCP6: HHATL; NbExp=3; IntAct=EBI-17263240, EBI-5916693;
CC       P15941-11; O60725: ICMT; NbExp=3; IntAct=EBI-17263240, EBI-11721771;
CC       P15941-11; Q9Y5U4: INSIG2; NbExp=3; IntAct=EBI-17263240, EBI-8503746;
CC       P15941-11; P11215: ITGAM; NbExp=3; IntAct=EBI-17263240, EBI-2568251;
CC       P15941-11; Q969L2: MAL2; NbExp=3; IntAct=EBI-17263240, EBI-944295;
CC       P15941-11; Q13021: MALL; NbExp=3; IntAct=EBI-17263240, EBI-750078;
CC       P15941-11; Q9P0N8: MARCH2; NbExp=3; IntAct=EBI-17263240, EBI-10317612;
CC       P15941; P08581: MET; NbExp=2; IntAct=EBI-2804728, EBI-1039152;
CC       P15941-11; Q6N075: MFSD5; NbExp=3; IntAct=EBI-17263240, EBI-3920969;
CC       P15941-11; P30301: MIP; NbExp=3; IntAct=EBI-17263240, EBI-8449636;
CC       P15941-11; Q96S97: MYADM; NbExp=3; IntAct=EBI-17263240, EBI-13301517;
CC       P15941-11; O95167: NDUFA3; NbExp=3; IntAct=EBI-17263240, EBI-1246131;
CC       P15941-11; Q99519: NEU1; NbExp=3; IntAct=EBI-17263240, EBI-721517;
CC       P15941-11; Q92982: NINJ1; NbExp=3; IntAct=EBI-17263240, EBI-2802124;
CC       P15941-11; Q9NZG7: NINJ2; NbExp=3; IntAct=EBI-17263240, EBI-10317425;
CC       P15941-11; Q16617: NKG7; NbExp=3; IntAct=EBI-17263240, EBI-3919611;
CC       P15941-11; Q8N912: NRAC; NbExp=3; IntAct=EBI-17263240, EBI-12051377;
CC       P15941-11; Q8NH19: OR10AG1; NbExp=3; IntAct=EBI-17263240, EBI-13339917;
CC       P15941-11; Q6TCH4: PAQR6; NbExp=3; IntAct=EBI-17263240, EBI-17265310;
CC       P15941-11; P26678: PLN; NbExp=3; IntAct=EBI-17263240, EBI-692836;
CC       P15941-11; P60201-2: PLP1; NbExp=3; IntAct=EBI-17263240, EBI-12188331;
CC       P15941-11; Q8IY26: PLPP6; NbExp=3; IntAct=EBI-17263240, EBI-11721828;
CC       P15941-11; P54315: PNLIPRP1; NbExp=3; IntAct=EBI-17263240, EBI-8652812;
CC       P15941-11; Q59EV6: PPGB; NbExp=3; IntAct=EBI-17263240, EBI-14210385;
CC       P15941-11; P30405: PPIF; NbExp=3; IntAct=EBI-17263240, EBI-5544229;
CC       P15941-11; Q96AA3: RFT1; NbExp=3; IntAct=EBI-17263240, EBI-6269616;
CC       P15941-11; Q02161-2: RHD; NbExp=3; IntAct=EBI-17263240, EBI-17249212;
CC       P15941-11; Q8TAC9: SCAMP5; NbExp=3; IntAct=EBI-17263240, EBI-2695784;
CC       P15941-11; Q9Y6D0: SELENOK; NbExp=3; IntAct=EBI-17263240, EBI-9679163;
CC       P15941-11; Q8N6R1: SERP2; NbExp=3; IntAct=EBI-17263240, EBI-749270;
CC       P15941-11; P11686: SFTPC; NbExp=3; IntAct=EBI-17263240, EBI-10197617;
CC       P15941-11; Q8IWU4: SLC30A8; NbExp=3; IntAct=EBI-17263240, EBI-10262251;
CC       P15941-11; Q969S0: SLC35B4; NbExp=3; IntAct=EBI-17263240, EBI-10281213;
CC       P15941-11; Q6ICL7: SLC35E4; NbExp=3; IntAct=EBI-17263240, EBI-12867720;
CC       P15941-11; Q9NVC3: SLC38A7; NbExp=3; IntAct=EBI-17263240, EBI-10314552;
CC       P15941-11; Q9NRQ5: SMCO4; NbExp=3; IntAct=EBI-17263240, EBI-8640191;
CC       P15941-11; B2RUZ4: SMIM1; NbExp=3; IntAct=EBI-17263240, EBI-12188413;
CC       P15941-11; Q9NZ01: TECR; NbExp=3; IntAct=EBI-17263240, EBI-2877718;
CC       P15941-11; P07204: THBD; NbExp=3; IntAct=EBI-17263240, EBI-941422;
CC       P15941-11; Q9BZW4: TM6SF2; NbExp=3; IntAct=EBI-17263240, EBI-13082040;
CC       P15941-11; P17152: TMEM11; NbExp=3; IntAct=EBI-17263240, EBI-723946;
CC       P15941-11; A0PK00: TMEM120B; NbExp=3; IntAct=EBI-17263240, EBI-10171534;
CC       P15941-11; Q9BTD3: TMEM121; NbExp=3; IntAct=EBI-17263240, EBI-12155101;
CC       P15941-11; Q5BJH2-2: TMEM128; NbExp=3; IntAct=EBI-17263240, EBI-10694905;
CC       P15941-11; Q9BVK8: TMEM147; NbExp=3; IntAct=EBI-17263240, EBI-348587;
CC       P15941-11; Q9Y6G1: TMEM14A; NbExp=3; IntAct=EBI-17263240, EBI-2800360;
CC       P15941-11; Q9P0S9: TMEM14C; NbExp=3; IntAct=EBI-17263240, EBI-2339195;
CC       P15941-11; Q14656: TMEM187; NbExp=3; IntAct=EBI-17263240, EBI-13046724;
CC       P15941-11; Q8NBD8: TMEM229B; NbExp=3; IntAct=EBI-17263240, EBI-12195227;
CC       P15941-11; Q9BU79: TMEM243; NbExp=3; IntAct=EBI-17263240, EBI-12887458;
CC       P15941-11; Q8N2M4: TMEM86A; NbExp=3; IntAct=EBI-17263240, EBI-12015604;
CC       P15941-11; Q8N661: TMEM86B; NbExp=3; IntAct=EBI-17263240, EBI-2548832;
CC       P15941-11; Q5BJF2: TMEM97; NbExp=3; IntAct=EBI-17263240, EBI-12111910;
CC       P15941-11; Q9Y2Y6: TMEM98; NbExp=3; IntAct=EBI-17263240, EBI-7333781;
CC       P15941-11; O14763: TNFRSF10B; NbExp=3; IntAct=EBI-17263240, EBI-518882;
CC       P15941-11; Q8N609: TRAM1L1; NbExp=3; IntAct=EBI-17263240, EBI-11996766;
CC       P15941-11; Q5BVD1: TTMP; NbExp=3; IntAct=EBI-17263240, EBI-10243654;
CC       P15941; P26368: U2AF2; NbExp=2; IntAct=EBI-2804728, EBI-742339;
CC       P15941-11; Q53HI1: UNC50; NbExp=3; IntAct=EBI-17263240, EBI-7601760;
CC       P15941-11; O95183: VAMP5; NbExp=3; IntAct=EBI-17263240, EBI-10191195;
CC       P15941-11; Q9BQB6: VKORC1; NbExp=3; IntAct=EBI-17263240, EBI-6256462;
CC       P15941-11; Q8IVQ6: ZDHHC21; NbExp=3; IntAct=EBI-17263240, EBI-2849773;
CC   -!- SUBCELLULAR LOCATION: Apical cell membrane
CC       {ECO:0000269|PubMed:11118479, ECO:0000269|PubMed:12832415,
CC       ECO:0000269|PubMed:12939402, ECO:0000269|PubMed:15471854,
CC       ECO:0000269|PubMed:15972891, ECO:0000269|PubMed:16507569,
CC       ECO:0000269|PubMed:17524503, ECO:0000269|PubMed:17545600}; Single-pass
CC       type I membrane protein {ECO:0000269|PubMed:11118479,
CC       ECO:0000269|PubMed:12832415, ECO:0000269|PubMed:12939402,
CC       ECO:0000269|PubMed:15471854, ECO:0000269|PubMed:15972891,
CC       ECO:0000269|PubMed:16507569, ECO:0000269|PubMed:17524503,
CC       ECO:0000269|PubMed:17545600}. Note=Exclusively located in the apical
CC       domain of the plasma membrane of highly polarized epithelial cells.
CC       After endocytosis, internalized and recycled to the cell membrane.
CC       Located to microvilli and to the tips of long filopodial protusions.
CC   -!- SUBCELLULAR LOCATION: [Isoform 5]: Secreted.
CC   -!- SUBCELLULAR LOCATION: [Isoform Y]: Secreted.
CC   -!- SUBCELLULAR LOCATION: [Isoform 9]: Secreted.
CC   -!- SUBCELLULAR LOCATION: [Mucin-1 subunit beta]: Cell membrane. Cytoplasm.
CC       Nucleus. Note=On EGF and PDGFRB stimulation, transported to the nucleus
CC       through interaction with CTNNB1, a process which is stimulated by
CC       phosphorylation. On HRG stimulation, colocalizes with JUP/gamma-catenin
CC       at the nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=17;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1; Synonyms=A;
CC         IsoId=P15941-1; Sequence=Displayed;
CC       Name=2; Synonyms=B;
CC         IsoId=P15941-2; Sequence=VSP_003280;
CC       Name=3; Synonyms=C;
CC         IsoId=P15941-3; Sequence=VSP_003281;
CC       Name=4; Synonyms=D;
CC         IsoId=P15941-4; Sequence=VSP_003282;
CC       Name=5; Synonyms=SEC;
CC         IsoId=P15941-5; Sequence=VSP_003288, VSP_003289;
CC       Name=6; Synonyms=X;
CC         IsoId=P15941-6; Sequence=VSP_003283, VSP_003284;
CC       Name=Y; Synonyms=MUC1/Y;
CC         IsoId=P15941-7; Sequence=VSP_003285;
CC       Name=8; Synonyms=Z;
CC         IsoId=P15941-8; Sequence=VSP_003286;
CC       Name=9; Synonyms=S;
CC         IsoId=P15941-9; Sequence=VSP_003286, VSP_003287;
CC       Name=F;
CC         IsoId=P15941-10; Sequence=VSP_035046, VSP_035047;
CC       Name=Y-LSP;
CC         IsoId=P15941-11; Sequence=VSP_003280, VSP_003285;
CC       Name=S2;
CC         IsoId=P15941-12; Sequence=VSP_003280, VSP_003285, VSP_003287;
CC       Name=M6;
CC         IsoId=P15941-13; Sequence=VSP_003286, VSP_046962, VSP_046963;
CC       Name=ZD; Synonyms=J19;
CC         IsoId=P15941-14; Sequence=VSP_047575, VSP_047576;
CC       Name=T10;
CC         IsoId=P15941-15; Sequence=VSP_003280, VSP_047873;
CC       Name=E2;
CC         IsoId=P15941-16; Sequence=VSP_003280, VSP_047872;
CC       Name=J13;
CC         IsoId=P15941-17; Sequence=VSP_003280, VSP_003285, VSP_047874;
CC   -!- TISSUE SPECIFICITY: Expressed on the apical surface of epithelial
CC       cells, especially of airway passages, breast and uterus. Also expressed
CC       in activated and unactivated T-cells. Overexpressed in epithelial
CC       tumors, such as breast or ovarian cancer and also in non-epithelial
CC       tumor cells. Isoform Y is expressed in tumor cells only.
CC       {ECO:0000269|PubMed:15513966, ECO:0000269|PubMed:9212228}.
CC   -!- DEVELOPMENTAL STAGE: During fetal development, expressed at low levels
CC       in the colonic epithelium from 13 weeks of gestation.
CC       {ECO:0000269|PubMed:9536947}.
CC   -!- PTM: Highly glycosylated (N- and O-linked carbohydrates and sialic
CC       acid). O-glycosylated to a varying degree on serine and threonine
CC       residues within each tandem repeat, ranging from mono- to penta-
CC       glycosylation. The average density ranges from about 50% in human milk
CC       to over 90% in T47D breast cancer cells. Further sialylation occurs
CC       during recycling. Membrane-shed glycoproteins from kidney and breast
CC       cancer cells have preferentially sialyated core 1 structures, while
CC       secreted forms from the same tissues display mainly core 2 structures.
CC       The O-glycosylated content is overlapping in both these tissues with
CC       terminal fucose and galactose, 2- and 3-linked galactose, 3- and 3,6-
CC       linked GalNAc-ol and 4-linked GlcNAc predominating. Differentially O-
CC       glycosylated in breast carcinomas with 3,4-linked GlcNAc. N-
CC       glycosylation consists of high-mannose, acidic complex-type and hybrid
CC       glycans in the secreted form MUC1/SEC, and neutral complex-type in the
CC       transmembrane form, MUC1/TM. {ECO:0000269|PubMed:10373415,
CC       ECO:0000269|PubMed:7744025, ECO:0000269|PubMed:9312074,
CC       ECO:0000269|PubMed:9597769}.
CC   -!- PTM: Proteolytic cleavage in the SEA domain occurs in the endoplasmic
CC       reticulum by an autoproteolytic mechanism and requires the full-length
CC       SEA domain as well as requiring a Ser, Thr or Cys residue at the P + 1
CC       site. Cleavage at this site also occurs on isoform MUC1/X but not on
CC       isoform MUC1/Y. Ectodomain shedding is mediated by ADAM17.
CC       {ECO:0000269|PubMed:11341784, ECO:0000269|PubMed:12441351,
CC       ECO:0000269|PubMed:15987679}.
CC   -!- PTM: Dual palmitoylation on cysteine residues in the CQC motif is
CC       required for recycling from endosomes back to the plasma membrane.
CC       {ECO:0000269|PubMed:16507569}.
CC   -!- PTM: Phosphorylated on tyrosines and serine residues in the C-terminal.
CC       Phosphorylation on tyrosines in the C-terminal increases the nuclear
CC       location of MUC1 and beta-catenin. Phosphorylation by PKC delta induces
CC       binding of MUC1 to beta-catenin/CTNNB1 and thus decreases the formation
CC       of the beta-catenin/E-cadherin complex. Src-mediated phosphorylation
CC       inhibits interaction with GSK3B. Src- and EGFR-mediated phosphorylation
CC       on Tyr-1229 increases binding to beta-catenin/CTNNB1. GSK3B-mediated
CC       phosphorylation on Ser-1227 decreases this interaction but restores the
CC       formation of the beta-cadherin/E-cadherin complex. On T-cell receptor
CC       activation, phosphorylated by LCK. PDGFR-mediated phosphorylation
CC       increases nuclear colocalization of MUC1CT and CTNNB1.
CC       {ECO:0000269|PubMed:11152665, ECO:0000269|PubMed:11483589,
CC       ECO:0000269|PubMed:11877440, ECO:0000269|PubMed:12750561,
CC       ECO:0000269|PubMed:14521915, ECO:0000269|PubMed:15513966,
CC       ECO:0000269|PubMed:16288032, ECO:0000269|PubMed:17545600,
CC       ECO:0000269|PubMed:7664271, ECO:0000269|PubMed:7988707,
CC       ECO:0000269|PubMed:9819408}.
CC   -!- PTM: The N-terminal sequence has been shown to begin at position 24 or
CC       28. {ECO:0000269|PubMed:11341784}.
CC   -!- POLYMORPHISM: The number of repeats is highly polymorphic. It varies
CC       from 21 to 125 in the northern European population. The most frequent
CC       alleles contains 41 and 85 repeats. The tandemly repeated icosapeptide
CC       underlies polymorphism at three positions:
CC       PAPGSTAP[PAQT]AHGVTSAP[DT/ES]R, DT -> ES and the single replacements P
CC       -> A, P -> Q and P-> T. The most frequent replacement DT -> ES occurs
CC       in up to 50% of the repeats.
CC   -!- DISEASE: Note=MUC1/CA 15-3 is used as a serological clinical marker of
CC       breast cancer to monitor response to breast cancer treatment and
CC       disease recurrence (PubMed:20816948). Decreased levels over time may be
CC       indicative of a positive response to treatment. Conversely, increased
CC       levels may indicate disease progression. At an early stage disease,
CC       only 21% of patients exhibit high MUC1/CA 15-3 levels, that is why CA
CC       15-3 is not a useful screening test. Most antibodies target the highly
CC       immunodominant core peptide domain of 20 amino acid
CC       (APDTRPAPGSTAPPAHGVTS) tandem repeats. Some antibodies recognize
CC       glycosylated epitopes. {ECO:0000269|PubMed:20816948}.
CC   -!- DISEASE: Medullary cystic kidney disease 1 (MCKD1) [MIM:174000]: A form
CC       of tubulointerstitial nephropathy characterized by formation of renal
CC       cysts at the corticomedullary junction. It is characterized by adult
CC       onset of impaired renal function and salt wasting resulting in end-
CC       stage renal failure by the sixth decade. {ECO:0000269|PubMed:23396133}.
CC       Note=The disease is caused by mutations affecting the gene represented
CC       in this entry.
CC   -!- MISCELLANEOUS: The name KL-6 was originally that of a murine monoclonal
CC       antibody reacting with pulmonary adenocarcinoma cell lines and
CC       pulmonary epithelial cells. This antibody recognizes a sialylated
CC       carbohydrate chain on MUC1.
CC   -!- MISCELLANEOUS: [Isoform Y-LSP]: Lacks the mucin repeats. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform ZD]: Lacks the mucin repeats. Exists as a
CC       disulfide-linked oligomer. {ECO:0000305}.
CC   -!- CAUTION: O-glycosylation sites are annotated in first sequence repeat
CC       only. Residues at similar position are probably glycosylated in all
CC       repeats. Experimental sites were determined in a synthetic peptide
CC       glycosylated in vitro (PubMed:7744025, PubMed:9597769).
CC       {ECO:0000305|PubMed:7744025, ECO:0000305|PubMed:9597769}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD14369.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAD14376.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Mucin database;
CC       URL="http://www.medkem.gu.se/mucinbiology/databases/";
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/muc1/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J05582; AAA60019.1; -; mRNA.
DR   EMBL; M32738; AAA35804.1; -; mRNA.
DR   EMBL; M32739; AAA35806.1; -; mRNA.
DR   EMBL; M34089; AAA35807.1; -; mRNA.
DR   EMBL; M34088; AAA35805.1; -; mRNA.
DR   EMBL; J05581; AAA59876.1; -; mRNA.
DR   EMBL; M61170; AAB53150.1; -; Genomic_DNA.
DR   EMBL; X52229; CAA36478.1; ALT_SEQ; mRNA.
DR   EMBL; X52228; CAA36477.1; ALT_SEQ; mRNA.
DR   EMBL; M35093; AAB59612.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; X80761; CAA56734.1; -; mRNA.
DR   EMBL; U60259; AAD10856.1; -; mRNA.
DR   EMBL; U60260; AAD10857.1; -; mRNA.
DR   EMBL; U60261; AAD10858.1; -; mRNA.
DR   EMBL; AF125525; AAD27842.1; -; mRNA.
DR   EMBL; AY466157; AAR28764.1; -; mRNA.
DR   EMBL; AY327582; AAP97013.1; -; mRNA.
DR   EMBL; AY327584; AAP97015.1; -; mRNA.
DR   EMBL; AY327586; AAP97017.1; -; mRNA.
DR   EMBL; AY327587; AAP97018.1; -; mRNA.
DR   EMBL; EF583653; ABQ59628.1; -; mRNA.
DR   EMBL; EF670711; ABS01298.1; -; mRNA.
DR   EMBL; EF670712; ABS01299.1; -; mRNA.
DR   EMBL; FJ226040; ACI25172.1; -; mRNA.
DR   EMBL; FJ226047; ACI25179.1; -; mRNA.
DR   EMBL; AF348143; AAK30142.1; -; mRNA.
DR   EMBL; AY463543; AAR18816.1; -; Genomic_DNA.
DR   EMBL; AL713999; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471121; EAW53116.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53117.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53118.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53119.1; -; Genomic_DNA.
DR   EMBL; BC120974; AAI20975.1; -; mRNA.
DR   EMBL; BC120975; AAI20976.1; -; mRNA.
DR   EMBL; Z17324; CAA78972.1; -; mRNA.
DR   EMBL; Z17325; CAA78973.1; -; mRNA.
DR   EMBL; M31823; AAA35757.1; -; mRNA.
DR   EMBL; S81781; AAD14376.1; ALT_INIT; mRNA.
DR   EMBL; S81736; AAD14369.1; ALT_INIT; mRNA.
DR   EMBL; M21868; AAA59874.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS1098.1; -. [P15941-8]
DR   CCDS; CCDS30882.1; -. [P15941-11]
DR   CCDS; CCDS30883.1; -. [P15941-7]
DR   CCDS; CCDS41408.1; -. [P15941-12]
DR   CCDS; CCDS41409.1; -. [P15941-10]
DR   CCDS; CCDS55641.1; -. [P15941-6]
DR   CCDS; CCDS55642.1; -. [P15941-13]
DR   PIR; A35175; A35175.
DR   RefSeq; NP_001018016.1; NM_001018016.2. [P15941-11]
DR   RefSeq; NP_001018017.1; NM_001018017.2. [P15941-7]
DR   RefSeq; NP_001037855.1; NM_001044390.2. [P15941-10]
DR   RefSeq; NP_001037856.1; NM_001044391.2.
DR   RefSeq; NP_001037857.1; NM_001044392.2. [P15941-12]
DR   RefSeq; NP_001037858.1; NM_001044393.2.
DR   RefSeq; NP_001191214.1; NM_001204285.1.
DR   RefSeq; NP_001191215.1; NM_001204286.1.
DR   RefSeq; NP_001191216.1; NM_001204287.1.
DR   RefSeq; NP_001191217.1; NM_001204288.1.
DR   RefSeq; NP_001191218.1; NM_001204289.1.
DR   RefSeq; NP_001191219.1; NM_001204290.1.
DR   RefSeq; NP_001191220.1; NM_001204291.1.
DR   RefSeq; NP_001191221.1; NM_001204292.1.
DR   RefSeq; NP_001191222.1; NM_001204293.1. [P15941-13]
DR   RefSeq; NP_001191223.1; NM_001204294.1. [P15941-6]
DR   RefSeq; NP_001191224.1; NM_001204295.1.
DR   RefSeq; NP_001191225.1; NM_001204296.1.
DR   RefSeq; NP_001191226.1; NM_001204297.1.
DR   RefSeq; NP_002447.4; NM_002456.5. [P15941-8]
DR   PDB; 1SM3; X-ray; 1.95 A; P=919-931.
DR   PDB; 2ACM; NMR; -; A=1042-1097, B=1098-1152.
DR   PDB; 2FO4; X-ray; 2.70 A; P=140-146.
DR   PDB; 5T6P; X-ray; 1.97 A; E/F=921-928.
DR   PDB; 5T78; X-ray; 2.20 A; E/F=921-928.
DR   PDB; 6FZQ; X-ray; 1.70 A; P=921-926.
DR   PDB; 6FZR; X-ray; 1.80 A; P=921-926.
DR   PDBsum; 1SM3; -.
DR   PDBsum; 2ACM; -.
DR   PDBsum; 2FO4; -.
DR   PDBsum; 5T6P; -.
DR   PDBsum; 5T78; -.
DR   PDBsum; 6FZQ; -.
DR   PDBsum; 6FZR; -.
DR   SMR; P15941; -.
DR   BioGrid; 110669; 48.
DR   DIP; DIP-41890N; -.
DR   IntAct; P15941; 121.
DR   MINT; P15941; -.
DR   STRING; 9606.ENSP00000484824; -.
DR   ChEMBL; CHEMBL3580494; -.
DR   DrugBank; DB11090; Potassium nitrate.
DR   DrugBank; DB06584; TG4010.
DR   MEROPS; S71.001; -.
DR   GlyConnect; 372; -.
DR   GlyConnect; 373; -.
DR   GlyConnect; 374; -.
DR   GlyConnect; 375; -.
DR   GlyConnect; 376; -.
DR   GlyConnect; 377; -.
DR   GlyConnect; 413; -.
DR   iPTMnet; P15941; -.
DR   PhosphoSitePlus; P15941; -.
DR   SwissPalm; P15941; -.
DR   UniCarbKB; P15941; -.
DR   BioMuta; MUC1; -.
DR   DMDM; 296439295; -.
DR   CPTAC; CPTAC-146; -.
DR   CPTAC; CPTAC-147; -.
DR   CPTAC; CPTAC-719; -.
DR   CPTAC; CPTAC-730; -.
DR   jPOST; P15941; -.
DR   MassIVE; P15941; -.
DR   MaxQB; P15941; -.
DR   PaxDb; P15941; -.
DR   PeptideAtlas; P15941; -.
DR   PRIDE; P15941; -.
DR   ProteomicsDB; 1779; -.
DR   ProteomicsDB; 53249; -. [P15941-1]
DR   ProteomicsDB; 53250; -. [P15941-10]
DR   ProteomicsDB; 53251; -. [P15941-2]
DR   ProteomicsDB; 53252; -. [P15941-3]
DR   ProteomicsDB; 53253; -. [P15941-4]
DR   ProteomicsDB; 53254; -. [P15941-5]
DR   ProteomicsDB; 53255; -. [P15941-6]
DR   ProteomicsDB; 53256; -. [P15941-7]
DR   ProteomicsDB; 53257; -. [P15941-8]
DR   ProteomicsDB; 53258; -. [P15941-9]
DR   ProteomicsDB; 58806; -.
DR   ProteomicsDB; 6245; -.
DR   ProteomicsDB; 69255; -.
DR   ProteomicsDB; 69256; -.
DR   ProteomicsDB; 767; -.
DR   ABCD; P15941; -.
DR   Antibodypedia; 1298; 4363 antibodies.
DR   DNASU; 4582; -.
DR   Ensembl; ENST00000337604; ENSP00000338983; ENSG00000185499. [P15941-8]
DR   Ensembl; ENST00000342482; ENSP00000342814; ENSG00000185499. [P15941-16]
DR   Ensembl; ENST00000343256; ENSP00000339690; ENSG00000185499. [P15941-10]
DR   Ensembl; ENST00000368389; ENSP00000357374; ENSG00000185499. [P15941-9]
DR   Ensembl; ENST00000368390; ENSP00000357375; ENSG00000185499. [P15941-7]
DR   Ensembl; ENST00000368392; ENSP00000357377; ENSG00000185499. [P15941-11]
DR   Ensembl; ENST00000368393; ENSP00000357378; ENSG00000185499. [P15941-13]
DR   Ensembl; ENST00000368396; ENSP00000357381; ENSG00000185499. [P15941-12]
DR   Ensembl; ENST00000368398; ENSP00000357383; ENSG00000185499. [P15941-6]
DR   GeneID; 4582; -.
DR   KEGG; hsa:4582; -.
DR   UCSC; uc001fia.4; human. [P15941-1]
DR   CTD; 4582; -.
DR   DisGeNET; 4582; -.
DR   GeneCards; MUC1; -.
DR   GeneReviews; MUC1; -.
DR   HGNC; HGNC:7508; MUC1.
DR   HPA; ENSG00000185499; Tissue enhanced (gallbladder, kidney, lung).
DR   MalaCards; MUC1; -.
DR   MIM; 113720; gene.
DR   MIM; 158340; gene.
DR   MIM; 174000; phenotype.
DR   neXtProt; NX_P15941; -.
DR   OpenTargets; ENSG00000185499; -.
DR   Orphanet; 88949; MUC1-related autosomal dominant tubulointerstitial kidney disease.
DR   PharmGKB; PA31309; -.
DR   eggNOG; ENOG410IX6R; Eukaryota.
DR   eggNOG; ENOG410ZQ7Z; LUCA.
DR   GeneTree; ENSGT00710000106874; -.
DR   HOGENOM; CLU_1386987_0_0_1; -.
DR   InParanoid; P15941; -.
DR   KO; K06568; -.
DR   OrthoDB; 945460at2759; -.
DR   PhylomeDB; P15941; -.
DR   Reactome; R-HSA-5083625; Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC).
DR   Reactome; R-HSA-5083632; Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS).
DR   Reactome; R-HSA-5083636; Defective GALNT12 causes colorectal cancer 1 (CRCS1).
DR   Reactome; R-HSA-5621480; Dectin-2 family.
DR   Reactome; R-HSA-6785807; Interleukin-4 and Interleukin-13 signaling.
DR   Reactome; R-HSA-913709; O-linked glycosylation of mucins.
DR   Reactome; R-HSA-977068; Termination of O-glycan biosynthesis.
DR   SIGNOR; P15941; -.
DR   ChiTaRS; MUC1; human.
DR   EvolutionaryTrace; P15941; -.
DR   GeneWiki; MUC1; -.
DR   GenomeRNAi; 4582; -.
DR   Pharos; P15941; Tbio.
DR   PRO; PR:P15941; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; P15941; protein.
DR   Bgee; ENSG00000185499; Expressed in body of stomach and 198 other tissues.
DR   ExpressionAtlas; P15941; baseline and differential.
DR   Genevisible; P15941; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IBA:GO_Central.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; HDA:UniProtKB.
DR   GO; GO:0005796; C:Golgi lumen; TAS:Reactome.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0000790; C:nuclear chromatin; IDA:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0031982; C:vesicle; HDA:UniProtKB.
DR   GO; GO:0002039; F:p53 binding; IPI:BHF-UCL.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IDA:BHF-UCL.
DR   GO; GO:0003712; F:transcription coregulator activity; IDA:BHF-UCL.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; IDA:BHF-UCL.
DR   GO; GO:0006978; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; IDA:BHF-UCL.
DR   GO; GO:0033629; P:negative regulation of cell adhesion mediated by integrin; IDA:CACAO.
DR   GO; GO:1902166; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IDA:BHF-UCL.
DR   GO; GO:0010944; P:negative regulation of transcription by competitive promoter binding; IDA:BHF-UCL.
DR   GO; GO:0016266; P:O-glycan processing; TAS:Reactome.
DR   GO; GO:0090240; P:positive regulation of histone H4 acetylation; IDA:BHF-UCL.
DR   GO; GO:0036003; P:positive regulation of transcription from RNA polymerase II promoter in response to stress; IDA:BHF-UCL.
DR   GO; GO:0043618; P:regulation of transcription from RNA polymerase II promoter in response to stress; IDA:BHF-UCL.
DR   GO; GO:0002223; P:stimulatory C-type lectin receptor signaling pathway; TAS:Reactome.
DR   DisProt; DP01790; -.
DR   Gene3D; 3.30.70.960; -; 1.
DR   InterPro; IPR000082; SEA_dom.
DR   InterPro; IPR036364; SEA_dom_sf.
DR   Pfam; PF01390; SEA; 1.
DR   SMART; SM00200; SEA; 1.
DR   SUPFAM; SSF82671; SSF82671; 1.
DR   PROSITE; PS50024; SEA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Autocatalytic cleavage; Cell membrane;
KW   Cytoplasm; Direct protein sequencing; Disulfide bond; Glycoprotein;
KW   Lipoprotein; Membrane; Nucleus; Palmitate; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; Secreted; Signal; Transmembrane;
KW   Transmembrane helix; Tumor suppressor.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000269|PubMed:10373415,
FT                   ECO:0000269|PubMed:11341784"
FT   CHAIN           24..1255
FT                   /note="Mucin-1"
FT                   /id="PRO_0000019277"
FT   CHAIN           24..1097
FT                   /note="Mucin-1 subunit alpha"
FT                   /id="PRO_0000317446"
FT   CHAIN           1098..1255
FT                   /note="Mucin-1 subunit beta"
FT                   /id="PRO_0000317447"
FT   TOPO_DOM        24..1158
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1159..1181
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1182..1255
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REPEAT          61..80
FT                   /note="1; approximate"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          81..100
FT                   /note="2; approximate"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          101..120
FT                   /note="3"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          121..140
FT                   /note="4"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          141..160
FT                   /note="5"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          161..180
FT                   /note="6"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          181..200
FT                   /note="7"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          201..220
FT                   /note="8"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          221..240
FT                   /note="9"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          241..260
FT                   /note="10"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          261..280
FT                   /note="11"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          281..300
FT                   /note="12"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          301..320
FT                   /note="13"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          321..340
FT                   /note="14"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          341..360
FT                   /note="15"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          361..380
FT                   /note="16"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          381..400
FT                   /note="17"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          401..420
FT                   /note="18"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          421..440
FT                   /note="19"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          441..460
FT                   /note="20"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          461..480
FT                   /note="21"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          481..500
FT                   /note="22"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          501..520
FT                   /note="23"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          521..540
FT                   /note="24"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          541..560
FT                   /note="25"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          561..580
FT                   /note="26"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          581..600
FT                   /note="27"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          601..620
FT                   /note="28"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          621..640
FT                   /note="29"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          641..660
FT                   /note="30"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          661..680
FT                   /note="31"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          681..700
FT                   /note="32"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          701..720
FT                   /note="33"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          721..740
FT                   /note="34"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          741..760
FT                   /note="35"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          761..780
FT                   /note="36"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          781..800
FT                   /note="37"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          801..820
FT                   /note="38"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          821..840
FT                   /note="39"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          841..860
FT                   /note="40"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          861..880
FT                   /note="41"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          881..900
FT                   /note="42"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          901..920
FT                   /note="43"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          921..940
FT                   /note="44"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          941..960
FT                   /note="45"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          961..980
FT                   /note="46; approximate"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          981..1000
FT                   /note="47; approximate"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   REPEAT          1001..1020
FT                   /note="48; approximate"
FT                   /evidence="ECO:0000269|PubMed:11350974"
FT   DOMAIN          1039..1148
FT                   /note="SEA"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00188"
FT   REGION          126..965
FT                   /note="42 X 20 AA approximate tandem repeats of P-A-P-G-S-
FT                   T-A-P-P-A-H-G-V-T-S-A-P-D-T-R"
FT   REGION          1192..1228
FT                   /note="Interaction with P53"
FT   REGION          1223..1230
FT                   /note="Required for interaction with GSK3B"
FT   REGION          1233..1241
FT                   /note="Required for interaction with beta- and gamma-
FT                   catenins"
FT   MOTIF           1203..1206
FT                   /note="Interaction with GRB2"
FT   MOTIF           1229..1232
FT                   /note="Interaction with SRC and ESR1"
FT   MOTIF           1243..1246
FT                   /note="Required for interaction with AP1S2"
FT   SITE            1097..1098
FT                   /note="Cleavage; by autolysis"
FT   MOD_RES         1203
FT                   /note="Phosphotyrosine; by PDGFR"
FT                   /evidence="ECO:0000269|PubMed:14521915,
FT                   ECO:0000269|PubMed:17545600"
FT   MOD_RES         1212
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000269|PubMed:14521915"
FT   MOD_RES         1218
FT                   /note="Phosphotyrosine; by PDGFR"
FT                   /evidence="ECO:0000269|PubMed:17545600"
FT   MOD_RES         1224
FT                   /note="Phosphothreonine; by PKC/PRKCD"
FT                   /evidence="ECO:0000269|PubMed:11877440"
FT   MOD_RES         1227
FT                   /note="Phosphoserine; by GSK3-beta"
FT                   /evidence="ECO:0000244|PubMed:23186163,
FT                   ECO:0000269|PubMed:9819408"
FT   MOD_RES         1229
FT                   /note="Phosphotyrosine; by CSK, EGFR and SRC"
FT                   /evidence="ECO:0000269|PubMed:11152665,
FT                   ECO:0000269|PubMed:11483589, ECO:0000269|PubMed:14521915,
FT                   ECO:0000269|PubMed:17545600"
FT   MOD_RES         1243
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000269|PubMed:14521915"
FT   LIPID           1184
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000269|PubMed:16507569"
FT   LIPID           1186
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000269|PubMed:16507569"
FT   CARBOHYD        131
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000305|PubMed:7744025,
FT                   ECO:0000305|PubMed:9597769"
FT   CARBOHYD        139
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000305|PubMed:7744025,
FT                   ECO:0000305|PubMed:9597769"
FT   CARBOHYD        140
FT                   /note="O-linked (GalNAc...) serine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        144
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        957
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        975
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1029
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1055
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1133
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         19..21
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|Ref.25"
FT                   /id="VSP_003281"
FT   VAR_SEQ         19
FT                   /note="T -> TATTAPKPAT (in isoform 2, isoform Y-LSP,
FT                   isoform E2, isoform J13, isoform S2 and isoform T10)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:22941036, ECO:0000303|PubMed:2318825,
FT                   ECO:0000303|PubMed:2597151, ECO:0000303|PubMed:8608966,
FT                   ECO:0000303|Ref.15"
FT                   /id="VSP_003280"
FT   VAR_SEQ         20..31
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|Ref.25"
FT                   /id="VSP_003282"
FT   VAR_SEQ         54..1151
FT                   /note="Missing (in isoform E2)"
FT                   /evidence="ECO:0000303|PubMed:22941036"
FT                   /id="VSP_047872"
FT   VAR_SEQ         54..1093
FT                   /note="Missing (in isoform T10)"
FT                   /evidence="ECO:0000303|PubMed:22941036"
FT                   /id="VSP_047873"
FT   VAR_SEQ         54..1053
FT                   /note="Missing (in isoform J13, isoform Y, isoform Y-LSP
FT                   and isoform S2)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:15969018, ECO:0000303|PubMed:22941036,
FT                   ECO:0000303|PubMed:7925397, ECO:0000303|PubMed:9212228,
FT                   ECO:0000303|Ref.15"
FT                   /id="VSP_003285"
FT   VAR_SEQ         54..1035
FT                   /note="Missing (in isoform 8, isoform 9 and isoform M6)"
FT                   /evidence="ECO:0000303|PubMed:22941036,
FT                   ECO:0000303|PubMed:9212228, ECO:0000303|Ref.12,
FT                   ECO:0000303|Ref.16"
FT                   /id="VSP_003286"
FT   VAR_SEQ         54..96
FT                   /note="VSMTSSVLSSHSPGSGSSTTQGQDVTLAPATEPASGSAATWGQ -> IPAPT
FT                   TTKSCRETFLKCFCRFINKGVFWASPILSSGQDLWWYN (in isoform ZD)"
FT                   /evidence="ECO:0000303|PubMed:15623537,
FT                   ECO:0000303|PubMed:22941036"
FT                   /id="VSP_047575"
FT   VAR_SEQ         54..87
FT                   /note="VSMTSSVLSSHSPGSGSSTTQGQDVTLAPATEPA -> IPAPTTTKSCRETF
FT                   LKCFCRFINKGVFWASPILS (in isoform F)"
FT                   /evidence="ECO:0000303|Ref.14"
FT                   /id="VSP_035046"
FT   VAR_SEQ         54..70
FT                   /note="VSMTSSVLSSHSPGSGS -> IPAPTTTKSCRETFLKW (in isoform
FT                   6)"
FT                   /evidence="ECO:0000303|PubMed:22941036,
FT                   ECO:0000303|PubMed:9212228"
FT                   /id="VSP_003283"
FT   VAR_SEQ         71..1095
FT                   /note="Missing (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:22941036,
FT                   ECO:0000303|PubMed:9212228"
FT                   /id="VSP_003284"
FT   VAR_SEQ         88..1139
FT                   /note="Missing (in isoform F)"
FT                   /evidence="ECO:0000303|Ref.14"
FT                   /id="VSP_035047"
FT   VAR_SEQ         97..1255
FT                   /note="Missing (in isoform ZD)"
FT                   /evidence="ECO:0000303|PubMed:15623537,
FT                   ECO:0000303|PubMed:22941036"
FT                   /id="VSP_047576"
FT   VAR_SEQ         1077..1181
FT                   /note="Missing (in isoform 9 and isoform S2)"
FT                   /evidence="ECO:0000303|PubMed:22941036, ECO:0000303|Ref.12,
FT                   ECO:0000303|Ref.15"
FT                   /id="VSP_003287"
FT   VAR_SEQ         1077..1087
FT                   /note="FLQIYKQGGFL -> VSIGLSFPMLP (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:2351132"
FT                   /id="VSP_003288"
FT   VAR_SEQ         1088..1255
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:2351132"
FT                   /id="VSP_003289"
FT   VAR_SEQ         1141..1180
FT                   /note="VSDVPFPFSAQSGAGVPGWGIALLVLVCVLVALAIVYLIA -> GCLSVPPK
FT                   ELRAAGHLSSPGYLPSYERVPHLPHPWALCAP (in isoform M6)"
FT                   /evidence="ECO:0000303|PubMed:22941036, ECO:0000303|Ref.16"
FT                   /id="VSP_046962"
FT   VAR_SEQ         1181..1255
FT                   /note="Missing (in isoform M6)"
FT                   /evidence="ECO:0000303|PubMed:22941036, ECO:0000303|Ref.16"
FT                   /id="VSP_046963"
FT   VAR_SEQ         1232..1255
FT                   /note="VSAGNGGSSLSYTNPAVAATSANL -> RQNGWSTMPRGALPEESQG (in
FT                   isoform J13)"
FT                   /evidence="ECO:0000303|PubMed:22941036"
FT                   /id="VSP_047874"
FT   VARIANT         1117
FT                   /note="V -> M (in dbSNP:rs1611770)"
FT                   /evidence="ECO:0000269|PubMed:15969018,
FT                   ECO:0000269|PubMed:22941036, ECO:0000269|Ref.17"
FT                   /id="VAR_019390"
FT   VARIANT         1142
FT                   /note="S -> N (in dbSNP:rs11465207)"
FT                   /evidence="ECO:0000269|Ref.17"
FT                   /id="VAR_019391"
FT   MUTAGEN         1098
FT                   /note="S->A,D,E,F,G,H,I,K,L,M,N,P,Q,R,V,W,Y: Completely
FT                   abrogates cleavage."
FT                   /evidence="ECO:0000269|PubMed:15987679"
FT   MUTAGEN         1098
FT                   /note="S->C,T: Almost complete cleavage."
FT                   /evidence="ECO:0000269|PubMed:15987679"
FT   MUTAGEN         1116
FT                   /note="D->A: Greatly reduced formation of isoform 5/isoform
FT                   Y complex."
FT                   /evidence="ECO:0000269|PubMed:10197628"
FT   MUTAGEN         1116
FT                   /note="D->E: No effect on formation of isoform 5/isoform Y
FT                   complex."
FT                   /evidence="ECO:0000269|PubMed:10197628"
FT   MUTAGEN         1184
FT                   /note="C->A: S-palmitoylation reduced by 50%. Complete loss
FT                   of palmitoylation, no effect on endocytosis, recycling
FT                   inhibited and AP1S1 binding reduced by 30%; when associated
FT                   with C-1186. Accumulates in intracellular compartments;
FT                   when associated with C-1186 and N-1203."
FT                   /evidence="ECO:0000269|PubMed:16507569"
FT   MUTAGEN         1186
FT                   /note="C->A: S-palmitoylation reduced by 50%. Complete loss
FT                   of palmitoylation, no effect on endocytosis, recycling
FT                   inhibited, and AP1S1 binding reduced by 30%; when
FT                   associated with C-1184. Accumulates in intracellular
FT                   compartments; when associated with C-1184 and N-1203."
FT                   /evidence="ECO:0000269|PubMed:16507569"
FT   MUTAGEN         1187..1189
FT                   /note="RRK->AAA: No nuclear targeting of HRG-stimulated
FT                   MUC1 C-terminal nor JUP/gamma-catenin. No effect on
FT                   interaction with JUP/gamma-catenin."
FT                   /evidence="ECO:0000269|PubMed:12939402,
FT                   ECO:0000269|PubMed:16507569"
FT   MUTAGEN         1187..1189
FT                   /note="RRK->QQQ: No effect on palmitoylation."
FT                   /evidence="ECO:0000269|PubMed:12939402,
FT                   ECO:0000269|PubMed:16507569"
FT   MUTAGEN         1191
FT                   /note="Y->F: No effect on EGFR-mediated phosphorylation."
FT                   /evidence="ECO:0000269|PubMed:11483589,
FT                   ECO:0000269|PubMed:15471854"
FT   MUTAGEN         1191
FT                   /note="Y->N: No effect on endocytosis."
FT                   /evidence="ECO:0000269|PubMed:11483589,
FT                   ECO:0000269|PubMed:15471854"
FT   MUTAGEN         1203
FT                   /note="Y->E: No effect on nuclear colocalization of MUC1CT
FT                   and CTNNB1. No effect on in vitro PDFGR-induced cell
FT                   invasiveness."
FT                   /evidence="ECO:0000269|PubMed:11483589,
FT                   ECO:0000269|PubMed:15471854, ECO:0000269|PubMed:16507569,
FT                   ECO:0000269|PubMed:17545600"
FT   MUTAGEN         1203
FT                   /note="Y->F: No effect on EGFR-mediated phosphorylation. No
FT                   nuclear localization of MUC1CT. Reduced in vitro PDGFR-
FT                   induced cell invasiveness."
FT                   /evidence="ECO:0000269|PubMed:11483589,
FT                   ECO:0000269|PubMed:15471854, ECO:0000269|PubMed:16507569,
FT                   ECO:0000269|PubMed:17545600"
FT   MUTAGEN         1203
FT                   /note="Y->N: Reduced endocytosis by 30%. Greatly reduced
FT                   binding to AP1S2 and GRB2. Binding AP1S1 reduced by 25%.
FT                   Reduced endocytosis by 77%; when associated with N-1243.
FT                   Accumulates in intracellular compartments; when associated
FT                   with C-1184 and C-1186."
FT                   /evidence="ECO:0000269|PubMed:11483589,
FT                   ECO:0000269|PubMed:15471854, ECO:0000269|PubMed:16507569,
FT                   ECO:0000269|PubMed:17545600"
FT   MUTAGEN         1209
FT                   /note="Y->F: Some reduction in EGFR-mediated
FT                   phosphorylation."
FT                   /evidence="ECO:0000269|PubMed:11483589"
FT   MUTAGEN         1218
FT                   /note="Y->F: No effect on EGFR-mediated phosphorylation. No
FT                   nuclear colocalization of MUC1CT and CTNNB1."
FT                   /evidence="ECO:0000269|PubMed:11483589,
FT                   ECO:0000269|PubMed:17545600"
FT   MUTAGEN         1223
FT                   /note="S->A: No change in PRKCD- nor GSK3B-mediated
FT                   phosphorylation."
FT                   /evidence="ECO:0000269|PubMed:11877440,
FT                   ECO:0000269|PubMed:9819408"
FT   MUTAGEN         1224
FT                   /note="T->A: Loss of PRKCD-mediated phosphorylation.
FT                   Decreased PRKCD binding. No increased binding to CTNNB1 in
FT                   the presence of autophosphorylated PRKCD. Increases
FT                   formation of E-cadherin/beta-catenin complex."
FT                   /evidence="ECO:0000269|PubMed:11877440"
FT   MUTAGEN         1227
FT                   /note="S->A: No change in PRKCD-mediated phosphorylation.
FT                   Loss of GSK3B-mediated phosphorylation. CTNNB1."
FT                   /evidence="ECO:0000269|PubMed:11877440,
FT                   ECO:0000269|PubMed:9819408"
FT   MUTAGEN         1229
FT                   /note="Y->F: Greatly reduced EGFR- and Src-mediated
FT                   phosphorylation. No nuclear localization of MUC1CT. Reduced
FT                   in vitro PDGFR-mediated phosphorylation. Decreased Src-
FT                   binding."
FT                   /evidence="ECO:0000269|PubMed:11152665,
FT                   ECO:0000269|PubMed:11483589, ECO:0000269|PubMed:14688481,
FT                   ECO:0000269|PubMed:15471854"
FT   MUTAGEN         1229
FT                   /note="Y->N: No effect on endocytosis."
FT                   /evidence="ECO:0000269|PubMed:11152665,
FT                   ECO:0000269|PubMed:11483589, ECO:0000269|PubMed:14688481,
FT                   ECO:0000269|PubMed:15471854"
FT   MUTAGEN         1243
FT                   /note="Y->N: Reduces binding to AP1S2 by 33%. Greatly
FT                   reduced binding to GRB2. Reduced endocytosis by 50%.
FT                   Reduced endocytosis by 77%; when associated with N-1203."
FT                   /evidence="ECO:0000269|PubMed:15471854"
FT   CONFLICT        2
FT                   /note="T -> A (in Ref. 24; AAD14369)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        134
FT                   /note="P -> Q (in Ref. 22; AAA35757)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        154
FT                   /note="P -> Q (in Ref. 22; AAA35757)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1021
FT                   /note="S -> T (in Ref. 2; AAA35805/AAA35807 and 3;
FT                   AAA59876)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1143
FT                   /note="D -> G (in Ref. 11; AAP97018)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1193
FT                   /note="Q -> L (in Ref. 13; AAK30142)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1231
FT                   /note="K -> T (in Ref. 9; AAD10858)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1251
FT                   /note="T -> A (in Ref. 1; AAA60019)"
FT                   /evidence="ECO:0000305"
FT   STRAND          1042..1052
FT                   /evidence="ECO:0000244|PDB:2ACM"
FT   HELIX           1056..1059
FT                   /evidence="ECO:0000244|PDB:2ACM"
FT   HELIX           1064..1080
FT                   /evidence="ECO:0000244|PDB:2ACM"
FT   TURN            1082..1085
FT                   /evidence="ECO:0000244|PDB:2ACM"
FT   STRAND          1086..1096
FT                   /evidence="ECO:0000244|PDB:2ACM"
FT   STRAND          1099..1107
FT                   /evidence="ECO:0000244|PDB:2ACM"
FT   TURN            1109..1111
FT                   /evidence="ECO:0000244|PDB:2ACM"
FT   HELIX           1114..1132
FT                   /evidence="ECO:0000244|PDB:2ACM"
FT   STRAND          1136..1142
FT                   /evidence="ECO:0000244|PDB:2ACM"
SQ   SEQUENCE   1255 AA;  122102 MW;  5E28DFC4C20D9A82 CRC64;
     MTPGTQSPFF LLLLLTVLTV VTGSGHASST PGGEKETSAT QRSSVPSSTE KNAVSMTSSV
     LSSHSPGSGS STTQGQDVTL APATEPASGS AATWGQDVTS VPVTRPALGS TTPPAHDVTS
     APDNKPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS
     APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS
     APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS
     APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS
     APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS
     APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS
     APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS
     APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS
     APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS
     APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS
     APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS
     APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS
     APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS
     APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDNRPALGS TAPPVHNVTS
     ASGSASGSAS TLVHNGTSAR ATTTPASKST PFSIPSHHSD TPTTLASHST KTDASSTHHS
     SVPPLTSSNH STSPQLSTGV SFFFLSFHIS NLQFNSSLED PSTDYYQELQ RDISEMFLQI
     YKQGGFLGLS NIKFRPGSVV VQLTLAFREG TINVHDVETQ FNQYKTEAAS RYNLTISDVS
     VSDVPFPFSA QSGAGVPGWG IALLVLVCVL VALAIVYLIA LAVCQCRRKN YGQLDIFPAR
     DTYHPMSEYP TYHTHGRYVP PSSTDRSPYE KVSAGNGGSS LSYTNPAVAA TSANL
//
ID   Q7Z538_HUMAN            Unreviewed;       158 AA.
AC   Q7Z538;
DT   01-OCT-2003, integrated into UniProtKB/TrEMBL.
DT   01-OCT-2003, sequence version 1.
DT   22-APR-2020, entry version 61.
DE   SubName: Full=Mucin short variant PC2 {ECO:0000313|EMBL:AAP97027.1};
GN   Name=MUC1 {ECO:0000313|EMBL:AAP97027.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAP97027.1};
RN   [1] {ECO:0000313|EMBL:AAP97027.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Zhang L.X., Lu H.J.;
RL   Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [2] {ECO:0000313|EMBL:AAP97027.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=22941036; DOI=10.1007/s00262-012-1325-2;
RA   Zhang L., Vlad A., Milcarek C., Finn O.J.;
RT   "Human mucin MUC1 RNA undergoes different types of alternative splicing
RT   resulting in multiple isoforms.";
RL   Cancer Immunol. Immunother. 62:423-435(2013).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY327598; AAP97027.1; -; mRNA.
DR   RefSeq; NP_001037858.1; NM_001044393.2.
DR   PeptideAtlas; Q7Z538; -.
DR   PRIDE; Q7Z538; -.
DR   DNASU; 4582; -.
DR   GeneID; 4582; -.
DR   CTD; 4582; -.
DR   eggNOG; ENOG410IX6R; Eukaryota.
DR   eggNOG; ENOG410ZQ7Z; LUCA.
DR   ChiTaRS; MUC1; human.
DR   GenomeRNAi; 4582; -.
DR   Genevisible; Q7Z538; HS.
PE   2: Evidence at transcript level;
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           24..158
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5004296928"
FT   REGION          26..57
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   158 AA;  16632 MW;  2FDFC9E30A99E41E CRC64;
     MTPGTQSPFF LLLLLTVLTV VTGSGHASST PGGEKETSAT QRSSVLSSTE KNAIPAPTTT
     KSCRETFLKC FCRFINKGVF WASPILSSVW GWGARLGHRA AGAGLCSGCA GHCLSHCLGC
     LSVPPKELRA AGHLSSPGYL PSYERVPHLP HPWALCAP
//
ID   Q7Z551_HUMAN            Unreviewed;       150 AA.
AC   Q7Z551;
DT   01-OCT-2003, integrated into UniProtKB/TrEMBL.
DT   01-OCT-2003, sequence version 1.
DT   22-APR-2020, entry version 77.
DE   SubName: Full=Mucin short variant S1 {ECO:0000313|EMBL:AAP97014.1};
GN   Name=MUC1 {ECO:0000313|EMBL:AAP97014.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAP97014.1};
RN   [1] {ECO:0000313|EMBL:AAP97014.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Zhang L.X., Lu H.J.;
RL   Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [2] {ECO:0000313|EMBL:AAP97014.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=22941036; DOI=10.1007/s00262-012-1325-2;
RA   Zhang L., Vlad A., Milcarek C., Finn O.J.;
RT   "Human mucin MUC1 RNA undergoes different types of alternative splicing
RT   resulting in multiple isoforms.";
RL   Cancer Immunol. Immunother. 62:423-435(2013).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY327583; AAP97014.1; -; mRNA.
DR   RefSeq; NP_001037856.1; NM_001044391.2.
DR   MEROPS; S71.001; -.
DR   PeptideAtlas; Q7Z551; -.
DR   PRIDE; Q7Z551; -.
DR   DNASU; 4582; -.
DR   GeneID; 4582; -.
DR   CTD; 4582; -.
DR   PharmGKB; PA31309; -.
DR   eggNOG; ENOG410IX6R; Eukaryota.
DR   eggNOG; ENOG410ZQ7Z; LUCA.
DR   ChiTaRS; MUC1; human.
DR   GenomeRNAi; 4582; -.
DR   Genevisible; Q7Z551; HS.
DR   Gene3D; 3.30.70.960; -; 1.
DR   InterPro; IPR036364; SEA_dom_sf.
PE   2: Evidence at transcript level;
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           24..150
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5004296931"
FT   REGION          24..63
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          109..139
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        112..139
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   150 AA;  16223 MW;  99A1BD4C2504A0FF CRC64;
     MTPGTQSPFF LLLLLTVLTV VTGSGHASST PGGEKETSAT QRSSVPSSTE KNAFNSSLED
     PSTDYYQELQ RDISEMAVCQ CRRKNYGQLD IFPARDTYHP MSEYPTYHTH GRYAPPSSTD
     RSPYEKVSAG NGGSSLSYTN PAVAATSANL
//
ID   A0A024QZJ4_HUMAN        Unreviewed;      1972 AA.
AC   A0A024QZJ4;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 50.
DE   SubName: Full=Epididymis secretory sperm binding protein {ECO:0000313|EMBL:ADO22484.1};
DE   SubName: Full=Myosin, heavy polypeptide 11, smooth muscle, isoform CRA_a {ECO:0000313|EMBL:EAW53925.1};
GN   Name=MYH11 {ECO:0000313|EMBL:EAW53925.1};
GN   ORFNames=hCG_19652 {ECO:0000313|EMBL:EAW53925.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW53925.1};
RN   [1] {ECO:0000313|EMBL:EAW53925.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW53925.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ADO22484.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Hoernsten L., Su C., Osbourn A.E., Hellman U., Wernstedt C., Oliw E.H.;
RL   Submitted (SEP-2009) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase
CC       superfamily. Myosin family. {ECO:0000256|PROSITE-ProRule:PRU00782,
CC       ECO:0000256|SAAS:SAAS00572438}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; GQ900967; ADO22484.1; -; mRNA.
DR   EMBL; CH471226; EAW53925.1; -; Genomic_DNA.
DR   RefSeq; NP_002465.1; NM_002474.2.
DR   Antibodypedia; 1966; 689 antibodies.
DR   GeneID; 4629; -.
DR   KEGG; hsa:4629; -.
DR   CTD; 4629; -.
DR   EuPathDB; HostDB:ENSG00000133392.16; -.
DR   eggNOG; KOG0161; Eukaryota.
DR   eggNOG; COG5022; LUCA.
DR   HOGENOM; CLU_000192_4_3_1; -.
DR   KO; K10352; -.
DR   PhylomeDB; A0A024QZJ4; -.
DR   ChiTaRS; MYH11; human.
DR   GenomeRNAi; 4629; -.
DR   Bgee; ENSG00000133392; Expressed in saphenous vein and 235 other tissues.
DR   GO; GO:0016459; C:myosin complex; IEA:UniProtKB-KW.
DR   GO; GO:0051015; F:actin filament binding; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0003774; F:motor activity; IEA:UniProtKB-UniRule.
DR   Gene3D; 2.30.30.360; -; 1.
DR   Gene3D; 3.40.850.10; -; 1.
DR   Gene3D; 4.10.270.10; -; 1.
DR   InterPro; IPR000048; IQ_motif_EF-hand-BS.
DR   InterPro; IPR036961; Kinesin_motor_dom_sf.
DR   InterPro; IPR001609; Myosin_head_motor_dom.
DR   InterPro; IPR027401; Myosin_IQ_contain_sf.
DR   InterPro; IPR004009; Myosin_N.
DR   InterPro; IPR008989; Myosin_S1_N.
DR   InterPro; IPR002928; Myosin_tail.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   Pfam; PF00063; Myosin_head; 1.
DR   Pfam; PF02736; Myosin_N; 1.
DR   Pfam; PF01576; Myosin_tail_1; 1.
DR   PRINTS; PR00193; MYOSINHEAVY.
DR   SMART; SM00015; IQ; 1.
DR   SMART; SM00242; MYSc; 1.
DR   SUPFAM; SSF50084; SSF50084; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS50096; IQ; 1.
DR   PROSITE; PS51456; MYOSIN_MOTOR; 1.
DR   PROSITE; PS51844; SH3_LIKE; 1.
PE   2: Evidence at transcript level;
KW   Actin-binding {ECO:0000256|PROSITE-ProRule:PRU00782,
KW   ECO:0000256|SAAS:SAAS01238310};
KW   ATP-binding {ECO:0000256|PROSITE-ProRule:PRU00782,
KW   ECO:0000256|SAAS:SAAS00875240};
KW   Coiled coil {ECO:0000256|SAAS:SAAS01040361, ECO:0000256|SAM:Coils};
KW   Motor protein {ECO:0000256|PROSITE-ProRule:PRU00782,
KW   ECO:0000256|SAAS:SAAS01033784};
KW   Myosin {ECO:0000256|PROSITE-ProRule:PRU00782,
KW   ECO:0000256|SAAS:SAAS01033784};
KW   Nucleotide-binding {ECO:0000256|PROSITE-ProRule:PRU00782,
KW   ECO:0000256|SAAS:SAAS00875240}.
FT   DOMAIN          31..81
FT                   /note="Myosin N-terminal SH3-like"
FT                   /evidence="ECO:0000259|PROSITE:PS51844"
FT   DOMAIN          85..783
FT                   /note="Myosin motor"
FT                   /evidence="ECO:0000259|PROSITE:PS51456"
FT   NP_BIND         178..185
FT                   /note="ATP"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00782"
FT   REGION          661..683
FT                   /note="Actin-binding"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00782"
FT   REGION          858..882
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1744..1800
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1866..1972
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          1180..1575
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1577..1719
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        1761..1787
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1866..1915
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1945..1972
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   1972 AA;  227339 MW;  67665BB2AECE1277 CRC64;
     MAQKGQLSDD EKFLFVDKNF INSPVAQADW AAKRLVWVPS EKQGFEAASI KEEKGDEVVV
     ELVENGKKVT VGKDDIQKMN PPKFSKVEDM AELTCLNEAS VLHNLRERYF SGLIYTYSGL
     FCVVVNPYKH LPIYSEKIVD MYKGKKRHEM PPHIYAIADT AYRSMLQDRE DQSILCTGES
     GAGKTENTKK VIQYLAVVAS SHKGKKDTSI TGELEKQLLQ ANPILEAFGN AKTVKNDNSS
     RFGKFIRINF DVTGYIVGAN IETYLLEKSR AIRQARDERT FHIFYYMIAG AKEKMRSDLL
     LEGFNNYTFL SNGFVPIPAA QDDEMFQETV EAMAIMGFSE EEQLSILKVV SSVLQLGNIV
     FKKERNTDQA SMPDNTAAQK VCHLMGINVT DFTRSILTPR IKVGRDVVQK AQTKEQADFA
     VEALAKATYE RLFRWILTRV NKALDKTHRQ GASFLGILDI AGFEIFEVNS FEQLCINYTN
     EKLQQLFNHT MFILEQEEYQ REGIEWNFID FGLDLQPCIE LIERPNNPPG VLALLDEECW
     FPKATDKSFV EKLCTEQGSH PKFQKPKQLK DKTEFSIIHY AGKVDYNASA WLTKNMDPLN
     DNVTSLLNAS SDKFVADLWK DVDRIVGLDQ MAKMTESSLP SASKTKKGMF RTVGQLYKEQ
     LGKLMTTLRN TTPNFVRCII PNHEKRSGKL DAFLVLEQLR CNGVLEGIRI CRQGFPNRIV
     FQEFRQRYEI LAANAIPKGF MDGKQACILM IKALELDPNL YRIGQSKIFF RTGVLAHLEE
     ERDLKITDVI MAFQAMCRGY LARKAFAKRQ QQLTAMKVIQ RNCAAYLKLR NWQWWRLFTK
     VKPLLQVTRQ EEEMQAKEDE LQKTKERQQK AENELKELEQ KHSQLTEEKN LLQEQLQAET
     ELYAEAEEMR VRLAAKKQEL EEILHEMEAR LEEEEDRGQQ LQAERKKMAQ QMLDLEEQLE
     EEEAARQKLQ LEKVTAEAKI KKLEDEILVM DDQNNKLSKE RKLLEERISD LTTNLAEEEE
     KAKNLTKLKN KHESMISELE VRLKKEEKSR QELEKLKRKL EGDASDFHEQ IADLQAQIAE
     LKMQLAKKEE ELQAALARLD DEIAQKNNAL KKIRELEGHI SDLQEDLDSE RAARNKAEKQ
     KRDLGEELEA LKTELEDTLD STATQQELRA KREQEVTVLK KALDEETRSH EAQVQEMRQK
     HAQAVEELTE QLEQFKRAKA NLDKNKQTLE KENADLAGEL RVLGQAKQEV EHKKKKLEAQ
     VQELQSKCSD GERARAELND KVHKLQNEVE SVTGMLNEAE GKAIKLAKDV ASLSSQLQDT
     QELLQEETRQ KLNVSTKLRQ LEEERNSLQD QLDEEMEAKQ NLERHISTLN IQLSDSKKKL
     QDFASTVEAL EEGKKRFQKE IENLTQQYEE KAAAYDKLEK TKNRLQQELD DLVVDLDNQR
     QLVSNLEKKQ RKFDQLLAEE KNISSKYADE RDRAEAEARE KETKALSLAR ALEEALEAKE
     ELERTNKMLK AEMEDLVSSK DDVGKNVHEL EKSKRALETQ MEEMKTQLEE LEDELQATED
     AKLRLEVNMQ ALKGQFERDL QARDEQNEEK RRQLQRQLHE YETELEDERK QRALAAAAKK
     KLEGDLKDLE LQADSAIKGR EEAIKQLRKL QAQMKDFQRE LEDARASRDE IFATAKENEK
     KAKSLEADLM QLQEDLAAAE RARKQADLEK EELAEELASS LSGRNALQDE KRRLEARIAQ
     LEEELEEEQG NMEAMSDRVR KATQQAEQLS NELATERSTA QKNESARQQL ERQNKELRSK
     LHEMEGAVKS KFKSTIAALE AKIAQLEEQV EQEAREKQAA TKSLKQKDKK LKEILLQVED
     ERKMAEQYKE QAEKGNARVK QLKRQLEEAE EESQRINANR RKLQRELDEA TESNEAMGRE
     VNALKSKLRR GNETSFVPSR RSGGRRVIEN ADGSEEETDT RDADFNGTKA SE
//
ID   A0A024QZJ6_HUMAN        Unreviewed;      1938 AA.
AC   A0A024QZJ6;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 46.
DE   SubName: Full=Myosin, heavy polypeptide 11, smooth muscle, isoform CRA_b {ECO:0000313|EMBL:EAW53930.1};
GN   Name=MYH11 {ECO:0000313|EMBL:EAW53930.1};
GN   ORFNames=hCG_19652 {ECO:0000313|EMBL:EAW53930.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW53930.1};
RN   [1] {ECO:0000313|EMBL:EAW53930.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW53930.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase
CC       superfamily. Myosin family. {ECO:0000256|PROSITE-ProRule:PRU00782,
CC       ECO:0000256|SAAS:SAAS00572438}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH471226; EAW53930.1; -; Genomic_DNA.
DR   RefSeq; NP_074035.1; NM_022844.2.
DR   SMR; A0A024QZJ6; -.
DR   PRIDE; A0A024QZJ6; -.
DR   Antibodypedia; 1966; 689 antibodies.
DR   GeneID; 4629; -.
DR   CTD; 4629; -.
DR   EuPathDB; HostDB:ENSG00000133392.16; -.
DR   eggNOG; KOG0161; Eukaryota.
DR   eggNOG; COG5022; LUCA.
DR   HOGENOM; CLU_000192_8_1_1; -.
DR   ChiTaRS; MYH11; human.
DR   GenomeRNAi; 4629; -.
DR   Bgee; ENSG00000133392; Expressed in saphenous vein and 235 other tissues.
DR   ExpressionAtlas; A0A024QZJ6; baseline and differential.
DR   GO; GO:0016459; C:myosin complex; IEA:UniProtKB-KW.
DR   GO; GO:0051015; F:actin filament binding; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0003774; F:motor activity; IEA:UniProtKB-UniRule.
DR   Gene3D; 2.30.30.360; -; 1.
DR   Gene3D; 3.40.850.10; -; 1.
DR   Gene3D; 4.10.270.10; -; 1.
DR   InterPro; IPR000048; IQ_motif_EF-hand-BS.
DR   InterPro; IPR036961; Kinesin_motor_dom_sf.
DR   InterPro; IPR001609; Myosin_head_motor_dom.
DR   InterPro; IPR027401; Myosin_IQ_contain_sf.
DR   InterPro; IPR004009; Myosin_N.
DR   InterPro; IPR008989; Myosin_S1_N.
DR   InterPro; IPR002928; Myosin_tail.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   Pfam; PF00063; Myosin_head; 1.
DR   Pfam; PF02736; Myosin_N; 1.
DR   Pfam; PF01576; Myosin_tail_1; 1.
DR   PRINTS; PR00193; MYOSINHEAVY.
DR   SMART; SM00015; IQ; 1.
DR   SMART; SM00242; MYSc; 1.
DR   SUPFAM; SSF50084; SSF50084; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS50096; IQ; 1.
DR   PROSITE; PS51456; MYOSIN_MOTOR; 1.
DR   PROSITE; PS51844; SH3_LIKE; 1.
PE   3: Inferred from homology;
KW   Actin-binding {ECO:0000256|PROSITE-ProRule:PRU00782,
KW   ECO:0000256|SAAS:SAAS01238310};
KW   ATP-binding {ECO:0000256|PROSITE-ProRule:PRU00782,
KW   ECO:0000256|SAAS:SAAS00875240};
KW   Coiled coil {ECO:0000256|SAAS:SAAS01040361, ECO:0000256|SAM:Coils};
KW   Motor protein {ECO:0000256|PROSITE-ProRule:PRU00782,
KW   ECO:0000256|SAAS:SAAS01033784};
KW   Myosin {ECO:0000256|PROSITE-ProRule:PRU00782,
KW   ECO:0000256|SAAS:SAAS01033784};
KW   Nucleotide-binding {ECO:0000256|PROSITE-ProRule:PRU00782,
KW   ECO:0000256|SAAS:SAAS00875240}.
FT   DOMAIN          31..81
FT                   /note="Myosin N-terminal SH3-like"
FT                   /evidence="ECO:0000259|PROSITE:PS51844"
FT   DOMAIN          85..783
FT                   /note="Myosin motor"
FT                   /evidence="ECO:0000259|PROSITE:PS51456"
FT   NP_BIND         178..185
FT                   /note="ATP"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00782"
FT   REGION          661..683
FT                   /note="Actin-binding"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00782"
FT   REGION          858..882
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1744..1800
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1867..1938
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          1180..1575
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1577..1719
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        1761..1787
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1867..1915
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   1938 AA;  223577 MW;  61D4A502A155BEC0 CRC64;
     MAQKGQLSDD EKFLFVDKNF INSPVAQADW AAKRLVWVPS EKQGFEAASI KEEKGDEVVV
     ELVENGKKVT VGKDDIQKMN PPKFSKVEDM AELTCLNEAS VLHNLRERYF SGLIYTYSGL
     FCVVVNPYKH LPIYSEKIVD MYKGKKRHEM PPHIYAIADT AYRSMLQDRE DQSILCTGES
     GAGKTENTKK VIQYLAVVAS SHKGKKDTSI TGELEKQLLQ ANPILEAFGN AKTVKNDNSS
     RFGKFIRINF DVTGYIVGAN IETYLLEKSR AIRQARDERT FHIFYYMIAG AKEKMRSDLL
     LEGFNNYTFL SNGFVPIPAA QDDEMFQETV EAMAIMGFSE EEQLSILKVV SSVLQLGNIV
     FKKERNTDQA SMPDNTAAQK VCHLMGINVT DFTRSILTPR IKVGRDVVQK AQTKEQADFA
     VEALAKATYE RLFRWILTRV NKALDKTHRQ GASFLGILDI AGFEIFEVNS FEQLCINYTN
     EKLQQLFNHT MFILEQEEYQ REGIEWNFID FGLDLQPCIE LIERPNNPPG VLALLDEECW
     FPKATDKSFV EKLCTEQGSH PKFQKPKQLK DKTEFSIIHY AGKVDYNASA WLTKNMDPLN
     DNVTSLLNAS SDKFVADLWK DVDRIVGLDQ MAKMTESSLP SASKTKKGMF RTVGQLYKEQ
     LGKLMTTLRN TTPNFVRCII PNHEKRSGKL DAFLVLEQLR CNGVLEGIRI CRQGFPNRIV
     FQEFRQRYEI LAANAIPKGF MDGKQACILM IKALELDPNL YRIGQSKIFF RTGVLAHLEE
     ERDLKITDVI MAFQAMCRGY LARKAFAKRQ QQLTAMKVIQ RNCAAYLKLR NWQWWRLFTK
     VKPLLQVTRQ EEEMQAKEDE LQKTKERQQK AENELKELEQ KHSQLTEEKN LLQEQLQAET
     ELYAEAEEMR VRLAAKKQEL EEILHEMEAR LEEEEDRGQQ LQAERKKMAQ QMLDLEEQLE
     EEEAARQKLQ LEKVTAEAKI KKLEDEILVM DDQNNKLSKE RKLLEERISD LTTNLAEEEE
     KAKNLTKLKN KHESMISELE VRLKKEEKSR QELEKLKRKL EGDASDFHEQ IADLQAQIAE
     LKMQLAKKEE ELQAALARLD DEIAQKNNAL KKIRELEGHI SDLQEDLDSE RAARNKAEKQ
     KRDLGEELEA LKTELEDTLD STATQQELRA KREQEVTVLK KALDEETRSH EAQVQEMRQK
     HAQAVEELTE QLEQFKRAKA NLDKNKQTLE KENADLAGEL RVLGQAKQEV EHKKKKLEAQ
     VQELQSKCSD GERARAELND KVHKLQNEVE SVTGMLNEAE GKAIKLAKDV ASLSSQLQDT
     QELLQEETRQ KLNVSTKLRQ LEEERNSLQD QLDEEMEAKQ NLERHISTLN IQLSDSKKKL
     QDFASTVEAL EEGKKRFQKE IENLTQQYEE KAAAYDKLEK TKNRLQQELD DLVVDLDNQR
     QLVSNLEKKQ RKFDQLLAEE KNISSKYADE RDRAEAEARE KETKALSLAR ALEEALEAKE
     ELERTNKMLK AEMEDLVSSK DDVGKNVHEL EKSKRALETQ MEEMKTQLEE LEDELQATED
     AKLRLEVNMQ ALKGQFERDL QARDEQNEEK RRQLQRQLHE YETELEDERK QRALAAAAKK
     KLEGDLKDLE LQADSAIKGR EEAIKQLRKL QAQMKDFQRE LEDARASRDE IFATAKENEK
     KAKSLEADLM QLQEDLAAAE RARKQADLEK EELAEELASS LSGRNALQDE KRRLEARIAQ
     LEEELEEEQG NMEAMSDRVR KATQQAEQLS NELATERSTA QKNESARQQL ERQNKELRSK
     LHEMEGAVKS KFKSTIAALE AKIAQLEEQV EQEAREKQAA TKSLKQKDKK LKEILLQVED
     ERKMAEQYKE QAEKGNARVK QLKRQLEEAE EESQRINANR RKLQRELDEA TESNEAMGRE
     VNALKSKLRG PPPQETSQ
//
ID   MYH11_HUMAN             Reviewed;        1972 AA.
AC   P35749; D2JYH7; O00396; O94944; P78422; Q3MIV8; Q3MNF0; Q3MNF1;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   27-APR-2001, sequence version 3.
DT   22-APR-2020, entry version 208.
DE   RecName: Full=Myosin-11;
DE   AltName: Full=Myosin heavy chain 11;
DE   AltName: Full=Myosin heavy chain, smooth muscle isoform;
DE   AltName: Full=SMMHC;
GN   Name=MYH11; Synonyms=KIAA0866;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3), AND TISSUE SPECIFICITY.
RX   PubMed=16000639; DOI=10.1152/ajpcell.00244.2004;
RA   Leguillette R., Gil F.R., Zitouni N., Lajoie-Kadoch S., Sobieszek A.,
RA   Lauzon A.M.;
RT   "(+)Insert smooth muscle myosin heavy chain (SM-B) isoform expression in
RT   human tissues.";
RL   Am. J. Physiol. 289:C1277-C1285(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10493829; DOI=10.1006/geno.1999.5927;
RA   Loftus B.J., Kim U.-J., Sneddon V.P., Kalush F., Brandon R., Fuhrmann J.,
RA   Mason T., Crosby M.L., Barnstead M., Cronin L., Mays A.D., Cao Y., Xu R.X.,
RA   Kang H.-L., Mitchell S., Eichler E.E., Harris P.C., Venter J.C.,
RA   Adams M.D.;
RT   "Genome duplications and other features in 12 Mb of DNA sequence from human
RT   chromosome 16p and 16q.";
RL   Genomics 60:295-308(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10048485; DOI=10.1093/dnares/5.6.355;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XII. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 5:355-364(1998).
RN   [4]
RP   SEQUENCE REVISION.
RA   Nagase T., Kikuno R., Yamakawa H., Ohara O.;
RL   Submitted (JAN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (SEP-2009) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G.,
RA   Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E.,
RA   Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J., Buckingham J.M.,
RA   Callen D.F., Campbell C.S., Campbell M.L., Campbell E.W., Caoile C.,
RA   Challacombe J.F., Chasteen L.A., Chertkov O., Chi H.C., Christensen M.,
RA   Clark L.M., Cohn J.D., Denys M., Detter J.C., Dickson M.,
RA   Dimitrijevic-Bussod M., Escobar J., Fawcett J.J., Flowers D., Fotopulos D.,
RA   Glavina T., Gomez M., Gonzales E., Goodstein D., Goodwin L.A., Grady D.L.,
RA   Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E.,
RA   Huang W., Israni S., Jett J., Jewett P.B., Kadner K., Kimball H.,
RA   Kobayashi A., Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y.,
RA   Lowry S., Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L., Rash S.,
RA   Retterer J., Ricke D.O., Robinson D.L., Rodriguez A., Salamov A.,
RA   Saunders E.H., Scott D., Shough T., Stallings R.L., Stalvey M.,
RA   Sutherland R.D., Tapia R., Tesmer J.G., Thayer N., Thompson L.S., Tice H.,
RA   Torney D.C., Tran-Gyamfi M., Tsai M., Ulanovsky L.E., Ustaszewska A.,
RA   Vo N., White P.S., Williams A.L., Wills P.L., Wu J.-R., Wu K., Yang J.,
RA   DeJong P., Bruce D., Doggett N.A., Deaven L., Schmutz J., Grimwood J.,
RA   Richardson P., Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M.,
RA   Myers R.M., Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 4).
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 885-1972 (ISOFORM 1/2).
RX   PubMed=7684189; DOI=10.1002/ajmg.1320460110;
RA   Matsuoka R., Yoshida M.C., Furutani Y., Imamura S., Kanda N.,
RA   Yanagisawa M., Masaki T., Takao A.;
RT   "Human smooth muscle myosin heavy chain gene mapped to chromosomal region
RT   16q12.";
RL   Am. J. Med. Genet. 46:61-67(1993).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1093-1972 (ISOFORM 1/2).
RC   TISSUE=Hippocampus;
RA   Okajima K.;
RL   Submitted (NOV-1992) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H., Mangini N.J.,
RA   Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R., Yamagishi S.,
RA   Shabanowitz J., Hearing V.J., Wu C., Appella E., Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1954, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by enrichment
RT   and fractionation of phosphopeptides with strong anion exchange
RT   chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-8; SER-23; SER-1954 AND
RP   THR-1958, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   VARIANTS AAT4 1241-ARG--LEU-1264 DEL AND GLN-1758.
RX   PubMed=16444274; DOI=10.1038/ng1721;
RA   Zhu L., Vranckx R., Khau Van Kien P., Lalande A., Boisset N., Mathieu F.,
RA   Wegman M., Glancy L., Gasc J.-M., Brunotte F., Bruneval P., Wolf J.-E.,
RA   Michel J.-B., Jeunemaitre X.;
RT   "Mutations in myosin heavy chain 11 cause a syndrome associating thoracic
RT   aortic aneurysm/aortic dissection and patent ductus arteriosus.";
RL   Nat. Genet. 38:343-349(2006).
CC   -!- FUNCTION: Muscle contraction.
CC   -!- SUBUNIT: Muscle myosin is a hexameric protein that consists of 2 heavy
CC       chain subunits (MHC), 2 alkali light chain subunits (MLC) and 2
CC       regulatory light chain subunits (MLC-2).
CC   -!- INTERACTION:
CC       P35749; O14950: MYL12B; NbExp=2; IntAct=EBI-1052928, EBI-1642165;
CC   -!- SUBCELLULAR LOCATION: Melanosome {ECO:0000269|PubMed:17081065}.
CC       Note=Identified by mass spectrometry in melanosome fractions from stage
CC       I to stage IV. Thick filaments of the myofibrils.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=SM-A;
CC         IsoId=P35749-1; Sequence=Displayed;
CC       Name=2; Synonyms=SM-B1;
CC         IsoId=P35749-2; Sequence=VSP_043017;
CC       Name=3; Synonyms=SM-B2;
CC         IsoId=P35749-3; Sequence=VSP_043017, VSP_043018;
CC       Name=4;
CC         IsoId=P35749-4; Sequence=VSP_043018;
CC   -!- TISSUE SPECIFICITY: Smooth muscle; expressed in the umbilical artery,
CC       bladder, esophagus and trachea. Isoform 1 is mostly found in slowly
CC       contracting tonic muscles. {ECO:0000269|PubMed:16000639}.
CC   -!- DOMAIN: The rodlike tail sequence is highly repetitive, showing cycles
CC       of a 28-residue repeat pattern composed of 4 heptapeptides,
CC       characteristic for alpha-helical coiled coils.
CC   -!- DOMAIN: Limited proteolysis of myosin heavy chain produces 1 light
CC       meromyosin (LMM) and 1 heavy meromyosin (HMM). HMM can be further
CC       cleaved into 2 globular subfragments (S1) and 1 rod-shaped subfragment
CC       (S2). {ECO:0000305}.
CC   -!- DISEASE: Note=A chromosomal aberration involving MYH11 is found in
CC       acute myeloid leukemia of M4EO subtype. Pericentric inversion
CC       inv(16)(p13;q22). The inversion produces a fusion protein consisting of
CC       the 165 N-terminal residues of CBF-beta (PEPB2) and the tail region of
CC       MYH11.
CC   -!- DISEASE: Aortic aneurysm, familial thoracic 4 (AAT4) [MIM:132900]: A
CC       disease characterized by permanent dilation of the thoracic aorta
CC       usually due to degenerative changes in the aortic wall. It is primarily
CC       associated with a characteristic histologic appearance known as 'medial
CC       necrosis' or 'Erdheim cystic medial necrosis' in which there is
CC       degeneration and fragmentation of elastic fibers, loss of smooth muscle
CC       cells, and an accumulation of basophilic ground substance.
CC       {ECO:0000269|PubMed:16444274}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: [Isoform 2]: This isoform with a 7 AA insert in the head
CC       domain is predominantly expressed in rapidly contracting phasic
CC       muscles. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 3]: This isoform with a 7 AA insert in the head
CC       domain is predominantly expressed in rapidly contracting phasic
CC       muscles. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase
CC       superfamily. Myosin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA74889.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/MYH11ID43.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY520816; AAS98910.1; -; mRNA.
DR   EMBL; AY520817; AAS98911.1; -; mRNA.
DR   EMBL; AF001548; AAC31665.1; -; Genomic_DNA.
DR   EMBL; U91323; AAC35212.1; -; Genomic_DNA.
DR   EMBL; AB020673; BAA74889.2; ALT_INIT; mRNA.
DR   EMBL; GU143399; ACZ58373.1; -; Genomic_DNA.
DR   EMBL; GU143400; ACZ58374.1; -; Genomic_DNA.
DR   EMBL; AC024120; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC026401; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC130651; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471226; EAW53924.1; -; Genomic_DNA.
DR   EMBL; CH471226; EAW53926.1; -; Genomic_DNA.
DR   EMBL; BC101677; AAI01678.1; -; mRNA.
DR   EMBL; BC104906; AAI04907.1; -; mRNA.
DR   EMBL; BC143364; AAI43365.1; -; mRNA.
DR   EMBL; D10667; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; X69292; CAA49154.1; -; mRNA.
DR   CCDS; CCDS10565.1; -. [P35749-1]
DR   CCDS; CCDS10566.1; -. [P35749-4]
DR   CCDS; CCDS45423.1; -. [P35749-2]
DR   CCDS; CCDS45424.1; -. [P35749-3]
DR   RefSeq; NP_001035202.1; NM_001040113.1. [P35749-3]
DR   RefSeq; NP_001035203.1; NM_001040114.1. [P35749-2]
DR   RefSeq; NP_002465.1; NM_002474.2. [P35749-1]
DR   RefSeq; NP_074035.1; NM_022844.2. [P35749-4]
DR   RefSeq; XP_016878739.1; XM_017023250.1. [P35749-3]
DR   SMR; P35749; -.
DR   BioGrid; 110714; 67.
DR   DIP; DIP-47268N; -.
DR   IntAct; P35749; 49.
DR   MINT; P35749; -.
DR   STRING; 9606.ENSP00000379616; -.
DR   DrugBank; DB04444; Tetrafluoroaluminate Ion.
DR   iPTMnet; P35749; -.
DR   MetOSite; P35749; -.
DR   PhosphoSitePlus; P35749; -.
DR   SwissPalm; P35749; -.
DR   BioMuta; MYH11; -.
DR   DMDM; 13432177; -.
DR   jPOST; P35749; -.
DR   MassIVE; P35749; -.
DR   MaxQB; P35749; -.
DR   PaxDb; P35749; -.
DR   PeptideAtlas; P35749; -.
DR   PRIDE; P35749; -.
DR   ProteomicsDB; 55147; -. [P35749-1]
DR   ProteomicsDB; 55148; -. [P35749-2]
DR   ProteomicsDB; 55149; -. [P35749-3]
DR   ProteomicsDB; 61796; -.
DR   Antibodypedia; 1966; 689 antibodies.
DR   Ensembl; ENST00000300036; ENSP00000300036; ENSG00000133392. [P35749-1]
DR   Ensembl; ENST00000396324; ENSP00000379616; ENSG00000133392. [P35749-2]
DR   Ensembl; ENST00000452625; ENSP00000407821; ENSG00000133392. [P35749-3]
DR   Ensembl; ENST00000576790; ENSP00000458731; ENSG00000133392. [P35749-4]
DR   Ensembl; ENST00000612165; ENSP00000478092; ENSG00000276480. [P35749-3]
DR   Ensembl; ENST00000616422; ENSP00000478816; ENSG00000276480. [P35749-4]
DR   Ensembl; ENST00000621545; ENSP00000478109; ENSG00000276480. [P35749-2]
DR   Ensembl; ENST00000634050; ENSP00000488461; ENSG00000276480. [P35749-1]
DR   GeneID; 4629; -.
DR   KEGG; hsa:4629; -.
DR   UCSC; uc002ddv.4; human. [P35749-1]
DR   CTD; 4629; -.
DR   DisGeNET; 4629; -.
DR   GeneCards; MYH11; -.
DR   GeneReviews; MYH11; -.
DR   HGNC; HGNC:7569; MYH11.
DR   HPA; ENSG00000133392; Tissue enhanced (smooth muscle, urinary bladder).
DR   MalaCards; MYH11; -.
DR   MIM; 132900; phenotype.
DR   MIM; 160745; gene.
DR   neXtProt; NX_P35749; -.
DR   OpenTargets; ENSG00000133392; -.
DR   Orphanet; 98829; Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22).
DR   Orphanet; 229; Familial aortic dissection.
DR   Orphanet; 91387; Familial thoracic aortic aneurysm and aortic dissection.
DR   Orphanet; 2241; Megacystis-microcolon-intestinal hypoperistalsis syndrome.
DR   Orphanet; 706; NON RARE IN EUROPE: Patent arterial duct.
DR   PharmGKB; PA31367; -.
DR   eggNOG; KOG0161; Eukaryota.
DR   eggNOG; COG5022; LUCA.
DR   GeneTree; ENSGT00940000155421; -.
DR   HOGENOM; CLU_000192_4_2_1; -.
DR   InParanoid; P35749; -.
DR   KO; K10352; -.
DR   OMA; QGNHVKF; -.
DR   OrthoDB; 47111at2759; -.
DR   PhylomeDB; P35749; -.
DR   TreeFam; TF333601; -.
DR   Reactome; R-HSA-3928663; EPHA-mediated growth cone collapse.
DR   Reactome; R-HSA-416572; Sema4D induced cell migration and growth-cone collapse.
DR   Reactome; R-HSA-445355; Smooth Muscle Contraction.
DR   Reactome; R-HSA-5625740; RHO GTPases activate PKNs.
DR   Reactome; R-HSA-5625900; RHO GTPases activate CIT.
DR   Reactome; R-HSA-5627117; RHO GTPases Activate ROCKs.
DR   Reactome; R-HSA-5627123; RHO GTPases activate PAKs.
DR   ChiTaRS; MYH11; human.
DR   GeneWiki; MYH11; -.
DR   GenomeRNAi; 4629; -.
DR   Pharos; P35749; Tbio.
DR   PRO; PR:P35749; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   RNAct; P35749; protein.
DR   Bgee; ENSG00000133392; Expressed in saphenous vein and 235 other tissues.
DR   ExpressionAtlas; P35749; baseline and differential.
DR   Genevisible; P35749; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005859; C:muscle myosin complex; TAS:ProtInc.
DR   GO; GO:0032982; C:myosin filament; IEA:UniProtKB-KW.
DR   GO; GO:0051015; F:actin filament binding; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0003774; F:motor activity; IEA:InterPro.
DR   GO; GO:0008307; F:structural constituent of muscle; IMP:UniProtKB.
DR   GO; GO:0048739; P:cardiac muscle fiber development; IMP:UniProtKB.
DR   GO; GO:0048251; P:elastic fiber assembly; IMP:UniProtKB.
DR   GO; GO:0006936; P:muscle contraction; TAS:Reactome.
DR   GO; GO:0030241; P:skeletal muscle myosin thick filament assembly; ISS:UniProtKB.
DR   GO; GO:0006939; P:smooth muscle contraction; ISS:UniProtKB.
DR   Gene3D; 2.30.30.360; -; 1.
DR   Gene3D; 3.40.850.10; -; 1.
DR   Gene3D; 4.10.270.10; -; 1.
DR   InterPro; IPR000048; IQ_motif_EF-hand-BS.
DR   InterPro; IPR036961; Kinesin_motor_dom_sf.
DR   InterPro; IPR001609; Myosin_head_motor_dom.
DR   InterPro; IPR027401; Myosin_IQ_contain_sf.
DR   InterPro; IPR004009; Myosin_N.
DR   InterPro; IPR008989; Myosin_S1_N.
DR   InterPro; IPR002928; Myosin_tail.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   Pfam; PF00063; Myosin_head; 1.
DR   Pfam; PF02736; Myosin_N; 1.
DR   Pfam; PF01576; Myosin_tail_1; 1.
DR   PRINTS; PR00193; MYOSINHEAVY.
DR   SMART; SM00015; IQ; 1.
DR   SMART; SM00242; MYSc; 1.
DR   SUPFAM; SSF50084; SSF50084; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS50096; IQ; 1.
DR   PROSITE; PS51456; MYOSIN_MOTOR; 1.
DR   PROSITE; PS51844; SH3_LIKE; 1.
PE   1: Evidence at protein level;
KW   Actin-binding; Alternative splicing; Aortic aneurysm; ATP-binding;
KW   Calmodulin-binding; Chromosomal rearrangement; Coiled coil;
KW   Disease mutation; Methylation; Motor protein; Muscle protein; Myosin;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Proto-oncogene;
KW   Reference proteome; Thick filament.
FT   CHAIN           1..1972
FT                   /note="Myosin-11"
FT                   /id="PRO_0000123424"
FT   DOMAIN          31..81
FT                   /note="Myosin N-terminal SH3-like"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01190"
FT   DOMAIN          85..783
FT                   /note="Myosin motor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00782"
FT   DOMAIN          786..815
FT                   /note="IQ"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00116"
FT   NP_BIND         178..185
FT                   /note="ATP"
FT                   /evidence="ECO:0000255"
FT   REGION          661..683
FT                   /note="Actin-binding"
FT                   /evidence="ECO:0000250"
FT   REGION          762..776
FT                   /note="Actin-binding"
FT                   /evidence="ECO:0000250"
FT   REGION          1935..1972
FT                   /note="C-terminal"
FT   COILED          844..1934
FT                   /evidence="ECO:0000255"
FT   MOD_RES         8
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         23
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         40
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q7Z406"
FT   MOD_RES         129
FT                   /note="N6,N6,N6-trimethyllysine"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         1177
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q7Z406"
FT   MOD_RES         1684
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q63862"
FT   MOD_RES         1722
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q63862"
FT   MOD_RES         1954
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18318008,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         1958
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         1971
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O08638"
FT   VAR_SEQ         211
FT                   /note="T -> TQGPSFAY (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:16000639"
FT                   /id="VSP_043017"
FT   VAR_SEQ         1930..1972
FT                   /note="RGNETSFVPSRRSGGRRVIENADGSEEETDTRDADFNGTKASE -> GPPPQ
FT                   ETSQ (in isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:16000639"
FT                   /id="VSP_043018"
FT   VARIANT         1104
FT                   /note="A -> T (in dbSNP:rs34263860)"
FT                   /id="VAR_050205"
FT   VARIANT         1234
FT                   /note="A -> T (in dbSNP:rs16967494)"
FT                   /id="VAR_030239"
FT   VARIANT         1241..1264
FT                   /note="Missing (in AAT4)"
FT                   /evidence="ECO:0000269|PubMed:16444274"
FT                   /id="VAR_031734"
FT   VARIANT         1289
FT                   /note="V -> A (in dbSNP:rs16967510)"
FT                   /id="VAR_030240"
FT   VARIANT         1310
FT                   /note="V -> M (in dbSNP:rs7196804)"
FT                   /id="VAR_030241"
FT   VARIANT         1508
FT                   /note="M -> V (in dbSNP:rs35176378)"
FT                   /id="VAR_050206"
FT   VARIANT         1758
FT                   /note="R -> Q (in AAT4; dbSNP:rs142546324)"
FT                   /evidence="ECO:0000269|PubMed:16444274"
FT                   /id="VAR_031735"
FT   CONFLICT        887..889
FT                   /note="EEK -> NSE (in Ref. 9; D10667)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1558
FT                   /note="T -> S (in Ref. 9; D10667)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1610..1611
FT                   /note="KQ -> NE (in Ref. 9; D10667)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1786
FT                   /note="A -> S (in Ref. 10; CAA49154)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1958
FT                   /note="T -> L (in Ref. 9; D10667)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1972 AA;  227339 MW;  67665BB2AECE1277 CRC64;
     MAQKGQLSDD EKFLFVDKNF INSPVAQADW AAKRLVWVPS EKQGFEAASI KEEKGDEVVV
     ELVENGKKVT VGKDDIQKMN PPKFSKVEDM AELTCLNEAS VLHNLRERYF SGLIYTYSGL
     FCVVVNPYKH LPIYSEKIVD MYKGKKRHEM PPHIYAIADT AYRSMLQDRE DQSILCTGES
     GAGKTENTKK VIQYLAVVAS SHKGKKDTSI TGELEKQLLQ ANPILEAFGN AKTVKNDNSS
     RFGKFIRINF DVTGYIVGAN IETYLLEKSR AIRQARDERT FHIFYYMIAG AKEKMRSDLL
     LEGFNNYTFL SNGFVPIPAA QDDEMFQETV EAMAIMGFSE EEQLSILKVV SSVLQLGNIV
     FKKERNTDQA SMPDNTAAQK VCHLMGINVT DFTRSILTPR IKVGRDVVQK AQTKEQADFA
     VEALAKATYE RLFRWILTRV NKALDKTHRQ GASFLGILDI AGFEIFEVNS FEQLCINYTN
     EKLQQLFNHT MFILEQEEYQ REGIEWNFID FGLDLQPCIE LIERPNNPPG VLALLDEECW
     FPKATDKSFV EKLCTEQGSH PKFQKPKQLK DKTEFSIIHY AGKVDYNASA WLTKNMDPLN
     DNVTSLLNAS SDKFVADLWK DVDRIVGLDQ MAKMTESSLP SASKTKKGMF RTVGQLYKEQ
     LGKLMTTLRN TTPNFVRCII PNHEKRSGKL DAFLVLEQLR CNGVLEGIRI CRQGFPNRIV
     FQEFRQRYEI LAANAIPKGF MDGKQACILM IKALELDPNL YRIGQSKIFF RTGVLAHLEE
     ERDLKITDVI MAFQAMCRGY LARKAFAKRQ QQLTAMKVIQ RNCAAYLKLR NWQWWRLFTK
     VKPLLQVTRQ EEEMQAKEDE LQKTKERQQK AENELKELEQ KHSQLTEEKN LLQEQLQAET
     ELYAEAEEMR VRLAAKKQEL EEILHEMEAR LEEEEDRGQQ LQAERKKMAQ QMLDLEEQLE
     EEEAARQKLQ LEKVTAEAKI KKLEDEILVM DDQNNKLSKE RKLLEERISD LTTNLAEEEE
     KAKNLTKLKN KHESMISELE VRLKKEEKSR QELEKLKRKL EGDASDFHEQ IADLQAQIAE
     LKMQLAKKEE ELQAALARLD DEIAQKNNAL KKIRELEGHI SDLQEDLDSE RAARNKAEKQ
     KRDLGEELEA LKTELEDTLD STATQQELRA KREQEVTVLK KALDEETRSH EAQVQEMRQK
     HAQAVEELTE QLEQFKRAKA NLDKNKQTLE KENADLAGEL RVLGQAKQEV EHKKKKLEAQ
     VQELQSKCSD GERARAELND KVHKLQNEVE SVTGMLNEAE GKAIKLAKDV ASLSSQLQDT
     QELLQEETRQ KLNVSTKLRQ LEEERNSLQD QLDEEMEAKQ NLERHISTLN IQLSDSKKKL
     QDFASTVEAL EEGKKRFQKE IENLTQQYEE KAAAYDKLEK TKNRLQQELD DLVVDLDNQR
     QLVSNLEKKQ RKFDQLLAEE KNISSKYADE RDRAEAEARE KETKALSLAR ALEEALEAKE
     ELERTNKMLK AEMEDLVSSK DDVGKNVHEL EKSKRALETQ MEEMKTQLEE LEDELQATED
     AKLRLEVNMQ ALKGQFERDL QARDEQNEEK RRQLQRQLHE YETELEDERK QRALAAAAKK
     KLEGDLKDLE LQADSAIKGR EEAIKQLRKL QAQMKDFQRE LEDARASRDE IFATAKENEK
     KAKSLEADLM QLQEDLAAAE RARKQADLEK EELAEELASS LSGRNALQDE KRRLEARIAQ
     LEEELEEEQG NMEAMSDRVR KATQQAEQLS NELATERSTA QKNESARQQL ERQNKELRSK
     LHEMEGAVKS KFKSTIAALE AKIAQLEEQV EQEAREKQAA TKSLKQKDKK LKEILLQVED
     ERKMAEQYKE QAEKGNARVK QLKRQLEEAE EESQRINANR RKLQRELDEA TESNEAMGRE
     VNALKSKLRR GNETSFVPSR RSGGRRVIEN ADGSEEETDT RDADFNGTKA SE
//
ID   A8CDT9_HUMAN            Unreviewed;      1828 AA.
AC   A8CDT9;
DT   13-NOV-2007, integrated into UniProtKB/TrEMBL.
DT   13-NOV-2007, sequence version 1.
DT   26-FEB-2020, entry version 73.
DE   SubName: Full=MYO5A variant protein {ECO:0000313|EMBL:BAF80583.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAF80583.1};
RN   [1] {ECO:0000313|EMBL:BAF80583.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAF80583.1};
RA   Yamakawa H., Kikuno R.F., Nagase T., Ohara O.;
RT   "Multiplex amplification and cloning of 5'-ends of cDNA by ligase-free
RT   recombination: Preparation of full-lemgth cDNA clones encoding motor
RT   proteins.";
RL   Submitted (JAN-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase
CC       superfamily. Myosin family. {ECO:0000256|PROSITE-ProRule:PRU00782,
CC       ECO:0000256|SAAS:SAAS00572438}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB290180; BAF80583.1; -; mRNA.
DR   RefSeq; NP_001135967.1; NM_001142495.1.
DR   PeptideAtlas; A8CDT9; -.
DR   PRIDE; A8CDT9; -.
DR   GeneID; 4644; -.
DR   CTD; 4644; -.
DR   PharmGKB; PA31407; -.
DR   eggNOG; KOG0160; Eukaryota.
DR   eggNOG; KOG0161; Eukaryota.
DR   eggNOG; COG5022; LUCA.
DR   OrthoDB; 311886at2759; -.
DR   GenomeRNAi; 4644; -.
DR   Genevisible; A8CDT9; HS.
DR   GO; GO:0016459; C:myosin complex; IEA:UniProtKB-KW.
DR   GO; GO:0051015; F:actin filament binding; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0003774; F:motor activity; IEA:UniProtKB-UniRule.
DR   CDD; cd15478; Myo5a_CBD; 1.
DR   CDD; cd01380; MYSc_Myo5; 1.
DR   Gene3D; 2.30.30.360; -; 1.
DR   Gene3D; 3.40.850.10; -; 1.
DR   InterPro; IPR002710; Dilute_dom.
DR   InterPro; IPR000048; IQ_motif_EF-hand-BS.
DR   InterPro; IPR036961; Kinesin_motor_dom_sf.
DR   InterPro; IPR037988; Myo5a_CBD.
DR   InterPro; IPR001609; Myosin_head_motor_dom.
DR   InterPro; IPR004009; Myosin_N.
DR   InterPro; IPR008989; Myosin_S1_N.
DR   InterPro; IPR036103; MYSc_Myo5.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   Pfam; PF01843; DIL; 1.
DR   Pfam; PF00612; IQ; 6.
DR   Pfam; PF00063; Myosin_head; 1.
DR   PRINTS; PR00193; MYOSINHEAVY.
DR   SMART; SM01132; DIL; 1.
DR   SMART; SM00015; IQ; 6.
DR   SMART; SM00242; MYSc; 1.
DR   SUPFAM; SSF52540; SSF52540; 3.
DR   PROSITE; PS51126; DILUTE; 1.
DR   PROSITE; PS50096; IQ; 6.
DR   PROSITE; PS51456; MYOSIN_MOTOR; 1.
DR   PROSITE; PS51844; SH3_LIKE; 1.
PE   2: Evidence at transcript level;
KW   Actin-binding {ECO:0000256|PROSITE-ProRule:PRU00782,
KW   ECO:0000256|SAAS:SAAS01238310};
KW   ATP-binding {ECO:0000256|PROSITE-ProRule:PRU00782,
KW   ECO:0000256|SAAS:SAAS00875240};
KW   Coiled coil {ECO:0000256|SAAS:SAAS01040361, ECO:0000256|SAM:Coils};
KW   Motor protein {ECO:0000256|PROSITE-ProRule:PRU00782,
KW   ECO:0000256|SAAS:SAAS01033784};
KW   Myosin {ECO:0000256|PROSITE-ProRule:PRU00782,
KW   ECO:0000256|SAAS:SAAS01033784};
KW   Nucleotide-binding {ECO:0000256|PROSITE-ProRule:PRU00782,
KW   ECO:0000256|SAAS:SAAS00875240}.
FT   DOMAIN          8..60
FT                   /note="Myosin N-terminal SH3-like"
FT                   /evidence="ECO:0000259|PROSITE:PS51844"
FT   DOMAIN          69..763
FT                   /note="Myosin motor"
FT                   /evidence="ECO:0000259|PROSITE:PS51456"
FT   DOMAIN          1507..1783
FT                   /note="Dilute"
FT                   /evidence="ECO:0000259|PROSITE:PS51126"
FT   NP_BIND         163..170
FT                   /note="ATP"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00782"
FT   REGION          598..631
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          643..665
FT                   /note="Actin-binding"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00782"
FT   COILED          915..949
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          971..1098
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1155..1189
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1196..1231
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1323..1364
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1371..1412
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        598..614
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   1828 AA;  212259 MW;  F8ADE83570ED0B76 CRC64;
     MAASELYTKF ARVWIPDPEE VWKSAELLKD YKPGDKVLLL HLEEGKDLEY HLDPKTKELP
     HLRNPDILVG ENDLTALSYL HEPAVLHNLR VRFIDSKLIY TYCGIVLVAI NPYEQLPIYG
     EDIINAYSGQ NMGDMDPHIF AVAEEAYKQM ARDERNQSII VSGESGAGKT VSAKYAMRYF
     ATVSGSASEA NVEEKVLASN PIMESIGNAK TTRNDNSSRF GKYIEIGFDK RYRIIGANMR
     TYLLEKSRVV FQAEEERNYH IFYQLCASAK LPEFKMLRLG NADNFNYTKQ GGSPVIEGVD
     DAKEMAHTRQ ACTLLGISES HQMGIFRILA GILHLGNVGF TSRDADSCTI PPKHEPLCIF
     CDLMGVDYEE MCHWLCHRKL ATATETYIKP ISKLQATNAR DALAKHIYAK LFNWIVDNVN
     QALHSAVKQH SFIGVLDIYG FETFEINSFE QFCINYANEK LQQQFNMHVF KLEQEEYMKE
     QIPWTLIDFY DNQPCINLIE SKLGILDLLD EECKMPKGTD DTWAQKLYNT HLNKCALFEK
     PRLSNKAFII QHFADKVEYQ CEGFLEKNKD TVFEEQIKVL KSSKFKMLPE LFQDDEKAIS
     PTSATSSGRT PLTRTPAKPT KGRPGQMAKE HKKTVGHQFR NSLHLLMETL NATTPHYVRC
     IKPNDFKFPF TFDEKRAVQQ LRACGVLETI RISAAGFPSR WTYQEFFSRY RVLMKQKDVL
     SDRKQTCKNV LEKLILDKDK YQFGKTKIFF RAGQVAYLEK LRADKLRAAC IRIQKTIRGW
     LLRKKYLRMR KAAITMQRYV RGYQARCYAK FLRRTKAATI IQKYWRMYVV RRRYKIRRAA
     TIVLQSYLRG FLARNRYRKI LREHKAVIIQ KRVRGWLART HYKRSMHAII YLQCCFRRMM
     AKRELKKLKI EARSVERYKK LHIGMENKIM QLQRKVDEQN KDYKCLVEKL TNLEGIYNSE
     TEKLRSDLER LQLSEEEAKV ATGRVLSLQE EIAKLRKDLE QTRSEKKCIE EHADRYKQET
     EQLVSNLKEE NTLLKQEKEA LNHRIVQQAK EMTETMEKKL VEETKQLELD LNDERLRYQN
     LLNEFSRLEE RYDDLKEEMT LMVHVPKPGH KRTDSTHSSN ESEYIFSSEI AEMEDIPSRT
     EEPSEKKVPL DMSLFLKLQK RVTELEQEKQ VMQDELDRKE EQVLRSKAKE EERPQIRGAE
     LEYESLKRQE LESENKKLKN ELNELRKALS EKSAPEVTAP GAPAYRVLME QLTSVSEELD
     VRKEEVLILR SQLVSQKEAI QPKDDKNTMT DSTILLEDVQ KMKDKGEIAQ AYIGLKETNR
     LLESQLQSQK RSHENEAEAL RGEIQSLKEE NNRQQQLLAQ NLQLPPEARI EASLQHEITR
     LTNENLDLME QLEKQDKTVR KLKKQLKVFA KKIGELEVGQ MENISPGQII DEPIRPVNIP
     RKEKDFQGML EYKKEDEQKL VKNLILELKP RGVAVNLIPG LPAYILFMCV RHADYLNDDQ
     KVRSLLTSTI NSIKKVLKKR GDDFETVSFW LSNTCRFLHC LKQYSGEEGF MKHNTSRQNE
     HCLTNFDLAE YRQVLSDLAI QIYQQLVRVL ENILQPMIVS GMLEHETIQG VSGVKPTGLR
     KRTSSIADEG TYTLDSILRQ LNSFHSVMCQ HGMDPELIKQ VVKQMFYIIG AITLNNLLLR
     KDMCSWSKGM QIRYNVSQLE EWLRDKNLMN SGAKETLEPL IQAAQLLQVK KKTDDDAEAI
     CSMCNALTTA QIVKVLNLYT PVNEFEERVS VSFIRTIQMR LRDRKDSPQL LMDAKHIFPV
     TFPFNPSSLA LETIQIPASL GLGFISRV
//
ID   Q9UES4_HUMAN            Unreviewed;       206 AA.
AC   Q9UES4;
DT   01-MAY-2000, integrated into UniProtKB/TrEMBL.
DT   01-MAY-2000, sequence version 1.
DT   11-DEC-2019, entry version 70.
DE   SubName: Full=Myosin V {ECO:0000313|EMBL:AAC83703.1};
DE   Flags: Fragment;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAC83703.1};
RN   [1] {ECO:0000313|EMBL:AAC83703.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Skin {ECO:0000313|EMBL:AAC83703.1};
RX   PubMed=9826529; DOI=10.1006/bbrc.1998.9644;
RA   Lambert J., Naeyaert J.M., Callens T., De Paepe A., Messiaen L.;
RT   "Human myosin V gene produces different transcripts in a cell type-specific
RT   manner.";
RL   Biochem. Biophys. Res. Commun. 252:329-333(1998).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF090426; AAC83703.1; -; mRNA.
DR   RefSeq; NP_000250.3; NM_000259.3.
DR   PeptideAtlas; Q9UES4; -.
DR   PRIDE; Q9UES4; -.
DR   GeneID; 4644; -.
DR   KEGG; hsa:4644; -.
DR   CTD; 4644; -.
DR   PharmGKB; PA31407; -.
DR   eggNOG; KOG0160; Eukaryota.
DR   eggNOG; KOG0161; Eukaryota.
DR   eggNOG; COG5022; LUCA.
DR   KO; K10357; -.
DR   OrthoDB; 311886at2759; -.
DR   GenomeRNAi; 4644; -.
DR   Genevisible; Q9UES4; HS.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   COILED          1..24
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          132..184
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   NON_TER         1
FT                   /evidence="ECO:0000313|EMBL:AAC83703.1"
FT   NON_TER         206
FT                   /evidence="ECO:0000313|EMBL:AAC83703.1"
SQ   SEQUENCE   206 AA;  23612 MW;  4E445C84828A95D9 CRC64;
     RQELESENKK LKNELNELRK ALSEKSAPEV TAPGAPAYRV LMEQLTSVSE ELDVRKEEVL
     ILRSQLVSQK EAIQPKDDKN TMTDSTILLE DVQKMKDKGE IAQAYIGLKE TNRSSALDYH
     ELNEDGELWL VYEGLKQANR LLESQLQSQK RSHENEAEAL RGEIQSLKEE NNRQQQLLAQ
     NLQLPPEARI EASLQHEITR LTNENL
//
ID   MYO5A_HUMAN             Reviewed;        1855 AA.
AC   Q9Y4I1; A8MZC5; O60653; Q07902; Q16249; Q9UE30; Q9UE31;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   22-APR-2020, entry version 198.
DE   RecName: Full=Unconventional myosin-Va;
DE   AltName: Full=Dilute myosin heavy chain, non-muscle;
DE   AltName: Full=Myosin heavy chain 12;
DE   AltName: Full=Myosin-12;
DE   AltName: Full=Myoxin;
GN   Name=MYO5A; Synonyms=MYH12;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Skin;
RA   Meurers B.H., Zimmermann R., Vosberg H.P.;
RT   "The complete cDNA for human myosin heavy chain 12, a class V myosin.";
RL   Submitted (SEP-1996) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT CYS-1246.
RX   PubMed=9207796; DOI=10.1038/ng0797-289;
RA   Pastural E., Barrat F.J., Dufourcq-Lagelouse R., Certain S., Sanal O.,
RA   Jabado N., Seger R., Griscelli C., Fischer A., de Saint Basile G.;
RT   "Griscelli disease maps to chromosome 15q21 and is associated with
RT   mutations in the myosin-Va gene.";
RL   Nat. Genet. 16:289-292(1997).
RN   [3]
RP   ERRATUM OF PUBMED:9207796.
RA   Pastural E., Barrat F.J., Dufourcq-Lagelouse R., Certain S., Sanal O.,
RA   Jabado N., Seger R., Griscelli C., Fischer A., de Saint Basile G.;
RL   Nat. Genet. 23:373-373(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R., Fahey J.,
RA   Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G., Johnson E.,
RA   Jones C., Kamat A., Kaur A., Locke D.P., Madan A., Munson G., Jaffe D.B.,
RA   Lui A., Macdonald P., Mauceli E., Naylor J.W., Nesbitt R., Nicol R.,
RA   O'Leary S.B., Ratcliffe A., Rounsley S., She X., Sneddon K.M.B.,
RA   Stewart S., Sougnez C., Stone S.M., Topham K., Vincent D., Wang S.,
RA   Zimmer A.R., Birren B.W., Hood L., Lander E.S., Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human chromosome
RT   15.";
RL   Nature 440:671-675(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 638-1477 (ISOFORM 2).
RC   TISSUE=Fetal brain;
RX   PubMed=8188282; DOI=10.1006/geno.1994.1088;
RA   Engle L.J., Kennett R.H.;
RT   "Cloning, analysis, and chromosomal localization of myoxin (MYH12), the
RT   human homologue to the mouse dilute gene.";
RL   Genomics 19:407-416(1994).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1061-1498 (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=7835087; DOI=10.1159/000133937;
RA   Moore K.J., Testa J.R., Francke U., Milatovich A., Copeland N.G.,
RA   Jenkins N.A.;
RT   "Cloning and regional assignment of the human myosin heavy chain 12 (MYH12)
RT   gene to chromosome band 15q21.";
RL   Cytogenet. Cell Genet. 69:53-58(1995).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1358-1460 (ISOFORM 3).
RA   Edgar A.J., Bennett J.P.;
RT   "Inhibition of dendrite formation in melanocytes transiently transfected
RT   with antisense DNA to myosin V.";
RL   Submitted (MAR-1998) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   FUNCTION.
RX   PubMed=10448864; DOI=10.1038/23072;
RA   Mehta A.D., Rock R.S., Rief M., Spudich J.A., Mooseker M.S., Cheney R.E.;
RT   "Myosin-V is a processive actin-based motor.";
RL   Nature 400:590-593(1999).
RN   [9]
RP   INTERACTION WITH MLPH.
RX   PubMed=12062444; DOI=10.1016/s0014-5793(02)02634-0;
RA   Nagashima K., Torii S., Yi Z., Igarashi M., Okamoto K., Takeuchi T.,
RA   Izumi T.;
RT   "Melanophilin directly links Rab27a and myosin Va through its distinct
RT   coiled-coil regions.";
RL   FEBS Lett. 517:233-238(2002).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1452, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   INTERACTION WITH RAB10.
RX   PubMed=22908308; DOI=10.1083/jcb.201111091;
RA   Chen Y., Wang Y., Zhang J., Deng Y., Jiang L., Song E., Wu X.S.,
RA   Hammer J.A., Xu T., Lippincott-Schwartz J.;
RT   "Rab10 and myosin-Va mediate insulin-stimulated GLUT4 storage vesicle
RT   translocation in adipocytes.";
RL   J. Cell Biol. 198:545-560(2012).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-600 AND SER-1652, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   VARIANT CYS-1246.
RX   PubMed=10733681; DOI=10.1046/j.1523-1747.2000.00933.x;
RA   Lambert J., Naeyaert J.-M., De Paepe A., Van Coster R., Ferster A.,
RA   Song M., Messiaen L.;
RT   "Arg-Cys substitution at codon 1246 of the human myosin Va gene is not
RT   associated with Griscelli syndrome.";
RL   J. Invest. Dermatol. 114:731-733(2000).
RN   [19]
RP   INVOLVEMENT IN GS1.
RX   PubMed=10704277; DOI=10.1006/geno.1999.6081;
RA   Pastural E., Ersoy F., Yalman N., Wulffraat N., Grillo E., Ozkinay F.,
RA   Tezcan I., Gedikoglu G., Philippe N., Fischer A., de Saint Basile G.;
RT   "Two genes are responsible for Griscelli syndrome at the same 15q21
RT   locus.";
RL   Genomics 63:299-306(2000).
RN   [20]
RP   INVOLVEMENT IN ELEJAS.
RX   PubMed=12058346; DOI=10.1086/341606;
RA   Anikster Y., Huizing M., Anderson P.D., Fitzpatrick D.L., Klar A.,
RA   Gross-Kieselstein E., Berkun Y., Shazberg G., Gahl W.A., Hurvitz H.;
RT   "Evidence that Griscelli syndrome with neurological involvement is caused
RT   by mutations in RAB27A, not MYO5A.";
RL   Am. J. Hum. Genet. 71:407-414(2002).
RN   [21]
RP   ERRATUM OF PUBMED:12058346.
RA   Anikster Y., Huizing M., Anderson P.D., Fitzpatrick D.L., Klar A.,
RA   Gross-Kieselstein E., Berkun Y., Shazberg G., Gahl W.A., Hurvitz H.;
RL   Am. J. Hum. Genet. 71:1007-1007(2002).
RN   [22]
RP   INVOLVEMENT IN GS3.
RX   PubMed=12897212; DOI=10.1172/jci200318264;
RA   Menasche G., Ho C.H., Sanal O., Feldmann J., Tezcan I., Ersoy F.,
RA   Houdusse A., Fischer A., de Saint Basile G.;
RT   "Griscelli syndrome restricted to hypopigmentation results from a
RT   melanophilin defect (GS3) or a MYO5A F-exon deletion (GS1).";
RL   J. Clin. Invest. 112:450-456(2003).
CC   -!- FUNCTION: Processive actin-based motor that can move in large steps
CC       approximating the 36-nm pseudo-repeat of the actin filament. Involved
CC       in melanosome transport. Also mediates the transport of vesicles to the
CC       plasma membrane. May also be required for some polarization process
CC       involved in dendrite formation. {ECO:0000269|PubMed:10448864}.
CC   -!- SUBUNIT: May be a homodimer, which associates with multiple calmodulin
CC       or myosin light chains (By similarity). Interacts with RIPL2, the
CC       interaction is required for its role in dendrite formation (By
CC       similarity). Interacts with MLPH (PubMed:12062444). Interacts with
CC       SYTL4 (By similarity). Interacts with MYRIP (By similarity). Interacts
CC       with RAB10; mediates the transport to the plasma membrane of
CC       SLC2A4/GLUT4 storage vesicles (PubMed:22908308). Interacts with FMR1;
CC       this interaction occurs in association with polyribosome (By
CC       similarity). {ECO:0000250|UniProtKB:Q99104,
CC       ECO:0000269|PubMed:12062444, ECO:0000269|PubMed:22908308}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9Y4I1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y4I1-2; Sequence=VSP_003351;
CC       Name=3;
CC         IsoId=Q9Y4I1-3; Sequence=VSP_003352;
CC   -!- TISSUE SPECIFICITY: Detected in melanocytes.
CC   -!- DISEASE: Griscelli syndrome 1 (GS1) [MIM:214450]: Rare autosomal
CC       recessive disorder that results in pigmentary dilution of the skin and
CC       hair, the presence of large clumps of pigment in hair shafts, silvery-
CC       gray hair and accumulation of melanosomes in melanocytes. GS1 patients
CC       show developmental delay, hypotonia and mental retardation, without
CC       apparent immune abnormalities. {ECO:0000269|PubMed:10704277}. Note=The
CC       disease is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Griscelli syndrome 3 (GS3) [MIM:609227]: Rare autosomal
CC       recessive disorder characterized by pigmentary dilution of the skin and
CC       hair, the presence of large clumps of pigment in hair shafts, and an
CC       accumulation of melanosomes in melanocytes, without other clinical
CC       manifestations. {ECO:0000269|PubMed:12897212}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Elejalde syndrome (ELEJAS) [MIM:256710]: Autosomal recessive
CC       condition characterized by skin hypopigmentation, the presence of large
CC       clumps of pigment in hair shafts, silvery-gray hair, accumulation of
CC       melanosomes in melanocytes and primary neurological abnormalities.
CC       Elejalde syndrome may be the same entity as Griscelli syndrome type I.
CC       {ECO:0000269|PubMed:12058346}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase
CC       superfamily. Myosin family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=MYO5Abase; Note=MYO5A mutation db;
CC       URL="http://structure.bmc.lu.se/idbase/MYO5Abase/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Y07759; CAA69035.1; -; mRNA.
DR   EMBL; Y07759; CAA69036.1; -; mRNA.
DR   EMBL; U90942; AAD00702.1; -; mRNA.
DR   EMBL; AC010674; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC018902; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC025917; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z22957; CAA80533.1; -; mRNA.
DR   EMBL; S74799; AAB33211.1; -; mRNA.
DR   EMBL; AF055459; AAC14188.1; -; mRNA.
DR   CCDS; CCDS42037.1; -. [Q9Y4I1-1]
DR   CCDS; CCDS45262.1; -. [Q9Y4I1-2]
DR   PIR; A53016; A53016.
DR   PIR; A59254; A59254.
DR   PIR; B59254; B59254.
DR   PIR; I52966; I52966.
DR   RefSeq; NP_000250.3; NM_000259.3.
DR   RefSeq; XP_005254454.1; XM_005254397.3. [Q9Y4I1-3]
DR   PDB; 4D07; X-ray; 1.85 A; B=1275-1297.
DR   PDB; 4J5L; X-ray; 2.20 A; A/B=1448-1855.
DR   PDB; 4LLI; X-ray; 2.20 A; A/B=1467-1855.
DR   PDB; 4LX1; X-ray; 1.87 A; A/B=1464-1855.
DR   PDB; 4LX2; X-ray; 1.50 A; A=1464-1855.
DR   PDB; 5JCY; X-ray; 1.80 A; A=1464-1855.
DR   PDB; 5JCZ; X-ray; 2.06 A; B/C/E=1464-1855.
DR   PDBsum; 4D07; -.
DR   PDBsum; 4J5L; -.
DR   PDBsum; 4LLI; -.
DR   PDBsum; 4LX1; -.
DR   PDBsum; 4LX2; -.
DR   PDBsum; 5JCY; -.
DR   PDBsum; 5JCZ; -.
DR   SMR; Q9Y4I1; -.
DR   BioGrid; 110728; 92.
DR   CORUM; Q9Y4I1; -.
DR   IntAct; Q9Y4I1; 55.
DR   MINT; Q9Y4I1; -.
DR   STRING; 9606.ENSP00000382177; -.
DR   CarbonylDB; Q9Y4I1; -.
DR   iPTMnet; Q9Y4I1; -.
DR   MetOSite; Q9Y4I1; -.
DR   PhosphoSitePlus; Q9Y4I1; -.
DR   SwissPalm; Q9Y4I1; -.
DR   BioMuta; MYO5A; -.
DR   DMDM; 296439234; -.
DR   EPD; Q9Y4I1; -.
DR   jPOST; Q9Y4I1; -.
DR   MassIVE; Q9Y4I1; -.
DR   PaxDb; Q9Y4I1; -.
DR   PeptideAtlas; Q9Y4I1; -.
DR   PRIDE; Q9Y4I1; -.
DR   ProteomicsDB; 86207; -. [Q9Y4I1-1]
DR   ProteomicsDB; 86208; -. [Q9Y4I1-2]
DR   ProteomicsDB; 86209; -. [Q9Y4I1-3]
DR   Antibodypedia; 686; 152 antibodies.
DR   Ensembl; ENST00000356338; ENSP00000348693; ENSG00000197535. [Q9Y4I1-2]
DR   Ensembl; ENST00000399231; ENSP00000382177; ENSG00000197535. [Q9Y4I1-1]
DR   GeneID; 4644; -.
DR   KEGG; hsa:4644; -.
DR   UCSC; uc002abx.5; human. [Q9Y4I1-1]
DR   CTD; 4644; -.
DR   DisGeNET; 4644; -.
DR   GeneCards; MYO5A; -.
DR   HGNC; HGNC:7602; MYO5A.
DR   HPA; ENSG00000197535; Tissue enhanced (brain, parathyroid gland).
DR   MalaCards; MYO5A; -.
DR   MIM; 160777; gene.
DR   MIM; 214450; phenotype.
DR   MIM; 256710; phenotype.
DR   MIM; 609227; phenotype.
DR   neXtProt; NX_Q9Y4I1; -.
DR   OpenTargets; ENSG00000197535; -.
DR   Orphanet; 79476; Griscelli syndrome type 1.
DR   Orphanet; 79478; Griscelli syndrome type 3.
DR   Orphanet; 33445; Neuroectodermal melanolysosomal disease.
DR   PharmGKB; PA31407; -.
DR   eggNOG; KOG0160; Eukaryota.
DR   eggNOG; KOG0161; Eukaryota.
DR   eggNOG; COG5022; LUCA.
DR   GeneTree; ENSGT00940000155347; -.
DR   HOGENOM; CLU_000192_9_2_1; -.
DR   InParanoid; Q9Y4I1; -.
DR   KO; K10357; -.
DR   OMA; IAFKWET; -.
DR   OrthoDB; 311886at2759; -.
DR   PhylomeDB; Q9Y4I1; -.
DR   TreeFam; TF328771; -.
DR   Reactome; R-HSA-1445148; Translocation of SLC2A4 (GLUT4) to the plasma membrane.
DR   Reactome; R-HSA-2029482; Regulation of actin dynamics for phagocytic cup formation.
DR   Reactome; R-HSA-264876; Insulin processing.
DR   ChiTaRS; MYO5A; human.
DR   GeneWiki; MYO5A; -.
DR   GenomeRNAi; 4644; -.
DR   Pharos; Q9Y4I1; Tbio.
DR   PRO; PR:Q9Y4I1; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   RNAct; Q9Y4I1; protein.
DR   Bgee; ENSG00000197535; Expressed in dorsolateral prefrontal cortex and 223 other tissues.
DR   ExpressionAtlas; Q9Y4I1; baseline and differential.
DR   Genevisible; Q9Y4I1; HS.
DR   GO; GO:0042641; C:actomyosin; IEA:Ensembl.
DR   GO; GO:0005623; C:cell; IEA:GOC.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0032433; C:filopodium tip; IDA:UniProtKB.
DR   GO; GO:0098978; C:glutamatergic synapse; IEA:Ensembl.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:Ensembl.
DR   GO; GO:0030426; C:growth cone; NAS:UniProtKB.
DR   GO; GO:0032593; C:insulin-responsive compartment; ISS:UniProtKB.
DR   GO; GO:0005882; C:intermediate filament; IEA:Ensembl.
DR   GO; GO:0042470; C:melanosome; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0035371; C:microtubule plus-end; IEA:Ensembl.
DR   GO; GO:0043005; C:neuron projection; NAS:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0001750; C:photoreceptor outer segment; IEA:Ensembl.
DR   GO; GO:0098794; C:postsynapse; IEA:Ensembl.
DR   GO; GO:0001726; C:ruffle; IDA:UniProtKB.
DR   GO; GO:0005790; C:smooth endoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0016461; C:unconventional myosin complex; IEA:Ensembl.
DR   GO; GO:0051015; F:actin filament binding; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005509; F:calcium ion binding; IEA:Ensembl.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0097718; F:disordered domain specific binding; IEA:Ensembl.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0000146; F:microfilament motor activity; NAS:UniProtKB.
DR   GO; GO:0017137; F:Rab GTPase binding; IPI:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0030048; P:actin filament-based movement; NAS:UniProtKB.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; ISS:UniProtKB.
DR   GO; GO:0007268; P:chemical synaptic transmission; IEA:Ensembl.
DR   GO; GO:0099089; P:establishment of endoplasmic reticulum localization to postsynapse; IEA:Ensembl.
DR   GO; GO:0006887; P:exocytosis; IEA:Ensembl.
DR   GO; GO:0048820; P:hair follicle maturation; IEA:Ensembl.
DR   GO; GO:0030073; P:insulin secretion; IEA:Ensembl.
DR   GO; GO:0031987; P:locomotion involved in locomotory behavior; IEA:Ensembl.
DR   GO; GO:0042759; P:long-chain fatty acid biosynthetic process; IEA:Ensembl.
DR   GO; GO:0042438; P:melanin biosynthetic process; IEA:Ensembl.
DR   GO; GO:0030318; P:melanocyte differentiation; IEA:Ensembl.
DR   GO; GO:0032402; P:melanosome transport; NAS:UniProtKB.
DR   GO; GO:0042552; P:myelination; IEA:Ensembl.
DR   GO; GO:0042476; P:odontogenesis; IEA:Ensembl.
DR   GO; GO:0006892; P:post-Golgi vesicle-mediated transport; IMP:UniProtKB.
DR   GO; GO:0072659; P:protein localization to plasma membrane; ISS:UniProtKB.
DR   GO; GO:0031585; P:regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; IEA:Ensembl.
DR   GO; GO:0099566; P:regulation of postsynaptic cytosolic calcium ion concentration; IEA:Ensembl.
DR   GO; GO:0032252; P:secretory granule localization; IEA:Ensembl.
DR   GO; GO:0050808; P:synapse organization; IEA:Ensembl.
DR   GO; GO:0030050; P:vesicle transport along actin filament; IMP:UniProtKB.
DR   GO; GO:0016192; P:vesicle-mediated transport; ISS:UniProtKB.
DR   GO; GO:0007601; P:visual perception; IEA:Ensembl.
DR   CDD; cd15478; Myo5a_CBD; 1.
DR   CDD; cd01380; MYSc_Myo5; 1.
DR   Gene3D; 2.30.30.360; -; 1.
DR   Gene3D; 3.40.850.10; -; 1.
DR   InterPro; IPR002710; Dilute_dom.
DR   InterPro; IPR000048; IQ_motif_EF-hand-BS.
DR   InterPro; IPR036961; Kinesin_motor_dom_sf.
DR   InterPro; IPR037988; Myo5a_CBD.
DR   InterPro; IPR001609; Myosin_head_motor_dom.
DR   InterPro; IPR004009; Myosin_N.
DR   InterPro; IPR008989; Myosin_S1_N.
DR   InterPro; IPR036103; MYSc_Myo5.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   Pfam; PF01843; DIL; 1.
DR   Pfam; PF00612; IQ; 6.
DR   Pfam; PF00063; Myosin_head; 1.
DR   PRINTS; PR00193; MYOSINHEAVY.
DR   SMART; SM01132; DIL; 1.
DR   SMART; SM00015; IQ; 6.
DR   SMART; SM00242; MYSc; 1.
DR   SUPFAM; SSF52540; SSF52540; 3.
DR   PROSITE; PS51126; DILUTE; 1.
DR   PROSITE; PS50096; IQ; 6.
DR   PROSITE; PS51456; MYOSIN_MOTOR; 1.
DR   PROSITE; PS51844; SH3_LIKE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Actin-binding; Alternative splicing;
KW   ATP-binding; Calmodulin-binding; Coiled coil; Motor protein; Myosin;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Protein transport;
KW   Reference proteome; Repeat; Transport.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:22814378"
FT   CHAIN           2..1855
FT                   /note="Unconventional myosin-Va"
FT                   /id="PRO_0000123456"
FT   DOMAIN          8..60
FT                   /note="Myosin N-terminal SH3-like"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01190"
FT   DOMAIN          69..763
FT                   /note="Myosin motor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00782"
FT   DOMAIN          766..788
FT                   /note="IQ 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00116"
FT   DOMAIN          789..818
FT                   /note="IQ 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00116"
FT   DOMAIN          814..836
FT                   /note="IQ 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00116"
FT   DOMAIN          837..861
FT                   /note="IQ 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00116"
FT   DOMAIN          862..883
FT                   /note="IQ 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00116"
FT   DOMAIN          885..914
FT                   /note="IQ 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00116"
FT   DOMAIN          1534..1810
FT                   /note="Dilute"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00503"
FT   NP_BIND         163..170
FT                   /note="ATP"
FT                   /evidence="ECO:0000255"
FT   REGION          643..665
FT                   /note="Actin-binding"
FT                   /evidence="ECO:0000255"
FT   COILED          914..1237
FT                   /evidence="ECO:0000255"
FT   COILED          1338..1445
FT                   /evidence="ECO:0000255"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000244|PubMed:22814378"
FT   MOD_RES         600
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         1032
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QYF3"
FT   MOD_RES         1452
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         1652
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         1760
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         1321..1347
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:7835087,
FT                   ECO:0000303|PubMed:8188282, ECO:0000303|Ref.1"
FT                   /id="VSP_003351"
FT   VAR_SEQ         1413
FT                   /note="L -> LYFEELYADDPKKYQSYRISLYKRMI (in isoform 3)"
FT                   /evidence="ECO:0000303|Ref.7"
FT                   /id="VSP_003352"
FT   VARIANT         627
FT                   /note="M -> T (in dbSNP:rs16964944)"
FT                   /id="VAR_056180"
FT   VARIANT         1246
FT                   /note="R -> C (in dbSNP:rs1058219)"
FT                   /evidence="ECO:0000269|PubMed:10733681,
FT                   ECO:0000269|PubMed:9207796"
FT                   /id="VAR_010645"
FT   VARIANT         1673
FT                   /note="S -> L (in dbSNP:rs9282796)"
FT                   /id="VAR_056181"
FT   CONFLICT        198
FT                   /note="A -> T (in Ref. 1; CAA69035/CAA69036 and 2;
FT                   AAD00702)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        362
FT                   /note="E -> D (in Ref. 1; CAA69035/CAA69036 and 2;
FT                   AAD00702)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        668
FT                   /note="F -> L (in Ref. 1; CAA69035/CAA69036)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        833
FT                   /note="Missing (in Ref. 5; CAA80533)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        863
FT                   /note="E -> G (in Ref. 1; CAA69035/CAA69036)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        922
FT                   /note="H -> R (in Ref. 1; CAA69035/CAA69036)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1061
FT                   /note="V -> L (in Ref. 6; AAB33211)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1089
FT                   /note="E -> Q (in Ref. 5; CAA80533)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1177
FT                   /note="D -> E (in Ref. 6; AAB33211)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1465..1477
FT                   /note="NIPRKEKDFQGML -> SVLCACCVSVTVR (in Ref. 5;
FT                   CAA80533)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1471
FT                   /note="K -> N (in Ref. 6; AAB33211)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1484
FT                   /note="E -> D (in Ref. 6; AAB33211)"
FT                   /evidence="ECO:0000305"
FT   STRAND          1285..1289
FT                   /evidence="ECO:0000244|PDB:4D07"
FT   STRAND          1475..1478
FT                   /evidence="ECO:0000244|PDB:4LX2"
FT   HELIX           1481..1483
FT                   /evidence="ECO:0000244|PDB:4LX2"
FT   HELIX           1484..1491
FT                   /evidence="ECO:0000244|PDB:4LX2"
FT   TURN            1492..1494
FT                   /evidence="ECO:0000244|PDB:4LX2"
FT   HELIX           1500..1502
FT                   /evidence="ECO:0000244|PDB:4LX2"
FT   TURN            1505..1507
FT                   /evidence="ECO:0000244|PDB:4LLI"
FT   HELIX           1508..1522
FT                   /evidence="ECO:0000244|PDB:4LX2"
FT   HELIX           1526..1547
FT                   /evidence="ECO:0000244|PDB:4LX2"
FT   HELIX           1551..1570
FT                   /evidence="ECO:0000244|PDB:4LX2"
FT   HELIX           1575..1577
FT                   /evidence="ECO:0000244|PDB:4LX2"
FT   HELIX           1583..1586
FT                   /evidence="ECO:0000244|PDB:4LX2"
FT   STRAND          1591..1594
FT                   /evidence="ECO:0000244|PDB:4LX2"
FT   HELIX           1596..1621
FT                   /evidence="ECO:0000244|PDB:4LX2"
FT   HELIX           1622..1624
FT                   /evidence="ECO:0000244|PDB:4LX2"
FT   HELIX           1625..1629
FT                   /evidence="ECO:0000244|PDB:4LX2"
FT   HELIX           1661..1677
FT                   /evidence="ECO:0000244|PDB:4LX2"
FT   HELIX           1682..1706
FT                   /evidence="ECO:0000244|PDB:4LX2"
FT   STRAND          1708..1710
FT                   /evidence="ECO:0000244|PDB:4LX2"
FT   HELIX           1713..1732
FT                   /evidence="ECO:0000244|PDB:4LX2"
FT   HELIX           1740..1743
FT                   /evidence="ECO:0000244|PDB:4LX2"
FT   HELIX           1745..1755
FT                   /evidence="ECO:0000244|PDB:4LX2"
FT   HELIX           1761..1770
FT                   /evidence="ECO:0000244|PDB:4LX2"
FT   HELIX           1776..1785
FT                   /evidence="ECO:0000244|PDB:4LX2"
FT   STRAND          1790..1792
FT                   /evidence="ECO:0000244|PDB:5JCZ"
FT   HELIX           1798..1807
FT                   /evidence="ECO:0000244|PDB:4LX2"
FT   TURN            1808..1810
FT                   /evidence="ECO:0000244|PDB:4LX2"
FT   HELIX           1838..1840
FT                   /evidence="ECO:0000244|PDB:4LX2"
FT   HELIX           1845..1847
FT                   /evidence="ECO:0000244|PDB:4LX2"
FT   STRAND          1852..1855
FT                   /evidence="ECO:0000244|PDB:4LX2"
SQ   SEQUENCE   1855 AA;  215405 MW;  78FD3B1D08D90A0A CRC64;
     MAASELYTKF ARVWIPDPEE VWKSAELLKD YKPGDKVLLL HLEEGKDLEY HLDPKTKELP
     HLRNPDILVG ENDLTALSYL HEPAVLHNLR VRFIDSKLIY TYCGIVLVAI NPYEQLPIYG
     EDIINAYSGQ NMGDMDPHIF AVAEEAYKQM ARDERNQSII VSGESGAGKT VSAKYAMRYF
     ATVSGSASEA NVEEKVLASN PIMESIGNAK TTRNDNSSRF GKYIEIGFDK RYRIIGANMR
     TYLLEKSRVV FQAEEERNYH IFYQLCASAK LPEFKMLRLG NADNFNYTKQ GGSPVIEGVD
     DAKEMAHTRQ ACTLLGISES HQMGIFRILA GILHLGNVGF TSRDADSCTI PPKHEPLCIF
     CELMGVDYEE MCHWLCHRKL ATATETYIKP ISKLQATNAR DALAKHIYAK LFNWIVDNVN
     QALHSAVKQH SFIGVLDIYG FETFEINSFE QFCINYANEK LQQQFNMHVF KLEQEEYMKE
     QIPWTLIDFY DNQPCINLIE SKLGILDLLD EECKMPKGTD DTWAQKLYNT HLNKCALFEK
     PRLSNKAFII QHFADKVEYQ CEGFLEKNKD TVFEEQIKVL KSSKFKMLPE LFQDDEKAIS
     PTSATSSGRT PLTRTPAKPT KGRPGQMAKE HKKTVGHQFR NSLHLLMETL NATTPHYVRC
     IKPNDFKFPF TFDEKRAVQQ LRACGVLETI RISAAGFPSR WTYQEFFSRY RVLMKQKDVL
     SDRKQTCKNV LEKLILDKDK YQFGKTKIFF RAGQVAYLEK LRADKLRAAC IRIQKTIRGW
     LLRKKYLRMR KAAITMQRYV RGYQARCYAK FLRRTKAATI IQKYWRMYVV RRRYKIRRAA
     TIVLQSYLRG FLARNRYRKI LREHKAVIIQ KRVRGWLART HYKRSMHAII YLQCCFRRMM
     AKRELKKLKI EARSVERYKK LHIGMENKIM QLQRKVDEQN KDYKCLVEKL TNLEGIYNSE
     TEKLRSDLER LQLSEEEAKV ATGRVLSLQE EIAKLRKDLE QTRSEKKCIE EHADRYKQET
     EQLVSNLKEE NTLLKQEKEA LNHRIVQQAK EMTETMEKKL VEETKQLELD LNDERLRYQN
     LLNEFSRLEE RYDDLKEEMT LMVHVPKPGH KRTDSTHSSN ESEYIFSSEI AEMEDIPSRT
     EEPSEKKVPL DMSLFLKLQK RVTELEQEKQ VMQDELDRKE EQVLRSKAKE EERPQIRGAE
     LEYESLKRQE LESENKKLKN ELNELRKALS EKSAPEVTAP GAPAYRVLME QLTSVSEELD
     VRKEEVLILR SQLVSQKEAI QPKDDKNTMT DSTILLEDVQ KMKDKGEIAQ AYIGLKETNR
     SSALDYHELN EDGELWLVYE GLKQANRLLE SQLQSQKRSH ENEAEALRGE IQSLKEENNR
     QQQLLAQNLQ LPPEARIEAS LQHEITRLTN ENLDLMEQLE KQDKTVRKLK KQLKVFAKKI
     GELEVGQMEN ISPGQIIDEP IRPVNIPRKE KDFQGMLEYK KEDEQKLVKN LILELKPRGV
     AVNLIPGLPA YILFMCVRHA DYLNDDQKVR SLLTSTINSI KKVLKKRGDD FETVSFWLSN
     TCRFLHCLKQ YSGEEGFMKH NTSRQNEHCL TNFDLAEYRQ VLSDLAIQIY QQLVRVLENI
     LQPMIVSGML EHETIQGVSG VKPTGLRKRT SSIADEGTYT LDSILRQLNS FHSVMCQHGM
     DPELIKQVVK QMFYIIGAIT LNNLLLRKDM CSWSKGMQIR YNVSQLEEWL RDKNLMNSGA
     KETLEPLIQA AQLLQVKKKT DDDAEAICSM CNALTTAQIV KVLNLYTPVN EFEERVSVSF
     IRTIQMRLRD RKDSPQLLMD AKHIFPVTFP FNPSSLALET IQIPASLGLG FISRV
//
ID   NCOA1_HUMAN             Reviewed;        1441 AA.
AC   Q15788; O00150; O43792; O43793; Q13071; Q13420; Q2T9G5; Q53SX3; Q6GVI5;
AC   Q7KYV3;
DT   11-OCT-2004, integrated into UniProtKB/Swiss-Prot.
DT   11-SEP-2007, sequence version 3.
DT   22-APR-2020, entry version 193.
DE   RecName: Full=Nuclear receptor coactivator 1;
DE            Short=NCoA-1;
DE            EC=2.3.1.48;
DE   AltName: Full=Class E basic helix-loop-helix protein 74;
DE            Short=bHLHe74;
DE   AltName: Full=Protein Hin-2;
DE   AltName: Full=RIP160;
DE   AltName: Full=Renal carcinoma antigen NY-REN-52;
DE   AltName: Full=Steroid receptor coactivator 1;
DE            Short=SRC-1;
GN   Name=NCOA1; Synonyms=BHLHE74, SRC1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), INTERACTION WITH GTF2B, AND
RP   VARIANTS LYS-457; LYS-466; PRO-474; THR-591; ALA-685; PHE-999 AND THR-1154.
RX   PubMed=8754792; DOI=10.1210/endo.137.8.8754792;
RA   Takeshita A., Yen P.M., Misiti S., Cardona G.R., Liu Y., Chin W.W.;
RT   "Molecular cloning and properties of a full-length putative thyroid hormone
RT   receptor coactivator.";
RL   Endocrinology 137:3594-3597(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, TISSUE
RP   SPECIFICITY, AND MUTAGENESIS OF 636-LEU-LEU-637; 693-LEU-LEU-694 AND
RP   752-LEU-LEU-753.
RX   PubMed=9427757; DOI=10.1093/emboj/17.1.232;
RA   Kalkhoven E., Valentine J.E., Heery D.M., Parker M.G.;
RT   "Isoforms of steroid receptor coactivator 1 differ in their ability to
RT   potentiate transcription by the oestrogen receptor.";
RL   EMBO J. 17:232-243(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS LYS-457; LYS-466;
RP   PRO-474; THR-591; ALA-685; PHE-999 AND THR-1154.
RC   TISSUE=Heart muscle, and Skeletal muscle;
RX   PubMed=9575154; DOI=10.1074/jbc.273.20.12101;
RA   Onate S.A., Boonyaratanakornkit V., Spencer T.E., Tsai S.Y., Tsai M.-J.,
RA   Edwards D.P., O'Malley B.W.;
RT   "The steroid receptor coactivator-1 contains multiple receptor interacting
RT   and activation domains that cooperatively enhance the activation function 1
RT   (AF1) and AF2 domains of steroid receptors.";
RL   J. Biol. Chem. 273:12101-12108(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ILE-1238 AND SER-1272.
RG   SeattleSNPs variation discovery resource;
RL   Submitted (JUN-2007) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 363-1441 (ISOFORM 1), FUNCTION, INTERACTION
RP   WITH ESR1; RXRA; GCCR; PGR AND THRA, AND VARIANTS LYS-457; LYS-466;
RP   PRO-474; THR-591; ALA-685; ALA-794; PHE-999 AND THR-1154.
RX   PubMed=7481822; DOI=10.1126/science.270.5240.1354;
RA   Onate S.A., Tsai S.Y., Tsai M.-J., O'Malley B.W.;
RT   "Sequence and characterization of a coactivator for the steroid hormone
RT   receptor superfamily.";
RL   Science 270:1354-1357(1995).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 865-1441 (ISOFORM 2).
RX   PubMed=11831720; DOI=10.1006/viro.1995.1161;
RA   Raineri I., Soler M., Senn H.-P.;
RT   "Analysis of human immunodeficiency virus type 1 promoter insertion in
RT   vivo.";
RL   Virology 208:359-364(1995).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 868-1441 (ISOFORM 2), CHROMOSOMAL
RP   TRANSLOCATION WITH PAX3, AND TISSUE SPECIFICITY.
RX   PubMed=15313887; DOI=10.1158/0008-5472.can-04-0844;
RA   Wachtel M., Dettling M., Koscielniak E., Stegmaier S., Treuner J.,
RA   Simon-Klingenstein K., Buehlmann P., Niggli F.K., Schaefer B.W.;
RT   "Gene expression signatures identify rhabdomyosarcoma subtypes and detect a
RT   novel t(2;2)(q35;p23) translocation fusing PAX3 to NCOA1.";
RL   Cancer Res. 64:5539-5545(2004).
RN   [11]
RP   IDENTIFICATION (ISOFORM 2), FUNCTION, AND ALTERNATIVE SPLICING.
RX   PubMed=9223431; DOI=10.1006/bbrc.1997.6911;
RA   Hayashi Y., Ohmori S., Ito T., Seo H.;
RT   "A splicing variant of steroid receptor coactivator-1 (SRC-1E): the major
RT   isoform of SRC-1 to mediate thyroid hormone action.";
RL   Biochem. Biophys. Res. Commun. 236:83-87(1997).
RN   [12]
RP   FUNCTION AS A HISTONE ACETYLTRANSFERASE, AND INTERACTION WITH PCAF.
RX   PubMed=9296499; DOI=10.1038/38304;
RA   Spencer T.E., Jenster G., Burcin M.M., Allis C.D., Zhou J., Mizzen C.A.,
RA   McKenna N.J., Onate S.A., Tsai S.Y., Tsai M.-J., O'Malley B.W.;
RT   "Steroid receptor coactivator-1 is a histone acetyltransferase.";
RL   Nature 389:194-198(1997).
RN   [13]
RP   FUNCTION.
RX   PubMed=9223281; DOI=10.1073/pnas.94.15.7879;
RA   Jenster G., Spencer T.E., Burcin M.M., Tsai S.Y., Tsai M.-J.,
RA   O'Malley B.W.;
RT   "Steroid receptor induction of gene transcription: a two-step model.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:7879-7884(1997).
RN   [14]
RP   IDENTIFICATION AS A RENAL CANCER ANTIGEN.
RC   TISSUE=Renal cell carcinoma;
RX   PubMed=10508479;
RX   DOI=10.1002/(sici)1097-0215(19991112)83:4<456::aid-ijc4>3.0.co;2-5;
RA   Scanlan M.J., Gordan J.D., Williamson B., Stockert E., Bander N.H.,
RA   Jongeneel C.V., Gure A.O., Jaeger D., Jaeger E., Knuth A., Chen Y.-T.,
RA   Old L.J.;
RT   "Antigens recognized by autologous antibody in patients with renal-cell
RT   carcinoma.";
RL   Int. J. Cancer 83:456-464(1999).
RN   [15]
RP   INTERACTION WITH NCOA6.
RX   PubMed=10567404; DOI=10.1074/jbc.274.48.34283;
RA   Lee S.-K., Anzick S.L., Choi J.-E., Bubendorf L., Guan X.-Y., Jung Y.-K.,
RA   Kallioniemi O.-P., Kononen J., Trent J.M., Azorsa D., Jhun B.-H.,
RA   Cheong J.H., Lee Y.C., Meltzer P.S., Lee J.W.;
RT   "A nuclear factor ASC-2, as a cancer-amplified transcriptional coactivator
RT   essential for ligand-dependent transactivation by nuclear receptors in
RT   vivo.";
RL   J. Biol. Chem. 274:34283-34293(1999).
RN   [16]
RP   FUNCTION.
RX   PubMed=10449719; DOI=10.1073/pnas.96.17.9485;
RA   Liu Z., Wong J., Tsai S.Y., Tsai M.-J., O'Malley B.W.;
RT   "Steroid receptor coactivator-1 (SRC-1) enhances ligand-dependent and
RT   receptor-dependent cell-free transcription of chromatin.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:9485-9490(1999).
RN   [17]
RP   PHOSPHORYLATION AT SER-372; SER-395; SER-517; SER-569; SER-1033; THR-1179
RP   AND SER-1185.
RX   PubMed=10660621; DOI=10.1074/jbc.275.6.4475;
RA   Rowan B.G., Weigel N.L., O'Malley B.W.;
RT   "Phosphorylation of steroid receptor coactivator-1. Identification of the
RT   phosphorylation sites and phosphorylation through the mitogen-activated
RT   protein kinase pathway.";
RL   J. Biol. Chem. 275:4475-4483(2000).
RN   [18]
RP   INTERACTION WITH COPS5.
RX   PubMed=10722692; DOI=10.1074/jbc.275.12.8540;
RA   Chauchereau A., Georgiakaki M., Perrin-Wolff M., Milgrom E., Loosfelt H.;
RT   "JAB1 interacts with both the progesterone receptor and SRC-1.";
RL   J. Biol. Chem. 275:8540-8548(2000).
RN   [19]
RP   INTERACTION WITH NCOA2.
RX   PubMed=10594042; DOI=10.1128/mcb.20.1.402-415.2000;
RA   Carrero P., Okamoto K., Coumailleau P., O'Brien S., Tanaka H.,
RA   Poellinger L.;
RT   "Redox-regulated recruitment of the transcriptional coactivators CREB-
RT   binding protein and SRC-1 to hypoxia-inducible factor 1alpha.";
RL   Mol. Cell. Biol. 20:402-415(2000).
RN   [20]
RP   INTERACTION WITH DDX5.
RX   PubMed=11250900; DOI=10.1093/emboj/20.6.1341;
RA   Watanabe M., Yanagisawa J., Kitagawa H., Takeyama K., Ogawa S., Arao Y.,
RA   Suzawa M., Kobayashi Y., Yano T., Yoshikawa H., Masuhiro Y., Kato S.;
RT   "A subfamily of RNA-binding DEAD-box proteins acts as an estrogen receptor
RT   alpha coactivator through the N-terminal activation domain (AF-1) with an
RT   RNA coactivator, SRA.";
RL   EMBO J. 20:1341-1352(2001).
RN   [21]
RP   INTERACTION WITH STAT3.
RX   PubMed=11773079; DOI=10.1074/jbc.m111486200;
RA   Giraud S., Bienvenu F., Avril S., Gascan H., Heery D.M., Coqueret O.;
RT   "Functional interaction of STAT3 transcription factor with the coactivator
RT   NcoA/SRC1a.";
RL   J. Biol. Chem. 277:8004-8011(2002).
RN   [22]
RP   INTERACTION WITH PRMT2.
RX   PubMed=12039952; DOI=10.1074/jbc.m201053200;
RA   Qi C., Chang J., Zhu Y., Yeldandi A.V., Rao S.M., Zhu Y.-J.;
RT   "Identification of protein arginine methyltransferase 2 as a coactivator
RT   for estrogen receptor alpha.";
RL   J. Biol. Chem. 277:28624-28630(2002).
RN   [23]
RP   INTERACTION WITH STAT6.
RX   PubMed=12138096; DOI=10.1074/jbc.m203556200;
RA   Litterst C.M., Pfitzner E.;
RT   "An LXXLL motif in the transactivation domain of STAT6 mediates recruitment
RT   of NCoA-1/SRC-1.";
RL   J. Biol. Chem. 277:36052-36060(2002).
RN   [24]
RP   SUMOYLATION AT LYS-732 AND LYS-774, UBIQUITINATION, AND MUTAGENESIS OF
RP   LYS-732; LYS-774; LYS-800; LYS-846 AND LYS-1378.
RX   PubMed=12529333; DOI=10.1074/jbc.m207148200;
RA   Chauchereau A., Amazit L., Quesne M., Guiochon-Mantel A., Milgrom E.;
RT   "Sumoylation of the progesterone receptor and of the steroid receptor
RT   coactivator SRC-1.";
RL   J. Biol. Chem. 278:12335-12343(2003).
RN   [25]
RP   FUNCTION, AND INTERACTION WITH STAT5A AND STAT5B.
RX   PubMed=12954634; DOI=10.1074/jbc.m303644200;
RA   Litterst C.M., Kliem S., Marilley D., Pfitzner E.;
RT   "NCoA-1/SRC-1 is an essential coactivator of STAT5 that binds to the FDL
RT   motif in the alpha-helical region of the STAT5 transactivation domain.";
RL   J. Biol. Chem. 278:45340-45351(2003).
RN   [26]
RP   INTERACTION WITH NR3C1.
RX   PubMed=12917342; DOI=10.1128/mcb.23.17.6210-6220.2003;
RA   Hsiao P.W., Fryer C.J., Trotter K.W., Wang W., Archer T.K.;
RT   "BAF60a mediates critical interactions between nuclear receptors and the
RT   BRG1 chromatin-remodeling complex for transactivation.";
RL   Mol. Cell. Biol. 23:6210-6220(2003).
RN   [27]
RP   INTERACTION WITH UBE2L3.
RX   PubMed=15367689; DOI=10.1128/mcb.24.19.8716-8726.2004;
RA   Verma S., Ismail A., Gao X., Fu G., Li X., O'Malley B.W., Nawaz Z.;
RT   "The ubiquitin-conjugating enzyme UBCH7 acts as a coactivator for steroid
RT   hormone receptors.";
RL   Mol. Cell. Biol. 24:8716-8726(2004).
RN   [28]
RP   INTERACTION WITH PSMB9.
RX   PubMed=16957778; DOI=10.1038/sj.emboj.7601306;
RA   Zhang H., Sun L., Liang J., Yu W., Zhang Y., Wang Y., Chen Y., Li R.,
RA   Sun X., Shang Y.;
RT   "The catalytic subunit of the proteasome is engaged in the entire process
RT   of estrogen receptor-regulated transcription.";
RL   EMBO J. 25:4223-4233(2006).
RN   [29]
RP   INTERACTION WITH ASXL1.
RX   PubMed=16606617; DOI=10.1074/jbc.m512616200;
RA   Cho Y.S., Kim E.J., Park U.H., Sin H.S., Um S.J.;
RT   "Additional sex comb-like 1 (ASXL1), in cooperation with SRC-1, acts as a
RT   ligand-dependent coactivator for retinoic acid receptor.";
RL   J. Biol. Chem. 281:17588-17598(2006).
RN   [30]
RP   INTERACTION WITH TTLL5.
RC   TISSUE=Testis;
RX   PubMed=17116691; DOI=10.1128/mcb.01360-06;
RA   He Y., Simons S.S. Jr.;
RT   "STAMP, a novel predicted factor assisting TIF2 actions in glucocorticoid
RT   receptor-mediated induction and repression.";
RL   Mol. Cell. Biol. 27:1467-1485(2007).
RN   [31]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [32]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [33]
RP   INTERACTION WITH RXRA.
RX   PubMed=19786558; DOI=10.1124/mol.109.057000;
RA   Cho Y., Noshiro M., Choi M., Morita K., Kawamoto T., Fujimoto K., Kato Y.,
RA   Makishima M.;
RT   "The basic helix-loop-helix proteins differentiated embryo chondrocyte
RT   (DEC) 1 and DEC2 function as corepressors of retinoid X receptors.";
RL   Mol. Pharmacol. 76:1360-1369(2009).
RN   [34]
RP   INTERACTION WITH PRMT6.
RX   PubMed=20047962; DOI=10.1093/nar/gkp1203;
RA   Harrison M.J., Tang Y.H., Dowhan D.H.;
RT   "Protein arginine methyltransferase 6 regulates multiple aspects of gene
RT   expression.";
RL   Nucleic Acids Res. 38:2201-2216(2010).
RN   [35]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-395, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [36]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-22; SER-372; SER-395; SER-698
RP   AND SER-1372, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [37]
RP   INTERACTION WITH TRIP4.
RX   PubMed=25219498; DOI=10.1016/j.molcel.2014.08.007;
RA   Yoo H.M., Kang S.H., Kim J.Y., Lee J.E., Seong M.W., Lee S.W., Ka S.H.,
RA   Sou Y.S., Komatsu M., Tanaka K., Lee S.T., Noh D.Y., Baek S.H., Jeon Y.J.,
RA   Chung C.H.;
RT   "Modification of ASC1 by UFM1 is crucial for ERalpha transactivation and
RT   breast cancer development.";
RL   Mol. Cell 56:261-274(2014).
RN   [38]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-846, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [39]
RP   INTERACTION WITH VDR.
RX   PubMed=28698609; DOI=10.1038/s41598-017-05081-x;
RA   Tamura M., Ishizawa M., Isojima T., Oezen S., Oka A., Makishima M.,
RA   Kitanaka S.;
RT   "Functional analyses of a novel missense and other mutations of the vitamin
RT   D receptor in association with alopecia.";
RL   Sci. Rep. 7:5102-5102(2017).
RN   [40]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 623-710 IN COMPLEX WITH PPARG.
RX   PubMed=9744270; DOI=10.1038/25931;
RA   Nolte R.T., Wisely G.B., Westin S., Cobb J.E., Lambert M.H., Kurokawa R.,
RA   Rosenfeld M.G., Willson T.M., Glass C.K., Milburn M.V.;
RT   "Ligand binding and co-activator assembly of the peroxisome proliferator-
RT   activated receptor-gamma.";
RL   Nature 395:137-143(1998).
RN   [41]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 687-696 IN COMPLEX WITH PPARA.
RX   PubMed=11698662; DOI=10.1073/pnas.241410198;
RA   Xu H.E., Lambert M.H., Montana V.G., Plunket K.D., Moore L.B.,
RA   Collins J.L., Oplinger J.A., Kliewer S.A., Gampe R.T. Jr., McKee D.D.,
RA   Moore J.T., Willson T.M.;
RT   "Structural determinants of ligand binding selectivity between the
RT   peroxisome proliferator-activated receptors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:13919-13924(2001).
RN   [42]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 686-700 IN COMPLEX WITH ESRRG.
RX   PubMed=11864604; DOI=10.1016/s1097-2765(02)00444-6;
RA   Greschik H., Wurtz J.-M., Sanglier S., Bourguet W., van Dorsselaer A.,
RA   Moras D., Renaud J.-P.;
RT   "Structural and functional evidence for ligand-independent transcriptional
RT   activation by the estrogen-related receptor 3.";
RL   Mol. Cell 9:303-313(2002).
RN   [43]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 257-385 IN COMPLEX WITH 795-808 OF
RP   STAT6.
RX   PubMed=14757047; DOI=10.1016/j.jmb.2003.12.057;
RA   Razeto A., Ramakrishnan V., Litterst C.M., Giller K., Griesinger C.,
RA   Carlomagno T., Lakomek N., Heimburg T., Lodrini M., Pfitzner E., Becker S.;
RT   "Structure of the NCoA-1/SRC-1 PAS-B domain bound to the LXXLL motif of the
RT   STAT6 transactivation domain.";
RL   J. Mol. Biol. 336:319-329(2004).
CC   -!- FUNCTION: Nuclear receptor coactivator that directly binds nuclear
CC       receptors and stimulates the transcriptional activities in a hormone-
CC       dependent fashion. Involved in the coactivation of different nuclear
CC       receptors, such as for steroids (PGR, GR and ER), retinoids (RXRs),
CC       thyroid hormone (TRs) and prostanoids (PPARs). Also involved in
CC       coactivation mediated by STAT3, STAT5A, STAT5B and STAT6 transcription
CC       factors. Displays histone acetyltransferase activity toward H3 and H4;
CC       the relevance of such activity remains however unclear. Plays a central
CC       role in creating multisubunit coactivator complexes that act via
CC       remodeling of chromatin, and possibly acts by participating in both
CC       chromatin remodeling and recruitment of general transcription factors.
CC       Required with NCOA2 to control energy balance between white and brown
CC       adipose tissues. Required for mediating steroid hormone response.
CC       Isoform 2 has a higher thyroid hormone-dependent transactivation
CC       activity than isoform 1 and isoform 3. {ECO:0000269|PubMed:10449719,
CC       ECO:0000269|PubMed:12954634, ECO:0000269|PubMed:7481822,
CC       ECO:0000269|PubMed:9223281, ECO:0000269|PubMed:9223431,
CC       ECO:0000269|PubMed:9296499, ECO:0000269|PubMed:9427757}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=acetyl-CoA + L-lysyl-[protein] = CoA + H(+) + N(6)-acetyl-L-
CC         lysyl-[protein]; Xref=Rhea:RHEA:45948, Rhea:RHEA-COMP:9752,
CC         Rhea:RHEA-COMP:10731, ChEBI:CHEBI:15378, ChEBI:CHEBI:29969,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57288, ChEBI:CHEBI:61930; EC=2.3.1.48;
CC   -!- SUBUNIT: Interacts with the methyltransferase CARM1 (By similarity).
CC       Interacts with NCOA6 and NCOA2. Interacts with the FDL motif of STAT5A
CC       and STAT5B. Interacts with the LXXLL motif of STAT6. Interacts with
CC       STAT3 following IL-6 stimulation. Interacts with the basal
CC       transcription factor GTF2B. Interacts with the histone
CC       acetyltransferases EP300 and CREBBP. Interacts with PCAF, COPS5, NR3C1
CC       and TTLL5/STAMP. Interacts with PSMB9. Interacts with UBE2L3; they
CC       functionally interact to regulate progesterone receptor transcriptional
CC       activity. Interacts with PRMT2 and DDX5. Interacts with ASXL1.
CC       Interacts with PRMT6. Interacts (via LXXLL 1, 2 and 3 motifs) with RORC
CC       (via AF-2 motif). Interacts in a ligand-dependent fashion with RXRA.
CC       Interacts with TRIP4. Interacts with NR4A3 (By similarity). Interacts
CC       with VDR. {ECO:0000250|UniProtKB:P70365, ECO:0000269|PubMed:10567404,
CC       ECO:0000269|PubMed:10594042, ECO:0000269|PubMed:10722692,
CC       ECO:0000269|PubMed:11250900, ECO:0000269|PubMed:11698662,
CC       ECO:0000269|PubMed:11773079, ECO:0000269|PubMed:11864604,
CC       ECO:0000269|PubMed:12039952, ECO:0000269|PubMed:12138096,
CC       ECO:0000269|PubMed:12917342, ECO:0000269|PubMed:12954634,
CC       ECO:0000269|PubMed:14757047, ECO:0000269|PubMed:15367689,
CC       ECO:0000269|PubMed:16606617, ECO:0000269|PubMed:16957778,
CC       ECO:0000269|PubMed:17116691, ECO:0000269|PubMed:19786558,
CC       ECO:0000269|PubMed:20047962, ECO:0000269|PubMed:25219498,
CC       ECO:0000269|PubMed:28698609, ECO:0000269|PubMed:7481822,
CC       ECO:0000269|PubMed:8754792, ECO:0000269|PubMed:9296499,
CC       ECO:0000269|PubMed:9744270}.
CC   -!- INTERACTION:
CC       Q15788; P59598: Asxl1; Xeno; NbExp=2; IntAct=EBI-455189, EBI-5743705;
CC       Q15788; P03372: ESR1; NbExp=8; IntAct=EBI-455189, EBI-78473;
CC       Q15788; P19785: Esr1; Xeno; NbExp=3; IntAct=EBI-455189, EBI-346765;
CC       Q15788; Q63ZY3: KANK2; NbExp=4; IntAct=EBI-455189, EBI-2556193;
CC       Q15788; P25799: Nfkb1; Xeno; NbExp=2; IntAct=EBI-455189, EBI-643958;
CC       Q15788; Q13133: NR1H3; NbExp=15; IntAct=EBI-455189, EBI-781356;
CC       Q15788; Q96RI1: NR1H4; NbExp=4; IntAct=EBI-455189, EBI-1250177;
CC       Q15788; Q96RI1-2: NR1H4; NbExp=5; IntAct=EBI-455189, EBI-9640524;
CC       Q15788; O75469: NR1I2; NbExp=5; IntAct=EBI-455189, EBI-3905991;
CC       Q15788; P06536: Nr3c1; Xeno; NbExp=2; IntAct=EBI-455189, EBI-1187143;
CC       Q15788; Q9BTK6: PAGR1; NbExp=4; IntAct=EBI-455189, EBI-2372223;
CC       Q15788; P28065: PSMB9; NbExp=3; IntAct=EBI-455189, EBI-603300;
CC       Q15788; P10276: RARA; NbExp=7; IntAct=EBI-455189, EBI-413374;
CC       Q15788; P51449: RORC; NbExp=2; IntAct=EBI-455189, EBI-3908771;
CC       Q15788; P19793: RXRA; NbExp=14; IntAct=EBI-455189, EBI-78598;
CC       Q15788; Q13569: TDG; NbExp=8; IntAct=EBI-455189, EBI-348333;
CC       Q15788-2; Q13569: TDG; NbExp=2; IntAct=EBI-5327712, EBI-348333;
CC       Q15788; P56581: Tdg; Xeno; NbExp=4; IntAct=EBI-455189, EBI-4320525;
CC       Q15788; P14373: TRIM27; NbExp=3; IntAct=EBI-455189, EBI-719493;
CC       Q15788; P11473: VDR; NbExp=3; IntAct=EBI-455189, EBI-286357;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00981}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=SRC-1A, SRC1a;
CC         IsoId=Q15788-1; Sequence=Displayed;
CC       Name=2; Synonyms=SRC-1E, SRC1e;
CC         IsoId=Q15788-2; Sequence=VSP_011739;
CC       Name=3; Synonyms=SRC-1 (-Q);
CC         IsoId=Q15788-3; Sequence=VSP_011738;
CC   -!- TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:15313887,
CC       ECO:0000269|PubMed:9427757}.
CC   -!- DOMAIN: The C-terminal (1107-1441) part mediates the histone
CC       acetyltransferase (HAT) activity.
CC   -!- DOMAIN: Contains 7 Leu-Xaa-Xaa-Leu-Leu (LXXLL) motifs. LXXLL motifs 3,
CC       4 and 5 are essential for the association with nuclear receptors. LXXLL
CC       motif 7, which is not present in isoform 2, increases the affinity for
CC       steroid receptors in vitro.
CC   -!- PTM: Sumoylated; sumoylation increases its interaction with PGR and
CC       prolongs its retention in the nucleus. It does not prevent its
CC       ubiquitination and does not exert a clear effect on the stability of
CC       the protein. {ECO:0000269|PubMed:12529333}.
CC   -!- PTM: Ubiquitinated; leading to proteasome-mediated degradation.
CC       Ubiquitination and sumoylation take place at different sites.
CC       {ECO:0000269|PubMed:12529333}.
CC   -!- DISEASE: Note=A chromosomal aberration involving NCOA1 is a cause of
CC       rhabdomyosarcoma. Translocation t(2;2)(q35;p23) with PAX3 generates the
CC       NCOA1-PAX3 oncogene consisting of the N-terminus part of PAX3 and the
CC       C-terminus part of NCOA1. The fusion protein acts as a transcriptional
CC       activator. Rhabdomyosarcoma is the most common soft tissue carcinoma in
CC       childhood, representing 5-8% of all malignancies in children.
CC       {ECO:0000269|PubMed:15313887}.
CC   -!- MISCELLANEOUS: [Isoform 2]: Major form. Contains a domain at its C-
CC       terminus (1241-1399) that is able to mediate transactivation.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the SRC/p160 nuclear receptor coactivator
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA64187.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAC50305.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/ncoa1/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U59302; AAC50631.1; -; mRNA.
DR   EMBL; AJ000881; CAA04371.1; -; mRNA.
DR   EMBL; AJ000882; CAA04372.1; -; mRNA.
DR   EMBL; U90661; AAB50242.1; -; mRNA.
DR   EMBL; EF660499; ABS29266.1; -; Genomic_DNA.
DR   EMBL; AC013459; AAX93184.1; -; Genomic_DNA.
DR   EMBL; AC093798; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471053; EAX00746.1; -; Genomic_DNA.
DR   EMBL; BC111533; AAI11534.1; -; mRNA.
DR   EMBL; BC111534; AAI11535.1; -; mRNA.
DR   EMBL; U40396; AAC50305.1; ALT_INIT; mRNA.
DR   EMBL; U19179; AAA64187.1; ALT_INIT; mRNA.
DR   EMBL; AY633656; AAT47737.1; -; mRNA.
DR   CCDS; CCDS1712.1; -. [Q15788-1]
DR   CCDS; CCDS1713.1; -. [Q15788-2]
DR   CCDS; CCDS42660.1; -. [Q15788-3]
DR   PIR; A57620; A57620.
DR   PIR; PC4363; PC4363.
DR   PIR; PC4364; PC4364.
DR   RefSeq; NP_003734.3; NM_003743.4. [Q15788-1]
DR   RefSeq; NP_671756.1; NM_147223.2. [Q15788-2]
DR   RefSeq; NP_671766.1; NM_147233.2. [Q15788-3]
DR   RefSeq; XP_005264682.1; XM_005264625.1. [Q15788-1]
DR   RefSeq; XP_005264683.1; XM_005264626.1. [Q15788-3]
DR   RefSeq; XP_005264685.1; XM_005264628.1.
DR   RefSeq; XP_016860657.1; XM_017005168.1.
DR   RefSeq; XP_016860658.1; XM_017005169.1.
DR   PDB; 1FM6; X-ray; 2.10 A; B/E/V/Y=676-700.
DR   PDB; 1FM9; X-ray; 2.10 A; B/E=676-700.
DR   PDB; 1K4W; X-ray; 1.90 A; B=686-700.
DR   PDB; 1K74; X-ray; 2.30 A; B/E=676-700.
DR   PDB; 1K7L; X-ray; 2.50 A; B/D/F/H=680-700.
DR   PDB; 1KV6; X-ray; 2.70 A; C/D=686-700.
DR   PDB; 1N4H; X-ray; 2.10 A; B=686-700.
DR   PDB; 1NQ7; X-ray; 1.50 A; B=687-696.
DR   PDB; 1NRL; X-ray; 2.00 A; C/D=676-700.
DR   PDB; 1P8D; X-ray; 2.80 A; C/D=676-700.
DR   PDB; 1PZL; X-ray; 2.10 A; B=687-700.
DR   PDB; 1RDT; X-ray; 2.40 A; B=676-700.
DR   PDB; 1TFC; X-ray; 2.40 A; C/D=686-700.
DR   PDB; 1U3R; X-ray; 2.21 A; C/D=630-640.
DR   PDB; 1U3S; X-ray; 2.50 A; C/D=630-640.
DR   PDB; 1X76; X-ray; 2.20 A; C/D=630-640.
DR   PDB; 1X78; X-ray; 2.30 A; C/D=630-640.
DR   PDB; 1X7B; X-ray; 2.30 A; C/D=630-640.
DR   PDB; 1X7J; X-ray; 2.30 A; C/D=630-640.
DR   PDB; 1XIU; X-ray; 2.50 A; E/F=686-700.
DR   PDB; 1XV9; X-ray; 2.70 A; E/F/G/H=685-697.
DR   PDB; 1XVP; X-ray; 2.60 A; E/F/G/H=685-697.
DR   PDB; 1YY4; X-ray; 2.70 A; C/D=630-640.
DR   PDB; 1YYE; X-ray; 2.03 A; C/D=630-640.
DR   PDB; 1ZAF; X-ray; 2.20 A; C/D=630-640.
DR   PDB; 2A3I; X-ray; 1.95 A; B=1430-1441.
DR   PDB; 2C52; NMR; -; B=920-970.
DR   PDB; 2FVJ; X-ray; 1.99 A; B=628-640.
DR   PDB; 2GTK; X-ray; 2.10 A; B=631-640.
DR   PDB; 2HBH; X-ray; 2.65 A; B=686-700.
DR   PDB; 2HC4; X-ray; 2.20 A; B=686-700.
DR   PDB; 2HCD; X-ray; 2.60 A; B=686-700.
DR   PDB; 2HFP; X-ray; 2.00 A; B=680-700.
DR   PDB; 2NPA; X-ray; 2.30 A; B/D=683-697.
DR   PDB; 2NV7; X-ray; 2.10 A; C/D=631-640.
DR   PDB; 2P54; X-ray; 1.79 A; B=686-696.
DR   PDB; 2PRG; X-ray; 2.30 A; C=623-710.
DR   PDB; 3BEJ; X-ray; 1.90 A; E/F=676-700.
DR   PDB; 3BQD; X-ray; 2.50 A; B=1429-1441.
DR   PDB; 3CTB; X-ray; 2.00 A; A/B=678-700.
DR   PDB; 3CWD; X-ray; 2.40 A; C/D=685-700.
DR   PDB; 3DCT; X-ray; 2.50 A; B=741-761.
DR   PDB; 3DCU; X-ray; 2.95 A; B=741-761.
DR   PDB; 3DR1; X-ray; 2.70 A; B=686-700.
DR   PDB; 3ET1; X-ray; 2.50 A; P/Q=681-696.
DR   PDB; 3ET3; X-ray; 1.95 A; P=680-695.
DR   PDB; 3FEI; X-ray; 2.40 A; Z=744-756.
DR   PDB; 3FEJ; X-ray; 2.01 A; B=628-640.
DR   PDB; 3FUR; X-ray; 2.30 A; H=629-640.
DR   PDB; 3FXV; X-ray; 2.26 A; B=744-756.
DR   PDB; 3G8I; X-ray; 2.20 A; Z=744-756.
DR   PDB; 3G9E; X-ray; 2.30 A; B=628-640.
DR   PDB; 3GYT; X-ray; 2.40 A; B=1429-1441.
DR   PDB; 3GYU; X-ray; 2.40 A; B=1429-1441.
DR   PDB; 3H0A; X-ray; 2.10 A; B/E=629-640.
DR   PDB; 3HC5; X-ray; 2.60 A; B=741-761.
DR   PDB; 3HC6; X-ray; 3.20 A; B=741-761.
DR   PDB; 3HVL; X-ray; 2.10 A; A/B=678-700.
DR   PDB; 3IPQ; X-ray; 2.00 A; B=676-700.
DR   PDB; 3IPS; X-ray; 2.26 A; C/D=676-700.
DR   PDB; 3IPU; X-ray; 2.40 A; C/D=676-700.
DR   PDB; 3KMR; X-ray; 1.80 A; C=686-698.
DR   PDB; 3LMP; X-ray; 1.90 A; C=686-700.
DR   PDB; 3OKH; X-ray; 2.50 A; B=744-757.
DR   PDB; 3OKI; X-ray; 2.00 A; B/D=744-757.
DR   PDB; 3OLF; X-ray; 1.90 A; B/D=744-757.
DR   PDB; 3OLL; X-ray; 1.50 A; C/D=683-701.
DR   PDB; 3OLS; X-ray; 2.20 A; C/D=683-701.
DR   PDB; 3OMK; X-ray; 1.90 A; B/D=744-757.
DR   PDB; 3OMM; X-ray; 2.10 A; B/D=744-757.
DR   PDB; 3OMO; X-ray; 2.21 A; C/D=683-701.
DR   PDB; 3OMP; X-ray; 2.05 A; C/D=683-701.
DR   PDB; 3OMQ; X-ray; 1.97 A; C/D=683-701.
DR   PDB; 3OOF; X-ray; 2.29 A; B/D=744-757.
DR   PDB; 3OOK; X-ray; 2.29 A; B/D=744-757.
DR   PDB; 3P88; X-ray; 2.95 A; B=745-755.
DR   PDB; 3P89; X-ray; 2.30 A; B=745-755.
DR   PDB; 3QT0; X-ray; 2.50 A; C=685-700.
DR   PDB; 3RUT; X-ray; 3.00 A; B=745-755.
DR   PDB; 3RUU; X-ray; 2.50 A; B=745-755.
DR   PDB; 3RVF; X-ray; 3.10 A; B=741-761.
DR   PDB; 3S9S; X-ray; 2.55 A; B=685-697.
DR   PDB; 3T03; X-ray; 2.10 A; C/D=683-700.
DR   PDB; 3UU7; X-ray; 2.20 A; F/G=686-698.
DR   PDB; 3UUA; X-ray; 2.05 A; F/G=686-698.
DR   PDB; 3UUD; X-ray; 1.60 A; C/D=686-698.
DR   PDB; 3V9Y; X-ray; 2.10 A; B=686-700.
DR   PDB; 3VN2; X-ray; 2.18 A; C=685-700.
DR   PDB; 4DK7; X-ray; 2.45 A; B/D=745-756.
DR   PDB; 4DK8; X-ray; 2.75 A; B/D=745-756.
DR   PDB; 4DM6; X-ray; 1.90 A; E/F=676-700.
DR   PDB; 4DM8; X-ray; 2.30 A; C/D=676-700.
DR   PDB; 4DQM; X-ray; 2.75 A; B/D=1432-1441.
DR   PDB; 4F9M; X-ray; 1.90 A; C=686-700.
DR   PDB; 4FGY; X-ray; 2.84 A; B=686-696.
DR   PDB; 4G1D; X-ray; 2.90 A; B=686-700.
DR   PDB; 4G1Y; X-ray; 2.85 A; B=686-700.
DR   PDB; 4G1Z; X-ray; 2.50 A; B=686-700.
DR   PDB; 4G20; X-ray; 2.90 A; B=686-700.
DR   PDB; 4G21; X-ray; 2.90 A; B=686-700.
DR   PDB; 4G2H; X-ray; 2.50 A; B=686-700.
DR   PDB; 4HEE; X-ray; 2.50 A; Y=676-700.
DR   PDB; 4J5X; X-ray; 2.80 A; A/B/C/D=678-700.
DR   PDB; 4JYG; X-ray; 2.35 A; F/G=686-698.
DR   PDB; 4JYH; X-ray; 2.60 A; C/G=686-698.
DR   PDB; 4JYI; X-ray; 1.90 A; F/G=686-698.
DR   PDB; 4MG5; X-ray; 2.05 A; C/D=686-698.
DR   PDB; 4MG6; X-ray; 2.10 A; C/D=686-698.
DR   PDB; 4MG7; X-ray; 2.15 A; C/D=686-698.
DR   PDB; 4MG8; X-ray; 1.85 A; C/D=686-698.
DR   PDB; 4MG9; X-ray; 2.00 A; F/G=686-698.
DR   PDB; 4MGA; X-ray; 1.80 A; C/D=686-698.
DR   PDB; 4MGB; X-ray; 1.85 A; C/D=686-698.
DR   PDB; 4MGC; X-ray; 2.15 A; F/G=686-698.
DR   PDB; 4MGD; X-ray; 1.90 A; F/G=686-698.
DR   PDB; 4RUJ; X-ray; 2.35 A; B=686-700.
DR   PDB; 4RUP; X-ray; 2.75 A; B=686-700.
DR   PDB; 4TUZ; X-ray; 1.90 A; F/G=686-698.
DR   PDB; 4TV1; X-ray; 1.85 A; C/D=686-698.
DR   PDB; 4UDA; X-ray; 2.03 A; B=1427-1441.
DR   PDB; 4UDB; X-ray; 2.36 A; B=1427-1441.
DR   PDB; 4Y29; X-ray; 1.98 A; B=1432-1441.
DR   PDB; 5A86; X-ray; 2.25 A; C/D=682-698.
DR   PDB; 5AVI; X-ray; 2.70 A; B/D=676-700.
DR   PDB; 5AVL; X-ray; 2.80 A; B=676-700.
DR   PDB; 5AZT; X-ray; 3.45 A; C=683-697.
DR   PDB; 5DSH; X-ray; 2.95 A; B=685-700.
DR   PDB; 5DV3; X-ray; 2.75 A; B=685-700.
DR   PDB; 5DV6; X-ray; 2.80 A; B=685-700.
DR   PDB; 5DV8; X-ray; 2.75 A; B=685-700.
DR   PDB; 5DVC; X-ray; 2.30 A; B=685-700.
DR   PDB; 5DWL; X-ray; 2.20 A; B=685-700.
DR   PDB; 5E7V; X-ray; 2.40 A; B=686-700.
DR   PDB; 5GTN; X-ray; 1.85 A; B=685-700.
DR   PDB; 5GTO; X-ray; 2.10 A; B=685-700.
DR   PDB; 5GTP; X-ray; 2.35 A; B=685-700.
DR   PDB; 5HJS; X-ray; 1.72 A; C/D=676-700.
DR   PDB; 5JI0; X-ray; 1.98 A; E/F=676-700.
DR   PDB; 5JMM; X-ray; 2.10 A; F/G=686-698.
DR   PDB; 5L7E; X-ray; 1.86 A; B=1432-1441.
DR   PDB; 5L7G; X-ray; 2.01 A; B=1432-1441.
DR   PDB; 5L7H; X-ray; 1.84 A; B=1432-1441.
DR   PDB; 5MWP; X-ray; 1.82 A; B=1427-1441.
DR   PDB; 5MWY; X-ray; 1.75 A; B=1427-1441.
DR   PDB; 5MX7; X-ray; 1.98 A; B1=686-700.
DR   PDB; 5NKY; X-ray; 2.10 A; B=686-700.
DR   PDB; 5NMA; X-ray; 2.80 A; B=686-700.
DR   PDB; 5NMB; X-ray; 2.50 A; B2=686-700.
DR   PDB; 5NWM; NMR; -; A=257-385.
DR   PDB; 5OW7; X-ray; 2.10 A; B=686-700.
DR   PDB; 5OW9; X-ray; 2.40 A; B=686-700.
DR   PDB; 5OWD; X-ray; 2.15 A; B=686-700.
DR   PDB; 5Q0J; X-ray; 2.00 A; B/D=744-757.
DR   PDB; 5Q0K; X-ray; 1.80 A; B=744-757.
DR   PDB; 5Q0L; X-ray; 2.50 A; B/D=744-757.
DR   PDB; 5Q0M; X-ray; 2.20 A; B=744-757.
DR   PDB; 5Q0N; X-ray; 2.40 A; B/D=744-757.
DR   PDB; 5Q0O; X-ray; 1.90 A; B/D=744-757.
DR   PDB; 5Q0P; X-ray; 1.80 A; B/D=744-757.
DR   PDB; 5Q0Q; X-ray; 2.60 A; B/D=744-757.
DR   PDB; 5Q0R; X-ray; 1.91 A; B=744-757.
DR   PDB; 5Q0S; X-ray; 2.50 A; B/D=744-757.
DR   PDB; 5Q0T; X-ray; 2.14 A; B=744-757.
DR   PDB; 5Q0U; X-ray; 1.90 A; B/D=744-757.
DR   PDB; 5Q0V; X-ray; 1.87 A; B/D=744-757.
DR   PDB; 5Q0W; X-ray; 1.90 A; B=744-757.
DR   PDB; 5Q0X; X-ray; 2.26 A; B=744-757.
DR   PDB; 5Q0Y; X-ray; 2.20 A; B/D=744-757.
DR   PDB; 5Q0Z; X-ray; 2.26 A; B/D=744-757.
DR   PDB; 5Q10; X-ray; 2.20 A; B=744-757.
DR   PDB; 5Q11; X-ray; 2.20 A; B=744-757.
DR   PDB; 5Q12; X-ray; 2.00 A; B=744-757.
DR   PDB; 5Q13; X-ray; 1.90 A; B/D=744-757.
DR   PDB; 5Q14; X-ray; 1.85 A; B/D=744-757.
DR   PDB; 5Q15; X-ray; 1.90 A; B/D=744-757.
DR   PDB; 5Q16; X-ray; 2.00 A; B/D=744-757.
DR   PDB; 5Q18; X-ray; 1.90 A; B/D=744-757.
DR   PDB; 5Q19; X-ray; 1.98 A; B/D=744-757.
DR   PDB; 5Q1A; X-ray; 2.00 A; B/D=744-757.
DR   PDB; 5Q1B; X-ray; 2.30 A; B/D=744-757.
DR   PDB; 5Q1C; X-ray; 2.30 A; B/D=744-757.
DR   PDB; 5Q1D; X-ray; 1.89 A; B/D=744-757.
DR   PDB; 5Q1E; X-ray; 1.85 A; B=744-757.
DR   PDB; 5Q1F; X-ray; 2.30 A; B/D=744-757.
DR   PDB; 5Q1G; X-ray; 2.00 A; B=744-757.
DR   PDB; 5Q1H; X-ray; 2.20 A; B/D/F/H=744-757.
DR   PDB; 5Q1I; X-ray; 1.95 A; B=744-757.
DR   PDB; 5X0R; X-ray; 2.67 A; C/D=676-700.
DR   PDB; 5X8U; X-ray; 2.00 A; B=686-700.
DR   PDB; 5X8W; X-ray; 2.30 A; B=686-700.
DR   PDB; 5Y44; X-ray; 2.35 A; B=745-755.
DR   PDB; 5YCN; X-ray; 2.15 A; B=685-700.
DR   PDB; 5YCP; X-ray; 2.00 A; B=685-700.
DR   PDB; 5YP6; X-ray; 2.20 A; B=688-695.
DR   PDB; 6A5W; X-ray; 2.88 A; B/D=745-756.
DR   PDB; 6A5X; X-ray; 2.60 A; B=745-755.
DR   PDB; 6A5Y; X-ray; 2.10 A; B/F=685-700.
DR   PDB; 6A5Z; X-ray; 2.95 A; E/F/G/I=685-700.
DR   PDB; 6A60; X-ray; 3.05 A; B/F=685-700.
DR   PDB; 6BNS; X-ray; 2.56 A; A/B=678-710.
DR   PDB; 6E3G; X-ray; 2.10 A; C/D=688-695.
DR   PDB; 6FO7; X-ray; 2.59 A; B=686-700.
DR   PDB; 6FO8; X-ray; 2.30 A; B=686-700.
DR   PDB; 6FO9; X-ray; 2.70 A; B=686-700.
DR   PDB; 6FOB; X-ray; 2.75 A; B=686-700.
DR   PDB; 6FOD; X-ray; 2.50 A; B=686-700.
DR   PDB; 6GEV; X-ray; 1.54 A; B=1427-1441.
DR   PDB; 6GG8; X-ray; 1.80 A; B=1427-1441.
DR   PDB; 6HTY; X-ray; 2.22 A; A/B=678-700.
DR   PDB; 6ICJ; X-ray; 2.48 A; B=676-700.
DR   PDB; 6IJR; X-ray; 2.85 A; B/D=685-700.
DR   PDB; 6IJS; X-ray; 2.15 A; B=685-700.
DR   PDB; 6ILQ; X-ray; 2.41 A; B=676-700.
DR   PDB; 6ITM; X-ray; 2.50 A; B/D=744-757.
DR   PDB; 6JQ7; X-ray; 2.55 A; B=685-700.
DR   PDB; 6P9F; X-ray; 2.80 A; A/B=683-696.
DR   PDB; 6SSQ; X-ray; 2.30 A; F/G=686-698.
DR   PDB; 6U25; X-ray; 2.61 A; A=683-696.
DR   PDBsum; 1FM6; -.
DR   PDBsum; 1FM9; -.
DR   PDBsum; 1K4W; -.
DR   PDBsum; 1K74; -.
DR   PDBsum; 1K7L; -.
DR   PDBsum; 1KV6; -.
DR   PDBsum; 1N4H; -.
DR   PDBsum; 1NQ7; -.
DR   PDBsum; 1NRL; -.
DR   PDBsum; 1P8D; -.
DR   PDBsum; 1PZL; -.
DR   PDBsum; 1RDT; -.
DR   PDBsum; 1TFC; -.
DR   PDBsum; 1U3R; -.
DR   PDBsum; 1U3S; -.
DR   PDBsum; 1X76; -.
DR   PDBsum; 1X78; -.
DR   PDBsum; 1X7B; -.
DR   PDBsum; 1X7J; -.
DR   PDBsum; 1XIU; -.
DR   PDBsum; 1XV9; -.
DR   PDBsum; 1XVP; -.
DR   PDBsum; 1YY4; -.
DR   PDBsum; 1YYE; -.
DR   PDBsum; 1ZAF; -.
DR   PDBsum; 2A3I; -.
DR   PDBsum; 2C52; -.
DR   PDBsum; 2FVJ; -.
DR   PDBsum; 2GTK; -.
DR   PDBsum; 2HBH; -.
DR   PDBsum; 2HC4; -.
DR   PDBsum; 2HCD; -.
DR   PDBsum; 2HFP; -.
DR   PDBsum; 2NPA; -.
DR   PDBsum; 2NV7; -.
DR   PDBsum; 2P54; -.
DR   PDBsum; 2PRG; -.
DR   PDBsum; 3BEJ; -.
DR   PDBsum; 3BQD; -.
DR   PDBsum; 3CTB; -.
DR   PDBsum; 3CWD; -.
DR   PDBsum; 3DCT; -.
DR   PDBsum; 3DCU; -.
DR   PDBsum; 3DR1; -.
DR   PDBsum; 3ET1; -.
DR   PDBsum; 3ET3; -.
DR   PDBsum; 3FEI; -.
DR   PDBsum; 3FEJ; -.
DR   PDBsum; 3FUR; -.
DR   PDBsum; 3FXV; -.
DR   PDBsum; 3G8I; -.
DR   PDBsum; 3G9E; -.
DR   PDBsum; 3GYT; -.
DR   PDBsum; 3GYU; -.
DR   PDBsum; 3H0A; -.
DR   PDBsum; 3HC5; -.
DR   PDBsum; 3HC6; -.
DR   PDBsum; 3HVL; -.
DR   PDBsum; 3IPQ; -.
DR   PDBsum; 3IPS; -.
DR   PDBsum; 3IPU; -.
DR   PDBsum; 3KMR; -.
DR   PDBsum; 3LMP; -.
DR   PDBsum; 3OKH; -.
DR   PDBsum; 3OKI; -.
DR   PDBsum; 3OLF; -.
DR   PDBsum; 3OLL; -.
DR   PDBsum; 3OLS; -.
DR   PDBsum; 3OMK; -.
DR   PDBsum; 3OMM; -.
DR   PDBsum; 3OMO; -.
DR   PDBsum; 3OMP; -.
DR   PDBsum; 3OMQ; -.
DR   PDBsum; 3OOF; -.
DR   PDBsum; 3OOK; -.
DR   PDBsum; 3P88; -.
DR   PDBsum; 3P89; -.
DR   PDBsum; 3QT0; -.
DR   PDBsum; 3RUT; -.
DR   PDBsum; 3RUU; -.
DR   PDBsum; 3RVF; -.
DR   PDBsum; 3S9S; -.
DR   PDBsum; 3T03; -.
DR   PDBsum; 3UU7; -.
DR   PDBsum; 3UUA; -.
DR   PDBsum; 3UUD; -.
DR   PDBsum; 3V9Y; -.
DR   PDBsum; 3VN2; -.
DR   PDBsum; 4DK7; -.
DR   PDBsum; 4DK8; -.
DR   PDBsum; 4DM6; -.
DR   PDBsum; 4DM8; -.
DR   PDBsum; 4DQM; -.
DR   PDBsum; 4F9M; -.
DR   PDBsum; 4FGY; -.
DR   PDBsum; 4G1D; -.
DR   PDBsum; 4G1Y; -.
DR   PDBsum; 4G1Z; -.
DR   PDBsum; 4G20; -.
DR   PDBsum; 4G21; -.
DR   PDBsum; 4G2H; -.
DR   PDBsum; 4HEE; -.
DR   PDBsum; 4J5X; -.
DR   PDBsum; 4JYG; -.
DR   PDBsum; 4JYH; -.
DR   PDBsum; 4JYI; -.
DR   PDBsum; 4MG5; -.
DR   PDBsum; 4MG6; -.
DR   PDBsum; 4MG7; -.
DR   PDBsum; 4MG8; -.
DR   PDBsum; 4MG9; -.
DR   PDBsum; 4MGA; -.
DR   PDBsum; 4MGB; -.
DR   PDBsum; 4MGC; -.
DR   PDBsum; 4MGD; -.
DR   PDBsum; 4RUJ; -.
DR   PDBsum; 4RUP; -.
DR   PDBsum; 4TUZ; -.
DR   PDBsum; 4TV1; -.
DR   PDBsum; 4UDA; -.
DR   PDBsum; 4UDB; -.
DR   PDBsum; 4Y29; -.
DR   PDBsum; 5A86; -.
DR   PDBsum; 5AVI; -.
DR   PDBsum; 5AVL; -.
DR   PDBsum; 5AZT; -.
DR   PDBsum; 5DSH; -.
DR   PDBsum; 5DV3; -.
DR   PDBsum; 5DV6; -.
DR   PDBsum; 5DV8; -.
DR   PDBsum; 5DVC; -.
DR   PDBsum; 5DWL; -.
DR   PDBsum; 5E7V; -.
DR   PDBsum; 5GTN; -.
DR   PDBsum; 5GTO; -.
DR   PDBsum; 5GTP; -.
DR   PDBsum; 5HJS; -.
DR   PDBsum; 5JI0; -.
DR   PDBsum; 5JMM; -.
DR   PDBsum; 5L7E; -.
DR   PDBsum; 5L7G; -.
DR   PDBsum; 5L7H; -.
DR   PDBsum; 5MWP; -.
DR   PDBsum; 5MWY; -.
DR   PDBsum; 5MX7; -.
DR   PDBsum; 5NKY; -.
DR   PDBsum; 5NMA; -.
DR   PDBsum; 5NMB; -.
DR   PDBsum; 5NWM; -.
DR   PDBsum; 5OW7; -.
DR   PDBsum; 5OW9; -.
DR   PDBsum; 5OWD; -.
DR   PDBsum; 5Q0J; -.
DR   PDBsum; 5Q0K; -.
DR   PDBsum; 5Q0L; -.
DR   PDBsum; 5Q0M; -.
DR   PDBsum; 5Q0N; -.
DR   PDBsum; 5Q0O; -.
DR   PDBsum; 5Q0P; -.
DR   PDBsum; 5Q0Q; -.
DR   PDBsum; 5Q0R; -.
DR   PDBsum; 5Q0S; -.
DR   PDBsum; 5Q0T; -.
DR   PDBsum; 5Q0U; -.
DR   PDBsum; 5Q0V; -.
DR   PDBsum; 5Q0W; -.
DR   PDBsum; 5Q0X; -.
DR   PDBsum; 5Q0Y; -.
DR   PDBsum; 5Q0Z; -.
DR   PDBsum; 5Q10; -.
DR   PDBsum; 5Q11; -.
DR   PDBsum; 5Q12; -.
DR   PDBsum; 5Q13; -.
DR   PDBsum; 5Q14; -.
DR   PDBsum; 5Q15; -.
DR   PDBsum; 5Q16; -.
DR   PDBsum; 5Q18; -.
DR   PDBsum; 5Q19; -.
DR   PDBsum; 5Q1A; -.
DR   PDBsum; 5Q1B; -.
DR   PDBsum; 5Q1C; -.
DR   PDBsum; 5Q1D; -.
DR   PDBsum; 5Q1E; -.
DR   PDBsum; 5Q1F; -.
DR   PDBsum; 5Q1G; -.
DR   PDBsum; 5Q1H; -.
DR   PDBsum; 5Q1I; -.
DR   PDBsum; 5X0R; -.
DR   PDBsum; 5X8U; -.
DR   PDBsum; 5X8W; -.
DR   PDBsum; 5Y44; -.
DR   PDBsum; 5YCN; -.
DR   PDBsum; 5YCP; -.
DR   PDBsum; 5YP6; -.
DR   PDBsum; 6A5W; -.
DR   PDBsum; 6A5X; -.
DR   PDBsum; 6A5Y; -.
DR   PDBsum; 6A5Z; -.
DR   PDBsum; 6A60; -.
DR   PDBsum; 6BNS; -.
DR   PDBsum; 6E3G; -.
DR   PDBsum; 6FO7; -.
DR   PDBsum; 6FO8; -.
DR   PDBsum; 6FO9; -.
DR   PDBsum; 6FOB; -.
DR   PDBsum; 6FOD; -.
DR   PDBsum; 6GEV; -.
DR   PDBsum; 6GG8; -.
DR   PDBsum; 6HTY; -.
DR   PDBsum; 6ICJ; -.
DR   PDBsum; 6IJR; -.
DR   PDBsum; 6IJS; -.
DR   PDBsum; 6ILQ; -.
DR   PDBsum; 6ITM; -.
DR   PDBsum; 6JQ7; -.
DR   PDBsum; 6P9F; -.
DR   PDBsum; 6SSQ; -.
DR   PDBsum; 6U25; -.
DR   SMR; Q15788; -.
DR   BioGrid; 114200; 119.
DR   ComplexPortal; CPX-711; PPARgamma-NCOA1 activated nuclear receptor complex.
DR   CORUM; Q15788; -.
DR   DIP; DIP-30877N; -.
DR   IntAct; Q15788; 46.
DR   MINT; Q15788; -.
DR   STRING; 9606.ENSP00000385216; -.
DR   BindingDB; Q15788; -.
DR   ChEMBL; CHEMBL1615387; -.
DR   DrugBank; DB07530; (1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol.
DR   DrugBank; DB06908; (2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID.
DR   DrugBank; DB07557; (5BETA)-PREGNANE-3,20-DIONE.
DR   DrugBank; DB08220; (8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid.
DR   DrugBank; DB08742; 1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z).
DR   DrugBank; DB07119; 1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL.
DR   DrugBank; DB06832; 2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL.
DR   DrugBank; DB07009; 2-(5-HYDROXY-NAPHTHALEN-1-YL)-1,3-BENZOOXAZOL-6-OL.
DR   DrugBank; DB07215; 2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID.
DR   DrugBank; DB06875; 3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE.
DR   DrugBank; DB07236; 3-(6-HYDROXY-NAPHTHALEN-2-YL)-BENZO[D]ISOOXAZOL-6-OL.
DR   DrugBank; DB07230; 3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE.
DR   DrugBank; DB07150; 4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME.
DR   DrugBank; DB07198; 5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE.
DR   DrugBank; DB06927; [5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE.
DR   DrugBank; DB08915; Aleglitazar.
DR   DrugBank; DB04652; Corticosterone.
DR   DrugBank; DB01645; Genistein.
DR   DrugBank; DB07724; Indeglitazar.
DR   DrugBank; DB08231; Myristic acid.
DR   DrugBank; DB07080; N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE.
DR   GuidetoPHARMACOLOGY; 2693; -.
DR   iPTMnet; Q15788; -.
DR   PhosphoSitePlus; Q15788; -.
DR   BioMuta; NCOA1; -.
DR   DMDM; 158518533; -.
DR   CPTAC; CPTAC-1255; -.
DR   EPD; Q15788; -.
DR   jPOST; Q15788; -.
DR   MassIVE; Q15788; -.
DR   MaxQB; Q15788; -.
DR   PaxDb; Q15788; -.
DR   PeptideAtlas; Q15788; -.
DR   PRIDE; Q15788; -.
DR   ProteomicsDB; 60761; -. [Q15788-1]
DR   ProteomicsDB; 60762; -. [Q15788-2]
DR   ProteomicsDB; 60763; -. [Q15788-3]
DR   Antibodypedia; 27525; 395 antibodies.
DR   Ensembl; ENST00000288599; ENSP00000288599; ENSG00000084676. [Q15788-2]
DR   Ensembl; ENST00000348332; ENSP00000320940; ENSG00000084676. [Q15788-1]
DR   Ensembl; ENST00000395856; ENSP00000379197; ENSG00000084676. [Q15788-3]
DR   Ensembl; ENST00000405141; ENSP00000385097; ENSG00000084676. [Q15788-2]
DR   Ensembl; ENST00000406961; ENSP00000385216; ENSG00000084676. [Q15788-1]
DR   GeneID; 8648; -.
DR   KEGG; hsa:8648; -.
DR   UCSC; uc002rfj.4; human. [Q15788-1]
DR   CTD; 8648; -.
DR   DisGeNET; 8648; -.
DR   GeneCards; NCOA1; -.
DR   HGNC; HGNC:7668; NCOA1.
DR   HPA; ENSG00000084676; Low tissue specificity.
DR   MIM; 602691; gene.
DR   neXtProt; NX_Q15788; -.
DR   OpenTargets; ENSG00000084676; -.
DR   PharmGKB; PA31470; -.
DR   eggNOG; ENOG410IQ5S; Eukaryota.
DR   eggNOG; ENOG410XPF9; LUCA.
DR   GeneTree; ENSGT00950000183021; -.
DR   HOGENOM; CLU_001988_0_0_1; -.
DR   InParanoid; Q15788; -.
DR   KO; K09101; -.
DR   OMA; MTHGTAI; -.
DR   OrthoDB; 59971at2759; -.
DR   PhylomeDB; Q15788; -.
DR   TreeFam; TF332652; -.
DR   Reactome; R-HSA-1368082; RORA activates gene expression.
DR   Reactome; R-HSA-1368108; BMAL1:CLOCK,NPAS2 activates circadian gene expression.
DR   Reactome; R-HSA-159418; Recycling of bile acids and salts.
DR   Reactome; R-HSA-192105; Synthesis of bile acids and bile salts.
DR   Reactome; R-HSA-193368; Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol.
DR   Reactome; R-HSA-193807; Synthesis of bile acids and bile salts via 27-hydroxycholesterol.
DR   Reactome; R-HSA-1989781; PPARA activates gene expression.
DR   Reactome; R-HSA-211976; Endogenous sterols.
DR   Reactome; R-HSA-2151201; Transcriptional activation of mitochondrial biogenesis.
DR   Reactome; R-HSA-2426168; Activation of gene expression by SREBF (SREBP).
DR   Reactome; R-HSA-3214847; HATs acetylate histones.
DR   Reactome; R-HSA-381340; Transcriptional regulation of white adipocyte differentiation.
DR   Reactome; R-HSA-3899300; SUMOylation of transcription cofactors.
DR   Reactome; R-HSA-400206; Regulation of lipid metabolism by PPARalpha.
DR   Reactome; R-HSA-400253; Circadian Clock.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   Reactome; R-HSA-9029569; NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux.
DR   Reactome; R-HSA-9623433; NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis.
DR   SignaLink; Q15788; -.
DR   SIGNOR; Q15788; -.
DR   ChiTaRS; NCOA1; human.
DR   EvolutionaryTrace; Q15788; -.
DR   GeneWiki; Nuclear_receptor_coactivator_1; -.
DR   GenomeRNAi; 8648; -.
DR   Pharos; Q15788; Tchem.
DR   PRO; PR:Q15788; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q15788; protein.
DR   Bgee; ENSG00000084676; Expressed in forebrain and 239 other tissues.
DR   ExpressionAtlas; Q15788; baseline and differential.
DR   Genevisible; Q15788; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0043005; C:neuron projection; IEA:Ensembl.
DR   GO; GO:0000790; C:nuclear chromatin; IDA:BHF-UCL.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0032991; C:protein-containing complex; IMP:CAFA.
DR   GO; GO:0050681; F:androgen receptor binding; NAS:UniProtKB.
DR   GO; GO:0017162; F:aryl hydrocarbon receptor binding; IPI:CAFA.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISA:NTNU_SB.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0030331; F:estrogen receptor binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0004402; F:histone acetyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0035257; F:nuclear hormone receptor binding; IDA:UniProtKB.
DR   GO; GO:0016922; F:nuclear receptor binding; IPI:UniProtKB.
DR   GO; GO:0030374; F:nuclear receptor transcription coactivator activity; IDA:UniProtKB.
DR   GO; GO:0033142; F:progesterone receptor binding; IEA:Ensembl.
DR   GO; GO:0046983; F:protein dimerization activity; IEA:InterPro.
DR   GO; GO:0047485; F:protein N-terminus binding; IPI:UniProtKB.
DR   GO; GO:0044877; F:protein-containing complex binding; IEA:Ensembl.
DR   GO; GO:0046965; F:retinoid X receptor binding; IEA:Ensembl.
DR   GO; GO:0001012; F:RNA polymerase II regulatory region DNA binding; IEA:Ensembl.
DR   GO; GO:0003713; F:transcription coactivator activity; IDA:UniProtKB.
DR   GO; GO:0030521; P:androgen receptor signaling pathway; NAS:UniProtKB.
DR   GO; GO:0015721; P:bile acid and bile salt transport; TAS:Reactome.
DR   GO; GO:0032870; P:cellular response to hormone stimulus; IBA:GO_Central.
DR   GO; GO:1904017; P:cellular response to Thyroglobulin triiodothyronine; IEA:Ensembl.
DR   GO; GO:0021549; P:cerebellum development; IEA:Ensembl.
DR   GO; GO:0021987; P:cerebral cortex development; IEA:Ensembl.
DR   GO; GO:0044849; P:estrous cycle; IEA:Ensembl.
DR   GO; GO:0021766; P:hippocampus development; IEA:Ensembl.
DR   GO; GO:0043967; P:histone H4 acetylation; IEA:Ensembl.
DR   GO; GO:0021854; P:hypothalamus development; IEA:Ensembl.
DR   GO; GO:0060713; P:labyrinthine layer morphogenesis; IEA:Ensembl.
DR   GO; GO:0007595; P:lactation; IEA:Ensembl.
DR   GO; GO:0008584; P:male gonad development; IEA:Ensembl.
DR   GO; GO:0060179; P:male mating behavior; IEA:Ensembl.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0045925; P:positive regulation of female receptivity; IEA:Ensembl.
DR   GO; GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0000435; P:positive regulation of transcription from RNA polymerase II promoter by galactose; IDA:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:2001038; P:regulation of cellular response to drug; IEA:Ensembl.
DR   GO; GO:0019216; P:regulation of lipid metabolic process; TAS:Reactome.
DR   GO; GO:0002155; P:regulation of thyroid hormone mediated signaling pathway; IEA:Ensembl.
DR   GO; GO:0032355; P:response to estradiol; IEA:Ensembl.
DR   GO; GO:0032570; P:response to progesterone; IEA:Ensembl.
DR   GO; GO:0032526; P:response to retinoic acid; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IDA:UniProtKB.
DR   CDD; cd00083; HLH; 1.
DR   CDD; cd00130; PAS; 1.
DR   Gene3D; 1.10.287.1070; -; 1.
DR   Gene3D; 4.10.280.10; -; 1.
DR   InterPro; IPR011598; bHLH_dom.
DR   InterPro; IPR010011; DUF1518.
DR   InterPro; IPR036638; HLH_DNA-bd_sf.
DR   InterPro; IPR028819; NCOA1.
DR   InterPro; IPR009110; Nuc_rcpt_coact.
DR   InterPro; IPR014920; Nuc_rcpt_coact_Ncoa-typ.
DR   InterPro; IPR037077; Nuc_rcpt_coact_Ncoa_int_sf.
DR   InterPro; IPR017426; Nuclear_rcpt_coactivator.
DR   InterPro; IPR000014; PAS.
DR   InterPro; IPR035965; PAS-like_dom_sf.
DR   InterPro; IPR013767; PAS_fold.
DR   InterPro; IPR014935; SRC/p160_LXXLL.
DR   PANTHER; PTHR10684; PTHR10684; 1.
DR   PANTHER; PTHR10684:SF1; PTHR10684:SF1; 1.
DR   Pfam; PF07469; DUF1518; 2.
DR   Pfam; PF00010; HLH; 1.
DR   Pfam; PF08815; Nuc_rec_co-act; 1.
DR   Pfam; PF00989; PAS; 1.
DR   Pfam; PF08832; SRC-1; 1.
DR   PIRSF; PIRSF038181; Nuclear_receptor_coactivator; 1.
DR   SMART; SM01151; DUF1518; 2.
DR   SMART; SM00353; HLH; 1.
DR   SMART; SM00091; PAS; 1.
DR   SUPFAM; SSF47459; SSF47459; 1.
DR   SUPFAM; SSF55785; SSF55785; 2.
DR   SUPFAM; SSF69125; SSF69125; 1.
DR   PROSITE; PS50888; BHLH; 1.
DR   PROSITE; PS50112; PAS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Activator; Acyltransferase;
KW   Alternative splicing; Chromosomal rearrangement; Isopeptide bond;
KW   Methylation; Nucleus; Phosphoprotein; Polymorphism; Proto-oncogene;
KW   Reference proteome; Repeat; Transcription; Transcription regulation;
KW   Transferase; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:19413330"
FT   CHAIN           2..1441
FT                   /note="Nuclear receptor coactivator 1"
FT                   /id="PRO_0000094400"
FT   DOMAIN          23..80
FT                   /note="bHLH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00981"
FT   DOMAIN          109..180
FT                   /note="PAS"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00140"
FT   REGION          361..567
FT                   /note="Interaction with STAT3"
FT                   /evidence="ECO:0000269|PubMed:11773079"
FT   REGION          781..988
FT                   /note="Interaction with CREBBP"
FT   MOTIF           46..50
FT                   /note="LXXLL motif 1"
FT   MOTIF           112..116
FT                   /note="LXXLL motif 2"
FT   MOTIF           633..637
FT                   /note="LXXLL motif 3"
FT   MOTIF           690..694
FT                   /note="LXXLL motif 4"
FT   MOTIF           749..753
FT                   /note="LXXLL motif 5"
FT   MOTIF           913..917
FT                   /note="LXXLL motif 6"
FT   MOTIF           1435..1439
FT                   /note="LXXLL motif 7"
FT   COMPBIAS        389..682
FT                   /note="Ser-rich"
FT   COMPBIAS        1053..1138
FT                   /note="Gln-rich"
FT   SITE            867..868
FT                   /note="Breakpoint for translocation to form PAX3-NCOA1
FT                   oncogene"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000244|PubMed:19413330"
FT   MOD_RES         22
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         372
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163,
FT                   ECO:0000269|PubMed:10660621"
FT   MOD_RES         395
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:10660621"
FT   MOD_RES         517
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:10660621"
FT   MOD_RES         558
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P70365"
FT   MOD_RES         569
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:10660621"
FT   MOD_RES         698
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         1033
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:10660621"
FT   MOD_RES         1073
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P70365"
FT   MOD_RES         1091
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P70365"
FT   MOD_RES         1124
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P70365"
FT   MOD_RES         1131
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P70365"
FT   MOD_RES         1179
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:10660621"
FT   MOD_RES         1185
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:10660621"
FT   MOD_RES         1372
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   CROSSLNK        732
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000269|PubMed:12529333"
FT   CROSSLNK        774
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000269|PubMed:12529333"
FT   CROSSLNK        846
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   VAR_SEQ         1385
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:8754792"
FT                   /id="VSP_011738"
FT   VAR_SEQ         1386..1441
FT                   /note="QVQQVQVFADVQCTVNLVGGDPYLNQPGPLGTQKPTSGPQTPQAQQKSLLQQ
FT                   LLTE -> DKKTEEFFSVVTTD (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11831720,
FT                   ECO:0000303|PubMed:15313887, ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:9427757"
FT                   /id="VSP_011739"
FT   VARIANT         457
FT                   /note="Q -> K (in dbSNP:rs1049015)"
FT                   /evidence="ECO:0000269|PubMed:7481822,
FT                   ECO:0000269|PubMed:8754792, ECO:0000269|PubMed:9575154"
FT                   /id="VAR_019768"
FT   VARIANT         466
FT                   /note="N -> K (in dbSNP:rs1049016)"
FT                   /evidence="ECO:0000269|PubMed:7481822,
FT                   ECO:0000269|PubMed:8754792, ECO:0000269|PubMed:9575154"
FT                   /id="VAR_019769"
FT   VARIANT         474
FT                   /note="S -> P (in dbSNP:rs1049018)"
FT                   /evidence="ECO:0000269|PubMed:7481822,
FT                   ECO:0000269|PubMed:8754792, ECO:0000269|PubMed:9575154"
FT                   /id="VAR_019770"
FT   VARIANT         591
FT                   /note="I -> T (in dbSNP:rs1049020)"
FT                   /evidence="ECO:0000269|PubMed:7481822,
FT                   ECO:0000269|PubMed:8754792, ECO:0000269|PubMed:9575154"
FT                   /id="VAR_019771"
FT   VARIANT         685
FT                   /note="E -> A (in dbSNP:rs1049021)"
FT                   /evidence="ECO:0000269|PubMed:7481822,
FT                   ECO:0000269|PubMed:8754792, ECO:0000269|PubMed:9575154"
FT                   /id="VAR_019772"
FT   VARIANT         794
FT                   /note="P -> A (in dbSNP:rs1049025)"
FT                   /evidence="ECO:0000269|PubMed:7481822"
FT                   /id="VAR_019773"
FT   VARIANT         999
FT                   /note="S -> F (in dbSNP:rs1049032)"
FT                   /evidence="ECO:0000269|PubMed:7481822,
FT                   ECO:0000269|PubMed:8754792, ECO:0000269|PubMed:9575154"
FT                   /id="VAR_019774"
FT   VARIANT         1154
FT                   /note="M -> T (in dbSNP:rs1049038)"
FT                   /evidence="ECO:0000269|PubMed:7481822,
FT                   ECO:0000269|PubMed:8754792, ECO:0000269|PubMed:9575154"
FT                   /id="VAR_019775"
FT   VARIANT         1238
FT                   /note="V -> I (in dbSNP:rs56099330)"
FT                   /evidence="ECO:0000269|Ref.4"
FT                   /id="VAR_038832"
FT   VARIANT         1272
FT                   /note="P -> S (in dbSNP:rs1804645)"
FT                   /evidence="ECO:0000269|Ref.4"
FT                   /id="VAR_034882"
FT   MUTAGEN         636..637
FT                   /note="LL->AA: Slightly affects interactions with steroid
FT                   receptors. Abolishes interactions with steroid receptors;
FT                   when associated with A-693; A-694; A-752 and A-753."
FT                   /evidence="ECO:0000269|PubMed:9427757"
FT   MUTAGEN         693..694
FT                   /note="LL->AA: Slightly affects interactions with steroid
FT                   receptors. Abolishes interactions with steroid receptors;
FT                   when associated with A-636; A-637; A-752 and A-753."
FT                   /evidence="ECO:0000269|PubMed:9427757"
FT   MUTAGEN         732
FT                   /note="K->R: Abolishes sumoylation; when associated with R-
FT                   774."
FT                   /evidence="ECO:0000269|PubMed:12529333"
FT   MUTAGEN         752..753
FT                   /note="LL->AA: Slightly affects interactions with steroid
FT                   receptors. Abolishes interactions with steroid receptors;
FT                   when associated with A-636; A-637; A-693 and A-694."
FT                   /evidence="ECO:0000269|PubMed:9427757"
FT   MUTAGEN         774
FT                   /note="K->R: Abolishes sumoylation; when associated with R-
FT                   732."
FT                   /evidence="ECO:0000269|PubMed:12529333"
FT   MUTAGEN         800
FT                   /note="K->R: Does not affect sumoylation of the protein."
FT                   /evidence="ECO:0000269|PubMed:12529333"
FT   MUTAGEN         846
FT                   /note="K->R: Does not affect sumoylation of the protein."
FT                   /evidence="ECO:0000269|PubMed:12529333"
FT   MUTAGEN         1378
FT                   /note="K->R: Does not affect sumoylation of the protein."
FT                   /evidence="ECO:0000269|PubMed:12529333"
FT   CONFLICT        1035
FT                   /note="Missing (in Ref. 10; AAT47737)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1370
FT                   /note="Q -> H (in Ref. 9; AAA64187)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1382
FT                   /note="D -> G (in Ref. 10; AAT47737)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1435
FT                   /note="L -> R (in Ref. 3; AAB50242)"
FT                   /evidence="ECO:0000305"
FT   STRAND          261..266
FT                   /evidence="ECO:0000244|PDB:5NWM"
FT   STRAND          272..276
FT                   /evidence="ECO:0000244|PDB:5NWM"
FT   HELIX           278..283
FT                   /evidence="ECO:0000244|PDB:5NWM"
FT   HELIX           288..299
FT                   /evidence="ECO:0000244|PDB:5NWM"
FT   HELIX           309..319
FT                   /evidence="ECO:0000244|PDB:5NWM"
FT   STRAND          320..324
FT                   /evidence="ECO:0000244|PDB:5NWM"
FT   STRAND          328..331
FT                   /evidence="ECO:0000244|PDB:5NWM"
FT   STRAND          337..347
FT                   /evidence="ECO:0000244|PDB:5NWM"
FT   STRAND          350..353
FT                   /evidence="ECO:0000244|PDB:5NWM"
FT   STRAND          357..365
FT                   /evidence="ECO:0000244|PDB:5NWM"
FT   HELIX           632..638
FT                   /evidence="ECO:0000244|PDB:2FVJ"
FT   HELIX           684..686
FT                   /evidence="ECO:0000244|PDB:5HJS"
FT   HELIX           688..695
FT                   /evidence="ECO:0000244|PDB:1NQ7"
FT   HELIX           747..753
FT                   /evidence="ECO:0000244|PDB:5Q0K"
FT   TURN            924..926
FT                   /evidence="ECO:0000244|PDB:2C52"
FT   HELIX           929..941
FT                   /evidence="ECO:0000244|PDB:2C52"
FT   HELIX           945..947
FT                   /evidence="ECO:0000244|PDB:2C52"
FT   HELIX           952..954
FT                   /evidence="ECO:0000244|PDB:2C52"
FT   TURN            958..962
FT                   /evidence="ECO:0000244|PDB:2C52"
FT   STRAND          964..966
FT                   /evidence="ECO:0000244|PDB:2C52"
FT   HELIX           1434..1440
FT                   /evidence="ECO:0000244|PDB:6GEV"
SQ   SEQUENCE   1441 AA;  156757 MW;  25EF6F389489121E CRC64;
     MSGLGDSSSD PANPDSHKRK GSPCDTLASS TEKRRREQEN KYLEELAELL SANISDIDSL
     SVKPDKCKIL KKTVDQIQLM KRMEQEKSTT DDDVQKSDIS SSSQGVIEKE SLGPLLLEAL
     DGFFFVVNCE GRIVFVSENV TSYLGYNQEE LMNTSVYSIL HVGDHAEFVK NLLPKSLVNG
     VPWPQEATRR NSHTFNCRML IHPPDEPGTE NQEACQRYEV MQCFTVSQPK SIQEDGEDFQ
     SCLICIARRL PRPPAITGVE SFMTKQDTTG KIISIDTSSL RAAGRTGWED LVRKCIYAFF
     QPQGREPSYA RQLFQEVMTR GTASSPSYRF ILNDGTMLSA HTKCKLCYPQ SPDMQPFIMG
     IHIIDREHSG LSPQDDTNSG MSIPRVNPSV NPSISPAHGV ARSSTLPPSN SNMVSTRINR
     QQSSDLHSSS HSNSSNSQGS FGCSPGSQIV ANVALNQGQA SSQSSNPSLN LNNSPMEGTG
     ISLAQFMSPR RQVTSGLATR PRMPNNSFPP NISTLSSPVG MTSSACNNNN RSYSNIPVTS
     LQGMNEGPNN SVGFSASSPV LRQMSSQNSP SRLNIQPAKA ESKDNKEIAS ILNEMIQSDN
     SSSDGKPLDS GLLHNNDRLS DGDSKYSQTS HKLVQLLTTT AEQQLRHADI DTSCKDVLSC
     TGTSNSASAN SSGGSCPSSH SSLTERHKIL HRLLQEGSPS DITTLSVEPD KKDSASTSVS
     VTGQVQGNSS IKLELDASKK KESKDHQLLR YLLDKDEKDL RSTPNLSLDD VKVKVEKKEQ
     MDPCNTNPTP MTKPTPEEIK LEAQSQFTAD LDQFDQLLPT LEKAAQLPGL CETDRMDGAV
     TSVTIKSEIL PASLQSATAR PTSRLNRLPE LELEAIDNQF GQPGTGDQIP WTNNTVTAIN
     QSKSEDQCIS SQLDELLCPP TTVEGRNDEK ALLEQLVSFL SGKDETELAE LDRALGIDKL
     VQGGGLDVLS ERFPPQQATP PLIMEERPNL YSQPYSSPSP TANLPSPFQG MVRQKPSLGT
     MPVQVTPPRG AFSPGMGMQP RQTLNRPPAA PNQLRLQLQQ RLQGQQQLIH QNRQAILNQF
     AATAPVGINM RSGMQQQITP QPPLNAQMLA QRQRELYSQQ HRQRQLIQQQ RAMLMRQQSF
     GNNLPPSSGL PVQMGNPRLP QGAPQQFPYP PNYGTNPGTP PASTSPFSQL AANPEASLAN
     RNSMVSRGMT GNIGGQFGTG INPQMQQNVF QYPGAGMVPQ GEANFAPSLS PGSSMVPMPI
     PPPQSSLLQQ TPPASGYQSP DMKAWQQGAI GNNNVFSQAV QNQPTPAQPG VYNNMSITVS
     MAGGNTNVQN MNPMMAQMQM SSLQMPGMNT VCPEQINDPA LRHTGLYCNQ LSSTDLLKTE
     ADGTQQVQQV QVFADVQCTV NLVGGDPYLN QPGPLGTQKP TSGPQTPQAQ QKSLLQQLLT
     E
//
ID   A0A0A0MRX8_HUMAN        Unreviewed;       446 AA.
AC   A0A0A0MRX8;
DT   07-JAN-2015, integrated into UniProtKB/TrEMBL.
DT   07-JAN-2015, sequence version 1.
DT   22-APR-2020, entry version 47.
DE   RecName: Full=Nuclear factor 1 {ECO:0000256|RuleBase:RU000690};
GN   Name=NFIB {ECO:0000313|Ensembl:ENSP00000370321};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000370321, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000370321, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L.,
RA   Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S.,
RA   Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K.,
RA   Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C.,
RA   Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E.,
RA   Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M.,
RA   Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J.,
RA   Frankish A., Frankland J.A., French L., Fricker D.G., Garner P.,
RA   Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S.,
RA   Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E.,
RA   McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V.,
RA   Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S.,
RA   Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K.,
RA   Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J.,
RA   Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M.,
RA   West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L.,
RA   Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J.,
RA   Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [2] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [3] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [4] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [5] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [6] {ECO:0000313|Ensembl:ENSP00000370321}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (NOV-2014) to UniProtKB.
CC   -!- FUNCTION: Recognizes and binds the palindromic sequence 5'-
CC       TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the
CC       origin of replication of adenovirus type 2. These proteins are
CC       individually capable of activating transcription and replication.
CC       {ECO:0000256|RuleBase:RU000690}.
CC   -!- SUBUNIT: Binds DNA as a homodimer. {ECO:0000256|RuleBase:RU000690}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|RuleBase:RU000690,
CC       ECO:0000256|SAAS:SAAS00573677}.
CC   -!- SIMILARITY: Belongs to the CTF/NF-I family.
CC       {ECO:0000256|RuleBase:RU000690}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL136366; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL137017; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL441963; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL449443; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001177667.1; NM_001190738.1.
DR   jPOST; A0A0A0MRX8; -.
DR   PeptideAtlas; A0A0A0MRX8; -.
DR   PRIDE; A0A0A0MRX8; -.
DR   Antibodypedia; 1309; 197 antibodies.
DR   Ensembl; ENST00000380934; ENSP00000370321; ENSG00000147862.
DR   GeneID; 4781; -.
DR   UCSC; uc022bdp.1; human.
DR   CTD; 4781; -.
DR   EuPathDB; HostDB:ENSG00000147862.14; -.
DR   HGNC; HGNC:7785; NFIB.
DR   OpenTargets; ENSG00000147862; -.
DR   eggNOG; KOG3663; Eukaryota.
DR   eggNOG; ENOG410Y16G; LUCA.
DR   GeneTree; ENSGT00950000182916; -.
DR   ChiTaRS; NFIB; human.
DR   GenomeRNAi; 4781; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000147862; Expressed in cerebral cortex and 248 other tissues.
DR   ExpressionAtlas; A0A0A0MRX8; baseline and differential.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IEA:InterPro.
DR   GO; GO:0006260; P:DNA replication; IEA:UniProtKB-KW.
DR   InterPro; IPR000647; CTF/NFI.
DR   InterPro; IPR020604; CTF/NFI_DNA-bd-dom.
DR   InterPro; IPR019739; CTF/NFI_DNA-bd_CS.
DR   InterPro; IPR019548; CTF/NFI_DNA-bd_N.
DR   InterPro; IPR003619; MAD_homology1_Dwarfin-type.
DR   PANTHER; PTHR11492; PTHR11492; 1.
DR   Pfam; PF00859; CTF_NFI; 1.
DR   Pfam; PF03165; MH1; 1.
DR   Pfam; PF10524; NfI_DNAbd_pre-N; 1.
DR   SMART; SM00523; DWA; 1.
DR   PROSITE; PS00349; CTF_NFI_1; 1.
DR   PROSITE; PS51080; CTF_NFI_2; 1.
PE   1: Evidence at protein level;
KW   Activator {ECO:0000256|RuleBase:RU000690};
KW   DNA replication {ECO:0000256|RuleBase:RU000690};
KW   DNA-binding {ECO:0000256|RuleBase:RU000690};
KW   Nucleus {ECO:0000256|RuleBase:RU000690, ECO:0000256|SAAS:SAAS00464850};
KW   Proteomics identification {ECO:0000213|EPD:A0A0A0MRX8,
KW   ECO:0000213|MaxQB:A0A0A0MRX8, ECO:0000213|PeptideAtlas:A0A0A0MRX8,
KW   ECO:0000213|ProteomicsDB:A0A0A0MRX8};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Transcription {ECO:0000256|RuleBase:RU000690,
KW   ECO:0000256|SAAS:SAAS00094697};
KW   Transcription regulation {ECO:0000256|RuleBase:RU000690,
KW   ECO:0000256|SAAS:SAAS00094697}.
FT   DOMAIN          27..221
FT                   /note="CTF/NF-I"
FT                   /evidence="ECO:0000259|PROSITE:PS51080"
FT   REGION          215..234
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          278..390
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          403..446
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        278..300
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        313..327
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        344..365
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        424..446
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   446 AA;  50290 MW;  1EFD52F36D29368D CRC64;
     MERIPVSVDF WVVCCAVLKC NPGIPKRMST LCFGFSDEFH PFIEALLPHV RAIAYTWFNL
     QARKRKYFKK HEKRMSKDEE RAVKDELLSE KPEIKQKWAS RLLAKLRKDI RQEYREDFVL
     TVTGKKHPCC VLSNPDQKGK IRRIDCLRQA DKVWRLDLVM VILFKGIPLE STDGERLMKS
     PHCTNPALCV QPHHITVSVK ELDLFLAYYV QEQDSGQSGS PSHNDPAKNP PGYLEDSFVK
     SGVFNVSELV RVSRTPITQG TGVNFPIGEI PSQPYYHDMN SGVNLQRSLS SPPSSKRPKT
     ISIDENMEPS PTGDFYPSPS SPAAGSRTWH ERDQDMSSPT TMKKPEKPLF SSASPQDSSP
     RLSTFPQHHH PGIPGVAHSV ISTRTPPPPS PLPFPTQAIL PPAPSSYFSH PTIRYPPHLN
     PQDTLKNYVP SYDPSSPQTS QSWYLG
//
ID   NFIB_HUMAN              Reviewed;         420 AA.
AC   O00712; G3V1P1; H7BYE8; O00166; Q12858; Q5VW29; Q63HM5; Q6ZNF9; Q96J45;
DT   01-JUN-2001, integrated into UniProtKB/Swiss-Prot.
DT   15-MAR-2004, sequence version 2.
DT   22-APR-2020, entry version 179.
DE   RecName: Full=Nuclear factor 1 B-type;
DE            Short=NF1-B;
DE            Short=Nuclear factor 1/B;
DE   AltName: Full=CCAAT-box-binding transcription factor;
DE            Short=CTF;
DE   AltName: Full=Nuclear factor I/B;
DE            Short=NF-I/B;
DE            Short=NFI-B;
DE   AltName: Full=TGGCA-binding protein;
GN   Name=NFIB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9484777; DOI=10.1038/sj.onc.1201609;
RA   Geurts J.M.W., Schoenmakers E.F.P.M., Roijer E., Astroem A.-K., Stenman G.,
RA   van de Ven W.J.M.;
RT   "Identification of NFIB as recurrent translocation partner gene of HMGIC in
RT   pleomorphic adenomas.";
RL   Oncogene 16:865-872(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RC   TISSUE=Foreskin;
RX   PubMed=9099724; DOI=10.1074/jbc.272.16.10739;
RA   Liu Y., Bernard H.U., Apt D.;
RT   "NFI-B3, a novel transcriptional repressor of the nuclear factor I family,
RT   is generated by alternative RNA processing.";
RL   J. Biol. Chem. 272:10739-10745(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Amygdala;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 5 AND 6).
RC   TISSUE=Colon epithelium;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L.,
RA   Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S.,
RA   Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K.,
RA   Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C.,
RA   Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E.,
RA   Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M.,
RA   Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J.,
RA   Frankish A., Frankland J.A., French L., Fricker D.G., Garner P.,
RA   Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S.,
RA   Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E.,
RA   McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V.,
RA   Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S.,
RA   Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K.,
RA   Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J.,
RA   Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M.,
RA   West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L.,
RA   Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J.,
RA   Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Cervix;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 20-283.
RX   PubMed=7590749; DOI=10.1006/geno.1995.1107;
RA   Qian F., Kruse U., Lichter P., Sippel A.E.;
RT   "Chromosomal localization of the four genes (NFIA, B, C, and X) for the
RT   human transcription factor nuclear factor I by FISH.";
RL   Genomics 28:66-73(1995).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-264 AND SER-328, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-312; SER-328 AND SER-333, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-312; SER-328 AND SER-333, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-292 AND SER-295, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   9AATAD MOTIF.
RX   PubMed=31375868; DOI=10.1007/s00018-019-03251-w;
RA   Piskacek M., Havelka M., Jendruchova K., Knight A., Keegan L.P.;
RT   "The evolution of the 9aaTAD domain in Sp2 proteins: inactivation with
RT   valines and intron reservoirs.";
RL   Cell. Mol. Life Sci. 0:0-0(2019).
RN   [15]
RP   FUNCTION, INVOLVEMENT IN MACID, VARIANTS MACID 37-ARG--GLY-420 DEL;
RP   89-ARG--GLY-420 DEL; THR-114; GLU-126 AND PRO-132, CHARACTERIZATION OF
RP   VARIANTS MACID THR-114; GLU-126 AND PRO-132, VARIANT LEU-356, AND
RP   CHARACTERIZATION OF VARIANT LEU-356.
RX   PubMed=30388402; DOI=10.1016/j.ajhg.2018.10.006;
RA   Schanze I., Bunt J., Lim J.W.C., Schanze D., Dean R.J., Alders M.,
RA   Blanchet P., Attie-Bitach T., Berland S., Boogert S., Boppudi S.,
RA   Bridges C.J., Cho M.T., Dobyns W.B., Donnai D., Douglas J., Earl D.L.,
RA   Edwards T.J., Faivre L., Fregeau B., Genevieve D., Gerard M., Gatinois V.,
RA   Holder-Espinasse M., Huth S.F., Izumi K., Kerr B., Lacaze E., Lakeman P.,
RA   Mahida S., Mirzaa G.M., Morgan S.M., Nowak C., Peeters H., Petit F.,
RA   Pilz D.T., Puechberty J., Reinstein E., Riviere J.B., Santani A.B.,
RA   Schneider A., Sherr E.H., Smith-Hicks C., Wieland I., Zackai E., Zhao X.,
RA   Gronostajski R.M., Zenker M., Richards L.J.;
RT   "NFIB haploinsufficiency is associated with intellectual disability and
RT   macrocephaly.";
RL   Am. J. Hum. Genet. 103:752-768(2018).
CC   -!- FUNCTION: Transcriptional activator of GFAP, essential for proper brain
CC       development (PubMed:30388402). Recognizes and binds the palindromic
CC       sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters
CC       and in the origin of replication of adenovirus type 2. These proteins
CC       are individually capable of activating transcription and replication.
CC       {ECO:0000269|PubMed:30388402}.
CC   -!- SUBUNIT: Binds DNA as a homodimer.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=O00712-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O00712-3; Sequence=Not described;
CC       Name=3; Synonyms=NFI-B3;
CC         IsoId=O00712-2; Sequence=VSP_003545, VSP_003546;
CC       Name=4;
CC         IsoId=O00712-4; Sequence=VSP_044462;
CC       Name=5;
CC         IsoId=O00712-5; Sequence=VSP_045065;
CC       Name=6;
CC         IsoId=O00712-6; Sequence=VSP_054713, VSP_054714;
CC   -!- DOMAIN: The 9aaTAD motif is a transactivation domain present in a large
CC       number of yeast and animal transcription factors.
CC       {ECO:0000269|PubMed:31375868}.
CC   -!- DISEASE: Macrocephaly, acquired, with impaired intellectual development
CC       (MACID) [MIM:618286]: An autosomal dominant disorder characterized by
CC       postnatal macrocephaly and borderline to mild mental retardation.
CC       Additional variable neurodevelopmental features include muscular
CC       hypotonia, motor and speech delay, attention deficit disorder, autism
CC       spectrum disorder, and behavioral abnormalities. Some patients present
CC       corpus callosum dysgenesis. {ECO:0000269|PubMed:30388402}. Note=The
CC       disease is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the CTF/NF-I family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00436}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U85193; AAB41899.1; -; mRNA.
DR   EMBL; U70862; AAB51197.1; -; mRNA.
DR   EMBL; BT007266; AAP35930.1; -; mRNA.
DR   EMBL; AK131233; BAD18416.1; -; mRNA.
DR   EMBL; BX648416; CAH56156.1; -; mRNA.
DR   EMBL; BX648845; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AL136366; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL441963; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL137017; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL449443; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471071; EAW58697.1; -; Genomic_DNA.
DR   EMBL; CH471071; EAW58699.1; -; Genomic_DNA.
DR   EMBL; BC001283; AAH01283.1; -; mRNA.
DR   EMBL; U07810; AAA93125.1; -; mRNA.
DR   CCDS; CCDS55291.1; -. [O00712-5]
DR   CCDS; CCDS6474.1; -. [O00712-1]
DR   CCDS; CCDS65007.1; -. [O00712-6]
DR   RefSeq; NP_001177666.1; NM_001190737.1. [O00712-5]
DR   RefSeq; NP_001177667.1; NM_001190738.1.
DR   RefSeq; NP_001269716.1; NM_001282787.1. [O00712-6]
DR   RefSeq; NP_005587.2; NM_005596.3. [O00712-1]
DR   BioGrid; 110853; 17.
DR   DIP; DIP-61433N; -.
DR   IntAct; O00712; 8.
DR   STRING; 9606.ENSP00000370340; -.
DR   iPTMnet; O00712; -.
DR   PhosphoSitePlus; O00712; -.
DR   BioMuta; NFIB; -.
DR   EPD; O00712; -.
DR   jPOST; O00712; -.
DR   MassIVE; O00712; -.
DR   PaxDb; O00712; -.
DR   PeptideAtlas; O00712; -.
DR   PRIDE; O00712; -.
DR   ProteomicsDB; 32394; -.
DR   ProteomicsDB; 43594; -.
DR   ProteomicsDB; 48006; -. [O00712-1]
DR   ProteomicsDB; 48007; -. [O00712-2]
DR   ProteomicsDB; 65511; -.
DR   Antibodypedia; 1309; 197 antibodies.
DR   DNASU; 4781; -.
DR   Ensembl; ENST00000380953; ENSP00000370340; ENSG00000147862. [O00712-5]
DR   Ensembl; ENST00000380959; ENSP00000370346; ENSG00000147862. [O00712-1]
DR   Ensembl; ENST00000543693; ENSP00000442888; ENSG00000147862. [O00712-6]
DR   GeneID; 4781; -.
DR   KEGG; hsa:4781; -.
DR   UCSC; uc003zld.4; human. [O00712-1]
DR   CTD; 4781; -.
DR   DisGeNET; 4781; -.
DR   GeneCards; NFIB; -.
DR   HGNC; HGNC:7785; NFIB.
DR   HPA; ENSG00000147862; Low tissue specificity.
DR   MalaCards; NFIB; -.
DR   MIM; 600728; gene.
DR   MIM; 618286; phenotype.
DR   neXtProt; NX_O00712; -.
DR   OpenTargets; ENSG00000147862; -.
DR   PharmGKB; PA31591; -.
DR   eggNOG; KOG3663; Eukaryota.
DR   eggNOG; ENOG410Y16G; LUCA.
DR   GeneTree; ENSGT00950000182916; -.
DR   HOGENOM; CLU_061490_0_0_1; -.
DR   InParanoid; O00712; -.
DR   KO; K09169; -.
DR   PhylomeDB; O00712; -.
DR   TreeFam; TF313889; -.
DR   Reactome; R-HSA-73980; RNA Polymerase III Transcription Termination.
DR   Reactome; R-HSA-749476; RNA Polymerase III Abortive And Retractive Initiation.
DR   SignaLink; O00712; -.
DR   SIGNOR; O00712; -.
DR   ChiTaRS; NFIB; human.
DR   GeneWiki; NFIB_(gene); -.
DR   GenomeRNAi; 4781; -.
DR   Pharos; O00712; Tbio.
DR   PRO; PR:O00712; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   RNAct; O00712; protein.
DR   Bgee; ENSG00000147862; Expressed in cerebral cortex and 248 other tissues.
DR   ExpressionAtlas; O00712; baseline and differential.
DR   Genevisible; O00712; HS.
DR   GO; GO:0044300; C:cerebellar mossy fiber; ISS:UniProtKB.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0000790; C:nuclear chromatin; ISA:NTNU_SB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IDA:NTNU_SB.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IDA:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0003714; F:transcription corepressor activity; IDA:UniProtKB.
DR   GO; GO:0021960; P:anterior commissure morphogenesis; ISS:UniProtKB.
DR   GO; GO:0007420; P:brain development; IMP:UniProtKB.
DR   GO; GO:0060689; P:cell differentiation involved in salivary gland development; IEA:Ensembl.
DR   GO; GO:0002062; P:chondrocyte differentiation; ISS:UniProtKB.
DR   GO; GO:0060486; P:club cell differentiation; ISS:UniProtKB.
DR   GO; GO:0071679; P:commissural neuron axon guidance; ISS:UniProtKB.
DR   GO; GO:0006260; P:DNA replication; IEA:UniProtKB-KW.
DR   GO; GO:0010001; P:glial cell differentiation; ISS:UniProtKB.
DR   GO; GO:0030902; P:hindbrain development; IEA:Ensembl.
DR   GO; GO:0061141; P:lung ciliated cell differentiation; ISS:UniProtKB.
DR   GO; GO:0043392; P:negative regulation of DNA binding; IDA:UniProtKB.
DR   GO; GO:2000795; P:negative regulation of epithelial cell proliferation involved in lung morphogenesis; ISS:UniProtKB.
DR   GO; GO:2000791; P:negative regulation of mesenchymal cell proliferation involved in lung development; ISS:UniProtKB.
DR   GO; GO:1902894; P:negative regulation of pri-miRNA transcription by RNA polymerase II; IMP:BHF-UCL.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0021740; P:principal sensory nucleus of trigeminal nerve development; ISS:UniProtKB.
DR   GO; GO:0009617; P:response to bacterium; IEA:Ensembl.
DR   GO; GO:0060662; P:salivary gland cavitation; IEA:Ensembl.
DR   GO; GO:0060509; P:type I pneumocyte differentiation; ISS:UniProtKB.
DR   GO; GO:0060510; P:type II pneumocyte differentiation; ISS:UniProtKB.
DR   InterPro; IPR000647; CTF/NFI.
DR   InterPro; IPR020604; CTF/NFI_DNA-bd-dom.
DR   InterPro; IPR019739; CTF/NFI_DNA-bd_CS.
DR   InterPro; IPR019548; CTF/NFI_DNA-bd_N.
DR   InterPro; IPR003619; MAD_homology1_Dwarfin-type.
DR   PANTHER; PTHR11492; PTHR11492; 1.
DR   Pfam; PF00859; CTF_NFI; 1.
DR   Pfam; PF03165; MH1; 1.
DR   Pfam; PF10524; NfI_DNAbd_pre-N; 1.
DR   SMART; SM00523; DWA; 1.
DR   PROSITE; PS00349; CTF_NFI_1; 1.
DR   PROSITE; PS51080; CTF_NFI_2; 1.
PE   1: Evidence at protein level;
KW   Activator; Alternative splicing; Disease mutation; DNA replication;
KW   DNA-binding; Mental retardation; Methylation; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Transcription; Transcription regulation.
FT   CHAIN           1..420
FT                   /note="Nuclear factor 1 B-type"
FT                   /id="PRO_0000100195"
FT   DNA_BIND        1..195
FT                   /note="CTF/NF-I"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00436"
FT   MOTIF           397..405
FT                   /note="9aaTAD"
FT                   /evidence="ECO:0000269|PubMed:31375868"
FT   MOD_RES         264
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         286
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P97863"
FT   MOD_RES         292
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         295
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         312
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         328
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163"
FT   MOD_RES         333
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         335
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P97863"
FT   MOD_RES         388
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P97863"
FT   VAR_SEQ         1..252
FT                   /note="Missing (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_054713"
FT   VAR_SEQ         1..10
FT                   /note="MMYSPICLTQ -> MERIPVSVDFWVVCCAVLKCNPGIPMERIPVSVDFWVV
FT                   CCAVLKCNPGIPKRMSTLCFGFS (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_044462"
FT   VAR_SEQ         187..188
FT                   /note="QD -> AR (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:9099724"
FT                   /id="VSP_003545"
FT   VAR_SEQ         189..420
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:9099724"
FT                   /id="VSP_003546"
FT   VAR_SEQ         416..420
FT                   /note="SWYLG -> PNGSGQVVGKVPGHFTPVLAPSPHPSAVRPVTLSMTDTKPITT
FT                   STEAYTASGTSQANRYVGLSPRDPSFLHQQQLRICDWTMNQNGRHLYPSTSEDTLGITW
FT                   QSPGTWASLVPFQVSNRTPILPANVQNYGLNIIGEPFLQAETSN (in isoform
FT                   6)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_054714"
FT   VAR_SEQ         416
FT                   /note="S -> PNGSGQVVGKVPGHFTPVLAPSPHPSAVRPVTLSMTDTKPITTSTEA
FT                   YTASGTSQANRYVGLSPRDPSFLHQQQS (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_045065"
FT   VARIANT         37..420
FT                   /note="Missing (in MACID)"
FT                   /evidence="ECO:0000269|PubMed:30388402"
FT                   /id="VAR_081859"
FT   VARIANT         89..420
FT                   /note="Missing (in MACID)"
FT                   /evidence="ECO:0000269|PubMed:30388402"
FT                   /id="VAR_081860"
FT   VARIANT         114
FT                   /note="K -> T (in MACID; significant decrease of GFAP
FT                   transcriptional activation; dbSNP:rs1554709683)"
FT                   /evidence="ECO:0000269|PubMed:30388402"
FT                   /id="VAR_081861"
FT   VARIANT         126
FT                   /note="K -> E (in MACID; significant decrease of GFAP
FT                   transcriptional activation; dbSNP:rs1554709662)"
FT                   /evidence="ECO:0000269|PubMed:30388402"
FT                   /id="VAR_081862"
FT   VARIANT         132
FT                   /note="L -> P (in MACID; significant decrease of GFAP
FT                   transcriptional activation; dbSNP:rs1554709654)"
FT                   /evidence="ECO:0000269|PubMed:30388402"
FT                   /id="VAR_081863"
FT   VARIANT         356
FT                   /note="S -> L (likely benign private rare variant; does not
FT                   affect GFAP transcriptional activation;
FT                   dbSNP:rs1554639196)"
FT                   /evidence="ECO:0000269|PubMed:30388402"
FT                   /id="VAR_081864"
FT   CONFLICT        17
FT                   /note="I -> M (in Ref. 1; AAB41899)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        37
FT                   /note="R -> G (in Ref. 4; BAD18416)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        74
FT                   /note="S -> F (in Ref. 5; BX648845)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        198
FT                   /note="N -> S (in Ref. 4; BAD18416)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        284
FT                   /note="S -> R (in Ref. 5; BX648845)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   420 AA;  47442 MW;  0F71635FE9D64FA4 CRC64;
     MMYSPICLTQ DEFHPFIEAL LPHVRAIAYT WFNLQARKRK YFKKHEKRMS KDEERAVKDE
     LLSEKPEIKQ KWASRLLAKL RKDIRQEYRE DFVLTVTGKK HPCCVLSNPD QKGKIRRIDC
     LRQADKVWRL DLVMVILFKG IPLESTDGER LMKSPHCTNP ALCVQPHHIT VSVKELDLFL
     AYYVQEQDSG QSGSPSHNDP AKNPPGYLED SFVKSGVFNV SELVRVSRTP ITQGTGVNFP
     IGEIPSQPYY HDMNSGVNLQ RSLSSPPSSK RPKTISIDEN MEPSPTGDFY PSPSSPAAGS
     RTWHERDQDM SSPTTMKKPE KPLFSSASPQ DSSPRLSTFP QHHHPGIPGV AHSVISTRTP
     PPPSPLPFPT QAILPPAPSS YFSHPTIRYP PHLNPQDTLK NYVPSYDPSS PQTSQSWYLG
//
ID   Q5VW26_HUMAN            Unreviewed;       570 AA.
AC   Q5VW26;
DT   07-DEC-2004, integrated into UniProtKB/TrEMBL.
DT   07-DEC-2004, sequence version 1.
DT   22-APR-2020, entry version 145.
DE   RecName: Full=Nuclear factor 1 {ECO:0000256|RuleBase:RU000690};
GN   Name=NFIB {ECO:0000313|EMBL:EAW58698.1,
GN   ECO:0000313|Ensembl:ENSP00000380711};
GN   ORFNames=hCG_1742080 {ECO:0000313|EMBL:EAW58698.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000380711, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|EMBL:EAW58698.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|Ensembl:ENSP00000380711, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L.,
RA   Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S.,
RA   Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K.,
RA   Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C.,
RA   Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E.,
RA   Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M.,
RA   Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J.,
RA   Frankish A., Frankland J.A., French L., Fricker D.G., Garner P.,
RA   Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S.,
RA   Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E.,
RA   McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V.,
RA   Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S.,
RA   Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K.,
RA   Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J.,
RA   Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M.,
RA   West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L.,
RA   Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J.,
RA   Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [3] {ECO:0000313|EMBL:EAW58698.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [5] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [6] {ECO:0000313|Ensembl:ENSP00000380711}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
RN   [7] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [8] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Recognizes and binds the palindromic sequence 5'-
CC       TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the
CC       origin of replication of adenovirus type 2. These proteins are
CC       individually capable of activating transcription and replication.
CC       {ECO:0000256|RuleBase:RU000690}.
CC   -!- SUBUNIT: Binds DNA as a homodimer. {ECO:0000256|RuleBase:RU000690}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|RuleBase:RU000690,
CC       ECO:0000256|SAAS:SAAS00573677}.
CC   -!- SIMILARITY: Belongs to the CTF/NF-I family.
CC       {ECO:0000256|RuleBase:RU000690}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL136366; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL137017; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL441963; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL449443; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471071; EAW58698.1; -; Genomic_DNA.
DR   RefSeq; XP_005251524.1; XM_005251467.2.
DR   ProteomicsDB; 65509; -.
DR   Antibodypedia; 1309; 197 antibodies.
DR   Ensembl; ENST00000397581; ENSP00000380711; ENSG00000147862.
DR   GeneID; 4781; -.
DR   UCSC; uc064sed.1; human.
DR   CTD; 4781; -.
DR   EuPathDB; HostDB:ENSG00000147862.14; -.
DR   HGNC; HGNC:7785; NFIB.
DR   OpenTargets; ENSG00000147862; -.
DR   eggNOG; KOG3663; Eukaryota.
DR   eggNOG; ENOG410Y16G; LUCA.
DR   GeneTree; ENSGT00950000182916; -.
DR   OMA; HLNPQET; -.
DR   OrthoDB; 967862at2759; -.
DR   ChiTaRS; NFIB; human.
DR   GenomeRNAi; 4781; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000147862; Expressed in cerebral cortex and 248 other tissues.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IEA:InterPro.
DR   GO; GO:0006260; P:DNA replication; IEA:UniProtKB-KW.
DR   InterPro; IPR000647; CTF/NFI.
DR   InterPro; IPR020604; CTF/NFI_DNA-bd-dom.
DR   InterPro; IPR019739; CTF/NFI_DNA-bd_CS.
DR   InterPro; IPR019548; CTF/NFI_DNA-bd_N.
DR   InterPro; IPR003619; MAD_homology1_Dwarfin-type.
DR   PANTHER; PTHR11492; PTHR11492; 1.
DR   Pfam; PF00859; CTF_NFI; 1.
DR   Pfam; PF03165; MH1; 1.
DR   Pfam; PF10524; NfI_DNAbd_pre-N; 1.
DR   SMART; SM00523; DWA; 1.
DR   PROSITE; PS00349; CTF_NFI_1; 1.
DR   PROSITE; PS51080; CTF_NFI_2; 1.
PE   1: Evidence at protein level;
KW   Activator {ECO:0000256|RuleBase:RU000690};
KW   DNA replication {ECO:0000256|RuleBase:RU000690};
KW   DNA-binding {ECO:0000256|RuleBase:RU000690};
KW   Nucleus {ECO:0000256|RuleBase:RU000690, ECO:0000256|SAAS:SAAS00464850};
KW   Proteomics identification {ECO:0000213|EPD:Q5VW26,
KW   ECO:0000213|MaxQB:Q5VW26, ECO:0000213|PeptideAtlas:Q5VW26,
KW   ECO:0000213|ProteomicsDB:Q5VW26};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Transcription {ECO:0000256|RuleBase:RU000690,
KW   ECO:0000256|SAAS:SAAS00094697};
KW   Transcription regulation {ECO:0000256|RuleBase:RU000690,
KW   ECO:0000256|SAAS:SAAS00094697}.
FT   DOMAIN          2..195
FT                   /note="CTF/NF-I"
FT                   /evidence="ECO:0000259|PROSITE:PS51080"
FT   REGION          189..208
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          252..365
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          383..474
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        252..274
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        287..301
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        318..339
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        398..421
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        444..474
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   570 AA;  63433 MW;  0AC3ECE983FDD069 CRC64;
     MMYSPICLTQ DEFHPFIEAL LPHVRAIAYT WFNLQARKRK YFKKHEKRMS KDEERAVKDE
     LLSEKPEIKQ KWASRLLAKL RKDIRQEYRE DFVLTVTGKK HPCCVLSNPD QKGKIRRIDC
     LRQADKVWRL DLVMVILFKG IPLESTDGER LMKSPHCTNP ALCVQPHHIT VSVKELDLFL
     AYYVQEQDSG QSGSPSHNDP AKNPPGYLED SFVKSGVFNV SELVRVSRTP ITQGTGVNFP
     IGEIPSQPYY HDMNSGVNLQ RSLSSPPSSK RPKTISIDEN MEPSPTGDFY PSPSSPAAGS
     RTWHERDQDM SSPTTMKKPE KPLFSSASPQ DSSPRLSTFP QHHHPGIPGV AHSVISTRTP
     PPPSPLPFPT QAILPPAPSS YFSHPTIRYP PHLNPQDTLK NYVPSYDPSS PQTSQPNGSG
     QVVGKVPGHF TPVLAPSPHP SAVRPVTLSM TDTKPITTST EGEAASPTAT TYTASGTSQA
     NRYVGLSPRD PSFLHQQQLR ICDWTMNQNG RHLYPSTSED TLGITWQSPG TWASLVPFQV
     SNRTPILPAN VQNYGLNIIG EPFLQAETSN
//
ID   Q5VW28_HUMAN            Unreviewed;       420 AA.
AC   Q5VW28;
DT   10-MAY-2005, integrated into UniProtKB/TrEMBL.
DT   10-MAY-2005, sequence version 1.
DT   22-APR-2020, entry version 136.
DE   RecName: Full=Nuclear factor 1 {ECO:0000256|RuleBase:RU000690};
GN   Name=NFIB {ECO:0000313|EMBL:ALQ33690.1};
GN   ORFNames=hCG_1742080 {ECO:0000313|EMBL:EAW58694.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAF83292.1};
RN   [1] {ECO:0000313|EMBL:EAW58694.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW58694.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:BAF83292.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Heart {ECO:0000313|EMBL:BAF83292.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:ALQ33690.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by Alternative
RT   Splicing.";
RL   Cell 164:805-817(2016).
CC   -!- FUNCTION: Recognizes and binds the palindromic sequence 5'-
CC       TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the
CC       origin of replication of adenovirus type 2. These proteins are
CC       individually capable of activating transcription and replication.
CC       {ECO:0000256|RuleBase:RU000690}.
CC   -!- SUBUNIT: Binds DNA as a homodimer. {ECO:0000256|RuleBase:RU000690}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|RuleBase:RU000690,
CC       ECO:0000256|SAAS:SAAS00573677}.
CC   -!- SIMILARITY: Belongs to the CTF/NF-I family.
CC       {ECO:0000256|RuleBase:RU000690}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; KU178232; ALQ33690.1; -; mRNA.
DR   EMBL; AK290603; BAF83292.1; -; mRNA.
DR   EMBL; CH471071; EAW58694.1; -; Genomic_DNA.
DR   RefSeq; NP_005587.2; NM_005596.3.
DR   Antibodypedia; 1309; 197 antibodies.
DR   DNASU; 4781; -.
DR   GeneID; 4781; -.
DR   KEGG; hsa:4781; -.
DR   UCSC; uc003zle.4; human.
DR   CTD; 4781; -.
DR   EuPathDB; HostDB:ENSG00000147862.14; -.
DR   PharmGKB; PA31591; -.
DR   eggNOG; KOG3663; Eukaryota.
DR   eggNOG; ENOG410Y16G; LUCA.
DR   HOGENOM; CLU_012576_3_0_1; -.
DR   KO; K09169; -.
DR   ChiTaRS; NFIB; human.
DR   GenomeRNAi; 4781; -.
DR   Bgee; ENSG00000147862; Expressed in cerebral cortex and 248 other tissues.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IEA:InterPro.
DR   GO; GO:0006260; P:DNA replication; IEA:UniProtKB-KW.
DR   InterPro; IPR000647; CTF/NFI.
DR   InterPro; IPR020604; CTF/NFI_DNA-bd-dom.
DR   InterPro; IPR019739; CTF/NFI_DNA-bd_CS.
DR   InterPro; IPR019548; CTF/NFI_DNA-bd_N.
DR   InterPro; IPR003619; MAD_homology1_Dwarfin-type.
DR   PANTHER; PTHR11492; PTHR11492; 1.
DR   Pfam; PF00859; CTF_NFI; 1.
DR   Pfam; PF03165; MH1; 1.
DR   Pfam; PF10524; NfI_DNAbd_pre-N; 1.
DR   SMART; SM00523; DWA; 1.
DR   PROSITE; PS00349; CTF_NFI_1; 1.
DR   PROSITE; PS51080; CTF_NFI_2; 1.
PE   2: Evidence at transcript level;
KW   Activator {ECO:0000256|RuleBase:RU000690};
KW   DNA replication {ECO:0000256|RuleBase:RU000690};
KW   DNA-binding {ECO:0000256|RuleBase:RU000690};
KW   Nucleus {ECO:0000256|RuleBase:RU000690, ECO:0000256|SAAS:SAAS00464850};
KW   Transcription {ECO:0000256|RuleBase:RU000690,
KW   ECO:0000256|SAAS:SAAS00094697};
KW   Transcription regulation {ECO:0000256|RuleBase:RU000690,
KW   ECO:0000256|SAAS:SAAS00094697}.
FT   DOMAIN          2..195
FT                   /note="CTF/NF-I"
FT                   /evidence="ECO:0000259|PROSITE:PS51080"
FT   REGION          189..208
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          252..364
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          377..420
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        252..274
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        287..301
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        318..339
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        398..420
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   420 AA;  47442 MW;  0F71635FE9D64FA4 CRC64;
     MMYSPICLTQ DEFHPFIEAL LPHVRAIAYT WFNLQARKRK YFKKHEKRMS KDEERAVKDE
     LLSEKPEIKQ KWASRLLAKL RKDIRQEYRE DFVLTVTGKK HPCCVLSNPD QKGKIRRIDC
     LRQADKVWRL DLVMVILFKG IPLESTDGER LMKSPHCTNP ALCVQPHHIT VSVKELDLFL
     AYYVQEQDSG QSGSPSHNDP AKNPPGYLED SFVKSGVFNV SELVRVSRTP ITQGTGVNFP
     IGEIPSQPYY HDMNSGVNLQ RSLSSPPSSK RPKTISIDEN MEPSPTGDFY PSPSSPAAGS
     RTWHERDQDM SSPTTMKKPE KPLFSSASPQ DSSPRLSTFP QHHHPGIPGV AHSVISTRTP
     PPPSPLPFPT QAILPPAPSS YFSHPTIRYP PHLNPQDTLK NYVPSYDPSS PQTSQSWYLG
//
ID   Q5XUU0_HUMAN            Unreviewed;      1989 AA.
AC   Q5XUU0;
DT   23-NOV-2004, integrated into UniProtKB/TrEMBL.
DT   23-NOV-2004, sequence version 1.
DT   11-DEC-2019, entry version 84.
DE   SubName: Full=Ninein isoform 6 {ECO:0000313|EMBL:AAU86898.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAU86898.1};
RN   [1] {ECO:0000313|EMBL:AAU86898.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Hong Y.-R., Wu C.-H., Cheng T.-S.;
RT   "Characterization, expression and functional aspects of human ninein
RT   isoforms.";
RL   Submitted (AUG-2004) to the EMBL/GenBank/DDBJ databases.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation of
CC       feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00448}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY736182; AAU86898.1; -; mRNA.
DR   RefSeq; NP_065972.3; NM_020921.3.
DR   RefSeq; NP_891989.2; NM_182944.2.
DR   PeptideAtlas; Q5XUU0; -.
DR   PRIDE; Q5XUU0; -.
DR   GeneID; 51199; -.
DR   CTD; 51199; -.
DR   PharmGKB; PA31630; -.
DR   eggNOG; ENOG410IK59; Eukaryota.
DR   eggNOG; ENOG410Z1RR; LUCA.
DR   OrthoDB; 95801at2759; -.
DR   GenomeRNAi; 51199; -.
DR   Genevisible; Q5XUU0; HS.
DR   GO; GO:0005813; C:centrosome; IEA:InterPro.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0034454; P:microtubule anchoring at centrosome; IEA:InterPro.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR029664; NIN.
DR   PANTHER; PTHR18905:SF11; PTHR18905:SF11; 1.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   PROSITE; PS50222; EF_HAND_2; 5.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN          8..43
FT                   /note="EF-hand"
FT                   /evidence="ECO:0000259|PROSITE:PS50222"
FT   DOMAIN          60..77
FT                   /note="EF-hand"
FT                   /evidence="ECO:0000259|PROSITE:PS50222"
FT   DOMAIN          182..217
FT                   /note="EF-hand"
FT                   /evidence="ECO:0000259|PROSITE:PS50222"
FT   DOMAIN          219..252
FT                   /note="EF-hand"
FT                   /evidence="ECO:0000259|PROSITE:PS50222"
FT   DOMAIN          317..352
FT                   /note="EF-hand"
FT                   /evidence="ECO:0000259|PROSITE:PS50222"
FT   REGION          1152..1190
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          362..403
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          423..472
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          480..514
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          530..564
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          633..689
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          698..721
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          767..809
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          833..882
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          905..925
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          962..982
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          998..1025
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1074..1094
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1252..1300
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1318..1338
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1447..1471
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1488..1536
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1558..1620
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1630..1650
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1709..1729
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1754..1816
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1856..1883
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1929..1949
FT                   /evidence="ECO:0000256|SAM:Coils"
SQ   SEQUENCE   1989 AA;  231106 MW;  E8B1DEA2ECDFD48C CRC64;
     MDEVEQDQHE ARLKELFDSF DTTGTGSLGQ EELTDLCHML SLEEVAPVLQ QTLLQDNLLG
     RVHFDQFKEA LILILSRTLS NEEHFQEPDC SLEAQPKYVR GGKRYGRRSL PEFQESVEEF
     PEVTVIEPLD EEARPSYIPA GDCSEHWKTQ RSEEYEAEGQ LRFWNPDDLN ASQSGSSPPQ
     DWIEEKLQEV CEDLGITRDG HLDRKKLVSI CEQYGLQNVD GEILEEVFHN LDPDGTMSVE
     DFFYGLFKNG KSLTPSASTP YRQLKRHLSM QSFDESGRRT TTSSAMTSTI GFRVISCLDD
     GMGHASVERI LDTWQEEGIE NSQEILKALD FSLDGNINLT ELTLALENEL LVTKNSIHQA
     ALASFKAEVR HLLERVDQVV REKEKLRSDL DKAEKLKSSM ASEVDDHHAA IERRNEYNLR
     KLDEEYKERI AALKNELRKE REQILQQAGK QRLELEQEIE KAKTEENYIR DRLALSLKEN
     SRLENELLEN AEKLAEYENL TNKLQRNLEN VLAEKFGDLD PSSAEFFLQE ERLTQMRNEY
     ERQCRVLQDQ VDELQSELEE YRAQGRVFRL PLKNSPSEEV EANSGGIEPE HGLGSEECNP
     LNMSIEAELV IEQMKEQHHR DICCLRLELE DKVRHYEKQL DETVVSCKKA QENMKQRHEN
     ETHTLEKQIS DLKNEIAELQ GQAAVLKEAH HEATCRHEEE KKQLQVKLEE EKTHLQEKLR
     LQHEMELKAR LTQAQASFER EREGLQSSAW TEEKVRGLTQ ELEQFHQEQL TSLVEKHTLE
     KEELRKELLE KHQRELQEGR EKMETECNRR TTQIEAQFQS DCQKVTERCE SALQSLEGRY
     RQELKDLQEQ QREEKSQWEF EKDELTQECA EAQELLKETL KREKTTSLVL TQEREMLEKT
     YKEHLNSMVV ERQQLLQDLE DLRNVSETQQ SLLSDQILEL KSSHIRELRE REEVLCQAGA
     SEQLASQRLE RLEMEHAQER QEMMSKLLAM ENIHKATCET ADRERAEMST EISRLQSKIK
     EMQQATSPLS MLQSGCQVIG EEEVEGDGAL SLLHQGEQLL EENGDVFLSL QRAHEQAVKE
     NVKMATEISR LQQRLQKLEP GLVMSSCLDE PATEFFGNTA EQTEPFLQQN RTKQVEGVTR
     RHVLSDLEDD EVRDLGSTGT SSVQRQEVKI EESEASVEGF SELENSEETR TESWELKNQI
     SQLQEQLMML CADCDRASEK KQDLLFDVSV LKKKLKMLER IPEASPKYKL LYEDVSREND
     CLQEELRMME TRYDEALENN KELTAEVFRL QDELKKMEEV TETFLSLEKS YDEVKIENEE
     LNVLVLRLQG KIEKLQESVV QRCDCCLWEA SLENLEIEPD GNILQLNQTL EECVPRVRSV
     HHVIEECKQE NQYLEGNTQL LEKVKAHEIA WLHGTIQTHQ ERPRVQNQVI LEENTTLLGF
     QDKHFQHQAT IAELELEKTK LQELTRKLKE RVTILVKQKD VLSHGEKEEE LKAMMHDLQI
     TCSEMQQKVE LLRYESEKLQ QENSILRNEI TTLNEEDSIS NLKLGTLNGS QEEMWQKTET
     VKQENAAVQK MVENLKKQIS ELKIKNQQLD LENTELSQKN SQNQEKLQEL NQRLTEMLCQ
     KEKEPGNSAL EEREQEKFNL KEELERCKVQ SSTLVSSLEA ELSEVKIQTH IVQQENHLLK
     DELEKMKQLH RCPDLSDFQQ KISSVLSYNE KLLKEKEALS EELNSCVDKL AKSSLLEHRI
     ATMKQEQKSW EHQSASLKSQ LVASQEKVQN LEDTVQNVNL QMSRMKSDLR VTQQEKEALK
     QEVMSLHKQL QNAGGKSWAP EIATHPSGLH NQQKRLSWDK LDHLMNEEQQ LLWQENERLQ
     TMVQNTKAEL THSREKVRQL ESNLLPKHQK HLNPSGTMNP TEQEKLSLKR ECDQFQKEQS
     PANRKVSQMN SLEQELETIH LENEGLKKKQ VKLDEQLMEN SVVGSSREGC SSLPEIVCED
     AAPEVHCDA
//
ID   NIN_HUMAN               Reviewed;        2090 AA.
AC   Q8N4C6; A6NDB8; B7WPA3; C9JSB6; C9JSG2; C9JXL2; Q5BKU3; Q6P0P6; Q9BWU6;
AC   Q9C012; Q9C013; Q9C014; Q9H5I6; Q9HAT7; Q9HBY5; Q9HCK7; Q9UH61;
DT   19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2010, sequence version 4.
DT   22-APR-2020, entry version 165.
DE   RecName: Full=Ninein;
DE            Short=hNinein;
DE   AltName: Full=Glycogen synthase kinase 3 beta-interacting protein;
DE            Short=GSK3B-interacting protein;
GN   Name=NIN; Synonyms=KIAA1565;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5), SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, INTERACTION WITH GSK3B, AND VARIANTS PRO-1125 AND GLU-1320.
RC   TISSUE=Fetal liver;
RX   PubMed=11004522; DOI=10.1016/s0167-4781(00)00127-5;
RA   Hong Y.-R., Chen C.-H., Chang J.-H., Wang S.-K., Sy W.-D., Chou C.-K.,
RA   Howng S.-L.;
RT   "Cloning and characterization of a novel human ninein protein that
RT   interacts with the glycogen synthase kinase 3beta.";
RL   Biochim. Biophys. Acta 1492:513-516(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND VARIANTS
RP   PRO-1125 AND GLU-1320.
RX   PubMed=11162463; DOI=10.1006/bbrc.2000.4050;
RA   Hong Y.-R., Chen C.-H., Chuo M.-H., Liou S.-Y., Howng S.-L.;
RT   "Genomic organization and molecular characterization of the human ninein
RT   gene.";
RL   Biochem. Biophys. Res. Commun. 279:989-995(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 4), PARTIAL NUCLEOTIDE SEQUENCE
RP   [MRNA] (ISOFORM 3), FUNCTION, ALTERNATIVE SPLICING, SUBCELLULAR LOCATION,
RP   AND VARIANTS PRO-1125 AND GLU-1320.
RC   TISSUE=Thymus;
RX   PubMed=15190203;
RA   Stillwell E.E., Zhou J., Joshi H.C.;
RT   "Human ninein is a centrosomal autoantigen recognized by CREST patient sera
RT   and plays a regulatory role in microtubule nucleation.";
RL   Cell Cycle 3:923-930(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 6).
RC   TISSUE=Brain;
RX   PubMed=10997877; DOI=10.1093/dnares/7.4.271;
RA   Nagase T., Kikuno R., Nakayama M., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVIII. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 7:273-281(2000).
RN   [5]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S., Sun H.,
RA   Du H., Pepin K., Artiguenave F., Robert C., Cruaud C., Bruels T.,
RA   Jaillon O., Friedlander L., Samson G., Brottier P., Cure S., Segurens B.,
RA   Aniere F., Samain S., Crespeau H., Abbasi N., Aiach N., Boscus D.,
RA   Dickhoff R., Dors M., Dubois I., Friedman C., Gouyvenoux M., James R.,
RA   Madan A., Mairey-Estrada B., Mangenot S., Martins N., Menard M., Oztas S.,
RA   Ratcliffe A., Shaffer T., Trask B., Vacherie B., Bellemere C., Belser C.,
RA   Besnard-Gonnet M., Bartol-Mavel D., Boutard M., Briez-Silla S.,
RA   Combette S., Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C.,
RA   Muselet D., Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P.,
RA   Trybou A., Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L., Verdier J.,
RA   Verdier-Discala C., Hillier L.W., Fulton L., McPherson J., Matsuda F.,
RA   Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W., Quetier F.,
RA   Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 9), NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 1-434 (ISOFORM 8), AND NUCLEOTIDE SEQUENCE [LARGE
RP   SCALE MRNA] OF 1877-2090 (ISOFORM 4).
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1561-2090 (ISOFORMS 1 AND 7).
RC   TISSUE=Bone marrow;
RA   Choquette M.C., de Medicis E.;
RT   "3' isoforms of human ninein.";
RL   Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1928-2090 (ISOFORM 7).
RC   TISSUE=Hepatoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [10]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=11956314;
RA   Ou Y.Y., Mack G.J., Zhang M., Rattner J.B.;
RT   "CEP110 and ninein are located in a specific domain of the centrosome
RT   associated with centrosome maturation.";
RL   J. Cell Sci. 115:1825-1835(2002).
RN   [11]
RP   SUBCELLULAR LOCATION.
RX   PubMed=12403812; DOI=10.1083/jcb.200204023;
RA   Dammermann A., Merdes A.;
RT   "Assembly of centrosomal proteins and microtubule organization depends on
RT   PCM-1.";
RL   J. Cell Biol. 159:255-266(2002).
RN   [12]
RP   HOMOOLIGOMERIZATION, SUBCELLULAR LOCATION, DEVELOPMENTAL STAGE, DOMAIN, AND
RP   PHOSPHORYLATION.
RX   PubMed=12927815; DOI=10.1016/s0006-291x(03)01510-9;
RA   Chen C.-H., Howng S.-L., Cheng T.-S., Chou M.-H., Huang C.-Y., Hong Y.-R.;
RT   "Molecular characterization of human ninein protein: two distinct
RT   subdomains required for centrosomal targeting and regulating signals in
RT   cell cycle.";
RL   Biochem. Biophys. Res. Commun. 308:975-983(2003).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND SUBCELLULAR LOCATION [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.;
RT   "Proteomic characterization of the human centrosome by protein correlation
RT   profiling.";
RL   Nature 426:570-574(2003).
RN   [14]
RP   INTERACTION WITH C14ORF166.
RX   PubMed=15147888; DOI=10.1016/j.febslet.2004.04.024;
RA   Howng S.-L., Hsu H.-C., Cheng T.-S., Lee Y.-L., Chang L.-K., Lu P.-J.,
RA   Hong Y.-R.;
RT   "A novel ninein-interaction protein, CGI-99, blocks ninein phosphorylation
RT   by GSK3beta and is highly expressed in brain tumors.";
RL   FEBS Lett. 566:162-168(2004).
RN   [15]
RP   AUTOANTIBODY.
RX   PubMed=9506584;
RX   DOI=10.1002/1529-0131(199803)41:3<551::aid-art22>3.0.co;2-x;
RA   Mack G.J., Rees J., Sandblom O., Balczon R., Fritzler M.J., Rattner J.B.;
RT   "Autoantibodies to a group of centrosomal proteins in human autoimmune sera
RT   reactive with the centrosome.";
RL   Arthritis Rheum. 41:551-558(1998).
RN   [16]
RP   AUTOANTIBODY.
RX   PubMed=14503922; DOI=10.1186/1471-2431-3-11;
RA   Fritzler M.J., Zhang M., Stinton L.M., Rattner J.B.;
RT   "Spectrum of centrosome autoantibodies in childhood varicella and post-
RT   varicella acute cerebellar ataxia.";
RL   BMC Pediatr. 3:11-11(2003).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1550, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1550, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [19]
RP   INTERACTION WITH AUNIP.
RX   PubMed=20596670; DOI=10.3892/ijo_00000691;
RA   Lieu A.S., Cheng T.S., Chou C.H., Wu C.H., Hsu C.Y., Huang C.Y.,
RA   Chang L.K., Loh J.K., Chang C.S., Hsu C.M., Howng S.L., Hong Y.R.;
RT   "Functional characterization of AIBp, a novel Aurora-A binding protein in
RT   centrosome structure and spindle formation.";
RL   Int. J. Oncol. 37:429-436(2010).
RN   [20]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=23386061; DOI=10.1038/emboj.2013.3;
RA   Kodani A., Salome Sirerol-Piquer M., Seol A., Garcia-Verdugo J.M.,
RA   Reiter J.F.;
RT   "Kif3a interacts with Dynactin subunit p150 Glued to organize centriole
RT   subdistal appendages.";
RL   EMBO J. 32:597-607(2013).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-152 AND SER-1550, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [22]
RP   INTERACTION WITH CCDC120.
RX   PubMed=28422092; DOI=10.1038/ncomms15057;
RA   Huang N., Xia Y., Zhang D., Wang S., Bao Y., He R., Teng J., Chen J.;
RT   "Hierarchical assembly of centriole subdistal appendages via centrosome
RT   binding proteins CCDC120 and CCDC68.";
RL   Nat. Commun. 8:15057-15057(2017).
RN   [23]
RP   VARIANT [LARGE SCALE ANALYSIS] GLU-1320.
RX   PubMed=18987736; DOI=10.1038/nature07485;
RA   Ley T.J., Mardis E.R., Ding L., Fulton B., McLellan M.D., Chen K.,
RA   Dooling D., Dunford-Shore B.H., McGrath S., Hickenbotham M., Cook L.,
RA   Abbott R., Larson D.E., Koboldt D.C., Pohl C., Smith S., Hawkins A.,
RA   Abbott S., Locke D., Hillier L.W., Miner T., Fulton L., Magrini V.,
RA   Wylie T., Glasscock J., Conyers J., Sander N., Shi X., Osborne J.R.,
RA   Minx P., Gordon D., Chinwalla A., Zhao Y., Ries R.E., Payton J.E.,
RA   Westervelt P., Tomasson M.H., Watson M., Baty J., Ivanovich J., Heath S.,
RA   Shannon W.D., Nagarajan R., Walter M.J., Link D.C., Graubert T.A.,
RA   DiPersio J.F., Wilson R.K.;
RT   "DNA sequencing of a cytogenetically normal acute myeloid leukaemia
RT   genome.";
RL   Nature 456:66-72(2008).
RN   [24]
RP   VARIANTS SCKL7 ARG-1222 AND SER-1709.
RX   PubMed=22933543; DOI=10.1210/jc.2012-2150;
RA   Dauber A., Lafranchi S.H., Maliga Z., Lui J.C., Moon J.E., McDeed C.,
RA   Henke K., Zonana J., Kingman G.A., Pers T.H., Baron J., Rosenfeld R.G.,
RA   Hirschhorn J.N., Harris M.P., Hwa V.;
RT   "Novel microcephalic primordial dwarfism disorder associated with variants
RT   in the centrosomal protein ninein.";
RL   J. Clin. Endocrinol. Metab. 97:E2140-E2151(2012).
CC   -!- FUNCTION: Centrosomal protein required in the positioning and anchorage
CC       of the microtubule minus-end in epithelial cells (PubMed:15190203,
CC       PubMed:23386061). May also act as a centrosome maturation factor
CC       (PubMed:11956314). May play a role in microtubule nucleation, by
CC       recruiting the gamma-tubulin ring complex to the centrosome
CC       (PubMed:15190203). Overexpression does not perturb nucleation or
CC       elongation of microtubules but suppresses release of microtubules
CC       (PubMed:15190203). Required for centriole organization and microtubule
CC       anchoring at the mother centriole (PubMed:23386061).
CC       {ECO:0000269|PubMed:11956314, ECO:0000269|PubMed:15190203,
CC       ECO:0000269|PubMed:23386061}.
CC   -!- SUBUNIT: Homooligomer. Interacts with GSK3B/GSK3-beta via its C-
CC       terminal domain (PubMed:11004522). Interacts with C14ORF166, such
CC       interaction may prevent its phosphorylation by GSK3B (PubMed:15147888).
CC       Interacts with AUNIP (via N-terminus) (PubMed:20596670). Identified in
CC       a complex with AUNIP and AURKA (PubMed:20596670). Interacts with
CC       CCDC120 (PubMed:28422092). Interacts (via C-terminus) with CEP250 (By
CC       similarity). Interacts with CEP170 (By similarity). Interacts with the
CC       gamma-tubulin ring complex component TUBGCP3 (By similarity). Interacts
CC       with gamma-tubulin (By similarity). Isoform 6 does not interact with
CC       CEP170 or CEP250 (By similarity). {ECO:0000250|UniProtKB:Q61043,
CC       ECO:0000269|PubMed:11004522, ECO:0000269|PubMed:15147888,
CC       ECO:0000269|PubMed:20596670, ECO:0000269|PubMed:28422092}.
CC   -!- INTERACTION:
CC       Q8N4C6; Q96HB5: CCDC120; NbExp=11; IntAct=EBI-1164022, EBI-744556;
CC       Q8N4C6; P49841: GSK3B; NbExp=3; IntAct=EBI-1164022, EBI-373586;
CC       Q8N4C6; Q9Y224: RTRAF; NbExp=4; IntAct=EBI-1164022, EBI-1104547;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule organizing
CC       center, centrosome {ECO:0000269|PubMed:11004522,
CC       ECO:0000269|PubMed:11956314, ECO:0000269|PubMed:12403812,
CC       ECO:0000269|PubMed:12927815, ECO:0000269|PubMed:14654843,
CC       ECO:0000269|PubMed:15190203}. Cytoplasm, cytoskeleton, microtubule
CC       organizing center, centrosome, centriole {ECO:0000269|PubMed:23386061}.
CC       Note=Component of the core centrosome. Arranged in a tubular
CC       conformation with an open and a closed end within the centrosome. In
CC       the mother centrosome, it localizes at both ends of the centrosome
CC       tube, including the site of centrosome duplication, while in the
CC       daughter centrosome it is present only at the closed end. Requires PCM1
CC       for centrosome localization. Localizes to the subdistal appendage
CC       region of the centriole in a DCTN1-dependent manner.
CC       {ECO:0000269|PubMed:11956314, ECO:0000269|PubMed:12403812,
CC       ECO:0000269|PubMed:23386061}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 6]: Cytoplasm
CC       {ECO:0000250|UniProtKB:Q61043}. Note=Seems to have a dominant-negative
CC       effect on localization of other isoforms, promoting their dissociation
CC       from the centrosome. {ECO:0000250|UniProtKB:Q61043}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=9;
CC       Name=1; Synonyms=Lm;
CC         IsoId=Q8N4C6-1; Sequence=Displayed;
CC       Name=2; Synonyms=Isotype 3;
CC         IsoId=Q8N4C6-2; Sequence=VSP_010952;
CC       Name=3; Synonyms=Isotype 2;
CC         IsoId=Q8N4C6-10; Sequence=VSP_010952, VSP_010960;
CC       Name=4; Synonyms=Isotype 1;
CC         IsoId=Q8N4C6-4; Sequence=VSP_010952, VSP_010957, VSP_010958;
CC       Name=5;
CC         IsoId=Q8N4C6-5; Sequence=VSP_010950;
CC       Name=6;
CC         IsoId=Q8N4C6-6; Sequence=VSP_010953, VSP_010954, VSP_010955,
CC                                  VSP_010956;
CC       Name=7; Synonyms=B;
CC         IsoId=Q8N4C6-7; Sequence=VSP_010960;
CC       Name=8;
CC         IsoId=Q8N4C6-9; Sequence=VSP_040039;
CC       Name=9;
CC         IsoId=Q8N4C6-11; Sequence=VSP_010953;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Highly expressed in heart and skeletal
CC       muscle. Isoform 1 is more expressed than isoform 5.
CC       {ECO:0000269|PubMed:11004522, ECO:0000269|PubMed:11162463}.
CC   -!- DEVELOPMENTAL STAGE: In interphase cells, it is localized in the
CC       centrosome. Decreases in metaphase and anaphase and reappears in
CC       telophase. {ECO:0000269|PubMed:12927815}.
CC   -!- DOMAIN: There is conflicting information regarding the regions required
CC       for centrosomal localization. One study shows that the region 1601-1682
CC       is necessary and sufficient for targeting to the centrosome
CC       (PubMed:12927815). Another study shows that a separate region, 1291-
CC       1575, is important for centrosomal localization (PubMed:15190203).
CC       However, a third study shows that the coiled-coil region (373-1885) is
CC       not sufficient for centrosomal localization and instead localizes to
CC       cytoplasmic speckles (By similarity). The observed differences might be
CC       due to oligomerization of the longer coiled-coil domain-containing
CC       sequence, which would mask the shorter centrosomal targeting sequences
CC       (By similarity). {ECO:0000250|UniProtKB:Q61043,
CC       ECO:0000269|PubMed:12927815, ECO:0000269|PubMed:15190203}.
CC   -!- DOMAIN: The N-terminal domain is important for targeting to the mother
CC       centriole, although it is not sufficient by itself for centrosomal
CC       localization. {ECO:0000250|UniProtKB:Q61043}.
CC   -!- PTM: Phosphorylated by AURKA/Aurora kinase A and PKA kinases but not
CC       CK2 or AURKB/ Aurora kinase B. {ECO:0000269|PubMed:12927815}.
CC   -!- DISEASE: Seckel syndrome 7 (SCKL7) [MIM:614851]: A rare autosomal
CC       recessive disorder characterized by proportionate dwarfism of prenatal
CC       onset associated with low birth weight, growth retardation, severe
CC       microcephaly with a bird-headed like appearance, and mental
CC       retardation. {ECO:0000269|PubMed:22933543}. Note=The disease is caused
CC       by mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: Antibodies against NIN are present in sera from patients
CC       with autoimmune diseases that developed autoantibodies against
CC       centrosomal proteins.
CC   -!- MISCELLANEOUS: [Isoform 2]: Dubious isoform produced through aberrant
CC       splice sites. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 3]: Dubious isoform produced through aberrant
CC       splice sites. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 4]: Dubious isoform produced through aberrant
CC       splice sites. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH65521.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAH65521.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=AAK00628.1; Type=Miscellaneous discrepancy; Note=Several sequencing errors.; Evidence={ECO:0000305};
CC       Sequence=AAK00629.1; Type=Miscellaneous discrepancy; Note=Several sequencing errors and frameshifts.; Evidence={ECO:0000305};
CC       Sequence=AAK00630.1; Type=Miscellaneous discrepancy; Note=Several sequencing errors.; Evidence={ECO:0000305};
CC       Sequence=BAB13391.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAB15640.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/NINID176.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF212162; AAF23015.2; -; mRNA.
DR   EMBL; AF302773; AAG33512.2; -; mRNA.
DR   EMBL; AF223937; AAK00628.1; ALT_SEQ; mRNA.
DR   EMBL; AF223938; AAK00629.1; ALT_SEQ; mRNA.
DR   EMBL; AF223939; AAK00630.1; ALT_SEQ; mRNA.
DR   EMBL; AB046785; BAB13391.2; ALT_INIT; mRNA.
DR   EMBL; AL133485; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL606834; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC034708; AAH34708.2; -; mRNA.
DR   EMBL; BC065521; AAH65521.1; ALT_SEQ; mRNA.
DR   EMBL; BC090932; AAH90932.1; -; mRNA.
DR   EMBL; AY027794; AAK27375.1; -; mRNA.
DR   EMBL; AY027795; AAK27376.1; -; mRNA.
DR   EMBL; AY027796; AAK27377.1; -; mRNA.
DR   EMBL; AF186776; AAG17027.1; -; mRNA.
DR   EMBL; AK027054; BAB15640.1; ALT_INIT; mRNA.
DR   CCDS; CCDS32078.2; -. [Q8N4C6-11]
DR   CCDS; CCDS32079.1; -. [Q8N4C6-1]
DR   RefSeq; NP_057434.4; NM_016350.4. [Q8N4C6-11]
DR   RefSeq; NP_065972.3; NM_020921.3.
DR   RefSeq; NP_891989.2; NM_182944.2.
DR   RefSeq; NP_891991.1; NM_182946.1.
DR   RefSeq; XP_011535125.1; XM_011536823.2. [Q8N4C6-5]
DR   SMR; Q8N4C6; -.
DR   BioGrid; 119372; 313.
DR   IntAct; Q8N4C6; 118.
DR   MINT; Q8N4C6; -.
DR   STRING; 9606.ENSP00000371472; -.
DR   BindingDB; Q8N4C6; -.
DR   iPTMnet; Q8N4C6; -.
DR   PhosphoSitePlus; Q8N4C6; -.
DR   BioMuta; NIN; -.
DR   DMDM; 311033487; -.
DR   EPD; Q8N4C6; -.
DR   jPOST; Q8N4C6; -.
DR   MassIVE; Q8N4C6; -.
DR   MaxQB; Q8N4C6; -.
DR   PaxDb; Q8N4C6; -.
DR   PeptideAtlas; Q8N4C6; -.
DR   PRIDE; Q8N4C6; -.
DR   ProteomicsDB; 71907; -. [Q8N4C6-1]
DR   ProteomicsDB; 71908; -. [Q8N4C6-10]
DR   ProteomicsDB; 71909; -. [Q8N4C6-11]
DR   ProteomicsDB; 71910; -. [Q8N4C6-2]
DR   ProteomicsDB; 71911; -. [Q8N4C6-4]
DR   ProteomicsDB; 71912; -. [Q8N4C6-5]
DR   ProteomicsDB; 71913; -. [Q8N4C6-6]
DR   ProteomicsDB; 71914; -. [Q8N4C6-7]
DR   ProteomicsDB; 71915; -. [Q8N4C6-9]
DR   Antibodypedia; 23688; 133 antibodies.
DR   Ensembl; ENST00000245441; ENSP00000245441; ENSG00000100503. [Q8N4C6-7]
DR   Ensembl; ENST00000324330; ENSP00000324210; ENSG00000100503. [Q8N4C6-11]
DR   Ensembl; ENST00000382041; ENSP00000371472; ENSG00000100503. [Q8N4C6-1]
DR   Ensembl; ENST00000382043; ENSP00000371474; ENSG00000100503. [Q8N4C6-11]
DR   Ensembl; ENST00000530997; ENSP00000436092; ENSG00000100503. [Q8N4C6-7]
DR   GeneID; 51199; -.
DR   KEGG; hsa:51199; -.
DR   UCSC; uc001wyi.3; human. [Q8N4C6-1]
DR   CTD; 51199; -.
DR   DisGeNET; 51199; -.
DR   GeneCards; NIN; -.
DR   HGNC; HGNC:14906; NIN.
DR   HPA; ENSG00000100503; Low tissue specificity.
DR   MalaCards; NIN; -.
DR   MIM; 608684; gene.
DR   MIM; 614851; phenotype.
DR   neXtProt; NX_Q8N4C6; -.
DR   OpenTargets; ENSG00000100503; -.
DR   Orphanet; 319675; Microcephalic primordial dwarfism, Dauber type.
DR   PharmGKB; PA31630; -.
DR   eggNOG; ENOG410IK59; Eukaryota.
DR   eggNOG; ENOG410Z1RR; LUCA.
DR   GeneTree; ENSGT00660000095541; -.
DR   HOGENOM; CLU_001462_1_1_1; -.
DR   InParanoid; Q8N4C6; -.
DR   KO; K16476; -.
DR   OMA; WEHQSES; -.
DR   OrthoDB; 95801at2759; -.
DR   PhylomeDB; Q8N4C6; -.
DR   TreeFam; TF325139; -.
DR   SIGNOR; Q8N4C6; -.
DR   ChiTaRS; NIN; human.
DR   GeneWiki; NIN_(gene); -.
DR   GenomeRNAi; 51199; -.
DR   Pharos; Q8N4C6; Tbio.
DR   PRO; PR:Q8N4C6; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   RNAct; Q8N4C6; protein.
DR   Bgee; ENSG00000100503; Expressed in amniotic fluid and 198 other tissues.
DR   ExpressionAtlas; Q8N4C6; baseline and differential.
DR   Genevisible; Q8N4C6; HS.
DR   GO; GO:0045177; C:apical part of cell; IEA:Ensembl.
DR   GO; GO:0044295; C:axonal growth cone; IEA:Ensembl.
DR   GO; GO:0120103; C:centriolar subdistal appendage; IDA:GO_Central.
DR   GO; GO:0005814; C:centriole; IDA:UniProtKB.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0097539; C:ciliary transition fiber; IBA:GO_Central.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0036449; C:microtubule minus-end; IEA:Ensembl.
DR   GO; GO:0072686; C:mitotic spindle; IDA:UniProtKB.
DR   GO; GO:0097431; C:mitotic spindle pole; IBA:GO_Central.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0000242; C:pericentriolar material; IDA:MGI.
DR   GO; GO:0005886; C:plasma membrane; IEA:Ensembl.
DR   GO; GO:0000922; C:spindle pole; IMP:MGI.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0019900; F:kinase binding; IEA:Ensembl.
DR   GO; GO:0010457; P:centriole-centriole cohesion; IMP:GO_Central.
DR   GO; GO:0051642; P:centrosome localization; IBA:GO_Central.
DR   GO; GO:0090222; P:centrosome-templated microtubule nucleation; IBA:GO_Central.
DR   GO; GO:0048668; P:collateral sprouting; IEA:Ensembl.
DR   GO; GO:0021540; P:corpus callosum morphogenesis; IEA:Ensembl.
DR   GO; GO:0021957; P:corticospinal tract morphogenesis; IEA:Ensembl.
DR   GO; GO:0034454; P:microtubule anchoring at centrosome; IMP:UniProtKB.
DR   GO; GO:0050772; P:positive regulation of axonogenesis; IEA:Ensembl.
DR   GO; GO:0031116; P:positive regulation of microtubule polymerization; IEA:Ensembl.
DR   GO; GO:0008104; P:protein localization; IMP:GO_Central.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR029664; NIN.
DR   PANTHER; PTHR18905:SF11; PTHR18905:SF11; 1.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   PROSITE; PS50222; EF_HAND_2; 5.
PE   1: Evidence at protein level;
KW   Alternative splicing; Coiled coil; Cytoplasm; Cytoskeleton;
KW   Disease mutation; Dwarfism; GTP-binding; Mental retardation; Microtubule;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Reference proteome;
KW   Repeat.
FT   CHAIN           1..2090
FT                   /note="Ninein"
FT                   /id="PRO_0000096844"
FT   DOMAIN          8..43
FT                   /note="EF-hand 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   DOMAIN          42..77
FT                   /note="EF-hand 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   DOMAIN          182..217
FT                   /note="EF-hand 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   DOMAIN          219..252
FT                   /note="EF-hand 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   DOMAIN          317..352
FT                   /note="EF-hand 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   NP_BIND         245..252
FT                   /note="GTP"
FT                   /evidence="ECO:0000255"
FT   NP_BIND         300..304
FT                   /note="GTP"
FT                   /evidence="ECO:0000255"
FT   NP_BIND         420..423
FT                   /note="GTP"
FT                   /evidence="ECO:0000255"
FT   REGION          802..1505
FT                   /note="Important for interaction with CEP170"
FT                   /evidence="ECO:0000250|UniProtKB:Q61043"
FT   COILED          357..570
FT                   /evidence="ECO:0000255"
FT   COILED          625..1027
FT                   /evidence="ECO:0000255"
FT   COILED          1068..1099
FT                   /evidence="ECO:0000255"
FT   COILED          1181..1341
FT                   /evidence="ECO:0000255"
FT   COILED          1441..1816
FT                   /evidence="ECO:0000255"
FT   COILED          1854..1885
FT                   /evidence="ECO:0000255"
FT   COILED          1922..2067
FT                   /evidence="ECO:0000255"
FT   MOD_RES         152
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         269
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61043"
FT   MOD_RES         1550
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17525332,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163"
FT   MOD_RES         1837
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61043"
FT   VAR_SEQ         1..38
FT                   /note="Missing (in isoform 8)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_040039"
FT   VAR_SEQ         1..35
FT                   /note="MDEVEQDQHEARLKELFDSFDTTGTGSLGQEELTD -> MAEVTVPRVYVVF
FT                   GIHCIMAKASSDVQVSGFHRKIQHVKNE (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:11004522"
FT                   /id="VSP_010950"
FT   VAR_SEQ         492..508
FT                   /note="Missing (in isoform 2, isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15190203,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_010952"
FT   VAR_SEQ         800..1512
FT                   /note="Missing (in isoform 6 and isoform 9)"
FT                   /evidence="ECO:0000303|PubMed:10997877,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_010953"
FT   VAR_SEQ         1555
FT                   /note="Missing (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:10997877"
FT                   /id="VSP_010954"
FT   VAR_SEQ         1960..1988
FT                   /note="MQHLRSTATPSPSPHAWDLQLLQQQACPM -> NSVVGSSREGCSSLPEIVC
FT                   EDAAPEVHCDA (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:10997877"
FT                   /id="VSP_010955"
FT   VAR_SEQ         1989..2090
FT                   /note="Missing (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:10997877"
FT                   /id="VSP_010956"
FT   VAR_SEQ         2027..2046
FT                   /note="GNQEQLVTVMEERMIEVEQK -> ALLPEQRAVHADSYRRIGHL (in
FT                   isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15190203,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_010957"
FT   VAR_SEQ         2047..2090
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15190203,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_010958"
FT   VAR_SEQ         2065..2090
FT                   /note="VSLPGHLCSPTSHSSFNSSFTSLYCH -> LCKNTKADAMVKDLYVENAQLL
FT                   KALEVTEQRQKTAEKKNYLLEEKIASLSNIVRNLTPAPLTSTPPLRS (in isoform
FT                   3 and isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:14702039, ECO:0000303|Ref.8"
FT                   /id="VSP_010960"
FT   VARIANT         1111
FT                   /note="P -> A (in dbSNP:rs2236316)"
FT                   /id="VAR_019453"
FT   VARIANT         1125
FT                   /note="Q -> P (in dbSNP:rs12882191)"
FT                   /evidence="ECO:0000269|PubMed:11004522,
FT                   ECO:0000269|PubMed:11162463, ECO:0000269|PubMed:15190203"
FT                   /id="VAR_051235"
FT   VARIANT         1222
FT                   /note="Q -> R (in SCKL7; does not disrupt protein
FT                   expression or localization or affect mitotic functions in
FT                   an obvious way; dbSNP:rs187464517)"
FT                   /evidence="ECO:0000269|PubMed:22933543"
FT                   /id="VAR_069083"
FT   VARIANT         1320
FT                   /note="G -> E (in dbSNP:rs2073347)"
FT                   /evidence="ECO:0000269|PubMed:11004522,
FT                   ECO:0000269|PubMed:11162463, ECO:0000269|PubMed:15190203,
FT                   ECO:0000269|PubMed:18987736"
FT                   /id="VAR_019454"
FT   VARIANT         1709
FT                   /note="N -> S (in SCKL7; does not disrupt protein
FT                   expression or localization or affect mitotic functions in
FT                   an obvious way; dbSNP:rs387907308)"
FT                   /evidence="ECO:0000269|PubMed:22933543"
FT                   /id="VAR_069084"
FT   VARIANT         1837
FT                   /note="S -> T (in dbSNP:rs12717411)"
FT                   /id="VAR_019455"
FT   VARIANT         1934
FT                   /note="Q -> E (in dbSNP:rs2295847)"
FT                   /id="VAR_051236"
FT   CONFLICT        137
FT                   /note="H -> Y (in Ref. 1; AAF23015 and 2; AAG33512)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        177
FT                   /note="S -> F (in Ref. 1; AAF23015)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        203
FT                   /note="N -> D (in Ref. 2; AAG33512)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        223
FT                   /note="M -> I (in Ref. 2; AAG33512)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        295
FT                   /note="F -> I (in Ref. 2; AAG33512)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        369
FT                   /note="I -> V (in Ref. 2; AAG33512)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        399
FT                   /note="L -> S (in Ref. 2; AAG33512)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        568
FT                   /note="L -> F (in Ref. 2; AAG33512)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        809
FT                   /note="R -> I (in Ref. 1; AAF23015)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        812
FT                   /note="S -> T (in Ref. 2; AAG33512)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        945
FT                   /note="K -> I (in Ref. 2; AAG33512)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        977
FT                   /note="D -> A (in Ref. 2; AAG33512)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        980
FT                   /note="R -> G (in Ref. 1; AAF23015)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1054
FT                   /note="Q -> H (in Ref. 2; AAG33512)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1067
FT                   /note="L -> F (in Ref. 2; AAG33512)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1070
FT                   /note="L -> Q (in Ref. 1; AAF23015)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1150
FT                   /note="D -> G (in Ref. 1; AAF23015)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1237
FT                   /note="M -> I (in Ref. 1; AAF23015)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   2090 AA;  243249 MW;  51D27CD38A369209 CRC64;
     MDEVEQDQHE ARLKELFDSF DTTGTGSLGQ EELTDLCHML SLEEVAPVLQ QTLLQDNLLG
     RVHFDQFKEA LILILSRTLS NEEHFQEPDC SLEAQPKYVR GGKRYGRRSL PEFQESVEEF
     PEVTVIEPLD EEARPSHIPA GDCSEHWKTQ RSEEYEAEGQ LRFWNPDDLN ASQSGSSPPQ
     DWIEEKLQEV CEDLGITRDG HLNRKKLVSI CEQYGLQNVD GEMLEEVFHN LDPDGTMSVE
     DFFYGLFKNG KSLTPSASTP YRQLKRHLSM QSFDESGRRT TTSSAMTSTI GFRVFSCLDD
     GMGHASVERI LDTWQEEGIE NSQEILKALD FSLDGNINLT ELTLALENEL LVTKNSIHQA
     ALASFKAEIR HLLERVDQVV REKEKLRSDL DKAEKLKSLM ASEVDDHHAA IERRNEYNLR
     KLDEEYKERI AALKNELRKE REQILQQAGK QRLELEQEIE KAKTEENYIR DRLALSLKEN
     SRLENELLEN AEKLAEYENL TNKLQRNLEN VLAEKFGDLD PSSAEFFLQE ERLTQMRNEY
     ERQCRVLQDQ VDELQSELEE YRAQGRVLRL PLKNSPSEEV EANSGGIEPE HGLGSEECNP
     LNMSIEAELV IEQMKEQHHR DICCLRLELE DKVRHYEKQL DETVVSCKKA QENMKQRHEN
     ETHTLEKQIS DLKNEIAELQ GQAAVLKEAH HEATCRHEEE KKQLQVKLEE EKTHLQEKLR
     LQHEMELKAR LTQAQASFER EREGLQSSAW TEEKVRGLTQ ELEQFHQEQL TSLVEKHTLE
     KEELRKELLE KHQRELQEGR EKMETECNRR TSQIEAQFQS DCQKVTERCE SALQSLEGRY
     RQELKDLQEQ QREEKSQWEF EKDELTQECA EAQELLKETL KREKTTSLVL TQEREMLEKT
     YKEHLNSMVV ERQQLLQDLE DLRNVSETQQ SLLSDQILEL KSSHKRELRE REEVLCQAGA
     SEQLASQRLE RLEMEHDQER QEMMSKLLAM ENIHKATCET ADRERAEMST EISRLQSKIK
     EMQQATSPLS MLQSGCQVIG EEEVEGDGAL SLLQQGEQLL EENGDVLLSL QRAHEQAVKE
     NVKMATEISR LQQRLQKLEP GLVMSSCLDE PATEFFGNTA EQTEQFLQQN RTKQVEGVTR
     RHVLSDLEDD EVRDLGSTGT SSVQRQEVKI EESEASVEGF SELENSEETR TESWELKNQI
     SQLQEQLMML CADCDRASEK KQDLLFDVSV LKKKLKMLER IPEASPKYKL LYEDVSREND
     CLQEELRMME TRYDEALENN KELTAEVFRL QDELKKMEEV TETFLSLEKS YDEVKIENEG
     LNVLVLRLQG KIEKLQESVV QRCDCCLWEA SLENLEIEPD GNILQLNQTL EECVPRVRSV
     HHVIEECKQE NQYLEGNTQL LEKVKAHEIA WLHGTIQTHQ ERPRVQNQVI LEENTTLLGF
     QDKHFQHQAT IAELELEKTK LQELTRKLKE RVTILVKQKD VLSHGEKEEE LKAMMHDLQI
     TCSEMQQKVE LLRYESEKLQ QENSILRNEI TTLNEEDSIS NLKLGTLNGS QEEMWQKTET
     VKQENAAVQK MVENLKKQIS ELKIKNQQLD LENTELSQKN SQNQEKLQEL NQRLTEMLCQ
     KEKEPGNSAL EEREQEKFNL KEELERCKVQ SSTLVSSLEA ELSEVKIQTH IVQQENHLLK
     DELEKMKQLH RCPDLSDFQQ KISSVLSYNE KLLKEKEALS EELNSCVDKL AKSSLLEHRI
     ATMKQEQKSW EHQSASLKSQ LVASQEKVQN LEDTVQNVNL QMSRMKSDLR VTQQEKEALK
     QEVMSLHKQL QNAGGKSWAP EIATHPSGLH NQQKRLSWDK LDHLMNEEQQ LLWQENERLQ
     TMVQNTKAEL THSREKVRQL ESNLLPKHQK HLNPSGTMNP TEQEKLSLKR ECDQFQKEQS
     PANRKVSQMN SLEQELETIH LENEGLKKKQ VKLDEQLMEM QHLRSTATPS PSPHAWDLQL
     LQQQACPMVP REQFLQLQRQ LLQAERINQH LQEELENRTS ETNTPQGNQE QLVTVMEERM
     IEVEQKLKLV KRLLQEKVNQ LKEQVSLPGH LCSPTSHSSF NSSFTSLYCH
//
ID   A0A0S2Z4Z9_HUMAN        Unreviewed;       471 AA.
AC   A0A0S2Z4Z9;
DT   17-FEB-2016, integrated into UniProtKB/TrEMBL.
DT   17-FEB-2016, sequence version 1.
DT   22-APR-2020, entry version 27.
DE   SubName: Full=Non-POU domain containing octamer-binding isoform 1 {ECO:0000313|EMBL:ALQ33692.1};
DE   Flags: Fragment;
GN   Name=NONO {ECO:0000313|EMBL:ALQ33692.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ALQ33692.1};
RN   [1] {ECO:0000313|EMBL:ALQ33692.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by Alternative
RT   Splicing.";
RL   Cell 164:805-817(2016).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; KU178234; ALQ33692.1; -; mRNA.
DR   RefSeq; NP_001138880.1; NM_001145408.1.
DR   RefSeq; NP_001138881.1; NM_001145409.1.
DR   RefSeq; NP_031389.3; NM_007363.4.
DR   SMR; A0A0S2Z4Z9; -.
DR   IntAct; A0A0S2Z4Z9; 1.
DR   PRIDE; A0A0S2Z4Z9; -.
DR   Antibodypedia; 13516; 516 antibodies.
DR   GeneID; 4841; -.
DR   KEGG; hsa:4841; -.
DR   CTD; 4841; -.
DR   KO; K13214; -.
DR   OMA; MRMGQMG; -.
DR   OrthoDB; 1274880at2759; -.
DR   PhylomeDB; A0A0S2Z4Z9; -.
DR   ChiTaRS; NONO; human.
DR   GenomeRNAi; 4841; -.
DR   ExpressionAtlas; A0A0S2Z4Z9; baseline and differential.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0090575; C:RNA polymerase II transcription factor complex; IEA:Ensembl.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0070888; F:E-box binding; IEA:Ensembl.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0007623; P:circadian rhythm; IEA:Ensembl.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl.
DR   GO; GO:0042752; P:regulation of circadian rhythm; IEA:Ensembl.
DR   CDD; cd12588; RRM1_p54nrb; 1.
DR   Gene3D; 3.30.70.330; -; 2.
DR   InterPro; IPR012975; NOPS.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR034552; p54nrb_RRM1.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   Pfam; PF08075; NOPS; 1.
DR   Pfam; PF00076; RRM_1; 2.
DR   SMART; SM00360; RRM; 2.
DR   SUPFAM; SSF54928; SSF54928; 1.
DR   PROSITE; PS50102; RRM; 2.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   RNA-binding {ECO:0000256|PROSITE-ProRule:PRU00176}.
FT   DOMAIN          74..146
FT                   /note="RRM"
FT                   /evidence="ECO:0000259|PROSITE:PS50102"
FT   DOMAIN          148..229
FT                   /note="RRM"
FT                   /evidence="ECO:0000259|PROSITE:PS50102"
FT   REGION          1..51
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          443..471
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          275..368
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   NON_TER         471
FT                   /evidence="ECO:0000313|EMBL:ALQ33692.1"
SQ   SEQUENCE   471 AA;  54232 MW;  26BBD3828F5B9E49 CRC64;
     MQSNKTFNLE KQNHTPRKHH QHHHQQQHHQ QQQQQPPPPP IPANGQQASS QNEGLTIDLK
     NFRKPGEKTF TQRSRLFVGN LPPDITEEEM RKLFEKYGKA GEVFIHKDKG FGFIRLETRT
     LAEIAKVELD NMPLRGKQLR VRFACHSASL TVRNLPQYVS NELLEEAFSV FGQVERAVVI
     VDDRGRPSGK GIVEFSGKPA ARKALDRCSE GSFLLTTFPR PVTVEPMDQL DDEEGLPEKL
     VIKNQQFHKE REQPPRFAQP GSFEYEYAMR WKALIEMEKQ QQDQVDRNIK EAREKLEMEM
     EAARHEHQVM LMRQDLMRRQ EELRRMEELH NQEVQKRKQL ELRQEEERRR REEEMRRQQE
     EMMRRQQEGF KGTFPDAREQ EIRMGQMAMG GAMGINNRGA MPPAPVPAGT PAPPGPATMM
     PDGTLGLTPP TTERFGQAAT MEGIGAIGGT PPAFNRAAPG AEFAPNKRRR Y
//
ID   NONO_HUMAN              Reviewed;         471 AA.
AC   Q15233; B7Z4C2; D3DVV4; F5GYZ3; O00201; P30807; Q12786; Q9BQC5;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2005, sequence version 4.
DT   22-APR-2020, entry version 214.
DE   RecName: Full=Non-POU domain-containing octamer-binding protein;
DE            Short=NonO protein;
DE   AltName: Full=54 kDa nuclear RNA- and DNA-binding protein;
DE   AltName: Full=55 kDa nuclear protein;
DE   AltName: Full=DNA-binding p52/p100 complex, 52 kDa subunit;
DE   AltName: Full=NMT55;
DE   AltName: Full=p54(nrb);
DE            Short=p54nrb;
GN   Name=NONO; Synonyms=NRB54;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND PROTEIN SEQUENCE OF 252-267;
RP   273-279 AND 283-289.
RX   PubMed=8371983; DOI=10.1093/nar/21.17.4085;
RA   Dong B., Horowitz D.S., Kobayashi R., Krainer A.R.;
RT   "Purification and cDNA cloning of HeLa cell p54nrb, a nuclear protein with
RT   two RNA recognition motifs and extensive homology to human splicing factor
RT   PSF and Drosophila NONA/BJ6.";
RL   Nucleic Acids Res. 21:4085-4092(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Mammary carcinoma;
RX   PubMed=9360842; DOI=10.1097/00019606-199708000-00005;
RA   Traish A.M., Huang Y.-H., Ashba J., Pronovost M., Pavao M., McAneny D.B.,
RA   Moreland R.B.;
RT   "Loss of expression of a 55 kDa nuclear protein (nmt55) in estrogen
RT   receptor-negative human breast cancer.";
RL   Diagn. Mol. Pathol. 6:209-221(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Blood;
RX   PubMed=9341872; DOI=10.1007/s004390050553;
RA   Peters U., Haberhausen G., Kostrzewa M., Nolte D., Mueller U.;
RT   "AFX1 and p54nrb: fine mapping, genomic structure, and exclusion as
RT   candidate genes of X-linked dystonia parkinsonism.";
RL   Hum. Genet. 100:569-572(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Honore B., Rasmussen H.H., Celis J.E.;
RT   "54 kDa human protein.";
RL   Submitted (JAN-1994) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L.,
RA   Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C.,
RA   Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A.,
RA   Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P.,
RA   Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D.,
RA   Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D.,
RA   Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L.,
RA   Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P.,
RA   Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G.,
RA   Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J.,
RA   Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D.,
RA   Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L.,
RA   Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z.,
RA   Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O.,
RA   Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H.,
RA   Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T.,
RA   Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L.,
RA   Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R.,
RA   Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y.,
RA   Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K.,
RA   Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J.,
RA   Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L.,
RA   Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S.,
RA   Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A.,
RA   Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L.,
RA   Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S.,
RA   Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C.,
RA   Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S.,
RA   Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V.,
RA   Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K.,
RA   Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B.,
RA   Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C.,
RA   d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q.,
RA   Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N.,
RA   Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A.,
RA   Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J.,
RA   Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A.,
RA   Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L.,
RA   Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S.,
RA   Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Cervix, Kidney, Muscle, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   PROTEIN SEQUENCE OF 2-21 AND 133-153, BLOCKAGE OF N-TERMINUS, AND SUBUNIT.
RX   PubMed=8439294; DOI=10.1042/bj2900267;
RA   Zhang W.-W., Zhang L.-X., Busch R.K., Farres J., Busch H.;
RT   "Purification and characterization of a DNA-binding heterodimer of 52 and
RT   100 kDa from HeLa cells.";
RL   Biochem. J. 290:267-272(1993).
RN   [11]
RP   PROTEIN SEQUENCE OF 76-91; 127-135; 177-184; 257-270 AND 435-456, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [12]
RP   CHROMOSOMAL TRANSLOCATION WITH TFE3.
RX   PubMed=9393982; DOI=10.1038/sj.onc.1201394;
RA   Clark J., Lu Y.-J., Sidhar S.K., Parker C., Gill S., Smedley D.,
RA   Hamoudi R., Linehan W.M., Shipley J., Cooper C.S.;
RT   "Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in
RT   papillary renal cell carcinoma.";
RL   Oncogene 15:2233-2239(1997).
RN   [13]
RP   IDENTIFICATION IN A COMPLEX WITH SFPQ AND TOP1.
RX   PubMed=9756848; DOI=10.1074/jbc.273.41.26261;
RA   Straub T., Grue P., Uhse A., Lisby M., Knudsen B.R., Tange T.O.,
RA   Westergaard O., Boege F.;
RT   "The RNA-splicing factor PSF/p54 controls DNA-topoisomerase I activity by a
RT   direct interaction.";
RL   J. Biol. Chem. 273:26261-26264(1998).
RN   [14]
RP   FUNCTION IN DNA UNWINDING.
RX   PubMed=10858305; DOI=10.1021/bi992898e;
RA   Straub T., Knudsen B.R., Boege F.;
RT   "PSF/p54(nrb) stimulates 'jumping' of DNA topoisomerase I between separate
RT   DNA helices.";
RL   Biochemistry 39:7552-7558(2000).
RN   [15]
RP   FUNCTION IN NUCLEAR RETENTION OF A-TO-I EDITED RNAS, AND IDENTIFICATION IN
RP   A COMPLEX WITH NONO AND MATR3.
RX   PubMed=11525732; DOI=10.1016/s0092-8674(01)00466-4;
RA   Zhang Z., Carmichael G.G.;
RT   "The fate of dsRNA in the nucleus: a p54(nrb)-containing complex mediates
RT   the nuclear retention of promiscuously A-to-I edited RNAs.";
RL   Cell 106:465-475(2001).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY, FUNCTION IN TRANSCRIPTION REGULATION,
RP   AND IDENTIFICATION IN A COMPLEX WITH SFPQ AND NR5A1.
RX   PubMed=11897684; DOI=10.1210/endo.143.4.8748;
RA   Sewer M.B., Nguyen V.Q., Huang C.J., Tucker P.W., Kagawa N., Waterman M.R.;
RT   "Transcriptional activation of human CYP17 in H295R adrenocortical cells
RT   depends on complex formation among p54(nrb)/NonO, protein-associated
RT   splicing factor, and SF-1, a complex that also participates in repression
RT   of transcription.";
RL   Endocrinology 143:1280-1290(2002).
RN   [17]
RP   INTERACTION WITH PSQF AND U5 SNRNA, AND IDENTIFICATION IN U5/4/6 SNRNP AND
RP   SPLICEOSOME COMPLEXES.
RX   PubMed=12403470; DOI=10.1017/s1355838202022070;
RA   Peng R., Dye B.T., Perez I., Barnard D.C., Thompson A.B., Patton J.G.;
RT   "PSF and p54nrb bind a conserved stem in U5 snRNA.";
RL   RNA 8:1334-1347(2002).
RN   [18]
RP   FUNCTION IN DNA REPAIR, IDENTIFICATION BY MASS SPECTROMETRY, DNA-BINDING,
RP   AND SUBUNIT.
RX   PubMed=15590677; DOI=10.1074/jbc.m412758200;
RA   Bladen C.L., Udayakumar D., Takeda Y., Dynan W.S.;
RT   "Identification of the polypyrimidine tract binding protein-associated
RT   splicing factor.p54(nrb) complex as a candidate DNA double-strand break
RT   rejoining factor.";
RL   J. Biol. Chem. 280:5205-5210(2005).
RN   [19]
RP   INTERACTION WITH PSPC1.
RX   PubMed=16148043; DOI=10.1091/mbc.e05-06-0587;
RA   Fox A.H., Bond C.S., Lamond A.I.;
RT   "P54nrb forms a heterodimer with PSP1 that localizes to paraspeckles in an
RT   RNA-dependent manner.";
RL   Mol. Biol. Cell 16:5304-5315(2005).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-450, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-450, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [22]
RP   IDENTIFICATION IN A COMPLEX WITH SFPQ AND WASL, AND INTERACTION WITH WASL.
RX   PubMed=16767080; DOI=10.1038/ncb1433;
RA   Wu X., Yoo Y., Okuhama N.N., Tucker P.W., Liu G., Guan J.L.;
RT   "Regulation of RNA-polymerase-II-dependent transcription by N-WASP and its
RT   nuclear-binding partners.";
RL   Nat. Cell Biol. 8:756-763(2006).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-428 AND THR-450, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa cells
RT   and high confident phosphopeptide identification by cross-validation of
RT   MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-450, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17693683; DOI=10.1074/mcp.m700120-mcp200;
RA   Tang L.-Y., Deng N., Wang L.-S., Dai J., Wang Z.-L., Jiang X.-S., Li S.-J.,
RA   Li L., Sheng Q.-H., Wu D.-Q., Li L., Zeng R.;
RT   "Quantitative phosphoproteome profiling of Wnt3a-mediated signaling
RT   network: indicating the involvement of ribonucleoside-diphosphate reductase
RT   M2 subunit phosphorylation at residue serine 20 in canonical Wnt signal
RT   transduction.";
RL   Mol. Cell. Proteomics 6:1952-1967(2007).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-450, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-428 AND THR-450, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-450, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [28]
RP   INTERACTION WITH RNF43.
RX   PubMed=18655028; DOI=10.1002/pmic.200800083;
RA   Miyamoto K., Sakurai H., Sugiura T.;
RT   "Proteomic identification of a PSF/p54nrb heterodimer as RNF43 oncoprotein-
RT   interacting proteins.";
RL   Proteomics 8:2907-2910(2008).
RN   [29]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [30]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-428 AND THR-450, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [31]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-5; LYS-11 AND LYS-198, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [32]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-147; THR-440 AND THR-450, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [33]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [34]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-450, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [35]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RX   PubMed=22002106; DOI=10.1074/mcp.m111.013680;
RA   Ahmad Y., Boisvert F.M., Lundberg E., Uhlen M., Lamond A.I.;
RT   "Systematic analysis of protein pools, isoforms, and modifications
RT   affecting turnover and subcellular localization.";
RL   Mol. Cell. Proteomics 11:M111.013680.01-M111.013680.15(2012).
RN   [36]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-6; SER-262 AND THR-450, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [37]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-450, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [38]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-456, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [39]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-5 AND LYS-371, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [40]
RP   INTERACTION WITH ERCC6.
RX   PubMed=26030138; DOI=10.1371/journal.pone.0128558;
RA   Nicolai S., Filippi S., Caputo M., Cipak L., Gregan J., Ammerer G.,
RA   Frontini M., Willems D., Prantera G., Balajee A.S., Proietti-De-Santis L.;
RT   "Identification of Novel Proteins Co-Purifying with Cockayne Syndrome Group
RT   B (CSB) Reveals Potential Roles for CSB in RNA Metabolism and Chromatin
RT   Dynamics.";
RL   PLoS ONE 10:E0128558-E0128558(2015).
RN   [41]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [42]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH PRKDC; XRCC5; XRCC6;
RP   SFPQ; HEXIM1; PSPC1; RBM14 AND MATR3.
RX   PubMed=28712728; DOI=10.1016/j.molcel.2017.06.020;
RA   Morchikh M., Cribier A., Raffel R., Amraoui S., Cau J., Severac D.,
RA   Dubois E., Schwartz O., Bennasser Y., Benkirane M.;
RT   "HEXIM1 and NEAT1 Long non-coding RNA form a multi-subunit complex that
RT   regulates DNA-mediated innate immune response.";
RL   Mol. Cell 67:387-399(2017).
RN   [43]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-5; LYS-60; LYS-96; LYS-99;
RP   LYS-126; LYS-190; LYS-198; LYS-243; LYS-249; LYS-371 AND LYS-467, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [44]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 53-312 IN COMPLEX WITH PSPC1,
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF TYR-267 AND TRP-271.
RX   PubMed=22416126; DOI=10.1073/pnas.1120792109;
RA   Passon D.M., Lee M., Rackham O., Stanley W.A., Sadowska A., Filipovska A.,
RA   Fox A.H., Bond C.S.;
RT   "Structure of the heterodimer of human NONO and paraspeckle protein
RT   component 1 and analysis of its role in subnuclear body formation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:4846-4850(2012).
RN   [45]
RP   INVOLVEMENT IN MRXS34, AND FUNCTION.
RX   PubMed=26571461; DOI=10.1038/nn.4169;
RG   DDD Study;
RA   Mircsof D., Langouet M., Rio M., Moutton S., Siquier-Pernet K.,
RA   Bole-Feysot C., Cagnard N., Nitschke P., Gaspar L., Znidaric M., Alibeu O.,
RA   Fritz A.K., Wolfer D.P., Schroeter A., Bosshard G., Rudin M., Koester C.,
RA   Crestani F., Seebeck P., Boddaert N., Prescott K., Hines R., Moss S.J.,
RA   Fritschy J.M., Munnich A., Amiel J., Brown S.A., Tyagarajan S.K.,
RA   Colleaux L.;
RT   "Mutations in NONO lead to syndromic intellectual disability and inhibitory
RT   synaptic defects.";
RL   Nat. Neurosci. 18:1731-1736(2015).
CC   -!- FUNCTION: DNA- and RNA binding protein, involved in several nuclear
CC       processes. Binds the conventional octamer sequence in double-stranded
CC       DNA. Also binds single-stranded DNA and RNA at a site independent of
CC       the duplex site. Involved in pre-mRNA splicing, probably as a
CC       heterodimer with SFPQ. Interacts with U5 snRNA, probably by binding to
CC       a purine-rich sequence located on the 3' side of U5 snRNA stem 1b.
CC       Together with PSPC1, required for the formation of nuclear
CC       paraspeckles. The SFPQ-NONO heteromer associated with MATR3 may play a
CC       role in nuclear retention of defective RNAs. The SFPQ-NONO heteromer
CC       may be involved in DNA unwinding by modulating the function of
CC       topoisomerase I/TOP1. The SFPQ-NONO heteromer may be involved in DNA
CC       non-homologous end joining (NHEJ) required for double-strand break
CC       repair and V(D)J recombination and may stabilize paired DNA ends. In
CC       vitro, the complex strongly stimulates DNA end joining, binds directly
CC       to the DNA substrates and cooperates with the Ku70/G22P1-Ku80/XRCC5
CC       (Ku) dimer to establish a functional preligation complex. NONO is
CC       involved in transcriptional regulation. The SFPQ-NONO-NR5A1 complex
CC       binds to the CYP17 promoter and regulates basal and cAMP-dependent
CC       transcriptional activity. NONO binds to an enhancer element in long
CC       terminal repeats of endogenous intracisternal A particles (IAPs) and
CC       activates transcription. Regulates the circadian clock by repressing
CC       the transcriptional activator activity of the CLOCK-ARNTL/BMAL1
CC       heterodimer. Important for the functional organization of GABAergic
CC       synapses. Plays a specific and important role in the regulation of
CC       synaptic RNAs and GPHN/gephyrin scaffold structure, through the
CC       regulation of GABRA2 transcript. Plays a role in the regulation of DNA
CC       virus-mediated innate immune response by assembling into the HDP-RNP
CC       complex, a complex that serves as a platform for IRF3 phosphorylation
CC       and subsequent innate immune response activation through the cGAS-STING
CC       pathway (PubMed:28712728). {ECO:0000250|UniProtKB:Q99K48,
CC       ECO:0000269|PubMed:10858305, ECO:0000269|PubMed:11525732,
CC       ECO:0000269|PubMed:11897684, ECO:0000269|PubMed:15590677,
CC       ECO:0000269|PubMed:22416126, ECO:0000269|PubMed:26571461,
CC       ECO:0000269|PubMed:28712728}.
CC   -!- SUBUNIT: Monomer and component of the SFPQ-NONO complex, which is
CC       probably a heterotetramer of two 52 kDa (NONO) and two 100 kDa (SFPQ)
CC       subunits (PubMed:8439294, PubMed:15590677). NONO is a component of
CC       spliceosome and U5.4/6 snRNP complexes (PubMed:12403470). Interacts
CC       with CPNE4 (via VWFA domain) (By similarity). Forms heterodimers with
CC       PSPC1; this involves formation of a coiled coil domain by helices from
CC       both proteins (PubMed:16148043, PubMed:22416126). Part of complex
CC       consisting of SFPQ, NONO and MATR3 (PubMed:11525732). Part of a complex
CC       consisting of SFPQ, NONO and NR5A1 (PubMed:11897684). Part of a complex
CC       consisting of SFPQ, NONO and TOP1 (PubMed:9756848). Interacts with SPI1
CC       (By similarity). Interacts with RNF43 (PubMed:18655028). Interacts with
CC       PER1 and PER2 (By similarity). Part of the HDP-RNP complex composed of
CC       at least HEXIM1, PRKDC, XRCC5, XRCC6, paraspeckle proteins (SFPQ, NONO,
CC       PSPC1, RBM14, and MATR3) and NEAT1 RNA (PubMed:28712728). Interacts
CC       (via second RRM domain) with WASL; the interaction is direct
CC       (PubMed:16767080). Component of a multiprotein complex with WASL and
CC       SFPQ (PubMed:16767080). Interacts with ERCC6 (PubMed:26030138).
CC       {ECO:0000250|UniProtKB:Q99K48, ECO:0000269|PubMed:11525732,
CC       ECO:0000269|PubMed:11897684, ECO:0000269|PubMed:12403470,
CC       ECO:0000269|PubMed:15590677, ECO:0000269|PubMed:16148043,
CC       ECO:0000269|PubMed:16767080, ECO:0000269|PubMed:18655028,
CC       ECO:0000269|PubMed:22416126, ECO:0000269|PubMed:26030138,
CC       ECO:0000269|PubMed:28712728, ECO:0000269|PubMed:8439294,
CC       ECO:0000269|PubMed:9756848}.
CC   -!- INTERACTION:
CC       Q15233; Q15233; NbExp=5; IntAct=EBI-350527, EBI-350527;
CC       Q15233; Q9H3H3: C11orf68; NbExp=3; IntAct=EBI-350527, EBI-721765;
CC       Q15233; Q9H3H3-3: C11orf68; NbExp=3; IntAct=EBI-350527, EBI-12002214;
CC       Q15233; Q53ET0: CRTC2; NbExp=2; IntAct=EBI-350527, EBI-1181987;
CC       Q15233-2; P26196: DDX6; NbExp=3; IntAct=EBI-10203843, EBI-351257;
CC       Q15233; Q8AZK7: EBNA-LP; Xeno; NbExp=2; IntAct=EBI-350527, EBI-1185167;
CC       Q15233-2; P61968: LMO4; NbExp=3; IntAct=EBI-10203843, EBI-2798728;
CC       Q15233; Q13526: PIN1; NbExp=4; IntAct=EBI-350527, EBI-714158;
CC       Q15233-2; Q13526: PIN1; NbExp=3; IntAct=EBI-10203843, EBI-714158;
CC       Q15233-2; P54646: PRKAA2; NbExp=3; IntAct=EBI-10203843, EBI-1383852;
CC       Q15233; Q8WXF1: PSPC1; NbExp=11; IntAct=EBI-350527, EBI-1392258;
CC       Q15233-2; Q8WXF1: PSPC1; NbExp=3; IntAct=EBI-10203843, EBI-1392258;
CC       Q15233; Q8WXF1-1: PSPC1; NbExp=7; IntAct=EBI-350527, EBI-15974663;
CC       Q15233; Q8WXF1-2: PSPC1; NbExp=4; IntAct=EBI-350527, EBI-12135327;
CC       Q15233; P23246: SFPQ; NbExp=5; IntAct=EBI-350527, EBI-355453;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Nucleus, nucleolus. Nucleus speckle.
CC       Note=Detected in punctate subnuclear structures often located adjacent
CC       to splicing speckles, called paraspeckles.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q15233-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q15233-2; Sequence=VSP_045470;
CC   -!- TISSUE SPECIFICITY: Heart, brain, placenta, lung, liver, skeletal
CC       muscle, kidney and pancreas. Also found in a number of breast tumor
CC       cell lines. {ECO:0000269|PubMed:9341872}.
CC   -!- PTM: The N-terminus is blocked.
CC   -!- DISEASE: Note=A chromosomal aberration involving NONO may be a cause of
CC       papillary renal cell carcinoma (PRCC). Translocation
CC       t(X;X)(p11.2;q13.1) with TFE3. {ECO:0000269|PubMed:9393982}.
CC   -!- DISEASE: Mental retardation, X-linked, syndromic, 34 (MRXS34)
CC       [MIM:300967]: A mental retardation syndrome characterized by
CC       intellectual deficit, delayed psychomotor development, poor speech, and
CC       dysmorphic features. Mental retardation is defined by significantly
CC       below average general intellectual functioning associated with
CC       impairments in adaptive behavior and manifested during the
CC       developmental period. {ECO:0000269|PubMed:26571461}. Note=The disease
CC       is caused by mutations affecting the gene represented in this entry.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/NONOID168.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L14599; AAC37578.1; -; mRNA.
DR   EMBL; U89867; AAC51852.1; -; mRNA.
DR   EMBL; Y11289; CAA72157.1; -; Genomic_DNA.
DR   EMBL; Y11290; CAA72157.1; JOINED; Genomic_DNA.
DR   EMBL; Y11291; CAA72157.1; JOINED; Genomic_DNA.
DR   EMBL; Y11292; CAA72157.1; JOINED; Genomic_DNA.
DR   EMBL; Y11293; CAA72157.1; JOINED; Genomic_DNA.
DR   EMBL; Y11294; CAA72157.1; JOINED; Genomic_DNA.
DR   EMBL; Y11295; CAA72157.1; JOINED; Genomic_DNA.
DR   EMBL; Y11296; CAA72157.1; JOINED; Genomic_DNA.
DR   EMBL; Y11297; CAA72157.1; JOINED; Genomic_DNA.
DR   EMBL; Y11298; CAA72157.1; JOINED; Genomic_DNA.
DR   EMBL; U02493; AAA03427.1; -; mRNA.
DR   EMBL; AK297144; BAH12508.1; -; mRNA.
DR   EMBL; CR456761; CAG33042.1; -; mRNA.
DR   EMBL; AL590762; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471132; EAX05298.1; -; Genomic_DNA.
DR   EMBL; CH471132; EAX05299.1; -; Genomic_DNA.
DR   EMBL; CH471132; EAX05300.1; -; Genomic_DNA.
DR   EMBL; BC002364; AAH02364.1; -; mRNA.
DR   EMBL; BC003129; AAH03129.1; -; mRNA.
DR   EMBL; BC012141; AAH12141.1; -; mRNA.
DR   EMBL; BC028299; AAH28299.1; -; mRNA.
DR   EMBL; BC069616; AAH69616.1; -; mRNA.
DR   EMBL; BC069639; AAH69639.1; -; mRNA.
DR   CCDS; CCDS14410.1; -. [Q15233-1]
DR   CCDS; CCDS55445.1; -. [Q15233-2]
DR   PIR; G01211; G01211.
DR   PIR; S29769; S29769.
DR   PIR; S41768; S41768.
DR   RefSeq; NP_001138880.1; NM_001145408.1. [Q15233-1]
DR   RefSeq; NP_001138881.1; NM_001145409.1. [Q15233-1]
DR   RefSeq; NP_001138882.1; NM_001145410.1. [Q15233-2]
DR   RefSeq; NP_031389.3; NM_007363.4. [Q15233-1]
DR   PDB; 3SDE; X-ray; 1.90 A; B=53-312.
DR   PDB; 5IFM; X-ray; 2.60 A; A/B/C/D/E/F/G/H/I/J/K/L=53-312.
DR   PDBsum; 3SDE; -.
DR   PDBsum; 5IFM; -.
DR   SMR; Q15233; -.
DR   BioGrid; 110904; 305.
DR   CORUM; Q15233; -.
DR   DIP; DIP-29951N; -.
DR   IntAct; Q15233; 93.
DR   MINT; Q15233; -.
DR   STRING; 9606.ENSP00000276079; -.
DR   iPTMnet; Q15233; -.
DR   MetOSite; Q15233; -.
DR   PhosphoSitePlus; Q15233; -.
DR   SwissPalm; Q15233; -.
DR   BioMuta; NONO; -.
DR   DMDM; 67469924; -.
DR   REPRODUCTION-2DPAGE; IPI00304596; -.
DR   SWISS-2DPAGE; Q15233; -.
DR   EPD; Q15233; -.
DR   jPOST; Q15233; -.
DR   MassIVE; Q15233; -.
DR   MaxQB; Q15233; -.
DR   PaxDb; Q15233; -.
DR   PeptideAtlas; Q15233; -.
DR   PRIDE; Q15233; -.
DR   ProteomicsDB; 24887; -.
DR   ProteomicsDB; 60494; -. [Q15233-1]
DR   TopDownProteomics; Q15233-1; -. [Q15233-1]
DR   Antibodypedia; 13516; 516 antibodies.
DR   DNASU; 4841; -.
DR   Ensembl; ENST00000276079; ENSP00000276079; ENSG00000147140. [Q15233-1]
DR   Ensembl; ENST00000373841; ENSP00000362947; ENSG00000147140. [Q15233-1]
DR   Ensembl; ENST00000373856; ENSP00000362963; ENSG00000147140. [Q15233-1]
DR   Ensembl; ENST00000535149; ENSP00000441364; ENSG00000147140. [Q15233-2]
DR   GeneID; 4841; -.
DR   KEGG; hsa:4841; -.
DR   UCSC; uc004dzn.5; human. [Q15233-1]
DR   CTD; 4841; -.
DR   DisGeNET; 4841; -.
DR   GeneCards; NONO; -.
DR   HGNC; HGNC:7871; NONO.
DR   HPA; ENSG00000147140; Low tissue specificity.
DR   MalaCards; NONO; -.
DR   MIM; 300084; gene.
DR   MIM; 300967; phenotype.
DR   neXtProt; NX_Q15233; -.
DR   OpenTargets; ENSG00000147140; -.
DR   Orphanet; 466791; Macrocephaly-intellectual disability-left ventricular non compaction syndrome.
DR   Orphanet; 319308; MiT family translocation renal cell carcinoma.
DR   PharmGKB; PA31680; -.
DR   eggNOG; KOG0115; Eukaryota.
DR   eggNOG; ENOG410XQA0; LUCA.
DR   GeneTree; ENSGT00940000154442; -.
DR   HOGENOM; CLU_027185_2_0_1; -.
DR   InParanoid; Q15233; -.
DR   KO; K13214; -.
DR   OMA; MRMGQMG; -.
DR   PhylomeDB; Q15233; -.
DR   TreeFam; TF315795; -.
DR   SIGNOR; Q15233; -.
DR   ChiTaRS; NONO; human.
DR   GeneWiki; NONO; -.
DR   GenomeRNAi; 4841; -.
DR   Pharos; Q15233; Tbio.
DR   PRO; PR:Q15233; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   RNAct; Q15233; protein.
DR   Bgee; ENSG00000147140; Expressed in endometrium epithelium and 110 other tissues.
DR   ExpressionAtlas; Q15233; baseline and differential.
DR   Genevisible; Q15233; HS.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0016363; C:nuclear matrix; IDA:BHF-UCL.
DR   GO; GO:0016607; C:nuclear speck; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0042382; C:paraspeckles; IDA:MGI.
DR   GO; GO:0090575; C:RNA polymerase II transcription factor complex; ISS:BHF-UCL.
DR   GO; GO:0003682; F:chromatin binding; ISS:BHF-UCL.
DR   GO; GO:0070888; F:E-box binding; ISS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0003676; F:nucleic acid binding; IBA:GO_Central.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISS:BHF-UCL.
DR   GO; GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0002218; P:activation of innate immune response; IDA:UniProtKB.
DR   GO; GO:0007623; P:circadian rhythm; ISS:UniProtKB.
DR   GO; GO:0006310; P:DNA recombination; IEA:UniProtKB-KW.
DR   GO; GO:0006281; P:DNA repair; IEA:UniProtKB-KW.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0006397; P:mRNA processing; TAS:ProtInc.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; IBA:GO_Central.
DR   GO; GO:1903377; P:negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0042752; P:regulation of circadian rhythm; ISS:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IBA:GO_Central.
DR   GO; GO:0008380; P:RNA splicing; TAS:ProtInc.
DR   CDD; cd12588; RRM1_p54nrb; 1.
DR   Gene3D; 3.30.70.330; -; 2.
DR   InterPro; IPR012975; NOPS.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR034552; p54nrb_RRM1.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   Pfam; PF08075; NOPS; 1.
DR   Pfam; PF00076; RRM_1; 2.
DR   SMART; SM00360; RRM; 2.
DR   SUPFAM; SSF54928; SSF54928; 1.
DR   PROSITE; PS50102; RRM; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Activator; Alternative splicing;
KW   Biological rhythms; Chromosomal rearrangement; Coiled coil;
KW   Direct protein sequencing; DNA damage; DNA recombination; DNA repair;
KW   DNA-binding; Immunity; Innate immunity; Isopeptide bond;
KW   Mental retardation; Methylation; mRNA processing; mRNA splicing; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat; Repressor; RNA-binding;
KW   Transcription; Transcription regulation; Ubl conjugation.
FT   CHAIN           1..471
FT                   /note="Non-POU domain-containing octamer-binding protein"
FT                   /id="PRO_0000081683"
FT   DOMAIN          74..141
FT                   /note="RRM 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   DOMAIN          148..229
FT                   /note="RRM 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   REGION          54..373
FT                   /note="DBHS"
FT   COILED          268..372
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        30..35
FT                   /note="Poly-Gln"
FT   COMPBIAS        36..42
FT                   /note="Poly-Pro"
FT   COMPBIAS        348..351
FT                   /note="Poly-Arg"
FT   SITE            377..378
FT                   /note="Breakpoint for translocation to form NONO-TFE3"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99K48"
FT   MOD_RES         5
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         6
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         11
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         147
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         198
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         262
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         295
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99K48"
FT   MOD_RES         371
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99K48"
FT   MOD_RES         428
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:17924679,
FT                   ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19690332"
FT   MOD_RES         440
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         450
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:16964243,
FT                   ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:17693683,
FT                   ECO:0000244|PubMed:17924679, ECO:0000244|PubMed:18220336,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         456
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   CROSSLNK        5
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        60
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        96
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        99
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        126
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        190
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        198
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        243
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        249
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        371
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        467
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   VAR_SEQ         1..89
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_045470"
FT   MUTAGEN         267
FT                   /note="Y->A: Abolishes interaction with PSPC1 and
FT                   localization in nuclear paraspeckles; when associated with
FT                   A-271."
FT                   /evidence="ECO:0000269|PubMed:22416126"
FT   MUTAGEN         271
FT                   /note="W->A: Abolishes interaction with PSPC1 and
FT                   localization in nuclear paraspeckles; when associated with
FT                   A-267."
FT                   /evidence="ECO:0000269|PubMed:22416126"
FT   CONFLICT        151
FT                   /note="T -> H (in Ref. 1; AAC37578)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        358..359
FT                   /note="QQ -> HE (in Ref. 3; CAA72157 and 4; AAA03427)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        366..367
FT                   /note="QQ -> HE (in Ref. 3; CAA72157 and 4; AAA03427)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        387
FT                   /note="M -> I (in Ref. 5; BAH12508)"
FT                   /evidence="ECO:0000305"
FT   STRAND          55..60
FT                   /evidence="ECO:0000244|PDB:5IFM"
FT   HELIX           72..74
FT                   /evidence="ECO:0000244|PDB:3SDE"
FT   STRAND          75..80
FT                   /evidence="ECO:0000244|PDB:3SDE"
FT   HELIX           87..94
FT                   /evidence="ECO:0000244|PDB:3SDE"
FT   HELIX           95..97
FT                   /evidence="ECO:0000244|PDB:3SDE"
FT   STRAND          100..106
FT                   /evidence="ECO:0000244|PDB:3SDE"
FT   TURN            107..110
FT                   /evidence="ECO:0000244|PDB:3SDE"
FT   STRAND          111..118
FT                   /evidence="ECO:0000244|PDB:3SDE"
FT   HELIX           119..129
FT                   /evidence="ECO:0000244|PDB:3SDE"
FT   STRAND          140..143
FT                   /evidence="ECO:0000244|PDB:3SDE"
FT   STRAND          149..154
FT                   /evidence="ECO:0000244|PDB:3SDE"
FT   HELIX           161..168
FT                   /evidence="ECO:0000244|PDB:3SDE"
FT   TURN            169..171
FT                   /evidence="ECO:0000244|PDB:5IFM"
FT   STRAND          174..182
FT                   /evidence="ECO:0000244|PDB:3SDE"
FT   STRAND          187..197
FT                   /evidence="ECO:0000244|PDB:3SDE"
FT   HELIX           198..210
FT                   /evidence="ECO:0000244|PDB:3SDE"
FT   STRAND          213..218
FT                   /evidence="ECO:0000244|PDB:3SDE"
FT   STRAND          223..226
FT                   /evidence="ECO:0000244|PDB:3SDE"
FT   STRAND          230..234
FT                   /evidence="ECO:0000244|PDB:5IFM"
FT   HELIX           238..240
FT                   /evidence="ECO:0000244|PDB:3SDE"
FT   HELIX           245..250
FT                   /evidence="ECO:0000244|PDB:3SDE"
FT   STRAND          255..257
FT                   /evidence="ECO:0000244|PDB:3SDE"
FT   HELIX           263..303
FT                   /evidence="ECO:0000244|PDB:3SDE"
FT   HELIX           308..311
FT                   /evidence="ECO:0000244|PDB:5IFM"
SQ   SEQUENCE   471 AA;  54232 MW;  26BBD3828F5B9E49 CRC64;
     MQSNKTFNLE KQNHTPRKHH QHHHQQQHHQ QQQQQPPPPP IPANGQQASS QNEGLTIDLK
     NFRKPGEKTF TQRSRLFVGN LPPDITEEEM RKLFEKYGKA GEVFIHKDKG FGFIRLETRT
     LAEIAKVELD NMPLRGKQLR VRFACHSASL TVRNLPQYVS NELLEEAFSV FGQVERAVVI
     VDDRGRPSGK GIVEFSGKPA ARKALDRCSE GSFLLTTFPR PVTVEPMDQL DDEEGLPEKL
     VIKNQQFHKE REQPPRFAQP GSFEYEYAMR WKALIEMEKQ QQDQVDRNIK EAREKLEMEM
     EAARHEHQVM LMRQDLMRRQ EELRRMEELH NQEVQKRKQL ELRQEEERRR REEEMRRQQE
     EMMRRQQEGF KGTFPDAREQ EIRMGQMAMG GAMGINNRGA MPPAPVPAGT PAPPGPATMM
     PDGTLGLTPP TTERFGQAAT MEGIGAIGGT PPAFNRAAPG AEFAPNKRRR Y
//
ID   NSD1_HUMAN              Reviewed;        2696 AA.
AC   Q96L73; Q96PD8; Q96RN7;
DT   03-JUL-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   22-APR-2020, entry version 187.
DE   RecName: Full=Histone-lysine N-methyltransferase, H3 lysine-36 specific;
DE            EC=2.1.1.357 {ECO:0000269|PubMed:21196496};
DE   AltName: Full=Androgen receptor coactivator 267 kDa protein;
DE   AltName: Full=Androgen receptor-associated protein of 267 kDa;
DE   AltName: Full=H3-K36-HMTase;
DE   AltName: Full=Lysine N-methyltransferase 3B;
DE   AltName: Full=Nuclear receptor-binding SET domain-containing protein 1;
DE            Short=NR-binding SET domain-containing protein;
GN   Name=NSD1; Synonyms=ARA267, KMT3B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND INTERACTION WITH AR.
RX   PubMed=11509567; DOI=10.1074/jbc.m104765200;
RA   Wang X., Yeh S., Wu G., Hsu C.-L., Wang L., Chang T., Yang Y., Guo Y.,
RA   Chang C.;
RT   "Identification and characterization of a novel androgen receptor
RT   coregulator ARA267-alpha in prostate cancer cells.";
RL   J. Biol. Chem. 276:40417-40423(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=11733144; DOI=10.1016/s0378-1119(01)00750-8;
RA   Kurotaki N., Harada N., Yoshiura K., Sugano S., Niikawa N., Matsumoto N.;
RT   "Molecular characterization of NSD1, a human homologue of the mouse Nsd1
RT   gene.";
RL   Gene 279:197-204(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), AND CHROMOSOMAL TRANSLOCATION WITH
RP   NUP98.
RX   PubMed=11493482; DOI=10.1182/blood.v98.4.1264;
RA   Jaju R.J., Fidler C., Haas O.A., Strickson A.J., Watkins F., Clark K.,
RA   Cross N.C., Cheng J.F., Aplan P.D., Kearney L., Boultwood J.,
RA   Wainscoat J.S.;
RT   "A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de novo
RT   childhood acute myeloid leukemia.";
RL   Blood 98:1264-1267(2001).
RN   [4]
RP   INVOLVEMENT IN SOTOS1.
RX   PubMed=11896389; DOI=10.1038/ng863;
RA   Kurotaki N., Imaizumi K., Harada N., Masuno M., Kondoh T., Nagai T.,
RA   Ohashi H., Naritomi K., Tsukahara M., Makita Y., Sugimoto T., Sonoda T.,
RA   Hasegawa T., Chinen Y., Tomita Ha H.A., Kinoshita A., Mizuguchi T.,
RA   Yoshiura Ki K., Ohta T., Kishino T., Fukushima Y., Niikawa N.,
RA   Matsumoto N.;
RT   "Haploinsufficiency of NSD1 causes Sotos syndrome.";
RL   Nat. Genet. 30:365-366(2002).
RN   [5]
RP   INVOLVEMENT IN SOTOS1 AND BWS.
RX   PubMed=14997421; DOI=10.1086/383093;
RA   Baujat G., Rio M., Rossignol S., Sanlaville D., Lyonnet S., Le Merrer M.,
RA   Munnich A., Gicquel C., Cormier-Daire V., Colleaux L.;
RT   "Paradoxical NSD1 mutations in Beckwith-Wiedemann syndrome and 11p15
RT   anomalies in Sotos syndrome.";
RL   Am. J. Hum. Genet. 74:715-720(2004).
RN   [6]
RP   INVOLVEMENT IN MYELODYSPLASTIC SYNDROME.
RX   PubMed=15382262; DOI=10.1002/gcc.20103;
RA   La Starza R., Gorello P., Rosati R., Riezzo A., Veronese A., Ferrazzi E.,
RA   Martelli M.F., Negrini M., Mecucci C.;
RT   "Cryptic insertion producing two NUP98/NSD1 chimeric transcripts in adult
RT   refractory anemia with an excess of blasts.";
RL   Genes Chromosomes Cancer 41:395-399(2004).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-766, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Prostate cancer;
RX   PubMed=17487921; DOI=10.1002/elps.200600782;
RA   Giorgianni F., Zhao Y., Desiderio D.M., Beranova-Giorgianni S.;
RT   "Toward a global characterization of the phosphoproteome in prostate cancer
RT   cells: identification of phosphoproteins in the LNCaP cell line.";
RL   Electrophoresis 28:2027-2034(2007).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2471, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-2462, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-483 AND SER-486, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-483; SER-486; SER-2369 AND
RP   SER-2471, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-2616, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [15]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-906 AND LYS-1339, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 1852-2082 IN COMPLEX WITH
RP   S-ADENOSYL-L-METHIONINE AND ZINC IONS, FUNCTION, CATALYTIC ACTIVITY,
RP   MUTAGENESIS OF ARG-1914 AND ARG-1952, AND CHARACTERIZATION OF SOTOS1
RP   VARIANTS GLN-1984; GLN-2005 AND GLN-2017.
RX   PubMed=21196496; DOI=10.1074/jbc.m110.204115;
RA   Qiao Q., Li Y., Chen Z., Wang M., Reinberg D., Xu R.M.;
RT   "The structure of NSD1 reveals an autoregulatory mechanism underlying
RT   histone H3K36 methylation.";
RL   J. Biol. Chem. 286:8361-8368(2011).
RN   [17]
RP   VARIANTS SOTOS1 LEU-1616; PRO-1637; TRP-1674; VAL-1792; ARG-1925; GLN-2005;
RP   GLN-2017; GLN-2143 AND SER-2183, AND VARIANTS LEU-614; THR-691; PRO-726;
RP   PRO-1036; ILE-1091; ILE-2250 AND THR-2261.
RX   PubMed=12464997; DOI=10.1086/345647;
RA   Douglas J., Hanks S., Temple I.K., Davies S., Murray A., Upadhyaya M.,
RA   Tomkins S., Hughes H.E., Cole T.R.P., Rahman N.;
RT   "NSD1 mutations are the major cause of Sotos syndrome and occur in some
RT   cases of Weaver syndrome but are rare in other overgrowth phenotypes.";
RL   Am. J. Hum. Genet. 72:132-143(2003).
RN   [18]
RP   VARIANTS SOTOS1 ASN-1687; ASP-1955; GLN-1984; CYS-1997 AND TRP-2017.
RX   PubMed=12807965; DOI=10.1136/jmg.40.6.436;
RA   Rio M., Clech L., Amiel J., Faivre L., Lyonnet S., Le Merrer M., Odent S.,
RA   Lacombe D., Edery P., Brauner R., Raoul O., Gosset P., Prieur M.,
RA   Vekemans M., Munnich A., Colleaux L., Cormier-Daire V.;
RT   "Spectrum of NSD1 mutations in Sotos and Weaver syndromes.";
RL   J. Med. Genet. 40:436-440(2003).
RN   [19]
RP   VARIANT [LARGE SCALE ANALYSIS] PRO-726.
RX   PubMed=18987736; DOI=10.1038/nature07485;
RA   Ley T.J., Mardis E.R., Ding L., Fulton B., McLellan M.D., Chen K.,
RA   Dooling D., Dunford-Shore B.H., McGrath S., Hickenbotham M., Cook L.,
RA   Abbott R., Larson D.E., Koboldt D.C., Pohl C., Smith S., Hawkins A.,
RA   Abbott S., Locke D., Hillier L.W., Miner T., Fulton L., Magrini V.,
RA   Wylie T., Glasscock J., Conyers J., Sander N., Shi X., Osborne J.R.,
RA   Minx P., Gordon D., Chinwalla A., Zhao Y., Ries R.E., Payton J.E.,
RA   Westervelt P., Tomasson M.H., Watson M., Baty J., Ivanovich J., Heath S.,
RA   Shannon W.D., Nagarajan R., Walter M.J., Link D.C., Graubert T.A.,
RA   DiPersio J.F., Wilson R.K.;
RT   "DNA sequencing of a cytogenetically normal acute myeloid leukaemia
RT   genome.";
RL   Nature 456:66-72(2008).
CC   -!- FUNCTION: Histone methyltransferase that dimethylates Lys-36 of histone
CC       H3 (H3K36me2). Transcriptional intermediary factor capable of both
CC       negatively or positively influencing transcription, depending on the
CC       cellular context. {ECO:0000269|PubMed:21196496}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-lysyl(36)-[histone H3] + 2 S-adenosyl-L-methionine = 2 H(+)
CC         + N(6),N(6)-dimethyl-L-lysyl(36)-[histone H3] + 2 S-adenosyl-L-
CC         homocysteine; Xref=Rhea:RHEA:60308, Rhea:RHEA-COMP:9785, Rhea:RHEA-
CC         COMP:9787, ChEBI:CHEBI:15378, ChEBI:CHEBI:29969, ChEBI:CHEBI:57856,
CC         ChEBI:CHEBI:59789, ChEBI:CHEBI:61976; EC=2.1.1.357;
CC         Evidence={ECO:0000269|PubMed:21196496};
CC   -!- SUBUNIT: Interacts with the ligand-binding domains of RARA and THRA in
CC       the absence of ligand; in the presence of ligand the interaction is
CC       severely disrupted but some binding still occurs. Interacts with the
CC       ligand-binding domains of RXRA and ESRRA only in the presence of
CC       ligand. Interacts with ZNF496 (By similarity). Interacts with AR
CC       DNA- and ligand-binding domains. {ECO:0000250,
CC       ECO:0000269|PubMed:11509567, ECO:0000269|PubMed:21196496}.
CC   -!- INTERACTION:
CC       Q96L73-2; O95994: AGR2; NbExp=3; IntAct=EBI-11110981, EBI-712648;
CC       Q96L73-2; Q86Z20: CCDC125; NbExp=3; IntAct=EBI-11110981, EBI-11977221;
CC       Q96L73-2; A8MQ03: CYSRT1; NbExp=3; IntAct=EBI-11110981, EBI-3867333;
CC       Q96L73-2; Q3LI66: KRTAP6-2; NbExp=3; IntAct=EBI-11110981, EBI-11962084;
CC       Q96L73-2; Q99750: MDFI; NbExp=3; IntAct=EBI-11110981, EBI-724076;
CC       Q96L73; Q04206: RELA; NbExp=2; IntAct=EBI-2862434, EBI-73886;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=ARA267-beta;
CC         IsoId=Q96L73-1; Sequence=Displayed;
CC       Name=2; Synonyms=ARA267-alpha;
CC         IsoId=Q96L73-2; Sequence=VSP_007682, VSP_007683;
CC       Name=3;
CC         IsoId=Q96L73-3; Sequence=VSP_007684;
CC   -!- TISSUE SPECIFICITY: Expressed in the fetal/adult brain, kidney,
CC       skeletal muscle, spleen, and the thymus, and faintly in the lung.
CC   -!- DISEASE: Sotos syndrome 1 (SOTOS1) [MIM:117550]: A childhood overgrowth
CC       syndrome characterized by pre- and postnatal overgrowth, developmental
CC       delay, mental retardation, advanced bone age, and abnormal craniofacial
CC       morphology including macrodolichocephaly with frontal bossing,
CC       frontoparietal sparseness of hair, apparent hypertelorism, downslanting
CC       palpebral fissures, and facial flushing. Common oral findings include:
CC       premature eruption of teeth; high, arched palate; pointed chin and,
CC       more rarely, prognathism. {ECO:0000269|PubMed:11896389,
CC       ECO:0000269|PubMed:12464997, ECO:0000269|PubMed:12807965,
CC       ECO:0000269|PubMed:14997421}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Beckwith-Wiedemann syndrome (BWS) [MIM:130650]: A disorder
CC       characterized by anterior abdominal wall defects including exomphalos
CC       (omphalocele), pre- and postnatal overgrowth, and macroglossia.
CC       Additional less frequent complications include specific developmental
CC       defects and a predisposition to embryonal tumors.
CC       {ECO:0000269|PubMed:14997421}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Note=A chromosomal aberration involving NSD1 is found in
CC       childhood acute myeloid leukemia. Translocation t(5;11)(q35;p15.5) with
CC       NUP98.
CC   -!- DISEASE: Note=A chromosomal aberration involving NSD1 is found in an
CC       adult form of myelodysplastic syndrome (MDS). Insertion of NUP98 into
CC       NSD1 generates a NUP98-NSD1 fusion product.
CC       {ECO:0000269|PubMed:15382262}.
CC   -!- SIMILARITY: Belongs to the class V-like SAM-binding methyltransferase
CC       superfamily. {ECO:0000255|PROSITE-ProRule:PRU00190}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/NSD1ID356.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF380302; AAL27991.1; -; mRNA.
DR   EMBL; AY049721; AAL06645.1; -; mRNA.
DR   EMBL; AF395588; AAL40694.1; -; mRNA.
DR   EMBL; AF322907; AAK92049.1; -; mRNA.
DR   CCDS; CCDS4412.1; -. [Q96L73-1]
DR   CCDS; CCDS4413.1; -. [Q96L73-2]
DR   RefSeq; NP_071900.2; NM_022455.4. [Q96L73-1]
DR   RefSeq; NP_758859.1; NM_172349.2. [Q96L73-2]
DR   PDB; 3OOI; X-ray; 1.75 A; A=1852-2082.
DR   PDBsum; 3OOI; -.
DR   SMR; Q96L73; -.
DR   BioGrid; 122135; 47.
DR   DIP; DIP-58517N; -.
DR   IntAct; Q96L73; 23.
DR   STRING; 9606.ENSP00000395929; -.
DR   BindingDB; Q96L73; -.
DR   ChEMBL; CHEMBL3588738; -.
DR   MoonDB; Q96L73; Predicted.
DR   iPTMnet; Q96L73; -.
DR   PhosphoSitePlus; Q96L73; -.
DR   BioMuta; NSD1; -.
DR   DMDM; 32469769; -.
DR   EPD; Q96L73; -.
DR   jPOST; Q96L73; -.
DR   MassIVE; Q96L73; -.
DR   MaxQB; Q96L73; -.
DR   PaxDb; Q96L73; -.
DR   PeptideAtlas; Q96L73; -.
DR   PRIDE; Q96L73; -.
DR   ProteomicsDB; 77153; -. [Q96L73-1]
DR   ProteomicsDB; 77154; -. [Q96L73-2]
DR   ProteomicsDB; 77155; -. [Q96L73-3]
DR   Antibodypedia; 29208; 175 antibodies.
DR   Ensembl; ENST00000347982; ENSP00000343209; ENSG00000165671. [Q96L73-2]
DR   Ensembl; ENST00000354179; ENSP00000346111; ENSG00000165671. [Q96L73-2]
DR   Ensembl; ENST00000439151; ENSP00000395929; ENSG00000165671. [Q96L73-1]
DR   GeneID; 64324; -.
DR   KEGG; hsa:64324; -.
DR   UCSC; uc003mfr.5; human. [Q96L73-1]
DR   CTD; 64324; -.
DR   DisGeNET; 64324; -.
DR   GeneCards; NSD1; -.
DR   GeneReviews; NSD1; -.
DR   HGNC; HGNC:14234; NSD1.
DR   HPA; ENSG00000165671; Low tissue specificity.
DR   MalaCards; NSD1; -.
DR   MIM; 117550; phenotype.
DR   MIM; 130650; phenotype.
DR   MIM; 606681; gene.
DR   neXtProt; NX_Q96L73; -.
DR   OpenTargets; ENSG00000165671; -.
DR   Orphanet; 228415; 5q35 microduplication syndrome.
DR   Orphanet; 238613; Beckwith-Wiedemann syndrome due to NSD1 mutation.
DR   Orphanet; 1627; Deletion 5q35.
DR   Orphanet; 821; Sotos syndrome.
DR   Orphanet; 3447; Weaver syndrome.
DR   PharmGKB; PA31790; -.
DR   eggNOG; KOG1081; Eukaryota.
DR   eggNOG; COG2940; LUCA.
DR   GeneTree; ENSGT00940000155027; -.
DR   HOGENOM; CLU_000756_0_0_1; -.
DR   InParanoid; Q96L73; -.
DR   KO; K15588; -.
DR   OMA; ETHKEER; -.
DR   OrthoDB; 507784at2759; -.
DR   PhylomeDB; Q96L73; -.
DR   TreeFam; TF329088; -.
DR   Reactome; R-HSA-3214841; PKMTs methylate histone lysines.
DR   SIGNOR; Q96L73; -.
DR   ChiTaRS; NSD1; human.
DR   GenomeRNAi; 64324; -.
DR   Pharos; Q96L73; Tbio.
DR   PRO; PR:Q96L73; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; Q96L73; protein.
DR   Bgee; ENSG00000165671; Expressed in corpus callosum and 192 other tissues.
DR   ExpressionAtlas; Q96L73; baseline and differential.
DR   Genevisible; Q96L73; HS.
DR   GO; GO:0000785; C:chromatin; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0050681; F:androgen receptor binding; IDA:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; ISS:UniProtKB.
DR   GO; GO:0030331; F:estrogen receptor binding; ISS:UniProtKB.
DR   GO; GO:0046975; F:histone methyltransferase activity (H3-K36 specific); IDA:UniProtKB.
DR   GO; GO:0042799; F:histone methyltransferase activity (H4-K20 specific); ISS:UniProtKB.
DR   GO; GO:0042974; F:retinoic acid receptor binding; ISS:UniProtKB.
DR   GO; GO:0046965; F:retinoid X receptor binding; ISS:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IDA:MGI.
DR   GO; GO:0046966; F:thyroid hormone receptor binding; ISS:UniProtKB.
DR   GO; GO:0003712; F:transcription coregulator activity; IDA:UniProtKB.
DR   GO; GO:0003714; F:transcription corepressor activity; ISS:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IDA:UniProtKB.
DR   GO; GO:0016571; P:histone methylation; ISS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0000414; P:regulation of histone H3-K36 methylation; IMP:MGI.
DR   GO; GO:0033135; P:regulation of peptidyl-serine phosphorylation; IMP:MGI.
DR   GO; GO:1903025; P:regulation of RNA polymerase II regulatory region sequence-specific DNA binding; IMP:MGI.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IBA:GO_Central.
DR   Gene3D; 3.30.40.10; -; 4.
DR   InterPro; IPR006560; AWS_dom.
DR   InterPro; IPR041306; C5HCH.
DR   InterPro; IPR003616; Post-SET_dom.
DR   InterPro; IPR000313; PWWP_dom.
DR   InterPro; IPR001214; SET_dom.
DR   InterPro; IPR019786; Zinc_finger_PHD-type_CS.
DR   InterPro; IPR011011; Znf_FYVE_PHD.
DR   InterPro; IPR001965; Znf_PHD.
DR   InterPro; IPR019787; Znf_PHD-finger.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   Pfam; PF17907; AWS; 1.
DR   Pfam; PF17982; C5HCH; 1.
DR   Pfam; PF00855; PWWP; 2.
DR   Pfam; PF00856; SET; 1.
DR   SMART; SM00570; AWS; 1.
DR   SMART; SM00249; PHD; 5.
DR   SMART; SM00508; PostSET; 1.
DR   SMART; SM00293; PWWP; 2.
DR   SMART; SM00317; SET; 1.
DR   SUPFAM; SSF57903; SSF57903; 3.
DR   PROSITE; PS51215; AWS; 1.
DR   PROSITE; PS50868; POST_SET; 1.
DR   PROSITE; PS50812; PWWP; 2.
DR   PROSITE; PS50280; SET; 1.
DR   PROSITE; PS01359; ZF_PHD_1; 2.
DR   PROSITE; PS50016; ZF_PHD_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing; Chromatin regulator;
KW   Chromosomal rearrangement; Chromosome; Disease mutation; Isopeptide bond;
KW   Metal-binding; Methyltransferase; Nucleus; Phosphoprotein; Polymorphism;
KW   Proto-oncogene; Reference proteome; Repeat; Repressor;
KW   S-adenosyl-L-methionine; Transcription; Transcription regulation;
KW   Transferase; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..2696
FT                   /note="Histone-lysine N-methyltransferase, H3 lysine-36
FT                   specific"
FT                   /id="PRO_0000186070"
FT   DOMAIN          323..388
FT                   /note="PWWP 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00162"
FT   DOMAIN          1756..1818
FT                   /note="PWWP 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00162"
FT   DOMAIN          1890..1940
FT                   /note="AWS"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00562"
FT   DOMAIN          1942..2059
FT                   /note="SET"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00190"
FT   DOMAIN          2066..2082
FT                   /note="Post-SET"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00155"
FT   ZN_FING         1543..1589
FT                   /note="PHD-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00146"
FT   ZN_FING         1590..1646
FT                   /note="PHD-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00146"
FT   ZN_FING         1707..1751
FT                   /note="PHD-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00146"
FT   ZN_FING         2118..2165
FT                   /note="PHD-type 4; atypical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00146"
FT   REGION          1952..1954
FT                   /note="S-adenosyl-L-methionine binding"
FT   REGION          1994..1997
FT                   /note="S-adenosyl-L-methionine binding"
FT   REGION          2020..2021
FT                   /note="S-adenosyl-L-methionine binding"
FT   REGION          2060..2066
FT                   /note="Inhibits enzyme activity in the absence of bound
FT                   histone"
FT   COMPBIAS        2207..2421
FT                   /note="Pro-rich"
FT   BINDING         2065
FT                   /note="S-adenosyl-L-methionine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00190,
FT                   ECO:0000269|PubMed:21196496"
FT   BINDING         2071
FT                   /note="S-adenosyl-L-methionine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00190,
FT                   ECO:0000269|PubMed:21196496"
FT   MOD_RES         117
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O88491"
FT   MOD_RES         483
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         486
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         766
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17487921"
FT   MOD_RES         1510
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O88491"
FT   MOD_RES         2369
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         2462
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         2471
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:23186163"
FT   CROSSLNK        906
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        1339
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        2616
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25218447"
FT   VAR_SEQ         1..269
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11509567"
FT                   /id="VSP_007682"
FT   VAR_SEQ         270..279
FT                   /note="QLNSINLSFQ -> MPLKTRTALS (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11509567"
FT                   /id="VSP_007683"
FT   VAR_SEQ         310..412
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:11493482"
FT                   /id="VSP_007684"
FT   VARIANT         614
FT                   /note="V -> L (in dbSNP:rs3733875)"
FT                   /evidence="ECO:0000269|PubMed:12464997"
FT                   /id="VAR_015775"
FT   VARIANT         691
FT                   /note="A -> T (in dbSNP:rs28932177)"
FT                   /evidence="ECO:0000269|PubMed:12464997"
FT                   /id="VAR_015776"
FT   VARIANT         726
FT                   /note="S -> P (in dbSNP:rs28932178)"
FT                   /evidence="ECO:0000269|PubMed:12464997,
FT                   ECO:0000269|PubMed:18987736"
FT                   /id="VAR_015777"
FT   VARIANT         1036
FT                   /note="A -> P (in dbSNP:rs28932179)"
FT                   /evidence="ECO:0000269|PubMed:12464997"
FT                   /id="VAR_015778"
FT   VARIANT         1091
FT                   /note="L -> I (in dbSNP:rs35597015)"
FT                   /evidence="ECO:0000269|PubMed:12464997"
FT                   /id="VAR_015779"
FT   VARIANT         1616
FT                   /note="H -> L (in SOTOS1)"
FT                   /evidence="ECO:0000269|PubMed:12464997"
FT                   /id="VAR_015780"
FT   VARIANT         1637
FT                   /note="L -> P (in SOTOS1)"
FT                   /evidence="ECO:0000269|PubMed:12464997"
FT                   /id="VAR_015781"
FT   VARIANT         1674
FT                   /note="C -> W (in SOTOS1)"
FT                   /evidence="ECO:0000269|PubMed:12464997"
FT                   /id="VAR_015782"
FT   VARIANT         1687
FT                   /note="I -> N (in SOTOS1)"
FT                   /evidence="ECO:0000269|PubMed:12807965"
FT                   /id="VAR_015783"
FT   VARIANT         1792
FT                   /note="G -> V (in SOTOS1)"
FT                   /evidence="ECO:0000269|PubMed:12464997"
FT                   /id="VAR_015784"
FT   VARIANT         1925
FT                   /note="C -> R (in SOTOS1)"
FT                   /evidence="ECO:0000269|PubMed:12464997"
FT                   /id="VAR_015785"
FT   VARIANT         1955
FT                   /note="G -> D (in SOTOS1)"
FT                   /evidence="ECO:0000269|PubMed:12807965"
FT                   /id="VAR_015786"
FT   VARIANT         1984
FT                   /note="R -> Q (in SOTOS1; loss of enzyme activity;
FT                   dbSNP:rs587784169)"
FT                   /evidence="ECO:0000269|PubMed:12807965,
FT                   ECO:0000269|PubMed:21196496"
FT                   /id="VAR_015787"
FT   VARIANT         1997
FT                   /note="Y -> C (in SOTOS1; dbSNP:rs797045825)"
FT                   /evidence="ECO:0000269|PubMed:12807965"
FT                   /id="VAR_015788"
FT   VARIANT         2005
FT                   /note="R -> Q (in SOTOS1; strongly reduced enzyme activity;
FT                   dbSNP:rs587784174)"
FT                   /evidence="ECO:0000269|PubMed:12464997,
FT                   ECO:0000269|PubMed:21196496"
FT                   /id="VAR_015789"
FT   VARIANT         2017
FT                   /note="R -> Q (in SOTOS1; loss of enzyme activity;
FT                   dbSNP:rs587784177)"
FT                   /evidence="ECO:0000269|PubMed:12464997,
FT                   ECO:0000269|PubMed:21196496"
FT                   /id="VAR_015790"
FT   VARIANT         2017
FT                   /note="R -> W (in SOTOS1; dbSNP:rs587784176)"
FT                   /evidence="ECO:0000269|PubMed:12807965"
FT                   /id="VAR_015791"
FT   VARIANT         2143
FT                   /note="H -> Q (in SOTOS1; dbSNP:rs121908068)"
FT                   /evidence="ECO:0000269|PubMed:12464997"
FT                   /id="VAR_015792"
FT   VARIANT         2183
FT                   /note="C -> S (in SOTOS1; dbSNP:rs121908069)"
FT                   /evidence="ECO:0000269|PubMed:12464997"
FT                   /id="VAR_015793"
FT   VARIANT         2250
FT                   /note="M -> I (in dbSNP:rs35848863)"
FT                   /evidence="ECO:0000269|PubMed:12464997"
FT                   /id="VAR_015794"
FT   VARIANT         2261
FT                   /note="M -> T (in dbSNP:rs34165241)"
FT                   /evidence="ECO:0000269|PubMed:12464997"
FT                   /id="VAR_015795"
FT   MUTAGEN         1914
FT                   /note="R->C: Reduced enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:21196496"
FT   MUTAGEN         1952
FT                   /note="R->W: Nearly abolished enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:21196496"
FT   CONFLICT        1306
FT                   /note="H -> D (in Ref. 3; AAK92049)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1397
FT                   /note="P -> Q (in Ref. 3; AAK92049)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1478
FT                   /note="A -> V (in Ref. 3; AAK92049)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1959..1960
FT                   /note="KT -> QE (in Ref. 3; AAK92049)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1963
FT                   /note="K -> R (in Ref. 3; AAK92049)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1982
FT                   /note="R -> M (in Ref. 3; AAK92049)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1986..1991
FT                   /note="RYAQEH -> KHAHEN (in Ref. 3; AAK92049)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1995
FT                   /note="N -> H (in Ref. 3; AAK92049)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2001
FT                   /note="L -> I (in Ref. 3; AAK92049)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2016
FT                   /note="A -> S (in Ref. 3; AAK92049)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2022
FT                   /note="C -> S (in Ref. 3; AAK92049)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2030
FT                   /note="Q -> L (in Ref. 3; AAK92049)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2033
FT                   /note="S -> T (in Ref. 3; AAK92049)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2045..2046
FT                   /note="LS -> VC (in Ref. 3; AAK92049)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2049
FT                   /note="K -> P (in Ref. 3; AAK92049)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2061
FT                   /note="E -> D (in Ref. 3; AAK92049)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2066
FT                   /note="G -> E (in Ref. 3; AAK92049)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2071
FT                   /note="K -> R (in Ref. 3; AAK92049)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2075
FT                   /note="P -> S (in Ref. 3; AAK92049)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2304..2305
FT                   /note="TK -> AQ (in Ref. 3; AAK92049)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2352
FT                   /note="R -> S (in Ref. 3; AAK92049)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2539
FT                   /note="L -> S (in Ref. 3; AAK92049)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2543
FT                   /note="P -> S (in Ref. 3; AAK92049)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2567..2591
FT                   /note="PGPLSQSPGLVKQAKQMVGGQQLPA -> QGFFTKSPALVENKGKTKWVGRP
FT                   TNYLH (in Ref. 3; AAK92049)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2597
FT                   /note="G -> W (in Ref. 3; AAK92049)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2608..2612
FT                   /note="ASLPT -> PSSPN (in Ref. 3; AAK92049)"
FT                   /evidence="ECO:0000305"
FT   HELIX           1852..1863
FT                   /evidence="ECO:0000244|PDB:3OOI"
FT   HELIX           1889..1891
FT                   /evidence="ECO:0000244|PDB:3OOI"
FT   STRAND          1901..1903
FT                   /evidence="ECO:0000244|PDB:3OOI"
FT   HELIX           1912..1915
FT                   /evidence="ECO:0000244|PDB:3OOI"
FT   TURN            1922..1924
FT                   /evidence="ECO:0000244|PDB:3OOI"
FT   HELIX           1928..1930
FT                   /evidence="ECO:0000244|PDB:3OOI"
FT   HELIX           1935..1938
FT                   /evidence="ECO:0000244|PDB:3OOI"
FT   STRAND          1944..1948
FT                   /evidence="ECO:0000244|PDB:3OOI"
FT   STRAND          1950..1960
FT                   /evidence="ECO:0000244|PDB:3OOI"
FT   STRAND          1967..1970
FT                   /evidence="ECO:0000244|PDB:3OOI"
FT   STRAND          1973..1976
FT                   /evidence="ECO:0000244|PDB:3OOI"
FT   HELIX           1978..1990
FT                   /evidence="ECO:0000244|PDB:3OOI"
FT   STRAND          1998..2002
FT                   /evidence="ECO:0000244|PDB:3OOI"
FT   STRAND          2005..2013
FT                   /evidence="ECO:0000244|PDB:3OOI"
FT   HELIX           2015..2018
FT                   /evidence="ECO:0000244|PDB:3OOI"
FT   STRAND          2026..2034
FT                   /evidence="ECO:0000244|PDB:3OOI"
FT   STRAND          2037..2046
FT                   /evidence="ECO:0000244|PDB:3OOI"
SQ   SEQUENCE   2696 AA;  296652 MW;  4E80E6DCD9A24C81 CRC64;
     MDQTCELPRR NCLLPFSNPV NLDAPEDKDS PFGNGQSNFS EPLNGCTMQL STVSGTSQNA
     YGQDSPSCYI PLRRLQDLAS MINVEYLNGS ADGSESFQDP EKSDSRAQTP IVCTSLSPGG
     PTALAMKQEP SCNNSPELQV KVTKTIKNGF LHFENFTCVD DADVDSEMDP EQPVTEDESI
     EEIFEETQTN ATCNYETKSE NGVKVAMGSE QDSTPESRHG AVKSPFLPLA PQTETQKNKQ
     RNEVDGSNEK AALLPAPFSL GDTNITIEEQ LNSINLSFQD DPDSSTSTLG NMLELPGTSS
     SSTSQELPFC QPKKKSTPLK YEVGDLIWAK FKRRPWWPCR ICSDPLINTH SKMKVSNRRP
     YRQYYVEAFG DPSERAWVAG KAIVMFEGRH QFEELPVLRR RGKQKEKGYR HKVPQKILSK
     WEASVGLAEQ YDVPKGSKNR KCIPGSIKLD SEEDMPFEDC TNDPESEHDL LLNGCLKSLA
     FDSEHSADEK EKPCAKSRAR KSSDNPKRTS VKKGHIQFEA HKDERRGKIP ENLGLNFISG
     DISDTQASNE LSRIANSLTG SNTAPGSFLF SSCGKNTAKK EFETSNGDSL LGLPEGALIS
     KCSREKNKPQ RSLVCGSKVK LCYIGAGDEE KRSDSISICT TSDDGSSDLD PIEHSSESDN
     SVLEIPDAFD RTENMLSMQK NEKIKYSRFA ATNTRVKAKQ KPLISNSHTD HLMGCTKSAE
     PGTETSQVNL SDLKASTLVH KPQSDFTNDA LSPKFNLSSS ISSENSLIKG GAANQALLHS
     KSKQPKFRSI KCKHKENPVM AEPPVINEEC SLKCCSSDTK GSPLASISKS GKVDGLKLLN
     NMHEKTRDSS DIETAVVKHV LSELKELSYR SLGEDVSDSG TSKPSKPLLF SSASSQNHIP
     IEPDYKFSTL LMMLKDMHDS KTKEQRLMTA QNLVSYRSPG RGDCSTNSPV GVSKVLVSGG
     STHNSEKKGD GTQNSANPSP SGGDSALSGE LSASLPGLLS DKRDLPASGK SRSDCVTRRN
     CGRSKPSSKL RDAFSAQMVK NTVNRKALKT ERKRKLNQLP SVTLDAVLQG DRERGGSLRG
     GAEDPSKEDP LQIMGHLTSE DGDHFSDVHF DSKVKQSDPG KISEKGLSFE NGKGPELDSV
     MNSENDELNG VNQVVPKKRW QRLNQRRTKP RKRMNRFKEK ENSECAFRVL LPSDPVQEGR
     DEFPEHRTPS ASILEEPLTE QNHADCLDSA GPRLNVCDKS SASIGDMEKE PGIPSLTPQA
     ELPEPAVRSE KKRLRKPSKW LLEYTEEYDQ IFAPKKKQKK VQEQVHKVSS RCEEESLLAR
     GRSSAQNKQV DENSLISTKE EPPVLEREAP FLEGPLAQSE LGGGHAELPQ LTLSVPVAPE
     VSPRPALESE ELLVKTPGNY ESKRQRKPTK KLLESNDLDP GFMPKKGDLG LSKKCYEAGH
     LENGITESCA TSYSKDFGGG TTKIFDKPRK RKRQRHAAAK MQCKKVKNDD SSKEIPGSEG
     ELMPHRTATS PKETVEEGVE HDPGMPASKK MQGERGGGAA LKENVCQNCE KLGELLLCEA
     QCCGAFHLEC LGLTEMPRGK FICNECRTGI HTCFVCKQSG EDVKRCLLPL CGKFYHEECV
     QKYPPTVMQN KGFRCSLHIC ITCHAANPAN VSASKGRLMR CVRCPVAYHA NDFCLAAGSK
     ILASNSIICP NHFTPRRGCR NHEHVNVSWC FVCSEGGSLL CCDSCPAAFH RECLNIDIPE
     GNWYCNDCKA GKKPHYREIV WVKVGRYRWW PAEICHPRAV PSNIDKMRHD VGEFPVLFFG
     SNDYLWTHQA RVFPYMEGDV SSKDKMGKGV DGTYKKALQE AAARFEELKA QKELRQLQED
     RKNDKKPPPY KHIKVNRPIG RVQIFTADLS EIPRCNCKAT DENPCGIDSE CINRMLLYEC
     HPTVCPAGGR CQNQCFSKRQ YPEVEIFRTL QRGWGLRTKT DIKKGEFVNE YVGELIDEEE
     CRARIRYAQE HDITNFYMLT LDKDRIIDAG PKGNYARFMN HCCQPNCETQ KWSVNGDTRV
     GLFALSDIKA GTELTFNYNL ECLGNGKTVC KCGAPNCSGF LGVRPKNQPI ATEEKSKKFK
     KKQQGKRRTQ GEITKEREDE CFSCGDAGQL VSCKKPGCPK VYHADCLNLT KRPAGKWECP
     WHQCDICGKE AASFCEMCPS SFCKQHREGM LFISKLDGRL SCTEHDPCGP NPLEPGEIRE
     YVPPPVPLPP GPSTHLAEQS TGMAAQAPKM SDKPPADTNQ MLSLSKKALA GTCQRPLLPE
     RPLERTDSRP QPLDKVRDLA GSGTKSQSLV SSQRPLDRPP AVAGPRPQLS DKPSPVTSPS
     SSPSVRSQPL ERPLGTADPR LDKSIGAASP RPQSLEKTSV PTGLRLPPPD RLLITSSPKP
     QTSDRPTDKP HASLSQRLPP PEKVLSAVVQ TLVAKEKALR PVDQNTQSKN RAALVMDLID
     LTPRQKERAA SPHQVTPQAD EKMPVLESSS WPASKGLGHM PRAVEKGCVS DPLQTSGKAA
     APSEDPWQAV KSLTQARLLS QPPAKAFLYE PTTQASGRAS AGAEQTPGPL SQSPGLVKQA
     KQMVGGQQLP ALAAKSGQSF RSLGKAPASL PTEEKKLVTT EQSPWALGKA SSRAGLWPIV
     AGQTLAQSCW SAGSTQTLAQ TCWSLGRGQD PKPEQNTLPA LNQAPSSHKC AESEQK
//
ID   Q96MN8_HUMAN            Unreviewed;       942 AA.
AC   Q96MN8;
DT   01-DEC-2001, integrated into UniProtKB/TrEMBL.
DT   01-DEC-2001, sequence version 1.
DT   22-APR-2020, entry version 80.
DE   SubName: Full=cDNA FLJ32105 fis, clone OCBBF2001402, moderately similar to Mus musculus NSD1 protein mRNA {ECO:0000313|EMBL:BAB71247.1};
DE   Flags: Fragment;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAB71247.1};
RN   [1] {ECO:0000313|EMBL:BAB71247.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAB71247.1};
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M.,
RA   Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S.,
RA   Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S.,
RA   Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H.,
RA   Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M.,
RA   Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M.,
RA   Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y.,
RA   Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N.,
RA   Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S.,
RA   Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T.,
RA   Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M.,
RA   Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y.,
RA   Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y.,
RA   Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T.,
RA   Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK056667; BAB71247.1; -; mRNA.
DR   RefSeq; NP_758859.1; NM_172349.2.
DR   PeptideAtlas; Q96MN8; -.
DR   PRIDE; Q96MN8; -.
DR   GeneID; 64324; -.
DR   CTD; 64324; -.
DR   PharmGKB; PA31790; -.
DR   eggNOG; KOG1081; Eukaryota.
DR   eggNOG; COG2940; LUCA.
DR   GenomeRNAi; 64324; -.
DR   Genevisible; Q96MN8; HS.
PE   2: Evidence at transcript level;
FT   REGION          135..162
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          520..539
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          584..683
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          715..741
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          760..782
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          891..918
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        522..539
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        584..636
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        724..738
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   NON_TER         942
FT                   /evidence="ECO:0000313|EMBL:BAB71247.1"
SQ   SEQUENCE   942 AA;  103771 MW;  43C0991BD30CC527 CRC64;
     MKVSNRRPYR QYYVEAFGDP SERAWVAGKA IVMFEGRHQF EELPVLRRRG KQKEKGYRHK
     VPQKILSKWE ASVGLAEQYD VPKGSKNRKC IPGSIKLDSE EDMPFEDCTN DPESEHDLLL
     NGCLKSLAFD SEHSADEKEK PCAKSRARKS SDNPKRTSVK KGHIQFEAHK DERRGKIPEN
     LGLNFISGDI SDTQASNELS RIANSLTGSN TAPGSFLFSS CGKNTAKKEF ETSNGDSLLG
     LPEGALISKC SREKNKPQRS LVCGSKVKLC YIGAGDEEKR SDSISICTTS DDGSSDLDPI
     EHSSESDNSV LEIPDAFDRT ENMLSMQKNE KIKYSRFAAT NTRVKAKQKP LISNSHTDHL
     MGCTKSAEPG TETSQVNLSD LKASTLVHKP QSDFTNDALS PKFNLSSSIS SENSLIKGGA
     ANQALLHSKS KQPKFRSIKC KHKENPVMAE PPVINEECSL KCCSSDTKGS PLASISKSGK
     VDGLKLLNNM HEKTRDSSDI ETAVVKHVLS ELKELSYRSL GEDVSDSGTS KPSKPLLFSS
     ASSQNHIPIE PDYKFSTLLM MLKDMHDSKT KEQRLMTAQN LVSYRSPGRG DCSTNSPVGV
     SKVLVSGGST HNSEKKGDGT QNSANPSPSG GDSALSGELS ASLPGLLSDK RDLPASGKSR
     SDCVTRRNCG RSKPSSKLRD AFSAQMVKNT VNRKALKTER KRKLNQLPSV TLDAVLQGDR
     ERGGSLRGGA EDPSKEDPLQ IMGHLTSEDG DHFSDVHFDS KVKQSDPGKI SEKGLSFENG
     KGPELDSVMN SENDELNGVN QVVPKKRWQR LNQRRTKPRK RMNRFKEKEN SECAFRVLLP
     SDPVQEGRDE FPEHRTPSAS ILEEPLTEQN HADCLDSAGP RLNVCDKSSA SIGDMEKEPG
     IPSLTPQAEL PEPAVRSEKK RLRKPSKWLL EYTEEYDQIF AP
//
ID   A0A024R5M9_HUMAN        Unreviewed;      2101 AA.
AC   A0A024R5M9;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 49.
DE   SubName: Full=Nuclear mitotic apparatus protein 1, isoform CRA_a {ECO:0000313|EMBL:EAW74824.1};
GN   Name=NUMA1 {ECO:0000313|EMBL:EAW74824.1};
GN   ORFNames=hCG_2017131 {ECO:0000313|EMBL:EAW74824.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW74824.1};
RN   [1] {ECO:0000313|EMBL:EAW74824.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW74824.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH471076; EAW74821.1; -; Genomic_DNA.
DR   EMBL; CH471076; EAW74824.1; -; Genomic_DNA.
DR   RefSeq; NP_001273490.1; NM_001286561.1.
DR   RefSeq; XP_011543368.1; XM_011545066.1.
DR   RefSeq; XP_016873319.1; XM_017017830.1.
DR   RefSeq; XP_016873320.1; XM_017017831.1.
DR   Antibodypedia; 16895; 388 antibodies.
DR   GeneID; 4926; -.
DR   CTD; 4926; -.
DR   EuPathDB; HostDB:ENSG00000137497.17; -.
DR   eggNOG; ENOG410IFJ8; Eukaryota.
DR   eggNOG; ENOG41125FF; LUCA.
DR   OrthoDB; 524033at2759; -.
DR   ChiTaRS; NUMA1; human.
DR   GenomeRNAi; 4926; -.
DR   Bgee; ENSG00000137497; Expressed in myometrium and 238 other tissues.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0000139; C:Golgi membrane; IEA:InterPro.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   InterPro; IPR026650; NUMA1.
DR   PANTHER; PTHR18902:SF24; PTHR18902:SF24; 1.
PE   4: Predicted;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   REGION          549..593
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          746..766
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          926..958
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          988..1013
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1090..1225
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1275..1296
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1720..1747
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1812..1887
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1941..2101
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          216..250
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          278..319
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          327..400
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          415..449
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          468..491
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          789..823
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          828..862
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          867..922
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1367..1405
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1409..1443
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1462..1511
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1516..1550
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1558..1679
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        549..564
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        565..593
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        926..953
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        997..1013
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1090..1104
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1144..1161
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1195..1225
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1720..1742
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1816..1848
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1859..1881
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1950..1973
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2000..2014
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2015..2044
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2059..2086
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   2101 AA;  236516 MW;  18D8C4A34409ADE9 CRC64;
     MTLHATRGAA LLSWVNSLHV ADPVEAVLQL QDCSIFIKII DRIHGTEEGQ QILKQPVSER
     LDFVCSFLQK NRKHPSSPEC LVSAQKVLEG SELELAKMTM LLLYHSTMSS KSPRDWEQFE
     YKIQAELAVI LKFVLDHEDG LNLNEDLENF LQKAPVPSTC SSTFPEELSP PSHQAKREIR
     FLELQKVASS SSGNNFLSGS PASPMGDILQ TPQFQMRRLK KQLADERSNR DELELELAEN
     RKLLTEKDAQ IAMMQQRIDR LALLNEKQAA SPLEPKELEE LRDKNESLTM RLHETLKQCQ
     DLKTEKSQMD RKINQLSEEN GDLSFKLREF ASHLQQLQDA LNELTEEHSK ATQEWLEKQA
     QLEKELSAAL QDKKCLEEKN EILQGKLSQL EEHLSQLQDN PPQEKGEVLG DVLQLETLKQ
     EAATLAANNT QLQARVEMLE TERGQQEAKL LAERGHFEEE KQQLSSLITD LQSSISNLSQ
     AKEELEQASQ AHGARLTAQV ASLTSELTTL NATIQQQDQE LAGLKQQAKE KQAQLAQTLQ
     QQEQASQGLR HQVEQLSSSL KQKEQQLKEV AEKQEATRQD HAQQLATAAE EREASLRERD
     AALKQLEALE KEKAAKLEIL QQQLQVANEA RDSAQTSVTQ AQREKAELSR KVEELQACVE
     TARQEQHEAQ AQVAELELQL RSEQQKATEK ERVAQEKDQL QEQLQALKES LKVTKGSLEE
     EKRRAADALE EQQRCISELK AETRSLVEQH KRERKELEEE RAGRKGLEAR LQQLGEAHQA
     ETEVLRRELA EAMAAQHTAE SECEQLVKEV AAWRERYEDS QQEEAQYGAM FQEQLMTLKE
     ECEKARQELQ EAKEKVAGIE SHSELQISRQ QNELAELHAN LARALQQVQE KEVRAQKLAD
     DLSTLQEKMA ATSKEVARLE TLVRKAGEQQ ETASRELVKE PARAGDRQPE WLEEQQGRQF
     CSTQAALQAM EREAEQMGNE LERLRAALME SQGQQQEERG QQEREVARLT QERGRAQADL
     ALEKAARAEL EMRLQNALNE QRVEFATLQE ALAHALTEKE GKDQELAKLR GLEAAQIKEL
     EELRQTVKQL KEQLAKKEKE HASGSGAQSE AAGRTEPTGP KLEALRAEVS KLEQQCQKQQ
     EQADSLERSL EAERASRAER DSALETLQGQ LEEKAQELGH SQSALASAQR ELAAFRTKVQ
     DHSKAEDEWK AQVARGRQEA ERKNSLISSL EEEVSILNRQ VLEKEGESKE LKRLVMAESE
     KSQKLEERLR LLQAETASNS ARAAERSSAL REEVQSLREE AEKQRVASEN LRQELTSQAE
     RAEELGQELK AWQEKFFQKE QALSTLQLEH TSTQALVSEL LPAKHLCQQL QAEQAAAEKR
     HREELEQSKQ AAGGLRAELL RAQRELGELI PLRQKVAEQE RTAQQLRAEK ASYAEQLSML
     KKAHGLLAEE NRGLGERANL GRQFLEVELD QAREKYVQEL AAVRADAETR LAEVQREAQS
     TARELEVMTA KYEGAKVKVL EERQRFQEER QKLTAQVEEL SKKLADSDQA SKVQQQKLKA
     VQAQGGESQQ EAQRLQAQLN ELQAQLSQKE QAAEHYKLQM EKAKTHYDAK KQQNQELQEQ
     LRSLEQLQKE NKELRAEAER LGHELQQAGL KTKEAEQTCR HLTAQVRSLE AQVAHADQQL
     RDLGKFQVAT DALKSREPQA KPQLDLSIDS LDLSCEEGTP LSITSKLPRT QPDGTSVPGE
     PASPISQRLP PKVESLESLY FTPIPARSQA PLESSLDSLG DVFLDSGRKT RSARRRTTQI
     INITMTKKLD VEEPDSANSS FYSTRSAPAS QASLRATSST QSLARLGSPD YGNSALLSLP
     GYRPTTRSSA RRSQAGVSSG APPGRNSFYM GTCQDEPEQL DDWNRIAELQ QRNRVCPPHL
     KTCYPLESRP SLSLGTITDE EMKTGDPQET LRRASMQPIQ IAEGTGITTR QQRKRVSLEP
     HQGPGTPESK KATSCFPRPM TPRDRHEGRK QSTTEAQKKA APASTKQADR RQSMAFSILN
     TPKKLGNSLL RRGASKKALS KASPNTRSGT RRSPRIATTT ASAATAAAIG ATPRAKGKAK
     H
//
ID   NUMA1_HUMAN             Reviewed;        2115 AA.
AC   Q14980; H0YH75; Q14981; Q9BTE9;
DT   19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   17-APR-2007, sequence version 2.
DT   22-APR-2020, entry version 187.
DE   RecName: Full=Nuclear mitotic apparatus protein 1 {ECO:0000312|HGNC:HGNC:8059};
DE   AltName: Full=Nuclear matrix protein-22 {ECO:0000303|PubMed:9730450};
DE            Short=NMP-22 {ECO:0000303|PubMed:9730450};
DE   AltName: Full=Nuclear mitotic apparatus protein {ECO:0000303|PubMed:1541630, ECO:0000303|PubMed:1541636};
DE            Short=NuMA protein {ECO:0000303|PubMed:1541630, ECO:0000303|PubMed:1541636};
DE   AltName: Full=SP-H antigen {ECO:0000303|PubMed:8408288};
GN   Name=NUMA1 {ECO:0000312|HGNC:HGNC:8059};
GN   Synonyms=NMP22 {ECO:0000303|PubMed:9730450},
GN   NUMA {ECO:0000303|PubMed:1541630};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND SUBCELLULAR LOCATION.
RX   PubMed=1541630; DOI=10.1083/jcb.116.6.1303;
RA   Yang C.H., Lambie E.J., Snyder M.;
RT   "NuMA: an unusually long coiled-coil related protein in the mammalian
RT   nucleus.";
RL   J. Cell Biol. 116:1303-1317(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND SUBCELLULAR LOCATION.
RX   PubMed=1541636; DOI=10.1083/jcb.116.6.1395;
RA   Compton D.A., Szilak I., Cleveland D.W.;
RT   "Primary structure of NuMA, an intranuclear protein that defines a novel
RT   pathway for segregation of proteins at mitosis.";
RL   J. Cell Biol. 116:1395-1408(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8408288;
RA   Maekawa T., Kuriyama R.;
RT   "Primary structure and microtubule-interacting domain of the SP-H antigen:
RT   a mitotic map located at the spindle pole characterized as a homologous
RT   protein to NuMA.";
RL   J. Cell Sci. 105:589-600(1993).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.-S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1576-2115 (ISOFORM 1), NUCLEOTIDE SEQUENCE
RP   [MRNA] OF 975-1776 (ISOFORM 3), NUCLEOTIDE SEQUENCE [MRNA] OF 610-1763
RP   (ISOFORM 4), AND ALTERNATIVE SPLICING.
RX   PubMed=8505359;
RA   Tang T.K., Tang C.J., Chen Y.L., Wu C.W.;
RT   "Nuclear proteins of the bovine esophageal epithelium. II. The NuMA gene
RT   gives rise to multiple mRNAs and gene products reactive with monoclonal
RT   antibody W1.";
RL   J. Cell Sci. 104:249-260(1993).
RN   [8]
RP   SUBCELLULAR LOCATION (ISOFORMS 3 AND 4), ALTERNATIVE SPLICING (ISOFORMS 3
RP   AND 4), MUTAGENESIS OF ARG-1984 AND LYS-1988, AND NUCLEAR LOCALIZATION
RP   SIGNAL.
RX   PubMed=7962183;
RA   Tang T.K., Tang C.J., Chao Y.J., Wu C.W.;
RT   "Nuclear mitotic apparatus protein (NuMA): spindle association, nuclear
RT   targeting and differential subcellular localization of various NuMA
RT   isoforms.";
RL   J. Cell Sci. 107:1389-1402(1994).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, PHOSPHORYLATION AT THR-2015; THR-2055;
RP   SER-2087 AND THR-2106, AND MUTAGENESIS OF THR-2015; THR-2055; SER-2087 AND
RP   THR-2106.
RX   PubMed=7769006;
RA   Compton D.A., Luo C.;
RT   "Mutation of the predicted p34cdc2 phosphorylation sites in NuMA impair the
RT   assembly of the mitotic spindle and block mitosis.";
RL   J. Cell Sci. 108:621-633(1995).
RN   [10]
RP   USE IN DIAGNOSTIC TESTS.
RX   PubMed=9730450; DOI=10.1016/s0090-4295(98)00219-2;
RA   Landman J., Chang Y., Kavaler E., Droller M.J., Liu B.C.;
RT   "Sensitivity and specificity of NMP-22, telomerase, and BTA in the
RT   detection of human bladder cancer.";
RL   Urology 52:398-402(1998).
RN   [11]
RP   SUBCELLULAR LOCATION, AND ASSOCIATION WITH THE DYNEIN-DYNACTIN COMPLEX.
RX   PubMed=10811826; DOI=10.1083/jcb.149.4.851;
RA   Merdes A., Heald R., Samejima K., Earnshaw W.C., Cleveland D.W.;
RT   "Formation of spindle poles by dynein/dynactin-dependent transport of
RT   NuMA.";
RL   J. Cell Biol. 149:851-862(2000).
RN   [12]
RP   FUNCTION, AND INTERACTION WITH THE IMPORTIN ALPHA/IMPORTIN BETA RECEPTOR.
RX   PubMed=11163243; DOI=10.1016/s0092-8674(01)00194-5;
RA   Nachury M.V., Maresca T.J., Salmon W.C., Waterman-Storer C.M., Heald R.,
RA   Weis K.;
RT   "Importin beta is a mitotic target of the small GTPase Ran in spindle
RT   assembly.";
RL   Cell 104:95-106(2001).
RN   [13]
RP   INTERACTION WITH GPSM2, AND SUBCELLULAR LOCATION.
RX   PubMed=11781568; DOI=10.1038/ncb1201-1069;
RA   Du Q., Stukenberg P.T., Macara I.G.;
RT   "A mammalian partner of inscuteable binds NuMA and regulates mitotic
RT   spindle organization.";
RL   Nat. Cell Biol. 3:1069-1075(2001).
RN   [14]
RP   FUNCTION, AND INTERACTION WITH KPNB1.
RX   PubMed=11229403; DOI=10.1126/science.1057661;
RA   Wiese C., Wilde A., Moore M.S., Adam S.A., Merdes A., Zheng Y.;
RT   "Role of importin-beta in coupling Ran to downstream targets in microtubule
RT   assembly.";
RL   Science 291:653-656(2001).
RN   [15]
RP   FUNCTION, INTERACTION WITH GPSM2 AND MICROTUBULES, SUBCELLULAR LOCATION,
RP   AND DOMAINS.
RX   PubMed=12445386; DOI=10.1016/s0960-9822(02)01298-8;
RA   Du Q., Taylor L., Compton D.A., Macara I.G.;
RT   "LGN blocks the ability of NuMA to bind and stabilize microtubules. A
RT   mechanism for mitotic spindle assembly regulation.";
RL   Curr. Biol. 12:1928-1933(2002).
RN   [16]
RP   INTERACTION WITH TNKS AND TNKS2.
RX   PubMed=12080061; DOI=10.1074/jbc.m203916200;
RA   Sbodio J.I., Chi N.W.;
RT   "Identification of a tankyrase-binding motif shared by IRAP, TAB182, and
RT   human TRF1 but not mouse TRF1. NuMA contains this RXXPDG motif and is a
RT   novel tankyrase partner.";
RL   J. Biol. Chem. 277:31887-31892(2002).
RN   [17]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH TUBULIN AND MICROTUBULES,
RP   AND TUBULIN-BINDING DOMAIN.
RX   PubMed=11956313;
RA   Haren L., Merdes A.;
RT   "Direct binding of NuMA to tubulin is mediated by a novel sequence motif in
RT   the tail domain that bundles and stabilizes microtubules.";
RL   J. Cell Sci. 115:1815-1824(2002).
RN   [18]
RP   FUNCTION, ADP-RIBOSYLATION, INTERACTION WITH TNKS, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=16076287; DOI=10.1042/bj20050885;
RA   Chang W., Dynek J.N., Smith S.;
RT   "NuMA is a major acceptor of poly(ADP-ribosyl)ation by tankyrase 1 in
RT   mitosis.";
RL   Biochem. J. 391:177-184(2005).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1757, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1757; SER-1769; THR-1776;
RP   SER-1840 AND THR-2106, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [22]
RP   FUNCTION, AND INTERACTION WITH DYNEIN-DYNACTIN COMPLEX AND RAE1.
RX   PubMed=17172455; DOI=10.1073/pnas.0609582104;
RA   Wong R.W., Blobel G., Coutavas E.;
RT   "Rae1 interaction with NuMA is required for bipolar spindle formation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:19783-19787(2006).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2077, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa cells
RT   and high confident phosphopeptide identification by cross-validation of
RT   MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-388; SER-395; SER-820;
RP   SER-1601; SER-1757 AND SER-1760, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1757, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1757, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=T-cell;
RX   PubMed=19367720; DOI=10.1021/pr800500r;
RA   Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
RT   "Phosphorylation analysis of primary human T lymphocytes using sequential
RT   IMAC and titanium oxide enrichment.";
RL   J. Proteome Res. 7:5167-5176(2008).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-169; SER-203; THR-211;
RP   SER-1721; SER-1724; SER-1728; SER-1757; SER-1769; SER-1772; TYR-1774;
RP   THR-1776; SER-1788; SER-1789; SER-1792; SER-1800; THR-1804; SER-1830;
RP   SER-1833; SER-1834; TYR-1836; SER-1840; SER-1862; SER-1887; SER-1969;
RP   SER-1991 AND THR-2000, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [28]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [29]
RP   FUNCTION.
RX   PubMed=19255246; DOI=10.1083/jcb.200810091;
RA   Silk A.D., Holland A.J., Cleveland D.W.;
RT   "Requirements for NuMA in maintenance and establishment of mammalian
RT   spindle poles.";
RL   J. Cell Biol. 184:677-690(2009).
RN   [30]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-203; SER-1225; SER-1757;
RP   SER-1769; THR-1776; SER-1788 AND SER-1800, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [31]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-379; LYS-891 AND LYS-1511, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [32]
RP   GLYCOSYLATION AT SER-1844.
RX   PubMed=20068230; DOI=10.1126/scisignal.2000526;
RA   Wang Z., Udeshi N.D., Slawson C., Compton P.D., Sakabe K., Cheung W.D.,
RA   Shabanowitz J., Hunt D.F., Hart G.W.;
RT   "Extensive crosstalk between O-GlcNAcylation and phosphorylation regulates
RT   cytokinesis.";
RL   Sci. Signal. 3:RA2-RA2(2010).
RN   [33]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-169; SER-203; THR-211;
RP   SER-271; SER-1187; SER-1225; SER-1757; SER-1769; SER-1830; SER-1862;
RP   SER-1969; SER-1991; THR-2000 AND SER-2003, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [34]
RP   REVIEW.
RX   PubMed=20137953; DOI=10.1016/j.tcb.2010.01.003;
RA   Radulescu A.E., Cleveland D.W.;
RT   "NuMA after 30 years: the matrix revisited.";
RL   Trends Cell Biol. 20:214-222(2010).
RN   [35]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [36]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1757, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [37]
RP   FUNCTION, AND INTERACTION WITH DYNEIN-DYNACTIN COMPLEX.
RX   PubMed=23027904; DOI=10.1083/jcb.201203166;
RA   Kotak S., Busso C., Goenczy P.;
RT   "Cortical dynein is critical for proper spindle positioning in human
RT   cells.";
RL   J. Cell Biol. 199:97-110(2012).
RN   [38]
RP   FUNCTION, INTERACTION WITH GPSM2, SUBCELLULAR LOCATION, PHOSPHORYLATION AT
RP   THR-1047; SER-1769; SER-1772; SER-1789 AND SER-1834 BY PLK1, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=22327364; DOI=10.1038/ncb2440;
RA   Kiyomitsu T., Cheeseman I.M.;
RT   "Chromosome- and spindle-pole-derived signals generate an intrinsic code
RT   for spindle position and orientation.";
RL   Nat. Cell Biol. 14:311-317(2012).
RN   [39]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [40]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH EPB41 AND EPB41L2,
RP   PROBABLE PHOSPHORYLATION AT THR-2015; THR-2055 AND SER-2087 BY CDK1, AND
RP   MUTAGENESIS OF THR-2015; THR-2055 AND SER-2087.
RX   PubMed=23870127; DOI=10.1016/j.cell.2013.06.010;
RA   Kiyomitsu T., Cheeseman I.M.;
RT   "Cortical dynein and asymmetric membrane elongation coordinately position
RT   the spindle in anaphase.";
RL   Cell 154:391-402(2013).
RN   [41]
RP   FUNCTION, PHOSPHORYLATION AT THR-2015; THR-2055; SER-2087 AND THR-2106,
RP   SUBCELLULAR LOCATION, IDENTIFICATION BY MASS SPECTROMETRY, AND MUTAGENESIS
RP   OF THR-2055.
RX   PubMed=23921553; DOI=10.1038/emboj.2013.172;
RA   Kotak S., Busso C., Goenczy P.;
RT   "NuMA phosphorylation by CDK1 couples mitotic progression with cortical
RT   dynein function.";
RL   EMBO J. 32:2517-2529(2013).
RN   [42]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-169; SER-271; SER-1757;
RP   SER-1769; SER-1830; SER-1834; SER-1840; SER-1844; SER-1862; SER-1887;
RP   SER-1969; SER-1991; THR-2000; SER-2047; THR-2055 AND SER-2062, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [43]
RP   FUNCTION, INTERACTION WITH GPSM2, SUBCELLULAR LOCATION, DOMAIN, AND
RP   MUTAGENESIS OF THR-2055.
RX   PubMed=24109598; DOI=10.1091/mbc.e13-05-0277;
RA   Seldin L., Poulson N.D., Foote H.P., Lechler T.;
RT   "NuMA localization, stability, and function in spindle orientation involve
RT   4.1 and Cdk1 interactions.";
RL   Mol. Biol. Cell 24:3651-3662(2013).
RN   [44]
RP   FUNCTION, INTERACTION WITH EPB41 AND EPB41L2, PHOSPHATIDYLINOSITOL-BINDING,
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF THR-2055.
RX   PubMed=24996901; DOI=10.15252/embj.201488147;
RA   Kotak S., Busso C., Goenczy P.;
RT   "NuMA interacts with phosphoinositides and links the mitotic spindle with
RT   the plasma membrane.";
RL   EMBO J. 33:1815-1830(2014).
RN   [45]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-162; THR-163; SER-169;
RP   SER-271; SER-1225; SER-1757 AND SER-1788, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [46]
RP   FUNCTION, SUBCELLULAR LOCATION, PHOSPHORYLATION AT THR-2055, DOMAIN,
RP   PHOSPHATIDYLINOSITOL-BINDING, AND MUTAGENESIS OF THR-2055.
RX   PubMed=24371089; DOI=10.1091/mbc.e13-08-0474;
RA   Zheng Z., Wan Q., Meixiong G., Du Q.;
RT   "Cell cycle-regulated membrane binding of NuMA contributes to efficient
RT   anaphase chromosome separation.";
RL   Mol. Biol. Cell 25:606-619(2014).
RN   [47]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1766, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [48]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1766, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [49]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1766, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [50]
RP   FUNCTION, SUBUNIT, UBIQUITINATION, INTERACTION WITH ABRAXAS2; KPNB1 AND
RP   DYNEIN-DYNACTIN COMPLEX, IDENTIFICATION BY MASS SPECTROMETRY, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=26195665; DOI=10.1083/jcb.201503039;
RA   Yan K., Li L., Wang X., Hong R., Zhang Y., Yang H., Lin M., Zhang S.,
RA   He Q., Zheng D., Tang J., Yin Y., Shao G.;
RT   "The deubiquitinating enzyme complex BRISC is required for proper mitotic
RT   spindle assembly in mammalian cells.";
RL   J. Cell Biol. 210:209-224(2015).
RN   [51]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=25657325; DOI=10.1091/mbc.e14-09-1366;
RA   Ohta S., Wood L., Toramoto I., Yagyu K., Fukagawa T., Earnshaw W.C.;
RT   "CENP-32 is required to maintain centrosomal dominance in bipolar spindle
RT   assembly.";
RL   Mol. Biol. Cell 26:1225-1237(2015).
RN   [52]
RP   SUBCELLULAR LOCATION.
RX   PubMed=26562023; DOI=10.1371/journal.pone.0142798;
RA   Ohta S., Hamada M., Sato N., Toramoto I.;
RT   "Polyglutamylated tubulin binding protein C1orf96/CSAP is involved in
RT   microtubule stabilization in mitotic spindles.";
RL   PLoS ONE 10:E0142798-E0142798(2015).
RN   [53]
RP   IDENTIFICATION IN A SPINDLE ORIENTATION COMPLEX.
RX   PubMed=26766442; DOI=10.1016/j.devcel.2015.12.016;
RA   Chiu C.W., Monat C., Robitaille M., Lacomme M., Daulat A.M., Macleod G.,
RA   McNeill H., Cayouette M., Angers S.;
RT   "SAPCD2 controls spindle orientation and asymmetric divisions by negatively
RT   regulating the Galphai-LGN-NuMA ternary complex.";
RL   Dev. Cell 36:50-62(2016).
RN   [54]
RP   FUNCTION, INTERACTION WITH MICROTUBULES, SUBCELLULAR LOCATION, DOMAIN, AND
RP   NUCLEAR LOCALIZATION SIGNAL.
RX   PubMed=26765568; DOI=10.7554/elife.12504;
RA   Seldin L., Muroyama A., Lechler T.;
RT   "NuMA-microtubule interactions are critical for spindle orientation and the
RT   morphogenesis of diverse epidermal structures.";
RL   Elife 5:0-0(2016).
RN   [55]
RP   FUNCTION, INTERACTION WITH GPSM2 AND SPAG5, AND SUBCELLULAR LOCATION.
RX   PubMed=27462074; DOI=10.1074/jbc.m116.724831;
RA   Chu X., Chen X., Wan Q., Zheng Z., Du Q.;
RT   "Nuclear mitotic apparatus (NuMA) interacts with and regulates astrin at
RT   the mitotic spindle.";
RL   J. Biol. Chem. 291:20055-20067(2016).
RN   [56]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1699; LYS-1766 AND LYS-1822, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [57]
RP   ELECTRON MICROSCOPY, SUBUNIT, SUBCELLULAR LOCATION, AND PUTATIVE STRUCTURAL
RP   FUNCTION.
RX   PubMed=10075938; DOI=10.1093/emboj/18.6.1689;
RA   Harborth J., Wang J., Gueth-Hallonet C., Weber K., Osborn M.;
RT   "Self assembly of NuMA: multiarm oligomers as structural units of a nuclear
RT   lattice.";
RL   EMBO J. 18:1689-1700(1999).
RN   [58]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 1899-1926 IN COMPLEX WITH GPSM2,
RP   FUNCTION, INTERACTION WITH GPSM2, SUBCELLULAR LOCATION, MUTAGENESIS OF
RP   GLU-1910, AND DOMAIN.
RX   PubMed=21816348; DOI=10.1016/j.molcel.2011.07.011;
RA   Zhu J., Wen W., Zheng Z., Shang Y., Wei Z., Xiao Z., Pan Z., Du Q.,
RA   Wang W., Zhang M.;
RT   "LGN/mInsc and LGN/NuMA complex structures suggest distinct functions in
RT   asymmetric cell division for the Par3/mInsc/LGN and Galphai/LGN/NuMA
RT   pathways.";
RL   Mol. Cell 43:418-431(2011).
RN   [59]
RP   SUBCELLULAR LOCATION.
RX   PubMed=26246606; DOI=10.1091/mbc.e15-02-0113;
RA   Carvalhal S., Ribeiro S.A., Arocena M., Kasciukovic T., Temme A.,
RA   Koehler K., Huebner A., Griffis E.R.;
RT   "The nucleoporin ALADIN regulates Aurora A localization to ensure robust
RT   mitotic spindle formation.";
RL   Mol. Biol. Cell 26:3424-3438(2015).
CC   -!- FUNCTION: Microtubule (MT)-binding protein that plays a role in the
CC       formation and maintenance of the spindle poles and the alignement and
CC       the segregation of chromosomes during mitotic cell division
CC       (PubMed:7769006, PubMed:17172455, PubMed:19255246, PubMed:24996901,
CC       PubMed:26195665, PubMed:27462074). Functions to tether the minus ends
CC       of MTs at the spindle poles, which is critical for the establishment
CC       and maintenance of the spindle poles (PubMed:12445386,
CC       PubMed:11956313). Plays a role in the establishment of the mitotic
CC       spindle orientation during metaphase and elongation during anaphase in
CC       a dynein-dynactin-dependent manner (PubMed:23870127, PubMed:24109598,
CC       PubMed:24996901, PubMed:26765568). In metaphase, part of a ternary
CC       complex composed of GPSM2 and G(i) alpha proteins, that regulates the
CC       recruitment and anchorage of the dynein-dynactin complex in the mitotic
CC       cell cortex regions situated above the two spindle poles, and hence
CC       regulates the correct oritentation of the mitotic spindle
CC       (PubMed:23027904, PubMed:22327364, PubMed:23921553). During anaphase,
CC       mediates the recruitment and accumulation of the dynein-dynactin
CC       complex at the cell membrane of the polar cortical region through
CC       direct association with phosphatidylinositol 4,5-bisphosphate
CC       (PI(4,5)P2), and hence participates in the regulation of the spindle
CC       elongation and chromosome segregation (PubMed:22327364,
CC       PubMed:23921553, PubMed:24996901, PubMed:24371089). Binds also to other
CC       polyanionic phosphoinositides, such as phosphatidylinositol 3-phosphate
CC       (PIP), lysophosphatidic acid (LPA) and phosphatidylinositol
CC       triphosphate (PIP3), in vitro (PubMed:24996901, PubMed:24371089). Also
CC       required for proper orientation of the mitotic spindle during
CC       asymmetric cell divisions (PubMed:21816348). Plays a role in mitotic MT
CC       aster assembly (PubMed:11163243, PubMed:11229403, PubMed:12445386).
CC       Involved in anastral spindle assembly (PubMed:25657325). Positively
CC       regulates TNKS protein localization to spindle poles in mitosis
CC       (PubMed:16076287). Highly abundant component of the nuclear matrix
CC       where it may serve a non-mitotic structural role, occupies the majority
CC       of the nuclear volume (PubMed:10075938). Required for epidermal
CC       differentiation and hair follicle morphogenesis (By similarity).
CC       {ECO:0000250|UniProtKB:E9Q7G0, ECO:0000269|PubMed:11163243,
CC       ECO:0000269|PubMed:11229403, ECO:0000269|PubMed:11956313,
CC       ECO:0000269|PubMed:12445386, ECO:0000269|PubMed:16076287,
CC       ECO:0000269|PubMed:17172455, ECO:0000269|PubMed:19255246,
CC       ECO:0000269|PubMed:22327364, ECO:0000269|PubMed:23027904,
CC       ECO:0000269|PubMed:23870127, ECO:0000269|PubMed:23921553,
CC       ECO:0000269|PubMed:24109598, ECO:0000269|PubMed:24371089,
CC       ECO:0000269|PubMed:24996901, ECO:0000269|PubMed:25657325,
CC       ECO:0000269|PubMed:26195665, ECO:0000269|PubMed:26765568,
CC       ECO:0000269|PubMed:27462074, ECO:0000269|PubMed:7769006,
CC       ECO:0000305|PubMed:10075938, ECO:0000305|PubMed:21816348}.
CC   -!- SUBUNIT: Homodimer (PubMed:10075938). Also forms multiarm oligomers by
CC       association of C-terminal tail domains, oligomers may further assemble
CC       to form a hexagonal nuclear lattice-like network (PubMed:10075938).
CC       Associates with the dynein-dynactin complex; this association promotes
CC       the transport and accumulation of NUMA1 at the mitotic spindle poles
CC       that is inhibited by the BRISC complex in a PLK1-dependent manner
CC       (PubMed:10811826, PubMed:17172455, PubMed:23027904, PubMed:22327364,
CC       PubMed:26195665). Part of a spindle orientation complex at least
CC       composed of GNAI1, GPSM2 and NUMA1 (PubMed:26766442). Interacts (via C-
CC       terminus) with microtubules (MTs); this interaction is direct and
CC       promotes both MT bundle formation and stability in a dynein-dynactin
CC       complex- and CDK1-independent manner (PubMed:12445386, PubMed:11956313,
CC       PubMed:26765568). Interacts with EPB41 and EPB41L2; these interactions
CC       are negatively regulated by CDK1 during metaphase and are important for
CC       anaphase-specific localization of NUMA1 in symmetrically dividing cells
CC       (PubMed:23870127, PubMed:24996901). Interacts (via C-terminus) with
CC       GPSM2 (via TPR repeats); this interaction is direct, prevented by
CC       competitive binding of INSC, is inhibited in a PLK1-dependent manner,
CC       blocks the association of NUMA1 with MTs and inhibits NUMA1-induced MT
CC       bundle formation, prevents the association of NUMA1 with SPAG5, induces
CC       mitotic spindle pole localization of GPSM2, both metaphase cell cortex
CC       localization of NUMA1 and mitotic spindle organization
CC       (PubMed:11781568, PubMed:12445386, PubMed:22327364, PubMed:24109598,
CC       PubMed:27462074, PubMed:21816348). Does not interact with GPSM2 during
CC       anaphase (PubMed:23870127). Interacts (via C-terminus) with the nuclear
CC       importin alpha/importin beta receptor; this interaction is inhibited by
CC       RanGTP (PubMed:11163243). Interacts (via C-terminus) with KPNB1; this
CC       interaction is inhibited by RanGTP and the BRISC complex
CC       (PubMed:11229403, PubMed:26195665). Interacts with ABRAXAS2 and the
CC       BRISC complex; these interactions regulate mitotic spindle assembly
CC       (PubMed:26195665). Interacts (via N-terminal end of the coiled-coil
CC       domain) with RAE1; this interaction promotes mitotic spindle formation
CC       (PubMed:17172455). Interacts (via C-terminus) with SPAG5 (via C-
CC       terminus); this interaction promotes the recruitment of SPAG5 to the
CC       MTs at spindle poles in a dynein-dynactin-dependent manner and
CC       regulates mitotic spindle organization and proper chromosome alignment
CC       during mitosis (PubMed:27462074). Interacts with TNKS; this interaction
CC       occurs at the onset of mitosis (PubMed:12080061, PubMed:16076287).
CC       Interacts with TNKS2 (PubMed:12080061). Interacts with tubulin
CC       (PubMed:11956313). {ECO:0000269|PubMed:10075938,
CC       ECO:0000269|PubMed:10811826, ECO:0000269|PubMed:11163243,
CC       ECO:0000269|PubMed:11229403, ECO:0000269|PubMed:11781568,
CC       ECO:0000269|PubMed:11956313, ECO:0000269|PubMed:12080061,
CC       ECO:0000269|PubMed:12445386, ECO:0000269|PubMed:16076287,
CC       ECO:0000269|PubMed:17172455, ECO:0000269|PubMed:21816348,
CC       ECO:0000269|PubMed:22327364, ECO:0000269|PubMed:23027904,
CC       ECO:0000269|PubMed:23870127, ECO:0000269|PubMed:24109598,
CC       ECO:0000269|PubMed:24996901, ECO:0000269|PubMed:26195665,
CC       ECO:0000269|PubMed:26765568, ECO:0000269|PubMed:26766442,
CC       ECO:0000269|PubMed:27462074}.
CC   -!- INTERACTION:
CC       Q14980; Q2TAC2: CCDC57; NbExp=3; IntAct=EBI-521611, EBI-2808286;
CC       Q14980; Q53SE7: FLJ13057; NbExp=3; IntAct=EBI-521611, EBI-10172181;
CC       Q14980; P63096: GNAI1; NbExp=4; IntAct=EBI-521611, EBI-618639;
CC       Q14980; P81274: GPSM2; NbExp=6; IntAct=EBI-521611, EBI-618655;
CC       Q14980-2; Q8VDU0: Gpsm2; Xeno; NbExp=2; IntAct=EBI-10981450, EBI-7575403;
CC       Q14980; P78406: RAE1; NbExp=6; IntAct=EBI-521611, EBI-724495;
CC       Q14980; Q9NYB0: TERF2IP; NbExp=2; IntAct=EBI-521611, EBI-750109;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:1541630,
CC       ECO:0000269|PubMed:23921553, ECO:0000269|PubMed:27462074}. Nucleus,
CC       nucleoplasm {ECO:0000269|PubMed:10811826}. Nucleus matrix
CC       {ECO:0000269|PubMed:10075938, ECO:0000269|PubMed:11956313,
CC       ECO:0000269|PubMed:1541636, ECO:0000269|PubMed:7962183}. Chromosome
CC       {ECO:0000269|PubMed:1541630}. Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:11956313, ECO:0000269|PubMed:12445386,
CC       ECO:0000269|PubMed:26765568}. Cytoplasm, cytoskeleton, microtubule
CC       organizing center, centrosome {ECO:0000269|PubMed:10811826,
CC       ECO:0000269|PubMed:1541630, ECO:0000269|PubMed:1541636,
CC       ECO:0000269|PubMed:25657325, ECO:0000269|PubMed:26562023,
CC       ECO:0000269|PubMed:26765568}. Cytoplasm, cytoskeleton, spindle pole
CC       {ECO:0000269|PubMed:10811826, ECO:0000269|PubMed:11781568,
CC       ECO:0000269|PubMed:11956313, ECO:0000269|PubMed:12445386,
CC       ECO:0000269|PubMed:1541630, ECO:0000269|PubMed:1541636,
CC       ECO:0000269|PubMed:16076287, ECO:0000269|PubMed:21816348,
CC       ECO:0000269|PubMed:22327364, ECO:0000269|PubMed:23870127,
CC       ECO:0000269|PubMed:23921553, ECO:0000269|PubMed:24109598,
CC       ECO:0000269|PubMed:24996901, ECO:0000269|PubMed:25657325,
CC       ECO:0000269|PubMed:26195665, ECO:0000269|PubMed:26246606,
CC       ECO:0000269|PubMed:26562023, ECO:0000269|PubMed:27462074,
CC       ECO:0000269|PubMed:7769006, ECO:0000269|PubMed:7962183}. Cytoplasm,
CC       cell cortex {ECO:0000269|PubMed:21816348, ECO:0000269|PubMed:22327364,
CC       ECO:0000269|PubMed:23870127, ECO:0000269|PubMed:23921553,
CC       ECO:0000269|PubMed:24109598, ECO:0000269|PubMed:24996901}. Cell
CC       membrane {ECO:0000269|PubMed:24371089, ECO:0000269|PubMed:24996901};
CC       Lipid-anchor {ECO:0000269|PubMed:24371089,
CC       ECO:0000269|PubMed:24996901}; Cytoplasmic side
CC       {ECO:0000269|PubMed:24371089, ECO:0000269|PubMed:24996901}. Lateral
CC       cell membrane {ECO:0000250|UniProtKB:E9Q7G0}. Note=Mitotic cell cycle-
CC       dependent shuttling protein that relocalizes from the interphase
CC       nucleus to the spindle poles and cell cortex (PubMed:1541636,
CC       PubMed:10811826). The localization to the spindle poles is regulated by
CC       AAAS (PubMed:26246606). In interphase, resides in the nuclear matrix
CC       (PubMed:1541630, PubMed:1541636, PubMed:23921553). In prophase,
CC       restricted to the interchromatin or condensed chromosome space
CC       (PubMed:10811826). In prometaphase, after nuclear envelope disassembly,
CC       forms aggregates both in the spindle midzone and at duplicated
CC       centrosomes and astral microtubules (MTs) of the bipolar spindle
CC       apparatus (PubMed:10811826). Translocates from the spindle midzone
CC       towards the spindle poles along spindle fibers in a MT- and dynein-
CC       dynactin-dependent manner until the anaphase onset (PubMed:1541636,
CC       PubMed:10811826). In metaphase, recruited to the polar cortical region
CC       in a GPSM2- and GNAI1-dependent manner (PubMed:23870127,
CC       PubMed:24109598, PubMed:24996901). Excluded from the metaphase
CC       equatorial cortical region in a RanGTP-dependent manner
CC       (PubMed:22327364, PubMed:23870127). Phosphorylation on Thr-2055 by CDK1
CC       results in its localization at spindle poles in metaphase, but not at
CC       the cell cortex (PubMed:23921553). In anaphase, recruited and anchored
CC       at the cell membrane of the polar cortical region in a EPB41-,
CC       EPB41L2-, phosphatidylinositol-dependent and GPSM2- and G(i) alpha
CC       proteins-independent manner (PubMed:23870127, PubMed:24996901,
CC       PubMed:24109598, PubMed:24371089). Excluded from the anaphase
CC       equatorial region of the cell cortex in a RACGAP1- and KIF23-dependent
CC       and RanGTP-independent manner (PubMed:24996901). Associated with astral
CC       MTs emanating from the spindle poles during anaphase (PubMed:12445386,
CC       PubMed:24996901). Nonphosphorylated Thr-2055 localizes at the cell
CC       cortex, weakly during metaphase and more prominently during anaphase in
CC       a phosphatase PPP2CA-dependent manner (PubMed:23921553). As mitosis
CC       progresses it reassociates with telophase chromosomes very early during
CC       nuclear reformation, before substantial accumulation of lamins on
CC       chromosomal surfaces is evident (PubMed:1541636). Localizes to the tips
CC       of cortical MTs in prometaphase (PubMed:26765568). Localizes along MTs
CC       and specifically to both MT plus and minus ends (PubMed:26765568).
CC       Accumulates also at MT tips near the cell periphery (PubMed:26765568).
CC       Colocalizes with GPSM2 at mitotic spindle poles during mitosis
CC       (PubMed:11781568, PubMed:21816348). Colocalizes with SPAG5 at mitotic
CC       spindle at prometaphase and at mitotic spindle poles at metaphase and
CC       anaphase (PubMed:27462074). Colocalizes with ABRO1 at mitotic spindle
CC       poles (PubMed:26195665). Colocalized with TNKS from prophase through to
CC       anaphase in mitosis (PubMed:16076287). Colocalizes with tubulin alpha
CC       (PubMed:12445386). CCSAP is essential for its centrosomal localization
CC       (PubMed:26562023). In horizontally retinal progenitor dividing cells,
CC       localized to the lateral cortical region (By similarity).
CC       {ECO:0000250|UniProtKB:E9Q7G0, ECO:0000269|PubMed:10811826,
CC       ECO:0000269|PubMed:11781568, ECO:0000269|PubMed:12445386,
CC       ECO:0000269|PubMed:1541630, ECO:0000269|PubMed:1541636,
CC       ECO:0000269|PubMed:16076287, ECO:0000269|PubMed:21816348,
CC       ECO:0000269|PubMed:22327364, ECO:0000269|PubMed:23870127,
CC       ECO:0000269|PubMed:23921553, ECO:0000269|PubMed:24109598,
CC       ECO:0000269|PubMed:24371089, ECO:0000269|PubMed:24996901,
CC       ECO:0000269|PubMed:26195665, ECO:0000269|PubMed:26246606,
CC       ECO:0000269|PubMed:26562023, ECO:0000269|PubMed:26765568,
CC       ECO:0000269|PubMed:27462074}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 3]: Cytoplasm, cytosol
CC       {ECO:0000269|PubMed:7962183}. Cytoplasm, cytoskeleton, microtubule
CC       organizing center, centrosome {ECO:0000269|PubMed:7962183}. Cytoplasm,
CC       cytoskeleton, spindle pole {ECO:0000269|PubMed:7962183}. Note=During
CC       interphase, mainly clustered at the centrosomal region in the cytosol.
CC       After entry into mitosis, detected at mitotic spindle poles.
CC       {ECO:0000269|PubMed:7962183}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 4]: Cytoplasm, cytosol
CC       {ECO:0000269|PubMed:7962183}. Cytoplasm, cytoskeleton, microtubule
CC       organizing center, centrosome {ECO:0000269|PubMed:7962183}. Cytoplasm,
CC       cytoskeleton, spindle pole {ECO:0000269|PubMed:7962183}. Note=During
CC       interphase, mainly clustered at the centrosomal region in the cytosol.
CC       After entry into mitosis, detected at mitotic spindle poles.
CC       {ECO:0000269|PubMed:7962183}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1; Synonyms=Numa-1, p230;
CC         IsoId=Q14980-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q14980-2; Sequence=VSP_012910;
CC       Name=3; Synonyms=Numa-m {ECO:0000303|PubMed:7962183}, p195;
CC         IsoId=Q14980-3; Sequence=VSP_044378;
CC       Name=4; Synonyms=Numa-s {ECO:0000303|PubMed:7962183}, p194;
CC         IsoId=Q14980-4; Sequence=VSP_044379;
CC       Name=5;
CC         IsoId=Q14980-5; Sequence=VSP_054146;
CC   -!- DOMAIN: The C-terminal tubulin-binding domain mediates direct binding
CC       to microtubules, independently of dynein-dynactin complex, and induces
CC       their bundling and stabilization (PubMed:11956313). The 4.1-binding
CC       domain is necessary for its cortical stability and spindle orientation
CC       (PubMed:24109598). {ECO:0000269|PubMed:11956313,
CC       ECO:0000269|PubMed:24109598}.
CC   -!- PTM: Phosphorylation and dephosphorylation on Thr-2055 regulates the
CC       extent of cortical NUMA1 and the dynein-dynactin complex localization
CC       during mitotic metaphase and anaphase (PubMed:23921553). In metaphase,
CC       phosphorylation on Thr-2055 occurs in a kinase CDK1-dependent manner;
CC       this phosphorylation maintains low levels of cortical dynein-dynactin
CC       complex at metaphase, and hence proper spindle positioning
CC       (PubMed:7769006, PubMed:23921553, PubMed:24371089). In anaphase,
CC       dephosphorylated on Thr-2055 by phosphatase PPP2CA; this
CC       dephosphorylation stimulates its membrane association and with the
CC       dynein-dynactin complex its enrichment at the cell cortex, and hence
CC       robust spindle elongation (PubMed:23921553, PubMed:24371089). Probably
CC       also phosphorylated on Thr-2015 and Ser-2087 by CDK1; these
CC       phosphorylations may regulate its cell cortex recruitment during
CC       metaphase and anaphase (PubMed:23870127). Phosphorylated on Thr-1047,
CC       Ser-1769, Ser-1772, Ser-1789 and Ser-1834 by PLK1; these
CC       phosphorylations induce cortical dynein-dynactin complex dissociation
CC       from the NUMA1-GPSM2 complex and negatively regulates cortical dynein-
CC       dynactin complex localization (PubMed:22327364).
CC       {ECO:0000269|PubMed:22327364, ECO:0000269|PubMed:23870127,
CC       ECO:0000269|PubMed:23921553, ECO:0000269|PubMed:24371089,
CC       ECO:0000269|PubMed:7769006}.
CC   -!- PTM: ADP-ribosylated by TNKS at the onset of mitosis; ADP-ribosylation
CC       is not required for its localization to spindle poles
CC       (PubMed:16076287). {ECO:0000269|PubMed:16076287}.
CC   -!- PTM: O-glycosylated during cytokinesis at sites identical or close to
CC       phosphorylation sites, this interferes with the phosphorylation status
CC       (PubMed:20068230). {ECO:0000269|PubMed:20068230}.
CC   -!- PTM: Ubiquitinated with 'Lys-63'-linked polyubiquitin chains.
CC       Deubiquitination by the BRISC complex is important for the
CC       incorporation of NUMA1 into mitotic spindle poles and normal spindle
CC       pole function, probably by modulating interactions between NUMA1,
CC       dynein-dynactin complex and importin-beta.
CC       {ECO:0000269|PubMed:26195665}.
CC   -!- MISCELLANEOUS: Also known as nuclear matrix protein-22/NMP-22/NMP22, an
CC       antigen used in diagnostic tests of bladder cancer.
CC       {ECO:0000269|PubMed:9730450}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA77670.1; Type=Frameshift; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/NUMAID119.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z14227; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; Z14228; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; Z14229; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; Z11583; CAA77669.1; -; mRNA.
DR   EMBL; Z11584; CAA77670.1; ALT_FRAME; mRNA.
DR   EMBL; AP002490; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471076; EAW74826.1; -; Genomic_DNA.
DR   EMBL; BC004165; AAH04165.1; -; mRNA.
DR   CCDS; CCDS31633.1; -. [Q14980-1]
DR   CCDS; CCDS66156.1; -. [Q14980-2]
DR   PIR; A42184; A42184.
DR   RefSeq; NP_001273490.1; NM_001286561.1. [Q14980-2]
DR   RefSeq; NP_006176.2; NM_006185.3. [Q14980-1]
DR   RefSeq; XP_006718627.1; XM_006718564.1. [Q14980-1]
DR   PDB; 3RO2; X-ray; 2.30 A; B=1899-1926.
DR   PDB; 5GXW; X-ray; 2.39 A; B=1984-2010.
DR   PDB; 6HC2; X-ray; 4.31 A; B/D/F/H/J/L/N/P/R/T/V/X=1860-1928.
DR   PDBsum; 3RO2; -.
DR   PDBsum; 5GXW; -.
DR   PDBsum; 6HC2; -.
DR   SMR; Q14980; -.
DR   BioGrid; 110980; 133.
DR   CORUM; Q14980; -.
DR   DIP; DIP-32937N; -.
DR   ELM; Q14980; -.
DR   IntAct; Q14980; 80.
DR   MINT; Q14980; -.
DR   STRING; 9606.ENSP00000377298; -.
DR   CarbonylDB; Q14980; -.
DR   iPTMnet; Q14980; -.
DR   MetOSite; Q14980; -.
DR   PhosphoSitePlus; Q14980; -.
DR   SwissPalm; Q14980; -.
DR   BioMuta; NUMA1; -.
DR   DMDM; 145559510; -.
DR   CPTAC; CPTAC-937; -.
DR   EPD; Q14980; -.
DR   jPOST; Q14980; -.
DR   MassIVE; Q14980; -.
DR   MaxQB; Q14980; -.
DR   PaxDb; Q14980; -.
DR   PeptideAtlas; Q14980; -.
DR   PRIDE; Q14980; -.
DR   ProteomicsDB; 38621; -.
DR   ProteomicsDB; 60272; -. [Q14980-1]
DR   ProteomicsDB; 60273; -. [Q14980-2]
DR   ProteomicsDB; 78989; -.
DR   Antibodypedia; 16895; 388 antibodies.
DR   DNASU; 4926; -.
DR   Ensembl; ENST00000351960; ENSP00000260051; ENSG00000137497. [Q14980-5]
DR   Ensembl; ENST00000358965; ENSP00000351851; ENSG00000137497. [Q14980-2]
DR   Ensembl; ENST00000393695; ENSP00000377298; ENSG00000137497. [Q14980-1]
DR   Ensembl; ENST00000613205; ENSP00000480172; ENSG00000137497. [Q14980-5]
DR   Ensembl; ENST00000620566; ENSP00000478624; ENSG00000137497. [Q14980-2]
DR   GeneID; 4926; -.
DR   KEGG; hsa:4926; -.
DR   UCSC; uc001ork.3; human. [Q14980-1]
DR   CTD; 4926; -.
DR   DisGeNET; 4926; -.
DR   GeneCards; NUMA1; -.
DR   HGNC; HGNC:8059; NUMA1.
DR   HPA; ENSG00000137497; Low tissue specificity.
DR   MalaCards; NUMA1; -.
DR   MIM; 164009; gene.
DR   neXtProt; NX_Q14980; -.
DR   OpenTargets; ENSG00000137497; -.
DR   Orphanet; 520; Acute promyelocytic leukemia.
DR   PharmGKB; PA31844; -.
DR   eggNOG; ENOG410IFJ8; Eukaryota.
DR   eggNOG; ENOG41125FF; LUCA.
DR   GeneTree; ENSGT00950000183078; -.
DR   HOGENOM; CLU_006666_1_0_1; -.
DR   InParanoid; Q14980; -.
DR   KO; K16808; -.
DR   OMA; WDQFEYK; -.
DR   OrthoDB; 524033at2759; -.
DR   PhylomeDB; Q14980; -.
DR   TreeFam; TF334442; -.
DR   Reactome; R-HSA-380320; Recruitment of NuMA to mitotic centrosomes.
DR   Reactome; R-HSA-68875; Mitotic Prophase.
DR   SIGNOR; Q14980; -.
DR   ChiTaRS; NUMA1; human.
DR   GeneWiki; Nuclear_mitotic_apparatus_protein_1; -.
DR   GenomeRNAi; 4926; -.
DR   Pharos; Q14980; Tbio.
DR   PRO; PR:Q14980; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; Q14980; protein.
DR   Bgee; ENSG00000137497; Expressed in myometrium and 238 other tissues.
DR   ExpressionAtlas; Q14980; baseline and differential.
DR   Genevisible; Q14980; HS.
DR   GO; GO:0005623; C:cell; IEA:GOC.
DR   GO; GO:0005938; C:cell cortex; IDA:UniProtKB.
DR   GO; GO:0099738; C:cell cortex region; IDA:UniProtKB.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005694; C:chromosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0055028; C:cortical microtubule; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:1905720; C:cytoplasmic microtubule bundle; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0019897; C:extrinsic component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IEA:InterPro.
DR   GO; GO:0097575; C:lateral cell cortex; ISS:UniProtKB.
DR   GO; GO:0016328; C:lateral plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0097427; C:microtubule bundle; IDA:UniProtKB.
DR   GO; GO:0036449; C:microtubule minus-end; IDA:UniProtKB.
DR   GO; GO:0035371; C:microtubule plus-end; IDA:UniProtKB.
DR   GO; GO:0072686; C:mitotic spindle; IDA:UniProtKB.
DR   GO; GO:0061673; C:mitotic spindle astral microtubule; IDA:UniProtKB.
DR   GO; GO:1990023; C:mitotic spindle midzone; IDA:UniProtKB.
DR   GO; GO:0097431; C:mitotic spindle pole; IDA:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0016363; C:nuclear matrix; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:0005819; C:spindle; TAS:ProtInc.
DR   GO; GO:0005876; C:spindle microtubule; IDA:UniProtKB.
DR   GO; GO:0000922; C:spindle pole; IDA:UniProtKB.
DR   GO; GO:0031616; C:spindle pole centrosome; IDA:UniProtKB.
DR   GO; GO:0097718; F:disordered domain specific binding; IMP:CAFA.
DR   GO; GO:0070840; F:dynein complex binding; IDA:UniProtKB.
DR   GO; GO:0008017; F:microtubule binding; IDA:UniProtKB.
DR   GO; GO:0051011; F:microtubule minus-end binding; IDA:UniProtKB.
DR   GO; GO:0051010; F:microtubule plus-end binding; IDA:UniProtKB.
DR   GO; GO:0035091; F:phosphatidylinositol binding; IDA:UniProtKB.
DR   GO; GO:0008022; F:protein C-terminus binding; IMP:CAFA.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:UniProtKB.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:UniProtKB.
DR   GO; GO:0005198; F:structural molecule activity; TAS:ProtInc.
DR   GO; GO:0015631; F:tubulin binding; IDA:UniProtKB.
DR   GO; GO:0055048; P:anastral spindle assembly; IMP:UniProtKB.
DR   GO; GO:0030953; P:astral microtubule organization; IDA:UniProtKB.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0007059; P:chromosome segregation; IEA:UniProtKB-KW.
DR   GO; GO:0000132; P:establishment of mitotic spindle orientation; IDA:UniProtKB.
DR   GO; GO:0051321; P:meiotic cell cycle; IEA:Ensembl.
DR   GO; GO:0001578; P:microtubule bundle formation; IMP:UniProtKB.
DR   GO; GO:0006997; P:nucleus organization; TAS:ProtInc.
DR   GO; GO:0030513; P:positive regulation of BMP signaling pathway; ISS:UniProtKB.
DR   GO; GO:0051984; P:positive regulation of chromosome segregation; IMP:UniProtKB.
DR   GO; GO:1905820; P:positive regulation of chromosome separation; IMP:UniProtKB.
DR   GO; GO:0051798; P:positive regulation of hair follicle development; ISS:UniProtKB.
DR   GO; GO:0032388; P:positive regulation of intracellular transport; IMP:UniProtKB.
DR   GO; GO:0045618; P:positive regulation of keratinocyte differentiation; ISS:UniProtKB.
DR   GO; GO:0031116; P:positive regulation of microtubule polymerization; IMP:UniProtKB.
DR   GO; GO:1902846; P:positive regulation of mitotic spindle elongation; IMP:UniProtKB.
DR   GO; GO:1904778; P:positive regulation of protein localization to cell cortex; IMP:UniProtKB.
DR   GO; GO:1902365; P:positive regulation of protein localization to spindle pole body; IDA:UniProtKB.
DR   GO; GO:1905832; P:positive regulation of spindle assembly; IMP:UniProtKB.
DR   GO; GO:0090235; P:regulation of metaphase plate congression; IMP:UniProtKB.
DR   GO; GO:0060236; P:regulation of mitotic spindle organization; IDA:UniProtKB.
DR   InterPro; IPR026650; NUMA1.
DR   PANTHER; PTHR18902:SF24; PTHR18902:SF24; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ADP-ribosylation; Alternative splicing;
KW   Cell cycle; Cell division; Cell membrane; Chromosome; Chromosome partition;
KW   Coiled coil; Cytoplasm; Cytoskeleton; Glycoprotein; Isopeptide bond;
KW   Lipid-binding; Lipoprotein; Membrane; Microtubule; Mitosis; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Ubl conjugation.
FT   CHAIN           1..2115
FT                   /note="Nuclear mitotic apparatus protein 1"
FT                   /id="PRO_0000057998"
FT   REGION          1..212
FT                   /note="Head (Globular)"
FT   REGION          1699..1876
FT                   /note="Membrane-binding domain 1"
FT                   /evidence="ECO:0000269|PubMed:24996901"
FT   REGION          1700..2115
FT                   /note="Tail (Globular)"
FT   REGION          1788..1810
FT                   /note="4.1-binding domain"
FT                   /evidence="ECO:0000269|PubMed:24109598,
FT                   ECO:0000269|PubMed:24996901"
FT   REGION          1882..1985
FT                   /note="Tubulin-binding domain"
FT                   /evidence="ECO:0000269|PubMed:11956313,
FT                   ECO:0000269|PubMed:12445386"
FT   REGION          1892..1926
FT                   /note="GPSM2-binding domain"
FT                   /evidence="ECO:0000269|PubMed:11781568,
FT                   ECO:0000269|PubMed:12445386, ECO:0000269|PubMed:21816348,
FT                   ECO:0000269|PubMed:24109598"
FT   REGION          1981..2060
FT                   /note="Membrane-binding domain 2"
FT                   /evidence="ECO:0000269|PubMed:24371089"
FT   COILED          213..1699
FT                   /evidence="ECO:0000255"
FT   MOTIF           1742..1748
FT                   /note="Tankyrase-binding domain"
FT                   /evidence="ECO:0000269|PubMed:12080061"
FT   MOTIF           1984..1989
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000269|PubMed:26765568,
FT                   ECO:0000269|PubMed:7962183"
FT   MOD_RES         162
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         163
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         169
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         203
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231"
FT   MOD_RES         211
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231"
FT   MOD_RES         271
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         379
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         388
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17525332"
FT   MOD_RES         395
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17525332"
FT   MOD_RES         820
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17525332"
FT   MOD_RES         891
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         1047
FT                   /note="Phosphothreonine; by PLK1"
FT                   /evidence="ECO:0000269|PubMed:22327364"
FT   MOD_RES         1187
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         1225
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:24275569"
FT   MOD_RES         1511
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         1601
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17525332"
FT   MOD_RES         1721
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         1724
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         1728
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         1757
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:16964243,
FT                   ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:17525332,
FT                   ECO:0000244|PubMed:18220336, ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19367720, ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         1760
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17525332"
FT   MOD_RES         1769
FT                   /note="Phosphoserine; by PLK1"
FT                   /evidence="ECO:0000244|PubMed:16964243,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163,
FT                   ECO:0000269|PubMed:22327364"
FT   MOD_RES         1772
FT                   /note="Phosphoserine; by PLK1"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000269|PubMed:22327364"
FT   MOD_RES         1774
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         1776
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:16964243,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332"
FT   MOD_RES         1788
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:24275569"
FT   MOD_RES         1789
FT                   /note="Phosphoserine; by PLK1"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000269|PubMed:22327364"
FT   MOD_RES         1792
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         1800
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332"
FT   MOD_RES         1804
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         1830
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163"
FT   MOD_RES         1833
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         1834
FT                   /note="Phosphoserine; by PLK1"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:22327364"
FT   MOD_RES         1836
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         1840
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:16964243,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163"
FT   MOD_RES         1844
FT                   /note="Phosphoserine; alternate"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         1862
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163"
FT   MOD_RES         1887
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         1969
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163"
FT   MOD_RES         1991
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163"
FT   MOD_RES         2000
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163"
FT   MOD_RES         2003
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         2015
FT                   /note="Phosphothreonine; by CDK1"
FT                   /evidence="ECO:0000269|PubMed:23921553,
FT                   ECO:0000269|PubMed:7769006"
FT   MOD_RES         2047
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         2055
FT                   /note="Phosphothreonine; by CDK1"
FT                   /evidence="ECO:0000244|PubMed:23186163,
FT                   ECO:0000269|PubMed:23921553, ECO:0000269|PubMed:7769006"
FT   MOD_RES         2062
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         2077
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17924679"
FT   MOD_RES         2087
FT                   /note="Phosphoserine; by CDK1"
FT                   /evidence="ECO:0000269|PubMed:23921553,
FT                   ECO:0000269|PubMed:7769006"
FT   MOD_RES         2106
FT                   /note="Phosphothreonine; by CDK1"
FT                   /evidence="ECO:0000244|PubMed:16964243,
FT                   ECO:0000269|PubMed:23921553, ECO:0000269|PubMed:7769006"
FT   CARBOHYD        1844
FT                   /note="O-linked (GlcNAc) serine; alternate"
FT                   /evidence="ECO:0000269|PubMed:20068230"
FT   CROSSLNK        1699
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        1766
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000244|PubMed:25114211"
FT   CROSSLNK        1766
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:25114211,
FT                   ECO:0000244|PubMed:25218447, ECO:0000244|PubMed:25772364,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        1822
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   VAR_SEQ         414..1549
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_054146"
FT   VAR_SEQ         1536..1549
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:1541636"
FT                   /id="VSP_012910"
FT   VAR_SEQ         1725..2115
FT                   /note="LDLSCEEGTPLSITSKLPRTQPDGTSVPGEPASPISQRLPPKVESLESLYFT
FT                   PIPARSQAPLESSLDSLGDVFLDSGRKTRSARRRTTQIINITMTKKLDVEEPDSANSSF
FT                   YSTRSAPASQASLRATSSTQSLARLGSPDYGNSALLSLPGYRPTTRSSARRSQAGVSSG
FT                   APPGRNSFYMGTCQDEPEQLDDWNRIAELQQRNRVCPPHLKTCYPLESRPSLSLGTITD
FT                   EEMKTGDPQETLRRASMQPIQIAEGTGITTRQQRKRVSLEPHQGPGTPESKKATSCFPR
FT                   PMTPRDRHEGRKQSTTEAQKKAAPASTKQADRRQSMAFSILNTPKKLGNSLLRRGASKK
FT                   ALSKASPNTRSGTRRSPRIATTTASAATAAAIGATPRAKGKAKH -> SQANSSQTPRD
FT                   SDACPHPGLVPGPSLAPSRSWPRGPGAWTVWALSLPCLLFS (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:8505359"
FT                   /id="VSP_044378"
FT   VAR_SEQ         1739..2115
FT                   /note="SKLPRTQPDGTSVPGEPASPISQRLPPKVESLESLYFTPIPARSQAPLESSL
FT                   DSLGDVFLDSGRKTRSARRRTTQIINITMTKKLDVEEPDSANSSFYSTRSAPASQASLR
FT                   ATSSTQSLARLGSPDYGNSALLSLPGYRPTTRSSARRSQAGVSSGAPPGRNSFYMGTCQ
FT                   DEPEQLDDWNRIAELQQRNRVCPPHLKTCYPLESRPSLSLGTITDEEMKTGDPQETLRR
FT                   ASMQPIQIAEGTGITTRQQRKRVSLEPHQGPGTPESKKATSCFPRPMTPRDRHEGRKQS
FT                   TTEAQKKAAPASTKQADRRQSMAFSILNTPKKLGNSLLRRGASKKALSKASPNTRSGTR
FT                   RSPRIATTTASAATAAAIGATPRAKGKAKH -> RSGGSLPPYVCLWSACCLSGCILVR
FT                   (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:8505359"
FT                   /id="VSP_044379"
FT   VARIANT         242
FT                   /note="K -> R (in dbSNP:rs34239655)"
FT                   /id="VAR_031679"
FT   VARIANT         794
FT                   /note="A -> G (in dbSNP:rs3750913)"
FT                   /id="VAR_031680"
FT   VARIANT         1153
FT                   /note="E -> D (in dbSNP:rs34311364)"
FT                   /id="VAR_031681"
FT   VARIANT         1825
FT                   /note="V -> M (in dbSNP:rs7949430)"
FT                   /id="VAR_031682"
FT   VARIANT         1836
FT                   /note="Y -> H (in dbSNP:rs35586429)"
FT                   /id="VAR_031683"
FT   VARIANT         2049
FT                   /note="A -> T (in dbSNP:rs5743685)"
FT                   /id="VAR_051248"
FT   MUTAGEN         1910
FT                   /note="E->A: Abolishes interaction with GPSM2."
FT                   /evidence="ECO:0000269|PubMed:21816348"
FT   MUTAGEN         1984
FT                   /note="R->G: No effect on nuclear localization."
FT                   /evidence="ECO:0000269|PubMed:7962183"
FT   MUTAGEN         1988
FT                   /note="K->E: Abolishes nuclear localization."
FT                   /evidence="ECO:0000269|PubMed:7962183"
FT   MUTAGEN         2015
FT                   /note="T->A: Abolishes association with the mitotic
FT                   spindle. Increases premature accumulation at the cell
FT                   cortex during metaphase; when associated with A-2055 and A-
FT                   2087."
FT                   /evidence="ECO:0000269|PubMed:23870127,
FT                   ECO:0000269|PubMed:7769006"
FT   MUTAGEN         2055
FT                   /note="T->A: Increases premature accumulation at the cell
FT                   membrane of the polar cortical region in prophase and
FT                   metaphase. Reduces association with the mitotic spindle.
FT                   Increased randomization of spindle orientation. Increases
FT                   premature accumulation at the cell cortex during metaphase;
FT                   when associated with A-2015 and A-2087."
FT                   /evidence="ECO:0000269|PubMed:23870127,
FT                   ECO:0000269|PubMed:23921553, ECO:0000269|PubMed:24109598,
FT                   ECO:0000269|PubMed:24371089, ECO:0000269|PubMed:24996901,
FT                   ECO:0000269|PubMed:7769006"
FT   MUTAGEN         2055
FT                   /note="T->D: Increases localization at the spindle poles.
FT                   Decreases localization at the cell cortex."
FT                   /evidence="ECO:0000269|PubMed:24109598"
FT   MUTAGEN         2055
FT                   /note="T->E: Absence of cell membrane association even in
FT                   anaphase. Increased localization at spindle poles and
FT                   chromosome congression defects. Does not localize to the
FT                   cortex in either metaphase or anaphase. Increased
FT                   randomization of spindle orientation."
FT                   /evidence="ECO:0000269|PubMed:23921553,
FT                   ECO:0000269|PubMed:24371089"
FT   MUTAGEN         2087
FT                   /note="S->A: Abolishes association with the mitotic
FT                   spindle. Increases premature accumulation at the cell
FT                   cortex during metaphase; when associated with A-2015 and A-
FT                   2055."
FT                   /evidence="ECO:0000269|PubMed:23870127,
FT                   ECO:0000269|PubMed:7769006"
FT   MUTAGEN         2106
FT                   /note="T->A: Abolishes association with the mitotic
FT                   spindle."
FT                   /evidence="ECO:0000269|PubMed:7769006"
FT   CONFLICT        772
FT                   /note="Q -> L (in Ref. 2; CAA77670)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        815..816
FT                   /note="ER -> DG (in Ref. 2; CAA77670)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        873
FT                   /note="E -> K (in Ref. 2; CAA77670)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1589
FT                   /note="L -> F (in Ref. 2; CAA77670)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1637
FT                   /note="S -> T (in Ref. 3; Z14227/Z14228)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1682
FT                   /note="S -> T (in Ref. 3; Z14227/Z14228)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1798
FT                   /note="L -> Q (in Ref. 3; CAA77669)"
FT                   /evidence="ECO:0000305"
FT   TURN            1917..1919
FT                   /evidence="ECO:0000244|PDB:3RO2"
FT   HELIX           1920..1922
FT                   /evidence="ECO:0000244|PDB:3RO2"
FT   STRAND          1995..1997
FT                   /evidence="ECO:0000244|PDB:5GXW"
SQ   SEQUENCE   2115 AA;  238260 MW;  DE734EC85B812CC7 CRC64;
     MTLHATRGAA LLSWVNSLHV ADPVEAVLQL QDCSIFIKII DRIHGTEEGQ QILKQPVSER
     LDFVCSFLQK NRKHPSSPEC LVSAQKVLEG SELELAKMTM LLLYHSTMSS KSPRDWEQFE
     YKIQAELAVI LKFVLDHEDG LNLNEDLENF LQKAPVPSTC SSTFPEELSP PSHQAKREIR
     FLELQKVASS SSGNNFLSGS PASPMGDILQ TPQFQMRRLK KQLADERSNR DELELELAEN
     RKLLTEKDAQ IAMMQQRIDR LALLNEKQAA SPLEPKELEE LRDKNESLTM RLHETLKQCQ
     DLKTEKSQMD RKINQLSEEN GDLSFKLREF ASHLQQLQDA LNELTEEHSK ATQEWLEKQA
     QLEKELSAAL QDKKCLEEKN EILQGKLSQL EEHLSQLQDN PPQEKGEVLG DVLQLETLKQ
     EAATLAANNT QLQARVEMLE TERGQQEAKL LAERGHFEEE KQQLSSLITD LQSSISNLSQ
     AKEELEQASQ AHGARLTAQV ASLTSELTTL NATIQQQDQE LAGLKQQAKE KQAQLAQTLQ
     QQEQASQGLR HQVEQLSSSL KQKEQQLKEV AEKQEATRQD HAQQLATAAE EREASLRERD
     AALKQLEALE KEKAAKLEIL QQQLQVANEA RDSAQTSVTQ AQREKAELSR KVEELQACVE
     TARQEQHEAQ AQVAELELQL RSEQQKATEK ERVAQEKDQL QEQLQALKES LKVTKGSLEE
     EKRRAADALE EQQRCISELK AETRSLVEQH KRERKELEEE RAGRKGLEAR LQQLGEAHQA
     ETEVLRRELA EAMAAQHTAE SECEQLVKEV AAWRERYEDS QQEEAQYGAM FQEQLMTLKE
     ECEKARQELQ EAKEKVAGIE SHSELQISRQ QNELAELHAN LARALQQVQE KEVRAQKLAD
     DLSTLQEKMA ATSKEVARLE TLVRKAGEQQ ETASRELVKE PARAGDRQPE WLEEQQGRQF
     CSTQAALQAM EREAEQMGNE LERLRAALME SQGQQQEERG QQEREVARLT QERGRAQADL
     ALEKAARAEL EMRLQNALNE QRVEFATLQE ALAHALTEKE GKDQELAKLR GLEAAQIKEL
     EELRQTVKQL KEQLAKKEKE HASGSGAQSE AAGRTEPTGP KLEALRAEVS KLEQQCQKQQ
     EQADSLERSL EAERASRAER DSALETLQGQ LEEKAQELGH SQSALASAQR ELAAFRTKVQ
     DHSKAEDEWK AQVARGRQEA ERKNSLISSL EEEVSILNRQ VLEKEGESKE LKRLVMAESE
     KSQKLEERLR LLQAETASNS ARAAERSSAL REEVQSLREE AEKQRVASEN LRQELTSQAE
     RAEELGQELK AWQEKFFQKE QALSTLQLEH TSTQALVSEL LPAKHLCQQL QAEQAAAEKR
     HREELEQSKQ AAGGLRAELL RAQRELGELI PLRQKVAEQE RTAQQLRAEK ASYAEQLSML
     KKAHGLLAEE NRGLGERANL GRQFLEVELD QAREKYVQEL AAVRADAETR LAEVQREAQS
     TARELEVMTA KYEGAKVKVL EERQRFQEER QKLTAQVEQL EVFQREQTKQ VEELSKKLAD
     SDQASKVQQQ KLKAVQAQGG ESQQEAQRLQ AQLNELQAQL SQKEQAAEHY KLQMEKAKTH
     YDAKKQQNQE LQEQLRSLEQ LQKENKELRA EAERLGHELQ QAGLKTKEAE QTCRHLTAQV
     RSLEAQVAHA DQQLRDLGKF QVATDALKSR EPQAKPQLDL SIDSLDLSCE EGTPLSITSK
     LPRTQPDGTS VPGEPASPIS QRLPPKVESL ESLYFTPIPA RSQAPLESSL DSLGDVFLDS
     GRKTRSARRR TTQIINITMT KKLDVEEPDS ANSSFYSTRS APASQASLRA TSSTQSLARL
     GSPDYGNSAL LSLPGYRPTT RSSARRSQAG VSSGAPPGRN SFYMGTCQDE PEQLDDWNRI
     AELQQRNRVC PPHLKTCYPL ESRPSLSLGT ITDEEMKTGD PQETLRRASM QPIQIAEGTG
     ITTRQQRKRV SLEPHQGPGT PESKKATSCF PRPMTPRDRH EGRKQSTTEA QKKAAPASTK
     QADRRQSMAF SILNTPKKLG NSLLRRGASK KALSKASPNT RSGTRRSPRI ATTTASAATA
     AAIGATPRAK GKAKH
//
ID   Q3SYK8_HUMAN            Unreviewed;       691 AA.
AC   Q3SYK8;
DT   11-OCT-2005, integrated into UniProtKB/TrEMBL.
DT   11-OCT-2005, sequence version 1.
DT   22-APR-2020, entry version 90.
DE   SubName: Full=NUMA1 protein {ECO:0000313|EMBL:AAI03766.1};
DE   Flags: Fragment;
GN   Name=NUMA1 {ECO:0000313|EMBL:AAI03766.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAI03766.1};
RN   [1] {ECO:0000313|EMBL:AAI03766.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis {ECO:0000313|EMBL:AAH27493.1}, and
RC   Uterus {ECO:0000313|EMBL:AAI03766.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M., Peck A.M.,
RA   Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S., Feolo M.,
RA   Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F., Schaefer C.F.,
RA   Buetow K., Bonner T.I., Haussler D., Kent J., Kiekhaus M., Furey T.,
RA   Brent M., Prange C., Schreiber K., Shapiro N., Bhat N.K., Hopkins R.F.,
RA   Hsie F., Driscoll T., Soares M.B., Casavant T.L., Scheetz T.E.,
RA   Brown-stein M.J., Usdin T.B., Toshiyuki S., Carninci P., Piao Y.,
RA   Dudekula D.B., Ko M.S., Kawakami K., Suzuki Y., Sugano S., Gruber C.E.,
RA   Smith M.R., Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y.,
RA   Wei C.L., Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W.,
RA   Fuh E., Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D., Granite S.J.,
RA   Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G., Blakesly R.W.,
RA   Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J.,
RA   Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L., Krzywinski M.I.,
RA   Liao N., Morin R., Morrin R., Palmquist D., Petrescu A.S., Skalska U.,
RA   Smailus D.E., Stott J.M., Schnerch A., Schein J.E., Jones S.J., Holt R.A.,
RA   Baross A., Marra M.A., Clifton S., Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC027493; AAH27493.1; -; mRNA.
DR   EMBL; BC103765; AAI03766.1; -; mRNA.
DR   RefSeq; NP_006176.2; NM_006185.3.
DR   DNASU; 4926; -.
DR   GeneID; 4926; -.
DR   KEGG; hsa:4926; -.
DR   CTD; 4926; -.
DR   PharmGKB; PA31844; -.
DR   eggNOG; ENOG410IFJ8; Eukaryota.
DR   eggNOG; ENOG41125FF; LUCA.
DR   KO; K16808; -.
DR   OrthoDB; 524033at2759; -.
DR   ChiTaRS; NUMA1; human.
DR   GenomeRNAi; 4926; -.
DR   GO; GO:0000139; C:Golgi membrane; IEA:InterPro.
DR   InterPro; IPR026650; NUMA1.
DR   PANTHER; PTHR18902:SF24; PTHR18902:SF24; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   REGION          549..596
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          216..250
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          278..319
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          327..400
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          415..449
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          468..491
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        549..564
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        565..596
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   NON_TER         691
FT                   /evidence="ECO:0000313|EMBL:AAI03766.1"
SQ   SEQUENCE   691 AA;  78315 MW;  06AB1952EDEE9A3D CRC64;
     MTLHATRGAA LLSWVNSLHV ADPVEAVLQL QDCSIFIKII DRIHGTEEGQ QILKQPVSER
     LDFVCSFLQK NRKHPSSPEC LVSAQKVLEG SELELAKMTM LLLYHSTMSS KSPRDWEQFE
     YKIQAELAVI LKFVLDHEDG LNLNEDLENF LQKAPVPSTC SSTFPEELSP PSHQAKREIR
     FLELQKVASS SSGNNFLSGS PASPMGDILQ TPQFQMRRLK KQLADERSNR DELELELAEN
     RKLLTEKDAQ IAMMQQRIDR LALLNEKQAA SPLEPKELEE LRDKNESLTM RLHETLKQCQ
     DLKTEKSQMD RKINQLSEEN GDLSFKLREF ASHLQQLQDA LNELTEEHSK ATQEWLEKQA
     QLEKELSAAL QDKKCLEEKN EILQGKLSQL EEHLSQLQDN PPQEKGEVLG DVLQLETLKQ
     EAATLAANNT QLQARVEMLE TERGQQEAKL LAERGHFEEE KQQLSSLITD LQSSISNLSQ
     AKEELEQASQ AHGARLTAQV ASLTSELTTL NATIQQQDQE LAGLKQQAKE KQAQLAQTLQ
     QQEQASQGLR HQVEQLSSSL KQKEQQLKEV AEKQEATRQD HAQQLATAAE EREASLRERD
     AALKQLEALE KEKAAKLEIL QQQLQVANEA RDSAQTSVTQ AQREKAELSR KVEELQACVE
     TARQEQHEAQ AQVAELELQL RSEQQKAKKK K
//
ID   Q4LE64_HUMAN            Unreviewed;      2121 AA.
AC   Q4LE64;
DT   02-AUG-2005, integrated into UniProtKB/TrEMBL.
DT   02-AUG-2005, sequence version 1.
DT   26-FEB-2020, entry version 82.
DE   SubName: Full=NUMA1 variant protein {ECO:0000313|EMBL:BAE06089.1};
DE   Flags: Fragment;
GN   Name=NUMA1 variant protein {ECO:0000313|EMBL:BAE06089.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAE06089.1};
RN   [1] {ECO:0000313|EMBL:BAE06089.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAE06089.1};
RA   Nakajima D., Saito K., Yamakawa H., Kikuno R.F., Nakayama M., Ohara R.,
RA   Okazaki N., Koga H., Nagase T., Ohara O.;
RT   "Preparation of a set of expression-ready clones of mammalian long cDNAs
RT   encoding large proteins by the ORF trap cloning method.";
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB210007; BAE06089.1; -; mRNA.
DR   RefSeq; NP_001273490.1; NM_001286561.1.
DR   RefSeq; NP_006176.2; NM_006185.3.
DR   RefSeq; XP_006718627.1; XM_006718564.1.
DR   PeptideAtlas; Q4LE64; -.
DR   PRIDE; Q4LE64; -.
DR   DNASU; 4926; -.
DR   GeneID; 4926; -.
DR   KEGG; hsa:4926; -.
DR   CTD; 4926; -.
DR   PharmGKB; PA31844; -.
DR   eggNOG; ENOG410IFJ8; Eukaryota.
DR   eggNOG; ENOG41125FF; LUCA.
DR   KO; K16808; -.
DR   OrthoDB; 524033at2759; -.
DR   ChiTaRS; NUMA1; human.
DR   GenomeRNAi; 4926; -.
DR   Genevisible; Q4LE64; HS.
DR   GO; GO:0000139; C:Golgi membrane; IEA:InterPro.
DR   InterPro; IPR026650; NUMA1.
DR   PANTHER; PTHR18902:SF24; PTHR18902:SF24; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   REGION          555..599
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          752..772
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          932..963
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1096..1231
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1281..1302
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1740..1767
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1832..1907
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1961..2121
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          222..256
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          284..325
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          333..406
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          421..455
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          474..497
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          795..829
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          834..868
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          873..928
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          973..1046
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1373..1411
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1415..1449
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1468..1517
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1522..1549
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1578..1699
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        555..570
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        571..599
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        932..959
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1096..1110
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1150..1167
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1201..1231
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1740..1762
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1836..1868
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1879..1901
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1970..1993
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2020..2034
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2035..2064
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2079..2106
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   NON_TER         1
FT                   /evidence="ECO:0000313|EMBL:BAE06089.1"
SQ   SEQUENCE   2121 AA;  238859 MW;  32080FE79C65BA1D CRC64;
     LSGITKMTLH ATRGAALLSW VNSLHVADPV EAVLQLQDCS IFIKIIDRIH GTEEGQQILK
     QPVSERLDFV CSFLQKNRKH PSSPECLVSA QKVLEGSELE LAKMTMLLLY HSTMSSKSPR
     DWEQFEYKIQ AELAVILKFV LDHEDGLNLN EDLENFLQKA PVPSTCSSTF PEELSPPSHQ
     AKREIRFLEL QKVASSSSGN NFLSGSPASP MGDILQTPQF QMRRLKKQLA DERSNRDELE
     LELAENRKLL TEKDAQIAMM QQRIDRLALL NEKQAASPLE PKELEELRDK NESLTMRLHE
     TLKQCQDLKT EKSQMDRKIN QLSEENGDLS FKLREFASHL QQLQDALNEL TEEHSKATQE
     WLEKQAQLEK ELSAALQDKK CLEEKNEILQ GKLSQLEEHL SQLQDNPPQE KGEVLGDVLQ
     LETLKQEAAT LAANNTQLQA RVEMLETERG QQEAKLLAER GHFEEEKQQL SSLITDLQSS
     ISNLSQAKEE LEQASQAHGA RLTAQVASLT SELTTLNATI QQQDQELAGL KQQAKEKQAQ
     LAQTLQQQEQ ASQGLRHQVE QLSSSLKQKE QQLKEVAEKQ EATRQDHAQQ LATAAEEREA
     SLRERDAALK QLEALEKEKA AKLEILQQQL QVANEARDSA QTSVTQAQRE KAELSRKVEE
     LQACVETARQ EQHEAQAQVA ELELQLRSEQ QKATEKERVA QEKDQLQEQL QALKESLKVT
     KGSLEEEKRR AADALEEQQR CISELKAETR SLVEQHKRER KELEEERAGR KGLEARLQQL
     GEAHQAETEV LRRELAEAMA AQHTAESECE QLVKEVAAWR ERYEDSQQEE AQYGAMFQEQ
     LMTLKEECEK ARQELQEAKE KVAGIESHSE LQISRQQNEL AELHANLARA LQQVQEKEVR
     AQKLADDLST LQEKMAATSK EVARLETLVR KAGEQQETAS RELVKEPARA GDRQPEWLEE
     QQGRQFCSTQ AALQAMEREA EQMGNELERL RAALMESQGQ QQEERGQQER EVARLTQERG
     RAQADLALEK AARAELEMRL QNALNEQRVE FATLQEALAH ALTEKEGKDQ ELAKLRGLEA
     AQIKELEELR QTVKQLKEQL AKKEKEHASG SGAQSEAAGR TEPTGPKLEA LRAEVSKLEQ
     QCQKQQEQAD SLERSLEAER ASRAERDSAL ETLQGQLEEK AQELGHSQSA LASAQRELAA
     FRTKVQDHSK AEDEWKAQVA RGRQEAERKN SLISSLEEEV SILNRQVLEK EGESKELKRL
     VMAESEKSQK LEERLRLLQA ETASNSARAA ERSSALREEV QSLREEAEKQ RVASENLRQE
     LTSQAERAEE LGQELKAWQE KFFQKEQALS TLQLEHTSTQ ALVSELLPAK HLCQQLQAEQ
     AAAEKRHREE LEQSKQAAGG LRAELLRAQR ELGELIPLRQ KVAEQERTAQ QLRAEKASYA
     EQLSMLKKAH GLLAEENRGL GERANLGRQF LEVELDQARE KYVQELAAVR ADAETRLAEV
     QREAQSTARE LEVMTAKYEG AKVKVLEERQ RFQEERQKLT AQVEQLEVFQ REQTKQVEEL
     SKKLADSDQA SKVQQQKLKA VQAQGGESQQ EAQRLQAQLN ELQAQLSQKE QAAEHYKLQM
     EKAKTHYDAK KQQNQELQEQ LRSLEQLQKE NKELRAEAER LGHELQQAGL KTKEAEQTCR
     HLTAQVRSLE AQVAHADQQL RDLGKFQVAT DALKSREPQA KPQLDLSIDS LDLSCEEGTP
     LSITSKLPRT QPDGTSVPGE PASPISQRLP PKVESLESLY FTPIPARSQA PLESSLDSLG
     DVFLDSGRKT RSARRRTTQI INITMTKKLD VEEPDSANSS FYSTRSAPAS QASLRATSST
     QSLARLGSPD YGNSALLSLP GYRPTTRSSA RRSQAGVSSG APPGRNSFYM GTCQDEPEQL
     DDWNRIAELQ QRNRVCPPHL KTCYPLESRP SLSLGTITDE EMKTGDPQET LRRASMQPIQ
     IAEGTGITTR QQRKRVSLEP HQGPGTPESK KATSCFPRPM TPRDRHEGRK QSTTEAQKKA
     APASTKQADR RQSMAFSILN TPKKLGNSLL RRGASKKALS KASPNTRSGT RRSPRIATTT
     ASAATAAAIG ATPRAKGKAK H
//
ID   B7ZAV2_HUMAN            Unreviewed;       916 AA.
AC   B7ZAV2;
DT   03-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   03-MAR-2009, sequence version 1.
DT   22-APR-2020, entry version 84.
DE   SubName: Full=Nuclear pore complex protein Nup214 {ECO:0000313|Ensembl:ENSP00000436793};
DE   SubName: Full=cDNA, FLJ79316, highly similar to Nuclear pore complex protein Nup214 {ECO:0000313|EMBL:BAH14788.1};
GN   Name=NUP214 {ECO:0000313|Ensembl:ENSP00000436793};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH14788.1};
RN   [1] {ECO:0000313|Ensembl:ENSP00000436793, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L.,
RA   Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S.,
RA   Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K.,
RA   Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C.,
RA   Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E.,
RA   Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M.,
RA   Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J.,
RA   Frankish A., Frankland J.A., French L., Fricker D.G., Garner P.,
RA   Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S.,
RA   Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E.,
RA   McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V.,
RA   Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S.,
RA   Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K.,
RA   Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J.,
RA   Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M.,
RA   West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L.,
RA   Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J.,
RA   Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [2] {ECO:0000213|PubMed:18691976}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [3] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [4] {ECO:0000313|EMBL:BAH14788.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Testis {ECO:0000313|EMBL:BAH14788.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [6] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Burckstummer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7] {ECO:0000313|Ensembl:ENSP00000436793}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
RN   [8] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [9] {ECO:0000213|PubMed:28112733}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL157938; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK316417; BAH14788.1; -; mRNA.
DR   RefSeq; NP_001305254.1; NM_001318325.1.
DR   ProteomicsDB; 7088; -.
DR   Antibodypedia; 18059; 62 antibodies.
DR   Ensembl; ENST00000483497; ENSP00000436793; ENSG00000126883.
DR   GeneID; 8021; -.
DR   UCSC; uc011mcg.4; human.
DR   CTD; 8021; -.
DR   EuPathDB; HostDB:ENSG00000126883.16; -.
DR   HGNC; HGNC:8064; NUP214.
DR   OpenTargets; ENSG00000126883; -.
DR   eggNOG; KOG3630; Eukaryota.
DR   eggNOG; ENOG410YBVS; LUCA.
DR   GeneTree; ENSGT00940000153253; -.
DR   HOGENOM; CLU_015268_0_0_1; -.
DR   OrthoDB; 747759at2759; -.
DR   ChiTaRS; NUP214; human.
DR   GenomeRNAi; 8021; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000126883; Expressed in testis and 204 other tissues.
DR   InterPro; IPR026054; Nucleoporin.
DR   InterPro; IPR041553; Nup214_FG.
DR   PANTHER; PTHR23193; PTHR23193; 1.
DR   Pfam; PF18617; Nup214_FG; 1.
PE   1: Evidence at protein level;
KW   Proteomics identification {ECO:0000213|EPD:B7ZAV2,
KW   ECO:0000213|MaxQB:B7ZAV2, ECO:0000213|PeptideAtlas:B7ZAV2,
KW   ECO:0000213|ProteomicsDB:B7ZAV2};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN          742..803
FT                   /note="Nup214_FG"
FT                   /evidence="ECO:0000259|Pfam:PF18617"
FT   REGION          60..142
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          163..234
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          264..293
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          305..365
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          710..729
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        60..84
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        97..139
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        165..198
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        212..234
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        305..325
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        340..365
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   916 AA;  87973 MW;  B712583CB93F3592 CRC64;
     MKSSLLLRGV HFCFHLPGTA KIETAVTSTP SASGQFSKPF SFSPSGTGFN FGIITPTPSS
     NFTAAQGATP STKESSQPDA FSSGGGSKPS YEAIPESSPP SGITSASNTT PGEPAASSSR
     PVAPSGTALS TTSSKLETPP SKLGELLFPS SLAGETLGSF SGLRVGQADD STKPTNKASS
     TSLTSTQPTK TSGVPSGFNF TAPPVLGKHT EPPVTSSATT TSVAPPAATS TSSTAVFGSL
     PVTSAGSSGV ISFGGTSLSA GKTSFSFGSQ QTNSTVPPSA PPPTTAATPL PTSFPTLSFG
     SLLSSATTPS LPMSAGRSTE EATSSALPEK PGDSEVSASA ASLLEEQQSA QLPQAPPQTS
     DSVKKEPVLA QPAVSNSGTA ASSTSLVALS AEATPATTGV PDARTEAVPP ASSFSVPGQT
     AVTAAAISSA GPVAVETSST PIASSTTSIV APGPSAEAAA FGTVTSGSSV FAQPPAASSS
     SAFNQLTNNT ATAPSATPVF GQVAASTAPS LFGQQTGSTA STAAATPQVS SSGFSSPAFG
     TTAPGVFGQT TFGQASVFGQ SASSAASVFS FSQPGFSSVP AFGQPASSTP TSTSGSVFGA
     ASSTSSSSSF SFGQSSPNTG GGLFGQSNAP AFGQSPGFGQ GGSVFGGTSA ATTTAATSGF
     SFCQASGFGS SNTGSVFGQA ASTGGIVFGQ QSSSSSGSVF GSGNTGRGGG FFSGLGGKPS
     QDAANKNPFS SASGGFGSTA TSNTSNLFGN SGAKTFGGFA SSSFGEQKPT GTFSSGGGSV
     ASQGFGFSSP NKTGGFGAAP VFGSPPTFGG SPGFGGVPAF GSAPAFTSPL GSTGGKVFGE
     GTAAASAGGF GFGSSSNTTS FGTLASQNAP TFGSLSQQTS GFGTQSSGFS GFGSGTGGFS
     FGSNNSSVQG FGGWRS
//
ID   NU214_HUMAN             Reviewed;        2090 AA.
AC   P35658; A6NFQ0; Q15010; Q3KQZ0; Q5JUP7; Q75R47; Q86XD3;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   22-JUL-2008, sequence version 2.
DT   22-APR-2020, entry version 203.
DE   RecName: Full=Nuclear pore complex protein Nup214;
DE   AltName: Full=214 kDa nucleoporin;
DE   AltName: Full=Nucleoporin Nup214;
DE   AltName: Full=Protein CAN;
GN   Name=NUP214; Synonyms=CAIN, CAN, KIAA0023;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), CHROMOSOMAL TRANSLOCATION WITH DEK,
RP   AND VARIANT SER-574.
RC   TISSUE=Testis;
RX   PubMed=1549122; DOI=10.1128/mcb.12.4.1687;
RA   Von Lindern M., Fornerod M., Van Baal S., Jaegle M., De Wit T., Buijs A.,
RA   Grosveld G.;
RT   "The translocation (6;9), associated with a specific subtype of acute
RT   myeloid leukemia, results in the fusion of two genes, dek and can, and the
RT   expression of a chimeric, leukemia-specific dek-can mRNA.";
RL   Mol. Cell. Biol. 12:1687-1697(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RA   Nagase T., Kikuno R., Ohara O.;
RT   "Homo sapiens mRNA for KIAA0023 splice variant 1 protein.";
RL   Submitted (JAN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RX   PubMed=7584026; DOI=10.1093/dnares/1.1.27;
RA   Nomura N., Miyajima N., Sazuka T., Tanaka A., Kawarabayasi Y., Sato S.,
RA   Nagase T., Seki N., Ishikawa K., Tabata S.;
RT   "Prediction of the coding sequences of unidentified human genes. I. The
RT   coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of
RT   randomly sampled cDNA clones from human immature myeloid cell line KG-1.";
RL   DNA Res. 1:27-35(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L.,
RA   Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S.,
RA   Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K.,
RA   Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C.,
RA   Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E.,
RA   Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M.,
RA   Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J.,
RA   Frankish A., Frankland J.A., French L., Fricker D.G., Garner P.,
RA   Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S.,
RA   Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E.,
RA   McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V.,
RA   Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S.,
RA   Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K.,
RA   Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J.,
RA   Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M.,
RA   West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L.,
RA   Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J.,
RA   Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4), AND VARIANT
RP   SER-574.
RC   TISSUE=Placenta, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   CHROMOSOMAL TRANSLOCATION WITH SET.
RX   PubMed=1630450; DOI=10.1128/mcb.12.8.3346;
RA   von Lindern M., van Baal S., Wiegant J., Raap A., Hagemeijer A.,
RA   Grosveld G.;
RT   "Can, a putative oncogene associated with myeloid leukemogenesis, may be
RT   activated by fusion of its 3' half to different genes: characterization of
RT   the set gene.";
RL   Mol. Cell. Biol. 12:3346-3355(1992).
RN   [7]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=8108440; DOI=10.1073/pnas.91.4.1519;
RA   Kraemer D., Wozniak R.W., Blobel G., Radu A.;
RT   "The human CAN protein, a putative oncogene product associated with myeloid
RT   leukemogenesis, is a nuclear pore complex protein that faces the
RT   cytoplasm.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:1519-1523(1994).
RN   [8]
RP   INTERACTION WITH NUP88 AND XPO1.
RX   PubMed=9049309; DOI=10.1093/emboj/16.4.807;
RA   Fornerod M., van Deursen J.M., van Baal S., Reynolds A., Davis D.,
RA   Murti K.G., Fransen J., Grosveld G.;
RT   "The human homologue of yeast CRM1 is in a dynamic subcomplex with
RT   CAN/Nup214 and the novel nuclear pore component Nup88.";
RL   EMBO J. 16:807-816(1997).
RN   [9]
RP   INTERACTION WITH XPO5.
RX   PubMed=11777942; DOI=10.1083/jcb.200110082;
RA   Brownawell A.M., Macara I.G.;
RT   "Exportin-5, a novel karyopherin, mediates nuclear export of double-
RT   stranded RNA binding proteins.";
RL   J. Cell Biol. 156:53-64(2002).
RN   [10]
RP   INTERACTION WITH ZFP36.
RX   PubMed=14766228; DOI=10.1016/j.bbrc.2004.01.080;
RA   Carman J.A., Nadler S.G.;
RT   "Direct association of tristetraprolin with the nucleoporin CAN/Nup214.";
RL   Biochem. Biophys. Res. Commun. 315:445-449(2004).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-430 AND THR-439, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa cells
RT   and high confident phosphopeptide identification by cross-validation of
RT   MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-651; SER-940 AND SER-1181,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-430; THR-434; THR-437;
RP   THR-439; SER-666; SER-970; SER-974; SER-1023 AND SER-1963, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [17]
RP   INTERACTION WITH HHV-1 PROTEIN UL25 (MICROBIAL INFECTION).
RX   PubMed=19386703; DOI=10.1128/jvi.02655-08;
RA   Pasdeloup D., Blondel D., Isidro A.L., Rixon F.J.;
RT   "Herpesvirus capsid association with the nuclear pore complex and viral DNA
RT   release involve the nucleoporin CAN/Nup214 and the capsid protein pUL25.";
RL   J. Virol. 83:6610-6623(2009).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-430 AND SER-989, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-657; THR-670; SER-678;
RP   SER-940; SER-1045; SER-1081; THR-1134; THR-1150; THR-1156; THR-1312 AND
RP   SER-1985, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-433; THR-434; THR-437;
RP   SER-657; THR-670; SER-678 AND SER-940, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [22]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT GLY-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-30; THR-416; SER-421;
RP   SER-430; SER-433; THR-434; THR-437; SER-651; SER-657; SER-666; THR-670;
RP   SER-678; SER-760; SER-940; THR-1021; SER-1023; SER-1045; SER-1056;
RP   SER-1081; THR-1156 AND SER-1353, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-430; SER-433 AND SER-678, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [25]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1538, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [26]
RP   INTERACTION WITH NUP88.
RX   PubMed=30543681; DOI=10.1371/journal.pgen.1007845;
RA   Bonnin E., Cabochette P., Filosa A., Juehlen R., Komatsuzaki S.,
RA   Hezwani M., Dickmanns A., Martinelli V., Vermeersch M., Supply L.,
RA   Martins N., Pirenne L., Ravenscroft G., Lombard M., Port S., Spillner C.,
RA   Janssens S., Roets E., Van Dorpe J., Lammens M., Kehlenbach R.H.,
RA   Ficner R., Laing N.G., Hoffmann K., Vanhollebeke B., Fahrenkrog B.;
RT   "Biallelic mutations in nucleoporin NUP88 cause lethal fetal akinesia
RT   deformation sequence.";
RL   PLoS Genet. 14:E1007845-E1007845(2018).
RN   [27]
RP   FUNCTION, INVOLVEMENT IN IIAE9, VARIANTS IIAE9 CYS-38 AND SER-387, AND
RP   CHARACTERIZATION OF VARIANT IIAE9 CYS-38.
RX   PubMed=31178128; DOI=10.1016/j.ajhg.2019.05.003;
RA   Fichtman B., Harel T., Biran N., Zagairy F., Applegate C.D., Salzberg Y.,
RA   Gilboa T., Salah S., Shaag A., Simanovsky N., Ayoubieh H., Sobreira N.,
RA   Punzi G., Pierri C.L., Hamosh A., Elpeleg O., Harel A., Edvardson S.;
RT   "Pathogenic variants in NUP214 cause 'plugged' nuclear pore channels and
RT   acute febrile encephalopathy.";
RL   Am. J. Hum. Genet. 105:48-64(2019).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) OF 1-434, AND BETA-PROPELLER DOMAIN.
RX   PubMed=17264208; DOI=10.1073/pnas.0610828104;
RA   Napetschnig J., Blobel G., Hoelz A.;
RT   "Crystal structure of the N-terminal domain of the human protooncogene
RT   Nup214/CAN.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:1783-1788(2007).
RN   [29]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 1-405 IN COMPLEX WITH DDX19B, AND
RP   MUTAGENESIS OF VAL-353 AND ASP-359.
RX   PubMed=19219046; DOI=10.1038/nsmb.1561;
RA   von Moeller H., Basquin C., Conti E.;
RT   "The mRNA export protein DBP5 binds RNA and the cytoplasmic nucleoporin
RT   NUP214 in a mutually exclusive manner.";
RL   Nat. Struct. Mol. Biol. 16:247-254(2009).
RN   [30]
RP   X-RAY CRYSTALLOGRAPHY (2.51 ANGSTROMS) OF 1-450 IN COMPLEX WITH DDX19B, AND
RP   COILED-COIL DOMAIN.
RX   PubMed=19208808; DOI=10.1073/pnas.0813267106;
RA   Napetschnig J., Kassube S.A., Debler E.W., Wong R.W., Blobel G., Hoelz A.;
RT   "Structural and functional analysis of the interaction between the
RT   nucleoporin Nup214 and the DEAD-box helicase Ddx19.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:3089-3094(2009).
RN   [31]
RP   VARIANTS [LARGE SCALE ANALYSIS] ALA-424; LEU-1378 AND VAL-1392.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
RN   [32]
RP   VARIANT IIAE9 GLY-154, AND INVOLVEMENT IN IIAE9.
RX   PubMed=30758658; DOI=10.1007/s00439-019-01979-w;
RA   Shamseldin H.E., Makhseed N., Ibrahim N., Al-Sheddi T., Alobeid E.,
RA   Abdulwahab F., Alkuraya F.S.;
RT   "NUP214 deficiency causes severe encephalopathy and microcephaly in
RT   humans.";
RL   Hum. Genet. 138:221-229(2019).
CC   -!- FUNCTION: Has a critical role in nucleocytoplasmic transport
CC       (PubMed:31178128). May serve as a docking site in the receptor-mediated
CC       import of substrates across the nuclear pore complex (PubMed:31178128,
CC       PubMed:8108440). {ECO:0000269|PubMed:31178128,
CC       ECO:0000303|PubMed:8108440}.
CC   -!- SUBUNIT: Homodimer. Interacts with ZFP36; this interaction increases
CC       upon lipopolysaccharide (LPS) stimulation (PubMed:14766228). Interacts
CC       with DDX19 (PubMed:19219046, PubMed:19208808). Interacts with NUP88
CC       (PubMed:9049309, PubMed:30543681). Interacts with XPO1
CC       (PubMed:9049309). Interacts with XPO5 (PubMed:11777942).
CC       {ECO:0000269|PubMed:11777942, ECO:0000269|PubMed:14766228,
CC       ECO:0000269|PubMed:19208808, ECO:0000269|PubMed:19219046,
CC       ECO:0000269|PubMed:30543681, ECO:0000269|PubMed:9049309}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with human herpes virus 1
CC       (HHV-1) protein UL25; this interaction might be essential to the capsid
CC       docking onto the host nuclear pore. {ECO:0000269|PubMed:19386703}.
CC   -!- INTERACTION:
CC       P35658-1; Q9UMR2-1: DDX19B; NbExp=9; IntAct=EBI-15757000, EBI-5773937;
CC   -!- SUBCELLULAR LOCATION: Nucleus, nuclear pore complex
CC       {ECO:0000269|PubMed:8108440}. Note=Cytoplasmic side of the nuclear pore
CC       complex. {ECO:0000269|PubMed:8108440}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=P35658-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P35658-2; Sequence=VSP_034896;
CC       Name=3;
CC         IsoId=P35658-3; Sequence=VSP_034897;
CC       Name=4;
CC         IsoId=P35658-4; Sequence=VSP_034896, VSP_034897;
CC       Name=5;
CC         IsoId=P35658-5; Sequence=VSP_034896, VSP_034898, VSP_034899;
CC   -!- TISSUE SPECIFICITY: Expressed in thymus, spleen, bone marrow, kidney,
CC       brain and testis, but hardly in all other tissues or in whole embryos
CC       during development.
CC   -!- DOMAIN: Contains FG repeats.
CC   -!- DOMAIN: The beta-propeller contains long interblade connector loops,
CC       and mediates interaction with DDX19B.
CC   -!- PTM: Probably glycosylated as it reacts with wheat germ agglutinin
CC       (WGA).
CC   -!- DISEASE: Note=A chromosomal aberration involving NUP214 is found in a
CC       subset of acute myeloid leukemia (AML); also known as acute non-
CC       lymphocytic leukemia. Translocation t(6;9)(p23;q34) with DEK. It
CC       results in the formation of a DEK-CAN fusion gene.
CC       {ECO:0000269|PubMed:1549122}.
CC   -!- DISEASE: Note=A chromosomal aberration involving NUP214 is found in
CC       some cases of acute undifferentiated leukemia (AUL). Translocation
CC       t(6;9)(q21;q34.1) with SET. {ECO:0000269|PubMed:1630450}.
CC   -!- DISEASE: Encephalopathy, acute, infection-induced, 9 (IIAE9)
CC       [MIM:618426]: An autosomal recessive disorder characterized by infancy-
CC       onset of episodic neurodevelopmental regression in association with
CC       infection-induced febrile illness. Clinical features include poor
CC       overall growth, seizures, myoclonic jerks, microcephaly, ataxia, and
CC       cerebellar atrophy. {ECO:0000269|PubMed:30758658,
CC       ECO:0000269|PubMed:31178128}. Note=Disease susceptibility is associated
CC       with variations affecting the gene represented in this entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD07398.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CANID29.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X64228; CAA45535.1; -; mRNA.
DR   EMBL; AB159230; BAD07398.1; ALT_INIT; mRNA.
DR   EMBL; D14689; BAA03515.1; -; mRNA.
DR   EMBL; AL157938; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC045620; AAH45620.2; -; mRNA.
DR   EMBL; BC105998; AAI05999.1; -; mRNA.
DR   CCDS; CCDS6940.1; -. [P35658-1]
DR   CCDS; CCDS83429.1; -. [P35658-4]
DR   PIR; S26058; S26058.
DR   RefSeq; NP_001305253.1; NM_001318324.1. [P35658-4]
DR   RefSeq; NP_001305254.1; NM_001318325.1.
DR   RefSeq; NP_005076.3; NM_005085.3. [P35658-1]
DR   PDB; 2OIT; X-ray; 1.65 A; A=1-434.
DR   PDB; 3FHC; X-ray; 2.80 A; A=1-405.
DR   PDB; 3FMO; X-ray; 2.51 A; A=1-450.
DR   PDB; 3FMP; X-ray; 3.19 A; A/C=1-450.
DR   PDB; 5DIS; X-ray; 2.85 A; D=1916-2027.
DR   PDBsum; 2OIT; -.
DR   PDBsum; 3FHC; -.
DR   PDBsum; 3FMO; -.
DR   PDBsum; 3FMP; -.
DR   PDBsum; 5DIS; -.
DR   SMR; P35658; -.
DR   BioGrid; 113717; 93.
DR   ComplexPortal; CPX-873; Nuclear pore complex.
DR   DIP; DIP-38367N; -.
DR   IntAct; P35658; 57.
DR   MINT; P35658; -.
DR   STRING; 9606.ENSP00000352400; -.
DR   TCDB; 1.I.1.1.3; the eukaryotic nuclear pore complex (e-npc) family.
DR   iPTMnet; P35658; -.
DR   MetOSite; P35658; -.
DR   PhosphoSitePlus; P35658; -.
DR   BioMuta; NUP214; -.
DR   DMDM; 205831380; -.
DR   EPD; P35658; -.
DR   jPOST; P35658; -.
DR   MassIVE; P35658; -.
DR   MaxQB; P35658; -.
DR   PaxDb; P35658; -.
DR   PeptideAtlas; P35658; -.
DR   PRIDE; P35658; -.
DR   ProteomicsDB; 55122; -. [P35658-1]
DR   ProteomicsDB; 55123; -. [P35658-2]
DR   ProteomicsDB; 55124; -. [P35658-3]
DR   ProteomicsDB; 55125; -. [P35658-4]
DR   ProteomicsDB; 55126; -. [P35658-5]
DR   Antibodypedia; 18059; 62 antibodies.
DR   Ensembl; ENST00000359428; ENSP00000352400; ENSG00000126883. [P35658-1]
DR   Ensembl; ENST00000411637; ENSP00000396576; ENSG00000126883. [P35658-4]
DR   GeneID; 8021; -.
DR   KEGG; hsa:8021; -.
DR   UCSC; uc004cag.4; human. [P35658-1]
DR   CTD; 8021; -.
DR   DisGeNET; 8021; -.
DR   GeneCards; NUP214; -.
DR   HGNC; HGNC:8064; NUP214.
DR   HPA; ENSG00000126883; Tissue enhanced (blood).
DR   MalaCards; NUP214; -.
DR   MIM; 114350; gene.
DR   MIM; 618426; phenotype.
DR   neXtProt; NX_P35658; -.
DR   OpenTargets; ENSG00000126883; -.
DR   Orphanet; 402014; Acute myeloid leukemia with t(6;9)(p23;q34).
DR   Orphanet; 99861; Precursor T-cell acute lymphoblastic leukemia.
DR   PharmGKB; PA31851; -.
DR   eggNOG; KOG3630; Eukaryota.
DR   eggNOG; ENOG410YBVS; LUCA.
DR   GeneTree; ENSGT00940000153253; -.
DR   HOGENOM; CLU_001606_0_0_1; -.
DR   InParanoid; P35658; -.
DR   KO; K14317; -.
DR   OMA; KCGCWSP; -.
DR   OrthoDB; 747759at2759; -.
DR   PhylomeDB; P35658; -.
DR   TreeFam; TF323517; -.
DR   Reactome; R-HSA-1169408; ISG15 antiviral mechanism.
DR   Reactome; R-HSA-159227; Transport of the SLBP independent Mature mRNA.
DR   Reactome; R-HSA-159230; Transport of the SLBP Dependant Mature mRNA.
DR   Reactome; R-HSA-159231; Transport of Mature mRNA Derived from an Intronless Transcript.
DR   Reactome; R-HSA-159236; Transport of Mature mRNA derived from an Intron-Containing Transcript.
DR   Reactome; R-HSA-165054; Rev-mediated nuclear export of HIV RNA.
DR   Reactome; R-HSA-168271; Transport of Ribonucleoproteins into the Host Nucleus.
DR   Reactome; R-HSA-168276; NS1 Mediated Effects on Host Pathways.
DR   Reactome; R-HSA-168325; Viral Messenger RNA Synthesis.
DR   Reactome; R-HSA-168333; NEP/NS2 Interacts with the Cellular Export Machinery.
DR   Reactome; R-HSA-170822; Regulation of Glucokinase by Glucokinase Regulatory Protein.
DR   Reactome; R-HSA-180746; Nuclear import of Rev protein.
DR   Reactome; R-HSA-180910; Vpr-mediated nuclear import of PICs.
DR   Reactome; R-HSA-191859; snRNP Assembly.
DR   Reactome; R-HSA-3108214; SUMOylation of DNA damage response and repair proteins.
DR   Reactome; R-HSA-3232142; SUMOylation of ubiquitinylation proteins.
DR   Reactome; R-HSA-3301854; Nuclear Pore Complex (NPC) Disassembly.
DR   Reactome; R-HSA-3371453; Regulation of HSF1-mediated heat shock response.
DR   Reactome; R-HSA-4085377; SUMOylation of SUMOylation proteins.
DR   Reactome; R-HSA-450520; HuR (ELAVL1) binds and stabilizes mRNA.
DR   Reactome; R-HSA-4551638; SUMOylation of chromatin organization proteins.
DR   Reactome; R-HSA-4570464; SUMOylation of RNA binding proteins.
DR   Reactome; R-HSA-4615885; SUMOylation of DNA replication proteins.
DR   Reactome; R-HSA-5578749; Transcriptional regulation by small RNAs.
DR   Reactome; R-HSA-5619107; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC).
DR   Reactome; R-HSA-6784531; tRNA processing in the nucleus.
DR   Reactome; R-HSA-9609690; HCMV Early Events.
DR   Reactome; R-HSA-9610379; HCMV Late Events.
DR   SignaLink; P35658; -.
DR   SIGNOR; P35658; -.
DR   ChiTaRS; NUP214; human.
DR   EvolutionaryTrace; P35658; -.
DR   GeneWiki; NUP214; -.
DR   GenomeRNAi; 8021; -.
DR   Pharos; P35658; Tbio.
DR   PRO; PR:P35658; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   RNAct; P35658; protein.
DR   Bgee; ENSG00000126883; Expressed in testis and 204 other tissues.
DR   ExpressionAtlas; P35658; baseline and differential.
DR   Genevisible; P35658; HS.
DR   GO; GO:1990876; C:cytoplasmic side of nuclear pore; IDA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0043657; C:host cell; IEA:GOC.
DR   GO; GO:0005643; C:nuclear pore; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005049; F:nuclear export signal receptor activity; IDA:GO_Central.
DR   GO; GO:0008139; F:nuclear localization sequence binding; IBA:GO_Central.
DR   GO; GO:0017056; F:structural constituent of nuclear pore; IBA:GO_Central.
DR   GO; GO:0075733; P:intracellular transport of virus; TAS:Reactome.
DR   GO; GO:0000278; P:mitotic cell cycle; IEA:Ensembl.
DR   GO; GO:0006406; P:mRNA export from nucleus; IMP:UniProtKB.
DR   GO; GO:0006611; P:protein export from nucleus; IMP:MGI.
DR   GO; GO:0006606; P:protein import into nucleus; IBA:GO_Central.
DR   GO; GO:0016925; P:protein sumoylation; TAS:Reactome.
DR   GO; GO:0051726; P:regulation of cell cycle; IEA:Ensembl.
DR   GO; GO:1900034; P:regulation of cellular response to heat; TAS:Reactome.
DR   GO; GO:0060964; P:regulation of gene silencing by miRNA; TAS:Reactome.
DR   GO; GO:0006110; P:regulation of glycolytic process; TAS:Reactome.
DR   GO; GO:0043488; P:regulation of mRNA stability; TAS:Reactome.
DR   GO; GO:0046822; P:regulation of nucleocytoplasmic transport; IMP:UniProtKB.
DR   GO; GO:0006405; P:RNA export from nucleus; IBA:GO_Central.
DR   GO; GO:0006409; P:tRNA export from nucleus; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; TAS:Reactome.
DR   GO; GO:0019083; P:viral transcription; TAS:Reactome.
DR   Gene3D; 2.130.10.10; -; 1.
DR   InterPro; IPR026054; Nucleoporin.
DR   InterPro; IPR041553; Nup214_FG.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   InterPro; IPR001680; WD40_repeat.
DR   PANTHER; PTHR23193; PTHR23193; 1.
DR   Pfam; PF18617; Nup214_FG; 1.
DR   SMART; SM00320; WD40; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Chromosomal rearrangement;
KW   Coiled coil; Disease mutation; Glycoprotein; Host-virus interaction;
KW   Isopeptide bond; mRNA transport; Nuclear pore complex; Nucleus;
KW   Phosphoprotein; Polymorphism; Protein transport; Proto-oncogene;
KW   Reference proteome; Repeat; Translocation; Transport; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:22223895"
FT   CHAIN           2..2090
FT                   /note="Nuclear pore complex protein Nup214"
FT                   /id="PRO_0000204861"
FT   REPEAT          41..93
FT                   /note="Blade 1"
FT   REPEAT          94..150
FT                   /note="Blade 2"
FT   REPEAT          151..193
FT                   /note="Blade 3"
FT   REPEAT          194..239
FT                   /note="Blade 4"
FT   REPEAT          240..303
FT                   /note="Blade 5"
FT   REPEAT          304..359
FT                   /note="Blade 6"
FT   REPEAT          360..404
FT                   /note="Blade 7"
FT   REGION          41..404
FT                   /note="Seven-bladed beta propeller"
FT   REGION          481..2076
FT                   /note="11 X 5 AA approximate repeats"
FT   REGION          740..768
FT                   /note="Leucine-zipper 1"
FT   REGION          861..882
FT                   /note="Leucine-zipper 2"
FT   REGION          1409..2084
FT                   /note="18 X 4 AA approximate repeats"
FT   REGION          1427..2085
FT                   /note="11 X 3 AA approximate repeats"
FT   COILED          680..1209
FT                   /evidence="ECO:0000269|PubMed:19208808"
FT   COMPBIAS        1213..2090
FT                   /note="Pro/Ser/Thr-rich"
FT   SITE            812..813
FT                   /note="Breakpoint"
FT   MOD_RES         2
FT                   /note="N-acetylglycine"
FT                   /evidence="ECO:0000244|PubMed:22223895"
FT   MOD_RES         30
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         416
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         421
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         430
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:16964243,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         433
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         434
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163"
FT   MOD_RES         437
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163"
FT   MOD_RES         439
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:16964243,
FT                   ECO:0000244|PubMed:18669648"
FT   MOD_RES         651
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18691976,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         657
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163"
FT   MOD_RES         666
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         670
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163"
FT   MOD_RES         678
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         760
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         940
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18691976,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         970
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         974
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         989
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332"
FT   MOD_RES         1021
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         1023
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         1045
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         1056
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         1081
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         1134
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         1150
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         1156
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         1181
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18691976"
FT   MOD_RES         1312
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         1353
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         1963
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         1985
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   CROSSLNK        1538
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   VAR_SEQ         590..601
FT                   /note="KFTAAATSTPVS -> N (in isoform 2, isoform 4 and
FT                   isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:7584026"
FT                   /id="VSP_034896"
FT   VAR_SEQ         648
FT                   /note="S -> SA (in isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_034897"
FT   VAR_SEQ         1139..1148
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:7584026"
FT                   /id="VSP_034898"
FT   VAR_SEQ         2026..2090
FT                   /note="FGSSSNTTSFGTLASQNAPTFGSLSQQTSGFGTQSSGFSGFGSGTGGFSFGS
FT                   NNSSVQGFGGWRS -> SLAMSLSPTLKGRLLLMRPKAGGGREQAAPGRKSNESRSLGH
FT                   LCMERALTSPLKVWEQQQHHILRHARESECPHFRITVPTDFWFWDPE (in isoform
FT                   5)"
FT                   /evidence="ECO:0000303|PubMed:7584026"
FT                   /id="VSP_034899"
FT   VARIANT         38
FT                   /note="R -> C (in IIAE9; decreased nuclear transport in
FT                   patient cells; decreased protein levels in patient cells)"
FT                   /evidence="ECO:0000269|PubMed:31178128"
FT                   /id="VAR_082629"
FT   VARIANT         154
FT                   /note="D -> G (in IIAE9; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:30758658"
FT                   /id="VAR_082630"
FT   VARIANT         387
FT                   /note="P -> S (in IIAE9)"
FT                   /evidence="ECO:0000269|PubMed:31178128"
FT                   /id="VAR_082631"
FT   VARIANT         424
FT                   /note="G -> A (in a breast cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035856"
FT   VARIANT         574
FT                   /note="P -> S (in dbSNP:rs103612)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:1549122"
FT                   /id="VAR_045691"
FT   VARIANT         1378
FT                   /note="P -> L (in a breast cancer sample; somatic mutation;
FT                   dbSNP:rs777822003)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035857"
FT   VARIANT         1392
FT                   /note="A -> V (in a breast cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035858"
FT   VARIANT         1592
FT                   /note="G -> A (in dbSNP:rs28594669)"
FT                   /id="VAR_061533"
FT   MUTAGEN         353
FT                   /note="V->A: Reduced binding to DDX19B."
FT                   /evidence="ECO:0000269|PubMed:19219046"
FT   MUTAGEN         359
FT                   /note="D->R: Impairs interaction with DDX19B."
FT                   /evidence="ECO:0000269|PubMed:19219046"
FT   CONFLICT        149
FT                   /note="G -> A (in Ref. 1; CAA45535)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        175
FT                   /note="A -> D (in Ref. 1; CAA45535)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1091..1092
FT                   /note="AA -> QL (in Ref. 1; CAA45535)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1872
FT                   /note="S -> N (in Ref. 5; AAH45620)"
FT                   /evidence="ECO:0000305"
FT   STRAND          4..7
FT                   /evidence="ECO:0000244|PDB:2OIT"
FT   STRAND          11..21
FT                   /evidence="ECO:0000244|PDB:2OIT"
FT   STRAND          24..26
FT                   /evidence="ECO:0000244|PDB:2OIT"
FT   STRAND          42..45
FT                   /evidence="ECO:0000244|PDB:2OIT"
FT   TURN            46..49
FT                   /evidence="ECO:0000244|PDB:2OIT"
FT   STRAND          50..55
FT                   /evidence="ECO:0000244|PDB:2OIT"
FT   STRAND          58..63
FT                   /evidence="ECO:0000244|PDB:2OIT"
FT   HELIX           64..67
FT                   /evidence="ECO:0000244|PDB:2OIT"
FT   STRAND          80..82
FT                   /evidence="ECO:0000244|PDB:2OIT"
FT   STRAND          87..89
FT                   /evidence="ECO:0000244|PDB:2OIT"
FT   STRAND          95..100
FT                   /evidence="ECO:0000244|PDB:2OIT"
FT   STRAND          106..113
FT                   /evidence="ECO:0000244|PDB:2OIT"
FT   TURN            114..116
FT                   /evidence="ECO:0000244|PDB:2OIT"
FT   STRAND          117..124
FT                   /evidence="ECO:0000244|PDB:2OIT"
FT   HELIX           125..129
FT                   /evidence="ECO:0000244|PDB:2OIT"
FT   STRAND          139..143
FT                   /evidence="ECO:0000244|PDB:2OIT"
FT   HELIX           148..150
FT                   /evidence="ECO:0000244|PDB:2OIT"
FT   STRAND          151..157
FT                   /evidence="ECO:0000244|PDB:2OIT"
FT   STRAND          164..169
FT                   /evidence="ECO:0000244|PDB:2OIT"
FT   STRAND          174..189
FT                   /evidence="ECO:0000244|PDB:2OIT"
FT   HELIX           191..193
FT                   /evidence="ECO:0000244|PDB:2OIT"
FT   STRAND          195..200
FT                   /evidence="ECO:0000244|PDB:2OIT"
FT   STRAND          207..211
FT                   /evidence="ECO:0000244|PDB:2OIT"
FT   STRAND          216..219
FT                   /evidence="ECO:0000244|PDB:2OIT"
FT   STRAND          225..229
FT                   /evidence="ECO:0000244|PDB:2OIT"
FT   STRAND          237..239
FT                   /evidence="ECO:0000244|PDB:3FMO"
FT   STRAND          241..250
FT                   /evidence="ECO:0000244|PDB:2OIT"
FT   STRAND          253..260
FT                   /evidence="ECO:0000244|PDB:2OIT"
FT   STRAND          265..267
FT                   /evidence="ECO:0000244|PDB:2OIT"
FT   STRAND          270..275
FT                   /evidence="ECO:0000244|PDB:2OIT"
FT   STRAND          286..289
FT                   /evidence="ECO:0000244|PDB:2OIT"
FT   STRAND          299..301
FT                   /evidence="ECO:0000244|PDB:2OIT"
FT   STRAND          305..310
FT                   /evidence="ECO:0000244|PDB:2OIT"
FT   HELIX           311..313
FT                   /evidence="ECO:0000244|PDB:2OIT"
FT   STRAND          315..320
FT                   /evidence="ECO:0000244|PDB:2OIT"
FT   STRAND          323..325
FT                   /evidence="ECO:0000244|PDB:3FMO"
FT   STRAND          327..331
FT                   /evidence="ECO:0000244|PDB:2OIT"
FT   STRAND          338..343
FT                   /evidence="ECO:0000244|PDB:2OIT"
FT   HELIX           345..347
FT                   /evidence="ECO:0000244|PDB:2OIT"
FT   STRAND          357..359
FT                   /evidence="ECO:0000244|PDB:3FMP"
FT   STRAND          362..368
FT                   /evidence="ECO:0000244|PDB:2OIT"
FT   STRAND          375..378
FT                   /evidence="ECO:0000244|PDB:2OIT"
FT   STRAND          381..383
FT                   /evidence="ECO:0000244|PDB:2OIT"
FT   STRAND          388..393
FT                   /evidence="ECO:0000244|PDB:2OIT"
FT   STRAND          396..405
FT                   /evidence="ECO:0000244|PDB:2OIT"
FT   HELIX           1925..1929
FT                   /evidence="ECO:0000244|PDB:5DIS"
FT   STRAND          1937..1941
FT                   /evidence="ECO:0000244|PDB:5DIS"
FT   TURN            1943..1945
FT                   /evidence="ECO:0000244|PDB:5DIS"
FT   HELIX           2016..2019
FT                   /evidence="ECO:0000244|PDB:5DIS"
SQ   SEQUENCE   2090 AA;  213620 MW;  EE6F0F3DE3D522C6 CRC64;
     MGDEMDAMIP EREMKDFQFR ALKKVRIFDS PEELPKERSS LLAVSNKYGL VFAGGASGLQ
     IFPTKNLLIQ NKPGDDPNKI VDKVQGLLVP MKFPIHHLAL SCDNLTLSAC MMSSEYGSII
     AFFDVRTFSN EAKQQKRPFA YHKLLKDAGG MVIDMKWNPT VPSMVAVCLA DGSIAVLQVT
     ETVKVCATLP STVAVTSVCW SPKGKQLAVG KQNGTVVQYL PTLQEKKVIP CPPFYESDHP
     VRVLDVLWIG TYVFAIVYAA ADGTLETSPD VVMALLPKKE EKHPEIFVNF MEPCYGSCTE
     RQHHYYLSYI EEWDLVLAAS AASTEVSILA RQSDQINWES WLLEDSSRAE LPVTDKSDDS
     LPMGVVVDYT NQVEITISDE KTLPPAPVLM LLSTDGVLCP FYMINQNPGV KSLIKTPERL
     SLEGERQPKS PGSTPTTPTS SQAPQKLDAS AAAAPASLPP SSPAAPIATF SLLPAGGAPT
     VFSFGSSSLK SSATVTGEPP SYSSGSDSSK AAPGPGPSTF SFVPPSKASL APTPAASPVA
     PSAASFSFGS SGFKPTLEST PVPSVSAPNI AMKPSFPPST SAVKVNLSEK FTAAATSTPV
     SSSQSAPPMS PFSSASKPAA SGPLSHPTPL SAPPSSVPLK SSVLPSPSGR SAQGSSSPVP
     SMVQKSPRIT PPAAKPGSPQ AKSLQPAVAE KQGHQWKDSD PVMAGIGEEI AHFQKELEEL
     KARTSKACFQ VGTSEEMKML RTESDDLHTF LLEIKETTES LHGDISSLKT TLLEGFAGVE
     EAREQNERNR DSGYLHLLYK RPLDPKSEAQ LQEIRRLHQY VKFAVQDVND VLDLEWDQHL
     EQKKKQRHLL VPERETLFNT LANNREIINQ QRKRLNHLVD SLQQLRLYKQ TSLWSLSSAV
     PSQSSIHSFD SDLESLCNAL LKTTIESHTK SLPKVPAKLS PMKQAQLRNF LAKRKTPPVR
     STAPASLSRS AFLSQRYYED LDEVSSTSSV SQSLESEDAR TSCKDDEAVV QAPRHAPVVR
     TPSIQPSLLP HAAPFAKSHL VHGSSPGVMG TSVATSASKI IPQGADSTML ATKTVKHGAP
     SPSHPISAPQ AAAAAALRRQ MASQAPAVNT LTESTLKNVP QVVNVQELKN NPATPSTAMG
     SSVPYSTAKT PHPVLTPVAA NQAKQGSLIN SLKPSGPTPA SGQLSSGDKA SGTAKIETAV
     TSTPSASGQF SKPFSFSPSG TGFNFGIITP TPSSNFTAAQ GATPSTKESS QPDAFSSGGG
     SKPSYEAIPE SSPPSGITSA SNTTPGEPAA SSSRPVAPSG TALSTTSSKL ETPPSKLGEL
     LFPSSLAGET LGSFSGLRVG QADDSTKPTN KASSTSLTST QPTKTSGVPS GFNFTAPPVL
     GKHTEPPVTS SATTTSVAPP AATSTSSTAV FGSLPVTSAG SSGVISFGGT SLSAGKTSFS
     FGSQQTNSTV PPSAPPPTTA ATPLPTSFPT LSFGSLLSSA TTPSLPMSAG RSTEEATSSA
     LPEKPGDSEV SASAASLLEE QQSAQLPQAP PQTSDSVKKE PVLAQPAVSN SGTAASSTSL
     VALSAEATPA TTGVPDARTE AVPPASSFSV PGQTAVTAAA ISSAGPVAVE TSSTPIASST
     TSIVAPGPSA EAAAFGTVTS GSSVFAQPPA ASSSSAFNQL TNNTATAPSA TPVFGQVAAS
     TAPSLFGQQT GSTASTAAAT PQVSSSGFSS PAFGTTAPGV FGQTTFGQAS VFGQSASSAA
     SVFSFSQPGF SSVPAFGQPA SSTPTSTSGS VFGAASSTSS SSSFSFGQSS PNTGGGLFGQ
     SNAPAFGQSP GFGQGGSVFG GTSAATTTAA TSGFSFCQAS GFGSSNTGSV FGQAASTGGI
     VFGQQSSSSS GSVFGSGNTG RGGGFFSGLG GKPSQDAANK NPFSSASGGF GSTATSNTSN
     LFGNSGAKTF GGFASSSFGE QKPTGTFSSG GGSVASQGFG FSSPNKTGGF GAAPVFGSPP
     TFGGSPGFGG VPAFGSAPAF TSPLGSTGGK VFGEGTAAAS AGGFGFGSSS NTTSFGTLAS
     QNAPTFGSLS QQTSGFGTQS SGFSGFGSGT GGFSFGSNNS SVQGFGGWRS
//
ID   NTM2B_HUMAN             Reviewed;         878 AA.
AC   A6NNL0; A6NM73;
DT   10-JUN-2008, integrated into UniProtKB/Swiss-Prot.
DT   10-JUN-2008, sequence version 2.
DT   22-APR-2020, entry version 89.
DE   RecName: Full=NUT family member 2B;
GN   Name=NUTM2B; Synonyms=FAM22B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=A6NNL0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=A6NNL0-2; Sequence=VSP_034025, VSP_034026, VSP_034027;
CC   -!- SIMILARITY: Belongs to the NUT family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL132656; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS60574.1; -. [A6NNL0-1]
DR   RefSeq; NP_001265424.1; NM_001278495.1. [A6NNL0-1]
DR   BioGrid; 609665; 1.
DR   STRING; 9606.ENSP00000394623; -.
DR   iPTMnet; A6NNL0; -.
DR   PhosphoSitePlus; A6NNL0; -.
DR   BioMuta; NUTM2B; -.
DR   jPOST; A6NNL0; -.
DR   MassIVE; A6NNL0; -.
DR   PaxDb; A6NNL0; -.
DR   PRIDE; A6NNL0; -.
DR   ProteomicsDB; 1615; -. [A6NNL0-1]
DR   ProteomicsDB; 1616; -. [A6NNL0-2]
DR   Antibodypedia; 70785; 9 antibodies.
DR   Ensembl; ENST00000429828; ENSP00000394623; ENSG00000188199. [A6NNL0-1]
DR   GeneID; 729262; -.
DR   KEGG; hsa:729262; -.
DR   UCSC; uc031wmo.1; human. [A6NNL0-1]
DR   CTD; 729262; -.
DR   DisGeNET; 729262; -.
DR   GeneCards; NUTM2B; -.
DR   HGNC; HGNC:23445; NUTM2B.
DR   HPA; ENSG00000188199; Low tissue specificity.
DR   MalaCards; NUTM2B; -.
DR   neXtProt; NX_A6NNL0; -.
DR   OpenTargets; ENSG00000188199; -.
DR   Orphanet; 457246; Clear cell sarcoma of kidney.
DR   Orphanet; 213711; Endometrial stromal sarcoma.
DR   PharmGKB; PA134908712; -.
DR   eggNOG; ENOG410J94Q; Eukaryota.
DR   eggNOG; ENOG4111C0H; LUCA.
DR   GeneTree; ENSGT00410000025793; -.
DR   InParanoid; A6NNL0; -.
DR   OMA; QGTERDI; -.
DR   OrthoDB; 425279at2759; -.
DR   PhylomeDB; A6NNL0; -.
DR   TreeFam; TF337728; -.
DR   ChiTaRS; NUTM2B; human.
DR   GenomeRNAi; 729262; -.
DR   Pharos; A6NNL0; Tdark.
DR   PRO; PR:A6NNL0; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; A6NNL0; protein.
DR   Bgee; ENSG00000188199; Expressed in apex of heart and 83 other tissues.
DR   ExpressionAtlas; A6NNL0; baseline and differential.
DR   Genevisible; A6NNL0; HS.
DR   InterPro; IPR024310; NUT.
DR   InterPro; IPR024309; NUT_N.
DR   PANTHER; PTHR22879; PTHR22879; 1.
DR   Pfam; PF12881; NUT; 1.
PE   3: Inferred from homology;
KW   Alternative splicing; Reference proteome.
FT   CHAIN           1..878
FT                   /note="NUT family member 2B"
FT                   /id="PRO_0000337992"
FT   COMPBIAS        278..285
FT                   /note="Poly-Pro"
FT   COMPBIAS        425..514
FT                   /note="Pro-rich"
FT   VAR_SEQ         617..653
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_034025"
FT   VAR_SEQ         657..672
FT                   /note="ERDVPDPQQGVGMETC -> PSDAPGTDRC (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_034026"
FT   VAR_SEQ         673..878
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_034027"
SQ   SEQUENCE   878 AA;  93984 MW;  AE5AC5B8AA17750D CRC64;
     MEVKGPSGRS FCCESEGQFK SCLKRHTPSL LLPSSWKGNS GSCLMAEALH RTSPTPNSCP
     LPLPLCRMSG VLCSRNLFTF KFSLFQLDSG ASGEPGHSLG LTLGFSYCGN CQTAVVSAQP
     EGMASNGAYP VLGPGVTANP GTSLSVFTAL PFTTPAPGPA HGPLLVTAGA PPGGPLVLST
     FPSTPLVTEQ DGCGPSGAGA SNVFVQMRTE VGPVKAAQAQ TLVLTQAPLV WQAPGALCGG
     VVCPPPLLLA AAPVVPVMAA QVVGGTQACE GGWSQGLPLP PPPPPAAQLP PIVSQGNAGP
     WPQGAHGESS LASSQAKAPP DDSCNPRSVY ENFRLWQHYK PLARRHLPQS PDTEALSCFL
     IPVLRSLARR KPTMTLEEGL WRAMREWQHT SNFDRMIFYE MAEKFLEFEA EEEMQIQKSQ
     WMKGPQCLPP PATPRLEPRG PPAPEVVKQP VYLPSKAGPK APTACLPPPR PQRPVTKARR
     PPPRPHRRAE TKARLPPPRP QRPAETKVPE EIPPEVVQEY VDIMEELLGP SLGATGEPEK
     QREEGKVKQP QEEDWTPPDP GLLSYIDKLC SQKDFVTKVE AVIHPQFLEE LLSPDPQMDF
     LALSQDLEQE EGLTLAQLVE KRLPPLKEKQ HARAAPSRGT ARLDSSSSKF AAGQGAERDV
     PDPQQGVGME TCPPQMTARD SQGRGRAHTG MARSEDSVVL LGCQDSPGLR AAWPTSPPQD
     HRPTCPGVGT KDALDLPGGS PVRESHGLAQ GSSEEEELPS LAFLLGSQHK LLPWWLPQSP
     VPASGLLSPE KWGPQGTHQS PSAERRGLNL APSPANKAKK RPLFGSLSPA EKTPYPGPGL
     RVSGEQSLTW GLGGPSQSQK RKGDPLVSRK EKKQHCSQ
//
ID   A0A075B6P9_HUMAN        Unreviewed;       557 AA.
AC   A0A075B6P9;
DT   01-OCT-2014, integrated into UniProtKB/TrEMBL.
DT   01-OCT-2014, sequence version 1.
DT   22-APR-2020, entry version 29.
DE   SubName: Full=NUT family member 2D {ECO:0000313|Ensembl:ENSP00000396080};
GN   Name=NUTM2D {ECO:0000313|Ensembl:ENSP00000396080};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000396080, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000396080, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [2] {ECO:0000313|Ensembl:ENSP00000396080}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2014) to UniProtKB.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL645612; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001009610.1; NM_001009610.1.
DR   PaxDb; A0A075B6P9; -.
DR   Ensembl; ENST00000412718; ENSP00000396080; ENSG00000214562.
DR   GeneID; 728130; -.
DR   KEGG; hsa:728130; -.
DR   UCSC; uc009xte.1; human.
DR   CTD; 728130; -.
DR   EuPathDB; HostDB:ENSG00000214562.13; -.
DR   HGNC; HGNC:23447; NUTM2D.
DR   OpenTargets; ENSG00000214562; -.
DR   eggNOG; ENOG410J94Q; Eukaryota.
DR   eggNOG; ENOG4111C0H; LUCA.
DR   GeneTree; ENSGT00410000025793; -.
DR   HOGENOM; CLU_035677_0_0_1; -.
DR   OrthoDB; 425279at2759; -.
DR   GenomeRNAi; 728130; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000214562; Expressed in apex of heart and 89 other tissues.
DR   ExpressionAtlas; A0A075B6P9; baseline and differential.
DR   InterPro; IPR024310; NUT.
DR   InterPro; IPR024309; NUT_N.
DR   PANTHER; PTHR22879; PTHR22879; 1.
DR   Pfam; PF12881; NUT; 1.
PE   4: Predicted;
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN          64..545
FT                   /note="NUT"
FT                   /evidence="ECO:0000259|Pfam:PF12881"
FT   REGION          201..252
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          345..494
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        204..218
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        355..376
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        389..404
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        465..481
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   557 AA;  59745 MW;  842141459EA5AC09 CRC64;
     MFQEPVYFQI FLFQLDSGAS GEPGHSLGLT LGFSHCGNCQ TAVVSAQPEG MASNGAYPAL
     GPGVTANPGT SLSVFTALPF TTPAPGPAHG PLLVTAGAPP GGPLVLSNFP STPLVTEQDG
     CGPSGAGASN VFVQMRTEVG PVKAAQAQTL VLTQTPLVWQ APGALCGGVV CPPPLLLAAA
     PVVPVMAAQV VGGTQACEGG WSQGLPLPPP PPPAAQLPPI VSQGNAGPWP QGAHGEGSLA
     SSQAKAPPDD SCNPRSVYEN FRLWQHYKPL ARRHLPQSPD TEALSCFLIP VLRSLARRKP
     TMTLEEGLWR AMREWQHTSN FDRMIFYEMA EKFLEFEAEE EMQIQKSQWM KGPQCLPPPA
     TPRLEPRGPP APEVVKQPVY LPSKAGPKAP TACLPPPRPQ RPVTKARRPP PRPHRRAETK
     ARLPPPRPQR PAETKVPEEI PPEVVQEYVD IMEELLGPSL GATGEPEKQR EEGEVKQPQE
     EDWTPPDPGL LSYTDKLCSQ KDFVTKVEAV IHPQFLEELL SPDPQMDFLA LSQELEQEEG
     LTLAQGAPSD APGTDRC
//
ID   NTM2A_HUMAN             Reviewed;         878 AA.
AC   Q8IVF1; A6NMX5; C9JDI1; Q5VZW1;
DT   12-DEC-2006, integrated into UniProtKB/Swiss-Prot.
DT   24-NOV-2009, sequence version 4.
DT   22-APR-2020, entry version 109.
DE   RecName: Full=NUT family member 2A;
GN   Name=NUTM2A; Synonyms=FAM22A, KIAA2020;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RA   Nagase T., Kikuno R., Ohara O.;
RT   "The nucleotide sequence of a long cDNA clone isolated from human.";
RL   Submitted (NOV-2002) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8IVF1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8IVF1-2; Sequence=VSP_034018, VSP_034020;
CC   -!- SIMILARITY: Belongs to the NUT family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC23116.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB095940; BAC23116.1; ALT_FRAME; mRNA.
DR   EMBL; AL157893; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS44452.1; -. [Q8IVF1-1]
DR   RefSeq; NP_001009610.1; NM_001009610.1.
DR   RefSeq; NP_001092808.1; NM_001099338.1. [Q8IVF1-1]
DR   RefSeq; XP_011538424.1; XM_011540122.2. [Q8IVF1-1]
DR   RefSeq; XP_016872096.1; XM_017016607.1. [Q8IVF1-2]
DR   IntAct; Q8IVF1; 1.
DR   STRING; 9606.ENSP00000371126; -.
DR   iPTMnet; Q8IVF1; -.
DR   PhosphoSitePlus; Q8IVF1; -.
DR   BioMuta; NUTM2A; -.
DR   DMDM; 269849751; -.
DR   jPOST; Q8IVF1; -.
DR   MassIVE; Q8IVF1; -.
DR   PaxDb; Q8IVF1; -.
DR   PeptideAtlas; Q8IVF1; -.
DR   PRIDE; Q8IVF1; -.
DR   ProteomicsDB; 70686; -. [Q8IVF1-1]
DR   ProteomicsDB; 70687; -. [Q8IVF1-2]
DR   Antibodypedia; 70852; 10 antibodies.
DR   Ensembl; ENST00000381689; ENSP00000371107; ENSG00000184923. [Q8IVF1-2]
DR   Ensembl; ENST00000381707; ENSP00000371126; ENSG00000184923. [Q8IVF1-1]
DR   GeneID; 728118; -.
DR   GeneID; 728130; -.
DR   KEGG; hsa:728118; -.
DR   KEGG; hsa:728130; -.
DR   UCSC; uc001kek.4; human. [Q8IVF1-1]
DR   CTD; 728118; -.
DR   CTD; 728130; -.
DR   DisGeNET; 728118; -.
DR   GeneCards; NUTM2A; -.
DR   HGNC; HGNC:23438; NUTM2A.
DR   HPA; ENSG00000184923; Low tissue specificity.
DR   MalaCards; NUTM2A; -.
DR   neXtProt; NX_Q8IVF1; -.
DR   OpenTargets; ENSG00000184923; -.
DR   Orphanet; 213711; Endometrial stromal sarcoma.
DR   PharmGKB; PA134875735; -.
DR   eggNOG; ENOG410J94Q; Eukaryota.
DR   eggNOG; ENOG4111C0H; LUCA.
DR   GeneTree; ENSGT00410000025793; -.
DR   HOGENOM; CLU_021726_0_0_1; -.
DR   InParanoid; Q8IVF1; -.
DR   OMA; YVDIMEG; -.
DR   OrthoDB; 425279at2759; -.
DR   PhylomeDB; Q8IVF1; -.
DR   TreeFam; TF337728; -.
DR   ChiTaRS; NUTM2A; human.
DR   Pharos; Q8IVF1; Tdark.
DR   PRO; PR:Q8IVF1; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; Q8IVF1; protein.
DR   Bgee; ENSG00000184923; Expressed in prefrontal cortex and 82 other tissues.
DR   Genevisible; Q8IVF1; HS.
DR   InterPro; IPR024310; NUT.
DR   InterPro; IPR024309; NUT_N.
DR   PANTHER; PTHR22879; PTHR22879; 1.
DR   Pfam; PF12881; NUT; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Reference proteome.
FT   CHAIN           1..878
FT                   /note="NUT family member 2A"
FT                   /id="PRO_0000266032"
FT   COMPBIAS        278..285
FT                   /note="Poly-Pro"
FT   COMPBIAS        425..514
FT                   /note="Pro-rich"
FT   VAR_SEQ         618..629
FT                   /note="LVEKRLLPLKEK -> GAPSDAPGTDRC (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.1"
FT                   /id="VSP_034018"
FT   VAR_SEQ         630..878
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.1"
FT                   /id="VSP_034020"
FT   CONFLICT        47
FT                   /note="K -> E (in Ref. 1; BAC23116)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        160
FT                   /note="A -> T (in Ref. 1; BAC23116)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        546
FT                   /note="E -> K (in Ref. 1; BAC23116)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   878 AA;  93890 MW;  B65B88FE85A912A1 CRC64;
     MEVKGPSGRS FCCESEGQFK SCLKRHTPSL LLPSSWKGNS GSCLMAKALH RMSPTPNSCP
     LPLPLCRMSG VLCSRNLFTF KFSLFQLDSG ASGEPGHSLG LTLGFSHCGN CQTAVVSAQP
     EGMASNGAYP ALGPGVTANP GTSLSVFTAL PFTTPAPGPA HGPLLVTAGA PPGGPLVLST
     LPSTPLVTEQ DGCGPSGAGA SNVFVQMRTE VGPVKAAQAQ TLVLTQAPLV WQAPGALCGG
     VVCPPPLLLA AAPVVPVMAA QVVGGTQACE GGWSQGLPLP PPPPPAAQLP PIVSQGNAGP
     WPQGAHGEGS LASSQAKAPP DDSCNPRSVY ENFRLWQHYK PLARRHLPQS PDTEALSCFL
     IPVLRSLARR KPTMTLEEGL WRAMREWQHT SNFDRMIFYE MAEKFLEFEA EEEMQIQKSQ
     WMKGPQCLPP PATPRLEPRG PPAPEVVKQP VYLPSKAGPK APTACLPPPR PQRPVTKARR
     PPPRPHRRAE TKARLPPPRP QRPAETKVPE EIPPEVVQEY VDIMEELLGP SLGATGEPEK
     QREEGEVKQP QEEDWTPPDP GLLSYTDKLC SQKDFVTKVE AVIHPQFLEE LLSPDPQMDF
     LALSQELEQE EGLTLAQLVE KRLLPLKEKQ HARAAPSRGT ARLDSSSSKF AAGQGAERDV
     PVPQQGVGME TCPPQTTARD SQGRGRAHTG MARSKDSVVL LGCQDSPGLR AARPTSPPQD
     HRPTCPGVGT KDALDLPGGS PVRESHGLAQ GSSEEEELPS LAFLLGSQHK LLPWWLPQSP
     VPASGLLSPE KWGPQGTHQF PSAERRGLNL APSPANKAKK RPLFGSLSPA EKTPHPGPGL
     RVSGEQSLTW GLGGPSQSQK RKGDPLVSRK EKKQRCSQ
//
ID   PA1B2_HUMAN             Reviewed;         229 AA.
AC   P68402; A8DPS5; A8DPS6; A8DPS7; E9PEJ5; E9PLP3; O00687; Q29459; Q6IBR6;
DT   23-NOV-2004, integrated into UniProtKB/Swiss-Prot.
DT   23-NOV-2004, sequence version 1.
DT   22-APR-2020, entry version 162.
DE   RecName: Full=Platelet-activating factor acetylhydrolase IB subunit beta;
DE            EC=3.1.1.47;
DE   AltName: Full=PAF acetylhydrolase 30 kDa subunit;
DE            Short=PAF-AH 30 kDa subunit;
DE   AltName: Full=PAF-AH subunit beta;
DE            Short=PAFAH subunit beta;
GN   Name=PAFAH1B2; Synonyms=PAFAHB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Fetal liver;
RX   PubMed=9144386; DOI=10.1006/bbrc.1997.6383;
RA   Adachi H., Tsujimoto M., Hattori M., Arai H., Inoue K.;
RT   "Differential tissue distribution of the beta- and gamma-subunits of human
RT   cytosolic platelet-activating factor acetylhydrolase (isoform I).";
RL   Biochem. Biophys. Res. Commun. 233:10-13(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3 AND 4), AND ALTERNATIVE
RP   SPLICING.
RC   TISSUE=Testis;
RX   PubMed=18155631; DOI=10.1016/j.prostaglandins.2007.10.005;
RA   Scott B.T., Olson N., Long G.L., Bovill E.G.;
RT   "Novel isoforms of intracellular platelet activating factor acetylhydrolase
RT   (PAFAH1b2) in human testis; encoded by alternatively spliced mRNAs.";
RL   Prostaglandins Other Lipid Mediat. 85:69-80(2008).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (FEB-2007) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.-S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 61-79, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, and Cajal-Retzius cell;
RA   Lubec G., Afjehi-Sadat L.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE
RP   ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE
RP   ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2 AND SER-64, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Inactivates PAF by removing the acetyl group at the sn-2
CC       position. This is a catalytic subunit.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine + H2O = 1-O-
CC         alkyl-sn-glycero-3-phosphocholine + acetate + H(+);
CC         Xref=Rhea:RHEA:17777, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30089, ChEBI:CHEBI:30909, ChEBI:CHEBI:36707; EC=3.1.1.47;
CC   -!- SUBUNIT: Cytosolic PAF-AH IB is formed of three subunits of 45 kDa
CC       (alpha), 30 kDa (beta) and 29 kDa (gamma). The catalytic activity of
CC       the enzyme resides in the beta and gamma subunits, whereas the alpha
CC       subunit has regulatory activity. Trimer formation is not essential for
CC       the catalytic activity.
CC   -!- INTERACTION:
CC       P68402; Q5SYC1: CLVS2; NbExp=3; IntAct=EBI-713724, EBI-12357161;
CC       P68402; Q15102: PAFAH1B3; NbExp=4; IntAct=EBI-713724, EBI-711522;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=P68402-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P68402-2; Sequence=VSP_042896;
CC       Name=3;
CC         IsoId=P68402-3; Sequence=VSP_043217;
CC       Name=4;
CC         IsoId=P68402-4; Sequence=VSP_044680;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:9144386}.
CC   -!- SIMILARITY: Belongs to the 'GDSL' lipolytic enzyme family. Platelet-
CC       activating factor acetylhydrolase IB beta/gamma subunits subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D63390; BAA19917.1; -; mRNA.
DR   EMBL; DQ836738; ABI58225.1; -; mRNA.
DR   EMBL; DQ836739; ABI58226.1; -; mRNA.
DR   EMBL; DQ836740; ABI58227.1; -; mRNA.
DR   EMBL; DQ836741; ABI58228.1; -; mRNA.
DR   EMBL; DQ836742; ABI58229.1; -; mRNA.
DR   EMBL; DQ836743; ABI58230.1; -; mRNA.
DR   EMBL; AK292973; BAF85662.1; -; mRNA.
DR   EMBL; CR456736; CAG33017.1; -; mRNA.
DR   EMBL; EF445007; ACA06040.1; -; Genomic_DNA.
DR   EMBL; AP005018; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471065; EAW67281.1; -; Genomic_DNA.
DR   EMBL; BC000398; AAH00398.1; -; mRNA.
DR   EMBL; BC019301; AAH19301.1; -; mRNA.
DR   CCDS; CCDS53713.1; -. [P68402-3]
DR   CCDS; CCDS53714.1; -. [P68402-4]
DR   CCDS; CCDS53715.1; -. [P68402-2]
DR   CCDS; CCDS8380.1; -. [P68402-1]
DR   PIR; JC5409; JC5409.
DR   RefSeq; NP_001171675.1; NM_001184746.1. [P68402-4]
DR   RefSeq; NP_001171676.1; NM_001184747.1. [P68402-2]
DR   RefSeq; NP_001171677.1; NM_001184748.1. [P68402-3]
DR   RefSeq; NP_001296360.1; NM_001309431.1.
DR   RefSeq; NP_002563.1; NM_002572.3. [P68402-1]
DR   PDB; 1VYH; X-ray; 3.40 A; A/B/E/F/I/J/M/N/Q/R=1-229.
DR   PDBsum; 1VYH; -.
DR   SMR; P68402; -.
DR   BioGrid; 111086; 55.
DR   IntAct; P68402; 22.
DR   STRING; 9606.ENSP00000435289; -.
DR   BindingDB; P68402; -.
DR   ChEMBL; CHEMBL4463; -.
DR   iPTMnet; P68402; -.
DR   PhosphoSitePlus; P68402; -.
DR   BioMuta; PAFAH1B2; -.
DR   DMDM; 55977294; -.
DR   REPRODUCTION-2DPAGE; IPI00026546; -.
DR   EPD; P68402; -.
DR   jPOST; P68402; -.
DR   MassIVE; P68402; -.
DR   PaxDb; P68402; -.
DR   PeptideAtlas; P68402; -.
DR   PRIDE; P68402; -.
DR   ProteomicsDB; 21857; -.
DR   ProteomicsDB; 57538; -. [P68402-1]
DR   ProteomicsDB; 57539; -. [P68402-2]
DR   ProteomicsDB; 57540; -. [P68402-3]
DR   Antibodypedia; 32310; 236 antibodies.
DR   Ensembl; ENST00000419197; ENSP00000388742; ENSG00000168092. [P68402-3]
DR   Ensembl; ENST00000527958; ENSP00000435289; ENSG00000168092. [P68402-1]
DR   Ensembl; ENST00000529887; ENSP00000434951; ENSG00000168092. [P68402-2]
DR   Ensembl; ENST00000530272; ENSP00000431365; ENSG00000168092. [P68402-4]
DR   GeneID; 5049; -.
DR   KEGG; hsa:5049; -.
DR   UCSC; uc009yzk.3; human. [P68402-1]
DR   CTD; 5049; -.
DR   DisGeNET; 5049; -.
DR   GeneCards; PAFAH1B2; -.
DR   HGNC; HGNC:8575; PAFAH1B2.
DR   HPA; ENSG00000168092; Low tissue specificity.
DR   MIM; 602508; gene.
DR   neXtProt; NX_P68402; -.
DR   OpenTargets; ENSG00000168092; -.
DR   PharmGKB; PA32906; -.
DR   eggNOG; ENOG410IMK6; Eukaryota.
DR   eggNOG; ENOG410XPWQ; LUCA.
DR   GeneTree; ENSGT00950000183199; -.
DR   HOGENOM; CLU_051989_2_0_1; -.
DR   InParanoid; P68402; -.
DR   KO; K16795; -.
DR   OMA; QYEXVIV; -.
DR   OrthoDB; 1604899at2759; -.
DR   PhylomeDB; P68402; -.
DR   TreeFam; TF323955; -.
DR   BRENDA; 3.1.1.47; 2681.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-6811436; COPI-independent Golgi-to-ER retrograde traffic.
DR   SIGNOR; P68402; -.
DR   ChiTaRS; PAFAH1B2; human.
DR   EvolutionaryTrace; P68402; -.
DR   GeneWiki; PAFAH1B2; -.
DR   GenomeRNAi; 5049; -.
DR   Pharos; P68402; Tchem.
DR   PRO; PR:P68402; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; P68402; protein.
DR   Bgee; ENSG00000168092; Expressed in secondary oocyte and 215 other tissues.
DR   ExpressionAtlas; P68402; baseline and differential.
DR   Genevisible; P68402; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0034774; C:secretory granule lumen; TAS:Reactome.
DR   GO; GO:0003847; F:1-alkyl-2-acetylglycerophosphocholine esterase activity; IEA:UniProtKB-EC.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0047179; F:platelet-activating factor acetyltransferase activity; IBA:GO_Central.
DR   GO; GO:0044877; F:protein-containing complex binding; IEA:Ensembl.
DR   GO; GO:0007420; P:brain development; IBA:GO_Central.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006629; P:lipid metabolic process; TAS:ProtInc.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0016239; P:positive regulation of macroautophagy; IMP:BHF-UCL.
DR   GO; GO:0007283; P:spermatogenesis; IEA:Ensembl.
DR   Gene3D; 3.40.50.1110; -; 1.
DR   InterPro; IPR013830; SGNH_hydro.
DR   InterPro; IPR036514; SGNH_hydro_sf.
DR   Pfam; PF13472; Lipase_GDSL_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cytoplasm;
KW   Direct protein sequencing; Hydrolase; Lipid degradation; Lipid metabolism;
KW   Phosphoprotein; Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692"
FT   CHAIN           2..229
FT                   /note="Platelet-activating factor acetylhydrolase IB
FT                   subunit beta"
FT                   /id="PRO_0000058151"
FT   ACT_SITE        48
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        193
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        196
FT                   /evidence="ECO:0000250"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692"
FT   MOD_RES         2
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163"
FT   MOD_RES         64
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         220
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61206"
FT   VAR_SEQ         133..229
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:18155631"
FT                   /id="VSP_043217"
FT   VAR_SEQ         138..229
FT                   /note="GLLPRGEKPNPLRQKNAKVNQLLKVSLPKLANVQLLDTDGGFVHSDGAISCH
FT                   DMFDFLHLTGGGYAKICKPLHELIMQLLEETPEEKQTTIA -> IIYWQDEQDYHERKV
FT                   QMD (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:18155631"
FT                   /id="VSP_042896"
FT   VAR_SEQ         139..229
FT                   /note="LLPRGEKPNPLRQKNAKVNQLLKVSLPKLANVQLLDTDGGFVHSDGAISCHD
FT                   MFDFLHLTGGGYAKICKPLHELIMQLLEETPEEKQTTIA -> KAAASKYSISEIVRLE
FT                   QGSVNWSIGTYPDDTPATTRPAILQLFTGKMSRITMKEKSRWTEEILH (in
FT                   isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:18155631"
FT                   /id="VSP_044680"
FT   HELIX           8..10
FT                   /evidence="ECO:0000244|PDB:1VYH"
FT   STRAND          19..21
FT                   /evidence="ECO:0000244|PDB:1VYH"
FT   HELIX           23..37
FT                   /evidence="ECO:0000244|PDB:1VYH"
FT   STRAND          41..47
FT                   /evidence="ECO:0000244|PDB:1VYH"
FT   HELIX           48..53
FT                   /evidence="ECO:0000244|PDB:1VYH"
FT   HELIX           57..62
FT                   /evidence="ECO:0000244|PDB:1VYH"
FT   HELIX           64..66
FT                   /evidence="ECO:0000244|PDB:1VYH"
FT   STRAND          68..72
FT                   /evidence="ECO:0000244|PDB:1VYH"
FT   HELIX           78..86
FT                   /evidence="ECO:0000244|PDB:1VYH"
FT   TURN            87..90
FT                   /evidence="ECO:0000244|PDB:1VYH"
FT   STRAND          96..101
FT                   /evidence="ECO:0000244|PDB:1VYH"
FT   HELIX           111..128
FT                   /evidence="ECO:0000244|PDB:1VYH"
FT   STRAND          133..137
FT                   /evidence="ECO:0000244|PDB:1VYH"
FT   STRAND          143..145
FT                   /evidence="ECO:0000244|PDB:1VYH"
FT   HELIX           148..163
FT                   /evidence="ECO:0000244|PDB:1VYH"
FT   STRAND          164..167
FT                   /evidence="ECO:0000244|PDB:1VYH"
FT   STRAND          170..173
FT                   /evidence="ECO:0000244|PDB:1VYH"
FT   TURN            188..190
FT                   /evidence="ECO:0000244|PDB:1VYH"
FT   STRAND          194..197
FT                   /evidence="ECO:0000244|PDB:1VYH"
FT   HELIX           199..219
FT                   /evidence="ECO:0000244|PDB:1VYH"
FT   CONFLICT        P68402-4:151
FT                   /note="V -> M (in Ref. 2; ABI58227/ABI58228)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   229 AA;  25569 MW;  14CF5D48621AA504 CRC64;
     MSQGDSNPAA IPHAAEDIQG DDRWMSQHNR FVLDCKDKEP DVLFVGDSMV QLMQQYEIWR
     ELFSPLHALN FGIGGDTTRH VLWRLKNGEL ENIKPKVIVV WVGTNNHENT AEEVAGGIEA
     IVQLINTRQP QAKIIVLGLL PRGEKPNPLR QKNAKVNQLL KVSLPKLANV QLLDTDGGFV
     HSDGAISCHD MFDFLHLTGG GYAKICKPLH ELIMQLLEET PEEKQTTIA
//
ID   V9HW44_HUMAN            Unreviewed;       229 AA.
AC   V9HW44;
DT   19-MAR-2014, integrated into UniProtKB/TrEMBL.
DT   19-MAR-2014, sequence version 1.
DT   22-APR-2020, entry version 56.
DE   SubName: Full=Epididymis secretory protein Li 303 {ECO:0000313|EMBL:ACI46020.1};
DE   SubName: Full=Epididymis secretory sperm binding protein {ECO:0000313|EMBL:ADO22372.1};
DE   SubName: Full=Platelet-activating factor acetylhydrolase, isoform Ib, beta subunit 30kDa, isoform CRA_a {ECO:0000313|EMBL:EAW67282.1};
GN   Name=HEL-S-303 {ECO:0000313|EMBL:ACI46020.1};
GN   Synonyms=PAFAH1B2 {ECO:0000313|EMBL:EAW67282.1};
GN   ORFNames=hCG_39271 {ECO:0000313|EMBL:EAW67282.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACI46020.1};
RN   [1] {ECO:0000313|EMBL:EAW67282.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW67282.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ACI46020.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J., Wang H., Liu J., Liu F.;
RL   Submitted (SEP-2008) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:ADO22372.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Hoernsten L., Su C., Osbourn A.E., Hellman U., Wernstedt C., Oliw E.H.;
RL   Submitted (SEP-2009) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; FJ224328; ACI46020.1; -; mRNA.
DR   EMBL; GQ891510; ADO22372.1; -; mRNA.
DR   EMBL; CH471065; EAW67282.1; -; Genomic_DNA.
DR   RefSeq; NP_002563.1; NM_002572.3.
DR   IntAct; V9HW44; 1.
DR   Antibodypedia; 32310; 236 antibodies.
DR   GeneID; 5049; -.
DR   KEGG; hsa:5049; -.
DR   UCSC; uc001pqe.4; human.
DR   CTD; 5049; -.
DR   EuPathDB; HostDB:ENSG00000168092.13; -.
DR   eggNOG; ENOG410IMK6; Eukaryota.
DR   eggNOG; ENOG410XPWQ; LUCA.
DR   HOGENOM; CLU_051989_2_0_1; -.
DR   KO; K16795; -.
DR   OMA; QYEXVIV; -.
DR   OrthoDB; 1604899at2759; -.
DR   ChiTaRS; PAFAH1B2; human.
DR   GenomeRNAi; 5049; -.
DR   Bgee; ENSG00000168092; Expressed in secondary oocyte and 215 other tissues.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0047179; F:platelet-activating factor acetyltransferase activity; IEA:Ensembl.
DR   GO; GO:0044877; F:protein-containing complex binding; IEA:Ensembl.
DR   GO; GO:0007420; P:brain development; IEA:Ensembl.
DR   GO; GO:0007283; P:spermatogenesis; IEA:Ensembl.
DR   Gene3D; 3.40.50.1110; -; 1.
DR   InterPro; IPR013830; SGNH_hydro.
DR   InterPro; IPR036514; SGNH_hydro_sf.
DR   Pfam; PF13472; Lipase_GDSL_2; 1.
PE   2: Evidence at transcript level;
KW   Hydrolase {ECO:0000313|EMBL:EAW67282.1}.
FT   DOMAIN          44..203
FT                   /note="SGNH_hydro"
FT                   /evidence="ECO:0000259|Pfam:PF13472"
SQ   SEQUENCE   229 AA;  25569 MW;  14CF5D48621AA504 CRC64;
     MSQGDSNPAA IPHAAEDIQG DDRWMSQHNR FVLDCKDKEP DVLFVGDSMV QLMQQYEIWR
     ELFSPLHALN FGIGGDTTRH VLWRLKNGEL ENIKPKVIVV WVGTNNHENT AEEVAGGIEA
     IVQLINTRQP QAKIIVLGLL PRGEKPNPLR QKNAKVNQLL KVSLPKLANV QLLDTDGGFV
     HSDGAISCHD MFDFLHLTGG GYAKICKPLH ELIMQLLEET PEEKQTTIA
//
ID   PAX7_HUMAN              Reviewed;         505 AA.
AC   P23759; E9PFV9; Q0VA99; Q2PJS5;
DT   01-NOV-1991, integrated into UniProtKB/Swiss-Prot.
DT   24-JUN-2015, sequence version 4.
DT   22-APR-2020, entry version 200.
DE   RecName: Full=Paired box protein Pax-7;
DE   AltName: Full=HuP1;
GN   Name=PAX7; Synonyms=HUP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=9339373; DOI=10.1006/geno.1997.4915;
RA   Vorobyov E., Mertsalov I., Dockhorn-Dworniczak B., Dworniczak B., Horst J.;
RT   "The genomic organization and the full coding region of the human PAX7
RT   gene.";
RL   Genomics 45:168-174(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RX   PubMed=16830101; DOI=10.1007/s00239-005-0163-7;
RA   Vorobyov E., Horst J.;
RT   "Getting the proto-Pax by the tail.";
RL   J. Mol. Evol. 63:153-164(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-467 (ISOFORMS 1/3).
RX   PubMed=7527137; DOI=10.1093/nar/22.22.4574;
RA   Schaefer B.W., Czerny T., Bernasconi M., Genini M., Busslinger M.;
RT   "Molecular cloning and characterization of a human PAX-7 cDNA expressed in
RT   normal and neoplastic myocytes.";
RL   Nucleic Acids Res. 22:4574-4582(1994).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 30-195 (ISOFORM 2).
RX   PubMed=2501086; DOI=10.1002/j.1460-2075.1989.tb03490.x;
RA   Burri M., Tromvoukis Y., Bopp D., Frigerio G., Noll M.;
RT   "Conservation of the paired domain in metazoans and its structure in three
RT   isolated human genes.";
RL   EMBO J. 8:1183-1190(1989).
RN   [8]
RP   INVOLVEMENT IN RMS2, AND CHROMOSOMAL TRANSLOCATION WITH FOXO1.
RX   PubMed=8187070;
RA   Davis R.J., D'Cruz C.M., Lovell M.A., Biegel J.A., Barr F.G.;
RT   "Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in
RT   alveolar rhabdomyosarcoma.";
RL   Cancer Res. 54:2869-2872(1994).
RN   [9]
RP   INTERACTION WITH DAXX.
RX   PubMed=10393185; DOI=10.1093/emboj/18.13.3702;
RA   Hollenbach A.D., Sublett J.E., McPherson C.J., Grosveld G.;
RT   "The Pax3-FKHR oncoprotein is unresponsive to the Pax3-associated repressor
RT   hDaxx.";
RL   EMBO J. 18:3702-3711(1999).
RN   [10]
RP   FUNCTION, VARIANTS MYOSCO CYS-56; 74-ARG--TYR-505 DEL AND 145-ARG--TYR-505
RP   DEL, AND CHARACTERIZATION OF VARIANT MYOSCO 145-ARG--TYR-505 DEL.
RX   PubMed=31092906; DOI=10.1038/s41436-019-0532-z;
RA   Feichtinger R.G., Mucha B.E., Hengel H., Orfi Z., Makowski C., Dort J.,
RA   D'Anjou G., Nguyen T.T.M., Buchert R., Juenger H., Freisinger P.,
RA   Baumeister S., Schoser B., Ahting U., Keimer R., Nguyen C.E., Fabre P.,
RA   Gauthier J., Miguet M., Lopes F., AlHakeem A., AlHashem A., Tabarki B.,
RA   Kandaswamy K.K., Bauer P., Steinbacher P., Prokisch H., Sturm M.,
RA   Strom T.M., Ellezam B., Mayr J.A., Schoels L., Michaud J.L., Campeau P.M.,
RA   Haack T.B., Dumont N.A.;
RT   "Biallelic variants in the transcription factor PAX7 are a new genetic
RT   cause of myopathy.";
RL   Genet. Med. 21:2521-2531(2019).
CC   -!- FUNCTION: Transcription factor that is involved in the regulation of
CC       muscle stem cells proliferation, playing a role in myogenesis and
CC       muscle regeneration. {ECO:0000269|PubMed:31092906}.
CC   -!- SUBUNIT: Can bind to DNA as a heterodimer with PAX3. Interacts with
CC       PAXBP1; the interaction links PAX7 to a WDR5-containing histone
CC       methyltransferase complex (By similarity). Interacts with DAXX
CC       (PubMed:10393185). {ECO:0000250|UniProtKB:P47239,
CC       ECO:0000269|PubMed:10393185}.
CC   -!- INTERACTION:
CC       P23759-2; Q9NX04: C1orf109; NbExp=3; IntAct=EBI-12859446, EBI-8643161;
CC       P23759-2; Q99828: CIB1; NbExp=3; IntAct=EBI-12859446, EBI-372594;
CC       P23759-2; Q8WUE5: CT55; NbExp=3; IntAct=EBI-12859446, EBI-6873363;
CC       P23759-2; Q9NSC5: HOMER3; NbExp=3; IntAct=EBI-12859446, EBI-748420;
CC       P23759-2; Q3SYF9: KRTAP19-7; NbExp=3; IntAct=EBI-12859446, EBI-10241353;
CC       P23759-2; Q96A72: MAGOHB; NbExp=3; IntAct=EBI-12859446, EBI-746778;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P47239}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=3;
CC         IsoId=P23759-3; Sequence=Displayed;
CC       Name=1; Synonyms=Long;
CC         IsoId=P23759-1; Sequence=VSP_057679;
CC       Name=2; Synonyms=Short;
CC         IsoId=P23759-2; Sequence=VSP_057678, VSP_057679;
CC   -!- DISEASE: Rhabdomyosarcoma 2 (RMS2) [MIM:268220]: A form of
CC       rhabdomyosarcoma, a highly malignant tumor of striated muscle derived
CC       from primitive mesenchymal cells and exhibiting differentiation along
CC       rhabdomyoblastic lines. Rhabdomyosarcoma is one of the most frequently
CC       occurring soft tissue sarcomas and the most common in children. It
CC       occurs in four forms: alveolar, pleomorphic, embryonal and botryoidal
CC       rhabdomyosarcomas. {ECO:0000269|PubMed:8187070}. Note=The gene
CC       represented in this entry is involved in disease pathogenesis. A
CC       chromosomal aberration involving PAX7 is found in rhabdomyosarcoma.
CC       Translocation t(1;13)(p36;q14) with FOXO1. The resulting protein is a
CC       transcriptional activator. {ECO:0000269|PubMed:8187070}.
CC   -!- DISEASE: Myopathy, congenital, progressive, with scoliosis (MYOSCO)
CC       [MIM:618578]: An autosomal recessive muscular disorder characterized by
CC       infantile onset of progressive muscular atrophy, hypotonia, ptosis,
CC       scoliosis and dysmorphic facial features. Disease severity is variable,
CC       ranging from mild to severe. {ECO:0000269|PubMed:31092906}. Note=The
CC       disease is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the paired homeobox family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X96743; CAA65520.1; -; mRNA.
DR   EMBL; X96744; CAA65521.1; -; Genomic_DNA.
DR   EMBL; X15042; CAA65521.1; JOINED; Genomic_DNA.
DR   EMBL; X15250; CAA65521.1; JOINED; Genomic_DNA.
DR   EMBL; X15251; CAA65521.1; JOINED; Genomic_DNA.
DR   EMBL; X96745; CAA65521.1; JOINED; Genomic_DNA.
DR   EMBL; X96746; CAA65521.1; JOINED; Genomic_DNA.
DR   EMBL; X96747; CAA65521.1; JOINED; Genomic_DNA.
DR   EMBL; X96748; CAA65521.1; JOINED; Genomic_DNA.
DR   EMBL; X96744; CAA65522.1; -; Genomic_DNA.
DR   EMBL; X15042; CAA65522.1; JOINED; Genomic_DNA.
DR   EMBL; X15250; CAA65522.1; JOINED; Genomic_DNA.
DR   EMBL; X15251; CAA65522.1; JOINED; Genomic_DNA.
DR   EMBL; X96745; CAA65522.1; JOINED; Genomic_DNA.
DR   EMBL; X96746; CAA65522.1; JOINED; Genomic_DNA.
DR   EMBL; X96747; CAA65522.1; JOINED; Genomic_DNA.
DR   EMBL; X96748; CAA65522.1; JOINED; Genomic_DNA.
DR   EMBL; DQ322591; ABC48797.1; -; mRNA.
DR   EMBL; AL021528; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471134; EAW94853.1; -; Genomic_DNA.
DR   EMBL; BC121165; AAI21166.1; -; mRNA.
DR   EMBL; BC121166; AAI21167.1; -; mRNA.
DR   EMBL; Z35141; CAA84513.1; -; mRNA.
DR   CCDS; CCDS186.1; -. [P23759-1]
DR   CCDS; CCDS44074.1; -. [P23759-3]
DR   CCDS; CCDS44075.1; -. [P23759-2]
DR   PIR; S78502; S78502.
DR   RefSeq; NP_001128726.1; NM_001135254.1. [P23759-3]
DR   RefSeq; NP_002575.1; NM_002584.2. [P23759-1]
DR   RefSeq; NP_039236.1; NM_013945.2. [P23759-2]
DR   SMR; P23759; -.
DR   BioGrid; 111115; 6.
DR   IntAct; P23759; 13.
DR   MINT; P23759; -.
DR   STRING; 9606.ENSP00000364524; -.
DR   iPTMnet; P23759; -.
DR   PhosphoSitePlus; P23759; -.
DR   BioMuta; PAX7; -.
DR   DMDM; 8247951; -.
DR   MassIVE; P23759; -.
DR   PaxDb; P23759; -.
DR   PeptideAtlas; P23759; -.
DR   PRIDE; P23759; -.
DR   ProteomicsDB; 20189; -.
DR   ProteomicsDB; 54148; -. [P23759-1]
DR   ProteomicsDB; 54149; -. [P23759-2]
DR   Antibodypedia; 14724; 687 antibodies.
DR   Ensembl; ENST00000375375; ENSP00000364524; ENSG00000009709. [P23759-1]
DR   Ensembl; ENST00000400661; ENSP00000383502; ENSG00000009709. [P23759-2]
DR   Ensembl; ENST00000420770; ENSP00000403389; ENSG00000009709. [P23759-3]
DR   GeneID; 5081; -.
DR   KEGG; hsa:5081; -.
DR   UCSC; uc001bay.3; human. [P23759-3]
DR   CTD; 5081; -.
DR   DisGeNET; 5081; -.
DR   GeneCards; PAX7; -.
DR   HGNC; HGNC:8621; PAX7.
DR   HPA; ENSG00000009709; Tissue enhanced (skeletal muscle, tongue).
DR   MalaCards; PAX7; -.
DR   MIM; 167410; gene.
DR   MIM; 268220; phenotype.
DR   MIM; 618578; phenotype.
DR   neXtProt; NX_P23759; -.
DR   OpenTargets; ENSG00000009709; -.
DR   Orphanet; 99756; Alveolar rhabdomyosarcoma.
DR   PharmGKB; PA32961; -.
DR   eggNOG; KOG0849; Eukaryota.
DR   eggNOG; ENOG410XS01; LUCA.
DR   GeneTree; ENSGT00940000156759; -.
DR   HOGENOM; CLU_019281_8_0_1; -.
DR   InParanoid; P23759; -.
DR   KO; K09381; -.
DR   OMA; CQRADSI; -.
DR   OrthoDB; 1126858at2759; -.
DR   TreeFam; TF351610; -.
DR   SIGNOR; P23759; -.
DR   ChiTaRS; PAX7; human.
DR   GeneWiki; PAX7; -.
DR   GenomeRNAi; 5081; -.
DR   Pharos; P23759; Tbio.
DR   PRO; PR:P23759; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; P23759; protein.
DR   Bgee; ENSG00000009709; Expressed in nasal cavity epithelium and 32 other tissues.
DR   Genevisible; P23759; HS.
DR   GO; GO:0000790; C:nuclear chromatin; ISA:NTNU_SB.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; TAS:ProtInc.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISA:NTNU_SB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc.
DR   GO; GO:0051216; P:cartilage development; IEA:Ensembl.
DR   GO; GO:0006338; P:chromatin remodeling; IEA:Ensembl.
DR   GO; GO:0021904; P:dorsal/ventral neural tube patterning; IEA:Ensembl.
DR   GO; GO:0048706; P:embryonic skeletal system development; IEA:Ensembl.
DR   GO; GO:0060415; P:muscle tissue morphogenesis; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; TAS:ProtInc.
DR   GO; GO:0048663; P:neuron fate commitment; IEA:Ensembl.
DR   GO; GO:0031062; P:positive regulation of histone methylation; IEA:Ensembl.
DR   GO; GO:2000288; P:positive regulation of myoblast proliferation; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IEA:Ensembl.
DR   GO; GO:0010453; P:regulation of cell fate commitment; IEA:Ensembl.
DR   GO; GO:0051101; P:regulation of DNA binding; IEA:Ensembl.
DR   GO; GO:0014813; P:skeletal muscle satellite cell commitment; IEA:Ensembl.
DR   GO; GO:0043403; P:skeletal muscle tissue regeneration; IEA:Ensembl.
DR   GO; GO:0021527; P:spinal cord association neuron differentiation; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   CDD; cd00131; PAX; 1.
DR   Gene3D; 1.10.10.10; -; 2.
DR   InterPro; IPR009057; Homeobox-like_sf.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR003654; OAR_dom.
DR   InterPro; IPR001523; Paired_dom.
DR   InterPro; IPR022106; Pax7_C.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   Pfam; PF00046; Homeodomain; 1.
DR   Pfam; PF00292; PAX; 1.
DR   Pfam; PF12360; Pax7; 1.
DR   PRINTS; PR00027; PAIREDBOX.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00351; PAX; 1.
DR   SUPFAM; SSF46689; SSF46689; 2.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS50803; OAR; 1.
DR   PROSITE; PS00034; PAIRED_1; 1.
DR   PROSITE; PS51057; PAIRED_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Chromosomal rearrangement; Developmental protein;
KW   Disease mutation; DNA-binding; Homeobox; Myogenesis; Nucleus; Paired box;
KW   Proto-oncogene; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN           1..505
FT                   /note="Paired box protein Pax-7"
FT                   /id="PRO_0000050194"
FT   DNA_BIND        34..163
FT                   /note="Paired"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00381"
FT   DNA_BIND        217..276
FT                   /note="Homeobox"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00108"
FT   REGION          27..210
FT                   /note="Sufficient to mediate interaction with PAXBP1"
FT                   /evidence="ECO:0000250|UniProtKB:P47239"
FT   REGION          37..93
FT                   /note="PAI subdomain"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00381"
FT   REGION          113..163
FT                   /note="RED subdomain"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00381"
FT   MOTIF           479..491
FT                   /note="OAR"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00138"
FT   VAR_SEQ         151..152
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_057678"
FT   VAR_SEQ         468..505
FT                   /note="TAVDYLAKNVSLSTQRRMKLGEHSAVLGLLPVETGQAY -> SECLVPWASP
FT                   VPIPSPTPRASCLFMESYKVVSGWGMSISQMEKLKSSQMEQFT (in isoform 1
FT                   and isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:9339373"
FT                   /id="VSP_057679"
FT   VARIANT         56
FT                   /note="R -> C (in MYOSCO)"
FT                   /evidence="ECO:0000269|PubMed:31092906"
FT                   /id="VAR_083265"
FT   VARIANT         74..505
FT                   /note="Missing (in MYOSCO)"
FT                   /evidence="ECO:0000269|PubMed:31092906"
FT                   /id="VAR_083266"
FT   VARIANT         145..505
FT                   /note="Missing (in MYOSCO; loss-of-function variant
FT                   resulting in a reduced muscle stem cell pool; the protein
FT                   is not detected in patient muscle)"
FT                   /evidence="ECO:0000269|PubMed:31092906"
FT                   /id="VAR_083267"
FT   CONFLICT        468
FT                   /note="T -> S (in Ref. 2; ABC48797)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   505 AA;  55119 MW;  E51CF8B3E8D4C3D9 CRC64;
     MAALPGTVPR MMRPAPGQNY PRTGFPLEVS TPLGQGRVNQ LGGVFINGRP LPNHIRHKIV
     EMAHHGIRPC VISRQLRVSH GCVSKILCRY QETGSIRPGA IGGSKPRQVA TPDVEKKIEE
     YKRENPGMFS WEIRDRLLKD GHCDRSTVPS GLVSSISRVL RIKFGKKEEE DEADKKEDDG
     EKKAKHSIDG ILGDKGNRLD EGSDVESEPD LPLKRKQRRS RTTFTAEQLE ELEKAFERTH
     YPDIYTREEL AQRTKLTEAR VQVWFSNRRA RWRKQAGANQ LAAFNHLLPG GFPPTGMPTL
     PPYQLPDSTY PTTTISQDGG STVHRPQPLP PSTMHQGGLA AAAAAADTSS AYGARHSFSS
     YSDSFMNPAA PSNHMNPVSN GLSPQVMSIL GNPSAVPPQP QADFSISPLH GGLDSATSIS
     ASCSQRADSI KPGDSLPTSQ AYCPPTYSTT GYSVDPVAGY QYGQYGQTAV DYLAKNVSLS
     TQRRMKLGEH SAVLGLLPVE TGQAY
//
ID   A0A024R4X8_HUMAN        Unreviewed;       321 AA.
AC   A0A024R4X8;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 51.
DE   SubName: Full=Paired box gene 8, isoform CRA_c {ECO:0000313|EMBL:EAW73635.1};
GN   Name=PAX8 {ECO:0000313|EMBL:EAW73635.1};
GN   ORFNames=hCG_26667 {ECO:0000313|EMBL:EAW73635.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW73635.1};
RN   [1] {ECO:0000313|EMBL:EAW73635.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW73635.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|SAAS:SAAS00117811}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH471217; EAW73631.1; -; Genomic_DNA.
DR   EMBL; CH471217; EAW73635.1; -; Genomic_DNA.
DR   RefSeq; NP_039247.1; NM_013953.3.
DR   Antibodypedia; 9626; 819 antibodies.
DR   GeneID; 7849; -.
DR   CTD; 7849; -.
DR   EuPathDB; HostDB:ENSG00000125618.16; -.
DR   eggNOG; KOG3862; Eukaryota.
DR   eggNOG; ENOG410ZT0S; LUCA.
DR   HOGENOM; CLU_019281_1_3_1; -.
DR   ChiTaRS; PAX8; human.
DR   GenomeRNAi; 7849; -.
DR   Bgee; ENSG00000125618; Expressed in right lobe of thyroid gland and 211 other tissues.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   CDD; cd00131; PAX; 1.
DR   Gene3D; 1.10.10.10; -; 2.
DR   InterPro; IPR009057; Homeobox-like_sf.
DR   InterPro; IPR001523; Paired_dom.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   Pfam; PF00292; PAX; 1.
DR   PRINTS; PR00027; PAIREDBOX.
DR   SMART; SM00351; PAX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00034; PAIRED_1; 1.
DR   PROSITE; PS51057; PAIRED_2; 1.
PE   4: Predicted;
KW   Developmental protein {ECO:0000256|SAAS:SAAS00476581};
KW   DNA-binding {ECO:0000256|SAAS:SAAS00476599};
KW   Nucleus {ECO:0000256|SAAS:SAAS00476573};
KW   Paired box {ECO:0000256|SAAS:SAAS00476583};
KW   Transcription {ECO:0000256|SAAS:SAAS00476577};
KW   Transcription regulation {ECO:0000256|SAAS:SAAS00476577}.
FT   DOMAIN          9..135
FT                   /note="Paired"
FT                   /evidence="ECO:0000259|PROSITE:PS51057"
FT   REGION          159..222
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          250..285
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          300..321
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        159..186
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        207..222
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        302..321
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   321 AA;  34909 MW;  DE1BC715C6C75532 CRC64;
     MPHNSIRSGH GGLNQLGGAF VNGRPLPEVV RQRIVDLAHQ GVRPCDISRQ LRVSHGCVSK
     ILGRYYETGS IRPGVIGGSK PKVATPKVVE KIGDYKRQNP TMFAWEIRDR LLAEGVCDND
     TVPSVSSINR IIRTKVQQPF NLPMDSCVAT KSLSPGHTLI PSSAVTPPES PQSDSLGSTY
     SINGLLGIAQ PGSDKRKMDD SDQDSCRLSI DSQSSSSGPR KHLRTDAFSQ HHLEPLECPF
     ERQHYPEAYA SPSHTKGEQG ERWWGPRCPD THPTSPPADR AAMPPLPSQA WWQEVNTLAM
     PMATPPTPPT ARPGASPTPA C
//
ID   A0A024R524_HUMAN        Unreviewed;       398 AA.
AC   A0A024R524;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 51.
DE   SubName: Full=Paired box gene 8, isoform CRA_d {ECO:0000313|EMBL:EAW73638.1};
GN   Name=PAX8 {ECO:0000313|EMBL:EAW73638.1};
GN   ORFNames=hCG_26667 {ECO:0000313|EMBL:EAW73638.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW73638.1};
RN   [1] {ECO:0000313|EMBL:EAW73638.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW73638.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|SAAS:SAAS00117811}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH471217; EAW73634.1; -; Genomic_DNA.
DR   EMBL; CH471217; EAW73638.1; -; Genomic_DNA.
DR   RefSeq; NP_039246.1; NM_013952.3.
DR   Antibodypedia; 9626; 819 antibodies.
DR   GeneID; 7849; -.
DR   CTD; 7849; -.
DR   EuPathDB; HostDB:ENSG00000125618.16; -.
DR   eggNOG; KOG3862; Eukaryota.
DR   eggNOG; ENOG410ZT0S; LUCA.
DR   HOGENOM; CLU_019281_4_1_1; -.
DR   ChiTaRS; PAX8; human.
DR   GenomeRNAi; 7849; -.
DR   Bgee; ENSG00000125618; Expressed in right lobe of thyroid gland and 211 other tissues.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   CDD; cd00131; PAX; 1.
DR   Gene3D; 1.10.10.10; -; 2.
DR   InterPro; IPR009057; Homeobox-like_sf.
DR   InterPro; IPR001523; Paired_dom.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   Pfam; PF00292; PAX; 1.
DR   PRINTS; PR00027; PAIREDBOX.
DR   SMART; SM00351; PAX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00034; PAIRED_1; 1.
DR   PROSITE; PS51057; PAIRED_2; 1.
PE   4: Predicted;
KW   Developmental protein {ECO:0000256|SAAS:SAAS00476581};
KW   DNA-binding {ECO:0000256|SAAS:SAAS00476599};
KW   Nucleus {ECO:0000256|SAAS:SAAS00476573};
KW   Paired box {ECO:0000256|SAAS:SAAS00476583};
KW   Transcription {ECO:0000256|SAAS:SAAS00476577};
KW   Transcription regulation {ECO:0000256|SAAS:SAAS00476577}.
FT   DOMAIN          9..135
FT                   /note="Paired"
FT                   /evidence="ECO:0000259|PROSITE:PS51057"
FT   REGION          159..222
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          326..362
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          377..398
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        159..186
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        207..222
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        379..398
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   398 AA;  43028 MW;  B8A48B2C8916723C CRC64;
     MPHNSIRSGH GGLNQLGGAF VNGRPLPEVV RQRIVDLAHQ GVRPCDISRQ LRVSHGCVSK
     ILGRYYETGS IRPGVIGGSK PKVATPKVVE KIGDYKRQNP TMFAWEIRDR LLAEGVCDND
     TVPSVSSINR IIRTKVQQPF NLPMDSCVAT KSLSPGHTLI PSSAVTPPES PQSDSLGSTY
     SINGLLGIAQ PGSDKRKMDD SDQDSCRLSI DSQSSSSGPR KHLRTDAFSQ HHLEPLECPF
     ERQHYPEAYA SPSHTKGEQG LYPLPLLNST LDDGKATLTP SNTPLGRNLS THQTYPVVAA
     PPFWICSKSA PGSRPSMPFP MLPPCTGSSR ARPSSQGERW WGPRCPDTHP TSPPADRAAM
     PPLPSQAWWQ EVNTLAMPMA TPPTPPTARP GASPTPAC
//
ID   PAX8_HUMAN              Reviewed;         450 AA.
AC   Q06710; Q09155; Q16337; Q16338; Q16339; Q4ZG35; Q96J49;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 2.
DT   22-APR-2020, entry version 192.
DE   RecName: Full=Paired box protein Pax-8;
GN   Name=PAX8;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND VARIANT LEU-329.
RC   TISSUE=Kidney;
RX   PubMed=1337742;
RA   Poleev A., Fickenscher H., Mundlos S., Winterpacht A., Zabel B., Fidler A.,
RA   Gruss P., Plachov D.;
RT   "PAX8, a human paired box gene: isolation and expression in developing
RT   thyroid, kidney and Wilms' tumors.";
RL   Development 116:611-623(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND ALTERNATIVE SPLICING.
RC   TISSUE=Kidney;
RX   PubMed=8413205; DOI=10.1128/mcb.13.10.6024;
RA   Kozmik Z., Kurzbauer R., Doerfler P., Busslinger M.;
RT   "Alternative splicing of Pax-8 gene transcripts is developmentally
RT   regulated and generates isoforms with different transactivation
RT   properties.";
RL   Mol. Cell. Biol. 13:6024-6035(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 3; 4 AND 5).
RX   PubMed=7737192; DOI=10.1111/j.1432-1033.1995.tb20338.x;
RA   Poleev A., Wendler F., Fickenscher H., Zannini M.S., Yaginuma K.,
RA   Abbott C., Plachov D.;
RT   "Distinct functional properties of three human paired-box-protein, PAX8,
RT   isoforms generated by alternative splicing in thyroid, kidney and Wilms'
RT   tumors.";
RL   Eur. J. Biochem. 228:899-911(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Cervix;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   INTERACTION WITH WWTR1.
RX   PubMed=19010321; DOI=10.1016/j.yexcr.2008.10.016;
RA   Di Palma T., D'Andrea B., Liguori G.L., Liguoro A., de Cristofaro T.,
RA   Del Prete D., Pappalardo A., Mascia A., Zannini M.;
RT   "TAZ is a coactivator for Pax8 and TTF-1, two transcription factors
RT   involved in thyroid differentiation.";
RL   Exp. Cell Res. 315:162-175(2009).
RN   [9]
RP   VARIANTS CHNG2 HIS-31 AND ARG-62.
RX   PubMed=9590296; DOI=10.1038/ng0598-83;
RA   Macchia P.E., Lapi P., Krude H., Pirro M.T., Missero C., Chiovato L.,
RA   Souabni A., Baserga M., Tassi V., Pinchera A., Fenzi G., Gruters A.,
RA   Busslinger M., Di Lauro R.;
RT   "PAX8 mutations associated with congenital hypothyroidism caused by thyroid
RT   dysgenesis.";
RL   Nat. Genet. 19:83-86(1998).
RN   [10]
RP   VARIANT CHNG2 TYR-57.
RX   PubMed=11232006; DOI=10.1210/jcem.86.1.7140;
RA   Vilain C., Rydlewski C., Duprez L., Heinrichs C., Abramowicz M.,
RA   Malvaux P., Renneboog B., Parma J., Costagliola S., Vassart G.;
RT   "Autosomal dominant transmission of congenital thyroid hypoplasia due to
RT   loss-of-function mutation of PAX8.";
RL   J. Clin. Endocrinol. Metab. 86:234-238(2001).
RN   [11]
RP   VARIANT CHNG2 PRO-40.
RX   PubMed=11502839; DOI=10.1210/jcem.86.8.7765;
RA   Congdon T., Nguyen L.Q., Nogueira C.R., Habiby R.L., Medeiros-Neto G.,
RA   Kopp P.;
RT   "A novel mutation (Q40P) in PAX8 associated with congenital hypothyroidism
RT   and thyroid hypoplasia: evidence for phenotypic variability in mother and
RT   child.";
RL   J. Clin. Endocrinol. Metab. 86:3962-3967(2001).
RN   [12]
RP   STRUCTURE BY NMR OF 1-143.
RX   PubMed=18829450; DOI=10.1074/jbc.m805717200;
RA   Codutti L., van Ingen H., Vascotto C., Fogolari F., Corazza A., Tell G.,
RA   Quadrifoglio F., Viglino P., Boelens R., Esposito G.;
RT   "The solution structure of DNA-free Pax-8 paired box domain accounts for
RT   redox regulation of transcriptional activity in the pax protein family.";
RL   J. Biol. Chem. 283:33321-33328(2008).
CC   -!- FUNCTION: Transcription factor for the thyroid-specific expression of
CC       the genes exclusively expressed in the thyroid cell type, maintaining
CC       the functional differentiation of such cells.
CC   -!- SUBUNIT: Interacts with WWTR1. {ECO:0000269|PubMed:19010321}.
CC   -!- INTERACTION:
CC       Q06710; Q00526: CDK3; NbExp=3; IntAct=EBI-2683132, EBI-1245761;
CC       Q06710; Q8TEW6: DOK4; NbExp=3; IntAct=EBI-2683132, EBI-6918542;
CC       Q06710; O75603: GCM2; NbExp=3; IntAct=EBI-2683132, EBI-10188645;
CC       Q06710; P31273: HOXC8; NbExp=3; IntAct=EBI-2683132, EBI-1752118;
CC       Q06710; P31274: HOXC9; NbExp=3; IntAct=EBI-2683132, EBI-1779423;
CC       Q06710; Q17RB8: LONRF1; NbExp=3; IntAct=EBI-2683132, EBI-2341787;
CC       Q06710; P19338: NCL; NbExp=2; IntAct=EBI-2683132, EBI-346967;
CC       Q06710; Q9UBE0: SAE1; NbExp=3; IntAct=EBI-2683132, EBI-743154;
CC       Q06710; Q9NRX5: SERINC1; NbExp=2; IntAct=EBI-2683132, EBI-2683145;
CC       Q06710; O75177-5: SS18L1; NbExp=3; IntAct=EBI-2683132, EBI-12035119;
CC       Q06710; Q08117-2: TLE5; NbExp=3; IntAct=EBI-2683132, EBI-11741437;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1; Synonyms=Pax8a;
CC         IsoId=Q06710-1; Sequence=Displayed;
CC       Name=2; Synonyms=Pax8b;
CC         IsoId=Q06710-2; Sequence=VSP_002372;
CC       Name=3; Synonyms=Pax8c;
CC         IsoId=Q06710-3; Sequence=VSP_002373;
CC       Name=4; Synonyms=Pax8d;
CC         IsoId=Q06710-4; Sequence=VSP_002374;
CC       Name=5; Synonyms=Pax8e;
CC         IsoId=Q06710-5; Sequence=VSP_002375;
CC   -!- TISSUE SPECIFICITY: Expressed in the excretory system, thyroid gland
CC       and Wilms tumors.
CC   -!- DEVELOPMENTAL STAGE: In developing excretory system, during thyroid
CC       differentiation and in adult thyroid.
CC   -!- DISEASE: Hypothyroidism, congenital, non-goitrous, 2 (CHNG2)
CC       [MIM:218700]: A disease characterized by thyroid dysgenesis, the most
CC       frequent cause of congenital hypothyroidism, accounting for 85% of
CC       case. The thyroid gland can be completely absent (athyreosis),
CC       ectopically located and/or severely hypoplastic. Ectopic thyroid gland
CC       is the most frequent malformation, with thyroid tissue being found most
CC       often at the base of the tongue. {ECO:0000269|PubMed:11232006,
CC       ECO:0000269|PubMed:11502839, ECO:0000269|PubMed:9590296}. Note=The
CC       disease is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PAX8ID382ch2q13.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X69699; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; L19606; AAA03539.1; -; mRNA.
DR   EMBL; S77904; AAB34216.1; -; mRNA.
DR   EMBL; S77905; AAB34217.2; -; mRNA.
DR   EMBL; S77906; AAB34218.2; -; mRNA.
DR   EMBL; AK292191; BAF84880.1; -; mRNA.
DR   EMBL; AC016683; AAX88880.1; -; Genomic_DNA.
DR   EMBL; CH471217; EAW73629.1; -; Genomic_DNA.
DR   EMBL; BC001060; AAH01060.1; -; mRNA.
DR   CCDS; CCDS42735.1; -. [Q06710-5]
DR   CCDS; CCDS42736.1; -. [Q06710-4]
DR   CCDS; CCDS46398.1; -. [Q06710-1]
DR   CCDS; CCDS46399.1; -. [Q06710-3]
DR   PIR; A54429; A54429.
DR   PIR; I53340; I53340.
DR   RefSeq; NP_003457.1; NM_003466.3. [Q06710-1]
DR   RefSeq; NP_039246.1; NM_013952.3. [Q06710-3]
DR   RefSeq; NP_039247.1; NM_013953.3. [Q06710-4]
DR   RefSeq; NP_054698.1; NM_013992.3. [Q06710-5]
DR   PDB; 2K27; NMR; -; A=1-143.
DR   PDBsum; 2K27; -.
DR   SMR; Q06710; -.
DR   BioGrid; 113604; 9.
DR   IntAct; Q06710; 23.
DR   STRING; 9606.ENSP00000263334; -.
DR   ChEMBL; CHEMBL2362980; -.
DR   iPTMnet; Q06710; -.
DR   PhosphoSitePlus; Q06710; -.
DR   BioMuta; PAX8; -.
DR   DMDM; 215273928; -.
DR   MassIVE; Q06710; -.
DR   PaxDb; Q06710; -.
DR   PeptideAtlas; Q06710; -.
DR   PRIDE; Q06710; -.
DR   ProteomicsDB; 58470; -. [Q06710-1]
DR   ProteomicsDB; 58471; -. [Q06710-2]
DR   ProteomicsDB; 58472; -. [Q06710-3]
DR   ProteomicsDB; 58473; -. [Q06710-4]
DR   ProteomicsDB; 58474; -. [Q06710-5]
DR   Antibodypedia; 9626; 819 antibodies.
DR   DNASU; 7849; -.
DR   Ensembl; ENST00000263334; ENSP00000263334; ENSG00000125618. [Q06710-1]
DR   Ensembl; ENST00000263335; ENSP00000263335; ENSG00000125618. [Q06710-4]
DR   Ensembl; ENST00000348715; ENSP00000314750; ENSG00000125618. [Q06710-3]
DR   Ensembl; ENST00000397647; ENSP00000380768; ENSG00000125618. [Q06710-5]
DR   Ensembl; ENST00000429538; ENSP00000395498; ENSG00000125618. [Q06710-1]
DR   GeneID; 7849; -.
DR   KEGG; hsa:7849; -.
DR   UCSC; uc002tjm.4; human. [Q06710-1]
DR   CTD; 7849; -.
DR   DisGeNET; 7849; -.
DR   GeneCards; PAX8; -.
DR   HGNC; HGNC:8622; PAX8.
DR   HPA; ENSG00000125618; Group enriched (kidney, thyroid gland).
DR   MalaCards; PAX8; -.
DR   MIM; 167415; gene.
DR   MIM; 218700; phenotype.
DR   neXtProt; NX_Q06710; -.
DR   OpenTargets; ENSG00000125618; -.
DR   Orphanet; 95713; Athyreosis.
DR   Orphanet; 146; Differentiated thyroid carcinoma.
DR   Orphanet; 95712; Thyroid ectopia.
DR   Orphanet; 95720; Thyroid hypoplasia.
DR   PharmGKB; PA32962; -.
DR   eggNOG; KOG3862; Eukaryota.
DR   eggNOG; ENOG410ZT0S; LUCA.
DR   GeneTree; ENSGT00940000161868; -.
DR   HOGENOM; CLU_019281_1_3_1; -.
DR   InParanoid; Q06710; -.
DR   KO; K09293; -.
DR   OMA; PRKQMRV; -.
DR   PhylomeDB; Q06710; -.
DR   TreeFam; TF315397; -.
DR   SIGNOR; Q06710; -.
DR   ChiTaRS; PAX8; human.
DR   EvolutionaryTrace; Q06710; -.
DR   GeneWiki; PAX8; -.
DR   GenomeRNAi; 7849; -.
DR   Pharos; Q06710; Tbio.
DR   PRO; PR:Q06710; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q06710; protein.
DR   Bgee; ENSG00000125618; Expressed in right lobe of thyroid gland and 211 other tissues.
DR   ExpressionAtlas; Q06710; baseline and differential.
DR   Genevisible; Q06710; HS.
DR   GO; GO:0000790; C:nuclear chromatin; ISA:NTNU_SB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IEA:Ensembl.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IDA:UniProtKB.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISA:NTNU_SB.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0004996; F:thyroid-stimulating hormone receptor activity; TAS:ProtInc.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB.
DR   GO; GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc.
DR   GO; GO:0001658; P:branching involved in ureteric bud morphogenesis; IEP:UniProtKB.
DR   GO; GO:0071371; P:cellular response to gonadotropin stimulus; IDA:UniProtKB.
DR   GO; GO:0007417; P:central nervous system development; IEP:UniProtKB.
DR   GO; GO:0042472; P:inner ear morphogenesis; ISS:UniProtKB.
DR   GO; GO:0001822; P:kidney development; IEP:UniProtKB.
DR   GO; GO:0003337; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; IEP:UniProtKB.
DR   GO; GO:0001823; P:mesonephros development; ISS:UniProtKB.
DR   GO; GO:0072278; P:metanephric comma-shaped body morphogenesis; IEP:UniProtKB.
DR   GO; GO:0072221; P:metanephric distal convoluted tubule development; ISS:UniProtKB.
DR   GO; GO:0072207; P:metanephric epithelium development; IEP:UniProtKB.
DR   GO; GO:0072289; P:metanephric nephron tubule formation; ISS:UniProtKB.
DR   GO; GO:0072284; P:metanephric S-shaped body morphogenesis; IEP:UniProtKB.
DR   GO; GO:1900215; P:negative regulation of apoptotic process involved in metanephric collecting duct development; ISS:UniProtKB.
DR   GO; GO:1900218; P:negative regulation of apoptotic process involved in metanephric nephron tubule development; ISS:UniProtKB.
DR   GO; GO:0010667; P:negative regulation of cardiac muscle cell apoptotic process; IEA:Ensembl.
DR   GO; GO:0072305; P:negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis; ISS:UniProtKB.
DR   GO; GO:1900212; P:negative regulation of mesenchymal cell apoptotic process involved in metanephros development; ISS:UniProtKB.
DR   GO; GO:0071599; P:otic vesicle development; IEP:UniProtKB.
DR   GO; GO:0090190; P:positive regulation of branching involved in ureteric bud morphogenesis; ISS:UniProtKB.
DR   GO; GO:0072108; P:positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis; ISS:UniProtKB.
DR   GO; GO:2000594; P:positive regulation of metanephric DCT cell differentiation; ISS:UniProtKB.
DR   GO; GO:2000611; P:positive regulation of thyroid hormone generation; IMP:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0039003; P:pronephric field specification; ISS:UniProtKB.
DR   GO; GO:0048793; P:pronephros development; ISS:UniProtKB.
DR   GO; GO:0042981; P:regulation of apoptotic process; ISS:UniProtKB.
DR   GO; GO:0072307; P:regulation of metanephric nephron tubule epithelial cell differentiation; ISS:UniProtKB.
DR   GO; GO:2000612; P:regulation of thyroid-stimulating hormone secretion; IMP:UniProtKB.
DR   GO; GO:0006790; P:sulfur compound metabolic process; IEA:Ensembl.
DR   GO; GO:0030878; P:thyroid gland development; IMP:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0001655; P:urogenital system development; ISS:UniProtKB.
DR   GO; GO:0003281; P:ventricular septum development; IEA:Ensembl.
DR   CDD; cd00131; PAX; 1.
DR   DisProt; DP01517; -.
DR   Gene3D; 1.10.10.10; -; 2.
DR   InterPro; IPR009057; Homeobox-like_sf.
DR   InterPro; IPR001523; Paired_dom.
DR   InterPro; IPR022130; Pax2_C.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   Pfam; PF00292; PAX; 1.
DR   Pfam; PF12403; Pax2_C; 1.
DR   PRINTS; PR00027; PAIREDBOX.
DR   SMART; SM00351; PAX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00034; PAIRED_1; 1.
DR   PROSITE; PS51057; PAIRED_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Congenital hypothyroidism;
KW   Developmental protein; Differentiation; Disease mutation; DNA-binding;
KW   Nucleus; Paired box; Phosphoprotein; Polymorphism; Reference proteome;
KW   Transcription; Transcription regulation.
FT   CHAIN           1..450
FT                   /note="Paired box protein Pax-8"
FT                   /id="PRO_0000050197"
FT   DNA_BIND        9..135
FT                   /note="Paired"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00381"
FT   REGION          12..68
FT                   /note="PAI subdomain"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00381"
FT   REGION          87..135
FT                   /note="RED subdomain"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00381"
FT   COMPBIAS        315..327
FT                   /note="Ser-rich"
FT   MOD_RES         303
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q00288"
FT   VAR_SEQ         260..450
FT                   /note="GLYPLPLLNSTLDDGKATLTPSNTPLGRNLSTHQTYPVVADPHSPFAIKQET
FT                   PEVSSSSSTPSSLSSSAFLDLQQVGSGVPPFNAFPHAASVYGQFTGQALLSGREMVGPT
FT                   LPGYPPHIPTSGQGSYASSAIAGMVAGSEYSGNAYGHTPYSSYSEAWRFPNSSLLSSPY
FT                   YYSSTSRPSAPPTTATAFDHL -> GERWWGPRCPDTHPTSPPADRAAMPPLPSQAWWQ
FT                   EVNTLAMPMATPPTPPTARPGASPTPAC (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:7737192"
FT                   /id="VSP_002374"
FT   VAR_SEQ         260..450
FT                   /note="GLYPLPLLNSTLDDGKATLTPSNTPLGRNLSTHQTYPVVADPHSPFAIKQET
FT                   PEVSSSSSTPSSLSSSAFLDLQQVGSGVPPFNAFPHAASVYGQFTGQALLSGREMVGPT
FT                   LPGYPPHIPTSGQGSYASSAIAGMVAGSEYSGNAYGHTPYSSYSEAWRFPNSSLLSSPY
FT                   YYSSTSRPSAPPTTATAFDHL -> EVNTLAMPMATPPTPPTARPGASPTPAC (in
FT                   isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:7737192"
FT                   /id="VSP_002375"
FT   VAR_SEQ         300..450
FT                   /note="DPHSPFAIKQETPEVSSSSSTPSSLSSSAFLDLQQVGSGVPPFNAFPHAASV
FT                   YGQFTGQALLSGREMVGPTLPGYPPHIPTSGQGSYASSAIAGMVAGSEYSGNAYGHTPY
FT                   SSYSEAWRFPNSSLLSSPYYYSSTSRPSAPPTTATAFDHL -> APPFWICSKSAPGSR
FT                   PSMPFPMLPPCTGSSRARPSSQGERWWGPRCPDTHPTSPPADRAAMPPLPSQAWWQEVN
FT                   TLAMPMATPPTPPTARPGASPTPAC (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:7737192"
FT                   /id="VSP_002373"
FT   VAR_SEQ         300..362
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:1337742"
FT                   /id="VSP_002372"
FT   VARIANT         31
FT                   /note="R -> H (in CHNG2; loss of activity;
FT                   dbSNP:rs104893657)"
FT                   /evidence="ECO:0000269|PubMed:9590296"
FT                   /id="VAR_012769"
FT   VARIANT         40
FT                   /note="Q -> P (in CHNG2; loss of activity;
FT                   dbSNP:rs104893656)"
FT                   /evidence="ECO:0000269|PubMed:11502839"
FT                   /id="VAR_012770"
FT   VARIANT         57
FT                   /note="C -> Y (in CHNG2; loss of activity;
FT                   dbSNP:rs104893659)"
FT                   /evidence="ECO:0000269|PubMed:11232006"
FT                   /id="VAR_012771"
FT   VARIANT         62
FT                   /note="L -> R (in CHNG2; loss of activity;
FT                   dbSNP:rs104893658)"
FT                   /evidence="ECO:0000269|PubMed:9590296"
FT                   /id="VAR_012772"
FT   VARIANT         329
FT                   /note="F -> L (in dbSNP:rs3188996)"
FT                   /evidence="ECO:0000269|PubMed:1337742"
FT                   /id="VAR_012773"
FT   CONFLICT        305
FT                   /note="F -> L (in Ref. 1; X69699)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        322
FT                   /note="S -> C (in Ref. 1; X69699)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        418
FT                   /note="R -> G (in Ref. 1; X69699)"
FT                   /evidence="ECO:0000305"
FT   STRAND          21..23
FT                   /evidence="ECO:0000244|PDB:2K27"
FT   HELIX           28..40
FT                   /evidence="ECO:0000244|PDB:2K27"
FT   HELIX           44..51
FT                   /evidence="ECO:0000244|PDB:2K27"
FT   HELIX           56..62
FT                   /evidence="ECO:0000244|PDB:2K27"
FT   HELIX           88..98
FT                   /evidence="ECO:0000244|PDB:2K27"
FT   STRAND          100..102
FT                   /evidence="ECO:0000244|PDB:2K27"
FT   HELIX           104..114
FT                   /evidence="ECO:0000244|PDB:2K27"
FT   TURN            119..121
FT                   /evidence="ECO:0000244|PDB:2K27"
FT   HELIX           125..135
FT                   /evidence="ECO:0000244|PDB:2K27"
SQ   SEQUENCE   450 AA;  48218 MW;  7FDAFA8CEAF20A0E CRC64;
     MPHNSIRSGH GGLNQLGGAF VNGRPLPEVV RQRIVDLAHQ GVRPCDISRQ LRVSHGCVSK
     ILGRYYETGS IRPGVIGGSK PKVATPKVVE KIGDYKRQNP TMFAWEIRDR LLAEGVCDND
     TVPSVSSINR IIRTKVQQPF NLPMDSCVAT KSLSPGHTLI PSSAVTPPES PQSDSLGSTY
     SINGLLGIAQ PGSDKRKMDD SDQDSCRLSI DSQSSSSGPR KHLRTDAFSQ HHLEPLECPF
     ERQHYPEAYA SPSHTKGEQG LYPLPLLNST LDDGKATLTP SNTPLGRNLS THQTYPVVAD
     PHSPFAIKQE TPEVSSSSST PSSLSSSAFL DLQQVGSGVP PFNAFPHAAS VYGQFTGQAL
     LSGREMVGPT LPGYPPHIPT SGQGSYASSA IAGMVAGSEY SGNAYGHTPY SSYSEAWRFP
     NSSLLSSPYY YSSTSRPSAP PTTATAFDHL
//
ID   R9W7C9_HUMAN            Unreviewed;       450 AA.
AC   R9W7C9; A0A024R4X3;
DT   18-SEP-2013, integrated into UniProtKB/TrEMBL.
DT   18-SEP-2013, sequence version 1.
DT   22-APR-2020, entry version 58.
DE   SubName: Full=Paired box 8 isoform 1 {ECO:0000313|EMBL:ALQ33862.1};
DE   SubName: Full=Paired box 8 transcript variant F {ECO:0000313|EMBL:AGN95866.1};
DE   SubName: Full=Paired box gene 8, isoform CRA_a {ECO:0000313|EMBL:EAW73632.1};
GN   Name=PAX8 {ECO:0000313|EMBL:AGN95866.1};
GN   ORFNames=hCG_26667 {ECO:0000313|EMBL:EAW73632.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AGN95866.1};
RN   [1] {ECO:0000313|EMBL:EAW73632.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW73632.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:AGN95866.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Szaflarski W.;
RT   "Alternative 3' acceptor site in the exon 2 of human PAX8 gene resulting in
RT   the expression of unknown mRNA variant found in thyroid hemiagenesis and
RT   some types of cancer.";
RL   Submitted (MAR-2013) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:ALQ33862.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by Alternative
RT   Splicing.";
RL   Cell 164:805-817(2016).
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|SAAS:SAAS00117811}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; KC733810; AGN95866.1; -; mRNA.
DR   EMBL; KU178404; ALQ33862.1; -; mRNA.
DR   EMBL; CH471217; EAW73632.1; -; Genomic_DNA.
DR   RefSeq; NP_003457.1; NM_003466.3.
DR   Antibodypedia; 9626; 819 antibodies.
DR   GeneID; 7849; -.
DR   KEGG; hsa:7849; -.
DR   UCSC; uc010yxt.3; human.
DR   CTD; 7849; -.
DR   EuPathDB; HostDB:ENSG00000125618.16; -.
DR   eggNOG; KOG3862; Eukaryota.
DR   eggNOG; ENOG410ZT0S; LUCA.
DR   KO; K09293; -.
DR   OMA; PRKQMRV; -.
DR   OrthoDB; 592933at2759; -.
DR   ChiTaRS; PAX8; human.
DR   GenomeRNAi; 7849; -.
DR   Bgee; ENSG00000125618; Expressed in right lobe of thyroid gland and 211 other tissues.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IEA:Ensembl.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0030154; P:cell differentiation; IEA:Ensembl.
DR   GO; GO:0007417; P:central nervous system development; IEA:Ensembl.
DR   GO; GO:0042472; P:inner ear morphogenesis; IEA:Ensembl.
DR   GO; GO:0072164; P:mesonephric tubule development; IEA:Ensembl.
DR   GO; GO:0072221; P:metanephric distal convoluted tubule development; IEA:Ensembl.
DR   GO; GO:0072289; P:metanephric nephron tubule formation; IEA:Ensembl.
DR   GO; GO:1900215; P:negative regulation of apoptotic process involved in metanephric collecting duct development; IEA:Ensembl.
DR   GO; GO:1900218; P:negative regulation of apoptotic process involved in metanephric nephron tubule development; IEA:Ensembl.
DR   GO; GO:0010667; P:negative regulation of cardiac muscle cell apoptotic process; IEA:Ensembl.
DR   GO; GO:0072305; P:negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis; IEA:Ensembl.
DR   GO; GO:0090190; P:positive regulation of branching involved in ureteric bud morphogenesis; IEA:Ensembl.
DR   GO; GO:0072108; P:positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis; IEA:Ensembl.
DR   GO; GO:2000594; P:positive regulation of metanephric DCT cell differentiation; IEA:Ensembl.
DR   GO; GO:2000611; P:positive regulation of thyroid hormone generation; IEA:Ensembl.
DR   GO; GO:0039003; P:pronephric field specification; IEA:Ensembl.
DR   GO; GO:0072307; P:regulation of metanephric nephron tubule epithelial cell differentiation; IEA:Ensembl.
DR   GO; GO:0072050; P:S-shaped body morphogenesis; IEA:Ensembl.
DR   GO; GO:0006790; P:sulfur compound metabolic process; IEA:Ensembl.
DR   GO; GO:0030878; P:thyroid gland development; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:Ensembl.
DR   GO; GO:0003281; P:ventricular septum development; IEA:Ensembl.
DR   CDD; cd00131; PAX; 1.
DR   Gene3D; 1.10.10.10; -; 2.
DR   InterPro; IPR009057; Homeobox-like_sf.
DR   InterPro; IPR001523; Paired_dom.
DR   InterPro; IPR022130; Pax2_C.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   Pfam; PF00292; PAX; 1.
DR   Pfam; PF12403; Pax2_C; 1.
DR   PRINTS; PR00027; PAIREDBOX.
DR   SMART; SM00351; PAX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00034; PAIRED_1; 1.
DR   PROSITE; PS51057; PAIRED_2; 1.
PE   2: Evidence at transcript level;
KW   Developmental protein {ECO:0000256|SAAS:SAAS00476581};
KW   DNA-binding {ECO:0000256|SAAS:SAAS00476599};
KW   Nucleus {ECO:0000256|SAAS:SAAS00476573};
KW   Paired box {ECO:0000256|SAAS:SAAS00476583};
KW   Transcription {ECO:0000256|SAAS:SAAS00476577};
KW   Transcription regulation {ECO:0000256|SAAS:SAAS00476577}.
FT   DOMAIN          9..135
FT                   /note="Paired"
FT                   /evidence="ECO:0000259|PROSITE:PS51057"
FT   REGION          159..222
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        159..186
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        207..222
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   450 AA;  48218 MW;  7FDAFA8CEAF20A0E CRC64;
     MPHNSIRSGH GGLNQLGGAF VNGRPLPEVV RQRIVDLAHQ GVRPCDISRQ LRVSHGCVSK
     ILGRYYETGS IRPGVIGGSK PKVATPKVVE KIGDYKRQNP TMFAWEIRDR LLAEGVCDND
     TVPSVSSINR IIRTKVQQPF NLPMDSCVAT KSLSPGHTLI PSSAVTPPES PQSDSLGSTY
     SINGLLGIAQ PGSDKRKMDD SDQDSCRLSI DSQSSSSGPR KHLRTDAFSQ HHLEPLECPF
     ERQHYPEAYA SPSHTKGEQG LYPLPLLNST LDDGKATLTP SNTPLGRNLS THQTYPVVAD
     PHSPFAIKQE TPEVSSSSST PSSLSSSAFL DLQQVGSGVP PFNAFPHAAS VYGQFTGQAL
     LSGREMVGPT LPGYPPHIPT SGQGSYASSA IAGMVAGSEY SGNAYGHTPY SSYSEAWRFP
     NSSLLSSPYY YSSTSRPSAP PTTATAFDHL
//
ID   A2RUU9_HUMAN            Unreviewed;      1859 AA.
AC   A2RUU9;
DT   06-MAR-2007, integrated into UniProtKB/TrEMBL.
DT   06-MAR-2007, sequence version 1.
DT   26-FEB-2020, entry version 59.
DE   SubName: Full=PCM1 protein {ECO:0000313|EMBL:AAI33053.1};
GN   Name=PCM1 {ECO:0000313|EMBL:AAI33053.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAI33053.1};
RN   [1] {ECO:0000313|EMBL:AAI33053.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M., Peck A.M.,
RA   Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S., Feolo M.,
RA   Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F., Schaefer C.F.,
RA   Buetow K., Bonner T.I., Haussler D., Kent J., Kiekhaus M., Furey T.,
RA   Brent M., Prange C., Schreiber K., Shapiro N., Bhat N.K., Hopkins R.F.,
RA   Hsie F., Driscoll T., Soares M.B., Casavant T.L., Scheetz T.E.,
RA   Brown-stein M.J., Usdin T.B., Toshiyuki S., Carninci P., Piao Y.,
RA   Dudekula D.B., Ko M.S., Kawakami K., Suzuki Y., Sugano S., Gruber C.E.,
RA   Smith M.R., Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y.,
RA   Wei C.L., Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W.,
RA   Fuh E., Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D., Granite S.J.,
RA   Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G., Blakesly R.W.,
RA   Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J.,
RA   Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L., Krzywinski M.I.,
RA   Liao N., Morin R., Morrin R., Palmquist D., Petrescu A.S., Skalska U.,
RA   Smailus D.E., Stott J.M., Schnerch A., Schein J.E., Jones S.J., Holt R.A.,
RA   Baross A., Marra M.A., Clifton S., Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC133052; AAI33053.1; -; mRNA.
DR   RefSeq; NP_001302437.1; NM_001315508.1.
DR   RefSeq; NP_006188.3; NM_006197.3.
DR   PeptideAtlas; A2RUU9; -.
DR   PRIDE; A2RUU9; -.
DR   DNASU; 5108; -.
DR   GeneID; 5108; -.
DR   KEGG; hsa:5108; -.
DR   CTD; 5108; -.
DR   PharmGKB; PA33073; -.
DR   eggNOG; ENOG410IEGR; Eukaryota.
DR   eggNOG; ENOG410YNFX; LUCA.
DR   KO; K16537; -.
DR   OrthoDB; 500021at2759; -.
DR   ChiTaRS; PCM1; human.
DR   GenomeRNAi; 5108; -.
DR   Genevisible; A2RUU9; HS.
DR   GO; GO:0005813; C:centrosome; IEA:InterPro.
DR   GO; GO:0060271; P:cilium assembly; IEA:InterPro.
DR   GO; GO:0034454; P:microtubule anchoring at centrosome; IEA:InterPro.
DR   GO; GO:0071539; P:protein localization to centrosome; IEA:InterPro.
DR   InterPro; IPR031446; PCM1_C.
DR   InterPro; IPR024138; Pericentriolar_Pcm1.
DR   PANTHER; PTHR14164; PTHR14164; 1.
DR   Pfam; PF15717; PCM1_C; 2.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN          1317..1783
FT                   /note="PCM1_C"
FT                   /evidence="ECO:0000259|Pfam:PF15717"
FT   DOMAIN          1781..1833
FT                   /note="PCM1_C"
FT                   /evidence="ECO:0000259|Pfam:PF15717"
FT   REGION          1..92
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          111..163
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          354..392
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          421..490
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          523..546
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          615..649
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          699..727
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          915..947
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1085..1109
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1152..1213
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1230..1309
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1670..1797
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1839..1859
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          270..293
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          652..682
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          732..769
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          826..853
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          989..1016
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1065..1085
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1462..1482
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        40..62
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        421..481
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        616..632
FT                   /note="Acidic"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        705..723
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        927..946
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1152..1175
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1194..1213
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1264..1292
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1670..1694
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1728..1743
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1744..1759
FT                   /note="Acidic"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1783..1797
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1840..1859
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   1859 AA;  209906 MW;  707537DEE9210CF3 CRC64;
     MATGGGPFED GMNDQDLPNW SSENVDDRLN NMDWGAQQKK ANRSSEKNKK KFGVESDKRV
     TNDISPESSP GVGRRRTKTP HTFPHSRYMS QMSVPEQAEL EKLKQRINFS DLDQRSIGSD
     SQGRATAANN KRQLSENRKP FNFLPMQINT NKSKDASTNP PNRETIGSAQ CKELFASALS
     NDLLQNCQVS EEDGRGEPAM ESSQIVSRLV QIRDYITKAS SMREDLVEKN ERSANVERLT
     HLIDHLKEQE KSYMKFLKKI LARDPQQEPM EEIENLKKQH DLLKRMLQQQ EQLRALQGRQ
     AALLALQHKA EQAIAVMDDS VVAETAGSLS GVSITSELNE ELNDLIQRFH NQLRDSQPPA
     VPDNRRQAES LSLTREVSQS RKPSASERLP DEKVELFSKM RVLQEKKQKM DKLLGELHTL
     RDQHLNNSSS SPQRSVDQRS TSAPSASVGL APVVNGESNS LTSSVPYPTA SLVSQNESEN
     EGHLNPSEKL QKLNEVRKRL NELRELVHYY EQTSDMMTDA VNENRKAEET EESEYDSEHE
     NSEPVTNIRN PQVASTWNEV NSHSNAQCVS NNRDGRTVNS NCEINNRSAA NIRALNMPPS
     LADCRYNREG EQEIHVAQGE DDEEEEEAEE EGVSGASLSS HRSSLVDEHP EDAEFEQKIN
     RLMAAKQKLR QLQDLVAMVQ DDDAAQGVIS ASASNLDDFY PAEEDTKQNS NNTRGNANKT
     QKDTGVNEKA REKFYEAKLQ QQQRELKQLQ EERKKLIDIQ EKIQALQTAC PDLQLSAASV
     GNCPTKKYMP AVTSTPTVNQ HETSTSKSVF EPEDSSIVDN ELWSEMRRHE MLREELRQRR
     KQLEALMAEH QRRQGLAETA SPVAVSLRSD GSENLCTPQQ SRTEKTMATW GGSTQCALDE
     EGDEDGYLSE GIVRTDEEEE EEQDASSNDN FSVCPSNSVN HNSYNGKETK NRWKNDCPFS
     ADENYRPLAK TRQQNISMQR QENLRWVSEL SYVEEKEQWQ EQINQLKKQL DFSVSICQTL
     MQDQQTLSCL LQTLLTGPYS VMPSNVASPQ VHFIMHQLNQ CYTQLTWQQN NVQRLKQMLN
     ELMRQQNQHP EKPGGKERGS SASHPPSPSL FCPFSFPTQP VNLFNIPGFT NFSSFAPGMN
     FSPLFPSNFG DFSQNISTPS EQQQPLAQNS SGKTEYMAFP KPFESSSSIG AEKPRNKKLP
     EEEVESSRTP WLYEQEGEVE KPFIKTGFSV SAEKSTSSNR KNQLDTNGRR RQFDEESLES
     FSSMPDPVDP TTVTKTFKTR KASAQASLAS KDKTPKSKSK KRNSTQLKSR VKNIKTGSDF
     SMFEALRDTI YSEVATLISQ NESRPHFLIE LFHELQLLNT DYLRQRALYA LQDIVSRHIS
     ESHEKGENVK SVNSGTWIAS NSELTPSESL ATTDDETFEK NFERETHKIS EQNDADNASV
     LSVSSNFEPF ATDDLGNTVI HLDQALARMR EYERMKTEAE SNSNMRCTCR IIEDGDGAGA
     GTTVNNLEET PVIENRSSQQ PVSEVSTIPC PRIDTQQLDR QIKAIMKEVI PFLKEHMDEV
     CSSQLLTSVR RMVLTLTQQN DESKEFVKFF HKQLGSILQD SLAKFAGRKL KDCGEDLLVE
     ISEVLFNELA FFKLMQDLDN NSITVKQRCK RKIEATGVIQ SCAKEAKRIL EDHGSPAGEI
     DDEDKDKDET ETVKQTQTSE VYDGPKNVRS DISDQEEDEE SEGCPVSINL SKAETQALTN
     YGSGEDENED EEMEEFEEGP VDVQTSLQAN TEATEENEHD EQEAESGNIS QKSDEEDFVK
     VEDLPLKLTI YSEADLRKEM VEEEQKNHLS GEICEMQTEE LAGNSETLKE PETVGAQSI
//
ID   B9EIS5_HUMAN            Unreviewed;      2016 AA.
AC   B9EIS5;
DT   24-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   24-MAR-2009, sequence version 1.
DT   26-FEB-2020, entry version 50.
DE   SubName: Full=PCM1 protein {ECO:0000313|EMBL:AAI40947.1};
GN   Name=PCM1 {ECO:0000313|EMBL:AAI40947.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAI40947.1};
RN   [1] {ECO:0000313|EMBL:AAI40947.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain {ECO:0000313|EMBL:AAI40947.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M., Peck A.M.,
RA   Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S., Feolo M.,
RA   Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F., Schaefer C.F.,
RA   Buetow K., Bonner T.I., Haussler D., Kent J., Kiekhaus M., Furey T.,
RA   Brent M., Prange C., Schreiber K., Shapiro N., Bhat N.K., Hopkins R.F.,
RA   Hsie F., Driscoll T., Soares M.B., Casavant T.L., Scheetz T.E.,
RA   Brown-stein M.J., Usdin T.B., Toshiyuki S., Carninci P., Piao Y.,
RA   Dudekula D.B., Ko M.S., Kawakami K., Suzuki Y., Sugano S., Gruber C.E.,
RA   Smith M.R., Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y.,
RA   Wei C.L., Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W.,
RA   Fuh E., Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D., Granite S.J.,
RA   Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G., Blakesly R.W.,
RA   Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J.,
RA   Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L., Krzywinski M.I.,
RA   Liao N., Morin R., Morrin R., Palmquist D., Petrescu A.S., Skalska U.,
RA   Smailus D.E., Stott J.M., Schnerch A., Schein J.E., Jones S.J., Holt R.A.,
RA   Baross A., Marra M.A., Clifton S., Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC140946; AAI40947.1; -; mRNA.
DR   RefSeq; NP_001302436.1; NM_001315507.1.
DR   PeptideAtlas; B9EIS5; -.
DR   PRIDE; B9EIS5; -.
DR   GeneID; 5108; -.
DR   CTD; 5108; -.
DR   eggNOG; ENOG410IEGR; Eukaryota.
DR   eggNOG; ENOG410YNFX; LUCA.
DR   OrthoDB; 500021at2759; -.
DR   ChiTaRS; PCM1; human.
DR   GenomeRNAi; 5108; -.
DR   GO; GO:0005813; C:centrosome; IEA:InterPro.
DR   GO; GO:0060271; P:cilium assembly; IEA:InterPro.
DR   GO; GO:0034454; P:microtubule anchoring at centrosome; IEA:InterPro.
DR   GO; GO:0071539; P:protein localization to centrosome; IEA:InterPro.
DR   InterPro; IPR031446; PCM1_C.
DR   InterPro; IPR024138; Pericentriolar_Pcm1.
DR   PANTHER; PTHR14164; PTHR14164; 1.
DR   Pfam; PF15717; PCM1_C; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN          1372..1990
FT                   /note="PCM1_C"
FT                   /evidence="ECO:0000259|Pfam:PF15717"
FT   REGION          1..92
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          111..165
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          354..392
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          421..492
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          523..548
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          614..652
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          699..727
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          915..947
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1085..1109
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1152..1211
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1232..1343
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1717..1860
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1872..1936
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1997..2016
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          270..293
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          493..513
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          652..682
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          732..769
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          826..853
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          989..1016
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1065..1085
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1517..1537
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        40..62
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        421..481
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        615..632
FT                   /note="Acidic"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        705..723
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        927..947
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1152..1175
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1194..1211
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1264..1292
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1309..1331
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1717..1741
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1775..1790
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1791..1806
FT                   /note="Acidic"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1820..1849
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1879..1896
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   2016 AA;  227672 MW;  992CBD7BBE2A343F CRC64;
     MATGGGPFED GMNDQDLPNW SNENVDDRLN NMDWGAQQKK ANRSSEKNKK KFGVESDKRV
     TNDISPESSP GVGRRRTKTP HTFPHSRYMS QMSVPEQAEL EKLKQRINFS DLDQRSIGSD
     SQGRATAANN KRQLSENRKP FNFLPMQINT NKSKDASTSP PNRETIGSAQ CKELFASALS
     NDLLQNCQVS EEDGRGEPAM ESSQIVSRLV QIRDYITKAS SMREDLVEKN ERSANVERLT
     HLIDHLKEQE KSYMKFLKKI LARDPQQEPM EEIENLKKQH DLLKRMLQQQ EQLRALQGRQ
     AALLALQHKA EQAIAVMDDS VVAETAGSLS GVSITSELNE ELNDLIQRFH NQLRDSQPPA
     VPDNRRQAES LSLTREVSQS RKPSASERLP DEKVELFSKM RVLQEKKQKM DKLLGELHTL
     RDQHLNNSSS SPQRSVDQRS TSAPSASVGL APVVNGESNS LTSSVPYPTA SLVSQNESEN
     EGHLNPSEKL QKLNEVRKRL NELRELVHYY EQTSDMMTDA VNENRKDEET EESEYDSEHE
     NSEPVTNIRN PQVASTWNEV NSHSNAQCVS NNRDGRTVNS NCEINNRSAA NIRALNVPPS
     LDCRYNREGE QEIHVAQGED DEEEEEEAEE EGVSGASLSS HRSSLVDEHP EDAEFEQKIN
     RLMAAKQKLR QLQDLVAMVQ DDDAAQGVIS ASASNLDDFY PAEEDTKQNS NNTRGNANKT
     QKDTGVNEKA REKFYEAKLQ QQQRELKQLQ EERKKLIDIQ EKIQALQTAC PDLQLSAASV
     GNCPTKKYMP AVTSTPTVNQ HETSTSKSVF EPEDSSIVDN ELWSEMRRHE MLREELRQRR
     KQLEALMAEH QRRQGLAETA SPVAVSLRSD GSENLCTPQQ SRTEKTMATW GGSTQCALDE
     EGDEDGYLSE GIVRTDEEEE EEQDASSNDN FSVCPSNSVN HNSYNGKETK NRWKNNCPFS
     ADENYRPLAK TRQQNISMQR QENLRWVSEL SYVEEKEQWQ EQINQLKKQL DFSVSICQTL
     MQDQQTLSCL LQTLLTGPYS VMPSNVASPQ VHFIMHQLNQ CYTQLTWQQN NVQRLKQMLN
     ELMRQQNQHP EKPGGKERGS SASHPPSPSL FCPFSFPTQP VNLFNIPGFT NFSSFAPGMN
     FSPLFPSNFG DFSQNISTPS EQQQPLAQNS SGKTEYMAFP KPFESSSSIG AEKPRNKKLP
     EEEVESSRTP WLYEQEGEVE KPFIKTGFSV SVEKSTSSNR KNQLDTNGRR RQFDEESLES
     FSSMPDPVDP TTVTKTFKTR KASAQASLAS KDKTPKSKSK KRNSTQLKSR VKNIRYESAS
     MSSTCEPCKS RNRHSAQTEE PVQAKVFSRK NHEQLEKIIK CNRSTEISSE TGSDFSMFEA
     LRDTIYSEVA TLISQNESRP HFLIELFHEL QLLNTDYLRQ RALYALQDIV SRHISESHEK
     GENVKSVNSG TWIASNSELT PSESLATTDD ETFEKNFERE THKISEQNDA DNASVLSVSS
     NFEPFATDDL GNTVIHLDQA LARMREYERM KTEAESNSNM RCTCRIIEDG DGAGAETPVI
     ENRSSQQPVS EVSTIPCPRI DTQQLDRQIK AIMKEVIPFL KEHMDEVCSS QLLTSVRRMV
     LTLTQQNDES KEFVKFFHKQ LGSILQDSLA KFAGRKLKDC GEDLLVEISE VLFNELAFFK
     LMQDLDNNSI TVKQRCKRKI EATGVIQSCA KEAKRILEDH GSPAGEIDDE DKDKDETETV
     KQTQTSEVYD GPKNVRSDIS DQEEDEESEG CPVSINLSKA ETQALTNYGS GEDENEDEEM
     EEFEEGPVDV QTSLQANTEA TEENEHDEQV LQRDFKKTAE SKNVPLEREA TSKNDQNNCP
     VKPCYLNILE DEQPLNSAAH KESPPTVDST QQPNPLPLRL PEMEPLVPRV KEVKSAQETP
     ESSLAGSPDT ESPVLVNDYE AESGNISQKS DEEDFVKVED LPLKLTIYSE ADLRKKMVEE
     EQKNHLSGEI CEMQTEELAG NSETLKEPET VGAQSI
//
ID   PCM1_HUMAN              Reviewed;        2024 AA.
AC   Q15154; A6NNN6; B4DYD5; E7ETA6; E7EV56; Q58F13; Q6P1K7; Q8NB85; Q9BWC1;
AC   Q9H4A2;
DT   23-JAN-2007, integrated into UniProtKB/Swiss-Prot.
DT   28-MAR-2018, sequence version 5.
DT   22-APR-2020, entry version 162.
DE   RecName: Full=Pericentriolar material 1 protein;
DE            Short=PCM-1;
DE            Short=hPCM-1;
GN   Name=PCM1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, AND VARIANTS
RP   SER-159 AND VAL-597.
RC   TISSUE=Liver;
RX   PubMed=8120099; DOI=10.1083/jcb.124.5.783;
RA   Balczon R., Bao L., Zimmer W.E.;
RT   "PCM-1, A 228-kD centrosome autoantigen with a distinct cell cycle
RT   distribution.";
RL   J. Cell Biol. 124:783-793(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M.,
RA   Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L.,
RA   Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S.,
RA   Asakawa T., Blechschmidt K., Bloom T., Borowsky M.L., Butler J., Cook A.,
RA   Corum B., DeArellano K., DeCaprio D., Dooley K.T., Dorris L. III,
RA   Engels R., Gloeckner G., Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K.,
RA   Jaffe D.B., Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C., O'Leary S.B.,
RA   O'Neill K., Parker S.C.J., Polley A., Raymond C.K., Reichwald K.,
RA   Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R., Smith C.L.,
RA   Sneddon T.P., Talamas J.A., Tenzin P., Topham K., Venkataraman V., Wen G.,
RA   Yamazaki S., Young S.K., Zeng Q., Zimmer A.R., Rosenthal A., Birren B.W.,
RA   Platzer M., Shimizu N., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 1-404 (ISOFORMS 1/2), AND VARIANT SER-159.
RC   TISSUE=Lung, Testis, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1244-2024 (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1527-1610 (ISOFORMS 1/2), SUBCELLULAR
RP   LOCATION, TISSUE SPECIFICITY, AND CHROMOSOMAL TRANSLOCATION WITH RET.
RX   PubMed=10980597; DOI=10.1038/sj.onc.1203772;
RA   Corvi R., Berger N., Balczon R., Romeo G.;
RT   "RET/PCM-1: a novel fusion gene in papillary thyroid carcinoma.";
RL   Oncogene 19:4236-4242(2000).
RN   [6]
RP   INTERACTION WITH HAP1.
RX   PubMed=9361024; DOI=10.1093/hmg/6.13.2205;
RA   Engelender S., Sharp A.H., Colomer V., Tokito M.K., Lanahan A., Worley P.,
RA   Holzbaur E.L.F., Ross C.A.;
RT   "Huntingtin-associated protein 1 (HAP1) interacts with the p150Glued
RT   subunit of dynactin.";
RL   Hum. Mol. Genet. 6:2205-2212(1997).
RN   [7]
RP   FUNCTION, INTERACTION WITH CETN3, AND SUBCELLULAR LOCATION.
RX   PubMed=12403812; DOI=10.1083/jcb.200204023;
RA   Dammermann A., Merdes A.;
RT   "Assembly of centrosomal proteins and microtubule organization depends on
RT   PCM-1.";
RL   J. Cell Biol. 159:255-266(2002).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND SUBCELLULAR LOCATION [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.;
RT   "Proteomic characterization of the human centrosome by protein correlation
RT   profiling.";
RL   Nature 426:570-574(2003).
RN   [9]
RP   INTERACTION WITH BBS8, AND SUBCELLULAR LOCATION.
RX   PubMed=14520415; DOI=10.1038/nature02030;
RA   Ansley S.J., Badano J.L., Blacque O.E., Hill J., Hoskins B.E., Leitch C.C.,
RA   Kim J.C., Ross A.J., Eichers E.R., Teslovich T.M., Mah A.K., Johnsen R.C.,
RA   Cavender J.C., Lewis R.A., Leroux M.R., Beales P.L., Katsanis N.;
RT   "Basal body dysfunction is a likely cause of pleiotropic Bardet-Biedl
RT   syndrome.";
RL   Nature 425:628-633(2003).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-65, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=15144186; DOI=10.1021/ac035352d;
RA   Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,
RA   Peters E.C.;
RT   "Robust phosphoproteomic profiling of tyrosine phosphorylation sites from
RT   human T cells using immobilized metal affinity chromatography and tandem
RT   mass spectrometry.";
RL   Anal. Chem. 76:2763-2772(2004).
RN   [11]
RP   INTERACTION WITH BBS4, AND SUBCELLULAR LOCATION.
RX   PubMed=15107855; DOI=10.1038/ng1352;
RA   Kim J.C., Badano J.L., Sibold S., Esmail M.A., Hill J., Hoskins B.E.,
RA   Leitch C.C., Venner K., Ansley S.J., Ross A.J., Leroux M.R., Katsanis N.,
RA   Beales P.L.;
RT   "The Bardet-Biedl protein BBS4 targets cargo to the pericentriolar region
RT   and is required for microtubule anchoring and cell cycle progression.";
RL   Nat. Genet. 36:462-470(2004).
RN   [12]
RP   TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=15184884; DOI=10.1038/sj.onc.1207740;
RA   Armes J.E., Hammet F., de Silva M., Ciciulla J., Ramus S.J., Soo W.-K.,
RA   Mahoney A., Yarovaya N., Henderson M.A., Gish K., Hutchins A.-M.,
RA   Price G.R., Venter D.J.;
RT   "Candidate tumor-suppressor genes on chromosome arm 8p in early-onset and
RT   high-grade breast cancers.";
RL   Oncogene 23:5697-5702(2004).
RN   [13]
RP   TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=16270321; DOI=10.1002/cncr.21538;
RA   Pils D., Horak P., Gleiss A., Sax C., Fabjani G., Moebus V.J.,
RA   Zielinski C., Reinthaller A., Zeillinger R., Krainer M.;
RT   "Five genes from chromosomal band 8p22 are significantly down-regulated in
RT   ovarian carcinoma: N33 and EFA6R have a potential impact on overall
RT   survival.";
RL   Cancer 104:2417-2429(2005).
RN   [14]
RP   CHROMOSOMAL TRANSLOCATION WITH JAK2.
RX   PubMed=15805263; DOI=10.1158/0008-5472.can-04-4263;
RA   Reiter A., Walz C., Watmore A., Schoch C., Blau I., Schlegelberger B.,
RA   Berger U., Telford N., Aruliah S., Yin J.A., Vanstraelen D., Barker H.F.,
RA   Taylor P.C., O'Driscoll A., Benedetti F., Rudolph C., Kolb H.-J.,
RA   Hochhaus A., Hehlmann R., Chase A., Cross N.C.P.;
RT   "The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute
RT   leukemia that fuses PCM1 to JAK2.";
RL   Cancer Res. 65:2662-2667(2005).
RN   [15]
RP   CHROMOSOMAL TRANSLOCATION WITH JAK2.
RX   PubMed=16034466; DOI=10.1038/sj.leu.2403879;
RA   Murati A., Gelsi-Boyer V., Adelaide J., Perot C., Talmant P., Giraudier S.,
RA   Lode L., Letessier A., Delaval B., Brunel V., Imbert M., Garand R.,
RA   Xerri L., Birnbaum D., Mozziconacci M.-J., Chaffanet M.;
RT   "PCM1-JAK2 fusion in myeloproliferative disorders and acute erythroid
RT   leukemia with t(8;9) translocation.";
RL   Leukemia 19:1692-1696(2005).
RN   [16]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=15659651; DOI=10.1091/mbc.e04-08-0688;
RA   Hames R.S., Crookes R.E., Straatman K.R., Merdes A., Hayes M.J.,
RA   Faragher A.J., Fry A.M.;
RT   "Dynamic recruitment of Nek2 kinase to the centrosome involves
RT   microtubules, PCM-1, and localized proteasomal degradation.";
RL   Mol. Biol. Cell 16:1711-1724(2005).
RN   [17]
RP   CHROMOSOMAL TRANSLOCATION WITH JAK2.
RX   PubMed=16091753; DOI=10.1038/sj.onc.1208850;
RA   Bousquet M., Quelen C., De Mas V., Duchayne E., Roquefeuil B., Delsol G.,
RA   Laurent G., Dastugue N., Brousset P.;
RT   "The t(8;9)(p22;p24) translocation in atypical chronic myeloid leukaemia
RT   yields a new PCM1-JAK2 fusion gene.";
RL   Oncogene 24:7248-7252(2005).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-65; SER-110 AND SER-1730, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [19]
RP   CHROMOSOMAL TRANSLOCATION WITH JAK2.
RX   PubMed=16769584;
RA   Bacher U., Reiter A., Haferlach T., Mueller L., Schnittger S., Kern W.,
RA   Schoch C.;
RT   "A combination of cytomorphology, cytogenetic analysis, fluorescence in
RT   situ hybridization and reverse transcriptase polymerase chain reaction for
RT   establishing clonality in cases of persisting hypereosinophilia.";
RL   Haematologica 91:817-820(2006).
RN   [20]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=16943179; DOI=10.1083/jcb.200606051;
RA   Srsen V., Gnadt N., Dammermann A., Merdes A.;
RT   "Inhibition of centrosome protein assembly leads to p53-dependent exit from
RT   the cell cycle.";
RL   J. Cell Biol. 174:625-630(2006).
RN   [21]
RP   TISSUE SPECIFICITY, AND CHROMOSOMAL TRANSLOCATION WITH JAK2.
RX   PubMed=16424865; DOI=10.1038/sj.leu.2404104;
RA   Adelaide J., Perot C., Gelsi-Boyer V., Pautas C., Murati A.,
RA   Copie-Bergman C., Imbert M., Chaffanet M., Birnbaum D., Mozziconacci M.-J.;
RT   "A t(8;9) translocation with PCM1-JAK2 fusion in a patient with T-cell
RT   lymphoma.";
RL   Leukemia 20:536-537(2006).
RN   [22]
RP   INTERACTION WITH NDE1 AND NDEL1, AND SUBCELLULAR LOCATION.
RX   PubMed=16291865; DOI=10.1091/mbc.e05-04-0360;
RA   Guo J., Yang Z., Song W., Chen Q., Wang F., Zhang Q., Zhu X.;
RT   "Nudel contributes to microtubule anchoring at the mother centriole and is
RT   involved in both dynein-dependent and -independent centrosomal protein
RT   assembly.";
RL   Mol. Biol. Cell 17:680-689(2006).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-65; SER-68 AND SER-69, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-65; SER-68; SER-69; SER-93;
RP   SER-960; SER-1231; SER-1257; SER-1260; SER-1263; SER-1730; SER-1765;
RP   SER-1768 AND SER-1776, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [25]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-65; SER-68; SER-69; SER-93;
RP   SER-1185; SER-1697; SER-1765; SER-1768; SER-1776 AND SER-1977, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [27]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-399, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [28]
RP   FUNCTION.
RX   PubMed=20551181; DOI=10.1242/jcs.065045;
RA   Sedjai F., Acquaviva C., Chevrier V., Chauvin J.P., Coppin E., Aouane A.,
RA   Coulier F., Tolun A., Pierres M., Birnbaum D., Rosnet O.;
RT   "Control of ciliogenesis by FOR20, a novel centrosome and pericentriolar
RT   satellite protein.";
RL   J. Cell Sci. 123:2391-2401(2010).
RN   [29]
RP   INTERACTION WITH PARD6A, AND SUBCELLULAR LOCATION.
RX   PubMed=20719959; DOI=10.1091/mbc.e10-05-0430;
RA   Kodani A., Tonthat V., Wu B., Suetterlin C.;
RT   "Par6 alpha interacts with the dynactin subunit p150 Glued and is a
RT   critical regulator of centrosomal protein recruitment.";
RL   Mol. Biol. Cell 21:3376-3385(2010).
RN   [30]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-65; SER-68; SER-69; SER-93;
RP   SER-861; SER-960 AND SER-1730, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [31]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [32]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-65; SER-68; SER-1730;
RP   SER-1765; SER-1768 AND SER-1958, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [33]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [34]
RP   FUNCTION IN CILIOGENESIS, UBIQUITINATION BY MIB1, INTERACTION WITH CEP131,
RP   ASSOCIATION WITH MICROTUBULE, AND SUBCELLULAR LOCATION.
RX   PubMed=24121310; DOI=10.1038/emboj.2013.223;
RA   Villumsen B.H., Danielsen J.R., Povlsen L., Sylvestersen K.B., Merdes A.,
RA   Beli P., Yang Y.G., Choudhary C., Nielsen M.L., Mailand N.,
RA   Bekker-Jensen S.;
RT   "A new cellular stress response that triggers centriolar satellite
RT   reorganization and ciliogenesis.";
RL   EMBO J. 32:3029-3040(2013).
RN   [35]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-65; SER-68; SER-69; SER-93;
RP   SER-110; SER-116; SER-119; SER-370; SER-372; SER-384; SER-588; THR-859;
RP   SER-861; SER-960; SER-977; SER-988; SER-991; SER-1229; SER-1231; SER-1257;
RP   SER-1697; SER-1730 AND SER-1977, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT
RP   SER-159 (VARIANT SER-159), VARIANT [LARGE SCALE ANALYSIS] SER-159, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [36]
RP   INTERACTION WITH MAP1LC3B; GABARAPAL2 AND GABARAP.
RX   PubMed=24089205; DOI=10.1038/nature12606;
RA   Tang Z., Lin M.G., Stowe T.R., Chen S., Zhu M., Stearns T., Franco B.,
RA   Zhong Q.;
RT   "Autophagy promotes primary ciliogenesis by removing OFD1 from centriolar
RT   satellites.";
RL   Nature 502:254-257(2013).
RN   [37]
RP   INTERACTION WITH CCDC13.
RX   PubMed=24816561; DOI=10.1242/jcs.147785;
RA   Staples C.J., Myers K.N., Beveridge R.D., Patil A.A., Howard A.E.,
RA   Barone G., Lee A.J., Swanton C., Howell M., Maslen S., Skehel J.M.,
RA   Boulton S.J., Collis S.J.;
RT   "Ccdc13 is a novel human centriolar satellite protein required for
RT   ciliogenesis and genome stability.";
RL   J. Cell Sci. 127:2910-2919(2014).
RN   [38]
RP   INTERACTION WITH CCDC113.
RX   PubMed=25074808; DOI=10.1242/jcs.157008;
RA   Firat-Karalar E.N., Sante J., Elliott S., Stearns T.;
RT   "Proteomic analysis of mammalian sperm cells identifies new components of
RT   the centrosome.";
RL   J. Cell Sci. 127:4128-4133(2014).
RN   [39]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1468, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [40]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [41]
RP   INTERACTION WITH KIAA0753; FOPNL AND OFD1.
RX   PubMed=26643951; DOI=10.1093/hmg/ddv488;
RA   Chevrier V., Bruel A.L., Van Dam T.J., Franco B., Lo Scalzo M., Lembo F.,
RA   Audebert S., Baudelet E., Isnardon D., Bole A., Borg J.P., Kuentz P.,
RA   Thevenon J., Burglen L., Faivre L., Riviere J.B., Huynen M.A., Birnbaum D.,
RA   Rosnet O., Thauvin-Robinet C.;
RT   "OFIP/KIAA0753 forms a complex with OFD1 and FOR20 at pericentriolar
RT   satellites and centrosomes and is mutated in one individual with oral-
RT   facial-digital syndrome.";
RL   Hum. Mol. Genet. 25:497-513(2016).
RN   [42]
RP   INTERACTION WITH CCDC66.
RX   PubMed=28235840; DOI=10.1242/jcs.196832;
RA   Conkar D., Culfa E., Odabasi E., Rauniyar N., Yates J.R. III,
RA   Firat-Karalar E.N.;
RT   "The centriolar satellite protein CCDC66 interacts with CEP290 and
RT   functions in cilium formation and trafficking.";
RL   J. Cell Sci. 130:1450-1462(2017).
RN   [43]
RP   PHOSPHORYLATION.
RX   PubMed=29973724; DOI=10.1038/s41586-018-0279-8;
RA   Rai A.K., Chen J.X., Selbach M., Pelkmans L.;
RT   "Kinase-controlled phase transition of membraneless organelles in
RT   mitosis.";
RL   Nature 559:211-216(2018).
CC   -!- FUNCTION: Required for centrosome assembly and function
CC       (PubMed:12403812, PubMed:15659651, PubMed:16943179). Essential for the
CC       correct localization of several centrosomal proteins including CEP250,
CC       CETN3, PCNT and NEK2 (PubMed:12403812, PubMed:15659651). Required to
CC       anchor microtubules to the centrosome (PubMed:12403812,
CC       PubMed:15659651). Involved in the biogenesis of cilia (PubMed:20551181,
CC       PubMed:24121310). {ECO:0000269|PubMed:12403812,
CC       ECO:0000269|PubMed:15659651, ECO:0000269|PubMed:16943179,
CC       ECO:0000269|PubMed:20551181, ECO:0000269|PubMed:24121310}.
CC   -!- SUBUNIT: Self-associates. Interacts with C2CD3 (By similarity).
CC       Interacts with BBS4, BBS8, CETN3, HAP1, NDE1, NDEL1, MAP1LC3B,
CC       GABARAPAL2, and GABARAP (PubMed:12403812, PubMed:14520415,
CC       PubMed:15107855, PubMed:16291865, PubMed:24089205, PubMed:9361024).
CC       Interacts with CEP131; the interaction increases in response to
CC       ultraviolet light (UV) radiation (PubMed:24121310). Associates with
CC       microtubule; association to microtubule is reduced in response to
CC       cellular stress, such as ultraviolet light (UV) radiation or heat
CC       shock, in a process that requires p38 MAP kinase signaling
CC       (PubMed:24121310). Interacts with CCDC113 (PubMed:25074808). Interacts
CC       with SSX2IP (By similarity). Interacts with CCDC13 (PubMed:24816561).
CC       Interacts with CEP290 (By similarity). Interacts with PARD6A
CC       (PubMed:20719959). Interacts with KIAA0753/OFIP, FOPNL/FOR20 and OFD1;
CC       the interaction with FOPNL/FOR20 and OFD1 may be mediated by
CC       KIAA0753/OFIP (PubMed:26643951). Interacts with CCDC66
CC       (PubMed:28235840). {ECO:0000250|UniProtKB:Q9R0L6,
CC       ECO:0000269|PubMed:12403812, ECO:0000269|PubMed:14520415,
CC       ECO:0000269|PubMed:15107855, ECO:0000269|PubMed:16291865,
CC       ECO:0000269|PubMed:20719959, ECO:0000269|PubMed:24089205,
CC       ECO:0000269|PubMed:24121310, ECO:0000269|PubMed:24816561,
CC       ECO:0000269|PubMed:25074808, ECO:0000269|PubMed:26643951,
CC       ECO:0000269|PubMed:28235840, ECO:0000269|PubMed:9361024}.
CC   -!- INTERACTION:
CC       Q15154; Q9NYB9: ABI2; NbExp=3; IntAct=EBI-741421, EBI-743598;
CC       Q15154-3; Q9NYB9-2: ABI2; NbExp=3; IntAct=EBI-11742977, EBI-11096309;
CC       Q15154; Q8NFJ9: BBS1; NbExp=2; IntAct=EBI-741421, EBI-1805484;
CC       Q15154; Q96RK4: BBS4; NbExp=17; IntAct=EBI-741421, EBI-1805814;
CC       Q15154; Q49A88: CCDC14; NbExp=6; IntAct=EBI-741421, EBI-751035;
CC       Q15154-3; Q8TD31-3: CCHCR1; NbExp=5; IntAct=EBI-11742977, EBI-10175300;
CC       Q15154; Q9UPN4: CEP131; NbExp=5; IntAct=EBI-741421, EBI-2558372;
CC       Q15154; Q9P209: CEP72; NbExp=7; IntAct=EBI-741421, EBI-739498;
CC       Q15154-3; Q9UIA0: CYTH4; NbExp=3; IntAct=EBI-11742977, EBI-11521003;
CC       Q15154-3; Q8IYI6: EXOC8; NbExp=3; IntAct=EBI-11742977, EBI-742102;
CC       Q15154-3; Q8TBF8: FAM81A; NbExp=5; IntAct=EBI-11742977, EBI-11993062;
CC       Q15154; O95166: GABARAP; NbExp=8; IntAct=EBI-741421, EBI-712001;
CC       Q15154; P60520: GABARAPL2; NbExp=2; IntAct=EBI-741421, EBI-720116;
CC       Q15154; P54256: Hap1; Xeno; NbExp=3; IntAct=EBI-741421, EBI-994539;
CC       Q15154; Q2KHM9: KIAA0753; NbExp=7; IntAct=EBI-741421, EBI-2805604;
CC       Q15154-3; Q96EZ8: MCRS1; NbExp=3; IntAct=EBI-11742977, EBI-348259;
CC       Q15154-3; Q7Z6G3-2: NECAB2; NbExp=5; IntAct=EBI-11742977, EBI-10172876;
CC       Q15154; O75665: OFD1; NbExp=8; IntAct=EBI-741421, EBI-716327;
CC       Q15154; O95613: PCNT; NbExp=8; IntAct=EBI-741421, EBI-530012;
CC       Q15154; Q8WXW3: PIBF1; NbExp=7; IntAct=EBI-741421, EBI-2558770;
CC       Q15154-3; Q15311: RALBP1; NbExp=3; IntAct=EBI-11742977, EBI-749285;
CC       Q15154; Q96R06: SPAG5; NbExp=2; IntAct=EBI-741421, EBI-413317;
CC       Q15154; Q9Y2D8: SSX2IP; NbExp=10; IntAct=EBI-741421, EBI-2212028;
CC       Q15154; Q9Y3C0: WASHC3; NbExp=5; IntAct=EBI-741421, EBI-712969;
CC       Q15154-3; Q9Y3C0: WASHC3; NbExp=3; IntAct=EBI-11742977, EBI-712969;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton. Cytoplasm, cytoskeleton,
CC       microtubule organizing center, centrosome {ECO:0000269|PubMed:14654843,
CC       ECO:0000269|PubMed:20719959}. Cytoplasmic granule
CC       {ECO:0000269|PubMed:15107855}. Cytoplasm, cytoskeleton, microtubule
CC       organizing center, centrosome, centriolar satellite
CC       {ECO:0000269|PubMed:15107855, ECO:0000269|PubMed:20719959}. Cytoplasm,
CC       cytoskeleton, cilium basal body {ECO:0000269|PubMed:24121310}.
CC       Note=Recruitment to the centrosome requires microtubules and dynein.
CC       The majority of the protein dissociates from the centrosome during
CC       metaphase and subsequently localizes to the cleavage site in telophase.
CC       Displaced from centriolar satellites and centrosome in response to
CC       cellular stress, such as ultraviolet light (UV) radiation or heat
CC       shock, in a process that requires p38 MAP kinase signaling.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q15154-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q15154-2; Sequence=VSP_022611;
CC       Name=3;
CC         IsoId=Q15154-3; Sequence=VSP_022609, VSP_022610;
CC       Name=4;
CC         IsoId=Q15154-4; Sequence=VSP_059399, VSP_022611, VSP_059401;
CC       Name=5;
CC         IsoId=Q15154-5; Sequence=VSP_059400;
CC   -!- TISSUE SPECIFICITY: Expressed in blood, bone marrow, breast, lymph
CC       node, ovary and thyroid. {ECO:0000269|PubMed:10980597,
CC       ECO:0000269|PubMed:15184884, ECO:0000269|PubMed:16270321,
CC       ECO:0000269|PubMed:16424865}.
CC   -!- INDUCTION: Expression is reduced in breast and ovarian cancer.
CC       {ECO:0000269|PubMed:15184884, ECO:0000269|PubMed:16270321}.
CC   -!- PTM: Ubiquitinated. Undergoes monoubiquitination catalyzed by the E3
CC       ubiquitin-protein ligase MIB1 in proliferating cells, preventing cilia
CC       formation (PubMed:24121310). Monoubiquitination by MIB1 is inhibited in
CC       response to cellular stress, such as ultraviolet light (UV) radiation
CC       or heat shock, resulting in cilia formation initiation
CC       (PubMed:24121310). {ECO:0000269|PubMed:24121310}.
CC   -!- PTM: Variant Ser-159 is phosphorylated. {ECO:0000244|PubMed:23186163}.
CC   -!- PTM: Phosphorylated on multiple serine and threonine residues by DYRK3
CC       during the G2-to-M transition, after the nuclear-envelope breakdown
CC       (PubMed:29973724). Phosphorylation by DYRK3 promotes disassembly of
CC       pericentriolar material (PubMed:29973724).
CC       {ECO:0000269|PubMed:29973724}.
CC   -!- DISEASE: Note=A chromosomal aberration involving PCM1 is found in
CC       papillary thyroid carcinomas (PTCs) (PubMed:10980597). Translocation
CC       t(8;10)(p21.3;q11.2) with RET links the protein kinase domain of RET to
CC       the major portion of PCM1 (PubMed:10980597).
CC       {ECO:0000269|PubMed:10980597}.
CC   -!- DISEASE: Note=A chromosomal aberration involving PCM1 is found in a
CC       variety of hematological malignancies including atypical chronic
CC       myeloid leukemia (atypical CML) and T-cell lymphoma (PubMed:15805263,
CC       PubMed:16034466, PubMed:16091753, PubMed:16769584, PubMed:16424865).
CC       Translocation t(8;9)(p22;p24) with JAK2 links the protein kinase domain
CC       of JAK2 to the major portion of PCM1 (PubMed:15805263, PubMed:16034466,
CC       PubMed:16091753, PubMed:16769584, PubMed:16424865).
CC       {ECO:0000269|PubMed:15805263, ECO:0000269|PubMed:16034466,
CC       ECO:0000269|PubMed:16091753, ECO:0000269|PubMed:16424865,
CC       ECO:0000269|PubMed:16769584}.
CC   -!- SIMILARITY: Belongs to the PCM1 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH27477.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=AAH65022.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=BAC03656.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=CAC14882.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L27841; AAA60120.1; -; mRNA.
DR   EMBL; AC087273; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC087625; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF458696; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC000453; AAH00453.1; -; mRNA.
DR   EMBL; BC027477; AAH27477.1; ALT_SEQ; mRNA.
DR   EMBL; BC065022; AAH65022.1; ALT_SEQ; mRNA.
DR   EMBL; AK091406; BAC03656.1; ALT_INIT; mRNA.
DR   EMBL; AJ297349; CAC14882.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS47812.1; -. [Q15154-1]
DR   CCDS; CCDS83255.1; -. [Q15154-4]
DR   CCDS; CCDS83256.1; -. [Q15154-5]
DR   CCDS; CCDS87582.1; -. [Q15154-3]
DR   PIR; A54103; A54103.
DR   RefSeq; NP_001302437.1; NM_001315508.1.
DR   RefSeq; NP_006188.3; NM_006197.3.
DR   PDB; 6HYL; X-ray; 1.56 A; A/B=1959-1972.
DR   PDB; 6HYM; X-ray; 1.86 A; A/B=1959-1972.
DR   PDBsum; 6HYL; -.
DR   PDBsum; 6HYM; -.
DR   SMR; Q15154; -.
DR   BioGrid; 111139; 311.
DR   CORUM; Q15154; -.
DR   DIP; DIP-42189N; -.
DR   IntAct; Q15154; 303.
DR   MINT; Q15154; -.
DR   STRING; 9606.ENSP00000327077; -.
DR   MoonDB; Q15154; Predicted.
DR   CarbonylDB; Q15154; -.
DR   iPTMnet; Q15154; -.
DR   MetOSite; Q15154; -.
DR   PhosphoSitePlus; Q15154; -.
DR   BioMuta; PCM1; -.
DR   DMDM; 296439495; -.
DR   EPD; Q15154; -.
DR   jPOST; Q15154; -.
DR   MassIVE; Q15154; -.
DR   PaxDb; Q15154; -.
DR   PeptideAtlas; Q15154; -.
DR   PRIDE; Q15154; -.
DR   ProteomicsDB; 1623; -.
DR   ProteomicsDB; 18163; -.
DR   ProteomicsDB; 18571; -.
DR   ProteomicsDB; 60471; -. [Q15154-1]
DR   ProteomicsDB; 60472; -. [Q15154-2]
DR   ProteomicsDB; 60473; -. [Q15154-3]
DR   Antibodypedia; 5155; 207 antibodies.
DR   DNASU; 5108; -.
DR   Ensembl; ENST00000325083; ENSP00000327077; ENSG00000078674.
DR   GeneID; 5108; -.
DR   KEGG; hsa:5108; -.
DR   UCSC; uc003wyi.5; human. [Q15154-1]
DR   UCSC; uc003wyj.5; human.
DR   UCSC; uc011kyh.3; human.
DR   CTD; 5108; -.
DR   DisGeNET; 5108; -.
DR   GeneCards; PCM1; -.
DR   HGNC; HGNC:8727; PCM1.
DR   HPA; ENSG00000078674; Low tissue specificity.
DR   MalaCards; PCM1; -.
DR   MIM; 600299; gene.
DR   neXtProt; NX_Q15154; -.
DR   Orphanet; 146; Differentiated thyroid carcinoma.
DR   PharmGKB; PA33073; -.
DR   eggNOG; ENOG410IEGR; Eukaryota.
DR   eggNOG; ENOG410YNFX; LUCA.
DR   InParanoid; Q15154; -.
DR   KO; K16537; -.
DR   OrthoDB; 500021at2759; -.
DR   PhylomeDB; Q15154; -.
DR   TreeFam; TF328740; -.
DR   Reactome; R-HSA-2565942; Regulation of PLK1 Activity at G2/M Transition.
DR   Reactome; R-HSA-380259; Loss of Nlp from mitotic centrosomes.
DR   Reactome; R-HSA-380270; Recruitment of mitotic centrosome proteins and complexes.
DR   Reactome; R-HSA-380284; Loss of proteins required for interphase microtubule organization from the centrosome.
DR   Reactome; R-HSA-380320; Recruitment of NuMA to mitotic centrosomes.
DR   Reactome; R-HSA-5620912; Anchoring of the basal body to the plasma membrane.
DR   Reactome; R-HSA-8854518; AURKA Activation by TPX2.
DR   SIGNOR; Q15154; -.
DR   ChiTaRS; PCM1; human.
DR   GeneWiki; PCM1; -.
DR   GenomeRNAi; 5108; -.
DR   Pharos; Q15154; Tbio.
DR   PRO; PR:Q15154; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   RNAct; Q15154; protein.
DR   Bgee; ENSG00000078674; Expressed in testis and 231 other tissues.
DR   ExpressionAtlas; Q15154; baseline and differential.
DR   Genevisible; Q15154; HS.
DR   GO; GO:0045177; C:apical part of cell; IEA:Ensembl.
DR   GO; GO:0034451; C:centriolar satellite; IDA:UniProtKB.
DR   GO; GO:0005814; C:centriole; IBA:GO_Central.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0036064; C:ciliary basal body; IBA:GO_Central.
DR   GO; GO:0035869; C:ciliary transition zone; IDA:GO_Central.
DR   GO; GO:0005737; C:cytoplasm; ISS:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0031965; C:nuclear membrane; IDA:HPA.
DR   GO; GO:0000242; C:pericentriolar material; ISS:BHF-UCL.
DR   GO; GO:0032991; C:protein-containing complex; IDA:MGI.
DR   GO; GO:0042802; F:identical protein binding; ISS:BHF-UCL.
DR   GO; GO:0007098; P:centrosome cycle; IMP:BHF-UCL.
DR   GO; GO:0097711; P:ciliary basal body-plasma membrane docking; TAS:Reactome.
DR   GO; GO:0060271; P:cilium assembly; IMP:UniProtKB.
DR   GO; GO:0031122; P:cytoplasmic microtubule organization; IMP:UniProtKB.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0022027; P:interkinetic nuclear migration; ISS:BHF-UCL.
DR   GO; GO:0035735; P:intraciliary transport involved in cilium assembly; IMP:UniProtKB.
DR   GO; GO:0034453; P:microtubule anchoring; ISS:BHF-UCL.
DR   GO; GO:0034454; P:microtubule anchoring at centrosome; IBA:GO_Central.
DR   GO; GO:0050768; P:negative regulation of neurogenesis; ISS:BHF-UCL.
DR   GO; GO:0001764; P:neuron migration; IEA:Ensembl.
DR   GO; GO:0097150; P:neuronal stem cell population maintenance; IEA:Ensembl.
DR   GO; GO:1905515; P:non-motile cilium assembly; IMP:GO_Central.
DR   GO; GO:0090316; P:positive regulation of intracellular protein transport; IMP:UniProtKB.
DR   GO; GO:0071539; P:protein localization to centrosome; IMP:SYSCILIA_CCNET.
DR   GO; GO:0010389; P:regulation of G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0035176; P:social behavior; IEA:Ensembl.
DR   InterPro; IPR031446; PCM1_C.
DR   InterPro; IPR024138; Pericentriolar_Pcm1.
DR   PANTHER; PTHR14164; PTHR14164; 1.
DR   Pfam; PF15717; PCM1_C; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cell projection;
KW   Chromosomal rearrangement; Cilium biogenesis/degradation; Coiled coil;
KW   Cytoplasm; Cytoskeleton; Phosphoprotein; Polymorphism; Proto-oncogene;
KW   Reference proteome; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:22223895"
FT   CHAIN           2..2024
FT                   /note="Pericentriolar material 1 protein"
FT                   /id="PRO_0000274037"
FT   REGION          1279..1799
FT                   /note="Interaction with HAP1"
FT                   /evidence="ECO:0000269|PubMed:9361024"
FT   REGION          1913..2024
FT                   /note="Interaction with BBS4"
FT                   /evidence="ECO:0000269|PubMed:15107855"
FT   COILED          218..301
FT                   /evidence="ECO:0000255"
FT   COILED          400..424
FT                   /evidence="ECO:0000255"
FT   COILED          487..543
FT                   /evidence="ECO:0000255"
FT   COILED          651..682
FT                   /evidence="ECO:0000255"
FT   COILED          726..769
FT                   /evidence="ECO:0000255"
FT   COILED          824..858
FT                   /evidence="ECO:0000255"
FT   COILED          1063..1089
FT                   /evidence="ECO:0000255"
FT   COILED          1515..1539
FT                   /evidence="ECO:0000255"
FT   SITE            1314..1315
FT                   /note="Breakpoint for translocation to form PCM1-JAK2
FT                   fusion protein"
FT   SITE            1369..1370
FT                   /note="Breakpoint for translocation to form PCM1-JAK2
FT                   fusion protein"
FT   SITE            1470..1471
FT                   /note="Breakpoint for translocation to form PCM1-JAK2
FT                   fusion protein"
FT   SITE            1609..1610
FT                   /note="Breakpoint for translocation to form PCM1-RET fusion
FT                   protein"
FT   SITE            1947..1948
FT                   /note="Breakpoint for translocation to form PCM1-JAK2
FT                   fusion protein"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000244|PubMed:22223895"
FT   MOD_RES         65
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:15144186,
FT                   ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         68
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:16964243,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         69
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:16964243,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163"
FT   MOD_RES         93
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         110
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         116
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         119
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         159
FT                   /note="Phosphoserine; in variant Ser-159"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         370
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         372
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         384
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         399
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         588
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         643
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R0L6"
FT   MOD_RES         859
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         861
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         866
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R0L6"
FT   MOD_RES         869
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R0L6"
FT   MOD_RES         872
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R0L6"
FT   MOD_RES         877
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R0L6"
FT   MOD_RES         960
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163"
FT   MOD_RES         977
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         988
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         991
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         1185
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332"
FT   MOD_RES         1188
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R0L6"
FT   MOD_RES         1229
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         1231
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         1257
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         1260
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         1262
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R0L6"
FT   MOD_RES         1263
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         1318
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R0L6"
FT   MOD_RES         1320
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R0L6"
FT   MOD_RES         1468
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         1573
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R0L6"
FT   MOD_RES         1697
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         1730
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163"
FT   MOD_RES         1765
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:21406692"
FT   MOD_RES         1768
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:21406692"
FT   MOD_RES         1776
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332"
FT   MOD_RES         1782
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R0L6"
FT   MOD_RES         1958
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21406692"
FT   MOD_RES         1977
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:23186163"
FT   VAR_SEQ         263
FT                   /note="R -> RENEEEDVRTIDSAVGSGSVAESTSLNIDVQSEASDTTAR (in
FT                   isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_022609"
FT   VAR_SEQ         492..2024
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_022610"
FT   VAR_SEQ         601
FT                   /note="L -> LA (in isoform 4)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_059399"
FT   VAR_SEQ         1315..1370
FT                   /note="RYESASMSSTCEPCKSRNRHSAQTEEPVQAKVFSRKNHEQLEKIIKCNRSTE
FT                   ISSE -> K (in isoform 2 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_022611"
FT   VAR_SEQ         1556..1563
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_059400"
FT   VAR_SEQ         1838..1947
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_059401"
FT   VARIANT         159
FT                   /note="N -> S (in dbSNP:rs412750)"
FT                   /evidence="ECO:0000244|PubMed:23186163,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:8120099"
FT                   /id="VAR_030164"
FT   VARIANT         176
FT                   /note="A -> D (in dbSNP:rs2285302)"
FT                   /id="VAR_030165"
FT   VARIANT         597
FT                   /note="M -> V (in dbSNP:rs208753)"
FT                   /evidence="ECO:0000269|PubMed:8120099"
FT                   /id="VAR_030166"
FT   VARIANT         600
FT                   /note="S -> P (in dbSNP:rs34325017)"
FT                   /id="VAR_047381"
FT   VARIANT         691
FT                   /note="A -> S (in dbSNP:rs17635381)"
FT                   /id="VAR_030167"
FT   VARIANT         871
FT                   /note="G -> V (in dbSNP:rs7009117)"
FT                   /id="VAR_030168"
FT   VARIANT         1251
FT                   /note="R -> H (in dbSNP:rs17514547)"
FT                   /id="VAR_030169"
FT   VARIANT         1326
FT                   /note="E -> D (in dbSNP:rs34932823)"
FT                   /id="VAR_047382"
FT   VARIANT         1543
FT                   /note="T -> I (in dbSNP:rs370429)"
FT                   /id="VAR_030170"
FT   VARIANT         1701
FT                   /note="K -> N (in dbSNP:rs36113670)"
FT                   /id="VAR_047383"
FT   VARIANT         1865
FT                   /note="N -> D (in dbSNP:rs35789133)"
FT                   /id="VAR_047384"
FT   CONFLICT        294
FT                   /note="R -> RG (in Ref. 1; AAA60120)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        311..312
FT                   /note="EQ -> DE (in Ref. 1; AAA60120)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        405
FT                   /note="E -> K (in Ref. 3; AAH27477)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        408
FT                   /note="Q -> K (in Ref. 3; AAH27477/AAH65022)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        430
FT                   /note="A -> S (in Ref. 1; AAA60120)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        447..448
FT                   /note="SV -> CL (in Ref. 1; AAA60120)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        760
FT                   /note="Q -> H (in Ref. 1; AAA60120)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        946
FT                   /note="G -> R (in Ref. 1; AAA60120)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        952
FT                   /note="R -> T (in Ref. 1; AAA60120)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1004
FT                   /note="Missing (in Ref. 1; AAA60120)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1086
FT                   /note="Q -> R (in Ref. 1; AAA60120)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1168
FT                   /note="Q -> R (in Ref. 1; AAA60120)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1169
FT                   /note="N -> I (in Ref. 1; AAA60120)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1170
FT                   /note="S -> L (in Ref. 1; AAA60120)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1342
FT                   /note="V -> L (in Ref. 1; AAA60120)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1382
FT                   /note="R -> Q (in Ref. 1; AAA60120)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1532
FT                   /note="T -> A (in Ref. 4; BAC03656)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1849
FT                   /note="S -> G (in Ref. 4; BAC03656)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1853..1864
FT                   /note="PLEREATSKNDQ -> HWNEKPLVKMTK (in Ref. 1; AAA60120)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1872
FT                   /note="C -> S (in Ref. 1; AAA60120)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1988
FT                   /note="E -> V (in Ref. 4; BAC03656)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1998
FT                   /note="I -> M (in Ref. 1; AAA60120)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   2024 AA;  228544 MW;  4625B991A443B6F3 CRC64;
     MATGGGPFED GMNDQDLPNW SNENVDDRLN NMDWGAQQKK ANRSSEKNKK KFGVESDKRV
     TNDISPESSP GVGRRRTKTP HTFPHSRYMS QMSVPEQAEL EKLKQRINFS DLDQRSIGSD
     SQGRATAANN KRQLSENRKP FNFLPMQINT NKSKDASTNP PNRETIGSAQ CKELFASALS
     NDLLQNCQVS EEDGRGEPAM ESSQIVSRLV QIRDYITKAS SMREDLVEKN ERSANVERLT
     HLIDHLKEQE KSYMKFLKKI LARDPQQEPM EEIENLKKQH DLLKRMLQQQ EQLRALQGRQ
     AALLALQHKA EQAIAVMDDS VVAETAGSLS GVSITSELNE ELNDLIQRFH NQLRDSQPPA
     VPDNRRQAES LSLTREVSQS RKPSASERLP DEKVELFSKM RVLQEKKQKM DKLLGELHTL
     RDQHLNNSSA SPQRSVDQRS TSAPSASVGL APVVNGESNS LTSSVPYPTA SLVSQNESEN
     EGHLNPSEKL QKLNEVRKRL NELRELVHYY EQTSDMMTDA VNENRKDEET EESEYDSEHE
     NSEPVTNIRN PQVASTWNEV NSHSNAQCVS NNRDGRTVNS NCEINNRSAA NIRALNMPPS
     LDCRYNREGE QEIHVAQGED DEEEEEEAEE EGVSGASLSS HRSSLVDEHP EDAEFEQKIN
     RLMAAKQKLR QLQDLVAMVQ DDDAAQGVIS ASASNLDDFY PAEEDTKQNS NNTRGNANKT
     QKDTGVNEKA REKFYEAKLQ QQQRELKQLQ EERKKLIDIQ EKIQALQTAC PDLQLSAASV
     GNCPTKKYMP AVTSTPTVNQ HETSTSKSVF EPEDSSIVDN ELWSEMRRHE MLREELRQRR
     KQLEALMAEH QRRQGLAETA SPVAVSLRSD GSENLCTPQQ SRTEKTMATW GGSTQCALDE
     EGDEDGYLSE GIVRTDEEEE EEQDASSNDN FSVCPSNSVN HNSYNGKETK NRWKNNCPFS
     ADENYRPLAK TRQQNISMQR QENLRWVSEL SYVEEKEQWQ EQINQLKKQL DFSVSICQTL
     MQDQQTLSCL LQTLLTGPYS VMPSNVASPQ VHFIMHQLNQ CYTQLTWQQN NVQRLKQMLN
     ELMRQQNQHP EKPGGKERGS SASHPPSPSL FCPFSFPTQP VNLFNIPGFT NFSSFAPGMN
     FSPLFPSNFG DFSQNISTPS EQQQPLAQNS SGKTEYMAFP KPFESSSSIG AEKPRNKKLP
     EEEVESSRTP WLYEQEGEVE KPFIKTGFSV SVEKSTSSNR KNQLDTNGRR RQFDEESLES
     FSSMPDPVDP TTVTKTFKTR KASAQASLAS KDKTPKSKSK KRNSTQLKSR VKNIRYESAS
     MSSTCEPCKS RNRHSAQTEE PVQAKVFSRK NHEQLEKIIK CNRSTEISSE TGSDFSMFEA
     LRDTIYSEVA TLISQNESRP HFLIELFHEL QLLNTDYLRQ RALYALQDIV SRHISESHEK
     GENVKSVNSG TWIASNSELT PSESLATTDD ETFEKNFERE THKISEQNDA DNASVLSVSS
     NFEPFATDDL GNTVIHLDQA LARMREYERM KTEAESNSNM RCTCRIIEDG DGAGAGTTVN
     NLEETPVIEN RSSQQPVSEV STIPCPRIDT QQLDRQIKAI MKEVIPFLKE HMDEVCSSQL
     LTSVRRMVLT LTQQNDESKE FVKFFHKQLG SILQDSLAKF AGRKLKDCGE DLLVEISEVL
     FNELAFFKLM QDLDNNSITV KQRCKRKIEA TGVIQSCAKE AKRILEDHGS PAGEIDDEDK
     DKDETETVKQ TQTSEVYDGP KNVRSDISDQ EEDEESEGCP VSINLSKAET QALTNYGSGE
     DENEDEEMEE FEEGPVDVQT SLQANTEATE ENEHDEQVLQ RDFKKTAESK NVPLEREATS
     KNDQNNCPVK PCYLNILEDE QPLNSAAHKE SPPTVDSTQQ PNPLPLRLPE MEPLVPRVKE
     VKSAQETPES SLAGSPDTES PVLVNDYEAE SGNISQKSDE EDFVKVEDLP LKLTIYSEAD
     LRKKMVEEEQ KNHLSGEICE MQTEELAGNS ETLKEPETVG AQSI
//
ID   A0A075B749_HUMAN        Unreviewed;      2482 AA.
AC   A0A075B749;
DT   01-OCT-2014, integrated into UniProtKB/TrEMBL.
DT   29-OCT-2014, sequence version 2.
DT   22-APR-2020, entry version 42.
DE   SubName: Full=Myomegalin {ECO:0000313|Ensembl:ENSP00000462316};
GN   Name=PDE4DIP {ECO:0000313|Ensembl:ENSP00000462316};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000462316, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000462316, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I., Aubin K., Babbage A.K., Bagguley C.L., Bailey J., Beasley H.,
RA   Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G., Clee C.,
RA   Cobley V., Collier R.E., Corby N., Coville G.J., Davies J., Deadman R.,
RA   Dunn M., Earthrowl M., Ellington A.G., Errington H., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Gay L., Ghori M.R.,
RA   Gibson R., Gilby L.M., Gillett W., Glithero R.J., Grafham D.V.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Hammond S., Harrison E.S.,
RA   Hart E., Haugen E., Heath P.D., Holmes S., Holt K., Howden P.J., Hunt A.R.,
RA   Hunt S.E., Hunter G., Isherwood J., James R., Johnson C., Johnson D.,
RA   Joy A., Kay M., Kershaw J.K., Kibukawa M., Kimberley A.M., King A.,
RA   Knights A.J., Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S., McLaren S., Milne S.,
RA   Mistry S., Moore M.J., Nickerson T., O'Dell C.N., Oliver K., Palmeiri A.,
RA   Palmer S.A., Parker A., Patel D., Pearce A.V., Peck A.I., Pelan S.,
RA   Phelps K., Phillimore B.J., Plumb R., Rajan J., Raymond C., Rouse G.,
RA   Saenphimmachak C., Sehra H.K., Sheridan E., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M., Steward C., Subramanian S., Sycamore N., Tracey A.,
RA   Tromans A., Van Helmond Z., Wall M., Wallis J.M., White S., Whitehead S.L.,
RA   Wilkinson J.E., Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z.,
RA   Coulson A., Vaudin M., Sulston J.E., Durbin R., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R., Banerjee R., Bryant S.P., Burford D.C.,
RA   Burrill W.D., Clegg S.M., Dhami P., Dovey O., Faulkner L.M., Gribble S.M.,
RA   Langford C.F., Pandian R.D., Porter K.M., Prigmore E.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [2] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [3] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Burckstummer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [4] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [5] {ECO:0000313|Ensembl:ENSP00000462316}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2014) to UniProtKB.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC239802; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC239804; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC245389; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; XP_011508477.1; XM_011510175.1.
DR   jPOST; A0A075B749; -.
DR   PeptideAtlas; A0A075B749; -.
DR   Antibodypedia; 2152; 119 antibodies.
DR   Ensembl; ENST00000585156; ENSP00000462316; ENSG00000178104.
DR   GeneID; 9659; -.
DR   UCSC; uc057kif.1; human.
DR   CTD; 9659; -.
DR   EuPathDB; HostDB:ENSG00000178104.19; -.
DR   HGNC; HGNC:15580; PDE4DIP.
DR   OpenTargets; ENSG00000178104; -.
DR   eggNOG; ENOG410J2NR; Eukaryota.
DR   eggNOG; ENOG411281S; LUCA.
DR   GeneTree; ENSGT00950000183190; -.
DR   OrthoDB; 15127at2759; -.
DR   ChiTaRS; PDE4DIP; human.
DR   GenomeRNAi; 9659; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000178104; Expressed in gastrocnemius and 226 other tissues.
DR   ExpressionAtlas; A0A075B749; baseline and differential.
DR   GO; GO:0005815; C:microtubule organizing center; IEA:InterPro.
DR   InterPro; IPR012943; Cnn_1N.
DR   InterPro; IPR010630; Olduvai_dom.
DR   Pfam; PF07989; Cnn_1N; 1.
DR   Pfam; PF06758; Olduvai; 1.
DR   SMART; SM01148; DUF1220; 1.
DR   PROSITE; PS51316; NBPF; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Proteomics identification {ECO:0000213|EPD:A0A075B749,
KW   ECO:0000213|MaxQB:A0A075B749, ECO:0000213|PeptideAtlas:A0A075B749,
KW   ECO:0000213|ProteomicsDB:A0A075B749};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN          1687..1778
FT                   /note="NBPF"
FT                   /evidence="ECO:0000259|PROSITE:PS51316"
FT   REGION          30..67
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          835..869
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1330..1350
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1727..1750
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1769..1826
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2217..2239
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2263..2292
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          142..162
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          178..209
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          225..259
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          305..342
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          378..412
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          420..440
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          492..519
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          534..561
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          611..656
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          685..705
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          717..737
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          750..770
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          797..817
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          885..912
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          920..954
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          964..984
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1000..1020
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1143..1177
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1239..1259
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1350..1377
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1487..1521
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1567..1587
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1702..1722
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1875..1895
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1977..2007
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          2033..2060
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          2065..2120
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          2128..2155
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          2422..2442
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        1780..1826
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2263..2278
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   2482 AA;  280468 MW;  881C3928A36A0E1C CRC64;
     MKGTDSGSCC RRRCDFGCCC RASRRAHYTP YRSGDATRTP QSPRQTPSRE RRRPEPAGSW
     AAAAEEEEAA AAATPWMRDY FAEDDGEMVP RTSHTAAFLS DTKDRGPPVQ SQIWRSGEKV
     PFVQTYSLRA FEKPPQVQTQ ALRDFEKHLN DLKKENFSLK LRIYFLEERM QQKYEASRED
     IYKRNIELKV EVESLKRELQ DKKQHLDKTW ADVENLNSQN EAELRRQFEE RQQETEHVYE
     LLENKIQLLQ EESRLAKNEA ARMAALVEAE KECNLELSEK LKGVTKNWED VPGDQVKPDQ
     YTEALAQRDK RIEELNQSLA AQERLVEQLS REKQQLLHLL EEPTSMEVQP MTEELLKQQK
     LNSHETTITQ QSVSDSHLAE LQEKIQQTEA TNKILQEKLN EMSYELKCAQ ESSQKQDGTI
     QNLKETLKSR ERETEELYQV IEGQNDTMAK LREMLHQSQL GQLHSSEGTS PAQQQVALLD
     LQSALFCSQL EIQKLQRVVR QKERQLADAK QCVQFVEAAA HESEQQKEAS WKHNQELRKA
     LQQLQEELQN KSQQLRAWEA EKYNEIRTQE QNIQHLNHSL SHKEQLLQEF RELLQYRDNS
     DKTLEANEML LEKLRQRIHD KAVALERAID EKFSALEEKE KELRQLRLAV RERDHDLERL
     RDVLSSNEAT MQSMESLLRA KGLEVEQLST TCQNLQWLKE EMETKFSRWQ KEQESIIQQL
     QTSLHDRNKE VEDLSATLLC KLGPGQSEIA EELCQRLQRK ERMLQDLLSD RNKQVLEHEM
     EIQGLLQSVS TREQESQAAA EKLVQALMER NSELQALRQY LGGRDSLMSQ APISNQQAEV
     TPTGRLGKQT DQGSMQIPSR DDSTSLTAKE DVSIPRSTLG DLDTVAGLEK ELSNAKEELE
     LMAKKERESQ MELSALQSMM AVQEEELQVQ AADMESLTRN IQIKEDLIKD LQMQLVDPED
     IPAMERLTQE VLLLREKVAS VESQGQEISG NRRQQLLLML EGLVDERSRL NEALQAERQL
     YSSLVKFHAH PESSERDRTL QVELEGAQVL RSRLEEVLGR SLERLNRLET LAAIGGAAAG
     DDTEDTSTEF TDSIEEEAAH HSHQQLVKVA LEKSLATVET QNPSFSPPSP MGGDSNRCLQ
     EEMLHLRAEF HQHLEEKRKA EEELKELKAQ IEEAGFSSVS HIRNTMLSLC LENAELKEQM
     GEAMSDGWEI EEDKEKGEVM VETVVTKEGL SESSLQAEFR KLQGKLKNAH NIINLLKEQL
     VLSSKEGNSK LTPELLVHLT STIERINTEL VGSPGKHQHQ EEGNVTVRPF PRPQSLDLGA
     TFTVDAHQLD NQSQPRDPGP QSAFSLPGST QHLRSQLSQC KQRYQDLQEK LLLSEATVFA
     QANELEKYRV MLSESLVKQD SKQIQVDLQD LGYETCGRSE NEAEREETTS PECEEHNSLK
     EMVLMEGLCS EQGRRGSTLA SSSERKPLEN QLGKQEEFRV YGKSENILVL RKDIKDLKAQ
     LQNANKVIQN LKSRVRSLSV TSDYSSSLER PRKLRAVGTL EGSSPHSVPD EDEGWLSDGT
     GAFYSPGLQA KKDLESLIQR VSQLEAQLPK NGLEEKLAEE LRSASWPGKY DSLIQDQARE
     LSYLRQKIRE GRGICYLITR HAKDTVKSFE DLLRSNDIDY YLGQSFREQL AQGSQLTERL
     TSKLSTKDHK SEKDQAGLEP LALRLSRELQ EKEKVIEVLQ AKLDARSLTP SSSHALSDSH
     RSPSSTSFLS DELEACSDMD IVSEYTHYEE KKASPSHSDS IHHSSHSAVL SSKPSSTSAS
     QGAKAESNSN PISLPTPQNT PKEANQAHSG FHFHSIPKLA SLPQAPLPSA PSSFLPFSPT
     GPLLLGCCET PVVSLAEAQQ ELQMLQKQLG ESASTVPPAS TATLLSNDLE ADSSYYLNSA
     QPHSPPRGTI ELGRILEPGY LGSSGKWDVM RPQKGSVSGD LSSGSSVYQL NSKPTGADLL
     EEHLGEIRNL RQRLEESICI NDRLREQLEH RLTSTARGRG STSNFYSQGL ESIPQLCNEN
     RVLREDNRRL QAQLSHVSRE HSQETESLRE ALLSSRSHLQ ELEKELEHQK VERQQLLEDL
     REKQQEVLHF REERLSLQEN DSRLQHKLVL LQQQCEEKQQ LFESLQSELQ IYEALYGNSK
     KGLKAYSLDA CHQIPLSSDL SHLVAEVRAL RGQLEQSIQG NNCLRLQLQQ QLESGAGKAS
     LSPSSINQNF PASTDPGNKQ LLLQDSAVSP PVRDVGMNSP ALVFPSSASS TPGSETPIIN
     RANGLGLDTS PVMKTPPKLE GDATDGSFAN KHGRHVIGHI DDYSALRQQI AEGKLLVKKI
     VSLVRSACSF PGLEAQGTEV LGSKGIHELR SSTSALHHAL EESASLLTMF WRAALPSTHI
     PVLPGKVGES TERELLELRT KVSKQERLLQ STTEHLKNAN QQKESMEQFI VSQLTRTHDV
     LKKARTNLEV KSLRALPCTP AL
//
ID   A0A087WYE4_HUMAN        Unreviewed;       176 AA.
AC   A0A087WYE4;
DT   29-OCT-2014, integrated into UniProtKB/TrEMBL.
DT   29-OCT-2014, sequence version 1.
DT   22-APR-2020, entry version 38.
DE   SubName: Full=Myomegalin {ECO:0000313|Ensembl:ENSP00000481731};
GN   Name=PDE4DIP {ECO:0000313|Ensembl:ENSP00000481731};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000481731, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000481731, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I., Aubin K., Babbage A.K., Bagguley C.L., Bailey J., Beasley H.,
RA   Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G., Clee C.,
RA   Cobley V., Collier R.E., Corby N., Coville G.J., Davies J., Deadman R.,
RA   Dunn M., Earthrowl M., Ellington A.G., Errington H., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Gay L., Ghori M.R.,
RA   Gibson R., Gilby L.M., Gillett W., Glithero R.J., Grafham D.V.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Hammond S., Harrison E.S.,
RA   Hart E., Haugen E., Heath P.D., Holmes S., Holt K., Howden P.J., Hunt A.R.,
RA   Hunt S.E., Hunter G., Isherwood J., James R., Johnson C., Johnson D.,
RA   Joy A., Kay M., Kershaw J.K., Kibukawa M., Kimberley A.M., King A.,
RA   Knights A.J., Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S., McLaren S., Milne S.,
RA   Mistry S., Moore M.J., Nickerson T., O'Dell C.N., Oliver K., Palmeiri A.,
RA   Palmer S.A., Parker A., Patel D., Pearce A.V., Peck A.I., Pelan S.,
RA   Phelps K., Phillimore B.J., Plumb R., Rajan J., Raymond C., Rouse G.,
RA   Saenphimmachak C., Sehra H.K., Sheridan E., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M., Steward C., Subramanian S., Sycamore N., Tracey A.,
RA   Tromans A., Van Helmond Z., Wall M., Wallis J.M., White S., Whitehead S.L.,
RA   Wilkinson J.E., Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z.,
RA   Coulson A., Vaudin M., Sulston J.E., Durbin R., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R., Banerjee R., Bryant S.P., Burford D.C.,
RA   Burrill W.D., Clegg S.M., Dhami P., Dovey O., Faulkner L.M., Gribble S.M.,
RA   Langford C.F., Pandian R.D., Porter K.M., Prigmore E.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000481731}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2014) to UniProtKB.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC239802; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC239804; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC245389; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001182190.1; NM_001195261.1.
DR   PeptideAtlas; A0A087WYE4; -.
DR   PRIDE; A0A087WYE4; -.
DR   Antibodypedia; 2152; 119 antibodies.
DR   Ensembl; ENST00000464103; ENSP00000481731; ENSG00000178104.
DR   GeneID; 9659; -.
DR   UCSC; uc021oui.1; human.
DR   CTD; 9659; -.
DR   EuPathDB; HostDB:ENSG00000178104.19; -.
DR   HGNC; HGNC:15580; PDE4DIP.
DR   OpenTargets; ENSG00000178104; -.
DR   eggNOG; ENOG410J2NR; Eukaryota.
DR   eggNOG; ENOG411281S; LUCA.
DR   GeneTree; ENSGT00950000183190; -.
DR   OrthoDB; 15127at2759; -.
DR   ChiTaRS; PDE4DIP; human.
DR   GenomeRNAi; 9659; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000178104; Expressed in gastrocnemius and 226 other tissues.
DR   ExpressionAtlas; A0A087WYE4; baseline and differential.
DR   GO; GO:0005815; C:microtubule organizing center; IEA:InterPro.
DR   InterPro; IPR012943; Cnn_1N.
DR   Pfam; PF07989; Cnn_1N; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Proteomics identification {ECO:0000213|MaxQB:A0A087WYE4,
KW   ECO:0000213|PeptideAtlas:A0A087WYE4, ECO:0000213|ProteomicsDB:A0A087WYE4};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN          13..78
FT                   /note="Cnn_1N"
FT                   /evidence="ECO:0000259|Pfam:PF07989"
FT   REGION          154..176
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          44..75
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          91..125
FT                   /evidence="ECO:0000256|SAM:Coils"
SQ   SEQUENCE   176 AA;  21161 MW;  0FEFE198622F04F0 CRC64;
     MFLCQGFRKY LPEHLNDLKK ENFSLKLRIY FLEERMQQKY EASREDIYKR NIELKVEVES
     LKRELQDKKQ HLDKTWADVE NLNSQNEAEL RRQFEERQQE TEHVYELLEN KIQLLQEESR
     LAKNEAARMA ALVEAEKECN LELSEKLKGV TKNWEDVPGD QVKPDQYTEA LAQRDK
//
ID   MYOME_HUMAN             Reviewed;        2346 AA.
AC   Q5VU43; A0A0A0MRM0; A0A0C4DFQ0; A2RU15; E9PL24; O75042; O75065; Q2YDC1;
AC   Q5VU42; Q5VU44; Q5VU45; Q5VU46; Q5VU47; Q5VU48; Q5VU49; Q68DU2; Q6AZ93;
AC   Q6PK88; Q86T40; Q86TB2; Q8N3W0; Q8TAY9; Q9HCP2; Q9HCP3; Q9HCP4; Q9HCP5;
DT   23-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   28-MAR-2018, sequence version 3.
DT   22-APR-2020, entry version 150.
DE   RecName: Full=Myomegalin;
DE   AltName: Full=Cardiomyopathy-associated protein 2;
DE   AltName: Full=Phosphodiesterase 4D-interacting protein;
GN   Name=PDE4DIP; Synonyms=CMYA2, KIAA0454, KIAA0477, MMGL;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 10; 11 AND 12), TISSUE SPECIFICITY,
RP   AND VARIANT THR-49.
RC   TISSUE=Myocardium;
RX   PubMed=11374908; DOI=10.1006/geno.2001.6527;
RA   Soejima H., Kawamoto S., Akai J., Miyoshi O., Arai Y., Morohka T.,
RA   Matsuo S., Niikawa N., Kimura A., Okubo K., Mukai T.;
RT   "Isolation of novel heart-specific genes using the BodyMap database.";
RL   Genomics 74:115-120(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 13), FUNCTION (ISOFORM 13), INTERACTION
RP   WITH AKAP9; GAMMA-TUBULIN RING COMPLEX; MAPRE1 AND MAPRE3 (ISOFORM 13),
RP   SUBCELLULAR LOCATION (ISOFORM 13), AND MUTAGENESIS (ISOFORM 13).
RX   PubMed=25217626; DOI=10.1242/jcs.155408;
RA   Wang Z., Zhang C., Qi R.Z.;
RT   "A newly identified myomegalin isoform functions in Golgi microtubule
RT   organization and ER-Golgi transport.";
RL   J. Cell Sci. 127:4904-4917(2014).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Brain;
RX   PubMed=9455484; DOI=10.1093/dnares/4.5.345;
RA   Seki N., Ohira M., Nagase T., Ishikawa K., Miyajima N., Nakajima D.,
RA   Nomura N., Ohara O.;
RT   "Characterization of cDNA clones in size-fractionated cDNA libraries from
RT   human brain.";
RL   DNA Res. 4:345-349(1997).
RN   [4]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 6 AND 7), AND VARIANTS
RP   CYS-708; ILE-1013; THR-1066; GLU-1359; GLU-1736 AND SER-1742.
RC   TISSUE=Amygdala, and Skeletal muscle;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANTS CYS-708 AND
RP   TRP-1396.
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2; 8 AND 9), AND VARIANT
RP   THR-49.
RC   TISSUE=Brain, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2261-2346 (ISOFORM 4).
RC   TISSUE=Skeletal muscle;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [9]
RP   CHROMOSOMAL TRANSLOCATION WITH PDGFRB.
RX   PubMed=12907457; DOI=10.1182/blood-2003-04-1150;
RA   Wilkinson K., Velloso E.R.P., Lopes L.F., Lee C., Aster J.C., Shipp M.A.,
RA   Aguiar R.C.T.;
RT   "Cloning of the t(1;5)(q23;q33) in a myeloproliferative disorder associated
RT   with eosinophilia: involvement of PDGFRB and response to imatinib.";
RL   Blood 102:4187-4190(2003).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-704, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-252 (ISOFORMS 13 AND 2), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   FUNCTION (ISOFORM 13), SUBCELLULAR LOCATION (ISOFORM 13), AND INTERACTION
RP   WITH AKAP9 AND CAMSAP2 (ISOFORM 13).
RX   PubMed=27666745; DOI=10.1016/j.devcel.2016.08.009;
RA   Wu J., de Heus C., Liu Q., Bouchet B.P., Noordstra I., Jiang K., Hua S.,
RA   Martin M., Yang C., Grigoriev I., Katrukha E.A., Altelaar A.F.,
RA   Hoogenraad C.C., Qi R.Z., Klumperman J., Akhmanova A.;
RT   "Molecular pathway of microtubule organization at the Golgi apparatus.";
RL   Dev. Cell 39:44-60(2016).
RN   [15]
RP   FUNCTION (ISOFORM 13), INTERACTION WITH AKAP9; CAMSAP2; MAPRE1 AND MAPRE3
RP   (ISOFORM 13), AND MUTAGENESIS (ISOFORM 13).
RX   PubMed=28814570; DOI=10.1083/jcb.201701024;
RA   Yang C., Wu J., de Heus C., Grigoriev I., Liv N., Yao Y., Smal I.,
RA   Meijering E., Klumperman J., Qi R.Z., Akhmanova A.;
RT   "EB1 and EB3 regulate microtubule minus end organization and Golgi
RT   morphology.";
RL   J. Cell Biol. 216:3179-3198(2017).
RN   [16]
RP   INTERACTION WITH AKAP9; CDK5RAP2; LGALS3BP AND MAPRE1 (ISOFORM 13),
RP   SUBCELLULAR LOCATION (ISOFORM 13), IDENTIFICATION BY MASS SPECTROMETRY
RP   (ISOFORM 13), MUTAGENESIS (ISOFORM 13), AND DOMAIN.
RX   PubMed=29162697; DOI=10.1073/pnas.1705682114;
RA   Bouguenina H., Salaun D., Mangon A., Muller L., Baudelet E., Camoin L.,
RA   Tachibana T., Cianferani S., Audebert S., Verdier-Pinard P., Badache A.;
RT   "EB1-binding-myomegalin protein complex promotes centrosomal microtubules
RT   functions.";
RL   Proc. Natl. Acad. Sci. U.S.A. 114:E10687-E10696(2017).
CC   -!- FUNCTION: Functions as an anchor sequestering components of the cAMP-
CC       dependent pathway to Golgi and/or centrosomes (By similarity).
CC       {ECO:0000250|UniProtKB:Q9WUJ3}.
CC   -!- FUNCTION: [Isoform 13]: Participates in microtubule dynamics, promoting
CC       microtubule assembly. Depending upon the cell context, may act at the
CC       level of the Golgi apparatus or that of the centrosome
CC       (PubMed:25217626, PubMed:27666745, PubMed:28814570, PubMed:29162697).
CC       In complex with AKAP9, recruits CAMSAP2 to the Golgi apparatus and
CC       tethers non-centrosomal minus-end microtubules to the Golgi, an
CC       important step for polarized cell movement (PubMed:27666745,
CC       PubMed:28814570). In complex with AKAP9, EB1/MAPRE1 and CDK5RAP2,
CC       contributes to microtubules nucleation and extension from the
CC       centrosome to the cell periphery, a crucial process for directed cell
CC       migration, mitotic spindle orientation and cell-cycle progression
CC       (PubMed:29162697). {ECO:0000269|PubMed:25217626,
CC       ECO:0000269|PubMed:27666745, ECO:0000269|PubMed:28814570,
CC       ECO:0000269|PubMed:29162697}.
CC   -!- SUBUNIT: Interacts with PDE4D (By similarity). Isoform 13 interacts
CC       with MAPRE1 and MAPRE3 (PubMed:25217626, PubMed:28814570,
CC       PubMed:29162697). Isoform 13 forms a pericentrosomal complex with
CC       AKAP9, CDK5RAP2 and EB1/MAPRE1; within this complex, may mediate
CC       MAPRE1-binding to CDK5RAP2 (PubMed:29162697). Interaction of isoform 13
CC       with AKAP9 stabilizes both proteins (PubMed:25217626, PubMed:27666745).
CC       Isoform 13 interacts (via N-terminus) with CAMSAP2; this interaction is
CC       much stronger in the presence of AKAP9 (PubMed:27666745). In complex
CC       with AKAP9, Isoform 13 recruits CAMSAP2 to the Golgi apparatus
CC       (PubMed:27666745, PubMed:28814570). Isoform 13 interacts with
CC       unglycosylated LGALS3BP; this interaction may connect the
CC       pericentrosomal complex to the gamma-tubulin ring complex (gamma-TuRC)
CC       to promote microtubule assembly and acetylation (PubMed:25217626,
CC       PubMed:29162697). {ECO:0000250|UniProtKB:Q9WUJ3,
CC       ECO:0000269|PubMed:25217626, ECO:0000269|PubMed:27666745,
CC       ECO:0000269|PubMed:28814570, ECO:0000269|PubMed:29162697}.
CC   -!- INTERACTION:
CC       Q5VU43; Q9H6F0; NbExp=3; IntAct=EBI-1105124, EBI-10307481;
CC       Q5VU43; Q8WTP8: AEN; NbExp=3; IntAct=EBI-1105124, EBI-8637627;
CC       Q5VU43-11; Q8R560: Ankrd1; Xeno; NbExp=2; IntAct=EBI-10769071, EBI-10817505;
CC       Q5VU43-2; Q92619: ARHGAP45; NbExp=3; IntAct=EBI-9640281, EBI-2825900;
CC       Q5VU43; Q13895: BYSL; NbExp=5; IntAct=EBI-1105124, EBI-358049;
CC       Q5VU43-2; Q13895: BYSL; NbExp=3; IntAct=EBI-9640281, EBI-358049;
CC       Q5VU43; Q9NX04: C1orf109; NbExp=3; IntAct=EBI-1105124, EBI-8643161;
CC       Q5VU43-2; Q9NX04: C1orf109; NbExp=3; IntAct=EBI-9640281, EBI-8643161;
CC       Q5VU43-2; Q8IYE0: CCDC146; NbExp=3; IntAct=EBI-9640281, EBI-10749669;
CC       Q5VU43-2; E9PSE9: CCDC198; NbExp=3; IntAct=EBI-9640281, EBI-11748295;
CC       Q5VU43; Q9NVL8: CCDC198; NbExp=3; IntAct=EBI-1105124, EBI-10238351;
CC       Q5VU43; Q9NX63: CHCHD3; NbExp=3; IntAct=EBI-1105124, EBI-743375;
CC       Q5VU43-11; Q9H0A8: COMMD4; NbExp=4; IntAct=EBI-10769071, EBI-1550064;
CC       Q5VU43-2; Q2TBE0: CWF19L2; NbExp=3; IntAct=EBI-9640281, EBI-5453285;
CC       Q5VU43-2; A0A0S2Z3U4: EGR2; NbExp=3; IntAct=EBI-9640281, EBI-16431598;
CC       Q5VU43-11; P04764: Eno1; Xeno; NbExp=2; IntAct=EBI-10769071, EBI-915852;
CC       Q5VU43-11; P15429: Eno3; Xeno; NbExp=2; IntAct=EBI-10769071, EBI-10817548;
CC       Q5VU43; Q3B820: FAM161A; NbExp=3; IntAct=EBI-1105124, EBI-719941;
CC       Q5VU43-2; Q9Y247: FAM50B; NbExp=3; IntAct=EBI-9640281, EBI-742802;
CC       Q5VU43; Q5TZK3: FAM74A6; NbExp=3; IntAct=EBI-1105124, EBI-10247271;
CC       Q5VU43; Q0D2H9: GOLGA8DP; NbExp=3; IntAct=EBI-1105124, EBI-10181276;
CC       Q5VU43; Q08AF8: GOLGA8G; NbExp=3; IntAct=EBI-1105124, EBI-10181260;
CC       Q5VU43; Q96CS2: HAUS1; NbExp=3; IntAct=EBI-1105124, EBI-2514791;
CC       Q5VU43-2; P09067: HOXB5; NbExp=3; IntAct=EBI-9640281, EBI-3893317;
CC       Q5VU43-2; P31273: HOXC8; NbExp=3; IntAct=EBI-9640281, EBI-1752118;
CC       Q5VU43; Q16891: IMMT; NbExp=2; IntAct=EBI-1105124, EBI-473801;
CC       Q5VU43; Q6P597: KLC3; NbExp=3; IntAct=EBI-1105124, EBI-1643885;
CC       Q5VU43; Q96BZ8: LENG1; NbExp=3; IntAct=EBI-1105124, EBI-726510;
CC       Q5VU43-2; Q96GY3: LIN37; NbExp=3; IntAct=EBI-9640281, EBI-748884;
CC       Q5VU43; P61968: LMO4; NbExp=4; IntAct=EBI-1105124, EBI-2798728;
CC       Q5VU43; Q15691: MAPRE1; NbExp=5; IntAct=EBI-1105124, EBI-1004115;
CC       Q5VU43-2; Q9UPY8: MAPRE3; NbExp=3; IntAct=EBI-9640281, EBI-726739;
CC       Q5VU43; A9UHW6: MIF4GD; NbExp=3; IntAct=EBI-1105124, EBI-373498;
CC       Q5VU43; Q5JR59: MTUS2; NbExp=3; IntAct=EBI-1105124, EBI-742948;
CC       Q5VU43-11; Q14896: MYBPC3; NbExp=5; IntAct=EBI-10769071, EBI-704176;
CC       Q5VU43-2; P52179-2: MYOM1; NbExp=3; IntAct=EBI-9640281, EBI-12010196;
CC       Q5VU43; P41227: NAA10; NbExp=3; IntAct=EBI-1105124, EBI-747693;
CC       Q5VU43-2; P41227: NAA10; NbExp=3; IntAct=EBI-9640281, EBI-747693;
CC       Q5VU43; Q6NYC8: PPP1R18; NbExp=3; IntAct=EBI-1105124, EBI-2557469;
CC       Q5VU43-11; P09456: Prkar1a; Xeno; NbExp=2; IntAct=EBI-10769071, EBI-916215;
CC       Q5VU43-11; P12368: Prkar2a; Xeno; NbExp=2; IntAct=EBI-10769071, EBI-919521;
CC       Q5VU43; Q8WWY3: PRPF31; NbExp=7; IntAct=EBI-1105124, EBI-1567797;
CC       Q5VU43; Q14D33: RTP5; NbExp=3; IntAct=EBI-1105124, EBI-10217913;
CC       Q5VU43; Q9BWG6: SCNM1; NbExp=3; IntAct=EBI-1105124, EBI-748391;
CC       Q5VU43-2; Q9BWG6: SCNM1; NbExp=3; IntAct=EBI-9640281, EBI-748391;
CC       Q5VU43; O00560: SDCBP; NbExp=4; IntAct=EBI-1105124, EBI-727004;
CC       Q5VU43-2; O00560: SDCBP; NbExp=4; IntAct=EBI-9640281, EBI-727004;
CC       Q5VU43; Q9H788: SH2D4A; NbExp=3; IntAct=EBI-1105124, EBI-747035;
CC       Q5VU43; Q9H788-2: SH2D4A; NbExp=3; IntAct=EBI-1105124, EBI-10308083;
CC       Q5VU43; Q9NUL5: SHFL; NbExp=3; IntAct=EBI-1105124, EBI-10313866;
CC       Q5VU43-11; P19429: TNNI3; NbExp=4; IntAct=EBI-10769071, EBI-704146;
CC       Q5VU43-11; P23693: Tnni3; Xeno; NbExp=2; IntAct=EBI-10769071, EBI-10817583;
CC       Q5VU43; Q08E77: UTP14C; NbExp=3; IntAct=EBI-1105124, EBI-10225961;
CC       Q5VU43-2; O43167: ZBTB24; NbExp=3; IntAct=EBI-9640281, EBI-744471;
CC       Q5VU43-2; Q9P1Z0: ZBTB4; NbExp=3; IntAct=EBI-9640281, EBI-2564133;
CC       Q5VU43; Q9BQ24: ZFYVE21; NbExp=3; IntAct=EBI-1105124, EBI-2849569;
CC       Q5VU43-2; Q9BRR0: ZKSCAN3; NbExp=3; IntAct=EBI-9640281, EBI-1965777;
CC       Q5VU43-2; Q15973: ZNF124; NbExp=3; IntAct=EBI-9640281, EBI-2555767;
CC       Q5VU43; Q9H9D4: ZNF408; NbExp=3; IntAct=EBI-1105124, EBI-347633;
CC       Q5VU43-2; Q86VK4-3: ZNF410; NbExp=3; IntAct=EBI-9640281, EBI-11741890;
CC       Q5VU43-2; Q96IQ9: ZNF414; NbExp=3; IntAct=EBI-9640281, EBI-744257;
CC       Q5VU43; Q9P0T4: ZNF581; NbExp=3; IntAct=EBI-1105124, EBI-745520;
CC       Q5VU43-2; Q9P0T4: ZNF581; NbExp=3; IntAct=EBI-9640281, EBI-745520;
CC       Q5VU43-2; Q96SQ5: ZNF587; NbExp=3; IntAct=EBI-9640281, EBI-6427977;
CC       Q5VU43-2; Q9H7X3: ZNF696; NbExp=3; IntAct=EBI-9640281, EBI-11090299;
CC       Q5VU43; Q16670: ZSCAN26; NbExp=3; IntAct=EBI-1105124, EBI-3920053;
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus {ECO:0000269|PubMed:27666745}.
CC       Cytoplasm, cytoskeleton, microtubule organizing center, centrosome
CC       {ECO:0000250|UniProtKB:Q9WUJ3}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 13]: Cytoplasm, cytoskeleton,
CC       microtubule organizing center, centrosome
CC       {ECO:0000269|PubMed:29162697}. Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:29162697}. Golgi apparatus
CC       {ECO:0000269|PubMed:25217626}. Note=Associated with the microtubule
CC       network at the growing distal tip of microtubules (PubMed:29162697).
CC       Targeting to the Golgi apparatus requires AKAP9 (PubMed:25217626).
CC       {ECO:0000269|PubMed:25217626, ECO:0000269|PubMed:29162697}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=12;
CC       Name=1;
CC         IsoId=Q5VU43-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q5VU43-2; Sequence=VSP_028772, VSP_028779;
CC       Name=3;
CC         IsoId=Q5VU43-3; Sequence=VSP_028773, VSP_028781, VSP_028782;
CC       Name=4;
CC         IsoId=Q5VU43-4; Sequence=VSP_028783;
CC       Name=6;
CC         IsoId=Q5VU43-6; Sequence=VSP_028779;
CC       Name=7;
CC         IsoId=Q5VU43-7; Sequence=VSP_028778, VSP_028780;
CC       Name=8;
CC         IsoId=Q5VU43-8; Sequence=VSP_028774, VSP_028775;
CC       Name=9;
CC         IsoId=Q5VU43-9; Sequence=VSP_028774, VSP_028776, VSP_028777;
CC       Name=10;
CC         IsoId=Q5VU43-10; Sequence=VSP_028776, VSP_028777;
CC       Name=11;
CC         IsoId=Q5VU43-11; Sequence=VSP_028775;
CC       Name=12;
CC         IsoId=Q5VU43-12; Sequence=VSP_028773, VSP_028776, VSP_028777;
CC       Name=13; Synonyms=Myomegalin variant 8 {ECO:0000303|PubMed:25217626},
CC       MMG {ECO:0000303|PubMed:27666745, ECO:0000303|PubMed:28814570}, MMG8
CC       {ECO:0000303|PubMed:25217626}, Short myomegalin-like EB1 binding
CC       protein {ECO:0000303|PubMed:29162697}, SMYLE
CC       {ECO:0000303|PubMed:29162697};
CC         IsoId=Q5VU43-13; Sequence=VSP_028772, VSP_059333, VSP_059334;
CC   -!- TISSUE SPECIFICITY: Highly expressed in adult and fetal heart, in
CC       skeletal muscle and, to a lower extent, in brain and placenta.
CC       {ECO:0000269|PubMed:11374908}.
CC   -!- DOMAIN: [Isoform 13]: residues 1-150 are involved in AKAP9-binding.
CC       {ECO:0000269|PubMed:29162697}.
CC   -!- DISEASE: Note=A chromosomal aberration involving PDE4DIP may be the
CC       cause of a myeloproliferative disorder (MBD) associated with
CC       eosinophilia. Translocation t(1;5)(q23;q33) that forms a PDE4DIP-PDGFRB
CC       fusion protein. {ECO:0000269|PubMed:12907457}.
CC   -!- MISCELLANEOUS: [Isoform 13]: Mutagenesis at position 311-312:LP->AA
CC       (loss of MAPRE1- and MAPRE3-binding and loss of association with
CC       microtubule ends, no effect on AKAP9- and CDK5RAP2-binding, relocalizes
CC       from EB1/MAPRE1 microtubule ends to centrosomal area).
CC       {ECO:0000269|PubMed:25217626, ECO:0000269|PubMed:28814570,
CC       ECO:0000269|PubMed:29162697, ECO:0000305}.
CC   -!- CAUTION: Was initially reported to localize in the cytoplasm and
CC       nucleus (PubMed:11374908). However, many reports in different species
CC       have shown that it is associated with the Golgi apparatus and the
CC       centrosome. {ECO:0000269|PubMed:11374908, ECO:0000269|PubMed:27666745}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH04860.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=BAA32299.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAA32322.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=CAD91152.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=CAH18128.1; Type=Miscellaneous discrepancy; Note=Probable cloning artifact.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PDE4DIP01q22ID180.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB042555; BAB17759.1; -; mRNA.
DR   EMBL; AB042556; BAB17760.1; -; mRNA.
DR   EMBL; AB042557; BAB17761.1; -; mRNA.
DR   EMBL; AB042558; BAB17762.1; -; mRNA.
DR   EMBL; AB007923; BAA32299.2; ALT_INIT; mRNA.
DR   EMBL; AB007946; BAA32322.2; ALT_INIT; mRNA.
DR   EMBL; HQ333476; ADO32613.1; -; mRNA.
DR   EMBL; AL831815; CAD38529.1; -; mRNA.
DR   EMBL; AL832024; CAD89923.1; -; mRNA.
DR   EMBL; AL833273; CAD91152.1; ALT_FRAME; mRNA.
DR   EMBL; CR749273; CAH18128.1; ALT_SEQ; mRNA.
DR   EMBL; AL590452; CAH72521.1; -; Genomic_DNA.
DR   EMBL; AL138791; CAH72521.1; JOINED; Genomic_DNA.
DR   EMBL; AL590452; CAH72522.1; -; Genomic_DNA.
DR   EMBL; AL138796; CAH72522.1; JOINED; Genomic_DNA.
DR   EMBL; AL590452; CAH72523.1; -; Genomic_DNA.
DR   EMBL; AL138796; CAH72523.1; JOINED; Genomic_DNA.
DR   EMBL; AL590452; CAH72524.1; -; Genomic_DNA.
DR   EMBL; AL138796; CAH72524.1; JOINED; Genomic_DNA.
DR   EMBL; AL590452; CAH72525.1; -; Genomic_DNA.
DR   EMBL; AL590452; CAH72526.1; -; Genomic_DNA.
DR   EMBL; AL138796; CAH72526.1; JOINED; Genomic_DNA.
DR   EMBL; AL590452; CAH72527.1; -; Genomic_DNA.
DR   EMBL; AL138796; CAH72527.1; JOINED; Genomic_DNA.
DR   EMBL; AL590452; CAH72528.1; -; Genomic_DNA.
DR   EMBL; AL138796; CAH72528.1; JOINED; Genomic_DNA.
DR   EMBL; AL138791; CAI22527.1; -; Genomic_DNA.
DR   EMBL; AL590452; CAI22527.1; JOINED; Genomic_DNA.
DR   EMBL; AL138796; CAI22822.1; -; Genomic_DNA.
DR   EMBL; AL590452; CAI22822.1; JOINED; Genomic_DNA.
DR   EMBL; AL138796; CAI22823.1; -; Genomic_DNA.
DR   EMBL; AL590452; CAI22823.1; JOINED; Genomic_DNA.
DR   EMBL; AL138796; CAI22824.1; -; Genomic_DNA.
DR   EMBL; AL590452; CAI22824.1; JOINED; Genomic_DNA.
DR   EMBL; AL138796; CAI22825.1; -; Genomic_DNA.
DR   EMBL; AL590452; CAI22825.1; JOINED; Genomic_DNA.
DR   EMBL; AL138796; CAI22826.1; -; Genomic_DNA.
DR   EMBL; AL590452; CAI22826.1; JOINED; Genomic_DNA.
DR   EMBL; AL138796; CAI22827.1; -; Genomic_DNA.
DR   EMBL; AL590452; CAI22827.1; JOINED; Genomic_DNA.
DR   EMBL; AC239802; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC245389; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC239804; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC004860; AAH04860.1; ALT_SEQ; mRNA.
DR   EMBL; BC025406; AAH25406.1; -; mRNA.
DR   EMBL; BC078660; AAH78660.1; -; mRNA.
DR   EMBL; BC110294; AAI10295.1; -; mRNA.
DR   EMBL; BC132717; AAI32718.1; -; mRNA.
DR   EMBL; BC152439; AAI52440.1; -; mRNA.
DR   EMBL; DA900724; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS72887.1; -. [Q5VU43-8]
DR   CCDS; CCDS72888.1; -. [Q5VU43-3]
DR   CCDS; CCDS72890.1; -. [Q5VU43-6]
DR   CCDS; CCDS72891.1; -. [Q5VU43-1]
DR   CCDS; CCDS72892.1; -. [Q5VU43-4]
DR   CCDS; CCDS72893.1; -. [Q5VU43-11]
DR   CCDS; CCDS72894.1; -. [Q5VU43-2]
DR   PIR; T00069; T00069.
DR   PIR; T00259; T00259.
DR   RefSeq; NP_001002810.1; NM_001002810.3. [Q5VU43-11]
DR   RefSeq; NP_001002811.2; NM_001002811.2. [Q5VU43-2]
DR   RefSeq; NP_001002812.2; NM_001002812.2. [Q5VU43-6]
DR   RefSeq; NP_001182189.1; NM_001195260.1.
DR   RefSeq; NP_001182190.1; NM_001195261.1.
DR   RefSeq; NP_001185761.2; NM_001198832.2. [Q5VU43-3]
DR   RefSeq; NP_001185763.3; NM_001198834.3. [Q5VU43-4]
DR   RefSeq; NP_055459.5; NM_014644.5. [Q5VU43-1]
DR   RefSeq; NP_071754.3; NM_022359.5. [Q5VU43-8]
DR   RefSeq; XP_016855361.1; XM_016999872.1.
DR   RefSeq; XP_016855362.1; XM_016999873.1.
DR   RefSeq; XP_016858514.1; XM_017003025.1.
DR   RefSeq; XP_016858515.1; XM_017003026.1.
DR   SMR; Q5VU43; -.
DR   BioGrid; 115017; 151.
DR   DIP; DIP-51263N; -.
DR   IntAct; Q5VU43; 177.
DR   MINT; Q5VU43; -.
DR   STRING; 9606.ENSP00000358363; -.
DR   iPTMnet; Q5VU43; -.
DR   PhosphoSitePlus; Q5VU43; -.
DR   BioMuta; PDE4DIP; -.
DR   DMDM; 74747041; -.
DR   EPD; Q5VU43; -.
DR   jPOST; Q5VU43; -.
DR   MassIVE; Q5VU43; -.
DR   PaxDb; Q5VU43; -.
DR   PeptideAtlas; Q5VU43; -.
DR   PRIDE; Q5VU43; -.
DR   ProteomicsDB; 21657; -.
DR   ProteomicsDB; 65374; -. [Q5VU43-1]
DR   ProteomicsDB; 65375; -. [Q5VU43-10]
DR   ProteomicsDB; 65376; -. [Q5VU43-11]
DR   ProteomicsDB; 65377; -. [Q5VU43-12]
DR   ProteomicsDB; 65378; -. [Q5VU43-2]
DR   ProteomicsDB; 65379; -. [Q5VU43-3]
DR   ProteomicsDB; 65380; -. [Q5VU43-4]
DR   ProteomicsDB; 65381; -. [Q5VU43-6]
DR   ProteomicsDB; 65382; -. [Q5VU43-7]
DR   ProteomicsDB; 65383; -. [Q5VU43-8]
DR   ProteomicsDB; 65384; -. [Q5VU43-9]
DR   Antibodypedia; 2152; 119 antibodies.
DR   DNASU; 9659; -.
DR   Ensembl; ENST00000313431; ENSP00000316434; ENSG00000178104. [Q5VU43-2]
DR   Ensembl; ENST00000369347; ENSP00000358353; ENSG00000178104. [Q5VU43-11]
DR   Ensembl; ENST00000369349; ENSP00000358355; ENSG00000178104. [Q5VU43-6]
DR   Ensembl; ENST00000369351; ENSP00000358357; ENSG00000178104. [Q5VU43-7]
DR   Ensembl; ENST00000369354; ENSP00000358360; ENSG00000178104. [Q5VU43-1]
DR   Ensembl; ENST00000369356; ENSP00000358363; ENSG00000178104. [Q5VU43-4]
DR   Ensembl; ENST00000529945; ENSP00000433392; ENSG00000178104. [Q5VU43-13]
DR   Ensembl; ENST00000530472; ENSP00000482121; ENSG00000178104. [Q5VU43-8]
DR   Ensembl; ENST00000618462; ENSP00000479409; ENSG00000178104. [Q5VU43-3]
DR   GeneID; 9659; -.
DR   KEGG; hsa:9659; -.
DR   UCSC; uc001emb.3; human. [Q5VU43-1]
DR   UCSC; uc057kja.1; human.
DR   CTD; 9659; -.
DR   DisGeNET; 653513; -.
DR   DisGeNET; 9659; -.
DR   GeneCards; PDE4DIP; -.
DR   HGNC; HGNC:15580; PDE4DIP.
DR   HPA; ENSG00000178104; Group enriched (heart muscle, skeletal muscle).
DR   MIM; 608117; gene.
DR   neXtProt; NX_Q5VU43; -.
DR   OpenTargets; ENSG00000178104; -.
DR   PharmGKB; PA33131; -.
DR   eggNOG; ENOG410J2NR; Eukaryota.
DR   eggNOG; ENOG411281S; LUCA.
DR   GeneTree; ENSGT00950000183190; -.
DR   HOGENOM; CLU_897036_0_0_1; -.
DR   InParanoid; Q5VU43; -.
DR   KO; K16549; -.
DR   OMA; DSEVCAQ; -.
DR   OrthoDB; 15127at2759; -.
DR   PhylomeDB; Q5VU43; -.
DR   TreeFam; TF329233; -.
DR   SIGNOR; Q5VU43; -.
DR   ChiTaRS; PDE4DIP; human.
DR   GeneWiki; Myomegalin; -.
DR   GenomeRNAi; 9659; -.
DR   Pharos; Q5VU43; Tbio.
DR   PRO; PR:Q5VU43; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q5VU43; protein.
DR   Bgee; ENSG00000178104; Expressed in gastrocnemius and 226 other tissues.
DR   ExpressionAtlas; Q5VU43; baseline and differential.
DR   Genevisible; Q5VU43; HS.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0030016; C:myofibril; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0019899; F:enzyme binding; ISS:UniProtKB.
DR   GO; GO:0060090; F:molecular adaptor activity; IDA:UniProtKB.
DR   GO; GO:0030953; P:astral microtubule organization; IMP:UniProtKB.
DR   GO; GO:0034622; P:cellular protein-containing complex assembly; ISS:UniProtKB.
DR   GO; GO:0090063; P:positive regulation of microtubule nucleation; IMP:UniProtKB.
DR   GO; GO:1903358; P:regulation of Golgi organization; IDA:UniProtKB.
DR   InterPro; IPR012943; Cnn_1N.
DR   InterPro; IPR010630; Olduvai_dom.
DR   Pfam; PF07989; Cnn_1N; 1.
DR   Pfam; PF06758; Olduvai; 1.
DR   SMART; SM01148; DUF1220; 1.
DR   PROSITE; PS51316; ODV; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Chromosomal rearrangement; Coiled coil; Cytoplasm;
KW   Cytoskeleton; Golgi apparatus; Phosphoprotein; Polymorphism;
KW   Reference proteome.
FT   CHAIN           1..2346
FT                   /note="Myomegalin"
FT                   /id="PRO_0000307690"
FT   DOMAIN          1551..1642
FT                   /note="Olduvai"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00647"
FT   COILED          41..132
FT                   /evidence="ECO:0000255"
FT   COILED          162..205
FT                   /evidence="ECO:0000255"
FT   COILED          238..318
FT                   /evidence="ECO:0000255"
FT   COILED          350..684
FT                   /evidence="ECO:0000255"
FT   COILED          743..936
FT                   /evidence="ECO:0000255"
FT   COILED          1002..1043
FT                   /evidence="ECO:0000255"
FT   COILED          1096..1124
FT                   /evidence="ECO:0000255"
FT   COILED          1212..1240
FT                   /evidence="ECO:0000255"
FT   COILED          1346..1385
FT                   /evidence="ECO:0000255"
FT   COILED          1431..1455
FT                   /evidence="ECO:0000255"
FT   COILED          1736..1760
FT                   /evidence="ECO:0000255"
FT   COILED          1840..2077
FT                   /evidence="ECO:0000255"
FT   COILED          2273..2312
FT                   /evidence="ECO:0000255"
FT   SITE            742..743
FT                   /note="Breakpoint for insertion to form PDE4DIP-PDGFRB
FT                   fusion protein"
FT   MOD_RES         704
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   VAR_SEQ         1..210
FT                   /note="MSNGYRTLSQHLNDLKKENFSLKLRIYFLEERMQQKYEASREDIYKRNIELK
FT                   VEVESLKRELQDKKQHLDKTWADVENLNSQNEAELRRQFEERQQETEHVYELLENKIQL
FT                   LQEESRLAKNEAARMAALVEAEKECNLELSEKLKGVTKNWEDVPGDQVKPDQYTEALAQ
FT                   RDKRIEELNQSLAAQERLVEQLSREKQQLLHLLEEPTSME -> MKEICRICARELCGN
FT                   QRRWIFHTASKLNLQVLLSHVLGKDVPRDGKAEFACSKCAFMLDRIYRFDTVIARIEAL
FT                   SIERLQKLLLEKDRLKFCIASMYRKNNDDSGAEIKAGNGTVDMSVLPDARYSALLQEDF
FT                   AYSGFECWVENEDQIQEPHSCHGSEGPGNRPRRCRGCAALRVADSDYEAICKVPRKVAR
FT                   SISCGPSSRWSTSICTEEPALSEVGPPDLASTKVPPDGESMEEETPGSSVESLDASVQA
FT                   SPPQQKDEETERSAKELGKCDCCSDDQAPQHGCNHKLELALSMIKGLDYKPIQSPRGSR
FT                   LPIPVKSSLPGAKPGPSMTDGVSSGFLNRSLKPLYKTPVSYPLELSDLQELWDDLCEDY
FT                   LPLR (in isoform 2 and isoform 13)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:9455484"
FT                   /id="VSP_028772"
FT   VAR_SEQ         1..10
FT                   /note="MSNGYRTLSQ -> MEQTWTRDYFAEDDGEMVPRTSHTAAFLSDTKDRGPPV
FT                   QSQIWRSGEKVPFVQTYSLRAFEKPPQVQTQALRDFEK (in isoform 3 and
FT                   isoform 12)"
FT                   /evidence="ECO:0000303|PubMed:11374908,
FT                   ECO:0000303|PubMed:9455484"
FT                   /id="VSP_028773"
FT   VAR_SEQ         1..10
FT                   /note="MSNGYRTLSQ -> MKGTDSGSCCRRRCDFGCCCRASRRAHYTPYRSGDATR
FT                   TPQSPRQTPSRERRRPEPAGSWAAAAEEEEAAAAATPWMRDYFAEDDGEMVPRTSHTAA
FT                   FLSDTKDRGPPVQSQIWRSGEKVPFVQTYSLRAFEKPPQVQTQALRDFEK (in
FT                   isoform 8 and isoform 9)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_028774"
FT   VAR_SEQ         174..2346
FT                   /note="Missing (in isoform 8 and isoform 11)"
FT                   /evidence="ECO:0000303|PubMed:11374908,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_028775"
FT   VAR_SEQ         174
FT                   /note="R -> I (in isoform 9, isoform 10 and isoform 12)"
FT                   /evidence="ECO:0000303|PubMed:11374908,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_028776"
FT   VAR_SEQ         175..2346
FT                   /note="Missing (in isoform 9, isoform 10 and isoform 12)"
FT                   /evidence="ECO:0000303|PubMed:11374908,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_028777"
FT   VAR_SEQ         940..953
FT                   /note="AAAGDDTEDTSTEF -> GELESVRIHHKHAY (in isoform 13)"
FT                   /id="VSP_059333"
FT   VAR_SEQ         954..2346
FT                   /note="Missing (in isoform 13)"
FT                   /id="VSP_059334"
FT   VAR_SEQ         968..988
FT                   /note="QLVKVALEKSLATVETQNPSF -> QVSQCQGLGLPGWTAHSPSEV (in
FT                   isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_028778"
FT   VAR_SEQ         970..2346
FT                   /note="Missing (in isoform 2 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:17974005, ECO:0000303|PubMed:9455484"
FT                   /id="VSP_028779"
FT   VAR_SEQ         989..2346
FT                   /note="Missing (in isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_028780"
FT   VAR_SEQ         1082..1191
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:9455484"
FT                   /id="VSP_028781"
FT   VAR_SEQ         1695..1756
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:9455484"
FT                   /id="VSP_028782"
FT   VAR_SEQ         2334..2346
FT                   /note="VKSLRALPCTPAL -> EPCKKRSHQKSLKQQERWACPPFVQLPIC (in
FT                   isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_028783"
FT   VARIANT         13
FT                   /note="N -> S (in dbSNP:rs3010980)"
FT                   /id="VAR_036627"
FT   VARIANT         25
FT                   /note="R -> L (in dbSNP:rs1664022)"
FT                   /id="VAR_036628"
FT   VARIANT         49
FT                   /note="I -> T (in dbSNP:rs573724)"
FT                   /evidence="ECO:0000269|PubMed:11374908,
FT                   ECO:0000269|PubMed:15489334"
FT                   /id="VAR_036629"
FT   VARIANT         143
FT                   /note="K -> E (in dbSNP:rs1747958)"
FT                   /id="VAR_056951"
FT   VARIANT         150
FT                   /note="N -> S (in dbSNP:rs3010980)"
FT                   /id="VAR_056952"
FT   VARIANT         167
FT                   /note="A -> T (in dbSNP:rs2590120)"
FT                   /id="VAR_036630"
FT   VARIANT         171
FT                   /note="R -> K (in dbSNP:rs3121544)"
FT                   /id="VAR_051204"
FT   VARIANT         391
FT                   /note="E -> A (in dbSNP:rs1324366)"
FT                   /id="VAR_051205"
FT   VARIANT         410
FT                   /note="E -> V (in dbSNP:rs1061308)"
FT                   /id="VAR_051206"
FT   VARIANT         482
FT                   /note="H -> R (in dbSNP:rs1698681)"
FT                   /id="VAR_051207"
FT   VARIANT         681
FT                   /note="R -> H (in dbSNP:rs1629011)"
FT                   /id="VAR_051208"
FT   VARIANT         708
FT                   /note="R -> C (in dbSNP:rs1628172)"
FT                   /evidence="ECO:0000269|PubMed:16710414,
FT                   ECO:0000269|PubMed:17974005"
FT                   /id="VAR_051209"
FT   VARIANT         1013
FT                   /note="F -> I (in dbSNP:rs1698624)"
FT                   /evidence="ECO:0000269|PubMed:17974005"
FT                   /id="VAR_051210"
FT   VARIANT         1066
FT                   /note="A -> T (in dbSNP:rs1698647)"
FT                   /evidence="ECO:0000269|PubMed:17974005"
FT                   /id="VAR_051211"
FT   VARIANT         1359
FT                   /note="K -> E (in dbSNP:rs1747958)"
FT                   /evidence="ECO:0000269|PubMed:17974005"
FT                   /id="VAR_051212"
FT   VARIANT         1396
FT                   /note="R -> W (in dbSNP:rs2798901)"
FT                   /id="VAR_080232"
FT   VARIANT         1736
FT                   /note="V -> E (in dbSNP:rs1778159)"
FT                   /evidence="ECO:0000269|PubMed:17974005"
FT                   /id="VAR_051213"
FT   VARIANT         1742
FT                   /note="A -> S (in dbSNP:rs1698605)"
FT                   /evidence="ECO:0000269|PubMed:17974005"
FT                   /id="VAR_051214"
FT   CONFLICT        33
FT                   /note="M -> T (in Ref. 5; CAD89923)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        98
FT                   /note="T -> M (in Ref. 1; BAB17761/BAB17762)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        109
FT                   /note="I -> M (in Ref. 1; BAB17759/BAB17760/BAB17761/
FT                   BAB17762 and 7; AAH25406/AAI10295)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        401
FT                   /note="R -> Q (in Ref. 5; CAD91152)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        643
FT                   /note="M -> V (in Ref. 5; CAD91152)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        776
FT                   /note="L -> P (in Ref. 5; CAD91152)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        783
FT                   /note="M -> I (in Ref. 5; CAD38529 and 7; AAI32718)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        830
FT                   /note="L -> P (in Ref. 5; CAD91152)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        863
FT                   /note="L -> P (in Ref. 5; CAD38529)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1266
FT                   /note="K -> E (in Ref. 5; CAH18128)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1286
FT                   /note="E -> G (in Ref. 5; CAD91152)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1356
FT                   /note="K -> R (in Ref. 5; CAD91152)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1397
FT                   /note="K -> E (in Ref. 5; CAD91152)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1454
FT                   /note="K -> E (in Ref. 5; CAH18128)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1504
FT                   /note="R -> Q (in Ref. 5; CAH18128)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1598
FT                   /note="H -> R (in Ref. 5; CAH18128)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1610
FT                   /note="T -> P (in Ref. 5; CAH18128)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1727
FT                   /note="L -> P (in Ref. 5; CAH18128)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1757
FT                   /note="A -> T (in Ref. 5; CAH18128)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1867
FT                   /note="R -> C (in Ref. 5; CAH18128)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1910
FT                   /note="D -> E (in Ref. 5; CAH18128)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2001
FT                   /note="E -> G (in Ref. 5; CAH18128)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2088
FT                   /note="Missing (in Ref. 5; CAH18128)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2291
FT                   /note="R -> Q (in Ref. 5; CAH18128)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2317
FT                   /note="Q -> R (in Ref. 5; CAH18128)"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         Q5VU43-2:252
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         Q5VU43-13:252
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
SQ   SEQUENCE   2346 AA;  265103 MW;  8A29AA1514759B0C CRC64;
     MSNGYRTLSQ HLNDLKKENF SLKLRIYFLE ERMQQKYEAS REDIYKRNIE LKVEVESLKR
     ELQDKKQHLD KTWADVENLN SQNEAELRRQ FEERQQETEH VYELLENKIQ LLQEESRLAK
     NEAARMAALV EAEKECNLEL SEKLKGVTKN WEDVPGDQVK PDQYTEALAQ RDKRIEELNQ
     SLAAQERLVE QLSREKQQLL HLLEEPTSME VQPMTEELLK QQKLNSHETT ITQQSVSDSH
     LAELQEKIQQ TEATNKILQE KLNEMSYELK CAQESSQKQD GTIQNLKETL KSRERETEEL
     YQVIEGQNDT MAKLREMLHQ SQLGQLHSSE GTSPAQQQVA LLDLQSALFC SQLEIQKLQR
     VVRQKERQLA DAKQCVQFVE AAAHESEQQK EASWKHNQEL RKALQQLQEE LQNKSQQLRA
     WEAEKYNEIR TQEQNIQHLN HSLSHKEQLL QEFRELLQYR DNSDKTLEAN EMLLEKLRQR
     IHDKAVALER AIDEKFSALE EKEKELRQLR LAVRERDHDL ERLRDVLSSN EATMQSMESL
     LRAKGLEVEQ LSTTCQNLQW LKEEMETKFS RWQKEQESII QQLQTSLHDR NKEVEDLSAT
     LLCKLGPGQS EIAEELCQRL QRKERMLQDL LSDRNKQVLE HEMEIQGLLQ SVSTREQESQ
     AAAEKLVQAL MERNSELQAL RQYLGGRDSL MSQAPISNQQ AEVTPTGRLG KQTDQGSMQI
     PSRDDSTSLT AKEDVSIPRS TLGDLDTVAG LEKELSNAKE ELELMAKKER ESQMELSALQ
     SMMAVQEEEL QVQAADMESL TRNIQIKEDL IKDLQMQLVD PEDIPAMERL TQEVLLLREK
     VASVESQGQE ISGNRRQQLL LMLEGLVDER SRLNEALQAE RQLYSSLVKF HAHPESSERD
     RTLQVELEGA QVLRSRLEEV LGRSLERLNR LETLAAIGGA AAGDDTEDTS TEFTDSIEEE
     AAHHSHQQLV KVALEKSLAT VETQNPSFSP PSPMGGDSNR CLQEEMLHLR AEFHQHLEEK
     RKAEEELKEL KAQIEEAGFS SVSHIRNTML SLCLENAELK EQMGEAMSDG WEIEEDKEKG
     EVMVETVVTK EGLSESSLQA EFRKLQGKLK NAHNIINLLK EQLVLSSKEG NSKLTPELLV
     HLTSTIERIN TELVGSPGKH QHQEEGNVTV RPFPRPQSLD LGATFTVDAH QLDNQSQPRD
     PGPQSAFSLP GSTQHLRSQL SQCKQRYQDL QEKLLLSEAT VFAQANELEK YRVMLTGESL
     VKQDSKQIQV DLQDLGYETC GRSENEAERE ETTSPECEEH NSLKEMVLME GLCSEQGRRG
     STLASSSERK PLENQLGKQE EFRVYGKSEN ILVLRKDIKD LKAQLQNANK VIQNLKSRVR
     SLSVTSDYSS SLERPRKLRA VGTLEGSSPH SVPDEDEGWL SDGTGAFYSP GLQAKKDLES
     LIQRVSQLEA QLPKNGLEEK LAEELRSASW PGKYDSLIQD QARELSYLRQ KIREGRGICY
     LITRHAKDTV KSFEDLLRSN DIDYYLGQSF REQLAQGSQL TERLTSKLST KDHKSEKDQA
     GLEPLALRLS RELQEKEKVI EVLQAKLDAR SLTPSSSHAL SDSHRSPSST SFLSDELEAC
     SDMDIVSEYT HYEEKKASPS HSDSIHHSSH SAVLSSKPSS TSASQGAKAE SNSNPISLPT
     PQNTPKEANQ AHSGFHFHSI PKLASLPQAP LPSAPSSFLP FSPTGPLLLG CCETPVVSLA
     EAQQELQMLQ KQLGESASTV PPASTATLLS NDLEADSSYY LNSAQPHSPP RGTIELGRIL
     EPGYLGSSGK WDVMRPQKGS VSGDLSSGSS VYQLNSKPTG ADLLEEHLGE IRNLRQRLEE
     SICINDRLRE QLEHRLTSTA RGRGSTSNFY SQGLESIPQL CNENRVLRED NRRLQAQLSH
     VSREHSQETE SLREALLSSR SHLQELEKEL EHQKVERQQL LEDLREKQQE VLHFREERLS
     LQENDSRLQH KLVLLQQQCE EKQQLFESLQ SELQIYEALY GNSKKGLKAY SLDACHQIPL
     SSDLSHLVAE VRALRGQLEQ SIQGNNCLRL QLQQQLESGA GKASLSPSSI NQNFPASTDP
     GNKQLLLQDS AVSPPVRDVG MNSPALVFPS SASSTPGSET PIINRANGLG LDTSPVMKTP
     PKLEGDATDG SFANKHGRHV IGHIDDYSAL RQQIAEGKLL VKKIVSLVRS ACSFPGLEAQ
     GTEVLGSKGI HELRSSTSAL HHALEESASL LTMFWRAALP STHIPVLPGK VGESTERELL
     ELRTKVSKQE RLLQSTTEHL KNANQQKESM EQFIVSQLTR THDVLKKART NLEVKSLRAL
     PCTPAL
//
ID   A0A024R5L7_HUMAN        Unreviewed;       610 AA.
AC   A0A024R5L7;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 34.
DE   SubName: Full=Phosphatidylinositol binding clathrin assembly protein, isoform CRA_c {ECO:0000313|EMBL:EAW75122.1};
GN   Name=PICALM {ECO:0000313|EMBL:EAW75122.1};
GN   ORFNames=hCG_1730090 {ECO:0000313|EMBL:EAW75122.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW75122.1};
RN   [1] {ECO:0000313|EMBL:EAW75122.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW75122.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH471076; EAW75122.1; -; Genomic_DNA.
DR   RefSeq; NP_001008660.1; NM_001008660.2.
DR   SMR; A0A024R5L7; -.
DR   PRIDE; A0A024R5L7; -.
DR   Antibodypedia; 17636; 185 antibodies.
DR   GeneID; 8301; -.
DR   CTD; 8301; -.
DR   EuPathDB; HostDB:ENSG00000073921.17; -.
DR   HOGENOM; CLU_014080_0_0_1; -.
DR   OrthoDB; 1592722at2759; -.
DR   ChiTaRS; PICALM; human.
DR   GenomeRNAi; 8301; -.
DR   Bgee; ENSG00000073921; Expressed in corpus callosum and 233 other tissues.
DR   ExpressionAtlas; A0A024R5L7; baseline and differential.
DR   GO; GO:0030136; C:clathrin-coated vesicle; IEA:InterPro.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005545; F:1-phosphatidylinositol binding; IEA:InterPro.
DR   GO; GO:0030276; F:clathrin binding; IEA:InterPro.
DR   GO; GO:0048268; P:clathrin coat assembly; IEA:InterPro.
DR   GO; GO:0006897; P:endocytosis; IEA:InterPro.
DR   Gene3D; 1.20.58.150; -; 1.
DR   Gene3D; 1.25.40.90; -; 1.
DR   InterPro; IPR011417; ANTH_dom.
DR   InterPro; IPR014712; Clathrin_AP_dom2.
DR   InterPro; IPR013809; ENTH.
DR   InterPro; IPR008942; ENTH_VHS.
DR   InterPro; IPR030412; PICALM.
DR   PANTHER; PTHR22951:SF16; PTHR22951:SF16; 2.
DR   Pfam; PF07651; ANTH; 1.
DR   SMART; SM00273; ENTH; 1.
DR   SUPFAM; SSF48464; SSF48464; 1.
DR   PROSITE; PS50942; ENTH; 1.
PE   4: Predicted;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN          14..145
FT                   /note="ENTH"
FT                   /evidence="ECO:0000259|PROSITE:PS50942"
FT   REGION          509..530
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          321..348
FT                   /evidence="ECO:0000256|SAM:Coils"
SQ   SEQUENCE   610 AA;  66393 MW;  3B0D0AEB901CF85D CRC64;
     MSGQSLTDRI TAAQHSVTGS AVSKTVCKAT THEIMGPKKK HLDYLIQCTN EMNVNIPQLA
     DSLFERTTNS SWVVVFKSLI TTHHLMVYGN ERFIQYLASR NTLFNLSNFL DKSGLQGYDM
     STFIRRYSRY LNEKAVSYRQ VAFDFTKVKR GADGVMRTMN TEKLLKTVPI IQNQMDALLD
     FNVNSNELTN GVINAAFMLL FKDAIRLFAA YNEGIINLLE KYFDMKKNQC KEGLDIYKKF
     LTRMTRISEF LKVAEQVGID RGDIPDLSQA PSSLLDALEQ HLASLEGKKI KDSTAASRAT
     TLSNAVSSLA STGLSLTKVD EREKQAALEE EQARLKALKE QRLKELAKKP HTSLTTAASP
     VSTSAGGIMT APAIDIFSTP SSSNSTSKLP NDLLDLQQPT FHPSVHPMST ASQVASTWGG
     FTPSPVAQPH PSAGLNVDFE SVFGNKSTNV IVDSGGFDEL GGLLKPTVAS QNQNLPVAKL
     PPSKLVSDDL DSSLANLVGN LGIGNGTTKN DVNWSQPGEK KLTGGSNWQP KVAPTTAWNA
     ATMNGMHFPQ YAPPVMAYPA TTPTGMIGYG IPPQMGSVPV MTQPTLIYSQ PVMRPPNPFG
     PVSGAQIQFM
//
ID   A0A024R5P1_HUMAN        Unreviewed;       652 AA.
AC   A0A024R5P1;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 49.
DE   SubName: Full=Phosphatidylinositol binding clathrin assembly protein, isoform CRA_i {ECO:0000313|EMBL:EAW75128.1};
GN   Name=PICALM {ECO:0000313|EMBL:EAW75128.1};
GN   ORFNames=hCG_1730090 {ECO:0000313|EMBL:EAW75128.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW75128.1};
RN   [1] {ECO:0000313|EMBL:EAW75128.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW75128.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH471076; EAW75127.1; -; Genomic_DNA.
DR   EMBL; CH471076; EAW75128.1; -; Genomic_DNA.
DR   RefSeq; NP_009097.2; NM_007166.3.
DR   Antibodypedia; 17636; 185 antibodies.
DR   GeneID; 8301; -.
DR   KEGG; hsa:8301; -.
DR   CTD; 8301; -.
DR   EuPathDB; HostDB:ENSG00000073921.17; -.
DR   eggNOG; KOG0251; Eukaryota.
DR   eggNOG; ENOG410XQ90; LUCA.
DR   KO; K20044; -.
DR   OMA; LNGMHFP; -.
DR   OrthoDB; 1592722at2759; -.
DR   ChiTaRS; PICALM; human.
DR   GenomeRNAi; 8301; -.
DR   Bgee; ENSG00000073921; Expressed in corpus callosum and 233 other tissues.
DR   GO; GO:0005905; C:clathrin-coated pit; IEA:Ensembl.
DR   GO; GO:0030136; C:clathrin-coated vesicle; IEA:InterPro.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0005545; F:1-phosphatidylinositol binding; IEA:InterPro.
DR   GO; GO:0030276; F:clathrin binding; IEA:InterPro.
DR   GO; GO:0150093; P:amyloid-beta clearance by transcytosis; IEA:Ensembl.
DR   GO; GO:0007409; P:axonogenesis; IEA:Ensembl.
DR   GO; GO:0048268; P:clathrin coat assembly; IEA:InterPro.
DR   GO; GO:0072583; P:clathrin-dependent endocytosis; IEA:Ensembl.
DR   GO; GO:0048813; P:dendrite morphogenesis; IEA:Ensembl.
DR   GO; GO:0030097; P:hemopoiesis; IEA:Ensembl.
DR   GO; GO:0007611; P:learning or memory; IEA:Ensembl.
DR   GO; GO:0090647; P:modulation of age-related behavioral decline; IEA:Ensembl.
DR   GO; GO:1902963; P:negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process; IEA:Ensembl.
DR   GO; GO:1902004; P:positive regulation of amyloid-beta formation; IEA:Ensembl.
DR   GO; GO:1902961; P:positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; IEA:Ensembl.
DR   GO; GO:0016188; P:synaptic vesicle maturation; IEA:Ensembl.
DR   GO; GO:0035459; P:vesicle cargo loading; IEA:Ensembl.
DR   Gene3D; 1.20.58.150; -; 1.
DR   Gene3D; 1.25.40.90; -; 1.
DR   InterPro; IPR011417; ANTH_dom.
DR   InterPro; IPR014712; Clathrin_AP_dom2.
DR   InterPro; IPR013809; ENTH.
DR   InterPro; IPR008942; ENTH_VHS.
DR   InterPro; IPR030412; PICALM.
DR   PANTHER; PTHR22951:SF16; PTHR22951:SF16; 1.
DR   Pfam; PF07651; ANTH; 1.
DR   SMART; SM00273; ENTH; 1.
DR   SUPFAM; SSF48464; SSF48464; 1.
DR   PROSITE; PS50942; ENTH; 1.
PE   4: Predicted;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN          14..145
FT                   /note="ENTH"
FT                   /evidence="ECO:0000259|PROSITE:PS50942"
FT   REGION          559..580
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          321..348
FT                   /evidence="ECO:0000256|SAM:Coils"
SQ   SEQUENCE   652 AA;  70755 MW;  AC3227E9D32AFEDA CRC64;
     MSGQSLTDRI TAAQHSVTGS AVSKTVCKAT THEIMGPKKK HLDYLIQCTN EMNVNIPQLA
     DSLFERTTNS SWVVVFKSLI TTHHLMVYGN ERFIQYLASR NTLFNLSNFL DKSGLQGYDM
     STFIRRYSRY LNEKAVSYRQ VAFDFTKVKR GADGVMRTMN TEKLLKTVPI IQNQMDALLD
     FNVNSNELTN GVINAAFMLL FKDAIRLFAA YNEGIINLLE KYFDMKKNQC KEGLDIYKKF
     LTRMTRISEF LKVAEQVGID RGDIPDLSQA PSSLLDALEQ HLASLEGKKI KDSTAASRAT
     TLSNAVSSLA STGLSLTKVD EREKQAALEE EQARLKALKE QRLKELAKKP HTSLTTAASP
     VSTSAGGIMT APAIDIFSTP SSSNSTSKLP NDLLDLQQPT FHPSVHPMST ASQVASTWGD
     PFSATVDAVD DAIPSLNPFL TKSSGDVHLS ISSDVSTFTT RTPTHEMFVG FTPSPVAQPH
     PSAGLNVDFE SVFGNKSTNV IVDSGGFDEL GGLLKPTVAS QNQNLPVAKL PPSKLVSDDL
     DSSLANLVGN LGIGNGTTKN DVNWSQPGEK KLTGGSNWQP KVAPTTAWNA ATMAPPVMAY
     PATTPTGMIG YGIPPQMGSV PVMTQPTLIY SQPVMRPPNP FGPVSGAQIQ FM
//
ID   PICAL_HUMAN             Reviewed;         652 AA.
AC   Q13492; B4DTM3; E9PN05; F8VPG7; O60700; Q4LE54; Q6GMQ6; Q86XZ9;
DT   15-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   22-APR-2020, entry version 188.
DE   RecName: Full=Phosphatidylinositol-binding clathrin assembly protein;
DE   AltName: Full=Clathrin assembly lymphoid myeloid leukemia protein;
GN   Name=PICALM; Synonyms=CALM;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), CHROMOSOMAL TRANSLOCATION, TISSUE
RP   SPECIFICITY, AND VARIANTS CYS-578 AND GLU-579.
RX   PubMed=8643484; DOI=10.1073/pnas.93.10.4804;
RA   Dreyling M.H., Martinez-Climent J.A., Zheng M., Mao J., Rowley J.D.,
RA   Bohlander S.K.;
RT   "The t(10;11)(p13;q14) in the U937 cell line results in the fusion of the
RT   AF10 gene and CALM, encoding a new member of the AP-3 clathrin assembly
RT   protein family.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:4804-4809(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RC   TISSUE=Brain;
RA   Nakajima D., Saito K., Yamakawa H., Kikuno R.F., Nakayama M., Ohara R.,
RA   Okazaki N., Koga H., Nagase T., Ohara O.;
RT   "Preparation of a set of expression-ready clones of mammalian long cDNAs
RT   encoding large proteins by the ORF trap cloning method.";
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.-S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=PNS;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 575-652 (ISOFORMS 1 AND 2), AND VARIANTS
RP   CYS-578 AND GLU-579.
RC   TISSUE=Bone marrow;
RX   PubMed=9737689; DOI=10.1038/sj.leu.2401109;
RA   Silliman C.C., McGavran L., Wei Q., Miller L.A., Li S., Hunger S.P.;
RT   "Alternative splicing in wild-type AF10 and CALM cDNAs and in AF10-CALM and
RT   CALM-AF10 fusion cDNAs produced by the t(10;11)(p13-14;q14-q21) suggests a
RT   potential role for truncated AF10 polypeptides.";
RL   Leukemia 12:1404-1410(1998).
RN   [8]
RP   FUNCTION, INTERACTION WITH CLATHRIN, AND SUBCELLULAR LOCATION.
RX   PubMed=10436022; DOI=10.1091/mbc.10.8.2687;
RA   Tebar F., Bohlander S.K., Sorkin A.;
RT   "Clathrin assembly lymphoid myeloid leukemia (CALM) protein: localization
RT   in endocytic-coated pits, interactions with clathrin, and the impact of
RT   overexpression on clathrin-mediated traffic.";
RL   Mol. Biol. Cell 10:2687-2702(1999).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH AP2A1 AND CLATHRIN.
RX   PubMed=16262731; DOI=10.1111/j.1600-0854.2005.00355.x;
RA   Meyerholz A., Hinrichsen L., Groos S., Esk P.C., Brandes G.,
RA   Ungewickell E.J.;
RT   "Effect of clathrin assembly lymphoid myeloid leukemia protein depletion on
RT   clathrin coat formation.";
RL   Traffic 6:1225-1234(2005).
RN   [10]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH PIMREG.
RX   PubMed=16491119; DOI=10.1038/sj.onc.1209438;
RA   Archangelo L.F., Glaesner J., Krause A., Bohlander S.K.;
RT   "The novel CALM interactor CATS influences the subcellular localization of
RT   the leukemogenic fusion protein CALM/AF10.";
RL   Oncogene 25:4099-4109(2006).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   FUNCTION, AND INTERACTION WITH VAMP2; VAMP3 AND VAMP8.
RX   PubMed=22118466; DOI=10.1016/j.cell.2011.10.038;
RA   Miller S.E., Sahlender D.A., Graham S.C., Honing S., Robinson M.S.,
RA   Peden A.A., Owen D.J.;
RT   "The molecular basis for the endocytosis of small R-SNAREs by the clathrin
RT   adaptor CALM.";
RL   Cell 147:1118-1131(2011).
RN   [16]
RP   FUNCTION, AND INTERACTION WITH VAMP2.
RX   PubMed=21808019; DOI=10.1073/pnas.1107067108;
RA   Koo S.J., Markovic S., Puchkov D., Mahrenholz C.C., Beceren-Braun F.,
RA   Maritzen T., Dernedde J., Volkmer R., Oschkinat H., Haucke V.;
RT   "SNARE motif-mediated sorting of synaptobrevin by the endocytic adaptors
RT   clathrin assembly lymphoid myeloid leukemia (CALM) and AP180 at synapses.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:13540-13545(2011).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [18]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [19]
RP   FUNCTION, AND INTERACTION WITH VAMP7.
RX   PubMed=23741335; DOI=10.1371/journal.pone.0064514;
RA   Sahlender D.A., Kozik P., Miller S.E., Peden A.A., Robinson M.S.;
RT   "Uncoupling the functions of CALM in VAMP sorting and clathrin-coated pit
RT   formation.";
RL   PLoS ONE 8:E64514-E64514(2013).
RN   [20]
RP   FUNCTION, AND INTERACTION WITH LC3/MAP1LC3A.
RX   PubMed=24067654; DOI=10.1073/pnas.1315110110;
RA   Tian Y., Chang J.C., Fan E.Y., Flajolet M., Greengard P.;
RT   "Adaptor complex AP2/PICALM, through interaction with LC3, targets
RT   Alzheimer's APP-CTF for terminal degradation via autophagy.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:17071-17076(2013).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16; SER-20; SER-303 AND
RP   SER-315, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [23]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-238, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [24]
RP   FUNCTION.
RX   PubMed=25241929; DOI=10.1038/ncomms5998;
RA   Moreau K., Fleming A., Imarisio S., Lopez Ramirez A., Mercer J.L.,
RA   Jimenez-Sanchez M., Bento C.F., Puri C., Zavodszky E., Siddiqi F.,
RA   Lavau C.P., Betton M., O'Kane C.J., Wechsler D.S., Rubinsztein D.C.;
RT   "PICALM modulates autophagy activity and tau accumulation.";
RL   Nat. Commun. 5:4998-4998(2014).
RN   [25]
RP   FUNCTION.
RX   PubMed=25898166; DOI=10.1016/j.devcel.2015.03.002;
RA   Miller S.E., Mathiasen S., Bright N.A., Pierre F., Kelly B.T., Kladt N.,
RA   Schauss A., Merrifield C.J., Stamou D., Hoening S., Owen D.J.;
RT   "CALM regulates clathrin-coated vesicle size and maturation by directly
RT   sensing and driving membrane curvature.";
RL   Dev. Cell 33:163-175(2015).
RN   [26]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [27]
RP   FUNCTION.
RX   PubMed=27574975; DOI=10.1371/journal.pone.0162050;
RA   Moshkanbaryans L., Xue J., Wark J.R., Robinson P.J., Graham M.E.;
RT   "A Novel Sequence in AP180 and CALM Promotes Efficient Clathrin Binding and
RT   Assembly.";
RL   PLoS ONE 11:E0162050-E0162050(2016).
CC   -!- FUNCTION: Cytoplasmic adapter protein that plays a critical role in
CC       clathrin-mediated endocytosis which is important in processes such as
CC       internalization of cell receptors, synaptic transmission or removal of
CC       apoptotic cells. Recruits AP-2 and attaches clathrin triskelions to the
CC       cytoplasmic side of plasma membrane leading to clathrin-coated vesicles
CC       (CCVs) assembly (PubMed:10436022, PubMed:16262731, PubMed:27574975).
CC       Furthermore, regulates clathrin-coated vesicle size and maturation by
CC       directly sensing and driving membrane curvature (PubMed:25898166). In
CC       addition to binding to clathrin, mediates the endocytosis of small R-
CC       SNARES (Soluble NSF Attachment Protein REceptors) between plasma
CC       membranes and endosomes including VAMP2, VAMP3, VAMP4, VAMP7 or VAMP8
CC       (PubMed:22118466, PubMed:21808019, PubMed:23741335). In turn, PICALM-
CC       dependent SNARE endocytosis is required for the formation and
CC       maturation of autophagic precursors (PubMed:25241929). Modulates
CC       thereby autophagy and the turnover of autophagy substrates such as
CC       MAPT/TAU or amyloid precursor protein cleaved C-terminal fragment (APP-
CC       CTF) (PubMed:25241929, PubMed:24067654). {ECO:0000269|PubMed:10436022,
CC       ECO:0000269|PubMed:16262731, ECO:0000269|PubMed:21808019,
CC       ECO:0000269|PubMed:22118466, ECO:0000269|PubMed:23741335,
CC       ECO:0000269|PubMed:24067654, ECO:0000269|PubMed:25241929,
CC       ECO:0000269|PubMed:25898166, ECO:0000269|PubMed:27574975}.
CC   -!- SUBUNIT: Binds to clathrin; involves primarily the C-terminal
CC       sequences, but the full-length protein is required for full binding
CC       capacity. Binds phosphatidylinositol 4,5- bisphosphate. Interacts with
CC       PIMREG; this interaction may change the subcellular location into the
CC       nucleus (PubMed:16491119). Interacts with AP2A1 (via its alpha-
CC       appendage domain) (PubMed:16262731). Interacts (via N-terminus) with
CC       VAMP2; VAMP3; VAMP7 and VAMP8 (Via N-terminus) (PubMed:22118466,
CC       PubMed:21808019, PubMed:23741335). Interacts with LC3/MAP1LC3A
CC       (PubMed:24067654). {ECO:0000269|PubMed:16262731,
CC       ECO:0000269|PubMed:16491119, ECO:0000269|PubMed:21808019,
CC       ECO:0000269|PubMed:22118466, ECO:0000269|PubMed:23741335,
CC       ECO:0000269|PubMed:24067654}.
CC   -!- INTERACTION:
CC       Q13492-3; P54253: ATXN1; NbExp=3; IntAct=EBI-11031437, EBI-930964;
CC       Q13492-3; P0C7T5: ATXN1L; NbExp=3; IntAct=EBI-11031437, EBI-8624731;
CC       Q13492; Q14192: FHL2; NbExp=8; IntAct=EBI-2803688, EBI-701903;
CC       Q13492-3; Q96K80: ZC3H10; NbExp=3; IntAct=EBI-11031437, EBI-742550;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:16262731}.
CC       Membrane, clathrin-coated pit {ECO:0000269|PubMed:10436022}. Golgi
CC       apparatus {ECO:0000269|PubMed:10436022}. Cytoplasmic vesicle, clathrin-
CC       coated vesicle {ECO:0000269|PubMed:10436022}. Nucleus
CC       {ECO:0000269|PubMed:16491119}. Note=Colocalized with clathrin in the
CC       Golgi area (PubMed:10436022). Interaction with PIMREG may target PICALM
CC       to the nucleus in some cells (PubMed:16491119).
CC       {ECO:0000269|PubMed:10436022, ECO:0000269|PubMed:16491119}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1; Synonyms=Type I;
CC         IsoId=Q13492-1; Sequence=Displayed;
CC       Name=2; Synonyms=Type II;
CC         IsoId=Q13492-2; Sequence=VSP_004067;
CC       Name=3;
CC         IsoId=Q13492-3; Sequence=VSP_009607, VSP_009608;
CC       Name=4;
CC         IsoId=Q13492-4; Sequence=VSP_044567, VSP_009607;
CC       Name=5;
CC         IsoId=Q13492-5; Sequence=VSP_044568;
CC   -!- TISSUE SPECIFICITY: Expressed in all tissues examined.
CC       {ECO:0000269|PubMed:8643484}.
CC   -!- DISEASE: Note=A chromosomal aberration involving PICALM is found in
CC       diffuse histiocytic lymphomas. Translocation t(10;11)(p13;q14) with
CC       MLLT10. {ECO:0000269|PubMed:8643484}.
CC   -!- SIMILARITY: Belongs to the PICALM/SNAP91 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAE06099.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CALMID64.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U45976; AAB07762.1; -; mRNA.
DR   EMBL; AK300275; BAG62035.1; -; mRNA.
DR   EMBL; AB210017; BAE06099.1; ALT_INIT; mRNA.
DR   EMBL; AP000767; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471076; EAW75120.1; -; Genomic_DNA.
DR   EMBL; BC048259; AAH48259.2; -; mRNA.
DR   EMBL; BC064357; AAH64357.1; -; mRNA.
DR   EMBL; BC073961; AAH73961.1; -; mRNA.
DR   EMBL; AF060939; AAC16711.1; -; mRNA.
DR   EMBL; AF060940; AAC16712.1; -; mRNA.
DR   CCDS; CCDS31653.1; -. [Q13492-3]
DR   CCDS; CCDS55783.1; -. [Q13492-4]
DR   CCDS; CCDS55784.1; -. [Q13492-5]
DR   CCDS; CCDS8272.1; -. [Q13492-1]
DR   RefSeq; NP_001008660.1; NM_001008660.2. [Q13492-3]
DR   RefSeq; NP_001193875.1; NM_001206946.1. [Q13492-5]
DR   RefSeq; NP_001193876.1; NM_001206947.1. [Q13492-4]
DR   RefSeq; NP_009097.2; NM_007166.3. [Q13492-1]
DR   RefSeq; XP_005274388.1; XM_005274331.2. [Q13492-2]
DR   SMR; Q13492; -.
DR   BioGrid; 113902; 111.
DR   ELM; Q13492; -.
DR   IntAct; Q13492; 79.
DR   MINT; Q13492; -.
DR   STRING; 9606.ENSP00000377015; -.
DR   MoonDB; Q13492; Curated.
DR   MoonProt; Q13492; -.
DR   iPTMnet; Q13492; -.
DR   MetOSite; Q13492; -.
DR   PhosphoSitePlus; Q13492; -.
DR   SwissPalm; Q13492; -.
DR   BioMuta; PICALM; -.
DR   DMDM; 116242714; -.
DR   EPD; Q13492; -.
DR   jPOST; Q13492; -.
DR   MassIVE; Q13492; -.
DR   MaxQB; Q13492; -.
DR   PaxDb; Q13492; -.
DR   PeptideAtlas; Q13492; -.
DR   PRIDE; Q13492; -.
DR   ProteomicsDB; 22268; -.
DR   ProteomicsDB; 28286; -.
DR   ProteomicsDB; 59489; -. [Q13492-1]
DR   ProteomicsDB; 59490; -. [Q13492-2]
DR   ProteomicsDB; 59491; -. [Q13492-3]
DR   Antibodypedia; 17636; 185 antibodies.
DR   Ensembl; ENST00000356360; ENSP00000348718; ENSG00000073921. [Q13492-2]
DR   Ensembl; ENST00000393346; ENSP00000377015; ENSG00000073921. [Q13492-1]
DR   Ensembl; ENST00000526033; ENSP00000433846; ENSG00000073921. [Q13492-5]
DR   Ensembl; ENST00000528398; ENSP00000434884; ENSG00000073921. [Q13492-4]
DR   Ensembl; ENST00000532317; ENSP00000436958; ENSG00000073921. [Q13492-3]
DR   GeneID; 8301; -.
DR   KEGG; hsa:8301; -.
DR   UCSC; uc001pbl.4; human. [Q13492-1]
DR   CTD; 8301; -.
DR   DisGeNET; 8301; -.
DR   GeneCards; PICALM; -.
DR   HGNC; HGNC:15514; PICALM.
DR   HPA; ENSG00000073921; Low tissue specificity.
DR   MalaCards; PICALM; -.
DR   MIM; 603025; gene.
DR   neXtProt; NX_Q13492; -.
DR   NIAGADS; ENSG00000073921; -.
DR   OpenTargets; ENSG00000073921; -.
DR   Orphanet; 99861; Precursor T-cell acute lymphoblastic leukemia.
DR   PharmGKB; PA33287; -.
DR   eggNOG; KOG0251; Eukaryota.
DR   eggNOG; ENOG410XQ90; LUCA.
DR   GeneTree; ENSGT00950000183068; -.
DR   HOGENOM; CLU_014080_0_0_1; -.
DR   InParanoid; Q13492; -.
DR   KO; K20044; -.
DR   OMA; LNGMHFP; -.
DR   OrthoDB; 1592722at2759; -.
DR   PhylomeDB; Q13492; -.
DR   TreeFam; TF314861; -.
DR   Reactome; R-HSA-432722; Golgi Associated Vesicle Biogenesis.
DR   Reactome; R-HSA-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   Reactome; R-HSA-8856828; Clathrin-mediated endocytosis.
DR   SIGNOR; Q13492; -.
DR   ChiTaRS; PICALM; human.
DR   GeneWiki; PICALM; -.
DR   GenomeRNAi; 8301; -.
DR   Pharos; Q13492; Tbio.
DR   PRO; PR:Q13492; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; Q13492; protein.
DR   Bgee; ENSG00000073921; Expressed in corpus callosum and 233 other tissues.
DR   ExpressionAtlas; Q13492; baseline and differential.
DR   Genevisible; Q13492; HS.
DR   GO; GO:0009986; C:cell surface; IDA:ARUK-UCL.
DR   GO; GO:0045334; C:clathrin-coated endocytic vesicle; NAS:ARUK-UCL.
DR   GO; GO:0005905; C:clathrin-coated pit; IDA:UniProtKB.
DR   GO; GO:0030136; C:clathrin-coated vesicle; IMP:ARUK-UCL.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005769; C:early endosome; IDA:ARUK-UCL.
DR   GO; GO:0070381; C:endosome to plasma membrane transport vesicle; IDA:ARUK-UCL.
DR   GO; GO:0098894; C:extrinsic component of presynaptic endocytic zone membrane; IBA:GO_Central.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0031224; C:intrinsic component of membrane; ISS:ARUK-UCL.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0097418; C:neurofibrillary tangle; IMP:Alzheimers_University_of_Toronto.
DR   GO; GO:0043025; C:neuronal cell body; IDA:Alzheimers_University_of_Toronto.
DR   GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0045211; C:postsynaptic membrane; ISS:BHF-UCL.
DR   GO; GO:0042734; C:presynaptic membrane; ISS:BHF-UCL.
DR   GO; GO:0008021; C:synaptic vesicle; IBA:GO_Central.
DR   GO; GO:0031982; C:vesicle; ISS:Alzheimers_University_of_Toronto.
DR   GO; GO:0005545; F:1-phosphatidylinositol binding; ISS:UniProtKB.
DR   GO; GO:0001540; F:amyloid-beta binding; IC:ARUK-UCL.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0030276; F:clathrin binding; IDA:UniProtKB.
DR   GO; GO:0032050; F:clathrin heavy chain binding; IDA:BHF-UCL.
DR   GO; GO:0050750; F:low-density lipoprotein particle receptor binding; IPI:ARUK-UCL.
DR   GO; GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; ISS:ARUK-UCL.
DR   GO; GO:0017137; F:Rab GTPase binding; IPI:ARUK-UCL.
DR   GO; GO:0000149; F:SNARE binding; IDA:UniProtKB.
DR   GO; GO:0048156; F:tau protein binding; IPI:Alzheimers_University_of_Toronto.
DR   GO; GO:0150093; P:amyloid-beta clearance by transcytosis; IGI:ARUK-UCL.
DR   GO; GO:0007409; P:axonogenesis; IEA:Ensembl.
DR   GO; GO:0048268; P:clathrin coat assembly; IMP:BHF-UCL.
DR   GO; GO:1905224; P:clathrin-coated pit assembly; IDA:UniProtKB.
DR   GO; GO:0072583; P:clathrin-dependent endocytosis; IMP:Alzheimers_University_of_Toronto.
DR   GO; GO:0048813; P:dendrite morphogenesis; IEA:Ensembl.
DR   GO; GO:0006897; P:endocytosis; IDA:UniProtKB.
DR   GO; GO:0016197; P:endosomal transport; IMP:BHF-UCL.
DR   GO; GO:0030097; P:hemopoiesis; IEA:Ensembl.
DR   GO; GO:0055072; P:iron ion homeostasis; IMP:Alzheimers_University_of_Toronto.
DR   GO; GO:0007611; P:learning or memory; ISS:ARUK-UCL.
DR   GO; GO:0097753; P:membrane bending; IMP:ARUK-UCL.
DR   GO; GO:0061024; P:membrane organization; TAS:Reactome.
DR   GO; GO:0090647; P:modulation of age-related behavioral decline; ISS:ARUK-UCL.
DR   GO; GO:0010629; P:negative regulation of gene expression; IMP:Alzheimers_University_of_Toronto.
DR   GO; GO:1902963; P:negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process; ISS:Alzheimers_University_of_Toronto.
DR   GO; GO:2000009; P:negative regulation of protein localization to cell surface; IMP:ARUK-UCL.
DR   GO; GO:1903077; P:negative regulation of protein localization to plasma membrane; IMP:ARUK-UCL.
DR   GO; GO:0048261; P:negative regulation of receptor-mediated endocytosis; IDA:BHF-UCL.
DR   GO; GO:1902004; P:positive regulation of amyloid-beta formation; IMP:Alzheimers_University_of_Toronto.
DR   GO; GO:1902961; P:positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; ISS:Alzheimers_University_of_Toronto.
DR   GO; GO:0043547; P:positive regulation of GTPase activity; IMP:ARUK-UCL.
DR   GO; GO:1901216; P:positive regulation of neuron death; IMP:Alzheimers_University_of_Toronto.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL.
DR   GO; GO:0065003; P:protein-containing complex assembly; TAS:ProtInc.
DR   GO; GO:0031623; P:receptor internalization; IMP:BHF-UCL.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; IDA:UniProtKB.
DR   GO; GO:1902959; P:regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; IMP:Alzheimers_University_of_Toronto.
DR   GO; GO:0030100; P:regulation of endocytosis; IMP:BHF-UCL.
DR   GO; GO:0032880; P:regulation of protein localization; IDA:BHF-UCL.
DR   GO; GO:0097494; P:regulation of vesicle size; IMP:ARUK-UCL.
DR   GO; GO:0016185; P:synaptic vesicle budding from presynaptic endocytic zone membrane; IBA:GO_Central.
DR   GO; GO:0048488; P:synaptic vesicle endocytosis; IBA:GO_Central.
DR   GO; GO:0016188; P:synaptic vesicle maturation; ISS:Alzheimers_University_of_Toronto.
DR   GO; GO:0006900; P:vesicle budding from membrane; IMP:ARUK-UCL.
DR   GO; GO:0035459; P:vesicle cargo loading; IMP:Alzheimers_University_of_Toronto.
DR   GO; GO:0016192; P:vesicle-mediated transport; TAS:ProtInc.
DR   Gene3D; 1.20.58.150; -; 1.
DR   Gene3D; 1.25.40.90; -; 1.
DR   InterPro; IPR011417; ANTH_dom.
DR   InterPro; IPR014712; Clathrin_AP_dom2.
DR   InterPro; IPR013809; ENTH.
DR   InterPro; IPR008942; ENTH_VHS.
DR   InterPro; IPR030412; PICALM.
DR   PANTHER; PTHR22951:SF16; PTHR22951:SF16; 1.
DR   Pfam; PF07651; ANTH; 1.
DR   SMART; SM00273; ENTH; 1.
DR   SUPFAM; SSF48464; SSF48464; 1.
DR   PROSITE; PS50942; ENTH; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Cell membrane;
KW   Chromosomal rearrangement; Coated pit; Cytoplasmic vesicle; Endocytosis;
KW   Golgi apparatus; Isopeptide bond; Membrane; Nucleus; Phosphoprotein;
KW   Polymorphism; Proto-oncogene; Reference proteome; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:22814378"
FT   CHAIN           2..652
FT                   /note="Phosphatidylinositol-binding clathrin assembly
FT                   protein"
FT                   /id="PRO_0000187062"
FT   DOMAIN          14..145
FT                   /note="ENTH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00243"
FT   REGION          221..294
FT                   /note="Interaction with PIMREG"
FT                   /evidence="ECO:0000269|PubMed:16491119"
FT   SITE            648..649
FT                   /note="Breakpoint for translocation to form CALM/MLLT10
FT                   fusion protein"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:22814378"
FT   MOD_RES         16
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         20
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         303
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         315
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   CROSSLNK        238
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25218447"
FT   VAR_SEQ         1..51
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_044567"
FT   VAR_SEQ         420..469
FT                   /note="Missing (in isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_009607"
FT   VAR_SEQ         420..426
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|Ref.3"
FT                   /id="VSP_044568"
FT   VAR_SEQ         593
FT                   /note="M -> MNGMHFPQY (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_009608"
FT   VAR_SEQ         594..613
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:9737689"
FT                   /id="VSP_004067"
FT   VARIANT         158
FT                   /note="T -> P (in dbSNP:rs12800974)"
FT                   /id="VAR_028191"
FT   VARIANT         383
FT                   /note="S -> F (in dbSNP:rs12222608)"
FT                   /id="VAR_028192"
FT   VARIANT         578
FT                   /note="W -> C (in dbSNP:rs1043858)"
FT                   /evidence="ECO:0000269|PubMed:8643484,
FT                   ECO:0000269|PubMed:9737689"
FT                   /id="VAR_028193"
FT   VARIANT         579
FT                   /note="Q -> E (in dbSNP:rs1043859)"
FT                   /evidence="ECO:0000269|PubMed:8643484,
FT                   ECO:0000269|PubMed:9737689"
FT                   /id="VAR_028194"
FT   VARIANT         641
FT                   /note="F -> L (in dbSNP:rs556337)"
FT                   /id="VAR_028195"
FT   CONFLICT        132
FT                   /note="N -> D (in Ref. 2; BAG62035)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        212
FT                   /note="N -> H (in Ref. 1; AAB07762)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        331
FT                   /note="E -> G (in Ref. 2; BAG62035)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   652 AA;  70755 MW;  AC3227E9D32AFEDA CRC64;
     MSGQSLTDRI TAAQHSVTGS AVSKTVCKAT THEIMGPKKK HLDYLIQCTN EMNVNIPQLA
     DSLFERTTNS SWVVVFKSLI TTHHLMVYGN ERFIQYLASR NTLFNLSNFL DKSGLQGYDM
     STFIRRYSRY LNEKAVSYRQ VAFDFTKVKR GADGVMRTMN TEKLLKTVPI IQNQMDALLD
     FNVNSNELTN GVINAAFMLL FKDAIRLFAA YNEGIINLLE KYFDMKKNQC KEGLDIYKKF
     LTRMTRISEF LKVAEQVGID RGDIPDLSQA PSSLLDALEQ HLASLEGKKI KDSTAASRAT
     TLSNAVSSLA STGLSLTKVD EREKQAALEE EQARLKALKE QRLKELAKKP HTSLTTAASP
     VSTSAGGIMT APAIDIFSTP SSSNSTSKLP NDLLDLQQPT FHPSVHPMST ASQVASTWGD
     PFSATVDAVD DAIPSLNPFL TKSSGDVHLS ISSDVSTFTT RTPTHEMFVG FTPSPVAQPH
     PSAGLNVDFE SVFGNKSTNV IVDSGGFDEL GGLLKPTVAS QNQNLPVAKL PPSKLVSDDL
     DSSLANLVGN LGIGNGTTKN DVNWSQPGEK KLTGGSNWQP KVAPTTAWNA ATMAPPVMAY
     PATTPTGMIG YGIPPQMGSV PVMTQPTLIY SQPVMRPPNP FGPVSGAQIQ FM
//
ID   A0A024RB02_HUMAN        Unreviewed;       858 AA.
AC   A0A024RB02;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 48.
DE   SubName: Full=PTPRF interacting protein, binding protein 1 (Liprin beta 1), isoform CRA_a {ECO:0000313|EMBL:EAW96559.1};
GN   Name=PPFIBP1 {ECO:0000313|EMBL:EAW96559.1};
GN   ORFNames=hCG_38765 {ECO:0000313|EMBL:EAW96559.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW96559.1};
RN   [1] {ECO:0000313|EMBL:EAW96559.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW96559.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH471094; EAW96558.1; -; Genomic_DNA.
DR   EMBL; CH471094; EAW96559.1; -; Genomic_DNA.
DR   RefSeq; NP_001185844.1; NM_001198915.1.
DR   Antibodypedia; 1098; 153 antibodies.
DR   GeneID; 8496; -.
DR   CTD; 8496; -.
DR   EuPathDB; HostDB:ENSG00000110841.13; -.
DR   eggNOG; KOG1899; Eukaryota.
DR   eggNOG; ENOG410XSFF; LUCA.
DR   ChiTaRS; PPFIBP1; human.
DR   GenomeRNAi; 8496; -.
DR   Bgee; ENSG00000110841; Expressed in epithelium of mammary gland and 233 other tissues.
DR   CDD; cd09563; SAM_liprin-beta1_2_repeat1; 1.
DR   CDD; cd09566; SAM_liprin-beta1_2_repeat2; 1.
DR   CDD; cd09569; SAM_liprin-beta1_2_repeat3; 1.
DR   Gene3D; 1.10.150.50; -; 3.
DR   Gene3D; 1.20.5.1160; -; 2.
DR   InterPro; IPR042180; IF_rod_dom_coil1B.
DR   InterPro; IPR029515; Liprin.
DR   InterPro; IPR037617; Liprin-beta_SAM_rpt_1.
DR   InterPro; IPR037618; Liprin-beta_SAM_rpt_2.
DR   InterPro; IPR037619; Liprin-beta_SAM_rpt_3.
DR   InterPro; IPR030437; PPFIBP1.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR013761; SAM/pointed_sf.
DR   PANTHER; PTHR12587; PTHR12587; 1.
DR   PANTHER; PTHR12587:SF16; PTHR12587:SF16; 1.
DR   Pfam; PF00536; SAM_1; 2.
DR   Pfam; PF07647; SAM_2; 1.
DR   SMART; SM00454; SAM; 3.
DR   SUPFAM; SSF47769; SSF47769; 3.
DR   PROSITE; PS50105; SAM_DOMAIN; 2.
PE   4: Predicted;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN          494..558
FT                   /note="SAM"
FT                   /evidence="ECO:0000259|PROSITE:PS50105"
FT   DOMAIN          566..629
FT                   /note="SAM"
FT                   /evidence="ECO:0000259|PROSITE:PS50105"
FT   REGION          267..286
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          310..481
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          9..43
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          54..74
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          99..140
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          152..186
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        319..338
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   858 AA;  96965 MW;  D5BE6B7D1D47C76A CRC64;
     MLQQELLSRT SLETQKLDLM AEISNLKLKL TAVEKDRLDY EDKFRDTEGL IQEINDLRLK
     VSEMDSERLQ YEKKLKSTKS LMAKLSSMKI KVGQMQYEKQ RMEQKWESLK DELASLKEQL
     EEKESEVKRL QEKLVCKMKG EGVEIVDRDI EVQKMKKAVE SLMAANEEKD RKIEDLRQCL
     NRYKKMQDTV VLAQGKDGEY EELLNSSSIS SLLDAQGFSD LEKSPSPTPV MGSPSCDPFN
     TSVPEEFHTT ILQVSIPSLL PATVSMETSE KSKLTPKPET SFEENDGNII LGATVDTQLC
     DKLLTSSLQK SSSLGNLKKE TSDGEKETIQ KTSEDRAPAE SRPFGTLPPR PPGQDTSMDD
     NPFGTRKVRS SFGRGFFKIK SNKRTASAPN LAETEKETAE HLDLAGASSR PKDSQRNSPF
     QIPPPSPDSK KKSRGIMKLF GKLRRSQSTT FNPDDMSEPE FKRGGTRATA GPRLGWSRDL
     GQSNSDLDMP FAKWTKEQVC NWLMEQGLGS YLNSGKHWIA SGQTLLQASQ QDLEKELGIK
     HSLHRKKLQL ALQALGSEEE TNHGKLDFNW VTRWLDDIGL PQYKTQFDEG RVDGRMLHYM
     TVDDLLSLKV VSVLHHLSIK RAIQVLRINN FEPNCLRRRP SDENTIAPSE VQKWTNHRVM
     EWLRSVDLAE YAPNLRGSGV HGGLMVLEPR FNVETMAQLL NIPPNKTLLR RHLATHFNLL
     IGAEAQHQKR DAMELPDYVL LTATAKVKPK KLAFSNFGNL RKKKQEDGEE YVCPMELGQA
     SGSASKKGFK PGLDMRLYEE DDLDRLEQME DSEGTVRQIG AFSEGINNLT HMLKEDDMFK
     DFAARSPSAS ITDEDSNV
//
ID   LIPB1_HUMAN             Reviewed;        1011 AA.
AC   Q86W92; O75336; Q86X70; Q9NY03; Q9ULJ0;
DT   16-FEB-2004, integrated into UniProtKB/Swiss-Prot.
DT   07-MAR-2006, sequence version 2.
DT   22-APR-2020, entry version 163.
DE   RecName: Full=Liprin-beta-1;
DE   AltName: Full=Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 1;
DE            Short=PTPRF-interacting protein-binding protein 1;
DE   AltName: Full=hSGT2;
GN   Name=PPFIBP1; Synonyms=KIAA1230;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), VARIANT LEU-148, TISSUE
RP   SPECIFICITY, AND FUNCTION.
RX   PubMed=9624153; DOI=10.1074/jbc.273.25.15611;
RA   Serra-Pages C., Medley Q.G., Tang M., Hart A., Streuli M.;
RT   "Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-
RT   interacting proteins.";
RL   J. Biol. Chem. 273:15611-15620(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANT LEU-148.
RC   TISSUE=Brain;
RX   PubMed=10574462; DOI=10.1093/dnares/6.5.337;
RA   Nagase T., Ishikawa K., Kikuno R., Hirosawa M., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XV. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 6:337-345(1999).
RN   [3]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5), AND VARIANT LEU-148.
RA   Junjian L., Cheng J., Rouli Z., Jie Z.;
RT   "L2, a different isoform of Liprin beta 1, is expressed in high level in
RT   liver tissue.";
RL   Submitted (MAR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5), AND VARIANT LEU-148.
RC   TISSUE=Brain;
RA   Sato T., Jigami Y., Uemura H.;
RT   "hSGT2, a liprin related human gene, restores the glycolytic gene
RT   expression of the gcr2 mutant of Saccharomyces cerevisiae.";
RL   Submitted (SEP-2000) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4), AND VARIANT
RP   LEU-148.
RC   TISSUE=Brain, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INTERACTION WITH S100A4.
RX   PubMed=11836260; DOI=10.1074/jbc.m110976200;
RA   Kriajevska M., Fischer-Larsen M., Moertz E., Vorm O., Tulchinsky E.,
RA   Grigorian M., Ambartsumian N., Lukanidin E.;
RT   "Liprin beta 1, a member of the family of LAR transmembrane tyrosine
RT   phosphatase-interacting proteins, is a new target for the metastasis-
RT   associated protein S100A4 (Mts1).";
RL   J. Biol. Chem. 277:5229-5235(2002).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37; THR-39; SER-40; SER-466;
RP   SER-579; SER-601; SER-999; SER-1001; SER-1003 AND THR-1005, PHOSPHORYLATION
RP   [LARGE SCALE ANALYSIS] AT SER-523 (ISOFORM 2), AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-601, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-322, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37; SER-40; SER-999 AND
RP   SER-1001, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-999, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-540; SER-601 AND SER-794, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-466; SER-540 AND SER-794, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-471, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: May regulate the disassembly of focal adhesions. Did not bind
CC       receptor-like tyrosine phosphatases type 2A.
CC       {ECO:0000269|PubMed:9624153}.
CC   -!- SUBUNIT: Forms homodimers and heterodimers. Interacts with S100A4 in a
CC       calcium-dependent mode. {ECO:0000269|PubMed:11836260}.
CC   -!- INTERACTION:
CC       Q86W92; P40425: PBX2; NbExp=3; IntAct=EBI-1045582, EBI-348489;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q86W92-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q86W92-2; Sequence=VSP_009397, VSP_009398, VSP_009399,
CC                                  VSP_009400;
CC       Name=3;
CC         IsoId=Q86W92-3; Sequence=VSP_009394;
CC       Name=4;
CC         IsoId=Q86W92-4; Sequence=VSP_009397;
CC       Name=5; Synonyms=L2;
CC         IsoId=Q86W92-5; Sequence=VSP_009395, VSP_009396;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Absent in liver.
CC       {ECO:0000269|PubMed:9624153}.
CC   -!- DOMAIN: The N-terminal coiled coil regions mediate homodimerization
CC       preferentially and heterodimerization type beta/beta. The C-terminal,
CC       non-coiled coil regions mediate heterodimerization type beta/alpha and
CC       interaction with S100A4.
CC   -!- MISCELLANEOUS: [Isoform 5]: Due to intron retention. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the liprin family. Liprin-beta subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH46159.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAA86544.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF034802; AAC26103.1; -; mRNA.
DR   EMBL; AB033056; BAA86544.2; ALT_INIT; mRNA.
DR   EMBL; AJ276680; CAB77544.1; -; mRNA.
DR   EMBL; AB049149; BAB39690.1; -; mRNA.
DR   EMBL; BC046159; AAH46159.1; ALT_INIT; mRNA.
DR   EMBL; BC050281; AAH50281.1; -; mRNA.
DR   CCDS; CCDS55812.1; -. [Q86W92-1]
DR   CCDS; CCDS55813.1; -. [Q86W92-4]
DR   CCDS; CCDS55814.1; -. [Q86W92-3]
DR   CCDS; CCDS8713.1; -. [Q86W92-2]
DR   RefSeq; NP_001185844.1; NM_001198915.1. [Q86W92-3]
DR   RefSeq; NP_001185845.1; NM_001198916.1. [Q86W92-4]
DR   RefSeq; NP_003613.3; NM_003622.3. [Q86W92-2]
DR   RefSeq; NP_803193.2; NM_177444.2. [Q86W92-1]
DR   SMR; Q86W92; -.
DR   BioGrid; 114068; 47.
DR   DIP; DIP-42195N; -.
DR   IntAct; Q86W92; 32.
DR   MINT; Q86W92; -.
DR   STRING; 9606.ENSP00000314724; -.
DR   iPTMnet; Q86W92; -.
DR   MetOSite; Q86W92; -.
DR   PhosphoSitePlus; Q86W92; -.
DR   BioMuta; PPFIBP1; -.
DR   DMDM; 90185247; -.
DR   EPD; Q86W92; -.
DR   jPOST; Q86W92; -.
DR   MassIVE; Q86W92; -.
DR   MaxQB; Q86W92; -.
DR   PaxDb; Q86W92; -.
DR   PeptideAtlas; Q86W92; -.
DR   PRIDE; Q86W92; -.
DR   ProteomicsDB; 70131; -. [Q86W92-1]
DR   ProteomicsDB; 70132; -. [Q86W92-2]
DR   ProteomicsDB; 70133; -. [Q86W92-3]
DR   ProteomicsDB; 70134; -. [Q86W92-4]
DR   ProteomicsDB; 70135; -. [Q86W92-5]
DR   Antibodypedia; 1098; 153 antibodies.
DR   Ensembl; ENST00000228425; ENSP00000228425; ENSG00000110841. [Q86W92-2]
DR   Ensembl; ENST00000318304; ENSP00000314724; ENSG00000110841. [Q86W92-1]
DR   Ensembl; ENST00000535047; ENSP00000444046; ENSG00000110841. [Q86W92-5]
DR   Ensembl; ENST00000537927; ENSP00000445425; ENSG00000110841. [Q86W92-3]
DR   Ensembl; ENST00000542629; ENSP00000443442; ENSG00000110841. [Q86W92-4]
DR   GeneID; 8496; -.
DR   KEGG; hsa:8496; -.
DR   UCSC; uc001rhz.3; human. [Q86W92-1]
DR   CTD; 8496; -.
DR   DisGeNET; 8496; -.
DR   GeneCards; PPFIBP1; -.
DR   HGNC; HGNC:9249; PPFIBP1.
DR   HPA; ENSG00000110841; Low tissue specificity.
DR   MIM; 603141; gene.
DR   neXtProt; NX_Q86W92; -.
DR   OpenTargets; ENSG00000110841; -.
DR   PharmGKB; PA33570; -.
DR   eggNOG; KOG1899; Eukaryota.
DR   eggNOG; ENOG410XSFF; LUCA.
DR   GeneTree; ENSGT00950000182675; -.
DR   HOGENOM; CLU_011689_2_0_1; -.
DR   InParanoid; Q86W92; -.
DR   OMA; CNWLQDQ; -.
DR   PhylomeDB; Q86W92; -.
DR   TreeFam; TF314207; -.
DR   Reactome; R-HSA-388844; Receptor-type tyrosine-protein phosphatases.
DR   ChiTaRS; PPFIBP1; human.
DR   GeneWiki; PPFIBP1; -.
DR   GenomeRNAi; 8496; -.
DR   Pharos; Q86W92; Tbio.
DR   PRO; PR:Q86W92; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; Q86W92; protein.
DR   Bgee; ENSG00000110841; Expressed in epithelium of mammary gland and 233 other tissues.
DR   ExpressionAtlas; Q86W92; baseline and differential.
DR   Genevisible; Q86W92; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; NAS:ProtInc.
DR   GO; GO:0048786; C:presynaptic active zone; IBA:GO_Central.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0007155; P:cell adhesion; TAS:ProtInc.
DR   GO; GO:0007528; P:neuromuscular junction development; IBA:GO_Central.
DR   GO; GO:0050808; P:synapse organization; IBA:GO_Central.
DR   CDD; cd09563; SAM_liprin-beta1_2_repeat1; 1.
DR   CDD; cd09566; SAM_liprin-beta1_2_repeat2; 1.
DR   CDD; cd09569; SAM_liprin-beta1_2_repeat3; 1.
DR   Gene3D; 1.10.150.50; -; 3.
DR   Gene3D; 1.20.5.1160; -; 2.
DR   InterPro; IPR042180; IF_rod_dom_coil1B.
DR   InterPro; IPR029515; Liprin.
DR   InterPro; IPR037617; Liprin-beta_SAM_rpt_1.
DR   InterPro; IPR037618; Liprin-beta_SAM_rpt_2.
DR   InterPro; IPR037619; Liprin-beta_SAM_rpt_3.
DR   InterPro; IPR030437; PPFIBP1.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR013761; SAM/pointed_sf.
DR   PANTHER; PTHR12587; PTHR12587; 1.
DR   PANTHER; PTHR12587:SF16; PTHR12587:SF16; 1.
DR   Pfam; PF00536; SAM_1; 2.
DR   Pfam; PF07647; SAM_2; 1.
DR   SMART; SM00454; SAM; 3.
DR   SUPFAM; SSF47769; SSF47769; 3.
DR   PROSITE; PS50105; SAM_DOMAIN; 2.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Coiled coil; Isopeptide bond;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat; Ubl conjugation.
FT   CHAIN           1..1011
FT                   /note="Liprin-beta-1"
FT                   /id="PRO_0000191034"
FT   DOMAIN          647..711
FT                   /note="SAM 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00184"
FT   DOMAIN          719..782
FT                   /note="SAM 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00184"
FT   DOMAIN          804..876
FT                   /note="SAM 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00184"
FT   COILED          156..405
FT                   /evidence="ECO:0000255"
FT   MOD_RES         37
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231"
FT   MOD_RES         39
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         40
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231"
FT   MOD_RES         322
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         434
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8C8U0"
FT   MOD_RES         466
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         540
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         579
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         601
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163"
FT   MOD_RES         636
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8C8U0"
FT   MOD_RES         794
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         999
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692"
FT   MOD_RES         1001
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231"
FT   MOD_RES         1003
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         1005
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   CROSSLNK        471
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   VAR_SEQ         1..153
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10574462"
FT                   /id="VSP_009394"
FT   VAR_SEQ         158..170
FT                   /note="ELLSRTSLETQKL -> VCAEARTKMGFPC (in isoform 5)"
FT                   /evidence="ECO:0000303|Ref.4, ECO:0000303|Ref.5"
FT                   /id="VSP_009395"
FT   VAR_SEQ         171..1011
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|Ref.4, ECO:0000303|Ref.5"
FT                   /id="VSP_009396"
FT   VAR_SEQ         233..263
FT                   /note="Missing (in isoform 2 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:9624153"
FT                   /id="VSP_009397"
FT   VAR_SEQ         302
FT                   /note="D -> DENFKKKLKEKN (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:9624153"
FT                   /id="VSP_009398"
FT   VAR_SEQ         349
FT                   /note="K -> KKGK (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:9624153"
FT                   /id="VSP_009399"
FT   VAR_SEQ         544
FT                   /note="L -> LDRKRSASAPTL (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:9624153"
FT                   /id="VSP_009400"
FT   VARIANT         148
FT                   /note="V -> L (in dbSNP:rs2194816)"
FT                   /evidence="ECO:0000269|PubMed:10574462,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:9624153,
FT                   ECO:0000269|Ref.4, ECO:0000269|Ref.5"
FT                   /id="VAR_017758"
FT   CONFLICT        308
FT                   /note="M -> K (in Ref. 6; AAH46159)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        453
FT                   /note="C -> R (in Ref. 1; AAC26103)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        553
FT                   /note="E -> A (in Ref. 1; AAC26103)"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         Q86W92-2:523
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
SQ   SEQUENCE   1011 AA;  114024 MW;  20E30DD99ACD5A92 CRC64;
     MMSDASDMLA AALEQMDGII AGSKALEYSN GIFDCQSPTS PFMGSLRALH LVEDLRGLLE
     MMETDEKEGL RCQIPDSTAE TLVEWLQSQM TNGHLPGNGD VYQERLARLE NDKESLVLQV
     SVLTDQVEAQ GEKIRDLEFC LEEHREKVNA TEEMLQQELL SRTSLETQKL DLMAEISNLK
     LKLTAVEKDR LDYEDKFRDT EGLIQEINDL RLKVSEMDSE RLQYEKKLKS TKSLMAKLSS
     MKIKVGQMQY EKQRMEQKWE SLKDELASLK EQLEEKESEV KRLQEKLVCK MKGEGVEIVD
     RDIEVQKMKK AVESLMAANE EKDRKIEDLR QCLNRYKKMQ DTVVLAQGKD GEYEELLNSS
     SISSLLDAQG FSDLEKSPSP TPVMGSPSCD PFNTSVPEEF HTTILQVSIP SLLPATVSME
     TSEKSKLTPK PETSFEENDG NIILGATVDT QLCDKLLTSS LQKSSSLGNL KKETSDGEKE
     TIQKTSEDRA PAESRPFGTL PPRPPGQDTS MDDNPFGTRK VRSSFGRGFF KIKSNKRTAS
     APNLAETEKE TAEHLDLAGA SSRPKDSQRN SPFQIPPPSP DSKKKSRGIM KLFGKLRRSQ
     STTFNPDDMS EPEFKRGGTR ATAGPRLGWS RDLGQSNSDL DMPFAKWTKE QVCNWLMEQG
     LGSYLNSGKH WIASGQTLLQ ASQQDLEKEL GIKHSLHRKK LQLALQALGS EEETNHGKLD
     FNWVTRWLDD IGLPQYKTQF DEGRVDGRML HYMTVDDLLS LKVVSVLHHL SIKRAIQVLR
     INNFEPNCLR RRPSDENTIA PSEVQKWTNH RVMEWLRSVD LAEYAPNLRG SGVHGGLMVL
     EPRFNVETMA QLLNIPPNKT LLRRHLATHF NLLIGAEAQH QKRDAMELPD YVLLTATAKV
     KPKKLAFSNF GNLRKKKQED GEEYVCPMEL GQASGSASKK GFKPGLDMRL YEEDDLDRLE
     QMEDSEGTVR QIGAFSEGIN NLTHMLKEDD MFKDFAARSP SASITDEDSN V
//
ID   A0A0S2Z456_HUMAN        Unreviewed;       491 AA.
AC   A0A0S2Z456;
DT   17-FEB-2016, integrated into UniProtKB/TrEMBL.
DT   17-FEB-2016, sequence version 1.
DT   22-APR-2020, entry version 21.
DE   SubName: Full=Papillary renal cell carcinoma isoform 1 {ECO:0000313|EMBL:ALQ33731.1};
DE   Flags: Fragment;
GN   Name=PRCC {ECO:0000313|EMBL:ALQ33731.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ALQ33731.1};
RN   [1] {ECO:0000313|EMBL:ALQ33731.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by Alternative
RT   Splicing.";
RL   Cell 164:805-817(2016).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; KU178273; ALQ33731.1; -; mRNA.
DR   RefSeq; NP_005964.3; NM_005973.4.
DR   PRIDE; A0A0S2Z456; -.
DR   Antibodypedia; 4485; 67 antibodies.
DR   GeneID; 5546; -.
DR   KEGG; hsa:5546; -.
DR   CTD; 5546; -.
DR   KO; K13105; -.
DR   OMA; DNKLTRR; -.
DR   OrthoDB; 817156at2759; -.
DR   PhylomeDB; A0A0S2Z456; -.
DR   ChiTaRS; PRCC; human.
DR   GenomeRNAi; 5546; -.
DR   ExpressionAtlas; A0A0S2Z456; baseline and differential.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   InterPro; IPR018800; PRCC.
DR   PANTHER; PTHR13621; PTHR13621; 1.
DR   Pfam; PF10253; PRCC; 1.
PE   2: Evidence at transcript level;
FT   REGION          1..244
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          260..313
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          432..454
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        11..25
FT                   /note="Acidic"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        46..98
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        117..132
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        136..169
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        170..193
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        215..244
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        285..306
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        434..450
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   NON_TER         491
FT                   /evidence="ECO:0000313|EMBL:ALQ33731.1"
SQ   SEQUENCE   491 AA;  52418 MW;  F99CFD9D42725D57 CRC64;
     MSLVAYASSD ESEPDEAEPE PEEEEAVAPT SGPALGGLFA SLPAPKGPAL LPPPPQMLAP
     AFPPPLLLPP PTGDPRLQPP PPLPFGLGGF PPPPGVSPAE AAGVGEGLGL GLPSPRGPGL
     NLPPPIGGAG PPLGLPKPKK RKEPVKIAAP ELHKGDSDSE EDEPTKKKTI LQGSSEGTGL
     SALLPQPKNL TVKETNRLLL PHAFSRKPSD GSPDTKPSRL ASKTKTSSLA PVVGTTTTTP
     SPSAIKAAAK SAALQVTKQI TQEEDDSDEE VAPENFFSLP EKAEPPGVEP YPYPIPTVPE
     ELPPGTEPEP AFQDDAANAP LEFKMAAGSS GAPWMPKPGD DYSYNQFSTY GDANAAGAYY
     QDYYSGGYYP AQDPALVPPQ EIAPDASFID DEAFKRLQGK RNRGREEINF VEIKGDDQLS
     GAQQWMTKSL TEEKTMKSFS KKKGEQPTGQ QRRKHQITYL IHQAKERELE LKNTWSENKL
     SRRQTQAKYG F
//
ID   A0A0S2Z470_HUMAN        Unreviewed;       459 AA.
AC   A0A0S2Z470;
DT   17-FEB-2016, integrated into UniProtKB/TrEMBL.
DT   17-FEB-2016, sequence version 1.
DT   22-APR-2020, entry version 19.
DE   SubName: Full=Papillary renal cell carcinoma isoform 3 {ECO:0000313|EMBL:ALQ33733.1};
DE   Flags: Fragment;
GN   Name=PRCC {ECO:0000313|EMBL:ALQ33733.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ALQ33733.1};
RN   [1] {ECO:0000313|EMBL:ALQ33733.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by Alternative
RT   Splicing.";
RL   Cell 164:805-817(2016).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; KU178275; ALQ33733.1; -; mRNA.
DR   RefSeq; XP_005245371.1; XM_005245314.1.
DR   IntAct; A0A0S2Z470; 1.
DR   PeptideAtlas; A0A0S2Z470; -.
DR   PRIDE; A0A0S2Z470; -.
DR   GeneID; 5546; -.
DR   CTD; 5546; -.
DR   OrthoDB; 817156at2759; -.
DR   ChiTaRS; PRCC; human.
DR   GenomeRNAi; 5546; -.
DR   InterPro; IPR018800; PRCC.
DR   PANTHER; PTHR13621; PTHR13621; 1.
DR   Pfam; PF10253; PRCC; 1.
PE   1: Evidence at protein level;
FT   REGION          1..244
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          260..313
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          396..422
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        11..25
FT                   /note="Acidic"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        46..98
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        117..132
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        136..169
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        170..193
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        215..244
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        285..306
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        402..418
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   NON_TER         459
FT                   /evidence="ECO:0000313|EMBL:ALQ33733.1"
SQ   SEQUENCE   459 AA;  48960 MW;  421D6056F31FA7A1 CRC64;
     MSLVAYASSD ESEPDEAEPE PEEEEAVAPT SGPALGGLFA SLPAPKGPAL LPPPPQMLAP
     AFPPPLLLPP PTGDPRLQPP PPLPFGLGGF PPPPGVSPAE AAGVGEGLGL GLPSPRGPGL
     NLPPPIGGAG PPLGLPKPKK RKEPVKIAAP ELHKGDSDSE EDEPTKKKTI LQGSSEGTGL
     SALLPQPKNL TVKETNRLLL PHAFSRKPSD GSPDTKPSRL ASKTKTSSLA PVVGTTTTTP
     SPSAIKAAAK SAALQVTKQI TQEEDDSDEE VAPENFFSLP EKAEPPGVEP YPYPIPTVPE
     ELPPGTEPEP AFQDDAANAP LEFKMAAGSS GAPWMPKPGD DYSYNQFSTY GDANAAGAYY
     QFKRLQGKRN RGREEINFVE IKGDDQLSGA QQWMTKSLTE EKTMKSFSKK KGEQPTGQQR
     RKHQITYLIH QAKERELELK NTWSENKLSR RQTQAKYGF
//
ID   PRCC_HUMAN              Reviewed;         491 AA.
AC   Q92733; A8K1F7; O00665; O00724; Q5SZ06;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1997, sequence version 1.
DT   22-APR-2020, entry version 170.
DE   RecName: Full=Proline-rich protein PRCC;
DE   AltName: Full=Papillary renal cell carcinoma translocation-associated gene protein;
GN   Name=PRCC; Synonyms=TPRC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CHROMOSOMAL TRANSLOCATION WITH TFE3.
RC   TISSUE=Monocyte;
RX   PubMed=8872474; DOI=10.1093/hmg/5.9.1333;
RA   Sidhar S.K., Clark J., Gill S., Hamoudi R., Crew A.J., Gwilliam R.,
RA   Ross M., Linehan W.M., Birdsall S., Shipley J., Cooper C.S.;
RT   "The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma
RT   fuses a novel gene PRCC to the TFE3 transcription factor gene.";
RL   Hum. Mol. Genet. 5:1333-1338(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND CHROMOSOMAL TRANSLOCATION WITH TFE3.
RX   PubMed=8986805; DOI=10.1073/pnas.93.26.15294;
RA   Weterman M.A.J., Wilbrink M., Geurts van Kessel A.;
RT   "Fusion of the transcription factor TFE3 gene to a novel gene, PRCC, in
RT   t(X;1)(p11;q21)-positive papillary renal cell carcinomas.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:15294-15298(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT SER-136.
RC   TISSUE=Caudate nucleus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION, INTERACTION WITH MAD2L2, AND SUBCELLULAR LOCATION.
RX   PubMed=11717438; DOI=10.1073/pnas.241304198;
RA   Weterman M.A., van Groningen J.J., Tertoolen L., van Kessel A.G.;
RT   "Impairment of MAD2B-PRCC interaction in mitotic checkpoint defective
RT   t(X;1)-positive renal cell carcinomas.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:13808-13813(2001).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-218, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-157; SER-159 AND SER-267, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-97; SER-114; SER-157;
RP   SER-159; SER-212; THR-239 AND SER-241, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-157 AND SER-159, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-157; SER-159 AND SER-241, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-114; SER-157 AND SER-159, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: May regulate cell cycle progression through interaction with
CC       MAD2L2. {ECO:0000269|PubMed:11717438}.
CC   -!- SUBUNIT: Interacts with MAD2L2; the interaction is direct.
CC       {ECO:0000269|PubMed:11717438}.
CC   -!- INTERACTION:
CC       Q92733; Q9NSC5: HOMER3; NbExp=3; IntAct=EBI-4397741, EBI-748420;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11717438}.
CC   -!- TISSUE SPECIFICITY: Ubiquitous in fetal and adult tissues.
CC   -!- DISEASE: Note=A chromosomal aberration involving PRCC is found in
CC       patients with papillary renal cell carcinoma. Translocation
CC       t(X;1)(p11.2;q21.2) with TFE3. {ECO:0000269|PubMed:8872474,
CC       ECO:0000269|PubMed:8986805}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PRCCID69.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X97124; CAA65791.1; -; mRNA.
DR   EMBL; X99720; CAA68060.1; -; Genomic_DNA.
DR   EMBL; AK289872; BAF82561.1; -; mRNA.
DR   EMBL; AL590666; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471121; EAW52909.1; -; Genomic_DNA.
DR   EMBL; BC004913; AAH04913.1; -; mRNA.
DR   CCDS; CCDS1157.1; -.
DR   RefSeq; NP_005964.3; NM_005973.4.
DR   BioGrid; 111537; 54.
DR   IntAct; Q92733; 37.
DR   MINT; Q92733; -.
DR   STRING; 9606.ENSP00000271526; -.
DR   iPTMnet; Q92733; -.
DR   PhosphoSitePlus; Q92733; -.
DR   BioMuta; PRCC; -.
DR   DMDM; 2498802; -.
DR   EPD; Q92733; -.
DR   jPOST; Q92733; -.
DR   MassIVE; Q92733; -.
DR   MaxQB; Q92733; -.
DR   PaxDb; Q92733; -.
DR   PeptideAtlas; Q92733; -.
DR   PRIDE; Q92733; -.
DR   ProteomicsDB; 75429; -.
DR   Antibodypedia; 4485; 67 antibodies.
DR   Ensembl; ENST00000271526; ENSP00000271526; ENSG00000143294.
DR   GeneID; 5546; -.
DR   KEGG; hsa:5546; -.
DR   UCSC; uc001fqa.4; human.
DR   CTD; 5546; -.
DR   DisGeNET; 5546; -.
DR   GeneCards; PRCC; -.
DR   HGNC; HGNC:9343; PRCC.
DR   HPA; ENSG00000143294; Low tissue specificity.
DR   MalaCards; PRCC; -.
DR   MIM; 179755; gene.
DR   neXtProt; NX_Q92733; -.
DR   OpenTargets; ENSG00000143294; -.
DR   Orphanet; 319308; MiT family translocation renal cell carcinoma.
DR   PharmGKB; PA33704; -.
DR   eggNOG; KOG3903; Eukaryota.
DR   eggNOG; ENOG4111HM1; LUCA.
DR   GeneTree; ENSGT00390000009042; -.
DR   HOGENOM; CLU_032704_0_0_1; -.
DR   InParanoid; Q92733; -.
DR   KO; K13105; -.
DR   OMA; DNKLTRR; -.
DR   OrthoDB; 817156at2759; -.
DR   PhylomeDB; Q92733; -.
DR   TreeFam; TF318780; -.
DR   Reactome; R-HSA-72163; mRNA Splicing - Major Pathway.
DR   SIGNOR; Q92733; -.
DR   ChiTaRS; PRCC; human.
DR   GeneWiki; PRCC_(gene); -.
DR   GenomeRNAi; 5546; -.
DR   Pharos; Q92733; Tbio.
DR   PRO; PR:Q92733; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q92733; protein.
DR   Bgee; ENSG00000143294; Expressed in adrenal gland and 226 other tissues.
DR   ExpressionAtlas; Q92733; baseline and differential.
DR   Genevisible; Q92733; HS.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0007093; P:mitotic cell cycle checkpoint; IDA:UniProtKB.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome.
DR   InterPro; IPR018800; PRCC.
DR   PANTHER; PTHR13621; PTHR13621; 1.
DR   Pfam; PF10253; PRCC; 1.
PE   1: Evidence at protein level;
KW   Cell cycle; Chromosomal rearrangement; Nucleus; Phosphoprotein;
KW   Polymorphism; Proto-oncogene; Reference proteome.
FT   CHAIN           1..491
FT                   /note="Proline-rich protein PRCC"
FT                   /id="PRO_0000058568"
FT   REGION          1..100
FT                   /note="Mediates interaction with MAD2L2"
FT                   /evidence="ECO:0000269|PubMed:11717438"
FT   COMPBIAS        18..25
FT                   /note="Poly-Glu"
FT   COMPBIAS        52..55
FT                   /note="Poly-Pro"
FT   COMPBIAS        79..84
FT                   /note="Poly-Pro"
FT   COMPBIAS        91..94
FT                   /note="Poly-Pro"
FT   COMPBIAS        235..239
FT                   /note="Poly-Thr"
FT   MOD_RES         97
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         114
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         157
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         159
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         212
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         218
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983"
FT   MOD_RES         239
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         241
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         267
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   VARIANT         136
FT                   /note="P -> S (in dbSNP:rs11264542)"
FT                   /evidence="ECO:0000269|PubMed:14702039"
FT                   /id="VAR_024341"
SQ   SEQUENCE   491 AA;  52418 MW;  F99CFD9D42725D57 CRC64;
     MSLVAYASSD ESEPDEAEPE PEEEEAVAPT SGPALGGLFA SLPAPKGPAL LPPPPQMLAP
     AFPPPLLLPP PTGDPRLQPP PPLPFGLGGF PPPPGVSPAE AAGVGEGLGL GLPSPRGPGL
     NLPPPIGGAG PPLGLPKPKK RKEPVKIAAP ELHKGDSDSE EDEPTKKKTI LQGSSEGTGL
     SALLPQPKNL TVKETNRLLL PHAFSRKPSD GSPDTKPSRL ASKTKTSSLA PVVGTTTTTP
     SPSAIKAAAK SAALQVTKQI TQEEDDSDEE VAPENFFSLP EKAEPPGVEP YPYPIPTVPE
     ELPPGTEPEP AFQDDAANAP LEFKMAAGSS GAPWMPKPGD DYSYNQFSTY GDANAAGAYY
     QDYYSGGYYP AQDPALVPPQ EIAPDASFID DEAFKRLQGK RNRGREEINF VEIKGDDQLS
     GAQQWMTKSL TEEKTMKSFS KKKGEQPTGQ QRRKHQITYL IHQAKERELE LKNTWSENKL
     SRRQTQAKYG F
//
ID   Q96FT4_HUMAN            Unreviewed;       491 AA.
AC   Q96FT4;
DT   01-DEC-2001, integrated into UniProtKB/TrEMBL.
DT   01-DEC-2001, sequence version 1.
DT   11-DEC-2019, entry version 80.
DE   SubName: Full=Papillary renal cell carcinoma (Translocation-associated) {ECO:0000313|EMBL:AAH10450.1};
GN   Name=PRCC {ECO:0000313|EMBL:AAH10450.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH10450.1};
RN   [1] {ECO:0000313|EMBL:AAH10450.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain {ECO:0000313|EMBL:AAH10450.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M., Peck A.M.,
RA   Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S., Feolo M.,
RA   Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F., Schaefer C.F.,
RA   Buetow K., Bonner T.I., Haussler D., Kent J., Kiekhaus M., Furey T.,
RA   Brent M., Prange C., Schreiber K., Shapiro N., Bhat N.K., Hopkins R.F.,
RA   Hsie F., Driscoll T., Soares M.B., Casavant T.L., Scheetz T.E.,
RA   Brown-stein M.J., Usdin T.B., Toshiyuki S., Carninci P., Piao Y.,
RA   Dudekula D.B., Ko M.S., Kawakami K., Suzuki Y., Sugano S., Gruber C.E.,
RA   Smith M.R., Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y.,
RA   Wei C.L., Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W.,
RA   Fuh E., Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D., Granite S.J.,
RA   Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G., Blakesly R.W.,
RA   Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J.,
RA   Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L., Krzywinski M.I.,
RA   Liao N., Morin R., Morrin R., Palmquist D., Petrescu A.S., Skalska U.,
RA   Smailus D.E., Stott J.M., Schnerch A., Schein J.E., Jones S.J., Holt R.A.,
RA   Baross A., Marra M.A., Clifton S., Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC010450; AAH10450.1; -; mRNA.
DR   RefSeq; NP_005964.3; NM_005973.4.
DR   PeptideAtlas; Q96FT4; -.
DR   PRIDE; Q96FT4; -.
DR   GeneID; 5546; -.
DR   KEGG; hsa:5546; -.
DR   CTD; 5546; -.
DR   PharmGKB; PA33704; -.
DR   eggNOG; KOG3903; Eukaryota.
DR   eggNOG; ENOG4111HM1; LUCA.
DR   KO; K13105; -.
DR   OrthoDB; 817156at2759; -.
DR   ChiTaRS; PRCC; human.
DR   GenomeRNAi; 5546; -.
DR   Genevisible; Q96FT4; HS.
DR   InterPro; IPR018800; PRCC.
DR   PANTHER; PTHR13621; PTHR13621; 1.
DR   Pfam; PF10253; PRCC; 1.
PE   2: Evidence at transcript level;
FT   REGION          1..244
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          260..313
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          432..454
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        11..25
FT                   /note="Acidic"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        46..98
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        117..132
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        136..169
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        170..193
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        215..244
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        285..306
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        434..450
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   491 AA;  52422 MW;  4A808B462FC48126 CRC64;
     MSLVAYASSD ESEPDEAEPE PEEEEAVAPT SGPALGGLFA SLPAPKGPAL LPPPPQMLAP
     AFPPPLLLPP PTGDPRLQPP PPLPFGLGGF PPPPGVSPAE AAGVGEGLGL GLPSPRGPGL
     NLPPPIGGAG PPLGLPKPKK RKEPVKIAAP ELHKGDSDSE EDEPTKKKTI LQGSSEGTGL
     SALLPQPKNL TVKETNRLLL PHAFSRKPSD GSPDTKPSRL ASKTKTSSLA PVVGTTTTTP
     SPSAIKAAAK SAALQVTKQI TQEEDDSDEE VAPENFFSLP EKAEPPGVEP YPYPIPTVPE
     ELPPGTEPEP AFQDDAANAP LEFKMAAGSS GAPWMPKPGD DYSYNQFSTY GDANAAGAYY
     QDYYSGGYYP AQDPALVPTQ EIAPDASFID DEAFKRLQGK RNRGREEINF VEIKGDDQLS
     GAQQWMTKSL TEEKTMKSFS KKKGEQPTGQ QRRKHQITYL IHQAKERELE LKNTWSENKL
     SRRQTQAKYG F
//
ID   PRRX1_HUMAN             Reviewed;         245 AA.
AC   P54821; B5BUM7; O60807;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1999, sequence version 2.
DT   22-APR-2020, entry version 175.
DE   RecName: Full=Paired mesoderm homeobox protein 1;
DE   AltName: Full=Homeobox protein PHOX1;
DE   AltName: Full=Paired-related homeobox protein 1;
DE            Short=PRX-1;
GN   Name=PRRX1; Synonyms=PMX1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=19054851; DOI=10.1038/nmeth.1273;
RA   Goshima N., Kawamura Y., Fukumoto A., Miura A., Honma R., Satoh R.,
RA   Wakamatsu A., Yamamoto J., Kimura K., Nishikawa T., Andoh T., Iida Y.,
RA   Ishikawa K., Ito E., Kagawa N., Kaminaga C., Kanehori K., Kawakami B.,
RA   Kenmochi K., Kimura R., Kobayashi M., Kuroita T., Kuwayama H., Maruyama Y.,
RA   Matsuo K., Minami K., Mitsubori M., Mori M., Morishita R., Murase A.,
RA   Nishikawa A., Nishikawa S., Okamoto T., Sakagami N., Sakamoto Y.,
RA   Sasaki Y., Seki T., Sono S., Sugiyama A., Sumiya T., Takayama T.,
RA   Takayama Y., Takeda H., Togashi T., Yahata K., Yamada H., Yanagisawa Y.,
RA   Endo Y., Imamoto F., Kisu Y., Tanaka S., Isogai T., Imai J., Watanabe S.,
RA   Nomura N.;
RT   "Human protein factory for converting the transcriptome into an in vitro-
RT   expressed proteome.";
RL   Nat. Methods 5:1011-1017(2008).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 19-197 (ISOFORM 2).
RX   PubMed=1509260; DOI=10.1126/science.257.5073.1089;
RA   Grueneberg D.A., Natesan S., Alexandre C., Gilman M.Z.;
RT   "Human and Drosophila homeodomain proteins that enhance the DNA-binding
RT   activity of serum response factor.";
RL   Science 257:1089-1095(1992).
RN   [5]
RP   VARIANT AGOTC SER-113.
RX   PubMed=21294718; DOI=10.1111/j.1399-0004.2010.01531.x;
RA   Sergi C., Kamnasaran D.;
RT   "PRRX1 is mutated in a fetus with agnathia-otocephaly.";
RL   Clin. Genet. 79:293-295(2011).
CC   -!- FUNCTION: Acts as a transcriptional regulator of muscle creatine kinase
CC       (MCK) and so has a role in the establishment of diverse mesodermal
CC       muscle types. The protein binds to an A/T-rich element in the muscle
CC       creatine enhancer (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       P54821; Q9BW66: CINP; NbExp=3; IntAct=EBI-12828023, EBI-739784;
CC       P54821; P51687: SUOX; NbExp=3; IntAct=EBI-12828023, EBI-3921347;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=PMX1-B;
CC         IsoId=P54821-1; Sequence=Displayed;
CC       Name=2; Synonyms=PMX1-A;
CC         IsoId=P54821-2; Sequence=VSP_002278;
CC   -!- DISEASE: Agnathia-otocephaly complex (AGOTC) [MIM:202650]: A rare
CC       condition characterized by mandibular hypoplasia or agnathia,
CC       ventromedial auricular malposition (melotia) and/or auricular fusion
CC       (synotia), and microstomia with oroglossal hypoplasia or aglossia.
CC       Holoprosencephaly is the most commonly identified association, but
CC       skeletal, genitourinary, and cardiovascular anomalies, and situs
CC       inversus have been reported. The disorder is almost always lethal.
CC       {ECO:0000269|PubMed:21294718}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the paired homeobox family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB451463; BAG70277.1; -; mRNA.
DR   EMBL; Z97200; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC074993; AAH74993.1; -; mRNA.
DR   EMBL; M95929; AAA60085.1; -; mRNA.
DR   CCDS; CCDS1290.1; -. [P54821-1]
DR   CCDS; CCDS1291.1; -. [P54821-2]
DR   RefSeq; NP_008833.1; NM_006902.4. [P54821-2]
DR   RefSeq; NP_073207.1; NM_022716.3. [P54821-1]
DR   SMR; P54821; -.
DR   BioGrid; 111405; 1.
DR   CORUM; P54821; -.
DR   IntAct; P54821; 2.
DR   STRING; 9606.ENSP00000239461; -.
DR   iPTMnet; P54821; -.
DR   PhosphoSitePlus; P54821; -.
DR   BioMuta; PRRX1; -.
DR   DMDM; 6174916; -.
DR   jPOST; P54821; -.
DR   MassIVE; P54821; -.
DR   PaxDb; P54821; -.
DR   PeptideAtlas; P54821; -.
DR   PRIDE; P54821; -.
DR   ProteomicsDB; 56732; -. [P54821-1]
DR   ProteomicsDB; 56733; -. [P54821-2]
DR   Antibodypedia; 34372; 399 antibodies.
DR   DNASU; 5396; -.
DR   Ensembl; ENST00000239461; ENSP00000239461; ENSG00000116132. [P54821-1]
DR   Ensembl; ENST00000367760; ENSP00000356734; ENSG00000116132. [P54821-2]
DR   GeneID; 5396; -.
DR   KEGG; hsa:5396; -.
DR   UCSC; uc001ghe.4; human. [P54821-1]
DR   CTD; 5396; -.
DR   DisGeNET; 5396; -.
DR   GeneCards; PRRX1; -.
DR   HGNC; HGNC:9142; PRRX1.
DR   HPA; ENSG00000116132; Low tissue specificity.
DR   MalaCards; PRRX1; -.
DR   MIM; 167420; gene.
DR   MIM; 202650; phenotype.
DR   neXtProt; NX_P54821; -.
DR   OpenTargets; ENSG00000116132; -.
DR   Orphanet; 990; Agnathia-holoprosencephaly-situs inversus syndrome.
DR   PharmGKB; PA33466; -.
DR   eggNOG; KOG0490; Eukaryota.
DR   eggNOG; ENOG410YIJ3; LUCA.
DR   GeneTree; ENSGT00940000159466; -.
DR   InParanoid; P54821; -.
DR   KO; K09329; -.
DR   OMA; YPPTCAN; -.
DR   OrthoDB; 1413050at2759; -.
DR   PhylomeDB; P54821; -.
DR   TreeFam; TF351612; -.
DR   SIGNOR; P54821; -.
DR   ChiTaRS; PRRX1; human.
DR   GeneWiki; PRRX1; -.
DR   GenomeRNAi; 5396; -.
DR   Pharos; P54821; Tbio.
DR   PRO; PR:P54821; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; P54821; protein.
DR   Bgee; ENSG00000116132; Expressed in tendon and 208 other tissues.
DR   ExpressionAtlas; P54821; baseline and differential.
DR   Genevisible; P54821; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0000790; C:nuclear chromatin; ISA:NTNU_SB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISA:NTNU_SB.
DR   GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; IEA:Ensembl.
DR   GO; GO:0071837; F:HMG box domain binding; IEA:Ensembl.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0003713; F:transcription coactivator activity; TAS:ProtInc.
DR   GO; GO:0048844; P:artery morphogenesis; IEA:Ensembl.
DR   GO; GO:0051216; P:cartilage development; IEA:Ensembl.
DR   GO; GO:0048701; P:embryonic cranial skeleton morphogenesis; IEA:Ensembl.
DR   GO; GO:0030326; P:embryonic limb morphogenesis; IEA:Ensembl.
DR   GO; GO:0042472; P:inner ear morphogenesis; IEA:Ensembl.
DR   GO; GO:0042474; P:middle ear morphogenesis; IEA:Ensembl.
DR   GO; GO:0048664; P:neuron fate determination; IEA:Ensembl.
DR   GO; GO:0097150; P:neuronal stem cell population maintenance; IEA:Ensembl.
DR   GO; GO:0002053; P:positive regulation of mesenchymal cell proliferation; IEA:Ensembl.
DR   GO; GO:0045880; P:positive regulation of smoothened signaling pathway; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IEA:Ensembl.
DR   GO; GO:0070570; P:regulation of neuron projection regeneration; IEA:Ensembl.
DR   GO; GO:0060021; P:roof of mouth development; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like_sf.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR003654; OAR_dom.
DR   Pfam; PF00046; Homeodomain; 1.
DR   Pfam; PF03826; OAR; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS50803; OAR; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Developmental protein; Disease mutation;
KW   DNA-binding; Homeobox; Nucleus; Phosphoprotein; Reference proteome.
FT   CHAIN           1..245
FT                   /note="Paired mesoderm homeobox protein 1"
FT                   /id="PRO_0000049251"
FT   DNA_BIND        94..153
FT                   /note="Homeobox"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00108"
FT   MOTIF           222..235
FT                   /note="OAR"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00138"
FT   MOD_RES         21
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P63014"
FT   MOD_RES         160
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P63013"
FT   MOD_RES         197
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         200..245
FT                   /note="SAMATYSATCANNSPAQGINMANSIANLRLKAKEYSLQRNQVPTVN -> RS
FT                   SSLPRCCLHEGLHNGF (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:1509260"
FT                   /id="VSP_002278"
FT   VARIANT         113
FT                   /note="F -> S (in AGOTC; dbSNP:rs387906667)"
FT                   /evidence="ECO:0000269|PubMed:21294718"
FT                   /id="VAR_066414"
SQ   SEQUENCE   245 AA;  27296 MW;  7CA4B7FD9492FC19 CRC64;
     MTSSYGHVLE RQPALGGRLD SPGNLDTLQA KKNFSVSHLL DLEEAGDMVA AQADENVGEA
     GRSLLESPGL TSGSDTPQQD NDQLNSEEKK KRKQRRNRTT FNSSQLQALE RVFERTHYPD
     AFVREDLARR VNLTEARVQV WFQNRRAKFR RNERAMLANK NASLLKSYSG DVTAVEQPIV
     PRPAPRPTDY LSWGTASPYS AMATYSATCA NNSPAQGINM ANSIANLRLK AKEYSLQRNQ
     VPTVN
//
ID   B4DMM4_HUMAN            Unreviewed;       819 AA.
AC   B4DMM4;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   11-DEC-2019, entry version 57.
DE   SubName: Full=cDNA FLJ60304, highly similar to Rab GTPase-binding effector protein 1 {ECO:0000313|EMBL:BAG59936.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG59936.1};
RN   [1] {ECO:0000313|EMBL:BAG59936.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAG59936.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK297535; BAG59936.1; -; mRNA.
DR   RefSeq; NP_001278510.1; NM_001291581.1.
DR   PeptideAtlas; B4DMM4; -.
DR   PRIDE; B4DMM4; -.
DR   GeneID; 9135; -.
DR   CTD; 9135; -.
DR   OrthoDB; 1369937at2759; -.
DR   GenomeRNAi; 9135; -.
DR   GO; GO:0005768; C:endosome; IEA:InterPro.
DR   GO; GO:0008083; F:growth factor activity; IEA:InterPro.
DR   GO; GO:0005096; F:GTPase activator activity; IEA:InterPro.
DR   GO; GO:0006897; P:endocytosis; IEA:InterPro.
DR   InterPro; IPR003914; Rabaptin.
DR   InterPro; IPR029880; Rabaptin-5.
DR   InterPro; IPR018514; Rabaptin_coiled-coil.
DR   InterPro; IPR015390; Rabaptin_Rab5-bd_dom.
DR   PANTHER; PTHR31179; PTHR31179; 1.
DR   PANTHER; PTHR31179:SF5; PTHR31179:SF5; 1.
DR   Pfam; PF09311; Rab5-bind; 1.
DR   Pfam; PF03528; Rabaptin; 1.
DR   PRINTS; PR01432; RABAPTIN.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN          11..452
FT                   /note="Rabaptin"
FT                   /evidence="ECO:0000259|Pfam:PF03528"
FT   DOMAIN          490..796
FT                   /note="Rab5-bind"
FT                   /evidence="ECO:0000259|Pfam:PF09311"
FT   REGION          272..295
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          21..41
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          64..84
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          97..179
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          195..243
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          507..541
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          560..612
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          656..746
FT                   /evidence="ECO:0000256|SAM:Coils"
SQ   SEQUENCE   819 AA;  94109 MW;  A72A1B3B5D8F492C CRC64;
     MAQPGPASQP DEDLKRQNAV LQAAQDDLGH LRTQLWEAQA EMENIKAVAT VSENTKQEAI
     DEVKRQWREE VASLQAVMKE TVRDYEHQFH LRLEQERTQW AQYRESAERE IADLRRRLSE
     GQEEENLENE MKKAQEDAEK LRSVVMPMEK EIAALKDKLT EAEDKIKELE ASKVKELNHY
     LEAEKSCRTD LEMYVAVLNT QKSVLQEDAE KLRKELHEVC HLLKQERQQH NQLKHTWQKA
     NDQFLESQRL LMRDMQRMEI VLTSEQLRQV EELKKKDQED DEQQRLNKRK DHKKADVEEE
     IKIPVVCALT QEESSAQLSN EEEHLDSTRG SVHSLDAGLL LPSGDPFSKS DNDMFKDGLR
     RAQSTDSLGT SGSLQSKALG YNYKAKSAGN LDESDFGPLV GADSVSENFD TASLGSLQMP
     SGFMLTKDQE RAIKAMTPEQ EETASLLSSV TQGMESAYVS PSGYRLVSET EWNLLQKEVH
     NAGNKLGRRC DMCSNYEKQL QGIQIQEAET RDQVKKLQLM LRQANDQLEK TMKDKQELED
     FIKQSSEDSS HQISALVLRA QASEILLEEL QQGLSQAKRD VQEQMAVLMQ SREQVSEELV
     RLQKDNDSLQ GKHSLHVSLQ QAEDFILPDT TEALRELVLK YREDIINVRT AADHVEEKLK
     AEILFLKEQI QAEQCLKENL EETLQLEIEN CKEEIASISS LKAELERIKV EKGQLESTLR
     EKSQQLESLQ EIKISLEEQL KKETAAKATV EQLMFEEKNK AHRLQTELDV SEQVQRDFVK
     LSQTLQVQLE RIRQADSLER IRAILNDTKL TDINQLPET
//
ID   RABE1_HUMAN             Reviewed;         862 AA.
AC   Q15276; B2RAG7; O95369; Q8IVX3;
DT   24-MAY-2004, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   22-APR-2020, entry version 187.
DE   RecName: Full=Rab GTPase-binding effector protein 1;
DE   AltName: Full=Rabaptin-4;
DE   AltName: Full=Rabaptin-5;
DE   AltName: Full=Rabaptin-5alpha;
DE   AltName: Full=Renal carcinoma antigen NY-REN-17;
GN   Name=RABEP1; Synonyms=RAB5EP, RABPT5, RABPT5A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR LOCATION, AND
RP   INTERACTION WITH RAB5A.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=8521472; DOI=10.1016/0092-8674(95)90120-5;
RA   Stenmark H., Vitale G., Ulrich O., Zerial M.;
RT   "Rabaptin-5 is a direct effector of the small GTPase Rab5 in endocytic
RT   membrane fusion.";
RL   Cell 83:423-432(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, SUBCELLULAR LOCATION, AND
RP   INTERACTION WITH RAB4A AND RAB5A.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=10698684; DOI=10.1042/bj3460593;
RA   Nagelkerken B., van Anken E., van Raak M., Gerez L., Mohrmann K.,
RA   van Uden N., Holthuizen J., Pelkmans L., van der Sluijs P.;
RT   "Rabaptin4, a novel effector of the small GTPase rab4a, is recruited to
RT   perinuclear recycling vesicles.";
RL   Biochem. J. 346:593-601(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 807-819, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [6]
RP   INTERACTION WITH RABGEF1.
RX   PubMed=9323142; DOI=10.1016/s0092-8674(00)80380-3;
RA   Horiuchi H., Lippe R., McBride H.M., Rubino M., Woodman P., Stenmark H.,
RA   Rybin V., Wilm M., Ashman K., Mann M., Zerial M.;
RT   "A novel Rab5 GDP/GTP exchange factor complexed to Rabaptin-5 links
RT   nucleotide exchange to effector recruitment and function.";
RL   Cell 90:1149-1159(1997).
RN   [7]
RP   PROTEOLYTIC CLEAVAGE BY CASPASES IN APOPTOTIC CELLS.
RX   PubMed=9321397; DOI=10.1093/emboj/16.20.6182;
RA   Cosulich S.C., Horiuchi H., Zerial M., Clarke P.R., Woodman P.G.;
RT   "Cleavage of rabaptin-5 blocks endosome fusion during apoptosis.";
RL   EMBO J. 16:6182-6191(1997).
RN   [8]
RP   INTERACTION WITH TSC2.
RX   PubMed=9045618; DOI=10.1074/jbc.272.10.6097;
RA   Xiao G.-H., Shoarinejad F., Jin F., Golemis E.A., Yeung R.S.;
RT   "The tuberous sclerosis 2 gene product, tuberin, functions as a Rab5 GTPase
RT   activating protein (GAP) in modulating endocytosis.";
RL   J. Biol. Chem. 272:6097-6100(1997).
RN   [9]
RP   IDENTIFICATION AS A RENAL CANCER ANTIGEN.
RC   TISSUE=Renal cell carcinoma;
RX   PubMed=10508479;
RX   DOI=10.1002/(sici)1097-0215(19991112)83:4<456::aid-ijc4>3.0.co;2-5;
RA   Scanlan M.J., Gordan J.D., Williamson B., Stockert E., Bander N.H.,
RA   Jongeneel C.V., Gure A.O., Jaeger D., Jaeger E., Knuth A., Chen Y.-T.,
RA   Old L.J.;
RT   "Antigens recognized by autologous antibody in patients with renal-cell
RT   carcinoma.";
RL   Int. J. Cancer 83:456-464(1999).
RN   [10]
RP   FUNCTION, AND INTERACTION WITH RABGEF1.
RX   PubMed=11452015; DOI=10.1091/mbc.12.7.2219;
RA   Lippe R., Miaczynska M., Rybin V., Runge A., Zerial M.;
RT   "Functional synergy between Rab5 effector Rabaptin-5 and exchange factor
RT   Rabex-5 when physically associated in a complex.";
RL   Mol. Biol. Cell 12:2219-2228(2001).
RN   [11]
RP   INTERACTION WITH GGA1; GGA2; GGA3; AP1G1 AND AP1G2, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=12505986; DOI=10.1093/emboj/cdg015;
RA   Mattera R., Arighi C.N., Lodge R., Zerial M., Bonifacino J.S.;
RT   "Divalent interaction of the GGAs with the Rabaptin-5-Rabex-5 complex.";
RL   EMBO J. 22:78-88(2003).
RN   [12]
RP   FUNCTION, INTERACTION WITH RAB4A AND AP1G1, AND SUBCELLULAR LOCATION.
RX   PubMed=12773381; DOI=10.1093/emboj/cdg257;
RA   Deneka M., Neeft M., Popa I., van Oort M., Sprong H., Oorschot V.,
RA   Klumperman J., Schu P., van der Sluijs P.;
RT   "Rabaptin-5alpha/rabaptin-4 serves as a linker between rab4 and gamma(1)-
RT   adaptin in membrane recycling from endosomes.";
RL   EMBO J. 22:2645-2657(2003).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-407, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-407 AND SER-410, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-407, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [18]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-282, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [19]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH ECPAS.
RX   PubMed=20682791; DOI=10.1074/jbc.m110.154120;
RA   Gorbea C., Pratt G., Ustrell V., Bell R., Sahasrabudhe S., Hughes R.E.,
RA   Rechsteiner M.;
RT   "A protein interaction network for Ecm29 links the 26 S proteasome to
RT   molecular motors and endosomal components.";
RL   J. Biol. Chem. 285:31616-31633(2010).
RN   [20]
RP   INTERACTION WITH RAB4A.
RX   PubMed=20098723; DOI=10.1371/journal.pbio.1000283;
RA   Hoogenraad C.C., Popa I., Futai K., Martinez-Sanchez E.,
RA   Sanchez-Martinez E., Wulf P.S., van Vlijmen T., Dortland B.R., Oorschot V.,
RA   Govers R., Monti M., Heck A.J., Sheng M., Klumperman J., Rehmann H.,
RA   Jaarsma D., Kapitein L.C., van der Sluijs P.;
RT   "Neuron specific Rab4 effector GRASP-1 coordinates membrane specialization
RT   and maturation of recycling endosomes.";
RL   PLoS Biol. 8:E1000283-E1000283(2010).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-407 AND SER-410, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-407 AND SER-410, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [24]
RP   FUNCTION.
RX   PubMed=22841712; DOI=10.1016/j.febslet.2012.07.055;
RA   Ninkovic M., Mitkovski M., Kohl T., Stuhmer W., Pardo L.A.;
RT   "Physical and functional interaction of KV10.1 with Rabaptin-5 impacts ion
RT   channel trafficking.";
RL   FEBS Lett. 586:3077-3084(2012).
RN   [25]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-377; SER-407 AND SER-410, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-374; SER-407; THR-408 AND
RP   SER-410, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (2.31 ANGSTROMS) OF 789-862 IN COMPLEX WITH RAB5A,
RP   SUBUNIT, AND MUTAGENESIS OF ASP-812; GLU-815; GLN-818; ASP-820; PHE-821;
RP   VAL-822; GLN-826 AND GLN-829.
RX   PubMed=15378032; DOI=10.1038/nsmb832;
RA   Zhu G., Zhai P., Liu J., Terzyan S., Li G., Zhang X.C.;
RT   "Structural basis of Rab5-Rabaptin5 interaction in endocytosis.";
RL   Nat. Struct. Mol. Biol. 11:975-983(2004).
CC   -!- FUNCTION: Rab effector protein acting as linker between gamma-adaptin,
CC       RAB4A and RAB5A. Involved in endocytic membrane fusion and membrane
CC       trafficking of recycling endosomes. Involved in KCNH1 channels
CC       trafficking to and from the cell membrane (PubMed:22841712). Stimulates
CC       RABGEF1 mediated nucleotide exchange on RAB5A. Mediates the traffic of
CC       PKD1:PKD2 complex from the endoplasmic reticulum through the Golgi to
CC       the cilium (By similarity). {ECO:0000250|UniProtKB:O35551,
CC       ECO:0000269|PubMed:10698684, ECO:0000269|PubMed:11452015,
CC       ECO:0000269|PubMed:12773381, ECO:0000269|PubMed:22841712,
CC       ECO:0000269|PubMed:8521472}.
CC   -!- SUBUNIT: Homodimer when bound to RAB5A (PubMed:15378032). Heterodimer
CC       with RABGEF1 (PubMed:11452015, PubMed:9323142). The heterodimer binds
CC       RAB4A and RAB5A that have been activated by GTP-binding
CC       (PubMed:10698684, PubMed:8521472, PubMed:20098723). Binds TSC2, GGA1,
CC       GGA2, GGA3, AP1G1 and AP1G2 (PubMed:12505986, PubMed:12773381,
CC       PubMed:9045618). Interacts with ECPAS (PubMed:20682791). Interacts with
CC       KCNH1 (By similarity). Interacts with PKD1 (via C-terminal domain) and
CC       GGA1; the interactions recruit PKD1:PKD2 complex to GGA1 and ARL3 at
CC       trans-Golgi network (By similarity). Interacts with KCNH1 (By
CC       similarity). {ECO:0000250|UniProtKB:O35550,
CC       ECO:0000250|UniProtKB:O35551, ECO:0000269|PubMed:10698684,
CC       ECO:0000269|PubMed:11452015, ECO:0000269|PubMed:12505986,
CC       ECO:0000269|PubMed:12773381, ECO:0000269|PubMed:15378032,
CC       ECO:0000269|PubMed:20098723, ECO:0000269|PubMed:20682791,
CC       ECO:0000269|PubMed:8521472, ECO:0000269|PubMed:9045618,
CC       ECO:0000269|PubMed:9323142}.
CC   -!- INTERACTION:
CC       Q15276; Q9NYB9-2: ABI2; NbExp=3; IntAct=EBI-447043, EBI-11096309;
CC       Q15276; Q13155: AIMP2; NbExp=3; IntAct=EBI-447043, EBI-745226;
CC       Q15276; O43747: AP1G1; NbExp=2; IntAct=EBI-447043, EBI-447609;
CC       Q15276; O75843: AP1G2; NbExp=2; IntAct=EBI-447043, EBI-373637;
CC       Q15276; Q99728: BARD1; NbExp=3; IntAct=EBI-447043, EBI-473181;
CC       Q15276; Q96HB5: CCDC120; NbExp=3; IntAct=EBI-447043, EBI-744556;
CC       Q15276; A5D8V7: CCDC151; NbExp=3; IntAct=EBI-447043, EBI-8466445;
CC       Q15276; Q6P1J9: CDC73; NbExp=3; IntAct=EBI-447043, EBI-930143;
CC       Q15276; Q07002: CDK18; NbExp=3; IntAct=EBI-447043, EBI-746238;
CC       Q15276; Q8IVW4: CDKL3; NbExp=3; IntAct=EBI-447043, EBI-3919850;
CC       Q15276; Q86XR8-3: CEP57; NbExp=3; IntAct=EBI-447043, EBI-11752486;
CC       Q15276; Q96M91: CFAP53; NbExp=3; IntAct=EBI-447043, EBI-742422;
CC       Q15276; Q14241: ELOA; NbExp=3; IntAct=EBI-447043, EBI-742350;
CC       Q15276; Q56NI9: ESCO2; NbExp=3; IntAct=EBI-447043, EBI-3951849;
CC       Q15276; Q9Y247: FAM50B; NbExp=3; IntAct=EBI-447043, EBI-742802;
CC       Q15276; Q86YD7: FAM90A1; NbExp=3; IntAct=EBI-447043, EBI-6658203;
CC       Q15276; Q9UJY5: GGA1; NbExp=8; IntAct=EBI-447043, EBI-447141;
CC       Q15276; Q9UJY4: GGA2; NbExp=7; IntAct=EBI-447043, EBI-447646;
CC       Q15276; Q9NZ52: GGA3; NbExp=4; IntAct=EBI-447043, EBI-447404;
CC       Q15276; Q96BZ8: LENG1; NbExp=3; IntAct=EBI-447043, EBI-726510;
CC       Q15276; Q9NZL9: MAT2B; NbExp=3; IntAct=EBI-447043, EBI-10317491;
CC       Q15276; Q96EZ8: MCRS1; NbExp=3; IntAct=EBI-447043, EBI-348259;
CC       Q15276; Q9HAT8: PELI2; NbExp=3; IntAct=EBI-447043, EBI-448407;
CC       Q15276; Q99959-2: PKP2; NbExp=3; IntAct=EBI-447043, EBI-10987518;
CC       Q15276; O43395: PRPF3; NbExp=3; IntAct=EBI-447043, EBI-744322;
CC       Q15276; P20338: RAB4A; NbExp=3; IntAct=EBI-447043, EBI-722284;
CC       Q15276; P61018: RAB4B; NbExp=3; IntAct=EBI-447043, EBI-10218066;
CC       Q15276; Q9UJ41-2: RABGEF1; NbExp=2; IntAct=EBI-447043, EBI-6448458;
CC       Q15276; Q9H2S5: RNF39; NbExp=3; IntAct=EBI-447043, EBI-12235180;
CC       Q15276; Q13573: SNW1; NbExp=3; IntAct=EBI-447043, EBI-632715;
CC       Q15276; P49675: STAR; NbExp=3; IntAct=EBI-447043, EBI-722932;
CC       Q15276; Q8IZW8: TNS4; NbExp=3; IntAct=EBI-447043, EBI-7543499;
CC       Q15276; Q9UL33-2: TRAPPC2L; NbExp=3; IntAct=EBI-447043, EBI-11119202;
CC       Q15276; Q9NRE2: TSHZ2; NbExp=3; IntAct=EBI-447043, EBI-10687282;
CC       Q15276; P0CB47: UBTFL1; NbExp=3; IntAct=EBI-447043, EBI-17208936;
CC       Q15276; O75604: USP2; NbExp=3; IntAct=EBI-447043, EBI-743272;
CC       Q15276; Q5TAP6: UTP14C; NbExp=3; IntAct=EBI-447043, EBI-11737646;
CC       Q15276; Q9Y3C0: WASHC3; NbExp=3; IntAct=EBI-447043, EBI-712969;
CC       Q15276; P68590: yscH; Xeno; NbExp=2; IntAct=EBI-447043, EBI-2845098;
CC       Q15276; Q7Z4V0: ZNF438; NbExp=3; IntAct=EBI-447043, EBI-11962468;
CC       Q15276; Q96KM6: ZNF512B; NbExp=3; IntAct=EBI-447043, EBI-1049952;
CC       Q15276; Q6NX45: ZNF774; NbExp=3; IntAct=EBI-447043, EBI-10251462;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Early endosome. Recycling endosome.
CC       Cytoplasmic vesicle.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=Rabaptin-5;
CC         IsoId=Q15276-1; Sequence=Displayed;
CC       Name=2; Synonyms=Rabaptin-4;
CC         IsoId=Q15276-2; Sequence=VSP_010451;
CC   -!- PTM: Proteolytic cleavage by caspases in apoptotic cells causes loss of
CC       endosome fusion activity. {ECO:0000269|PubMed:9321397}.
CC   -!- SIMILARITY: Belongs to the rabaptin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X91141; CAA62580.1; -; mRNA.
DR   EMBL; AF098638; AAC70781.1; -; mRNA.
DR   EMBL; AK314183; BAG36864.1; -; mRNA.
DR   EMBL; BC041700; AAH41700.1; -; mRNA.
DR   CCDS; CCDS42243.1; -. [Q15276-2]
DR   CCDS; CCDS45592.1; -. [Q15276-1]
DR   RefSeq; NP_001077054.1; NM_001083585.2. [Q15276-2]
DR   RefSeq; NP_001278510.1; NM_001291581.1.
DR   RefSeq; NP_004694.2; NM_004703.5. [Q15276-1]
DR   PDB; 1P4U; X-ray; 2.20 A; B=435-447.
DR   PDB; 1TU3; X-ray; 2.31 A; F/G/H/I/J=789-862.
DR   PDB; 1X79; X-ray; 2.41 A; B/C=551-661.
DR   PDB; 4N3Y; X-ray; 2.20 A; B/C=552-642.
DR   PDB; 4N3Z; X-ray; 3.10 A; B/C=552-642.
DR   PDB; 4Q9U; X-ray; 4.62 A; C/D/G/H=552-642.
DR   PDBsum; 1P4U; -.
DR   PDBsum; 1TU3; -.
DR   PDBsum; 1X79; -.
DR   PDBsum; 4N3Y; -.
DR   PDBsum; 4N3Z; -.
DR   PDBsum; 4Q9U; -.
DR   SMR; Q15276; -.
DR   BioGrid; 114583; 83.
DR   CORUM; Q15276; -.
DR   DIP; DIP-29350N; -.
DR   IntAct; Q15276; 76.
DR   MINT; Q15276; -.
DR   STRING; 9606.ENSP00000445408; -.
DR   iPTMnet; Q15276; -.
DR   MetOSite; Q15276; -.
DR   PhosphoSitePlus; Q15276; -.
DR   BioMuta; RABEP1; -.
DR   DMDM; 116242743; -.
DR   EPD; Q15276; -.
DR   jPOST; Q15276; -.
DR   MassIVE; Q15276; -.
DR   MaxQB; Q15276; -.
DR   PaxDb; Q15276; -.
DR   PeptideAtlas; Q15276; -.
DR   PRIDE; Q15276; -.
DR   ProteomicsDB; 60509; -. [Q15276-1]
DR   ProteomicsDB; 60510; -. [Q15276-2]
DR   Antibodypedia; 3875; 107 antibodies.
DR   Ensembl; ENST00000341923; ENSP00000339569; ENSG00000029725. [Q15276-2]
DR   Ensembl; ENST00000537505; ENSP00000445408; ENSG00000029725. [Q15276-1]
DR   GeneID; 9135; -.
DR   KEGG; hsa:9135; -.
DR   UCSC; uc032ery.2; human. [Q15276-1]
DR   CTD; 9135; -.
DR   DisGeNET; 9135; -.
DR   GeneCards; RABEP1; -.
DR   HGNC; HGNC:17677; RABEP1.
DR   HPA; ENSG00000029725; Low tissue specificity.
DR   MIM; 603616; gene.
DR   neXtProt; NX_Q15276; -.
DR   OpenTargets; ENSG00000029725; -.
DR   PharmGKB; PA134884097; -.
DR   eggNOG; KOG0993; Eukaryota.
DR   eggNOG; ENOG410XSZ1; LUCA.
DR   GeneTree; ENSGT00530000063743; -.
DR   HOGENOM; CLU_016882_0_0_1; -.
DR   InParanoid; Q15276; -.
DR   KO; K12480; -.
DR   OMA; LGYNNKA; -.
DR   OrthoDB; 1369937at2759; -.
DR   PhylomeDB; Q15276; -.
DR   TreeFam; TF329365; -.
DR   Reactome; R-HSA-8854214; TBC/RABGAPs.
DR   SIGNOR; Q15276; -.
DR   ChiTaRS; RABEP1; human.
DR   EvolutionaryTrace; Q15276; -.
DR   GeneWiki; RABEP1; -.
DR   GenomeRNAi; 9135; -.
DR   Pharos; Q15276; Tbio.
DR   PRO; PR:Q15276; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q15276; protein.
DR   Bgee; ENSG00000029725; Expressed in corpus callosum and 216 other tissues.
DR   ExpressionAtlas; Q15276; baseline and differential.
DR   Genevisible; Q15276; HS.
DR   GO; GO:0005769; C:early endosome; TAS:ProtInc.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0030139; C:endocytic vesicle; IDA:UniProtKB.
DR   GO; GO:0005768; C:endosome; IDA:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0032991; C:protein-containing complex; IMP:CAFA.
DR   GO; GO:0055037; C:recycling endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0008083; F:growth factor activity; IEA:InterPro.
DR   GO; GO:0005096; F:GTPase activator activity; IEA:InterPro.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:CAFA.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0006897; P:endocytosis; TAS:ProtInc.
DR   GO; GO:0006893; P:Golgi to plasma membrane transport; ISS:UniProtKB.
DR   GO; GO:0061025; P:membrane fusion; TAS:ProtInc.
DR   GO; GO:1903441; P:protein localization to ciliary membrane; ISS:UniProtKB.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   GO; GO:0016192; P:vesicle-mediated transport; IMP:UniProtKB.
DR   InterPro; IPR003914; Rabaptin.
DR   InterPro; IPR029880; Rabaptin-5.
DR   InterPro; IPR018514; Rabaptin_coiled-coil.
DR   InterPro; IPR015390; Rabaptin_Rab5-bd_dom.
DR   PANTHER; PTHR31179; PTHR31179; 1.
DR   PANTHER; PTHR31179:SF5; PTHR31179:SF5; 1.
DR   Pfam; PF09311; Rab5-bind; 1.
DR   Pfam; PF03528; Rabaptin; 1.
DR   PRINTS; PR01432; RABAPTIN.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Apoptosis; Coiled coil;
KW   Cytoplasm; Cytoplasmic vesicle; Direct protein sequencing; Endocytosis;
KW   Endosome; Phosphoprotein; Polymorphism; Protein transport;
KW   Reference proteome; Transport.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000244|PubMed:22814378"
FT   CHAIN           2..862
FT                   /note="Rab GTPase-binding effector protein 1"
FT                   /id="PRO_0000187556"
FT   COILED          11..345
FT                   /evidence="ECO:0000255"
FT   COILED          534..816
FT                   /evidence="ECO:0000255"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000244|PubMed:22814378"
FT   MOD_RES         282
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         374
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         377
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         407
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:16964243,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         408
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         410
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   VAR_SEQ         758..790
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10698684"
FT                   /id="VSP_010451"
FT   VARIANT         640
FT                   /note="E -> G (in dbSNP:rs3026099)"
FT                   /id="VAR_028106"
FT   MUTAGEN         812
FT                   /note="D->K: No effect on RAB5A binding affinity."
FT                   /evidence="ECO:0000269|PubMed:15378032"
FT   MUTAGEN         815
FT                   /note="E->K: No effect on RAB5A binding affinity."
FT                   /evidence="ECO:0000269|PubMed:15378032"
FT   MUTAGEN         818
FT                   /note="Q->W: Strongly decreases RAB5A binding affinity."
FT                   /evidence="ECO:0000269|PubMed:15378032"
FT   MUTAGEN         820
FT                   /note="D->K: Strongly decreases RAB5A binding affinity."
FT                   /evidence="ECO:0000269|PubMed:15378032"
FT   MUTAGEN         821
FT                   /note="F->R: Strongly decreases RAB5A binding affinity."
FT                   /evidence="ECO:0000269|PubMed:15378032"
FT   MUTAGEN         822
FT                   /note="V->D: Strongly decreases RAB5A binding affinity."
FT                   /evidence="ECO:0000269|PubMed:15378032"
FT   MUTAGEN         826
FT                   /note="Q->A: Strongly decreases RAB5A binding affinity."
FT                   /evidence="ECO:0000269|PubMed:15378032"
FT   MUTAGEN         829
FT                   /note="Q->A: Strongly decreases RAB5A binding affinity."
FT                   /evidence="ECO:0000269|PubMed:15378032"
FT   CONFLICT        149
FT                   /note="S -> Y (in Ref. 1; CAA62580 and 2; AAC70781)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        628
FT                   /note="M -> I (in Ref. 3; BAG36864)"
FT                   /evidence="ECO:0000305"
FT   HELIX           553..633
FT                   /evidence="ECO:0000244|PDB:4N3Y"
FT   HELIX           805..836
FT                   /evidence="ECO:0000244|PDB:1TU3"
FT   HELIX           841..847
FT                   /evidence="ECO:0000244|PDB:1TU3"
SQ   SEQUENCE   862 AA;  99290 MW;  CAAF91638B8ED516 CRC64;
     MAQPGPASQP DVSLQQRVAE LEKINAEFLR AQQQLEQEFN QKRAKFKELY LAKEEDLKRQ
     NAVLQAAQDD LGHLRTQLWE AQAEMENIKA IATVSENTKQ EAIDEVKRQW REEVASLQAV
     MKETVRDYEH QFHLRLEQER TQWAQYRESA EREIADLRRR LSEGQEEENL ENEMKKAQED
     AEKLRSVVMP MEKEIAALKD KLTEAEDKIK ELEASKVKEL NHYLEAEKSC RTDLEMYVAV
     LNTQKSVLQE DAEKLRKELH EVCHLLEQER QQHNQLKHTW QKANDQFLES QRLLMRDMQR
     MEIVLTSEQL RQVEELKKKD QEDDEQQRLN KRKDHKKADV EEEIKIPVVC ALTQEESSAQ
     LSNEEEHLDS TRGSVHSLDA GLLLPSGDPF SKSDNDMFKD GLRRAQSTDS LGTSGSLQSK
     ALGYNYKAKS AGNLDESDFG PLVGADSVSE NFDTASLGSL QMPSGFMLTK DQERAIKAMT
     PEQEETASLL SSVTQGMESA YVSPSGYRLV SETEWNLLQK EVHNAGNKLG RRCDMCSNYE
     KQLQGIQIQE AETRDQVKKL QLMLRQANDQ LEKTMKDKQE LEDFIKQSSE DSSHQISALV
     LRAQASEILL EELQQGLSQA KRDVQEQMAV LMQSREQVSE ELVRLQKDND SLQGKHSLHV
     SLQQAEDFIL PDTTEALREL VLKYREDIIN VRTAADHVEE KLKAEILFLK EQIQAEQCLK
     ENLEETLQLE IENCKEEIAS ISSLKAELER IKVEKGQLES TLREKSQQLE SLQEIKISLE
     EQLKKETAAK ATVEQLMFEE KNKAQRLQTE LDVSEQVQRD FVKLSQTLQV QLERIRQADS
     LERIRAILND TKLTDINQLP ET
//
ID   RBM15_HUMAN             Reviewed;         977 AA.
AC   Q96T37; A1A693; Q3ZB86; Q4V760; Q5D058; Q5T613; Q86VW9; Q96PE4; Q96SC5;
AC   Q96SC6; Q96SC9; Q96SD0; Q96T38; Q9BRA5; Q9H6R8; Q9H9Y0;
DT   27-MAR-2002, integrated into UniProtKB/Swiss-Prot.
DT   27-JUN-2003, sequence version 2.
DT   22-APR-2020, entry version 188.
DE   RecName: Full=RNA-binding protein 15 {ECO:0000305};
DE   AltName: Full=One-twenty two protein 1 {ECO:0000303|PubMed:16129689};
DE   AltName: Full=RNA-binding motif protein 15 {ECO:0000303|PubMed:11431691};
GN   Name=RBM15 {ECO:0000303|PubMed:11431691, ECO:0000312|HGNC:HGNC:14959};
GN   Synonyms=OTT {ECO:0000303|PubMed:16129689},
GN   OTT1 {ECO:0000303|PubMed:16129689};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3), AND CHROMOSOMAL
RP   TRANSLOCATION WITH MKL1.
RX   PubMed=11431691; DOI=10.1038/90054;
RA   Ma Z., Morris S.W., Valentine V., Li M., Herbrick J.-A., Cui X., Bouman D.,
RA   Li Y., Mehta P.K., Nizetic D., Kaneko Y., Chan G.C.F., Chan L.C.,
RA   Squire J., Scherer S.W., Hitzler J.K.;
RT   "Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of
RT   acute megakaryoblastic leukemia.";
RL   Nat. Genet. 28:220-221(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], FUNCTION, AND CHROMOSOMAL
RP   TRANSLOCATION WITH MKL1.
RX   PubMed=11344311; DOI=10.1073/pnas.101001498;
RA   Mercher T., Coniat M.B.-L., Monni R., Mauchauffe M., Khac F.N., Gressin L.,
RA   Mugneret F., Leblanc T., Dastugue N., Berger R., Bernard O.A.;
RT   "Involvement of a human gene related to the Drosophila spen gene in the
RT   recurrent t(1;22) translocation of acute megakaryocytic leukemia.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:5776-5779(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   PARTIAL NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Hepatoma, and Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 21-977 (ISOFORM 1).
RC   TISSUE=Melanoma, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INTERACTION WITH EBV BSFL2/BMLF1 (MICROBIAL INFECTION).
RX   PubMed=16129689; DOI=10.1074/jbc.m501725200;
RA   Hiriart E., Gruffat H., Buisson M., Mikaelian I., Keppler S., Meresse P.,
RA   Mercher T., Bernard O.A., Sergeant A., Manet E.;
RT   "Interaction of the Epstein-Barr virus mRNA export factor EB2 with human
RT   Spen proteins SHARP, OTT1, and a novel member of the family, OTT3, links
RT   Spen proteins with splicing regulation and mRNA export.";
RL   J. Biol. Chem. 280:36935-36945(2005).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-568; SER-622 AND SER-700, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, ALTERNATIVE INITIATION (ISOFORM 4),
RP   RNA-BINDING, AND INTERACTION WITH NXF1.
RX   PubMed=17001072; DOI=10.1074/jbc.m608745200;
RA   Lindtner S., Zolotukhin A.S., Uranishi H., Bear J., Kulkarni V.,
RA   Smulevitch S., Samiotaki M., Panayotou G., Felber B.K., Pavlakis G.N.;
RT   "RNA-binding motif protein 15 binds to the RNA transport element RTE and
RT   provides a direct link to the NXF1 export pathway.";
RL   J. Biol. Chem. 281:36915-36928(2006).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-294, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-568; SER-670 AND SER-674, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-257; SER-259; SER-292;
RP   SER-294; THR-568; SER-670; SER-674; SER-741 AND SER-935, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [16]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=19786495; DOI=10.1093/nar/gkp782;
RA   Zolotukhin A.S., Uranishi H., Lindtner S., Bear J., Pavlakis G.N.,
RA   Felber B.K.;
RT   "Nuclear export factor RBM15 facilitates the access of DBP5 to mRNA.";
RL   Nucleic Acids Res. 37:7151-7162(2009).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-670 AND SER-674, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [18]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-450, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-109; SER-210; SER-257;
RP   SER-259; SER-294; SER-365; THR-568; SER-622; SER-670; SER-765 AND SER-935,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [21]
RP   SUBCELLULAR LOCATION.
RX   PubMed=19586903; DOI=10.1074/jbc.m109.040113;
RA   Uranishi H., Zolotukhin A.S., Lindtner S., Warming S., Zhang G.M., Bear J.,
RA   Copeland N.G., Jenkins N.A., Pavlakis G.N., Felber B.K.;
RT   "The RNA-binding motif protein 15B (RBM15B/OTT3) acts as cofactor of the
RT   nuclear export receptor NXF1.";
RL   J. Biol. Chem. 284:26106-26116(2009).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-109; SER-294; THR-568;
RP   SER-741 AND SER-765, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [23]
RP   INTERACTION WITH SETD1B, AND MUTAGENESIS OF LYS-795; LYS-898 AND PHE-923.
RX   PubMed=22927943; DOI=10.1371/journal.pone.0042965;
RA   Lee J.H., Skalnik D.G.;
RT   "Rbm15-Mkl1 interacts with the Setd1b histone H3-Lys4 methyltransferase via
RT   a SPOC domain that is required for cytokine-independent proliferation.";
RL   PLoS ONE 7:E42965-E42965(2012).
RN   [24]
RP   IDENTIFICATION IN A MACOM-LIKE COMPLEX, AND SUBCELLULAR LOCATION.
RX   PubMed=24100041; DOI=10.1074/jbc.m113.500397;
RA   Horiuchi K., Kawamura T., Iwanari H., Ohashi R., Naito M., Kodama T.,
RA   Hamakubo T.;
RT   "Identification of Wilms' tumor 1-associating protein complex and its role
RT   in alternative splicing and the cell cycle.";
RL   J. Biol. Chem. 288:33292-33302(2013).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-179; SER-208; SER-253;
RP   SER-257; SER-259; SER-292; SER-294; THR-568; SER-622; SER-656; SER-670;
RP   SER-674; SER-700; SER-741; SER-765; SER-767; SER-781 AND SER-935, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-109; SER-257; SER-259;
RP   TYR-266; SER-292; SER-294; THR-568; SER-670; SER-674; SER-700 AND SER-741,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [27]
RP   FUNCTION, METHYLATION AT ARG-578, UBIQUITINATION, INTERACTION WITH SF3B1,
RP   AND MUTAGENESIS OF 574-ARG--ARG-578 AND ARG-578.
RX   PubMed=26575292; DOI=10.7554/elife.07938;
RA   Zhang L., Tran N.T., Su H., Wang R., Lu Y., Tang H., Aoyagi S., Guo A.,
RA   Khodadadi-Jamayran A., Zhou D., Qian K., Hricik T., Cote J., Han X.,
RA   Zhou W., Laha S., Abdel-Wahab O., Levine R.L., Raffel G., Liu Y., Chen D.,
RA   Li H., Townes T., Wang H., Deng H., Zheng Y.G., Leslie C., Luo M., Zhao X.;
RT   "Cross-talk between PRMT1-mediated methylation and ubiquitylation on RBM15
RT   controls RNA splicing.";
RL   Elife 4:0-0(2015).
RN   [28]
RP   FUNCTION, RNA-BINDING, AND IDENTIFICATION IN THE WMM COMPLEX.
RX   PubMed=27602518; DOI=10.1038/nature19342;
RA   Patil D.P., Chen C.K., Pickering B.F., Chow A., Jackson C., Guttman M.,
RA   Jaffrey S.R.;
RT   "m(6)A RNA methylation promotes XIST-mediated transcriptional repression.";
RL   Nature 537:369-373(2016).
RN   [29]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-246; LYS-406; LYS-420; LYS-445
RP   AND LYS-744, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: RNA-binding protein that acts as a key regulator of N6-
CC       methyladenosine (m6A) methylation of RNAs, thereby regulating different
CC       processes, such as hematopoietic cell homeostasis, alternative splicing
CC       of mRNAs and X chromosome inactivation mediated by Xist RNA
CC       (PubMed:27602518). Associated component of the WMM complex, a complex
CC       that mediates N6-methyladenosine (m6A) methylation of RNAs, a
CC       modification that plays a role in the efficiency of mRNA splicing and
CC       RNA processing (By similarity). Plays a key role in m6A methylation,
CC       possibly by binding target RNAs and recruiting the WMM complex
CC       (PubMed:27602518). Involved in random X inactivation mediated by Xist
CC       RNA: acts by binding Xist RNA and recruiting the WMM complex, which
CC       mediates m6A methylation, leading to target YTHDC1 reader on Xist RNA
CC       and promoting transcription repression activity of Xist
CC       (PubMed:27602518). Required for the development of multiple tissues,
CC       such as the maintenance of the homeostasis of long-term hematopoietic
CC       stem cells and for megakaryocyte (MK) and B-cell differentiation (By
CC       similarity). Regulates megakaryocyte differentiation by regulating
CC       alternative splicing of genes important for megakaryocyte
CC       differentiation; probably regulates alternative splicing via m6A
CC       regulation (PubMed:26575292). Required for placental vascular branching
CC       morphogenesis and embryonic development of the heart and spleen (By
CC       similarity). Acts as a regulator of thrombopoietin response in
CC       hematopoietic stem cells by regulating alternative splicing of MPL (By
CC       similarity). May also function as an mRNA export factor, stimulating
CC       export and expression of RTE-containing mRNAs which are present in many
CC       retrotransposons that require to be exported prior to splicing
CC       (PubMed:17001072, PubMed:19786495). High affinity binding of pre-mRNA
CC       to RBM15 may allow targeting of the mRNP to the export helicase DBP5 in
CC       a manner that is independent of splicing-mediated NXF1 deposition,
CC       resulting in export prior to splicing (PubMed:17001072,
CC       PubMed:19786495). May be implicated in HOX gene regulation
CC       (PubMed:11344311). {ECO:0000250|UniProtKB:Q0VBL3,
CC       ECO:0000269|PubMed:17001072, ECO:0000269|PubMed:19786495,
CC       ECO:0000269|PubMed:26575292, ECO:0000269|PubMed:27602518,
CC       ECO:0000305|PubMed:11344311}.
CC   -!- SUBUNIT: Component of the WMM complex, a N6-methyltransferase complex
CC       composed of a catalytic subcomplex, named MAC, and of an associated
CC       subcomplex, named MACOM (PubMed:27602518). The MAC subcomplex is
CC       composed of METTL3 and METTL14 (PubMed:27602518). The MACOM subcomplex
CC       is composed of WTAP, ZC3H13, CBLL1/HAKAI, VIRMA, and, in some cases of
CC       RBM15 (RBM15 or RBM15B) (PubMed:27602518). Also component of a MACOM-
CC       like complex, named WTAP complex, composed of WTAP, ZC3H13, CBLL1,
CC       VIRMA, RBM15, BCLAF1 and THRAP3 (PubMed:24100041). Interacts with RBPJ
CC       (By similarity). Interacts (via SPOC domain) with SETD1B
CC       (PubMed:22927943). Interacts with NXF1, the interaction is required to
CC       promote mRNA export (PubMed:17001072). Interacts with SF3B1
CC       (PubMed:26575292). {ECO:0000250|UniProtKB:Q0VBL3,
CC       ECO:0000269|PubMed:17001072, ECO:0000269|PubMed:22927943,
CC       ECO:0000269|PubMed:24100041, ECO:0000269|PubMed:26575292,
CC       ECO:0000269|PubMed:27602518}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with Epstein-Barr virus
CC       BSFL2/BMLF1. {ECO:0000269|PubMed:16129689}.
CC   -!- INTERACTION:
CC       Q96T37-3; Q8IZP0-5: ABI1; NbExp=3; IntAct=EBI-12041043, EBI-11743294;
CC       Q96T37; Q13137: CALCOCO2; NbExp=3; IntAct=EBI-2514922, EBI-739580;
CC       Q96T37; Q9C0F1: CEP44; NbExp=3; IntAct=EBI-2514922, EBI-744115;
CC       Q96T37; Q92841: DDX17; NbExp=5; IntAct=EBI-2514922, EBI-746012;
CC       Q96T37; Q9BRK4: LZTS2; NbExp=3; IntAct=EBI-2514922, EBI-741037;
CC       Q96T37; Q8IVL1: NAV2; NbExp=3; IntAct=EBI-2514922, EBI-741200;
CC       Q96T37-3; Q9H2G4: TSPYL2; NbExp=3; IntAct=EBI-12041043, EBI-947459;
CC   -!- SUBCELLULAR LOCATION: Nucleus speckle {ECO:0000269|PubMed:19586903,
CC       ECO:0000269|PubMed:24100041}. Nucleus, nucleoplasm
CC       {ECO:0000269|PubMed:17001072, ECO:0000269|PubMed:19786495,
CC       ECO:0000269|PubMed:24100041}. Nucleus envelope
CC       {ECO:0000269|PubMed:19586903}. Nucleus membrane
CC       {ECO:0000269|PubMed:19786495}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:19786495}. Note=Colocalizes at the nuclear pore
CC       with DBP5 and NXF1. {ECO:0000269|PubMed:19786495}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing, Alternative initiation; Named isoforms=4;
CC       Name=1; Synonyms=RBM15s+ae;
CC         IsoId=Q96T37-1; Sequence=Displayed;
CC       Name=2; Synonyms=RBM15L;
CC         IsoId=Q96T37-2; Sequence=VSP_005811;
CC       Name=3; Synonyms=RBM15S;
CC         IsoId=Q96T37-3; Sequence=VSP_005812;
CC       Name=4;
CC         IsoId=Q96T37-4; Sequence=VSP_053877, VSP_005811;
CC   -!- PTM: Methylated at Arg-578 by PRMT1, leading to promote ubiquitination
CC       by CNOT4 and subsequent degradation by the proteasome.
CC       {ECO:0000269|PubMed:26575292}.
CC   -!- PTM: Ubiquitinated by CNOT4 following methylation at Arg-578 by PRMT1.
CC       {ECO:0000269|PubMed:26575292}.
CC   -!- DISEASE: Note=A chromosomal aberration involving RBM15 may be a cause
CC       of acute megakaryoblastic leukemia. Translocation t(1;22)(p13;q13) with
CC       MKL1. Although both reciprocal fusion transcripts are detected in acute
CC       megakaryoblastic leukemia (AMKL, FAB-M7), the RBM15-MKL1 chimeric
CC       protein has all the putative functional domains encoded by each gene
CC       and is the candidate oncogene. {ECO:0000269|PubMed:11344311,
CC       ECO:0000269|PubMed:11431691}.
CC   -!- MISCELLANEOUS: [Isoform 4]: Produced by alternative initiation of
CC       isoform 2. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the RRM Spen family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB14088.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAB15185.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/OTTID175.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF368062; AAK54722.1; -; mRNA.
DR   EMBL; AF368063; AAK54723.1; -; mRNA.
DR   EMBL; AF368064; AAK54724.1; -; mRNA.
DR   EMBL; AF364035; AAK56920.1; ALT_TERM; mRNA.
DR   EMBL; AJ303089; CAC38828.1; ALT_TERM; mRNA.
DR   EMBL; AJ303090; CAC38829.1; ALT_TERM; mRNA.
DR   EMBL; AJ297259; CAC38861.1; -; Genomic_DNA.
DR   EMBL; AJ297259; CAC38862.1; -; Genomic_DNA.
DR   EMBL; AK022541; BAB14088.1; ALT_INIT; mRNA.
DR   EMBL; AK025596; BAB15185.1; ALT_INIT; mRNA.
DR   EMBL; AL355488; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471122; EAW56439.1; -; Genomic_DNA.
DR   EMBL; BC006397; AAH06397.2; -; mRNA.
DR   EMBL; BC047479; AAH47479.1; -; mRNA.
DR   EMBL; BC062316; AAH62316.1; -; mRNA.
DR   EMBL; BC098140; AAH98140.1; -; mRNA.
DR   EMBL; BC103493; AAI03494.1; -; mRNA.
DR   EMBL; BC103507; AAI03508.1; -; mRNA.
DR   EMBL; BK005915; DAA05818.1; -; mRNA.
DR   CCDS; CCDS59198.1; -. [Q96T37-3]
DR   CCDS; CCDS822.1; -. [Q96T37-1]
DR   RefSeq; NP_001188474.1; NM_001201545.1. [Q96T37-3]
DR   RefSeq; NP_073605.4; NM_022768.4. [Q96T37-1]
DR   BioGrid; 122293; 61.
DR   CORUM; Q96T37; -.
DR   IntAct; Q96T37; 33.
DR   MINT; Q96T37; -.
DR   STRING; 9606.ENSP00000358799; -.
DR   iPTMnet; Q96T37; -.
DR   PhosphoSitePlus; Q96T37; -.
DR   SwissPalm; Q96T37; -.
DR   BioMuta; RBM15; -.
DR   DMDM; 32363506; -.
DR   EPD; Q96T37; -.
DR   jPOST; Q96T37; -.
DR   MassIVE; Q96T37; -.
DR   MaxQB; Q96T37; -.
DR   PaxDb; Q96T37; -.
DR   PeptideAtlas; Q96T37; -.
DR   PRIDE; Q96T37; -.
DR   ProteomicsDB; 78180; -. [Q96T37-1]
DR   ProteomicsDB; 78181; -. [Q96T37-2]
DR   ProteomicsDB; 78182; -. [Q96T37-3]
DR   Antibodypedia; 4448; 121 antibodies.
DR   DNASU; 64783; -.
DR   Ensembl; ENST00000369784; ENSP00000358799; ENSG00000162775. [Q96T37-1]
DR   Ensembl; ENST00000487146; ENSP00000473552; ENSG00000162775. [Q96T37-3]
DR   Ensembl; ENST00000602849; ENSP00000473638; ENSG00000162775. [Q96T37-2]
DR   Ensembl; ENST00000618772; ENSP00000483133; ENSG00000162775. [Q96T37-1]
DR   Ensembl; ENST00000652342; ENSP00000498328; ENSG00000162775. [Q96T37-4]
DR   Ensembl; ENST00000652747; ENSP00000498634; ENSG00000162775. [Q96T37-3]
DR   GeneID; 64783; -.
DR   KEGG; hsa:64783; -.
DR   UCSC; uc001dzl.1; human. [Q96T37-1]
DR   CTD; 64783; -.
DR   DisGeNET; 64783; -.
DR   GeneCards; RBM15; -.
DR   HGNC; HGNC:14959; RBM15.
DR   HPA; ENSG00000162775; Tissue enhanced (bone).
DR   MalaCards; RBM15; -.
DR   MIM; 606077; gene.
DR   neXtProt; NX_Q96T37; -.
DR   OpenTargets; ENSG00000162775; -.
DR   Orphanet; 402023; Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13).
DR   PharmGKB; PA34264; -.
DR   eggNOG; KOG0112; Eukaryota.
DR   eggNOG; ENOG410XSAC; LUCA.
DR   GeneTree; ENSGT00940000158161; -.
DR   InParanoid; Q96T37; -.
DR   KO; K13190; -.
DR   OMA; REPWSLE; -.
DR   OrthoDB; 367857at2759; -.
DR   PhylomeDB; Q96T37; -.
DR   TreeFam; TF315637; -.
DR   SIGNOR; Q96T37; -.
DR   ChiTaRS; RBM15; human.
DR   GeneWiki; RBM15; -.
DR   GenomeRNAi; 64783; -.
DR   Pharos; Q96T37; Tbio.
DR   PRO; PR:Q96T37; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q96T37; protein.
DR   Bgee; ENSG00000162775; Expressed in secondary oocyte and 232 other tissues.
DR   ExpressionAtlas; Q96T37; baseline and differential.
DR   Genevisible; Q96T37; HS.
DR   GO; GO:0031965; C:nuclear membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016607; C:nuclear speck; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:UniProtKB.
DR   GO; GO:0036396; C:RNA N6-methyladenosine methyltransferase complex; IDA:UniProtKB.
DR   GO; GO:0003729; F:mRNA binding; IDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0001569; P:branching involved in blood vessel morphogenesis; IEA:Ensembl.
DR   GO; GO:0009048; P:dosage compensation by inactivation of X chromosome; IDA:UniProtKB.
DR   GO; GO:0045638; P:negative regulation of myeloid cell differentiation; IEA:Ensembl.
DR   GO; GO:0060674; P:placenta blood vessel development; IEA:Ensembl.
DR   GO; GO:0007221; P:positive regulation of transcription of Notch receptor target; IEA:Ensembl.
DR   GO; GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; IDA:UniProtKB.
DR   GO; GO:0045652; P:regulation of megakaryocyte differentiation; IDA:UniProtKB.
DR   GO; GO:0001510; P:RNA methylation; IDA:UniProtKB.
DR   GO; GO:0048536; P:spleen development; IEA:Ensembl.
DR   GO; GO:0038163; P:thrombopoietin-mediated signaling pathway; ISS:UniProtKB.
DR   GO; GO:0060412; P:ventricular septum morphogenesis; IEA:Ensembl.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   CDD; cd12553; RRM1_RBM15; 1.
DR   CDD; cd12555; RRM2_RBM15; 1.
DR   CDD; cd12557; RRM3_RBM15; 1.
DR   Gene3D; 2.40.290.10; -; 1.
DR   Gene3D; 3.30.70.330; -; 3.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR034470; RBM15_RRM1.
DR   InterPro; IPR034472; RBM15_RRM2.
DR   InterPro; IPR034473; RBM15_RRM3.
DR   InterPro; IPR000504; RRM_dom.
DR   InterPro; IPR016194; SPOC-like_C_dom_sf.
DR   InterPro; IPR012921; SPOC_C.
DR   InterPro; IPR010912; SPOC_met.
DR   Pfam; PF00076; RRM_1; 2.
DR   Pfam; PF07744; SPOC; 1.
DR   SMART; SM00360; RRM; 3.
DR   SUPFAM; SSF100939; SSF100939; 1.
DR   SUPFAM; SSF54928; SSF54928; 2.
DR   PROSITE; PS50102; RRM; 3.
DR   PROSITE; PS50917; SPOC; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative initiation; Alternative splicing;
KW   Chromosomal rearrangement; Host-virus interaction; Isopeptide bond;
KW   Membrane; Methylation; Nucleus; Phosphoprotein; Proto-oncogene;
KW   Reference proteome; Repeat; RNA-binding; Ubl conjugation.
FT   CHAIN           1..977
FT                   /note="RNA-binding protein 15"
FT                   /id="PRO_0000081777"
FT   DOMAIN          170..252
FT                   /note="RRM 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   DOMAIN          374..451
FT                   /note="RRM 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   DOMAIN          455..529
FT                   /note="RRM 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   DOMAIN          777..956
FT                   /note="SPOC"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00249"
FT   COMPBIAS        60..166
FT                   /note="Gly/Ser-rich"
FT   COMPBIAS        616..732
FT                   /note="Arg-rich"
FT   SITE            954..955
FT                   /note="Breakpoint for translocation to form RBM15-MKL1"
FT                   /evidence="ECO:0000269|PubMed:11344311,
FT                   ECO:0000269|PubMed:11431691"
FT   MOD_RES         109
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:24275569"
FT   MOD_RES         179
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         208
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         210
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         253
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         257
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         259
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         266
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         292
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         294
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:16964243,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         365
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         450
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         568
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:18220336, ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         578
FT                   /note="Asymmetric dimethylarginine; alternate; by PRMT1"
FT                   /evidence="ECO:0000269|PubMed:26575292"
FT   MOD_RES         578
FT                   /note="Omega-N-methylarginine; alternate; by PRMT1"
FT                   /evidence="ECO:0000269|PubMed:26575292"
FT   MOD_RES         622
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163"
FT   MOD_RES         656
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         670
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18220336,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         674
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18220336,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         700
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         741
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         765
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163"
FT   MOD_RES         767
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         781
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         935
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163"
FT   CROSSLNK        246
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        406
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        420
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        445
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        744
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   VAR_SEQ         1..44
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_053877"
FT   VAR_SEQ         955..977
FT                   /note="GFGFQIGVRYENKKRENLALTLL -> AKLVEQRMKIWNSKL (in
FT                   isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:11431691,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_005812"
FT   VAR_SEQ         956..977
FT                   /note="FGFQIGVRYENKKRENLALTLL -> AS (in isoform 2 and
FT                   isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:11431691"
FT                   /id="VSP_005811"
FT   MUTAGEN         574..578
FT                   /note="RDRDR->KDKDK: Decreased, but not abolished
FT                   methylation by PRMT1."
FT                   /evidence="ECO:0000269|PubMed:26575292"
FT   MUTAGEN         578
FT                   /note="R->K: Decreased methylation by PRMT1, leading to
FT                   decreased ubiquitination by CNOT4."
FT                   /evidence="ECO:0000269|PubMed:26575292"
FT   MUTAGEN         795
FT                   /note="K->A: Disrupts interaction with SETD1B."
FT                   /evidence="ECO:0000269|PubMed:22927943"
FT   MUTAGEN         898
FT                   /note="K->A: Disrupts interaction with SETD1B."
FT                   /evidence="ECO:0000269|PubMed:22927943"
FT   MUTAGEN         923
FT                   /note="F->A: Disrupts interaction with SETD1B."
FT                   /evidence="ECO:0000269|PubMed:22927943"
FT   CONFLICT        99
FT                   /note="H -> L (in Ref. 1; AAK54722/AAK54723/AAK54724 and 3;
FT                   BAB14088)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        227
FT                   /note="D -> N (in Ref. 6; AAI03494)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        705
FT                   /note="R -> G (in Ref. 1; AAK54722/AAK54723/AAK54724 and 3;
FT                   BAB14088)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   977 AA;  107189 MW;  FB26AFE246E40282 CRC64;
     MRTAGRDPVP RRSPRWRRAV PLCETSAGRR VTQLRGDDLR RPATMKGKER SPVKAKRSRG
     GEDSTSRGER SKKLGGSGGS NGSSSGKTDS GGGSRRSLHL DKSSSRGGSR EYDTGGGSSS
     SRLHSYSSPS TKNSSGGGES RSSSRGGGGE SRSSGAASSA PGGGDGAEYK TLKISELGSQ
     LSDEAVEDGL FHEFKRFGDV SVKISHLSGS GSGDERVAFV NFRRPEDARA AKHARGRLVL
     YDRPLKIEAV YVSRRRSRSP LDKDTYPPSA SVVGASVGGH RHPPGGGGGQ RSLSPGGAAL
     GYRDYRLQQL ALGRLPPPPP PPLPRDLERE RDYPFYERVR PAYSLEPRVG AGAGAAPFRE
     VDEISPEDDQ RANRTLFLGN LDITVTESDL RRAFDRFGVI TEVDIKRPSR GQTSTYGFLK
     FENLDMSHRA KLAMSGKIII RNPIKIGYGK ATPTTRLWVG GLGPWVPLAA LAREFDRFGT
     IRTIDYRKGD SWAYIQYESL DAAHAAWTHM RGFPLGGPDR RLRVDFADTE HRYQQQYLQP
     LPLTHYELVT DAFGHRAPDP LRGARDRTPP LLYRDRDRDL YPDSDWVPPP PPVRERSTRT
     AATSVPAYEP LDSLDRRRDG WSLDRDRGDR DLPSSRDQPR KRRLPEESGG RHLDRSPESD
     RPRKRHCAPS PDRSPELSSS RDRYNSDNDR SSRLLLERPS PIRDRRGSLE KSQGDKRDRK
     NSASAERDRK HRTTAPTEGK SPLKKEDRSD GSAPSTSTAS SKLKSPSQKQ DGGTAPVASA
     SPKLCLAWQG MLLLKNSNFP SNMHLLQGDL QVASSLLVEG STGGKVAQLK ITQRLRLDQP
     KLDEVTRRIK VAGPNGYAIL LAVPGSSDSR SSSSSAASDT ATSTQRPLRN LVSYLKQKQA
     AGVISLPVGG NKDKENTGVL HAFPPCEFSQ QFLDSPAKAL AKSEEDYLVM IIVRGFGFQI
     GVRYENKKRE NLALTLL
//
ID   A0A0A0MTC1_HUMAN        Unreviewed;      5256 AA.
AC   A0A0A0MTC1;
DT   07-JAN-2015, integrated into UniProtKB/TrEMBL.
DT   07-JAN-2015, sequence version 1.
DT   22-APR-2020, entry version 48.
DE   SubName: Full=E3 ubiquitin-protein ligase RNF213 {ECO:0000313|Ensembl:ENSP00000425956};
GN   Name=RNF213 {ECO:0000313|Ensembl:ENSP00000425956};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000425956, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000425956, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R., Gnerre S.,
RA   Goldstein S., Grafham D.V., Grocock R., Hafez N., Hagopian D.S., Hart E.,
RA   Norman C.H., Humphray S., Jaffe D.B., Jones M., Kamal M., Khodiyar V.K.,
RA   LaButti K., Laird G., Lehoczky J., Liu X., Lokyitsang T., Loveland J.,
RA   Lui A., Macdonald P., Major J.E., Matthews L., Mauceli E., McCarroll S.A.,
RA   Mihalev A.H., Mudge J., Nguyen C., Nicol R., O'Leary S.B., Osoegawa K.,
RA   Schwartz D.C., Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in the
RT   human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [2] {ECO:0000213|PubMed:18691976}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [3] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [4] {ECO:0000213|PubMed:18318008}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by enrichment
RT   and fractionation of phosphopeptides with strong anion exchange
RT   chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [5] {ECO:0000213|PubMed:19369195}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [6] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [7] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [8] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Burckstummer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [10] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12] {ECO:0000213|PubMed:25218447}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [13] {ECO:0000313|Ensembl:ENSP00000425956}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (NOV-2014) to UniProtKB.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC123764; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC124319; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KC877677; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF510430; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; XP_005257602.2; XM_005257545.4.
DR   RefSeq; XP_005257603.2; XM_005257546.4.
DR   RefSeq; XP_006722058.1; XM_006721995.3.
DR   jPOST; A0A0A0MTC1; -.
DR   PeptideAtlas; A0A0A0MTC1; -.
DR   PRIDE; A0A0A0MTC1; -.
DR   Antibodypedia; 46314; 187 antibodies.
DR   Ensembl; ENST00000508628; ENSP00000425956; ENSG00000173821.
DR   GeneID; 57674; -.
DR   UCSC; uc060ldc.1; human.
DR   CTD; 57674; -.
DR   EuPathDB; HostDB:ENSG00000173821.19; -.
DR   HGNC; HGNC:14539; RNF213.
DR   OpenTargets; ENSG00000173821; -.
DR   GeneTree; ENSGT00630000089884; -.
DR   OMA; NLIVCPH; -.
DR   OrthoDB; 840at2759; -.
DR   ChiTaRS; RNF213; human.
DR   GenomeRNAi; 57674; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000173821; Expressed in adult mammalian kidney and 192 other tissues.
DR   ExpressionAtlas; A0A0A0MTC1; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0016887; F:ATPase activity; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IEA:InterPro.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR031248; RNF213.
DR   InterPro; IPR018957; Znf_C3HC4_RING-type.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   PANTHER; PTHR22605; PTHR22605; 2.
DR   Pfam; PF00097; zf-C3HC4; 1.
DR   SMART; SM00382; AAA; 2.
DR   SMART; SM00184; RING; 1.
DR   SUPFAM; SSF52540; SSF52540; 2.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00175,
KW   ECO:0000256|SAAS:SAAS00988536};
KW   Proteomics identification {ECO:0000213|EPD:A0A0A0MTC1,
KW   ECO:0000213|MaxQB:A0A0A0MTC1, ECO:0000213|PeptideAtlas:A0A0A0MTC1,
KW   ECO:0000213|ProteomicsDB:A0A0A0MTC1};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00175, ECO:0000256|SAAS:SAAS00988536};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00175,
KW   ECO:0000256|SAAS:SAAS00988536}.
FT   DOMAIN          4046..4084
FT                   /note="RING-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50089"
FT   REGION          27..84
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          109..414
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          863..883
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1442..1462
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        32..46
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        167..204
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        260..277
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        300..316
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        345..359
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        360..413
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   5256 AA;  596487 MW;  AC42E9F881CADA18 CRC64;
     MECPSCQHVS KEETPKFCSQ CGERLPPAAP IADSENNNST MASASEGEME CGQELKEEGG
     PCLFPGSDSW QENPEEPCSK ASWTVQEGAT SEVLVDAAVD LISDEWEAAN AIPSKRRKQD
     AAPLEAASVP SADCEQSKKK KRKKKKKGNK SASSELASLP LSPASPCHLT LLSNPWPQDT
     ALPHSQAQQS GPTGQPSQPP GTATTPLEGD GLSAPTEVGD SPLQAQALGE AGVATGSEAQ
     SSPQFQDHTE GEDQDASIPS GGRGLSQEGT GPPTSAGEGH SRTEDAAQEL LLPESKGGSS
     EPGTELQTTE QQAGASASMA VDAVAEPANA VKGAGKEMKE KTQRMKQPPA TTPPFKTHCQ
     EAETKTKDEM AAAEEKVGKN EQGEPEDLKK PEGKNRSAAA VKNEKEQKNQ EADVQEVKAS
     TLSPGGGVTV FFHAIISLHF PFNPDLHKVF IRGGEEFGES KWDSNICELH YTRDLGHDRV
     LVEGIVCISK KHLDKYIPYK YVIYNGESFE YEFIYKHQQK KGEYVNRCLF IKSSLLGSGD
     WHQYYDIVYM KPHGRLQKVM NHITDGPRKD LVKGKQIAAA LMLDSTFSIL QTWDTINLNS
     FFTQFEQFCF VLQQPMIYEG QAQLWTDLQY REKEVKRYLW QHLKKHVVPL PDGKSTDFLP
     VDCPVRSKLK TGLIVLFVVE KIELLLEGSL DWLCHLLTSD ASSPDEFHRD LSHILGIPQS
     WRLYLVNLCQ RCMDTRTYTW LGALPVLHCC MELAPRHKDA WRQPEDTWAA LEGLSFSPFR
     EQMLDTSSLL QFMREKQHLL SIDEPLFRSW FSLLPLSHLV MYMENFIEHL GRFPAHILDC
     LSGIYYRLPG LEQVLNTQDV QDVQNVQNIL EMLLRLLDTY RDKIPEEALS PSYLTVCLKL
     HEAICSSTKL LKFYELPALS AEIVCRMIRL LSLVDSAGQR DETGNNSVQT VFQGTLAATK
     RWLREVFTKN MLTSSGASFT YVKEIEVWRR LVEIQFPAEH GWKESLLGDM EWRLTKEEPL
     SQITAYCNSC WDTKGLEDSV AKTFEKCIIE AVSSACQSQT SILQGFSYSD LRKFGIVLSA
     VITKSWPRTA DNFDDILKHL LTLADVKHVF RLCGTDEKIL ANVTEDAKRL IAVADSVLTK
     VVGDLLSGTI LVGQLELIIK HKNQFLDIWQ LREKSLSPQD EQCAVEEALD WRREELLLLK
     KEKRCVDSLL KMCGNVKHLI QVDFGVLAVR HSQDLSSKRL NDTVTVRLST SSNSQRATHY
     HLSSQVQEMA GKIDLLRDSH IFQLFWREAA EPLSEPKEDQ EAAELLSEPE EESERHILEL
     EEVYDYLYQP SYRKFIKLHQ DLKSGEVTLA EIDVIFKDFV NKYTDLDSEL KIMCTVDHQD
     QRDWIKDRVE QIKEYHHLHQ AVHAAKVILQ VKESLGLNGD FSVLNTLLNF TDNFDDFRRE
     TLDQINQELI QAKKLLQDIS EARCKGLQAL SLRKEFICWV REALGGINEL KVFVDLASIS
     AGENDIDVDR VACFHDAVQG YASLLFKLDP SVDFSAFMKH LKKLWKALDK DQYLPRKLCD
     SARNLEWLKT VNESHGSVER SSLTLATAIN QRGIYVIQAP KGGQKISPDT VLHLILPESP
     GSHEESREYS LEEVKELLNK LMLMSGKKDR NNTEVERFSE VFCSVQRLSQ AFIDLHSAGN
     MLFRTWIAMA YCSPKQGVSL QMDFGLDLVT ELKEGGDVTE LLAALCRQME HFLDSWKRFV
     TQKRMEHFYL NFYTAEQLVY LSTELRKQPP SDAALTMLSF IKSNCTLRDV LRASVGCGSE
     AARYRMRRVM EELPLMLLSE FSLVDKLRII MEQSMRCLPA FLPDCLDLET LGHCLAHLAG
     MGGSPVERCL PRGLQVGQPN LVVCGHSEVL PAALAVYMQT PSQPLPTYDE VLLCTPATTF
     EEVALLLRRC LTLGSLGHKV YSLLFADQLS YEVARQAEEL FHNLCTQQHR EDYQLVMVCD
     GDWEHCYLPS AFSQHKVFVT PQAPLEAIQA YLAGHYRVPK QTLSAAAVFN DRLCVGIVAS
     ERAGVGKSLY VKRLHDKMKM QLNVKNVPLK TIRLIDPQVD ESRVLGALLP FLDAQYQKVP
     VLFHLDVTSS VQTGIWVFLF KLLILQYLMD INGKMWLRNP CHLYIVEILE RRTSVPSRSS
     SALRTRVPQF SFLDIFPKVT CRPPKEVIDM ELSALRSDTE PGMDLWEFCS ETFQRPYQYL
     RRFNQNQDLD TFQYQEGSVE GTPEECLQHF LFHCGVINPS WSELRNFARF LNYQLRDCEA
     SLFCNPSFIG DTLRGFKKFV VTFMIFMARD FATPSLHTSD QSPGKHMVTM DGVREEDLAP
     FSLRKRWESE PHPYVFFNDD HTTMTFIGFH LQPNINGSVD AISHLTGKVI KRDVMTRDLY
     QGLLLQRVPF NVDFDKLPRH KKLERLCLTL GIPQATDPDK TYELTTDNML KILAIEMRFR
     CGIPVIIMGE TGCGKTRLIK FLSDLRRGGT NADTIKLVKV HGGTTADMIY SRVREAENVA
     FANKDQHQLD TILFFDEANT TEAISCIKEV LCDHMVDGQP LAEDSGLHII AACNPYRKHS
     EEMICRLESA GLGYRVSMEE TADRLGSIPL RQLVYRVHAL PPSLIPLVWD FGQLSDVAEK
     LYIQQIVQRL VESISLDENG TRVITEVLCA SQGFMRKTED ECSFVSLRDV ERCVKVFRWF
     HEHSAMLLAQ LNAFLSKSSV SKNHTERDPV LWSLMLAIGV CYHASLEKKD SYRKAIARFF
     PKPYDDSRLL LDEITRAQDL FLDGVPLRKT IAKNLALKEN VFMMVVCIEL KIPLFLVGKP
     GSSKSLAKTI VADAMQGPAA YSDLFRSLKQ VHLVSFQCSP HSTPQGIIST FRQCARFQQG
     KDLQQYVSVV VLDEVGLAED SPKMPLKTLH PLLEDGCIED DPAPHKKVGF VGISNWALDP
     AKMNRGIFVS RGSPNETELI ESAKGICSSD ILVQDRVQGY FASFAKAYET VCKRQDKEFF
     GLRDYYSLIK MVFAAAKASN RKPSPQDIAQ AVLRNFSGKD DIQALDIFLA NLPEAKCSEE
     VSPMQLIKQN IFGPSQKVPG GEQEDAESRY LLVLTKNYVA LQILQQTFFE GDQQPEIIFG
     SGFPKDQEYT QLCRNINRVK ICMETGKMVL LLNLQNLYES LYDALNQYYV HLGGQKYVDL
     GLGTHRVKCR VHPNFRLIVI EEKDVVYKHF PIPLINRLEK HYLDINTVLE KWQKSIVEEL
     CAWVEKFINV KAHHFQKRHK YSPSDVFIGY HSDACASVVL QVIERQGPRA LTEELHQKVS
     EEAKSILLNC ATPDAVVRLS AYSLGGFAAE WLSQEYFHRQ RHNSFADFLQ AHLHTADLER
     HAIFTEITTF SRLLTSHDCE ILESEVTGRA PKPTLLWLQQ FDTEYSFLKE VRNCLTNTAK
     CKILIFQTDF EDGIRSAQLI ASAKYSVINE INKIRENEDR IFVYFITKLS RVGRGTAYVG
     FHGGLWQSVH IDDLRRSTLM VSDVTRLQHV TISQLFAPGD LPELGLEHRA EDGHEEAMET
     EASTSGEVAE VAEEAMETES SEKVGKETSE LGGSDVSILD TTRLLRSCVQ SAVGMLRDQN
     ESCTRNMRRV VLLLGLLNED DACHASFLRV SKMRLSVFLK KQEESQFHPL EWLAREACNQ
     DALQEAGTFR HTLWKRVQGA VTPLLASMIS FIDRDGNLEL LTRPDTPPWA RDLWMFIFSD
     TMLLNIPLVM NNERHKGEMA YIVVQNHMNL SENASNNVPF SWKIKDYLEE LWVQAQYITD
     AEGLPKKFVD IFQQTPLGRF LAQLHGEPQQ ELLQCYLKDF ILLTMRVSTE EELKFLQMAL
     WSCTRKLKAA SEAPEEEVSL PWVHLAYQRF RSRLQNFSRI LTIYPQVLHS LMEARWNHEL
     AGCEMTLDAF AAMACTEMLT RNTLKPSPQA WLQLVKNLSM PLELICSDEH MQGSGSLAQA
     VIREVRAQWS RIFSTALFVE HVLLGTESRV PELQGLVTEH VFLLDKCLRE NSDVKTHGPF
     EAVMRTLCEC KETASKTLSR FGIQPCSICL GDAKDPVCLP CDHVHCLRCL RAWFASEQMI
     CPYCLTALPD EFSPAVSQAH REAIEKHARF RQMCNSFFVD LVSTICFKDN APPEKEVIES
     LLSLLFVQKG RLRDAAQRHC EHTKSLSPFN DVVDKTPVIR SVILKLLLKY SFHDVKDYIQ
     EYLTLLKKKA FITEDKTELY MLFINCLEDS ILEKTSAYSR NDELNHLEEE GRFLKAYSPA
     SRGREPANEA SVEYLQEVAR IRLCLDRAAD FLSEPEGGPE MAKEKQCYLQ QVKQFCIRVE
     NDWHRVYLVR KLSSQRGMEF VQGLSKPGRP HQWVFPKDVV KQQGLRQDHP GQMDRYLVYG
     DEYKALRDAV AKAVLECKPL GIKTALKACK TPQSQQSAYF LLTLFREVAI LYRSHNASLH
     PTPEQCEAVS KFIGECKILS PPDISRFATS LVDNSVPLLR AGPSDSNLDG TVTEMAIHAA
     AVLLCGQNEL LEPLKNLAFS PATMAHAFLP TMPEDLLAQA RRWKGLERVH WYTCPNGHPC
     SVGECGRPME QSICIDCHAP IGGIDHKPRD GFHLVKDKAD RTQTGHVLGN PQRRDVVTCD
     RGLPPVVFLL IRLLTHLALL LGASQSSQAL INIIKPPVRD PKGFLQQHIL KDLEQLAKML
     GHSADETIGV VHLVLRRLLQ EQHQLSSRRL LNFDTELSTK EMRNNWEKEI AAVISPELEH
     LDKTLPTMNN LISQDKRISS NPVAKIIYGD PVTFLPHLPR KSVVHCSKIW SCRKRITVEY
     LQHIVEQKNG KERVPILWHF LQKEAELRLV KFLPEILALQ RDLVKQFQNV QQVEYSSIRG
     FLSKHSSDGL RQLLHNRITV FLSTWNKLRR SLETNGEINL PKDYCSTDLD LDTEFEILLP
     RRRGLGLCAT ALVSYLIRLH NEIVYAVEKL SKENNSYSVD AAEVTELHVI SYEVERDLTP
     LILSNCQYQV EEGRETVQEF DLEKIQRQIV SRFLQGKPRL SLKGIPTLVY RHDWNYEHLF
     MDIKNKMAQD SLPSSVISAI SGQLQSYSDA CEVLSVVEVT LGFLSTAGGD PNMQLNVYTQ
     DILQMGDQTI HVLKALNRCQ LKHTIALWQF LSAHKSEQLL RLHKEPFGEI SSRYKADLSP
     ENAKLLSTFL NQTGLDAFLL ELHEMIILKL KNPQTQTEER FRPQWSLRDT LVSYMQTKES
     EILPEMASQF PEEILLASCV SVWKTAAVLK WNREMR
//
ID   A0A0A0MTR7_HUMAN        Unreviewed;      5207 AA.
AC   A0A0A0MTR7;
DT   07-JAN-2015, integrated into UniProtKB/TrEMBL.
DT   07-JAN-2015, sequence version 1.
DT   22-APR-2020, entry version 48.
DE   SubName: Full=E3 ubiquitin-protein ligase RNF213 {ECO:0000313|Ensembl:ENSP00000464087};
GN   Name=RNF213 {ECO:0000313|Ensembl:ENSP00000464087};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000464087, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000464087, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R., Gnerre S.,
RA   Goldstein S., Grafham D.V., Grocock R., Hafez N., Hagopian D.S., Hart E.,
RA   Norman C.H., Humphray S., Jaffe D.B., Jones M., Kamal M., Khodiyar V.K.,
RA   LaButti K., Laird G., Lehoczky J., Liu X., Lokyitsang T., Loveland J.,
RA   Lui A., Macdonald P., Major J.E., Matthews L., Mauceli E., McCarroll S.A.,
RA   Mihalev A.H., Mudge J., Nguyen C., Nicol R., O'Leary S.B., Osoegawa K.,
RA   Schwartz D.C., Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in the
RT   human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [2] {ECO:0000213|PubMed:18691976}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [3] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [4] {ECO:0000213|PubMed:18318008}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by enrichment
RT   and fractionation of phosphopeptides with strong anion exchange
RT   chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [5] {ECO:0000213|PubMed:19369195}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [6] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [7] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [8] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Burckstummer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [10] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12] {ECO:0000213|PubMed:25218447}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [13] {ECO:0000313|Ensembl:ENSP00000464087}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (NOV-2014) to UniProtKB.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC123764; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC124319; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KC877677; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF510430; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001243000.2; NM_001256071.2.
DR   EPD; A0A0A0MTR7; -.
DR   jPOST; A0A0A0MTR7; -.
DR   PeptideAtlas; A0A0A0MTR7; -.
DR   PRIDE; A0A0A0MTR7; -.
DR   Antibodypedia; 46314; 187 antibodies.
DR   Ensembl; ENST00000582970; ENSP00000464087; ENSG00000173821.
DR   GeneID; 57674; -.
DR   KEGG; hsa:57674; -.
DR   UCSC; uc021uen.3; human.
DR   CTD; 57674; -.
DR   EuPathDB; HostDB:ENSG00000173821.19; -.
DR   HGNC; HGNC:14539; RNF213.
DR   OpenTargets; ENSG00000173821; -.
DR   eggNOG; ENOG410IE7S; Eukaryota.
DR   eggNOG; ENOG410Z1EV; LUCA.
DR   GeneTree; ENSGT00630000089884; -.
DR   HOGENOM; CLU_000066_0_0_1; -.
DR   KO; K22754; -.
DR   ChiTaRS; RNF213; human.
DR   GenomeRNAi; 57674; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000173821; Expressed in adult mammalian kidney and 192 other tissues.
DR   ExpressionAtlas; A0A0A0MTR7; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0016887; F:ATPase activity; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IEA:InterPro.
DR   GO; GO:0001525; P:angiogenesis; IEA:Ensembl.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR031248; RNF213.
DR   InterPro; IPR018957; Znf_C3HC4_RING-type.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   PANTHER; PTHR22605; PTHR22605; 2.
DR   Pfam; PF00097; zf-C3HC4; 1.
DR   SMART; SM00382; AAA; 2.
DR   SMART; SM00184; RING; 1.
DR   SUPFAM; SSF52540; SSF52540; 2.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00175,
KW   ECO:0000256|SAAS:SAAS00988536};
KW   Proteomics identification {ECO:0000213|EPD:A0A0A0MTR7,
KW   ECO:0000213|MaxQB:A0A0A0MTR7, ECO:0000213|PeptideAtlas:A0A0A0MTR7,
KW   ECO:0000213|ProteomicsDB:A0A0A0MTR7};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00175, ECO:0000256|SAAS:SAAS00988536};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00175,
KW   ECO:0000256|SAAS:SAAS00988536}.
FT   DOMAIN          3997..4035
FT                   /note="RING-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50089"
FT   REGION          1..20
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          27..365
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          814..834
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1393..1413
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        32..46
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        118..155
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        211..228
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        251..267
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        296..310
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        311..364
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   5207 AA;  591408 MW;  A66146709A630E03 CRC64;
     MECPSCQHVS KEETPKFCSQ CGERLPPAAP IADSENNNST MASASEGEME CGQELKEEGG
     PCLFPGSDSW QENPEEPCSK ASWTVQESKK KKRKKKKKGN KSASSELASL PLSPASPCHL
     TLLSNPWPQD TALPHSQAQQ SGPTGQPSQP PGTATTPLEG DGLSAPTEVG DSPLQAQALG
     EAGVATGSEA QSSPQFQDHT EGEDQDASIP SGGRGLSQEG TGPPTSAGEG HSRTEDAAQE
     LLLPESKGGS SEPGTELQTT EQQAGASASM AVDAVAEPAN AVKGAGKEMK EKTQRMKQPP
     ATTPPFKTHC QEAETKTKDE MAAAEEKVGK NEQGEPEDLK KPEGKNRSAA AVKNEKEQKN
     QEADVQEVKA STLSPGGGVT VFFHAIISLH FPFNPDLHKV FIRGGEEFGE SKWDSNICEL
     HYTRDLGHDR VLVEGIVCIS KKHLDKYIPY KYVIYNGESF EYEFIYKHQQ KKGEYVNRCL
     FIKSSLLGSG DWHQYYDIVY MKPHGRLQKV MNHITDGPRK DLVKGKQIAA ALMLDSTFSI
     LQTWDTINLN SFFTQFEQFC FVLQQPMIYE GQAQLWTDLQ YREKEVKRYL WQHLKKHVVP
     LPDGKSTDFL PVDCPVRSKL KTGLIVLFVV EKIELLLEGS LDWLCHLLTS DASSPDEFHR
     DLSHILGIPQ SWRLYLVNLC QRCMDTRTYT WLGALPVLHC CMELAPRHKD AWRQPEDTWA
     ALEGLSFSPF REQMLDTSSL LQFMREKQHL LSIDEPLFRS WFSLLPLSHL VMYMENFIEH
     LGRFPAHILD CLSGIYYRLP GLEQVLNTQD VQDVQNVQNI LEMLLRLLDT YRDKIPEEAL
     SPSYLTVCLK LHEAICSSTK LLKFYELPAL SAEIVCRMIR LLSLVDSAGQ RDETGNNSVQ
     TVFQGTLAAT KRWLREVFTK NMLTSSGASF TYVKEIEVWR RLVEIQFPAE HGWKESLLGD
     MEWRLTKEEP LSQITAYCNS CWDTKGLEDS VAKTFEKCII EAVSSACQSQ TSILQGFSYS
     DLRKFGIVLS AVITKSWPRT ADNFDDILKH LLTLADVKHV FRLCGTDEKI LANVTEDAKR
     LIAVADSVLT KVVGDLLSGT ILVGQLELII KHKNQFLDIW QLREKSLSPQ DEQCAVEEAL
     DWRREELLLL KKEKRCVDSL LKMCGNVKHL IQVDFGVLAV RHSQDLSSKR LNDTVTVRLS
     TSSNSQRATH YHLSSQVQEM AGKIDLLRDS HIFQLFWREA AEPLSEPKED QEAAELLSEP
     EEESERHILE LEEVYDYLYQ PSYRKFIKLH QDLKSGEVTL AEIDVIFKDF VNKYTDLDSE
     LKIMCTVDHQ DQRDWIKDRV EQIKEYHHLH QAVHAAKVIL QVKESLGLNG DFSVLNTLLN
     FTDNFDDFRR ETLDQINQEL IQAKKLLQDI SEARCKGLQA LSLRKEFICW VREALGGINE
     LKVFVDLASI SAGENDIDVD RVACFHDAVQ GYASLLFKLD PSVDFSAFMK HLKKLWKALD
     KDQYLPRKLC DSARNLEWLK TVNESHGSVE RSSLTLATAI NQRGIYVIQA PKGGQKISPD
     TVLHLILPES PGSHEESREY SLEEVKELLN KLMLMSGKKD RNNTEVERFS EVFCSVQRLS
     QAFIDLHSAG NMLFRTWIAM AYCSPKQGVS LQMDFGLDLV TELKEGGDVT ELLAALCRQM
     EHFLDSWKRF VTQKRMEHFY LNFYTAEQLV YLSTELRKQP PSDAALTMLS FIKSNCTLRD
     VLRASVGCGS EAARYRMRRV MEELPLMLLS EFSLVDKLRI IMEQSMRCLP AFLPDCLDLE
     TLGHCLAHLA GMGGSPVERC LPRGLQVGQP NLVVCGHSEV LPAALAVYMQ TPSQPLPTYD
     EVLLCTPATT FEEVALLLRR CLTLGSLGHK VYSLLFADQL SYEVARQAEE LFHNLCTQQH
     REDYQLVMVC DGDWEHCYLP SAFSQHKVFV TPQAPLEAIQ AYLAGHYRVP KQTLSAAAVF
     NDRLCVGIVA SERAGVGKSL YVKRLHDKMK MQLNVKNVPL KTIRLIDPQV DESRVLGALL
     PFLDAQYQKV PVLFHLDVTS SVQTGIWVFL FKLLILQYLM DINGKMWLRN PCHLYIVEIL
     ERRTSVPSRS SSALRTRVPQ FSFLDIFPKV TCRPPKEVID MELSALRSDT EPGMDLWEFC
     SETFQRPYQY LRRFNQNQDL DTFQYQEGSV EGTPEECLQH FLFHCGVINP SWSELRNFAR
     FLNYQLRDCE ASLFCNPSFI GDTLRGFKKF VVTFMIFMAR DFATPSLHTS DQSPGKHMVT
     MDGVREEDLA PFSLRKRWES EPHPYVFFND DHTTMTFIGF HLQPNINGSV DAISHLTGKV
     IKRDVMTRDL YQGLLLQRVP FNVDFDKLPR HKKLERLCLT LGIPQATDPD KTYELTTDNM
     LKILAIEMRF RCGIPVIIMG ETGCGKTRLI KFLSDLRRGG TNADTIKLVK VHGGTTADMI
     YSRVREAENV AFANKDQHQL DTILFFDEAN TTEAISCIKE VLCDHMVDGQ PLAEDSGLHI
     IAACNPYRKH SEEMICRLES AGLGYRVSME ETADRLGSIP LRQLVYRVHA LPPSLIPLVW
     DFGQLSDVAE KLYIQQIVQR LVESISLDEN GTRVITEVLC ASQGFMRKTE DECSFVSLRD
     VERCVKVFRW FHEHSAMLLA QLNAFLSKSS VSKNHTERDP VLWSLMLAIG VCYHASLEKK
     DSYRKAIARF FPKPYDDSRL LLDEITRAQD LFLDGVPLRK TIAKNLALKE NVFMMVVCIE
     LKIPLFLVGK PGSSKSLAKT IVADAMQGPA AYSDLFRSLK QVHLVSFQCS PHSTPQGIIS
     TFRQCARFQQ GKDLQQYVSV VVLDEVGLAE DSPKMPLKTL HPLLEDGCIE DDPAPHKKVG
     FVGISNWALD PAKMNRGIFV SRGSPNETEL IESAKGICSS DILVQDRVQG YFASFAKAYE
     TVCKRQDKEF FGLRDYYSLI KMVFAAAKAS NRKPSPQDIA QAVLRNFSGK DDIQALDIFL
     ANLPEAKCSE EVSPMQLIKQ NIFGPSQKVP GGEQEDAESR YLLVLTKNYV ALQILQQTFF
     EGDQQPEIIF GSGFPKDQEY TQLCRNINRV KICMETGKMV LLLNLQNLYE SLYDALNQYY
     VHLGGQKYVD LGLGTHRVKC RVHPNFRLIV IEEKDVVYKH FPIPLINRLE KHYLDINTVL
     EKWQKSIVEE LCAWVEKFIN VKAHHFQKRH KYSPSDVFIG YHSDACASVV LQVIERQGPR
     ALTEELHQKV SEEAKSILLN CATPDAVVRL SAYSLGGFAA EWLSQEYFHR QRHNSFADFL
     QAHLHTADLE RHAIFTEITT FSRLLTSHDC EILESEVTGR APKPTLLWLQ QFDTEYSFLK
     EVRNCLTNTA KCKILIFQTD FEDGIRSAQL IASAKYSVIN EINKIRENED RIFVYFITKL
     SRVGRGTAYV GFHGGLWQSV HIDDLRRSTL MVSDVTRLQH VTISQLFAPG DLPELGLEHR
     AEDGHEEAME TEASTSGEVA EVAEEAMETE SSEKVGKETS ELGGSDVSIL DTTRLLRSCV
     QSAVGMLRDQ NESCTRNMRR VVLLLGLLNE DDACHASFLR VSKMRLSVFL KKQEESQFHP
     LEWLAREACN QDALQEAGTF RHTLWKRVQG AVTPLLASMI SFIDRDGNLE LLTRPDTPPW
     ARDLWMFIFS DTMLLNIPLV MNNERHKGEM AYIVVQNHMN LSENASNNVP FSWKIKDYLE
     ELWVQAQYIT DAEGLPKKFV DIFQQTPLGR FLAQLHGEPQ QELLQCYLKD FILLTMRVST
     EEELKFLQMA LWSCTRKLKA ASEAPEEEVS LPWVHLAYQR FRSRLQNFSR ILTIYPQVLH
     SLMEARWNHE LAGCEMTLDA FAAMACTEML TRNTLKPSPQ AWLQLVKNLS MPLELICSDE
     HMQGSGSLAQ AVIREVRAQW SRIFSTALFV EHVLLGTESR VPELQGLVTE HVFLLDKCLR
     ENSDVKTHGP FEAVMRTLCE CKETASKTLS RFGIQPCSIC LGDAKDPVCL PCDHVHCLRC
     LRAWFASEQM ICPYCLTALP DEFSPAVSQA HREAIEKHAR FRQMCNSFFV DLVSTICFKD
     NAPPEKEVIE SLLSLLFVQK GRLRDAAQRH CEHTKSLSPF NDVVDKTPVI RSVILKLLLK
     YSFHDVKDYI QEYLTLLKKK AFITEDKTEL YMLFINCLED SILEKTSAYS RNDELNHLEE
     EGRFLKAYSP ASRGREPANE ASVEYLQEVA RIRLCLDRAA DFLSEPEGGP EMAKEKQCYL
     QQVKQFCIRV ENDWHRVYLV RKLSSQRGME FVQGLSKPGR PHQWVFPKDV VKQQGLRQDH
     PGQMDRYLVY GDEYKALRDA VAKAVLECKP LGIKTALKAC KTPQSQQSAY FLLTLFREVA
     ILYRSHNASL HPTPEQCEAV SKFIGECKIL SPPDISRFAT SLVDNSVPLL RAGPSDSNLD
     GTVTEMAIHA AAVLLCGQNE LLEPLKNLAF SPATMAHAFL PTMPEDLLAQ ARRWKGLERV
     HWYTCPNGHP CSVGECGRPM EQSICIDCHA PIGGIDHKPR DGFHLVKDKA DRTQTGHVLG
     NPQRRDVVTC DRGLPPVVFL LIRLLTHLAL LLGASQSSQA LINIIKPPVR DPKGFLQQHI
     LKDLEQLAKM LGHSADETIG VVHLVLRRLL QEQHQLSSRR LLNFDTELST KEMRNNWEKE
     IAAVISPELE HLDKTLPTMN NLISQDKRIS SNPVAKIIYG DPVTFLPHLP RKSVVHCSKI
     WSCRKRITVE YLQHIVEQKN GKERVPILWH FLQKEAELRL VKFLPEILAL QRDLVKQFQN
     VQQVEYSSIR GFLSKHSSDG LRQLLHNRIT VFLSTWNKLR RSLETNGEIN LPKDYCSTDL
     DLDTEFEILL PRRRGLGLCA TALVSYLIRL HNEIVYAVEK LSKENNSYSV DAAEVTELHV
     ISYEVERDLT PLILSNCQYQ VEEGRETVQE FDLEKIQRQI VSRFLQGKPR LSLKGIPTLV
     YRHDWNYEHL FMDIKNKMAQ DSLPSSVISA ISGQLQSYSD ACEVLSVVEV TLGFLSTAGG
     DPNMQLNVYT QDILQMGDQT IHVLKALNRC QLKHTIALWQ FLSAHKSEQL LRLHKEPFGE
     ISSRYKADLS PENAKLLSTF LNQTGLDAFL LELHEMIILK LKNPQTQTEE RFRPQWSLRD
     TLVSYMQTKE SEILPEMASQ FPEEILLASC VSVWKTAAVL KWNREMR
//
ID   RN213_HUMAN             Reviewed;        5207 AA.
AC   Q63HN8; C9JCP4; D6RI12; F8WKS1; Q658P6; Q69YK7; Q6MZR1; Q8IWF4; Q8IZX1;
AC   Q8IZX2; Q8N406; Q8TEU0; Q9H6C9; Q9H6H9; Q9H6P3; Q9H8A9; Q9HCF4; Q9HCL8;
DT   20-FEB-2007, integrated into UniProtKB/Swiss-Prot.
DT   21-MAR-2012, sequence version 3.
DT   22-APR-2020, entry version 154.
DE   RecName: Full=E3 ubiquitin-protein ligase RNF213 {ECO:0000305};
DE            EC=2.3.2.27 {ECO:0000269|PubMed:21799892};
DE            EC=3.6.4.- {ECO:0000269|PubMed:21799892};
DE   AltName: Full=ALK lymphoma oligomerization partner on chromosome 17 {ECO:0000303|PubMed:12112524};
DE   AltName: Full=Mysterin {ECO:0000303|PubMed:26126547};
DE   AltName: Full=RING finger protein 213 {ECO:0000305};
DE   AltName: Full=RING-type E3 ubiquitin transferase RNF213 {ECO:0000305};
GN   Name=RNF213 {ECO:0000312|HGNC:HGNC:14539};
GN   Synonyms=ALO17 {ECO:0000303|PubMed:12112524},
GN   C17orf27 {ECO:0000312|HGNC:HGNC:14539},
GN   KIAA1554 {ECO:0000303|PubMed:10997877},
GN   KIAA1618 {ECO:0000303|PubMed:10997877},
GN   MYSTR {ECO:0000303|PubMed:26126547};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, CATALYTIC ACTIVITY,
RP   AUTOUBIQUITINATION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, VARIANTS
RP   ASP-3962; GLN-4062; SER-4608; ASN-4863; ASP-4950; VAL-5021; GLU-5160 AND
RP   GLY-5176, AND VARIANTS MYMY2 ASN-4013 AND LYS-4810.
RX   PubMed=21799892; DOI=10.1371/journal.pone.0022542;
RA   Liu W., Morito D., Takashima S., Mineharu Y., Kobayashi H., Hitomi T.,
RA   Hashikata H., Matsuura N., Yamazaki S., Toyoda A., Kikuta K., Takagi Y.,
RA   Harada K.H., Fujiyama A., Herzig R., Krischek B., Zou L., Kim J.E.,
RA   Kitakaze M., Miyamoto S., Nagata K., Hashimoto N., Koizumi A.;
RT   "Identification of RNF213 as a susceptibility gene for moyamoya disease and
RT   its possible role in vascular development.";
RL   PLoS ONE 6:E22542-E22542(2011).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 3021-5207 (ISOFORMS 1/2).
RC   TISSUE=Endometrium, Lymph node, Melanoma, and Uterus;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R., Gnerre S.,
RA   Goldstein S., Grafham D.V., Grocock R., Hafez N., Hagopian D.S., Hart E.,
RA   Norman C.H., Humphray S., Jaffe D.B., Jones M., Kamal M., Khodiyar V.K.,
RA   LaButti K., Laird G., Lehoczky J., Liu X., Lokyitsang T., Loveland J.,
RA   Lui A., Macdonald P., Major J.E., Matthews L., Mauceli E., McCarroll S.A.,
RA   Mihalev A.H., Mudge J., Nguyen C., Nicol R., O'Leary S.B., Osoegawa K.,
RA   Schwartz D.C., Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in the
RT   human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 4).
RC   TISSUE=Eye, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-163 (ISOFORMS 1 AND 2/3), AND CHROMOSOMAL
RP   TRANSLOCATION WITH ALK.
RX   PubMed=12112524; DOI=10.1002/gcc.10033;
RA   Cools J., Wlodarska I., Somers R., Mentens N., Pedeutour F., Maes B.,
RA   De Wolf-Peeters C., Pauwels P., Hagemeijer A., Marynen P.;
RT   "Identification of novel fusion partners of ALK, the anaplastic lymphoma
RT   kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic
RT   tumor.";
RL   Genes Chromosomes Cancer 34:354-362(2002).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 136-1509 AND 3888-5207 (ISOFORMS
RP   1/2).
RC   TISSUE=Brain;
RX   PubMed=10997877; DOI=10.1093/dnares/7.4.271;
RA   Nagase T., Kikuno R., Nakayama M., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVIII. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 7:273-281(2000).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 3770-5207 (ISOFORMS 1/2).
RC   TISSUE=Spleen, and Thyroid;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1258, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1258, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1258, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by enrichment
RT   and fractionation of phosphopeptides with strong anion exchange
RT   chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1258, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1258, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [13]
RP   INTERACTION WITH M.TUBERCULOSIS RV3655C (MICROBIAL INFECTION), AND
RP   INDUCTION (MICROBIAL INFECTION).
RX   PubMed=20454556; DOI=10.1371/journal.pone.0010474;
RA   Danelishvili L., Yamazaki Y., Selker J., Bermudez L.E.;
RT   "Secreted Mycobacterium tuberculosis Rv3654c and Rv3655c proteins
RT   participate in the suppression of macrophage apoptosis.";
RL   PLoS ONE 5:E10474-E10474(2010).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-217 AND SER-1258, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1258, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-217; SER-1258 AND SER-2273,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-208; SER-217 AND SER-1258,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1151, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [20]
RP   FUNCTION, SUBUNIT, AND MUTAGENESIS OF LYS-2426; GLU-2488; LYS-2775 AND
RP   GLU-2845.
RX   PubMed=24658080; DOI=10.1038/srep04442;
RA   Morito D., Nishikawa K., Hoseki J., Kitamura A., Kotani Y., Kiso K.,
RA   Kinjo M., Fujiyoshi Y., Nagata K.;
RT   "Moyamoya disease-associated protein mysterin/RNF213 is a novel AAA+
RT   ATPase, which dynamically changes its oligomeric state.";
RL   Sci. Rep. 4:4442-4442(2014).
RN   [21]
RP   INDUCTION.
RX   PubMed=26070522; DOI=10.1016/j.jstrokecerebrovasdis.2015.01.041;
RA   Zhao S., Gong Z., Zhang J., Xu X., Liu P., Guan W., Jing L., Peng T.,
RA   Teng J., Jia Y.;
RT   "Elevated serum microRNA Let-7c in Moyamoya disease.";
RL   J. Stroke Cerebrovasc. Dis. 24:1709-1714(2015).
RN   [22]
RP   FUNCTION, AND INDUCTION.
RX   PubMed=26278786; DOI=10.1038/srep13191;
RA   Ohkubo K., Sakai Y., Inoue H., Akamine S., Ishizaki Y., Matsushita Y.,
RA   Sanefuji M., Torisu H., Ihara K., Sardiello M., Hara T.;
RT   "Moyamoya disease susceptibility gene RNF213 links inflammatory and
RT   angiogenic signals in endothelial cells.";
RL   Sci. Rep. 5:13191-13191(2015).
RN   [23]
RP   FUNCTION.
RX   PubMed=26766444; DOI=10.1016/j.devcel.2015.12.015;
RA   Scholz B., Korn C., Wojtarowicz J., Mogler C., Augustin I., Boutros M.,
RA   Niehrs C., Augustin H.G.;
RT   "Endothelial RSPO3 controls vascular stability and pruning through non-
RT   canonical WNT/Ca(2+)/NFAT signaling.";
RL   Dev. Cell 36:79-93(2016).
RN   [24]
RP   VARIANTS GLU-2554; VAL-3891; GLY-3915; MET-4567 AND MET-4765, AND VARIANTS
RP   MYMY2 THR-4399 AND LYS-4810.
RX   PubMed=21048783; DOI=10.1038/jhg.2010.132;
RA   Kamada F., Aoki Y., Narisawa A., Abe Y., Komatsuzaki S., Kikuchi A.,
RA   Kanno J., Niihori T., Ono M., Ishii N., Owada Y., Fujimura M., Mashimo Y.,
RA   Suzuki Y., Hata A., Tsuchiya S., Tominaga T., Matsubara Y., Kure S.;
RT   "A genome-wide association study identifies RNF213 as the first Moyamoya
RT   disease gene.";
RL   J. Hum. Genet. 56:34-40(2011).
RN   [25]
RP   VARIANTS MYMY2 THR-4399 AND LYS-4810, AND VARIANTS ARG-4007; LEU-4367;
RP   PRO-4586; VAL-4631; ASP-4950; VAL-5021 AND ILE-5136.
RX   PubMed=23110205; DOI=10.1371/journal.pone.0048179;
RA   Wu Z., Jiang H., Zhang L., Xu X., Zhang X., Kang Z., Song D., Zhang J.,
RA   Guan M., Gu Y.;
RT   "Molecular analysis of RNF213 gene for moyamoya disease in the Chinese Han
RT   population.";
RL   PLoS ONE 7:E48179-E48179(2012).
RN   [26]
RP   CHARACTERIZATION OF VARIANT MYMY2 LYS-4810.
RX   PubMed=23994138; DOI=10.1016/j.bbrc.2013.08.067;
RA   Hitomi T., Habu T., Kobayashi H., Okuda H., Harada K.H., Osafune K.,
RA   Taura D., Sone M., Asaka I., Ameku T., Watanabe A., Kasahara T., Sudo T.,
RA   Shiota F., Hashikata H., Takagi Y., Morito D., Miyamoto S., Nakao K.,
RA   Koizumi A.;
RT   "The moyamoya disease susceptibility variant RNF213 R4810K (rs112735431)
RT   induces genomic instability by mitotic abnormality.";
RL   Biochem. Biophys. Res. Commun. 439:419-426(2013).
RN   [27]
RP   VARIANT THR-4185.
RX   PubMed=25043520; DOI=10.1111/ijs.12306;
RA   Smith K.R., Leventer R.J., Mackay M.T., Pope K., Gillies G.,
RA   Delatycki M.B., Amor D.J., Bahlo M., Lockhart P.J.;
RT   "Identification of a novel RNF213 variant in a family with heterogeneous
RT   intracerebral vasculopathy.";
RL   Int. J. Stroke 9:E26-E27(2014).
RN   [28]
RP   VARIANTS MYMY2 ASN-4013 AND LYS-4810, AND VARIANTS ALA-529 DEL; GLN-3922;
RP   TYR-3997; CYS-4019; VAL-4076; LYS-4115 DEL; GLU-4237; THR-4732 AND
RP   ILE-5163.
RX   PubMed=25278557; DOI=10.1161/strokeaha.114.006244;
RG   University of Washington Center for Mendelian Genomics;
RA   Cecchi A.C., Guo D., Ren Z., Flynn K., Santos-Cortez R.L., Leal S.M.,
RA   Wang G.T., Regalado E.S., Steinberg G.K., Shendure J., Bamshad M.J.,
RA   Grotta J.C., Nickerson D.A., Pannu H., Milewicz D.M.;
RT   "RNF213 rare variants in an ethnically diverse population with Moyamoya
RT   disease.";
RL   Stroke 45:3200-3207(2014).
RN   [29]
RP   VARIANT PHE-4118, AND INVOLVEMENT IN MYMY2.
RX   PubMed=26198278; DOI=10.1002/ajmg.a.37230;
RA   Harel T., Posey J.E., Graham B.H., Walkiewicz M., Yang Y., Lalani S.R.,
RA   Belmont J.W.;
RT   "Atypical presentation of moyamoya disease in an infant with a de novo
RT   RNF213 variant.";
RL   Am. J. Med. Genet. A 167A:2742-2747(2015).
RN   [30]
RP   CHARACTERIZATION OF VARIANT MYMY2 LYS-4810, FUNCTION, SUBUNIT, AND
RP   MUTAGENESIS OF GLU-2488.
RX   PubMed=26126547; DOI=10.1161/jaha.115.002146;
RA   Kobayashi H., Matsuda Y., Hitomi T., Okuda H., Shioi H., Matsuda T.,
RA   Imai H., Sone M., Taura D., Harada K.H., Habu T., Takagi Y., Miyamoto S.,
RA   Koizumi A.;
RT   "Biochemical and functional characterization of RNF213 (Mysterin) R4810K, a
RT   susceptibility mutation of Moyamoya disease, in angiogenesis in vitro and
RT   in vivo.";
RL   J. Am. Heart Assoc. 4:0-0(2015).
RN   [31]
RP   VARIANTS VAL-1622; MET-3933 AND CYS-4131, AND VARIANT MYMY2 LYS-4810.
RX   PubMed=25956231; DOI=10.1016/j.jns.2015.04.019;
RA   Lee M.J., Chen Y.F., Fan P.C., Wang K.C., Wang K., Wang J., Kuo M.F.;
RT   "Mutation genotypes of RNF213 gene from moyamoya patients in Taiwan.";
RL   J. Neurol. Sci. 353:161-165(2015).
RN   [32]
RP   VARIANTS CYS-4019; LYS-4042; ALA-4146 AND LEU-4677, CHARACTERIZATION OF
RP   VARIANT MYMY2 ASN-4013, AND CHARACTERIZATION OF VARIANTS CYS-4019 AND
RP   ALA-4146.
RX   PubMed=27736983; DOI=10.1371/journal.pone.0164759;
RA   Kobayashi H., Brozman M., Kyselova K., Viszlayova D., Morimoto T.,
RA   Roubec M., Skoloudik D., Petrovicova A., Juskanic D., Strauss J., Halaj M.,
RA   Kurray P., Hranai M., Harada K.H., Inoue S., Yoshida Y., Habu T.,
RA   Herzig R., Youssefian S., Koizumi A.;
RT   "RNF213 rare variants in Slovakian and Czech moyamoya disease patients.";
RL   PLoS ONE 11:E0164759-E0164759(2016).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase involved in angiogenesis
CC       (PubMed:21799892, PubMed:26278786, PubMed:26766444, PubMed:26126547).
CC       Involved in the non-canonical Wnt signaling pathway in vascular
CC       development: acts by mediating ubiquitination and degradation of FLNA
CC       and NFATC2 downstream of RSPO3, leading to inhibit the non-canonical
CC       Wnt signaling pathway and promoting vessel regression
CC       (PubMed:26766444). Also has ATPase activity (PubMed:24658080,
CC       PubMed:26126547). {ECO:0000269|PubMed:21799892,
CC       ECO:0000269|PubMed:24658080, ECO:0000269|PubMed:26126547,
CC       ECO:0000269|PubMed:26278786, ECO:0000269|PubMed:26766444}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +
CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-
CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;
CC         EC=2.3.2.27; Evidence={ECO:0000269|PubMed:21799892};
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000305|PubMed:21799892}.
CC   -!- SUBUNIT: Homooligomer; probably forms homohexamers.
CC       {ECO:0000269|PubMed:24658080, ECO:0000269|PubMed:26126547}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with M.tuberculosis protein
CC       Rv3655c, which impairs caspase-8 activation and suppresses macrophage
CC       apoptosis by blocking the extrinsic pathway.
CC       {ECO:0000269|PubMed:20454556}.
CC   -!- INTERACTION:
CC       Q63HN8-6; Q08379: GOLGA2; NbExp=3; IntAct=EBI-10248548, EBI-618309;
CC       Q63HN8-6; Q6A162: KRT40; NbExp=3; IntAct=EBI-10248548, EBI-10171697;
CC       Q63HN8-6; Q04864: REL; NbExp=3; IntAct=EBI-10248548, EBI-307352;
CC       Q63HN8-6; P36406: TRIM23; NbExp=3; IntAct=EBI-10248548, EBI-740098;
CC       Q63HN8-6; P14373: TRIM27; NbExp=3; IntAct=EBI-10248548, EBI-719493;
CC       Q63HN8-6; Q15654: TRIP6; NbExp=3; IntAct=EBI-10248548, EBI-742327;
CC       Q63HN8-6; Q5T124: UBXN11; NbExp=3; IntAct=EBI-10248548, EBI-746004;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:21799892}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q63HN8-3; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q63HN8-4; Sequence=VSP_042417;
CC       Name=3;
CC         IsoId=Q63HN8-5; Sequence=VSP_042418, VSP_042419;
CC       Name=4;
CC         IsoId=Q63HN8-6; Sequence=VSP_042416, VSP_042420;
CC   -!- TISSUE SPECIFICITY: Widely expressed (at protein level).
CC       {ECO:0000269|PubMed:21799892}.
CC   -!- INDUCTION: Down-regulated by let-7c miRNA, which binds to the 3'-UTR
CC       transcript of RNF213 (PubMed:26070522). Induced by pro-inflammatory
CC       cytokines (PubMed:26278786). {ECO:0000269|PubMed:26070522,
CC       ECO:0000269|PubMed:26278786}.
CC   -!- INDUCTION: (Microbial infection) Is up-regulated in macrophages
CC       infected by M.tuberculosis. {ECO:0000269|PubMed:20454556}.
CC   -!- DOMAIN: The RING-type zinc finger domain is required for the ubiquitin-
CC       protein ligase activity. {ECO:0000269|PubMed:21799892}.
CC   -!- PTM: Autoubiquitinated. {ECO:0000269|PubMed:21799892}.
CC   -!- DISEASE: Moyamoya disease 2 (MYMY2) [MIM:607151]: A progressive
CC       cerebral angiopathy characterized by bilateral intracranial carotid
CC       artery stenosis and telangiectatic vessels in the region of the basal
CC       ganglia. The abnormal vessels resemble a 'puff of smoke' (moyamoya) on
CC       cerebral angiogram. Affected individuals can develop transient ischemic
CC       attacks and/or cerebral infarction, and rupture of the collateral
CC       vessels can cause intracranial hemorrhage. Hemiplegia of sudden onset
CC       and epileptic seizures constitute the prevailing presentation in
CC       childhood, while subarachnoid bleeding occurs more frequently in
CC       adults. {ECO:0000269|PubMed:21048783, ECO:0000269|PubMed:21799892,
CC       ECO:0000269|PubMed:23110205, ECO:0000269|PubMed:23994138,
CC       ECO:0000269|PubMed:25278557, ECO:0000269|PubMed:25956231,
CC       ECO:0000269|PubMed:26126547, ECO:0000269|PubMed:26198278,
CC       ECO:0000269|PubMed:27736983}. Note=Disease susceptibility is associated
CC       with variations affecting the gene represented in this entry.
CC   -!- DISEASE: Note=A chromosomal aberration involving RNF213 is associated
CC       with anaplastic large-cell lymphoma (ALCL). Translocation
CC       t(2;17)(p23;q25) with ALK. {ECO:0000269|PubMed:12112524}.
CC   -!- MISCELLANEOUS: [Isoform 1]: Major isoform detected in all tissues
CC       examined.
CC   -!- MISCELLANEOUS: [Isoform 2]: Minor isoform with restricted expression.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the AAA ATPase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH32220.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAB13444.1; Type=Miscellaneous discrepancy; Note=Probable cloning artifact.; Evidence={ECO:0000305};
CC       Sequence=BAB14708.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAB15212.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAB15280.1; Type=Erroneous termination; Note=Truncated C-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAB15330.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=CAH10615.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=CAH56189.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/ALO17ID480.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB537889; BAK53191.1; -; mRNA.
DR   EMBL; AL832920; CAH10615.1; ALT_FRAME; mRNA.
DR   EMBL; AL833201; CAH56308.1; -; mRNA.
DR   EMBL; BX640932; CAE45967.1; -; mRNA.
DR   EMBL; BX647946; CAH56189.1; ALT_INIT; mRNA.
DR   EMBL; AC123764; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC124319; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC032220; AAH32220.1; ALT_INIT; mRNA.
DR   EMBL; BC036891; AAH36891.1; -; mRNA.
DR   EMBL; BC040341; AAH40341.1; -; mRNA.
DR   EMBL; AF397204; AAN63520.1; -; mRNA.
DR   EMBL; AF397205; AAN63521.1; -; mRNA.
DR   EMBL; AB046774; BAB13380.1; -; mRNA.
DR   EMBL; AB046838; BAB13444.1; ALT_SEQ; mRNA.
DR   EMBL; AK023871; BAB14708.1; ALT_INIT; mRNA.
DR   EMBL; AK025676; BAB15212.1; ALT_INIT; mRNA.
DR   EMBL; AK025914; BAB15280.1; ALT_SEQ; mRNA.
DR   EMBL; AK026038; BAB15330.1; ALT_INIT; mRNA.
DR   EMBL; AK074030; BAB84856.1; -; mRNA.
DR   CCDS; CCDS11772.1; -. [Q63HN8-5]
DR   CCDS; CCDS58606.1; -. [Q63HN8-3]
DR   RefSeq; NP_001243000.2; NM_001256071.2.
DR   RefSeq; NP_066005.2; NM_020954.3. [Q63HN8-5]
DR   SMR; Q63HN8; -.
DR   BioGrid; 121705; 50.
DR   IntAct; Q63HN8; 43.
DR   MINT; Q63HN8; -.
DR   STRING; 9606.ENSP00000464087; -.
DR   iPTMnet; Q63HN8; -.
DR   MetOSite; Q63HN8; -.
DR   PhosphoSitePlus; Q63HN8; -.
DR   SwissPalm; Q63HN8; -.
DR   BioMuta; RNF213; -.
DR   DMDM; 380865458; -.
DR   EPD; Q63HN8; -.
DR   jPOST; Q63HN8; -.
DR   MassIVE; Q63HN8; -.
DR   MaxQB; Q63HN8; -.
DR   PaxDb; Q63HN8; -.
DR   PeptideAtlas; Q63HN8; -.
DR   PRIDE; Q63HN8; -.
DR   ProteomicsDB; 65884; -. [Q63HN8-3]
DR   ProteomicsDB; 65885; -. [Q63HN8-4]
DR   ProteomicsDB; 65886; -. [Q63HN8-5]
DR   ProteomicsDB; 65887; -. [Q63HN8-6]
DR   DNASU; 57674; -.
DR   Ensembl; ENST00000319921; ENSP00000324392; ENSG00000173821. [Q63HN8-5]
DR   GeneID; 57674; -.
DR   KEGG; hsa:57674; -.
DR   UCSC; uc002jyf.5; human. [Q63HN8-3]
DR   CTD; 57674; -.
DR   DisGeNET; 57674; -.
DR   GeneCards; RNF213; -.
DR   HGNC; HGNC:14539; RNF213.
DR   HPA; ENSG00000173821; Low tissue specificity.
DR   MalaCards; RNF213; -.
DR   MIM; 607151; phenotype.
DR   MIM; 613768; gene.
DR   neXtProt; NX_Q63HN8; -.
DR   OpenTargets; ENSG00000173821; -.
DR   Orphanet; 2573; Moyamoya disease.
DR   PharmGKB; PA162401681; -.
DR   eggNOG; ENOG410IE7S; Eukaryota.
DR   eggNOG; ENOG410Z1EV; LUCA.
DR   GeneTree; ENSGT00630000089884; -.
DR   HOGENOM; CLU_011233_0_0_1; -.
DR   InParanoid; Q63HN8; -.
DR   KO; K22754; -.
DR   TreeFam; TF343131; -.
DR   Reactome; R-HSA-9635465; Suppression of apoptosis.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; RNF213; human.
DR   GeneWiki; RNF213; -.
DR   GenomeRNAi; 57674; -.
DR   Pharos; Q63HN8; Tbio.
DR   PRO; PR:Q63HN8; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q63HN8; protein.
DR   Bgee; ENSG00000173821; Expressed in adult mammalian kidney and 192 other tissues.
DR   Genevisible; Q63HN8; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0016887; F:ATPase activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:UniProtKB.
DR   GO; GO:0001525; P:angiogenesis; IMP:UniProtKB.
DR   GO; GO:2000051; P:negative regulation of non-canonical Wnt signaling pathway; IMP:UniProtKB.
DR   GO; GO:0051865; P:protein autoubiquitination; IDA:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IDA:UniProtKB.
DR   GO; GO:0000209; P:protein polyubiquitination; TAS:Reactome.
DR   GO; GO:0016567; P:protein ubiquitination; IDA:UniProtKB.
DR   GO; GO:0002040; P:sprouting angiogenesis; IMP:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IMP:UniProtKB.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR031248; RNF213.
DR   InterPro; IPR018957; Znf_C3HC4_RING-type.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   PANTHER; PTHR22605; PTHR22605; 2.
DR   Pfam; PF00097; zf-C3HC4; 1.
DR   SMART; SM00382; AAA; 2.
DR   SMART; SM00184; RING; 1.
DR   SUPFAM; SSF52540; SSF52540; 2.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Angiogenesis; Chromosomal rearrangement; Coiled coil;
KW   Cytoplasm; Disease mutation; Hydrolase; Isopeptide bond; Metal-binding;
KW   Phosphoprotein; Proto-oncogene; Reference proteome; Transferase;
KW   Ubl conjugation; Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN           1..5207
FT                   /note="E3 ubiquitin-protein ligase RNF213"
FT                   /id="PRO_0000415917"
FT   ZN_FING         3997..4036
FT                   /note="RING-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00175"
FT   COILED          343..374
FT                   /evidence="ECO:0000255"
FT   MOD_RES         208
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         217
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         1258
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18318008,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976,
FT                   ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         2273
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   CROSSLNK        1151
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25218447"
FT   VAR_SEQ         1..4650
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_042416"
FT   VAR_SEQ         87
FT                   /note="E -> EGATSEVLVDAAVDLISDEWEAANAIPSKRRKQDAAPLEAASVPSAD
FT                   CEQ (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_042417"
FT   VAR_SEQ         1009..1063
FT                   /note="SQTSILQGFSYSDLRKFGIVLSAVITKSWPRTADNFNDILKHLLTLADVKHV
FT                   FRL -> VNNLSSWETDSGSQLCSAMTQLRAMKHPLGLSSSANSEIGKWAPSSLAKGNG
FT                   AEI (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:17974005"
FT                   /id="VSP_042418"
FT   VAR_SEQ         1064..5207
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:17974005"
FT                   /id="VSP_042419"
FT   VAR_SEQ         4651..4660
FT                   /note="QEQHQLSSRR -> MTRKSAPTSG (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_042420"
FT   VARIANT         529
FT                   /note="Missing (rare variant detected in a sporadic case of
FT                   Moyamoya disease in Caucasian population)"
FT                   /evidence="ECO:0000269|PubMed:25278557"
FT                   /id="VAR_075635"
FT   VARIANT         1622
FT                   /note="A -> V (rare variant detected in a sporadic case of
FT                   Moyamoya disease in East Asian population)"
FT                   /evidence="ECO:0000269|PubMed:25956231"
FT                   /id="VAR_075636"
FT   VARIANT         2554
FT                   /note="D -> E (in dbSNP:rs138516230)"
FT                   /evidence="ECO:0000269|PubMed:21048783"
FT                   /id="VAR_067020"
FT   VARIANT         3891
FT                   /note="M -> V (rare variant detected in a sporadic case of
FT                   Moyamoya disease)"
FT                   /evidence="ECO:0000269|PubMed:21048783"
FT                   /id="VAR_067021"
FT   VARIANT         3915
FT                   /note="E -> G (in dbSNP:rs61740658)"
FT                   /evidence="ECO:0000269|PubMed:21048783"
FT                   /id="VAR_067022"
FT   VARIANT         3922
FT                   /note="R -> Q (rare variant detected in a sporadic case of
FT                   Moyamoya disease in Caucasian population)"
FT                   /evidence="ECO:0000269|PubMed:25278557"
FT                   /id="VAR_075637"
FT   VARIANT         3933
FT                   /note="V -> M (rare variant detected in a sporadic case of
FT                   Moyamoya disease in East Asian population)"
FT                   /evidence="ECO:0000269|PubMed:25956231"
FT                   /id="VAR_075638"
FT   VARIANT         3962
FT                   /note="N -> D (variant detected in cases of Moyamoya
FT                   disease in Caucasian populations)"
FT                   /evidence="ECO:0000269|PubMed:21799892"
FT                   /id="VAR_067023"
FT   VARIANT         3997
FT                   /note="C -> Y (rare variant detected in a sporadic case of
FT                   Moyamoya disease in Caucasian population)"
FT                   /evidence="ECO:0000269|PubMed:25278557"
FT                   /id="VAR_075639"
FT   VARIANT         4007
FT                   /note="P -> R (rare variant detected in a sporadic case of
FT                   Moyamoya disease in East Asian population)"
FT                   /evidence="ECO:0000269|PubMed:23110205"
FT                   /id="VAR_075640"
FT   VARIANT         4013
FT                   /note="D -> N (in MYMY2; variant detected in cases of
FT                   Moyamoya disease in Caucasian and Asian populations;
FT                   inhibitory effect on angiogenic activity of vascular
FT                   endothelial cells)"
FT                   /evidence="ECO:0000269|PubMed:21799892,
FT                   ECO:0000269|PubMed:25278557, ECO:0000269|PubMed:27736983"
FT                   /id="VAR_067024"
FT   VARIANT         4019
FT                   /note="R -> C (rare variant detected in a sporadic case of
FT                   Moyamoya disease in Caucasian population; associated with
FT                   K-4042 in cases of Moyamoya disease in Slovakian and Czech
FT                   populations; inhibitory effect on angiogenic activity of
FT                   vascular endothelial cells)"
FT                   /evidence="ECO:0000269|PubMed:25278557,
FT                   ECO:0000269|PubMed:27736983"
FT                   /id="VAR_075641"
FT   VARIANT         4042
FT                   /note="E -> K (rare variant associated with C-4019 in cases
FT                   of Moyamoya disease in Slovakian and Czech populations)"
FT                   /evidence="ECO:0000269|PubMed:27736983"
FT                   /id="VAR_079573"
FT   VARIANT         4062
FT                   /note="R -> Q (variant detected in cases of Moyamoya
FT                   disease in Caucasian populations)"
FT                   /evidence="ECO:0000269|PubMed:21799892"
FT                   /id="VAR_067025"
FT   VARIANT         4076
FT                   /note="I -> V (rare variant detected in a sporadic case of
FT                   Moyamoya disease in Asian population)"
FT                   /evidence="ECO:0000269|PubMed:25278557"
FT                   /id="VAR_075642"
FT   VARIANT         4115
FT                   /note="Missing (rare variant detected in a sporadic case of
FT                   Moyamoya disease in Caucasian population)"
FT                   /evidence="ECO:0000269|PubMed:25278557"
FT                   /id="VAR_075643"
FT   VARIANT         4118
FT                   /note="S -> F (rare variant detected in a sporadic case of
FT                   Moyamoya disease in Caucasian population)"
FT                   /evidence="ECO:0000269|PubMed:26198278"
FT                   /id="VAR_075644"
FT   VARIANT         4131
FT                   /note="R -> C (rare variant detected in a sporadic case of
FT                   Moyamoya disease in East Asian population)"
FT                   /evidence="ECO:0000269|PubMed:25956231"
FT                   /id="VAR_075645"
FT   VARIANT         4146
FT                   /note="V -> A (rare variant detected in cases of Moyamoya
FT                   disease in Slovakian and Czech populations; inhibitory
FT                   effect on angiogenic activity of vascular endothelial
FT                   cells)"
FT                   /evidence="ECO:0000269|PubMed:27736983"
FT                   /id="VAR_079574"
FT   VARIANT         4185
FT                   /note="K -> T (found in a heterozygous family with
FT                   heterogeneous intracerebral vasculopathy)"
FT                   /evidence="ECO:0000269|PubMed:25043520"
FT                   /id="VAR_075646"
FT   VARIANT         4237
FT                   /note="D -> E (rare variant detected in a sporadic case of
FT                   Moyamoya disease in Caucasian population)"
FT                   /evidence="ECO:0000269|PubMed:25278557"
FT                   /id="VAR_075647"
FT   VARIANT         4367
FT                   /note="Q -> L (rare variant detected in a sporadic case of
FT                   Moyamoya disease in East Asian population)"
FT                   /evidence="ECO:0000269|PubMed:23110205"
FT                   /id="VAR_075648"
FT   VARIANT         4399
FT                   /note="A -> T (in MYMY2; dbSNP:rs148731719)"
FT                   /evidence="ECO:0000269|PubMed:21048783,
FT                   ECO:0000269|PubMed:23110205"
FT                   /id="VAR_067026"
FT   VARIANT         4567
FT                   /note="V -> M (rare variant detected in a sporadic case of
FT                   Moyamoya disease; dbSNP:rs145282452)"
FT                   /evidence="ECO:0000269|PubMed:21048783"
FT                   /id="VAR_067027"
FT   VARIANT         4586
FT                   /note="T -> P (rare variant detected in a sporadic case of
FT                   Moyamoya disease in East Asian population)"
FT                   /evidence="ECO:0000269|PubMed:23110205"
FT                   /id="VAR_075649"
FT   VARIANT         4608
FT                   /note="P -> S (variant detected in cases of Moyamoya
FT                   disease in Caucasian populations)"
FT                   /evidence="ECO:0000269|PubMed:21799892"
FT                   /id="VAR_067028"
FT   VARIANT         4631
FT                   /note="L -> V (rare variant detected in a sporadic case of
FT                   Moyamoya disease in East Asian population)"
FT                   /evidence="ECO:0000269|PubMed:23110205"
FT                   /id="VAR_075650"
FT   VARIANT         4677
FT                   /note="W -> L (rare polymorphism)"
FT                   /evidence="ECO:0000269|PubMed:27736983"
FT                   /id="VAR_079575"
FT   VARIANT         4732
FT                   /note="K -> T (rare variant detected in a sporadic case of
FT                   Moyamoya disease in Caucasian population)"
FT                   /evidence="ECO:0000269|PubMed:25278557"
FT                   /id="VAR_075651"
FT   VARIANT         4765
FT                   /note="V -> M (rare variant detected in a sporadic case of
FT                   Moyamoya disease)"
FT                   /evidence="ECO:0000269|PubMed:21048783"
FT                   /id="VAR_067029"
FT   VARIANT         4810
FT                   /note="R -> K (in MYMY2; very frequent in individuals
FT                   affected by Moyamoya disease; strongly increases the risk
FT                   of Moyamoya disease; induces genomic instability; shows
FT                   decreased ATPase activity, possibly caused by stabilization
FT                   of the oligomeric state)"
FT                   /evidence="ECO:0000269|PubMed:21048783,
FT                   ECO:0000269|PubMed:21799892, ECO:0000269|PubMed:23110205,
FT                   ECO:0000269|PubMed:23994138, ECO:0000269|PubMed:25278557,
FT                   ECO:0000269|PubMed:25956231, ECO:0000269|PubMed:26126547"
FT                   /id="VAR_067030"
FT   VARIANT         4863
FT                   /note="D -> N (variant detected in cases of Moyamoya
FT                   disease in East Asian populations)"
FT                   /evidence="ECO:0000269|PubMed:21799892"
FT                   /id="VAR_067031"
FT   VARIANT         4950
FT                   /note="E -> D (variant detected in cases of Moyamoya
FT                   disease in East Asian populations and rare variant detected
FT                   in a sporadic case of Moyamoya disease)"
FT                   /evidence="ECO:0000269|PubMed:21799892,
FT                   ECO:0000269|PubMed:23110205"
FT                   /id="VAR_067032"
FT   VARIANT         5021
FT                   /note="A -> V (variant detected in cases of Moyamoya
FT                   disease in East Asian populations and rare variant detected
FT                   in a sporadic case of Moyamoya disease; dbSNP:rs138130613)"
FT                   /evidence="ECO:0000269|PubMed:21799892,
FT                   ECO:0000269|PubMed:23110205"
FT                   /id="VAR_067033"
FT   VARIANT         5136
FT                   /note="M -> I (rare variant detected in a sporadic case of
FT                   Moyamoya disease in East Asian population)"
FT                   /evidence="ECO:0000269|PubMed:23110205"
FT                   /id="VAR_075652"
FT   VARIANT         5160
FT                   /note="D -> E (variant detected in cases of Moyamoya
FT                   disease in East Asian populations)"
FT                   /evidence="ECO:0000269|PubMed:21799892"
FT                   /id="VAR_067034"
FT   VARIANT         5163
FT                   /note="V -> I (rare variant detected in a sporadic case of
FT                   Moyamoya disease in Caucasian population)"
FT                   /evidence="ECO:0000269|PubMed:25278557"
FT                   /id="VAR_075653"
FT   VARIANT         5176
FT                   /note="E -> G (variant detected in cases of Moyamoya
FT                   disease in East Asian populations)"
FT                   /evidence="ECO:0000269|PubMed:21799892"
FT                   /id="VAR_067035"
FT   MUTAGEN         2426
FT                   /note="K->A: Decreased ATPase activity."
FT                   /evidence="ECO:0000269|PubMed:24658080"
FT   MUTAGEN         2488
FT                   /note="E->A: Decreased ATPase activity."
FT                   /evidence="ECO:0000269|PubMed:24658080"
FT   MUTAGEN         2488
FT                   /note="E->Q: Loss of ATPase hydrolysis. Stabilization of
FT                   the oligomeric state. Inhibited angiogenesis."
FT                   /evidence="ECO:0000269|PubMed:26126547"
FT   MUTAGEN         2775
FT                   /note="K->A: Decreased ATPase activity."
FT                   /evidence="ECO:0000269|PubMed:24658080"
FT   MUTAGEN         2845
FT                   /note="E->A: Decreased ATPase activity."
FT                   /evidence="ECO:0000269|PubMed:24658080"
FT   CONFLICT        270
FT                   /note="M -> T (in Ref. 4; AAH36891/AAH40341)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        321
FT                   /note="M -> T (in Ref. 4; AAH36891/AAH40341)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        369
FT                   /note="K -> N (in Ref. 4; AAH36891)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1045
FT                   /note="N -> D (in Ref. 1; BAK53191 and 6; BAB13444)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1133
FT                   /note="Q -> K (in Ref. 6; BAB13444)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1195
FT                   /note="V -> M (in Ref. 6; BAB13444)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1272
FT                   /note="E -> Q (in Ref. 6; BAB13444)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1331
FT                   /note="D -> G (in Ref. 6; BAB13444)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        3323
FT                   /note="R -> G (in Ref. 2; CAH56189)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        4220
FT                   /note="E -> G (in Ref. 7; BAB15212)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        4571
FT                   /note="D -> G (in Ref. 7; BAB15280)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        4853
FT                   /note="K -> R (in Ref. 7; BAB15212)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        4892
FT                   /note="N -> S (in Ref. 7; BAB15212)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        5139
FT                   /note="L -> S (in Ref. 7; BAB15280)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        5187
FT                   /note="L -> P (in Ref. 7; BAB15330)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   5207 AA;  591407 MW;  9BA6847099EE6E08 CRC64;
     MECPSCQHVS KEETPKFCSQ CGERLPPAAP IADSENNNST MASASEGEME CGQELKEEGG
     PCLFPGSDSW QENPEEPCSK ASWTVQESKK KKRKKKKKGN KSASSELASL PLSPASPCHL
     TLLSNPWPQD TALPHSQAQQ SGPTGQPSQP PGTATTPLEG DGLSAPTEVG DSPLQAQALG
     EAGVATGSEA QSSPQFQDHT EGEDQDASIP SGGRGLSQEG TGPPTSAGEG HSRTEDAAQE
     LLLPESKGGS SEPGTELQTT EQQAGASASM AVDAVAEPAN AVKGAGKEMK EKTQRMKQPP
     ATTPPFKTHC QEAETKTKDE MAAAEEKVGK NEQGEPEDLK KPEGKNRSAA AVKNEKEQKN
     QEADVQEVKA STLSPGGGVT VFFHAIISLH FPFNPDLHKV FIRGGEEFGE SKWDSNICEL
     HYTRDLGHDR VLVEGIVCIS KKHLDKYIPY KYVIYNGESF EYEFIYKHQQ KKGEYVNRCL
     FIKSSLLGSG DWHQYYDIVY MKPHGRLQKV MNHITDGPRK DLVKGKQIAA ALMLDSTFSI
     LQTWDTINLN SFFTQFEQFC FVLQQPMIYE GQAQLWTDLQ YREKEVKRYL WQHLKKHVVP
     LPDGKSTDFL PVDCPVRSKL KTGLIVLFVV EKIELLLEGS LDWLCHLLTS DASSPDEFHR
     DLSHILGIPQ SWRLYLVNLC QRCMDTRTYT WLGALPVLHC CMELAPRHKD AWRQPEDTWA
     ALEGLSFSPF REQMLDTSSL LQFMREKQHL LSIDEPLFRS WFSLLPLSHL VMYMENFIEH
     LGRFPAHILD CLSGIYYRLP GLEQVLNTQD VQDVQNVQNI LEMLLRLLDT YRDKIPEEAL
     SPSYLTVCLK LHEAICSSTK LLKFYELPAL SAEIVCRMIR LLSLVDSAGQ RDETGNNSVQ
     TVFQGTLAAT KRWLREVFTK NMLTSSGASF TYVKEIEVWR RLVEIQFPAE HGWKESLLGD
     MEWRLTKEEP LSQITAYCNS CWDTKGLEDS VAKTFEKCII EAVSSACQSQ TSILQGFSYS
     DLRKFGIVLS AVITKSWPRT ADNFNDILKH LLTLADVKHV FRLCGTDEKI LANVTEDAKR
     LIAVADSVLT KVVGDLLSGT ILVGQLELII KHKNQFLDIW QLREKSLSPQ DEQCAVEEAL
     DWRREELLLL KKEKRCVDSL LKMCGNVKHL IQVDFGVLAV RHSQDLSSKR LNDTVTVRLS
     TSSNSQRATH YHLSSQVQEM AGKIDLLRDS HIFQLFWREA AEPLSEPKED QEAAELLSEP
     EEESERHILE LEEVYDYLYQ PSYRKFIKLH QDLKSGEVTL AEIDVIFKDF VNKYTDLDSE
     LKIMCTVDHQ DQRDWIKDRV EQIKEYHHLH QAVHAAKVIL QVKESLGLNG DFSVLNTLLN
     FTDNFDDFRR ETLDQINQEL IQAKKLLQDI SEARCKGLQA LSLRKEFICW VREALGGINE
     LKVFVDLASI SAGENDIDVD RVACFHDAVQ GYASLLFKLD PSVDFSAFMK HLKKLWKALD
     KDQYLPRKLC DSARNLEWLK TVNESHGSVE RSSLTLATAI NQRGIYVIQA PKGGQKISPD
     TVLHLILPES PGSHEESREY SLEEVKELLN KLMLMSGKKD RNNTEVERFS EVFCSVQRLS
     QAFIDLHSAG NMLFRTWIAM AYCSPKQGVS LQMDFGLDLV TELKEGGDVT ELLAALCRQM
     EHFLDSWKRF VTQKRMEHFY LNFYTAEQLV YLSTELRKQP PSDAALTMLS FIKSNCTLRD
     VLRASVGCGS EAARYRMRRV MEELPLMLLS EFSLVDKLRI IMEQSMRCLP AFLPDCLDLE
     TLGHCLAHLA GMGGSPVERC LPRGLQVGQP NLVVCGHSEV LPAALAVYMQ TPSQPLPTYD
     EVLLCTPATT FEEVALLLRR CLTLGSLGHK VYSLLFADQL SYEVARQAEE LFHNLCTQQH
     REDYQLVMVC DGDWEHCYLP SAFSQHKVFV TPQAPLEAIQ AYLAGHYRVP KQTLSAAAVF
     NDRLCVGIVA SERAGVGKSL YVKRLHDKMK MQLNVKNVPL KTIRLIDPQV DESRVLGALL
     PFLDAQYQKV PVLFHLDVTS SVQTGIWVFL FKLLILQYLM DINGKMWLRN PCHLYIVEIL
     ERRTSVPSRS SSALRTRVPQ FSFLDIFPKV TCRPPKEVID MELSALRSDT EPGMDLWEFC
     SETFQRPYQY LRRFNQNQDL DTFQYQEGSV EGTPEECLQH FLFHCGVINP SWSELRNFAR
     FLNYQLRDCE ASLFCNPSFI GDTLRGFKKF VVTFMIFMAR DFATPSLHTS DQSPGKHMVT
     MDGVREEDLA PFSLRKRWES EPHPYVFFND DHTTMTFIGF HLQPNINGSV DAISHLTGKV
     IKRDVMTRDL YQGLLLQRVP FNVDFDKLPR HKKLERLCLT LGIPQATDPD KTYELTTDNM
     LKILAIEMRF RCGIPVIIMG ETGCGKTRLI KFLSDLRRGG TNADTIKLVK VHGGTTADMI
     YSRVREAENV AFANKDQHQL DTILFFDEAN TTEAISCIKE VLCDHMVDGQ PLAEDSGLHI
     IAACNPYRKH SEEMICRLES AGLGYRVSME ETADRLGSIP LRQLVYRVHA LPPSLIPLVW
     DFGQLSDVAE KLYIQQIVQR LVESISLDEN GTRVITEVLC ASQGFMRKTE DECSFVSLRD
     VERCVKVFRW FHEHSAMLLA QLNAFLSKSS VSKNHTERDP VLWSLMLAIG VCYHASLEKK
     DSYRKAIARF FPKPYDDSRL LLDEITRAQD LFLDGVPLRK TIAKNLALKE NVFMMVVCIE
     LKIPLFLVGK PGSSKSLAKT IVADAMQGPA AYSDLFRSLK QVHLVSFQCS PHSTPQGIIS
     TFRQCARFQQ GKDLQQYVSV VVLDEVGLAE DSPKMPLKTL HPLLEDGCIE DDPAPHKKVG
     FVGISNWALD PAKMNRGIFV SRGSPNETEL IESAKGICSS DILVQDRVQG YFASFAKAYE
     TVCKRQDKEF FGLRDYYSLI KMVFAAAKAS NRKPSPQDIA QAVLRNFSGK DDIQALDIFL
     ANLPEAKCSE EVSPMQLIKQ NIFGPSQKVP GGEQEDAESR YLLVLTKNYV ALQILQQTFF
     EGDQQPEIIF GSGFPKDQEY TQLCRNINRV KICMETGKMV LLLNLQNLYE SLYDALNQYY
     VHLGGQKYVD LGLGTHRVKC RVHPNFRLIV IEEKDVVYKH FPIPLINRLE KHYLDINTVL
     EKWQKSIVEE LCAWVEKFIN VKAHHFQKRH KYSPSDVFIG YHSDACASVV LQVIERQGPR
     ALTEELHQKV SEEAKSILLN CATPDAVVRL SAYSLGGFAA EWLSQEYFHR QRHNSFADFL
     QAHLHTADLE RHAIFTEITT FSRLLTSHDC EILESEVTGR APKPTLLWLQ QFDTEYSFLK
     EVRNCLTNTA KCKILIFQTD FEDGIRSAQL IASAKYSVIN EINKIRENED RIFVYFITKL
     SRVGRGTAYV GFHGGLWQSV HIDDLRRSTL MVSDVTRLQH VTISQLFAPG DLPELGLEHR
     AEDGHEEAME TEASTSGEVA EVAEEAMETE SSEKVGKETS ELGGSDVSIL DTTRLLRSCV
     QSAVGMLRDQ NESCTRNMRR VVLLLGLLNE DDACHASFLR VSKMRLSVFL KKQEESQFHP
     LEWLAREACN QDALQEAGTF RHTLWKRVQG AVTPLLASMI SFIDRDGNLE LLTRPDTPPW
     ARDLWMFIFS DTMLLNIPLV MNNERHKGEM AYIVVQNHMN LSENASNNVP FSWKIKDYLE
     ELWVQAQYIT DAEGLPKKFV DIFQQTPLGR FLAQLHGEPQ QELLQCYLKD FILLTMRVST
     EEELKFLQMA LWSCTRKLKA ASEAPEEEVS LPWVHLAYQR FRSRLQNFSR ILTIYPQVLH
     SLMEARWNHE LAGCEMTLDA FAAMACTEML TRNTLKPSPQ AWLQLVKNLS MPLELICSDE
     HMQGSGSLAQ AVIREVRAQW SRIFSTALFV EHVLLGTESR VPELQGLVTE HVFLLDKCLR
     ENSDVKTHGP FEAVMRTLCE CKETASKTLS RFGIQPCSIC LGDAKDPVCL PCDHVHCLRC
     LRAWFASEQM ICPYCLTALP DEFSPAVSQA HREAIEKHAR FRQMCNSFFV DLVSTICFKD
     NAPPEKEVIE SLLSLLFVQK GRLRDAAQRH CEHTKSLSPF NDVVDKTPVI RSVILKLLLK
     YSFHDVKDYI QEYLTLLKKK AFITEDKTEL YMLFINCLED SILEKTSAYS RNDELNHLEE
     EGRFLKAYSP ASRGREPANE ASVEYLQEVA RIRLCLDRAA DFLSEPEGGP EMAKEKQCYL
     QQVKQFCIRV ENDWHRVYLV RKLSSQRGME FVQGLSKPGR PHQWVFPKDV VKQQGLRQDH
     PGQMDRYLVY GDEYKALRDA VAKAVLECKP LGIKTALKAC KTPQSQQSAY FLLTLFREVA
     ILYRSHNASL HPTPEQCEAV SKFIGECKIL SPPDISRFAT SLVDNSVPLL RAGPSDSNLD
     GTVTEMAIHA AAVLLCGQNE LLEPLKNLAF SPATMAHAFL PTMPEDLLAQ ARRWKGLERV
     HWYTCPNGHP CSVGECGRPM EQSICIDCHA PIGGIDHKPR DGFHLVKDKA DRTQTGHVLG
     NPQRRDVVTC DRGLPPVVFL LIRLLTHLAL LLGASQSSQA LINIIKPPVR DPKGFLQQHI
     LKDLEQLAKM LGHSADETIG VVHLVLRRLL QEQHQLSSRR LLNFDTELST KEMRNNWEKE
     IAAVISPELE HLDKTLPTMN NLISQDKRIS SNPVAKIIYG DPVTFLPHLP RKSVVHCSKI
     WSCRKRITVE YLQHIVEQKN GKERVPILWH FLQKEAELRL VKFLPEILAL QRDLVKQFQN
     VQQVEYSSIR GFLSKHSSDG LRQLLHNRIT VFLSTWNKLR RSLETNGEIN LPKDYCSTDL
     DLDTEFEILL PRRRGLGLCA TALVSYLIRL HNEIVYAVEK LSKENNSYSV DAAEVTELHV
     ISYEVERDLT PLILSNCQYQ VEEGRETVQE FDLEKIQRQI VSRFLQGKPR LSLKGIPTLV
     YRHDWNYEHL FMDIKNKMAQ DSLPSSVISA ISGQLQSYSD ACEVLSVVEV TLGFLSTAGG
     DPNMQLNVYT QDILQMGDQT IHVLKALNRC QLKHTIALWQ FLSAHKSEQL LRLHKEPFGE
     ISSRYKADLS PENAKLLSTF LNQTGLDAFL LELHEMIILK LKNPQTQTEE RFRPQWSLRD
     TLVSYMQTKE SEILPEMASQ FPEEILLASC VSVWKTAAVL KWNREMR
//
ID   RPN1_HUMAN              Reviewed;         607 AA.
AC   P04843; B2R5Z0; D3DNB6; Q68DT1;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   13-AUG-1987, sequence version 1.
DT   22-APR-2020, entry version 196.
DE   RecName: Full=Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1;
DE   AltName: Full=Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 67 kDa subunit;
DE   AltName: Full=Ribophorin I;
DE            Short=RPN-I;
DE   AltName: Full=Ribophorin-1;
DE   Flags: Precursor;
GN   Name=RPN1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3034581; DOI=10.1002/j.1460-2075.1987.tb04721.x;
RA   Crimaudo C., Hortsch M., Gausepohl H., Meyer D.I.;
RT   "Human ribophorins I and II: the primary structure and membrane topology of
RT   two highly conserved rough endoplasmic reticulum-specific glycoproteins.";
RL   EMBO J. 6:75-82(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Amygdala;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterine endothelium;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cervix;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=12643545; DOI=10.1021/pr025562r;
RA   Basrur V., Yang F., Kushimoto T., Higashimoto Y., Yasumoto K., Valencia J.,
RA   Muller J., Vieira W.D., Watabe H., Shabanowitz J., Hearing V.J., Hunt D.F.,
RA   Appella E.;
RT   "Proteomic analysis of early melanosomes: identification of novel
RT   melanosomal proteins.";
RL   J. Proteome Res. 2:69-79(2003).
RN   [7]
RP   TISSUE SPECIFICITY.
RX   PubMed=12887896; DOI=10.1016/s1097-2765(03)00243-0;
RA   Kelleher D.J., Karaoglu D., Mandon E.C., Gilmore R.;
RT   "Oligosaccharyltransferase isoforms that contain different catalytic STT3
RT   subunits have distinct enzymatic properties.";
RL   Mol. Cell 12:101-111(2003).
RN   [8]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H., Mangini N.J.,
RA   Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R., Yamagishi S.,
RA   Shabanowitz J., Hearing V.J., Wu C., Appella E., Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [9]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-299.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of multiple
RT   enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-187, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   IDENTIFICATION IN THE OLIGOSACCHARYLTRANSFERASE COMPLEX.
RX   PubMed=25135935; DOI=10.1083/jcb.201404083;
RA   Cherepanova N.A., Shrimal S., Gilmore R.;
RT   "Oxidoreductase activity is necessary for N-glycosylation of cysteine-
RT   proximal acceptor sites in glycoproteins.";
RL   J. Cell Biol. 206:525-539(2014).
RN   [13]
RP   IDENTIFICATION IN THE OLIGOSACCHARYLTRANSFERASE COMPLEX.
RX   PubMed=23606741; DOI=10.1242/jcs.115410;
RA   Dumax-Vorzet A., Roboti P., High S.;
RT   "OST4 is a subunit of the mammalian oligosaccharyltransferase required for
RT   efficient N-glycosylation.";
RL   J. Cell Sci. 126:2595-2606(2013).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-538, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Subunit of the oligosaccharyl transferase (OST) complex that
CC       catalyzes the initial transfer of a defined glycan
CC       (Glc(3)Man(9)GlcNAc(2) in eukaryotes) from the lipid carrier dolichol-
CC       pyrophosphate to an asparagine residue within an Asn-X-Ser/Thr
CC       consensus motif in nascent polypeptide chains, the first step in
CC       protein N-glycosylation. N-glycosylation occurs cotranslationally and
CC       the complex associates with the Sec61 complex at the channel-forming
CC       translocon complex that mediates protein translocation across the
CC       endoplasmic reticulum (ER). All subunits are required for a maximal
CC       enzyme activity. {ECO:0000250|UniProtKB:E2RQ08}.
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBUNIT: Component of the oligosaccharyltransferase (OST) complex. OST
CC       exists in two different complex forms which contain common core
CC       subunits RPN1, RPN2, OST48, OST4, DAD1 and TMEM258, either STT3A or
CC       STT3B as catalytic subunits, and form-specific accessory subunits
CC       (PubMed:23606741, PubMed:25135935). STT3A complex assembly occurs
CC       through the formation of 3 subcomplexes. Subcomplex 1 contains RPN1 and
CC       TMEM258, subcomplex 2 contains the STT3A-specific subunits STT3A,
CC       DC2/OSTC, and KCP2 as well as the core subunit OST4, and subcomplex 3
CC       contains RPN2, DAD1, and OST48. The STT3A complex can form stable
CC       complexes with the Sec61 complex or with both the Sec61 and TRAP
CC       complexes (By similarity). {ECO:0000250|UniProtKB:E2RQ08,
CC       ECO:0000269|PubMed:23606741, ECO:0000269|PubMed:25135935}.
CC   -!- INTERACTION:
CC       P04843; P49069: CAMLG; NbExp=3; IntAct=EBI-355963, EBI-1748958;
CC       P04843; O43765: SGTA; NbExp=7; IntAct=EBI-355963, EBI-347996;
CC       P04843; Q8TCJ2: STT3B; NbExp=2; IntAct=EBI-355963, EBI-2256290;
CC       P04843; Q9UMX0: UBQLN1; NbExp=4; IntAct=EBI-355963, EBI-741480;
CC       P04843; Q9UMX0-2: UBQLN1; NbExp=3; IntAct=EBI-355963, EBI-10173939;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum
CC       {ECO:0000250|UniProtKB:E2RQ08, ECO:0000250|UniProtKB:Q9GMB0}.
CC       Endoplasmic reticulum membrane; Single-pass type I membrane protein
CC       {ECO:0000305}. Melanosome. Note=Identified by mass spectrometry in
CC       melanosome fractions from stage I to stage IV.
CC   -!- TISSUE SPECIFICITY: Expressed in all tissues tested.
CC       {ECO:0000269|PubMed:12887896}.
CC   -!- SIMILARITY: Belongs to the OST1 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Y00281; CAA68392.1; -; mRNA.
DR   EMBL; AK312369; BAG35287.1; -; mRNA.
DR   EMBL; CR749284; CAH18139.1; -; mRNA.
DR   EMBL; CH471052; EAW79306.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW79307.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW79308.1; -; Genomic_DNA.
DR   EMBL; BC010839; AAH10839.1; -; mRNA.
DR   CCDS; CCDS3051.1; -.
DR   PIR; A26168; A26168.
DR   RefSeq; NP_002941.1; NM_002950.3.
DR   PDB; 6S7O; EM; 3.50 A; E=1-607.
DR   PDB; 6S7T; EM; 3.50 A; E=1-607.
DR   PDBsum; 6S7O; -.
DR   PDBsum; 6S7T; -.
DR   SMR; P04843; -.
DR   BioGrid; 112099; 222.
DR   CORUM; P04843; -.
DR   DIP; DIP-38152N; -.
DR   IntAct; P04843; 96.
DR   MINT; P04843; -.
DR   STRING; 9606.ENSP00000296255; -.
DR   TCDB; 9.B.142.3.17; the integral membrane glycosyltransferase family 39 (gt39) family.
DR   GlyConnect; 1186; -.
DR   iPTMnet; P04843; -.
DR   PhosphoSitePlus; P04843; -.
DR   SwissPalm; P04843; -.
DR   BioMuta; RPN1; -.
DR   DMDM; 132559; -.
DR   CPTAC; CPTAC-125; -.
DR   CPTAC; CPTAC-126; -.
DR   EPD; P04843; -.
DR   jPOST; P04843; -.
DR   MassIVE; P04843; -.
DR   MaxQB; P04843; -.
DR   PaxDb; P04843; -.
DR   PeptideAtlas; P04843; -.
DR   PRIDE; P04843; -.
DR   ProteomicsDB; 51749; -.
DR   TopDownProteomics; P04843; -.
DR   Antibodypedia; 4058; 527 antibodies.
DR   DNASU; 6184; -.
DR   Ensembl; ENST00000296255; ENSP00000296255; ENSG00000163902.
DR   GeneID; 6184; -.
DR   KEGG; hsa:6184; -.
DR   UCSC; uc003ekr.2; human.
DR   CTD; 6184; -.
DR   DisGeNET; 6184; -.
DR   GeneCards; RPN1; -.
DR   HGNC; HGNC:10381; RPN1.
DR   HPA; ENSG00000163902; Low tissue specificity.
DR   MalaCards; RPN1; -.
DR   MIM; 180470; gene.
DR   neXtProt; NX_P04843; -.
DR   OpenTargets; ENSG00000163902; -.
DR   Orphanet; 402020; Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2).
DR   PharmGKB; PA34777; -.
DR   eggNOG; KOG2291; Eukaryota.
DR   eggNOG; ENOG410XQVZ; LUCA.
DR   GeneTree; ENSGT00390000009630; -.
DR   InParanoid; P04843; -.
DR   KO; K12666; -.
DR   OMA; TMKIHYE; -.
DR   OrthoDB; 1294725at2759; -.
DR   PhylomeDB; P04843; -.
DR   TreeFam; TF312988; -.
DR   Reactome; R-HSA-1799339; SRP-dependent cotranslational protein targeting to membrane.
DR   Reactome; R-HSA-446203; Asparagine N-linked glycosylation.
DR   SIGNOR; P04843; -.
DR   UniPathway; UPA00378; -.
DR   ChiTaRS; RPN1; human.
DR   GeneWiki; RPN1; -.
DR   GenomeRNAi; 6184; -.
DR   Pharos; P04843; Tbio.
DR   PRO; PR:P04843; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; P04843; protein.
DR   Bgee; ENSG00000163902; Expressed in corpus epididymis and 231 other tissues.
DR   ExpressionAtlas; P04843; baseline and differential.
DR   Genevisible; P04843; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0008250; C:oligosaccharyltransferase complex; IBA:GO_Central.
DR   GO; GO:0005791; C:rough endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0004579; F:dolichyl-diphosphooligosaccharide-protein glycotransferase activity; IBA:GO_Central.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0006464; P:cellular protein modification process; TAS:ProtInc.
DR   GO; GO:0018279; P:protein N-linked glycosylation via asparagine; IMP:UniProtKB.
DR   InterPro; IPR007676; Ribophorin_I.
DR   PANTHER; PTHR21049; PTHR21049; 1.
DR   Pfam; PF04597; Ribophorin_I; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Endoplasmic reticulum; Glycoprotein;
KW   Isopeptide bond; Membrane; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   SIGNAL          1..23
FT   CHAIN           24..607
FT                   /note="Dolichyl-diphosphooligosaccharide--protein
FT                   glycosyltransferase subunit 1"
FT                   /id="PRO_0000022241"
FT   TOPO_DOM        24..438
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        439..457
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        458..607
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         187
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         538
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q91YQ5"
FT   CARBOHYD        299
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19159218"
FT   CROSSLNK        538
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:25114211"
SQ   SEQUENCE   607 AA;  68569 MW;  A2351A9CFABAEB6C CRC64;
     MEAPAAGLFL LLLLGTWAPA PGSASSEAPP LINEDVKRTV DLSSHLAKVT AEVVLAHLGG
     GSTSRATSFL LALEPELEAR LAHLGVQVKG EDEEENNLEV RETKIKGKSG RFFTVKLPVA
     LDPGAKISVI VETVYTHVLH PYPTQITQSE KQFVVFEGNH YFYSPYPTKT QTMRVKLASR
     NVESYTKLGN PTRSEDLLDY GPFRDVPAYS QDTFKVHYEN NSPFLTITSM TRVIEVSHWG
     NIAVEENVDL KHTGAVLKGP FSRYDYQRQP DSGISSIRSF KTILPAAAQD VYYRDEIGNV
     STSHLLILDD SVEMEIRPRF PLFGGWKTHY IVGYNLPSYE YLYNLGDQYA LKMRFVDHVF
     DEQVIDSLTV KIILPEGAKN IEIDSPYEIS RAPDELHYTY LDTFGRPVIV AYKKNLVEQH
     IQDIVVHYTF NKVLMLQEPL LVVAAFYILF FTVIIYVRLD FSITKDPAAE ARMKVACITE
     QVLTLVNKRI GLYRHFDETV NRYKQSRDIS TLNSGKKSLE TEHKALTSEI ALLQSRLKTE
     GSDLCDRVSE MQKLDAQVKE LVLKSAVEAE RLVAGKLKKD TYIENEKLIS GKRQELVTKI
     DHILDAL
//
ID   B4E1S6_HUMAN            Unreviewed;       126 AA.
AC   B4E1S6;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   22-APR-2020, entry version 84.
DE   RecName: Full=Syndecan {ECO:0000256|RuleBase:RU000649};
GN   Name=SDC4 {ECO:0000313|EMBL:EAW75860.1};
GN   ORFNames=hCG_38363 {ECO:0000313|EMBL:EAW75860.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG64888.1};
RN   [1] {ECO:0000313|EMBL:EAW75860.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW75860.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:BAG64888.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Trachea {ECO:0000313|EMBL:BAG64888.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Cell surface proteoglycan. {ECO:0000256|RuleBase:RU000649}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000256|RuleBase:RU000649}; Single-
CC       pass type I membrane protein {ECO:0000256|RuleBase:RU000649}.
CC   -!- SIMILARITY: Belongs to the syndecan proteoglycan family.
CC       {ECO:0000256|RuleBase:RU000649}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK303964; BAG64888.1; -; mRNA.
DR   EMBL; CH471077; EAW75860.1; -; Genomic_DNA.
DR   RefSeq; XP_011527279.1; XM_011528977.2.
DR   MaxQB; B4E1S6; -.
DR   PeptideAtlas; B4E1S6; -.
DR   PRIDE; B4E1S6; -.
DR   ProteomicsDB; 5783; -.
DR   GeneID; 6385; -.
DR   CTD; 6385; -.
DR   eggNOG; ENOG410IXIG; Eukaryota.
DR   eggNOG; ENOG4111QSA; LUCA.
DR   ChiTaRS; SDC4; human.
DR   GenomeRNAi; 6385; -.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   InterPro; IPR003585; Neurexin-like.
DR   InterPro; IPR001050; Syndecan.
DR   InterPro; IPR027789; Syndecan/Neurexin_dom.
DR   InterPro; IPR030479; Syndecan_CS.
DR   PANTHER; PTHR10915; PTHR10915; 1.
DR   Pfam; PF01034; Syndecan; 1.
DR   SMART; SM00294; 4.1m; 1.
DR   PROSITE; PS00964; SYNDECAN; 1.
PE   2: Evidence at transcript level;
KW   Glycoprotein {ECO:0000256|RuleBase:RU000649};
KW   Heparan sulfate {ECO:0000256|RuleBase:RU000649};
KW   Membrane {ECO:0000256|SAAS:SAAS00281482, ECO:0000256|SAM:Phobius};
KW   Proteoglycan {ECO:0000256|RuleBase:RU000649};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00281482, ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00281482,
KW   ECO:0000256|SAM:Phobius}.
FT   TRANSMEM        74..98
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          97..115
FT                   /note="4.1m"
FT                   /evidence="ECO:0000259|SMART:SM00294"
FT   REGION          14..58
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        31..50
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   126 AA;  13910 MW;  FFFFA5D3D4B914A4 CRC64;
     MIGPEVVHPL VPLDNHIPER AGSGSQVPTE PKKLEENEVI PKRISPVEES EDVSNKVSMS
     STVQGSNIFE RTEVLAALIV GGIVGILFAV FLILLLMYRM KKKDEGSYDL GKKPIYKKAP
     TNEFYA
//
ID   SDC4_HUMAN              Reviewed;         198 AA.
AC   P31431; O00773; Q16833; Q53FN9; Q6FGN3;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1998, sequence version 2.
DT   22-APR-2020, entry version 203.
DE   RecName: Full=Syndecan-4;
DE            Short=SYND4;
DE   AltName: Full=Amphiglycan;
DE   AltName: Full=Ryudocan core protein;
DE   Flags: Precursor;
GN   Name=SDC4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND VARIANT
RP   LEU-12.
RC   TISSUE=Lung fibroblast;
RX   PubMed=1500433; DOI=10.1083/jcb.118.4.961;
RA   David G., van der Schueren B., Marynen P., Cassiman J.-J.,
RA   van den Berghe H.;
RT   "Molecular cloning of amphiglycan, a novel integral membrane heparan
RT   sulfate proteoglycan expressed by epithelial and fibroblastic cells.";
RL   J. Cell Biol. 118:961-969(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=7916598; DOI=10.1006/bbrc.1993.1122;
RA   Kojima T., Inazawa J., Takamatsu J., Rosenberg R.D., Saito H.;
RT   "Human ryudocan core protein: molecular cloning and characterization of the
RT   cDNA, and chromosomal localization of the gene.";
RL   Biochem. Biophys. Res. Commun. 190:814-822(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Placenta;
RX   PubMed=8797100; DOI=10.1093/oxfordjournals.jbchem.a021338;
RA   Takagi A., Kojima T., Tsuzuki S., Katsumi A., Yamazaki T., Sugiura I.,
RA   Hamaguchi M., Saito H.;
RT   "Structural organization and promoter activity of the human ryudocan
RT   gene.";
RL   J. Biochem. 119:979-984(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT LEU-12.
RC   TISSUE=Stomach;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J., Buck D., Burrill W.D.,
RA   Butler A.P., Carder C., Carter N.P., Chapman J.C., Clamp M., Clark G.,
RA   Clark L.N., Clark S.Y., Clee C.M., Clegg S., Cobley V.E., Collier R.E.,
RA   Connor R.E., Corby N.R., Coulson A., Coville G.J., Deadman R., Dhami P.D.,
RA   Dunn M., Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H., Rice C.M.,
RA   Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S., Skuce C.D.,
RA   Smith M.L., Soderlund C., Steward C.A., Sulston J.E., Swann R.M.,
RA   Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A., Tracey A.,
RA   Tromans A.C., Vaudin M., Wall M., Wallis J.M., Whitehead S.L.,
RA   Whittaker P., Willey D.L., Williams L., Williams S.A., Wilming L.,
RA   Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 75-153 (ISOFORM 2).
RA   Hillier L., Clark N., Dubuque T., Elliston K., Hawkins M., Holman M.,
RA   Hultman M., Kucaba T., Le M., Lennon G., Marra M., Parsons J., Rifkin L.,
RA   Rohlfing T., Soares M., Tan F., Trevaskis E., Waterston R., Williamson A.,
RA   Wohldmann P., Wilson R.;
RT   "The WashU-Merck EST project.";
RL   Submitted (MAR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 125-153 (ISOFORM 2).
RC   TISSUE=Uterus;
RX   PubMed=8889549; DOI=10.1101/gr.6.9.807;
RA   Hillier L.D., Lennon G., Becker M., Bonaldo M.F., Chiapelli B., Chissoe S.,
RA   Dietrich N., DuBuque T., Favello A., Gish W., Hawkins M., Hultman M.,
RA   Kucaba T., Lacy M., Le M., Le N., Mardis E., Moore B., Morris M.,
RA   Parsons J., Prange C., Rifkin L., Rohlfing T., Schellenberg K.,
RA   Bento Soares M., Tan F., Thierry-Meg J., Trevaskis E., Underwood K.,
RA   Wohldman P., Waterston R., Wilson R., Marra M.;
RT   "Generation and analysis of 280,000 human expressed sequence tags.";
RL   Genome Res. 6:807-828(1996).
RN   [12]
RP   SHEDDING, AND SUBCELLULAR LOCATION.
RX   PubMed=9169435; DOI=10.1074/jbc.272.23.14713;
RA   Subramanian S.V., Fitzgerald M.L., Bernfield M.;
RT   "Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth
RT   factor receptor activation.";
RL   J. Biol. Chem. 272:14713-14720(1997).
RN   [13]
RP   ALTERNATIVE SPLICING (ISOFORM 2), AND SUBCELLULAR LOCATION.
RX   PubMed=14675776; DOI=10.1016/s0014-5793(03)01354-1;
RA   Xing Y., Xu Q., Lee C.;
RT   "Widespread production of novel soluble protein isoforms by alternative
RT   splicing removal of transmembrane anchoring domains.";
RL   FEBS Lett. 555:572-578(2003).
RN   [14]
RP   INTERACTION WITH CDCP1.
RX   PubMed=16007225; DOI=10.1038/sj.onc.1208582;
RA   Bhatt A.S., Erdjument-Bromage H., Tempst P., Craik C.S., Moasser M.M.;
RT   "Adhesion signaling by a novel mitotic substrate of src kinases.";
RL   Oncogene 24:5333-5343(2005).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   FUNCTION.
RX   PubMed=22660413; DOI=10.1038/ncb2502;
RA   Baietti M.F., Zhang Z., Mortier E., Melchior A., Degeest G., Geeraerts A.,
RA   Ivarsson Y., Depoortere F., Coomans C., Vermeiren E., Zimmermann P.,
RA   David G.;
RT   "Syndecan-syntenin-ALIX regulates the biogenesis of exosomes.";
RL   Nat. Cell Biol. 14:677-685(2012).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   STRUCTURE BY NMR OF 171-198.
RX   PubMed=11456484; DOI=10.1021/bi002750r;
RA   Shin J., Lee W., Lee D., Koo B.-K., Han I., Lim Y., Woods A.,
RA   Couchman J.R., Oh E.-S.;
RT   "Solution structure of the dimeric cytoplasmic domain of syndecan-4.";
RL   Biochemistry 40:8471-8478(2001).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 193-198 IN COMPLEX WITH SDCBP.
RX   PubMed=12842047; DOI=10.1016/s0969-2126(03)00125-4;
RA   Kang B.S., Cooper D.R., Devedjiev Y., Derewenda U., Derewenda Z.S.;
RT   "Molecular roots of degenerate specificity in syntenin's PDZ2 domain:
RT   reassessment of the PDZ recognition paradigm.";
RL   Structure 11:845-853(2003).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 182-198 IN COMPLEX WITH SDCBP.
RX   PubMed=16533050; DOI=10.1021/bi052225y;
RA   Grembecka J., Cierpicki T., Devedjiev Y., Derewenda U., Kang B.S.,
RA   Bushweller J.H., Derewenda Z.S.;
RT   "The binding of the PDZ tandem of syntenin to target proteins.";
RL   Biochemistry 45:3674-3683(2006).
CC   -!- FUNCTION: Cell surface proteoglycan that bears heparan sulfate.
CC       Regulates exosome biogenesis in concert with SDCBP and PDCD6IP
CC       (PubMed:22660413). {ECO:0000269|PubMed:22660413}.
CC   -!- SUBUNIT: Homodimer. Interacts (via its cytoplasmic domain) with GIPC
CC       (via its PDZ domain). Interacts (via its cytoplasmic domain) with
CC       NUDT16L1 (By similarity). Interacts with CDCP1 and SDCBP.
CC       {ECO:0000250|UniProtKB:O35988, ECO:0000269|PubMed:12842047,
CC       ECO:0000269|PubMed:16007225, ECO:0000269|PubMed:16533050}.
CC   -!- INTERACTION:
CC       P31431; P31431; NbExp=3; IntAct=EBI-3913237, EBI-3913237;
CC       P31431; P16871: IL7R; NbExp=3; IntAct=EBI-3913237, EBI-80490;
CC       P31431; P21145: MAL; NbExp=3; IntAct=EBI-3913237, EBI-3932027;
CC       P31431; Q01453: PMP22; NbExp=3; IntAct=EBI-3913237, EBI-2845982;
CC       P31431; P17252: PRKCA; NbExp=2; IntAct=EBI-3913237, EBI-1383528;
CC       P31431; P34741: SDC2; NbExp=2; IntAct=EBI-3913237, EBI-1172957;
CC       P31431; O75056: SDC3; NbExp=2; IntAct=EBI-3913237, EBI-1642090;
CC       P31431; O43765: SGTA; NbExp=6; IntAct=EBI-3913237, EBI-347996;
CC       P31431; Q96EQ0: SGTB; NbExp=3; IntAct=EBI-3913237, EBI-744081;
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Membrane {ECO:0000255}; Single-pass
CC       type I membrane protein {ECO:0000255}. Secreted
CC       {ECO:0000269|PubMed:9169435}. Note=Shedding of the ectodomain produces
CC       a soluble form. {ECO:0000269|PubMed:9169435}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P31431-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P31431-2; Sequence=VSP_044449;
CC   -!- TISSUE SPECIFICITY: Expressed in epithelial and fibroblastic cells.
CC       {ECO:0000269|PubMed:1500433}.
CC   -!- PTM: Shedding is enhanced by a number of factors such as heparanase,
CC       thrombin or EGF. Also by stress and wound healing. PMA-mediated
CC       shedding is inhibited by TIMP3. {ECO:0000269|PubMed:9169435}.
CC   -!- MISCELLANEOUS: [Isoform 2]: Soluble form, lacks the transmembrane
CC       domain. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the syndecan proteoglycan family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X67016; CAA47406.1; -; mRNA.
DR   EMBL; D13292; BAA02550.1; -; mRNA.
DR   EMBL; D79206; BAA19613.1; -; Genomic_DNA.
DR   EMBL; AK312507; BAG35408.1; -; mRNA.
DR   EMBL; CR542045; CAG46842.1; -; mRNA.
DR   EMBL; CR542074; CAG46871.1; -; mRNA.
DR   EMBL; AK222695; BAD96415.1; -; mRNA.
DR   EMBL; AK223243; BAD96963.1; -; mRNA.
DR   EMBL; AL021578; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471077; EAW75861.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW75862.1; -; Genomic_DNA.
DR   EMBL; BC030805; AAH30805.1; -; mRNA.
DR   EMBL; AA151028; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AA258502; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS13350.1; -. [P31431-1]
DR   PIR; JC1457; JC1457.
DR   RefSeq; NP_002990.2; NM_002999.3. [P31431-1]
DR   PDB; 1EJP; NMR; -; A/B=171-198.
DR   PDB; 1EJQ; NMR; -; A/B=171-198.
DR   PDB; 1OBY; X-ray; 1.85 A; P/Q=193-198.
DR   PDB; 1YBO; X-ray; 2.30 A; C/D=182-198.
DR   PDBsum; 1EJP; -.
DR   PDBsum; 1EJQ; -.
DR   PDBsum; 1OBY; -.
DR   PDBsum; 1YBO; -.
DR   SMR; P31431; -.
DR   BioGrid; 112286; 22.
DR   CORUM; P31431; -.
DR   DIP; DIP-29945N; -.
DR   ELM; P31431; -.
DR   IntAct; P31431; 25.
DR   MINT; P31431; -.
DR   STRING; 9606.ENSP00000361818; -.
DR   TCDB; 9.A.35.1.1; the peptide translocating syndecan (syndecan) family.
DR   iPTMnet; P31431; -.
DR   PhosphoSitePlus; P31431; -.
DR   BioMuta; SDC4; -.
DR   DMDM; 2851418; -.
DR   EPD; P31431; -.
DR   jPOST; P31431; -.
DR   MassIVE; P31431; -.
DR   PaxDb; P31431; -.
DR   PeptideAtlas; P31431; -.
DR   PRIDE; P31431; -.
DR   ProteomicsDB; 54789; -. [P31431-1]
DR   TopDownProteomics; P31431-1; -. [P31431-1]
DR   Antibodypedia; 969; 472 antibodies.
DR   DNASU; 6385; -.
DR   Ensembl; ENST00000372733; ENSP00000361818; ENSG00000124145. [P31431-1]
DR   GeneID; 6385; -.
DR   KEGG; hsa:6385; -.
DR   UCSC; uc002xnu.4; human. [P31431-1]
DR   CTD; 6385; -.
DR   DisGeNET; 6385; -.
DR   GeneCards; SDC4; -.
DR   HGNC; HGNC:10661; SDC4.
DR   HPA; ENSG00000124145; Tissue enhanced (liver).
DR   MIM; 600017; gene.
DR   neXtProt; NX_P31431; -.
DR   OpenTargets; ENSG00000124145; -.
DR   PharmGKB; PA35591; -.
DR   eggNOG; ENOG410IXIG; Eukaryota.
DR   eggNOG; ENOG4111QSA; LUCA.
DR   GeneTree; ENSGT00940000160663; -.
DR   HOGENOM; CLU_046599_3_0_1; -.
DR   InParanoid; P31431; -.
DR   KO; K16338; -.
DR   OMA; GSWVPTE; -.
DR   OrthoDB; 1507361at2759; -.
DR   PhylomeDB; P31431; -.
DR   TreeFam; TF320463; -.
DR   Reactome; R-HSA-1971475; A tetrasaccharide linker sequence is required for GAG synthesis.
DR   Reactome; R-HSA-2022928; HS-GAG biosynthesis.
DR   Reactome; R-HSA-2024096; HS-GAG degradation.
DR   Reactome; R-HSA-202733; Cell surface interactions at the vascular wall.
DR   Reactome; R-HSA-3000170; Syndecan interactions.
DR   Reactome; R-HSA-3560783; Defective B4GALT7 causes EDS, progeroid type.
DR   Reactome; R-HSA-3560801; Defective B3GAT3 causes JDSSDHD.
DR   Reactome; R-HSA-3656237; Defective EXT2 causes exostoses 2.
DR   Reactome; R-HSA-3656253; Defective EXT1 causes exostoses 1, TRPS2 and CHDS.
DR   Reactome; R-HSA-4420332; Defective B3GALT6 causes EDSP2 and SEMDJL1.
DR   Reactome; R-HSA-975634; Retinoid metabolism and transport.
DR   SIGNOR; P31431; -.
DR   ChiTaRS; SDC4; human.
DR   EvolutionaryTrace; P31431; -.
DR   GeneWiki; SDC4; -.
DR   GenomeRNAi; 6385; -.
DR   Pharos; P31431; Tbio.
DR   PRO; PR:P31431; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   RNAct; P31431; protein.
DR   Bgee; ENSG00000124145; Expressed in nasal cavity epithelium and 226 other tissues.
DR   Genevisible; P31431; HS.
DR   GO; GO:0009986; C:cell surface; IBA:GO_Central.
DR   GO; GO:0043034; C:costamere; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; IEA:Ensembl.
DR   GO; GO:0005796; C:Golgi lumen; TAS:Reactome.
DR   GO; GO:0005887; C:integral component of plasma membrane; NAS:UniProtKB.
DR   GO; GO:0043202; C:lysosomal lumen; TAS:Reactome.
DR   GO; GO:0045121; C:membrane raft; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0001968; F:fibronectin binding; IEA:Ensembl.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005080; F:protein kinase C binding; IEA:Ensembl.
DR   GO; GO:0070053; F:thrombospondin receptor activity; IMP:BHF-UCL.
DR   GO; GO:0016477; P:cell migration; IBA:GO_Central.
DR   GO; GO:0006024; P:glycosaminoglycan biosynthetic process; TAS:Reactome.
DR   GO; GO:0006027; P:glycosaminoglycan catabolic process; TAS:Reactome.
DR   GO; GO:0060122; P:inner ear receptor cell stereocilium organization; IEA:Ensembl.
DR   GO; GO:0050900; P:leukocyte migration; TAS:Reactome.
DR   GO; GO:0042130; P:negative regulation of T cell proliferation; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0001843; P:neural tube closure; IEA:Ensembl.
DR   GO; GO:1903543; P:positive regulation of exosomal secretion; IMP:UniProtKB.
DR   GO; GO:1903553; P:positive regulation of extracellular exosome assembly; IMP:UniProtKB.
DR   GO; GO:0051894; P:positive regulation of focal adhesion assembly; IEA:Ensembl.
DR   GO; GO:0045860; P:positive regulation of protein kinase activity; IEA:Ensembl.
DR   GO; GO:0051496; P:positive regulation of stress fiber assembly; IEA:Ensembl.
DR   GO; GO:0010762; P:regulation of fibroblast migration; IEA:Ensembl.
DR   GO; GO:0001523; P:retinoid metabolic process; TAS:Reactome.
DR   GO; GO:0001657; P:ureteric bud development; IEA:Ensembl.
DR   GO; GO:0042060; P:wound healing; IEA:Ensembl.
DR   DisProt; DP01434; -.
DR   InterPro; IPR003585; Neurexin-like.
DR   InterPro; IPR001050; Syndecan.
DR   InterPro; IPR027789; Syndecan/Neurexin_dom.
DR   InterPro; IPR030479; Syndecan_CS.
DR   PANTHER; PTHR10915; PTHR10915; 1.
DR   Pfam; PF01034; Syndecan; 1.
DR   SMART; SM00294; 4.1m; 1.
DR   PROSITE; PS00964; SYNDECAN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Glycoprotein; Heparan sulfate;
KW   Membrane; Polymorphism; Proteoglycan; Reference proteome; Secreted; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL          1..18
FT                   /evidence="ECO:0000255"
FT   CHAIN           19..198
FT                   /note="Syndecan-4"
FT                   /id="PRO_0000033511"
FT   TOPO_DOM        19..145
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        146..170
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        171..198
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        39
FT                   /note="O-linked (Xyl...) (heparan sulfate) serine"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        61
FT                   /note="O-linked (Xyl...) (heparan sulfate) serine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        63
FT                   /note="O-linked (Xyl...) (heparan sulfate) serine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         149..198
FT                   /note="ALIVGGIVGILFAVFLILLLMYRMKKKDEGSYDLGKKPIYKKAPTNEFYA
FT                   -> GCPEH (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:8889549, ECO:0000303|Ref.10"
FT                   /id="VSP_044449"
FT   VARIANT         12
FT                   /note="F -> L (in dbSNP:rs2228384)"
FT                   /evidence="ECO:0000269|PubMed:1500433, ECO:0000269|Ref.6"
FT                   /id="VAR_021851"
FT   STRAND          192..194
FT                   /evidence="ECO:0000244|PDB:1EJQ"
FT   STRAND          196..198
FT                   /evidence="ECO:0000244|PDB:1OBY"
SQ   SEQUENCE   198 AA;  21642 MW;  8229AA2733F77A10 CRC64;
     MAPARLFALL LFFVGGVAES IRETEVIDPQ DLLEGRYFSG ALPDDEDVVG PGQESDDFEL
     SGSGDLDDLE DSMIGPEVVH PLVPLDNHIP ERAGSGSQVP TEPKKLEENE VIPKRISPVE
     ESEDVSNKVS MSSTVQGSNI FERTEVLAAL IVGGIVGILF AVFLILLLMY RMKKKDEGSY
     DLGKKPIYKK APTNEFYA
//
ID   S45A3_HUMAN             Reviewed;         553 AA.
AC   Q96JT2; A8K2U9;
DT   13-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   22-APR-2020, entry version 127.
DE   RecName: Full=Solute carrier family 45 member 3;
DE   AltName: Full=Prostate cancer-associated protein 6;
DE   AltName: Full=Prostein;
GN   Name=SLC45A3; Synonyms=PCANAP6, PRST;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND INDUCTION.
RC   TISSUE=Prostate;
RX   PubMed=11245466;
RA   Xu J., Kalos M., Stolk J.A., Zasloff E.J., Zhang X., Houghton R.L.,
RA   Filho A.M., Nolasco M., Badaro R., Reed S.G.;
RT   "Identification and characterization of prostein, a novel prostate-specific
RT   protein.";
RL   Cancer Res. 61:1563-1568(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Thalamus, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=PNS;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   TISSUE SPECIFICITY.
RX   PubMed=14997204; DOI=10.1038/sj.bjc.6601642;
RA   Kiessling A., Stevanovic S., Fuessel S., Weigle B., Rieger M.A., Temme A.,
RA   Rieber E.P., Schmitz M.;
RT   "Identification of an HLA-A(*)0201-restricted T-cell epitope derived from
RT   the prostate cancer-associated protein prostein.";
RL   Br. J. Cancer 90:1034-1040(2004).
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Prostate specific. Expressed in all prostatic
CC       glandular cells. Expressed both in normal and cancerous prostates.
CC       {ECO:0000269|PubMed:11245466, ECO:0000269|PubMed:14997204}.
CC   -!- INDUCTION: Up-regulated by androgens. {ECO:0000269|PubMed:11245466}.
CC   -!- MISCELLANEOUS: Marker for prostate cells. May be used, in case of
CC       prostate cancers, as a target antigen for prostate carcinomas-directed
CC       cytotoxic T-cell lymphocytes.
CC   -!- SIMILARITY: Belongs to the glycoside-pentoside-hexuronide (GPH) cation
CC       symporter transporter (TC 2.A.2) family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY033593; AAK54386.1; -; mRNA.
DR   EMBL; AK290364; BAF83053.1; -; mRNA.
DR   EMBL; AK313479; BAG36263.1; -; mRNA.
DR   EMBL; CH471067; EAW91575.1; -; Genomic_DNA.
DR   EMBL; BC050416; AAH50416.1; -; mRNA.
DR   CCDS; CCDS1458.1; -.
DR   RefSeq; NP_149093.1; NM_033102.2.
DR   RefSeq; XP_005245613.1; XM_005245556.3.
DR   RefSeq; XP_005245614.1; XM_005245557.4.
DR   RefSeq; XP_016858127.1; XM_017002638.1.
DR   BioGrid; 124520; 1.
DR   STRING; 9606.ENSP00000356113; -.
DR   TCDB; 2.A.2.4.8; the glycoside-pentoside-hexuronide (gph):cation symporter family.
DR   iPTMnet; Q96JT2; -.
DR   PhosphoSitePlus; Q96JT2; -.
DR   BioMuta; SLC45A3; -.
DR   DMDM; 46396996; -.
DR   jPOST; Q96JT2; -.
DR   MassIVE; Q96JT2; -.
DR   MaxQB; Q96JT2; -.
DR   PaxDb; Q96JT2; -.
DR   PeptideAtlas; Q96JT2; -.
DR   PRIDE; Q96JT2; -.
DR   ProteomicsDB; 77008; -.
DR   Antibodypedia; 20683; 191 antibodies.
DR   Ensembl; ENST00000367145; ENSP00000356113; ENSG00000158715.
DR   GeneID; 85414; -.
DR   KEGG; hsa:85414; -.
DR   UCSC; uc001hda.2; human.
DR   CTD; 85414; -.
DR   DisGeNET; 85414; -.
DR   GeneCards; SLC45A3; -.
DR   HGNC; HGNC:8642; SLC45A3.
DR   HPA; ENSG00000158715; Tissue enriched (prostate).
DR   MIM; 605097; gene.
DR   neXtProt; NX_Q96JT2; -.
DR   OpenTargets; ENSG00000158715; -.
DR   PharmGKB; PA32981; -.
DR   eggNOG; KOG0637; Eukaryota.
DR   eggNOG; ENOG410XPTR; LUCA.
DR   GeneTree; ENSGT00950000182914; -.
DR   HOGENOM; CLU_015081_2_2_1; -.
DR   InParanoid; Q96JT2; -.
DR   KO; K15379; -.
DR   OMA; SACDVSM; -.
DR   OrthoDB; 1230185at2759; -.
DR   PhylomeDB; Q96JT2; -.
DR   TreeFam; TF325412; -.
DR   Reactome; R-HSA-189200; Cellular hexose transport.
DR   ChiTaRS; SLC45A3; human.
DR   GeneWiki; SLC45A3; -.
DR   GenomeRNAi; 85414; -.
DR   Pharos; Q96JT2; Tbio.
DR   PRO; PR:Q96JT2; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q96JT2; protein.
DR   Bgee; ENSG00000158715; Expressed in prostate gland and 154 other tissues.
DR   Genevisible; Q96JT2; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0008506; F:sucrose:proton symporter activity; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0051119; F:sugar transmembrane transporter activity; TAS:Reactome.
DR   GO; GO:0008645; P:hexose transmembrane transport; TAS:Reactome.
DR   GO; GO:0045723; P:positive regulation of fatty acid biosynthetic process; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0010907; P:positive regulation of glucose metabolic process; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0048713; P:regulation of oligodendrocyte differentiation; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0015770; P:sucrose transport; ISS:ParkinsonsUK-UCL.
DR   InterPro; IPR011701; MFS.
DR   InterPro; IPR036259; MFS_trans_sf.
DR   Pfam; PF07690; MFS_1; 1.
DR   SUPFAM; SSF103473; SSF103473; 1.
PE   2: Evidence at transcript level;
KW   Membrane; Reference proteome; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN           1..553
FT                   /note="Solute carrier family 45 member 3"
FT                   /id="PRO_0000122519"
FT   TRANSMEM        19..39
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        52..72
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        88..108
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        120..140
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        161..181
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        198..218
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        275..295
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        323..343
FT                   /note="Helical; Name=8"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        353..373
FT                   /note="Helical; Name=9"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        382..402
FT                   /note="Helical; Name=10"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        522..542
FT                   /note="Helical; Name=11"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        455..458
FT                   /note="Poly-Pro"
SQ   SEQUENCE   553 AA;  59323 MW;  0AFA23FBC742A667 CRC64;
     MVQRLWVSRL LRHRKAQLLL VNLLTFGLEV CLAAGITYVP PLLLEVGVEE KFMTMVLGIG
     PVLGLVCVPL LGSASDHWRG RYGRRRPFIW ALSLGILLSL FLIPRAGWLA GLLCPDPRPL
     ELALLILGVG LLDFCGQVCF TPLEALLSDL FRDPDHCRQA YSVYAFMISL GGCLGYLLPA
     IDWDTSALAP YLGTQEECLF GLLTLIFLTC VAATLLVAEE AALGPTEPAE GLSAPSLSPH
     CCPCRARLAF RNLGALLPRL HQLCCRMPRT LRRLFVAELC SWMALMTFTL FYTDFVGEGL
     YQGVPRAEPG TEARRHYDEG VRMGSLGLFL QCAISLVFSL VMDRLVQRFG TRAVYLASVA
     AFPVAAGATC LSHSVAVVTA SAALTGFTFS ALQILPYTLA SLYHREKQVF LPKYRGDTGG
     ASSEDSLMTS FLPGPKPGAP FPNGHVGAGG SGLLPPPPAL CGASACDVSV RVVVGEPTEA
     RVVPGRGICL DLAILDSAFL LSQVAPSLFM GSIVQLSQSV TAYMVSAAGL GLVAIYFATQ
     VVFDKSDLAK YSA
//
ID   A0A024RC40_HUMAN        Unreviewed;       418 AA.
AC   A0A024RC40;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 37.
DE   SubName: Full=Synovial sarcoma translocation, chromosome 18, isoform CRA_b {ECO:0000313|EMBL:EAX01211.1};
GN   Name=SS18 {ECO:0000313|EMBL:EAX01211.1};
GN   ORFNames=hCG_37175 {ECO:0000313|EMBL:EAX01211.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAX01211.1};
RN   [1] {ECO:0000313|EMBL:EAX01211.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAX01211.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH471088; EAX01211.1; -; Genomic_DNA.
DR   RefSeq; NP_001007560.1; NM_001007559.2.
DR   PRIDE; A0A024RC40; -.
DR   Antibodypedia; 22102; 141 antibodies.
DR   GeneID; 6760; -.
DR   KEGG; hsa:6760; -.
DR   CTD; 6760; -.
DR   EuPathDB; HostDB:ENSG00000141380.13; -.
DR   eggNOG; KOG3227; Eukaryota.
DR   eggNOG; ENOG41128HA; LUCA.
DR   KO; K15623; -.
DR   OMA; MLDENAH; -.
DR   OrthoDB; 1442230at2759; -.
DR   PhylomeDB; A0A024RC40; -.
DR   ChiTaRS; SS18; human.
DR   GenomeRNAi; 6760; -.
DR   Bgee; ENSG00000141380; Expressed in kidney and 224 other tissues.
DR   ExpressionAtlas; A0A024RC40; baseline and differential.
DR   GO; GO:0005881; C:cytoplasmic microtubule; IEA:Ensembl.
DR   GO; GO:0071564; C:npBAF complex; IEA:Ensembl.
DR   GO; GO:0016514; C:SWI/SNF complex; IEA:Ensembl.
DR   GO; GO:0003713; F:transcription coactivator activity; IEA:InterPro.
DR   GO; GO:0000902; P:cell morphogenesis; IEA:Ensembl.
DR   GO; GO:0048013; P:ephrin receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:Ensembl.
DR   GO; GO:0000226; P:microtubule cytoskeleton organization; IEA:Ensembl.
DR   GO; GO:0097150; P:neuronal stem cell population maintenance; IEA:Ensembl.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   InterPro; IPR007726; SS18_fam.
DR   Pfam; PF05030; SSXT; 1.
PE   4: Predicted;
FT   REGION          77..118
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          188..418
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        188..246
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        320..339
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        348..392
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   418 AA;  45929 MW;  7E089D557538252F CRC64;
     MSVAFAAPRQ RGKGEITPAA IQKMLDDNNH LIQCIMDSQN KGKTSECSQY QQMLHTNLVY
     LATIADSNQN MQSLLPAPPT QNMPMGPGGM NQSGPPPPPR SHNMPSDGMV GGGPPAPHMQ
     NQMNGQMPGP NHMPMQGPGP NQLNMTNSSM NMPSSSHGSM GGYNHSVPSS QSMPVQNQMT
     MSQGQPMGNY GPRPNMSMQP NQGPMMHQQP PSQQYNMPQG GGQHYQGQQP PMGMMGQVNQ
     GNHMMGQRQI PPYRPPQQGP PQQYSGQEDY YGDQYSHGGQ GPPEGMNQQY YPDGHNDYGY
     QQPSYPEQGY DRPYEDSSQH YYEGGNSQYG QQQDAYQGPP PQQGYPPQQQ QYPGQQGYPG
     QQQGYGPSQG GPGPQYPNYP QGQGQQYGGY RPTQPGPPQP PQQRPYGYDQ GQYGNYQQ
//
ID   B4DLD3_HUMAN            Unreviewed;       395 AA.
AC   B4DLD3;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   22-APR-2020, entry version 85.
DE   SubName: Full=Protein SSXT {ECO:0000313|Ensembl:ENSP00000438066};
DE   SubName: Full=cDNA FLJ58120, highly similar to SSXT protein {ECO:0000313|EMBL:BAG59495.1};
GN   Name=SS18 {ECO:0000313|Ensembl:ENSP00000438066};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG59495.1};
RN   [1] {ECO:0000313|Ensembl:ENSP00000438066, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16177791; DOI=10.1038/nature03983;
RA   Nusbaum C., Zody M.C., Borowsky M.L., Kamal M., Kodira C.D., Taylor T.D.,
RA   Whittaker C.A., Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Abouelleil A., Allen N.R., Anderson S., Bloom T., Bugalter B., Butler J.,
RA   Cook A., DeCaprio D., Engels R., Garber M., Gnirke A., Hafez N., Hall J.L.,
RA   Norman C.H., Itoh T., Jaffe D.B., Kuroki Y., Lehoczky J., Lui A.,
RA   Macdonald P., Mauceli E., Mikkelsen T.S., Naylor J.W., Nicol R., Nguyen C.,
RA   Noguchi H., O'Leary S.B., O'Neill K., Piqani B., Smith C.L., Talamas J.A.,
RA   Topham K., Totoki Y., Toyoda A., Wain H.M., Young S.K., Zeng Q.,
RA   Zimmer A.R., Fujiyama A., Hattori M., Birren B.W., Sakaki Y., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 18.";
RL   Nature 437:551-555(2005).
RN   [2] {ECO:0000313|EMBL:BAG59495.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Tongue {ECO:0000313|EMBL:BAG59495.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|Ensembl:ENSP00000438066}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC091021; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK296949; BAG59495.1; -; mRNA.
DR   RefSeq; NP_001295130.1; NM_001308201.1.
DR   RefSeq; XP_011524447.1; XM_011526145.1.
DR   ProteomicsDB; 4526; -.
DR   Antibodypedia; 22102; 141 antibodies.
DR   Ensembl; ENST00000542420; ENSP00000438066; ENSG00000141380.
DR   GeneID; 6760; -.
DR   UCSC; uc010xbi.3; human.
DR   CTD; 6760; -.
DR   EuPathDB; HostDB:ENSG00000141380.13; -.
DR   HGNC; HGNC:11340; SS18.
DR   OpenTargets; ENSG00000141380; -.
DR   eggNOG; KOG3227; Eukaryota.
DR   eggNOG; ENOG41128HA; LUCA.
DR   GeneTree; ENSGT00940000156352; -.
DR   HOGENOM; CLU_054580_1_0_1; -.
DR   ChiTaRS; SS18; human.
DR   GenomeRNAi; 6760; -.
DR   Proteomes; UP000005640; Chromosome 18.
DR   Bgee; ENSG00000141380; Expressed in kidney and 224 other tissues.
DR   ExpressionAtlas; B4DLD3; baseline and differential.
DR   GO; GO:0003713; F:transcription coactivator activity; IEA:InterPro.
DR   InterPro; IPR007726; SS18_fam.
DR   Pfam; PF05030; SSXT; 1.
PE   1: Evidence at protein level;
KW   Proteomics identification {ECO:0000213|EPD:B4DLD3,
KW   ECO:0000213|MaxQB:B4DLD3, ECO:0000213|PeptideAtlas:B4DLD3,
KW   ECO:0000213|ProteomicsDB:B4DLD3};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   REGION          52..95
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          169..395
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        169..223
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        297..316
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        325..369
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   395 AA;  43519 MW;  791BCA279022C064 CRC64;
     MLDDNNHLIQ CIMDSQNKGK TSECSQYQQM LHTNLVYLAT IADSNQNMQS LLPAPPTQNM
     PMGPGGMNQS GPPPPPRSHN MPSDGMVGGG PPAPHMQNQM NGQMPGPNHM PMQGPGPNQL
     NMTNSSMNMP SSSHGSMGGY NHSVPSSQSM PVQNQMTMSQ GQPMGNYGPR PNMSMQPNQG
     PMMHQQPPSQ QYNMPQGGGQ HYQGQQPPMG MMGQVNQGNH MMGQRQIPPY RPPQQGPPQQ
     YSGQEDYYGD QYSHGGQGPP EGMNQQYYPD GHNDYGYQQP SYPEQGYDRP YEDSSQHYYE
     GGNSQYGQQQ DAYQGPPPQQ GYPPQQQQYP GQQGYPGQQQ GYGPSQGGPG PQYPNYPQGQ
     GQQYGGYRPT QPGPPQPPQQ RPYGYDQGQY GNYQQ
//
ID   B4DR34_HUMAN            Unreviewed;       336 AA.
AC   B4DR34;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   22-APR-2020, entry version 68.
DE   SubName: Full=cDNA FLJ59390, highly similar to SSXT protein {ECO:0000313|EMBL:BAG61146.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG61146.1};
RN   [1] {ECO:0000313|EMBL:BAG61146.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK299082; BAG61146.1; -; mRNA.
DR   RefSeq; XP_006722590.1; XM_006722527.2.
DR   MaxQB; B4DR34; -.
DR   PeptideAtlas; B4DR34; -.
DR   PRIDE; B4DR34; -.
DR   ProteomicsDB; 4922; -.
DR   GeneID; 6760; -.
DR   CTD; 6760; -.
DR   eggNOG; KOG3227; Eukaryota.
DR   eggNOG; ENOG41128HA; LUCA.
DR   GenomeRNAi; 6760; -.
PE   2: Evidence at transcript level;
FT   REGION          1..80
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          117..336
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        7..21
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        55..80
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        117..164
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        238..257
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        266..310
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   336 AA;  36886 MW;  75B1F14CB4B956A3 CRC64;
     MPMGPGGMNQ SGPPPPPRSH NMPSDGMVGG GPPAPHMQNQ MNGQMPGPNH MPMQGPGPNQ
     LNMTNSSMNM PSSSHGSMGG YNHSVPSSQS MPVQNQMTMS QGQPMGNYGP RPNMSMQPNQ
     GPMMHQQPPS QQYNMPQGGG QHYQGQQPPM GMMGQVNQGN HMMGQRQIPP YRPPQQGPPQ
     QYSGQEDYYG DQYSHGGQGP PEGMNQQYYP DGHNDYGYQQ PSYPEQGYDR PYEDSSQHYY
     EGGNSQYGQQ QDAYQGPPPQ QGYPPQQQQY PGQQGYPGQQ QGYGPSQGGP GPQYPNYPQG
     QGQQYGGYRP TQPGPPQPPQ QRPYGYDQGQ YGNYQQ
//
ID   B4E2J6_HUMAN            Unreviewed;       335 AA.
AC   B4E2J6;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   22-APR-2020, entry version 63.
DE   SubName: Full=cDNA FLJ58566, highly similar to SSXT protein {ECO:0000313|EMBL:BAG65158.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG65158.1};
RN   [1] {ECO:0000313|EMBL:BAG65158.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Trachea {ECO:0000313|EMBL:BAG65158.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK304305; BAG65158.1; -; mRNA.
DR   RefSeq; XP_011524454.1; XM_011526152.2.
DR   MaxQB; B4E2J6; -.
DR   PeptideAtlas; B4E2J6; -.
DR   PRIDE; B4E2J6; -.
DR   ProteomicsDB; 5827; -.
DR   GeneID; 6760; -.
DR   CTD; 6760; -.
DR   GenomeRNAi; 6760; -.
DR   GO; GO:0003713; F:transcription coactivator activity; IEA:InterPro.
DR   InterPro; IPR007726; SS18_fam.
DR   Pfam; PF05030; SSXT; 1.
PE   2: Evidence at transcript level;
FT   REGION          19..66
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          140..335
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        140..194
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        237..256
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        265..309
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   335 AA;  36452 MW;  A26BA61269370C44 CRC64;
     MLHTNLVYLA TIADSNQNMQ SLLPAPPTQN MPMGPGGMNQ SGPPPPPRSH NMPSDGMVGG
     GPPAPHMQNQ MNGQMPGPNH MPMQGPGPNQ LNMTNSSMNM PSSSHGSMGG YNHSVPSSQS
     MPVQNQMTMS QGQPMGNYGP RPNMSMQPNQ GPMMHQQPPS QQYNMPQGGG QHYQGQQPPM
     GMMGQVNQGN HMMGQRQIPP YRPPQQGPPQ QYSGQEDYYG DQYSHGGQGP PEGMNQQYYP
     DGNSQYGQQQ DAYQGPPPQQ GYPPQQQQYP GQQGYPGQQQ GYGPSQGGPG PQYPNYPQGQ
     GQQYGGYRPT QPGPPQPPQQ RPYGYDQGQY GNYQQ
//
ID   SSXT_HUMAN              Reviewed;         418 AA.
AC   Q15532; B0YJ95; Q16404; Q4VAX1; Q9BXC6;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   31-JAN-2002, sequence version 3.
DT   22-APR-2020, entry version 163.
DE   RecName: Full=Protein SSXT;
DE   AltName: Full=Protein SYT;
DE   AltName: Full=Synovial sarcoma translocated to X chromosome protein;
GN   Name=SS18; Synonyms=SSXT, SYT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND SSXT-SSX2 FUSION PROTEIN.
RC   TISSUE=Synovial sarcoma;
RX   PubMed=7951320; DOI=10.1038/ng0894-502;
RA   Clark J., Rocques P.J., Crew A.J., Gill S., Shipley J., Chan A.M.-L.,
RA   Gusterson B.A., Cooper C.S.;
RT   "Identification of novel genes, SYT and SSX, involved in the
RT   t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma.";
RL   Nat. Genet. 7:502-508(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=11368913; DOI=10.1016/s0378-1119(01)00412-7;
RA   Brodin B., Haslam K., Yang K., Bartolazzi A., Xie Y., Starborg M.,
RA   Lundeberg J., Larsson O.;
RT   "Cloning and characterization of spliced fusion transcript variants of
RT   synovial sarcoma: SYT/SSX4, SYT/SSX4v, and SYT/SSX2v. Possible regulatory
RT   role of the fusion gene product in wild type SYT expression.";
RL   Gene 268:173-182(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (FEB-2007) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 405-410 (SSXT-SSX2 FUSION PROTEIN), AND
RP   CHROMOSOMAL TRANSLOCATION WITH SSX2.
RX   PubMed=7495284;
RA   Fligman I., Lonardo F., Jhanwar S.C., Gerald W.L., Woodruff J., Ladanyi M.;
RT   "Molecular diagnosis of synovial sarcoma and characterization of a variant
RT   SYT-SSX2 fusion transcript.";
RL   Am. J. Pathol. 147:1592-1599(1995).
RN   [7]
RP   CHROMOSOMAL TRANSLOCATION WITH SSX1, AND CHROMOSOMAL TRANSLOCATION WITH
RP   SSX2.
RX   PubMed=7539744; DOI=10.1002/j.1460-2075.1995.tb07228.x;
RA   Crew A.J., Clark J., Fisher C., Gill S., Grimer R., Chand A., Shipley J.,
RA   Gusterson B.A., Cooper C.S.;
RT   "Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology
RT   to the Kruppel-associated box in human synovial sarcoma.";
RL   EMBO J. 14:2333-2340(1995).
RN   [8]
RP   INTERACTION WITH MLLT10.
RX   PubMed=11423977; DOI=10.1038/sj.onc.1204419;
RA   de Bruijn D.R., dos Santos N.R., Thijssen J., Balemans M., Debernardi S.,
RA   Linder B., Young B.D., Geurts van Kessel A.;
RT   "The synovial sarcoma associated protein SYT interacts with the acute
RT   leukemia associated protein AF10.";
RL   Oncogene 20:3281-3289(2001).
RN   [9]
RP   FUNCTION, ALTERNATIVE SPLICING, AND INTERACTION WITH RBM14.
RX   PubMed=15919756; DOI=10.1210/en.2004-1513;
RA   Iwasaki T., Koibuchi N., Chin W.W.;
RT   "Synovial sarcoma translocation (SYT) encodes a nuclear receptor
RT   coactivator.";
RL   Endocrinology 146:3892-3899(2005).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [11]
RP   FUNCTION, AND IDENTIFICATION IN THE GBAF COMPLEX.
RX   PubMed=29374058; DOI=10.1074/jbc.ra117.001065;
RA   Alpsoy A., Dykhuizen E.C.;
RT   "Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog
RT   GLTSCR1-like form SWI/SNF chromatin remodeling subcomplexes.";
RL   J. Biol. Chem. 293:3892-3903(2018).
CC   -!- FUNCTION: Appears to function synergistically with RBM14 as a
CC       transcriptional coactivator. Isoform 1 and isoform 2 function in
CC       nuclear receptor coactivation. Isoform 1 and isoform 2 function in
CC       general transcriptional coactivation. Component of SWI/SNF chromatin
CC       remodeling subcomplex GBAF that carries out key enzymatic activities,
CC       changing chromatin structure by altering DNA-histone contacts within a
CC       nucleosome in an ATP-dependent manner (PubMed:29374058).
CC       {ECO:0000269|PubMed:15919756, ECO:0000269|PubMed:29374058}.
CC   -!- SUBUNIT: Interacts with MLLT10. Isoform 1 interacts with RBM14 isoform
CC       1. Isoform 2 interacts with RBM14 isoform 1. Component of the
CC       multiprotein chromatin-remodeling complexes SWI/SNF: SWI/SNF-A (BAF),
CC       SWI/SNF-B (PBAF) and related complexes. The canonical complex contains
CC       a catalytic subunit (either SMARCA4/BRG1/BAF190A or
CC       SMARCA2/BRM/BAF190B) and at least SMARCE1, ACTL6A/BAF53,
CC       SMARCC1/BAF155, SMARCC2/BAF170, and SMARCB1/SNF5/BAF47. Other subunits
CC       specific to each of the complexes may also be present permitting
CC       several possible combinations developmentally and tissue specific.
CC       Component of the SWI/SNF (GBAF) subcomplex, which includes at least
CC       BICRA or BICRAL (mutually exclusive), BRD9, SS18, the core BAF
CC       subunits, SMARCA2/BRM, SMARCA4/BRG1/BAF190A, ACTL6A/BAF53,
CC       SMARCC1/BAF155, and SMARCD1/BAF60A (PubMed:29374058).
CC       {ECO:0000269|PubMed:11423977, ECO:0000269|PubMed:15919756,
CC       ECO:0000269|PubMed:29374058}.
CC   -!- INTERACTION:
CC       Q15532; P15336: ATF2; NbExp=2; IntAct=EBI-2560599, EBI-1170906;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=SYTins, SYT-L;
CC         IsoId=Q15532-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q15532-2; Sequence=VSP_006258;
CC   -!- TISSUE SPECIFICITY: Fairly ubiquitously expressed. Expressed in
CC       synovial sarcomas and in other human cell lines. The fusion genes SSXT-
CC       SSX1 and SSXT-SSX2 are expressed only in synovial sarcomas.
CC   -!- DISEASE: Note=A chromosomal aberration involving SS18 may be a cause of
CC       synovial sarcoma. Translocation t(X;18)(p11.2;q11.2). The translocation
CC       is specifically found in more than 80% of synovial sarcoma. The fusion
CC       products SSXT-SSX1 or SSXT-SSX2 are probably responsible for
CC       transforming activity. Heterogeneity in the position of the breakpoint
CC       can occur (low frequency). {ECO:0000269|PubMed:7495284,
CC       ECO:0000269|PubMed:7539744}.
CC   -!- SIMILARITY: Belongs to the SS18 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAK21314.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=CAA55792.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/SS18ID84ch18q11.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X79201; CAA55792.1; ALT_INIT; mRNA.
DR   EMBL; X79200; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AF343880; AAK21314.1; ALT_INIT; mRNA.
DR   EMBL; EF445031; ACA06073.1; -; Genomic_DNA.
DR   EMBL; CH471088; EAX01210.1; -; Genomic_DNA.
DR   EMBL; BC096223; AAH96223.1; -; mRNA.
DR   EMBL; S79894; AAB35674.1; ALT_TERM; mRNA.
DR   CCDS; CCDS32807.1; -. [Q15532-1]
DR   CCDS; CCDS54183.1; -. [Q15532-2]
DR   PIR; S46269; S46269.
DR   RefSeq; NP_001007560.1; NM_001007559.2. [Q15532-1]
DR   RefSeq; NP_001295130.1; NM_001308201.1.
DR   RefSeq; NP_005628.2; NM_005637.3. [Q15532-2]
DR   BioGrid; 112638; 51.
DR   ComplexPortal; CPX-4084; GBAF (SWI/SNF) ATP-dependent chromatin remodeling complex, ACTL6A-BICRA-SMARCA2 variant.
DR   ComplexPortal; CPX-4203; GBAF (SWI/SNF) ATP-dependent chromatin remodeling complex, ACTL6A-BICRAL-SMARCA2 variant.
DR   ComplexPortal; CPX-4206; GBAF (SWI/SNF) ATP-dependent chromatin remodeling complex, ACTL6A-BICRA-SMARCA4 variant.
DR   ComplexPortal; CPX-4207; GBAF (SWI/SNF) ATP-dependent chromatin remodeling complex, ACTL6A-BICRAL-SMARCA4 variant.
DR   ComplexPortal; CPX-4223; GBAF (SWI/SNF) ATP-dependent chromatin remodeling complex, ACTL6B-BICRA-SMARCA2 variant.
DR   ComplexPortal; CPX-4224; GBAF (SWI/SNF) ATP-dependent chromatin remodeling complex, ACTL6B-BICRAL-SMARCA2 variant.
DR   ComplexPortal; CPX-4225; GBAF (SWI/SNF) ATP-dependent chromatin remodeling complex, ACTL6B-BICRA-SMARCA4 variant.
DR   ComplexPortal; CPX-4226; GBAF (SWI/SNF) ATP-dependent chromatin remodeling complex, ACTL6B-BICRAL-SMARCA4 variant.
DR   IntAct; Q15532; 42.
DR   STRING; 9606.ENSP00000414516; -.
DR   iPTMnet; Q15532; -.
DR   PhosphoSitePlus; Q15532; -.
DR   BioMuta; SS18; -.
DR   EPD; Q15532; -.
DR   jPOST; Q15532; -.
DR   MassIVE; Q15532; -.
DR   MaxQB; Q15532; -.
DR   PaxDb; Q15532; -.
DR   PeptideAtlas; Q15532; -.
DR   PRIDE; Q15532; -.
DR   ProteomicsDB; 60621; -. [Q15532-1]
DR   ProteomicsDB; 60622; -. [Q15532-2]
DR   Antibodypedia; 22102; 141 antibodies.
DR   DNASU; 6760; -.
DR   Ensembl; ENST00000269137; ENSP00000269137; ENSG00000141380. [Q15532-2]
DR   Ensembl; ENST00000415083; ENSP00000414516; ENSG00000141380. [Q15532-1]
DR   GeneID; 6760; -.
DR   KEGG; hsa:6760; -.
DR   UCSC; uc002kvm.4; human. [Q15532-1]
DR   CTD; 6760; -.
DR   DisGeNET; 6760; -.
DR   GeneCards; SS18; -.
DR   HGNC; HGNC:11340; SS18.
DR   HPA; ENSG00000141380; Low tissue specificity.
DR   MalaCards; SS18; -.
DR   MIM; 600192; gene.
DR   neXtProt; NX_Q15532; -.
DR   OpenTargets; ENSG00000141380; -.
DR   Orphanet; 3273; Synovial sarcoma.
DR   PharmGKB; PA36164; -.
DR   eggNOG; KOG3227; Eukaryota.
DR   eggNOG; ENOG41128HA; LUCA.
DR   GeneTree; ENSGT00940000156352; -.
DR   InParanoid; Q15532; -.
DR   KO; K15623; -.
DR   OMA; MLDENAH; -.
DR   OrthoDB; 715844at2759; -.
DR   PhylomeDB; Q15532; -.
DR   TreeFam; TF330999; -.
DR   SIGNOR; Q15532; -.
DR   ChiTaRS; SS18; human.
DR   GeneWiki; SS18; -.
DR   GenomeRNAi; 6760; -.
DR   Pharos; Q15532; Tbio.
DR   PRO; PR:Q15532; -.
DR   Proteomes; UP000005640; Chromosome 18.
DR   RNAct; Q15532; protein.
DR   Bgee; ENSG00000141380; Expressed in kidney and 224 other tissues.
DR   ExpressionAtlas; Q15532; baseline and differential.
DR   Genevisible; Q15532; HS.
DR   GO; GO:0005881; C:cytoplasmic microtubule; IEA:Ensembl.
DR   GO; GO:0071564; C:npBAF complex; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0016514; C:SWI/SNF complex; IDA:UniProtKB.
DR   GO; GO:0030374; F:nuclear receptor transcription coactivator activity; IDA:UniProtKB.
DR   GO; GO:0000902; P:cell morphogenesis; IEA:Ensembl.
DR   GO; GO:0048013; P:ephrin receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:Ensembl.
DR   GO; GO:0000226; P:microtubule cytoskeleton organization; IEA:Ensembl.
DR   GO; GO:0097150; P:neuronal stem cell population maintenance; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IBA:GO_Central.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   InterPro; IPR007726; SS18_fam.
DR   Pfam; PF05030; SSXT; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Activator; Alternative splicing; Chromosomal rearrangement;
KW   Nucleus; Proto-oncogene; Reference proteome; Repeat; Transcription;
KW   Transcription regulation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:22814378"
FT   CHAIN           2..418
FT                   /note="Protein SSXT"
FT                   /id="PRO_0000181823"
FT   REPEAT          344..356
FT                   /note="1"
FT   REPEAT          357..369
FT                   /note="2"
FT   REGION          2..186
FT                   /note="Transcriptional activation"
FT   REGION          344..369
FT                   /note="2 X 13 AA imperfect tandem repeats"
FT   MOTIF           50..53
FT                   /note="SH2-binding"
FT                   /evidence="ECO:0000255"
FT   MOTIF           374..377
FT                   /note="SH2-binding"
FT                   /evidence="ECO:0000255"
FT   MOTIF           392..401
FT                   /note="SH3-binding"
FT                   /evidence="ECO:0000255"
FT   MOTIF           413..416
FT                   /note="SH2-binding"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        95..99
FT                   /note="Poly-Pro"
FT   COMPBIAS        175..418
FT                   /note="Gln-rich"
FT   SITE            366..367
FT                   /note="Breakpoint for translocation to form the SSXT-SSX1
FT                   fusion protein (rare)"
FT                   /evidence="ECO:0000269|PubMed:7539744"
FT   SITE            410..411
FT                   /note="Breakpoint for translocation to form the SSXT-SSX1
FT                   or SSXT-SSX2 fusion proteins"
FT                   /evidence="ECO:0000269|PubMed:7539744"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000244|PubMed:22814378"
FT   VAR_SEQ         295..325
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:7951320"
FT                   /id="VSP_006258"
SQ   SEQUENCE   418 AA;  45929 MW;  7E089D557538252F CRC64;
     MSVAFAAPRQ RGKGEITPAA IQKMLDDNNH LIQCIMDSQN KGKTSECSQY QQMLHTNLVY
     LATIADSNQN MQSLLPAPPT QNMPMGPGGM NQSGPPPPPR SHNMPSDGMV GGGPPAPHMQ
     NQMNGQMPGP NHMPMQGPGP NQLNMTNSSM NMPSSSHGSM GGYNHSVPSS QSMPVQNQMT
     MSQGQPMGNY GPRPNMSMQP NQGPMMHQQP PSQQYNMPQG GGQHYQGQQP PMGMMGQVNQ
     GNHMMGQRQI PPYRPPQQGP PQQYSGQEDY YGDQYSHGGQ GPPEGMNQQY YPDGHNDYGY
     QQPSYPEQGY DRPYEDSSQH YYEGGNSQYG QQQDAYQGPP PQQGYPPQQQ QYPGQQGYPG
     QQQGYGPSQG GPGPQYPNYP QGQGQQYGGY RPTQPGPPQP PQQRPYGYDQ GQYGNYQQ
//
ID   Q4VAX0_HUMAN            Unreviewed;       387 AA.
AC   Q4VAX0;
DT   05-JUL-2005, integrated into UniProtKB/TrEMBL.
DT   05-JUL-2005, sequence version 1.
DT   22-APR-2020, entry version 121.
DE   SubName: Full=Synovial sarcoma translocation, chromosome 18 {ECO:0000313|EMBL:AAH96224.1};
DE   SubName: Full=Synovial sarcoma translocation, chromosome 18, isoform CRA_a {ECO:0000313|EMBL:EAX01209.1};
DE   SubName: Full=cDNA FLJ57021, highly similar to SSXT protein {ECO:0000313|EMBL:BAG63015.1};
DE   SubName: Full=cDNA, FLJ79201, highly similar to SSXT protein {ECO:0000313|EMBL:BAH14673.1};
GN   Name=SS18 {ECO:0000313|EMBL:AAH96224.1};
GN   ORFNames=hCG_37175 {ECO:0000313|EMBL:EAX01209.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH96224.1};
RN   [1] {ECO:0000313|EMBL:EAX01209.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:AAH96224.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M., Peck A.M.,
RA   Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S., Feolo M.,
RA   Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F., Schaefer C.F.,
RA   Buetow K., Bonner T.I., Haussler D., Kent J., Kiekhaus M., Furey T.,
RA   Brent M., Prange C., Schreiber K., Shapiro N., Bhat N.K., Hopkins R.F.,
RA   Hsie F., Driscoll T., Soares M.B., Casavant T.L., Scheetz T.E.,
RA   Brown-stein M.J., Usdin T.B., Toshiyuki S., Carninci P., Piao Y.,
RA   Dudekula D.B., Ko M.S., Kawakami K., Suzuki Y., Sugano S., Gruber C.E.,
RA   Smith M.R., Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y.,
RA   Wei C.L., Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W.,
RA   Fuh E., Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D., Granite S.J.,
RA   Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G., Blakesly R.W.,
RA   Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J.,
RA   Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L., Krzywinski M.I.,
RA   Liao N., Morin R., Morrin R., Palmquist D., Petrescu A.S., Skalska U.,
RA   Smailus D.E., Stott J.M., Schnerch A., Schein J.E., Jones S.J., Holt R.A.,
RA   Baross A., Marra M.A., Clifton S., Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3] {ECO:0000313|EMBL:EAX01209.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:BAG63015.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Synovial membrane tissue {ECO:0000313|EMBL:BAG63015.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000313|EMBL:BAH14673.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Placenta {ECO:0000313|EMBL:BAH14673.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC096221; AAH96221.1; -; mRNA.
DR   EMBL; BC096224; AAH96224.1; -; mRNA.
DR   EMBL; AK301504; BAG63015.1; -; mRNA.
DR   EMBL; AK316302; BAH14673.1; -; mRNA.
DR   EMBL; CH471088; EAX01209.1; -; Genomic_DNA.
DR   EMBL; CH471088; EAX01213.1; -; Genomic_DNA.
DR   RefSeq; NP_005628.2; NM_005637.3.
DR   Antibodypedia; 22102; 141 antibodies.
DR   DNASU; 6760; -.
DR   GeneID; 6760; -.
DR   UCSC; uc002kvn.4; human.
DR   CTD; 6760; -.
DR   EuPathDB; HostDB:ENSG00000141380.13; -.
DR   PharmGKB; PA36164; -.
DR   ChiTaRS; SS18; human.
DR   GenomeRNAi; 6760; -.
DR   Bgee; ENSG00000141380; Expressed in kidney and 224 other tissues.
DR   GO; GO:0003713; F:transcription coactivator activity; IEA:InterPro.
DR   InterPro; IPR007726; SS18_fam.
DR   Pfam; PF05030; SSXT; 1.
PE   2: Evidence at transcript level;
FT   REGION          77..118
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          188..387
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        188..246
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        289..308
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        317..361
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   387 AA;  42216 MW;  A1D64C2C588C532A CRC64;
     MSVAFAAPRQ RGKGEITPAA IQKMLDDNNH LIQCIMDSQN KGKTSECSQY QQMLHTNLVY
     LATIADSNQN MQSLLPAPPT QNMPMGPGGM NQSGPPPPPR SHNMPSDGMV GGGPPAPHMQ
     NQMNGQMPGP NHMPMQGPGP NQLNMTNSSM NMPSSSHGSM GGYNHSVPSS QSMPVQNQMT
     MSQGQPMGNY GPRPNMSMQP NQGPMMHQQP PSQQYNMPQG GGQHYQGQQP PMGMMGQVNQ
     GNHMMGQRQI PPYRPPQQGP PQQYSGQEDY YGDQYSHGGQ GPPEGMNQQY YPDGNSQYGQ
     QQDAYQGPPP QQGYPPQQQQ YPGQQGYPGQ QQGYGPSQGG PGPQYPNYPQ GQGQQYGGYR
     PTQPGPPQPP QQRPYGYDQG QYGNYQQ
//
ID   B4DSR7_HUMAN            Unreviewed;       416 AA.
AC   B4DSR7;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   26-FEB-2020, entry version 49.
DE   SubName: Full=cDNA FLJ58470, highly similar to SS18-like protein 1 {ECO:0000313|EMBL:BAG61729.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG61729.1};
RN   [1] {ECO:0000313|EMBL:BAG61729.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAG61729.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK299881; BAG61729.1; -; mRNA.
DR   RefSeq; XP_005260446.1; XM_005260389.3.
DR   MaxQB; B4DSR7; -.
DR   PeptideAtlas; B4DSR7; -.
DR   GeneID; 26039; -.
DR   CTD; 26039; -.
DR   eggNOG; KOG3227; Eukaryota.
DR   eggNOG; ENOG41128HA; LUCA.
DR   OrthoDB; 1442230at2759; -.
DR   GenomeRNAi; 26039; -.
DR   GO; GO:0003713; F:transcription coactivator activity; IEA:InterPro.
DR   InterPro; IPR007726; SS18_fam.
DR   Pfam; PF05030; SSXT; 1.
PE   2: Evidence at transcript level;
FT   REGION          72..162
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          192..280
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          311..387
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        72..150
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        192..228
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        235..256
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        311..386
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   416 AA;  45291 MW;  79D8B103A767CB92 CRC64;
     MSVAFASARP RGKGEVTQQT IQKMLDENHH LIQCILEYQS KGKTAECTQY QQILHRNLVY
     LATIADSNQN MQSLLPAPPT QNMNLGPGAL TQSGSSQGLH SQGSLSDAIS TGLPPSSLLQ
     GQIGNGPSHV SMQQTAPNTL PTTSMSISGP GYSHAGPASQ GVPMQGQGTI GNYVSRTNIN
     MQSNPVSMMQ QQAATSHYSS AQGGSQHYQG QSSIAMMGQG SQGSSMMGQR PMAPYRPSQQ
     GSSQQYLGQE EYYGEQYSHS QGAAEPMGQQ YYPDGHGDYA YQQSSYTEQS YDRSFEESTQ
     HYYEGGNSQY SQQQAGYQQG AAQQQTYSQQ QYPSQQSYPG QQQGYGSAQG APSQYPGYQQ
     GQGQQYGSYR APQTAPSAQQ QRPYGYEQAS FLDVSRCAHP PRLSRHNEDF SYGHEE
//
ID   CREST_HUMAN             Reviewed;         396 AA.
AC   O75177; A6NNE3; A8K620; B3KWR8; E1P5H7; Q5JXJ3; Q6MZV9; Q6NTH3; Q6XYD9;
AC   Q8NE69; Q9BR55; Q9H4K6;
DT   31-JAN-2002, integrated into UniProtKB/Swiss-Prot.
DT   31-JAN-2002, sequence version 2.
DT   22-APR-2020, entry version 157.
DE   RecName: Full=Calcium-responsive transactivator;
DE   AltName: Full=SS18-like protein 1;
DE   AltName: Full=SYT homolog 1;
GN   Name=SS18L1; Synonyms=CREST, KIAA0693;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9734811; DOI=10.1093/dnares/5.3.169;
RA   Ishikawa K., Nagase T., Suyama M., Miyajima N., Tanaka A., Kotani H.,
RA   Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. X. The
RT   complete sequences of 100 new cDNA clones from brain which can code for
RT   large proteins in vitro.";
RL   DNA Res. 5:169-176(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Small intestine;
RX   PubMed=11230166; DOI=10.1101/gr.gr1547r;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H., Lauber J.,
RA   Duesterhoeft A., Beyer A., Koehrer K., Strack N., Mewes H.-W.,
RA   Ottenwaelder B., Obermaier B., Tampe J., Heubner D., Wambutt R., Korn B.,
RA   Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and analysis of
RT   500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RA   Wan D.F., Qin W.X., Zhou X.M., Zhang P.P., Jiang H.Q., Gu J.R.;
RT   "Novel Homo sapiens cDNA clones with function of promoting mice NIH/3T3
RT   cells' growth.";
RL   Submitted (DEC-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4).
RC   TISSUE=Brain, and Synovium;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J., Buck D., Burrill W.D.,
RA   Butler A.P., Carder C., Carter N.P., Chapman J.C., Clamp M., Clark G.,
RA   Clark L.N., Clark S.Y., Clee C.M., Clegg S., Cobley V.E., Collier R.E.,
RA   Connor R.E., Corby N.R., Coulson A., Coville G.J., Deadman R., Dhami P.D.,
RA   Dunn M., Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H., Rice C.M.,
RA   Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S., Skuce C.D.,
RA   Smith M.L., Soderlund C., Steward C.A., Sulston J.E., Swann R.M.,
RA   Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A., Tracey A.,
RA   Tromans A.C., Vaudin M., Wall M., Wallis J.M., Whitehead S.L.,
RA   Whittaker P., Willey D.L., Williams L., Williams S.A., Wilming L.,
RA   Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 5), AND VARIANT
RP   ILE-189.
RC   TISSUE=Lymph, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=18331714; DOI=10.1016/j.devcel.2007.12.007;
RA   Wang X., Yang Y., Duan Q., Jiang N., Huang Y., Darzynkiewicz Z., Dai W.;
RT   "sSgo1, a major splice variant of Sgo1, functions in centriole cohesion
RT   where it is regulated by Plk1.";
RL   Dev. Cell 14:331-341(2008).
CC   -!- FUNCTION: Transcriptional activator which is required for calcium-
CC       dependent dendritic growth and branching in cortical neurons. Recruits
CC       CREB-binding protein (CREBBP) to nuclear bodies. Component of the
CC       CREST-BRG1 complex, a multiprotein complex that regulates promoter
CC       activation by orchestrating a calcium-dependent release of a repressor
CC       complex and a recruitment of an activator complex. In resting neurons,
CC       transcription of the c-FOS promoter is inhibited by BRG1-dependent
CC       recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium
CC       influx, RB1 is dephosphorylated by calcineurin, which leads to release
CC       of the repressor complex. At the same time, there is increased
CC       recruitment of CREBBP to the promoter by a CREST-dependent mechanism,
CC       which leads to transcriptional activation. The CREST-BRG1 complex also
CC       binds to the NR2B promoter, and activity-dependent induction of NR2B
CC       expression involves a release of HDAC1 and recruitment of CREBBP (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Homodimer. Dimerization may be necessary for its function in
CC       neuronal dendritic development. Interacts (via C-terminus) with CREBBP
CC       (via N-terminus), EP300 and SMARCA4/BRG1. Interacts with the nBAF
CC       complex. Association with CREBBP facilitates transcription while the
CC       association with SMARCA4/BRG1 suppresses CREST-mediated transcription
CC       in resting neurons (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       O75177-5; Q86V38: ATN1; NbExp=3; IntAct=EBI-12035119, EBI-11954292;
CC       O75177-5; O95429: BAG4; NbExp=3; IntAct=EBI-12035119, EBI-2949658;
CC       O75177-5; Q6AI39: BICRAL; NbExp=3; IntAct=EBI-12035119, EBI-1012434;
CC       O75177-5; Q6P1W5: C1orf94; NbExp=3; IntAct=EBI-12035119, EBI-946029;
CC       O75177-5; Q53EZ4: CEP55; NbExp=3; IntAct=EBI-12035119, EBI-747776;
CC       O75177; P33240: CSTF2; NbExp=3; IntAct=EBI-744674, EBI-711360;
CC       O75177; Q92567: FAM168A; NbExp=4; IntAct=EBI-744674, EBI-7957930;
CC       O75177; A0A0S2Z4Q4: HGS; NbExp=3; IntAct=EBI-744674, EBI-16429135;
CC       O75177-5; A0A0S2Z4Q4: HGS; NbExp=3; IntAct=EBI-12035119, EBI-16429135;
CC       O75177-5; O14964: HGS; NbExp=3; IntAct=EBI-12035119, EBI-740220;
CC       O75177; P17931: LGALS3; NbExp=3; IntAct=EBI-744674, EBI-1170392;
CC       O75177; Q6NVH9: LGALS3; NbExp=3; IntAct=EBI-744674, EBI-10187804;
CC       O75177; Q8NDC0: MAPK1IP1L; NbExp=3; IntAct=EBI-744674, EBI-741424;
CC       O75177-5; Q8NDC0: MAPK1IP1L; NbExp=3; IntAct=EBI-12035119, EBI-741424;
CC       O75177; Q96PC5: MIA2; NbExp=3; IntAct=EBI-744674, EBI-1050253;
CC       O75177-5; Q96HR8: NAF1; NbExp=3; IntAct=EBI-12035119, EBI-2515597;
CC       O75177-5; Q06710: PAX8; NbExp=3; IntAct=EBI-12035119, EBI-2683132;
CC       O75177-5; Q8HWS3: RFX6; NbExp=3; IntAct=EBI-12035119, EBI-746118;
CC       O75177; Q15427: SF3B4; NbExp=4; IntAct=EBI-744674, EBI-348469;
CC       O75177-5; Q15427: SF3B4; NbExp=3; IntAct=EBI-12035119, EBI-348469;
CC       O75177; P14678-2: SNRPB; NbExp=3; IntAct=EBI-744674, EBI-372475;
CC       O75177; Q5TAL4: SNRPC; NbExp=3; IntAct=EBI-744674, EBI-10246938;
CC       O75177-5; Q9BWW4: SSBP3; NbExp=3; IntAct=EBI-12035119, EBI-2902395;
CC       O75177-5; Q13470-2: TNK1; NbExp=3; IntAct=EBI-12035119, EBI-11018037;
CC       O75177-5; Q70EL1-9: USP54; NbExp=3; IntAct=EBI-12035119, EBI-11975223;
CC       O75177-5; Q8NF64-3: ZMIZ2; NbExp=3; IntAct=EBI-12035119, EBI-12011330;
CC       O75177-5; Q96E35: ZMYND19; NbExp=3; IntAct=EBI-12035119, EBI-746595;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Chromosome, centromere,
CC       kinetochore {ECO:0000250}. Note=Localizes to nuclear bodies.
CC       Colocalizes with SGO1 at kinetochore (By similarity). {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=O75177-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O75177-2; Sequence=VSP_038700;
CC       Name=3;
CC         IsoId=O75177-3; Sequence=VSP_038698;
CC       Name=4;
CC         IsoId=O75177-4; Sequence=VSP_038697;
CC       Name=5;
CC         IsoId=O75177-5; Sequence=VSP_038699;
CC   -!- TISSUE SPECIFICITY: Ubiquitous; with lowest levels in spleen.
CC   -!- DOMAIN: The MFD (multi-functional domain) domain is involved in
CC       transcription transactivation, nuclear body targeting and dimerization.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the SS18 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA31668.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/SS18L1ID474ch20q13.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB014593; BAA31668.1; ALT_INIT; mRNA.
DR   EMBL; BX640848; CAE45918.1; -; mRNA.
DR   EMBL; AY203931; AAP34454.1; -; mRNA.
DR   EMBL; AK125656; BAG54230.1; -; mRNA.
DR   EMBL; AK291485; BAF84174.1; -; mRNA.
DR   EMBL; AL078633; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471077; EAW75393.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW75392.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW75395.1; -; Genomic_DNA.
DR   EMBL; BC034494; AAH34494.1; -; mRNA.
DR   EMBL; BC068993; AAH68993.1; -; mRNA.
DR   CCDS; CCDS13491.1; -. [O75177-1]
DR   RefSeq; NP_001288707.1; NM_001301778.1. [O75177-4]
DR   RefSeq; NP_945173.1; NM_198935.2. [O75177-1]
DR   RefSeq; XP_005260448.1; XM_005260391.1. [O75177-2]
DR   RefSeq; XP_011527066.1; XM_011528764.2. [O75177-2]
DR   RefSeq; XP_011527069.1; XM_011528767.1. [O75177-5]
DR   BioGrid; 117505; 45.
DR   IntAct; O75177; 34.
DR   MINT; O75177; -.
DR   STRING; 9606.ENSP00000333012; -.
DR   iPTMnet; O75177; -.
DR   PhosphoSitePlus; O75177; -.
DR   BioMuta; SS18L1; -.
DR   EPD; O75177; -.
DR   jPOST; O75177; -.
DR   MassIVE; O75177; -.
DR   MaxQB; O75177; -.
DR   PaxDb; O75177; -.
DR   PeptideAtlas; O75177; -.
DR   PRIDE; O75177; -.
DR   ProteomicsDB; 49845; -. [O75177-1]
DR   ProteomicsDB; 49846; -. [O75177-2]
DR   ProteomicsDB; 49847; -. [O75177-3]
DR   ProteomicsDB; 49848; -. [O75177-4]
DR   ProteomicsDB; 49849; -. [O75177-5]
DR   Antibodypedia; 44341; 138 antibodies.
DR   DNASU; 26039; -.
DR   Ensembl; ENST00000331758; ENSP00000333012; ENSG00000184402. [O75177-1]
DR   Ensembl; ENST00000370848; ENSP00000359885; ENSG00000184402. [O75177-3]
DR   GeneID; 26039; -.
DR   KEGG; hsa:26039; -.
DR   UCSC; uc002ycb.4; human. [O75177-1]
DR   CTD; 26039; -.
DR   DisGeNET; 26039; -.
DR   GeneCards; SS18L1; -.
DR   HGNC; HGNC:15592; SS18L1.
DR   HPA; ENSG00000184402; Low tissue specificity.
DR   MIM; 606472; gene.
DR   neXtProt; NX_O75177; -.
DR   OpenTargets; ENSG00000184402; -.
DR   PharmGKB; PA37989; -.
DR   eggNOG; KOG3227; Eukaryota.
DR   eggNOG; ENOG41128HA; LUCA.
DR   GeneTree; ENSGT00940000159853; -.
DR   HOGENOM; CLU_054580_1_0_1; -.
DR   InParanoid; O75177; -.
DR   OMA; PYRASQQ; -.
DR   PhylomeDB; O75177; -.
DR   TreeFam; TF330999; -.
DR   SIGNOR; O75177; -.
DR   ChiTaRS; SS18L1; human.
DR   GeneWiki; SS18L1; -.
DR   GenomeRNAi; 26039; -.
DR   Pharos; O75177; Tbio.
DR   PRO; PR:O75177; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   RNAct; O75177; protein.
DR   Bgee; ENSG00000184402; Expressed in forebrain and 232 other tissues.
DR   ExpressionAtlas; O75177; baseline and differential.
DR   Genevisible; O75177; HS.
DR   GO; GO:0000777; C:condensed chromosome kinetochore; IEA:UniProtKB-SubCell.
DR   GO; GO:0000780; C:condensed nuclear chromosome, centromeric region; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0000776; C:kinetochore; IDA:MGI.
DR   GO; GO:0071565; C:nBAF complex; IEA:Ensembl.
DR   GO; GO:0016604; C:nuclear body; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0003713; F:transcription coactivator activity; IEA:InterPro.
DR   GO; GO:0006325; P:chromatin organization; IEA:UniProtKB-KW.
DR   GO; GO:0016358; P:dendrite development; IEA:Ensembl.
DR   GO; GO:0050775; P:positive regulation of dendrite morphogenesis; IBA:GO_Central.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   InterPro; IPR007726; SS18_fam.
DR   Pfam; PF05030; SSXT; 1.
PE   1: Evidence at protein level;
KW   Activator; Alternative splicing; Calcium; Centromere; Chromatin regulator;
KW   Chromosome; Kinetochore; Nucleus; Polymorphism; Reference proteome; Repeat;
KW   Transcription; Transcription regulation.
FT   CHAIN           1..396
FT                   /note="Calcium-responsive transactivator"
FT                   /id="PRO_0000181825"
FT   REGION          1..148
FT                   /note="N-terminal auto-inhibitory domain; necessary for
FT                   interaction with SMARCA4/BRG1"
FT                   /evidence="ECO:0000250"
FT   REGION          149..232
FT                   /note="Methionine-rich intra-molecular domain"
FT                   /evidence="ECO:0000250"
FT   REGION          246..317
FT                   /note="MFD domain"
FT                   /evidence="ECO:0000250"
FT   REGION          334..396
FT                   /note="Necessary for nuclear localization"
FT                   /evidence="ECO:0000250"
FT   REGION          387..396
FT                   /note="Necessary for interaction with CREBBP and for the
FT                   recruitment of CREBBP to the nuclear bodies"
FT                   /evidence="ECO:0000250"
FT   MOTIF           50..53
FT                   /note="SH2-binding"
FT                   /evidence="ECO:0000255"
FT   MOTIF           353..356
FT                   /note="SH2-binding"
FT                   /evidence="ECO:0000255"
FT   MOTIF           371..379
FT                   /note="SH3-binding"
FT                   /evidence="ECO:0000255"
FT   MOTIF           391..394
FT                   /note="SH2-binding"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        190..396
FT                   /note="Gln-rich"
FT   VAR_SEQ         1..131
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_038697"
FT   VAR_SEQ         1..82
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|Ref.3"
FT                   /id="VSP_038698"
FT   VAR_SEQ         1..49
FT                   /note="MSVAFASARPRGKGEVTQQTIQKMLDENHHLIQCILEYQSKGKTAECTQ ->
FT                   MQSLSTEARYVPRVPQHRDQISPRSPQHGGQICPRSPLHRGQICPRSPPARR (in
FT                   isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_038699"
FT   VAR_SEQ         1..23
FT                   /note="MSVAFASARPRGKGEVTQQTIQK -> M (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11230166"
FT                   /id="VSP_038700"
FT   VARIANT         189
FT                   /note="M -> I (in dbSNP:rs17853304)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_062534"
FT   VARIANT         321
FT                   /note="A -> T (in dbSNP:rs36106901)"
FT                   /id="VAR_053691"
FT   CONFLICT        128
FT                   /note="S -> G (in Ref. 2; CAE45918)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        139
FT                   /note="T -> S (in Ref. 4; BAF84174)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        143
FT                   /note="T -> A (in Ref. 4; BAG54230)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   396 AA;  42990 MW;  B76B7D61C7DF5592 CRC64;
     MSVAFASARP RGKGEVTQQT IQKMLDENHH LIQCILEYQS KGKTAECTQY QQILHRNLVY
     LATIADSNQN MQSLLPAPPT QNMNLGPGAL TQSGSSQGLH SQGSLSDAIS TGLPPSSLLQ
     GQIGNGPSHV SMQQTAPNTL PTTSMSISGP GYSHAGPASQ GVPMQGQGTI GNYVSRTNIN
     MQSNPVSMMQ QQAATSHYSS AQGGSQHYQG QSSIAMMGQG SQGSSMMGQR PMAPYRPSQQ
     GSSQQYLGQE EYYGEQYSHS QGAAEPMGQQ YYPDGHGDYA YQQSSYTEQS YDRSFEESTQ
     HYYEGGNSQY SQQQAGYQQG AAQQQTYSQQ QYPSQQSYPG QQQGYGSAQG APSQYPGYQQ
     GQGQQYGSYR APQTAPSAQQ QRPYGYEQGQ YGNYQQ
//
ID   STRN_HUMAN              Reviewed;         780 AA.
AC   O43815; Q3KP65; Q53TQ8; Q9NP38;
DT   11-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   06-MAR-2007, sequence version 4.
DT   22-APR-2020, entry version 187.
DE   RecName: Full=Striatin;
GN   Name=STRN;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=9693043; DOI=10.1006/geno.1998.5342;
RA   Moqrich A., Mattei M.-G., Bartoli M., Rakitina T., Baillat G., Monneron A.,
RA   Castets F.;
RT   "Cloning of human striatin cDNA (STRN), gene mapping to 2p22-p21, and
RT   preferential expression in brain.";
RL   Genomics 51:136-139(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-245, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-245, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-245, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-227; SER-229; SER-245 AND
RP   SER-259, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-245, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Calmodulin-binding protein which may function as scaffolding
CC       or signaling protein and may play a role in dendritic Ca(2+) signaling.
CC   -!- SUBUNIT: Interacts with protein phosphatase 2A (PP2A) (Potential).
CC       Interacts with CTTNBP2; this interaction may regulate dendritic spine
CC       distribution of STRN. Activation of glutamate receptors weakens the
CC       interaction with CTTNBP2 (By similarity). {ECO:0000250, ECO:0000305}.
CC   -!- INTERACTION:
CC       O43815; Q9P2B4: CTTNBP2NL; NbExp=6; IntAct=EBI-1046642, EBI-1774273;
CC       O43815; Q9Y3A3: MOB4; NbExp=5; IntAct=EBI-1046642, EBI-713935;
CC       O43815; Q9BUL8: PDCD10; NbExp=5; IntAct=EBI-1046642, EBI-740195;
CC       O43815-2; Q9BUL8: PDCD10; NbExp=3; IntAct=EBI-1266294, EBI-740195;
CC       O43815; P67775: PPP2CA; NbExp=5; IntAct=EBI-1046642, EBI-712311;
CC       O43815; P30153: PPP2R1A; NbExp=8; IntAct=EBI-1046642, EBI-302388;
CC       O43815-2; P30153: PPP2R1A; NbExp=3; IntAct=EBI-1266294, EBI-302388;
CC       O43815; Q6NUQ1: RINT1; NbExp=3; IntAct=EBI-1046642, EBI-726876;
CC       O43815; Q9Y6E0: STK24; NbExp=3; IntAct=EBI-1046642, EBI-740175;
CC       O43815; O00506: STK25; NbExp=4; IntAct=EBI-1046642, EBI-618295;
CC       O43815; Q13033: STRN3; NbExp=9; IntAct=EBI-1046642, EBI-1053857;
CC       O43815; Q9UBB9: TFIP11; NbExp=3; IntAct=EBI-1046642, EBI-1105213;
CC       O43815; Q9H2K2: TNKS2; NbExp=2; IntAct=EBI-1046642, EBI-4398527;
CC       O43815; Q9Y228: TRAF3IP3; NbExp=2; IntAct=EBI-1046642, EBI-765817;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Membrane {ECO:0000250};
CC       Peripheral membrane protein {ECO:0000250}. Cell projection, dendritic
CC       spine {ECO:0000250}. Note=CTTNBP2-binding may regulate dendritic spine
CC       distribution. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O43815-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O43815-2; Sequence=VSP_023495, VSP_023496;
CC   -!- TISSUE SPECIFICITY: Preferentially expressed in brain.
CC       {ECO:0000269|PubMed:9693043}.
CC   -!- SIMILARITY: Belongs to the WD repeat striatin family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/STRNID44243ch2p22.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ223814; CAA11560.1; -; mRNA.
DR   EMBL; AC007404; AAY24273.1; -; Genomic_DNA.
DR   EMBL; AC007382; AAF66162.1; -; Genomic_DNA.
DR   EMBL; BC106879; AAI06880.1; -; mRNA.
DR   CCDS; CCDS1784.1; -. [O43815-1]
DR   RefSeq; NP_003153.2; NM_003162.3. [O43815-1]
DR   BioGrid; 112674; 98.
DR   CORUM; O43815; -.
DR   ELM; O43815; -.
DR   IntAct; O43815; 73.
DR   MINT; O43815; -.
DR   STRING; 9606.ENSP00000263918; -.
DR   iPTMnet; O43815; -.
DR   PhosphoSitePlus; O43815; -.
DR   BioMuta; STRN; -.
DR   EPD; O43815; -.
DR   jPOST; O43815; -.
DR   MassIVE; O43815; -.
DR   MaxQB; O43815; -.
DR   PaxDb; O43815; -.
DR   PeptideAtlas; O43815; -.
DR   PRIDE; O43815; -.
DR   ProteomicsDB; 49179; -. [O43815-1]
DR   ProteomicsDB; 49180; -. [O43815-2]
DR   Antibodypedia; 2791; 169 antibodies.
DR   Ensembl; ENST00000263918; ENSP00000263918; ENSG00000115808. [O43815-1]
DR   Ensembl; ENST00000379213; ENSP00000368513; ENSG00000115808. [O43815-2]
DR   GeneID; 6801; -.
DR   KEGG; hsa:6801; -.
DR   UCSC; uc002rpn.4; human. [O43815-1]
DR   CTD; 6801; -.
DR   DisGeNET; 6801; -.
DR   GeneCards; STRN; -.
DR   HGNC; HGNC:11424; STRN.
DR   HPA; ENSG00000115808; Low tissue specificity.
DR   MIM; 614765; gene.
DR   neXtProt; NX_O43815; -.
DR   OpenTargets; ENSG00000115808; -.
DR   PharmGKB; PA36224; -.
DR   eggNOG; KOG0642; Eukaryota.
DR   eggNOG; ENOG410XR31; LUCA.
DR   GeneTree; ENSGT00950000183095; -.
DR   HOGENOM; CLU_009108_2_0_1; -.
DR   InParanoid; O43815; -.
DR   KO; K17608; -.
DR   OMA; GHTSIFN; -.
DR   OrthoDB; 334070at2759; -.
DR   PhylomeDB; O43815; -.
DR   TreeFam; TF313387; -.
DR   Reactome; R-HSA-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-HSA-2219530; Constitutive Signaling by Aberrant PI3K in Cancer.
DR   Reactome; R-HSA-6811558; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling.
DR   Reactome; R-HSA-9009391; Extra-nuclear estrogen signaling.
DR   SignaLink; O43815; -.
DR   ChiTaRS; STRN; human.
DR   GeneWiki; STRN; -.
DR   GenomeRNAi; 6801; -.
DR   Pharos; O43815; Tbio.
DR   PRO; PR:O43815; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; O43815; protein.
DR   Bgee; ENSG00000115808; Expressed in corpus callosum and 200 other tissues.
DR   Genevisible; O43815; HS.
DR   GO; GO:0005923; C:bicellular tight junction; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0030425; C:dendrite; IBA:GO_Central.
DR   GO; GO:0043197; C:dendritic spine; ISS:UniProtKB.
DR   GO; GO:0090443; C:FAR/SIN/STRIPAK complex; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; ISS:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; ISS:UniProtKB.
DR   GO; GO:0014069; C:postsynaptic density; ISS:UniProtKB.
DR   GO; GO:0045211; C:postsynaptic membrane; ISS:UniProtKB.
DR   GO; GO:0070016; F:armadillo repeat domain binding; IPI:UniProtKB.
DR   GO; GO:0005516; F:calmodulin binding; ISS:UniProtKB.
DR   GO; GO:0030331; F:estrogen receptor binding; IPI:UniProtKB.
DR   GO; GO:0051721; F:protein phosphatase 2A binding; IDA:UniProtKB.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:UniProtKB.
DR   GO; GO:0070830; P:bicellular tight junction assembly; NAS:UniProtKB.
DR   GO; GO:0016358; P:dendrite development; ISS:UniProtKB.
DR   GO; GO:0007626; P:locomotory behavior; ISS:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; IMP:UniProtKB.
DR   GO; GO:0016055; P:Wnt signaling pathway; IMP:UniProtKB.
DR   Gene3D; 2.130.10.10; -; 2.
DR   InterPro; IPR020472; G-protein_beta_WD-40_rep.
DR   InterPro; IPR013258; Striatin_N.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR019775; WD40_repeat_CS.
DR   InterPro; IPR017986; WD40_repeat_dom.
DR   InterPro; IPR036322; WD40_repeat_dom_sf.
DR   Pfam; PF08232; Striatin; 1.
DR   Pfam; PF00400; WD40; 5.
DR   PRINTS; PR00320; GPROTEINBRPT.
DR   SMART; SM00320; WD40; 6.
DR   SUPFAM; SSF50978; SSF50978; 1.
DR   PROSITE; PS00678; WD_REPEATS_1; 4.
DR   PROSITE; PS50082; WD_REPEATS_2; 4.
DR   PROSITE; PS50294; WD_REPEATS_REGION; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calmodulin-binding; Cell junction; Cell projection;
KW   Coiled coil; Cytoplasm; Membrane; Phosphoprotein; Reference proteome;
KW   Repeat; Synapse; WD repeat.
FT   CHAIN           1..780
FT                   /note="Striatin"
FT                   /id="PRO_0000051232"
FT   REPEAT          461..500
FT                   /note="WD 1"
FT   REPEAT          514..553
FT                   /note="WD 2"
FT   REPEAT          567..606
FT                   /note="WD 3"
FT   REPEAT          662..701
FT                   /note="WD 4"
FT   REPEAT          704..743
FT                   /note="WD 5"
FT   REPEAT          750..779
FT                   /note="WD 6"
FT   REGION          55..63
FT                   /note="Caveolin-binding"
FT                   /evidence="ECO:0000255"
FT   REGION          149..166
FT                   /note="Calmodulin-binding"
FT                   /evidence="ECO:0000255"
FT   COILED          53..120
FT                   /evidence="ECO:0000255"
FT   MOD_RES         137
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O55106"
FT   MOD_RES         225
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:O55106"
FT   MOD_RES         227
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         229
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         245
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         259
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   VAR_SEQ         29..40
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_023495"
FT   VAR_SEQ         311..348
FT                   /note="EKEDQCLMPEAWNVDQGVITKLKEQYKKERKGKKGVKR -> G (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_023496"
FT   CONFLICT        191
FT                   /note="S -> I (in Ref. 1; CAA11560)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        423
FT                   /note="L -> P (in Ref. 1; CAA11560)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        611
FT                   /note="T -> I (in Ref. 1; CAA11560)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        677
FT                   /note="P -> S (in Ref. 1; CAA11560)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   780 AA;  86132 MW;  DDB18A11102BEA35 CRC64;
     MDEQAGPGVF FSNNHPGAGG AKGLGPLAEA AAAGDGAAAA GAARAQYSLP GILHFLQHEW
     ARFEVERAQW EVERAELQAQ IAFLQGERKG QENLKKDLVR RIKMLEYALK QERAKYHKLK
     YGTELNQGDM KPPSYDSDEG NETEVQPQQN SQLMWKQGRQ LLRQYLQEVG YTDTILDVKS
     KRVRALLGFS SDVTDREDDK NQDSVVNGTE AEVKETAMIA KSELTDSASV LDNFKFLESA
     AADFSDEDED DDVDGREKSV IDTSTIVRKK ALPDSGEDRD TKEALKEFDF LVTSEEGDNE
     SRSAGDGTDW EKEDQCLMPE AWNVDQGVIT KLKEQYKKER KGKKGVKRPN RSKLQDMLAN
     LRDVDELPSL QPSVGSPSRP SSSRLPEHEI NRADEVEALT FPPSSGKSFI MGADEALESE
     LGLGELAGLT VANEADSLTY DIANNKDALR KTWNPKFTLR SHFDGIRALA FHPIEPVLIT
     ASEDHTLKMW NLQKTAPAKK STSLDVEPIY TFRAHKGPVL CVVMSSNGEQ CYSGGTDGLI
     QGWNTTNPNI DPYDSYDPSV LRGPLLGHTD AVWGLAYSAA HQRLLSCSAD GTLRLWNTTE
     VAPALSVFND TKELGIPASV DLVSSDPSHM VASFSKGYTS IFNMETQQRI LTLESNVDTT
     ANSSCQINRV ISHPTLPISI TAHEDRHIKF YDNNTGKLIH SMVAHLEAVT SLAVDPNGLY
     LMSGSHDCSI RLWNLESKTC IQEFTAHRKK FEESIHDVAF HPSKCYIASA GADALAKVFV
//
ID   A0A384MTX4_HUMAN        Unreviewed;       301 AA.
AC   A0A384MTX4;
DT   05-DEC-2018, integrated into UniProtKB/TrEMBL.
DT   05-DEC-2018, sequence version 1.
DT   22-APR-2020, entry version 9.
DE   SubName: Full=Epididymis secretory sperm binding protein {ECO:0000313|EMBL:ADO22470.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ADO22470.1};
RN   [1] {ECO:0000313|EMBL:ADO22470.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Hoernsten L., Su C., Osbourn A.E., Hellman U., Wernstedt C., Oliw E.H.;
RL   Submitted (SEP-2009) to the EMBL/GenBank/DDBJ databases.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|PROSITE-ProRule:PRU00649}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; GQ900953; ADO22470.1; -; mRNA.
DR   RefSeq; NP_006747.1; NM_006756.3.
DR   SMR; A0A384MTX4; -.
DR   Antibodypedia; 6001; 207 antibodies.
DR   GeneID; 6917; -.
DR   KEGG; hsa:6917; -.
DR   CTD; 6917; -.
DR   KO; K03145; -.
DR   OMA; TTFCECT; -.
DR   ExpressionAtlas; A0A384MTX4; baseline and differential.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003676; F:nucleic acid binding; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:1901919; P:positive regulation of exoribonuclease activity; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:InterPro.
DR   Gene3D; 1.10.472.30; -; 1.
DR   Gene3D; 1.20.930.10; -; 1.
DR   InterPro; IPR035100; TF_IIS-typ.
DR   InterPro; IPR003617; TFIIS/CRSP70_N_sub.
DR   InterPro; IPR035441; TFIIS/LEDGF_dom_sf.
DR   InterPro; IPR003618; TFIIS_cen_dom.
DR   InterPro; IPR036575; TFIIS_cen_dom_sf.
DR   InterPro; IPR017923; TFIIS_N.
DR   InterPro; IPR006289; TFSII.
DR   InterPro; IPR001222; Znf_TFIIS.
DR   Pfam; PF08711; Med26; 1.
DR   Pfam; PF01096; TFIIS_C; 1.
DR   Pfam; PF07500; TFIIS_M; 1.
DR   PIRSF; PIRSF006704; TF_IIS; 1.
DR   SMART; SM00510; TFS2M; 1.
DR   SMART; SM00509; TFS2N; 1.
DR   SMART; SM00440; ZnF_C2C2; 1.
DR   SUPFAM; SSF46942; SSF46942; 1.
DR   SUPFAM; SSF47676; SSF47676; 1.
DR   TIGRFAMs; TIGR01385; TFSII; 1.
DR   PROSITE; PS51321; TFIIS_CENTRAL; 1.
DR   PROSITE; PS51319; TFIIS_N; 1.
DR   PROSITE; PS00466; ZF_TFIIS_1; 1.
DR   PROSITE; PS51133; ZF_TFIIS_2; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00472};
KW   Nucleus {ECO:0000256|PROSITE-ProRule:PRU00649};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00472};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00472}.
FT   DOMAIN          3..80
FT                   /note="TFIIS N-terminal"
FT                   /evidence="ECO:0000259|PROSITE:PS51319"
FT   DOMAIN          140..256
FT                   /note="TFIIS central"
FT                   /evidence="ECO:0000259|PROSITE:PS51321"
FT   DOMAIN          259..299
FT                   /note="TFIIS-type"
FT                   /evidence="ECO:0000259|PROSITE:PS51133"
FT   ZN_FING         259..299
FT                   /note="TFIIS-type"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00472"
FT   REGION          80..137
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          223..243
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        80..95
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        96..116
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   301 AA;  33970 MW;  8A685107A56D2DA1 CRC64;
     MEDEVVRFAK KMDKMVQKKN AAGALDLLKE LKNIPMTLEL LQSTRIGMSV NAIRKQSTDE
     EVTSLAKSLI KSWKKLLDGP STEKDLDEKK KEPAITSQNS PEAREESTSS GNVSNRKDET
     NARDTYVSSF PRAPSTSDSV RLKCREMLAA ALRTGDDYIA IGADEEELGS QIEEAIYQEI
     RNTDMKYKNR VRSRISNLKD AKNPNLRKNV LCGNIPPDLF ARMTAEEMAS DELKEMRKNL
     TKEAIREHQM AKTGGTQTDL FTCGKCKKKN CTYTQVQTRS ADEPMTTFVV CNECGNRWKF
     C
//
ID   B7Z4W0_HUMAN            Unreviewed;       280 AA.
AC   B7Z4W0;
DT   03-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   03-MAR-2009, sequence version 1.
DT   22-APR-2020, entry version 64.
DE   SubName: Full=cDNA FLJ51911, highly similar to Transcription elongation factor A protein 1 {ECO:0000313|EMBL:BAH12696.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH12696.1};
RN   [1] {ECO:0000313|EMBL:BAH12696.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|PROSITE-ProRule:PRU00649}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK297957; BAH12696.1; -; mRNA.
DR   RefSeq; NP_958845.1; NM_201437.2.
DR   PeptideAtlas; B7Z4W0; -.
DR   PRIDE; B7Z4W0; -.
DR   GeneID; 6917; -.
DR   CTD; 6917; -.
DR   GenomeRNAi; 6917; -.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003746; F:translation elongation factor activity; IEA:UniProtKB-KW.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:InterPro.
DR   Gene3D; 1.10.472.30; -; 1.
DR   Gene3D; 1.20.930.10; -; 1.
DR   InterPro; IPR035100; TF_IIS-typ.
DR   InterPro; IPR003617; TFIIS/CRSP70_N_sub.
DR   InterPro; IPR035441; TFIIS/LEDGF_dom_sf.
DR   InterPro; IPR003618; TFIIS_cen_dom.
DR   InterPro; IPR036575; TFIIS_cen_dom_sf.
DR   InterPro; IPR017923; TFIIS_N.
DR   InterPro; IPR006289; TFSII.
DR   InterPro; IPR001222; Znf_TFIIS.
DR   Pfam; PF08711; Med26; 1.
DR   Pfam; PF01096; TFIIS_C; 1.
DR   Pfam; PF07500; TFIIS_M; 1.
DR   PIRSF; PIRSF006704; TF_IIS; 1.
DR   SMART; SM00510; TFS2M; 1.
DR   SMART; SM00509; TFS2N; 1.
DR   SMART; SM00440; ZnF_C2C2; 1.
DR   SUPFAM; SSF46942; SSF46942; 1.
DR   SUPFAM; SSF47676; SSF47676; 1.
DR   TIGRFAMs; TIGR01385; TFSII; 1.
DR   PROSITE; PS51321; TFIIS_CENTRAL; 1.
DR   PROSITE; PS51319; TFIIS_N; 1.
DR   PROSITE; PS00466; ZF_TFIIS_1; 1.
DR   PROSITE; PS51133; ZF_TFIIS_2; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Elongation factor {ECO:0000313|EMBL:BAH12696.1};
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00472};
KW   Nucleus {ECO:0000256|PROSITE-ProRule:PRU00649};
KW   Protein biosynthesis {ECO:0000313|EMBL:BAH12696.1};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00472};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00472}.
FT   DOMAIN          1..59
FT                   /note="TFIIS N-terminal"
FT                   /evidence="ECO:0000259|PROSITE:PS51319"
FT   DOMAIN          119..235
FT                   /note="TFIIS central"
FT                   /evidence="ECO:0000259|PROSITE:PS51321"
FT   DOMAIN          238..278
FT                   /note="TFIIS-type"
FT                   /evidence="ECO:0000259|PROSITE:PS51133"
FT   ZN_FING         238..278
FT                   /note="TFIIS-type"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00472"
FT   REGION          58..116
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          202..222
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        58..74
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        75..95
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   280 AA;  31674 MW;  318336FC090137F0 CRC64;
     MEDEVVRFAK KMDKMVQKKN APTRIGMSVN AIRKQSTDEE VTSLAKSLIK SWKKLLDGPS
     TEKDLDEKKK EPAITSQNSP EAREESTSSG NVSNRKDETN ARDTYVSSFP RAPSTSDSVR
     LKCREMLAAA LRTGDDYIAI GADEEELGSQ IEEAIYQEIR NTDMKYKNRV RSRISNLKDA
     KNPNLRKNVL CGNIPPDLFA RMTAEEMASD ELKEMRKNLT KEAIREHQMA KTGGTQTDLF
     TCGKCKKKNC TYTQVQTRSA DEPMTTFVVC NECGNRWKFC
//
ID   TCEA1_HUMAN             Reviewed;         301 AA.
AC   P23193; A6NF25; A8K339; Q15563; Q6FG87;
DT   01-NOV-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 2.
DT   22-APR-2020, entry version 208.
DE   RecName: Full=Transcription elongation factor A protein 1;
DE   AltName: Full=Transcription elongation factor S-II protein 1;
DE   AltName: Full=Transcription elongation factor TFIIS.o;
GN   Name=TCEA1; Synonyms=GTF2S, TFIIS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Kidney;
RX   PubMed=1708494; DOI=10.1093/nar/19.5.1073;
RA   Yoo O., Yoon H., Baek K., Jeon C., Miyamoto K., Ueno A., Agarwal K.;
RT   "Cloning, expression and characterization of the human transcription
RT   elongation factor, TFIIS.";
RL   Nucleic Acids Res. 19:1073-1079(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1378807; DOI=10.1016/0378-1119(92)90522-q;
RA   Chen H.C., England L., Kane C.M.;
RT   "Characterization of a HeLa cDNA clone encoding the human SII protein, an
RT   elongation factor for RNA polymerase II.";
RL   Gene 116:253-258(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Placenta;
RX   PubMed=8112616; DOI=10.1016/0378-1119(94)90767-6;
RA   Park H.R., Baek K.H., Jeon C.J., Agarwal K., Yoo O.;
RT   "Characterization of the gene encoding the human transcriptional elongation
RT   factor TFIIS.";
RL   Gene 139:263-267(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S., Neubert P.,
RA   Kstrang K., Schatten R., Shen B., Henze S., Mar W., Korn B., Zuo D., Hu Y.,
RA   LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M.,
RA   Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L.,
RA   Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S.,
RA   Asakawa T., Blechschmidt K., Bloom T., Borowsky M.L., Butler J., Cook A.,
RA   Corum B., DeArellano K., DeCaprio D., Dooley K.T., Dorris L. III,
RA   Engels R., Gloeckner G., Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K.,
RA   Jaffe D.B., Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C., O'Leary S.B.,
RA   O'Neill K., Parker S.C.J., Polley A., Raymond C.K., Reichwald K.,
RA   Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R., Smith C.L.,
RA   Sneddon T.P., Talamas J.A., Tenzin P., Topham K., Venkataraman V., Wen G.,
RA   Yamazaki S., Young S.K., Zeng Q., Zimmer A.R., Rosenthal A., Birren B.W.,
RA   Platzer M., Shimizu N., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 1-9 AND 32-44, ACETYLATION AT MET-1, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY.
RC   TISSUE=T-cell;
RA   Bienvenut W.V., Kanor S., Tissot J.-D., Quadroni M.;
RL   Submitted (MAY-2006) to UniProtKB.
RN   [10]
RP   CHROMOSOMAL TRANSLOCATION WITH PLAG1.
RX   PubMed=10029085;
RA   Astroem A.-K., Voz M.L., Kas K., Roeijer E., Wedell B., Mandahl N.,
RA   Van de Ven W., Mark J., Stenman G.;
RT   "Conserved mechanism of PLAG1 activation in salivary gland tumors with and
RT   without chromosome 8q12 abnormalities: identification of SII as a new
RT   fusion partner gene.";
RL   Cancer Res. 59:918-923(1999).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-100, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=T-cell;
RX   PubMed=19367720; DOI=10.1021/pr800500r;
RA   Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
RT   "Phosphorylation analysis of primary human T lymphocytes using sequential
RT   IMAC and titanium oxide enrichment.";
RL   J. Proteome Res. 7:5167-5176(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-97 AND SER-100, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-100, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   INTERACTION WITH UBR5 AND CDK9.
RX   PubMed=21127351; DOI=10.1074/jbc.m110.176628;
RA   Cojocaru M., Bouchard A., Cloutier P., Cooper J.J., Varzavand K.,
RA   Price D.H., Coulombe B.;
RT   "Transcription factor IIS cooperates with the E3 ligase UBR5 to
RT   ubiquitinate the CDK9 subunit of the positive transcription elongation
RT   factor B.";
RL   J. Biol. Chem. 286:5012-5022(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-97 AND SER-100, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-57; SER-81 AND SER-100, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-100, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [22]
RP   STRUCTURE BY NMR OF 256-301.
RX   PubMed=7626141; DOI=10.1038/365277a0;
RA   Qian X., Jeon C., Yoon H., Agarwal K., Weiss M.A.;
RT   "Structure of a new nucleic-acid-binding motif in eukaryotic
RT   transcriptional elongation factor TFIIS.";
RL   Nature 365:277-279(1993).
CC   -!- FUNCTION: Necessary for efficient RNA polymerase II transcription
CC       elongation past template-encoded arresting sites. The arresting sites
CC       in DNA have the property of trapping a certain fraction of elongating
CC       RNA polymerases that pass through, resulting in locked ternary
CC       complexes. Cleavage of the nascent transcript by S-II allows the
CC       resumption of elongation from the new 3'-terminus.
CC   -!- SUBUNIT: Interacts with EAF2 (By similarity). Associates with UBR5 and
CC       forms a transcription regulatory complex made of CDK9, RNAP II, UBR5
CC       and TFIIS/TCEA1 that can stimulate target gene transcription (e.g.
CC       gamma fibrinogen/FGG) by recruiting their promoters. {ECO:0000250,
CC       ECO:0000269|PubMed:21127351}.
CC   -!- INTERACTION:
CC       P23193; Q92917: GPKOW; NbExp=3; IntAct=EBI-2608271, EBI-746309;
CC       P23193; Q8WVC0: LEO1; NbExp=4; IntAct=EBI-2608271, EBI-932432;
CC       P23193; Q8N7H5: PAF1; NbExp=4; IntAct=EBI-2608271, EBI-2607770;
CC       P23193; P24928: POLR2A; NbExp=5; IntAct=EBI-2608271, EBI-295301;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=P23193-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P23193-2; Sequence=VSP_006409;
CC   -!- DISEASE: Note=A chromosomal aberration involving TCEA1 may be a cause
CC       of salivary gland pleiomorphic adenomas (PA) [181030]. Pleiomorphic
CC       adenomas are the most common benign epithelial tumors of the salivary
CC       gland. Translocation t(3;8)(p21;q12) with PLAG1.
CC       {ECO:0000269|PubMed:10029085}.
CC   -!- MISCELLANEOUS: S-II binds to RNA-polymerase II in the absence of
CC       transcription.
CC   -!- SIMILARITY: Belongs to the TFS-II family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X62585; CAA44470.1; -; mRNA.
DR   EMBL; X57198; CAA40484.1; -; mRNA.
DR   EMBL; M81601; AAA61138.1; -; mRNA.
DR   EMBL; X73534; CAA51940.1; -; Genomic_DNA.
DR   EMBL; AK290454; BAF83143.1; -; mRNA.
DR   EMBL; CR542221; CAG47017.1; -; mRNA.
DR   EMBL; BT019995; AAV38798.1; -; mRNA.
DR   EMBL; AC100821; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC072460; AAH72460.1; -; mRNA.
DR   CCDS; CCDS47857.1; -. [P23193-2]
DR   CCDS; CCDS47858.1; -. [P23193-1]
DR   PIR; S17361; S17361.
DR   PIR; S26831; S26831.
DR   PIR; S34159; S34159.
DR   RefSeq; NP_006747.1; NM_006756.3. [P23193-1]
DR   RefSeq; NP_958845.1; NM_201437.2. [P23193-2]
DR   PDB; 1TFI; NMR; -; A=252-301.
DR   PDB; 3NDQ; X-ray; 1.93 A; A=131-232.
DR   PDB; 5IY6; EM; 7.20 A; U=1-301.
DR   PDB; 5IY7; EM; 8.60 A; U=1-301.
DR   PDB; 5IY8; EM; 7.90 A; U=1-301.
DR   PDB; 5IYA; EM; 5.40 A; U=1-301.
DR   PDB; 5IYB; EM; 3.90 A; U=1-301.
DR   PDB; 5IYC; EM; 3.90 A; U=1-301.
DR   PDB; 6O9L; EM; 7.20 A; U=1-301.
DR   PDBsum; 1TFI; -.
DR   PDBsum; 3NDQ; -.
DR   PDBsum; 5IY6; -.
DR   PDBsum; 5IY7; -.
DR   PDBsum; 5IY8; -.
DR   PDBsum; 5IYA; -.
DR   PDBsum; 5IYB; -.
DR   PDBsum; 5IYC; -.
DR   PDBsum; 6O9L; -.
DR   SMR; P23193; -.
DR   BioGrid; 112779; 76.
DR   DIP; DIP-48480N; -.
DR   IntAct; P23193; 38.
DR   STRING; 9606.ENSP00000428426; -.
DR   iPTMnet; P23193; -.
DR   MetOSite; P23193; -.
DR   PhosphoSitePlus; P23193; -.
DR   SwissPalm; P23193; -.
DR   BioMuta; TCEA1; -.
DR   DMDM; 1174652; -.
DR   EPD; P23193; -.
DR   jPOST; P23193; -.
DR   MassIVE; P23193; -.
DR   MaxQB; P23193; -.
DR   PaxDb; P23193; -.
DR   PeptideAtlas; P23193; -.
DR   PRIDE; P23193; -.
DR   ProteomicsDB; 54061; -. [P23193-1]
DR   ProteomicsDB; 54062; -. [P23193-2]
DR   Antibodypedia; 6001; 207 antibodies.
DR   DNASU; 6917; -.
DR   Ensembl; ENST00000396401; ENSP00000395483; ENSG00000187735. [P23193-2]
DR   Ensembl; ENST00000521604; ENSP00000428426; ENSG00000187735. [P23193-1]
DR   GeneID; 6917; -.
DR   KEGG; hsa:6917; -.
DR   UCSC; uc003xru.5; human. [P23193-1]
DR   CTD; 6917; -.
DR   DisGeNET; 6917; -.
DR   GeneCards; TCEA1; -.
DR   HGNC; HGNC:11612; TCEA1.
DR   HPA; ENSG00000187735; Low tissue specificity.
DR   MIM; 601425; gene.
DR   neXtProt; NX_P23193; -.
DR   OpenTargets; ENSG00000187735; -.
DR   PharmGKB; PA36371; -.
DR   eggNOG; KOG1105; Eukaryota.
DR   eggNOG; COG1594; LUCA.
DR   GeneTree; ENSGT00940000155121; -.
DR   HOGENOM; CLU_037637_2_0_1; -.
DR   InParanoid; P23193; -.
DR   KO; K03145; -.
DR   OMA; TTFCECT; -.
DR   OrthoDB; 1579101at2759; -.
DR   PhylomeDB; P23193; -.
DR   TreeFam; TF314970; -.
DR   Reactome; R-HSA-112382; Formation of RNA Pol II elongation complex.
DR   Reactome; R-HSA-167152; Formation of HIV elongation complex in the absence of HIV Tat.
DR   Reactome; R-HSA-167200; Formation of HIV-1 elongation complex containing HIV-1 Tat.
DR   Reactome; R-HSA-167238; Pausing and recovery of Tat-mediated HIV elongation.
DR   Reactome; R-HSA-167243; Tat-mediated HIV elongation arrest and recovery.
DR   Reactome; R-HSA-167246; Tat-mediated elongation of the HIV-1 transcript.
DR   Reactome; R-HSA-167287; HIV elongation arrest and recovery.
DR   Reactome; R-HSA-167290; Pausing and recovery of HIV elongation.
DR   Reactome; R-HSA-674695; RNA Polymerase II Pre-transcription Events.
DR   Reactome; R-HSA-6781823; Formation of TC-NER Pre-Incision Complex.
DR   Reactome; R-HSA-6781827; Transcription-Coupled Nucleotide Excision Repair (TC-NER).
DR   Reactome; R-HSA-6782135; Dual incision in TC-NER.
DR   Reactome; R-HSA-6782210; Gap-filling DNA repair synthesis and ligation in TC-NER.
DR   Reactome; R-HSA-6796648; TP53 Regulates Transcription of DNA Repair Genes.
DR   Reactome; R-HSA-75955; RNA Polymerase II Transcription Elongation.
DR   SIGNOR; P23193; -.
DR   ChiTaRS; TCEA1; human.
DR   EvolutionaryTrace; P23193; -.
DR   GeneWiki; TCEA1; -.
DR   GenomeRNAi; 6917; -.
DR   Pharos; P23193; Tbio.
DR   PRO; PR:P23193; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   RNAct; P23193; protein.
DR   Bgee; ENSG00000187735; Expressed in bone marrow and 240 other tissues.
DR   ExpressionAtlas; P23193; baseline and differential.
DR   Genevisible; P23193; HS.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005669; C:transcription factor TFIID complex; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:1901919; P:positive regulation of exoribonuclease activity; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; TAS:Reactome.
DR   GO; GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome.
DR   GO; GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome.
DR   Gene3D; 1.10.472.30; -; 1.
DR   Gene3D; 1.20.930.10; -; 1.
DR   InterPro; IPR035100; TF_IIS-typ.
DR   InterPro; IPR003617; TFIIS/CRSP70_N_sub.
DR   InterPro; IPR035441; TFIIS/LEDGF_dom_sf.
DR   InterPro; IPR003618; TFIIS_cen_dom.
DR   InterPro; IPR036575; TFIIS_cen_dom_sf.
DR   InterPro; IPR017923; TFIIS_N.
DR   InterPro; IPR006289; TFSII.
DR   InterPro; IPR001222; Znf_TFIIS.
DR   Pfam; PF08711; Med26; 1.
DR   Pfam; PF01096; TFIIS_C; 1.
DR   Pfam; PF07500; TFIIS_M; 1.
DR   PIRSF; PIRSF006704; TF_IIS; 1.
DR   SMART; SM00510; TFS2M; 1.
DR   SMART; SM00509; TFS2N; 1.
DR   SMART; SM00440; ZnF_C2C2; 1.
DR   SUPFAM; SSF46942; SSF46942; 1.
DR   SUPFAM; SSF47676; SSF47676; 1.
DR   TIGRFAMs; TIGR01385; TFSII; 1.
DR   PROSITE; PS51321; TFIIS_CENTRAL; 1.
DR   PROSITE; PS51319; TFIIS_N; 1.
DR   PROSITE; PS00466; ZF_TFIIS_1; 1.
DR   PROSITE; PS51133; ZF_TFIIS_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Chromosomal rearrangement;
KW   Direct protein sequencing; DNA-binding; Isopeptide bond; Metal-binding;
KW   Nucleus; Phosphoprotein; Reference proteome; Transcription;
KW   Transcription regulation; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..301
FT                   /note="Transcription elongation factor A protein 1"
FT                   /id="PRO_0000121446"
FT   DOMAIN          3..80
FT                   /note="TFIIS N-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00649"
FT   DOMAIN          140..256
FT                   /note="TFIIS central"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00651"
FT   ZN_FING         259..299
FT                   /note="TFIIS-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00472"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000244|PubMed:22814378, ECO:0000269|Ref.9"
FT   MOD_RES         57
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         81
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         97
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:21406692"
FT   MOD_RES         100
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   CROSSLNK        55
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q15560"
FT   VAR_SEQ         22..42
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:1708494"
FT                   /id="VSP_006409"
FT   CONFLICT        127
FT                   /note="V -> L (in Ref. 2; AAA61138)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        141
FT                   /note="R -> Q (in Ref. 3; CAA51940)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        205
FT                   /note="N -> Y (in Ref. 3; CAA51940)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        237
FT                   /note="R -> W (in Ref. 3; CAA51940)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        285
FT                   /note="M -> V (in Ref. 3; CAA51940)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        300
FT                   /note="F -> I (in Ref. 6; AC100821)"
FT                   /evidence="ECO:0000305"
FT   HELIX           139..151
FT                   /evidence="ECO:0000244|PDB:3NDQ"
FT   HELIX           152..156
FT                   /evidence="ECO:0000244|PDB:3NDQ"
FT   HELIX           157..161
FT                   /evidence="ECO:0000244|PDB:3NDQ"
FT   HELIX           165..180
FT                   /evidence="ECO:0000244|PDB:3NDQ"
FT   STRAND          182..184
FT                   /evidence="ECO:0000244|PDB:3NDQ"
FT   HELIX           185..198
FT                   /evidence="ECO:0000244|PDB:3NDQ"
FT   HELIX           204..211
FT                   /evidence="ECO:0000244|PDB:3NDQ"
FT   HELIX           217..222
FT                   /evidence="ECO:0000244|PDB:3NDQ"
FT   TURN            225..227
FT                   /evidence="ECO:0000244|PDB:3NDQ"
FT   STRAND          264..266
FT                   /evidence="ECO:0000244|PDB:1TFI"
FT   STRAND          271..276
FT                   /evidence="ECO:0000244|PDB:1TFI"
FT   STRAND          278..283
FT                   /evidence="ECO:0000244|PDB:1TFI"
FT   STRAND          286..294
FT                   /evidence="ECO:0000244|PDB:1TFI"
FT   STRAND          297..299
FT                   /evidence="ECO:0000244|PDB:1TFI"
SQ   SEQUENCE   301 AA;  33970 MW;  8A685107A56D2DA1 CRC64;
     MEDEVVRFAK KMDKMVQKKN AAGALDLLKE LKNIPMTLEL LQSTRIGMSV NAIRKQSTDE
     EVTSLAKSLI KSWKKLLDGP STEKDLDEKK KEPAITSQNS PEAREESTSS GNVSNRKDET
     NARDTYVSSF PRAPSTSDSV RLKCREMLAA ALRTGDDYIA IGADEEELGS QIEEAIYQEI
     RNTDMKYKNR VRSRISNLKD AKNPNLRKNV LCGNIPPDLF ARMTAEEMAS DELKEMRKNL
     TKEAIREHQM AKTGGTQTDL FTCGKCKKKN CTYTQVQTRS ADEPMTTFVV CNECGNRWKF
     C
//
ID   A0A024R5T1_HUMAN        Unreviewed;       682 AA.
AC   A0A024R5T1;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 49.
DE   SubName: Full=Transcription factor 12 (HTF4, helix-loop-helix transcription factors 4), isoform CRA_c {ECO:0000313|EMBL:EAW77517.1};
GN   Name=TCF12 {ECO:0000313|EMBL:EAW77517.1};
GN   ORFNames=hCG_40686 {ECO:0000313|EMBL:EAW77517.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW77517.1};
RN   [1] {ECO:0000313|EMBL:EAW77517.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW77517.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH471082; EAW77513.1; -; Genomic_DNA.
DR   EMBL; CH471082; EAW77516.1; -; Genomic_DNA.
DR   EMBL; CH471082; EAW77517.1; -; Genomic_DNA.
DR   RefSeq; NP_001309086.1; NM_001322157.1.
DR   RefSeq; NP_001309094.1; NM_001322165.1.
DR   RefSeq; NP_003196.1; NM_003205.3.
DR   RefSeq; NP_996921.1; NM_207038.1.
DR   Antibodypedia; 913; 367 antibodies.
DR   GeneID; 6938; -.
DR   KEGG; hsa:6938; -.
DR   CTD; 6938; -.
DR   EuPathDB; HostDB:ENSG00000140262.17; -.
DR   eggNOG; KOG3910; Eukaryota.
DR   eggNOG; ENOG410XYUA; LUCA.
DR   KO; K15603; -.
DR   OrthoDB; 571132at2759; -.
DR   ChiTaRS; TCF12; human.
DR   GenomeRNAi; 6938; -.
DR   Bgee; ENSG00000140262; Expressed in corpus callosum and 235 other tissues.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0046983; F:protein dimerization activity; IEA:InterPro.
DR   CDD; cd00083; HLH; 1.
DR   Gene3D; 4.10.280.10; -; 1.
DR   InterPro; IPR011598; bHLH_dom.
DR   InterPro; IPR036638; HLH_DNA-bd_sf.
DR   Pfam; PF00010; HLH; 1.
DR   SMART; SM00353; HLH; 1.
DR   SUPFAM; SSF47459; SSF47459; 1.
DR   PROSITE; PS50888; BHLH; 1.
PE   4: Predicted;
FT   DOMAIN          577..630
FT                   /note="BHLH"
FT                   /evidence="ECO:0000259|PROSITE:PS50888"
FT   REGION          25..122
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          140..219
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          281..313
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          349..395
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          462..580
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          651..682
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        29..80
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        99..122
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        140..167
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        462..517
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        518..550
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        557..580
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        668..682
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   682 AA;  72965 MW;  9736113D9361D3F5 CRC64;
     MNPQQQRMAA IGTDKELSDL LDFSAMFSPP VNSGKTRPTT LGSSQFSGSG IDERGGTTSW
     GTSGQPSPSY DSSRGFTDSP HYSDHLNDSR LGAHEGLSPT PFMNSNLMGK TSERGSFSLY
     SRDTGLPGCQ SSLLRQDLGL GSPAQLSSSG KPGTAYYSFS ATSSRRRPLH DSAALDPLQA
     KKVRKVPPGL PSSVYAPSPN SDDFNRESPS YPSPKPPTSM FASTFFMQDG THNSSDLWSS
     SNGMSQPGFG GILGTSTSHM SQSSSYGNLH SHDRLSYPPH SVSPTDINTS LPPMSSFHRG
     STSSSPYVAA SHTPPINGSD SILGTRGNAA GSSQTGDALG KALASIYSPD HTSSSFPSNP
     STPVGSPSPL TGTSQWPRPG GQAPSSPSYE NSLHSLQSRM EDRLDRLDDA IHVLRNHAVG
     PSTSLPAGHS DIHSLLGPSH NAPIGSLNSN YGGSSLVASS RSASMVGTHR EDSVSLNGNH
     SVLSSTVTTS STDLNHKTQE NYRGGLQSQS GTVVTTEIKT ENKEKDENLH EPPSSDDMKS
     DDESSQKDIK VSSRGRTSST NEDEDLNPEQ KIEREKERRM ANNARERLRV RDINEAFKEL
     GRMCQLHLKS EKPQTKLLIL HQAVAVILSL EQQVRERNLN PKAACLKRRE EEKVSAVSAE
     PPTTLPGTHP GLSETTNPMG HM
//
ID   A0A024R5Z0_HUMAN        Unreviewed;       706 AA.
AC   A0A024R5Z0;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 41.
DE   SubName: Full=Transcription factor 12 (HTF4, helix-loop-helix transcription factors 4), isoform CRA_b {ECO:0000313|EMBL:EAW77514.1};
GN   Name=TCF12 {ECO:0000313|EMBL:EAW77514.1};
GN   ORFNames=hCG_40686 {ECO:0000313|EMBL:EAW77514.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW77514.1};
RN   [1] {ECO:0000313|EMBL:EAW77514.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW77514.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH471082; EAW77514.1; -; Genomic_DNA.
DR   RefSeq; NP_001309080.1; NM_001322151.1.
DR   RefSeq; NP_001309088.1; NM_001322159.1.
DR   RefSeq; NP_001309091.1; NM_001322162.1.
DR   RefSeq; NP_996919.1; NM_207036.1.
DR   RefSeq; NP_996920.1; NM_207037.1.
DR   SMR; A0A024R5Z0; -.
DR   PRIDE; A0A024R5Z0; -.
DR   Antibodypedia; 913; 367 antibodies.
DR   GeneID; 6938; -.
DR   CTD; 6938; -.
DR   EuPathDB; HostDB:ENSG00000140262.17; -.
DR   eggNOG; KOG3910; Eukaryota.
DR   eggNOG; ENOG410XYUA; LUCA.
DR   HOGENOM; CLU_021099_2_0_1; -.
DR   OMA; SSRGRTX; -.
DR   OrthoDB; 571132at2759; -.
DR   PhylomeDB; A0A024R5Z0; -.
DR   ChiTaRS; TCF12; human.
DR   GenomeRNAi; 6938; -.
DR   Bgee; ENSG00000140262; Expressed in corpus callosum and 235 other tissues.
DR   ExpressionAtlas; A0A024R5Z0; baseline and differential.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005667; C:transcription factor complex; IEA:Ensembl.
DR   GO; GO:0035497; F:cAMP response element binding; IEA:Ensembl.
DR   GO; GO:0070888; F:E-box binding; IEA:Ensembl.
DR   GO; GO:0071837; F:HMG box domain binding; IEA:Ensembl.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:Ensembl.
DR   GO; GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IEA:Ensembl.
DR   CDD; cd00083; HLH; 1.
DR   Gene3D; 4.10.280.10; -; 1.
DR   InterPro; IPR011598; bHLH_dom.
DR   InterPro; IPR036638; HLH_DNA-bd_sf.
DR   Pfam; PF00010; HLH; 1.
DR   SMART; SM00353; HLH; 1.
DR   SUPFAM; SSF47459; SSF47459; 1.
DR   PROSITE; PS50888; BHLH; 1.
PE   4: Predicted;
FT   DOMAIN          601..654
FT                   /note="BHLH"
FT                   /evidence="ECO:0000259|PROSITE:PS50888"
FT   REGION          25..122
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          140..219
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          281..313
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          349..392
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          492..604
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          675..706
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        29..80
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        99..122
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        140..167
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        492..541
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        542..574
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        581..604
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        692..706
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   706 AA;  75845 MW;  75B7B4173C9B660D CRC64;
     MNPQQQRMAA IGTDKELSDL LDFSAMFSPP VNSGKTRPTT LGSSQFSGSG IDERGGTTSW
     GTSGQPSPSY DSSRGFTDSP HYSDHLNDSR LGAHEGLSPT PFMNSNLMGK TSERGSFSLY
     SRDTGLPGCQ SSLLRQDLGL GSPAQLSSSG KPGTAYYSFS ATSSRRRPLH DSAALDPLQA
     KKVRKVPPGL PSSVYAPSPN SDDFNRESPS YPSPKPPTSM FASTFFMQDG THNSSDLWSS
     SNGMSQPGFG GILGTSTSHM SQSSSYGNLH SHDRLSYPPH SVSPTDINTS LPPMSSFHRG
     STSSSPYVAA SHTPPINGSD SILGTRGNAA GSSQTGDALG KALASIYSPD HTSSSFPSNP
     STPVGSPSPL TGTSQWPRPG GQAPSSPSYE NSLHSLKNRV EQQLHEHLQD AMSFLKDVCE
     QSRMEDRLDR LDDAIHVLRN HAVGPSTSLP AGHSDIHSLL GPSHNAPIGS LNSNYGGSSL
     VASSRSASMV GTHREDSVSL NGNHSVLSST VTTSSTDLNH KTQENYRGGL QSQSGTVVTT
     EIKTENKEKD ENLHEPPSSD DMKSDDESSQ KDIKVSSRGR TSSTNEDEDL NPEQKIEREK
     ERRMANNARE RLRVRDINEA FKELGRMCQL HLKSEKPQTK LLILHQAVAV ILSLEQQVRE
     RNLNPKAACL KRREEEKVSA VSAEPPTTLP GTHPGLSETT NPMGHM
//
ID   F5GY10_HUMAN            Unreviewed;       536 AA.
AC   F5GY10;
DT   28-JUN-2011, integrated into UniProtKB/TrEMBL.
DT   28-JUN-2011, sequence version 1.
DT   22-APR-2020, entry version 72.
DE   SubName: Full=Transcription factor 12 {ECO:0000313|Ensembl:ENSP00000440017};
GN   Name=TCF12 {ECO:0000313|Ensembl:ENSP00000440017};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000440017, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000213|PubMed:16964243}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000440017, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R., Fahey J.,
RA   Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G., Johnson E.,
RA   Jones C., Kamat A., Kaur A., Locke D.P., Madan A., Munson G., Jaffe D.B.,
RA   Lui A., Macdonald P., Mauceli E., Naylor J.W., Nesbitt R., Nicol R.,
RA   O'Leary S.B., Ratcliffe A., Rounsley S., She X., Sneddon K.M., Stewart S.,
RA   Sougnez C., Stone S.M., Topham K., Vincent D., Wang S., Zimmer A.R.,
RA   Birren B.W., Hood L., Lander E.S., Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human chromosome
RT   15.";
RL   Nature 440:671-675(2006).
RN   [3] {ECO:0000213|PubMed:17525332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R., Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [4] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [5] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [6] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [7] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [8] {ECO:0000313|Ensembl:ENSP00000440017}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [9] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11] {ECO:0000213|PubMed:25218447}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [12] {ECO:0000213|PubMed:25755297}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurethsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to replication
RT   stress reveals novel small ubiquitin-like modified target proteins and
RT   acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [13] {ECO:0000213|PubMed:28112733}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC010999; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC016525; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC090511; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC090532; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF456057; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001293148.1; NM_001306219.2.
DR   EPD; F5GY10; -.
DR   jPOST; F5GY10; -.
DR   MaxQB; F5GY10; -.
DR   PeptideAtlas; F5GY10; -.
DR   PRIDE; F5GY10; -.
DR   ProteomicsDB; 24589; -.
DR   Antibodypedia; 913; 367 antibodies.
DR   Ensembl; ENST00000543579; ENSP00000440017; ENSG00000140262.
DR   GeneID; 6938; -.
DR   UCSC; uc010bft.4; human.
DR   CTD; 6938; -.
DR   EuPathDB; HostDB:ENSG00000140262.17; -.
DR   HGNC; HGNC:11623; TCF12.
DR   OpenTargets; ENSG00000140262; -.
DR   eggNOG; KOG3910; Eukaryota.
DR   eggNOG; ENOG410XYUA; LUCA.
DR   GeneTree; ENSGT00940000155047; -.
DR   OrthoDB; 571132at2759; -.
DR   ChiTaRS; TCF12; human.
DR   GenomeRNAi; 6938; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000140262; Expressed in corpus callosum and 235 other tissues.
DR   ExpressionAtlas; F5GY10; baseline and differential.
DR   GO; GO:0046983; F:protein dimerization activity; IEA:InterPro.
DR   CDD; cd00083; HLH; 1.
DR   Gene3D; 4.10.280.10; -; 1.
DR   InterPro; IPR011598; bHLH_dom.
DR   InterPro; IPR036638; HLH_DNA-bd_sf.
DR   Pfam; PF00010; HLH; 1.
DR   SMART; SM00353; HLH; 1.
DR   SUPFAM; SSF47459; SSF47459; 1.
DR   PROSITE; PS50888; BHLH; 1.
PE   1: Evidence at protein level;
KW   Proteomics identification {ECO:0000213|EPD:F5GY10,
KW   ECO:0000213|MaxQB:F5GY10, ECO:0000213|PeptideAtlas:F5GY10,
KW   ECO:0000213|ProteomicsDB:F5GY10};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN          431..484
FT                   /note="BHLH"
FT                   /evidence="ECO:0000259|PROSITE:PS50888"
FT   REGION          79..143
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          179..222
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          322..434
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          505..536
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        79..101
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        111..143
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        322..371
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        372..404
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        411..434
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        522..536
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   536 AA;  58023 MW;  F3822C94BCA627F4 CRC64;
     MYCAYPVPGM GSNSLMYYYN GKTVYAPSPN SDDFNRESPS YPSPKPPTSM FASTFFMQDG
     THNSSDLWSS SNGMSQPGFG GILGTSTSHM SQSSSYGNLH SHDRLSYPPH SVSPTDINTS
     LPPMSSFHRG STSSSPYVAA SHTPPINGSD SILGTRGNAA GSSQTGDALG KALASIYSPD
     HTSSSFPSNP STPVGSPSPL TGTSQWPRPG GQAPSSPSYE NSLHSLKNRV EQQLHEHLQD
     AMSFLKDVCE QSRMEDRLDR LDDAIHVLRN HAVGPSTSLP AGHSDIHSLL GPSHNAPIGS
     LNSNYGGSSL VASSRSASMV GTHREDSVSL NGNHSVLSST VTTSSTDLNH KTQENYRGGL
     QSQSGTVVTT EIKTENKEKD ENLHEPPSSD DMKSDDESSQ KDIKVSSRGR TSSTNEDEDL
     NPEQKIEREK ERRMANNARE RLRVRDINEA FKELGRMCQL HLKSEKPQTK LLILHQAVAV
     ILSLEQQVRE RNLNPKAACL KRREEEKVSA VSAEPPTTLP GTHPGLSETT NPMGHM
//
ID   HTF4_HUMAN              Reviewed;         682 AA.
AC   Q99081; B4E1W1; Q7Z3D9; Q86TC1; Q86VM2;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   22-APR-2020, entry version 187.
DE   RecName: Full=Transcription factor 12;
DE            Short=TCF-12;
DE   AltName: Full=Class B basic helix-loop-helix protein 20;
DE            Short=bHLHb20;
DE   AltName: Full=DNA-binding protein HTF4;
DE   AltName: Full=E-box-binding protein;
DE   AltName: Full=Transcription factor HTF-4;
GN   Name=TCF12; Synonyms=BHLHB20, HEB, HTF4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1446075; DOI=10.3109/10425179209020819;
RA   Zhang Y., Bina M.;
RT   "The nucleotide sequence of the human transcription factor HTF4a cDNA.";
RL   DNA Seq. 2:397-403(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Skeletal muscle;
RX   PubMed=1312219; DOI=10.1128/mcb.12.3.1031;
RA   Hu J.S., Olson E.N., Kingston R.E.;
RT   "HEB, a helix-loop-helix protein related to E2A and ITF2 that can modulate
RT   the DNA-binding ability of myogenic regulatory factors.";
RL   Mol. Cell. Biol. 12:1031-1042(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Endometrium, and Skeletal muscle;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R., Fahey J.,
RA   Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G., Johnson E.,
RA   Jones C., Kamat A., Kaur A., Locke D.P., Madan A., Munson G., Jaffe D.B.,
RA   Lui A., Macdonald P., Mauceli E., Naylor J.W., Nesbitt R., Nicol R.,
RA   O'Leary S.B., Ratcliffe A., Rounsley S., She X., Sneddon K.M.B.,
RA   Stewart S., Sougnez C., Stone S.M., Topham K., Vincent D., Wang S.,
RA   Zimmer A.R., Birren B.W., Hood L., Lander E.S., Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human chromosome
RT   15.";
RL   Nature 440:671-675(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 352-682.
RX   PubMed=1886779; DOI=10.1093/nar/19.16.4555;
RA   Zhang Y., Babin J., Feldhaus A.L., Singh H., Sharp P.A., Bina M.;
RT   "HTF4: a new human helix-loop-helix protein.";
RL   Nucleic Acids Res. 19:4555-4555(1991).
RN   [9]
RP   GENE ORGANIZATION, AND ALTERNATIVE SPLICING.
RX   PubMed=12826747; DOI=10.1159/000071042;
RA   Gan T.I., Rowen L., Nesbitt R., Roe B.A., Wu H., Hu P., Yao Z., Kim U.J.,
RA   O'Sickey T., Bina M.;
RT   "Genomic organization of human TCF12 gene and spliced mRNA variants
RT   producing isoforms of transcription factor HTF4.";
RL   Cytogenet. Genome Res. 98:245-248(2002).
RN   [10]
RP   INTERACTION WITH RUNX1T1.
RX   PubMed=16616331; DOI=10.1016/j.ccr.2006.03.012;
RA   Liu Y., Cheney M.D., Gaudet J.J., Chruszcz M., Lukasik S.M., Sugiyama D.,
RA   Lary J., Cole J., Dauter Z., Minor W., Speck N.A., Bushweller J.H.;
RT   "The tetramer structure of the Nervy homology two domain, NHR2, is critical
RT   for AML1/ETO's activity.";
RL   Cancer Cell 9:249-260(2006).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [12]
RP   DOMAIN.
RX   PubMed=17467953; DOI=10.1016/j.ygeno.2007.02.003;
RA   Piskacek S., Gregor M., Nemethova M., Grabner M., Kovarik P., Piskacek M.;
RT   "Nine-amino-acid transactivation domain: establishment and prediction
RT   utilities.";
RL   Genomics 89:756-768(2007).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-313, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-67; SER-333 AND THR-557, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-559, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-47; SER-67; SER-79; SER-98;
RP   SER-116; THR-313; SER-333; SER-540; SER-558 AND SER-559, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [21]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-519 AND LYS-550, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [22]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-519, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.o114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to replication
RT   stress reveals novel small ubiquitin-like modified target proteins and
RT   acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [23]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-110; LYS-181; LYS-519; LYS-609
RP   AND LYS-653, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (2.91 ANGSTROMS) OF 177-200 IN COMPLEX WITH RUNX1T1,
RP   INTERACTION WITH AML1-MTG8/ETO, AND MUTAGENESIS OF PRO-187; PRO-191 AND
RP   SER-192.
RX   PubMed=23812588; DOI=10.1038/nature12287;
RA   Sun X.J., Wang Z., Wang L., Jiang Y., Kost N., Soong T.D., Chen W.Y.,
RA   Tang Z., Nakadai T., Elemento O., Fischle W., Melnick A., Patel D.J.,
RA   Nimer S.D., Roeder R.G.;
RT   "A stable transcription factor complex nucleated by oligomeric AML1-ETO
RT   controls leukaemogenesis.";
RL   Nature 500:93-97(2013).
RN   [25]
RP   INTERACTION WITH BHLHA9.
RX   PubMed=25466284; DOI=10.1016/j.ajhg.2014.10.012;
RA   Malik S., Percin F.E., Bornholdt D., Albrecht B., Percesepe A., Koch M.C.,
RA   Landi A., Fritz B., Khan R., Mumtaz S., Akarsu N.A., Grzeschik K.H.;
RT   "Mutations affecting the BHLHA9 DNA-binding domain cause MSSD, mesoaxial
RT   synostotic syndactyly with phalangeal reduction, Malik-Percin type.";
RL   Am. J. Hum. Genet. 95:649-659(2014).
RN   [26]
RP   STRUCTURE BY NMR OF 11-28 IN COMPLEX WITH RUNX1T1, AND SUBUNIT.
RX   PubMed=19204326; DOI=10.1182/blood-2008-06-161307;
RA   Park S., Chen W., Cierpicki T., Tonelli M., Cai X., Speck N.A.,
RA   Bushweller J.H.;
RT   "Structure of the AML1-ETO eTAFH domain-HEB peptide complex and its
RT   contribution to AML1-ETO activity.";
RL   Blood 113:3558-3567(2009).
RN   [27]
RP   VARIANTS CRS3 PRO-600 AND GLU-614.
RX   PubMed=23354436; DOI=10.1038/ng.2531;
RG   500 Whole-Genome Sequences (WGS500) Consortium;
RA   Sharma V.P., Fenwick A.L., Brockop M.S., McGowan S.J., Goos J.A.,
RA   Hoogeboom A.J., Brady A.F., Jeelani N.O., Lynch S.A., Mulliken J.B.,
RA   Murray D.J., Phipps J.M., Sweeney E., Tomkins S.E., Wilson L.C.,
RA   Bennett S., Cornall R.J., Broxholme J., Kanapin A., Johnson D., Wall S.A.,
RA   van der Spek P.J., Mathijssen I.M., Maxson R.E., Twigg S.R., Wilkie A.O.;
RT   "Mutations in TCF12, encoding a basic helix-loop-helix partner of TWIST1,
RT   are a frequent cause of coronal craniosynostosis.";
RL   Nat. Genet. 45:304-307(2013).
RN   [28]
RP   VARIANT CRS3 ARG-483.
RX   PubMed=25271085; DOI=10.1038/ejhg.2014.205;
RA   Paumard-Hernandez B., Berges-Soria J., Barroso E., Rivera-Pedroza C.I.,
RA   Perez-Carrizosa V., Benito-Sanz S., Lopez-Messa E., Santos F.,
RA   Garcia-Recuero I.I., Romance A., Ballesta-Martinez J.M., Lopez-Gonzalez V.,
RA   Campos-Barros A., Cruz J., Guillen-Navarro E., Sanchez Del Pozo J.,
RA   Lapunzina P., Garcia-Minaur S., Heath K.E.;
RT   "Expanding the mutation spectrum in 182 Spanish probands with
RT   craniosynostosis: identification and characterization of novel TCF12
RT   variants.";
RL   Eur. J. Hum. Genet. 23:907-914(2015).
CC   -!- FUNCTION: Transcriptional regulator. Involved in the initiation of
CC       neuronal differentiation. Activates transcription by binding to the E
CC       box (5'-CANNTG-3').
CC   -!- SUBUNIT: Efficient DNA binding requires dimerization with another bHLH
CC       protein. Forms homo- or heterooligomers with myogenin, E12 and ITF2
CC       proteins. Interacts with PTF1A. Interacts with NEUROD2 (By similarity).
CC       Interacts with RUNX1T1. Interacts with AML1-MTG8/ETO (via nervy
CC       homology region 2 in oligomerized form) (PubMed:23812588). Interacts
CC       with BHLHA9 (PubMed:25466284). {ECO:0000250|UniProtKB:Q61286,
CC       ECO:0000269|PubMed:16616331, ECO:0000269|PubMed:19204326,
CC       ECO:0000269|PubMed:23812588, ECO:0000269|PubMed:25466284}.
CC   -!- INTERACTION:
CC       Q99081-3; Q0P5N6: ARL16; NbExp=3; IntAct=EBI-11952764, EBI-10186132;
CC       Q99081; Q8IUR7: ARMC8; NbExp=3; IntAct=EBI-722877, EBI-1049469;
CC       Q99081-3; Q9NQ33: ASCL3; NbExp=3; IntAct=EBI-11952764, EBI-12108222;
CC       Q99081; Q6XD76: ASCL4; NbExp=3; IntAct=EBI-722877, EBI-10254793;
CC       Q99081-3; Q6XD76: ASCL4; NbExp=3; IntAct=EBI-11952764, EBI-10254793;
CC       Q99081; Q96MC5: BMERB1; NbExp=3; IntAct=EBI-722877, EBI-718468;
CC       Q99081; Q9NX04: C1orf109; NbExp=3; IntAct=EBI-722877, EBI-8643161;
CC       Q99081-3; P51946: CCNH; NbExp=3; IntAct=EBI-11952764, EBI-741406;
CC       Q99081-3; Q86Y33-5: CDC20B; NbExp=3; IntAct=EBI-11952764, EBI-11983537;
CC       Q99081; P42773: CDKN2C; NbExp=5; IntAct=EBI-722877, EBI-711290;
CC       Q99081-3; P42773: CDKN2C; NbExp=4; IntAct=EBI-11952764, EBI-711290;
CC       Q99081; Q8IYR0: CFAP206; NbExp=3; IntAct=EBI-722877, EBI-749051;
CC       Q99081-3; P61024: CKS1B; NbExp=3; IntAct=EBI-11952764, EBI-456371;
CC       Q99081-3; P51800-3: CLCNKA; NbExp=3; IntAct=EBI-11952764, EBI-11980535;
CC       Q99081; O75575: CRCP; NbExp=3; IntAct=EBI-722877, EBI-2654687;
CC       Q99081-3; P26196: DDX6; NbExp=3; IntAct=EBI-11952764, EBI-351257;
CC       Q99081; Q3B7T1-5: EDRF1; NbExp=3; IntAct=EBI-722877, EBI-10240074;
CC       Q99081-3; O15197-2: EPHB6; NbExp=3; IntAct=EBI-11952764, EBI-10182490;
CC       Q99081-3; Q8IYI6: EXOC8; NbExp=3; IntAct=EBI-11952764, EBI-742102;
CC       Q99081-3; Q9Y247: FAM50B; NbExp=3; IntAct=EBI-11952764, EBI-742802;
CC       Q99081-3; Q6QHK4: FIGLA; NbExp=3; IntAct=EBI-11952764, EBI-11976617;
CC       Q99081; O75593: FOXH1; NbExp=2; IntAct=EBI-722877, EBI-1759806;
CC       Q99081-3; Q14451-3: GRB7; NbExp=3; IntAct=EBI-11952764, EBI-11991632;
CC       Q99081-3; Q969Y2: GTPBP3; NbExp=3; IntAct=EBI-11952764, EBI-740290;
CC       Q99081-3; O96004: HAND1; NbExp=3; IntAct=EBI-11952764, EBI-11320290;
CC       Q99081-3; P61296-2: HAND2; NbExp=3; IntAct=EBI-11952764, EBI-13086076;
CC       Q99081-3; A0A024R8L2: hCG_1987119; NbExp=3; IntAct=EBI-11952764, EBI-14103818;
CC       Q99081; Q96MH2: HEXIM2; NbExp=4; IntAct=EBI-722877, EBI-5460660;
CC       Q99081-3; Q96MH2: HEXIM2; NbExp=4; IntAct=EBI-11952764, EBI-5460660;
CC       Q99081; Q9BPY8: HOPX; NbExp=3; IntAct=EBI-722877, EBI-10295883;
CC       Q99081-3; P41134: ID1; NbExp=3; IntAct=EBI-11952764, EBI-1215527;
CC       Q99081; Q02363: ID2; NbExp=2; IntAct=EBI-722877, EBI-713450;
CC       Q99081; Q02535: ID3; NbExp=4; IntAct=EBI-722877, EBI-1387094;
CC       Q99081-3; Q02535: ID3; NbExp=4; IntAct=EBI-11952764, EBI-1387094;
CC       Q99081-3; Q8TBB1: LNX1; NbExp=3; IntAct=EBI-11952764, EBI-739832;
CC       Q99081; Q96S90: LYSMD1; NbExp=3; IntAct=EBI-722877, EBI-10293291;
CC       Q99081; O60336: MAPKBP1; NbExp=3; IntAct=EBI-722877, EBI-947402;
CC       Q99081; Q6P2C6: MLLT6; NbExp=3; IntAct=EBI-722877, EBI-5773143;
CC       Q99081; Q8NDC4: MORN4; NbExp=3; IntAct=EBI-722877, EBI-10269566;
CC       Q99081-3; Q8NDC4: MORN4; NbExp=3; IntAct=EBI-11952764, EBI-10269566;
CC       Q99081; Q8WVZ3: MORN4; NbExp=3; IntAct=EBI-722877, EBI-10277137;
CC       Q99081-3; O60682: MSC; NbExp=3; IntAct=EBI-11952764, EBI-740310;
CC       Q99081-3; A6NI15: MSGN1; NbExp=3; IntAct=EBI-11952764, EBI-11991020;
CC       Q99081; Q9UJ70: NAGK; NbExp=3; IntAct=EBI-722877, EBI-372578;
CC       Q99081-3; Q9HC98-4: NEK6; NbExp=3; IntAct=EBI-11952764, EBI-11750983;
CC       Q99081-3; Q13562: NEUROD1; NbExp=4; IntAct=EBI-11952764, EBI-3908303;
CC       Q99081-3; Q92886: NEUROG1; NbExp=3; IntAct=EBI-11952764, EBI-10279647;
CC       Q99081; Q9Y4Z2: NEUROG3; NbExp=4; IntAct=EBI-722877, EBI-10328570;
CC       Q99081-3; Q9Y4Z2: NEUROG3; NbExp=7; IntAct=EBI-11952764, EBI-10328570;
CC       Q99081-3; Q96IV0: NGLY1; NbExp=3; IntAct=EBI-11952764, EBI-6165879;
CC       Q99081-3; Q02577: NHLH2; NbExp=3; IntAct=EBI-11952764, EBI-5378683;
CC       Q99081; Q9UJX0: OSGIN1; NbExp=4; IntAct=EBI-722877, EBI-9057006;
CC       Q99081-3; Q13526: PIN1; NbExp=3; IntAct=EBI-11952764, EBI-714158;
CC       Q99081-3; O43741: PRKAB2; NbExp=3; IntAct=EBI-11952764, EBI-1053424;
CC       Q99081; P25786: PSMA1; NbExp=4; IntAct=EBI-722877, EBI-359352;
CC       Q99081; P47897: QARS; NbExp=4; IntAct=EBI-722877, EBI-347462;
CC       Q99081; P47897-2: QARS; NbExp=3; IntAct=EBI-722877, EBI-10209725;
CC       Q99081-3; Q9Y5S9: RBM8A; NbExp=3; IntAct=EBI-11952764, EBI-447231;
CC       Q99081; Q1RLL8: RNASEL; NbExp=3; IntAct=EBI-722877, EBI-10239181;
CC       Q99081-3; Q06455-4: RUNX1T1; NbExp=2; IntAct=EBI-11952764, EBI-10224192;
CC       Q99081-3; O14796: SH2D1B; NbExp=3; IntAct=EBI-11952764, EBI-3923013;
CC       Q99081; Q9NZD8: SPG21; NbExp=4; IntAct=EBI-722877, EBI-742688;
CC       Q99081; P30626: SRI; NbExp=3; IntAct=EBI-722877, EBI-750459;
CC       Q99081; P42229: STAT5A; NbExp=3; IntAct=EBI-722877, EBI-749537;
CC       Q99081; O75716: STK16; NbExp=3; IntAct=EBI-722877, EBI-749295;
CC       Q99081; P17542: TAL1; NbExp=4; IntAct=EBI-722877, EBI-1753878;
CC       Q99081-3; Q8IYX1: TBC1D21; NbExp=3; IntAct=EBI-11952764, EBI-12018146;
CC       Q99081-3; O43680: TCF21; NbExp=3; IntAct=EBI-11952764, EBI-723267;
CC       Q99081-3; Q7RTU1: TCF23; NbExp=3; IntAct=EBI-11952764, EBI-12127592;
CC       Q99081; Q6ZMU5: TRIM72; NbExp=3; IntAct=EBI-722877, EBI-2341648;
CC       Q99081-3; Q6ZMU5: TRIM72; NbExp=3; IntAct=EBI-11952764, EBI-2341648;
CC       Q99081; Q99598: TSNAX; NbExp=3; IntAct=EBI-722877, EBI-742638;
CC       Q99081-3; Q99598: TSNAX; NbExp=3; IntAct=EBI-11952764, EBI-742638;
CC       Q99081-3; Q9UNY4-2: TTF2; NbExp=3; IntAct=EBI-11952764, EBI-11980463;
CC       Q99081; Q8WVJ9: TWIST2; NbExp=3; IntAct=EBI-722877, EBI-1797313;
CC       Q99081-3; Q8WVJ9: TWIST2; NbExp=3; IntAct=EBI-11952764, EBI-1797313;
CC       Q99081; Q548N1: VPS28; NbExp=3; IntAct=EBI-722877, EBI-10243107;
CC       Q99081-3; Q9UK41: VPS28; NbExp=3; IntAct=EBI-11952764, EBI-727424;
CC       Q99081-3; Q15007: WTAP; NbExp=3; IntAct=EBI-11952764, EBI-751647;
CC       Q99081-3; A0A0S2Z6P0: ZNF688; NbExp=3; IntAct=EBI-11952764, EBI-16429989;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=a;
CC         IsoId=Q99081-1; Sequence=Displayed;
CC       Name=2; Synonyms=b;
CC         IsoId=Q99081-2; Sequence=VSP_039109, VSP_039110;
CC       Name=3; Synonyms=c;
CC         IsoId=Q99081-3; Sequence=VSP_040024;
CC       Name=4;
CC         IsoId=Q99081-4; Sequence=VSP_057419, VSP_057420;
CC   -!- TISSUE SPECIFICITY: Expressed in several tissues and cell types
CC       including skeletal muscle, thymus, and a B-cell line.
CC   -!- DOMAIN: the 9aaTAD motif is a transactivation domain present in a large
CC       number of yeast and animal transcription factors.
CC       {ECO:0000269|PubMed:17467953}.
CC   -!- DISEASE: Craniosynostosis 3 (CRS3) [MIM:615314]: A primary abnormality
CC       of skull growth involving premature fusion of one or more cranial
CC       sutures. The growth velocity of the skull often cannot match that of
CC       the developing brain resulting in an abnormal head shape and, in some
CC       cases, increased intracranial pressure, which must be treated promptly
CC       to avoid permanent neurodevelopmental disability.
CC       {ECO:0000269|PubMed:23354436, ECO:0000269|PubMed:25271085}. Note=The
CC       disease is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/TCF12ID406.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M83233; AAB62389.1; -; mRNA.
DR   EMBL; M80627; AAA58632.1; -; mRNA.
DR   EMBL; AL831981; CAD89914.1; -; mRNA.
DR   EMBL; AK304007; BAG64923.1; -; mRNA.
DR   EMBL; BX537967; CAD97931.1; -; mRNA.
DR   EMBL; AC010999; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC016525; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC090511; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC090532; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF456057; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471082; EAW77512.1; -; Genomic_DNA.
DR   EMBL; BC050556; AAH50556.1; -; mRNA.
DR   EMBL; M65209; AAC37571.1; -; mRNA.
DR   EMBL; BK001049; DAA01129.1; -; mRNA.
DR   CCDS; CCDS10159.1; -. [Q99081-1]
DR   CCDS; CCDS10160.1; -. [Q99081-3]
DR   CCDS; CCDS42042.1; -. [Q99081-2]
DR   CCDS; CCDS76761.1; -. [Q99081-4]
DR   PIR; A42121; A42121.
DR   RefSeq; NP_001293149.1; NM_001306220.2. [Q99081-4]
DR   RefSeq; NP_001309080.1; NM_001322151.1. [Q99081-3]
DR   RefSeq; NP_001309086.1; NM_001322157.1. [Q99081-1]
DR   RefSeq; NP_001309088.1; NM_001322159.1. [Q99081-3]
DR   RefSeq; NP_001309091.1; NM_001322162.1. [Q99081-3]
DR   RefSeq; NP_001309094.1; NM_001322165.1. [Q99081-1]
DR   RefSeq; NP_003196.1; NM_003205.3. [Q99081-1]
DR   RefSeq; NP_996919.1; NM_207036.1. [Q99081-3]
DR   RefSeq; NP_996920.1; NM_207037.1. [Q99081-3]
DR   RefSeq; NP_996921.1; NM_207038.1. [Q99081-1]
DR   RefSeq; NP_996923.1; NM_207040.1. [Q99081-2]
DR   PDB; 2KNH; NMR; -; B=11-28.
DR   PDB; 4JOL; X-ray; 2.91 A; E/F/G/H=177-200.
DR   PDBsum; 2KNH; -.
DR   PDBsum; 4JOL; -.
DR   SMR; Q99081; -.
DR   BioGrid; 112798; 85.
DR   CORUM; Q99081; -.
DR   DIP; DIP-29403N; -.
DR   IntAct; Q99081; 99.
DR   MINT; Q99081; -.
DR   STRING; 9606.ENSP00000388940; -.
DR   iPTMnet; Q99081; -.
DR   PhosphoSitePlus; Q99081; -.
DR   BioMuta; TCF12; -.
DR   DMDM; 1708332; -.
DR   EPD; Q99081; -.
DR   jPOST; Q99081; -.
DR   MassIVE; Q99081; -.
DR   MaxQB; Q99081; -.
DR   PaxDb; Q99081; -.
DR   PeptideAtlas; Q99081; -.
DR   PRIDE; Q99081; -.
DR   ProteomicsDB; 5790; -.
DR   ProteomicsDB; 78231; -. [Q99081-1]
DR   ProteomicsDB; 78232; -. [Q99081-2]
DR   ProteomicsDB; 78233; -. [Q99081-3]
DR   Antibodypedia; 913; 367 antibodies.
DR   DNASU; 6938; -.
DR   Ensembl; ENST00000267811; ENSP00000267811; ENSG00000140262. [Q99081-1]
DR   Ensembl; ENST00000333725; ENSP00000331057; ENSG00000140262. [Q99081-3]
DR   Ensembl; ENST00000343827; ENSP00000342459; ENSG00000140262. [Q99081-2]
DR   Ensembl; ENST00000438423; ENSP00000388940; ENSG00000140262. [Q99081-3]
DR   Ensembl; ENST00000537840; ENSP00000444696; ENSG00000140262. [Q99081-4]
DR   Ensembl; ENST00000557843; ENSP00000453737; ENSG00000140262. [Q99081-1]
DR   GeneID; 6938; -.
DR   KEGG; hsa:6938; -.
DR   UCSC; uc002aea.4; human. [Q99081-1]
DR   UCSC; uc010ugo.3; human.
DR   CTD; 6938; -.
DR   DisGeNET; 6938; -.
DR   GeneCards; TCF12; -.
DR   HGNC; HGNC:11623; TCF12.
DR   HPA; ENSG00000140262; Tissue enhanced (lymphoid).
DR   MalaCards; TCF12; -.
DR   MIM; 600480; gene.
DR   MIM; 615314; phenotype.
DR   neXtProt; NX_Q99081; -.
DR   OpenTargets; ENSG00000140262; -.
DR   Orphanet; 209916; Extraskeletal myxoid chondrosarcoma.
DR   Orphanet; 35099; Isolated brachycephaly.
DR   Orphanet; 35098; Isolated plagiocephaly.
DR   PharmGKB; PA36381; -.
DR   eggNOG; KOG3910; Eukaryota.
DR   eggNOG; ENOG410XYUA; LUCA.
DR   GeneTree; ENSGT00940000155047; -.
DR   HOGENOM; CLU_021099_2_0_1; -.
DR   InParanoid; Q99081; -.
DR   KO; K15603; -.
DR   OMA; SSRGRTX; -.
DR   OrthoDB; 571132at2759; -.
DR   PhylomeDB; Q99081; -.
DR   TreeFam; TF321672; -.
DR   Reactome; R-HSA-525793; Myogenesis.
DR   Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   SIGNOR; Q99081; -.
DR   ChiTaRS; TCF12; human.
DR   EvolutionaryTrace; Q99081; -.
DR   GeneWiki; TCF12; -.
DR   GenomeRNAi; 6938; -.
DR   Pharos; Q99081; Tbio.
DR   PRO; PR:Q99081; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   RNAct; Q99081; protein.
DR   Bgee; ENSG00000140262; Expressed in corpus callosum and 235 other tissues.
DR   ExpressionAtlas; Q99081; baseline and differential.
DR   Genevisible; Q99081; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0000790; C:nuclear chromatin; IDA:BHF-UCL.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:LIFEdb.
DR   GO; GO:0090575; C:RNA polymerase II transcription factor complex; IDA:BHF-UCL.
DR   GO; GO:0005667; C:transcription factor complex; IBA:GO_Central.
DR   GO; GO:0043425; F:bHLH transcription factor binding; IPI:BHF-UCL.
DR   GO; GO:0035497; F:cAMP response element binding; IEA:Ensembl.
DR   GO; GO:0035326; F:cis-regulatory region binding; IC:BHF-UCL.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IDA:NTNU_SB.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IDA:BHF-UCL.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISA:NTNU_SB.
DR   GO; GO:0070888; F:E-box binding; IEA:Ensembl.
DR   GO; GO:0071837; F:HMG box domain binding; IEA:Ensembl.
DR   GO; GO:0046982; F:protein heterodimerization activity; IBA:GO_Central.
DR   GO; GO:0042803; F:protein homodimerization activity; IBA:GO_Central.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0046332; F:SMAD binding; IPI:BHF-UCL.
DR   GO; GO:0008134; F:transcription factor binding; IPI:BHF-UCL.
DR   GO; GO:0006955; P:immune response; TAS:ProtInc.
DR   GO; GO:0007517; P:muscle organ development; TAS:ProtInc.
DR   GO; GO:0045666; P:positive regulation of neuron differentiation; IBA:GO_Central.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:NTNU_SB.
DR   GO; GO:1902036; P:regulation of hematopoietic stem cell differentiation; TAS:Reactome.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; TAS:ProtInc.
DR   CDD; cd00083; HLH; 1.
DR   Gene3D; 4.10.280.10; -; 1.
DR   InterPro; IPR011598; bHLH_dom.
DR   InterPro; IPR036638; HLH_DNA-bd_sf.
DR   Pfam; PF00010; HLH; 1.
DR   SMART; SM00353; HLH; 1.
DR   SUPFAM; SSF47459; SSF47459; 1.
DR   PROSITE; PS50888; BHLH; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Craniosynostosis;
KW   Developmental protein; Differentiation; Disease mutation; DNA-binding;
KW   Isopeptide bond; Neurogenesis; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transcription; Transcription regulation;
KW   Ubl conjugation.
FT   CHAIN           1..682
FT                   /note="Transcription factor 12"
FT                   /id="PRO_0000127228"
FT   DOMAIN          577..630
FT                   /note="bHLH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00981"
FT   REGION          119..140
FT                   /note="Leucine-zipper"
FT   REGION          182..196
FT                   /note="Interaction with RUNX1T1"
FT                   /evidence="ECO:0000269|PubMed:23812588"
FT   REGION          632..655
FT                   /note="Class A specific domain"
FT   MOTIF           19..27
FT                   /note="9aaTAD"
FT   MOD_RES         47
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         67
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         79
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         98
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         116
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         313
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         333
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         540
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         557
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:19690332"
FT   MOD_RES         558
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         559
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163"
FT   CROSSLNK        110
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        181
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        519
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:28112733"
FT   CROSSLNK        550
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25218447"
FT   CROSSLNK        609
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        653
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   VAR_SEQ         1..170
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_039109"
FT   VAR_SEQ         1..39
FT                   /note="MNPQQQRMAAIGTDKELSDLLDFSAMFSPPVNSGKTRPT -> MGKRYMHHP
FT                   QIQMISTVNLLVIHLLSHQPVCSLALSLCK (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_057419"
FT   VAR_SEQ         40..275
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_057420"
FT   VAR_SEQ         171..193
FT                   /note="DSAALDPLQAKKVRKVPPGLPSS -> MYCAYPVPGMGSNSLMYYYNGKT
FT                   (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_039110"
FT   VAR_SEQ         396
FT                   /note="L -> LKNRVEQQLHEHLQDAMSFLKDVCE (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_040024"
FT   VARIANT         300
FT                   /note="G -> S (in dbSNP:rs12442879)"
FT                   /id="VAR_049543"
FT   VARIANT         483
FT                   /note="L -> R (in CRS3; dbSNP:rs36060670)"
FT                   /evidence="ECO:0000269|PubMed:25271085"
FT                   /id="VAR_072271"
FT   VARIANT         600
FT                   /note="L -> P (in CRS3)"
FT                   /evidence="ECO:0000269|PubMed:23354436"
FT                   /id="VAR_070096"
FT   VARIANT         614
FT                   /note="Q -> E (in CRS3; dbSNP:rs886037641)"
FT                   /evidence="ECO:0000269|PubMed:23354436"
FT                   /id="VAR_070097"
FT   MUTAGEN         187
FT                   /note="P->A: Decreases interaction with RUNX1T1."
FT                   /evidence="ECO:0000269|PubMed:23812588"
FT   MUTAGEN         191
FT                   /note="P->A: Decreases interaction with RUNX1T1."
FT                   /evidence="ECO:0000269|PubMed:23812588"
FT   MUTAGEN         192
FT                   /note="S->A: Decreases interaction with RUNX1T1."
FT                   /evidence="ECO:0000269|PubMed:23812588"
FT   CONFLICT        523
FT                   /note="K -> E (in Ref. 4; CAD89914)"
FT                   /evidence="ECO:0000305"
FT   HELIX           15..18
FT                   /evidence="ECO:0000244|PDB:2KNH"
FT   TURN            24..26
FT                   /evidence="ECO:0000244|PDB:2KNH"
SQ   SEQUENCE   682 AA;  72965 MW;  9736113D9361D3F5 CRC64;
     MNPQQQRMAA IGTDKELSDL LDFSAMFSPP VNSGKTRPTT LGSSQFSGSG IDERGGTTSW
     GTSGQPSPSY DSSRGFTDSP HYSDHLNDSR LGAHEGLSPT PFMNSNLMGK TSERGSFSLY
     SRDTGLPGCQ SSLLRQDLGL GSPAQLSSSG KPGTAYYSFS ATSSRRRPLH DSAALDPLQA
     KKVRKVPPGL PSSVYAPSPN SDDFNRESPS YPSPKPPTSM FASTFFMQDG THNSSDLWSS
     SNGMSQPGFG GILGTSTSHM SQSSSYGNLH SHDRLSYPPH SVSPTDINTS LPPMSSFHRG
     STSSSPYVAA SHTPPINGSD SILGTRGNAA GSSQTGDALG KALASIYSPD HTSSSFPSNP
     STPVGSPSPL TGTSQWPRPG GQAPSSPSYE NSLHSLQSRM EDRLDRLDDA IHVLRNHAVG
     PSTSLPAGHS DIHSLLGPSH NAPIGSLNSN YGGSSLVASS RSASMVGTHR EDSVSLNGNH
     SVLSSTVTTS STDLNHKTQE NYRGGLQSQS GTVVTTEIKT ENKEKDENLH EPPSSDDMKS
     DDESSQKDIK VSSRGRTSST NEDEDLNPEQ KIEREKERRM ANNARERLRV RDINEAFKEL
     GRMCQLHLKS EKPQTKLLIL HQAVAVILSL EQQVRERNLN PKAACLKRRE EEKVSAVSAE
     PPTTLPGTHP GLSETTNPMG HM
//
ID   Q05BK6_HUMAN            Unreviewed;       366 AA.
AC   Q05BK6;
DT   14-NOV-2006, integrated into UniProtKB/TrEMBL.
DT   14-NOV-2006, sequence version 1.
DT   22-APR-2020, entry version 86.
DE   SubName: Full=TFG protein {ECO:0000313|EMBL:AAH41600.1};
GN   Name=TFG {ECO:0000313|EMBL:AAH41600.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH41600.1};
RN   [1] {ECO:0000313|EMBL:AAH41600.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain {ECO:0000313|EMBL:AAH41600.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M., Peck A.M.,
RA   Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S., Feolo M.,
RA   Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F., Schaefer C.F.,
RA   Buetow K., Bonner T.I., Haussler D., Kent J., Kiekhaus M., Furey T.,
RA   Brent M., Prange C., Schreiber K., Shapiro N., Bhat N.K., Hopkins R.F.,
RA   Hsie F., Driscoll T., Soares M.B., Casavant T.L., Scheetz T.E.,
RA   Brown-stein M.J., Usdin T.B., Toshiyuki S., Carninci P., Piao Y.,
RA   Dudekula D.B., Ko M.S., Kawakami K., Suzuki Y., Sugano S., Gruber C.E.,
RA   Smith M.R., Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y.,
RA   Wei C.L., Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W.,
RA   Fuh E., Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D., Granite S.J.,
RA   Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G., Blakesly R.W.,
RA   Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J.,
RA   Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L., Krzywinski M.I.,
RA   Liao N., Morin R., Morrin R., Palmquist D., Petrescu A.S., Skalska U.,
RA   Smailus D.E., Stott J.M., Schnerch A., Schein J.E., Jones S.J., Holt R.A.,
RA   Baross A., Marra M.A., Clifton S., Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [3] {ECO:0000213|PubMed:19413330}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [4] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [5] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Burckstummer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [6] {ECO:0000213|PubMed:22223895}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [7] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [8] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC041600; AAH41600.1; -; mRNA.
DR   RefSeq; NP_001182408.1; NM_001195479.1.
DR   IntAct; Q05BK6; 2.
DR   MetOSite; Q05BK6; -.
DR   MaxQB; Q05BK6; -.
DR   PeptideAtlas; Q05BK6; -.
DR   PRIDE; Q05BK6; -.
DR   ProteomicsDB; 58371; -.
DR   DNASU; 10342; -.
DR   GeneID; 10342; -.
DR   UCSC; uc062lzu.1; human.
DR   CTD; 10342; -.
DR   EuPathDB; HostDB:ENSG00000114354.12; -.
DR   eggNOG; ENOG410IH8P; Eukaryota.
DR   eggNOG; ENOG410Z8FQ; LUCA.
DR   HOGENOM; CLU_756394_0_0_1; -.
DR   ChiTaRS; TFG; human.
DR   GenomeRNAi; 10342; -.
DR   Bgee; ENSG00000114354; Expressed in secondary oocyte and 220 other tissues.
DR   GO; GO:0000139; C:Golgi membrane; IEA:GOC.
DR   GO; GO:0042802; F:identical protein binding; IEA:InterPro.
DR   GO; GO:0048208; P:COPII vesicle coating; IEA:InterPro.
DR   CDD; cd06401; PB1_TFG; 1.
DR   InterPro; IPR000270; PB1_dom.
DR   InterPro; IPR034857; PB1_TFG.
DR   InterPro; IPR033512; TFG.
DR   PANTHER; PTHR15335; PTHR15335; 1.
DR   Pfam; PF00564; PB1; 1.
DR   SMART; SM00666; PB1; 1.
DR   PROSITE; PS51745; PB1; 1.
PE   1: Evidence at protein level;
FT   DOMAIN          10..91
FT                   /note="PB1"
FT                   /evidence="ECO:0000259|PROSITE:PS51745"
FT   REGION          120..160
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          187..236
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        206..220
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   366 AA;  40691 MW;  AC0BD52B2DAD48F3 CRC64;
     MNGQLDLSGK LIIKAQLGED IRRIPIHNED ITYDELVLMM QRVFRGKLLS NDEVTIKYKD
     EDGDLITIFD SSDLSFAIQC SRILKLTLFV NGQPRPLESS QVKYLRRELI ELRNKVNRLL
     DSLEPPGEPG PSTNIPENDT VDGREEKSAS DSSGKQSTQV MAASMSAFDP LKNQDEINKN
     VMSAFGLTDD QVSGPPSAPA EDRSGTPDSI ASSSSAAHPP GVQPQQPPYT GAQTQAGQMY
     QQYSNRPAMV HSSRRLHLSS LNSMVFSIQQ AIVSRLDLNN LSSSRDMASN QLPRHQLLPF
     LVSLNNCLLS RHSSTRRAII LHKLTLPKLL SLLIILWLLP LNLEWLQANL GPINQDQVLL
     HFLEVP
//
ID   TFG_HUMAN               Reviewed;         400 AA.
AC   Q92734; D3DN49; G5E9V1; K0J5S8; K0J6K2; Q15656; Q969I2;
DT   02-FEB-2004, integrated into UniProtKB/Swiss-Prot.
DT   10-FEB-2009, sequence version 2.
DT   22-APR-2020, entry version 181.
DE   RecName: Full=Protein TFG;
DE   AltName: Full=TRK-fused gene protein;
GN   Name=TFG;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Pancreas;
RX   PubMed=9169129; DOI=10.1006/geno.1997.4625;
RA   Mencinger M., Panagopoluos I., Andreasson P., Lassen C., Mitelman F.,
RA   Aman P.;
RT   "Characterization and chromosomal mapping of the human TFG gene involved in
RT   thyroid carcinoma.";
RL   Genomics 41:327-331(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3 AND 4), VARIANT HMSNO LEU-285, AND
RP   ALTERNATIVE SPLICING.
RX   PubMed=22883144; DOI=10.1016/j.ajhg.2012.07.014;
RA   Ishiura H., Sako W., Yoshida M., Kawarai T., Tanabe O., Goto J.,
RA   Takahashi Y., Date H., Mitsui J., Ahsan B., Ichikawa Y., Iwata A.,
RA   Yoshino H., Izumi Y., Fujita K., Maeda K., Goto S., Koizumi H.,
RA   Morigaki R., Ikemura M., Yamauchi N., Murayama S., Nicholson G.A., Ito H.,
RA   Sobue G., Nakagawa M., Kaji R., Tsuji S.;
RT   "The TRK-fused gene is mutated in hereditary motor and sensory neuropathy
RT   with proximal dominant involvement.";
RL   Am. J. Hum. Genet. 91:320-329(2012).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, Placenta, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-193, AND CHROMOSOMAL TRANSLOCATION WITH
RP   NTRK1.
RX   PubMed=7565764; DOI=10.1128/mcb.15.11.6118;
RA   Greco A., Mariani C., Miranda C., Lupas A., Pagliardini S., Pomati M.,
RA   Pierotti M.A.;
RT   "The DNA rearrangement that generates the TRK-T3 oncogene involves a novel
RT   gene on chromosome 3 whose product has a potential coiled-coil domain.";
RL   Mol. Cell. Biol. 15:6118-6127(1995).
RN   [10]
RP   PROTEIN SEQUENCE OF 1-10; 15-22; 24-42 AND 48-57, ACETYLATION AT MET-1, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RA   Bienvenut W.V., Calvo F., Kolch W.;
RL   Submitted (FEB-2008) to UniProtKB.
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-197, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-197, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH SEC16B.
RX   PubMed=21478858; DOI=10.1038/ncb2225;
RA   Witte K., Schuh A.L., Hegermann J., Sarkeshik A., Mayers J.R., Schwarze K.,
RA   Yates J.R. III, Eimer S., Audhya A.;
RT   "TFG-1 function in protein secretion and oncogenesis.";
RL   Nat. Cell Biol. 13:550-558(2011).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-50 AND SER-197, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   FUNCTION, SUBUNIT, VARIANT SPG57 CYS-106, AND CHARACTERIZATION OF VARIANT
RP   SPG57 CYS-106.
RX   PubMed=23479643; DOI=10.1073/pnas.1217197110;
RA   Beetz C., Johnson A., Schuh A.L., Thakur S., Varga R.E., Fothergill T.,
RA   Hertel N., Bomba-Warczak E., Thiele H., Nurnberg G., Altmuller J.,
RA   Saxena R., Chapman E.R., Dent E.W., Nurnberg P., Audhya A.;
RT   "Inhibition of TFG function causes hereditary axon degeneration by
RT   impairing endoplasmic reticulum structure.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:5091-5096(2013).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-197, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [20]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-385 AND ARG-400, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [21]
RP   VARIANT [LARGE SCALE ANALYSIS] SER-149.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
RN   [22]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH PDCD6, CHARACTERIZATION OF
RP   VARIANT SPG57 CYS-106, AND CHARACTERIZATION OF VARIANT HMSNO LEU-285.
RX   PubMed=27813252; DOI=10.1111/febs.13949;
RA   Kanadome T., Shibata H., Kuwata K., Takahara T., Maki M.;
RT   "The calcium-binding protein ALG-2 promotes endoplasmic reticulum exit site
RT   localization and polymerization of Trk-fused gene (TFG) protein.";
RL   FEBS J. 284:56-76(2017).
RN   [23]
RP   VARIANTS SPG57 CYS-106 AND HIS-106, AND CHARACTERIZATION OF VARIANTS SPG57
RP   CYS-106 AND HIS-106.
RX   PubMed=27492651; DOI=10.1002/humu.23060;
RA   Harlalka G.V., McEntagart M.E., Gupta N., Skrzypiec A.E., Mucha M.W.,
RA   Chioza B.A., Simpson M.A., Sreekantan-Nair A., Pereira A., Guenther S.,
RA   Jahic A., Modarres H., Moore-Barton H., Trembath R.C., Kabra M.,
RA   Baple E.L., Thakur S., Patton M.A., Beetz C., Pawlak R., Crosby A.H.;
RT   "Novel genetic, clinical, and pathomechanistic insights into TFG-associated
RT   hereditary spastic paraplegia.";
RL   Hum. Mutat. 37:1157-1161(2016).
RN   [24]
RP   VARIANT SPG57 PRO-107.
RX   PubMed=30237576; DOI=10.1038/s41436-018-0138-x;
RA   Maddirevula S., Alzahrani F., Al-Owain M., Al Muhaizea M.A., Kayyali H.R.,
RA   AlHashem A., Rahbeeni Z., Al-Otaibi M., Alzaidan H.I., Balobaid A.,
RA   El Khashab H.Y., Bubshait D.K., Faden M., Yamani S.A., Dabbagh O.,
RA   Al-Mureikhi M., Jasser A.A., Alsaif H.S., Alluhaydan I., Seidahmed M.Z.,
RA   Alabbasi B.H., Almogarri I., Kurdi W., Akleh H., Qari A., Al Tala S.M.,
RA   Alhomaidi S., Kentab A.Y., Salih M.A., Chedrawi A., Alameer S., Tabarki B.,
RA   Shamseldin H.E., Patel N., Ibrahim N., Abdulwahab F., Samira M., Goljan E.,
RA   Abouelhoda M., Meyer B.F., Hashem M., Shaheen R., AlShahwan S.,
RA   Alfadhel M., Ben-Omran T., Al-Qattan M.M., Monies D., Alkuraya F.S.;
RT   "Autozygome and high throughput confirmation of disease genes candidacy.";
RL   Genet. Med. 21:736-742(2019).
CC   -!- FUNCTION: Plays a role in the normal dynamic function of the
CC       endoplasmic reticulum (ER) and its associated microtubules
CC       (PubMed:23479643, PubMed:27813252). Required for secretory cargo
CC       traffic from the endoplasmic reticulum to the Golgi apparatus
CC       (PubMed:21478858). {ECO:0000269|PubMed:21478858,
CC       ECO:0000269|PubMed:23479643, ECO:0000269|PubMed:27813252}.
CC   -!- SUBUNIT: Self-associates to form an oligomeric complex
CC       (PubMed:23479643). Interacts with PDCD6; promoting localization and
CC       polymerization of TFG at endoplasmic reticulum exit site
CC       (PubMed:27813252). Interacts with SEC16B (PubMed:21478858).
CC       {ECO:0000269|PubMed:21478858, ECO:0000269|PubMed:23479643,
CC       ECO:0000269|PubMed:27813252}.
CC   -!- INTERACTION:
CC       Q92734; Q92734; NbExp=7; IntAct=EBI-357061, EBI-357061;
CC       Q92734; P50995: ANXA11; NbExp=4; IntAct=EBI-357061, EBI-715243;
CC       Q92734; Q5T0G8: ANXA11; NbExp=3; IntAct=EBI-357061, EBI-10245225;
CC       Q92734; Q5VV41: ARHGEF16; NbExp=3; IntAct=EBI-357061, EBI-1057448;
CC       Q92734; Q8N9W6: BOLL; NbExp=4; IntAct=EBI-357061, EBI-998198;
CC       Q92734; Q8N9W6-4: BOLL; NbExp=3; IntAct=EBI-357061, EBI-11983447;
CC       Q92734; Q9NP55: BPIFA1; NbExp=3; IntAct=EBI-357061, EBI-953896;
CC       Q92734; Q5BKX5-3: C19orf54; NbExp=3; IntAct=EBI-357061, EBI-11976299;
CC       Q92734; Q53EZ4: CEP55; NbExp=6; IntAct=EBI-357061, EBI-747776;
CC       Q92734; O43186: CRX; NbExp=3; IntAct=EBI-357061, EBI-748171;
CC       Q92734; P33240: CSTF2; NbExp=6; IntAct=EBI-357061, EBI-711360;
CC       Q92734; Q15038: DAZAP2; NbExp=5; IntAct=EBI-357061, EBI-724310;
CC       Q92734; Q92997: DVL3; NbExp=3; IntAct=EBI-357061, EBI-739789;
CC       Q92734; Q01844: EWSR1; NbExp=3; IntAct=EBI-357061, EBI-739737;
CC       Q92734; O00167-2: EYA2; NbExp=3; IntAct=EBI-357061, EBI-12807776;
CC       Q92734; Q92567-2: FAM168A; NbExp=3; IntAct=EBI-357061, EBI-11978259;
CC       Q92734; O75593: FOXH1; NbExp=3; IntAct=EBI-357061, EBI-1759806;
CC       Q92734; A0A0S2Z4Q4: HGS; NbExp=3; IntAct=EBI-357061, EBI-16429135;
CC       Q92734; O14964: HGS; NbExp=3; IntAct=EBI-357061, EBI-740220;
CC       Q92734; P52597: HNRNPF; NbExp=3; IntAct=EBI-357061, EBI-352986;
CC       Q92734; Q0VD86: INCA1; NbExp=3; IntAct=EBI-357061, EBI-6509505;
CC       Q92734; Q5TA45: INTS11; NbExp=3; IntAct=EBI-357061, EBI-748258;
CC       Q92734; Q6PEX3: KRTAP26-1; NbExp=3; IntAct=EBI-357061, EBI-3957672;
CC       Q92734; Q14847-2: LASP1; NbExp=3; IntAct=EBI-357061, EBI-9088686;
CC       Q92734; Q96PV6: LENG8; NbExp=3; IntAct=EBI-357061, EBI-739546;
CC       Q92734; Q9Y5V3: MAGED1; NbExp=8; IntAct=EBI-357061, EBI-716006;
CC       Q92734; Q8NDC0: MAPK1IP1L; NbExp=6; IntAct=EBI-357061, EBI-741424;
CC       Q92734; Q71SY5: MED25; NbExp=3; IntAct=EBI-357061, EBI-394558;
CC       Q92734; Q8N6F8: METTL27; NbExp=3; IntAct=EBI-357061, EBI-8487781;
CC       Q92734; Q4VC12: MSS51; NbExp=3; IntAct=EBI-357061, EBI-11599933;
CC       Q92734; Q6IA69: NADSYN1; NbExp=3; IntAct=EBI-357061, EBI-748610;
CC       Q92734; Q8IV28: NID2; NbExp=3; IntAct=EBI-357061, EBI-10261509;
CC       Q92734; Q8TDS5: OXER1; NbExp=3; IntAct=EBI-357061, EBI-12813389;
CC       Q92734; Q9UBV8: PEF1; NbExp=6; IntAct=EBI-357061, EBI-724639;
CC       Q92734; Q99471: PFDN5; NbExp=3; IntAct=EBI-357061, EBI-357275;
CC       Q92734; O15496: PLA2G10; NbExp=3; IntAct=EBI-357061, EBI-726466;
CC       Q92734; Q58EX7: PLEKHG4; NbExp=3; IntAct=EBI-357061, EBI-949255;
CC       Q92734; O15162: PLSCR1; NbExp=2; IntAct=EBI-357061, EBI-740019;
CC       Q92734; Q16633: POU2AF1; NbExp=3; IntAct=EBI-357061, EBI-943588;
CC       Q92734; Q7Z5V6-2: PPP1R32; NbExp=3; IntAct=EBI-357061, EBI-12000762;
CC       Q92734; P86480: PRR20D; NbExp=3; IntAct=EBI-357061, EBI-12754095;
CC       Q92734; Q93062: RBPMS; NbExp=3; IntAct=EBI-357061, EBI-740322;
CC       Q92734; P78317: RNF4; NbExp=5; IntAct=EBI-357061, EBI-2340927;
CC       Q92734; O95486: SEC24A; NbExp=3; IntAct=EBI-357061, EBI-749911;
CC       Q92734; Q15428: SF3A2; NbExp=3; IntAct=EBI-357061, EBI-2462271;
CC       Q92734; Q15427: SF3B4; NbExp=3; IntAct=EBI-357061, EBI-348469;
CC       Q92734; Q53HV7-2: SMUG1; NbExp=3; IntAct=EBI-357061, EBI-12275818;
CC       Q92734; Q9NZD8: SPG21; NbExp=6; IntAct=EBI-357061, EBI-742688;
CC       Q92734; Q8IWL8: STH; NbExp=3; IntAct=EBI-357061, EBI-12843506;
CC       Q92734; O60806: TBX19; NbExp=3; IntAct=EBI-357061, EBI-12096770;
CC       Q92734; Q96LM6: TEX37; NbExp=3; IntAct=EBI-357061, EBI-743976;
CC       Q92734; Q5T6F2: UBAP2; NbExp=3; IntAct=EBI-357061, EBI-2514383;
CC       Q92734; Q7KZS0: UBE2I; NbExp=3; IntAct=EBI-357061, EBI-10180829;
CC       Q92734; A5D8V6: VPS37C; NbExp=6; IntAct=EBI-357061, EBI-2559305;
CC       Q92734; Q9NZC7-5: WWOX; NbExp=3; IntAct=EBI-357061, EBI-12040603;
CC       Q92734; Q9UJ78-2: ZMYM5; NbExp=3; IntAct=EBI-357061, EBI-17634549;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum
CC       {ECO:0000269|PubMed:27813252}. Note=Localizes to endoplasmic reticulum
CC       exit site (ERES), also known as transitional endoplasmic reticulum
CC       (tER) (PubMed:27813252, PubMed:21478858). {ECO:0000269|PubMed:21478858,
CC       ECO:0000269|PubMed:27813252}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q92734-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q92734-2; Sequence=VSP_047131;
CC       Name=3;
CC         IsoId=Q92734-3; Sequence=VSP_057414, VSP_057415;
CC       Name=4;
CC         IsoId=Q92734-4; Sequence=VSP_047131, VSP_057414, VSP_057415;
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- DISEASE: Note=A chromosomal aberration involving TFG is found in
CC       papillary thyroid carcinomas (PTCs). Translocation t(1;3)(q21;q11) with
CC       NTRK1. The TFG sequence is fused to the 3'-end of NTRK1 generating the
CC       TRKT3 (TRK-T3) fusion transcript. {ECO:0000269|PubMed:7565764}.
CC   -!- DISEASE: Neuropathy, hereditary motor and sensory, Okinawa type (HMSNO)
CC       [MIM:604484]: A neurodegenerative disorder characterized by young adult
CC       onset of proximal muscle weakness and atrophy, muscle cramps, and
CC       fasciculations, with later onset of distal sensory impairment. The
CC       disorder is slowly progressive and clinically resembles amyotrophic
CC       lateral sclerosis. {ECO:0000269|PubMed:22883144,
CC       ECO:0000269|PubMed:27813252}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Spastic paraplegia 57, autosomal recessive (SPG57)
CC       [MIM:615658]: A complicated form of spastic paraplegia, a
CC       neurodegenerative disorder characterized by a slow, gradual,
CC       progressive weakness and spasticity of the lower limbs. Rate of
CC       progression and the severity of symptoms are quite variable. Initial
CC       symptoms may include difficulty with balance, weakness and stiffness in
CC       the legs, muscle spasms, and dragging the toes when walking.
CC       Complicated forms are recognized by additional variable features
CC       including spastic quadriparesis, seizures, dementia, amyotrophy,
CC       extrapyramidal disturbance, cerebral or cerebellar atrophy, optic
CC       atrophy, and peripheral neuropathy, as well as by extra neurological
CC       manifestations. {ECO:0000269|PubMed:23479643,
CC       ECO:0000269|PubMed:27492651, ECO:0000269|PubMed:27813252,
CC       ECO:0000269|PubMed:30237576}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/TFGID281.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Y07968; CAA69264.1; -; mRNA.
DR   EMBL; AB731569; BAM48926.1; -; mRNA.
DR   EMBL; AB731570; BAM48927.1; -; mRNA.
DR   EMBL; AK093456; BAG52721.1; -; mRNA.
DR   EMBL; BT007428; AAP36096.1; -; mRNA.
DR   EMBL; CR456781; CAG33062.1; -; mRNA.
DR   EMBL; AC068763; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF457659; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF457666; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471052; EAW79813.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW79814.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW79815.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW79816.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW79817.1; -; Genomic_DNA.
DR   EMBL; BC001483; AAH01483.1; -; mRNA.
DR   EMBL; BC009241; AAH09241.1; -; mRNA.
DR   EMBL; BC023599; AAH23599.1; -; mRNA.
DR   EMBL; X85960; CAA59936.1; ALT_TERM; mRNA.
DR   CCDS; CCDS2939.1; -. [Q92734-1]
DR   CCDS; CCDS56266.1; -. [Q92734-2]
DR   RefSeq; NP_001007566.1; NM_001007565.2. [Q92734-1]
DR   RefSeq; NP_001182407.1; NM_001195478.1. [Q92734-1]
DR   RefSeq; NP_001182408.1; NM_001195479.1. [Q92734-2]
DR   RefSeq; NP_006061.2; NM_006070.5. [Q92734-1]
DR   RefSeq; XP_005247123.1; XM_005247066.1. [Q92734-2]
DR   RefSeq; XP_006713535.1; XM_006713472.1. [Q92734-1]
DR   RefSeq; XP_006713536.1; XM_006713473.1.
DR   RefSeq; XP_011510636.1; XM_011512334.1. [Q92734-1]
DR   RefSeq; XP_016861016.1; XM_017005527.1. [Q92734-2]
DR   RefSeq; XP_016861017.1; XM_017005528.1.
DR   RefSeq; XP_016861018.1; XM_017005529.1.
DR   RefSeq; XP_016861019.1; XM_017005530.1.
DR   SMR; Q92734; -.
DR   BioGrid; 115624; 141.
DR   IntAct; Q92734; 157.
DR   MINT; Q92734; -.
DR   STRING; 9606.ENSP00000240851; -.
DR   MoonDB; Q92734; Predicted.
DR   iPTMnet; Q92734; -.
DR   MetOSite; Q92734; -.
DR   PhosphoSitePlus; Q92734; -.
DR   SwissPalm; Q92734; -.
DR   BioMuta; TFG; -.
DR   DMDM; 223634676; -.
DR   EPD; Q92734; -.
DR   jPOST; Q92734; -.
DR   MassIVE; Q92734; -.
DR   MaxQB; Q92734; -.
DR   PaxDb; Q92734; -.
DR   PeptideAtlas; Q92734; -.
DR   PRIDE; Q92734; -.
DR   ProteomicsDB; 34050; -.
DR   ProteomicsDB; 75430; -. [Q92734-1]
DR   Antibodypedia; 15864; 308 antibodies.
DR   DNASU; 10342; -.
DR   Ensembl; ENST00000240851; ENSP00000240851; ENSG00000114354. [Q92734-1]
DR   Ensembl; ENST00000418917; ENSP00000397182; ENSG00000114354. [Q92734-2]
DR   Ensembl; ENST00000476228; ENSP00000417952; ENSG00000114354. [Q92734-2]
DR   Ensembl; ENST00000490574; ENSP00000419960; ENSG00000114354. [Q92734-1]
DR   Ensembl; ENST00000615993; ENSP00000479269; ENSG00000114354. [Q92734-3]
DR   Ensembl; ENST00000620299; ENSP00000479981; ENSG00000114354. [Q92734-3]
DR   GeneID; 10342; -.
DR   KEGG; hsa:10342; -.
DR   UCSC; uc003due.4; human. [Q92734-1]
DR   UCSC; uc031sau.2; human.
DR   CTD; 10342; -.
DR   DisGeNET; 10342; -.
DR   GeneCards; TFG; -.
DR   HGNC; HGNC:11758; TFG.
DR   HPA; ENSG00000114354; Low tissue specificity.
DR   MalaCards; TFG; -.
DR   MIM; 602498; gene.
DR   MIM; 604484; phenotype.
DR   MIM; 615658; phenotype.
DR   neXtProt; NX_Q92734; -.
DR   OpenTargets; ENSG00000114354; -.
DR   Orphanet; 435819; Autosomal dominant Charcot-Marie-Tooth disease type 2 due to TFG mutation.
DR   Orphanet; 431329; Autosomal recessive spastic paraplegia type 57.
DR   Orphanet; 146; Differentiated thyroid carcinoma.
DR   Orphanet; 209916; Extraskeletal myxoid chondrosarcoma.
DR   Orphanet; 90117; Hereditary motor and sensory neuropathy, Okinawa type.
DR   PharmGKB; PA36473; -.
DR   eggNOG; ENOG410IH8P; Eukaryota.
DR   eggNOG; ENOG410Z8FQ; LUCA.
DR   GeneTree; ENSGT00510000047809; -.
DR   HOGENOM; CLU_058059_2_0_1; -.
DR   InParanoid; Q92734; -.
DR   KO; K09292; -.
DR   OMA; MDGQVYQ; -.
DR   OrthoDB; 1379054at2759; -.
DR   PhylomeDB; Q92734; -.
DR   TreeFam; TF318743; -.
DR   Reactome; R-HSA-204005; COPII-mediated vesicle transport.
DR   SignaLink; Q92734; -.
DR   SIGNOR; Q92734; -.
DR   ChiTaRS; TFG; human.
DR   GeneWiki; TFG_(gene); -.
DR   GenomeRNAi; 10342; -.
DR   Pharos; Q92734; Tbio.
DR   PRO; PR:Q92734; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; Q92734; protein.
DR   Bgee; ENSG00000114354; Expressed in secondary oocyte and 220 other tissues.
DR   ExpressionAtlas; Q92734; baseline and differential.
DR   Genevisible; Q92734; HS.
DR   GO; GO:0005737; C:cytoplasm; NAS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070971; C:endoplasmic reticulum exit site; IDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IEA:GOC.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0048208; P:COPII vesicle coating; TAS:Reactome.
DR   GO; GO:0006888; P:endoplasmic reticulum to Golgi vesicle-mediated transport; IMP:UniProtKB.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; HMP:UniProtKB.
DR   CDD; cd06401; PB1_TFG; 1.
DR   InterPro; IPR000270; PB1_dom.
DR   InterPro; IPR034857; PB1_TFG.
DR   InterPro; IPR033512; TFG.
DR   PANTHER; PTHR15335; PTHR15335; 1.
DR   Pfam; PF00564; PB1; 1.
DR   SMART; SM00666; PB1; 1.
DR   PROSITE; PS51745; PB1; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Chromosomal rearrangement; Coiled coil;
KW   Direct protein sequencing; Disease mutation; Endoplasmic reticulum;
KW   ER-Golgi transport; Hereditary spastic paraplegia; Methylation;
KW   Neurodegeneration; Neuropathy; Phosphoprotein; Polymorphism;
KW   Proto-oncogene; Reference proteome; Transport.
FT   CHAIN           1..400
FT                   /note="Protein TFG"
FT                   /id="PRO_0000072500"
FT   DOMAIN          10..91
FT                   /note="PB1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01081"
FT   COILED          97..124
FT                   /evidence="ECO:0000255"
FT   SITE            193..194
FT                   /note="Breakpoint for translocation to form TRK-T3"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000244|PubMed:22223895, ECO:0000269|Ref.10"
FT   MOD_RES         50
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         197
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         385
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         400
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   VAR_SEQ         237..240
FT                   /note="Missing (in isoform 2 and isoform 4)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_047131"
FT   VAR_SEQ         274..284
FT                   /note="ASYSQQTGPQQ -> GFQSMERFHCK (in isoform 3 and isoform
FT                   4)"
FT                   /evidence="ECO:0000303|PubMed:22883144"
FT                   /id="VSP_057414"
FT   VAR_SEQ         285..400
FT                   /note="Missing (in isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:22883144"
FT                   /id="VSP_057415"
FT   VARIANT         106
FT                   /note="R -> C (in SPG57; defective self-assembly into an
FT                   oligomeric complex; impaired interaction with PDCD6; causes
FT                   mitochondrial fragmentation; dbSNP:rs587777175)"
FT                   /evidence="ECO:0000269|PubMed:23479643,
FT                   ECO:0000269|PubMed:27492651, ECO:0000269|PubMed:27813252"
FT                   /id="VAR_070986"
FT   VARIANT         106
FT                   /note="R -> H (in SPG57; causes mitochondrial
FT                   fragmentation; dbSNP:rs376971794)"
FT                   /evidence="ECO:0000269|PubMed:27492651"
FT                   /id="VAR_078075"
FT   VARIANT         107
FT                   /note="R -> P (in SPG57; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:30237576"
FT                   /id="VAR_082155"
FT   VARIANT         149
FT                   /note="A -> S (in a colorectal cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035668"
FT   VARIANT         211
FT                   /note="A -> V (in dbSNP:rs430945)"
FT                   /id="VAR_054322"
FT   VARIANT         285
FT                   /note="P -> L (in HMSNO; does not affect interaction with
FT                   PDCD6; dbSNP:rs207482230)"
FT                   /evidence="ECO:0000269|PubMed:22883144,
FT                   ECO:0000269|PubMed:27813252"
FT                   /id="VAR_068917"
FT   VARIANT         364
FT                   /note="T -> P (in dbSNP:rs6772054)"
FT                   /id="VAR_054323"
FT   CONFLICT        13
FT                   /note="I -> V (in Ref. 1; CAA69264 and 9; CAA59936)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   400 AA;  43448 MW;  D8A559D0F7314D1F CRC64;
     MNGQLDLSGK LIIKAQLGED IRRIPIHNED ITYDELVLMM QRVFRGKLLS NDEVTIKYKD
     EDGDLITIFD SSDLSFAIQC SRILKLTLFV NGQPRPLESS QVKYLRRELI ELRNKVNRLL
     DSLEPPGEPG PSTNIPENDT VDGREEKSAS DSSGKQSTQV MAASMSAFDP LKNQDEINKN
     VMSAFGLTDD QVSGPPSAPA EDRSGTPDSI ASSSSAAHPP GVQPQQPPYT GAQTQAGQIE
     GQMYQQYQQQ AGYGAQQPQA PPQQPQQYGI QYSASYSQQT GPQQPQQFQG YGQQPTSQAP
     APAFSGQPQQ LPAQPPQQYQ ASNYPAQTYT AQTSQPTNYT VAPASQPGMA PSQPGAYQPR
     PGFTSLPGST MTPPPSGPNP YARNRPPFGQ GYTQPGPGYR
//
ID   TMPS2_HUMAN             Reviewed;         492 AA.
AC   O15393; A8K6Z8; B2R8E5; B7Z459; D3DSJ2; F8WES1; Q6GTK7; Q9BXX1;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   03-OCT-2006, sequence version 3.
DT   22-APR-2020, entry version 188.
DE   RecName: Full=Transmembrane protease serine 2;
DE            EC=3.4.21.-;
DE   AltName: Full=Serine protease 10;
DE   Contains:
DE     RecName: Full=Transmembrane protease serine 2 non-catalytic chain;
DE   Contains:
DE     RecName: Full=Transmembrane protease serine 2 catalytic chain;
DE   Flags: Precursor;
GN   Name=TMPRSS2; Synonyms=PRSS10;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS MET-160 AND GLN-329.
RX   PubMed=9325052; DOI=10.1006/geno.1997.4845;
RA   Paoloni-Giacobino A., Chen H., Peitsch M.C., Rossier C., Antonarakis S.E.;
RT   "Cloning of the TMPRSS2 gene, which encodes a novel serine protease with
RT   transmembrane, LDLRA, and SRCR domains and maps to 21q22.3.";
RL   Genomics 44:309-320(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT MET-160.
RX   PubMed=11414763; DOI=10.1006/geno.2001.6551;
RA   Teng D.-H., Chen Y., Lian L., Ha P.C., Tavtigian S.V., Wong A.K.C.;
RT   "Mutation analyses of 268 candidate genes in human tumor cell lines.";
RL   Genomics 74:352-364(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), MUTAGENESIS OF SER-441, FUNCTION,
RP   AND SUBCELLULAR LOCATION.
RX   PubMed=11245484;
RA   Afar D.E.H., Vivanco I., Hubert R.S., Kuo J., Chen E., Saffran D.C.,
RA   Raitano A.B., Jakobovits A.;
RT   "Catalytic cleavage of the androgen-regulated TMPRSS2 protease results in
RT   its secretion by prostate and prostate cancer epithelia.";
RL   Cancer Res. 61:1686-1692(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Prostate, Testis, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10830953; DOI=10.1038/35012518;
RA   Hattori M., Fujiyama A., Taylor T.D., Watanabe H., Yada T., Park H.-S.,
RA   Toyoda A., Ishii K., Totoki Y., Choi D.-K., Groner Y., Soeda E., Ohki M.,
RA   Takagi T., Sakaki Y., Taudien S., Blechschmidt K., Polley A., Menzel U.,
RA   Delabar J., Kumpf K., Lehmann R., Patterson D., Reichwald K., Rump A.,
RA   Schillhabel M., Schudy A., Zimmermann W., Rosenthal A., Kudoh J.,
RA   Shibuya K., Kawasaki K., Asakawa S., Shintani A., Sasaki T., Nagamine K.,
RA   Mitsuyama S., Antonarakis S.E., Minoshima S., Shimizu N., Nordsiek G.,
RA   Hornischer K., Brandt P., Scharfe M., Schoen O., Desario A., Reichelt J.,
RA   Kauer G., Bloecker H., Ramser J., Beck A., Klages S., Hennig S.,
RA   Riesselmann L., Dagand E., Wehrmeyer S., Borzym K., Gardiner K.,
RA   Nizetic D., Francis F., Lehrach H., Reinhardt R., Yaspo M.-L.;
RT   "The DNA sequence of human chromosome 21.";
RL   Nature 405:311-319(2000).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=PNS;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   TISSUE SPECIFICITY.
RX   PubMed=11169526;
RX   DOI=10.1002/1096-9896(2000)9999:9999<::aid-path743>3.0.co;2-t;
RA   Vaarala M.H., Porvari K.S., Kellokumpu S., Kyllonen A.P., Vihko P.T.;
RT   "Expression of transmembrane serine protease TMPRSS2 in mouse and human
RT   tissues.";
RL   J. Pathol. 193:134-140(2001).
RN   [10]
RP   FUNCTION.
RX   PubMed=15537383; DOI=10.1042/bj20041066;
RA   Wilson S., Greer B., Hooper J., Zijlstra A., Walker B., Quigley J.,
RA   Hawthorne S.;
RT   "The membrane-anchored serine protease, TMPRSS2, activates PAR-2 in
RT   prostate cancer cells.";
RL   Biochem. J. 388:967-972(2005).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND GLYCOSYLATION.
RX   PubMed=20382709; DOI=10.2353/ajpath.2010.090665;
RA   Chen Y.W., Lee M.S., Lucht A., Chou F.P., Huang W., Havighurst T.C.,
RA   Kim K., Wang J.K., Antalis T.M., Johnson M.D., Lin C.Y.;
RT   "TMPRSS2, a serine protease expressed in the prostate on the apical surface
RT   of luminal epithelial cells and released into semen in prostasomes, is
RT   misregulated in prostate cancer cells.";
RL   Am. J. Pathol. 176:2986-2996(2010).
RN   [12]
RP   FUNCTION (MICROBIAL INFECTION), SUBCELLULAR LOCATION, AUTOCATALYTIC
RP   CLEAVAGE, AND INTERACTION WITH ACE2.
RX   PubMed=21068237; DOI=10.1128/jvi.02062-10;
RA   Shulla A., Heald-Sargent T., Subramanya G., Zhao J., Perlman S.,
RA   Gallagher T.;
RT   "A transmembrane serine protease is linked to the severe acute respiratory
RT   syndrome coronavirus receptor and activates virus entry.";
RL   J. Virol. 85:873-882(2011).
RN   [13]
RP   FUNCTION (MICROBIAL INFECTION), AND TISSUE SPECIFICITY.
RX   PubMed=21325420; DOI=10.1128/jvi.02232-10;
RA   Glowacka I., Bertram S., Muller M.A., Allen P., Soilleux E., Pfefferle S.,
RA   Steffen I., Tsegaye T.S., He Y., Gnirss K., Niemeyer D., Schneider H.,
RA   Drosten C., Pohlmann S.;
RT   "Evidence that TMPRSS2 activates the severe acute respiratory syndrome
RT   coronavirus spike protein for membrane fusion and reduces viral control by
RT   the humoral immune response.";
RL   J. Virol. 85:4122-4134(2011).
RN   [14]
RP   FUNCTION (MICROBIAL INFECTION).
RX   PubMed=23536651; DOI=10.1128/jvi.03372-12;
RA   Bertram S., Dijkman R., Habjan M., Heurich A., Gierer S., Glowacka I.,
RA   Welsch K., Winkler M., Schneider H., Hofmann-Winkler H., Thiel V.,
RA   Pohlmann S.;
RT   "TMPRSS2 activates the human coronavirus 229E for cathepsin-independent
RT   host cell entry and is expressed in viral target cells in the respiratory
RT   epithelium.";
RL   J. Virol. 87:6150-6160(2013).
RN   [15]
RP   FUNCTION (MICROBIAL INFECTION).
RX   PubMed=23966399; DOI=10.1128/jvi.01490-13;
RA   Abe M., Tahara M., Sakai K., Yamaguchi H., Kanou K., Shirato K., Kawase M.,
RA   Noda M., Kimura H., Matsuyama S., Fukuhara H., Mizuta K., Maenaka K.,
RA   Ami Y., Esumi M., Kato A., Takeda M.;
RT   "TMPRSS2 is an activating protease for respiratory parainfluenza viruses.";
RL   J. Virol. 87:11930-11935(2013).
RN   [16]
RP   FUNCTION (MICROBIAL INFECTION).
RX   PubMed=24027332; DOI=10.1128/jvi.01890-13;
RA   Shirato K., Kawase M., Matsuyama S.;
RT   "Middle East respiratory syndrome coronavirus infection mediated by the
RT   transmembrane serine protease TMPRSS2.";
RL   J. Virol. 87:12552-12561(2013).
RN   [17]
RP   FUNCTION (MICROBIAL INFECTION).
RX   PubMed=24227843; DOI=10.1128/jvi.02202-13;
RA   Heurich A., Hofmann-Winkler H., Gierer S., Liepold T., Jahn O.,
RA   Poehlmann S.;
RT   "TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by
RT   TMPRSS2 augments entry driven by the severe acute respiratory syndrome
RT   coronavirus spike protein.";
RL   J. Virol. 88:1293-1307(2014).
RN   [18]
RP   FUNCTION, AND INDUCTION.
RX   PubMed=25122198; DOI=10.1158/2159-8290.cd-13-1010;
RA   Lucas J.M., Heinlein C., Kim T., Hernandez S.A., Malik M.S., True L.D.,
RA   Morrissey C., Corey E., Montgomery B., Mostaghel E., Clegg N., Coleman I.,
RA   Brown C.M., Schneider E.L., Craik C., Simon J.A., Bedalov A., Nelson P.S.;
RT   "The androgen-regulated protease TMPRSS2 activates a proteolytic cascade
RT   involving components of the tumor microenvironment and promotes prostate
RT   cancer metastasis.";
RL   Cancer Discov. 4:1310-1325(2014).
RN   [19]
RP   FUNCTION.
RX   PubMed=26018085; DOI=10.1158/0008-5472.can-14-3297;
RA   Ko C.J., Huang C.C., Lin H.Y., Juan C.P., Lan S.W., Shyu H.Y., Wu S.R.,
RA   Hsiao P.W., Huang H.P., Shun C.T., Lee M.S.;
RT   "Androgen-Induced TMPRSS2 activates matriptase and promotes extracellular
RT   matrix degradation, prostate cancer cell invasion, tumor growth, and
RT   metastasis.";
RL   Cancer Res. 75:2949-2960(2015).
RN   [20]
RP   FUNCTION (MICROBIAL INFECTION).
RX   PubMed=32142651; DOI=10.1016/j.cell.2020.02.052;
RA   Hoffmann M., Kleine-Weber H., Schroeder S., Krueger N., Herrler T.,
RA   Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A.,
RA   Mueller M.A., Drosten C., Poehlmann S.;
RT   "SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a
RT   clinically proven protease inhibitor.";
RL   Cell 181:1-10(2020).
RN   [21]
RP   VARIANTS MET-160; CYS-254; GLN-329 AND ASN-491.
RX   PubMed=17918732; DOI=10.1002/humu.20617;
RA   Guipponi M., Toh M.-Y., Tan J., Park D., Hanson K., Ballana E., Kwong D.,
RA   Cannon P.Z.F., Wu Q., Gout A., Delorenzi M., Speed T.P., Smith R.J.H.,
RA   Dahl H.-H.M., Petersen M., Teasdale R.D., Estivill X., Park W.J.,
RA   Scott H.S.;
RT   "An integrated genetic and functional analysis of the role of type II
RT   transmembrane serine proteases (TMPRSSs) in hearing loss.";
RL   Hum. Mutat. 29:130-141(2008).
CC   -!- FUNCTION: Plasma membrane-anchored serine protease that participates in
CC       proteolytic cascades of relevance for the normal physiologic function
CC       of the prostate (PubMed:25122198). Androgen-induced TMPRSS2 activates
CC       several substrates that include pro-hepatocyte growth factor/HGF, the
CC       protease activated receptor-2/F2RL1 or matriptase/ST14 leading to
CC       extracellular matrix disruption and metastasis of prostate cancer cells
CC       (PubMed:15537383, PubMed:26018085, PubMed:25122198). In addition,
CC       activates trigeminal neurons and contribute to both spontaneous pain
CC       and mechanical allodynia (By similarity).
CC       {ECO:0000250|UniProtKB:Q9JIQ8, ECO:0000269|PubMed:15537383,
CC       ECO:0000269|PubMed:25122198, ECO:0000269|PubMed:26018085}.
CC   -!- FUNCTION: (Microbial infection) Facilitates human coronaviruses SARS-
CC       CoV and SARS-CoV-2 infections via two independent mechanisms,
CC       proteolytic cleavage of ACE2 receptor which promotes viral uptake, and
CC       cleavage of coronavirus spike glycoproteins which activates the
CC       glycoprotein for host cell entry (PubMed:24227843, PubMed:32142651).
CC       Proteolytically cleaves and activates the spike glycoproteins of human
CC       coronavirus 229E (HCoV-229E) and human coronavirus EMC (HCoV-EMC) and
CC       the fusion glycoproteins F0 of Sendai virus (SeV), human
CC       metapneumovirus (HMPV), human parainfluenza 1, 2, 3, 4a and 4b viruses
CC       (HPIV). Essential for spread and pathogenesis of influenza A virus
CC       (strains H1N1, H3N2 and H7N9); involved in proteolytic cleavage and
CC       activation of hemagglutinin (HA) protein which is essential for viral
CC       infectivity. {ECO:0000269|PubMed:21068237, ECO:0000269|PubMed:21325420,
CC       ECO:0000269|PubMed:23536651, ECO:0000269|PubMed:23966399,
CC       ECO:0000269|PubMed:24027332, ECO:0000269|PubMed:24227843,
CC       ECO:0000269|PubMed:32142651}.
CC   -!- SUBUNIT: The catalytically active form interacts with ACE2.
CC       {ECO:0000269|PubMed:21068237}.
CC   -!- INTERACTION:
CC       O15393; Q9BYF1: ACE2; NbExp=3; IntAct=EBI-12549863, EBI-7730807;
CC       O15393-2; Q15848: ADIPOQ; NbExp=3; IntAct=EBI-12345267, EBI-10827839;
CC       O15393-2; Q86W74-2: ANKRD46; NbExp=3; IntAct=EBI-12345267, EBI-12109402;
CC       O15393-2; P29972: AQP1; NbExp=3; IntAct=EBI-12345267, EBI-745213;
CC       O15393-2; O95393: BMP10; NbExp=3; IntAct=EBI-12345267, EBI-3922513;
CC       O15393-2; Q12982: BNIP2; NbExp=3; IntAct=EBI-12345267, EBI-752094;
CC       O15393-2; Q12983: BNIP3; NbExp=3; IntAct=EBI-12345267, EBI-749464;
CC       O15393-2; Q6PL45-2: BRICD5; NbExp=3; IntAct=EBI-12345267, EBI-12244618;
CC       O15393-2; Q86Z23: C1QL4; NbExp=3; IntAct=EBI-12345267, EBI-12062109;
CC       O15393-2; O14523: C2CD2L; NbExp=3; IntAct=EBI-12345267, EBI-12822627;
CC       O15393-2; Q9BXR6: CFHR5; NbExp=3; IntAct=EBI-12345267, EBI-11579371;
CC       O15393-2; Q9BXN2-6: CLEC7A; NbExp=3; IntAct=EBI-12345267, EBI-11989440;
CC       O15393-2; Q9NWW5: CLN6; NbExp=3; IntAct=EBI-12345267, EBI-6165897;
CC       O15393-2; Q96FZ5: CMTM7; NbExp=3; IntAct=EBI-12345267, EBI-2807956;
CC       O15393-2; Q6PI25: CNIH2; NbExp=3; IntAct=EBI-12345267, EBI-12815321;
CC       O15393-2; Q8TBE1: CNIH3; NbExp=3; IntAct=EBI-12345267, EBI-12208021;
CC       O15393-2; Q4LDR2: CTXN3; NbExp=3; IntAct=EBI-12345267, EBI-12019274;
CC       O15393-2; Q07325: CXCL9; NbExp=3; IntAct=EBI-12345267, EBI-3911467;
CC       O15393-2; Q9BQA9: CYBC1; NbExp=3; IntAct=EBI-12345267, EBI-2680384;
CC       O15393-2; P81534: DEFB103B; NbExp=3; IntAct=EBI-12345267, EBI-12074168;
CC       O15393-2; P56851: EDDM3B; NbExp=3; IntAct=EBI-12345267, EBI-10215665;
CC       O15393-2; Q9UKR5: ERG28; NbExp=3; IntAct=EBI-12345267, EBI-711490;
CC       O15393-2; Q92520: FAM3C; NbExp=3; IntAct=EBI-12345267, EBI-2876774;
CC       O15393-2; Q96IV6: FAXDC2; NbExp=3; IntAct=EBI-12345267, EBI-12142299;
CC       O15393-2; P24593: IGFBP5; NbExp=3; IntAct=EBI-12345267, EBI-720480;
CC       O15393-2; Q6ZSS7: MFSD6; NbExp=3; IntAct=EBI-12345267, EBI-2858252;
CC       O15393-2; O75425: MOSPD3; NbExp=3; IntAct=EBI-12345267, EBI-12179105;
CC       O15393-2; Q9NZG7: NINJ2; NbExp=3; IntAct=EBI-12345267, EBI-10317425;
CC       O15393-2; Q9UHJ9-5: PGAP2; NbExp=3; IntAct=EBI-12345267, EBI-12092917;
CC       O15393-2; Q9Y342: PLLP; NbExp=3; IntAct=EBI-12345267, EBI-3919291;
CC       O15393-2; P26678: PLN; NbExp=3; IntAct=EBI-12345267, EBI-692836;
CC       O15393-2; P60201-2: PLP1; NbExp=3; IntAct=EBI-12345267, EBI-12188331;
CC       O15393-2; Q04941: PLP2; NbExp=4; IntAct=EBI-12345267, EBI-608347;
CC       O15393-2; Q13635-3: PTCH1; NbExp=3; IntAct=EBI-12345267, EBI-14199621;
CC       O15393-2; P53801: PTTG1IP; NbExp=3; IntAct=EBI-12345267, EBI-3906138;
CC       O15393-2; O00767: SCD; NbExp=4; IntAct=EBI-12345267, EBI-2684237;
CC       O15393-2; Q96IW7: SEC22A; NbExp=3; IntAct=EBI-12345267, EBI-8652744;
CC       O15393-2; Q9Y6D0: SELENOK; NbExp=3; IntAct=EBI-12345267, EBI-9679163;
CC       O15393-2; P11686: SFTPC; NbExp=3; IntAct=EBI-12345267, EBI-10197617;
CC       O15393-2; P78382: SLC35A1; NbExp=3; IntAct=EBI-12345267, EBI-12870360;
CC       O15393-2; Q9NVC3: SLC38A7; NbExp=3; IntAct=EBI-12345267, EBI-10314552;
CC       O15393-2; B2RUZ4: SMIM1; NbExp=3; IntAct=EBI-12345267, EBI-12188413;
CC       O15393-2; O15400: STX7; NbExp=4; IntAct=EBI-12345267, EBI-3221827;
CC       O15393-2; Q9UNK0: STX8; NbExp=3; IntAct=EBI-12345267, EBI-727240;
CC       O15393-2; P17152: TMEM11; NbExp=3; IntAct=EBI-12345267, EBI-723946;
CC       O15393-2; A0PK00: TMEM120B; NbExp=3; IntAct=EBI-12345267, EBI-10171534;
CC       O15393-2; Q5BJH2-2: TMEM128; NbExp=3; IntAct=EBI-12345267, EBI-10694905;
CC       O15393-2; A2RU14: TMEM218; NbExp=3; IntAct=EBI-12345267, EBI-10173151;
CC       O15393-2; Q9H0R3: TMEM222; NbExp=3; IntAct=EBI-12345267, EBI-347385;
CC       O15393-2; Q8NBD8: TMEM229B; NbExp=3; IntAct=EBI-12345267, EBI-12195227;
CC       O15393-2; Q9BU79: TMEM243; NbExp=3; IntAct=EBI-12345267, EBI-12887458;
CC       O15393-2; Q9H2L4: TMEM60; NbExp=3; IntAct=EBI-12345267, EBI-2852148;
CC       O15393-2; Q9BSE2: TMEM79; NbExp=3; IntAct=EBI-12345267, EBI-8649725;
CC       O15393-2; Q8N2M4: TMEM86A; NbExp=3; IntAct=EBI-12345267, EBI-12015604;
CC       O15393-2; Q8N661: TMEM86B; NbExp=3; IntAct=EBI-12345267, EBI-2548832;
CC       O15393-2; P01375: TNF; NbExp=3; IntAct=EBI-12345267, EBI-359977;
CC       O15393-2; Q5BVD1: TTMP; NbExp=5; IntAct=EBI-12345267, EBI-10243654;
CC       O15393-2; O00526: UPK2; NbExp=3; IntAct=EBI-12345267, EBI-10179682;
CC       O15393-2; O95183: VAMP5; NbExp=3; IntAct=EBI-12345267, EBI-10191195;
CC       O15393-2; Q9BQB6: VKORC1; NbExp=3; IntAct=EBI-12345267, EBI-6256462;
CC       O15393-2; O95159: ZFPL1; NbExp=3; IntAct=EBI-12345267, EBI-718439;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:20382709,
CC       ECO:0000269|PubMed:21068237}; Single-pass type II membrane protein
CC       {ECO:0000269|PubMed:20382709, ECO:0000269|PubMed:21068237}.
CC   -!- SUBCELLULAR LOCATION: [Transmembrane protease serine 2 catalytic
CC       chain]: Secreted {ECO:0000269|PubMed:20382709}. Note=Activated by
CC       cleavage and secreted. {ECO:0000269|PubMed:11245484,
CC       ECO:0000269|PubMed:20382709}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O15393-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O15393-2; Sequence=VSP_045083;
CC   -!- TISSUE SPECIFICITY: Expressed in several tissues that comprise large
CC       populations of epithelial cells with the highest level of transcripts
CC       measured in the prostate gland. Expressed in type II pneumocytes in the
CC       lung (at protein level). Expressed strongly in small intestine. Also
CC       expressed in colon, stomach and salivary gland.
CC       {ECO:0000269|PubMed:11169526, ECO:0000269|PubMed:20382709,
CC       ECO:0000269|PubMed:21325420}.
CC   -!- INDUCTION: By androgenic hormones in vivo.
CC       {ECO:0000269|PubMed:25122198}.
CC   -!- PTM: Proteolytically processed; by an autocatalytic mechanism.
CC   -!- SIMILARITY: Belongs to the peptidase S1 family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00274}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/TMPRSS2ID42592ch21q22.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U75329; AAC51784.1; -; mRNA.
DR   EMBL; AF123453; AAD37117.1; -; mRNA.
DR   EMBL; AF270487; AAK29280.1; -; mRNA.
DR   EMBL; AK291813; BAF84502.1; -; mRNA.
DR   EMBL; AK296860; BAH12445.1; -; mRNA.
DR   EMBL; AK313338; BAG36142.1; -; mRNA.
DR   EMBL; AK222784; BAD96504.1; -; mRNA.
DR   EMBL; AP001610; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471079; EAX09597.1; -; Genomic_DNA.
DR   EMBL; CH471079; EAX09598.1; -; Genomic_DNA.
DR   EMBL; BC051839; AAH51839.1; -; mRNA.
DR   CCDS; CCDS33564.1; -. [O15393-1]
DR   CCDS; CCDS54486.1; -. [O15393-2]
DR   RefSeq; NP_001128571.1; NM_001135099.1. [O15393-2]
DR   RefSeq; NP_005647.3; NM_005656.3. [O15393-1]
DR   RefSeq; XP_011528033.1; XM_011529731.2.
DR   SMR; O15393; -.
DR   BioGrid; 112968; 2.
DR   IntAct; O15393; 61.
DR   STRING; 9606.ENSP00000381588; -.
DR   BindingDB; O15393; -.
DR   ChEMBL; CHEMBL1795140; -.
DR   GuidetoPHARMACOLOGY; 2421; -.
DR   MEROPS; S01.247; -.
DR   GlyConnect; 1848; -.
DR   iPTMnet; O15393; -.
DR   PhosphoSitePlus; O15393; -.
DR   SwissPalm; O15393; -.
DR   BioMuta; TMPRSS2; -.
DR   jPOST; O15393; -.
DR   MassIVE; O15393; -.
DR   MaxQB; O15393; -.
DR   PaxDb; O15393; -.
DR   PeptideAtlas; O15393; -.
DR   PRIDE; O15393; -.
DR   ProteomicsDB; 31938; -.
DR   ProteomicsDB; 48634; -. [O15393-1]
DR   Antibodypedia; 2685; 291 antibodies.
DR   DNASU; 7113; -.
DR   Ensembl; ENST00000332149; ENSP00000330330; ENSG00000184012. [O15393-1]
DR   Ensembl; ENST00000398585; ENSP00000381588; ENSG00000184012. [O15393-2]
DR   Ensembl; ENST00000458356; ENSP00000391216; ENSG00000184012. [O15393-1]
DR   GeneID; 7113; -.
DR   KEGG; hsa:7113; -.
DR   UCSC; uc002yzj.4; human. [O15393-1]
DR   CTD; 7113; -.
DR   DisGeNET; 7113; -.
DR   GeneCards; TMPRSS2; -.
DR   HGNC; HGNC:11876; TMPRSS2.
DR   HPA; ENSG00000184012; Tissue enhanced (intestine, pancreas, prostate).
DR   MIM; 602060; gene.
DR   neXtProt; NX_O15393; -.
DR   OpenTargets; ENSG00000184012; -.
DR   PharmGKB; PA36577; -.
DR   eggNOG; KOG3627; Eukaryota.
DR   eggNOG; COG5640; LUCA.
DR   GeneTree; ENSGT00940000155207; -.
DR   InParanoid; O15393; -.
DR   KO; K09633; -.
DR   OMA; DDWSESY; -.
DR   OrthoDB; 1314811at2759; -.
DR   PhylomeDB; O15393; -.
DR   TreeFam; TF351678; -.
DR   SIGNOR; O15393; -.
DR   ChiTaRS; TMPRSS2; human.
DR   GeneWiki; TMPRSS2; -.
DR   GenomeRNAi; 7113; -.
DR   Pharos; O15393; Tchem.
DR   PRO; PR:O15393; -.
DR   Proteomes; UP000005640; Chromosome 21.
DR   RNAct; O15393; protein.
DR   Bgee; ENSG00000184012; Expressed in mucosa of transverse colon and 141 other tissues.
DR   ExpressionAtlas; O15393; baseline and differential.
DR   Genevisible; O15393; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005044; F:scavenger receptor activity; IEA:InterPro.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro.
DR   GO; GO:0008236; F:serine-type peptidase activity; TAS:ProtInc.
DR   GO; GO:0046598; P:positive regulation of viral entry into host cell; IDA:UniProtKB.
DR   GO; GO:0016540; P:protein autoprocessing; IMP:UniProtKB.
DR   GO; GO:0006508; P:proteolysis; IDA:UniProtKB.
DR   CDD; cd00112; LDLa; 1.
DR   CDD; cd00190; Tryp_SPc; 1.
DR   Gene3D; 3.10.250.10; -; 1.
DR   Gene3D; 4.10.400.10; -; 1.
DR   InterPro; IPR036055; LDL_receptor-like_sf.
DR   InterPro; IPR023415; LDLR_class-A_CS.
DR   InterPro; IPR002172; LDrepeatLR_classA_rpt.
DR   InterPro; IPR009003; Peptidase_S1_PA.
DR   InterPro; IPR001314; Peptidase_S1A.
DR   InterPro; IPR001190; SRCR.
DR   InterPro; IPR017448; SRCR-like_dom.
DR   InterPro; IPR036772; SRCR-like_dom_sf.
DR   InterPro; IPR001254; Trypsin_dom.
DR   InterPro; IPR018114; TRYPSIN_HIS.
DR   InterPro; IPR033116; TRYPSIN_SER.
DR   Pfam; PF15494; SRCR_2; 1.
DR   Pfam; PF00089; Trypsin; 1.
DR   PRINTS; PR00722; CHYMOTRYPSIN.
DR   SMART; SM00192; LDLa; 1.
DR   SMART; SM00202; SR; 1.
DR   SMART; SM00020; Tryp_SPc; 1.
DR   SUPFAM; SSF50494; SSF50494; 1.
DR   SUPFAM; SSF56487; SSF56487; 1.
DR   SUPFAM; SSF57424; SSF57424; 1.
DR   PROSITE; PS01209; LDLRA_1; 1.
DR   PROSITE; PS50068; LDLRA_2; 1.
DR   PROSITE; PS50287; SRCR_2; 1.
DR   PROSITE; PS50240; TRYPSIN_DOM; 1.
DR   PROSITE; PS00134; TRYPSIN_HIS; 1.
DR   PROSITE; PS00135; TRYPSIN_SER; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Autocatalytic cleavage; Cell membrane;
KW   Disulfide bond; Glycoprotein; Hydrolase; Membrane; Polymorphism; Protease;
KW   Reference proteome; Secreted; Serine protease; Signal-anchor;
KW   Transmembrane; Transmembrane helix; Zymogen.
FT   CHAIN           1..255
FT                   /note="Transmembrane protease serine 2 non-catalytic chain"
FT                   /id="PRO_0000027855"
FT   CHAIN           256..492
FT                   /note="Transmembrane protease serine 2 catalytic chain"
FT                   /id="PRO_0000027856"
FT   TOPO_DOM        1..84
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        85..105
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        106..492
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          112..149
FT                   /note="LDL-receptor class A"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DOMAIN          150..242
FT                   /note="SRCR"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00196"
FT   DOMAIN          256..489
FT                   /note="Peptidase S1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00274"
FT   ACT_SITE        296
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        345
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        441
FT                   /note="Charge relay system"
FT   SITE            255..256
FT                   /note="Cleavage"
FT                   /evidence="ECO:0000269|PubMed:11245484"
FT   CARBOHYD        213
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        249
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        113..126
FT                   /evidence="ECO:0000250"
FT   DISULFID        120..139
FT                   /evidence="ECO:0000250"
FT   DISULFID        133..148
FT                   /evidence="ECO:0000250"
FT   DISULFID        172..231
FT                   /evidence="ECO:0000250"
FT   DISULFID        185..241
FT                   /evidence="ECO:0000250"
FT   DISULFID        244..365
FT                   /note="Interchain (between non-catalytic and catalytic
FT                   chains)"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124,
FT                   ECO:0000255|PROSITE-ProRule:PRU00196, ECO:0000255|PROSITE-
FT                   ProRule:PRU00274"
FT   DISULFID        281..297
FT                   /evidence="ECO:0000250"
FT   DISULFID        410..426
FT                   /evidence="ECO:0000250"
FT   DISULFID        437..465
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         1
FT                   /note="M -> MPPAPPGGESGCEERGAAGHIEHSRYLSLLDAVDNSKM (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_045083"
FT   VARIANT         160
FT                   /note="V -> M (in dbSNP:rs12329760)"
FT                   /evidence="ECO:0000269|PubMed:11414763,
FT                   ECO:0000269|PubMed:17918732, ECO:0000269|PubMed:9325052"
FT                   /id="VAR_027674"
FT   VARIANT         254
FT                   /note="S -> C"
FT                   /evidence="ECO:0000269|PubMed:17918732"
FT                   /id="VAR_038002"
FT   VARIANT         329
FT                   /note="E -> Q (in dbSNP:rs775137340)"
FT                   /evidence="ECO:0000269|PubMed:17918732,
FT                   ECO:0000269|PubMed:9325052"
FT                   /id="VAR_038003"
FT   VARIANT         449
FT                   /note="K -> N (in dbSNP:rs1056602)"
FT                   /id="VAR_011692"
FT   VARIANT         491
FT                   /note="D -> N (in dbSNP:rs779875214)"
FT                   /evidence="ECO:0000269|PubMed:17918732"
FT                   /id="VAR_038004"
FT   MUTAGEN         255
FT                   /note="R->Q: Loss of cleavage."
FT                   /evidence="ECO:0000269|PubMed:11245484"
FT   MUTAGEN         441
FT                   /note="S->A: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:11245484"
FT   CONFLICT        26
FT                   /note="Y -> H (in Ref. 4; BAF84502)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        62
FT                   /note="N -> S (in Ref. 4; BAH12445)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        163
FT                   /note="S -> P (in Ref. 4; BAF84502)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        242
FT                   /note="I -> L (in Ref. 1; AAC51784)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        489..491
FT                   /note="RAD -> KAN (in Ref. 1; AAC51784)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   492 AA;  53859 MW;  C05B5531C8A311C7 CRC64;
     MALNSGSPPA IGPYYENHGY QPENPYPAQP TVVPTVYEVH PAQYYPSPVP QYAPRVLTQA
     SNPVVCTQPK SPSGTVCTSK TKKALCITLT LGTFLVGAAL AAGLLWKFMG SKCSNSGIEC
     DSSGTCINPS NWCDGVSHCP GGEDENRCVR LYGPNFILQV YSSQRKSWHP VCQDDWNENY
     GRAACRDMGY KNNFYSSQGI VDDSGSTSFM KLNTSAGNVD IYKKLYHSDA CSSKAVVSLR
     CIACGVNLNS SRQSRIVGGE SALPGAWPWQ VSLHVQNVHV CGGSIITPEW IVTAAHCVEK
     PLNNPWHWTA FAGILRQSFM FYGAGYQVEK VISHPNYDSK TKNNDIALMK LQKPLTFNDL
     VKPVCLPNPG MMLQPEQLCW ISGWGATEEK GKTSEVLNAA KVLLIETQRC NSRYVYDNLI
     TPAMICAGFL QGNVDSCQGD SGGPLVTSKN NIWWLIGDTS WGSGCAKAYR PGVYGNVMVF
     TDWIYRQMRA DG
//
ID   TOP1_HUMAN              Reviewed;         765 AA.
AC   P11387; A8KA78; E1P5W3; O43256; Q12855; Q12856; Q15610; Q5TFY3; Q9UJN0;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2000, sequence version 2.
DT   22-APR-2020, entry version 226.
DE   RecName: Full=DNA topoisomerase 1;
DE            EC=5.6.2.1 {ECO:0000255|PROSITE-ProRule:PRU10130, ECO:0000269|PubMed:14594810, ECO:0000269|PubMed:16033260, ECO:0000269|PubMed:2833744};
DE   AltName: Full=DNA topoisomerase I;
GN   Name=TOP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=2833744; DOI=10.1073/pnas.85.8.2543;
RA   D'Arpa P., Machlin P.S., Ratrie H. III, Rothfield N.F., Cleveland D.W.,
RA   Earnshaw W.C.;
RT   "cDNA cloning of human DNA topoisomerase I: catalytic activity of a 67.7-
RT   kDa carboxyl-terminal fragment.";
RL   Proc. Natl. Acad. Sci. U.S.A. 85:2543-2547(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1851751;
RA   Kunze N., Yang G., Dolberg M., Sundarp R., Knippers R., Richter A.;
RT   "Structure of the human type I DNA topoisomerase gene.";
RL   J. Biol. Chem. 266:9610-9616(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J., Buck D., Burrill W.D.,
RA   Butler A.P., Carder C., Carter N.P., Chapman J.C., Clamp M., Clark G.,
RA   Clark L.N., Clark S.Y., Clee C.M., Clegg S., Cobley V.E., Collier R.E.,
RA   Connor R.E., Corby N.R., Coulson A., Coville G.J., Deadman R., Dhami P.D.,
RA   Dunn M., Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H., Rice C.M.,
RA   Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S., Skuce C.D.,
RA   Smith M.L., Soderlund C., Steward C.A., Sulston J.E., Swann R.M.,
RA   Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A., Tracey A.,
RA   Tromans A.C., Vaudin M., Wall M., Wallis J.M., Whitehead S.L.,
RA   Whittaker P., Willey D.L., Williams L., Williams S.A., Wilming L.,
RA   Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-14.
RX   PubMed=2176592; DOI=10.1111/j.1432-1033.1990.tb15620.x;
RA   Kunze N., Klein M., Richter A., Knippers R.;
RT   "Structural characterisation of the human DNA topoisomerase I gene
RT   promoter.";
RL   Eur. J. Biochem. 194:323-330(1990).
RN   [7]
RP   PROTEIN SEQUENCE OF 2-17; 107-117; 224-239; 253-262; 292-299; 355-362;
RP   426-434; 476-484; 509-532; 550-587; 591-615; 625-634; 656-663; 694-712;
RP   721-734 AND 736-742, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT
RP   SER-2, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Ovarian carcinoma;
RA   Bienvenut W.V., Lilla S., von Kriegsheim A., Lempens A., Kolch W.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 5-765, AND VARIANTS CPT-RESISTANT LEUKEMIA
RP   THR-370 AND SER-722.
RC   TISSUE=Peripheral blood;
RX   PubMed=7882333;
RA   Fujimori A., Harker W.G., Kohlhagen G., Hoki Y., Pommier Y.;
RT   "Mutation at the catalytic site of topoisomerase I in CEM/C2, a human
RT   leukemia cell line resistant to camptothecin.";
RL   Cancer Res. 55:1339-1346(1995).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 344-765.
RX   PubMed=2461859; DOI=10.1111/j.1432-1033.1988.tb14404.x;
RA   Oddou P., Schmidt U., Knippers R., Richter A.;
RT   "Monoclonal antibodies neutralizing mammalian DNA topoisomerase I
RT   activity.";
RL   Eur. J. Biochem. 177:523-529(1988).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 541-765.
RX   PubMed=2544263;
RA   Zhou B.S., Bastow K.F., Cheng Y.C.;
RT   "Characterization of the 3' region of the human DNA topoisomerase I gene.";
RL   Cancer Res. 49:3922-3927(1989).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 657-765.
RX   PubMed=2479024; DOI=10.1073/pnas.86.21.8492;
RA   Maul G.G., Jimenez S.A., Riggs E., Ziemnicka-Kotula D.;
RT   "Determination of an epitope of the diffuse systemic sclerosis marker
RT   antigen DNA topoisomerase I: sequence similarity with retroviral p30gag
RT   protein suggests a possible cause for autoimmunity in systemic sclerosis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:8492-8496(1989).
RN   [12]
RP   CHROMOSOMAL TRANSLOCATION WITH NUP98.
RX   PubMed=10556215;
RA   Ahuja H.G., Felix C.A., Aplan P.D.;
RT   "The t(11;20)(p15;q11) chromosomal translocation associated with therapy-
RT   related myelodysplastic syndrome results in an NUP98-TOP1 fusion.";
RL   Blood 94:3258-3261(1999).
RN   [13]
RP   SUMOYLATION AT LYS-117, SUBCELLULAR LOCATION, AND MUTAGENESIS OF LYS-103;
RP   LYS-117; LYS-153 AND TYR-723.
RX   PubMed=12149243; DOI=10.1074/jbc.m200388200;
RA   Rallabhandi P., Hashimoto K., Mo Y.-Y., Beck W.T., Moitra P.K., D'Arpa P.;
RT   "Sumoylation of topoisomerase I is involved in its partitioning between
RT   nucleoli and nucleoplasm and its clearing from nucleoli in response to
RT   camptothecin.";
RL   J. Biol. Chem. 277:40020-40026(2002).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [15]
RP   INTERACTION WITH SV40 LARGE T ANTIGEN (MICROBIAL INFECTION).
RX   PubMed=18003733; DOI=10.1128/jvi.01314-07;
RA   Khopde S., Simmons D.T.;
RT   "Simian virus 40 DNA replication is dependent on an interaction between
RT   topoisomerase I and the C-terminal end of T antigen.";
RL   J. Virol. 82:1136-1145(2008).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [18]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=19168442; DOI=10.1161/circresaha.108.183905;
RA   Eisenreich A., Bogdanov V.Y., Zakrzewicz A., Pries A., Antoniak S.,
RA   Poller W., Schultheiss H.P., Rauch U.;
RT   "Cdc2-like kinases and DNA topoisomerase I regulate alternative splicing of
RT   tissue factor in human endothelial cells.";
RL   Circ. Res. 104:589-599(2009).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-280, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [20]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT SER-10; SER-57 AND SER-112, CLEAVAGE OF INITIATOR METHIONINE
RP   [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [22]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT SER-10, CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE
RP   ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [23]
RP   FUNCTION.
RX   PubMed=22904072; DOI=10.1093/nar/gks779;
RA   Onishi Y., Kawano Y.;
RT   "Rhythmic binding of Topoisomerase I impacts on the transcription of Bmal1
RT   and circadian period.";
RL   Nucleic Acids Res. 40:9482-9492(2012).
RN   [24]
RP   PHOSPHORYLATION AT SER-506.
RX   PubMed=23185622; DOI=10.1371/journal.pone.0050427;
RA   Bandyopadhyay K., Li P., Gjerset R.A.;
RT   "CK2-mediated hyperphosphorylation of topoisomerase I targets serine 506,
RT   enhances topoisomerase I-DNA Binding, and increases cellular camptothecin
RT   sensitivity.";
RL   PLoS ONE 7:E50427-E50427(2012).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2 AND SER-10, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [26]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [27]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-117; LYS-134; LYS-153; LYS-158
RP   AND LYS-164, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [28]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-117, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [29]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-117; LYS-148; LYS-153 AND
RP   LYS-164, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [30]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-148; LYS-153; LYS-164 AND
RP   LYS-336, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.o114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to replication
RT   stress reveals novel small ubiquitin-like modified target proteins and
RT   acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [31]
RP   INTERACTION WITH ERCC6.
RX   PubMed=26030138; DOI=10.1371/journal.pone.0128558;
RA   Nicolai S., Filippi S., Caputo M., Cipak L., Gregan J., Ammerer G.,
RA   Frontini M., Willems D., Prantera G., Balajee A.S., Proietti-De-Santis L.;
RT   "Identification of Novel Proteins Co-Purifying with Cockayne Syndrome Group
RT   B (CSB) Reveals Potential Roles for CSB in RNA Metabolism and Chromatin
RT   Dynamics.";
RL   PLoS ONE 10:E0128558-E0128558(2015).
RN   [32]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-101; LYS-103; LYS-117; LYS-134;
RP   LYS-148; LYS-153; LYS-158; LYS-164; LYS-172; LYS-204; LYS-336; LYS-549;
RP   LYS-642; LYS-700 AND LYS-712, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [33]
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 175-765 IN COMPLEX WITH DNA, AND
RP   ACTIVE SITE.
RX   PubMed=9488644; DOI=10.1126/science.279.5356.1504;
RA   Redinbo M.R., Stewart L., Kuhn P., Champoux J.J., Hol W.G.J.;
RT   "Crystal structures of human topoisomerase I in covalent and noncovalent
RT   complexes with DNA.";
RL   Science 279:1504-1513(1998).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 215-765 OF MUTANT PHE-723 IN
RP   COMPLEX WITH DNA.
RX   PubMed=9488652; DOI=10.1126/science.279.5356.1534;
RA   Stewart L., Redinbo M.R., Qiu X., Hol W.G.J., Champoux J.J.;
RT   "A model for the mechanism of human topoisomerase I.";
RL   Science 279:1534-1541(1998).
RN   [35]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 203-765 IN COMPLEX WITH DNA, AND
RP   ACTIVE SITE.
RX   PubMed=10841763; DOI=10.1021/bi992690t;
RA   Redinbo M.R., Champoux J.J., Hol W.G.J.;
RT   "Novel insights into catalytic mechanism from a crystal structure of human
RT   topoisomerase I in complex with DNA.";
RL   Biochemistry 39:6832-6840(2000).
RN   [36]
RP   X-RAY CRYSTALLOGRAPHY (3.14 ANGSTROMS) OF 202-765 IN COMPLEX WITH DNA.
RX   PubMed=12209008; DOI=10.1073/pnas.192282699;
RA   Lesher D.T., Pommier Y., Stewart L., Redinbo M.R.;
RT   "8-Oxoguanine rearranges the active site of human topoisomerase I.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:12102-12107(2002).
RN   [37]
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 174-765 IN COMPLEXES WITH DNA AND
RP   TOPOTECAN, AND ACTIVE SITE.
RX   PubMed=12426403; DOI=10.1073/pnas.242259599;
RA   Staker B.L., Hjerrild K., Feese M.D., Behnke C.A., Burgin A.B. Jr.,
RA   Stewart L.;
RT   "The mechanism of topoisomerase I poisoning by a camptothecin analog.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:15387-15392(2002).
RN   [38]
RP   X-RAY CRYSTALLOGRAPHY (3.10 ANGSTROMS) OF 203-764 IN COMPLEX WITH DNA, AND
RP   ACTIVE SITE.
RX   PubMed=12533542; DOI=10.1074/jbc.m212930200;
RA   Chrencik J.E., Burgin A.B., Pommier Y., Stewart L., Redinbo M.R.;
RT   "Structural impact of the leukemia drug 1-beta-D-arabinofuranosylcytosine
RT   (Ara-C) on the covalent human topoisomerase I-DNA complex.";
RL   J. Biol. Chem. 278:12461-12466(2003).
RN   [39]
RP   X-RAY CRYSTALLOGRAPHY (3.13 ANGSTROMS) OF 174-765, MUTAGENESIS OF LYS-532,
RP   CATALYTIC ACTIVITY, AND FUNCTION.
RX   PubMed=14594810; DOI=10.1074/jbc.m309959200;
RA   Interthal H., Quigley P.M., Hol W.G., Champoux J.J.;
RT   "The role of lysine 532 in the catalytic mechanism of human topoisomerase
RT   I.";
RL   J. Biol. Chem. 279:2984-2992(2004).
RN   [40]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 201-765 IN COMPLEX WITH DNA AND
RP   TOPOTECAN, AND ACTIVE SITE.
RX   PubMed=15165849; DOI=10.1016/j.jmb.2004.03.077;
RA   Chrencik J.E., Staker B.L., Burgin A.B., Pourquier P., Pommier Y.,
RA   Stewart L., Redinbo M.R.;
RT   "Mechanisms of camptothecin resistance by human topoisomerase I
RT   mutations.";
RL   J. Mol. Biol. 339:773-784(2004).
RN   [41]
RP   X-RAY CRYSTALLOGRAPHY (3.00 ANGSTROMS) OF 174-765 IN COMPLEXES WITH DNA AND
RP   SYNTHETIC INHIBITORS, AND ACTIVE SITE.
RX   PubMed=15801827; DOI=10.1021/jm049146p;
RA   Staker B.L., Feese M.D., Cushman M., Pommier Y., Zembower D., Stewart L.,
RA   Burgin A.B.;
RT   "Structures of three classes of anticancer agents bound to the human
RT   topoisomerase I-DNA covalent complex.";
RL   J. Med. Chem. 48:2336-2345(2005).
RN   [42]
RP   X-RAY CRYSTALLOGRAPHY (3.10 ANGSTROMS) OF 174-765 IN COMPLEX WITH DNA AND
RP   SYNTHETIC INHIBITORS, CATALYTIC ACTIVITY, FUNCTION, AND ACTIVE SITE.
RX   PubMed=16033260; DOI=10.1021/jm050076b;
RA   Ioanoviciu A., Antony S., Pommier Y., Staker B.L., Stewart L., Cushman M.;
RT   "Synthesis and mechanism of action studies of a series of
RT   norindenoisoquinoline topoisomerase I poisons reveal an inhibitor with a
RT   flipped orientation in the ternary DNA-enzyme-inhibitor complex as
RT   determined by X-ray crystallographic analysis.";
RL   J. Med. Chem. 48:4803-4814(2005).
RN   [43]
RP   VARIANT CPT-RESISTANT LEUKEMIA GLY-533.
RX   PubMed=1849260; DOI=10.1093/nar/19.1.69;
RA   Tamura H., Kohchi C., Yamada R., Ikeda T., Koiwai O., Patterson E.,
RA   Keene J.D., Okada K., Kjeldsen E., Nishikawa K.;
RT   "Molecular cloning of a cDNA of a camptothecin-resistant human DNA
RT   topoisomerase I and identification of mutation sites.";
RL   Nucleic Acids Res. 19:69-75(1991).
RN   [44]
RP   VARIANT CPT-RESISTANT LUNG CANCER ALA-729.
RX   PubMed=1332703; DOI=10.1016/0006-291x(92)91094-7;
RA   Kubota N., Kanzawa F., Nishio K., Takeda Y., Ohmori T., Fujiwara Y.,
RA   Terashima Y., Saijo N.;
RT   "Detection of topoisomerase I gene point mutation in CPT-11 resistant lung
RT   cancer cell line.";
RL   Biochem. Biophys. Res. Commun. 188:571-577(1992).
RN   [45]
RP   VARIANT [LARGE SCALE ANALYSIS] BREAST CANCER ARG-326.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Releases the supercoiling and torsional tension of DNA
CC       introduced during the DNA replication and transcription by transiently
CC       cleaving and rejoining one strand of the DNA duplex. Introduces a
CC       single-strand break via transesterification at a target site in duplex
CC       DNA. The scissile phosphodiester is attacked by the catalytic tyrosine
CC       of the enzyme, resulting in the formation of a DNA-(3'-phosphotyrosyl)-
CC       enzyme intermediate and the expulsion of a 5'-OH DNA strand. The free
CC       DNA strand then rotates around the intact phosphodiester bond on the
CC       opposing strand, thus removing DNA supercoils. Finally, in the
CC       religation step, the DNA 5'-OH attacks the covalent intermediate to
CC       expel the active-site tyrosine and restore the DNA phosphodiester
CC       backbone (By similarity). Regulates the alternative splicing of tissue
CC       factor (F3) pre-mRNA in endothelial cells. Involved in the circadian
CC       transcription of the core circadian clock component ARNTL/BMAL1 by
CC       altering the chromatin structure around the ROR response elements
CC       (ROREs) on the ARNTL/BMAL1 promoter. {ECO:0000250|UniProtKB:Q13472,
CC       ECO:0000269|PubMed:14594810, ECO:0000269|PubMed:16033260,
CC       ECO:0000269|PubMed:19168442, ECO:0000269|PubMed:22904072,
CC       ECO:0000269|PubMed:2833744}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP-independent breakage of single-stranded DNA, followed by
CC         passage and rejoining.; EC=5.6.2.1; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU10130, ECO:0000269|PubMed:14594810,
CC         ECO:0000269|PubMed:16033260, ECO:0000269|PubMed:2833744};
CC   -!- ACTIVITY REGULATION: Specifically inhibited by camptothecin (CPT), a
CC       plant alkaloid with antitumor activity.
CC   -!- SUBUNIT: Monomer. Interacts with ERCC6 (PubMed:26030138).
CC       {ECO:0000269|PubMed:10841763, ECO:0000269|PubMed:12209008,
CC       ECO:0000269|PubMed:12533542, ECO:0000269|PubMed:15165849,
CC       ECO:0000269|PubMed:16033260, ECO:0000269|PubMed:26030138,
CC       ECO:0000269|PubMed:9488644, ECO:0000269|PubMed:9488652}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with SV40 Large T antigen;
CC       this interactions allows viral DNA replication.
CC       {ECO:0000269|PubMed:18003733}.
CC   -!- INTERACTION:
CC       P11387; P00519: ABL1; NbExp=7; IntAct=EBI-876302, EBI-375543;
CC       P11387; P01106: MYC; NbExp=2; IntAct=EBI-876302, EBI-447544;
CC       P11387; Q99801: NKX3-1; NbExp=6; IntAct=EBI-876302, EBI-1385894;
CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:12149243}.
CC       Nucleus, nucleoplasm {ECO:0000269|PubMed:12149243}. Note=Diffuse
CC       nuclear localization with some enrichment in nucleoli. On CPT
CC       treatment, cleared from nucleoli into nucleoplasm. Sumoylated forms
CC       found in both nucleoplasm and nucleoli.
CC   -!- TISSUE SPECIFICITY: Endothelial cells. {ECO:0000269|PubMed:19168442}.
CC   -!- PTM: Sumoylated. Lys-117 is the main site of sumoylation. Sumoylation
CC       plays a role in partitioning TOP1 between nucleoli and nucleoplasm.
CC       Levels are dramatically increased on camptothecin (CPT) treatment.
CC       {ECO:0000269|PubMed:12149243}.
CC   -!- PTM: Phosphorylation at Ser-506 by CK2 increases binding to supercoiled
CC       DNA and sensitivity to camptothecin. {ECO:0000269|PubMed:23185622}.
CC   -!- DISEASE: Note=A chromosomal aberration involving TOP1 is found in a
CC       form of therapy-related myelodysplastic syndrome. Translocation
CC       t(11;20)(p15;q11) with NUP98. {ECO:0000269|PubMed:10556215}.
CC   -!- MISCELLANEOUS: Eukaryotic topoisomerase I and II can relax both
CC       negative and positive supercoils, whereas prokaryotic enzymes relax
CC       only negative supercoils.
CC   -!- SIMILARITY: Belongs to the type IB topoisomerase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA36834.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/TOP1ID320ch20q11.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J03250; AAA61207.1; -; mRNA.
DR   EMBL; M60706; AAA61206.1; -; Genomic_DNA.
DR   EMBL; M60688; AAA61206.1; JOINED; Genomic_DNA.
DR   EMBL; M60689; AAA61206.1; JOINED; Genomic_DNA.
DR   EMBL; M60690; AAA61206.1; JOINED; Genomic_DNA.
DR   EMBL; M60691; AAA61206.1; JOINED; Genomic_DNA.
DR   EMBL; M60692; AAA61206.1; JOINED; Genomic_DNA.
DR   EMBL; M60693; AAA61206.1; JOINED; Genomic_DNA.
DR   EMBL; M60694; AAA61206.1; JOINED; Genomic_DNA.
DR   EMBL; M60695; AAA61206.1; JOINED; Genomic_DNA.
DR   EMBL; M60696; AAA61206.1; JOINED; Genomic_DNA.
DR   EMBL; M60697; AAA61206.1; JOINED; Genomic_DNA.
DR   EMBL; M60698; AAA61206.1; JOINED; Genomic_DNA.
DR   EMBL; M60699; AAA61206.1; JOINED; Genomic_DNA.
DR   EMBL; M60700; AAA61206.1; JOINED; Genomic_DNA.
DR   EMBL; M60701; AAA61206.1; JOINED; Genomic_DNA.
DR   EMBL; M60702; AAA61206.1; JOINED; Genomic_DNA.
DR   EMBL; M60703; AAA61206.1; JOINED; Genomic_DNA.
DR   EMBL; M60704; AAA61206.1; JOINED; Genomic_DNA.
DR   EMBL; M60705; AAA61206.1; JOINED; Genomic_DNA.
DR   EMBL; AK292943; BAF85632.1; -; mRNA.
DR   EMBL; AL035652; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL022394; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471077; EAW75994.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW75995.1; -; Genomic_DNA.
DR   EMBL; X52601; CAA36834.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; U07804; AAB60379.1; -; mRNA.
DR   EMBL; U07806; AAB60380.1; -; mRNA.
DR   EMBL; X16479; CAA34500.2; -; mRNA.
DR   EMBL; M27913; AAA61208.1; -; mRNA.
DR   CCDS; CCDS13312.1; -.
DR   PIR; A30887; ISHUT1.
DR   RefSeq; NP_003277.1; NM_003286.3.
DR   PDB; 1A31; X-ray; 2.10 A; A=175-765.
DR   PDB; 1A35; X-ray; 2.50 A; A=175-765.
DR   PDB; 1A36; X-ray; 2.80 A; A=175-765.
DR   PDB; 1EJ9; X-ray; 2.60 A; A=203-765.
DR   PDB; 1K4S; X-ray; 3.20 A; A=174-765.
DR   PDB; 1K4T; X-ray; 2.10 A; A=174-765.
DR   PDB; 1LPQ; X-ray; 3.14 A; A=202-765.
DR   PDB; 1NH3; X-ray; 3.10 A; A=203-765.
DR   PDB; 1R49; X-ray; 3.13 A; A=174-765.
DR   PDB; 1RR8; X-ray; 2.60 A; C=203-765.
DR   PDB; 1RRJ; X-ray; 2.30 A; A=201-765.
DR   PDB; 1SC7; X-ray; 3.00 A; A=174-765.
DR   PDB; 1SEU; X-ray; 3.00 A; A=174-765.
DR   PDB; 1T8I; X-ray; 3.00 A; A=174-765.
DR   PDB; 1TL8; X-ray; 3.10 A; A=174-765.
DR   PDBsum; 1A31; -.
DR   PDBsum; 1A35; -.
DR   PDBsum; 1A36; -.
DR   PDBsum; 1EJ9; -.
DR   PDBsum; 1K4S; -.
DR   PDBsum; 1K4T; -.
DR   PDBsum; 1LPQ; -.
DR   PDBsum; 1NH3; -.
DR   PDBsum; 1R49; -.
DR   PDBsum; 1RR8; -.
DR   PDBsum; 1RRJ; -.
DR   PDBsum; 1SC7; -.
DR   PDBsum; 1SEU; -.
DR   PDBsum; 1T8I; -.
DR   PDBsum; 1TL8; -.
DR   SMR; P11387; -.
DR   BioGrid; 113003; 217.
DR   CORUM; P11387; -.
DR   DIP; DIP-36356N; -.
DR   ELM; P11387; -.
DR   IntAct; P11387; 100.
DR   MINT; P11387; -.
DR   STRING; 9606.ENSP00000354522; -.
DR   BindingDB; P11387; -.
DR   ChEMBL; CHEMBL1781; -.
DR   DrugBank; DB07354; 2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM.
DR   DrugBank; DB08159; 4-(5,11-DIOXO-5H-INDENO[1,2-C]ISOQUINOLIN-6(11H)-YL)BUTANOATE.
DR   DrugBank; DB05482; 7-ethyl-10-hydroxycamptothecin.
DR   DrugBank; DB04690; Camptothecin.
DR   DrugBank; DB05806; Cositecan.
DR   DrugBank; DB04882; Edotecarin.
DR   DrugBank; DB05129; Elsamitrucin.
DR   DrugBank; DB11254; Hexylresorcinol.
DR   DrugBank; DB00762; Irinotecan.
DR   DrugBank; DB04967; Lucanthone.
DR   DrugBank; DB06159; Rubitecan.
DR   DrugBank; DB05630; Sodium stibogluconate.
DR   DrugBank; DB01030; Topotecan.
DR   DrugBank; DB14962; Trastuzumab deruxtecan.
DR   DrugBank; DB06069; XMT-1001.
DR   DrugCentral; P11387; -.
DR   iPTMnet; P11387; -.
DR   MetOSite; P11387; -.
DR   PhosphoSitePlus; P11387; -.
DR   SwissPalm; P11387; -.
DR   BioMuta; TOP1; -.
DR   DMDM; 12644118; -.
DR   SWISS-2DPAGE; P11387; -.
DR   EPD; P11387; -.
DR   jPOST; P11387; -.
DR   MassIVE; P11387; -.
DR   MaxQB; P11387; -.
DR   PaxDb; P11387; -.
DR   PeptideAtlas; P11387; -.
DR   PRIDE; P11387; -.
DR   ProteomicsDB; 52766; -.
DR   Antibodypedia; 3962; 402 antibodies.
DR   Ensembl; ENST00000361337; ENSP00000354522; ENSG00000198900.
DR   GeneID; 7150; -.
DR   KEGG; hsa:7150; -.
DR   UCSC; uc002xjl.4; human.
DR   CTD; 7150; -.
DR   DisGeNET; 7150; -.
DR   GeneCards; TOP1; -.
DR   HGNC; HGNC:11986; TOP1.
DR   HPA; ENSG00000198900; Low tissue specificity.
DR   MIM; 126420; gene.
DR   neXtProt; NX_P11387; -.
DR   OpenTargets; ENSG00000198900; -.
DR   PharmGKB; PA353; -.
DR   eggNOG; KOG0981; Eukaryota.
DR   eggNOG; COG3569; LUCA.
DR   GeneTree; ENSGT00940000155006; -.
DR   HOGENOM; CLU_009193_0_1_1; -.
DR   InParanoid; P11387; -.
DR   KO; K03163; -.
DR   OMA; CSLKYEH; -.
DR   OrthoDB; 303947at2759; -.
DR   PhylomeDB; P11387; -.
DR   TreeFam; TF105281; -.
DR   BRENDA; 5.99.1.2; 2681.
DR   Reactome; R-HSA-4615885; SUMOylation of DNA replication proteins.
DR   SIGNOR; P11387; -.
DR   ChiTaRS; TOP1; human.
DR   EvolutionaryTrace; P11387; -.
DR   GeneWiki; TOP1; -.
DR   GenomeRNAi; 7150; -.
DR   Pharos; P11387; Tclin.
DR   PRO; PR:P11387; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   RNAct; P11387; protein.
DR   Bgee; ENSG00000198900; Expressed in trabecular bone tissue and 231 other tissues.
DR   Genevisible; P11387; HS.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0005730; C:nucleolus; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0000932; C:P-body; IDA:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IEA:Ensembl.
DR   GO; GO:0032993; C:protein-DNA complex; IMP:CAFA.
DR   GO; GO:0031298; C:replication fork protection complex; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IMP:CAFA.
DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR   GO; GO:0003917; F:DNA topoisomerase type I (single strand cut, ATP-independent) activity; IDA:UniProtKB.
DR   GO; GO:0003690; F:double-stranded DNA binding; IMP:CAFA.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:CAFA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IMP:CAFA.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0003697; F:single-stranded DNA binding; IMP:CAFA.
DR   GO; GO:0097100; F:supercoiled DNA binding; IMP:CAFA.
DR   GO; GO:0006338; P:chromatin remodeling; IMP:UniProtKB.
DR   GO; GO:0007059; P:chromosome segregation; IBA:GO_Central.
DR   GO; GO:0032922; P:circadian regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:0007623; P:circadian rhythm; IEP:UniProtKB.
DR   GO; GO:0006260; P:DNA replication; IBA:GO_Central.
DR   GO; GO:0006265; P:DNA topological change; IDA:UniProtKB.
DR   GO; GO:0040016; P:embryonic cleavage; IEA:Ensembl.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IMP:CAFA.
DR   GO; GO:0016310; P:phosphorylation; NAS:UniProtKB.
DR   GO; GO:0012501; P:programmed cell death; NAS:UniProtKB.
DR   GO; GO:0042493; P:response to drug; IEP:UniProtKB.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   CDD; cd00659; Topo_IB_C; 1.
DR   DisProt; DP00075; -.
DR   Gene3D; 1.10.10.41; -; 1.
DR   Gene3D; 1.10.132.10; -; 1.
DR   Gene3D; 2.170.11.10; -; 1.
DR   Gene3D; 3.90.15.10; -; 1.
DR   InterPro; IPR011010; DNA_brk_join_enz.
DR   InterPro; IPR013034; DNA_topo_DNA_db_N_dom1.
DR   InterPro; IPR013030; DNA_topo_DNA_db_N_dom2.
DR   InterPro; IPR001631; TopoI.
DR   InterPro; IPR018521; TopoI_AS.
DR   InterPro; IPR025834; TopoI_C_dom.
DR   InterPro; IPR014711; TopoI_cat_a-hlx-sub_euk.
DR   InterPro; IPR014727; TopoI_cat_a/b-sub_euk.
DR   InterPro; IPR013500; TopoI_cat_euk.
DR   InterPro; IPR008336; TopoI_DNA-bd_euk.
DR   InterPro; IPR036202; TopoI_DNA-bd_euk_N_sf.
DR   InterPro; IPR013499; TopoI_euk.
DR   Pfam; PF14370; Topo_C_assoc; 1.
DR   Pfam; PF01028; Topoisom_I; 1.
DR   Pfam; PF02919; Topoisom_I_N; 1.
DR   PRINTS; PR00416; EUTPISMRASEI.
DR   SMART; SM00435; TOPEUc; 1.
DR   SUPFAM; SSF56349; SSF56349; 1.
DR   SUPFAM; SSF56741; SSF56741; 1.
DR   PROSITE; PS00176; TOPOISOMERASE_I_EUK; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Biological rhythms; Chromosomal rearrangement;
KW   Direct protein sequencing; DNA-binding; Host-virus interaction; Isomerase;
KW   Isopeptide bond; Nucleus; Phosphoprotein; Polymorphism; Proto-oncogene;
KW   Reference proteome; Topoisomerase; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000269|Ref.7"
FT   CHAIN           2..765
FT                   /note="DNA topoisomerase 1"
FT                   /id="PRO_0000145201"
FT   REGION          425..426
FT                   /note="Interaction with DNA"
FT   REGION          488..493
FT                   /note="Interaction with DNA"
FT   REGION          585..587
FT                   /note="Interaction with DNA"
FT   COMPBIAS        23..204
FT                   /note="Lys-rich"
FT   ACT_SITE        723
FT                   /note="O-(3'-phospho-DNA)-tyrosine intermediate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10130,
FT                   ECO:0000269|PubMed:10841763, ECO:0000269|PubMed:12426403,
FT                   ECO:0000269|PubMed:12533542, ECO:0000269|PubMed:15165849,
FT                   ECO:0000269|PubMed:15801827, ECO:0000269|PubMed:16033260,
FT                   ECO:0000269|PubMed:9488644"
FT   SITE            316
FT                   /note="Interaction with DNA"
FT   SITE            364
FT                   /note="Interaction with DNA"
FT   SITE            412
FT                   /note="Interaction with DNA"
FT   SITE            443
FT                   /note="Interaction with DNA"
FT   SITE            501
FT                   /note="Interaction with DNA"
FT   SITE            532
FT                   /note="Interaction with DNA"
FT   SITE            574
FT                   /note="Interaction with DNA"
FT   SITE            632
FT                   /note="Interaction with DNA"
FT   SITE            650
FT                   /note="Interaction with DNA"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000269|Ref.7"
FT   MOD_RES         2
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         10
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163"
FT   MOD_RES         57
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         112
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         172
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q04750"
FT   MOD_RES         280
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         506
FT                   /note="Phosphoserine; by CK2"
FT                   /evidence="ECO:0000269|PubMed:23185622"
FT   CROSSLNK        101
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        103
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO); alternate"
FT                   /evidence="ECO:0000305"
FT   CROSSLNK        103
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        117
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO); alternate"
FT   CROSSLNK        117
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000244|PubMed:25114211"
FT   CROSSLNK        117
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:25114211,
FT                   ECO:0000244|PubMed:25218447, ECO:0000244|PubMed:25772364,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        134
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        148
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25755297,
FT                   ECO:0000244|PubMed:25772364, ECO:0000244|PubMed:28112733"
FT   CROSSLNK        153
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO); alternate"
FT                   /evidence="ECO:0000305"
FT   CROSSLNK        153
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:25772364,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        158
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        164
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:25772364,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        172
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        204
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        336
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25755297,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        549
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        642
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        700
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        712
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   VARIANT         214
FT                   /note="G -> S (in dbSNP:rs6029542)"
FT                   /id="VAR_052592"
FT   VARIANT         326
FT                   /note="K -> R (in breast cancer; somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_036555"
FT   VARIANT         370
FT                   /note="M -> T (in CPT-resistant leukemia)"
FT                   /evidence="ECO:0000269|PubMed:7882333"
FT                   /id="VAR_010666"
FT   VARIANT         533
FT                   /note="D -> G (in CPT-resistant leukemia;
FT                   dbSNP:rs267607131)"
FT                   /evidence="ECO:0000269|PubMed:1849260"
FT                   /id="VAR_007530"
FT   VARIANT         722
FT                   /note="N -> S (in CPT-resistant leukemia)"
FT                   /evidence="ECO:0000269|PubMed:7882333"
FT                   /id="VAR_010667"
FT   VARIANT         729
FT                   /note="T -> A (in CPT-resistant lung cancer)"
FT                   /evidence="ECO:0000269|PubMed:1332703"
FT                   /id="VAR_007531"
FT   MUTAGEN         103
FT                   /note="K->R: Localizes in both nucleoplasm and nucleoli;
FT                   when associated with R-117 or R-153. Almost complete loss
FT                   of sumoylation, concentrates in nucleoli and no clearing
FT                   from nucleoli on CPT treatment; when associated with R-117
FT                   and R-153."
FT                   /evidence="ECO:0000269|PubMed:12149243"
FT   MUTAGEN         117
FT                   /note="K->R: 5-fold decrease in sumoylation. Localizes in
FT                   both nucleoplasm and nucleoli; when associated with or
FT                   without R-103 or R-153. Almost complete loss of
FT                   sumoylation, concentrates in nucleoli and no clearing from
FT                   nucleoli on CPT treatment; when associated with R-103 and
FT                   R-153."
FT                   /evidence="ECO:0000269|PubMed:12149243"
FT   MUTAGEN         153
FT                   /note="K->R: Localizes in both nucleoplasm and nucleoli;
FT                   when associated with R-103 or R-117. Almost complete loss
FT                   of sumoylation, concentrates in nucleoli and no clearing
FT                   from nucleoli on CPT treatment; when associated with R-103
FT                   and R-117."
FT                   /evidence="ECO:0000269|PubMed:12149243"
FT   MUTAGEN         532
FT                   /note="K->A: Almost abolishes enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:14594810"
FT   MUTAGEN         532
FT                   /note="K->R: Strongly reduced enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:14594810"
FT   MUTAGEN         723
FT                   /note="Y->F: No change in CPT-induced clearing from
FT                   nuclei."
FT                   /evidence="ECO:0000269|PubMed:12149243"
FT   CONFLICT        145
FT                   /note="A -> V (in Ref. 1; AAA61207)"
FT                   /evidence="ECO:0000305"
FT   HELIX           205..207
FT                   /evidence="ECO:0000244|PDB:1K4T"
FT   STRAND          220..222
FT                   /evidence="ECO:0000244|PDB:1A35"
FT   STRAND          236..238
FT                   /evidence="ECO:0000244|PDB:1A35"
FT   STRAND          240..242
FT                   /evidence="ECO:0000244|PDB:1A36"
FT   STRAND          245..247
FT                   /evidence="ECO:0000244|PDB:1A36"
FT   HELIX           251..261
FT                   /evidence="ECO:0000244|PDB:1A31"
FT   TURN            262..265
FT                   /evidence="ECO:0000244|PDB:1A31"
FT   HELIX           267..270
FT                   /evidence="ECO:0000244|PDB:1A31"
FT   HELIX           272..285
FT                   /evidence="ECO:0000244|PDB:1A31"
FT   HELIX           288..293
FT                   /evidence="ECO:0000244|PDB:1A31"
FT   HELIX           297..299
FT                   /evidence="ECO:0000244|PDB:1A31"
FT   HELIX           303..317
FT                   /evidence="ECO:0000244|PDB:1A31"
FT   HELIX           321..338
FT                   /evidence="ECO:0000244|PDB:1A31"
FT   STRAND          339..343
FT                   /evidence="ECO:0000244|PDB:1A31"
FT   STRAND          346..351
FT                   /evidence="ECO:0000244|PDB:1A31"
FT   STRAND          358..360
FT                   /evidence="ECO:0000244|PDB:1A31"
FT   STRAND          364..366
FT                   /evidence="ECO:0000244|PDB:1A31"
FT   TURN            368..371
FT                   /evidence="ECO:0000244|PDB:1A31"
FT   HELIX           379..381
FT                   /evidence="ECO:0000244|PDB:1A31"
FT   STRAND          383..385
FT                   /evidence="ECO:0000244|PDB:1A31"
FT   STRAND          396..398
FT                   /evidence="ECO:0000244|PDB:1SEU"
FT   STRAND          402..405
FT                   /evidence="ECO:0000244|PDB:1A31"
FT   STRAND          413..417
FT                   /evidence="ECO:0000244|PDB:1A31"
FT   TURN            419..421
FT                   /evidence="ECO:0000244|PDB:1A31"
FT   STRAND          424..427
FT                   /evidence="ECO:0000244|PDB:1A31"
FT   STRAND          431..433
FT                   /evidence="ECO:0000244|PDB:1K4S"
FT   HELIX           434..464
FT                   /evidence="ECO:0000244|PDB:1A31"
FT   HELIX           470..485
FT                   /evidence="ECO:0000244|PDB:1A31"
FT   TURN            495..497
FT                   /evidence="ECO:0000244|PDB:1A31"
FT   HELIX           504..506
FT                   /evidence="ECO:0000244|PDB:1A31"
FT   HELIX           509..511
FT                   /evidence="ECO:0000244|PDB:1A31"
FT   STRAND          514..518
FT                   /evidence="ECO:0000244|PDB:1A31"
FT   STRAND          521..530
FT                   /evidence="ECO:0000244|PDB:1A31"
FT   HELIX           532..534
FT                   /evidence="ECO:0000244|PDB:1A31"
FT   STRAND          536..542
FT                   /evidence="ECO:0000244|PDB:1A31"
FT   HELIX           545..553
FT                   /evidence="ECO:0000244|PDB:1A31"
FT   TURN            554..557
FT                   /evidence="ECO:0000244|PDB:1A31"
FT   TURN            564..567
FT                   /evidence="ECO:0000244|PDB:1A31"
FT   HELIX           570..580
FT                   /evidence="ECO:0000244|PDB:1A31"
FT   STRAND          581..583
FT                   /evidence="ECO:0000244|PDB:1NH3"
FT   HELIX           586..605
FT                   /evidence="ECO:0000244|PDB:1A31"
FT   STRAND          608..610
FT                   /evidence="ECO:0000244|PDB:1T8I"
FT   HELIX           612..625
FT                   /evidence="ECO:0000244|PDB:1A31"
FT   TURN            626..631
FT                   /evidence="ECO:0000244|PDB:1SC7"
FT   HELIX           640..643
FT                   /evidence="ECO:0000244|PDB:1K4T"
FT   HELIX           644..673
FT                   /evidence="ECO:0000244|PDB:1K4T"
FT   HELIX           678..710
FT                   /evidence="ECO:0000244|PDB:1K4T"
FT   STRAND          712..714
FT                   /evidence="ECO:0000244|PDB:1K4T"
FT   TURN            721..723
FT                   /evidence="ECO:0000244|PDB:1A31"
FT   HELIX           726..735
FT                   /evidence="ECO:0000244|PDB:1A31"
FT   HELIX           740..742
FT                   /evidence="ECO:0000244|PDB:1A31"
FT   HELIX           746..751
FT                   /evidence="ECO:0000244|PDB:1A31"
FT   HELIX           753..758
FT                   /evidence="ECO:0000244|PDB:1A31"
SQ   SEQUENCE   765 AA;  90726 MW;  6FBED540BCF7BE28 CRC64;
     MSGDHLHNDS QIEADFRLND SHKHKDKHKD REHRHKEHKK EKDREKSKHS NSEHKDSEKK
     HKEKEKTKHK DGSSEKHKDK HKDRDKEKRK EEKVRASGDA KIKKEKENGF SSPPQIKDEP
     EDDGYFVPPK EDIKPLKRPR DEDDADYKPK KIKTEDTKKE KKRKLEEEED GKLKKPKNKD
     KDKKVPEPDN KKKKPKKEEE QKWKWWEEER YPEGIKWKFL EHKGPVFAPP YEPLPENVKF
     YYDGKVMKLS PKAEEVATFF AKMLDHEYTT KEIFRKNFFK DWRKEMTNEE KNIITNLSKC
     DFTQMSQYFK AQTEARKQMS KEEKLKIKEE NEKLLKEYGF CIMDNHKERI ANFKIEPPGL
     FRGRGNHPKM GMLKRRIMPE DIIINCSKDA KVPSPPPGHK WKEVRHDNKV TWLVSWTENI
     QGSIKYIMLN PSSRIKGEKD WQKYETARRL KKCVDKIRNQ YREDWKSKEM KVRQRAVALY
     FIDKLALRAG NEKEEGETAD TVGCCSLRVE HINLHPELDG QEYVVEFDFL GKDSIRYYNK
     VPVEKRVFKN LQLFMENKQP EDDLFDRLNT GILNKHLQDL MEGLTAKVFR TYNASITLQQ
     QLKELTAPDE NIPAKILSYN RANRAVAILC NHQRAPPKTF EKSMMNLQTK IDAKKEQLAD
     ARRDLKSAKA DAKVMKDAKT KKVVESKKKA VQRLEEQLMK LEVQATDREE NKQIALGTSK
     LNYLDPRITV AWCKKWGVPI EKIYNKTQRE KFAWAIDMAD EDYEF
//
ID   Q9BVT2_HUMAN            Unreviewed;       176 AA.
AC   Q9BVT2;
DT   01-JUN-2001, integrated into UniProtKB/TrEMBL.
DT   01-JUN-2001, sequence version 1.
DT   11-DEC-2019, entry version 99.
DE   RecName: Full=TOPEUc domain-containing protein {ECO:0000259|SMART:SM00435};
DE   Flags: Fragment;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH00943.1};
RN   [1] {ECO:0000313|EMBL:AAH00943.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Placenta {ECO:0000313|EMBL:AAH00943.1};
RA   Strausberg R.;
RL   Submitted (NOV-2000) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC000943; AAH00943.1; -; mRNA.
DR   RefSeq; NP_003277.1; NM_003286.3.
DR   PeptideAtlas; Q9BVT2; -.
DR   PRIDE; Q9BVT2; -.
DR   GeneID; 7150; -.
DR   KEGG; hsa:7150; -.
DR   CTD; 7150; -.
DR   eggNOG; KOG0981; Eukaryota.
DR   eggNOG; COG3569; LUCA.
DR   KO; K03163; -.
DR   OrthoDB; 303947at2759; -.
DR   GenomeRNAi; 7150; -.
DR   GO; GO:0005694; C:chromosome; IEA:InterPro.
DR   GO; GO:0003677; F:DNA binding; IEA:InterPro.
DR   GO; GO:0003917; F:DNA topoisomerase type I (single strand cut, ATP-independent) activity; IEA:InterPro.
DR   GO; GO:0006265; P:DNA topological change; IEA:InterPro.
DR   Gene3D; 1.10.132.10; -; 1.
DR   InterPro; IPR011010; DNA_brk_join_enz.
DR   InterPro; IPR018521; TopoI_AS.
DR   InterPro; IPR025834; TopoI_C_dom.
DR   InterPro; IPR014727; TopoI_cat_a/b-sub_euk.
DR   InterPro; IPR013500; TopoI_cat_euk.
DR   InterPro; IPR013499; TopoI_euk.
DR   Pfam; PF14370; Topo_C_assoc; 1.
DR   Pfam; PF01028; Topoisom_I; 1.
DR   SMART; SM00435; TOPEUc; 1.
DR   SUPFAM; SSF56349; SSF56349; 1.
DR   PROSITE; PS00176; TOPOISOMERASE_I_EUK; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN          1..148
FT                   /note="TOPEUc"
FT                   /evidence="ECO:0000259|SMART:SM00435"
FT   COILED          55..89
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          95..122
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   NON_TER         1
FT                   /evidence="ECO:0000313|EMBL:AAH00943.1"
SQ   SEQUENCE   176 AA;  20342 MW;  2D922F02D032E4CD CRC64;
     RTYNASITLQ QQLKELTAPD ENIPAKILSY NRANRAVAIL CNHQRAPPKT FEKSMMNLQT
     KIDAKKEQLA DARRDLKSAK ADAKVMKDAK TKKVVESKKK AVQRLEEQLM KLEVQATDRE
     ENKQIALGTS KLNYLDPRIT VAWCKKWGVP IEKIYNKTQR EKFAWAIDMA DEDYEF
//
ID   A0A5F9UN72_HUMAN        Unreviewed;       158 AA.
AC   A0A5F9UN72;
DT   11-DEC-2019, integrated into UniProtKB/TrEMBL.
DT   11-DEC-2019, sequence version 1.
DT   26-FEB-2020, entry version 2.
DE   SubName: Full=Tropomyosin 4, isoform CRA_c {ECO:0000313|EMBL:EAW84524.1};
DE   SubName: Full=Tropomyosin alpha-4 chain {ECO:0000313|Ensembl:ENSP00000345230};
GN   Name=TPM4 {ECO:0000313|EMBL:EAW84524.1,
GN   ECO:0000313|Ensembl:ENSP00000345230};
GN   ORFNames=hCG_1999582 {ECO:0000313|EMBL:EAW84524.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000345230, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|EMBL:EAW84524.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|Ensembl:ENSP00000345230, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [3] {ECO:0000313|EMBL:EAW84524.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|Ensembl:ENSP00000345230}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (OCT-2019) to UniProtKB.
CC   -!- SIMILARITY: Belongs to the tropomyosin family.
CC       {ECO:0000256|RuleBase:RU004515}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC008894; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471106; EAW84524.1; -; Genomic_DNA.
DR   RefSeq; XP_011526534.1; XM_011528232.1.
DR   Ensembl; ENST00000344824; ENSP00000345230; ENSG00000167460.
DR   GeneID; 7171; -.
DR   HGNC; HGNC:12013; TPM4.
DR   OpenTargets; ENSG00000167460; -.
DR   GeneTree; ENSGT00950000182712; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   InterPro; IPR000533; Tropomyosin.
DR   Pfam; PF00261; Tropomyosin; 1.
DR   PRINTS; PR00194; TROPOMYOSIN.
DR   PROSITE; PS00326; TROPOMYOSIN; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAAS:SAAS00134284, ECO:0000256|SAM:Coils};
KW   Proteomics identification {ECO:0000213|EPD:A0A5F9UN72,
KW   ECO:0000213|MaxQB:A0A5F9UN72, ECO:0000213|PeptideAtlas:A0A5F9UN72,
KW   ECO:0000213|ProteomicsDB:A0A5F9UN72};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   COILED          15..154
FT                   /evidence="ECO:0000256|SAM:Coils"
SQ   SEQUENCE   158 AA;  18370 MW;  8AE836297E36ECC9 CRC64;
     MKVIENRAMK DEEKMEIQEM QLKEAKHIAE EADRKYEEVA RKLVILEGEL ERAEERAEVS
     ELKCGDLEEE LKNVTNNLKS LEAASEKYSE KEDKYEEEIK LLSDKLKEAE TRAEFAERTV
     AKLEKTIDDL EEKLAQAKEE NVGLHQTLDQ TLNELNCI
//
ID   K7ENT6_HUMAN            Unreviewed;       245 AA.
AC   K7ENT6;
DT   09-JAN-2013, integrated into UniProtKB/TrEMBL.
DT   13-NOV-2019, sequence version 3.
DT   22-APR-2020, entry version 43.
DE   SubName: Full=Tropomyosin alpha-4 chain {ECO:0000313|Ensembl:ENSP00000467087};
GN   Name=TPM4 {ECO:0000313|Ensembl:ENSP00000467087};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000467087, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000467087, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [2] {ECO:0000213|PubMed:19608861}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [3] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Burckstummer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [4] {ECO:0000313|Ensembl:ENSP00000467087}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (NOV-2012) to UniProtKB.
RN   [5] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [6] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- SIMILARITY: Belongs to the tropomyosin family.
CC       {ECO:0000256|RuleBase:RU004515}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC008894; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; XP_011526533.1; XM_011528231.2.
DR   RefSeq; XP_016882678.1; XM_017027189.1.
DR   IntAct; K7ENT6; 2.
DR   STRING; 9606.ENSP00000345230; -.
DR   jPOST; K7ENT6; -.
DR   PaxDb; K7ENT6; -.
DR   PeptideAtlas; K7ENT6; -.
DR   PRIDE; K7ENT6; -.
DR   Antibodypedia; 27276; 155 antibodies.
DR   Ensembl; ENST00000586833; ENSP00000467087; ENSG00000167460.
DR   GeneID; 7171; -.
DR   UCSC; uc060uws.1; human.
DR   CTD; 7171; -.
DR   EuPathDB; HostDB:ENSG00000167460.14; -.
DR   HGNC; HGNC:12013; TPM4.
DR   OpenTargets; ENSG00000167460; -.
DR   eggNOG; KOG1003; Eukaryota.
DR   eggNOG; ENOG410XR5K; LUCA.
DR   GeneTree; ENSGT00950000182712; -.
DR   HOGENOM; CLU_055027_3_2_1; -.
DR   ChiTaRS; TPM4; human.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000167460; Expressed in tendon of biceps brachii and 189 other tissues.
DR   ExpressionAtlas; K7ENT6; baseline and differential.
DR   InterPro; IPR000533; Tropomyosin.
DR   Pfam; PF00261; Tropomyosin; 1.
DR   PRINTS; PR00194; TROPOMYOSIN.
DR   PROSITE; PS00326; TROPOMYOSIN; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAAS:SAAS00134284, ECO:0000256|SAM:Coils};
KW   Proteomics identification {ECO:0000213|EPD:K7ENT6,
KW   ECO:0000213|MaxQB:K7ENT6, ECO:0000213|PeptideAtlas:K7ENT6,
KW   ECO:0000213|ProteomicsDB:K7ENT6};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   COILED          46..94
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          102..241
FT                   /evidence="ECO:0000256|SAM:Coils"
SQ   SEQUENCE   245 AA;  28116 MW;  1B8F91E36CACC2F2 CRC64;
     MSSMPATKFS FPFHIFLSCH LSARRIEGWN SNEAPPPRPT LAEGDVAALN RRIQLVEEEL
     DRAQERLATA LQKLEEAEKA ADESERGMKV IENRAMKDEE KMEIQEMQLK EAKHIAEEAD
     RKYEEVARKL VILEGELERA EERAEVSELK CGDLEEELKN VTNNLKSLEA ASEKYSEKED
     KYEEEIKLLS DKLKEAETRA EFAERTVAKL EKTIDDLEEK LAQAKEENVG LHQTLDQTLN
     ELNCI
//
ID   TPM4_HUMAN              Reviewed;         248 AA.
AC   P67936; P07226; Q15659; Q5U0D9; Q9BU85; Q9H8Q3; Q9UCS1; Q9UCS2; Q9UCS3;
AC   Q9UCS4;
DT   01-APR-1988, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   22-APR-2020, entry version 162.
DE   RecName: Full=Tropomyosin alpha-4 chain;
DE   AltName: Full=TM30p1;
DE   AltName: Full=Tropomyosin-4;
GN   Name=TPM4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Fibroblast;
RX   PubMed=3612796; DOI=10.1016/0022-2836(87)90710-8;
RA   McLeod A.R., Talbot K., Smillie L.B., Houlker C.;
RT   "Characterization of a cDNA defining a gene family encoding TM30p1, a human
RT   fibroblast tropomyosin.";
RL   J. Mol. Biol. 194:1-10(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Ovarian carcinoma, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Eye, Placenta, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 2-12.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A., Thomas G.R.,
RA   Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass spectrometric
RT   identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [7]
RP   PROTEIN SEQUENCE OF 2-11; 45-54; 56-69; 77-89; 133-146 AND 216-223,
RP   CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT ALA-2, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY.
RC   TISSUE=Platelet;
RA   Bienvenut W.V., Claeys D.;
RL   Submitted (NOV-2005) to UniProtKB.
RN   [8]
RP   PROTEIN SEQUENCE OF 9-31; 44-61; 89-95; 205-214 AND 231-243 (ISOFORM 1),
RP   FUNCTION, AND TISSUE SPECIFICITY.
RC   TISSUE=Platelet;
RX   PubMed=1836432; DOI=10.1111/j.1365-2362.1991.tb01397.x;
RA   Crabos M., Yamakado T., Heizmann C.W., Cerletti N., Buehler F.R., Erne P.;
RT   "The calcium binding protein tropomyosin in human platelets and cardiac
RT   tissue: elevation in hypertensive cardiac hypertrophy.";
RL   Eur. J. Clin. Invest. 21:472-478(1991).
RN   [9]
RP   PROTEIN SEQUENCE OF 13-27; 45-82; 132-142; 154-169 AND 216-228, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Afjehi-Sadat L., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 118-248.
RC   TISSUE=Fibroblast;
RX   PubMed=3865200; DOI=10.1073/pnas.82.23.7835;
RA   MacLeod A.R., Houlker C., Reinach F.C., Smillie L.B., Talbot K., Modi G.,
RA   Walsh F.S.;
RT   "A muscle-type tropomyosin in human fibroblasts: evidence for expression by
RT   an alternative RNA splicing mechanism.";
RL   Proc. Natl. Acad. Sci. U.S.A. 82:7835-7839(1985).
RN   [11]
RP   PROTEIN SEQUENCE OF 177-189 AND 228-247.
RC   TISSUE=Keratinocyte;
RX   PubMed=1286667; DOI=10.1002/elps.11501301199;
RA   Rasmussen H.H., van Damme J., Puype M., Gesser B., Celis J.E.,
RA   Vandekerckhove J.;
RT   "Microsequences of 145 proteins recorded in the two-dimensional gel protein
RT   database of normal human epidermal keratinocytes.";
RL   Electrophoresis 13:960-969(1992).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-177 AND LYS-215, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-216, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   VARIANT [LARGE SCALE ANALYSIS] GLN-204.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Binds to actin filaments in muscle and non-muscle cells.
CC       Plays a central role, in association with the troponin complex, in the
CC       calcium dependent regulation of vertebrate striated muscle contraction.
CC       Smooth muscle contraction is regulated by interaction with caldesmon.
CC       In non-muscle cells is implicated in stabilizing cytoskeleton actin
CC       filaments (By similarity). Binds calcium (PubMed:1836432).
CC       {ECO:0000250|UniProtKB:P09495, ECO:0000269|PubMed:1836432}.
CC   -!- SUBUNIT: Homodimer. Heterodimer of an alpha (TPM1, TPM3 or TPM4) and a
CC       beta (TPM2) chain. {ECO:0000250|UniProtKB:P04692}.
CC   -!- INTERACTION:
CC       P67936; O75564-2: JRK; NbExp=3; IntAct=EBI-1642100, EBI-17181882;
CC       P67936; Q9NRD5: PICK1; NbExp=3; IntAct=EBI-1642100, EBI-79165;
CC       P67936; O75365-2: PTP4A3; NbExp=2; IntAct=EBI-1642100, EBI-14013960;
CC       P67936; O95295: SNAPIN; NbExp=3; IntAct=EBI-1642100, EBI-296723;
CC       P67936; P06753: TPM3; NbExp=3; IntAct=EBI-1642100, EBI-355607;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000250|UniProtKB:P09495}. Note=Associates with F-actin stress
CC       fibers. {ECO:0000250|UniProtKB:P09495}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P67936-1, P07226-1;
CC         Sequence=Displayed;
CC       Name=2;
CC         IsoId=P67936-2, P07226-2;
CC         Sequence=VSP_006611;
CC   -!- TISSUE SPECIFICITY: Detected in cardiac tissue and platelets, the form
CC       found in cardiac tissue is a higher molecular weight than the form
CC       found in platelets. Expressed at higher levels in the platelets of
CC       hypertensive patients with cardiac hypertrophy than in the platelets of
CC       hypertensive patients without cardiac hypertrophy (at protein level).
CC       {ECO:0000269|PubMed:1836432}.
CC   -!- DOMAIN: The molecule is in a coiled coil structure that is formed by 2
CC       polypeptide chains. The sequence exhibits a prominent seven-residues
CC       periodicity.
CC   -!- SIMILARITY: Belongs to the tropomyosin family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/TPM4ID359.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X05276; CAA28888.1; -; mRNA.
DR   EMBL; AK023385; BAB14554.1; -; mRNA.
DR   EMBL; AK315076; BAG37545.1; -; mRNA.
DR   EMBL; BT019634; AAV38440.1; -; mRNA.
DR   EMBL; CH471106; EAW84521.1; -; Genomic_DNA.
DR   EMBL; BC002827; AAH02827.1; -; mRNA.
DR   EMBL; BC037576; AAH37576.1; -; mRNA.
DR   EMBL; BC067225; AAH67225.1; -; mRNA.
DR   EMBL; M12127; AAA36774.1; -; mRNA.
DR   CCDS; CCDS12338.1; -.
DR   CCDS; CCDS46007.1; -. [P67936-2]
DR   PIR; S07282; S07282.
DR   RefSeq; NP_001138632.1; NM_001145160.1. [P67936-2]
DR   RefSeq; NP_003281.1; NM_003290.2. [P67936-1]
DR   SMR; P67936; -.
DR   BioGrid; 113024; 127.
DR   IntAct; P67936; 69.
DR   DrugBank; DB12695; Phenethyl Isothiocyanate.
DR   iPTMnet; P67936; -.
DR   MetOSite; P67936; -.
DR   PhosphoSitePlus; P67936; -.
DR   SwissPalm; P67936; -.
DR   BioMuta; TPM4; -.
DR   DMDM; 54039751; -.
DR   DOSAC-COBS-2DPAGE; P67936; -.
DR   OGP; P07226; -.
DR   CPTAC; CPTAC-154; -.
DR   CPTAC; CPTAC-155; -.
DR   CPTAC; CPTAC-156; -.
DR   EPD; P67936; -.
DR   jPOST; P67936; -.
DR   MassIVE; P67936; -.
DR   PeptideAtlas; P67936; -.
DR   PRIDE; P67936; -.
DR   ProteomicsDB; 57525; -.
DR   ProteomicsDB; 57526; -. [P67936-2]
DR   Antibodypedia; 27276; 155 antibodies.
DR   DNASU; 7171; -.
DR   Ensembl; ENST00000643579; ENSP00000495347; ENSG00000167460. [P67936-1]
DR   Ensembl; ENST00000646974; ENSP00000494125; ENSG00000167460. [P67936-2]
DR   GeneID; 7171; -.
DR   KEGG; hsa:7171; -.
DR   UCSC; uc002ndi.3; human.
DR   CTD; 7171; -.
DR   DisGeNET; 7171; -.
DR   GeneCards; TPM4; -.
DR   HGNC; HGNC:12013; TPM4.
DR   HPA; ENSG00000167460; Low tissue specificity.
DR   MalaCards; TPM4; -.
DR   MIM; 600317; gene.
DR   neXtProt; NX_P67936; -.
DR   OpenTargets; ENSG00000167460; -.
DR   Orphanet; 140957; Autosomal dominant macrothrombocytopenia.
DR   Orphanet; 178342; Inflammatory myofibroblastic tumor.
DR   PharmGKB; PA36693; -.
DR   GeneTree; ENSGT00950000182712; -.
DR   HOGENOM; CLU_055027_0_0_1; -.
DR   InParanoid; P67936; -.
DR   KO; K10375; -.
DR   OMA; EDKCKQM; -.
DR   OrthoDB; 1576041at2759; -.
DR   PhylomeDB; P67936; -.
DR   TreeFam; TF351519; -.
DR   Reactome; R-HSA-390522; Striated Muscle Contraction.
DR   Reactome; R-HSA-445355; Smooth Muscle Contraction.
DR   ChiTaRS; TPM4; human.
DR   GeneWiki; TPM4; -.
DR   GenomeRNAi; 7171; -.
DR   Pharos; P67936; Tbio.
DR   PRO; PR:P67936; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; P67936; protein.
DR   Bgee; ENSG00000167460; Expressed in tendon of biceps brachii and 189 other tissues.
DR   ExpressionAtlas; P67936; baseline and differential.
DR   Genevisible; P67936; HS.
DR   GO; GO:0005884; C:actin filament; IBA:GO_Central.
DR   GO; GO:0005856; C:cytoskeleton; TAS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005862; C:muscle thin filament tropomyosin; TAS:ProtInc.
DR   GO; GO:0001725; C:stress fiber; IDA:MGI.
DR   GO; GO:0051015; F:actin filament binding; ISS:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; NAS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; ISS:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; ISS:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0008307; F:structural constituent of muscle; TAS:ProtInc.
DR   GO; GO:0007015; P:actin filament organization; IBA:GO_Central.
DR   GO; GO:0006936; P:muscle contraction; IBA:GO_Central.
DR   GO; GO:0030049; P:muscle filament sliding; TAS:Reactome.
DR   GO; GO:0001649; P:osteoblast differentiation; HDA:UniProtKB.
DR   InterPro; IPR000533; Tropomyosin.
DR   Pfam; PF00261; Tropomyosin; 1.
DR   PRINTS; PR00194; TROPOMYOSIN.
DR   PROSITE; PS00326; TROPOMYOSIN; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Actin-binding; Alternative splicing; Calcium; Coiled coil;
KW   Cytoplasm; Cytoskeleton; Direct protein sequencing; Metal-binding;
KW   Muscle protein; Phosphoprotein; Polymorphism; Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378,
FT                   ECO:0000269|PubMed:12665801, ECO:0000269|Ref.7"
FT   CHAIN           2..248
FT                   /note="Tropomyosin alpha-4 chain"
FT                   /id="PRO_0000205635"
FT   COILED          2..248
FT                   /evidence="ECO:0000250"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378,
FT                   ECO:0000269|Ref.7"
FT   MOD_RES         6
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P09495"
FT   MOD_RES         177
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         215
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         216
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   VAR_SEQ         1..44
FT                   /note="MAGLNSLEAVKRKIQALQQQADEAEDRAQGLQRELDGERERREK -> MEAI
FT                   KKKMQMLKLDKENAIDRAEQAEADKKAAEDKCKQVEEELTHLQKKLKGTEDELDKYSED
FT                   LKDAQEKLELTEKKASD (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_006611"
FT   VARIANT         204
FT                   /note="E -> Q (in a breast cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_036535"
FT   CONFLICT        59
FT                   /note="V -> F (in Ref. 5; AAH02827)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        152
FT                   /note="L -> S (in Ref. 10; AAA36774)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        162..163
FT                   /note="KN -> RT (in Ref. 10; AAA36774)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   248 AA;  28522 MW;  5D5CDF6BF76552A8 CRC64;
     MAGLNSLEAV KRKIQALQQQ ADEAEDRAQG LQRELDGERE RREKAEGDVA ALNRRIQLVE
     EELDRAQERL ATALQKLEEA EKAADESERG MKVIENRAMK DEEKMEIQEM QLKEAKHIAE
     EADRKYEEVA RKLVILEGEL ERAEERAEVS ELKCGDLEEE LKNVTNNLKS LEAASEKYSE
     KEDKYEEEIK LLSDKLKEAE TRAEFAERTV AKLEKTIDDL EEKLAQAKEE NVGLHQTLDQ
     TLNELNCI
//
ID   V9HW56_HUMAN            Unreviewed;       248 AA.
AC   V9HW56;
DT   19-MAR-2014, integrated into UniProtKB/TrEMBL.
DT   19-MAR-2014, sequence version 1.
DT   22-APR-2020, entry version 54.
DE   SubName: Full=Epididymis secretory protein Li 108 {ECO:0000313|EMBL:ACI45997.1};
DE   SubName: Full=Tropomyosin 4, isoform CRA_a {ECO:0000313|EMBL:EAW84523.1};
GN   Name=HEL-S-108 {ECO:0000313|EMBL:ACI45997.1};
GN   Synonyms=TPM4 {ECO:0000313|EMBL:EAW84523.1};
GN   ORFNames=hCG_1999582 {ECO:0000313|EMBL:EAW84523.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACI45997.1};
RN   [1] {ECO:0000313|EMBL:EAW84523.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW84523.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ACI45997.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J., Wang H., Liu J., Liu F.;
RL   Submitted (SEP-2008) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the tropomyosin family.
CC       {ECO:0000256|RuleBase:RU004515}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; FJ224305; ACI45997.1; -; mRNA.
DR   EMBL; CH471106; EAW84523.1; -; Genomic_DNA.
DR   RefSeq; NP_003281.1; NM_003290.2.
DR   IntAct; V9HW56; 2.
DR   Antibodypedia; 27276; 155 antibodies.
DR   GeneID; 7171; -.
DR   KEGG; hsa:7171; -.
DR   UCSC; uc002ndj.3; human.
DR   CTD; 7171; -.
DR   EuPathDB; HostDB:ENSG00000167460.14; -.
DR   HOGENOM; CLU_055027_3_0_1; -.
DR   KO; K10375; -.
DR   ChiTaRS; TPM4; human.
DR   GenomeRNAi; 7171; -.
DR   Bgee; ENSG00000167460; Expressed in tendon of biceps brachii and 189 other tissues.
DR   InterPro; IPR000533; Tropomyosin.
DR   Pfam; PF00261; Tropomyosin; 1.
DR   PRINTS; PR00194; TROPOMYOSIN.
DR   PROSITE; PS00326; TROPOMYOSIN; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAAS:SAAS00134284, ECO:0000256|SAM:Coils}.
FT   REGION          15..47
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          105..244
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        26..47
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   248 AA;  28522 MW;  5D5CDF6BF76552A8 CRC64;
     MAGLNSLEAV KRKIQALQQQ ADEAEDRAQG LQRELDGERE RREKAEGDVA ALNRRIQLVE
     EELDRAQERL ATALQKLEEA EKAADESERG MKVIENRAMK DEEKMEIQEM QLKEAKHIAE
     EADRKYEEVA RKLVILEGEL ERAEERAEVS ELKCGDLEEE LKNVTNNLKS LEAASEKYSE
     KEDKYEEEIK LLSDKLKEAE TRAEFAERTV AKLEKTIDDL EEKLAQAKEE NVGLHQTLDQ
     TLNELNCI
//
ID   TPR_HUMAN               Reviewed;        2363 AA.
AC   P12270; Q15624; Q15655; Q5SWY0; Q99968;
DT   01-OCT-1989, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 3.
DT   22-APR-2020, entry version 204.
DE   RecName: Full=Nucleoprotein TPR;
DE   AltName: Full=Megator;
DE   AltName: Full=NPC-associated intranuclear protein;
DE   AltName: Full=Translocated promoter region protein;
GN   Name=TPR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=1549355;
RA   Mitchell P.J., Cooper C.S.;
RT   "Nucleotide sequence analysis of human tpr cDNA clones.";
RL   Oncogene 7:383-388(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1437155;
RA   Mitchell P.J., Cooper C.S.;
RT   "The human tpr gene encodes a protein of 2094 amino acids that has
RT   extensive coiled-coil regions and an acidic C-terminal domain.";
RL   Oncogene 7:2329-2333(1992).
RN   [3]
RP   SEQUENCE REVISION, CHARACTERIZATION, AND SUBCELLULAR LOCATION.
RX   PubMed=7798308; DOI=10.1083/jcb.127.6.1515;
RA   Byrd D.A., Sweet D.J., Pante N., Konstantinov K.N., Guan T.,
RA   Saphire A.C.S., Mitchell P.J., Cooper C.S., Aebi U., Gerace L.;
RT   "Tpr, a large coiled coil protein whose amino terminus is involved in
RT   activation of oncogenic kinases, is localized to the cytoplasmic surface of
RT   the nuclear pore complex.";
RL   J. Cell Biol. 127:1515-1526(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Embryonic brain;
RX   PubMed=9024684; DOI=10.1083/jcb.136.3.515;
RA   Cordes V.C., Reidenbach S., Rackwitz H.R., Franke W.W.;
RT   "Identification of protein p270/Tpr as a constitutive component of the
RT   nuclear pore complex-attached intranuclear filaments.";
RL   J. Cell Biol. 136:515-529(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-191 (ISOFORM 1/2), AND CHROMOSOMAL
RP   REARRANGEMENT WITH NTRK1.
RX   PubMed=1532241;
RA   Greco A., Pierotti M.A., Bongarzone I., Pagliardini S., Lanzi C.,
RA   Della Porta G.;
RT   "TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in
RT   human papillary thyroid carcinomas.";
RL   Oncogene 7:237-242(1992).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-142 (ISOFORM 1/2).
RX   PubMed=3387099;
RA   King H.W.S., Tempest P.R., Merrifield K.R., Rance A.J.;
RT   "tpr homologues activate met and raf.";
RL   Oncogene 2:617-619(1988).
RN   [9]
RP   PROTEIN SEQUENCE OF 2-11; 502-511; 1192-1201 AND 1421-1427, CLEAVAGE OF
RP   INITIATOR METHIONINE, ACETYLATION AT ALA-2, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Hepatoma, and Osteosarcoma;
RA   Bienvenut W.V., Glen H., Brunton V.G., Frame M.C., Boldt K.,
RA   von Kriegsheim A.F., Kolch W.;
RL   Submitted (JUL-2007) to UniProtKB.
RN   [10]
RP   CHROMOSOMAL REARRANGEMENT WITH MET.
RX   PubMed=2300559; DOI=10.1073/pnas.87.2.738;
RA   Soman N.R., Wogan G.N., Rhim J.S.;
RT   "TPR-MET oncogenic rearrangement: detection by polymerase chain reaction
RT   amplification of the transcript and expression in human tumor cell lines.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:738-742(1990).
RN   [11]
RP   SUBCELLULAR LOCATION, AND NPC-BINDING DOMAIN AND NUCLEAR IMPORT DOMAIN.
RX   PubMed=9828100; DOI=10.1006/excr.1998.4246;
RA   Cordes V.C., Hase M.E., Muller L.;
RT   "Molecular segments of protein Tpr that confer nuclear targeting and
RT   association with the nuclear pore complex.";
RL   Exp. Cell Res. 245:43-56(1998).
RN   [12]
RP   FUNCTION, NPC-BINDING DOMAIN AND NUCLEAR IMPORT DOMAIN, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=9864356; DOI=10.1083/jcb.143.7.1801;
RA   Bangs P., Burke B., Powers C., Craig R., Purohit A., Doxsey S.;
RT   "Functional analysis of Tpr: identification of nuclear pore complex
RT   association and nuclear localization domains and a role in mRNA export.";
RL   J. Cell Biol. 143:1801-1812(1998).
RN   [13]
RP   HOMODIMERIZATION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF LEU-458 AND
RP   MET-489.
RX   PubMed=11514627; DOI=10.1091/mbc.12.8.2433;
RA   Hase M.E., Kuznetsov N.V., Cordes V.C.;
RT   "Amino acid substitutions of coiled-coil protein Tpr abrogate anchorage to
RT   the nuclear pore complex but not parallel, in-register homodimerization.";
RL   Mol. Biol. Cell 12:2433-2452(2001).
RN   [14]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=12424524; DOI=10.1007/s00412-002-0208-2;
RA   Kuznetsov N.V., Sandblad L., Hase M.E., Hunziker A., Hergt M., Cordes V.C.;
RT   "The evolutionarily conserved single-copy gene for murine Tpr encodes one
RT   prevalent isoform in somatic cells and lacks paralogs in higher
RT   eukaryotes.";
RL   Chromosoma 111:236-255(2002).
RN   [15]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=11952838; DOI=10.1046/j.1365-2443.2002.00525.x;
RA   Shibata S., Matsuoka Y., Yoneda Y.;
RT   "Nucleocytoplasmic transport of proteins and poly(A)+ RNA in reconstituted
RT   Tpr-less nuclei in living mammalian cells.";
RL   Genes Cells 7:421-434(2002).
RN   [16]
RP   SUBCELLULAR LOCATION.
RX   PubMed=11839768; DOI=10.1083/jcb.200106046;
RA   Frosst P., Guan T., Subauste C., Hahn K., Gerace L.;
RT   "Tpr is localized within the nuclear basket of the pore complex and has a
RT   role in nuclear protein export.";
RL   J. Cell Biol. 156:617-630(2002).
RN   [17]
RP   ABSENCE OF FUNCTION IN ANCHORING NUCLEOPORINS, INTERACTION WITH NUP153,
RP   HOMODIMERIZATION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF LEU-458 AND
RP   MET-489.
RX   PubMed=12802065; DOI=10.1091/mbc.e02-09-0620;
RA   Hase M.E., Cordes V.C.;
RT   "Direct interaction with nup153 mediates binding of Tpr to the periphery of
RT   the nuclear pore complex.";
RL   Mol. Biol. Cell 14:1923-1940(2003).
RN   [18]
RP   SUBCELLULAR LOCATION, AND IDENTIFICATION IN THE NUCLEAR PORE COMPLEX.
RX   PubMed=15229283; DOI=10.1091/mbc.e04-03-0165;
RA   Krull S., Thyberg J., Bjorkroth B., Rackwitz H.R., Cordes V.C.;
RT   "Nucleoporins as components of the nuclear pore complex core structure and
RT   Tpr as the architectural element of the nuclear basket.";
RL   Mol. Biol. Cell 15:4261-4277(2004).
RN   [19]
RP   FUNCTION IN NUCLEAR PROTEIN EXPORT, AND INTERACTION WITH HTT.
RX   PubMed=15654337; DOI=10.1038/ng1503;
RA   Cornett J., Cao F., Wang C.E., Ross C.A., Bates G.P., Li S.H., Li X.J.;
RT   "Polyglutamine expansion of huntingtin impairs its nuclear export.";
RL   Nat. Genet. 37:198-204(2005).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2073, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1185, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [22]
RP   FUNCTION IN STRESS-INDUCED NUCLEAR MRNA EXPORT, AND INTERACTION WITH HSF1.
RX   PubMed=17897941; DOI=10.1074/jbc.m704054200;
RA   Skaggs H.S., Xing H., Wilkerson D.C., Murphy L.A., Hong Y., Mayhew C.N.,
RA   Sarge K.D.;
RT   "HSF1-TPR interaction facilitates export of stress-induced HSP70 mRNA.";
RL   J. Biol. Chem. 282:33902-33907(2007).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2155, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa cells
RT   and high confident phosphopeptide identification by cross-validation of
RT   MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2050, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [25]
RP   INTERACTION WITH MAD2L1 AND MAD1L1, FUNCTION, IDENTIFICATION BY MASS
RP   SPECTROMETRY, AND SUBCELLULAR LOCATION.
RX   PubMed=18981471; DOI=10.1101/gad.1677208;
RA   Lee S.H., Sterling H., Burlingame A., McCormick F.;
RT   "Tpr directly binds to Mad1 and Mad2 and is important for the Mad1-Mad2-
RT   mediated mitotic spindle checkpoint.";
RL   Genes Dev. 22:2926-2931(2008).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2155, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [27]
RP   FUNCTION IN PROTEIN IMPORT, INTERACTION WITH MAPK1, PHOSPHORYLATION BY
RP   MAPK1, AND SUBCELLULAR LOCATION.
RX   PubMed=18794356; DOI=10.1128/mcb.00925-08;
RA   Vomastek T., Iwanicki M.P., Burack W.R., Tiwari D., Kumar D., Parsons J.T.,
RA   Weber M.J., Nandicoori V.K.;
RT   "Extracellular signal-regulated kinase 2 (ERK2) phosphorylation sites and
RT   docking domain on the nuclear pore complex protein Tpr cooperatively
RT   regulate ERK2-Tpr interaction.";
RL   Mol. Cell. Biol. 28:6954-6966(2008).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-379; SER-1185; SER-2048 AND
RP   SER-2155, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [29]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [30]
RP   ASSOCIATION WITH XPO1/CRM1 AND IMPORTIN ALPHA/IMPORTIN BETA RECEPTOR, AND
RP   INTERACTION WITH KPNB1.
RX   PubMed=19835572; DOI=10.1186/1471-2121-10-74;
RA   Ben-Efraim I., Frosst P.D., Gerace L.;
RT   "Karyopherin binding interactions and nuclear import mechanism of nuclear
RT   pore complex protein Tpr.";
RL   BMC Cell Biol. 10:74-74(2009).
RN   [31]
RP   FUNCTION, INTERACTION WITH MAD1L1; MAD2L1 AND TTK, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=19273613; DOI=10.1083/jcb.200811012;
RA   Lince-Faria M., Maffini S., Orr B., Ding Y., Florindo C., Sunkel C.E.,
RA   Tavares A., Johansen J., Johansen K.M., Maiato H.;
RT   "Spatiotemporal control of mitosis by the conserved spindle matrix protein
RT   Megator.";
RL   J. Cell Biol. 184:647-657(2009).
RN   [32]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1185; SER-2050 AND SER-2155,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [33]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-252; LYS-312; LYS-345; LYS-428;
RP   LYS-457; LYS-713; LYS-723; LYS-748 AND LYS-755, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [34]
RP   FUNCTION, ORGANIZATION OF PERINUCLEAR CHROMATIN, SUBCELLULAR LOCATION, AND
RP   PROTEOLYTIC PROCESSING.
RX   PubMed=20407419; DOI=10.1038/emboj.2010.54;
RA   Krull S., Dorries J., Boysen B., Reidenbach S., Magnius L., Norder H.,
RA   Thyberg J., Cordes V.C.;
RT   "Protein Tpr is required for establishing nuclear pore-associated zones of
RT   heterochromatin exclusion.";
RL   EMBO J. 29:1659-1673(2010).
RN   [35]
RP   FUNCTION, INTERACTION WITH DCTN1; DYNEIN; DYNLL1; MAD2L1; NUP153 AND
RP   TUBULIN, AND SUBCELLULAR LOCATION.
RX   PubMed=20133940; DOI=10.1074/jbc.m110.105890;
RA   Nakano H., Funasaka T., Hashizume C., Wong R.W.;
RT   "Nucleoporin translocated promoter region (Tpr) associates with dynein
RT   complex, preventing chromosome lagging formation during mitosis.";
RL   J. Biol. Chem. 285:10841-10849(2010).
RN   [36]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-379; SER-1185; THR-1692 AND
RP   SER-2155, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [37]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [38]
RP   FUNCTION IN UNSPLICED RNA EXPORT.
RX   PubMed=21613532; DOI=10.1261/rna.2616111;
RA   Coyle J.H., Bor Y.C., Rekosh D., Hammarskjold M.L.;
RT   "The Tpr protein regulates export of mRNAs with retained introns that
RT   traffic through the Nxf1 pathway.";
RL   RNA 17:1344-1356(2011).
RN   [39]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1185 AND SER-2073, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [40]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [41]
RP   FUNCTION IN UNSPLICED RNA EXPORT, INTERACTION WITH MAPK1, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=22253824; DOI=10.1371/journal.pone.0029921;
RA   Rajanala K., Nandicoori V.K.;
RT   "Localization of nucleoporin Tpr to the nuclear pore complex is essential
RT   for Tpr mediated regulation of the export of unspliced RNA.";
RL   PLoS ONE 7:E29921-E29921(2012).
RN   [42]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [43]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-379; SER-1185; THR-1692;
RP   SER-2034; SER-2037; SER-2048; SER-2050; THR-2137 AND SER-2155, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [44]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-379; SER-522; SER-523;
RP   SER-632; SER-1893 AND SER-2155, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [45]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-2111, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [46]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH MTA1.
RX   PubMed=24970816; DOI=10.18632/oncotarget.2095;
RA   Liu J., Xu D., Wang H., Zhang Y., Chang Y., Zhang J., Wang J., Li C.,
RA   Liu H., Zhao M., Lin C., Zhan Q., Huang C., Qian H.;
RT   "The subcellular distribution and function of MTA1 in cancer
RT   differentiation.";
RL   Oncotarget 5:5153-5164(2014).
CC   -!- FUNCTION: Component of the nuclear pore complex (NPC), a complex
CC       required for the trafficking across the nuclear envelope. Functions as
CC       a scaffolding element in the nuclear phase of the NPC essential for
CC       normal nucleocytoplasmic transport of proteins and mRNAs, plays a role
CC       in the establishment of nuclear-peripheral chromatin
CC       compartmentalization in interphase, and in the mitotic spindle
CC       checkpoint signaling during mitosis. Involved in the quality control
CC       and retention of unspliced mRNAs in the nucleus; in association with
CC       NUP153, regulates the nuclear export of unspliced mRNA species bearing
CC       constitutive transport element (CTE) in a NXF1- and KHDRBS1-independent
CC       manner. Negatively regulates both the association of CTE-containing
CC       mRNA with large polyribosomes and translation initiation. Does not play
CC       any role in Rev response element (RRE)-mediated export of unspliced
CC       mRNAs. Implicated in nuclear export of mRNAs transcribed from heat
CC       shock gene promoters; associates both with chromatin in the HSP70
CC       promoter and with mRNAs transcribed from this promoter under stress-
CC       induced conditions. Modulates the nucleocytoplasmic transport of
CC       activated MAPK1/ERK2 and huntingtin/HTT and may serve as a docking site
CC       for the XPO1/CRM1-mediated nuclear export complex. According to some
CC       authors, plays a limited role in the regulation of nuclear protein
CC       export (PubMed:22253824 and PubMed:11952838). Plays also a role as a
CC       structural and functional element of the perinuclear chromatin
CC       distribution; involved in the formation and/or maintenance of NPC-
CC       associated perinuclear heterochromatin exclusion zones (HEZs). Finally,
CC       acts as a spatial regulator of the spindle-assembly checkpoint (SAC)
CC       response ensuring a timely and effective recruitment of spindle
CC       checkpoint proteins like MAD1L1 and MAD2L1 to unattached kinetochore
CC       during the metaphase-anaphase transition before chromosome congression.
CC       Its N-terminus is involved in activation of oncogenic kinases.
CC       {ECO:0000269|PubMed:11952838, ECO:0000269|PubMed:15654337,
CC       ECO:0000269|PubMed:17897941, ECO:0000269|PubMed:18794356,
CC       ECO:0000269|PubMed:18981471, ECO:0000269|PubMed:19273613,
CC       ECO:0000269|PubMed:20133940, ECO:0000269|PubMed:20407419,
CC       ECO:0000269|PubMed:21613532, ECO:0000269|PubMed:22253824,
CC       ECO:0000269|PubMed:9864356}.
CC   -!- SUBUNIT: Interacts with IFI204 (via C-terminal region). Interacts with
CC       IFI203 (By similarity). Homodimer. Part of the nuclear pore complex
CC       (NPC). Associates with the XPO1/CRM1-mediated nuclear export complex,
CC       the Importin alpha/Importin beta receptor and the dynein 1 complex.
CC       Interacts (via C-terminal domain) with the KPNB1; the interaction
CC       occurs in a RanGTP-dependent manner. Interacts (via C-terminal
CC       regionand phosphorylated form) with MAPK1/ERK2 (via phosphorylated
CC       form); the interaction requires dimerization of MAPK1/ERK2 and
CC       increases following EGF stimulation. Interacts with MAPK3/ERK1; the
CC       interaction increases following EGF stimulation. Interacts (via coiled
CC       coil region) with NUP153; the interaction is direct. Interacts with
CC       HSF1; the interaction increases in a stress-responsive manner and
CC       stimulates export of stress-induced HSP70 mRNA. Interacts with
CC       huntingtin/HTT; the interaction is inhibited by aggregated
CC       huntingtin/HTT forms with expanded polyglutamine stretch. Interacts
CC       with MAD1L1 (via N-terminal region), MAD2L1, and TTK; the interactions
CC       occurs in a microtubule-independent manner. Interacts (via middle
CC       region) with DYNLL1. Interacts with DCTN1, dynein, NUP153 and tubulin.
CC       Interacts with MTA1. {ECO:0000250, ECO:0000269|PubMed:12802065,
CC       ECO:0000269|PubMed:15229283, ECO:0000269|PubMed:15654337,
CC       ECO:0000269|PubMed:17897941, ECO:0000269|PubMed:18794356,
CC       ECO:0000269|PubMed:18981471, ECO:0000269|PubMed:19273613,
CC       ECO:0000269|PubMed:19835572, ECO:0000269|PubMed:20133940,
CC       ECO:0000269|PubMed:22253824, ECO:0000269|PubMed:24970816}.
CC   -!- INTERACTION:
CC       P12270; Q9Y6D9: MAD1L1; NbExp=2; IntAct=EBI-1048528, EBI-742610;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12802065}. Nucleus
CC       membrane {ECO:0000269|PubMed:11514627, ECO:0000269|PubMed:11952838,
CC       ECO:0000269|PubMed:18794356, ECO:0000269|PubMed:9024684,
CC       ECO:0000269|PubMed:9828100, ECO:0000269|PubMed:9864356}; Peripheral
CC       membrane protein {ECO:0000269|PubMed:11514627,
CC       ECO:0000269|PubMed:9024684, ECO:0000269|PubMed:9828100,
CC       ECO:0000269|PubMed:9864356}; Nucleoplasmic side
CC       {ECO:0000269|PubMed:11514627, ECO:0000269|PubMed:9024684,
CC       ECO:0000269|PubMed:9828100, ECO:0000269|PubMed:9864356}. Nucleus
CC       envelope {ECO:0000269|PubMed:12424524, ECO:0000269|PubMed:7798308}.
CC       Nucleus, nuclear pore complex {ECO:0000269|PubMed:11514627,
CC       ECO:0000269|PubMed:11839768, ECO:0000269|PubMed:12802065,
CC       ECO:0000269|PubMed:15229283, ECO:0000269|PubMed:18981471,
CC       ECO:0000269|PubMed:7798308, ECO:0000269|PubMed:9024684,
CC       ECO:0000269|PubMed:9828100, ECO:0000269|PubMed:9864356}. Cytoplasm
CC       {ECO:0000269|PubMed:11952838, ECO:0000269|PubMed:12802065}. Cytoplasm,
CC       cytoskeleton, spindle {ECO:0000269|PubMed:19273613}. Chromosome,
CC       centromere, kinetochore {ECO:0000269|PubMed:18981471}. Nucleus membrane
CC       {ECO:0000269|PubMed:12802065, ECO:0000269|PubMed:15229283,
CC       ECO:0000269|PubMed:7798308}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:12802065, ECO:0000269|PubMed:15229283,
CC       ECO:0000269|PubMed:7798308}; Cytoplasmic side
CC       {ECO:0000269|PubMed:12802065, ECO:0000269|PubMed:15229283,
CC       ECO:0000269|PubMed:7798308}. Note=Detected as discrete intranuclear
CC       foci with IFI204 (By similarity). In interphase, localizes to the
CC       nucleoplasmic side of the nuclear pore complex (NPC) core structure,
CC       forming a fibrous structure called the nuclear basket. Detected
CC       exclusively to the cytoplasmic margin of NPC (PubMed:7798308). Docking
CC       to the inner nucleoplasmic side of the NPC is mediated through binding
CC       to nucleoporins. Anchored by NUP153 to the NPC. The assembly of the NPC
CC       is a stepwise process in which Trp-containing peripheral structures
CC       assemble after other components, including p62. Detected as filaments
CC       that emanate from the nuclear basket of the NPC and extend to the
CC       nucleolus to delineate a chromatin-free network extending from the
CC       nuclear envelope to the perinucleolar region. Detected in diffuse and
CC       discrete spheroidal intranuclear foci. Nucleocytoplasmic shuttling
CC       protein imported into the nucleus in a XPO1/CRM1- and Importin
CC       alpha/Importin beta receptor-dependent manner. Remains localized to the
CC       nuclear membrane after poliovirus (PV) infection. During mitosis,
CC       remains associated with the nuclear envelope until prometaphase.
CC       Associated with the mitotic spindle from late prometaphase until
CC       anaphase. Reorganized during mitosis in a viscous and dynamic nuclear-
CC       derived spindle matrix that embeds the microtubule spindle apparatus
CC       from pole to pole in a microtubule-independent manner. Recruited to the
CC       reforming nuclear envelope during telophase and cytokinesis. Detected
CC       at kinetochores during prometaphase (PubMed:18981471). Colocalizes with
CC       MAD2L1 in the spindle matrix but not at kinetochore (PubMed:19273613).
CC       Colocalizes with dynein, dynactin, tubulin at kinetochore during the
CC       metaphase-anaphase transition. Colocalizes with DYNLL1 at the mitotic
CC       spindle. {ECO:0000250, ECO:0000269|PubMed:18981471,
CC       ECO:0000269|PubMed:19273613, ECO:0000269|PubMed:7798308}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P12270-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P12270-2; Sequence=VSP_057406, VSP_057407;
CC   -!- TISSUE SPECIFICITY: Expressed in esophagus, ovary, liver, skin, smooth
CC       muscles, cerebrum and fetal cerebellum (at protein level). Highest in
CC       testis, lung, thymus, spleen and brain, lower levels in heart, liver
CC       and kidney. {ECO:0000269|PubMed:12424524, ECO:0000269|PubMed:9024684}.
CC   -!- DOMAIN: The N-terminal domain mediates intranuclear attachment to the
CC       nuclear pore complex. The C-terminal domain mediates its nuclear
CC       import.
CC   -!- PTM: Phosphorylated. Phosphorylation occurs on serine and threonine
CC       residues (comprised in the C-terminal region) by MAPK1/ERK2 and
CC       stabilizes the interaction between these two proteins.
CC       {ECO:0000269|PubMed:18794356}.
CC   -!- PTM: Proteolytically degraded after poliovirus (PV) infection;
CC       degradation is restricted to its unfolded C-terminal tail domain
CC       whereas its coiled-coil domain containing NCP- and NUP153-binding
CC       domains withstand degradation.
CC   -!- DISEASE: Note=A chromosomal aberration involving TPR has been found in
CC       papillary thyroid carcinomas (PTCs). Intrachromosomal rearrangement
CC       that links the 5'-end of the TPR gene to the protein kinase domain of
CC       NTRK1 forms the fusion protein TRK-T1. TRK-T1 is a 55 kDa protein
CC       reacting with antibodies against the carboxy terminus of the NTRK1
CC       protein. {ECO:0000269|PubMed:1532241}.
CC   -!- DISEASE: Note=Involved in tumorigenic rearrangements with the MET.
CC       {ECO:0000269|PubMed:2300559}.
CC   -!- SIMILARITY: Belongs to the TPR family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/TPRID282.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X63105; CAA44819.1; -; mRNA.
DR   EMBL; X66397; CAA47021.1; -; mRNA.
DR   EMBL; U69668; AAB48030.1; -; mRNA.
DR   EMBL; AL596220; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL133553; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471067; EAW91205.1; -; Genomic_DNA.
DR   EMBL; X62947; CAA44719.1; ALT_TERM; mRNA.
DR   EMBL; Y00672; CAA68681.1; -; mRNA.
DR   CCDS; CCDS41446.1; -. [P12270-1]
DR   PIR; S23741; S23741.
DR   RefSeq; NP_003283.2; NM_003292.2. [P12270-1]
DR   PDB; 5TO5; X-ray; 2.50 A; A/B=2-142.
DR   PDB; 5TO6; X-ray; 2.70 A; A/B/C/D=2-142.
DR   PDB; 5TO7; X-ray; 2.60 A; A/B/C/D=2-142.
DR   PDB; 5TVB; X-ray; 2.75 A; A/B=2-142.
DR   PDBsum; 5TO5; -.
DR   PDBsum; 5TO6; -.
DR   PDBsum; 5TO7; -.
DR   PDBsum; 5TVB; -.
DR   SMR; P12270; -.
DR   BioGrid; 113028; 113.
DR   ComplexPortal; CPX-873; Nuclear pore complex.
DR   DIP; DIP-50405N; -.
DR   IntAct; P12270; 53.
DR   MINT; P12270; -.
DR   STRING; 9606.ENSP00000356448; -.
DR   TCDB; 1.I.1.1.3; the eukaryotic nuclear pore complex (e-npc) family.
DR   iPTMnet; P12270; -.
DR   MetOSite; P12270; -.
DR   PhosphoSitePlus; P12270; -.
DR   SwissPalm; P12270; -.
DR   BioMuta; TPR; -.
DR   DMDM; 215274208; -.
DR   EPD; P12270; -.
DR   jPOST; P12270; -.
DR   MassIVE; P12270; -.
DR   MaxQB; P12270; -.
DR   PaxDb; P12270; -.
DR   PeptideAtlas; P12270; -.
DR   PRIDE; P12270; -.
DR   ProteomicsDB; 52840; -. [P12270-1]
DR   Antibodypedia; 11198; 209 antibodies.
DR   Ensembl; ENST00000367478; ENSP00000356448; ENSG00000047410. [P12270-1]
DR   Ensembl; ENST00000613151; ENSP00000483425; ENSG00000047410. [P12270-2]
DR   GeneID; 7175; -.
DR   KEGG; hsa:7175; -.
DR   UCSC; uc001grv.4; human. [P12270-1]
DR   UCSC; uc057nyz.1; human.
DR   CTD; 7175; -.
DR   DisGeNET; 7175; -.
DR   GeneCards; TPR; -.
DR   HGNC; HGNC:12017; TPR.
DR   HPA; ENSG00000047410; Low tissue specificity.
DR   MalaCards; TPR; -.
DR   MIM; 189940; gene.
DR   neXtProt; NX_P12270; -.
DR   OpenTargets; ENSG00000047410; -.
DR   Orphanet; 146; Differentiated thyroid carcinoma.
DR   PharmGKB; PA36696; -.
DR   eggNOG; KOG4674; Eukaryota.
DR   eggNOG; ENOG410XSA1; LUCA.
DR   GeneTree; ENSGT00730000111014; -.
DR   HOGENOM; CLU_001059_0_0_1; -.
DR   InParanoid; P12270; -.
DR   KO; K09291; -.
DR   OMA; KYDRVDP; -.
DR   OrthoDB; 20957at2759; -.
DR   PhylomeDB; P12270; -.
DR   TreeFam; TF350364; -.
DR   Reactome; R-HSA-1169408; ISG15 antiviral mechanism.
DR   Reactome; R-HSA-159227; Transport of the SLBP independent Mature mRNA.
DR   Reactome; R-HSA-159230; Transport of the SLBP Dependant Mature mRNA.
DR   Reactome; R-HSA-159231; Transport of Mature mRNA Derived from an Intronless Transcript.
DR   Reactome; R-HSA-159236; Transport of Mature mRNA derived from an Intron-Containing Transcript.
DR   Reactome; R-HSA-165054; Rev-mediated nuclear export of HIV RNA.
DR   Reactome; R-HSA-168271; Transport of Ribonucleoproteins into the Host Nucleus.
DR   Reactome; R-HSA-168276; NS1 Mediated Effects on Host Pathways.
DR   Reactome; R-HSA-168325; Viral Messenger RNA Synthesis.
DR   Reactome; R-HSA-168333; NEP/NS2 Interacts with the Cellular Export Machinery.
DR   Reactome; R-HSA-170822; Regulation of Glucokinase by Glucokinase Regulatory Protein.
DR   Reactome; R-HSA-180746; Nuclear import of Rev protein.
DR   Reactome; R-HSA-180910; Vpr-mediated nuclear import of PICs.
DR   Reactome; R-HSA-191859; snRNP Assembly.
DR   Reactome; R-HSA-3108214; SUMOylation of DNA damage response and repair proteins.
DR   Reactome; R-HSA-3232142; SUMOylation of ubiquitinylation proteins.
DR   Reactome; R-HSA-3301854; Nuclear Pore Complex (NPC) Disassembly.
DR   Reactome; R-HSA-3371453; Regulation of HSF1-mediated heat shock response.
DR   Reactome; R-HSA-4085377; SUMOylation of SUMOylation proteins.
DR   Reactome; R-HSA-4551638; SUMOylation of chromatin organization proteins.
DR   Reactome; R-HSA-4570464; SUMOylation of RNA binding proteins.
DR   Reactome; R-HSA-4615885; SUMOylation of DNA replication proteins.
DR   Reactome; R-HSA-5578749; Transcriptional regulation by small RNAs.
DR   Reactome; R-HSA-5619107; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC).
DR   Reactome; R-HSA-6784531; tRNA processing in the nucleus.
DR   Reactome; R-HSA-9609690; HCMV Early Events.
DR   Reactome; R-HSA-9610379; HCMV Late Events.
DR   SIGNOR; P12270; -.
DR   ChiTaRS; TPR; human.
DR   GenomeRNAi; 7175; -.
DR   Pharos; P12270; Tbio.
DR   PRO; PR:P12270; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; P12270; protein.
DR   Bgee; ENSG00000047410; Expressed in testis and 248 other tissues.
DR   ExpressionAtlas; P12270; baseline and differential.
DR   Genevisible; P12270; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005868; C:cytoplasmic dynein complex; IDA:UniProtKB.
DR   GO; GO:0019898; C:extrinsic component of membrane; IDA:UniProtKB.
DR   GO; GO:0043657; C:host cell; IEA:GOC.
DR   GO; GO:0000776; C:kinetochore; IDA:UniProtKB.
DR   GO; GO:0072686; C:mitotic spindle; IDA:UniProtKB.
DR   GO; GO:0005635; C:nuclear envelope; IDA:UniProtKB.
DR   GO; GO:0042405; C:nuclear inclusion body; IDA:UniProtKB.
DR   GO; GO:0031965; C:nuclear membrane; IDA:UniProtKB.
DR   GO; GO:0034399; C:nuclear periphery; IDA:UniProtKB.
DR   GO; GO:0005643; C:nuclear pore; IDA:UniProtKB.
DR   GO; GO:0044615; C:nuclear pore nuclear basket; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
DR   GO; GO:0070840; F:dynein complex binding; IDA:UniProtKB.
DR   GO; GO:0031072; F:heat shock protein binding; IDA:UniProtKB.
DR   GO; GO:0051019; F:mitogen-activated protein kinase binding; IDA:UniProtKB.
DR   GO; GO:0003729; F:mRNA binding; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0017056; F:structural constituent of nuclear pore; IDA:UniProtKB.
DR   GO; GO:0015631; F:tubulin binding; IDA:UniProtKB.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0034605; P:cellular response to heat; IDA:UniProtKB.
DR   GO; GO:0035457; P:cellular response to interferon-alpha; ISS:UniProtKB.
DR   GO; GO:0075733; P:intracellular transport of virus; TAS:Reactome.
DR   GO; GO:0007094; P:mitotic spindle assembly checkpoint; IMP:UniProtKB.
DR   GO; GO:0006406; P:mRNA export from nucleus; IBA:GO_Central.
DR   GO; GO:0031990; P:mRNA export from nucleus in response to heat stress; IDA:UniProtKB.
DR   GO; GO:0046832; P:negative regulation of RNA export from nucleus; IDA:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IMP:UniProtKB.
DR   GO; GO:0045947; P:negative regulation of translational initiation; IMP:UniProtKB.
DR   GO; GO:0006999; P:nuclear pore organization; IMP:UniProtKB.
DR   GO; GO:0031453; P:positive regulation of heterochromatin assembly; IMP:UniProtKB.
DR   GO; GO:0090316; P:positive regulation of intracellular protein transport; IMP:UniProtKB.
DR   GO; GO:0090267; P:positive regulation of mitotic cell cycle spindle assembly checkpoint; IMP:UniProtKB.
DR   GO; GO:0046827; P:positive regulation of protein export from nucleus; ISS:UniProtKB.
DR   GO; GO:0042307; P:positive regulation of protein import into nucleus; IMP:UniProtKB.
DR   GO; GO:0006606; P:protein import into nucleus; IMP:UniProtKB.
DR   GO; GO:0016925; P:protein sumoylation; TAS:Reactome.
DR   GO; GO:1900034; P:regulation of cellular response to heat; TAS:Reactome.
DR   GO; GO:0060964; P:regulation of gene silencing by miRNA; TAS:Reactome.
DR   GO; GO:0006110; P:regulation of glycolytic process; TAS:Reactome.
DR   GO; GO:0010965; P:regulation of mitotic sister chromatid separation; IMP:UniProtKB.
DR   GO; GO:1901673; P:regulation of mitotic spindle assembly; IMP:UniProtKB.
DR   GO; GO:0032880; P:regulation of protein localization; IMP:UniProtKB.
DR   GO; GO:0070849; P:response to epidermal growth factor; IDA:UniProtKB.
DR   GO; GO:0006405; P:RNA export from nucleus; IMP:UniProtKB.
DR   GO; GO:0006404; P:RNA import into nucleus; IDA:UniProtKB.
DR   GO; GO:0006409; P:tRNA export from nucleus; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; TAS:Reactome.
DR   GO; GO:0019083; P:viral transcription; TAS:Reactome.
DR   InterPro; IPR012929; TPR/MLP1.
DR   Pfam; PF07926; TPR_MLP1_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cell cycle; Cell division;
KW   Centromere; Chromosomal rearrangement; Chromosome; Coiled coil; Cytoplasm;
KW   Cytoskeleton; Direct protein sequencing; Kinetochore; Membrane;
KW   Methylation; Mitosis; mRNA transport; Nuclear pore complex; Nucleus;
KW   Phosphoprotein; Polymorphism; Protein transport; Proto-oncogene;
KW   Reference proteome; Translocation; Transport.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378,
FT                   ECO:0000269|Ref.9"
FT   CHAIN           2..2363
FT                   /note="Nucleoprotein TPR"
FT                   /id="PRO_0000204920"
FT   REGION          3..13
FT                   /note="Sufficient for interaction with TPR"
FT   REGION          14..117
FT                   /note="Necessary for interaction with HSF1"
FT                   /evidence="ECO:0000269|PubMed:17897941"
FT   REGION          437..513
FT                   /note="Necessary for association to the NPC"
FT   REGION          1218..1320
FT                   /note="Necessary for interaction with HSF1"
FT                   /evidence="ECO:0000269|PubMed:17897941"
FT   REGION          1812..1867
FT                   /note="Sufficient and essential for mediating its nuclear
FT                   import"
FT   COILED          29..370
FT                   /evidence="ECO:0000255"
FT   COILED          423..602
FT                   /evidence="ECO:0000255"
FT   COILED          661..1173
FT                   /evidence="ECO:0000255"
FT   COILED          1215..1630
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        527..530
FT                   /note="Poly-Ser"
FT   COMPBIAS        1833..1836
FT                   /note="Poly-Glu"
FT   COMPBIAS        1971..1978
FT                   /note="Poly-Asp"
FT   COMPBIAS        2309..2312
FT                   /note="Poly-Ser"
FT   SITE            191
FT                   /note="Breakpoint for translocation to form TRK-T1"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378,
FT                   ECO:0000269|Ref.9"
FT   MOD_RES         252
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         312
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         345
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         379
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         428
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         457
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         477
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:F6ZDS4"
FT   MOD_RES         522
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         523
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         632
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         713
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         723
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         748
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         755
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         1185
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:16964243,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         1690
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:F6ZDS4"
FT   MOD_RES         1692
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         1893
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         2034
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         2037
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         2048
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         2050
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17525332,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163"
FT   MOD_RES         2073
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:21406692"
FT   MOD_RES         2106
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:F6ZDS4"
FT   MOD_RES         2111
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         2116
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:F6ZDS4"
FT   MOD_RES         2137
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         2155
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17924679,
FT                   ECO:0000244|PubMed:18220336, ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         2163
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:F6ZDS4"
FT   MOD_RES         2343
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:F6ZDS4"
FT   MOD_RES         2345
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:F6ZDS4"
FT   MOD_RES         2354
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:F6ZDS4"
FT   VAR_SEQ         726
FT                   /note="E -> L (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:1549355"
FT                   /id="VSP_057406"
FT   VAR_SEQ         727..2363
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:1549355"
FT                   /id="VSP_057407"
FT   VARIANT         960
FT                   /note="S -> N (in dbSNP:rs3753565)"
FT                   /id="VAR_020429"
FT   VARIANT         1428
FT                   /note="V -> G (in dbSNP:rs35550453)"
FT                   /id="VAR_047289"
FT   VARIANT         1707
FT                   /note="T -> A (in dbSNP:rs35766045)"
FT                   /id="VAR_047290"
FT   MUTAGEN         458
FT                   /note="L->P: Diminishes association to NPC but not
FT                   homodimerization. Inhibits association to NPC, interaction
FT                   with NUP153 and nuclear membrane localization but not
FT                   homodimerization; when associated with P-489."
FT                   /evidence="ECO:0000269|PubMed:11514627,
FT                   ECO:0000269|PubMed:12802065"
FT   MUTAGEN         489
FT                   /note="M->P: Diminishes association to NPC but not
FT                   homodimerization. Inhibits association to NPC, interaction
FT                   with NUP153 and nuclear membrane localization but not
FT                   homodimerization; when associated with P-458."
FT                   /evidence="ECO:0000269|PubMed:11514627,
FT                   ECO:0000269|PubMed:12802065"
FT   CONFLICT        32
FT                   /note="Q -> R (in Ref. 5; CAA44719 and 6; CAA68681)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        779
FT                   /note="V -> I (in Ref. 4; AAB48030)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        906
FT                   /note="Q -> R (in Ref. 4; AAB48030)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1239
FT                   /note="Q -> E (in Ref. 3; CAA47021)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1952..1965
FT                   /note="Missing (in Ref. 3; CAA47021)"
FT                   /evidence="ECO:0000305"
FT   HELIX           5..8
FT                   /evidence="ECO:0000244|PDB:5TO5"
FT   HELIX           11..14
FT                   /evidence="ECO:0000244|PDB:5TO5"
FT   HELIX           19..140
FT                   /evidence="ECO:0000244|PDB:5TO5"
SQ   SEQUENCE   2363 AA;  267293 MW;  01E669CBDC496772 CRC64;
     MAAVLQQVLE RTELNKLPKS VQNKLEKFLA DQQSEIDGLK GRHEKFKVES EQQYFEIEKR
     LSHSQERLVN ETRECQSLRL ELEKLNNQLK ALTEKNKELE IAQDRNIAIQ SQFTRTKEEL
     EAEKRDLIRT NERLSQELEY LTEDVKRLNE KLKESNTTKG ELQLKLDELQ ASDVSVKYRE
     KRLEQEKELL HSQNTWLNTE LKTKTDELLA LGREKGNEIL ELKCNLENKK EEVSRLEEQM
     NGLKTSNEHL QKHVEDLLTK LKEAKEQQAS MEEKFHNELN AHIKLSNLYK SAADDSEAKS
     NELTRAVEEL HKLLKEAGEA NKAIQDHLLE VEQSKDQMEK EMLEKIGRLE KELENANDLL
     SATKRKGAIL SEEELAAMSP TAAAVAKIVK PGMKLTELYN AYVETQDQLL LEKLENKRIN
     KYLDEIVKEV EAKAPILKRQ REEYERAQKA VASLSVKLEQ AMKEIQRLQE DTDKANKQSS
     VLERDNRRME IQVKDLSQQI RVLLMELEEA RGNHVIRDEE VSSADISSSS EVISQHLVSY
     RNIEELQQQN QRLLVALREL GETREREEQE TTSSKITELQ LKLESALTEL EQLRKSRQHQ
     MQLVDSIVRQ RDMYRILLSQ TTGVAIPLHA SSLDDVSLAS TPKRPSTSQT VSTPAPVPVI
     ESTEAIEAKA ALKQLQEIFE NYKKEKAENE KIQNEQLEKL QEQVTDLRSQ NTKISTQLDF
     ASKRYEMLQD NVEGYRREIT SLHERNQKLT ATTQKQEQII NTMTQDLRGA NEKLAVAEVR
     AENLKKEKEM LKLSEVRLSQ QRESLLAEQR GQNLLLTNLQ TIQGILERSE TETKQRLSSQ
     IEKLEHEISH LKKKLENEVE QRHTLTRNLD VQLLDTKRQL DTETNLHLNT KELLKNAQKE
     IATLKQHLSN MEVQVASQSS QRTGKGQPSN KEDVDDLVSQ LRQTEEQVND LKERLKTSTS
     NVEQYQAMVT SLEESLNKEK QVTEEVRKNI EVRLKESAEF QTQLEKKLME VEKEKQELQD
     DKRRAIESME QQLSELKKTL SSVQNEVQEA LQRASTALSN EQQARRDCQE QAKIAVEAQN
     KYERELMLHA ADVEALQAAK EQVSKMASVR QHLEETTQKA ESQLLECKAS WEERERMLKD
     EVSKCVCRCE DLEKQNRLLH DQIEKLSDKV VASVKEGVQG PLNVSLSEEG KSQEQILEIL
     RFIRREKEIA ETRFEVAQVE SLRYRQRVEL LERELQELQD SLNAEREKVQ VTAKTMAQHE
     ELMKKTETMN VVMETNKMLR EEKERLEQDL QQMQAKVRKL ELDILPLQEA NAELSEKSGM
     LQAEKKLLEE DVKRWKARNQ HLVSQQKDPD TEEYRKLLSE KEVHTKRIQQ LTEEIGRLKA
     EIARSNASLT NNQNLIQSLK EDLNKVRTEK ETIQKDLDAK IIDIQEKVKT ITQVKKIGRR
     YKTQYEELKA QQDKVMETSA QSSGDHQEQH VSVQEMQELK ETLNQAETKS KSLESQVENL
     QKTLSEKETE ARNLQEQTVQ LQSELSRLRQ DLQDRTTQEE QLRQQITEKE EKTRKAIVAA
     KSKIAHLAGV KDQLTKENEE LKQRNGALDQ QKDELDVRIT ALKSQYEGRI SRLERELREH
     QERHLEQRDE PQEPSNKVPE QQRQITLKTT PASGERGIAS TSDPPTANIK PTPVVSTPSK
     VTAAAMAGNK STPRASIRPM VTPATVTNPT TTPTATVMPT TQVESQEAMQ SEGPVEHVPV
     FGSTSGSVRS TSPNVQPSIS QPILTVQQQT QATAFVQPTQ QSHPQIEPAN QELSSNIVEV
     VQSSPVERPS TSTAVFGTVS ATPSSSLPKR TREEEEDSTI EASDQVSDDT VEMPLPKKLK
     SVTPVGTEEE VMAEESTDGE VETQVYNQDS QDSIGEGVTQ GDYTPMEDSE ETSQSLQIDL
     GPLQSDQQTT TSSQDGQGKG DDVIVIDSDD EEEDDDENDG EHEDYEEDEE DDDDDEDDTG
     MGDEGEDSNE GTGSADGNDG YEADDAEGGD GTDPGTETEE SMGGGEGNHR AADSQNSGEG
     NTGAAESSFS QEVSREQQPS SASERQAPRA PQSPRRPPHP LPPRLTIHAP PQELGPPVQR
     IQMTRRQSVG RGLQLTPGIG GMQQHFFDDE DRTVPSTPTL VVPHRTDGFA EAIHSPQVAG
     VPRFRFGPPE DMPQTSSSHS DLGQLASQGG LGMYETPLFL AHEEESGGRS VPTTPLQVAA
     PVTVFTESTT SDASEHASQS VPMVTTSTGT LSTTNETATG DDGDEVFVEA ESEGISSEAG
     LEIDSQQEEE PVQASDESDL PSTSQDPPSS SSVDTSSSQP KPFRRVRLQT TLRQGVRGRQ
     FNRQRGVSHA MGGRGGINRG NIN
//
ID   TRIPB_HUMAN             Reviewed;        1979 AA.
AC   Q15643; B2RUT2; O14689; O15154; O95949; Q6MZL5;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   23-MAR-2010, sequence version 3.
DT   22-APR-2020, entry version 180.
DE   RecName: Full=Thyroid receptor-interacting protein 11;
DE            Short=TR-interacting protein 11;
DE            Short=TRIP-11;
DE   AltName: Full=Clonal evolution-related gene on chromosome 14 protein;
DE   AltName: Full=Golgi-associated microtubule-binding protein 210;
DE            Short=GMAP-210;
DE   AltName: Full=Trip230;
GN   Name=TRIP11; Synonyms=CEV14;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND INTERACTION WITH RB1 AND THRB.
RC   TISSUE=Fibroblast;
RX   PubMed=9256431; DOI=10.1073/pnas.94.17.9040;
RA   Chang K.-H., Chen Y., Chen T.-T., Chou W.-H., Chen P.-L., Ma Y.-T.,
RA   Yang-Feng T.L., Leng L., Tsai M.-J., O'Malley B.W., Lee W.-H.;
RT   "A thyroid hormone receptor coactivator negatively regulated by the
RT   retinoblastoma protein.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:9040-9045(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, SUBCELLULAR
RP   LOCATION, INTERACTION WITH MICROTUBULES, AND VARIANT SER-1827.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=10189370; DOI=10.1083/jcb.145.1.83;
RA   Infante C., Ramos-Morales F., Fedriani F., Bornens M., Rios R.M.;
RT   "GMAP-210, a cis-Golgi network-associated protein, is a minus end
RT   microtubule-binding protein.";
RL   J. Cell Biol. 145:83-98(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S., Sun H.,
RA   Du H., Pepin K., Artiguenave F., Robert C., Cruaud C., Bruels T.,
RA   Jaillon O., Friedlander L., Samson G., Brottier P., Cure S., Segurens B.,
RA   Aniere F., Samain S., Crespeau H., Abbasi N., Aiach N., Boscus D.,
RA   Dickhoff R., Dors M., Dubois I., Friedman C., Gouyvenoux M., James R.,
RA   Madan A., Mairey-Estrada B., Mangenot S., Martins N., Menard M., Oztas S.,
RA   Ratcliffe A., Shaffer T., Trask B., Vacherie B., Bellemere C., Belser C.,
RA   Besnard-Gonnet M., Bartol-Mavel D., Boutard M., Briez-Silla S.,
RA   Combette S., Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C.,
RA   Muselet D., Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P.,
RA   Trybou A., Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L., Verdier J.,
RA   Verdier-Discala C., Hillier L.W., Fulton L., McPherson J., Matsuda F.,
RA   Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W., Quetier F.,
RA   Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS LEU-39 AND SER-1827.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 257-1950 (ISOFORM 2).
RC   TISSUE=Salivary gland;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1188-1979, CHROMOSOMAL TRANSLOCATION WITH
RP   PDGFRB, TISSUE SPECIFICITY, AND VARIANT SER-1827.
RC   TISSUE=Leukemia;
RX   PubMed=9373237;
RA   Abe A., Emi N., Tanimoto M., Terasaki H., Marunouchi T., Saito H.;
RT   "Fusion of the platelet-derived growth factor receptor beta to a novel gene
RT   CEV14 in acute myelogenous leukemia after clonal evolution.";
RL   Blood 90:4271-4277(1997).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1757-1944, INTERACTION WITH THRB, AND VARIANT
RP   SER-1827.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=7776974; DOI=10.1210/mend.9.2.7776974;
RA   Lee J.W., Choi H.-S., Gyuris J., Brent R., Moore D.D.;
RT   "Two classes of proteins dependent on either the presence or absence of
RT   thyroid hormone for interaction with the thyroid hormone receptor.";
RL   Mol. Endocrinol. 9:243-254(1995).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1891, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   INTERACTION WITH IFT20.
RX   PubMed=19112494; DOI=10.1371/journal.pgen.1000315;
RA   Follit J.A., San Agustin J.T., Xu F., Jonassen J.A., Samtani R., Lo C.W.,
RA   Pazour G.J.;
RT   "The Golgin GMAP210/TRIP11 anchors IFT20 to the Golgi complex.";
RL   PLoS Genet. 4:E1000315-E1000315(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-464; SER-1842 AND THR-1846,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1842 AND THR-1846, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [13]
RP   INVOLVEMENT IN ACG1A, AND VARIANT ACG1A 264-ARG--GLN-1979 DEL.
RX   PubMed=20089971; DOI=10.1056/nejmoa0900158;
RA   Smits P., Bolton A.D., Funari V., Hong M., Boyden E.D., Lu L.,
RA   Manning D.K., Dwyer N.D., Moran J.L., Prysak M., Merriman B., Nelson S.F.,
RA   Bonafe L., Superti-Furga A., Ikegawa S., Krakow D., Cohn D.H.,
RA   Kirchhausen T., Warman M.L., Beier D.R.;
RT   "Lethal skeletal dysplasia in mice and humans lacking the golgin GMAP-
RT   210.";
RL   N. Engl. J. Med. 362:206-216(2010).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-464 AND SER-1842, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-464 AND SER-1891, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   FUNCTION.
RX   PubMed=25717001; DOI=10.1242/jcs.166710;
RA   Roboti P., Sato K., Lowe M.;
RT   "The golgin GMAP-210 is required for efficient membrane trafficking in the
RT   early secretory pathway.";
RL   J. Cell Sci. 128:1595-1606(2015).
RN   [18]
RP   FUNCTION, SUBCELLULAR LOCATION, DOMAIN, INTERACTION WITH RAB2A, AND
RP   MUTAGENESIS OF 2-MET--LEU-38 AND 1113-SER--LEU-1423.
RX   PubMed=25473115; DOI=10.1091/mbc.e14-10-1450;
RA   Sato K., Roboti P., Mironov A.A., Lowe M.;
RT   "Coupling of vesicle tethering and Rab binding is required for in vivo
RT   functionality of the golgin GMAP-210.";
RL   Mol. Biol. Cell 26:537-553(2015).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [20]
RP   FUNCTION, ALTERNATIVE SPLICING (ISOFORM 2), TISSUE SPECIFICITY, INVOLVEMENT
RP   IN ODCD, VARIANTS ACG1A 264-ARG--GLN-1979 DEL; 1160-GLN--GLN-1979 DEL;
RP   1167-ARG--GLN-1979 DEL; 1224-TRP--GLN-1979 DEL; 1321-LEU--GLN-1979 DEL AND
RP   1376-SER--GLN-1979 DEL, CHARACTERIZATION OF VARIANT ACG1A
RP   1224-TRP--GLN-1979 DEL, AND VARIANTS ODCD 105-VAL--GLN-196 DEL;
RP   196-GLN--GLN-1979 DEL; 264-ARG--GLN-1979 DEL; TYR-410; 1512-GLN--GLN-1979
RP   DEL AND VAL-1806.
RX   PubMed=30728324; DOI=10.1172/jci.insight.124701;
RA   Wehrle A., Witkos T.M., Unger S., Schneider J., Follit J.A., Hermann J.,
RA   Welting T., Fano V., Hietala M., Vatanavicharn N., Schoner K., Spranger J.,
RA   Schmidts M., Zabel B., Pazour G.J., Bloch-Zupan A., Nishimura G.,
RA   Superti-Furga A., Lowe M., Lausch E.;
RT   "Hypomorphic mutations of TRIP11 cause odontochondrodysplasia.";
RL   JCI Insight 4:0-0(2019).
RN   [21]
RP   VARIANT [LARGE SCALE ANALYSIS] ILE-1846.
RX   PubMed=18987736; DOI=10.1038/nature07485;
RA   Ley T.J., Mardis E.R., Ding L., Fulton B., McLellan M.D., Chen K.,
RA   Dooling D., Dunford-Shore B.H., McGrath S., Hickenbotham M., Cook L.,
RA   Abbott R., Larson D.E., Koboldt D.C., Pohl C., Smith S., Hawkins A.,
RA   Abbott S., Locke D., Hillier L.W., Miner T., Fulton L., Magrini V.,
RA   Wylie T., Glasscock J., Conyers J., Sander N., Shi X., Osborne J.R.,
RA   Minx P., Gordon D., Chinwalla A., Zhao Y., Ries R.E., Payton J.E.,
RA   Westervelt P., Tomasson M.H., Watson M., Baty J., Ivanovich J., Heath S.,
RA   Shannon W.D., Nagarajan R., Walter M.J., Link D.C., Graubert T.A.,
RA   DiPersio J.F., Wilson R.K.;
RT   "DNA sequencing of a cytogenetically normal acute myeloid leukaemia
RT   genome.";
RL   Nature 456:66-72(2008).
RN   [22]
RP   VARIANT ALA-559.
RX   PubMed=27717682; DOI=10.1016/j.jstrokecerebrovasdis.2016.09.003;
RA   Mukawa M., Nariai T., Onda H., Yoneyama T., Aihara Y., Hirota K., Kudo T.,
RA   Sumita K., Maehara T., Kawamata T., Kasuya H., Akagawa H.;
RT   "Exome sequencing identified CCER2 as a novel candidate gene for Moyamoya
RT   disease.";
RL   J. Stroke Cerebrovasc. Dis. 26:150-161(2017).
CC   -!- FUNCTION: Is a membrane tether required for vesicle tethering to Golgi.
CC       Has an essential role in the maintenance of Golgi structure and
CC       function (PubMed:25473115, PubMed:30728324). It is required for
CC       efficient anterograde and retrograde trafficking in the early secretory
CC       pathway, functioning at both the ER-to-Golgi intermediate compartment
CC       (ERGIC) and Golgi complex (PubMed:25717001). Binds the ligand binding
CC       domain of the thyroid receptor (THRB) in the presence of
CC       triiodothyronine and enhances THRB-modulated transcription.
CC       {ECO:0000269|PubMed:10189370, ECO:0000269|PubMed:25473115,
CC       ECO:0000269|PubMed:25717001, ECO:0000269|PubMed:30728324,
CC       ECO:0000269|PubMed:9256431}.
CC   -!- SUBUNIT: Interacts with the active form of RAB2A (PubMed:25473115).
CC       Interacts with IFT20 (PubMed:19112494). Binds RB1.
CC       {ECO:0000269|PubMed:19112494, ECO:0000269|PubMed:25473115}.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus, cis-Golgi network membrane
CC       {ECO:0000269|PubMed:10189370, ECO:0000269|PubMed:25473115}; Peripheral
CC       membrane protein {ECO:0000269|PubMed:10189370}. Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:10189370}. Endoplasmic reticulum-Golgi intermediate
CC       compartment membrane {ECO:0000269|PubMed:25473115}. Note=Associates
CC       with the ends of centrosome-nucleated microtubules.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q15643-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q15643-2; Sequence=VSP_060242;
CC   -!- TISSUE SPECIFICITY: Highly expressed in pancreas, muscle, heart,
CC       testis, peripheral blood leukocytes, and in several leukemia cell
CC       lines. Detected at intermediate levels in placenta and kidney, and at
CC       low levels in brain and lung. Isoform 1 and isoform 2 are expressed in
CC       articular chondrocytes (PubMed:30728324). {ECO:0000269|PubMed:10189370,
CC       ECO:0000269|PubMed:30728324, ECO:0000269|PubMed:9373237}.
CC   -!- DOMAIN: Extended rod-like protein with coiled-coil domains.
CC   -!- DOMAIN: The C-terminus is required for recruitment to the Golgi
CC       apparatus and endoplasmic reticulum-Golgi intermediate compartment.
CC       {ECO:0000269|PubMed:25473115}.
CC   -!- DISEASE: Note=A chromosomal aberration involving TRIP11 may be a cause
CC       of acute myelogenous leukemia. Translocation t(5;14)(q33;q32) with
CC       PDGFRB. The fusion protein may be involved in clonal evolution of
CC       leukemia and eosinophilia. {ECO:0000269|PubMed:9373237}.
CC   -!- DISEASE: Achondrogenesis 1A (ACG1A) [MIM:200600]: A form of
CC       achondrogenesis type 1, a lethal form of chondrodysplasia characterized
CC       by deficient ossification in the lumbar vertebrae and absent
CC       ossification in the sacral, pubic and ischial bones and clinically by
CC       stillbirth or early death. In addition to severe micromelia, there is a
CC       disproportionately large cranium due to marked edema of soft tissues.
CC       {ECO:0000269|PubMed:20089971, ECO:0000269|PubMed:30728324}. Note=The
CC       disease is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Odontochondrodysplasia (ODCD) [MIM:184260]: An autosomal
CC       recessive disorder of skeletal and dental development characterized by
CC       mesomelic shortening of tubular bones, ligamentous laxity, scoliosis,
CC       and dentinogenesis imperfecta involving both primary and secondary
CC       dentition. Radiologic features include trident pelvis, posteriorly
CC       flattened vertebrae, and brachydactyly with cone-shaped epiphyses.
CC       {ECO:0000269|PubMed:30728324}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB84386.1; Type=Frameshift; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CEV14ID96.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF007217; AAD09135.1; -; mRNA.
DR   EMBL; Y12490; CAA73095.1; -; mRNA.
DR   EMBL; AL049872; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC146845; AAI46846.1; -; mRNA.
DR   EMBL; BX641024; CAE46015.1; -; mRNA.
DR   EMBL; AF011368; AAB84386.1; ALT_FRAME; mRNA.
DR   EMBL; L40380; AAC41730.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS9899.1; -. [Q15643-1]
DR   PIR; T03719; T03719.
DR   RefSeq; NP_004230.2; NM_004239.4. [Q15643-1]
DR   SMR; Q15643; -.
DR   BioGrid; 114732; 34.
DR   DIP; DIP-40357N; -.
DR   IntAct; Q15643; 37.
DR   MINT; Q15643; -.
DR   STRING; 9606.ENSP00000267622; -.
DR   iPTMnet; Q15643; -.
DR   PhosphoSitePlus; Q15643; -.
DR   BioMuta; TRIP11; -.
DR   DMDM; 292495059; -.
DR   EPD; Q15643; -.
DR   jPOST; Q15643; -.
DR   MassIVE; Q15643; -.
DR   MaxQB; Q15643; -.
DR   PaxDb; Q15643; -.
DR   PeptideAtlas; Q15643; -.
DR   PRIDE; Q15643; -.
DR   ProteomicsDB; 60680; -.
DR   Antibodypedia; 121; 86 antibodies.
DR   Ensembl; ENST00000267622; ENSP00000267622; ENSG00000100815. [Q15643-1]
DR   GeneID; 9321; -.
DR   KEGG; hsa:9321; -.
DR   UCSC; uc001xzy.4; human. [Q15643-1]
DR   CTD; 9321; -.
DR   DisGeNET; 9321; -.
DR   GeneCards; TRIP11; -.
DR   HGNC; HGNC:12305; TRIP11.
DR   HPA; ENSG00000100815; Low tissue specificity.
DR   MalaCards; TRIP11; -.
DR   MIM; 184260; phenotype.
DR   MIM; 200600; phenotype.
DR   MIM; 604505; gene.
DR   neXtProt; NX_Q15643; -.
DR   OpenTargets; ENSG00000100815; -.
DR   Orphanet; 93299; Achondrogenesis type 1A.
DR   Orphanet; 166272; Odontochondrodysplasia.
DR   PharmGKB; PA36984; -.
DR   eggNOG; ENOG410IF24; Eukaryota.
DR   eggNOG; ENOG410XT0E; LUCA.
DR   GeneTree; ENSGT00710000106769; -.
DR   HOGENOM; CLU_001835_0_0_1; -.
DR   InParanoid; Q15643; -.
DR   KO; K23368; -.
DR   OMA; EQMNATH; -.
DR   OrthoDB; 153176at2759; -.
DR   PhylomeDB; Q15643; -.
DR   TreeFam; TF351148; -.
DR   Reactome; R-HSA-5620924; Intraflagellar transport.
DR   Reactome; R-HSA-6811438; Intra-Golgi traffic.
DR   SIGNOR; Q15643; -.
DR   ChiTaRS; TRIP11; human.
DR   GeneWiki; TRIP11; -.
DR   GenomeRNAi; 9321; -.
DR   Pharos; Q15643; Tbio.
DR   PRO; PR:Q15643; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   RNAct; Q15643; protein.
DR   Bgee; ENSG00000100815; Expressed in corpus callosum and 198 other tissues.
DR   ExpressionAtlas; Q15643; baseline and differential.
DR   Genevisible; Q15643; HS.
DR   GO; GO:0005623; C:cell; IEA:GOC.
DR   GO; GO:0005929; C:cilium; IEA:GOC.
DR   GO; GO:0005801; C:cis-Golgi network; IEA:Ensembl.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005793; C:endoplasmic reticulum-Golgi intermediate compartment; IDA:UniProtKB.
DR   GO; GO:0033116; C:endoplasmic reticulum-Golgi intermediate compartment membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0002079; C:inner acrosomal membrane; IEA:Ensembl.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0002081; C:outer acrosomal membrane; IEA:Ensembl.
DR   GO; GO:0030133; C:transport vesicle; TAS:Reactome.
DR   GO; GO:0003713; F:transcription coactivator activity; TAS:ProtInc.
DR   GO; GO:0051216; P:cartilage development; IMP:UniProtKB.
DR   GO; GO:0003413; P:chondrocyte differentiation involved in endochondral bone morphogenesis; IEA:Ensembl.
DR   GO; GO:0090161; P:Golgi ribbon formation; IMP:UniProtKB.
DR   GO; GO:0060122; P:inner ear receptor cell stereocilium organization; IEA:Ensembl.
DR   GO; GO:0035735; P:intraciliary transport involved in cilium assembly; TAS:Reactome.
DR   GO; GO:0006486; P:protein glycosylation; IEA:Ensembl.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; TAS:ProtInc.
DR   GO; GO:0003281; P:ventricular septum development; IEA:Ensembl.
DR   GO; GO:0099041; P:vesicle tethering to Golgi; IMP:UniProtKB.
DR   InterPro; IPR000237; GRIP_dom.
DR   PROSITE; PS50913; GRIP; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Chromosomal rearrangement; Coiled coil;
KW   Cytoplasm; Cytoskeleton; Disease mutation; Dwarfism; Golgi apparatus;
KW   Membrane; Phosphoprotein; Polymorphism; Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:25944712"
FT   CHAIN           2..1979
FT                   /note="Thyroid receptor-interacting protein 11"
FT                   /id="PRO_0000190076"
FT   DOMAIN          1774..1823
FT                   /note="GRIP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00250"
FT   REGION          2..38
FT                   /note="Amphipatic lipid-packing sensor required for
FT                   tethering of intra-Golgi vesicles"
FT                   /evidence="ECO:0000269|PubMed:25473115"
FT   REGION          1017..1195
FT                   /note="Involved in RAB2A binding"
FT                   /evidence="ECO:0000269|PubMed:25473115"
FT   REGION          1325..1599
FT                   /note="Involved in RAB2A binding"
FT                   /evidence="ECO:0000269|PubMed:25473115"
FT   COILED          52..1773
FT                   /evidence="ECO:0000255"
FT   SITE            1754..1755
FT                   /note="Breakpoint for translocation to form TRIP11-PDGFRB"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000244|PubMed:25944712"
FT   MOD_RES         464
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163"
FT   MOD_RES         1842
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231"
FT   MOD_RES         1846
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332"
FT   MOD_RES         1891
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:23186163"
FT   VAR_SEQ         410..438
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000269|PubMed:30728324"
FT                   /id="VSP_060242"
FT   VARIANT         39
FT                   /note="M -> L (in dbSNP:rs17127898)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_055861"
FT   VARIANT         105..196
FT                   /note="Missing (in ODCD; in-frame exon 4 skipping; due to a
FT                   nucleotide substitution that may also cause protein
FT                   truncation)"
FT                   /evidence="ECO:0000269|PubMed:30728324"
FT                   /id="VAR_082008"
FT   VARIANT         196..1979
FT                   /note="Missing (in ODCD; due to a nucleotide substitution
FT                   that causes protein truncation or in-frame exon 4
FT                   skipping)"
FT                   /evidence="ECO:0000269|PubMed:30728324"
FT                   /id="VAR_082009"
FT   VARIANT         264..1979
FT                   /note="Missing (in ACG1A and ODCD)"
FT                   /evidence="ECO:0000269|PubMed:20089971,
FT                   ECO:0000269|PubMed:30728324"
FT                   /id="VAR_082010"
FT   VARIANT         410
FT                   /note="D -> Y (in ODCD; due to a nucleotide substitution
FT                   that causes in-frame exon 9 skipping or results in missense
FT                   variant Y-410; patient cells contain both type of
FT                   transcripts; the transcript lacking exon 9 is the most
FT                   abundant)"
FT                   /evidence="ECO:0000269|PubMed:30728324"
FT                   /id="VAR_082011"
FT   VARIANT         506
FT                   /note="E -> A (in dbSNP:rs2273186)"
FT                   /id="VAR_055862"
FT   VARIANT         559
FT                   /note="V -> A"
FT                   /evidence="ECO:0000269|PubMed:27717682"
FT                   /id="VAR_079175"
FT   VARIANT         795
FT                   /note="V -> L (in dbSNP:rs34699762)"
FT                   /id="VAR_055863"
FT   VARIANT         884
FT                   /note="D -> G (in dbSNP:rs34967261)"
FT                   /id="VAR_055864"
FT   VARIANT         1040
FT                   /note="I -> V (in dbSNP:rs34805848)"
FT                   /id="VAR_055865"
FT   VARIANT         1107
FT                   /note="E -> D (in dbSNP:rs4619320)"
FT                   /id="VAR_060344"
FT   VARIANT         1160..1979
FT                   /note="Missing (in ACG1A)"
FT                   /evidence="ECO:0000269|PubMed:30728324"
FT                   /id="VAR_082012"
FT   VARIANT         1167..1979
FT                   /note="Missing (in ACG1A)"
FT                   /evidence="ECO:0000269|PubMed:30728324"
FT                   /id="VAR_082285"
FT   VARIANT         1224..1979
FT                   /note="Missing (in ACG1A; does not localize to cis-Golgi;
FT                   results in disruption of Golgi cisternal stack
FT                   architecture)"
FT                   /evidence="ECO:0000269|PubMed:30728324"
FT                   /id="VAR_082013"
FT   VARIANT         1321..1979
FT                   /note="Missing (in ACG1A)"
FT                   /evidence="ECO:0000269|PubMed:30728324"
FT                   /id="VAR_082014"
FT   VARIANT         1376..1979
FT                   /note="Missing (in ACG1A)"
FT                   /evidence="ECO:0000269|PubMed:30728324"
FT                   /id="VAR_082015"
FT   VARIANT         1413
FT                   /note="D -> A (in dbSNP:rs12884523)"
FT                   /id="VAR_060345"
FT   VARIANT         1503
FT                   /note="M -> V (in dbSNP:rs34839498)"
FT                   /id="VAR_055866"
FT   VARIANT         1512..1979
FT                   /note="Missing (in ODCD)"
FT                   /evidence="ECO:0000269|PubMed:30728324"
FT                   /id="VAR_082016"
FT   VARIANT         1576
FT                   /note="R -> H (in dbSNP:rs35007347)"
FT                   /id="VAR_055867"
FT   VARIANT         1749
FT                   /note="E -> A (in dbSNP:rs2273183)"
FT                   /id="VAR_055868"
FT   VARIANT         1752
FT                   /note="R -> K (in dbSNP:rs11851376)"
FT                   /id="VAR_055869"
FT   VARIANT         1806
FT                   /note="M -> V (in ODCD; due to a nucleotide substitution
FT                   that causes missplicing of exon 18 or results in missense
FT                   variant V-1806; patient cells contain both type of
FT                   transcripts; the transcript with the missense variant is
FT                   the most abundant)"
FT                   /evidence="ECO:0000269|PubMed:30728324"
FT                   /id="VAR_082017"
FT   VARIANT         1827
FT                   /note="G -> S (in dbSNP:rs1051340)"
FT                   /evidence="ECO:0000269|PubMed:10189370,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:7776974,
FT                   ECO:0000269|PubMed:9373237"
FT                   /id="VAR_060346"
FT   VARIANT         1846
FT                   /note="T -> I (in dbSNP:rs141259390)"
FT                   /evidence="ECO:0000269|PubMed:18987736"
FT                   /id="VAR_054151"
FT   MUTAGEN         2..38
FT                   /note="Missing: Abolishes tethering of intra-Golgi
FT                   vesicles."
FT                   /evidence="ECO:0000269|PubMed:25473115"
FT   MUTAGEN         1113..1423
FT                   /note="Missing: Abolishes interaction with RAB2A."
FT                   /evidence="ECO:0000269|PubMed:25473115"
FT   CONFLICT        121
FT                   /note="L -> F (in Ref. 1; AAD09135)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        382
FT                   /note="A -> G (in Ref. 1; AAD09135)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        391
FT                   /note="Q -> R (in Ref. 1; AAD09135)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        516
FT                   /note="D -> A (in Ref. 1; AAD09135)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        561..563
FT                   /note="KEK -> FVL (in Ref. 1; AAD09135)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1202
FT                   /note="N -> H (in Ref. 2)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1213
FT                   /note="K -> T (in Ref. 5; CAE46015)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1237
FT                   /note="H -> R (in Ref. 6; AAB84386)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1346..1347
FT                   /note="QQ -> HE (in Ref. 6; AAB84386)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1566
FT                   /note="E -> V (in Ref. 5; CAE46015)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1658..1665
FT                   /note="QLSVSQEQ -> RFCLSGT (in Ref. 1; AAD09135)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1670
FT                   /note="A -> R (in Ref. 1; AAD09135)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1979 AA;  227586 MW;  437EB5F5966BB1AE CRC64;
     MSSWLGGLGS GLGQSLGQVG GSLASLTGQI SNFTKDMLME GTEEVEAELP DSRTKEIEAI
     HAILRSENER LKKLCTDLEE KHEASEIQIK QQSTSYRNQL QQKEVEISHL KARQIALQDQ
     LLKLQSAAQS VPSGAGVPAT TASSSFAYGI SHHPSAFHDD DMDFGDIISS QQEINRLSNE
     VSRLESEVGH WRHIAQTSKA QGTDNSDQSE ICKLQNIIKE LKQNRSQEID DHQHEMSVLQ
     NAHQQKLTEI SRRHREELSD YEERIEELEN LLQQGGSGVI ETDLSKIYEM QKTIQVLQIE
     KVESTKKMEQ LEDKIKDINK KLSSAENDRD ILRREQEQLN VEKRQIMEEC ENLKLECSKL
     QPSAVKQSDT MTEKERILAQ SASVEEVFRL QQALSDAENE IMRLSSLNQD NSLAEDNLKL
     KMRIEVLEKE KSLLSQEKEE LQMSLLKLNN EYEVIKSTAT RDISLDSELH DLRLNLEAKE
     QELNQSISEK ETLIAEIEEL DRQNQEATKH MILIKDQLSK QQNEGDSIIS KLKQDLNDEK
     KRVHQLEDDK MDITKELDVQ KEKLIQSEVA LNDLHLTKQK LEDKVENLVD QLNKSQESNV
     SIQKENLELK EHIRQNEEEL SRIRNELMQS LNQDSNSNFK DTLLKEREAE VRNLKQNLSE
     LEQLNENLKK VAFDVKMENE KLVLACEDVR HQLEECLAGN NQLSLEKNTI VETLKMEKGE
     IEAELCWAKK RLLEEANKYE KTIEELSNAR NLNTSALQLE HEHLIKLNQK KDMEIAELKK
     NIEQMDTDHK ETKDVLSSSL EEQKQLTQLI NKKEIFIEKL KERSSKLQEE LDKYSQALRK
     NEILRQTIEE KDRSLGSMKE ENNHLQEELE RLREEQSRTA PVADPKTLDS VTELASEVSQ
     LNTIKEHLEE EIKHHQKIIE DQNQSKMQLL QSLQEQKKEM DEFRYQHEQM NATHTQLFLE
     KDEEIKSLQK TIEQIKTQLH EERQDIQTDN SDIFQETKVQ SLNIENGSEK HDLSKAETER
     LVKGIKEREL EIKLLNEKNI SLTKQIDQLS KDEVGKLTQI IQQKDLEIQA LHARISSTSH
     TQDVVYLQQQ LQAYAMEREK VFAVLNEKTR ENSHLKTEYH KMMDIVAAKE AALIKLQDEN
     KKLSTRFESS GQDMFRETIQ NLSRIIREKD IEIDALSQKC QTLLAVLQTS STGNEAGGVN
     SNQFEELLQE RDKLKQQVKK MEEWKQQVMT TVQNMQHESA QLQEELHQLQ AQVLVDSDNN
     SKLQVDYTGL IQSYEQNETK LKNFGQELAQ VQHSIGQLCN TKDLLLGKLD IISPQLSSAS
     LLTPQSAECL RASKSEVLSE SSELLQQELE ELRKSLQEKD ATIRTLQENN HRLSDSIAAT
     SELERKEHEQ TDSEIKQLKE KQDVLQKLLK EKDLLIKAKS DQLLSSNENF TNKVNENELL
     RQAVTNLKER ILILEMDIGK LKGENEKIVE TYRGKETEYQ ALQETNMKFS MMLREKEFEC
     HSMKEKALAF EQLLKEKEQG KTGELNQLLN AVKSMQEKTV VFQQERDQVM LALKQKQMEN
     TALQNEVQRL RDKEFRSNQE LERLRNHLLE SEDSYTREAL AAEDREAKLR KKVTVLEEKL
     VSSSNAMENA SHQASVQVES LQEQLNVVSK QRDETALQLS VSQEQVKQYA LSLANLQMVL
     EHFQQEEKAM YSAELEKQKQ LIAEWKKNAE NLEGKVISLQ ECLDEANAAL DSASRLTEQL
     DVKEEQIEEL KRQNELRQEM LDDVQKKLMS LANSSEGKVD KVLMRNLFIG HFHTPKNQRH
     EVLRLMGSIL GVRREEMEQL FHDDQGGVTR WMTGWLGGGS KSVPNTPLRP NQQSVVNSSF
     SELFVKFLET ESHPSIPPPK LSVHDMKPLD SPGRRKRDTN APESFKDTAE SRSGRRTDVN
     PFLAPRSAAV PLINPAGLGP GGPGHLLLKP ISDVLPTFTP LPALPDNSAG VVLKDLLKQ
//
ID   WDCP_HUMAN              Reviewed;         721 AA.
AC   Q9H6R7; D6W532; Q8IYK0; Q9HBP5;
DT   11-SEP-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   22-APR-2020, entry version 136.
DE   RecName: Full=WD repeat and coiled-coil-containing protein {ECO:0000305};
GN   Name=WDCP {ECO:0000312|HGNC:HGNC:26157}; Synonyms=C2orf44; ORFNames=PP384;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], INTERACTION WITH HCK, AND MUTAGENESIS OF
RP   PRO-540 AND PRO-543.
RX   PubMed=25469238; DOI=10.3892/br.2014.374;
RA   Yokoyama N., Miller W.T.;
RT   "Molecular characterization of WDCP, a novel fusion partner for the
RT   anaplastic lymphoma tyrosine kinase ALK.";
RL   Biomed. Rep. 3:9-13(2015).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RX   PubMed=15498874; DOI=10.1073/pnas.0404089101;
RA   Wan D., Gong Y., Qin W., Zhang P., Li J., Wei L., Zhou X., Li H., Qiu X.,
RA   Zhong F., He L., Yu J., Yao G., Jiang H., Qian L., Yu Y., Shu H., Chen X.,
RA   Xu H., Guo M., Pan Z., Chen Y., Ge C., Yang S., Gu J.;
RT   "Large-scale cDNA transfection screening for genes related to cancer
RT   development and progression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:15724-15729(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Hepatoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (DEC-2006) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   INTERACTION WITH HCK, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=12029088; DOI=10.1074/jbc.m202783200;
RA   Scott M.P., Zappacosta F., Kim E.Y., Annan R.S., Miller W.T.;
RT   "Identification of novel SH3 domain ligands for the Src family kinase Hck.
RT   Wiskott-Aldrich syndrome protein (WASP), WASP-interacting protein (WIP),
RT   and ELMO1.";
RL   J. Biol. Chem. 277:28238-28246(2002).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-299; SER-501 AND SER-523, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-690, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-690, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [13]
RP   CHROMOSOMAL TRANSLOCATION WITH ALK.
RX   PubMed=22327622; DOI=10.1038/nm.2673;
RA   Lipson D., Capelletti M., Yelensky R., Otto G., Parker A., Jarosz M.,
RA   Curran J.A., Balasubramanian S., Bloom T., Brennan K.W., Donahue A.,
RA   Downing S.R., Frampton G.M., Garcia L., Juhn F., Mitchell K.C., White E.,
RA   White J., Zwirko Z., Peretz T., Nechushtan H., Soussan-Gutman L., Kim J.,
RA   Sasaki H., Kim H.R., Park S.I., Ercan D., Sheehan C.E., Ross J.S.,
RA   Cronin M.T., Jaenne P.A., Stephens P.J.;
RT   "Identification of new ALK and RET gene fusions from colorectal and lung
RT   cancer biopsies.";
RL   Nat. Med. 18:382-384(2012).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-299; SER-468; THR-530;
RP   SER-686 AND SER-690, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   VARIANT [LARGE SCALE ANALYSIS] SER-454.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- SUBUNIT: Oligomer. Interacts with HCK (via SH3 domain).
CC       {ECO:0000269|PubMed:12029088, ECO:0000269|PubMed:25469238}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9H6R7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9H6R7-2; Sequence=VSP_027713, VSP_027714;
CC       Name=3;
CC         IsoId=Q9H6R7-3; Sequence=VSP_027712, VSP_027715;
CC   -!- PTM: Phosphorylated on Tyr when associated with HCK.
CC       {ECO:0000269|PubMed:25469238}.
CC   -!- DISEASE: Note=A chromosomal aberration involving WDCP is found in one
CC       subject with colorectal cancer. Translocation t(2;2)(p23.3;p23.1). A 5
CC       million base pair tandem duplication generates an in-frame WDCP-ALK
CC       gene fusion. {ECO:0000269|PubMed:22327622}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF218013; AAG17255.1; -; mRNA.
DR   EMBL; AK025598; BAB15186.1; -; mRNA.
DR   EMBL; AC104665; AAY24115.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00771.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00772.1; -; Genomic_DNA.
DR   EMBL; BC035698; AAH35698.1; -; mRNA.
DR   CCDS; CCDS1705.1; -. [Q9H6R7-1]
DR   CCDS; CCDS46229.1; -. [Q9H6R7-2]
DR   RefSeq; NP_001135791.1; NM_001142319.1. [Q9H6R7-2]
DR   RefSeq; NP_079479.1; NM_025203.2. [Q9H6R7-1]
DR   BioGrid; 123217; 56.
DR   IntAct; Q9H6R7; 53.
DR   MINT; Q9H6R7; -.
DR   STRING; 9606.ENSP00000295148; -.
DR   iPTMnet; Q9H6R7; -.
DR   PhosphoSitePlus; Q9H6R7; -.
DR   BioMuta; WDCP; -.
DR   DMDM; 74752699; -.
DR   EPD; Q9H6R7; -.
DR   jPOST; Q9H6R7; -.
DR   MassIVE; Q9H6R7; -.
DR   MaxQB; Q9H6R7; -.
DR   PaxDb; Q9H6R7; -.
DR   PeptideAtlas; Q9H6R7; -.
DR   PRIDE; Q9H6R7; -.
DR   ProteomicsDB; 81022; -. [Q9H6R7-1]
DR   ProteomicsDB; 81023; -. [Q9H6R7-2]
DR   ProteomicsDB; 81024; -. [Q9H6R7-3]
DR   Antibodypedia; 51026; 64 antibodies.
DR   Ensembl; ENST00000295148; ENSP00000295148; ENSG00000163026. [Q9H6R7-1]
DR   Ensembl; ENST00000406895; ENSP00000385816; ENSG00000163026. [Q9H6R7-2]
DR   GeneID; 80304; -.
DR   KEGG; hsa:80304; -.
DR   UCSC; uc002rep.3; human. [Q9H6R7-1]
DR   CTD; 80304; -.
DR   DisGeNET; 80304; -.
DR   GeneCards; WDCP; -.
DR   HGNC; HGNC:26157; WDCP.
DR   HPA; ENSG00000163026; Low tissue specificity.
DR   MIM; 616234; gene.
DR   neXtProt; NX_Q9H6R7; -.
DR   OpenTargets; ENSG00000163026; -.
DR   PharmGKB; PA147358716; -.
DR   eggNOG; ENOG410IJSA; Eukaryota.
DR   eggNOG; ENOG410YM0Q; LUCA.
DR   GeneTree; ENSGT00390000001660; -.
DR   HOGENOM; CLU_025195_0_0_1; -.
DR   InParanoid; Q9H6R7; -.
DR   OMA; WILLCAD; -.
DR   OrthoDB; 435947at2759; -.
DR   PhylomeDB; Q9H6R7; -.
DR   TreeFam; TF333528; -.
DR   GenomeRNAi; 80304; -.
DR   Pharos; Q9H6R7; Tdark.
DR   PRO; PR:Q9H6R7; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q9H6R7; protein.
DR   Bgee; ENSG00000163026; Expressed in female gonad and 141 other tissues.
DR   ExpressionAtlas; Q9H6R7; baseline and differential.
DR   Genevisible; Q9H6R7; HS.
DR   GO; GO:0019900; F:kinase binding; IPI:UniProtKB.
DR   GO; GO:0051259; P:protein complex oligomerization; IDA:UniProtKB.
DR   InterPro; IPR028041; WDCP.
DR   PANTHER; PTHR14897; PTHR14897; 1.
DR   Pfam; PF15390; WDCP; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Chromosomal rearrangement; Coiled coil;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat; WD repeat.
FT   CHAIN           1..721
FT                   /note="WD repeat and coiled-coil-containing protein"
FT                   /id="PRO_0000299501"
FT   REPEAT          55..98
FT                   /note="WD 1"
FT   REPEAT          154..194
FT                   /note="WD 2"
FT   REGION          539..545
FT                   /note="Interaction with HCK"
FT                   /evidence="ECO:0000269|PubMed:25469238"
FT   COILED          556..584
FT                   /evidence="ECO:0000255"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000244|PubMed:22814378"
FT   MOD_RES         299
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18691976,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         468
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         501
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18691976"
FT   MOD_RES         523
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18691976"
FT   MOD_RES         530
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         686
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         690
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163"
FT   VAR_SEQ         1..487
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15498874"
FT                   /id="VSP_027712"
FT   VAR_SEQ         488
FT                   /note="N -> M (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15498874"
FT                   /id="VSP_027715"
FT   VAR_SEQ         607..622
FT                   /note="KPYYLGPVVEKRAVLL -> IPTGFFSLLTVRALSR (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_027713"
FT   VAR_SEQ         623..721
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_027714"
FT   VARIANT         102
FT                   /note="T -> M (in dbSNP:rs3731620)"
FT                   /id="VAR_034834"
FT   VARIANT         454
FT                   /note="P -> S (in a breast cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035876"
FT   MUTAGEN         540
FT                   /note="P->A: Loss of interaction with HCK; when associated
FT                   with P-543."
FT                   /evidence="ECO:0000269|PubMed:25469238"
FT   MUTAGEN         543
FT                   /note="P->A: Loss of interaction with HCK; when associated
FT                   with P-543."
FT                   /evidence="ECO:0000269|PubMed:25469238"
SQ   SEQUENCE   721 AA;  79136 MW;  4A4164C81A693DAE CRC64;
     MELGKGKLLR TGLNALHQAV HPIHGLAWTD GNQVVLTDLR LHSGEVKFGD SKVIGQFECV
     CGLSWAPPVA DDTPVLLAVQ HEKHVTVWQL CPSPMESSKW LTSQTCEIRG SLPILPQGCV
     WHPKCAILTV LTAQDVSIFP NVHSDDSQVK ADINTQGRIH CACWTQDGLR LVVAVGSSLH
     SYIWDSAQKT LHRCSSCLVF DVDSHVCSIT ATVDSQVAIA TELPLDKICG LNASETFNIP
     PNSKDMTPYA LPVIGEVRSM DKEATDSETN SEVSVSSSYL EPLDLTHIHF NQHKSEGNSL
     ICLRKKDYLT GTGQDSSHLV LVTFKKAVTM TRKVTIPGIL VPDLIAFNLK AHVVAVASNT
     CNIILIYSVI PSSVPNIQQI RLENTERPKG ICFLTDQLLL ILVGKQKLTD TTFLPSSKSD
     QYAISLIVRE IMLEEEPSIT SGESQTTYST FSAPLNKANR KKLIESLSPD FCHQNKGLLL
     TVNTSSQNGR PGRTLIKEIQ SPLSSICDGS IALDAEPVTQ PASLPRHSST PDHTSTLEPP
     RLPQRKNLQS EKETYQLSKE VEILSRNLVE MQRCLSELTN RLHNGKKSSS VYPLSQDLPY
     VHIIYQKPYY LGPVVEKRAV LLCDGKLRLS TVQQTFGLSL IEMLHDSHWI LLSADSEGFI
     PLTFTATQEI IIRDGSLSRS DVFRDSFSHS PGAVSSLKVF TGLAAPSLDT TGCCNHVDGM
     A
//
ID   A0A024RDS3_HUMAN        Unreviewed;      1377 AA.
AC   A0A024RDS3;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 47.
DE   SubName: Full=Zinc finger protein 198, isoform CRA_b {ECO:0000313|EMBL:EAX08245.1};
GN   Name=ZNF198 {ECO:0000313|EMBL:EAX08245.1};
GN   ORFNames=hCG_20496 {ECO:0000313|EMBL:EAX08245.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAX08245.1};
RN   [1] {ECO:0000313|EMBL:EAX08245.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAX08245.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH471075; EAX08245.1; -; Genomic_DNA.
DR   EMBL; CH471075; EAX08246.1; -; Genomic_DNA.
DR   EMBL; CH471075; EAX08248.1; -; Genomic_DNA.
DR   RefSeq; NP_001177893.1; NM_001190964.2.
DR   RefSeq; NP_001177894.1; NM_001190965.2.
DR   RefSeq; NP_003444.1; NM_003453.4.
DR   RefSeq; NP_932072.1; NM_197968.3.
DR   RefSeq; XP_005266577.1; XM_005266520.3.
DR   RefSeq; XP_016876218.1; XM_017020729.1.
DR   Antibodypedia; 22277; 132 antibodies.
DR   GeneID; 7750; -.
DR   KEGG; hsa:7750; -.
DR   CTD; 7750; -.
DR   EuPathDB; HostDB:ENSG00000121741.16; -.
DR   eggNOG; ENOG410IE8I; Eukaryota.
DR   eggNOG; ENOG410XQR6; LUCA.
DR   HOGENOM; CLU_004099_0_0_1; -.
DR   OMA; SWETMEF; -.
DR   OrthoDB; 587724at2759; -.
DR   ChiTaRS; ZMYM2; human.
DR   GenomeRNAi; 7750; -.
DR   Bgee; ENSG00000121741; Expressed in kidney and 233 other tissues.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   InterPro; IPR021893; DUF3504.
DR   InterPro; IPR011017; TRASH_dom.
DR   InterPro; IPR010507; Znf_MYM.
DR   Pfam; PF12012; DUF3504; 1.
DR   Pfam; PF06467; zf-FCS; 8.
DR   SMART; SM00746; TRASH; 9.
PE   4: Predicted;
FT   DOMAIN          331..367
FT                   /note="TRASH"
FT                   /evidence="ECO:0000259|SMART:SM00746"
FT   DOMAIN          373..413
FT                   /note="TRASH"
FT                   /evidence="ECO:0000259|SMART:SM00746"
FT   DOMAIN          425..460
FT                   /note="TRASH"
FT                   /evidence="ECO:0000259|SMART:SM00746"
FT   DOMAIN          467..506
FT                   /note="TRASH"
FT                   /evidence="ECO:0000259|SMART:SM00746"
FT   DOMAIN          584..620
FT                   /note="TRASH"
FT                   /evidence="ECO:0000259|SMART:SM00746"
FT   DOMAIN          639..675
FT                   /note="TRASH"
FT                   /evidence="ECO:0000259|SMART:SM00746"
FT   DOMAIN          681..716
FT                   /note="TRASH"
FT                   /evidence="ECO:0000259|SMART:SM00746"
FT   DOMAIN          727..762
FT                   /note="TRASH"
FT                   /evidence="ECO:0000259|SMART:SM00746"
FT   DOMAIN          768..803
FT                   /note="TRASH"
FT                   /evidence="ECO:0000259|SMART:SM00746"
FT   REGION          85..177
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          273..305
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          983..1002
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1028..1064
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        85..115
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        150..177
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   1377 AA;  154911 MW;  2652D4C766492FF9 CRC64;
     MDTSSVGGLE LTDQTPVLLG STAMATSLTN VGNSFSGPAN PLVSRSNKFQ NSSVEDDDDV
     VFIEPVQPPP PSVPVVADQR TITFTSSKNE ELQGNDSKIT PSSKELASQK GSVSETIVID
     DEEDMETNQG QEKNSSNFIE RRPPETKNRT NDVDFSTSSF SRSKVNAGMG NSGITTEPDS
     EIQIANVTTL ETGVSSVNDG QLENTDGRDM NLMITHVTSL QNTNLGDVSN GLQSSNFGVN
     IQTYTPSLTS QTKTGVGPFN PGRMNVAGDV FQNGESATHH NPDSWISQSA SFPRNQKQPG
     VDSLSPVASL PKQIFQPSVQ QQPTKPVKVT CANCKKPLQK GQTAYQRKGS AHLFCSTTCL
     SSFSHKPAPK KLCVMCKKDI TTMKGTIVAQ VDSSESFQEF CSTSCLSLYE DKQNPTKGAL
     NKSRCTICGK LTEIRHEVSF KNMTHKLCSD HCFNRYRMAN GLIMNCCEQC GEYLPSKGAG
     NNVLVIDGQQ KRFCCQSCVS EYKQVGSHPS FLKEVRDHMQ DSFLMQPEKY GKLTTCTGCR
     TQCRFFDMTQ CIGPNGYMEP YCSTACMNSH KTKYAKSQSL GIICHFCKRN SLPQYQATMP
     DGKLYNFCNS SCVAKFQALS MQSSPNGQFV APSDIQLKCN YCKNSFCSKP EILEWENKVH
     QFCSKTCSDD YKKLHCIVTY CEYCQEEKTL HETVNFSGVK RPFCSEGCKL LYKQDFARRL
     GLRCVTCNYC SQLCKKGATK ELDGVVRDFC SEDCCKKFQD WYYKAARCDC CKSQGTLKER
     VQWRGEMKHF CDQHCLLRFY CQQNEPNMTT QKGPENLHYD QGCQTSRTKM TGSAPPPSPT
     PNKEMKNKAV LCKPLTMTKA TYCKPHMQTK SCQTDDTWRT EYVPVPIPVP VYIPVPMHMY
     SQNIPVPTTV PVPVPVPVFL PAPLDSSEKI PAAIEELKSK VSSDALDTEL LTMTDMMSED
     EGKTETTNIN SVIIETDIIG SDLLKNSDPE TQSSMPDVPY EPDLDIEIDF PRAAEELDME
     NEFLLPPVFG EEYEEQPRPR SKKKGAKRKA VSGYQSHDDS SDNSECSFPF KYTYGVNAWK
     HWVKTRQLDE DLLVLDELKS SKSVKLKEDL LSHTTAELNY GLAHFVNEIR RPNGENYAPD
     SIYYLCLGIQ EYLCGSNRKD NIFIDPGYQT FEQELNKILR SWQPSILPDG SIFSRVEEDY
     LWRIKQLGSH SPVALLNTLF YFNTKYFGLK TVEQHLRLSF GTVFRHWKKN PLTMENKACL
     RYQVSSLCGT DNEDKITTGK RKHEDDEPVF EQIENTANPS RCPVKMFECY LSKSPQNLNQ
     RMDVFYLQPE CSSSTDSPVW YTSTSLDRNT LENMLVRVLL VKDIYDKDNY ELDEDTD
//
ID   A8K126_HUMAN            Unreviewed;      1247 AA.
AC   A8K126;
DT   04-DEC-2007, integrated into UniProtKB/TrEMBL.
DT   04-DEC-2007, sequence version 1.
DT   11-DEC-2019, entry version 51.
DE   SubName: Full=cDNA FLJ76647, highly similar to Homo sapiens zinc finger protein 198 (ZNF198), mRNA {ECO:0000313|EMBL:BAF82430.1};
DE   Flags: Fragment;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAF82430.1};
RN   [1] {ECO:0000313|EMBL:BAF82430.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAF82430.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK289741; BAF82430.1; -; mRNA.
DR   RefSeq; NP_932072.1; NM_197968.3.
DR   IntAct; A8K126; 1.
DR   PeptideAtlas; A8K126; -.
DR   PRIDE; A8K126; -.
DR   GeneID; 7750; -.
DR   CTD; 7750; -.
DR   eggNOG; ENOG410IE8I; Eukaryota.
DR   eggNOG; ENOG410XQR6; LUCA.
DR   OrthoDB; 587724at2759; -.
DR   GenomeRNAi; 7750; -.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   InterPro; IPR021893; DUF3504.
DR   InterPro; IPR011017; TRASH_dom.
DR   InterPro; IPR010507; Znf_MYM.
DR   Pfam; PF12012; DUF3504; 1.
DR   Pfam; PF06467; zf-FCS; 8.
DR   SMART; SM00746; TRASH; 9.
PE   2: Evidence at transcript level;
FT   DOMAIN          331..367
FT                   /note="TRASH"
FT                   /evidence="ECO:0000259|SMART:SM00746"
FT   DOMAIN          373..413
FT                   /note="TRASH"
FT                   /evidence="ECO:0000259|SMART:SM00746"
FT   DOMAIN          425..460
FT                   /note="TRASH"
FT                   /evidence="ECO:0000259|SMART:SM00746"
FT   DOMAIN          467..506
FT                   /note="TRASH"
FT                   /evidence="ECO:0000259|SMART:SM00746"
FT   DOMAIN          584..620
FT                   /note="TRASH"
FT                   /evidence="ECO:0000259|SMART:SM00746"
FT   DOMAIN          639..675
FT                   /note="TRASH"
FT                   /evidence="ECO:0000259|SMART:SM00746"
FT   DOMAIN          681..716
FT                   /note="TRASH"
FT                   /evidence="ECO:0000259|SMART:SM00746"
FT   DOMAIN          727..762
FT                   /note="TRASH"
FT                   /evidence="ECO:0000259|SMART:SM00746"
FT   DOMAIN          768..803
FT                   /note="TRASH"
FT                   /evidence="ECO:0000259|SMART:SM00746"
FT   REGION          36..55
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          85..177
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          273..305
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          983..1002
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1028..1064
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        36..50
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        85..115
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        150..177
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   NON_TER         1247
FT                   /evidence="ECO:0000313|EMBL:BAF82430.1"
SQ   SEQUENCE   1247 AA;  139732 MW;  E7F36D42D7477F45 CRC64;
     MDTSSVGGLE LTDQTPVLLG STAMATSLTN VGNSLSGPAN PLVSRSNKFQ NSSVEDDDDV
     VFIEPVQPPP PSVPVVADQR TITFTSSKNE ELQGNDSKIT PSSKELASQK GSVSETIVID
     DEEDMETNQG QEKNSSNFIE RRPPETKNRT NDVDFSTSSF SRSKVNAGMG NSGITTEPDS
     EIQIANVTTL ETGVSSVNDG QLENTDGRDM NLMITHVTSL QNTNLGDVSN GLQSSNFGVN
     IQTYTPSLTS QTKTGVGPFN PGRMNVAGDV FQNGESATHH NPDSWISQSA SFPRNQKQPG
     VDSLSPVASL PKQIFQPSVQ QQPTKPVKVT CANCKKPLQK GQTAYQRKGS AHLFCSTTCL
     SSFSHKPAPK KLCVMCKKDI TTMKGTIVAQ VDSSESFQEF CSTSCLSLYE DKQNPTKGAL
     NKSRCTICGK LTEIRHEVSF KNMTHKLCSD HCFNRYRMAN GLIMNCCEQC GEYLPSKGAG
     NNVLVIDGQQ KRFCCQSCVS EYKQVGSHPS FLKEVRDHMQ DSFLMQPDKY GKLTTCTGCR
     TQCRFFDMTQ CIGPNGYMEP YCSTACMNSH KTKYAKSQSL GIICHFCKRN SLPQYQATMP
     DGKLYNFCNS SCVAKFQALS MQSSPNGQFV APSDIQLKCN YCKNSFCSKP EILEWENKVH
     QFCSKTCSDD YKKLHCIVTY CEYCQEEKTL HETVNFSGVK RPFCSEGCKL LYKQDFARRL
     GLRCVTCNYC SQLCKKGATK ELDGVVRDFC SEDCCKKFQD WYYKAARCDC CKSQGTLKER
     VQWRGEMKHF CDQHCLLRLY CQQNEPNMTT QKGPENLHYD QGCQTSRTKM TGSAPPPSPT
     PNKEMKNKAV LCKPLTMTKA TYCKPHMQTK SCQTDDTWRT EYVPVPIPVP VYIPVPMHMY
     SQNIPVPTTV PVPVPVPVFL PAPLDSSEKI PAAIEELKSK VSSDALDTEL LTMTDMMSED
     EGKTETTNIN SVIIETDIIG SDLLKNSDPE TQSSMPDVPY EPDLDIEIDF PRAAEELDME
     NEFLLPPVFG EEYEEQPRPR SKKKGAKRKA VSGYQSHDDS SDNSECSFPF KYTYGVNAWK
     HWVKTRQLDE DLLVLDELKS SKSVKLKEDL LSHTTAELNY GLAHFVNEIR RPNGENYAPD
     SIYYLCLGIQ EYLCGSNRKD NIFIDPGYQT FEQELNKILR SWQPSILPDG SIFSRVEEDY
     LWRIKQLGSH SPVALLNTLF YFNTKYFGLK TVEQHLRLSF GTVFRHW
//
ID   ZMYM2_HUMAN             Reviewed;        1377 AA.
AC   Q9UBW7; A6NDG0; A6NI02; O43212; O43434; O60898; Q5W0Q4; Q5W0T3; Q63HP0;
AC   Q8NE39; Q9H0V5; Q9H538; Q9UEU2;
DT   16-NOV-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   22-APR-2020, entry version 184.
DE   RecName: Full=Zinc finger MYM-type protein 2;
DE   AltName: Full=Fused in myeloproliferative disorders protein;
DE   AltName: Full=Rearranged in atypical myeloproliferative disorder protein;
DE   AltName: Full=Zinc finger protein 198;
GN   Name=ZMYM2; Synonyms=FIM, RAMP, ZNF198;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND CHROMOSOMAL TRANSLOCATION.
RX   PubMed=9576949; DOI=10.1073/pnas.95.10.5712;
RA   Popovici C., Adelaide J., Ollendorff V., Chaffanet M., Guasch G.,
RA   Jacrot M., Leroux D., Birnbaum D., Pebusque M.-J.;
RT   "Fibroblast growth factor receptor 1 is fused to FIM in stem-cell
RT   myeloproliferative disorder with t(8;13)(p12;q12).";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:5712-5717(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9716603;
RA   Reiter A., Sohal J., Kulkarni S., Chase A., Macdonald D.H.C.,
RA   Aguiar R.C.T., Goncalves C., Hernandez J.M., Jennings B.A., Goldman J.M.,
RA   Cross N.C.P.;
RT   "Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in
RT   the t(8;13)(p11;q12) myeloproliferative syndrome.";
RL   Blood 92:1735-1742(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9889006; DOI=10.1006/geno.1998.5634;
RA   Kulkarni S., Reiter A.J., Smedley D., Goldman J.M., Cross N.C.P.;
RT   "The genomic structure of ZNF198 and location of breakpoints in the t(8;13)
RT   myeloproliferative syndrome.";
RL   Genomics 55:118-121(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=11230166; DOI=10.1101/gr.gr1547r;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H., Lauber J.,
RA   Duesterhoeft A., Beyer A., Koehrer K., Strack N., Mewes H.-W.,
RA   Ottenwaelder B., Obermaier B., Tampe J., Heubner D., Wambutt R., Korn B.,
RA   Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and analysis of
RT   500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Endometrial tumor;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E., Griffiths-Jones S.,
RA   Jones M.C., Keenan S.J., Oliver K., Scott C.E., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Andrews D.T., Ashwell R.I.S., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Bannerjee R., Barlow K.F., Bates K., Beasley H., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M., Clegg S.C.,
RA   Cobley V., Collins J.E., Corby N., Coville G.J., Deloukas P., Dhami P.,
RA   Dunham I., Dunn M., Earthrowl M.E., Ellington A.G., Faulkner L.,
RA   Frankish A.G., Frankland J., French L., Garner P., Garnett J.,
RA   Gilbert J.G.R., Gilson C.J., Ghori J., Grafham D.V., Gribble S.M.,
RA   Griffiths C., Hall R.E., Hammond S., Harley J.L., Hart E.A., Heath P.D.,
RA   Howden P.J., Huckle E.J., Hunt P.J., Hunt A.R., Johnson C., Johnson D.,
RA   Kay M., Kimberley A.M., King A., Laird G.K., Langford C.J., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Lloyd C., Loveland J.E., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I., Pelan S.,
RA   Phillimore B., Porter K.M., Rice C.M., Searle S., Sehra H.K., Shownkeen R.,
RA   Skuce C.D., Smith M., Steward C.A., Sycamore N., Tester J., Thomas D.W.,
RA   Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Wilming L., Wray P.W., Wright M.W., Young L.,
RA   Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Beck S., Bentley D.R.,
RA   Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 152-1377 (ISOFORM 1).
RX   PubMed=9694738;
RA   Still I.H., Cowell J.K.;
RT   "The t(8;13) atypical myeloproliferative disorder: further analysis of the
RT   ZNF198 gene and lack of evidence for multiple genes disrupted on chromosome
RT   13.";
RL   Blood 92:1456-1458(1998).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 170-1020 (ISOFORM 1).
RX   PubMed=9499416; DOI=10.1093/hmg/7.4.637;
RA   Smedley D., Hamoudi R., Clark J., Warren W., Abdul-Rauf M., Somers G.,
RA   Venter D., Fagan K., Cooper C., Shipley J.;
RT   "The t(8;13)(p11;q11-12) rearrangement associated with an atypical
RT   myeloproliferative disorder fuses the fibroblast growth factor receptor 1
RT   gene to a novel gene RAMP.";
RL   Hum. Mol. Genet. 7:637-642(1998).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 621-1377 (ISOFORM 1).
RX   PubMed=9425908; DOI=10.1038/ng0198-84;
RA   Xiao S., Nalabolu S.R., Aster J.C., Ma J., Abruzzo L., Jaffe E.S.,
RA   Stone R., Weissman S.M., Hudson T.J., Fletcher J.A.;
RT   "FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13)
RT   leukaemia/lymphoma syndrome.";
RL   Nat. Genet. 18:84-87(1998).
RN   [12]
RP   IDENTIFICATION IN THE BHC COMPLEX WITH GSE1; GTF2I; HDAC1; HDAC2; HMG20B;
RP   KDM1A; RCOR1; PHF21A; ZNF217 AND ZMYM3.
RX   PubMed=12493763; DOI=10.1074/jbc.m208992200;
RA   Hakimi M.-A., Dong Y., Lane W.S., Speicher D.W., Shiekhattar R.;
RT   "A candidate X-linked mental retardation gene is a component of a new
RT   family of histone deacetylase-containing complexes.";
RL   J. Biol. Chem. 278:7234-7239(2003).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-838 AND THR-1376, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-305 AND THR-1376, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-305; SER-838 AND SER-958, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-159; SER-305 AND SER-838, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [20]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-88; LYS-98; LYS-104; LYS-253;
RP   LYS-297; LYS-441; LYS-529; LYS-532 AND LYS-649, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [21]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-88; LYS-297; LYS-325; LYS-529 AND
RP   LYS-576, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [22]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-88; LYS-98; LYS-441; LYS-513;
RP   LYS-529; LYS-532 AND LYS-700, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.o114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to replication
RT   stress reveals novel small ubiquitin-like modified target proteins and
RT   acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [23]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-48; LYS-88; LYS-98; LYS-104;
RP   LYS-147; LYS-253; LYS-297; LYS-312; LYS-325; LYS-348; LYS-366; LYS-417;
RP   LYS-441; LYS-491; LYS-503; LYS-513; LYS-529; LYS-532; LYS-576; LYS-603;
RP   LYS-649; LYS-658; LYS-688; LYS-700; LYS-709; LYS-764; LYS-788; LYS-812 AND
RP   LYS-829, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: May function as a transcription factor.
CC   -!- SUBUNIT: May be a component of a BHC histone deacetylase complex that
CC       contains HDAC1, HDAC2, HMG20B/BRAF35, KDM1A, RCOR1/CoREST,
CC       PHF21A/BHC80, ZMYM2, ZNF217, ZMYM3, GSE1 and GTF2I.
CC       {ECO:0000269|PubMed:12493763}.
CC   -!- INTERACTION:
CC       Q9UBW7; Q96IK5: GMCL1; NbExp=3; IntAct=EBI-2797576, EBI-2548508;
CC       Q9UBW7; Q9UHL9: GTF2IRD1; NbExp=5; IntAct=EBI-2797576, EBI-372530;
CC       Q9UBW7; Q9UKT9: IKZF3; NbExp=3; IntAct=EBI-2797576, EBI-747204;
CC       Q9UBW7; P22234: PAICS; NbExp=3; IntAct=EBI-2797576, EBI-712261;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UBW7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UBW7-2; Sequence=VSP_039065, VSP_039066, VSP_039067;
CC   -!- DISEASE: Note=A chromosomal aberration involving ZMYM2 may be a cause
CC       of stem cell leukemia lymphoma syndrome (SCLL). Translocation
CC       t(8;13)(p11;q12) with FGFR1. SCLL usually presents as lymphoblastic
CC       lymphoma in association with a myeloproliferative disorder, often
CC       accompanied by pronounced peripheral eosinophilia and/or prominent
CC       eosinophilic infiltrates in the affected bone marrow.
CC       {ECO:0000269|PubMed:9716603}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB88464.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=AAC23591.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=CAA73875.1; Type=Frameshift; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/ZNF198ID114.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Y13472; CAA73875.1; ALT_FRAME; mRNA.
DR   EMBL; AJ224901; CAA12204.1; -; mRNA.
DR   EMBL; AJ007676; CAA07604.1; -; Genomic_DNA.
DR   EMBL; AJ007677; CAA07604.1; JOINED; Genomic_DNA.
DR   EMBL; AJ007678; CAA07604.1; JOINED; Genomic_DNA.
DR   EMBL; AJ007679; CAA07604.1; JOINED; Genomic_DNA.
DR   EMBL; AJ007680; CAA07604.1; JOINED; Genomic_DNA.
DR   EMBL; AJ007681; CAA07604.1; JOINED; Genomic_DNA.
DR   EMBL; AJ007682; CAA07604.1; JOINED; Genomic_DNA.
DR   EMBL; AJ007683; CAA07604.1; JOINED; Genomic_DNA.
DR   EMBL; AJ007684; CAA07604.1; JOINED; Genomic_DNA.
DR   EMBL; AJ007685; CAA07604.1; JOINED; Genomic_DNA.
DR   EMBL; AJ007686; CAA07604.1; JOINED; Genomic_DNA.
DR   EMBL; AJ007687; CAA07604.1; JOINED; Genomic_DNA.
DR   EMBL; AJ007688; CAA07604.1; JOINED; Genomic_DNA.
DR   EMBL; AJ007689; CAA07604.1; JOINED; Genomic_DNA.
DR   EMBL; AJ007690; CAA07604.1; JOINED; Genomic_DNA.
DR   EMBL; AJ007691; CAA07604.1; JOINED; Genomic_DNA.
DR   EMBL; AJ007692; CAA07604.1; JOINED; Genomic_DNA.
DR   EMBL; AJ007693; CAA07604.1; JOINED; Genomic_DNA.
DR   EMBL; AJ007694; CAA07604.1; JOINED; Genomic_DNA.
DR   EMBL; AJ007695; CAA07604.1; JOINED; Genomic_DNA.
DR   EMBL; AJ007696; CAA07604.1; JOINED; Genomic_DNA.
DR   EMBL; AL136621; CAB66556.2; -; mRNA.
DR   EMBL; BX647944; CAH56193.1; -; mRNA.
DR   EMBL; AL137119; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL138688; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471075; EAX08244.1; -; Genomic_DNA.
DR   EMBL; CH471075; EAX08247.1; -; Genomic_DNA.
DR   EMBL; BC036372; AAH36372.1; -; mRNA.
DR   EMBL; AF060181; AAC23591.1; ALT_FRAME; mRNA.
DR   EMBL; AF035374; AAB88464.1; ALT_FRAME; mRNA.
DR   EMBL; AF012126; AAC01561.1; -; mRNA.
DR   CCDS; CCDS45016.1; -. [Q9UBW7-1]
DR   PIR; T45119; T45119.
DR   RefSeq; NP_001177893.1; NM_001190964.2. [Q9UBW7-1]
DR   RefSeq; NP_001177894.1; NM_001190965.2. [Q9UBW7-1]
DR   RefSeq; NP_003444.1; NM_003453.4. [Q9UBW7-1]
DR   RefSeq; NP_932072.1; NM_197968.3. [Q9UBW7-1]
DR   RefSeq; XP_005266577.1; XM_005266520.3. [Q9UBW7-1]
DR   RefSeq; XP_011533526.1; XM_011535224.2.
DR   RefSeq; XP_016876218.1; XM_017020729.1.
DR   BioGrid; 113534; 89.
DR   CORUM; Q9UBW7; -.
DR   IntAct; Q9UBW7; 63.
DR   MINT; Q9UBW7; -.
DR   STRING; 9606.ENSP00000479904; -.
DR   iPTMnet; Q9UBW7; -.
DR   PhosphoSitePlus; Q9UBW7; -.
DR   BioMuta; ZMYM2; -.
DR   DMDM; 17369677; -.
DR   EPD; Q9UBW7; -.
DR   jPOST; Q9UBW7; -.
DR   MassIVE; Q9UBW7; -.
DR   PaxDb; Q9UBW7; -.
DR   PeptideAtlas; Q9UBW7; -.
DR   PRIDE; Q9UBW7; -.
DR   ProteomicsDB; 84085; -. [Q9UBW7-1]
DR   ProteomicsDB; 84086; -. [Q9UBW7-2]
DR   Antibodypedia; 22277; 132 antibodies.
DR   DNASU; 7750; -.
DR   Ensembl; ENST00000382871; ENSP00000372324; ENSG00000121741. [Q9UBW7-1]
DR   Ensembl; ENST00000382874; ENSP00000372327; ENSG00000121741. [Q9UBW7-1]
DR   Ensembl; ENST00000610343; ENSP00000479904; ENSG00000121741. [Q9UBW7-1]
DR   GeneID; 7750; -.
DR   KEGG; hsa:7750; -.
DR   UCSC; uc031zxt.2; human. [Q9UBW7-1]
DR   CTD; 7750; -.
DR   DisGeNET; 7750; -.
DR   GeneCards; ZMYM2; -.
DR   HGNC; HGNC:12989; ZMYM2.
DR   HPA; ENSG00000121741; Low tissue specificity.
DR   MIM; 602221; gene.
DR   neXtProt; NX_Q9UBW7; -.
DR   OpenTargets; ENSG00000121741; -.
DR   PharmGKB; PA37569; -.
DR   eggNOG; ENOG410IE8I; Eukaryota.
DR   eggNOG; ENOG410XQR6; LUCA.
DR   GeneTree; ENSGT00940000157028; -.
DR   HOGENOM; CLU_004099_0_0_1; -.
DR   InParanoid; Q9UBW7; -.
DR   OMA; SWETMEF; -.
DR   OrthoDB; 587724at2759; -.
DR   PhylomeDB; Q9UBW7; -.
DR   TreeFam; TF336988; -.
DR   Reactome; R-HSA-1839117; Signaling by cytosolic FGFR1 fusion mutants.
DR   Reactome; R-HSA-5655302; Signaling by FGFR1 in disease.
DR   ChiTaRS; ZMYM2; human.
DR   GeneWiki; ZMYM2; -.
DR   GenomeRNAi; 7750; -.
DR   Pharos; Q9UBW7; Tbio.
DR   PRO; PR:Q9UBW7; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   RNAct; Q9UBW7; protein.
DR   Bgee; ENSG00000121741; Expressed in kidney and 233 other tissues.
DR   ExpressionAtlas; Q9UBW7; baseline and differential.
DR   Genevisible; Q9UBW7; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0016605; C:PML body; IDA:UniProtKB.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0031624; F:ubiquitin conjugating enzyme binding; IPI:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; NAS:UniProtKB.
DR   GO; GO:0022604; P:regulation of cell morphogenesis; IBA:GO_Central.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   InterPro; IPR021893; DUF3504.
DR   InterPro; IPR011017; TRASH_dom.
DR   InterPro; IPR010507; Znf_MYM.
DR   Pfam; PF12012; DUF3504; 1.
DR   Pfam; PF06467; zf-FCS; 8.
DR   SMART; SM00746; TRASH; 9.
PE   1: Evidence at protein level;
KW   Alternative splicing; Chromosomal rearrangement; Isopeptide bond;
KW   Metal-binding; Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW   Transcription; Transcription regulation; Ubl conjugation; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..1377
FT                   /note="Zinc finger MYM-type protein 2"
FT                   /id="PRO_0000191382"
FT   ZN_FING         352..386
FT                   /note="MYM-type 1"
FT   ZN_FING         398..436
FT                   /note="MYM-type 2"
FT   ZN_FING         445..480
FT                   /note="MYM-type 3"
FT   ZN_FING         491..549
FT                   /note="MYM-type 4"
FT   ZN_FING         559..597
FT                   /note="MYM-type 5"
FT   ZN_FING         605..652
FT                   /note="MYM-type 6"
FT   ZN_FING         660..694
FT                   /note="MYM-type 7"
FT   ZN_FING         701..740
FT                   /note="MYM-type 8"
FT   ZN_FING         747..781
FT                   /note="MYM-type 9"
FT   SITE            913..914
FT                   /note="Breakpoint for translocation to form ZMYM2-FGFR1"
FT   MOD_RES         159
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         305
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163"
FT   MOD_RES         838
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163"
FT   MOD_RES         958
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21406692"
FT   MOD_RES         1064
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9CU65"
FT   MOD_RES         1376
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332"
FT   CROSSLNK        48
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        88
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:25772364,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        98
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:28112733"
FT   CROSSLNK        104
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        147
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        253
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        297
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:25772364, ECO:0000244|PubMed:28112733"
FT   CROSSLNK        312
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        325
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25772364,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        348
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        366
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        417
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        441
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:28112733"
FT   CROSSLNK        491
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        503
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        513
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25755297,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        529
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:25772364,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        532
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:28112733"
FT   CROSSLNK        576
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25772364,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        603
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        649
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        658
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        688
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        700
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25755297,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        709
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        764
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        788
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        812
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        829
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   VAR_SEQ         165..251
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11230166"
FT                   /id="VSP_039065"
FT   VAR_SEQ         529..549
FT                   /note="KYGKLTTCTGCRTQCRFFDMT -> VSRNVNGVQGLNIFEHCYYCH (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11230166"
FT                   /id="VSP_039066"
FT   VAR_SEQ         550..1377
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11230166"
FT                   /id="VSP_039067"
FT   CONFLICT        102
FT                   /note="S -> P (in Ref. 4; CAH56193)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        110
FT                   /note="K -> E (in Ref. 7; AAH36372)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        304
FT                   /note="L -> V (in Ref. 4; CAB66556)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        330
FT                   /note="T -> S (in Ref. 4; CAB66556)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        411..412
FT                   /note="DK -> EQ (in Ref. 1; CAA73875)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        424
FT                   /note="R -> G (in Ref. 4; CAB66556)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        736
FT                   /note="K -> G (in Ref. 1; CAA73875)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        856
FT                   /note="T -> I (in Ref. 7; AAH36372)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        967
FT                   /note="Missing (in Ref. 9; AAB88464)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1009..1010
FT                   /note="DF -> IS (in Ref. 9; AAB88464)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1016
FT                   /note="Missing (in Ref. 9; AAB88464)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1259
FT                   /note="C -> R (in Ref. 7; AAH36372)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1377 AA;  154911 MW;  2652D4C766492FF9 CRC64;
     MDTSSVGGLE LTDQTPVLLG STAMATSLTN VGNSFSGPAN PLVSRSNKFQ NSSVEDDDDV
     VFIEPVQPPP PSVPVVADQR TITFTSSKNE ELQGNDSKIT PSSKELASQK GSVSETIVID
     DEEDMETNQG QEKNSSNFIE RRPPETKNRT NDVDFSTSSF SRSKVNAGMG NSGITTEPDS
     EIQIANVTTL ETGVSSVNDG QLENTDGRDM NLMITHVTSL QNTNLGDVSN GLQSSNFGVN
     IQTYTPSLTS QTKTGVGPFN PGRMNVAGDV FQNGESATHH NPDSWISQSA SFPRNQKQPG
     VDSLSPVASL PKQIFQPSVQ QQPTKPVKVT CANCKKPLQK GQTAYQRKGS AHLFCSTTCL
     SSFSHKPAPK KLCVMCKKDI TTMKGTIVAQ VDSSESFQEF CSTSCLSLYE DKQNPTKGAL
     NKSRCTICGK LTEIRHEVSF KNMTHKLCSD HCFNRYRMAN GLIMNCCEQC GEYLPSKGAG
     NNVLVIDGQQ KRFCCQSCVS EYKQVGSHPS FLKEVRDHMQ DSFLMQPEKY GKLTTCTGCR
     TQCRFFDMTQ CIGPNGYMEP YCSTACMNSH KTKYAKSQSL GIICHFCKRN SLPQYQATMP
     DGKLYNFCNS SCVAKFQALS MQSSPNGQFV APSDIQLKCN YCKNSFCSKP EILEWENKVH
     QFCSKTCSDD YKKLHCIVTY CEYCQEEKTL HETVNFSGVK RPFCSEGCKL LYKQDFARRL
     GLRCVTCNYC SQLCKKGATK ELDGVVRDFC SEDCCKKFQD WYYKAARCDC CKSQGTLKER
     VQWRGEMKHF CDQHCLLRFY CQQNEPNMTT QKGPENLHYD QGCQTSRTKM TGSAPPPSPT
     PNKEMKNKAV LCKPLTMTKA TYCKPHMQTK SCQTDDTWRT EYVPVPIPVP VYIPVPMHMY
     SQNIPVPTTV PVPVPVPVFL PAPLDSSEKI PAAIEELKSK VSSDALDTEL LTMTDMMSED
     EGKTETTNIN SVIIETDIIG SDLLKNSDPE TQSSMPDVPY EPDLDIEIDF PRAAEELDME
     NEFLLPPVFG EEYEEQPRPR SKKKGAKRKA VSGYQSHDDS SDNSECSFPF KYTYGVNAWK
     HWVKTRQLDE DLLVLDELKS SKSVKLKEDL LSHTTAELNY GLAHFVNEIR RPNGENYAPD
     SIYYLCLGIQ EYLCGSNRKD NIFIDPGYQT FEQELNKILR SWQPSILPDG SIFSRVEEDY
     LWRIKQLGSH SPVALLNTLF YFNTKYFGLK TVEQHLRLSF GTVFRHWKKN PLTMENKACL
     RYQVSSLCGT DNEDKITTGK RKHEDDEPVF EQIENTANPS RCPVKMFECY LSKSPQNLNQ
     RMDVFYLQPE CSSSTDSPVW YTSTSLDRNT LENMLVRVLL VKDIYDKDNY ELDEDTD
//
ID   ZN384_HUMAN             Reviewed;         577 AA.
AC   Q8TF68; O15407; Q7Z722; Q8N938;
DT   28-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   22-APR-2020, entry version 164.
DE   RecName: Full=Zinc finger protein 384;
DE   AltName: Full=CAG repeat protein 1;
DE   AltName: Full=CAS-interacting zinc finger protein;
DE   AltName: Full=Nuclear matrix transcription factor 4;
DE            Short=Nuclear matrix protein 4;
DE   AltName: Full=Trinucleotide repeat-containing gene 1 protein;
GN   Name=ZNF384; Synonyms=CAGH1, CIZ, NMP4, TNRC1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RA   Matsuo M.Y.;
RL   Submitted (AUG-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C.,
RA   Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R.,
RA   Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E.,
RA   Song X.-Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y.,
RA   Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G.,
RA   Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H.,
RA   Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S.,
RA   Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M.,
RA   Nguyen B.-V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H.,
RA   Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q.,
RA   Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V.,
RA   Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E.,
RA   Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R.,
RA   David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E.,
RA   D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N.,
RA   Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N.,
RA   Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R.,
RA   Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S.,
RA   LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H.,
RA   Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P.,
RA   Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G.,
RA   Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E.,
RA   Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S.,
RA   Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O.,
RA   Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y.,
RA   Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A.,
RA   Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F.,
RA   Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L.,
RA   Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G.,
RA   Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 395-577 (ISOFORMS 1/2/3).
RC   TISSUE=Brain cortex;
RX   PubMed=9225980; DOI=10.1007/s004390050476;
RA   Margolis R.L., Abraham M.R., Gatchell S.B., Li S.-H., Kidwai A.S.,
RA   Breschel T.S., Stine O.C., Callahan C., McInnis M.G., Ross C.A.;
RT   "cDNAs with long CAG trinucleotide repeats from human brain.";
RL   Hum. Genet. 100:114-122(1997).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-214, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-214, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
CC   -!- FUNCTION: Transcription factor that binds the consensus DNA sequence
CC       [GC]AAAAA. Seems to bind and regulate the promoters of MMP1, MMP3, MMP7
CC       and COL1A1 (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with BCAR1. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=Q8TF68-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8TF68-2; Sequence=VSP_006920;
CC       Name=3;
CC         IsoId=Q8TF68-3; Sequence=VSP_040314, VSP_040315;
CC   -!- SIMILARITY: Belongs to the krueppel C2H2-type zinc-finger protein
CC       family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/ZNF384ID42881ch12p13.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB070238; BAB85125.1; -; Genomic_DNA.
DR   EMBL; AK095734; BAC04618.1; -; mRNA.
DR   EMBL; AC125494; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471116; EAW88756.1; -; Genomic_DNA.
DR   EMBL; BC053361; AAH53361.1; -; mRNA.
DR   EMBL; U80738; AAB91437.1; -; mRNA.
DR   CCDS; CCDS31732.1; -. [Q8TF68-3]
DR   CCDS; CCDS44817.1; -. [Q8TF68-1]
DR   CCDS; CCDS8557.1; -. [Q8TF68-2]
DR   RefSeq; NP_001035009.1; NM_001039920.2. [Q8TF68-3]
DR   RefSeq; NP_001129206.1; NM_001135734.2. [Q8TF68-1]
DR   RefSeq; NP_597733.2; NM_133476.4. [Q8TF68-2]
DR   RefSeq; XP_016874430.1; XM_017018941.1. [Q8TF68-1]
DR   RefSeq; XP_016874431.1; XM_017018942.1. [Q8TF68-1]
DR   RefSeq; XP_016874432.1; XM_017018943.1. [Q8TF68-1]
DR   RefSeq; XP_016874438.1; XM_017018949.1. [Q8TF68-2]
DR   RefSeq; XP_016874439.1; XM_017018950.1. [Q8TF68-2]
DR   BioGrid; 128100; 14.
DR   IntAct; Q8TF68; 5.
DR   STRING; 9606.ENSP00000380019; -.
DR   iPTMnet; Q8TF68; -.
DR   PhosphoSitePlus; Q8TF68; -.
DR   SwissPalm; Q8TF68; -.
DR   BioMuta; ZNF384; -.
DR   DMDM; 296453052; -.
DR   EPD; Q8TF68; -.
DR   jPOST; Q8TF68; -.
DR   MassIVE; Q8TF68; -.
DR   MaxQB; Q8TF68; -.
DR   PaxDb; Q8TF68; -.
DR   PeptideAtlas; Q8TF68; -.
DR   PRIDE; Q8TF68; -.
DR   ProteomicsDB; 74568; -. [Q8TF68-1]
DR   ProteomicsDB; 74569; -. [Q8TF68-2]
DR   ProteomicsDB; 74570; -. [Q8TF68-3]
DR   Antibodypedia; 1314; 189 antibodies.
DR   Ensembl; ENST00000319770; ENSP00000321650; ENSG00000126746. [Q8TF68-2]
DR   Ensembl; ENST00000355772; ENSP00000348018; ENSG00000126746. [Q8TF68-3]
DR   Ensembl; ENST00000361959; ENSP00000354592; ENSG00000126746. [Q8TF68-1]
DR   Ensembl; ENST00000396801; ENSP00000380019; ENSG00000126746. [Q8TF68-1]
DR   GeneID; 171017; -.
DR   KEGG; hsa:171017; -.
DR   UCSC; uc001qqa.4; human. [Q8TF68-1]
DR   CTD; 171017; -.
DR   DisGeNET; 171017; -.
DR   GeneCards; ZNF384; -.
DR   HGNC; HGNC:11955; ZNF384.
DR   HPA; ENSG00000126746; Low tissue specificity.
DR   MIM; 609951; gene.
DR   neXtProt; NX_Q8TF68; -.
DR   OpenTargets; ENSG00000126746; -.
DR   PharmGKB; PA36644; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   eggNOG; COG5048; LUCA.
DR   GeneTree; ENSGT00940000156904; -.
DR   HOGENOM; CLU_028030_0_0_1; -.
DR   InParanoid; Q8TF68; -.
DR   KO; K23480; -.
DR   OMA; PTEKGCS; -.
DR   OrthoDB; 1318335at2759; -.
DR   PhylomeDB; Q8TF68; -.
DR   TreeFam; TF336115; -.
DR   ChiTaRS; ZNF384; human.
DR   GeneWiki; ZNF384; -.
DR   GenomeRNAi; 171017; -.
DR   Pharos; Q8TF68; Tbio.
DR   PRO; PR:Q8TF68; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; Q8TF68; protein.
DR   Bgee; ENSG00000126746; Expressed in testis and 231 other tissues.
DR   ExpressionAtlas; Q8TF68; baseline and differential.
DR   Genevisible; Q8TF68; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   Pfam; PF00096; zf-C2H2; 7.
DR   SMART; SM00355; ZnF_C2H2; 8.
DR   SUPFAM; SSF57667; SSF57667; 5.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 8.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 8.
PE   1: Evidence at protein level;
KW   Alternative splicing; DNA-binding; Metal-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; Transcription; Transcription regulation; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..577
FT                   /note="Zinc finger protein 384"
FT                   /id="PRO_0000047552"
FT   ZN_FING         228..250
FT                   /note="C2H2-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         256..278
FT                   /note="C2H2-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         284..306
FT                   /note="C2H2-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         317..339
FT                   /note="C2H2-type 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         345..367
FT                   /note="C2H2-type 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         373..397
FT                   /note="C2H2-type 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         403..425
FT                   /note="C2H2-type 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         433..455
FT                   /note="C2H2-type 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   COMPBIAS        461..521
FT                   /note="Gln-rich"
FT   COMPBIAS        466..499
FT                   /note="Ala-rich"
FT   MOD_RES         214
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231"
FT   VAR_SEQ         102..156
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_040314"
FT   VAR_SEQ         293..353
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_040315"
FT   VAR_SEQ         300..360
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_006920"
FT   CONFLICT        501
FT                   /note="Missing (in Ref. 1; BAB85125, 2; BAC04618, 4;
FT                   EAW88756, 5; AAH53361 and 6; AAB91437)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   577 AA;  63219 MW;  5899CAB02DBBE0CB CRC64;
     MEESHFNSNP YFWPSIPTVS GQIENTMFIN KMKDQLLPEK GCGLAPPHYP TLLTVPASVS
     LPSGISMDTE SKSDQLTPHS QASVTQNITV VPVPSTGLMT AGVSCSQRWR REGSQSRGPG
     LVITSPSGSL VTTASSAQTF PISAPMIVSA LPPGSQALQV VPDLSKKVAS TLTEEGGGGG
     GGGGSVAPKP PRGRKKKRML ESGLPEMNDP YVLSPEDDDD HQKDGKTYRC RMCSLTFYSK
     SEMQIHSKSH TETKPHKCPH CSKTFANSSY LAQHIRIHSG AKPYSCNFCE KSFRQLSHLQ
     QHTRIHSKMH TETIKPHKCP HCSKTFANTS YLAQHLRIHS GAKPYNCSYC QKAFRQLSHL
     QQHTRIHTGD RPYKCAHPGC EKAFTQLSNL QSHRRQHNKD KPFKCHNCHR AYTDAASLEV
     HLSTHTVKHA KVYTCTICSR AYTSETYLMK HMRKHNPPDL QQQVQAAAAA AAVAQAQAQA
     QAQAQAQAQA QAQAQASQAS QQQQQQQQQQ QQQQQQPPPH FQSPGAAPQG GGGGDSNPNP
     PPQCSFDLTP YKTAEHHKDI CLTVTTSTIQ VEHLASS
//
